<DOC>
<DOCNO>WT01-B18-1</DOCNO>
<DOCOLDNO>IA043-000787-B026-352</DOCOLDNO>
<DOCHDR>
http://www.alternativemedicine.com:80/alternativemedicine/book-definitiveguide_cover.shtml 206.12.188.18 19970305131305 text/html 3296
HTTP/1.0 200 OK
Date: Wed, 05 Mar 1997 13:10:37 GMT
Server: Apache/1.0.5
Content-type: text/html
</DOCHDR>
<!-- This document was created with HomeSite v2.0 Beta 2 -->
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">

<html>
<head>
	<title>Alternative Medicine: You Don't Have to Die</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" leftmargin="0" topmargin="0" link="#B00000" vlink="#B00000" alink="#B00000">

  <a name="top"></a>

<center>
 <table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="#ee0000">
  <tr valign="middle">
   <td align="left" bgcolor="#ee0000"><a href="/alternativemedicine/"><img src="/alternativemedicine/images/navbar_home.gif" width="63" height="20" border="0" alt="[home]"></a><a href="/alternativemedicine/digest/"><img src="/alternativemedicine/images/navbar_interactiveindex.gif" width="135" height="20" border="0" alt="[interactive index]"></a><a href="/alternativemedicine/books.shtml"><img src="/alternativemedicine/images/navbar_books.gif" width="69" height="20" border="0" alt="[books]"></a><a href="/alternativemedicine/subscription.shtml"><img src="/alternativemedicine/images/navbar_subscriptions.gif" width="119" height="20" border="0" alt="[subscriptions]"></a><a href="/alternativemedicine/discussionarea/"><img src="/alternativemedicine/images/navbar_discussion.gif" width="133" height="20" border="0" alt="[discussion area]"></a> <a href="/alternativemedicine/healthcenter/index.shtml"><img src="/alternativemedicine/images/navbar_healthcenter.gif" width="111" height="20" alt="[HealthCenter]" border=0></a></td>
   <td align="left" bgcolor="#ee0000" width="58"><a href="/alternativemedicine/information.shtml"><img src="/alternativemedicine/images/navbar_help.gif" width="50" height="20" border="0" alt="[help]"></a></td>
  </tr>
 </table>
</center>

<br><br>

<center>

<table width="100%" height="100%" border=0 cellpadding= cellspacing=0>

<tr valign=middle>

<td align=center><img src="images/blank.gif" width=1 height="100%" border=0 alt="Blank"></td>

<td align=center><img src="images/definitive_guide_cover.gif" width=600 height=806 border=2 alt="Definitive Guide Cover"></td>

<td align=center><img src="images/blank.gif" width=1 height="100%" border=0 alt="Blank"></td>

</tr>

</table>


</center>


<br><br>


  <table border="0" cellpadding="0" cellspacing="0" width="100%">
   <tr bgcolor="#ee0000">
    <td align="left" valign="middle"><a href="/alternativemedicine/disclaimer.shtml"><img src="/alternativemedicine/images/navbar_disclaimer.gif" width="95" height="20" border="0" alt="Disclaimer"></a></td>

    <td>
     <center>
      <font color="#FFFFFF" face="arial" size="1">
       Alternative Medicine Online &copy; 1996 by <b>Future Medicine Publishing</b>.<br>
       <!-- Web site design and hosting by <b>dotcom marketing corp.</b> (http://www.hdmdigital.com/) -->
      </font>
     </center>
    </td>

    <td align="right" valign="middle"><a href="mailto:info@alternativemedicine.com"><img src="/alternativemedicine/images/navbar_queries.gif" width=76 height=20 border=0 alt="Queries"></a></td>

    <td align="right" valign="middle">
     <a href="#top"><img src="/alternativemedicine/images/top.gif" width="20" height="20" border="0" alt="top"></a>
    </td>
   </tr>
  </table>


</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-2</DOCNO>
<DOCOLDNO>IA043-000787-B026-399</DOCOLDNO>
<DOCHDR>
http://www.alternativemedicine.com:80/alternativemedicine/books-definitiveguide-contents.shtml 206.12.188.18 19970305131554 text/html 10016
HTTP/1.0 200 OK
Date: Wed, 05 Mar 1997 13:13:24 GMT
Server: Apache/1.0.5
Content-type: text/html
</DOCHDR>
<html>
<head>
	<title>Alternative Medicine: The Definitive Guide; Table of Contents</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" leftmargin="0" topmargin="0" link="#B00000" vlink="#B00000" alink="#B00000">

<a name="top"></a>

<center>
 <table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="#ee0000">
  <tr valign="middle">
   <td align="left" bgcolor="#ee0000"><a href="/alternativemedicine/"><img src="/alternativemedicine/images/navbar_home.gif" width="63" height="20" border="0" alt="[home]"></a><a href="/alternativemedicine/digest/"><img src="/alternativemedicine/images/navbar_interactiveindex.gif" width="135" height="20" border="0" alt="[interactive index]"></a><a href="/alternativemedicine/books.shtml"><img src="/alternativemedicine/images/navbar_books.gif" width="69" height="20" border="0" alt="[books]"></a><a href="/alternativemedicine/subscription.shtml"><img src="/alternativemedicine/images/navbar_subscriptions.gif" width="119" height="20" border="0" alt="[subscriptions]"></a><a href="/alternativemedicine/discussionarea/"><img src="/alternativemedicine/images/navbar_discussion.gif" width="133" height="20" border="0" alt="[discussion area]"></a> <a href="/alternativemedicine/healthcenter/index.shtml"><img src="/alternativemedicine/images/navbar_healthcenter.gif" width="111" height="20" alt="[HealthCenter]" border=0></a></td>
   <td align="left" bgcolor="#ee0000" width="58"><a href="/alternativemedicine/information.shtml"><img src="/alternativemedicine/images/navbar_help.gif" width="50" height="20" border="0" alt="[help]"></a></td>
  </tr>
 </table>
</center>

<img src="images/altmedbook.gif" width="150" height="185" border="0" alt="The Definitive Guide" align="right">

<font face="arial" size="3">
 [<a href="book-definitiveguide.shtml"> Return to <b>The Definitive Guide</b></a>]
</font>

<p>


<font face="Arial" size="+3">
 Table of Contents
</font>
<hr size="1" width="50%" align="left">

<p>

<center>
<table width="96%" border="0"><tr>
<td valign="top">

<font face="Arial" size="3"><b>
 Letter to Health Professionals<br>
 Credits<br>
 Editorial Board<br>
 Contributors and Consultants<br>
 Chapter-by-Chapter Listing of Contributors and Consultants<br>
 Why This Book Was Written</b>

 <p>

 <font size="+2" face="Arial">
  Part One: The Future of Medicine
 </font>

 <blockquote>

 A New Understanding of Alternative Medicine<br>
 Medical Freedom and the Politics of Health Care

 </blockquote>

 <p>

 <font size="+2" face="Arial">
  Part Two: Alternative Therapies
 </font>

 <blockquote>

 Acupuncture<br>
 Applied Kinesiology<br>
 Aromatherapy<br>
 Ayurvedic Medicine<br>
 Biofeedback Training<br>
 Biological Dentistry<br>
 Bodywork<br>
 Cell Therapy<br>
 Chelation Therapy<br>
 Chiropractic<br>
 Colon Therapy<br>
 Craniosacral Therapy<br>
 Detoxification Therapy<br>
 Diet<br>
 Energy Medicine<br>
 Environmental Medicine<br>
 Enzyme Therapy<br>
 Fasting<br>
 Flower Remedies<br>
 Guided Imagery<br>
 Herbal Medicine<br>
 Homeopathy<br>
 Hydrotherapy<br>
 Hyperthermia<br>
 Hypnotherapy<br>
 Juice Therapy<br>
 Light Therapy<br>
 Magnetic Field Therapy<br>
 Meditation<br>
 Mind/Body Medicine<br>
 Naturopathic Medicine<br>
 Neural Therapy<br>
 Neruo-Lingusitic Programming<br>
 Nutritional Supplements<br>
 Orthomolecular Medicine<br>
 Osteopathy<br>
 Oxygen Therapy<br>
 Qigon<br>
 Reconstructive Therapy<br>
 Sound Therapy<br>
 Traditional Chinese Medicine<br>
 Veterinary Medicine<br>
 Yoga

 </blockquote>

 <p>

 <font size="+2" face="Arial">
  Part Three: Health Conditions
 </font>

 <blockquote>

 Addictions<br>
 AIDS<br>
 Allergies<br>
 Alzheimer's Disease and Senile Dementia<br>
 Arthritis<br>

 <blockquote>
  Osteoarthritis<br>
  Rheumatoid Arthritis<br>
  Gout<br>
 </blockquote>

 Autism<br>
 Back Pain<br>
 Cancer<br>
 Candidiasis<br>
 Children's Health<br>

 <blockquote>
  Colic<br>
  Stomachache<br>
  Ear Infections<br>
  Strep Throat<br>
  Fever<br>
  Viral and Bacterial Infections<br>
  Measles<br>
  Chickenpox<br>
  Mumps<br>
  Childhood Parasites<br>

  <blockquote>
   Pinworms<br>
   Head Lice<br>
  </blockquote>

  Hyperactivity<br>
 </blockquote>

 Chronic Fatigue Syndrome<br>
 Chronic Pain<br>
 Colds and Flus<br>
 Constipation<br>
 Diabetes<br>

 Female Health
 <blockquote>
  Menstrual Cramps<br>
  Absence of Menstruation (Amenorrhea)<br>
  Excessive Menstruation (Menorrhagia)<br>
  Premenstrual Syndrome (PMS)<br>
  Menopause<br>
  Bladder Infection<br>
  Vaginal Infection<br>
  Uterine Fibroids<br>
  Endometriosis<br>
  Endometrial Cancer<br>
  Ovarian Cysts<br>
  Cervical Cancer<br>
  Ovarian Cancer<br>
  Fibrocystic Breast Disease<br>
 </blockquote>

 Gastrointestinal Disorders<br>
 <blockquote>
  Gastritis<br>
  Colitis & Crohn's Disease<br>
  Irritable Bowel Syndrome<br>
  Ulcers<br>
  Diverticulosis & Diverticulitis<br>
  Diarrhea<br>
  Hemorrhoids<br>
 </blockquote>

 Headaches<br>

 Hearing Disorders<br>
 <blockquote>
  General Ear Pain<br>
  Ear Infection (Otitis Media)<br>
  Meniere's Disease<br>
 </blockquote>
 
 Tinnitus<br>
 <blockquote>
  Hearing Loss<br>
 </blockquote>

 Heart Disease<br>
 Hypertension (High Blood Pressure)<br>

 Male Health<br>
 <blockquote>
  Impotence<br>
  Benign Prostate Hypertrophy<br>
  Prostatitis<br>
  Prostatic Cancer<br>
 </blockquote>

 Mental Health<br>
 Multiple Sclerosis<br>
 Obesity and Weight Management<br>
 Osteoporosis<br>
 Parasitic Infections<br>

 Pregnancy and Childbirth<br>
 <blockquote>
  Preconception<br>
  Pregnancy<br>
  Childbirth<br>
  Post-partum Care<br>
 </blockquote>

 Respiratory Conditions<br>
 <blockquote>
  Hay Fever<br>
  Asthma<br>
  Bronchitis<br>
  Pneumonia<br>
  Sinusitis<br>
  Emphysema<br>
  Lung Cancer<br>
 </blockquote>

 Sexually Transmitted Diseases<br>
 <blockquote>
  Chlamydia<br>
  Gonorrhea<br>
  Syphilis<br>
  Herpes<br>
  Trichomonas<br>
  Genital Warts<br>
  Yeast Infections<br>
 </blockquote>

 Sleep Disorders<br>
 <blockquote>
  Insomnia<br>
  Sleep Apnea<br>
  Periodic Leg Movement Syndrome and Restless Leg Syndrome<br>
 </blockquote>

 Stress<br>

 Vision Disorders<br>
 <blockquote>
  Poor Eyesight<br>
  Cataracts<br>
  Conjunctivitis<br>
  Glaucoma<br>
  Lazy Eye<br>
  Macular Degeneration<br>
  Night Blindness<br>
  Retinal Detachment<br>
  Retinopathy<br>
 </blockquote>
</blockquote>

<p>
</td>
<td valign="top">

<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>


<b>Quick Reference Guide to Additional Health Conditions</b><br>
<blockquote>
 <i>How to Use This Section</i><br>
 Abscess<br>
 Acne<br>
 Ankylosing Spondylitis<br>
 Anorexia Nervosa<br>
 Bad Breath<br>
 Bed Sores<br>
 Bedwetting<br>
 Beriberi<br>
 Blood Clots<br>
 Body Odor<br>
 Boils<br>
 Bruises<br>
 Bulimia<br>
 Bunions<br>
 Burns<br>
 Bursitis<br>
 Cadmium Toxicity<br>
 Canker Sores<br>
 Carbuncles<br>
 Carpal Tunnel Syndrome<br>
 Cellulite<br>
 Cerebral Palsy<br>
 Chemical Poisoning<br>
 Chills<br>
 Cirrhosis<br>
 Cold Sores<br>
 Convulsion<br>
 Corns<br>
 Coughs<br>
 Cuts<br>
 Dandruff<br>
 Dermatitis<br>
 Dizziness<br>
 Dysentery<br>
 Eczema<br>
 Edema<br>
 Epilepsy<br>
 Fainting<br>
 Fear<br>
 Flatulence<br>
 Food Poisoning<br>
 Fractures<br>
 Frostbite<br>
 Fungal Infection<br>
 Gallbladder Disorders<br>
 Hair Loss<br>
 Hangover<br>
 Heavy Metal Toxicity<br>
 Hemorrhoids<br>
 Hepatitis<br>
 Hiatal Hernia<br>
 Hiccups<br>
 Hives<br>
 Hyperthyroidism<br>
 Infection<br>
 Inflammation<br>
 Insect Bites<br>
 Jaundice<br>
 Kidney Stones<br>
 Laryngitis<br>
 Longevity<br>
 Lupus<br>
 Memory and Cognition Problems<br>
 Mononucleosis<br>
 Motion Sickness<br>
 Muscular Cramps<br>
 Nail Problems<br>
 Nausea<br>
 Neuralgia/Neuropathy/Neuritis<br>
 Nose Bleeds<br>
 Pancreatitis<br>
 Paralysis<br>
 Parkinson's Disease<br>
 Pellagra<br>
 Periodontal (Gum) Disease<br>
 Pleurisy<br>
 Poison Oak/Ivy<br>
 Polio<br>
 Pre- and Postoperative<br>
 Psoriasis<br>
 Rashes<br>
 Raynaud's Disease<br>
 Ringworm<br>
 Sciatica<br>
 Shingles<br>
 Sore Throat<br>
 Sports Injuries<br>
 Sprains<br>
 Sties<br>
 Stroke<br>
 Sunburn<br>
 Swelling<br>
 Tendonitis<br>
 Tonsillitis<br>
 Tuberculosis<br>
 Urinary Problems<br>
 Varicose Veins<br>
 Vertigo<br>
 Viral Infections<br>
 Vomiting<br>
 Warts<br>
 Whooping Cough<br>
 Worms<br>
 Wounds<br>
 <i>Consult index for additional references to health conditions.</i>
 </blockquote>

 <p>
 
 <b>Glossary of Medical Terms</b><br>

 Illustrations of Body Systems<br>
 <blockquote>
  The Nervous System<br>
  The Skeletal System<br>
  The Gastrointestinal System<br>
  The Circulatory System<br>
  The Lymphatic System<br>
  The Urinary System<br>
  The Respiratory System<br>
  The Female Reproductive System<br>
  The Male Reproductive System<br>
 </blockquote>

 <p>

 <b>Appendix</b><br>
 <blockquote>
  Antibiotics<br>
  Probiotics<br>
 </blockquote>

 <p>

 <b>Endnotes</b>

 <p>

 <b>Index</b>

</font>
</td>
</tr></table>
</center>

 <p>

   <table border="0" cellpadding="0" cellspacing="0" width="100%">
   <tr bgcolor="#ee0000">
    <td align="left" valign="middle"><a href="/alternativemedicine/disclaimer.shtml"><img src="/alternativemedicine/images/navbar_disclaimer.gif" width="95" height="20" border="0" alt="Disclaimer"></a></td>

    <td>
     <center>
      <font color="#FFFFFF" face="arial" size="1">
       Alternative Medicine Online &copy; 1996 by <b>Future Medicine Publishing</b>.<br>
       <!-- Web site design and hosting by <b>dotcom marketing corp.</b> (http://www.hdmdigital.com/) -->
      </font>
     </center>
    </td>

    <td align="right" valign="middle"><a href="mailto:info@alternativemedicine.com"><img src="/alternativemedicine/images/navbar_queries.gif" width=76 height=20 border=0 alt="Queries"></a></td>

    <td align="right" valign="middle">
     <a href="#top"><img src="/alternativemedicine/images/top.gif" width="20" height="20" border="0" alt="top"></a>
    </td>
   </tr>
  </table>


</body>
</html>

</DOC>
<DOC>
<DOCNO>WT01-B18-3</DOCNO>
<DOCOLDNO>IA043-000787-B026-424</DOCOLDNO>
<DOCHDR>
http://www.alternativemedicine.com:80/alternativemedicine/book-dontdie_cover.shtml 206.12.188.18 19970305131718 text/html 3279
HTTP/1.0 200 OK
Date: Wed, 05 Mar 1997 13:14:48 GMT
Server: Apache/1.0.5
Content-type: text/html
</DOCHDR>
<!-- This document was created with HomeSite v2.0 Beta 2 -->
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<html>
<head>
	<title>Alternative Medicine: You Don't Have to Die</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" leftmargin="0" topmargin="0" link="#B00000" vlink="#B00000" alink="#B00000">

  <a name="top"></a>

<center>
 <table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="#ee0000">
  <tr valign="middle">
   <td align="left" bgcolor="#ee0000"><a href="/alternativemedicine/"><img src="/alternativemedicine/images/navbar_home.gif" width="63" height="20" border="0" alt="[home]"></a><a href="/alternativemedicine/digest/"><img src="/alternativemedicine/images/navbar_interactiveindex.gif" width="135" height="20" border="0" alt="[interactive index]"></a><a href="/alternativemedicine/books.shtml"><img src="/alternativemedicine/images/navbar_books.gif" width="69" height="20" border="0" alt="[books]"></a><a href="/alternativemedicine/subscription.shtml"><img src="/alternativemedicine/images/navbar_subscriptions.gif" width="119" height="20" border="0" alt="[subscriptions]"></a><a href="/alternativemedicine/discussionarea/"><img src="/alternativemedicine/images/navbar_discussion.gif" width="133" height="20" border="0" alt="[discussion area]"></a> <a href="/alternativemedicine/healthcenter/index.shtml"><img src="/alternativemedicine/images/navbar_healthcenter.gif" width="111" height="20" alt="[HealthCenter]" border=0></a></td>
   <td align="left" bgcolor="#ee0000" width="58"><a href="/alternativemedicine/information.shtml"><img src="/alternativemedicine/images/navbar_help.gif" width="50" height="20" border="0" alt="[help]"></a></td>
  </tr>
 </table>
</center>

<br><br>

<center>

<table width="100%" height="100%" border=0 cellpadding= cellspacing=0>

<tr valign=middle>

<td align=center><img src="images/blank.gif" width=1 height="100%" border=0 alt="Blank"></td>

<td align=center><img src="images/you_dont_die_cover.gif" width=389 height=619 border=2 alt="Book Cover"></td>

<td align=center><img src="images/blank.gif" width=1 height="100%" border=0 alt="Blank"></td>

</tr>

</table>


</center>


<br><br>


  <table border="0" cellpadding="0" cellspacing="0" width="100%">
   <tr bgcolor="#ee0000">
    <td align="left" valign="middle"><a href="/alternativemedicine/disclaimer.shtml"><img src="/alternativemedicine/images/navbar_disclaimer.gif" width="95" height="20" border="0" alt="Disclaimer"></a></td>

    <td>
     <center>
      <font color="#FFFFFF" face="arial" size="1">
       Alternative Medicine Online &copy; 1996 by <b>Future Medicine Publishing</b>.<br>
       <!-- Web site design and hosting by <b>dotcom marketing corp.</b> (http://www.hdmdigital.com/) -->
      </font>
     </center>
    </td>

    <td align="right" valign="middle"><a href="mailto:info@alternativemedicine.com"><img src="/alternativemedicine/images/navbar_queries.gif" width=76 height=20 border=0 alt="Queries"></a></td>

    <td align="right" valign="middle">
     <a href="#top"><img src="/alternativemedicine/images/top.gif" width="20" height="20" border="0" alt="top"></a>
    </td>
   </tr>
  </table>


</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-4</DOCNO>
<DOCOLDNO>IA043-000787-B026-474</DOCOLDNO>
<DOCHDR>
http://www.alternativemedicine.com:80/alternativemedicine/homerem_cover.shtml 206.12.188.18 19970305132001 text/html 2958
HTTP/1.0 200 OK
Date: Wed, 05 Mar 1997 13:17:34 GMT
Server: Apache/1.0.5
Content-type: text/html
</DOCHDR>
<!-- This document was created with HomeSite v2.0 Beta 2 -->
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<html>
<head>
        <title>Alternative Medicine: Natural Home Remedies</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" leftmargin="0" topmargin="0" link="#B00000" vlink="#B00000" alink="#B00000">

  <a name="top"></a>

<center>
 <table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="#ee0000">
  <tr valign="middle">
   <td align="left" bgcolor="#ee0000"><a href="/alternativemedicine/"><img src="/alternativemedicine/images/navbar_home.gif" width="63" height="20" border="0" alt="[home]"></a><a href="/alternativemedicine/digest/"><img src="/alternativemedicine/images/navbar_interactiveindex.gif" width="135" height="20" border="0" alt="[interactive index]"></a><a href="/alternativemedicine/books.shtml"><img src="/alternativemedicine/images/navbar_books.gif" width="69" height="20" border="0" alt="[books]"></a><a href="/alternativemedicine/subscription.shtml"><img src="/alternativemedicine/images/navbar_subscriptions.gif" width="119" height="20" border="0" alt="[subscriptions]"></a><a href="/alternativemedicine/discussionarea/"><img src="/alternativemedicine/images/navbar_discussion.gif" width="133" height="20" border="0" alt="[discussion area]"></a></td>
   <td align="left" bgcolor="#ee0000" width="58"><a href="/alternativemedicine/information.shtml"><img src="/alternativemedicine/images/navbar_help.gif" width="50" height="20" border="0" alt="[help]"></a></td>
  </tr>
 </table>
</center>

<br><br>

<center>

<table width="100%" height="100%" border=0 cellpadding= cellspacing=0>

<tr valign=middle>

<td align=center><img src="images/blank.gif" width=1 height="100%" border=0 alt="Blank"></td>

<td align=center><img src="images/home-rem_cover.gif" width=617 height=561 border=0 alt="Home Remedies"></td>

<td align=center><img src="images/blank.gif" width=1 height="100%" border=0 alt="Blank"></td>

</tr>

</table>


</center>


<br><br>


  <table border="0" cellpadding="0" cellspacing="0" width="100%">
   <tr bgcolor="#ee0000">
    <td>
     <center>
      <font color="#FFFFFF" face="arial" size="1">
       Alternative Medicine Online &copy; 1996 by <b>Future Medicine Publishing</b>.<br>
       Web site design and hosting by <b>dotcom marketing corp.</b> (http://www.hdmdigital.com/)
      </font>
     </center>
    </td>

    <td align="right" valign="middle"><a href="mailto:info@alternativemedicine.com"><img src="/alternativemedicine/images/navbar_queries.gif" width=76 height=20 border=0 alt="Queries"></a></td>

    <td align="right" valign="middle">
     <a href="#top"><img src="/alternativemedicine/images/top.gif" width="20" height="20" border="0" alt="top"></a>
    </td>
   </tr>
  </table>


</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-5</DOCNO>
<DOCOLDNO>IA043-000787-B026-525</DOCOLDNO>
<DOCHDR>
http://www.alternativemedicine.com:80/alternativemedicine/yellowpages_cover.shtml 206.12.188.18 19970305132409 text/html 3164
HTTP/1.0 200 OK
Date: Wed, 05 Mar 1997 13:21:42 GMT
Server: Apache/1.0.5
Content-type: text/html
</DOCHDR>
<!-- This document was created with HomeSite v2.0 Beta 3a -->
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">

<HTML>
<HEAD>
	<TITLE>Untitled</TITLE>
</HEAD>

<BODY>
<!-- This document was created with HomeSite v2.0 Beta 2 -->
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">

<html>
<head>
        <title>Alternative Medicine: Yellow Pages</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" leftmargin="0" topmargin="0" link="#B00000" vlink="#B00000" alink="#B00000">

  <a name="top"></a>

<center>
 <table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="#ee0000">
  <tr valign="middle">
   <td align="left" bgcolor="#ee0000"><a href="/alternativemedicine/"><img src="/alternativemedicine/images/navbar_home.gif" width="63" height="20" border="0" alt="[home]"></a><a href="/alternativemedicine/digest/"><img src="/alternativemedicine/images/navbar_interactiveindex.gif" width="135" height="20" border="0" alt="[interactive index]"></a><a href="/alternativemedicine/books.shtml"><img src="/alternativemedicine/images/navbar_books.gif" width="69" height="20" border="0" alt="[books]"></a><a href="/alternativemedicine/subscription.shtml"><img src="/alternativemedicine/images/navbar_subscriptions.gif" width="119" height="20" border="0" alt="[subscriptions]"></a><a href="/alternativemedicine/discussionarea/"><img src="/alternativemedicine/images/navbar_discussion.gif" width="133" height="20" border="0" alt="[discussion area]"></a></td>
   <td align="left" bgcolor="#ee0000" width="58"><a href="/alternativemedicine/information.shtml"><img src="/alternativemedicine/images/navbar_help.gif" width="50" height="20" border="0" alt="[help]"></a></td>
  </tr>
 </table>
</center>

<br><br>

<center>

<table width="100%" height="100%" border=0 cellpadding= cellspacing=0>

<tr valign=middle>

<td align=center><img src="images/blank.gif" width=1 height="100%" border=0 alt="Blank"></td>

<td align=center><img src="images/yellowpagesbook_cover.gif" width=600 height=779 border=2 alt="Yellow Pages Cover"></td>

<td align=center><img src="images/blank.gif" width=1 height="100%" border=0 alt="Blank"></td>

</tr>

</table>


</center>


<br><br>


  <table border="0" cellpadding="0" cellspacing="0" width="100%">
   <tr bgcolor="#ee0000">
    <td>
     <center>
      <font color="#FFFFFF" face="arial" size="1">
       Alternative Medicine Online &copy; 1996 by <b>Future Medicine Publishing</b>.<br>
       Web site design and hosting by <b>dotcom marketing corp.</b> (http://www.hdmdigital.com/)
      </font>
     </center>
    </td>

    <td align="right" valign="middle"><a href="mailto:info@alternativemedicine.com"><img src="/alternativemedicine/images/navbar_queries.gif" width=76 height=20 border=0 alt="Queries"></a></td>

    <td align="right" valign="middle">
     <a href="#top"><img src="/alternativemedicine/images/top.gif" width="20" height="20" border="0" alt="top"></a>
    </td>
   </tr>
  </table>


</body>
</html>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-6</DOCNO>
<DOCOLDNO>IA027-000287-B034-293</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/index.htm 192.138.168.29 19970114015209 text/html 2936
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Tuesday, 14-Jan-97 02:01:35 GMT
Last-modified: Friday, 10-Jan-97 15:03:14 GMT
Content-length: 2746
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Marine Science Institute - University of Texas at Austin
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" BACKGROUND="../../images/chalk.gif">

<CENTER><P><A NAME="top_home"></A><IMG SRC="images/banner.gif" ALT="[UTMSI Banner]" HEIGHT=61 WIDTH=600 ALIGN=BOTTOM>
<IMG SRC="wideshot.gif" ALT="[Visitors Center]" BORDER=3 HEIGHT=198 WIDTH=597></P></CENTER>

<P><I>Department of Marine Science, The University of Texas at Austin,
Marine Science Institute, 750 Channelview Drive, Port Aransas, Texas 78373</I></P>

<P>Our web pages contain many color photographs intended to give you a
flavor of the Marine Science Institute. You may wish to disable the image
autoload feature of your browser for faster viewing.</P>

<P><I>Last updated: January 10, 1997 by Lee A. Fuiman and Scott A. Holt</I>
<HR>
<CENTER><A HREF="mainmap.map"><IMG ISMAP SRC="mainmap.gif" HEIGHT=44 WIDTH=522></A></CENTER></P>

<P><B><FONT FACE="Brush Script MT"><FONT COLOR="#FF0000"><FONT SIZE=+3><A HREF="current/whatnew.htm">What's
New</A></FONT></FONT></FONT></B> on the UTMSI Web Site</P>

<DL>
<DT><A HREF="academic/acadmain.htm"><FONT SIZE="+2" COLOR="Red">Academic Programs</FONT></A> </DT>

<DD>Description of graduate, undergraduate, and summer programs at MSI</DD>
<DD><B>Online application for summer program at MSI</B></DD>

<DT><A HREF="staff/pers1995.htm"><FONT SIZE="+2" COLOR="Red">Faculty and Staff</FONT></A> </DT>

<DD>Research, academic, and administrative staff </DD>

<DT><A HREF="mes/mesdesc.htm"><FONT SIZE="+2" COLOR="Red">Marine Education Services</FONT></A> </DT>

<DD>Public outreach programs for K-12, teacher training, Mustang Island
Elderhostel </DD>

<DT><A HREF="geninfo.htm"><FONT SIZE="+2" COLOR="Red">General Information</FONT></A> </DT>

<DD>An introduction to the Institute, its history, physical facilities,
research programs, boats, and outreach activities </DD>

<DT><A HREF="current/currmain.htm"><FONT SIZE="+2" COLOR="Red">Current Events and Activities</FONT></A> </DT>

<DD>Boy Scouts' Oceanography Day, 50 Year Celebration, recent research
results and ongoing projects, seminars, R/V Longhorn and R/V Katy schedule,
tide predictions, and current activities at MSI </DD>

<DT><A HREF="hornspec.htm"><FONT SIZE="+2" COLOR="Red">Ships - <I>R/V LONGHORN </I></FONT></A><A HREF="katy.htm"><FONT SIZE="+2" COLOR="Red">and <I>R/V KATY</I> </FONT></A></DT>

<DD>Information and specifications
</DD>
</DL>
<HR>
<I>Send comments about this site to <A HREF="mailto:sholt@utmsi.zo.utexas.edu">Scott
Holt</A></I>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-7</DOCNO>
<DOCOLDNO>IA026-000281-B008-98</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/mainmap.map 192.138.168.29 19970113200640 text/html 321
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:16:00 GMT
Content-type: text/html
Content-length: 180
</DOCHDR>
<TITLE>Imagemap Error</TITLE><H1>Imagemap Error</H1>Your client did not send any coordinates. Either your client doesn't support imagemap or the map file was not accessed as a map.
</DOC>
<DOC>
<DOCNO>WT01-B18-8</DOCNO>
<DOCOLDNO>IA026-000281-B008-153</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/whatnew.htm 192.138.168.29 19970113200753 text/html 4330
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:18:33 GMT
Last-modified: Friday, 10-Jan-97 15:03:02 GMT
Content-length: 4141
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE> What's New UTMSI </TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P>

<CENTER>
</P><B><FONT SIZE="+3" COLOR="Red">What's New on the UTMSI Web Site</FONT></FONT></B> 
</CENTER>

<HR>

<P>
</P>Cruise schedules for the <A href="longhorn.htm">R/V Longhorn</A>
and <A href="katyschd.htm">R/V Katy</A> as well as the <A href="seminars.htm">Seminar Schedule</A>
are updated regularly. <BR>
<BR>
These other new items were added or changed on the web site in:</P>

<H3>January 1997</H3>
<UL>
<LI>Tony Amos has provided summaries of his <A HREF="../staff/afamos/weather.htm">weather data</A> for Port Aransas for the the eleven years from 1986 to 1996.   
<LI>Students can now apply for the 1997 Summer Program at MSI using our <A HREF="../forms/register.htm">electronic application</A>.
</UL>
<H3>December 1996</H3>
<UL>
<LI>The 1997 version of <A href="../CURRENT/OCEAN.htm">Oceanography Day </A> for area Boy Scouts will again be sponsored by the Marine Science Institute.  All the info is here.</I>
<LI>Tony Amos' monthly <A href="tides.htm">tide tables</A> (images, approx. 200 Kbytes each) were update for 1997. 
<LI>Summary descriptions of recent and ongoing research projects of the <A HREF="../mfrp/mfrpproj.htm">Marine Fish Reserach Program</A> were posted.
</UL>

<H3>October 1996</H3>

<UL>
<LI><A href="../STAFF/AFAMOS/TS-JOS96.htm">Tropical Storm Josephine</A> brings damaging tides to the South Texas coast.  Tony Amos explains October's bad tidings.</I>
</UL>


<H3>September 1996</H3>

<UL>
<LI><A href="../IMAGES/tony-trt.jpg">Tony Amos'</A> efforts to
rehabilitate injured sea turtles make headlines. (newspaper article
scanned courtesy of the <I>Corpus Christi Caller-Times</I> [622
Kb]). 
<LI>Text of the <A HREF="http://www.texasmonthly.com/archive/tex20/amos.html">Texas Monthly</A>
story on Tony Amos
</UL>

<H3>August 1996</H3>

<UL>
<LI><A href="../staff/afamos/amosfame.htm">Tony Amos</A>, one of <I>Texas Monthly</I>'s
Top 20 Texans. 
<LI><A href="50years/openhous.htm">Aftermath of the Open House</A>,
complete with <A href="50years/phototour.htm">photos</A> published
in the <I>South Jetty</I> newspaper, has been added to the Current
Events page. 
<LI>Color photographs of most of our <A href="../staff/pers1995.htm">faculty</A>
have replaced the black and white photos. 
</UL>

<H3>April 1996</H3>

<UL>
<LI>Details on upcoming events for the <A href="50years/openhous.htm">50 Year Celebration</A>,
including the Open House on May 25th. 
<LI>Direct access to <A href="http://www.utexas.edu/student/registrar/aboutscheds.html">Course Schedules</A>
for all courses in the upcoming semesters at The University of
Texas at Austin, including the Department of Marine Science and
classes in Port Aransas, has been added to the page that describes
Marine Science graduate courses. 
</UL>

<H3>March 1996</H3>

<UL>
<LI>Description of <A href="/academic/reuprog.htm">Research Experience for Undergraduates (REU) program</A>,
complete with application materials, was added to Academic Programs.

<LI>Tony Amos' monthly <A href="tides.htm">tide tables</A> for
1996 (images, approx. 200 Kbytes each) were enlarged. 
</UL>

<H3>January 1996</H3>

<UL>
<LI>Tony Amos' monthly <A href="tides.htm">tide tables</A> for
1996 (images, approx. 200 Kbytes each) were added to &quot;Current
Events and Activities&quot; 
<LI>A <A href="../images/hornflpl.gif">perspective layout image</A>
(203 Kbytes) of the <I>R/V LONGHORN </I>was added to &quot;Description
of R/V Longhorn&quot; (ship's specifications). 
<LI>The University of Texas at Austin searchable<B> </B>directory
of <A href="../msidir.htm">Faculty, Staff, and Students </A>was
added to the home page. 
</UL>

<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
<HR>

<P>
</P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-9</DOCNO>
<DOCOLDNO>IA026-000281-B009-64</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/academic/acadmain.htm 192.138.168.29 19970113201054 text/html 1345
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:21:43 GMT
Last-modified: Monday, 06-Jan-97 18:03:30 GMT
Content-length: 1156
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Academic Program - Department of Marine Science</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="../../images/chalk.gif" bgcolor="#FFFFFF" text="#000000" >

<H1 ALIGN=CENTER>Academic Programs</H1>

<CENTER><P><A HREF="../mainmap.map"><IMG ISMAP SRC="../images/mainmap.gif" HEIGHT=44 WIDTH=522></A>

<HR><IMG SRC="../images/educate1.gif" ALT="[Students on the R/V Longhorn]" BORDER=3 HEIGHT=314 WIDTH=444 ALIGN=BOTTOM>
</P></CENTER>

<UL>
<LI><A HREF="gradprog.htm">Graduate Program</A> </LI>

<LI>Undergraduate Program </LI>

<UL>
<LI><A HREF="summer97.htm#top">1997 Summer Courses</A> </LI>
<LI><A HREF="../forms/register.htm">Online Application for 1997 Summer Courses</A> </LI>
</UL>

<LI><A HREF="reuprog.htm">Research Experiences for Undergraduates</A> </LI>
</UL>

<P>
<HR></P>

<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE=5 BORDER=1 HEIGHT=75 WIDTH=225 ALIGN=ABSCENTER><A HREF="../../index.htm">Return
to MSI Home Page </A></P>

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-10</DOCNO>
<DOCOLDNO>IA026-000281-B009-131</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/pers1995.htm 192.138.168.29 19970113201133 text/html 11771
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:22:16 GMT
Last-modified: Monday, 18-Nov-96 16:52:52 GMT
Content-length: 11581
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE> Personnel Listing - UTMSI -</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<H1>
<CENTER>
<STRONG>Personnel<BR>
<A HREF="../mainmap.map"><IMG SRC="../images/mainmap.gif" ISMAP
USEMAP="../maimmap.htm#mainmap"></A></STRONG>
</CENTER>
</H1>

<HR>

<UL>
<LI><A HREF="#research">RESEARCH </A>
<LI><A HREF="#administration">ADMINISTRATION</A> 
<LI><A HREF="#faculty">DEPARTMENT OF MARINE SCIENCE</A>
<LI><A HREF="../msidir.htm">CONTACT INFORMATION (via SEARCHABLE
DATABASE)</A>
</UL>

<HR>

<H2><A NAME="research">RESEARCH</A></H2>

<P>
Listings for Fall 1996 (# Department of Marine Science Faculty,
* Student; **Part Time/Temporary)
<H3><A HREF="afamos.htm">Anthony F. Amos</A>, Research
Associate </H3>

<H4>PHYSICAL OCEANOGRAPHY, INSTRUMENTATION</H4>

<UL>
<LI>     Andrea R. Wickham, Laboratory Research Assistant IV, student, and antarctic explorer
extrodinare
</UL>

<H3>#<A HREF="arnold.htm">Connie R. Arnold</A>, Ph.D., Associate
Director Mariculture &amp; Senior Research Scientist</H3>

<P>
<I><B>MARICULTURE-FINFISH</B></I>
<UL>
<LI>   D. Allen Davis, Ph.D., Research Associate 
<LI>   Scott A. Holt, M.S., Research Associate 
<LI>  *Juan Pablo Lazo, M.S., Graduate Research Assistant
<LI>  *Eric S. Thoman, B.A., Teaching Assistant (UT-Austin)
<LI>   Maotang Li, B.S., Research Scientist Assistant
<LI>   Cameron M. Pratt, B.S., Laboratory Research Assistant IV
<LI> **Kathy F. Binney, B.S., Laboratory Research Assistant IV
<LI>   Janie Munoz, Laboratory Research Assistant III
<LI> **Dana J. Allen, Laboratory Research Assistant II
<LI> **Wm. Lyle Johnston, Laboratory Research Assistant I
</UL>

<H3>#<A HREF="benner.htm">Ronald H. Benner</A>, Ph.D., Research
Scientist </H3>

<P>
<I><B>MICROBIAL ECOLOGY</B></I>
<UL>
<LI>   Steven P. Opsahl, Ph.D., Postdoctoral Fellow
<LI>   Bopaiah A. Biddanda, Ph.D., Research Scientist Associate
I
<LI>  *Edith Kaiser, M.A., Teaching Assistant (UT-Austin)
<LI>  *Susan E. Ziegler, B.S., Fellowship
<LI>  *Andrew P. Biersmith, B.S., Graduate Research Assistant
<LI>  *Daniel Lara, B.S., Fellowship
<LI>   Brenda L. Black, B.S., Research Scientist Assistant
<LI>   Beau Hardegree, B.S., Research Scientist Assistant
</UL>

<H3>#<A HREF="buskey.htm">Edward J. Buskey</A>, Ph.D., Research
Scientist </H3>

<P>
<I><B>MARINE ZOOPLANKTON ECOLOGY</B></I>
<UL>
<LI>  *Scott E. Stewart, M.A., Graduate Research Assistant
<LI>  *Christopher J. Collumb, M.S., Graduate Research Assistant
<LI>  *Tracey McDonnell, B.A., Graduate Research Assistant
</UL>

<H3>#<A HREF="dunton.htm">Kenneth H. Dunton</A>, Ph.D., Research
Scientist </H3>

<P>
<I><B>SEAGRASS &amp; MACROALGAE BIOLOGY AND ECOLOGY</B></I>
<UL>
<LI>   Kelly M. Machalek, Ph.D., Postdoctoral Fellow
<LI>   Susan V. Schonberg, M.S., Research Scientist Associate
I
<LI>  *James E. Kaldy, M.S., Graduate Research Assistant
<LI>  *Kun-Seop Lee, M.A., Graduate Research Assistant
<LI>  *Christine Weilhoefer, B.S., Graduate Research Assistant
<LI>  *Harlan L. Miller, B.S., Graduate Research Assistant (UT-Austin)
<LI> **Joseph Kowalski, B.S., Research Scientist Assistant
<LI> **Carina Chiscano, B.S., Research Scientist Assistant
<LI> **Heather Alexander, Laboratory Research Assistant II
<LI> **Kimberly R. Jackson, Laboratory Research Assistant I
</UL>

<H3>#<A HREF="fuiman.htm">Lee A. Fuiman</A>, Ph.D., Research Scientist
</H3>

<P>
<I><B>FISH BIOLOGY</B></I>
<UL>
<LI>  *Michael E. Smith, M.A., Teaching Assistant (UT-Austin)
<LI>  *Kirsten R. Poling, B.S., Fellowship
<LI>  *Cynthia K. Faulk, B.S., Graduate Research Assistant
<LI> **Brendan C. Delbos, Laboratory Research Assistant II
</UL>

<H3>#<A HREF="gardner.htm">Wayne S. Gardner</A>, Ph.D., Director & Chairman
</H3>

<H3>#<A HREF="holt.htm">G. Joan Holt</A>, Ph.D., Research Scientist
</H3>

<P>
<I><B>MARICULTURE-LARVAL FISH STUDIES</B></I>
<P>
<UL>
<LI>  *Jay Rooker, M.S., Graduate Research Assistant
<LI>  *Sharon Herzka, M.A., Teaching Assistant (UT-Austin)
<LI>  *A. Claire Fernandez, B.S., Graduate Research Assistant

<LI> **Andy Soto, B.S., Research Scientist Assistant
<LI>   Patricia L. Pickering, B.S., Laboratory Research Assistant
IV
</UL>

<H3>#<A HREF="ingall.htm">Ellery D. Ingall</A>, Ph.D., Research
Scientist </H3>

<P>
<I><B>MARINE GEOCHEMISTRY, SEDIMENT CHEMISTRY</B></I>
<UL>
<LI>  *Lauren L. Clark, B.S., Graduate Research Assistant 
</UL>

<H3>#<A HREF="montagna.htm">Paul A. Montagna</A>, Ph.D., Research
Scientist </H3>

<P>
<I><B>BENTHIC ECOLOGY</B></I>
<UL>
<LI>   Richard D. Kalke, M.A., Research Scientist Associate III
<LI>  *M. Christine Ritter, M.S., Graduate Research Assistant
<LI>  *Gregory T. Street, B.A., Fellowship
<LI>  *Robert Burgess, B.A. (UT-Austin)
<LI> **Carrol A. Simanek, Laboratory Research Assistant II
</UL>

<H3>#<A HREF="thomas.htm">Peter Thomas</A>, Ph.D., Senior Research
Scientist </H3>

<P>
<I><B>MARINE TOXICOLOGY &amp; REPRODUCTIVE PHYSIOLOGY</B></I>
<UL>
<LI>   Yong Zhu, Ph.D., Research Scientist Associate I   
<LI>   Izhar A. Khan, Ph.D., Research Scientist Associate I
<LI>   Diane E. Breckenridge, M.S., Research Scientist Associate
I
<LI>  *Karen G. Rogowski, M.S., Graduate Research Assistant
<LI>  *Todd S. Sperry, B.A., Graduate Research Assistant
<LI>  *Charles D. Detweiler, B.S., Graduate Research Assistant
  
<LI>  *Mary Beth Hawkins, B.S., Graduate Research Assistant
<LI>  *Alyssa M. Dotte, B.S., Teaching Assistant (UT-Austin)
<LI>  *Katrina Loomis, B.S., Graduate Research Assistant
<LI>   William E. Beasley, Jr., B.F.A., Laboratory Research Assistant
IV
<LI>   Woodie R. Lawson, Laboratory Research Assistant II
</UL>

<P>
USFWS COOPERATIVE MARINE TOXICOLOGY FIELD UNIT
<UL>
<LI>Scott Carr, Ph.D., Unit Leader 
<LI>Jim Biedenbach, M.B.A.
</UL>

<H3>#<A HREF="whitledg.htm">Terry E. Whitledge</A>, Ph.D., Senior
Research Scientist </H3>

<P>
<I><B>MARINE NUTRIENT CHEMISTRY</B></I> 
<UL>
<LI>   Dean A. Stockwell, Ph.D., Research Associate
<LI>  *Gretchen Westrick, B.S., Teaching Assistant (UT-Austin)
<LI> **Marylynn I. Tinnin, B.S., Research Scientist Assistant
</UL>

<P>
<U><B>U.T. Austin Students</B></U> (in residence at Port Aransas,
Major Professor at Austin/Co-Supervisor at MSI) 
<UL>
<LI> Mary Beth Hawkins, B.S. (Division of Biological Sciences/Peter
Thomas, Supervisor)
<LI> Anna Katrina Loomis, B.S. (Zoology Department/Peter Thomas,
Supervisor)
<LI> Karen G. Rogowski, M.S. (Zoology Department/Peter Thomas,
Supervisor)
</UL>

<P>
<U><B>Visiting Scientists</B></U> 
<UL>
<LI>Greta A. Fryxell, Ph.D., Adjunct Professor, Department of
Botany, The University of Texas at Austin; Professor Emeritus,
Texas A&amp;M University.
</UL>

<HR>

<H2><A NAME="administration">ADMINISTRATION</A></H2>

<P>
(# Department of Marine Science Faculty * Student; **Part Time/Temporary)
<P>
#<STRONG>Wayne S. Gardner</STRONG>, Ph.D., Professor, Director, Chairman
<P>
<STRONG>John H. Thompson</STRONG>, B.B.A., Associate Director
Administration 
<P>
<U>Secretarial Office</U>
<UL>
<LI>Kathleen F. Quade, Administrative Associate 
<LI>Patricia S. Webb, Technical Secretary 
<LI>Carole A. Martindale, Senior Office Assistant, FAML
</UL>

<P>
<U>Personnel/Benefits Office</U>
<UL>
<LI>JoAnn S. Page, Administrative Associate
</UL>

<P>
<U>Fiscal Office</U>
<UL>
<LI>Lynn M. Amos, Executive Assistant 
<LI>Victoria W. Roberson, Accounting Clerk III 
<LI>Faye L. Smith, Accounting Clerk III
<LI>Dwanna K. Hamer, Accounting Clerk I
<LI>Barbara G. Howard, Stores Clerk III
<LI>Sandra Birdwell, Office Assistant
</UL>

<P>
<U>Office of Marine Education Services</U>
<UL>
<LI>Richard K. Tinnin, M.S., Research Associate 
<LI>Maureen L. Terry, M.E., Training Specialist II 
<LI>Robert V. Huntington, B.S., Research Scientist Assistant
<LI>Linda T. Fuiman, Office Assistant
</UL>

<P>
<U>Library</U>
<UL>
<LI>Ruth L. Grundy, B.S., M.L.S., Marine Science Librarian 
<LI>Tommye J. Adams, B.S., Library Assistant II 
</UL>

<P>

<P>
<U>Boat Operations</U>
<UL>
<LI>Noe T. Cantu, Boat Operations Supervisor 
<LI>John J. Turany, Boat Captain (R/V KATY) 
<LI>Hayden B. Abel, Boat Captain
<LI>Charles C. Rowe, Marine Technician
<LI>Mark W. McGarity, Mate 
<LI>Randy J. Pritchard, Mate
<LI>**Wm. Frank Walker, Cook
</UL>

<P>
<U>Maintenance</U>
<P>
John S. Shaw, Mechanic/Technician Supervisor
<P>
<U>Mechanical Section</U>
<UL>
<LI>Michael A. McGill, Plumber 
<LI>J. Charles Hutchins, Plant Maintenance Mechanic 
<LI>William E. Piepmeier, Refrigeration Mechanic
<LI>John L. Shedd, Electrician 
<LI>Veril D. Barr, Maintenance Worker II
</UL>

<P>
<U>Carpentry &amp; Painting Section</U>
<UL>
<LI>Michael W. Horn, Carpenter 
<LI>Charles L. Pearson, Carpenter 
<LI>Ollie T. Bandy, Painter
</UL>

<P>
<U>Support Section</U>
<UL>
<LI>Wyatt M. Harris, Storekeeper
<LI>Thomas Proietti, Jr., Building Attendant II
</UL>

<P>
<U>Grounds</U>
<UL>
<LI>Michael H.F. Gibson, Grounds Maintenance Leader
<LI>Amador M. Guajardo, Gardener 
<LI>David D. Hernandez, Maintenance Worker II
<LI>Benny Rodriguez, Gardener
</UL>

<P>
<U>Custodial</U>
<UL>
<LI>Dolores Villarreal, Building Attendant Leader 
<LI>Norma I. Otero, Assistant Building Attendant Leader 
<LI>Josephine R. Juarez, Building Attendant II
<LI>Elsa S. Benavides, Building Attendant II 
<LI>Maria L. Selvera, Building Attendant II
<LI>Patricia A. Lamas, Building Attendant II
</UL>

<P>
<U>Cafeteria</U>
<UL>
<LI>Antonia M. Longoria, Cook 
<LI>**Anita Mireles, Cook
</UL>

<P>
<U>Security</U>
<UL>
<LI>Adolphus J. Aldridge, Building Monitor 
<LI>Melvin E. Ervin, Guard, University Police 
<LI>Russel L. VanSchuyver, Guard, University Police
<LI>**Robert Johnson, Guard, University Police
</UL>

<HR>

<H2><A NAME="faculty">DEPARTMENT OF MARINE SCIENCE - </A>Spring
1996</H2>

<P>
<STRONG>Wayne S. Gardner</STRONG>, Ph.D., Professor & Chairman

<UL>
<LI><A HREF="arnold.htm">Connie R. Arnold</A>, Ph.D., Professor

<LI><A HREF="behrens.htm">E. William Behrens</A>, Ph.D., Associate
Professor
<LI><A HREF="benner.htm">Ronald H. Benner</A>, Ph.D., Associate
Professor 
<LI><A HREF="buskey.htm">Edward J. Buskey</A>, Ph.D., Associate
Professor 
<LI><A HREF="dunton.htm">Kenneth H. Dunton</A>, Ph.D., Assistant
Professor
<LI><A HREF="fuiman.htm">Lee A. Fuiman</A>, Ph.D., Associate Professor

<LI><A HREF="gardner.htm">Wayne S. Gardner</A>, Ph.D., Professor

<LI><A HREF="holt.htm">G. Joan Holt</A>, Ph.D., Associate Professor

<LI><A HREF="ingall.htm">Ellery D. Ingall</A>, Ph.D., Assistant
Professor
<LI><A HREF="maguire.htm">Bassett Maguire</A>, Ph.D. Professor

<LI><A HREF="montagna.htm">Paul A. Montagna</A>, Ph.D., Associate
Professor 
<LI>J. A. Colin Nicol, Ph.D., Professor Emeritus 
<LI>Carl H. Oppenheimer, Ph.D., Professor Emeritus 
<LI>Patrick L. Parker, Ph.D., Professor Emeritus 
<LI><A HREF="thomas.htm">Peter Thomas</A>, Ph.D., Professor 
<LI><A HREF="whitledg.htm">Terry E. Whitledge</A>, Ph.D., Professor

<LI>D. E. Wohlschlag, Ph.D., Professor Emeritus 
</UL>

<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-11</DOCNO>
<DOCOLDNO>IA026-000281-B009-239</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/mes/mesdesc.htm 192.138.168.29 19970113201306 text/html 12871
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:22:40 GMT
Last-modified: Monday, 25-Nov-96 16:31:32 GMT
Content-length: 12681
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Marine Education Services at UTMSI</TITLE>


</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<HR>

<H1>
<CENTER>
<STRONG>Marine Education Services</STRONG>
</CENTER>
</H1>

<CENTER>
<A HREF="../mainmap.map"><IMG SRC="../images/mainmap.gif" ISMAP USEMAP="../maimmap.htm#mainmap"></A>
</CENTER>

<HR>

<H2>
<CENTER>
<IMG SRC="../images/outrech1.gif" ALIGN="BOTTOM" BORDER=3>
</CENTER>
</H2>

<H3><A HREF="#visclass">Visiting Class Program</A></H3>

<H3><A HREF="#visitorctr">Visitor's Center</A></H3>

<H3><A HREF="#teacherwkshp">Teacher Workshops</A></H3>

<UL>
<LI><A HREF="wrkshp96.htm">1996 Spring Workshops</A>
</UL>

<H3><A HREF="#elderhostel">Mustang Island Elderhostel</A></H3>

<HR>

<H3><A NAME="visclass">Visiting Class Program</A></H3>

<P>
Each year for the past 22 years, a visiting class program has
hosted an average of 350 junior high, high school and college
science class groups (averaging over 10,000 students each year).
The majority of the classes come from all over Texas, but groups
also come from surrounding states such as Arkansas, Oklahoma,
Kansas, Missouri and Colorado. 
<P>
UTMSI is ideally located to allow easy access to a variety of
marine-influenced environments including the Aransas Pass channel,
an extensive bay and estuarine system, the hypersaline Laguna
Madre, and the Gulf of Mexico. Both temperate and tropical flora
and fauna can be found on the broad continental shelf, on surfswept
sand beaches and barrier islands, in sand and mudbottomed bays,
seagrass meadows, mangrove islands, oyster reefs and rock jetties.
 Facilities available for visiting class use include airconditioned
dormitories, a pier lab and access to the research vessels.
<H3><A NAME="visitorctr">Visitor's Center </A></H3>

<P>
Interest in marine science is also promoted by the Visitor Center,
open Monday through Friday from 8 a.m. to 5 p.m. Seven aquaria
show typical Texas coastal habitats and the organisms that live
in them, including Spartinablack mangrove marsh, oyster reef,
open bay bottom, rockjetty and offshore artificial reefs. Films
and video presentations are regularly shown in the auditorium
to groups of visitors.  Other displays in the main building highlight
current and past research projects and feature representative
specimens or photographs of local plants and animals. Over 40,000
visitors have toured the facility annually.  Group tours are available
if a request is made in writing at least two weeks before the
desired date. Tour groups are limited to 30 people unless special
permission is obtained.
<H3><A NAME="teacherwkshp">Teacher Workshops</A></H3>

<P>
The third major activity of the MES program involves the development
of a series of weekend teacher workshops. These are aimed at upgrading
the proficiency of classroom teachers at all levels by the introduction
of marine science topics and techniques into the curriculum of
all subjects, from science to art and history. Students of all
ages are fascinated by the oceans and once you have focused their
attention, whether it is on an aquarium, a shell or a photo of
earth from space, you can teach almost any subject using marine
science as the medium. Getting the student's attention and making
the subject exciting is half the battle in classroom education
today. By participating in the weekend workshops teachers will
gain practical experience with shipboard collecting gear, as well
as exposure to current research problems and methods and techniques
used by researchers to gain a better understanding of the marine
environment. The teachers will then be able to transfer to their
students the knowledge and experience gained through workshop
participation, thus enabling them to become more effective educators.

<P>
Workshop topics this year will feature Coastal Birds, Marine Aquariums
and WHALENET: An Internet computer workshop, as well as a variety
of field trip experiences.  The Coastal Studies Laboratory workshops
last all day Saturday and the UTMSI workshops last all day Saturday
with an evening lab and end at noon on Sunday.  There is a complete
listing of the workshops offered this year in the brochure.
<H3><A NAME="elderhostel">Mustang Island Elderhostel</A></H3>

<P>
In 1993, Marine Education Services assumed sponsorship of the Mustang Island ELDERHOSTEL Program, formerly sponsored by the Community Presbyterian Church.  Rick Tinnin is the program director and Judy Reynolds is the on-site coordinator.  The program has since grown into an ELDERHOSTEL Super-Site, sponsoring 23 programs each year.
<p>
ELDERHOSTEL programs are open to anyone over 55 and typically run 6 days and 5 nights, beginning on Sunday.  We run 18 programs out of Beachhead Condominiums, including three intergenerational programs in the summer.  Roland and Pat Boulanger are gracious hosts, providing office space and use of their large meeting room.  Most programs host 44 participants and a host couple who stay at the condo and serve as a valuable part of the program staff.  We also run two intensive studies and two service programs, housing the participants on campus in the dorms.  These programs host 24 participants and a host couple.
<p>
Fifteen of the regular programs and a Rockport program focus on coastal marine habitats, specifically Whooping Cranes and other winter and spring migrants.  Typical activities include a research cruise aboard the R/V KATY, scavenger hunts on the beach, a bus and walking tour of the Aransas National Wildlife Refuge and a Whooping Crane boat trip, trips to the Texas State Aquarium and the Los Barcos and Treasure Ship exhibits at the Corpus Christi Museum.
<p>
The three intergenerational programs host 20 grandparents who can each bring one grandchild between 10-13 years old.  The programs are active and fun and provide an opportunity for the grandparents to spend good quality time with their grandchildren.  This program includes beach and marsh field trips, a KATY trip, and trips to San Jose Island, the Texas State Aquarium, Los Barcos and the LEXINGTON.  MES staff provide field trip naturalist expertise and educational programs and tours are scheduled at the other sites.  A hot dog cookout on the beach one evening is a real hit with this group.
<p>
The Intensive Studies programs have an entirely different focus from the regular programs.  There are only 24 participants and they are housed on-site in the dorms.  These programs focus on a single theme for the week and participants are required to complete a project of their choice which might be a research paper or report, a presentation to the group on some aspect of the week's work, art work, a collection of some sort, etc.  Participants are sent a reading list and reference articles that they are expected to review before they come to the program so they will be better prepared to focus on the topic that is presented.  These programs provide a more in-depth educational experience with specific demands being made of the participants.  We host the ONLY marine, intensive studies program in the United States.  The two programs this year include Preserving Texas Coastal Habitats  in February '97 and Songbirds On The Move: Migration on the Texas Coast in April '97.  The February program focuses on endangered species of the area, specifically Whooping Cranes, Piping Plovers and other threatened migrants, their habitat and man's impact on it.  The April program, offered for the first time, will focus on spring migrants from the Gulf Beach to inland sites at the Aransas National Wildlife Refuge and on the King Ranch.
<p>
In October, we will launch a new program - two service Projects on Shamrock Island in cooperation with the Texas Nature Conservancy (TNC).  The TNC purchased Shamrock Island, a 110 acre shell and sand island sheltered behind Mustang Island, which is an important bird rookery for the area, home of hundreds of Roseate Spoonbills, egrets, herons, ibis, gulls, terns and other shore birds year round. The Nature Conservancy wants to build, at some time in the future, an observation tower and possibly boardwalks on the island in support of the Texas Birding Trail and to heighten public awareness and conservation of the island and its resources.  The ELDERHOSTEL Service Programs provide an excellent vehicle to assist communities, researchers and conservation groups with willing volunteers who are eager to take an active, working role in research or conservation projects.  Existing Service Projects include assisting researchers collecting data on Howler Monkeys in Costa Rica, participating in archaeological digs in Arizona and banding migrating birds in East Texas, to name a few.  Our project participants will conduct surveys of the plants and animals living on the island and in the shallow Seagrass beds adjacent to the island.  They will set up survey lines, measure and map changes in elevation and sample and record changes in vegetation along the transect lines across the island.  Our goal is to create a detailed topographic, vegetation and faunal map of the island.  This will aid TNC in developing a formal plan for allowing public access to the island during non-nesting periods of the year.  It is an ambitious project and will take several years to complete.  Other groups will assist in the mapping project, including the Port Aransas High School Marine Science class and members of the Texas Marine Education Association during their winter meeting in January 1997.  This program provides some interesting logistical problems.  The island can only be reached by boat.  Also, there is no shade and no facilities on the island.   We will transport the 26 participants and 5 MES program staff to the island aboard the DUKE from adjacent Wilson's Cut.  The DUKE will remain docked on-site to provide shade and rest room facilities for the group.  The Conservancy is providing a large, portable awning for shade on the island.  Future projects will include revegetating several bare, washover areas with Salt Marsh Cord Grass, building boardwalks and a bird census.  
<p>
A positive spinoff of the ELDERHOSTEL programs is the good will and positive image they promote within the community.  Participants pay a program fee and much of that fee is returned to the community.  Participants in these programs are treated to dinner at a different local restaurant each night.  Breakfast and lunch are provided on site with lunches catered each day.  Local transportation is provided through a cooperative agreement with the local school district.  Local boats are chartered for birding trips and trips to San Jose Island.  On average, each program week puts about $10,000 into the local economy to pay for housing, meals and trips.  In addition, proceeds from the programs pay half the salary of an employee in the UTMSI fiscal office.  This person is responsible for processing the mounds of paperwork each week that pays the bills generated by such a large program.
<p>
The University of Texas-Mustang Island ELDERHOSTEL Programs are academically strong and challenging programs, hosting over 900 participants each year.  The Marine Education Services Program and its staff, including Linda Fuiman and Bob Huntington, play a vital role in the success of these programs.  In addition, the excellent support facilities available at The University of Texas Marine Science Institute are showcased during each program and also contribute to their overall success.  Our weekly evaluations by the participants are outstanding and we host many returning ELDERHOSTELer's through our varied program offerings.  Participants also enjoy field trips to the Texas State Aquarium, the Lexington, a WWII aircraft carrier and Los Barcos, the Columbus Fleet on permanent display at the Corpus Christi Museum of Science.  For more information about the Mustang Island Elderhostel program, please send email to <A HREF="mailto: jrey@tenet.edu ">Judy Reynolds</A>, Program Coordinator. 
<p>
For information on the visiting class program or to register for a teacher workshop, please contact the Marine Education Services Program Office, Marine Science Institute, 750 Channelview Drive, Port Aransas, Texas 78373; Office phone: 512-749-6729; Fax: 512-749-6703, or send email to <A HREF="mailto: rtinnin@tenet.edu ">Rick Tinnin</A>.
<p>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-12</DOCNO>
<DOCOLDNO>IA026-000281-B010-70</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/geninfo.htm 192.138.168.29 19970113201535 text/html 11557
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:24:45 GMT
Last-modified: Friday, 03-Jan-97 20:26:16 GMT
Content-length: 11367
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>UT Marine Science Institute - General Information</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<H1>
<CENTER>
<FONT SIZE="+4">Marine Science Institute <BR>
and <BR>
Department of Marine Science
<H2><FONT SIZE="+3">The University of Texas at Austin</FONT><BR>
</FONT></H2>

<H1><A HREF="mainmap.map"><IMG SRC="images/mainmap.gif" ISMAP USEMAP="maimmap.htm#mainmap"></A>
</H1>

</CENTER>
</H1>

<HR>

<H2>
<CENTER>
<FONT SIZE=+3><STRONG>G</FONT>ENERAL   <FONT SIZE=+3>I</FONT>NFORMATION</STRONG>
</CENTER>
</H2>

<HR>

<UL>
<LI><A HREF="#History_location">history and location</A> 
<LI><A HREF="#Research_program">research programs</A> 
<LI><A HREF="#Physical_facilities">physical facilities</A> 
<UL>
<LI>laboratories 
<LI>library 
<LI>boats 
</UL>

<LI><A HREF="#Research_and_education">research and education</A>

<LI><A HREF="#Outreach">public outreach</A> 
</UL>

<HR>

<H3><A NAME="History_location"><STRONG>History and location</STRONG></A>
</H3>

<P>
The Marine Science Institute, in continuous use by resident research
staff since 1946, is the oldest marine laboratory on the Texas
Gulf Coast. After a modest beginning as a series of wooden structures,
The University of Texas at Austin has invested steadily in the
facility including major modern steel-and-concrete laboratory
construction phases in 1961, 1973, and 1974. The latest building
complex, completed in 1983, comprises an auditorium, library,
and visitor's center. The construction of a new research pier
in 1994 provides air-conditioned laboratory space over the Aransas
Pass tidal inlet. The pier is only a short walk from the main
laboratory buildings.</P>
<P>
The Institute is located in Port Aransas, Texas at the north end
of a barrier island and adjacent to the Aransas Pass tidal inlet,
which connects the Gulf of Mexico with a vast system of estuaries.
Within easy reach of the Institute are diverse marine and estuarine
environments of interest to researchers in many fields of scientific
endeavor. These environments include the open Gulf of Mexico beyond
the slope/shelf break, the shallow waters of the continental shelf
and the bays and lagoons behind the barrier islands. The Institute
is within a few hundred meters of both the Gulf beach and an extensive
estuarine/lagoon system. Within this estuarine system is a wide
variety of accessible habitats including <I>Spartina</I> and mangrove
marshes, oyster reefs, shallow mud-bottom bays and the most extensive
seagrass meadows in the northwestern Gulf of Mexico. In addition,
the regions to the north and south comprise one of the largest
lagoon systems in the world. They span a range of rainfall that
produces a salinity gradient from nearly fresh at the Louisiana
border to extremely hypersaline near the Mexican border. The region
is also the center of economically important fisheries, gas and
oil production, and marine-related tourism.</P>
<H3><A NAME="Research_program">Research Programs</A></H3>

<P>
Active research programs in marine science disciplines including
the physiology, biochemistry and ecology of marine plants and
animals; biological, chemical and physical oceanography; geochemistry;
mariculture; biochemical toxicology; and environmental monitoring,
have been established at the Institute for many years. Field oriented
projects focus on both the local environment and diverse sites
around the world. The Marine Science Institute staff totals 120
individuals including faculty, research scientists and associates,
postdoctoral fellows, graduate students, and technical and support
staff. The Department of Marine Science is the academic arm of
the Marine Science Institute with 14 faculty members and 5 Professors
Emeritus. Courses are taught primarily at the Institute in both
the summer session and the long term. Graduate research is concentrated
at the Institute.</P>
<H3><A NAME="Physical_facilities"><STRONG>Physical facilities</STRONG></A><A NAME="laboratory">
</A></H3>

<P>
The Institute's 83,000 sq. ft. central complex is located on 72
acres of beach-front land and consists of a series of interconnected
buildings containing laboratories, classrooms, televideo instruction
room, offices, a library, museum, exhibit halls, visitor's center,
auditorium, seminar rooms, and workshops. A 10,000 sq. ft. wet-laboratory
is supplied with filtered running seawater. Other structures on
the grounds of the Institute include 9,500 sq. ft. of dormitories,
a cafeteria, physical plant complex, garages, greenhouses, walk-in
freezers, and several outdoor pool/habitat tanks. The five-acre
boat basin provides quick access for our research vessels to both
the bay systems and the Gulf of Mexico. A new research pier allows
direct access for research projects in the Aransas Pass tidal
inlet connecting the Gulf with the bays. This 300 foot pier has
a 1200 sq. ft. lab at its base and a 150 sq. ft. instrument room
on the end. The terminus of the pier and instrument room house
a weather station, tide gauge, current meter, and sensors for
water temperature and salinity, all of which are transmitted to
real time data displays in the Visitor's Center and main laboratory.
The pier also has an electric winch for deploying sampling equipment
such as plankton nets and large-mesh tide traps to study fluxes
of biota through the inlet. A mile west of the main building complex,
the Fisheries and Mariculture Laboratory (FAML) occupies 26,000
sq. ft. of buildings on 10 acres adjacent to the ship channel.
This facility includes four large laboratories which provide for
temperature and photoperiod control. The FAML complex provides
facilities for research on spawning and rearing of marine finfish
and crustaceans and affords unique opportunities for research
utilizing captive animals. Both the main laboratories and the
FAML facility have office and laboratory space available for visiting
scientists.</P>
<P>
<STRONG>The Marine Science <A NAME="Library">Library</A></STRONG>
(MSL) is a branch library of the General Libraries and has more
than 50,000 volumes and is the primary source of marine related
information on the Gulf of Mexico. The fields covered include:
aquaculture/mariculture, biological and physical oceanography,
ichthyology, marine botany, marine chemistry, marine biochemistry
and geochemistry, marine ecology, marine geology, marine microbiology,
marine toxicology, respiratory and reproductive physiology of
marine animals, and the new field of marine viruses. MSL is particularly
strong in holdings of unpublished documents and reports on Texas
coastal resources. University faculty, staff, and students (UT
ID required) have access to interlibrary services, to on-line
bibliographic and abstracting services, and to UT-Austin Academic
Computing and Instructional Technology Services' mainframe computer
systems via remote-job-entry terminals. Persons not affiliated
with the University have acccess to the library's collections
via on-site visits, interlibrary services, and telephone reference.</P>
<P>
The <A HREF="hornspec.htm">R/V LONGHORN </A>is the largest of
the Institute's research vessels. The ship was modified in a major
refit in 1986 to give her an overall length of 105 ft. and is
equipped to carry out extensive offshore research. The LONGHORN
is currently a UNOLS vessel and is used in numerous NSF sponsored
projects throughout the Gulf of Mexico. The <A HREF="katy.htm">R/V KATY </A>is
a 57 ft. fiberglass trawler used in bay operations and is augmented
by a fleet of eleven 16-34 ft. research vessels used primarily
for estuarine studies. Four wheel drive and other vehicles are
available to provide access to coastal habitats.</P>
<H3><A NAME="Research_and_education"><STRONG>Research and education</STRONG></A>
</H3>

<P>
The Marine Science Institute is an organized research unit of
The University of Texas at Austin. The Institute's director reports
to the Provost of the University through the Dean of the College
of Natural Sciences. The Institute receives an operating budget
annually that is based on a two-year advanced budget approval
by the state legislature. Most research funds are based on grant
and contract research. Institute scientists have been awarded
133 research grants totaling over $11.8 million since 1990. These
awards have come from over 40 agencies and institutions including
$2.5 million from various NSF programs and have resulted in over
330 publications in refereed journals and numerous other articles
and reports. Institute scientists are engaged in both multi-investigator,
multi-disciplinary studies and individual research projects in
the local area and throughout the world. Many of these projects
are combinations of field and laboratory investigations. Funding
sources are acknowledged in all publications which appear in both
scientific journals and magazine and newspaper articles. While
the name of the University or the Institute cannot be used in
advertising, the funding agency or company can list and describe
funded projects in annual reports and other publications</P>
<H3><A NAME="Outreach"><STRONG>Public outreach</STRONG></A></H3>

<P>
In addition to research usage, the Institute serves as a marine
educational center for the region. Upper-level undergraduate and
graduate courses are taught in residence during the summer sessions,
typically involving 35-50 students from Texas and other states.
The Institute typically offers three courses during each of the
two summer sessions. The Department of Marine Science began offering
advanced degrees in 1991. Since then, enrollment has increased
by 6-8 students per year to the current enrollment of 34 students.
Enrollment in the Department is expected to continue increasing
over the next two years to about 40, a target that has been established
as an ideal &quot;carrying capacity&quot; for the Department.
The recent increase in graduate student enrollment in the department
has allowed Institute faculty to begin offering courses on-site
during the fall and spring semesters. Graduate students reside
in Port Aransas for thesis and dissertation research, supervised
by one or more of the resident staff, sometimes in collaboration
with other UT Austin faculty members on the main campus. In addition,
the Institute was designated as a site for NSF's &quot;Research
Experiences for Undergraduates&quot; program in 1994. The program
supports 10 undergraduates each summer, with an emphasis on minority
students. As part of the Marine Education Services program, the
Institute serves a large number of outside groups, primarily high
school and college classes, who visit the Institute during the
year. Hands-on teacher workshops are also provided. The total
number of visitors to take advantage of the Marine Education Services
program now exceeds 10,000 teachers and students annually. </P>

<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-13</DOCNO>
<DOCOLDNO>IA026-000281-B011-186</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/currmain.htm 192.138.168.29 19970113202036 text/html 1566
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:31:01 GMT
Last-modified: Wednesday, 18-Dec-96 23:41:32 GMT
Content-length: 1374
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Current Events and Activities UTMSI</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<CENTER><FONT SIZE=+2><B><FONT COLOR="Red">Current Events and Activities</FONT></B> </FONT></CENTER>

<CENTER><IMG SRC="../images/Satellit.gif" BORDER=3 HEIGHT=314 WIDTH=411>
</CENTER>
<UL>
<LI><A HREF="ocean.htm">Oceanography Day 1997</A> </LI>

<LI><A HREF="../current/50years/rackcard.jpg">50 Year Celebration and Open
House (344 Kb image)</A> </LI>

<LI><A HREF="orgresh.htm">Recent Research Results</A> </LI><BR>
<DL>
	<DT> <DD>
<DD><A HREF="../mfrp/mfrpproj.htm">Marine Fish Research Program</A></DL>

<LI><A HREF="seminars.htm">Seminar Schedule</A> </LI>

<LI><A HREF="../mes/wrkshp.htm">Teacher Workshop Schedule</A></A> </LI>

<LI><A HREF="longhorn.htm">R/V Longhorn Cruise Schedule</A> </LI>

<LI><A HREF="katyschd.htm">R/V Katy Cruise Schedule</A> </LI>

<LI><A HREF="tides.htm">Monthly Tide Predictions for Port Aransas</A> </LI>
</UL>

<P>
<HR></P>

<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-14</DOCNO>
<DOCOLDNO>IA026-000281-B012-72</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/hornspec.htm 192.138.168.29 19970113202249 text/html 7189
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:32:05 GMT
Last-modified: Wednesday, 13-Nov-96 22:15:00 GMT
Content-length: 6997
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>UTMSI - R/V Longhorn Specifications</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<H1>
<CENTER>
<IMG SRC="images/banner.gif" ALIGN="BOTTOM" ALT="[MSI Banner]">
<IMG SRC="images/longhorn.gif" ALIGN="BOTTOM" ALT="[R/V Longhorn]" BORDER=3>
<H1>Description of R/V Longhorn</H1>

</CENTER>
</H1>

<P>
<A HREF="current/longhorn.htm">Ship's schedule</A>
<P>
<A HREF="images/hornflpl.gif">Ship's floor plan</A>
<P>
For further information, contact <A HREF="mailto:thompson@utmsi.zo.utexas.edu">John Thompson
</A>
<HR>

<DIR>
<LI>BUILT: 1971 
<LI>REBUILT/STRETCH: 1986 
<LI>LENGTH: 103' 
<LI>BEAM: 24' 
<LI>GROSS TONNAGE: 152.76 
<LI>CREW: 4 
<LI>SCIENTIFIC PERSONNEL: 13 
<LI>MAIN ENGINE(S): 2, 360 HP EACH 
<LI>BOW THRUSTER: 80 HP
<LI>SHIP'S SERVICE GENERATORS: 2, 75 KW EACH
<LI>PROPELLERS: 2, FIXED PITCH
<LI>SPEED: 
<LI>9.5 KNOTS (CRUISING)
<LI>10 KNOTS (FULL)
<LI>1/2 KNOT (MINIMUM)
<LI>ENDURANCE: 14 DAYS
<LI>RANGE: 3,000 NAUTICAL MILES
<LI>FUEL CAPACITY: 11,000 GALLONS
<LI>LABORATORIES:
<LI>MAIN (DRY): 400 SQ.FT.
<LI>WET: 400 SQ.FT.
<LI>SEWAGE SYSTEM: 650 GALLONS
<LI>OWNERSHIP: Title is held by The University of Texas 
<LI>STATE I.D.# TX 5851 CC
</DIR>

<HR>

<P>
The <B>LONGHORN</B> was designed by Robert L. Harrelson as a general
purpose coastal oceanographic research vessel. She was built in
1971 by the Allied Shipyard. In June, 1986, a midlife refit and
lengthening project was completed by Master Marine Shipyard. A
20-ft. section was added amidships along with a new and enlarged
wheelhouse, all new living quarters below decks, and all new and
expanded laboratories. New electronic navigation and communication
aids were installed at the same time. The ship had previously
been repowered with GM 12V71 Diesels. Thus in 1986 the <B>LONGHORN</B>
entered into a new phase of her life as an enlarged, improved,
and rebuilt vessel.
<P>
<B>MAIN WINCH: </B>The main winch is a Dynacon and was new in
1993. This winch is hydraulically powered, is controlled from
a console station on the main deck and currently carries 9,600
ft. of 1/2&quot; 3 X 19. There is a four conductor slip ring and
a capability of handling 6,000 ft. of .680 conductor cable.
<P>
<B>HYDROGRAPHIC WINCHES: </B>Two hydrographic winches, Dynacon
Model 8000A, are available for water-bottle sampling, light coring,
dredging, plankton net, and CTD (conductivity, temperature, depth)
work. One winch has 10,000 ft. of 1/4&quot; 7 X 19 stainless wire
rope, the other winch will have 11,666 ft. of .322 diameter 3
conductor wire in 1996. Also, an extra spool, interchangeable
with either winch, for wire is available.
<P>
<B>CRANE: </B>TICO 150 marine crane. Lifting capacity 14,109 lbs.
at 6'6&quot; extension; 5,666 lbs. at 16'5&quot; extension (4'5&quot;
over the side); and 1,433 lbs. at 41' extension (29' over the
side).The crane is mounted amidships on the 01 deck.
<P>
<B>STERN FRAME: </B>Hydraulic; 12' horizontal clearance; 18' 6&quot;
vertical<B> </B>clearance; 8' clearance overboard; 9'6&quot; reach
inboard, 20,000 lbs. rated.
<P>
<B>DAVIT:</B> Hydraulic; 10' vertical clearance; 2,000 lbs. rated.
<H3>COMMUNICATIONS:</H3>

<UL>
<LI>Satellite: QualComm Omnitracs 200 SatCommunicator
<LI>VHF Radio: Unimetrics Sea Com 55 and Hummingbird (two units)

<LI>SSB Radio: Stephens 222 and Harris RF3200
<LI>Cellular Telephone: Petrocom (713-853-1263) and Southwestern
Bell (512-850-3038)
</UL>

<H3>NAVIGATION EQUIPMENT:</H3>

<UL>
<LI>Gyrocompass: Sperry SR-220
<LI>Loran: Loran Navigator LC-90 (2 units)
<LI>Radar: Furuno FCR-1411/6 (2 units, both with collision/anchor
alarms)
<LI>Depth Recorder: Morrow JMF-2001 and Furuno FE-814
<LI>Precision Depther Recorder:  Knudsen 320M Marine Echosounder
<LI>Data Printer: Furuno FP-70
<LI>GPS: Trimble NT200D GPS with differential capability, Trimble
Navtrac XL
<LI>Weatherfax Recorder: Alden Faxmate
</UL>

<H3>ELECTRICAL CAPABILITIES:</H3>

<UL>
<LI>Generators: two 75 kw diesel generator sets.
<LI>Supply: 110/220 phase throughout ship; also 12-volt dc in
lab; 208-volt 3 phase by advance request, lab or deck.
</UL>

<P>
<B>VAN CAPABILITIES</B>: Vans of modest size and weight (approximately
10' X 15' and 4,000 lbs.) can be accommodated. Given her size,
the vessel has a large open deck and reserve stability. A radio-
isotope/hazardous chemicals van is available at MSI at no extra
cost except for crane service to install.
<P>
<B>SMALL BOATS</B>: The LONGHORN is often used as a &quot;mother&quot;
ship on projects involving the use of various small craft. Adequate
deck space is available to carry two or three smaller boats to
remote locations. A 16' Carolina Skiff is available at no extra
charge. Numerous other small craft are also available at extra
expense.
<P>
<B>LABORATORY SALTWATER SUPPLY</B>: Unfiltered seawater is supplied
to two sinks in the wet laboratory on a continuous basis while
the ship is at sea.
<P>
<B>SEAWATER TANKS</B>: Seawater tanks are not permanently mounted,
however adequate deck space is available for installation of tanks
on a trip basis.
<P>
<B>COMPRESSED AIR SUPPLY</B>: Compressed air is supplied to both
the wet laboratory and the dry laboratory at 80 psi.
<H4>SHARED-USE EQUIPMENT: </H4>

<UL>
<LI>Trawls: Three 35' shrimp (otter), 60&quot; X 30&quot; doors.
<LI>Plankton nets: Several 1-meter nets.
<LI>Smith-McIntyre sediment samplers: 1 stainless steel; 2 steel.
<LI>Box-corer: Ocean Instruments Mark 1, 8&quot; X 12&quot; X
24&quot;.
<LI>Niskin bottles: Four (4) 30-liter and four (4) 5-liter.
<LI>Reversing thermometers: Four (4) unprotected deep-sea with
two (2) thermometer frames.
<LI>Piston corers: Two (2) each, 3&quot; diameter.
<LI>Rock dredge: Kahl #215WA400 benthic rock dredge, mouth opening
24&quot; X 15&quot;.
<LI>CTD: Sea Bird 911 plus; Sea Bird water sampling carousel;
12, 10-liter water sampling bottles; Seatec fluorometer; oxygen
sensor; transmissometer.
</UL>

<P>
<B>SAFETY EQUIPMENT</B>: Seventeen Stearns work suits (considered
&quot;constant wear industrial flotation suits&quot;); two each
20-man Switlik life rafts; two 15-person buoyant apparatus rectangular
platforms; two EPIRB; eight USCG-approved life rings, six with
automatic waterlights; life preservers for all hands.
<H3>PLANNED UPGRADES FOR 1997:</H3>

<P>
<B>Vessel</B> - add Marine Sat, upgrade hydro and CTD winch line monitor systems, upgrade
Dynacon; 347 tension display.
<P>
<B>Oceanographic instrumentation</B> - add field fluorometer, portable salinometer, acoustic
doppler profiler.

<HR> 
<P><IMG
SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5"
BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 

</BODY>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-15</DOCNO>
<DOCOLDNO>IA026-000281-B012-197</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/katy.htm 192.138.168.29 19970113202452 text/html 1717
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:34:37 GMT
Last-modified: Thursday, 14-Nov-96 15:24:48 GMT
Content-length: 1526
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>UTMSI - R/V Katy Specs</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">


<H1>
<CENTER>
<IMG SRC="images/katy.jpg" ALIGN="BOTTOM">
<H1>R/V Katy</H1>

</CENTER>
</H1>

<P>
<A HREF="current/katyschd.htm">Ship's schedule</A>
<P>
For further information, contact <A HREF="mailto:thompson@utmsi.zo.utexas.edu">John Thompson </A>
<HR>

<P>
The <I>R/V KATY </I>is 57 feet long, 16 feet 6 inches in beam,
6 feet draft, 40.8 gross tons, and 27 net tons. She is powered
by a single 671 Detroit Diesel. Top speed is about 10 knots. Belowdecks
living quarters include bunk space for six. There is a complete
galley with refrigerator and electric range. All the quarters
are air conditioned. Fuel capacity is 3,000 gallons and fresh
water capacity is 1,000 gallons. In addition to the normal controls
on the bridge, there is a stern steering station. A wet laboratory
space is semi-enclosed off the work deck, A compartment immediately
forward of the wet laboratory space can be used as a day room
for personnel, or can be rigged as an instrument room for research
projects. This vessel's primary utilization is as a stern trawler
for class trips. 

<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 

<P>
</P>
<HR> 

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-16</DOCNO>
<DOCOLDNO>IA026-000281-B013-77</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/longhorn.htm 192.138.168.29 19970113202821 text/html 3753
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:38:48 GMT
Last-modified: Monday, 13-Jan-97 19:05:42 GMT
Content-length: 3564
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>HTML document for the World Wide Web</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<P>

<CENTER>
<FONT SIZE="+2" FACE="Bookman Old Style"><STRONG>R/V LONGHORN LONG-TERM SCHEDULE</STRONG></FONT>
</CENTER>

<P>
<A HREF="../hornspec.htm">Ship's specifications</A></P>
<P>
For further information, contact <A HREF="mailto:thompson@utmsi.zo.utexas.edu">John Thompson </A></P>
<HR>

<P>
<A HREF="#schedule1997">1997 schedule</A>
<P>
<A HREF="#schedule1998">1998 schedule</A>
<HR>

<STRONG><PRE>
                              <A NAME="schedule1997">R/V LONGHORN
                            SCHEDULE -- 1997
                     LAST UPDATE: JANURARY 13, 1997

CRUISE  MAP INDEX/AREA     P.I./INSTITUTION/    PORTS       DAYS/AGENCY/
DATES    PURPOSE             PROPOSAL NO.                      STATUS
===========================================================================
21 JAN  NA9/GULF OF MEX.    CULBERTSON/TPWD    PORT ARANSAS   3/STATE
23 JAN  OTHER (FISHERIES)   ARTIFICIAL REEF                   F

27 JAN  NA9/GULF OF MEX.    DUNTON/UTMSI       PORT ARANSAS   2/USACE
28 JAN  BIOLOGICAL OCEAN.   EFFECT OF DREDGE.                 F

05 FEB  NA9/GULF OF MEX.    CULBERTSON/TPWD    PORT ARANSAS   3/STATE
07 FEB  OTHER (FISHERIES)   ARTIFICIAL REEF                   F

08 FEB  OUT OF SERVICE FOR MAJOR HAULOUT AND REPAIR
31 MAR

08 APR  NA9/GULF OF MEX.    BUSKEY/UTMSI       PORT ARANSAS   2/NSF
09 APR  BIOLOGICAL OCEAN.   OCE9529750                        F

15 APR  NA9/GULF OF MEX.    CULBERTSON/TPWD    PORT ARANSAS   3/STATE
17 APR  OTHER (FISHERIES)   ARTIFICIAL REEF                   F

26 APR  NA9/GULF OF MEX.    THOMPSON/UTMSI     PORT ARANSAS   1/OTHER
        TRAINING            OCEANOGRAPHY DAY                  F

12 MAY  NA9/GULF OF MEX.    DUNTON/UTMSI       PORT ARANSAS   2/USACE
13 MAY  BIOLOGICAL OCEAN.   EFFECT OF DREDGE.                 F

12 JUN  NA9/GULF OF MEX.    MONTAGNA/UTMSI     PORT ARANSAS   1/STATE
        TRAINING            INVERT. CLASS                     F

17 JUN  NA9/GULF OF MEX.    CULBERTSON/TPWD    PORT ARANSAS   3/STATE
19 JUN  OTHER (FISHERIES)   ARTIFICIAL REEF                   F

08 JUL  NA9/GULF OF MEX.    BUSKEY/UTMSI       PORT ARANSAS   2/NSF
09 JUL  BIOLOGICAL OCEAN.   OCE9529750                        F

04 AUG  NA9/GULF OF MEX.    MONTAGNA/UTMSI     PORT ARANSAS   4/EPA
07 AUG  BIOLOGICAL OCEAN.   #R825355-01-0

19 AUG  NA9/GULF OF MEX.    CULBERTSON/UTMSI   PORT ARANSAS   4/STATE
22 AUG  FISHERIES (OTHER)   ARTIFICIAL REEF                   F

07 OCT  NA9/GULF OF MEX.    BUSKEY/UTMSI       PORT ARANSAS   2/NSF
08 OCT  BIOLOGICAL OCEAN.   OCE9529750                        F


OTHER:  -- 7 ADDITIONAL DAYS TO BE SCHEDULED FOR TEXAS PARKS AND WILDLIFE
        -- 5 DAYS UNIVERSITY OF TEXAS STUDENT CRUISE, SUMMER, STATE
        -- ONE DAY EACH MONTH PHYSICAL OCEANOGRAPHY, LONGSECS, STATE
        -- APPROX. 20 DAYS, UT APPLIED RESEARCH LAB, NAVY SPAWAR
</PRE>
</STRONG>
<HR>

<STRONG><PRE>
                              <A NAME="schedule1998">R/V LONGHORN</A>
                            SCHEDULE -- 1998

in preparation
</PRE>
</STRONG>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-17</DOCNO>
<DOCOLDNO>IA026-000281-B014-25</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/katyschd.htm 192.138.168.29 19970113203306 text/html 3009
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:41:03 GMT
Last-modified: Thursday, 05-Dec-96 22:51:42 GMT
Content-length: 2818
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>R/V Katy Schedule</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P>

<CENTER>
<FONT SIZE="+2" FACE="Bookman Old Style"><STRONG>R/V KATY SCHEDULE</STRONG></FONT>
</CENTER>

<P>
<HR>
<A HREF="../katy.htm">Ship's description</A></P>
<P>
For further information, contact <A HREF="mailto:thompson@utmsi.zo.utexas.edu">John Thompson </A></P>

<P>
<I>Revised: November 12, 1996</P></I>
<HR>
<STRONG><PRE>
NOVEMBER
  01 1300-1700    AUSTIN COMMUNITY COLLEGE, AUSTIN  SALLY STRONG
  04 0800-1200    TEXAS PARKS AND WILDLIFE DEPT.    CARL CLONINGER
  04 1300-1700    TEXAS MILITARY INSTITUTE          MARY KENNEDY
  05 0800-1200    SOUTHPARK MIDDLE SCHOOL, CORPUS   DEBRA MIGET
  06 0800-1200    HYDE PARK HIGH SCHOOL, AUSTIN     ANNE CARREY
  06 1300-1700    LAGO VISTA ELEMENTARY             ANNE SPOONER
  07 0800-1200    LAGO VISTA ELEMENTARY             ANNE SPOONER
  08 0800-1200    ZAVALA ELEMENTARY, AUSTIN         TODD MCDOWELL
  08 1300-1700    BIOL DEPT, SOUTHW ADV COL, KEENE  DR. PETR
  09 0800-1200    MARE TEACHER WORKSHOP             MSI STAFF
  09 1300-1700    AUSTIN COMMUNITY COLLEGE, AUSTIN  DR. RODI
  11 0800-1200    TEXAS WESLEYAN UNIVERSITY         DR. DEATON
  12 0800-1200    PARKDALE BAPTIST SCHOOL           LYNDA DAVIES
  12 1300-1700    FAYETTEVILLE HS, ARKANSAS         ROBIN BUFF
  14 0800-1200    ELDERHOSTEL                       MSI STAFF
  15 1300-1700    AUSTIN COMMUNITY COLLEGE, AUSTIN  DR. ESTES
  16 0800-1200    INCARNATE WORD HS, SAN ANTONIO    NORMA COPELAND
  16 1300-1700    UT AT SAN ANTONIO                 VI LIEN
  18 0800-1200    NORTHSIDE ISD SAN ANTONIO         DEBBIE TRAYNOR
  18 1300-1700    TAMUCC                            DR. MCKEE
  19 1300-1700    TAMU KINGSVILLE                   DR. WOOD
  21 1300-1700    BRUNDRETT MS, PORT ARANSAS        ANDREA CANTU
  22 0800-1200    BRUNDRETT MS, PORT ARANSAS        ANDREA CANTU
  22 1300-1700    SOUTHWEST TEXAS STATE U.          DR. EARL
  23 0800-1200    FAUBION ELEMENTARY, CEDAR CREEK   CINDY WHEELER
  25 0800-1700    MCNEIL HS, AUSTIN                 ANITA GORDON
DECEMBER
  03 0800-1200    ROCKPORT FULTON HS                MARK DEHN
  05 0800-1700    ELDERHOSTEL                       MSI STAFF
  10 0800-1700    SAN DIEGO HS                      EDMOND EVERETT
  11 0800-1700    SAN DIEGO HS                      EDMOND EVERETT
  12 0800-1700    ELDERHOSTEL                       MSI STAFF
</PRE>
</STRONG><HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-18</DOCNO>
<DOCOLDNO>IA026-000281-B014-74</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/seminars.htm 192.138.168.29 19970113203402 text/html 2512
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:44:35 GMT
Last-modified: Monday, 06-Jan-97 14:59:54 GMT
Content-length: 2323
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Marine Science Institute - Seminar Sechedule</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<H2>
<CENTER>
<FONT SIZE="+3">Marine Science Institute <BR><EM>Seminar Schedule</EM>
</FONT></CENTER>
</H2>

<HR>

<P>
<STRONG>Unless otherwise noted, all seminars are in the Visitor's Center
Auditorium at 3:45 PM. For further information, E-Mail <A HREF="mailto:patty@utmsi.zo.utexas.edu">Patty Webb</A>
or phone 512-749-6741.</P>
<HR>


<PRE WIDTH=132>
  
<B>Monday,</B> <I><B>    John A . Raven</B>   </I><I>University of</I>       <I>Cost-benefit analysis of</I>    
<B>February</B>                     <I>Dundee</I>              <I>photon harvesting by marine</I>     
<B>3, 1997</B>                      <I>Scotland</I>           <I> phototrophs:  Biodiversity and bioenergetics</I>        
<B></B>                             <I></I>                    <I></I>
                                                                                       
<B>Friday,</B>    <I><B> Lisa Campbell</B>    </I><I>Texas A&M Univ.</I>     <I>The importance of Prochloroccus</I>    
<B>February</B>                     <I>Dept. Oceanog.</I>      <I>to community structure in </I>     
<B>21, 1997</B>                     <I></I>                    <I>the North Pacific Subtropical Gyre</I>        
<B></B>                             <I></I>                    <I></I>
                                                                                       
<B>Friday,</B>     <I><B>Randall Davis</B></I>    <I>Texas A&M Univ.</I>     <I>Distribution, abundance, and</I>    
<B>February </B>                    <I>Dept. Marine Biol.</I>  <I>Cetaceans in the Northern </I>     
<B>28, 1997</B>                     <I></I>                    <I>Gulf of Mexico</I>        
<B></B>                             <I></I>   <I></I>        
    
                                                                                     


</PRE>

</STRONG><HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-19</DOCNO>
<DOCOLDNO>IA026-000281-B014-122</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/afamos/weather.htm 192.138.168.29 19970113203422 text/html 961
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:45:09 GMT
Last-modified: Thursday, 09-Jan-97 17:05:24 GMT
Content-length: 771
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Port Aransas Weather Data Summary</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="../../images/chalk.gif" bgcolor="#FFFFFF" text="#000000" >

<H1 ALIGN=CENTER>Port Aransas Weather Data Summary<BR>
<FONT SIZE="+2">1986 - 1996 (inclusive)</FONT></H1>
<HR>

<UL>
<LI><A HREF="monthly.htm">Monthly summary</A>
<LI><A HREF="yearly.htm">Yearly summary</A>
<LI><A HREF="period.htm">11-year summary</A>
</UL>
<HR></P>

<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE=5 BORDER=1 HEIGHT=75 WIDTH=225 ALIGN=ABSCENTER><A HREF="../../index.htm">Return
to MSI Home Page </A></P>

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-20</DOCNO>
<DOCOLDNO>IA026-000281-B014-174</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/forms/register.htm 192.138.168.29 19970113203527 text/html 7320
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:45:41 GMT
Last-modified: Tuesday, 07-Jan-97 14:49:58 GMT
Content-length: 7130
Content-type: text/html
</DOCHDR>
<html>
<head>
<title>University of Texas Marine Science Institute - Summer Program Application</title>
</head>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<SCRIPT LANGUAGE="JavaScript">
<!-- Beginning of WebMania!/JavaScript Applet -------------
/* Copyright (C)1996,97 Q&D Software Development
All Rights Reserved.
*/
function checkdata()
{
     return confirm('Your registration for has been received and will be processed soon.');
}
// -- End of JavaScript code -------------- -->

</SCRIPT>
<center><h1>University of Texas - Marine Science Institute</h1></center>
<p>Please note: Although it is most unlikely that you will experience any problems responding to this form, certain non-standard browsers will not respond properly.  If you experience any difficulties (or if you are not using a forms-capable browser) you may e-mail your response to this form to: <a href="mailto:summer@utmsi.zo.utexas.edu">summer@utmsi.zo.utexas.edu</a>.
<p>
<center><h3>Summer Program Application Form</h3></center>
<FORM NAME="WM_1" ACTION="mailto:summer@utmsi.zo.utexas.edu" METHOD=POST onSubmit="return checkdata()">
<INPUT TYPE="hidden" NAME="Test1" VALUE="1">
<INPUT TYPE="hidden" NAME="Test2" VALUE="2">
<INPUT TYPE="hidden" NAME="WFTestWF" VALUE="2.0a">
 <CENTER><IMG SRC="../images/summer.jpg" WIDTH=299 HEIGHT=217 BORDER=0 ALT="class on R/V Katy deck"></CENTER>
     <p>To apply for the MSI Summer Program on this Web server, fill out this form. If your browser does not support forms, you can request a hardcopy of the application by e-mail:
 <A HREF="mailto: summer@utmsi.zo.utexas.edu">summer@utmsi.zo.utexas.edu</A> 
    <p><b>Application deadline: April 15, 1997</b><br>
    <p><p>
Note: Complete all fields below<p>
<hr><br>
    <p><b>PERSONAL INFORMATION:</b><br>
    <p><menu>
        <INPUT TYPE="radio" NAME="title" VALUE="Mr.">Mr.
        <INPUT TYPE="radio" NAME="title" VALUE="Ms." >Ms.
<br>
    </menu>
     <p><i>Student name</i>: <BR>           <INPUT TYPE="text" NAME="<i>Student_name</i>" SIZE=50 VALUE="">
    <p><i>Current address</i>:<BR>         <INPUT TYPE="text" NAME="<i>Current_address</i>" SIZE=75 VALUE="">
    <p><i>Permanent address</i>:<BR>       <INPUT TYPE="text" NAME="<i>Permanent_address</i>" SIZE=75 VALUE="">
    <p><i>Phone number</i>:<BR>            <INPUT TYPE="text" NAME="<i>Phone_number</i>" SIZE=50 VALUE="">
    <p><i>Social Security Number</i>:<BR>  <INPUT TYPE="text" NAME="<i>Social_Security_Number</i>" SIZE=50 VALUE="">
    <p><i>Email address</i>:<BR>           <INPUT TYPE="text" NAME="<i>Email_address</i>" SIZE=50 VALUE="">
    <p><hr>
<p>
<B>ACADEMIC STATUS:</B><br>
     <i>Current institution:</i>
    <p><menu>
        <INPUT TYPE="radio" NAME="inst" VALUE="Present student of UT Austin" >Present student of UT Austin
<br>
        <INPUT TYPE="radio" NAME="inst" VALUE="Former student of UT Austin">Former student of UT Austin
<br>
        <INPUT TYPE="radio" NAME="inst" VALUE="Other university">Student of other university
<br>
     </menu>
    <p><i>Institution (if other than UT Austin)</i>:
<br>
<INPUT TYPE="text" NAME="<i>Institution</i>" SIZE=50 VALUE="">
    <p><i>Major</i>:<BR>	<INPUT TYPE="text" NAME="<i>Major</i>" SIZE=50 VALUE="">
    <p><B>Non UT students must submit an official  transcript or course record and apply for transient student status.</B><br>
    <p><i>Classification as of June 1997:</i><br>
    <p><menu>
        <INPUT TYPE="radio" NAME="class" VALUE="Junior" >Junior
        <INPUT TYPE="radio" NAME="class" VALUE="Senior">Senior
        <INPUT TYPE="radio" NAME="class" VALUE="Masters">Masters
        <INPUT TYPE="radio" NAME="class" VALUE="PhD">PhD
        <INPUT TYPE="radio" NAME="class" VALUE="Other">Other
<br>
    </menu>
    <p><hr>
<h4>Courses (click on any course for a course description):</h4>
<b>First session, June 4-July 11</b><br>
     <INPUT TYPE="checkbox" NAME="course" VALUE="Marine Botany" ><A HREF="../academic/summer97.htm#botany">Marine Botany - MNS f352D</A>
<br>
    <INPUT TYPE="checkbox" NAME="course" VALUE="Marine Invertebrates"><A HREF="../academic/summer97.htm#inverts">Marine Invertebrates - MNS f3541</A>
<br>
<p>
<b>Second session, July 14-August 18</b><br>
    <INPUT TYPE="checkbox" NAME="course" VALUE="Biology of Fishes"><A HREF="../academic/summer97.htm#fishes">Biology of Fishes - MNS s354C</A>
<br>
    <INPUT TYPE="checkbox" NAME="course" VALUE="Marine Environmental Sciences"><A HREF="../academic/summer97.htm#envsci">Marine Environmental Sciences - MNS s354Q</A>
<br>
    <INPUT TYPE="checkbox" NAME="course" VALUE="Biological Oceanography (grad)"><A HREF="../academic/summer97.htm#biooce">Biological Oceanography (graduate only) - MNS s384T</A>
<BR>
<p>
    <i>Multiple courses may be chosen.</i>
    <p>Summer tuition and registration fees for in-state students are (estimates) $390.00 for one six-week session, 3 hours credit; or $530.00 for one six-week session, 6 hours credit.  For out-of-state students, summer tuition and registration fees are $1,025 for one six-week session, 3 hours credit; or $1,750 for one six-week session, 6 hours credit (this does not include lab or incidental fees). Further information on registration will be mailed after you have been accepted for admission.<br>
    <p><hr>
<h4>Residency:</h4>
    <p><menu>
        <INPUT TYPE="radio" NAME="residence" VALUE="Texas resident" >Texas resident
<br>
        <INPUT TYPE="radio" NAME="residence" VALUE="Non-resident">Non-resident
<br>
    </menu>
    <p><hr>
<h4>Housing:</h4><br>
    <p><menu>
        <INPUT TYPE="radio" NAME="housing" VALUE="I need housing" >I need housing
<br>
        <INPUT TYPE="radio" NAME="housing" VALUE="I do not need housing">I do not need housing
<br>
    </menu>
    <p><hr>
<h4>Scholarships:</h4>
Financial aid is available for students needing funds to cover both sessions of study.  The scholarship covers room and board for the second session attended.  A personal statement on why you should be considered for a scholarship is required.<br>
    <p><menu>
        <INPUT TYPE="radio" NAME="money" VALUE="I wish to apply" >I wish to apply
<br>
        <INPUT TYPE="radio" NAME="money" VALUE="I do not wish to apply">I do not wish to apply
<br>
    </menu>
    <p><b>Statement</b>:<br><TEXTAREA name="<b>Statement</b>" rows=4 cols=60></TEXTAREA><p>
<hr>
    <p><b>Comments/Questions:</b>:<br><TEXTAREA name="<b>Comments/Questions:</b>" rows=2 cols=60></TEXTAREA><p>
<p>

    <p><INPUT TYPE="hidden" NAME="WebFormID" VALUE="1">
    <p><INPUT TYPE="submit" VALUE="Submit Application Form"> <INPUT TYPE="reset" VALUE="Clear Form"> 
<p>
<hr>
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<HR> 
</FORM>
<p>
<hr><FONT SIZE=-2>WebMania!&#153; 2.0a Professional Edition - &#169;1995,96,97 Q&amp;D Software Development<br><a href="http://www.q-d.com" TARGET="_top">http://www.q-d.com</a></FONT>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-21</DOCNO>
<DOCOLDNO>IA026-000281-B014-243</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/CURRENT/OCEAN.htm 192.138.168.29 19970113203639 text/html 7080
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:46:45 GMT
Last-modified: Wednesday, 18-Dec-96 22:51:08 GMT
Content-length: 6888
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Oceanography Day 1997</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT="#000000" BACKGROUND="../../images/chalk.gif">

<H2 ALIGN=CENTER>Oceanography Day 1997</H2>

<P>
<HR></P>

<P>The University of Texas Marine Science Institute plans to host another
Oceanography Day, April 26, 1997. Our goal is to bring this exciting educational
program to an even greater number of Boy Scouts than attended the most
recent Oceanography Day in 1994, when 350 Scouts and 150 adult leaders
participated. These Scouters were from 100 different Scout troops in 50
different towns and cities. Oceanography Day includes a full day of activities
at the Marine Science Institute in Port Aransas. Scouts take a trip aboard
a Research Vessel, either the R/V LONGHORN or the R/V KATY, make a plankton
net, participate in a laboratory plankton identification session, and attend
presentations on exciting current research programs. Before coming to Oceanography
Day Scouts pass the first six requirements of the Oceanography Merit Badge.
During Oceanography Day the 7th (project) requirement is passed. After
Oceanography Day the final requirement (500 word report) is completed and
mailed to the Oceanography Day Chairman, who is also the Oceanography Merit
Badge Counselor. Scouts receive their approved blue cards in the mail and
their merit badge through their own troop. </P>

<P><IMG SRC="../IMAGES/flag.jpg" ALT="[Scouts saluting the flag]" HEIGHT=198 WIDTH=290 ALIGN=RIGHT BORDER=1>
<B>Requirements to Attend Oceanography Day:</B><BR>
</P>

<UL>
<LI>Obtain a copy of the Merit Badge Booklet 1983 revision or later and
read it.<BR>
</LI>

<LI>Complete in writing the first six requirements <B>as listed in the
merit badge booklet</B>.<BR>
</LI>

<DL>
<DD>-&quot;fill in the blank&quot; type answer sheets <B>are not acceptable</B>.<BR>
</DD>

<DD>-the work is expected to be the Scout's best effort (several hours
of study and diligent work are necessary).<BR>
</DD>

<DD>-include full name, age, school grade, troop #, mailing address, and
phone #.<BR>
</DD>
</DL>

<LI>Your work must be received before April 1, 1997. Your work will be
carefully reviewed. Additional work or corrected answers may be required
before you are approved to attend.<BR>
</LI>

<LI>Mail completed work to:<BR>
John Thompson, Oceanography Day Chairman, The University of Texas Marine
Science Institute, 750 Channelview Dr., Port Aransas, TX 78373-5015.<BR>
(Phone - 512-749-6760)<BR>
</LI>

<LI>Send your work by e-mail to <A HREF="mailto:thompson@utmsi.zo.utexas.edu">John Thompson</A></LI>
</UL>

<P><IMG SRC="../IMAGES/samples.jpg" ALT="[Scouts experimenting with samples]" HEIGHT=225 WIDTH=320 ALIGN=LEFT BORDER=1>
</P>

<P><B>Other Important Information:</B> </P>

<UL>
<LI>There is no charge for Oceanography Day.<BR>
</LI>

<LI>Scouts earn a special Oceanography Day patch (in addition to the merit
badge patch).<BR>
</LI>

<LI>Camping will be available on the MSI grounds.<BR>
</LI>

<LI>A related campfire program will be held Saturday evening.<BR>
</LI>

<LI>Oceanography Day is not for everyone. It requires a true interest in
marine science and oceanography and hard work. Attempts to qualify every
member of a Scout Troop for attendance are not encouraged.<BR>
</LI>
</UL>

<P><BR>
<BR>
<BR>
<B><I><CENTER><FONT SIZE="+2">Oceanography Day Instructors</FONT></CENTER></I></B>
<B>Terry Whitledge</B> <BR>
-Dr. Whitledge is a Chemical Oceanographer who has served as Chief Scientist
on dozens of cruises aboard large Research Vessels as well as MSI's own
R/V LONGHORN. Dr. Whitledge will be telling of his most recent adventures
aboard Russian Research Vessels and in the Pribilof Islands. </P>

<P><B>Tony Amos</B> <BR>
-Selected by Texas Monthly Magazine as one of the 20 most influential persons
in Texas for his outstanding work on Texas beaches and marine debris and
his conservation work with seabirds, marine mammals and turtles, Mr. Amos
is a Physical Oceanographer who has made 30 voyages to the Antarctic. </P>

<P><B>Ron Benner</B> <BR>
-Dr. Benner's research is in the area of microbial ecology. When he is
not in his laboratory at the Marine Science Institute in Port Aransas,
Dr. Benner may be in the Gulf of Mexico aboard the R/V LONGHORN or far
up the Amazon River in South America. </P>

<P><B>Paul Montagna</B> <BR>
-Dr. Montagna is a benthic ecologist. Dr. Montagna will be showing Scouts
some of the common forms of marine invertebrates found in the South Texas
area. </P>

<P><B>Ed Buskey</B> <BR>
-One of Dr. Buskey's research projects involves the study of copepods in
the tropics. Dr. Buskey and his students travel to Carrie Bow Cay, near
Belize, where much of their collecting is done by snorkeling. He will be
telling Scouts about life in the mangroves and bioluminescence living light
of the seas. </P>

<P><IMG SRC="../IMAGES/sampler.jpg" ALT="[Scout studying Plankton Sampler display" HEIGHT=297 WIDTH=225 ALIGN=RIGHT BORDER=1>
</P>

<P><B>Ken Dunton</B> <BR>
-Dr. Dunton and his students study Texas seagrasses as well as do research
on the Antarctic Peninsula (64&oslash; south latitude) and the High Arctic
(75&oslash; north latitude) where they study the adaptations made by polar
seaweeds to low temperatures and light and the thinning ozone layer. Dr.
Dunton will show Scouts how his team collects these measurements by diving
under the ice in both the Arctic and Antarctic. </P>

<P><B>Dean Stockwell</B> <BR>
-To reach his local study sites in the Nueces Basin, Dr. Stockwell operates
fast shallow draft jet-drive boats and ATV's and to reach his other study
sites under the Arctic Ice near the North Pole he travels aboard the U.S.
Navy's Nuclear Powered Submarine, the USS CAVALLA. </P>

<P><B>Ellery Ingall</B> <BR>
-Dr. Ingall is a marine chemist who studies the cycling of nutrients required
by all living things in the ocean. Recent work has taken him to the Gulf
of Mexico on the R/V LONGHORN and to the bottom of the ocean off Peru in
the Johnson Sea-Link Submersible. </P>

<P><B>Peter Thomas</B> <BR>
-Dr. Thomas studies reproduction in marine fish. He will show Scouts some
common fishes from this region. Dr. Thomas will describe how hormones control
fish reproduction and the effects of pollutants. </P>

<CENTER><P><IMG SRC="../IMAGES/longhrn2.jpg" ALT="[Scouts on the Longhorn]" HEIGHT=223 WIDTH=320 BORDER=1>
</P></CENTER>

<P>
<HR></P>

<P><IMG SRC="../images/wideshot.gif" ALT="[Visitors Center]" HSPACE=5 BORDER=1 HEIGHT=75 WIDTH=225 ALIGN=CENTER>
<A HREF="http://wwwutmsi.zo.utexas.edu/index.htm">Return to MSI Home Page</A>
</P>

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-22</DOCNO>
<DOCOLDNO>IA026-000281-B014-333</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/tides.htm 192.138.168.29 19970113203753 text/html 6230
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:48:44 GMT
Last-modified: Thursday, 19-Dec-96 15:56:08 GMT
Content-length: 6039
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
  
<TITLE></TITLE>   
<META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<CENTER><IMG
SRC="../images/banner.gif" ALT="[UTMSI Banner]" HEIGHT="61" WIDTH="600" ALIGN="BOTTOM">
<IMG
SRC="../images/wideshot.gif" ALT="[Visitors Center]" HEIGHT="198" WIDTH="597" ALIGN="BOTTOM" BORDER=3>
</CENTER>
<HR WIDTH="100%">
<CENTER><A HREF="mainmap.map"><IMG
ISMAP="ISMAP" SRC="../images/mainmap.gif" HEIGHT="44" WIDTH="522"></A>
</CENTER> 
<HR WIDTH="100%">
<B><FONT SIZE="+3" ><CENTER>Tide Predictions for Port Aransas, Texas</CENTER> </FONT></B> 
<P>Tide charts are provided for the following months by Tony Amos of the University of Texas Marine Science Institute: </P> 
<CENTER><TABLE>
<TR>
	<TD><A HREF="../images/tide_jan.gif"><STRONG>January</STRONG></A>  </TD>
	<TD> <A HREF="../images/tide_feb.gif"><STRONG>February</STRONG></A>  </TD>
	<TD> <A HREF="../images/tide_mar.gif"><STRONG>March</STRONG></A>  </TD>
	<TD> <A HREF="../images/tide_apr.gif"><STRONG>April</STRONG></A>  </TD>
	<TD><A HREF="../images/tide_may.gif"><STRONG>May</STRONG></A>  </TD>
	<TD> <A HREF="../images/tide_jun.gif"><STRONG>June</STRONG></A>  </TD>
</TR>
<TR>
	<TD> <A HREF="../images/tide_jul.gif"><STRONG>July</STRONG></A>  </TD>
	<TD> <A HREF="../images/tide_aug.gif"><STRONG>August</STRONG></A>  </TD>
	<TD> <A HREF="../images/tide_sep.gif"><STRONG>September</STRONG></A>  </TD>
	<TD> <A HREF="../images/tide_oct.gif"><STRONG>October</STRONG></A>  </TD>
	<TD> <A HREF="../images/tide_nov.gif"><STRONG>November</STRONG></A>  </TD>
	<TD> <A HREF="../images/tide_dec.gif"><STRONG>December</STRONG></A>  </TD>
</TR>
</TABLE>
</CENTER><P>  </P>
<H2>Information about the Amos Tide Calendar:</H2> 
<P>The calendar shows predicted tides for the Aransas Pass Ship Channel
connecting the Gulf of Mexico with Corpus Christi Bay. Other locations will soon
be available. Predictions are based on a one-year series of measurements made in
1973-1974 at the Army Corps of Engineers stilling well tower which is located
off the South Jetty of the Aransas Pass just east of the University of Texas
Marine Science Institute's facility in Port Aransas. From the series, 37
harmonic constituents of the astronomical tide were calculated and used in a
modification of the standard National Ocean Survey tidal prediction program to
make hourly water level predictions and the times of the highs and lows for each
day. The water level is adjusted to mean sea level rather than the Gulf Coast
Datum. Consequently, the annual and semi-annual variation in sea level can be
clearly seen in the position of the daily tide fluctuations relative to the zero
mean sea level line (Compare January when low tides prevail with October when
the opposite is true). Each hour is indicated by a vertical line connecting the
curve with the zero line. In general, slack water will be at the times which the
curve intersects the zero axis, but when the curve is offset as in January and
October, some interpolation may be necessary. Flood and ebb tidal currents will
be at a maximum at the times of high and low water respectively. This
astronomical tide is often radically changed by strong winds before and during
the passages of cold fronts and during extra tropical depressions. The
astronomical signal will still be found &quot;riding&quot; on top of the
meteorological surges. Past history has shown that the predicted times are quite
accurate, although the range of the tides in the predictions is somewhat
exaggerated. The author is working on new predictions based on a multi-year
tidal series measured at the UTMSI pier (since 1985). </P> 
<P>Local times of the highs and lows are listed beneath each daily box (all
heights are given in feet and all times are local). They are listed in &quot;order
of appearance&quot;; if the first tide extreme is a low then the time and height
will be preceded by L1, for the Low 1. Heights here are given in feet and
inches. The next tide will be H1 for High 1, etc. These numbers may be difficult
to read on some VGA screens. Note: the English units are given here because it
is the system most commonly used by the general public. The shaded areas each
day show the hours of darkness. Phases of the moon are shown for each day with
the New Moon (NM), First quarter (FQ), Full Moon (FM), and Last Quarter (LQ)
marked on the moon symbol where appropriate. The relative size and shape of the
moon will be quite close to reality each day, but the moon's orientation is
always vertical on the calendar. The author is working on a method of depicting
the moon as it appears to the observer. The symbols appear on the night of the
day closest to when the phase occurs, e.g. If full moon is at 1215 (24-hour
clock) on the 25th of a month, then the symbol will appear straddling midnight
of the 25th. Should it occur at 1145 then the symbol will appear on the 24th of
the month. </P> 
<P>The local time zone in use is given at the top of each monthly chart. When
Daylight Savings Time comes into effect in April and reverts to standard time in
October is depicted by either a shorter or longer day and the symbol &quot;CDT&quot;
for Central Daylight Time, or &quot;CST&quot; for Central Standard Time on the
day these changes take place. Notice how it messes up a perfectly good calendar.
This was one of the more difficult aspects of the calendar to program. If anyone
notes any obvious errors or has any comments, please contact Tony Amos by email.
Hard copies may be obtained by writing or E-mailing him a request. </P> 
<P><A HREF="mailto:afamos@utmsi.zo.utexas.edu">Send a message to Tony Amos</A>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-23</DOCNO>
<DOCOLDNO>IA026-000281-B015-245</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/mfrp/mfrpproj.htm 192.138.168.29 19970113204229 text/html 23269
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:52:37 GMT
Last-modified: Friday, 13-Dec-96 22:04:08 GMT
Content-length: 23079
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>HTML document for the World Wide Web</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<P>

<CENTER>
<H1><FONT SIZE="+2">University of Texas Marine Science Institute</FONT><BR>
Marine Fish Research Program
<hr>
<H2>Recent and Ongoing Projects (by laboratory)
</H2></CENTER>
</H1>
<MENU><UL>
<LI><A HREF="#arnold">Team Arnold/Davis</A>
<LI><A HREF="#fuiman">Team Fuiman</A>
<LI><A HREF="#jholt">Team Holt (J.)</A>
<LI><A HREF="#sholt">Team Holt (S.)</A>
<LI><A HREF="#thomas">Team Thomas</A>
</UL></MENU>
<HR>


<CENTER><B><A NAME="arnold"></A>Ongoing Projects - Team Arnold/Davis</B>
<P>
(Staff: D. Allen, L. Johnston, J. P. Lazo, M. Li, J. Munoz, E. Thoman)
</CENTER>
<P>
<B>Maturation Laboratory</B>: This laboratory utilizes temperature
and photoperiod manipulations to induce spawning on a year round
basis. The primary function of this laboratory is to evaluate
spawning conditions for new species and to provide a year-round
supply of eggs for a wide variety of research projects.
<P>
Current parents:
<P>
<UL><LI>Red drum (<I>Sciaenops ocellatus</I>)
<LI>Yellowtail snapper (<I>Ocyurus chrysurus</I>)
</UL><P>
Future parents:
<P>
<UL><LI>Red snapper (<I>Lutjanus campechanus</I>)
<LI>Grey snapper (<I>Lutjanus griseus</I>)
<LI>Florida pompano (<I>Trachinotus carolinus</I>)
<LI>Atlantic croaker (<I>Micropogonias undulatus</I>)
</UL><P>
<B>Nutrition laboratories</B>: These laboratories are primarily
utilized to elucidate nutritional requirements and evaluate practical
feed ingredients for use in commercial feeds.
<P>
<I><B>Development of low pollution feeds</B></I>: This research
seeks to optimize feed formulations to reduce waste products produced
by the culture animal. 
<P>
1) <I>Development of nutrient dense diets</I>: This research has
concentrated on evaluating the effects of dietary manipulations
on growth and nutrient retention of red drum as well as changes
in water quality parameters in closed systems. Additionally, the
effects of medium chain triglycerides on growth and body composition
are being evaluated as a mechanism to reduce fat stores in cultured
fish.
<P>
2) <I>Evaluation of feed supplements</I>: 
<P>
a) <U>Enzymatic supplements</U>: Utilizing red drum and pacific
white shrimp as test species, the effects of a dietary protease
supplement is currently being evaluated for its effects on apparent
protein digestion.
<P>
b) <U>Feed grade phosphorus sources</U>: Utilizing the pacific
white shrimp as the test species, several inorganic phosphorus
sources are being tested to determine if differences in biological
value can be identified in practical feeds. 
<P>
<I><B>Semi- and closed recirculation systems</B></I>: These systems
are primarily used to development and demonstrate closed recirculation
technologies for the production of marine species. Work is currently
underway to refine techniques for the mass production of food
size shrimp and the production of marine species of commercial
values. 
<P>
<hr>
<CENTER>
<B><A NAME="fuiman"></A>Ongoing Projects - Team Fuiman</B>
<P>
(Staff: C. Faulk, K. Poling, M. Smith)
</CENTER>

<P>
<B>Comparative Anatomical and Functional Development of Sensory
Systems in Three Sciaenid Fishes</B>: Kirsten Poling is documenting
the developmental changes in the end-organs of visual and mechanosensory
systems of red drum, spotted seatrout, and Atlantic croaker. She
is measuring developmental changes in the performance of these
systems in order to understand the relationship of form to function.
She will use all of this information to draw some conclusions
about the role of sensory system development in ontogenetic niche
shifts of the three species.
<P>
<B>Biomarkers of Larval Fitness in Croaker Exposed to Pesticides</B>:
This is Team Fuiman's portion of a joint project with Peter Thomas'
lab. Cindy Faulk is using a collection of behavioral assays to
determine whether parental exposure to a model pesticide (DDT)
has ecologically significant sublethal effects on the larvae they
produce. The assays measure burst and routine swimming as well
as the performance of the visual and auditory systems.
<P>
<B>Presence, Ontogeny, and Function of Two Types of Neuromasts
in the Lateral Line System of Red Drum</B>: This collaboration
with Jiakun Song (University of Maryland and Smithsonian Institution)
is based on the recent discovery that aminoglycoside antibiotics
damage lateral line canal neuromasts but not superficial neuromasts.
Our work on larval red drum addresses questions on the development
and differential function of these potentially very different
sensory endorgans.
<P>
<B>Predation Mortality of Larval Fishes: Peril of the Unfit or
the Unfortunate?</B>: This collaboration with Jim Cowan (Dauphin
Island Sea Lab, Alabama) is examining the question of whether
predation mortality during early life is the result of chance
encounters with predators or the predator evasion skills of the
larvae. Laboratory assays measure survival skills of individual
larvae to determine whether some individuals excel in several
skills (born athletes). Laboratory results will be incorporated
into an individual-based model and simulations will be performed
to predict the survival of athletes and non-athletes. These predictions
will then be tested in mesocosm trials.
<P>
<B>Physical and Physiological Effects of Temperature on Larval
Fish Swimming</B>: This collaboration with Bob Batty (Dunstaffnage
Marine Laboratory, Scotland) is measuring the importance of natural
variations in water viscosity to the swimming performance and
kinematics of Atlantic herring larvae. Both routine (slow, aerobic)
and burst (fast, anaerobic) swimming modes are being studied.
<P>
<B>Effects of Temperature and Salinity on the Interaction between
Red Drum Larvae and a Piscine Predator</B>: Locomotor and physiological
performance of both predator and prey may be influenced by differences
in temperature and salinity, but the magnitude of the effects
may differ for larvae and larger fishes. This project examines
the responsiveness and response effectiveness of red drum larvae,
and the capture success of larger pinfish under 12 combinations
of temperature and salinity to determine relative importance of
these two natural environmental variables to the predatory-prey
interaction.
<P>
<hr>

<CENTER>
<B><A NAME="jholt"></A>Ongoing Projects - Team Holt (J.)</B>
<P>
(Staff: P. Douillet, C. Fernandez, P. Pickering, J. Rooker)
</CENTER>

<P>
Larviculture and high density grow-out studies of marine species
in closed systems aimed at developing a mariculture approach to
the conservation of natural resources.
<P>
1. Mariculture development throughout the world is hampered by
the lack of reliable rearing systems and practical diets for the
larvae. For example, high yields of red drum depend upon feeding
the larvae live prey for one to several weeks. In order to reduce
the requirement for live prey, feeding and nutrition studies here
are focused on understanding the <B>developing digestive system
and nutrient requirements for larval sciaenids</B>. The goal is
to determine essential nutrients for larvae and the best means
for supplying those nutrients.
<P>
2. <B>Role of microbial ecology in larval fish culture and nutrition</B>
has been investigated by Philippe Douillet. Initially the study
aimed to develop a scheme for managing the composition of the
microbial community in intensive, closed culture for red drum
larvae. The second phase was to identify and culture beneficial
microbes to add to the larva cultures. Currently we are exploring
the possibility of using enzyme producing gut- bacteria to enhance
the utilization of artificial diets.
<P>
3. <B>Culture of tropical reef fish and shrimp</B> would function
to conserve natural reef resources by offering alternatives to
wild capture. Over the past we have successfully spawned seven
reef species and reared the larvae of three: cubbyu (<I>Equetus
umbrosus</I>), yellow-tail snapper (<I>Ocyurus chrysurus</I>)
and a cleaner shrimp (<I>Lysmata wurdemanni</I>). Using the techniques
we developed for rearing the larvae, together with micro-zooplankton
culture it is possible that many coral reef species can be grown
in culture.
<P>
<B>Biochemical measures of fish growth and condition</B> to evaluate
the condition or growth potential of lab cultured or natural populations
of fish larvae.
<P>
1. Several biochemical measures are under investigation including
<I><B>RNA-DNA ratio, lipids, and MPF (Mitosis Promoting Factor)</B></I>.
The RNA-DNA ratio has been examined in larvae raised in the laboratory
under various feeding, salinity and temperature conditions, and
in natural population of red drum. The measure is a good indicator
of recent history of feeding and perhaps temperature conditions.
Studies by Claire Fernandez and others are investigating further
the effect of temperature history on the RNA-DNA ratio.
<P>
2. In a collaborative project with Mark Westerman, the usefulness
of <I><B>cyclin-dependent kinase activity</B></I>, predominantly
Mitosis Promoting Factor, in assessing how biological and environmental
inputs affect growth of teleost larvae is being investigated.
Classes of lipids (<I>ie..</I> tags, steroles, etc.)<I> </I>vary
depending on the nutritional state of larvae; this will be examined
when we get access to an Iatroscan possibly later this year (automated
thin layer chromatograph with a flame ionization detector). Both
methods will be compared to the RNA-DNA ratio in larvae with different
growth histories. 
<P>
Larval fish studies to determine the <B>role of biological and
physical factors in growth and survival of natural populations</B>
of estuarine dependent fishes.
<P>
1. Overall the salinity tolerance of spotted seatrout is broad
but we have shown that early life stages have reduced tolerance
with 3 day old larvae being the most sensitive. Egg size varies
inversely with salinity in natural spawning populations and the
range of tolerance in pre-feeding larvae is directly related to
spawning salinity. Furthermore changing the salinity on adults
brought into the lab during the spawning season has detrimental
effects on the development of eggs and larvae. Possible hypotheses
to explain the data we have accumulated thus far are (1) long-term
acclimation by adults to salinity regulates the pattern of salinity
tolerance found in young larvae, (2) non-genetic, possible irreversible
adaptation of the embryo or larva regulates salinity tolerance
at the population level, or (3) stocks or populations of spotted
seatrout are genetically adapted to the prevailing salinity regime
of a bay system.
<P>
2. In a collaborative study with S. Holt we are trying to identify
<I><B>critical periods during the transport of red drum and other
sciaenids</B></I> from spawning sites to estuarine nursery grounds.
The role of physical factors and vertical positioning on transport
of eggs and larvae through the Aransas Pass has been examined
in several studies. We found that larval sciaenids could use modified
tidal stream transport to reach estuarine nursery areas, by staying
in near- bottom water in the pass on ebb tide and moving up on
flood tide. Vertical movement was not associated with feeding
since larvae feed only during daylight hours and flood and ebb
cycles do not follow a strict diurnal pattern. The objectives
of an ongoing study are to determine the temporal pattern of spawning,
estimate density of larvae, and determine birthdate distribution
of young fish that successfully recruit to the sea grass beds
with the goal of quantifying physical and biological conditions
that result in high survival.
<P>
3. Studies by Jay Rooker and Andy Soto are examining <I><B>how
feeding, growth and condition of larvae in the sea grass beds
are affected by habitat and competition</B></I>. They will present
their research at a brown bag seminar in the near future. 
<hr>

<CENTER>
<B><A NAME="sholt"></A>Ongoing Projects - Team Holt (S.)</B>
<P>
(Staff: K. Binney, C. Pratt, A. Soto)
</CENTER>

<P>
The central theme of research in Scott Holt's lab is fish ecology,
with emphasis on larval and juvenile life history stages. Virtually
all the studies are field oriented and are comparative, using
&quot;natural&quot; experiments, rather than manipulative.
<P>
Recent projects include:
<P>
<B>Studies of the temporal and spatial distribution of fish larvae</B>
in the Laguna Madre and the <B>impact of the brown tide</B> on
those larvae. We have seen a dramatic decline in the density of
all early-stage fish larvae (incl. spotted seatrout and black
drum) in areas of high brown tide concentrations. Joan has lab
data showing high mortality of eggs and nonfeeding larvae and
reductions in feeding success of older larvae. Our field data
reflect those impacts. 
<P>
<B>Studies of the utilization of different seagrass habitats by
larvae</B> in the Laguna Madre. Jim Tolan recently completed a
MS at TAMUCC looking at the occurrence of fish larvae and early
juveniles in <I>Halodule</I>, <I>Syringodium</I> and adjacent
bare bottom in the lower Laguna Madre. He found that highest densities
of juveniles of most species was in <I>Halodule</I> with little
difference between <I>Syringodium</I> and bare bottom. Early larval
stages were found in all habitats but specific distributions varied
by species. In general, early larvae of species which spawn in
the open bay or inshore Gulf, (ie. spotted seatrout and red drum)
were found primarily over unvegetated habitat whereas those species
which spawn in structured habitat, especially those with demersal
eggs (i.e., gobies and silversides), were more common over seagrasses.
<P>
The primary focus of the rest of our research over the past 6-8
years has been the <B>migration of fish larvae from offshore spawning
grounds to estuarine nursery areas</B> with emphasis on transport
processes involved in ingress through the tidal inlet. Our focus
has been on red drum but we have accumulated similar data for
all other sciaenids in the collections and a few other species
as well. Much of this research has been done in cooperation with
Joan Holt and several of her students. 
<P>
We have looked at the temporal and spatial (both horizontal and
vertical) distribution of larvae over several tidal cycles and
found them most abundant in offshore water, as it pulses in and
out of the estuary with each tidal cycle. Densities in estuarine
water are only 10-20% of those in offshore water and those larvae
are generally of the largest size classes we see in the plankton.
The larvae change their vertical position in the water column
such that they are concentrated near then bottom during the day
and on ebb tide (especially those in estuarine water), and throughout
(we think) the water column during the night and on flood tide.
Flood tides are generally at night during red drum spawning time,
complicating the tidal/diel migration pattern. Larvae also appear
to be concentrated at the boundary of the tidal front separating
estuarine water from offshore water.
<P>
We examined the daily ingress of red drum larvae (and other sciaenids
occurring in the same samples) over the entire spawning season.
We found that the temporal occurrence of larvae was highly pulsed,
with much higher densities of larvae occurring in 2-3 day pulses
which were seen every 10-15 days over the immigration period.
Preliminary analysis indicates that the pulses were correlated
with wind events. Larvae of most other sciaenids occurring at
the same time also showed the same pulsed occurrence, further
strengthening the implication of physical control of the distribution
pattern. Chris Drescher looked at RNA/DNA in these larvae for
her thesis work (details are given in Joan Holt's section)
<P>
These studies of larval immigration have extended to the nursery
areas where we are looking at post-settlement processes. We have
examined the spatial and temporal distribution of newly settled
red drum larvae throughout the potential nursery area. The larvae
were occasionally found in all sites examined but were much more
abundant and persistent in some sites than others. We suspect
the differences are driven largely by hydrodynamic processes and
that issue is ripe for future research. Jay Rooker has looked
at differences in condition and growth rates among sites and between
seagrass habitats. Red drum larvae and early juveniles are much
more abundant in Halodule than Thalassia seagrass but condition
was not different between those habitats. Andy Soto is looking
at food habitats of red drum and Atlantic croaker in those habitats.
We are currently determining mortality rates of red drum larvae
and early juveniles in those habitats but are still working on
the data. A study of predation rates in both habitats in the works.
<P>
In almost all of these studies we have used the analysis of otolith
microstructure (ie growth rings) in some way. Our lab is set up
to determine both annual age in adults and daily age of larvae.
The primary information obtained is age of the individual fish
which provides an estimate of overall growth rate and the hatch
date of each larva. Jay Rooker has also used the width of the
outer most rings to determine recent growth for comparison of
habitats effects. We previously looked at pinfish growth rates
between <I>Halodule</I> and <I>Syringodium</I> habitats in the
Laguna (using overall growth rates) and found no difference in
growth. Otolith analysis is also being used to determine growth
rates of adult black drum in the Laguna Madre.
<P>
Another line of research we are developing, but which has not
yet culminated in a funded project, is the study of <B>sounds
made by spawning adult fishes</B>, primarily sciaenids. We have
the hydrophone and sound analysis software and have recorded spawning
activity of several species. Interaction wit other worked in this
field is encouraging and hopefully leading to funded research.
<P>
<HR> 

<CENTER>
<B><A NAME="thomas"></A>Ongoing Projects - Team Thomas</B>
<P>
(Staff: C. Detweiler, B. Hawkins, I. Khan, K. Rogowski, T. Sperry,
Y. Zhu)
</CENTER>

<P>
<B>Demonstration of a progestin (20-beta-S) receptor on sperm
membranes</B> and its characterization in testes is one of the
hot (cool!) projects in Thomas' lab. 20-beta-S is the maturation
inducing steroid in sciaenids which has been shown to be involved
in final oocyte maturation in Atlantic croaker and spotted seatrout.
Regulation of the membrane receptor in testes and sperm membrane
preparations is being investigated. Search is on to find a physiological
function of the membrane receptor in the testis and on sperms.
<P>
Charles Detweiler is currently working on <B>hormonal regulation
of sperm motility</B> in Atlantic croaker and spotted seatrout. He is also
investigating possible involvement of calcium channels in sperm motility 
in croaker.
<P>
Todd Sperry has <B>characterized androgen receptors in the brain
and ovary</B> of croaker. The ovarian androgen receptor(s) has
different characteristics from those of the brain androgen receptor.
Once these initial characterizations are completed we will begin
to attempt to understand the physiological roles of multiple androgen
receptors in Atlantic croaker.
<P>
Karen Rogowski's project involves examining <B>the role of prolactin
and growth hormone in osmoregulation and reproduction</B> of red
drum and croaker. Her work includes isolation and purification
of the two hormones from pituitary glands, raising of the antibodies
to these hormones, and development and validation of radioimmunoassays
for the measurement of these hormones.
<P>
One of Yong Zhu's project is to determine <B>physiological function(s)
of somatolactin</B>, a recently discovered hormone in fish. Somatolactin
appears to be involved in adaptation of the fish to background
and illuminations. A collaborative project with Prof. Katsumi
Aida's group at the Tokyo University, is underway to construct
red drum somatolactin cDNA library and to develop molecular probes
for future studies on somatolactin gene expression. In addition,
he is working on the purification of 20-beta-<A NAME="start">S
membrane receptor from seatrout ovaries.</A>
<P>
Izhar Khan is involved in the projects on multifactorial <B>neuroendocrine 
control of gonadotropin secretion</B> in Atlantic croaker.  Role of the 
monoamine and amino acid neurotransmitters, neuropeptides, and gonadal 
steroids in the control of gonadotropin release from the pituitary is 
being investigated.  Collaborative work with Prof. Yonathan Zohar's group 
at the Center of Marine Biotechnology, University of Maryland, Baltimore 
is in progress to develop molecular probes for the localization and 
quantification of gonadotropin-releasing hormone mRNAs in croaker brain.  
Development of a comprehensive marine fish model of neuroendocrine 
control of gonadotropin release provides the basic framework for our 
<B>neuroendocrine toxicology program</B>.
<P>
Beth Hawkins has cloned and sequenced the <B>estrogen and progesterone
receptor genes</B>. She has developed molecular probes to localize
and quantify estrogen receptor mRNA by in situ hybridization.
These molecular tools will help us understand the GnRH and estrogen
receptor function in discrete brain areas that are involved in
the control of reproduction in croaker.
<P>
<B>Interactions of environmental chemicals with the 20-beta-S
membrane receptor</B>. A variety of chemicals have been shown
to bind to the membrane receptor. Attempts are being made to purify
this receptor. A series of in vitro and in vivo experiments are
planned to test whether the binding of the chemicals to this receptor
can alter normal receptor functions including final oocyte maturation,
ovulation and spawning success.
<P>
Investigation of life history stages of croaker susceptible <B>to
environmental endocrine disruptors</B>. This project proposes
to study the mechanisms of reproductive impairment by a variety
of chemicals including xenoestrogens and heavy metals during different
stages of gonadal cycle as well as teratogenic effects of the
chemicals due to parental exposure.
<P>
Another major project in reproductive toxicology is on the <B>interactions
of xenoestrogens with androgen and other steroid receptors</B>
using croaker as a model species.
<P>
<hr>
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> </BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-24</DOCNO>
<DOCOLDNO>IA026-000281-B015-300</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/STAFF/AFAMOS/TS-JOS96.htm 192.138.168.29 19970113204409 text/html 1739
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:54:20 GMT
Last-modified: Wednesday, 13-Nov-96 22:33:20 GMT
Content-length: 1547
Content-type: text/html
</DOCHDR>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<CENTER><IMG  SRC="ts-jos96.gif" BORDER=3></CENTER><BR>
The graph shows the predicted and recorded tides at the UTMSI Pier
Laboratory tide gage located off the South Jetty of the Aransas Pass (27
50.3'N; 097 03.0'W) which connects Corpus Christi Bay to the Gulf of
Mexico.  The graph covers a 14-day period starting 30 September 1996 during which
high tides from Tropical Storm Josephine caused considerable coastal
flooding and beach erosion.  The peak high came at 0158 CDT 07 October
1996 with a level of 3' 1" above Mean Sea Level (MSL).  At that time
Josephine still bore the ignominious name "Tropical Depression #10", but
even so, erosion from this storm produced the most beach erosion on
Mustang Island since Hurricane Allen in August 1980, slightly greater than
September 1988's Hurricane Gilbert erosion.<BR>
<BR>
The tides are referenced to MSL.  Note that almost all of October's tides
are above MSL.  October has the highest astronomical tides of the
year.  Note also that the storm-elevated water level remained high
for nearly a week and that it fortunately arrived as the
astronomical tides were in a diminishing period.  One week earlier
or later and an additional foot of water would have done even
greater damage.
<HR> 
<P><IMG
SRC="file:///E|/NETSCAPE/ns-home/docs/wideshot.gif" ALT="[Visitors Center]" HSPACE="5"
BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</DOC>
<DOC>
<DOCNO>WT01-B18-25</DOCNO>
<DOCOLDNO>IA026-000281-B018-298</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/afamos/amosfame.htm 192.138.168.29 19970113210134 text/html 1887
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:11:40 GMT
Last-modified: Wednesday, 13-Nov-96 22:30:14 GMT
Content-length: 1695
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
  
<TITLE>Tony Amos</TITLE>   
<META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<H1 ALIGN="CENTER">Tony Amos - A Most Impressive, Intriguing, and Influential
Texan</H1> 
<P>
</P>
<HR> 
<P><IMG
SRC="../../images/afamos1.jpg" ALT="Tony Amos with gear in hand" HEIGHT="249"
WIDTH="208" ALIGN="LEFT"><B>TONY
AMOS IN TEXAS TOP TWENTY -</B> &quot;The most impressive, intriguing, and
influential Texans of 1996&quot; - that is how <I>Texas Monthly</I> describes
them on the cover of the September issue. And while Chuck Norris occupies the
cover, it is &quot;<B><I>Altruistic Amos</I></B>&quot;, in his now familiar
Moses pose, complete with halo, who stands atop the table of contents page. Now,
kindly turn to page 114, for a full-page color photo of the
<I>MSI Mustang Island Moses</I> along with an accompanying highly complimentary
article. If you don't subscribe to <I>Texas Monthly</I>, you will want to at
least pick up the September issue. If you can't find that issue,
<A HREF="http://www.texasmonthly.com/archive/tex20/amos.html">click here</A> to
read the article on Tony directly from <I>Texas Monthly's</I> home page.</P> 
<P><BR></P>
<P><B>Tony on the beach, armed for a beach survey.</B></P> 
<P>
</P>
<P><BR></P>
<P><BR></P>
<P><BR></P>
<P><BR></P>
<HR> 
<P><A HREF="../../index.htm#top_home"><IMG
SRC="../wideshot.gif" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225"
ALIGN="CENTER"></A><A
HREF="../../index.htm#top_home">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-26</DOCNO>
<DOCOLDNO>IA026-000283-B017-304</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/50years/openhous.htm 192.138.168.29 19970113210317 text/html 4055
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:13:16 GMT
Last-modified: Sunday, 11-Aug-96 19:33:58 GMT
Content-length: 3866
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>UTMSI Open House</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY>

<P>

<CENTER>
<IMG SRC="../../images/group.jpg" ALIGN="BOTTOM">
<P>
<I>50 Years of the Science and the Sea</I>
<P>
Aftermath of the <I>Marine Science Institute's</I> <B>Open House</P></B>
<P>
Click <A HREF="phototour.htm">here</A> for a photo tour of the
event
</CENTER>

<P>
An Open House kicked off our celebration of <I><B>50 Years of
the Science and the Sea</B></I> at the <B>Marine Science Institute</B>.
It was held on Saturday, May 25, at the MSI adjacent to the Corpus
Christi Ship Channel in Port Aransas from 10 a.m. to 6 p.m.</P>
<P>
By all accounts the event was a great success. There were between
1000 and 1500 visitors to the Institute that day. Most were treated
to many tours of the facilities, including the popular Fisheries
and Mariculture Laboratory. About 120 people were lucky enough
to win a 2-hour science cruise aboard the R/V KATY, during which
they sampled the water to discover new and exciting things about
creatures that live in the bay. </P>
<P>
The community of Port Aransas gave strong support to our 50th
anniversary celebration. The local newspaper, the <A HREF="phototour.htm">South Jetty</A>,
ran several stories about the Institute and the Open House for
weeks prior to the event. Many local merchants, the Chamber of
Commerce, and the Library gladly allowed us to post announcements
for the Open House at their locations. The Mayor of Port Aransas
honored us by proclaiming May 25th as <I>&quot;University of Texas
Marine Science Institute Day.&quot;</I> Many civic groups, including
the Rotary Club, Lions Club, VFW, American Legion, Keep Port Aransas
Beautiful, and EMS Auxiliary, provided <A HREF="../../images/openhouse/ohtour8.gif">food and drink</A>
for our guests. EMS personnel were on hand all day. And most of
all, a huge number of residents came out to visit the Institute.
</P>
<P>
Here are some of the things that went on during the Open House:</P>
<H3><STRONG>&#183; Escorted and Self-Guided <A HREF="../../images/openhouse/ohtour1.gif">Tours</A></STRONG>
</H3>

<UL>
<LI>Research laboratories studying &quot;Animals Under Foot&quot;,
fish behavior, &quot;Seagrasses vs. Brown Tide,&quot; pollution
effects, oceanographic instrumentation, and more 
</UL>

<UL>
<LI><A HREF="../../images/openhouse/ohtour2.gif">Pier Laboratory</A>
over the Corpus Christi Ship Channel where the plankton collection
process was observed and the sounds of the underwater world were
heard 
</UL>

<UL>
<LI>Teaching facilities including the video classroom linking
graduate students in Port Aransas and Austin, a typical lecture
hall and a classroom laboratory 
</UL>

<UL>
<LI><A HREF="../../images/openhouse/ohtour5.gif">Fisheries and Mariculture Laboratory</A>
which features a fish greenhouse, a shrimp growing tank and raceways,
20-year-old redfish, yellowtail snapper, tropical coral reef fish,
and 100-pound ling. A free trolley provided transportation from
the MSI to the Fisheries and Mariculture Laboratory at regular
intervals 
</UL>

<P>
<B>&#183; Live demonstrations and touch tanks</B> filled with
sea <A HREF="../../images/openhouse/ohtour9.gif">creatures to see</A>
and touch</P> 
<P>
<B>&#183; Short presentations and discussions</B> by MSI scientists</P>

<P>
<B>&#183; Science</B> <B>cruises</B> on the Research Vessel <I>KATY</P></I>
<P>
<B>&#183; Continuous showing of marine science videos</B> from
7 to 15 minutes in length </P>
<H4>&#183; Educational presentations for children</H4>

<HR>

<P>
Open this colorful <A HREF="rackcard.jpg">flyer</A> to view additional
information on the open house and other 50th Anniversary events
(381K - jpeg)</P> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-27</DOCNO>
<DOCOLDNO>IA026-000283-B017-443</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/50years/phototour.htm 192.138.168.29 19970113210539 text/html 1883
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:15:46 GMT
Last-modified: Tuesday, 26-Nov-96 14:50:22 GMT
Content-length: 1693
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Photo Album of MSI's 50 Year Celebration Open House</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">


<H1 ALIGN="center">Photo Album of MSI's 50 Year Celebration Open
House</H1>

<HR>

<P>
For those who could not attend our Open House, we offer these
photographs to give you a flavor of the event. These pictures
appeared in the Port Aransas newspaper, <I>South Jetty</I>, on
May 30, 1996. Our thanks to <I><B>Murray Judson</B></I> for taking
the pictures. </P>
<HR>

<P>
<TABLE><TR><TD COLSTART="1"><A HREF="../../images/openhouse/ohtour1.gif">Tours</A></TD><TD COLSTART="2"><A HREF="../../images/openhouse/ohtour2.gif">Pier Lab</A></TD><TD COLSTART="3"><A HREF="../../images/openhouse/ohtour3.gif">Baby Fish</A></TD><TD COLSTART="4"><A HREF="../../images/openhouse/ohtour4.gif">Sign Up Now</A></TD><TD COLSTART="5"><A HREF="../../images/openhouse/ohtour5.gif">Fishery Lab</A></TD></TR><TR><TD COLSTART="1"><A HREF="../../images/openhouse/ohtour6.gif">Visitors' Center</A></TD><TD COLSTART="2"><A HREF="../../images/openhouse/ohtour7.gif">See Turtles</A></TD><TD COLSTART="3"><A HREF="../../images/openhouse/ohtour8.gif">Food for All</A></TD><TD COLSTART="4"><A HREF="../../images/openhouse/ohtour9.gif">Close-Up</A></TD><TD COLSTART="5"><A HREF="../../images/openhouse/ohtour10.gif">Displays</A></TD></TR></TABLE>
<HR> 
<P><IMG SRC="../../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-28</DOCNO>
<DOCOLDNO>IA026-000283-B018-52</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/academic/reuprog.htm 192.138.168.29 19970113210632 text/html 21494
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:16:52 GMT
Last-modified: Thursday, 11-Apr-96 15:12:06 GMT
Content-length: 21302
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">
<HTML><HEAD><TITLE>REU Program - UTMSI</TITLE></HEAD>
<BODY><CENTER><H3>Marine Science Institute</H3><H3>The University of Texas
at Austin</H3><H3>Undergraduate Student Summer Intern Program in Marine Science</H3><H4>
June 7 - August 16, 1996</H4></CENTER>
<HR>
<H2>PROGRAM 
</H2>
<P>The Marine Science Institute (MSI) will serve as a Research Experiences for
Undergraduates Site sponsored by the National Science Foundation for the Summer
of 1996.  The program will support 10 students to work with faculty and research
staff.  Financial support includes a $2500 stipend plus dormitory and food
service at the MSI for the ten-week session (June 7 - August 16).  Student
participants will work with faculty and research staff on a research topic and
in developing oral and written reports at the conclusion of the session. 
Research topics include studies on nutrient cycling and productivity in local
bays, marine botany, marine microbiology, marine viruses, zooplankton ecology,
benthic ecology, larval fish ecology, fish reproductive physiology and
mariculture.  All participants will be invited to participate in  research
cruises on the R/V LONGHORN to the Laguna Madre and Gulf of Mexico. 
</P>
<H2>FACILITIES 
</H2>
<P>The Marine Science Institute is located in Port Aransas, Texas, about 35
miles from Corpus Christi.  Facilities on the 72-acre campus include 83,000 sq.
ft. of research and teaching laboratories equipped for marine and estuarine
studies, while the Mariculture Lab occupies 26,000 sq. ft. on 10 acres. 
Dormitory facilities provide housing for up to 70 visitors and daily meal
service is provided in the cafeteria.  Located on Mustang Island bordering the
Gulf of Mexico and Corpus Christi/Aransas Bays, the MSI offers a large variety
of habitats for study. 
</P>
<H2>HOW TO APPLY 
</H2>
<P>Applicants must be citizens or permanent residents of the United States and
its possessions and must be enrolled in a degree program leading to a bachelor's
degree.  Students who will have received their bachelor's degree prior to August
17, 1996 are not eligible.  Applicants are required to submit 1) the completed
application form, 2) a letter describing their general background and interests
in pursuing a research experience, 3) a current undergraduate transcript, and 4)
one letter of reference from an individual familiar with the student's
performance by April 1, 1996, (please include your current and permanent
addresses, telephone numbers, and social security numbers), to: Student Summer
Intern Program, Marine Science Institute, The University of Texas, 750
Channelview Drive, Port Aransas, Texas  78373 (Telephone 512-749-6721; fax
512-749-6777).  Selections will be made by 1 May 1996.
</P>
<HR>
<H2>Faculty Research Profiles  
</H2>
<P>The opportunities for experiences in various laboratories and research
programs of faculty and staff in the Marine Science Institute and the Department
of Marine Science are described below.  Each section is written by a faculty
member  who had active undergraduate participation in the past.  They describe
the thrust of their programs and specific experience.
</P>
<H3>
Marine Chemistry - Dr. E. Ingall 
</H3>
<P>The flux of constituents to and from marine sediments exerts a strong
control on the composition of the oceans.  These fluxes are largely determined
by the chemical, physical and biological transformations that occur in sediments
shortly after deposition of a particle at the sediment-water interface.  My
research focuses on understanding these transformations by looking at trends in
sediment pore water and solid phase chemistry and by directly measuring sediment
fluxes.  An undergraduate student working in my lab would be exposed to the
various analytical techniques needed to characterize the chemistry of marine
sediments and waters.  The student will then apply these techniques to a small
research project where they will gather and interpret the data and present the
results.  For example, the REU student, who worked in my lab last year,
completed a project on the burial and preservation of the important nutrient
phosphorus in sediments from the Black Sea.  This work resulted in the
publication of an abstract for 1994 Fall American Geophysical Union meeting. 
</P>
<H3>Nutrient Chemistry and Phytoplankton Ecology - Dr. T. Whitledge
</H3>
<P>
Research experience for undergraduate students in my laboratory and field
studies concern the interaction of nutrient distributions and dynamics with
phytoplankton in Texas bays and estuaries and the Gulf of Mexico shelf. These 
studies investigate the effect of freshwater inflow on the nutrient availability
 and phytoplankton production in Texas estuaries.  This is a continuing project 
which was started in 1986 that is investigating the biological effects of 
nutrient inputs from the rivers in terms of phytoplankton production and
nutrient  regeneration processes.  Monthly surveys and biological productivity
measurements  have been conducted for the past six years during periods of
variable natural  inflows and freshwater releases from dams. Extensive
opportunities exist for  students to participate in both field and laboratory
work.   Other research  opportunities will be the effect of a persistent brown
tide bloom in Laguna Madre.  This project is investigating the hydrographic,
nutrient and phytoplankton growth relationships which prevail to maintain a
dense bloom of brown algae sp. in the Laguna Madre for the past three years. 
Monthly surveys and phytoplankton productivity studies have investigated the
role of nutrient enrichment processes in the maintenance of the phytoplankton
bloom conditions throughout the seasonal and annual cycles.    
</P>
<H3>Marine Botany - Dr. K. Dunton 
</H3>
<P>Undergraduate students have participated in a variety of projects in Dr.
Dunton's laboratory for the past six years.  Research activities are related to
field and laboratory studies on seagrasses, emergent vascular plants and marine
algae.  The students are often paired with either a post-doctoral or graduate
student under Dr. Dunton's supervision.  This provides the student an
opportunity to work alongside another young researcher and develop the project
he/she wishes to pursue.  Students are expected to develop their project to
address a particular question or hypothesis and are encouraged to participate
directly in the collection of samples and their analysis.  Specific techniques
that students have learned in my laboratory include the measurement of
photosynthesis in marine plants using oxygen electrodes to construct models of
plant production.  These measurements employ a variety of equipment, since the
approach involves both laboratory and field incubations.  Other projects are
more field oriented and involve making measurements related to the production
ecology of seagrasses or marsh vegetation (growth, biomass, sediment and water
column nutrient concentrations, etc.).  Still others have included work with
arctic kelp to examine nutrient effects on growth, nutrient uptake rates, etc. 
The diversity of on-going studies have always provided a stimulating atmosphere
for undergraduate students in this lab.   
</P>
<H3>Zooplankton Ecology - Dr. E. Buskey 
</H3>
<P>Research experiences for undergraduates in my laboratory would include
learning techniques for culturing marine phytoplankton and zooplankton, and
studying aspects of their feeding, growth and in the case of some dinoflagellate
species, their bioluminescence. We keep approximately 20 species of
phytoplankton in continuous culture, and use these species for culturing a
variety of protozoan and metazoan zooplankton species, including heterotrophic
dinoflagellates, ciliates and copepods. Protozoan species are isolated from
local waters and brought into continuous culture for study. We study their
feeding and growth under controlled laboratory conditions, and employ modern
staining techniques and epifluorescent microscopy for sample enumeration.
Studies presently underway include investigation of the effects of a nuisance
algal bloom on the growth and feeding of zooplankton. This small chrysophyte has
been present in local waters for the past 3.5 years at population densities
exceeding 106 cells ml-1, and has caused a major shift in zooplankton community
structure.Most species of zooplankton seem to grow and feed poorly on this
chrysophyte, especially at the high concentrations found in nature. Another
study involves an examination of the relationship between nutrition and
bioluminescence in heterotrophic dinoflagellate species. Most other
bioluminescent zooplankton seem to vary little in the brightness of their
bioluminescence, but the bioluminescence of heterotrophic dinoflagellates seems
to vary greatly with their nutritional state and growth rate. This research is
part of a larger effort to produce a model to predict the distribution of
bioluminescence in the sea.  Another major thrust of research in my laboratory
is studies of behavior of marine zooplankton, especially predator-prey
interactions. Studies involved in these studies would learn state-of-the-art
video-computer techniques for image and motion analysis. We have equipment
available for videotaping marine zooplankton in situ, and quantifying their
swimming behavior using a computerized motion analysis system. Studies presently
underway in my laboratory include a study of swarming behavior in marine
copepods and its role in avoiding predation by fish. This research includes
field work on mangrove-associated tropical copepods at the Smithsonian field
station at Carrie Bow Cay. We also are involved in studies of the factors
influencing selective feeding of larval fish on microzooplankton. We quantify
the behavior (including escape responses) and visual contrast of
microzooplankton prey to determine the factors influencing feeding selectivity
at the encounter, attack and capture phases of predatory behavior.  
</P>
<H3>Benthic Ecology and Invertebrate Zoology - Dr. P. Montagna 
</H3>
<P>Special emphases are being placed on meiofaunal and macrofaunal community
structure and population biology, and environmental studies.  Currently, my
laboratory is very active.  I have two Ph.D. students, one masters student, a
Postdoc and three technicians.  So, there are lot's of people to interact with. 
There are three programs in which undergraduates can participate.  The goal of
one project is to determine the importance of freshwater inflow to Texas
estuaries.  This is part of a multi-year, interdisciplinary program to determine
the affect of freshwater inflow on secondary productivity in Texas estuaries. 
The current focus is on the long-term climatic effects on inflow and nutrients,
which influence macrofaunal community structure and biomass.    The goal of
another project is to determine the effect of a persistent brown tide bloom in
the Laguna Madre.  This is an interdisciplinary effort to determine how brown
tide has effected the ecosystem.  Due to the persistent brown tide, turbidity is
now high, and we are concerned that the seagrass habitat is endangered.  Current
studies focus on how diversity and secondary production are effected and how the
food web has been altered by the presence of the brown tide organism.  In
particular, we are trying to understand the interactions between filter-feeding
organisms and the brown tide algae.    The goal of the third project is to
determine sublethal responses to contaminant exposure.  This is also a large
interdisciplinary program to determine if there are long-term consequences of
oil and gas production in the Gulf of Mexico.  The concern is that there may be
sublethal responses to production that have not been detected.  Our study
focuses on the response of meiofaunal community structure, harpacticoid
reproduction, genetics, and life history patterns, and meiofaunal toxicity
responses that are a result of environmental perturbations. 
</P>
<H3>Ecology of Developing Fishes - Dr. L. Fuiman 
</H3>
<P>Research projects in Dr. Lee A. Fuiman's laboratory focus on the ecology of
developing fishes.  Most of these studies require rearing of various fish
species from eggs, through larvae, to juveniles.  Undergraduate experiences here
will begin with the methods of small-scale fish culture, including cultivation
of algae, rotifers, and crustaceans.  This will expose students to a variety of
laboratory practices (preparation of sterile media, water-quality testing,
routine maintenance of cultures, data recording).  In the process of rearing the
fish, the undergraduate student will become acquainted with the life cycle of
the food organisms (algae, rotifers, crustaceans) as well as the development of
the fish.  Beyond fish culture duties, the student will participate in one or
more ongoing research projects on the ecology of developing fishes.  These are
likely to include tests of the development of sensory system function in fishes
(including the visual and mechanosensory systems), measurements of swimming
performance, and analyses anti-predator responses.  The student will work with
Dr. Fuiman and his graduate students in data acquisition and analysis.  These
research projects usually involve video recordings of experiments.  Data are
acquired from the video tapes by a computerized interface.  Thus, students may
gain experience in image analysis (including morphometry) and motion analysis
(frame-by-frame digitization) in the process of data acquisition.  Further
computing experience will come during data analysis.    There may also be an
opportunity for field research on the ecology of fishes.  This may include
survey research (collections of specimens at various sites) or experimental
field work.  Experiences here might include work with plankton nets, seines,
trawls, and experimental enclosures.
</P>
<H3>
Larval Fish Ecology and Larval Fishes - Dr. J. Holt 
</H3>
<P>Opportunities for research in larval fish ecology and aquaculture are
available in G. Joan Holt's labs at the Fisheries and Mariculture facility of
the Marine Science Institute.  At present there are four students, two
technicians and a postdoc studying many aspects of marine fish larvae who would
be available to interact with undergraduates working in the lab.  Areas of
ongoing research in which students may participate include: 
</P>
<P>Studies of the effects of changing salinity on spawning, egg and larva
development of spotted seatrout (Cynoscion nebulosus.</P> 
<P>Investigations into the requirements for spawning and raising tropical reef
fishes of the Gulf of Mexico and Caribbean Sea.</P>
<P>Evaluation of the role of microbial ecology in larval fish nutrition.</P> 
<P>Biochemical measures of fish growth including RNA/DNA for assessment of
habitat quality and nutritional status.</P> 
<P>Field studies focusing on the importance of seagrass beds as nursery habitat
for larval and juvenile fish.</P> 
<P>Larval fish feeding studies including the effects of prey behavior and
density on food selectivity by larval fish.</P>  
<P>Many undergraduates have worked in my lab during the summer and have gone on
to graduate studies in biology or marine biology.  Students are allowed to be
active participants in research projects and are encouraged to take part in
discussions about the results and planning for future studies.  These
opportunities allow undergraduate students to explore their latent curiosity in
marine science and to amplify this interest into defined career goals. 
</P>
<H3>Reproductive Fish Physiology - Dr. P. Thomas 
</H3>
<P>Students would receive broad training in reproductive fish physiology with
an emphasis on the terminal stages of the reproductive cycle, final oocyte
maturation and spawning.  The proposed project draws on previous experience with
training two undergraduate students, Toshma Thomas (Jackson College, 1990) and
Claire Fernandez (Texas A&amp;M University, 1991).  The spotted seatrout
(Cynoscion nebulosus), a well established model of reproductive endocrinology,
will be used for the experimental work.  Students would receive theoretical and
practical instruction in all aspects of the project and then gradually assume
greater responsibility for conducting their own research.  Adult seatrout with
fully grown gonads will be collected on their spawning grounds and acclimated to
laboratory conditions.  Training on the effective and humane care of wild fish
for research purposes will be prioritized.  Several methods to sex fish will be
evaluated.  Earlier in the reproductive season vitellogenin, a female specific
yolk protein precursor, and 11 ketotestosterone, the male sex steroid hormone
will be measured in the blood.  The sex and stage of gametogenesis will be
determined by intragonadal catheterization once the gonads have begun to
recrudesce.  Fish will be induced to spawn by the administration of
luteinizing-hormone releasing hormone analog.  Spawning success, fecundity and
fertilization success will be determined and the fertilized eggs will be exposed
to various environmental factors until 4 days after hatching when the larvae
begin feeding.  Environmental factors such as salinity, temperature, ammonia
levels and UV radiation would be investigated and biological endpoints such as
hatching success, percent deformities and survival could be measured.  Students
would be expected to develop their own research projects on reproductive
success.  A separate series of experiments would investigate the hormonal
control of final oocyte maturation using an in vitro germinal vesicle breakdown
bioassay technique.  Initially students would repeat structure-activity steroids
with hormones to learn the morphological changes associated with final oocyte
maturation and the concepts of hormone specificity at the receptor level. 
Afterwards students would be encouraged to develop their own research projects
on subjects such as the role of &quot;priming&quot; with gonadotropin on hormone
responsiveness, role of gap junctions, protein and RNA synthesis and ion
channels.  Well designed studies on the regulation of this process would be of
considerable scientific interest and publishable.  Finally, students would
obtain broader perspective on reproductive physiology by attending the weekly
journal club/research meetings in Thomas' laboratory and by learning about a
dozen different projects being conducted by students and postdoctoral fellows in
the laboratory. 
</P>
<H3>Fisheries and Mariculture - Dr. C. Arnold 
</H3>
<P>In the Fisheries and Mariculture Program there are several professional
biologists and graduate students which the students will spend some part of the
summer working with.  This will give the students a chance to participate in the
various areas of research.  As one of the state's most diversified mariculture
facilities, students are given a unique opportunity to be cross-trained in
various aspects of the culture of marine species which include:
</P>
<H4>Culture of unicellular microalgae
</H4>
<H4>Mass culture of marine algae and rotifers
</H4>
<H4>Maturation and reproduction of marine fish
</H4>
<H4>Production and care of larval and juvenile fish and shrimp
</H4>
<H4>Maintenance of marine species in intensive culture systems
</H4>
<H4>Fish and shrimp disease diagnostics 
</H4>
<HR>
<P>UTMSI offers exposure to a wide variety of scientific and culture expertise
allowing exposure to a broad area of the marine science as well as experience
that is applicable to the commercial mariculture industry. 
</P>
<HR>
<H2>REU APPLICATION</H2>
<P>
                        </P>
<P>Personal Information  
</P>
<P>Name:                </P>
<P>                                                                            
     </P>
<P>Social Security #: </P>
<P>Current Address:</P>
<P></P>
<P>Telephone:</P>
<P>E-mail:</P>
<P>Permanent Address:</P>
<P></P>
<P>Telephone:</P>
<P>Parent/Guardian (Emergency contact):</P>
<P>Sex (for housing):</P>
<P></P>
<P>Information for reporting to State, Federal and Equal Employment Opportunity
Agencies
</P>
<P>Birthdate:</P>
<P></P>
<P>Applicants Must Include:
</P>
<P>1.   This completed application form;
</P>
<P>2.   A letter describing their general background and interests in pursuing
a research experience;
</P>
<P>3.   A current undergraduate transcript;
</P>
<P>4.   One letter of reference from an individual familiar with the student's
performance by April 1, 1996.
</P>
<P></P>
<P>Mail to:
</P>
<ADDRESS>Undergraduate Student Summer Intern Program</ADDRESS>
<ADDRESS>The University of Texas at Austin</ADDRESS>
<ADDRESS>Marine Science Institute</ADDRESS>
<ADDRESS>750 Channelview Drive</ADDRESS>
<ADDRESS>Port Aransas, TX 78373</ADDRESS>
<HR> 
<P>
<A HREF="../index.htm#top_home"><IMG SRC="../images/smseal.jpg" ALIGN="BOTTOM">
Return to MSI Home Page</A>
</P>
<HR> 
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-29</DOCNO>
<DOCOLDNO>IA026-000283-B019-300</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/msidir.htm 192.138.168.29 19970113211827 text/html 1610
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:28:38 GMT
Last-modified: Thursday, 19-Dec-96 21:30:20 GMT
Content-length: 1419
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>UT Electronic Directory</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<CENTER><FONT COLOR="Red"><H1>Electronic Directory</H1></FONT></CENTER>

<CENTER>The University of Texas at Austin -- Students, Faculty, Staff
</CENTER><P>
<BR>
The correct mailing address for everyone at the Marine Science
Institute is:
<P>
<I><B>The University of Texas at Austin</B></I><BR>
<I><B>Marine Science Institute</B></I><BR>
<I><B>750 Channelview Drive</B></I><BR>
<I><B>Port Aransas, Texas 78373</B></I><P>

<FORM ACTION="http://ds1.utexas.edu:8888/So%3dThe%20University%20of%20Texas%20at%20Austin%2c%20st%3dTexas%2c%20c%3dUS">

<P>
<A HREF="http://ds1.utexas.edu:8888/Mo%3dThe%20University%20of%20Texas%20at%20Austin%2c%20st%3dTexas%2c%20c%3dUS">Enter name here:</A>
<INPUT NAME="S" VALUE="" SIZE=30><INPUT TYPE=submit VALUE=SEARCH>
</FORM>

<P><BR>
The <I>Electronic Directory </I>is published by the Computation
Center in cooperation with Data Processing, Office of Human Resources,
and the Registrar. <BR>
Copyright 1996, The University of Texas at
Austin.
<HR>
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-30</DOCNO>
<DOCOLDNO>IA026-000283-B020-57</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/academic/gradprog.htm 192.138.168.29 19970113212200 text/html 9239
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:31:27 GMT
Last-modified: Thursday, 14-Nov-96 15:05:42 GMT
Content-length: 9048
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">
<HTML>
<HEAD>
<TITLE>GENERAL INFORMATION FOR GRADUATE STUDENTS</TITLE> 
</HEAD> 
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<H1>
</H1>
<CENTER>
<H2>Graduate Degree Program</H2>
</CENTER>  
<HR> 
<H2>
</H2>
<CENTER>
<IMG SRC="../images/resrch1.gif" ALIGN="BOTTOM" BORDER=3> 
</CENTER>
<HR>
<P>These Web pages provide general information as a courtesy to viewers.
<A HREF="gopher://gopher.utexas.edu:3003/11/pub/registrar/catalog/cat-grad">The
Graduate Catalog</A> is the document of authority for rules and regulations
governing graduate study. The University reserves the right to change the
requirements given in the catalog at any time. 
</P>
<HR>
<DL>
<DT><A HREF="#General_info">General Information</A>
</DT>
<DD>Background about program, Master of Arts degree, Doctor of Philosophy,
areas of specialty
</DD>
<DT><A HREF="letter.htm">Dear Prospective Student</A>
</DT>
<DD>Letter from the Graduate Adviser
</DD>
<DT><A HREF="courses.htm">Courses</A>
</DT>
<DD>Descriptions and schedules for core and advanced courses in marine science
</DD>
<DT><A HREF="deadline.htm">Important Dates</A>
</DT>
<DD>Deadlines and dates related to admission
</DD>
<DT><A HREF="http://www.petersons.com/sites/gradinc/82953012.html">Peterson's
Guide Listing</A>
</DT>
<DD>Details from Peterson's Internet and Interactive Admissions Services  
</DD>
<DT><A HREF="http://www.utexas.edu/student/giac/">Office of Graduate and
International Admissions</A>
</DT>
<DD>Application forms and official information regarding admission to Graduate
Programs at The University of Texas at Austin 
</DD>
<DT><A HREF="mailto:gradinfo@utmsi.zo.utexas.edu">Graduate Information Packet
</A>
</DT>
<DD>E-mail request for information packet and admissions application 
</DD> 
</DL>
<HR> 
<H2>
</H2>
<CENTER>
<A NAME="General_info"><STRONG>General Information</STRONG></A>
</CENTER>  
<UL>
<LI><A HREF="#start">General Information for Graduate Students</A>
</LI>
<LI><A HREF="#MA_Degree">Master of Arts Degree Program</A>
</LI>
<LI><A HREF="#PhD_Degree">Doctor of Philosophy Degree Program</A>
</LI>
<LI><A HREF="#Area_Specialty">Area of Specialty</A>
</LI>
<LI><A HREF="#summary">Summary</A>
</LI> 
</UL>
<HR> 
<H2><A NAME="start">General Information for Graduate Students</A>
</H2> 
<P>
Graduate study in the Department of Marine Science requires course work at
Austin and Port Aransas and a research project at Austin or Port Aransas. The
exact program will be determined by the student's interest, the research field
of his supervisor and the required courses. At present, faculty work in the
basic and applied aspects of the four marine science subdisciplines: <I><B>marine
biology/ecology, marine chemistry, marine geology and physical oceanography</B></I>.
Marine science is the study of the marine environment including marine
organisms, processes, and systems so each student's program will involve direct
contact with the sea, its plants and animals and/or the physical and chemical
forces which drive it.
</P>
<P>
Facilities for graduate work in marine science are based in Austin and at the
shore-side laboratory of the Marine Science Institute in Port Aransas, Texas.
The Institute is located on the Aransas Pass ship channel among the dunes at the
tip of Mustang Island, with easy access to bays, beaches, and the Gulf of
Mexico. Environmental systems nearby include the hypersaline Laguna Madre,
seagrass meadows, fresh and salt water marshes, and the continental shelf. The
Port Aransas facility offers research vessels, a specialized library,
classrooms, laboratories, and flowing seawater system.
</P>
<P>
Course work taken in Austin often includes supporting work in other natural
science departments. At least one academic year is normally spent on the main
campus. Most students then reside in Port Aransas while they undertake thesis or
dissertation research at the Marine Science Institute. These students also take
additional courses there, including the majority of their core courses, other
organized courses, seminars, and training cruises. Graduate student apartments
are available at the Institute.
</P>
<P>
Admission requirements: The student's undergraduate training should include
twenty four semester hours in one of the life or physical sciences. At least
twelve of these hours must be in upper-division work. Adequate preparation in
mathematics is expected of all students.
</P>
<H2><A NAME="MA_Degree">Master of Arts Degree Program</A></H2> 
<P>
Approximately three years of graduate study, which will include original
research and practical experience as a Teaching Assistant, are required to
complete the Masters degree in Marine Science. Students must complete at least
thirty semester hours of acceptable graduate work in marine science and related
natural sciences. A maximum of nine hours of upper-division undergraduate
courses, no more than six of which may be in either the major or the minor, may
be counted. The student's program must include at least one core course in three
of the marine science subdisciplines mentioned above. Core courses are listed in
the Graduate Catalog and in the list attached to this document. A minor, which
is obligatory in every Masters degree program, consists of a minimum of six
hours in supporting work outside the major program. The relative number of hours
in the major or minor fields, as well as the nature of the supporting work, is
determined in consultation with the graduate advisor. A thesis is required and
will account for six hours of the total program. The Masters thesis shall be the
product of original research.
</P>
<H2><A NAME="PhD_Degree">Doctor of Philosophy Degree Program</A>
</H2> 
<P>
Four to six years of graduate study, which will include original research and
practical experience as a Teaching Assistant, are required to complete the Ph.D.
in Marine Science. The Doctoral program should contain no fewer than 18 hours of
acceptable graduate work in marine science and no less than 9 hours in
supporting areas, in addition to dissertation and supervised teaching. Of this
minimal requirement of 18 hours, 12 hours of core courses must be completed,
including at least one core course in each of the marine science subdisciplines
mentioned above. Core courses are listed in the Graduate Catalog and in the list
attached to this document. Supporting work from outside the major program (are
of specialty) may include courses taken at another institution. To be eligible
for admission to candidacy, all doctoral students must complete their core
courses and pass a qualifying examination in their area of specialization. This
examination will also confirm that students are competent in the other three
subdisciplines. Candidacy requirements should be completed by February of the
second year of a student's program if they hold a Master's degree and by
February of the third year if they entered the program with a Bachelor's degree.
All doctoral candidates write a dissertation based on the results of their
original research, and make a formal oral defense of the document to complete
the degree requirements.
</P>
<H2><A NAME="Area_Specialty">Area of Speciality</A></H2> 
<P>
Each graduate student will normally select one of the four subdisciplines as an
area of specialization. Based on the present faculty potential, marine biology,
marine chemistry, and marine geology would be the Department's strongest areas
of specialization for students. As an example, a doctoral student might base the
majority of his/her corse work and dissertation topic in marine biology. The
dissertation research would frequently integrate one or more of the other
subdisciplines studied. Students opting for a major thrust in marine chemistry
or marine geology would follow a similar program with chemistry or geology
forming the major part of their curriculum. Similarly, masters students would
specialize in one subdiscipline.
</P>
<H2><A NAME="summary">S</A>ummary</H2> 
<P>
If you plan to attend The University of Texas at Austin and study for a graduate
degree in the Department of Marine Science, you should keep the following points
in mind.
</P>
<UL>
<LI>Early application to The University and the Department is to your
advantage.
</LI>
<LI>The GRE exam must be taken and reported before you can be admitted.
</LI>
<LI>You will take courses at Austin and Port Aransas.
</LI>
<LI>The Graduate Advisor will guide your application, so keep in touch.
</LI>
<LI>Contact with possible faculty supervisors will help you plan. For this we
need to know your scientific interests.
</LI> 
</UL>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 

<P>
</P>
<HR> 
</BODY> 
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-31</DOCNO>
<DOCOLDNO>IA026-000283-B020-126</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/academic/summer97.htm 192.138.168.29 19970113212252 text/html 3445
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:33:40 GMT
Last-modified: Monday, 06-Jan-97 18:04:04 GMT
Content-length: 3256
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>HTML document for the World Wide Web</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="../../images/chalk.gif" bgcolor="#FFFFFF" text="#000000" >

<H1 ALIGN=CENTER><A NAME="top"></A>1997 Summer Courses </H1>
<hr>
<A HREF="../forms/register.htm">Online application</A> for these courses is now available.
<hr>

<H2 ALIGN=CENTER>Undergraduate Courses</H2>

<H3 ALIGN=CENTER>First Session June 4 - July 11</H3>

<H3><A NAME="botany">Marine Botany (MNS f352D)</A></H3>

<P>Exploration of the marine algae and seagrasses of the south Texas coast,
with emphasis on their taxonomy, physiology, and ecology; field trips to
representative coastal habitats. Requires several field trips in addition
to lecture hours, including one weekend trip. Offered on the letter-grade
basis only. Prerequisite: Upper-division standing; one of the following
courses: Biology 303, Botany 320, 321, 328, Marine Science 352C; and three
additional semester hours of biological science. Incidental fee $61.00.
<B>Dunton</B> </P>

<H3><A NAME="inverts">Marine Invertebrates (MNS f354)</A></H3>

<P>Study of invertebrate taxonomy, structure, behavior, and ecology, with
emphasis on field sampling and laboratory studies of invertebrate habitats
of the Texas coast. Prerequisite: Six semester hours of biology or consent
of instructor. Incidental fee $61.00 <B>Montagna</B> </P>

<H3 ALIGN=CENTER>Second Session July 14 - August 18 </H3>

<H3><A NAME="fishes">Biology of Fishes (MNS s354C)</A></H3>

<P>Anatomy, physiology, behavior, life history, taxonomy, and distribution
of fishes, with emphasis on field sampling and laboratory studies of the
coast biota. Requires several field trips in addition to lecture hours,
including one weekend trip. Prerequisite: Upper-division standing, six
semester hours of biological sciences, or consent of instructor. Incidental
fee $61.00 <B>Fuiman</B> </P>

<H3><A NAME="envsci">Marine Environmental Science (MNS s354Q)</A></H3>

<P>Application of the principles of marine science to the study of environmental
issues: toxicology, biogeochemical cycles, and biological and ecological
impacts of xenobiotic materials in the coastal zone. Prerequisite: CH 302
and BIO 302, 303, and 304. Incidental fee $61.00 <B>Ingall, Montagna, Thomas</B>

<HR></P>

<H2 ALIGN=CENTER>Graduate Course </H2>

<H3><A NAME="biooce">Biological Oceanography (MNS s384T)</A></H3>

<P>An advanced course in biological processes in oceanic and coastal waters
with emphasis on empirical and theoretical concepts of marine ecosystem
dynamics, primary and secondary production , and detrital cycling. Prerequisite:
Graduate standing; and either consent of instructor or the following: six
semester hours of biological science chosen from BIO 302, 303, 304, or
the equivalent, and CH 301 and 302, or the equivalent. Incidental fee $61.00
<B>Buskey</B> 
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-32</DOCNO>
<DOCOLDNO>IA026-000283-B020-172</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/afamos.htm 192.138.168.29 19970113212357 text/html 4779
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:34:46 GMT
Last-modified: Wednesday, 13-Nov-96 22:27:06 GMT
Content-length: 4587
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
  
<TITLE></TITLE>   
<META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P><IMG
SRC="../images/afamos.jpg" BORDER="3" HEIGHT="191" WIDTH="171"
ALIGN="BOTTOM"></P>
<P><B><I>Anthony (Tony) F. Amos</I></B> (<A
HREF="../staff/afamos/index.htm">more information</A>)</P>
<P>Research Associate, The University of Texas at Austin, Marine Science
Institute. </P> 
<P><B><I>Physical Oceanography</I></B> </P> 
<P>Tony Amos has been with The University of Texas Marine Science Institute in
Port Aransas for the past 20 years. His oceanographic career has spanned 34
years with research expeditions to all the world's oceans and many of its seas,
including 30 cruises to the Antarctic and five to the Arctic. He is a holder of
the US Antarctic Service Medal. In Texas he has studied several aspects of
near-shore and bay and estuarine processes (circulation, currents, hydrography,
and tides) and has conducted a long-term study of the barrier island beaches
which is now in its 19th year. To date 2,535 separate surveys have been
conducted, counting birds, people, marine debris, and measuring beach widths,
dune erosion/accretion, sea temperature and salinity. In addition, over 300
separate surveys have been made specifically to assess the marine debris
problem. Amos has served on a National Academy of Sciences/National Research
Council Marine Board Committee on Shipborne Waste, and various EPA, MMS, and
other committees on the marine debris problem. He is a member of the New York
Academy of Science, the American Geophysical Union, The American Ornithological
Union, the Texas Marine Mammal Stranding Network, the Sea Turtle Stranding and
Salvage Network, and an Honorary Lifetime Member of the Texas Marine Educators
Association. He is the Port Aransas Cooperative Weather Observer for the
National Weather Service, and writes for the Port Aransas South Jetty, The
Corpus Christi Caller-Times, and the South Texas Fishing News papers. Recently
he was selected as one of the &quot;Texas Twenty&quot; by Texas Monthly magazine
for his work on the environment. </P> 
<P><B><I>Research Interests</I></B> </P> 
<P>Current research interests include the US Antarctic Marine Living Resources
(AMLR) program, now entering its eighth year of field study. Amos' contribution
to AMLR is a survey of the physical oceanography of the Elephant Island region,
which is a major area of krill (<I>Euphausia superba</I>) concentration, and
supports a krill fishery with potential to expand and target other species.
Because krill supports numerous predators (seals, whales, penguins, and flying
seabirds), the multidisciplinary AMLR project seeks to understand the
relationship between krill and its predators and the physical, chemical, and
biological environment. </P> 
<P>Work on the Texas beaches continues and now includes a weekly survey of a
remote barrier island to search for nesting and stranded sea turtles and a study
of the standing stock of marine debris on an undisturbed beach.
</P> 
<P><B><I>Selected Publications</I></B> </P> 
<P>Amos, A.F. (In prep). Late summer ocean stratification and circulation near
Elephant Island, Antarctica. </P> 
<P>Silva, N., E.W. Helbling, V. Villafane, A.F. Amos and O. Holm-Hansen. 1995.
Variability in nutrient concentration around Elephant Island, Antarctica, during
1991-1993. <I>Polar Res.</I> 14(1), 69-82. </P> 
<P>Amos, A.F. 1994. AMLR Program: The underway data acquisition system.<I>
Ant. J. U.S</I>. 29(5), 201-204. </P> 
<P>Amos, A.F. 1994. AMLR Program: The mean summer windfield in the Elephant
Island area.<I> Ant. J. U.S</I>. 29(5), 204-206. </P> 
<P>Amos, A.F. 1993. AMLR Program: Interannual variability in the Elephant
Island surface waters in summer. <I>Ant. J. U.S.</I> 28(5), 201-204. </P> 
<P>Amos, A.F. 1993. The tides at Palmer Station. <I>Ant. J. U.S. </I>28(5),
162-164. </P> 
<P>Niiler, P.P., A.F. Amos and J.-H. Hu. 1991. Water masses and 200-db relative
geostrophic circulation in the western Bransfield Strait. <I>Deep-Sea Research</I>
38(8/9A):943-959. </P> 
<P>
</P>
<HR> 
<P>email to <A HREF="mailto:afamos@utmsi.zo.utexas.edu">Tony Amos</A></P> 
<P>
</P>
<HR> 
<P><A HREF="../index.htm#top_home"><IMG
SRC="../wideshot.gif" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225"
ALIGN="CENTER"></A><A
HREF="../index.htm#top_home">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-33</DOCNO>
<DOCOLDNO>IA026-000283-B020-226</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/arnold.htm 192.138.168.29 19970113212445 text/html 3381
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:35:23 GMT
Last-modified: Thursday, 14-Nov-96 14:56:58 GMT
Content-length: 3190
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE></TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<P><IMG SRC="../images/arnold.jpg" HEIGHT=191 WIDTH=171 ALIGN=BOTTOM
BORDER=3> </P>

<P><B><I>Connie R. Arnold</I></B> </P>

<P>Professor, Department of Marine Science; Associate Director - Mariculture,
Marine Science Institute. Ph.D., Texas A&amp;M University (1968), M.A.,
B.S., Southwest Texas State College (1962, 1960). </P>

<P><B><I>Fisheries and Mariculture</I></B> </P>

<P>Natural spawning of marine finfish and shrimp, high density water reuse
systems, larval fish ecology. </P>

<P><B><I>Research Interest</I></B> </P>

<P>To understand the life histories of marine fish and shrimp; involves
the study of the various stages in the life cycle. Research into the parameters
which regulate the natural spawning of the adults is important to the study
of all other life stages. It is also important that the spawning requirements
be well defined for each species being considered as an aquaculture species.
The high cost of land suitable for aquaculture and the environmental problems
of pond culture dictates the development of high density water reuse systems.
The development of low cost, low maintenance systems is of special research
interest. The study of larval finfish in the shallow water grass flats
and factors which affect their distribution and survival is part of the
overall goal of understanding the life cycle of marine organisms. </P>

<P><B><I>Selected Publications</I></B> </P>

<P>Davis, D.A., D. Jirsa and C.R. Arnold. 1995. Evaluation of soybean proteins
as replacements for menhaden fish meal in practical diets for the red drum,
<I>Sciaenops ocellatus</I>. <I>Journal of the World Aquaculture Society</I>
(in press). </P>

<P>Lewis, D.H., W. Wenxing and C.R. Arnold. 1995. Immunization of red drum
(<I>Sciaenops ocellatus</I>) with cell culture derived <I>Amyloodinium
ocellatum</I> dinospores. <I>Journal of Aquatic Animal Health</I> (in press).
</P>

<P>Riley, C.M., G.J. Holt and C.R. Arnold. 1995. Growth and morphology
of larval and juvenile captive bred yellowtail snapper <I>Ocyurus chrysurus</I>
(Bloch, 1791). <I>Fishery Bulletin</I> 93:179-185. </P>

<P>Thomas, P., C.R. Arnold and G.J. Holt. 1995. Sciaenid fishes. <I>In
</I>Broodstock Management and Egg and Larval Quality, N. Bromage and R.J.
Roberts (eds.), Blackwell Scientific Publishers. </P>

<P>Craig, S.R., G.J. Holt and C.R. Arnold. 1994. The effects of enriching
live foods with highly unsaturated fatty acids on the growth and fatty
acid composition of larval red drum <I>Sciaenops ocellatus</I>. <I>Journal
of the World Aquaculture Society</I> 25(3):424-431. </P>

<P>
<HR></P>

<P>email to <A HREF="mailto:arnold@utmsi.zo.utexas.edu">Dr. Connie R. Arnold</A></P>

<P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-34</DOCNO>
<DOCOLDNO>IA026-000283-B020-299</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/benner.htm 192.138.168.29 19970113212531 text/html 3684
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:36:13 GMT
Last-modified: Thursday, 14-Nov-96 14:57:00 GMT
Content-length: 3493
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">

<HTML>

<HEAD>



<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">

</HEAD> 

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<P>

<IMG SRC="../images/benner.jpg" ALIGN="BOTTOM" BORDER=3>

</P>

<P>

<I><B>Ronald H. Benner</B></I>

</P>

<P>

Associate Professor, Department of Marine Science; Research Scientist, Marine

Science Institute. Ph.D., University of Georgia (1984), B.S., Florida

International University (1979).

</P>

<P>

<I><B>Microbial Ecology/Biogeochemistry</B></I>

</P>

<P>

Microbial food webs; carbon and nitrogen cycling; bacterial growth and

metabolism; diagenesis of organic matter

</P>

<P>

<I><B>Research Interests</B></I>

</P>

<P>

Microorganisms have a profound impact on the composition of the Earth's

atmosphere, waters and soils, and thereby influence all life processes. Microbes

play key roles in the cycling of bioactive elements, such as C and N, in aquatic

ecosystems and in the transfer of these elements and energy into complex food

webs. Bacterial growth and activity in these systems is supported primarily by

non-living organic matter in both dissolved and particulate form. In the oceans,

dissolved organic matter (DOM) is by far the most abundant form of organic

carbon whereas in rivers and estuaries particulate organic matter (POM) is also

an important substrate supporting bacterial growth. DOM and POM are chemically

complex and are derived from a variety of sources. A primary research objective

is to characterize the compositions, sources, microbial transformations, and

fates of DOM and POM. In the open oceans, carbohydrates are major reactive

components of the DOM and ongoing studies are investigating rates of bacterial

utilization of carbohydrates and the factors controling bacterial growth and

respiration. Research on DOM and POM in the Amazon and Mississippi Rivers

indicates that it is derived from decaying vascular plant material in soils. The

DOM and POM in the rivers is rich in aromatic components, such as tannins and

lignins, and is highly resistant to bacterial oxidation. Bacterial growth in

these systems is relatively inefficient and is limited by the availability of

organic carbon.

</P>

<P>

<I><B>Selected Publications</B></I>

</P>

<P>

Benner, R., S. Opsahl, G. Chin-Leo, J.E. Richey, and B.R. Forsberg.  1995.

Bacterial carbon metabolism in the Amazon River system.  <I>Limnol.

Oceanogr</I>. 40:1262-1270.

</P>

<P>

Amon, R.M.W. and R. Benner. 1994. Rapid cycling of high-molecular-weight

dissolved organic matter in the ocean. <I>Nature</I> 369:549-552.

</P>

<P>

Pakulski, J.D. and R. Benner. 1994. Abundance and distribution of dissolved

carbohydrates in the ocean. <I>Limnol. Oceanogr</I>. 39:930-940.

</P>

<P>

Biddanda, B., S. Opsahl and R. Benner. 1994. Plankton respiration and carbon

flux through bacterioplankton on the Louisiana shelf.

<I>Limnol. Oceanogr</I>. 39:1259-1275.

</P>

<HR> 
<P>email to <A HREF="mailto:benner@utmsi.zo.utexas.edu">Dr. Ronald H. Benner</A></P> 
<P>
</P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY> 

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-35</DOCNO>
<DOCOLDNO>IA026-000283-B020-334</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/buskey.htm 192.138.168.29 19970113212644 text/html 3745
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:37:36 GMT
Last-modified: Thursday, 14-Nov-96 14:57:00 GMT
Content-length: 3554
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">

<HTML>

<HEAD>



<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">

</HEAD> 

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P>

<IMG SRC="../images/buskey.jpg" ALIGN="BOTTOM" BORDER=3>

</P>

<P>

<I><B>Edward J. Buskey</B></I>

</P>

<P>

Associate Professor, Department of Marine Science; Research Scientist, Marine

Science Institute. Ph.D., Biological Oceanography, Graduate School of

Oceanography, University of Rhode Island (1983), M.Sc., Zoology, University of

British Columbia (1976), B.A., Biology, Brown University (1974)

</P>

<P>

<I><B>Zooplankton Ecology</B></I>

</P>

<P>

Behavior and sensory perception of zooplankton; bioluminescence of marine

plankton; predator-prey interactions; photobehavior; role of zooplankton grazers

in phytoplankton bloom dynamics

</P>

<P>

<I><B>Research Interests</B></I>

</P>

<P>

My research interests in marine science have focused on studies of the

behavioral ecology of marine zooplankton, and how sensory perception mediates

behavioral adaptations for locating food resources, avoiding predators and

finding mates. Much of this research makes use of video

microcinematography and automated video-computer methods for image and motion

analysis. I am particularly interested in the role of photoreception in

mediating potential predator-prey interactions within the plankton, including

the role of bioluminescence in nocturnal predator-prey interactions, the role of

vision in the feeding of larval fish on zooplankton and the role of sunlight in

vertical migration of oceanic plankton to avoid visual predators. I am presently

involved in studies of behavior and sensory perception in heterotrophic

dinoflagellates, and in studies of the adaptive value of swarming and schooling

behavior to zooplankton living in mangrove habitats in Belize.  I am also

interested in the role of planktonic grazers in harmful algal bloom dynamics;

several ongoing studies suggest that a breakdown in grazer controls and changes

in the planktonic food web have contributed to the unprecedented persistence

of the  brown tide' algal bloom in Laguna Madre.

</P>

<P>

<I><B>Selected Publications</B></I>

</P>

<P>

Buskey, E.J., J.O. Peterson and J.W. Ambler. 1995. The role of photoreception in

the swarming behavior of the copepod <I>Dioithona oculata</I>. <I>Journal of

Marine and Freshwater Behavior and Physiology</I> 26:273-285.

</P>

<P>

Buskey, E.J. and C.J. Hyatt.  1995.  Effects of the Texas "brown tide" algal on

planktonic grazers.  <I> Mar. Ecol. Prog. Ser.</I> 126:285-292.

</P>

<P>

Buskey, E.J. 1994. Factors effecting feeding selectivity of visual predators on

the copepod <I>Acartia tonsa</I>: locomotion, visibility and escape responses.

<I>Hydrobiologia</I> 292/293: 447-453.

</P>

<P>

Buskey, E.J., C.J. Coulter, and S.L. Brown.  1994.  Feeding, growth and

bioluminescence of the heterotrophic dinoflagellate <I> Protoperidinium

huberi</I>.  <I> Mar. Biol.</I> 121:373-380.

</P>

<HR> 
<P>email to <A HREF="mailto:buskey@utmsi.zo.utexas.edu">Dr. Edward J. Buskey</A></P> 
<P>
</P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY> 

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-36</DOCNO>
<DOCOLDNO>IA026-000283-B021-33</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/dunton.htm 192.138.168.29 19970113212935 text/html 3958
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:38:21 GMT
Last-modified: Thursday, 14-Nov-96 14:22:42 GMT
Content-length: 3767
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">

<HTML>

<HEAD>



<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">

</HEAD> 

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<P>

<IMG SRC="../images/dunton.jpg" ALIGN="BOTTOM" BORDER=3>

</P>

<P>

<I><B>Kenneth H. Dunton</B></I>

</P>

<P>

Associate Professor, Department of Marine Science; Research Scientist, Marine

Science Institute. Ph.D., University of Alaska (1985), M.S., Western Washington

University (1977), B.S., University of Maine-Orono (1975).

</P>

<P>

<I><B>Marine Botany/Plant Physiological Ecology/Aquatic Food Webs</B></I>

</P>

<P>

Physiological ecology of seagrasses and macroalgae; photosynthesis in marine
plants; biology of high latitude kelps; biogeography of arctic marine flora and

fauna; use of stable isotopes in the elucidation of carbon flow in aquatic food

webs.

</P>

<P>

<I><B>Research Interests</B></I>

</P>

<P>

Marine plants, whether they include the kelp of the Polar Ocean or the

seagrasses of the subtropical Gulf of Mexico, are extremely valuable resources

to coastal ecosystems. They also possess amazingly similar seasonal patterns of

growth, exhibit circannual rhythms, and use stored carbon reserves in the

initiation of new tissue growth. In the Arctic, kelp display unique

physiological adaptations to life in a light-limited environment. Some of these

are just now being described; others, such as the phenomenon of dark carbon

fixation, remain somewhat of an enigma and are the focus of new research.

Estuarine seagrasses face similar problems with respect to degradation of their

light environment that result from decreases in water transparency due to

industrial activities and municipal development.  New funded projects include,

in the Arctic, the effects of UV radiation on kelp photosynthesis, in the Antarctic,

physiological mechanisms of cold temperature tolerance in polar macroalgae; in

Texas, the development of models to predict seagrass productivity and plant carbon

balance as a function of the <I> in situ </I> light environment and the effect of

freshwater inflows on

the production ecology of a local subtropical estuarine marsh.

Our work on the role of marine macrophytes in

aquatic food webs using stable carbon and nitrogen isotopes is also continuing,

and is currently focused on the Antarctic Peninsula and in south Texas.

</P>

<P>

<I><B>Selected Publications</B></I>

</P>

<P>

Henley, W.J. and K.H. Dunton. 1995. A seasonal comparison of carbon, nitrogen

and pigment content in <I>Laminaria solidungula</I> and

<I>L. saccharina</I> (Laminariales, Phaeophyta) in the Alaskan Arctic. J.

Phycology 31:325-331.

</P>

<P>

Dunton, K.H. 1994. Seasonal growth and biomass of the subtropical seagrass <I>Halodule

wrightii</I> in relation to continuous measurements of underwater irradiance.

<I>Mar. Biol.</I> 120:479-489.

</P>

<P>

Dunton, K.H. and D.A. Tomasko. 1994. <I>In situ</I> photosynthesis in the

seagrass <I>Halodule wrightii</I> in a hypersaline tropical lagoon. <I>Mar.

Ecol. Prog. Ser.</I> 107:281-293.

</P>

<P>

Dunton, K.H. 1992. Arctic biogeography: the paradox of the marine benthic fauna

and flora. <I>Trends Ecol. Evol.</I> 7(6):183-189.

</P>

<HR> 
<P>email to <A HREF="mailto:dunton@utmsi.zo.utexas.edu">Dr. Kenneth H. Dunton</A></P> 
<P>
</P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY> 

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-37</DOCNO>
<DOCOLDNO>IA026-000283-B021-100</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/fuiman.htm 192.138.168.29 19970113213014 text/html 3542
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:40:50 GMT
Last-modified: Thursday, 14-Nov-96 14:57:00 GMT
Content-length: 3351
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE></TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<P><IMG SRC="../images/fuiman.jpg" HEIGHT=191 WIDTH=171 ALIGN=BOTTOM BORDER=3></P>

<P><B><I>Lee A. Fuiman</I></B> (<A
HREF="../staff/fuiman/publications.htm">more information</A>)</P>

<P>Associate Professor, Department of Marine Science; Research Scientist,
Marine Science Institute. Ph.D., University of Michigan (1983); M.S., Cornell
University (1978); B.S., Southampton College of Long Island University
(1974). </P>

<P><B><I>Fish Biology</I></B> </P>

<P>Morphology, behavior, sensory biology of fish larvae.</P>

<P><B><I>Research Interests</I></B> </P>

<P>The past two decades have seen the biology of fish larvae blossom into
an exciting field of research. These tiny, usually transparent early life
stages had been neglected because of the difficulties in collecting, identifying,
and maintaining them. With many of these problems solved, field and laboratory
studies are leading to an understanding of how processes affecting larval
fishes may have serious consequences for populations of adult fishes. Survival
through the larval phase is, of course, necessary if populations are to
continue. Like adult fishes, larvae must find food and avoid predators.
However, unlike adults, they must do so during a period when their abilities
vary due to morphological, physiological, and behavioral changes that accrue
during development. </P>

<P>Recent and ongoing investigations involve both laboratory and field
experiments on the importance of predation in the life of fish larvae.
Behavioral experiments, recorded on video tape for subsequent frame-by-frame
motion analysis, provide details of the interaction between predators and
fish larvae as prey. Changes in responsiveness and response effectiveness
of larvae attacked by various predators are studied throughout the developmental
period. Parallel studies of sensory and locomotor development help determine
how behavior might be constrained by morphology. Variations in environmental
conditions (e.g., temperature, salinity, and pollutants) are also investigated
for their influence on larva behavior. Field experiments are used to form
ecological interpretations for the laboratory results. </P>

<P><B><I>Selected Publications</I></B> </P>

<P>Fuiman, L.A. 1994. The interplay of ontogeny and scaling in the interactions
of fish larvae and their predators. <I>Journal of Fish Biology</I> 45(Suppl.
A):55-79. </P>

<P>Fuiman, L.A. and A.E. Magurran. 1994. Development of predator defences
in fishes. <I>Reviews in Fish Biology and Fisheries</I> 4:145-183. </P>

<P>Fuiman, L.A., and R.S. Batty. 1994. Susceptibility of Atlantic herring
and plaice larvae to predation by juvenile cod and herring at two constant
temperatures. <I>Journal of Fish Biology</I> 44:23-34.</P>

<P>
<HR> 
<P>email to <A HREF="mailto:lee@utmsi.zo.utexas.edu">Dr. Lee A. Fuiman</A></P> 
<P>
</P>
<HR> 
<P>
<IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-38</DOCNO>
<DOCOLDNO>IA026-000283-B021-184</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/gardner.htm 192.138.168.29 19970113213121 text/html 3629
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:41:36 GMT
Last-modified: Monday, 18-Nov-96 16:43:36 GMT
Content-length: 3440
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE></TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<P><IMG SRC="../images/gardner.jpg" HEIGHT=191 WIDTH=171 ALIGN=BOTTOM
BORDER=3> </P>

<P><B><I>Wayne S. Gardner</I></B> </P>

<P>Professor, Department of Marine Science; Director, Marine Science Institute.  Ph.D., University of Wisconsin (1971); M.S., University of Wisconsin (1964); B.S., University of Wisconsin, Stevens Point (1963). </P>

<P><B><I>Water Chemistry/Ecosystem Dynamics</I></B> </P>

<P>Nitrogen dynamics in water column and sediments,  nutrient-organism interactions in coastal ecosystems. </P>

<P><B><I>Research Interest</I></B> </P>

<P>Nitrogen cycling is important in coastal and estuarine ecosystems because nitrogen is extensively transformed to a variety of  forms, by autotrophic and heterotrophic processes in the water and sediments, and is a nutrient that often limits the growth of  phytoplankton and other plants in these relatively shallow systems.   Internal regeneration is a dominant process providing nitrogen to plants whereas denitrification causes available nitrogen to be lost from estuarine and coastal ecosystems.  Major goals are to understand and quantify the biotic mechanisms and rates of nitrogen remineralization and the fate of the remineralized products in the water and at the sediment-water interface.  This information is needed to understand nitrogen biogeochemistry and also to quantify the relative importance of internal nitrogen regeneration compared to inputs from other sources in these highly productive ecosystems.  Nitrogen regeneration and transformation rates in the water and at the sediment-water interface are measured with 15-N as a tracer.  Ammonium concentrations and isotope ratios are measured by high performance liquid chromatography.  Denitrification rates will be determined using a Membrane Inlet Mass Spectrometer.  Nitrogen cycling studies will be conducted in Laguna Madre and other coastal ecosystems.</P>

<P><B><I>Selected Publications</I></B> </P>

<P>	Gardner, W.S., R. Benner, R.M.W. Amon, J.B. Cotner, Jr., J.F. Cavaletto, and J.R. Johnson.  1996.  Effects of high-molecular-weight dissolved organic matter on nitrogen dynamics in the Mississippi River plume.  Mar. Ecol. Prog. Ser.  133:2</P>

<P>Gardner, W.S., H.A. Bootsma, C. Evans, and P.A. St. John.  1995.  Improved chromatographic analysis of 15N:14N ratios in ammonium or nitrate for isotope addition experiments.  Mar. Chem. 48:271-282.
</P>

<P>	Gardner, W.S., J.F. Cavaletto, T.H. Johengen, J.R. Johnson, R.T. Heath, and J.B. Cotner.  1995.  Effects of the Zebra Mussel, Dreissena polymorpha, on community nitrogen dynamics in Saginaw Bay, Lake Huron.  J. Great Lakes Res. 21:529-544.</P>

<P>	Cotner, J.B., Jr., and W.S. Gardner.  1993.  Heterotrophic bacterial mediation of ammonium and dissolved free amino acid fluxes in the Mississippi River plume.  Mar. Ecol. Prog. Ser. 93:75-87. </P>



<P>
<HR></P>

<P>email to <A HREF="mailto:gardner@utmsi.zo.utexas.edu">Dr. Wayne S. Gardner</A></P>

<P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-39</DOCNO>
<DOCOLDNO>IA026-000283-B021-235</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/holt.htm 192.138.168.29 19970113213219 text/html 3357
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:43:14 GMT
Last-modified: Thursday, 14-Nov-96 14:22:42 GMT
Content-length: 3166
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">
<HTML>
<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD> 
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P>
<IMG SRC="../images/holt.jpg" ALIGN="BOTTOM" BORDER=3>
</P>
<P>
<I><B>G. Joan Holt</B></I>
</P>
<P>
Associate Professor, Department of Marine Science; Research Scientist, Marine
Science Institute. Ph.D., Texas A&amp;M University (1976), M.S., B.S., The
University of Texas at Arlington (1972, 1964).
</P>
<P>
<I><B>Larval Fish Ecology/Marine Aquaculture</B></I>
</P>
<P>
Feeding dynamics, nutrition, ichthyoplankton transport and recruitment, early
life history of reef fishes, RNA-DNA ratio, condition indices, osmoregulation.
</P>
<P>
<I><B>Research Interest</B></I>
</P>
<P>
Many physical, chemical and biological factors can potentially affect growth and
survival rates during the larval and juvenile stages of marine fish. My research
focuses on biological and physical factors that limit or alter larval fish
growth and development. This information is critical for understanding variable
survival in natural populations and for maximizing production in aquaculture
systems. Current research using this approach includes several studies designed
to decipher trophic interactions of larval fish, identify ontogenic changes in
nutritional requirements, and explore biochemical techniques useful for
determining physiological condition. 
</P>
<P>
Specific research projects include investigations of: 1) the influence of
salinity on feeding rates, development of osmoregulatory ability, and the
significance of free amino acids during osmotic adjustment, 2) the role of
microbial ecology in culture systems and microbes as a source of exogenous
enzymes for larval digestion, 3) lipid requirements with specific interest in
long chain fatty acids, 4) reproduction, larval growth, transport and
recruitment of Caribbean coral-reef fish, and 5) dynamics of larval fish visual
predation on zooplankton.
</P>
<P>
<I><B>Selected Publications</B></I>
</P>
<P>
Brinkmeyer, R.L. and G.J. Holt. 1995. Response of red drum larvae to graded
levels of menhaden oil semipurified microparticulate diets. <I>The Progressive
Fish-Culturist</I> 57(1):30-36.
</P>
<P>
Westerman, M. and G.J. Holt. 1994. RNA:DNA ratio during the critical period and
early larval growth of the red drum <I>Sciaenops ocellatus</I>.
<I>Marine Biology</I> 121:1-10.
</P>
<P>
Holt, G.J. 1993. The potential role of larvae fish culture in alleviating
population and habitat losses. <I>American Fisheries Society Symposium</I>
14:167-172.
</P>
<P>
Holt, G.J. 1992. Experimental studies of feeding in larval red drum. <I>Journal
of the World Aquaculture Society</I> 23(4):265-270.
</P>
<HR> 
<P>email to <A HREF="mailto:joan@utmsi.zo.utexas.edu">Dr. G. Joan Holt</A></P> 
<P>
</P>
<HR> 
<P>
<IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY> 
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-40</DOCNO>
<DOCOLDNO>IA026-000283-B021-298</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/ingall.htm 192.138.168.29 19970113213300 text/html 2971
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:43:36 GMT
Last-modified: Thursday, 14-Nov-96 14:57:00 GMT
Content-length: 2780
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">
<HTML>
<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD> 
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P>
<IMG SRC="../images/ingall.jpg" ALIGN="BOTTOM" BORDER=3>
</P>
<P>
<I><B>Ellery D. Ingall</B></I>
</P>
<P>
Assistant Professor, Department of Marine Science; Research Scientist, Marine
Science Institute. Ph.D., Yale University (1991), M.S., University of Utah
(1985), B.A., University of California-Santa Barbara (1981).
</P>
<P>
<I><B>Marine Chemistry</B></I>
</P>
<P>
Sediment diagenesis; carbon and phosphorus cycling.
</P>
<P>
<I><B>Research Interests</B></I>
</P>
<P>
The flux of constituents to and from marine sediments exerts a strong control on
the composition of the oceans. These fluxes are largely determined by the
chemical, physical and biological transformations that occur in sediments
shortly after deposition of a particle at the sediment-water interface. My
research focuses on understanding these transformations by looking at trends in
sediment pore water and solid phase chemistry and by directly measuring sediment
fluxes. Current research includes: 1) determining the effect of bottom water
anoxia on the burial and preservation of reactive phosphorus in marine
sediments, 2) identifying the specific types of organic phosphorus compounds
present in marine sediments, 3) developing realistic computer simulations of
sediment chemistry, 4) characterizing the processes at the sediment-water
interface in sediments of the Gulf of Mexico and the Peru Shelf in order to
understand phosphorite formation and organic matter diagenesis.
</P>
<P>
<I><B>Selected Publications</B></I>
</P>
<P>
Ingall, E.D. and R.A. Jahnke. 1994. Evidence for enhanced phosphorus
regeneration from marine sediments overlain by oxygen depleted waters. <I>Geochimica
et Cosmochimica Acta</I> 58:2571-2575.
</P>
<P>
Van Cappellen, P. and E.D. Ingall. 1994. Benthic phosphorus regeneration, net
primary production, and ocean anoxia: A model of the coupled marine
biogeochemical cycles of carbon and phosphorus. <I>Paleoceanography</I>
9:677-692.
</P>
<P>
Ingall, E.D., R.M. Bustin and P. Van Capellen. 1993. Influence of water column
anoxia on the burial and preservation of carbon and phosphorus in marine shales.
<I>Geochimica et Cosmochimica Acta</I> 57: 303-316.
</P>
<HR> 
<P>email to <A HREF="mailto:ingall@utmsi.zo.utexas.edu">Dr. Ellery D. Ingall</A></P> 
<P>
</P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY> 
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-41</DOCNO>
<DOCOLDNO>IA026-000283-B021-445</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/montagna.htm 192.138.168.29 19970113213401 text/html 3778
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:44:17 GMT
Last-modified: Thursday, 14-Nov-96 14:57:02 GMT
Content-length: 3587
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">

<HTML>

<HEAD>



<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">

</HEAD> 

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<P>

<IMG SRC="../images/montagna.jpg" ALIGN="BOTTOM" BORDER=3>

</P>

<P>

<I><B>Paul A. Montagna</B></I>

</P>

<P>

Associate Professor, Department of Marine Science; Research Scientist, Marine

Science Institute. Ph.D., University of South Carolina (1983), M.S.,

Northeastern University (1975), B.S., State University of New York at Stony

Brook (1971).

</P>

<P>

<I><B>Benthic Ecology</B></I>

</P>

<P>

Population and community ecology, trophic dynamics and environmental studies.

</P>

<P>

<I><B>Research Interests</B></I>

</P>

<P>

There are three size classes of bottom dwelling organisms: microbes, meiofauna,

and macrofauna. These benthic organisms modify or influence most geological,

chemical, and physical properties of shallow marine ecosystems. Research

programs are structured to study the relationships between the three groups of

organisms and the environment. This includes studies of invertebrate-microbial

interactions, benthic metabolism and nutrient recycling, population and

community ecology and energy flow within the benthos. The projects range from

estuarine to oceanic research. The estuarine work is focusing on the importance

of freshwater inflow in structuring benthic communities and maintaining benthic

productivity. This research also addresses questions about the utilization of

benthos and benthic habitats by living resources. The oceanic research addresses

questions about long-term sublethal effects on benthic populations due to

chronic low-level contamination.

</P>

<P>

<I><B>Recent Publications</B></I>

</P>

<P>

Mannino, A., and P.A. Montagna.  1996.  Fine-scale spatial variation of sediment

composition and salinity in Nueces Bay of South Texas.  <I>Texas Journal of Science</I>

48:1-14.

</P>

<P>

Martin, C.M., and P.A. Montagna.  1995.  Environmental assessment of La Quinta

Channel, Corpus Christi Bay, Texas.  <I>Texas Journal of Science</I> 47:203-222.

</P>

<P>

Montagna, P.A., and R.D. Kalke.  1995.  Ecology of infaunal Mollusca in south

Texas estuaries.  <I>American Malacological Bulletin</I> 11:163-175.

</P>

<P>

Montagna, P.A.  1995.  Rates of meiofaunal microbivory:  a review.  <I>Vie et

Milieu</I> 45:1-10.

</P>

<P>

Montagna, P.A., J.E. Bauer, D. Hardin, and R.B. Spies.  1995.  Meiofaunal and

microbial trophic interactions in a natural submarine hydrocarbon seep.  <I>Vie

et Milieu</I> 45:17-26.

</P>

<P>
Montagna, P.A., G.F. Blanchard and A. Dinet. 1995. Effect of production and

biomass of intertidal microphytobenthos on meiofaunal grazing rates. <I>Journal

of Experimental Marine Biology and Ecology</I> 185:149-165.

</P>

<P>

Montagna, P.A., D.A. Stockwell and R.D. Kalke. 1993. Dwarf surfclam

<I>Mulinia lateralis</I> (Say, 1822) populations and feeding during the Texas

brown tide event. <I>Journal of Shellfish Research</I> 12:433-442.

</P>

<P>

<HR> 
<P>email to <A HREF="mailto:paul@utmsi.zo.utexas.edu">Dr. Paul A. Montagna</A></P> 
<P>
</P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY> 

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-42</DOCNO>
<DOCOLDNO>IA026-000283-B022-196</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/thomas.htm 192.138.168.29 19970113213737 text/html 5118
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:46:38 GMT
Last-modified: Thursday, 14-Nov-96 14:57:02 GMT
Content-length: 4927
Content-type: text/html
</DOCHDR>
<html>
<head>
   <title></title>
   <meta name="GENERATOR" content="Mozilla/2.01Gold (Win32)">
</head>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">
<p><img src="../images/thomas.jpg" border=3 height=191 width=171 align=bottom></p>

<p><b><i>Peter Thomas </i></b>(<a href="../staff/thomas/publications.htm">more
information</a>)</p>

<p>Professor, Department of Marine Science; Senior Research Scientist,
Marine Science Institute. Ph.D., Leicester, England (1977), B.Sc. Hull,
England (1970). </p>

<p><b><i>Fish Reproductive Physiology/Marine Toxicology</i></b> </p>

<p>Purification and molecular actions of hormones and their receptors,
environmental endocrinology, applications of endocrinology to fish culture;
biochemical and environmental toxicology of marine fishes, especially reproductive
and endocrine toxicology. </p>

<p><b><i>Research Interests</i></b> </p>

<p>Most of the complex series of morphological, physiological, behavioral
and developmental changes that occur during the teleost reproductive cycle
are thought to be under endocrine control. However, the hormonal regulation
of many reproductive processes remains poorly understood, especially in
marine perciform fish, which represent the largest order of extant vertebrates.
Extensive research on Atlantic croaker and spotted seatrout in our laboratory
has identified several novel features of the endocrine control of reproduction
in these marine perciform fish, particularly during final oocyte maturation
and spawning. Research is being conducted on the purification and biological
actions of pituitary hormones and steroid hormone receptors, the cloning,
sequencing and expression of their mRNAs, the neuroendocrine control of
gonadotropin secretion, the biosynthesis and molecular actions of steroid
hormones, the physiological regulation of steroid hormone receptors, the
endocrine control of egg growth, spermatogenesis and meiotic maturation,
and applications of endocrinology to fish culture. The goal of this research
is to develop a comprehensive model of the endocrine control of reproduction
for representatives of this important vertebrate group. </p>

<p>The release of toxic chemicals into marine and estuarine environments
has increased dramatically as a result of rapid industrialization in many
regions of the world, but the long-term ecological consequences of increased
environmental contamination are not known. The development of early-warning
biomarkers of pollutant exposure may enable deleterious changes in the
environment to be detected early enough so that remedial actions can be
taken. Our research emphasis has been on the development of endocrine biomarkers
of impaired reproductive function in marine fish because relatively low
pollutant concentrations can disrupt fish reproduction with serious consequences
for the long-term survival of the entire population. The mechanisms of
chemical interference with reproductive endocrine function, the physiological
functions of ovarian and hepatic metal-binding proteins, and the role of
maternal transfer in the embryotoxicity of chemicals are under investigation.
In addition, reproductive biomarkers are being evaluated in fish collected
from contaminated sites in Texas and California. </p>

<p><b><i>Selected Publications</i></b> </p>

<p>Pinter, J. and P. Thomas. 1995. Characterization of a progestogen receptor
in the ovary of the spotted seatrout, <i>Cynoscion nebulosus</i>. <i>Biology
of Reproduction</i> 52:667-675. </p>

<p>Thomas, P. and L. Budiantara. 1995. Reproductive life history stages
sensitive to oil and napthalene in Atlantic croaker. <i>Marine Environmental
Research</i> 39:147-150. </p>

<p>Khan, I.A. and P. Thomas. 1994. Seasonal and daily variations in the
plasma gonadotropin II response to a LHRH analog and serotonin in Atlantic
croaker (<i>Micropogonias undulatus</i>): Evidence for mediation by 5-HT2
receptors. <i>The Journal of Experimental Zoology</i> 269:531-537. </p>

<p>Thomas, P. 1994. Hormonal control of final oocyte maturation in sciaenid
fishes. <i>In</i> Perspectives in Comparative Endocrinology. K.G. Davey,
R.E. Peter and S.S. Tobe (eds.), pp. 619-625. <i>Canadian Journal of Zoology</i>.
</p>

<p>Thomas, P. and H.W. Wofford. 1993. Effects of cadmium and aroclor 1254
on lipid peroxidation, glutathione peroxidase activity, and selected antioxidants
in Atlantic croaker tissues. <i>Aquatic Toxicology</i> 27:159-178. </p>

<p>
<hr></p>

<p>email to <a href="mailto:thomas@utmsi.zo.utexas.edu">Dr. Peter Thomas
</a></p>

<p>
<hr></p>

<p><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 

<p>
<hr></p>

</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-43</DOCNO>
<DOCOLDNO>IA026-000283-B023-244</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/whitledg.htm 192.138.168.29 19970113214346 text/html 5037
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:53:10 GMT
Last-modified: Thursday, 14-Nov-96 14:57:02 GMT
Content-length: 4846
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">

<HTML>

<HEAD>



<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">

</HEAD> 

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P>

<IMG SRC="../images/whitled.jpg" ALIGN="BOTTOM" BORDER=3>

</P>

<P>

<I><B>Terry E. Whitledge</B></I>

</P>

<P>

Professor, Department of Marine Science; Senior Research Scientist, Marine

Science Institute. Ph.D., University of Washington (1972), M.S., B.S., Western

Illinois University (1966, 1964).

</P>

<P>

<I><B>Marine Chemistry/Chemical Oceanography</B></I>

</P>

<P>

Nutrient chemistry; nitrogen cycle; biogeochemical processes; dynamics of

coastal ocean and estuaries; eutrophication and oxygen depletion; nutrient

uptake and regeneration; harmful algal blooms.

</P>

<P>

<I><B>Research Interests</B></I>

</P>

<P>

&#167; The variation of freshwater inflow into South Texas bays and estuaries is

being examined to document the effects upon the biological communities. Monthly

measurements of hydrography, nutrients and primary productivity are collected in

the Nueces/Corpus Christi Estuary to estimate the enhancement of biological

productivity created by freshwater releases.

</P>

<P>

&#167; The appearance of a &quot;brown tide&quot; algal bloom that has persisted

for almost six years changed the clear waters of Laguna Madre to a dark

brown color. Samples are collected in upper and lower Laguna Madre to

monitor the severity of the bloom conditions and to relate the distribution of

the organism to physical, chemical and biological processes. The appearance of

persistent algal blooms have become more common in the U.S. and internationally

during the past ten years. We are working with the National Assessment of

Nutrient Enrichment (NANE) and Harmful Algal Bloom (HAB) programs of NOAA to

better understand why these blooms are fouling coastal and estuarine waters,

contaminating sea food and killing marine fish and mammals.

</P>

<P>

&#167; More than 50% of the area of the U.S. drains into the

Mississippi/Atchafalaya River which has a greatly increased organic and nutrient

load as a result of human population increases and widespread use of

fertilizers. The resulting nutrient overenrichment of the river has created

areas of low oxygen near the bottom on the Gulf of Mexico continental shelf.

We are studying the

distribution of nutrients and their uptake by phytoplankton near the river delta

and their later regeneration in the zone of low oxygen.

</P>

<P>

&#167; The Chukchi Sea north of Bering Strait receives northward flowing water

from the North Pacific Ocean after transiting the Bering Sea. These waters

contain large quantities of nutrients which promote very high primary production

rates and ultimately feed the large populations of seals, whales and walrus.

However, these coastal waters of Alaska are undergoing dramatic changes with

respect to contamination and over-harvesting and are important in assessing the

extent of greenhouse warming and climate change. The atmospheric transport of

pesticides and other chemicals into the Arctic accumulates in ice and later in

organisms as they progress up the food chain. Russian and American scientists

are cooperating in programs to investigate the ecology of the Bering/Chukchi

Seas and to determine the changes that may be occurring due to human activities.

</P>

<P>

<I><B>Selected Publications</B></I>

</P>

<P>

Pakulski, J.D., R. Benner, R. Amon, B. Eadie and T.E. Whitledge. 1995. Community

metabolism and nutrient cycling in the Mississippi River plume: Evidence for

intense nitrification at intermediate salinities. <I>Mar. Ecol. Prog. Ser.</I>

117:207-218.

</P>

<P>

Feder, H.M., A.S. Naidu, J.M. Hameedi, S.C. Jewett, W.R. Johnson and T.E.

Whitledge. 1994. The Northeastern Chukchi Sea: Benthos-environmental

interaction. <I>Mar. Ecol. Prog. Ser.</I> 111:171-190.

</P>

<P>

Hansell, D.A., T.E. Whitledge and J.J. Goering. 1993. Patterns of nitrate

utilization and new production over the Bering/Chukchi Shelf. <I>Cont. Shelf

Res.</I> 13:601-627.

</P>

<P>

Dortch, Q. and T.E. Whitledge. 1992. Does nitrogen limit phytoplankton

production in the Mississippi River and nearby regions? <I>Cont. Shelf Res.</I>

12:1293-1309. 

<HR> 
<P>email to <A HREF="mailto:terry@utmsi.zo.utexas.edu">Dr. Terry E. Whitledge</A></P> 
<P>
</P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY> 

</HTML>


</DOC>
<DOC>
<DOCNO>WT01-B18-44</DOCNO>
<DOCOLDNO>IA026-000283-B024-90</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/behrens.htm 192.138.168.29 19970113214745 text/html 2914
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 21:57:54 GMT
Last-modified: Monday, 02-Dec-96 15:52:50 GMT
Content-length: 2725
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P>
<IMG SRC="../images/behrens.jpg" ALIGN="BOTTOM" BORDER=3>
<P>
<I><B>E. William Behrens</B></I>
<P>
Associate Professor, Department of Marine Science. Ph.D., Rice
University (1963), M.S. University of Michigan (1958), B.A., Cornell
University (1956).
<P>
<I><B>Marine Geology</B></I>
<P>
High-resolution and multichannel seismic reflection data acquisition,
processing, and interpretation; continental slope, sedimentology.
<P>
<I><B>Research Interest</B></I>
<P>
The history of the development of continental margins is contained
in their sediments. The study of continental slope sedimentary
records includes direct sampling and observation of water column
physical and chemical parameters, sediment mineralogy, texture,
and structures, micropaleontological content, geochemical and
isotopic composition, and acoustic characteristics. Remote sensing
(marine geophysics) is used to observe sediment thicknesses, stratigraphic
relationships of sedimentary units, structural context and style,
and acoustic characteristics related to diagenetic phenomena.
From a combination of remote sensing and ground truth data (cores),
research projects are designed to interpret the history of depositional,
diagenetic, tectonic, and environmental conditions and processes
that have created the existing features of continental margins.
The same tools of sediment sampling and analysis, and seismic
reflection profiling apply to the study of the history of deeper
oceanic as well as shallower coastal environments. 
<P>
<I><B>Selected Publications</B></I>
<P>
Behrens, E.W. 1994. Abyssal Sediment Waves in the Gulf of Mexico
- An Enigma. <I>Paleoceanography</I> 9:1087-1094.
<P>
Beckley, L.M. and E.W. Behrens. 1993. Seismic evidence for timing
of shallow salt emplacement on the Texas continental slope. <I>Trans.
Gulf Coast Assoc. Geological Societies</I> 43:25-30.
<P>
Satterfield, W.M. and E.W. Behrens. 1990. A Late Quaternary Canyon/Channel
System, Northwest Gulf of Mexico Continental Slope. <I>Marine
Geology</I> 92: 51-67.
<P>
Behrens, E.W. 1988. Geology of a Continental Slope Oil Seep, Northern
Gulf of Mexico, <I>American Association of Petroleum Geologists
Bulletin</I> 72:105-114.
<HR> 
<P>email to <A HREF="mailto:billb@utig.ig.utexas.edu">Dr. E. William Behrens</A></P> 
<P>
</P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-45</DOCNO>
<DOCOLDNO>IA026-000283-B024-311</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/maguire.htm 192.138.168.29 19970113215130 text/html 3596
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 22:02:06 GMT
Last-modified: Thursday, 14-Nov-96 14:57:02 GMT
Content-length: 3405
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P>
<I><B>Bassett Maguire, Jr.</B></I>
<P>
Professor, Department of Marine Science and Department of Zoology.
Ph.D., Cornell University (1957), B.A., Cornell University (1953).
<P>
<I><B>Ecosystem Function</B></I>
<P>
The dynamics of individual organisms, species populations, and
ecosystems, and on the ecosystem structure resulting from these
dynamics. 
<P>
<I><B>Research Interests</B></I>
<P>
Most of my work is on the dynamics of individual organisms, species
populations, and ecosystems, and on the ecosystem structure resulting
from these dynamics (and, in turn, the effects of the ecosystem's
structure on its dynamics). Primarily, this is being done on coral
reefs, and especially on the causes and patterns of coral color
change, including bleaching, and the effects of such changes on
coral colony dynamics and thereby on reef dynamics. Data showing
change in coral color (including bleaching) have been gathered
during several seasons over the last 4 years using a technique
which I have developed (and continue to elaborate and improve).
Observed color change patterns are being compared to patterns
of change of several environmental factors which are possible
causes of these changes in color. Growth rate of coral is known
to decrease when the extreme color change referred to as bleaching
occurs. Also, I have developed stereo techniques to evaluate the
growth rates of coral colonies, and am working on the correlations
between coral change patterns and the growth rates of the corals.
<P>
Some of my ecosystem work also involves experimental use of aquatic
communities and their dynamics when small samples, along with
a variety of levels of possibly important resources, are sealed
in glass and allowed to exchange only energy with the rest of
the world (mostly light in and heat out).
<P>
Finally, I am also working on knowledge based multimedia to be
used as information resources and for educational purposes in
with respect to biological concepts and dynamics.
<P>
<I><B>Selected Publications</B></I>
<P>
Maguire, B., Jr., B.M. Winsborough, J.-S. Seeler, S. Golubie,
and R.L. Folk. 1994. Recent fresh-water lacustrine stromatolites,
stromatolitic mats and oncoids from northeastern Mexico. In: Phanerozoic
Stromatolites II, J. Bertrand-Sarfati and C. Monty (eds.), pp.
71-100. Kluwer Academic Pub. Netherlands.
<P>
Maguire, B., Jr., J.C. Lang, A.J. King and P. Dustan. 1993. Non-invasive
research and monitoring in coral reefs. In: Global Aspects of
Coral Reefs, R.N. Ginsburg (ed.), pp. M16-M21. Rosenstiel School
of Marine and Atmospheric Science, University of Miami.
<P>
Maguire, B., Jr. and K. Scott. 1992. Long term lunar base operation:
Some ecological considerations. In: The Second Conference on Lunar
Bases and Space Activities in the 21st Century, W.W. Mandel (ed.),
pp. 531-536. NASA Conference Publication 3166, vol. 2. 
<HR> 
<P>email to <A HREF="mailto:b.maguire@mail.utexas.edu">Dr. Bassett Maguire</A></P> 
<P>
</P>
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-46</DOCNO>
<DOCOLDNO>IA026-000283-B025-6</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/mes/wrkshp96.htm 192.138.168.29 19970113215242 text/html 3307
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 22:03:27 GMT
Last-modified: Friday, 29-Dec-95 17:58:52 GMT
Content-length: 3118
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>HTML document for the World Wide Web</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY>

<H2>
<CENTER>
Marine Education Services
<H3>1996 SPRING WORKSHOP SCHEDULE</H3>

</CENTER>
</H2>

<DL>
<DT>Feb 10-11 
<DD><I><B>Coastal Birds: Ducks to Whoopers</B></I> - UTMSI, All
Level 
<DT>March 23-24 
<DD><I><B>Astronomy: Featuring GEMS Activities</B></I> - UTMSI,
All Level 
<DT>April 13-14 
<DD><I><B>Marine Aquariums: The Ocean in Your Classroom</B></I>
- UTMSI, All Level 
<DT>April 27 
<DD><I><B>Marine Aquariums: The Ocean in Your Classroom</B></I>
- CSL, All Level
<DT>May 4 
<DD><I><B>Basic Marine Science</B></I> - CSL, All Level
<DT>May 18-19 
<DD><I><B>WHALENET: The Ocean on the Internet Computer Workshop</B></I>
- UTMSI, All level
</DL>

<HR>

<P>
The workshops scheduled at the UT-Pan American Coastal Studies
Laboratory (CSL), located on South Padre Island, will be held
on Saturdays from 8:30 am to 8 pm. The CSL registration fee of
$28 includes all handouts and a catered lunch &amp; dinner. The
workshops held at UT Marine Science Institute (UTMSI), located
in Port Aransas, begin with registration on Friday night from
7-10 pm at the Visitors Center. Cost of UTMSI workshops is $55
which includes five meals, two nights in the dorms (bring your
own blanket &amp; towels), refreshments and all handouts. Workshops
at CSL are limited to 25 participants; workshops at UTMSI are
limited to 50 participants. You are encouraged to secure your
registration with full payment as early as possible, as space
is limited. Please make your check payable to The University of
Texas and mail to: Marine Education Services, UTMSI, 750 Channelview
Drive, Port Aransas, TX 78373. No refunds allowed.
<P>
Two workshops are scheduled to be held at CSL (April 27 &amp;
May 4) and four will be held at UTMSI (Feb 10, Mar 23, Apr 13
&amp; May 18). The Feb 10 workshop will focus on Coastal Birds
&amp; Whooping Cranes. The March 22 Astronomy workshop will feature
GEMS activities for all level teachers. The April 13 &amp; April
27 workshops will focus on Marine Aquariums and Terrariums, including
construction, set-up, maintenance, stocking &amp; trouble shooting.
The May 4 Basic Marine Science workshop will highlight field trip
sites including the beach, jetty and marsh as well as field study
techniques on South Padre Island and in the adjacent bay. The
May 18 WHALENET workshop features an interdisciplinary, student-centered,
telecomputing program that uses the Internet to access curriculum
materials and data electronically. In addition to the scheduled
workshops, the R/V KATY will be available for visiting class trips
out of Port Isabel during the week of April 29-May 3. Both the
visiting class program and the teacher workshop program receive
funding support through the Texas A&amp;M University Sea Grant
Office.
<HR>

<P>
<A HREF="../index.htm#top_home"><IMG SRC="../images/smseal.jpg"  ALIGN="BOTTOM"></A>
Return to MSI Home Page
<HR>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-47</DOCNO>
<DOCOLDNO>IA026-000283-B025-283</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/ocean.htm 192.138.168.29 19970113215643 text/html 7080
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 22:05:08 GMT
Last-modified: Wednesday, 18-Dec-96 22:51:08 GMT
Content-length: 6888
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Oceanography Day 1997</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT="#000000" BACKGROUND="../../images/chalk.gif">

<H2 ALIGN=CENTER>Oceanography Day 1997</H2>

<P>
<HR></P>

<P>The University of Texas Marine Science Institute plans to host another
Oceanography Day, April 26, 1997. Our goal is to bring this exciting educational
program to an even greater number of Boy Scouts than attended the most
recent Oceanography Day in 1994, when 350 Scouts and 150 adult leaders
participated. These Scouters were from 100 different Scout troops in 50
different towns and cities. Oceanography Day includes a full day of activities
at the Marine Science Institute in Port Aransas. Scouts take a trip aboard
a Research Vessel, either the R/V LONGHORN or the R/V KATY, make a plankton
net, participate in a laboratory plankton identification session, and attend
presentations on exciting current research programs. Before coming to Oceanography
Day Scouts pass the first six requirements of the Oceanography Merit Badge.
During Oceanography Day the 7th (project) requirement is passed. After
Oceanography Day the final requirement (500 word report) is completed and
mailed to the Oceanography Day Chairman, who is also the Oceanography Merit
Badge Counselor. Scouts receive their approved blue cards in the mail and
their merit badge through their own troop. </P>

<P><IMG SRC="../IMAGES/flag.jpg" ALT="[Scouts saluting the flag]" HEIGHT=198 WIDTH=290 ALIGN=RIGHT BORDER=1>
<B>Requirements to Attend Oceanography Day:</B><BR>
</P>

<UL>
<LI>Obtain a copy of the Merit Badge Booklet 1983 revision or later and
read it.<BR>
</LI>

<LI>Complete in writing the first six requirements <B>as listed in the
merit badge booklet</B>.<BR>
</LI>

<DL>
<DD>-&quot;fill in the blank&quot; type answer sheets <B>are not acceptable</B>.<BR>
</DD>

<DD>-the work is expected to be the Scout's best effort (several hours
of study and diligent work are necessary).<BR>
</DD>

<DD>-include full name, age, school grade, troop #, mailing address, and
phone #.<BR>
</DD>
</DL>

<LI>Your work must be received before April 1, 1997. Your work will be
carefully reviewed. Additional work or corrected answers may be required
before you are approved to attend.<BR>
</LI>

<LI>Mail completed work to:<BR>
John Thompson, Oceanography Day Chairman, The University of Texas Marine
Science Institute, 750 Channelview Dr., Port Aransas, TX 78373-5015.<BR>
(Phone - 512-749-6760)<BR>
</LI>

<LI>Send your work by e-mail to <A HREF="mailto:thompson@utmsi.zo.utexas.edu">John Thompson</A></LI>
</UL>

<P><IMG SRC="../IMAGES/samples.jpg" ALT="[Scouts experimenting with samples]" HEIGHT=225 WIDTH=320 ALIGN=LEFT BORDER=1>
</P>

<P><B>Other Important Information:</B> </P>

<UL>
<LI>There is no charge for Oceanography Day.<BR>
</LI>

<LI>Scouts earn a special Oceanography Day patch (in addition to the merit
badge patch).<BR>
</LI>

<LI>Camping will be available on the MSI grounds.<BR>
</LI>

<LI>A related campfire program will be held Saturday evening.<BR>
</LI>

<LI>Oceanography Day is not for everyone. It requires a true interest in
marine science and oceanography and hard work. Attempts to qualify every
member of a Scout Troop for attendance are not encouraged.<BR>
</LI>
</UL>

<P><BR>
<BR>
<BR>
<B><I><CENTER><FONT SIZE="+2">Oceanography Day Instructors</FONT></CENTER></I></B>
<B>Terry Whitledge</B> <BR>
-Dr. Whitledge is a Chemical Oceanographer who has served as Chief Scientist
on dozens of cruises aboard large Research Vessels as well as MSI's own
R/V LONGHORN. Dr. Whitledge will be telling of his most recent adventures
aboard Russian Research Vessels and in the Pribilof Islands. </P>

<P><B>Tony Amos</B> <BR>
-Selected by Texas Monthly Magazine as one of the 20 most influential persons
in Texas for his outstanding work on Texas beaches and marine debris and
his conservation work with seabirds, marine mammals and turtles, Mr. Amos
is a Physical Oceanographer who has made 30 voyages to the Antarctic. </P>

<P><B>Ron Benner</B> <BR>
-Dr. Benner's research is in the area of microbial ecology. When he is
not in his laboratory at the Marine Science Institute in Port Aransas,
Dr. Benner may be in the Gulf of Mexico aboard the R/V LONGHORN or far
up the Amazon River in South America. </P>

<P><B>Paul Montagna</B> <BR>
-Dr. Montagna is a benthic ecologist. Dr. Montagna will be showing Scouts
some of the common forms of marine invertebrates found in the South Texas
area. </P>

<P><B>Ed Buskey</B> <BR>
-One of Dr. Buskey's research projects involves the study of copepods in
the tropics. Dr. Buskey and his students travel to Carrie Bow Cay, near
Belize, where much of their collecting is done by snorkeling. He will be
telling Scouts about life in the mangroves and bioluminescence living light
of the seas. </P>

<P><IMG SRC="../IMAGES/sampler.jpg" ALT="[Scout studying Plankton Sampler display" HEIGHT=297 WIDTH=225 ALIGN=RIGHT BORDER=1>
</P>

<P><B>Ken Dunton</B> <BR>
-Dr. Dunton and his students study Texas seagrasses as well as do research
on the Antarctic Peninsula (64&oslash; south latitude) and the High Arctic
(75&oslash; north latitude) where they study the adaptations made by polar
seaweeds to low temperatures and light and the thinning ozone layer. Dr.
Dunton will show Scouts how his team collects these measurements by diving
under the ice in both the Arctic and Antarctic. </P>

<P><B>Dean Stockwell</B> <BR>
-To reach his local study sites in the Nueces Basin, Dr. Stockwell operates
fast shallow draft jet-drive boats and ATV's and to reach his other study
sites under the Arctic Ice near the North Pole he travels aboard the U.S.
Navy's Nuclear Powered Submarine, the USS CAVALLA. </P>

<P><B>Ellery Ingall</B> <BR>
-Dr. Ingall is a marine chemist who studies the cycling of nutrients required
by all living things in the ocean. Recent work has taken him to the Gulf
of Mexico on the R/V LONGHORN and to the bottom of the ocean off Peru in
the Johnson Sea-Link Submersible. </P>

<P><B>Peter Thomas</B> <BR>
-Dr. Thomas studies reproduction in marine fish. He will show Scouts some
common fishes from this region. Dr. Thomas will describe how hormones control
fish reproduction and the effects of pollutants. </P>

<CENTER><P><IMG SRC="../IMAGES/longhrn2.jpg" ALT="[Scouts on the Longhorn]" HEIGHT=223 WIDTH=320 BORDER=1>
</P></CENTER>

<P>
<HR></P>

<P><IMG SRC="../images/wideshot.gif" ALT="[Visitors Center]" HSPACE=5 BORDER=1 HEIGHT=75 WIDTH=225 ALIGN=CENTER>
<A HREF="http://wwwutmsi.zo.utexas.edu/index.htm">Return to MSI Home Page</A>
</P>

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-48</DOCNO>
<DOCOLDNO>IA026-000283-B029-173</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/orgresh.htm 192.138.168.29 19970113221907 text/html 10934
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 22:27:37 GMT
Last-modified: Wednesday, 18-Dec-96 15:29:34 GMT
Content-length: 10741
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Recent Research Results</TITLE>
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<H2>
<CENTER>
Recent Research Results
</CENTER>
</H2>
<HR>
<P>
<B>Anthony F. Amos'</B> research in 1995/1996 was centered in two main areas; the Texas coastal zone and Antarctica.  Locally, he completed the Corpus Christi Bay National Estuary Program (CCBNEP) project researching the history and trends of the incidence of bay/marine (anthropogenic) debris, continued the NOAA-sponsored program to monitor remote San Jose Island for sea-turtle stranding and nesting, and continued to survey the Mustang Island Gulf beach and monitor tides, currents, and weather at the UTMSI Pier Laboratory with real-time displays at the Visitors Center and the UTMSI Office.  In Antarctica he participated in year 7 or the NOAA/NMFS program Antarctic Living Marine Resources (AMLR) aboard the R/V YUZHMORGEOLOGIYA.
<P>
<B>Dr. Connie R. Arnold's</B> research has emphasized the development
of sustainable mariculture through responsible stewardship of
marine resources and the development of culture technologies.
Closed system research has included the evaluation of the interaction
of feeds and closed system dynamics, the demonstration of recirculation
systems technologies for the production of <I>Penaeus vannamei</I>,
and the development of large scale larval rearing protocols for
<I>Sciaenops ocellatus</I> and <I>Ocyurus chrysurus</I>. Nutrition
research has emphasized the continued development and testing
of &quot;low pollution&quot; feeds for marine species such as
<I>Sciaenops ocellatus</I> and <I>Penaeus vannamei</I>. Work on
early life history of fishes continued with an active field program
involving studies of larval transport and nursery area utilization
by red drum and other sciaenids. Results suggest that events during
the pelagic larval stage are quite important in regulating recruitment
to the nursery and ultimately population size in red drum. Additional
analysis of these data is currently underway. Work with cobia
(ling) is continuing with efforts to capture and transport additional
adults to enhance the population for spawning.
<P>
<B>Dr. Ronald H. Benner's</B> research group investigated various aspects of the carbon and nitrogen cycles in the oceans, estuaries, and rivers.  A new conceptual model, the Size-Reactivity Continuum Model, of the cycling of organic matter in aquatic environmental was developed.  Studies of the microbial utilization and chemical composition of organic matter of varying sizes revealed that macromolecular material is more reactive and less diagenetically altered than smaller molecules.  These findings are contrary to the common notions that small molecules cycle rapidly while macromolecular material is recalcitrant.
<P>
<B>Dr. Edward J. Buskey's</B> research group has completed studies
of swarming behavior of copepods in the mangrove prop root environment
in Belize. By forming these aggregations, the copepods are protected
from predators, avoid being dispersed into unfavorable habitats
and increase their opportunities for mating. They have also continued
studies of protozooplankton in the Gulf of Mexico, including laboratory
studies of sensory perception and feeding behavior of heterotrophic
dinoflagellates.
<P>
<B>Dr. Kenneth H. Dunton's </B>lab is currently focused on a variety of projects ranging from the High Arctic to the Antarctic.  These projects include collaborators from several institutions and have resulted in the development of new approaches and techniques for measuring marine primary productivity in aquatic plants.  In the Arctic, Dr. Dunton is collaborating with Dr. Pat Neale from the Smithsonian on support from NSF to evaluate the response of kelp to UV radiation, the project incorporates in situ (under ice) measurement of chlorophyll fluorescence to examine UV effects as well as experimental manipulations of the plants in the laboratory.  In the Antarctic, Dr. Dunton is collaborating with Dr. Val Gerard (SUNY of Stony Brook) and Dr. Ian Davison (Univ. Maine) on the adaptations made by polar seaweeds to maintain high rates of production at cold temperatures.  On this NSF funded project, Dr. Dunton has developed a new approach for measurement of photosynthesis using the stable isotope, carbon -13.  In Texas, Dr. Duntons work on seagrasses has expanded to include the development of integrative model to estimate seagrass productivity in the Laguna Madre.  This work is being conducted with colleagues from Texas Parks and Wildlife and Texas A&M University under funding for the U.S. Army Corps of Engineers.
<P>
<B>Dr. Lee A. Fuiman's</B> laboratory expanded its work on the implications of morphological development for ecological interactions of fish larvae by studying the effects of a model pesticide.  In collaboration with Dr. Peter Thomas laboratory, they measured significant changes in the sensory and locomotor abilities of Atlantic croaker larvae whose parents had been exposed to very low levels of the pesticide.  These sublethal effects could be ultimately lethal in an ecological sense because they compromise the ability of larvae to find sufficient food to survive and to escape from predators they encounter.
<P>
<B>Dr. G. Joan Holt's</B> research group developed methodology
for rearing two coral reef species <I>Lysmata wurdemani</I> and
<I>Equetus umbrosus</I>. A manuscript describing larval development
in <I>E. umbrosus</I> compared to the closely related species
<I>E. acuminatus</I> will show definitive differences in larval
development in the two species, resolving a taxonomic dilemma.
A major component of this year's research was a red drum transport
and recruitment study with Scott Holt. Spawning periodicity and
larval abundances provide the first data for the entire spawning
event. Forty-two percent of planktonic larvae were experiencing
some degree of food depravation, but only two percent were starved
or in poor condition. Variation in the biochemical condition of
larvae collected in estuarine seagrass was due to fish size and
water temperature, but not to differences in seagrass species.

<P>
<B>Dr. Ellery D. Ingall's</B> research has focused on the cycling
of nutrients in the ocean. Recent studies have demonstrated that
oxygen depleted bottom waters greatly enhance phosphorus regeneration
from sediments. Based on these observations a positive feedback
between water column anoxia, enhanced benthic phosphorus regeneration,
and marine productivity has been proposed and incorporated into
a large scale mathematical model of the ocean. The feedback effect
helps explain the widespread accumulation of organic-rich marine
sediments deposited from anoxic waters that are observed in the
geologic record.
<P>
<B>Dr. Paul A. Montagna's </B>research focuses on the importance
of benthic invertebrates in the ecology of the coastal zone. This
year, he has proved that grazing by meiofauna, the smallest invertebrates,
can control the rates of many microbial processes in natural and
disturbed sediments. He has also shown that small clams and snails
are good indicators of the importance of freshwater inflow to
maintain productivity in Texas estuaries.
<P>
<B>Dr. Curtis A. Suttle's</B> group has developed a number of
new approaches for investigating the roles of viruses in marine
ecosystems. These include a protocol for staining viruses so that
they can be visualized by epifluorescence microscopy, using fluorescently
tagged viruses to identify and quantify specific types of cells
that are susceptible to viral infection, and developing oligonucleotide
primers for virus DNA polymerase genes that allow the DNA from
known and unknown viruses to be amplified from seawater and identified.
These methods have helped to investigate the dynamics of host
and virus populations in nature, and to determine the existence
of previously unknown viruses in seawater.
<P>
<B>Richard K. Tinnin</B> heads the Marine Education Services Program.
MES hosts over 10,000 students each year who stay in the dorms
and participate in research vessel cruises and field trips to
the surrounding marine habitats. One thousand teachers last year
participated in 17 weekend teacher workshops. The Visitors Center
hosted over 40,000 visitors who enjoyed seven marine aquariums,
watched videos in the auditorium and toured the main laboratory
displays. MES is in the 2nd year of a 3 year pilot program for
an elementary education project, Marine Activities, Resources
and Education (MARE) in cooperation with The Lawrence Hall of
Science, UC Berkeley. Six Texas schools are pilot testing the
habitat oriented curriculum and writing Gulf coast activities
to be included in this exciting teacher training project. The
MARE curriculum uses the ocean as a central theme to link all
traditional subject matter in an interdisciplinary approach.
<P>
<B>Dr. Peter Thomas' </B>group has recently identified a steroid
receptor on croaker sperm. Steroid binding activity was previously
found in the sperm of humans and other mammals, but the binding
has not been characterized. Thomas' group have fully characterized
the steroid receptor in croaker sperm, the first extensive characterization
of such a receptor in any vertebrate species. The function of
this receptor is unknown at present, but may be associated with
sperm activation. Previous studies had indicated that somatolactin,
a pituitary hormone recently discovered in fish, is involved in
background adaptation. Further research has demonstrated that
purified somatolactin can act directly on chromatophores in fish
scales to cause melanin aggregation. These results suggest that
somatolactin enables fish to adapt to different backgrounds by
altering chromatophore function and hence body pigmentation.
<P>
<B>Dr. Terry E. Whitledge's</B> work has focused on the relationship
of nutrient availability and growth of the Texas brown tide in
the upper and lower Laguna Madre. Experimental ponds were used
to determine how different types of nitrogen fertilizers affect
relative species composition, biomass and growth rates of the
brown tide and other phytoplankton as a potential means of biological
control. Research was also continued on the enhanced productivity
and ecological effects of proposed freshwater and wastewater diversions
into Nueces Bay and Rincon Delta. 
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-49</DOCNO>
<DOCOLDNO>IA026-000283-B029-373</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/mes/wrkshp.htm 192.138.168.29 19970113222148 text/html 4201
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 22:31:24 GMT
Last-modified: Monday, 23-Dec-96 19:52:14 GMT
Content-length: 4012
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>HTML document for the World Wide Web</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<P>
<CENTER><B>University of Texas Marine Science Institute<BR>
Marine Education Services<P>
</B> <B><I><FONT SIZE="+2"><FONT COLOR="Red">1997 SPRING WORKSHOP SCHEDULE</FONT></FONT></I></B>
</CENTER><P>
<DL>

<DT>January 17-19<DD><DFN><B>Shamrock Island:  Contour Mapping</B></DFN><br>
<DFN>For All Level Teachers, UTMSI-Port Aransas  </DFN>
<P>

<DT>January 31-February 2<DD><DFN><B>The Ocean on the Internet</B></DFN><BR>
<DFN>For All Level Teachers, UTMSI-Port Aransas</DFN>
<P>

<DT>March 7-9<DD><DFN><B>Basic Marine Science</B></DFN><BR>
<DFN>For All Level Teachers, UTMSI-Port Aransas</DFN>
<P>

<DT>April 18-20<DD><DFN><B>Global Change</B></DFN><BR>
<DFN>5th-9th Grade Teachers, UTMSI-Port Aransas</DFN>
<P>

<DT>May 3<DD><DFN><B>Basic Marine Science</B></DFN><BR>
<DFN>For All Level Teachers, UT-Pan American Coastal Studies Laboratory</DFN>
<P>

<DT>May 10<DD><DFN><B>Global Change</B></DFN><BR>
<DFN>5th-9th Grade Teachers, UT-Pan American Coastal Studies Laboratory</DFN>
</DL>
<HR><P>
The workshops scheduled at the UT-Pan American Coastal Studies Laboratory (CSL), located on South Padre Island, 
will be held on Saturdays from 8:30 a.m. to 8 p.m.  The CSL registration fee of $28 includes all handouts and a 
catered lunch and dinner.  The workshops scheduled at the UT Marine Science Institute (UTMSI), located in Port 
Aransas, begin with registration on Friday night from 7-10 p.m. at the Visitors Center.  The cost of the UTMSI 
workshops is $55 which includes five meals, two nights in the dorms (bring your own blanket and towels), 
refreshments and all handouts.  Workshops at CSL are limited to 25 participants; workshops at UTMSI are limited to 
50 participants.  You are encouraged to secure your registration with full payment as early as possible. Please make 
your  check payable to The University of Texas, and mail it to:  Marine Education Services Program Office, The 
University of Texas, 750 Channelview Drive, Port Aransas, TX 78373.  No refunds allowed.<P>

Two workshops are scheduled to be held at the Coastal Studies Laboratory at South Padre Island (May 3 and May 10) 
and four will be held at UTMSI (January 17, January 31, March 7, and April 18).  The January 17, <B>Shamrock Island</B> 
workshop will feature a trip to an uninhabited bird rookery in east Corpus Christi Bay.  Participants will conduct a 
contour mapping field exercise.  The January 31 <A HREF="http://whale.wheelock.edu/">WHALENET</A>  workshop features an interdisciplinary, student-
centered telecomputing program that uses the Internet  to access curriculum materials and data electronically.  The 
March 7 (UTMSI) and May 3 (CSL) <B>Basic Marine Science</B>  workshops will highlight field trip sites including the 
beach, jetty and marsh, and field study techniques on barrier islands and in adjacent bays.  The April 18 (UTMSI) 
and May 10 (CSL) workshops will feature <B>Project TELLUS</B>, an interactive video curriculum for  middle school 
students on global change issues related to the Gulf of Mexico region.  Participants will receive a curriculum binder 
complete with an interactive video and activities on Biodiversity, Exotic Species, Water Quality, Climatic Change 
and Overpopulation.  In  addition to the scheduled workshops, the <I><B>R/V Katy</B></I> will be available for visiting class trips 
out of Port Isabel during the week of May 2-9. Both the Visiting Class program and the teacher workshop program 
receive funding support through the Texas A&M University Sea Grant office.

<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-50</DOCNO>
<DOCOLDNO>IA026-000283-B030-96</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/afamos/monthly.htm 192.138.168.29 19970113222301 text/html 13871
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 22:33:16 GMT
Last-modified: Thursday, 09-Jan-97 17:25:48 GMT
Content-length: 13679
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Port Aransas Monthly Weather Summary, 1986-1996</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="../../images/chalk.gif" bgcolor="#FFFFFF" text="#000000" >

<H1>Port Aransas Monthly Weather Summary, 1986-1996</H1>

<!-- The following table has been generated by the Internet Assistant Wizard for Microsoft Excel. You can find this add-in on "http://www.microsoft.com/msoffice/freestuf/msexcel/index.htm" -->
<!-- ------------------------- -->
<!-- START OF CONVERTED OUTPUT -->
<!-- ------------------------- -->
<Table border>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left"><B>
Mnt</B></TD>
<TD ALIGN="left"><B>
MnHi</B></TD>
<TD ALIGN="left"><B>
MnLo</B></TD>
<TD ALIGN="left"><B>
Medn</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
HiHi</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
LoHi</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
HiLo</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
LoLo</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
Rtotl</B></TD>
<TD ALIGN="left"><B>
Rmean</B></TD>
<TD ALIGN="left"><B>
Nrd</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
Daymx</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Jan</TD>
<TD ALIGN="right">
62.2</TD>
<TD ALIGN="right">
50.2</TD>
<TD ALIGN="right">
56.2</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
77.1</TD>
<TD ALIGN="right">
3</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
36.3</TD>
<TD ALIGN="right">
8</TD>
<TD ALIGN="right">
88</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
69.7</TD>
<TD ALIGN="right">
17</TD>
<TD ALIGN="right">
96</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
30.5</TD>
<TD ALIGN="right">
7</TD>
<TD ALIGN="right">
96</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
23.9</TD>
<TD ALIGN="right">
2.39</TD>
<TD ALIGN="right">
8</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
2.0</TD>
<TD ALIGN="right">
17</TD>
<TD ALIGN="right">
92</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Feb</TD>
<TD ALIGN="right">
64.5</TD>
<TD ALIGN="right">
53.1</TD>
<TD ALIGN="right">
58.8</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
78.8</TD>
<TD ALIGN="right">
46</TD>
<TD ALIGN="right">
92</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
29.4</TD>
<TD ALIGN="right">
37</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
65.3</TD>
<TD ALIGN="right">
33</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
26.4</TD>
<TD ALIGN="right">
37</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
34.1</TD>
<TD ALIGN="right">
3.41</TD>
<TD ALIGN="right">
8</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
5.4</TD>
<TD ALIGN="right">
41</TD>
<TD ALIGN="right">
93</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Mar</TD>
<TD ALIGN="right">
69.4</TD>
<TD ALIGN="right">
57.8</TD>
<TD ALIGN="right">
63.6</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
86.5</TD>
<TD ALIGN="right">
61</TD>
<TD ALIGN="right">
91</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
48.9</TD>
<TD ALIGN="right">
60</TD>
<TD ALIGN="right">
96</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
69.6</TD>
<TD ALIGN="right">
85</TD>
<TD ALIGN="right">
95</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
33.2</TD>
<TD ALIGN="right">
66</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
25.4</TD>
<TD ALIGN="right">
2.54</TD>
<TD ALIGN="right">
6</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
3.8</TD>
<TD ALIGN="right">
88</TD>
<TD ALIGN="right">
90</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Apr</TD>
<TD ALIGN="right">
75.6</TD>
<TD ALIGN="right">
65.4</TD>
<TD ALIGN="right">
70.5</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
89.0</TD>
<TD ALIGN="right">
109</TD>
<TD ALIGN="right">
88</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
57.2</TD>
<TD ALIGN="right">
96</TD>
<TD ALIGN="right">
87</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
75.5</TD>
<TD ALIGN="right">
117</TD>
<TD ALIGN="right">
91</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
41.9</TD>
<TD ALIGN="right">
93</TD>
<TD ALIGN="right">
87</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
21.9</TD>
<TD ALIGN="right">
2.19</TD>
<TD ALIGN="right">
6</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
2.5</TD>
<TD ALIGN="right">
95</TD>
<TD ALIGN="right">
91</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
May</TD>
<TD ALIGN="right">
82.1</TD>
<TD ALIGN="right">
73.1</TD>
<TD ALIGN="right">
77.6</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
89.4</TD>
<TD ALIGN="right">
150</TD>
<TD ALIGN="right">
90</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
69.4</TD>
<TD ALIGN="right">
121</TD>
<TD ALIGN="right">
94</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
81.1</TD>
<TD ALIGN="right">
151</TD>
<TD ALIGN="right">
90</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
56.3</TD>
<TD ALIGN="right">
121</TD>
<TD ALIGN="right">
96</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
31.8</TD>
<TD ALIGN="right">
3.54</TD>
<TD ALIGN="right">
7</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
4.9</TD>
<TD ALIGN="right">
124</TD>
<TD ALIGN="right">
92</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Jun</TD>
<TD ALIGN="right">
87.1</TD>
<TD ALIGN="right">
77.7</TD>
<TD ALIGN="right">
82.4</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
94.4</TD>
<TD ALIGN="right">
177</TD>
<TD ALIGN="right">
87</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
77.0</TD>
<TD ALIGN="right">
152</TD>
<TD ALIGN="right">
88</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
82.4</TD>
<TD ALIGN="right">
178</TD>
<TD ALIGN="right">
86</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
67.6</TD>
<TD ALIGN="right">
155</TD>
<TD ALIGN="right">
88</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
44.1</TD>
<TD ALIGN="right">
4.9</TD>
<TD ALIGN="right">
9</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
3.3</TD>
<TD ALIGN="right">
181</TD>
<TD ALIGN="right">
89</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Jul</TD>
<TD ALIGN="right">
88.4</TD>
<TD ALIGN="right">
79.2</TD>
<TD ALIGN="right">
83.8</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
93.7</TD>
<TD ALIGN="right">
189</TD>
<TD ALIGN="right">
96</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
81.8</TD>
<TD ALIGN="right">
188</TD>
<TD ALIGN="right">
90</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
84.7</TD>
<TD ALIGN="right">
188</TD>
<TD ALIGN="right">
94</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
69.2</TD>
<TD ALIGN="right">
205</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
13.5</TD>
<TD ALIGN="right">
1.5</TD>
<TD ALIGN="right">
4</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
2.5</TD>
<TD ALIGN="right">
208</TD>
<TD ALIGN="right">
89</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Aug</TD>
<TD ALIGN="right">
88.9</TD>
<TD ALIGN="right">
79.4</TD>
<TD ALIGN="right">
84.1</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
93.3</TD>
<TD ALIGN="right">
239</TD>
<TD ALIGN="right">
90</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
80.2</TD>
<TD ALIGN="right">
243</TD>
<TD ALIGN="right">
91</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
83.1</TD>
<TD ALIGN="right">
238</TD>
<TD ALIGN="right">
88</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
70.1</TD>
<TD ALIGN="right">
234</TD>
<TD ALIGN="right">
86</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
27.4</TD>
<TD ALIGN="right">
3.04</TD>
<TD ALIGN="right">
7</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
2.5</TD>
<TD ALIGN="right">
237</TD>
<TD ALIGN="right">
96</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Sep</TD>
<TD ALIGN="right">
87.0</TD>
<TD ALIGN="right">
76.6</TD>
<TD ALIGN="right">
81.8</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
93.3</TD>
<TD ALIGN="right">
245</TD>
<TD ALIGN="right">
95</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
70.1</TD>
<TD ALIGN="right">
263</TD>
<TD ALIGN="right">
91</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
83.4</TD>
<TD ALIGN="right">
262</TD>
<TD ALIGN="right">
95</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
57.2</TD>
<TD ALIGN="right">
265</TD>
<TD ALIGN="right">
95</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
43.7</TD>
<TD ALIGN="right">
4.85</TD>
<TD ALIGN="right">
10</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
4.2</TD>
<TD ALIGN="right">
250</TD>
<TD ALIGN="right">
96</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Oct</TD>
<TD ALIGN="right">
81.0</TD>
<TD ALIGN="right">
69.9</TD>
<TD ALIGN="right">
75.4</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
88.5</TD>
<TD ALIGN="right">
276</TD>
<TD ALIGN="right">
86</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
52.8</TD>
<TD ALIGN="right">
303</TD>
<TD ALIGN="right">
93</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
82.2</TD>
<TD ALIGN="right">
275</TD>
<TD ALIGN="right">
86</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
41.7</TD>
<TD ALIGN="right">
303</TD>
<TD ALIGN="right">
93</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
46.8</TD>
<TD ALIGN="right">
5.2</TD>
<TD ALIGN="right">
6</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
9.7</TD>
<TD ALIGN="right">
302</TD>
<TD ALIGN="right">
95</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Nov</TD>
<TD ALIGN="right">
72.3</TD>
<TD ALIGN="right">
60.5</TD>
<TD ALIGN="right">
66.4</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
94.1</TD>
<TD ALIGN="right">
309</TD>
<TD ALIGN="right">
88</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
42.9</TD>
<TD ALIGN="right">
333</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
79.1</TD>
<TD ALIGN="right">
305</TD>
<TD ALIGN="right">
95</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
35.9</TD>
<TD ALIGN="right">
330</TD>
<TD ALIGN="right">
93</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
17.1</TD>
<TD ALIGN="right">
1.9</TD>
<TD ALIGN="right">
6</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
2.0</TD>
<TD ALIGN="right">
321</TD>
<TD ALIGN="right">
95</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left">
Dec</TD>
<TD ALIGN="right">
64.8</TD>
<TD ALIGN="right">
53.1</TD>
<TD ALIGN="right">
58.9</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
79.5</TD>
<TD ALIGN="right">
341</TD>
<TD ALIGN="right">
94</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
27.5</TD>
<TD ALIGN="right">
357</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
74.3</TD>
<TD ALIGN="right">
337</TD>
<TD ALIGN="right">
95</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
12.2</TD>
<TD ALIGN="right">
357</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
22.0</TD>
<TD ALIGN="right">
2.45</TD>
<TD ALIGN="right">
9</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
2.8</TD>
<TD ALIGN="right">
362</TD>
<TD ALIGN="right">
94</TD>
</FONT></TR>
</Table>
<!-- ------------------------- -->
<!--  END OF CONVERTED OUTPUT  -->
<!-- ------------------------- -->
<P>
<B><U><FONT SIZE="+1">Explanation</FONT></U></B>:  <P>

<B><I><FONT SIZE="+1">Temperature (F) -</FONT></I></B>  <P>

	<B>MnHi - </B> Mean High  <BR>
	<B>MnLo - </B> Mean Low  <BR>
	<B>Medn - </B> Median (not mean because the NOAA equipment registers only high and low each day)  <BR>
	<B>HiHi - </B> Highest High  <BR>
	<B>LoHi - </B> Lowest High  <BR>
	<B>HiLo - </B> Highest Low  <BR>
	<B>LoLo - </B> Lowest Low  <P>

<B><I><FONT SIZE="+1">Rainfall (inches) -</FONT></I></B> <P>

	<B>Rtotl - </B> Total  <BR>
	<B>Rmean - </B> Mean (monthly or daily)  <BR>
	<B>Nrd - </B> Number of raindays  <BR>
	<B>Daymx - </B> Maximum in one day<BR>
	<B>Mnt - </B> Month  <BR>
	<B>Jdy - </B> Julian Day  <BR>
	<B>Yr - </B> Year    <P>

<B>Data courtesy of:</B>   <A HREF="index.htm">Tony Amos</A>, University of Texas at Austin, Marine Science Institute, 750 Channelview Drive, Port Aransas, Texas 78373<P>
<B>Data collected at:</B>  NOAA/National Weather Service Cooperative Weather Observer Station #1071, Port Aransas<P>

<B>Use for information purposes only.</B> 
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
 </BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-51</DOCNO>
<DOCOLDNO>IA026-000283-B030-170</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/afamos/yearly.htm 192.138.168.29 19970113222413 text/html 11249
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 22:34:37 GMT
Last-modified: Thursday, 09-Jan-97 17:24:52 GMT
Content-length: 11057
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Port Aransas Yearly Weather Summary, 1986-1996</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="../../images/chalk.gif" bgcolor="#FFFFFF" text="#000000" >

<H1>Port Aransas Yearly Weather Summary, 1986-1996</H1>

<!-- The following table has been generated by the Internet Assistant Wizard for Microsoft Excel. You can find this add-in on "http://www.microsoft.com/msoffice/freestuf/msexcel/index.htm" -->
<!-- ------------------------- -->
<!-- START OF CONVERTED OUTPUT -->
<!-- ------------------------- -->
<Table border>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left"><B>
Year</B></TD>
<TD ALIGN="left"><B>
MnHi</B></TD>
<TD ALIGN="left"><B>
MnLo</B></TD>
<TD ALIGN="left"><B>
Medn</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
HiHi</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
LoHi</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
HiLo</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
LoLo</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
Rtotl</B></TD>
<TD ALIGN="left"><B>
Rmean</B></TD>
<TD ALIGN="left"><B>
Nrd</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
Daymx</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1986</TD>
<TD ALIGN="right">
77.1</TD>
<TD ALIGN="right">
67.0</TD>
<TD ALIGN="right">
72.1</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
93.0</TD>
<TD ALIGN="right">
231</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
41.7</TD>
<TD ALIGN="right">
9</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
82.5</TD>
<TD ALIGN="right">
248</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
35.7</TD>
<TD ALIGN="right">
42</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
32.0</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
87</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
4.4</TD>
<TD ALIGN="right">
279</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1987</TD>
<TD ALIGN="right">
75.6</TD>
<TD ALIGN="right">
64.3</TD>
<TD ALIGN="right">
69.9</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
94.4</TD>
<TD ALIGN="right">
177</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
44.2</TD>
<TD ALIGN="right">
361</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
82.7</TD>
<TD ALIGN="right">
258</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
35.7</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
29.9</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
78</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
4.1</TD>
<TD ALIGN="right">
295</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1988</TD>
<TD ALIGN="right">
75.2</TD>
<TD ALIGN="right">
63.8</TD>
<TD ALIGN="right">
69.5</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
94.1</TD>
<TD ALIGN="right">
309</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
36.3</TD>
<TD ALIGN="right">
8</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
83.1</TD>
<TD ALIGN="right">
238</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
31.4</TD>
<TD ALIGN="right">
10</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
24.4</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
62</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
4.8</TD>
<TD ALIGN="right">
274</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1989</TD>
<TD ALIGN="right">
75.9</TD>
<TD ALIGN="right">
64.8</TD>
<TD ALIGN="right">
70.3</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
93.2</TD>
<TD ALIGN="right">
246</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
27.5</TD>
<TD ALIGN="right">
357</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
82.7</TD>
<TD ALIGN="right">
244</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
12.2</TD>
<TD ALIGN="right">
357</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
19.6</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
53</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
3.3</TD>
<TD ALIGN="right">
181</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1990</TD>
<TD ALIGN="right">
77.7</TD>
<TD ALIGN="right">
67.0</TD>
<TD ALIGN="right">
72.3</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
93.3</TD>
<TD ALIGN="right">
239</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
39.0</TD>
<TD ALIGN="right">
357</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
82.4</TD>
<TD ALIGN="right">
215</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
24.2</TD>
<TD ALIGN="right">
357</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
32.1</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
64</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
3.8</TD>
<TD ALIGN="right">
52</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1991</TD>
<TD ALIGN="right">
76.7</TD>
<TD ALIGN="right">
66.6</TD>
<TD ALIGN="right">
71.6</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
91.2</TD>
<TD ALIGN="right">
186</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
46.7</TD>
<TD ALIGN="right">
21</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
82.7</TD>
<TD ALIGN="right">
216</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
38.3</TD>
<TD ALIGN="right">
31</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
33.7</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
86</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
3.2</TD>
<TD ALIGN="right">
303</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1992</TD>
<TD ALIGN="right">
76.2</TD>
<TD ALIGN="right">
66.4</TD>
<TD ALIGN="right">
71.3</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
91.4</TD>
<TD ALIGN="right">
222</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
41.3</TD>
<TD ALIGN="right">
16</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
82.5</TD>
<TD ALIGN="right">
247</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
33.6</TD>
<TD ALIGN="right">
16</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
51.1</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
86</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
4.9</TD>
<TD ALIGN="right">
124</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1993</TD>
<TD ALIGN="right">
76.4</TD>
<TD ALIGN="right">
66.1</TD>
<TD ALIGN="right">
71.2</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
92.1</TD>
<TD ALIGN="right">
223</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
44.9</TD>
<TD ALIGN="right">
330</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
81.6</TD>
<TD ALIGN="right">
256</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
35.9</TD>
<TD ALIGN="right">
330</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
41.7</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
77</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
5.4</TD>
<TD ALIGN="right">
41</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1994</TD>
<TD ALIGN="right">
77.5</TD>
<TD ALIGN="right">
67.2</TD>
<TD ALIGN="right">
72.3</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
90.6</TD>
<TD ALIGN="right">
185</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
44.0</TD>
<TD ALIGN="right">
32</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
84.7</TD>
<TD ALIGN="right">
188</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
34.1</TD>
<TD ALIGN="right">
33</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
25.5</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
70</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
3.0</TD>
<TD ALIGN="right">
281</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1995</TD>
<TD ALIGN="right">
77.9</TD>
<TD ALIGN="right">
67.5</TD>
<TD ALIGN="right">
72.7</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
93.3</TD>
<TD ALIGN="right">
245</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
46.9</TD>
<TD ALIGN="right">
5</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
83.4</TD>
<TD ALIGN="right">
262</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
35.7</TD>
<TD ALIGN="right">
344</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
35.9</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
69</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
9.7</TD>
<TD ALIGN="right">
302</TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
1996</TD>
<TD ALIGN="right">
77.8</TD>
<TD ALIGN="right">
66.4</TD>
<TD ALIGN="right">
72.1</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
93.7</TD>
<TD ALIGN="right">
189</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
41.3</TD>
<TD ALIGN="right">
32</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
83.8</TD>
<TD ALIGN="right">
191</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
29.6</TD>
<TD ALIGN="right">
35</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
26.0</TD>
<TD ALIGN="right">
0.1</TD>
<TD ALIGN="right">
57</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
4.2</TD>
<TD ALIGN="right">
250</TD>
</FONT></TR>
</Table>
<!-- ------------------------- -->
<!--  END OF CONVERTED OUTPUT  -->
<!-- ------------------------- -->
<P>
<B><U><FONT SIZE="+1">Explanation</FONT></U></B>:  <P>

<B><I><FONT SIZE="+1">Temperature (F) -</FONT></I></B>  <P>

	<B>MnHi - </B> Mean High  <BR>
	<B>MnLo - </B> Mean Low  <BR>
	<B>Medn - </B> Median (not mean because the NOAA equipment registers only high and low each day)  <BR>
	<B>HiHi - </B> Highest High  <BR>
	<B>LoHi - </B> Lowest High  <BR>
	<B>HiLo - </B> Highest Low  <BR>
	<B>LoLo - </B> Lowest Low  <P>

<B><I><FONT SIZE="+1">Rainfall (inches) -</FONT></I></B> <P>

	<B>Rtotl - </B> Total  <BR>
	<B>Rmean - </B> Mean (monthly or daily)  <BR>
	<B>Nrd - </B> Number of raindays  <BR>
	<B>Daymx - </B> Maximum in one day<BR>
	<B>Mnt - </B> Month  <BR>
	<B>Jdy - </B> Julian Day  <BR>
	<B>Yr - </B> Year    <P>

<B>Data courtesy of:</B>   <A HREF="index.htm">Tony Amos</A>, University of Texas at Austin, Marine Science Institute, 750 Channelview Drive, Port Aransas, Texas 78373<P>
<B>Data collected at:</B>  NOAA/National Weather Service Cooperative Weather Observer Station #1071, Port Aransas<P>

<B>Use for information purposes only.</B> 
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
 </BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-52</DOCNO>
<DOCOLDNO>IA026-000283-B030-262</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/afamos/period.htm 192.138.168.29 19970113222529 text/html 4174
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 22:35:34 GMT
Last-modified: Thursday, 09-Jan-97 17:25:10 GMT
Content-length: 3983
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
    <TITLE>Port Aransas 11-Year Weather Summary, 1986-1996</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="../../images/chalk.gif" bgcolor="#FFFFFF" text="#000000" >

<H1>Port Aransas 11-Year Weather Summary, 1986-1996</H1>

<!-- The following table has been generated by the Internet Assistant Wizard for Microsoft Excel. You can find this add-in on "http://www.microsoft.com/msoffice/freestuf/msexcel/index.htm" -->
<!-- ------------------------- -->
<!-- START OF CONVERTED OUTPUT -->
<!-- ------------------------- -->
<Table border>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="left"><B>
MnHi</B></TD>
<TD ALIGN="left"><B>
MnLo</B></TD>
<TD ALIGN="left"><B>
Medn</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
HiHi</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
LoHi</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
HiLo</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
LoLo</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
Rtotl</B></TD>
<TD ALIGN="left"><B>
Rmean</B></TD>
<TD ALIGN="left"><B>
Nrd</B></TD>
<TD ALIGN="right"><B>
</B></TD>
<TD ALIGN="left"><B>
Daymx</B></TD>
<TD ALIGN="left"><B>
Jdy</B></TD>
<TD ALIGN="left"><B>
Yr</B></TD>
</FONT></TR>
<TR VALIGN="bottom"><FONT FACE="Arial">
<TD ALIGN="right">
76.8</TD>
<TD ALIGN="right">
66.1</TD>
<TD ALIGN="right">
71.5</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
94.4</TD>
<TD ALIGN="right">
177</TD>
<TD ALIGN="right">
87</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
27.5</TD>
<TD ALIGN="right">
357</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
84.7</TD>
<TD ALIGN="right">
188</TD>
<TD ALIGN="right">
94</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
12.2</TD>
<TD ALIGN="right">
357</TD>
<TD ALIGN="right">
89</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
351.7</TD>
<TD ALIGN="right">
32.0</TD>
<TD ALIGN="right">
83</TD>
<TD ALIGN="right">
</TD>
<TD ALIGN="right">
9.7</TD>
<TD ALIGN="right">
302</TD>
<TD ALIGN="right">
95</TD>
</FONT></TR>
</Table>
<!-- ------------------------- -->
<!--  END OF CONVERTED OUTPUT  -->
<!-- ------------------------- -->
<P>
<B><U><FONT SIZE="+1">Explanation</FONT></U></B>:  <P>

<B><I><FONT SIZE="+1">Temperature (F) -</FONT></I></B>  <P>

	<B>MnHi - </B> Mean High  <BR>
	<B>MnLo - </B> Mean Low  <BR>
	<B>Medn - </B> Median (not mean because the NOAA equipment registers only high and low each day)  <BR>
	<B>HiHi - </B> Highest High  <BR>
	<B>LoHi - </B> Lowest High  <BR>
	<B>HiLo - </B> Highest Low  <BR>
	<B>LoLo - </B> Lowest Low  <P>

<B><I><FONT SIZE="+1">Rainfall (inches) -</FONT></I></B> <P>

	<B>Rtotl - </B> Total  <BR>
	<B>Rmean - </B> Mean (monthly or daily)  <BR>
	<B>Nrd - </B> Number of raindays  <BR>
	<B>Daymx - </B> Maximum in one day<BR>
	<B>Mnt - </B> Month  <BR>
	<B>Jdy - </B> Julian Day  <BR>
	<B>Yr - </B> Year    <P>

<B>Data courtesy of:</B>   <A HREF="index.htm">Tony Amos</A>, University of Texas at Austin, Marine Science Institute, 750 Channelview Drive, Port Aransas, Texas 78373<P>
<B>Data collected at:</B>  NOAA/National Weather Service Cooperative Weather Observer Station #1071, Port Aransas<P>

<B>Use for information purposes only.</B> 
<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
 </BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-53</DOCNO>
<DOCOLDNO>IA026-000284-B014-173</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/current/mainmap.map 192.138.168.29 19970113223400 text/html 321
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 22:43:04 GMT
Content-type: text/html
Content-length: 180
</DOCHDR>
<TITLE>Imagemap Error</TITLE><H1>Imagemap Error</H1>Your client did not send any coordinates. Either your client doesn't support imagemap or the map file was not accessed as a map.
</DOC>
<DOC>
<DOCNO>WT01-B18-54</DOCNO>
<DOCOLDNO>IA027-000287-B034-338</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/academic/letter.htm 192.138.168.29 19970114015241 text/html 3708
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Tuesday, 14-Jan-97 02:03:25 GMT
Last-modified: Sunday, 13-Oct-96 15:51:44 GMT
Content-length: 3518
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Dear Prospective Graduate Student:</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY>

<P>
<B>Dear Prospective Graduate Student:</B>
<P>
The Department of Marine Science of The University of Texas at
Austin offers programs of study leading to the M.A. and Ph.D.
degrees in marine science. Graduate students usually begin their
academic program with coursework in the summer semester in Port
Aransas. They continue their coursework on the Austin campus before
moving to The University of Texas Marine Science Institute at
Port Aransas for specialized advanced courses and thesis or dissertation
research. Students are required to take core courses in the following
subdisciplines: marine biology, marine chemistry, marine geology
and physical oceanography.
<P>
The research and teaching interests of Faculty/Staff in the Department
of Marine Science/Marine Science Institute are primarily focused
in a wide range of marine environments but several interdisciplinary
marine programs are also available. The research programs of Dr.
Behrens and Dr. Maguire are located at the main campus in Austin
whereas those of the other faculty/staff are based at the Marine
Science Institute at Port Aransas which is on the Gulf coast near
Corpus Christi. The Marine Science Institute provides opportunities
to study living organisms in the laboratory and under field conditions.
A wide variety of environments are readily accessible, such as
the pass connecting Corpus Christi Bay with the Gulf of Mexico,
the continental shelf, and many bays and estuaries, including
brackish estuaries and the hypersaline Laguna Madre. Extensive
wet laboratory facilities with running sea water are available
for maintaining marine organisms. There are also specialized wet
laboratories and environmental chambers for mariculture, physiology,
behavior and toxicology research. 
<P>
Vessels include the R/V LONGHORN, a 105-foot research vessel with
navigation and laboratory capabilities for most research projects;
the R/V KATY, a 54-foot boat with dredge and trawl equipment for
collection of specimens; and a fleet of smaller boats for use
in bays and estuaries.
<P>
Modern laboratories are equipped to study vertebrate and invertebrate
biochemistry, physiology, behavior and ecology; viral, bacterial,
algal and seagrass physiology and ecology; mariculture; and marine
chemistry and biogeochemistry. The library has extensive holdings
in marine science and related disciplines. Remote terminals provide
direct access to the mainframe computers on the Austin campus.
<P>
Research and teaching assistantships and E.J. Lund Scholarships
are the major sources of financial aid for graduate students.
Currently 28 students are enrolled in the graduate program of
the Department of Marine Science. University apartments are available
for students use during their stay in Port Aransas.
<P>
Additional information on our graduate program can be obtained
by calling (512) 749-6721 or e-mail gradinfo@utmsi.zo.utexas.edu.
Prospective students should contact individual faculty members
for further details of their research programs.
<P>
Graduate Adviser 

<HR> 
<P><IMG
SRC="file:///E|/NETSCAPE/ns-home/docs/wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-55</DOCNO>
<DOCOLDNO>IA027-000287-B035-248</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/academic/courses.htm 192.138.168.29 19970114015845 text/html 8665
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Tuesday, 14-Jan-97 02:09:06 GMT
Last-modified: Wednesday, 13-Nov-96 20:43:10 GMT
Content-length: 8472
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>LIST OF MARINE SCIENCE CORE COURSES*</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 2.0z Beta">
</HEAD>

<BODY BACKGROUND="../../images/chalk.gif" bgcolor="#FFFFFF" text="#000000" >


<HR>

<H1>
<CENTER>
Graduate Courses
</CENTER>
</H1>

<UL>
<LI><A HREF="#Core">Core Courses</A>
<LI><A HREF="#Advanced ">Advanced Courses</A>
<LI><A HREF="http://www.utexas.edu/student/registrar/aboutscheds.html">University Course Schedules</A>
</UL>

<HR>

<H2>
<CENTER>
MARINE SCIENCE CORE COURSES*
</CENTER>
</H2>

<P>
<B>MNS 384F. <I>Marine Geology</I></B>. Marine Science 354F and
384F may not both be counted. Development of ocean basins; marine
and coastal depositional environments, processes, and sedimentary
parameters; marine field techniques. <I>Prerequisite</I>: Graduate
standing; six semester hours of general chemistry or mineralogy;
six semester hours of zoology, biology, or paleontology; and six
semester hours of upper-division geology or consent of instructor.
<P>
<B>MNS 384L. <I>Marine Chemistry</I></B>. May count as chemistry.
Chemical processes in the sea. <I>Prerequisite</I>: Graduate Standing,
general physics, and six semester hours of upper-division chemistry.
Three lecture hours and eight laboratory hours a week for one
semester.
<P>
<B>MNS 384N. <I>Physical Oceanography</I></B>. Marine Science
354N and 384N may not both be counted. Introduction to the physical
properties of seawater and physical processes in the ocean, including
energy exchanges, wave and tidal motions, and the general circulation.
<I>Prerequisite</I>: Graduate standing, calculus, and a course
in physics.
<P>
<B>MNS 384T. <I>Biological Oceanography</I></B>. An advanced course
in biological processes in oceanic and coastal waters with emphasis
on empirical and theoretical concepts of marine ecosystem dynamics,
primary and secondary production, and detrital cycling. <I>Prerequisite</I>:
Graduate standing; and either consent of instructor or the following:
six semester hours of biological science chosen from BIO 302,
303, 304, or the equivalent, and CH 301 and 302, or the equivalent.
<P>
*The Graduate Studies Committee of the Department of Marine Science
will periodically add or delete core courses from this list depending
upon program needs. In addition, the Committee may tailor a student's
core curriculum by substitution of other Marine Science courses
for one or more of those listed if the listed courses are unavailable
to the student for reasons beyond his/her control.
<H2>
<CENTER>
<A NAME="Advanced">Advanced Courses</A>
</CENTER>
</H2>

<P>
Additional graduate courses that have been offered recently in
the Department of Marine Science:
<P>
<B>MNS 384C. <I>Benthic Ecology</I></B>. Interactions among organisms,
sediments, and physical processes of estuarine and oceanic bottoms.
<I>Prerequisite</I>: Graduate standing, Marine Science 354 or
the equivalent, and consent of instructor.
<P>
<B>MNS 384D. <I>Selected Studies in Mariculture</I></B>. Only
one of the following may be counted: Marine Science 354D, 354V,
384D. Intensive recirculating systems, larval culture, parasites
and diseases, nutrition, endocrinology, and reproduction of marine
finfish and shellfish. <I>Prerequisite</I>: Graduate standing
and consent of instructor.
<P>
<B>MNS 384E. <I>Marine Microbial Ecology</I></B>. Marine Science
354E and 384E may not both be counted. Metabolism of photosynthetic
and chemosynthetic microorganisms in the sea. <I>Prerequisite</I>:
Graduate standing; six semester hours of biological science chosen
from Biology 302, 303, 304, or the equivalent; Chemistry 301 and
302, or the equivalent; and consent of instructor. Three lecture
hours and eight laboratory hours a week for one semester.
<P>
<B>MNS 384J. <I>Marine Ecology</I></B>. Principles of competition
and of predator-prey, herbivore-plant, and reproductive interactions
within diverse marine phyla. <I>Prerequisite</I>: Graduate standing,
a basic course in biological science, and consent of instructor.
<P>
<B>MNS 384K. <I>Ecology of Fishes</I></B>. Marine Science 354K
and 384K may not both be counted. Organismal, population, and
community ecology of marine and freshwater fishes. <I>Prerequisite</I>:
Graduate standing in marine science, zoology, or biological sciences;
and consent of instructor.
<P>
<B>MNS 384S. <I>Comparative Physiology of Marine Animals</I></B>.
Marine Science 354S and 384S may not both be counted. Aspects
of the physiology of vertebrates and invertebrates related to
life in marine and estuarine environments. Specific topics may
vary. <I>Prerequisite</I>: Graduate standing in zoology or biological
sciences, a course in general or comparative physiology, and consent
of instructor. Three lecture hours and six to eight laboratory
hours a week for one semester.
<P>
<B>MNS 384U. <I>Reproductive Physiology of Fishes</I></B>. Endocrine
and environmental control of reproductive cycles in teleost fishes.
<I>Prerequisite</I>: Graduate standing, a beginning course in
physiology, and consent of instructor.
<P>
<B>MNS 385. <I>Ecology of Marine Zooplankton</I></B>. Same as
Zoology 384L (Topic 17: <I>Ecology of Marine Zooplankton</I>).
Advanced studies of the processes affecting the distribution,
abundance, and production of the marine zooplankton. <I>Prerequisite</I>:
Graduate standing and consent of instructor. Recommended background:
Zoology 453 (or 353); at least one of the following: Zoology 432,
333, 436; Geology 392K; and Zoology 440, 369, or Botany 373K.
Three lecture hours and six laboratory hours a week for one semester.
<P>
<B>MNS 385C. <I>Physiology and Ecology of Marine Algae</I></B>.
A lecture, laboratory, and field course examining marine algae,
the primary producers. Nutrition, metabolism, and growth of marine
algae, as well as the factors responsible for their distribution
in nature. <I>Prerequisite</I>: Graduate standing and consent
of instructor.
<P>
<B>MNS 385D. <I>Marine Nutrient Chemistry</I></B>. The theory
and measurement of nutrient distributions and dynamics associated
with biological, geological, and physical processes in estuarine
and marine waters. <I>Prerequisite</I>: Graduate standing, a general
physics course, six semester hours of upper-division chemistry,
and consent of instructor. Three lecture hours and eight laboratory
hours a week for one semester.
<P>
<B>MNS 385E. <I>Marine Macrophytes</I></B>. A lecture, laboratory,
and field course that examines the systematics, ecology, and productivity
of marine macroalgae and seagrasses, strategies and seasonal patterns
of growth, photosynthesis, and carbon metabolism in relation to
<I>in situ</I> light environments. <I>Prerequisite</I>: Graduate
standing, six semester hours of upper-division botany, and consent
of instructor. Three lecture hours a week for one semester, with
forty hours of laboratory and fieldwork.
<P>
<B>MNS 386. <I>Phytoplankton Ecology</I></B>. Same as Zoology
384L (Topic 18: <I>Phytoplankton Ecology</I>). The interactions
of physiology, morphology, and behavior of microalgae with physical,
chemical, and biological features of the environment as related
to the distribution of marine phytoplankton. <I>Prerequisite</I>:
Graduate standing and consent of instructor. Recommended background:
Zoology 453 (or 353); at least one of the following: Zoology 432,
333, 436; Geology 392K; and Zoology 440, 369, or Botany 373K.
Three lecture hours and six laboratory hours a week for one semester.
<P>
<B>MNS 188, 388. <I>Marine Research Training Cruise</I></B>. Shipboard
training in marine research through participation in marine research
project and completion of report. <I>Prerequisite</I>: Graduate
standing and consent of instructor. One five-to seven-day cruise;
additional laboratory work is required for 388.
<P>
<B>MNS 191. <I>Seminar in Marine Science</I></B>. Recent advances
in the marine sciences, discussed by students, faculty and staff
members, and guest lecturers. Topics to be announced. <I>Prerequisite</I>:
Graduate standing. One lecture hour a week for one semester.

<HR> 
<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A

HREF="../../index.htm">Return to MSI Home Page </A></P>
<P>
</P>
<HR> 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-56</DOCNO>
<DOCOLDNO>IA027-000287-B036-202</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/academic/deadline.htm 192.138.168.29 19970114020526 text/html 2537
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Tuesday, 14-Jan-97 02:14:28 GMT
Last-modified: Wednesday, 10-Jan-96 17:11:06 GMT
Content-length: 2344
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>
<TITLE>DEADLINES  - UTMSI</TITLE>
</HEAD>

<BODY>



<H1><CENTER>Deadlines and Dates</CENTER></H1>
<HR>

<H3>DEADLINES: ADMISSION</H3>

<P>
The Graduate Admission Bulletin, which contains your application
materials, will be mailed to you under separate cover. In addition
to these materials, the Department of Marine Science requires
the enclosed &quot;Applicant's Academic Background - Course Work
Summary&quot; and &quot;Supplemental Information&quot; sheets.
All of these materials must be received
<P>
NO LATER THAN
<P>
OCTOBER 1,  for admission in the SPRING SEMESTER
<P>
FEBRUARY 1, for admission in the SUMMER SESSION
<P>
FEBRUARY 1, for admission in FALL SEMESTER
<P>
Please mail your Application form, official transcripts, GRE test
scores, and Application Fee to GRADUATE AND INTERNATIONAL ADMISSIONS
CENTER, P.O. BOX 7608, THE UNIVERSITY OF TEXAS AT AUSTIN, AUSTIN,
TEXAS 78713-7608. Your statement of objectives, supplemental information
sheets, and letters of reference may be mailed directly to GRADUATE
ADVISER, DEPARTMENT OF MARINE SCIENCE, MARINE SCIENCE INSTITUTE,
THE UNIVERSITY OF TEXAS, 750 CHANNELVIEW DRIVE, PORT ARANSAS,
TEXAS 78373.
<H3>DEADLINES: TEACHING ASSISTANTSHIPS</H3>

<P>
To be considered for a teaching assistantship for the academic year, all of the above materials must be <STRONG>received</STRONG>
by <B>JANUARY 1</B>. Applications completed after that date
will be considered for an alternate list.
<P>

You must register to take the GRE approximately five to six weeks before the specific examination
date. Please contact the EDUCATIONAL TESTING SERVICES, GRADUATE RECORDS
EXAMINATIONS, CN 6000, PRINCETON, NJ 08541-6000 for the exact registration deadlines.
<P>
Please be aware that a minimum of six weeks will pass between the time you take the GRE test and the
time your score will be sent to The University of Texas and it is not uncommon for the transcripts of
your previous college course work to arrive four to eight weeks after you order them from your former
school.
<P>
THE APPLICATION PROCESS IS EXPENSIVE AND TIME CONSUMING,
<P>
AN EARLY START IS TO YOUR ADVANTAGE 
<HR>

<P>
<A HREF="../index.htm#top_home"><IMG SRC="../images/smseal.jpg" ALIGN="BOTTOM">
Return to MSI Home Page</A>
<HR>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-57</DOCNO>
<DOCOLDNO>IA027-000287-B037-271</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/afamos/index.htm 192.138.168.29 19970114021307 text/html 1362
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Tuesday, 14-Jan-97 02:21:44 GMT
Last-modified: Thursday, 09-Jan-97 17:21:04 GMT
Content-length: 1170
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
  
<TITLE>Tony Amos' Information</TITLE>   
<META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<H1>Additional Information: Tony Amos</H1>

<UL>
<LI><A HREF="../afamos.htm">Personal profile</A>
<LI><A HREF="weather.htm">Port Aransas weather summaries for 1986-1996</A>
<LI><A HREF="TS-JOS96.htm">Tropical Storm Josephine's Damaging Tides</A>
</LI>
<LI><A HREF="amosfame.htm">Tony Amos</A>, one of <I>Texas Monthly</I>'s
Top 20 Texans. 
</LI>
<LI>Text of the <A HREF="http://www.texasmonthly.com/archive/tex20/amos.html">Texas
Monthly</A> story on Tony Amos
</LI>
<LI><A HREF="../../staff/afamos/tony-trt.jpg">Tony
Amos'</A> efforts to rehabilitate injured sea turtles make headlines. (newspaper
article scanned courtesy of the <I>Corpus Christi Caller-Times</I> [622 Kb]). 
</LI></UL>
<HR> 
<P><IMG
SRC="../wideshot.gif" ALT="[MSI view]" HSPACE="5" BORDER="3" HEIGHT="75"
WIDTH="225"><A
HREF="../../index.htm#top_home">
Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</BODY>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-58</DOCNO>
<DOCOLDNO>IA027-000287-B038-146</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/fuiman/publications.htm 192.138.168.29 19970114021911 text/html 13848
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Tuesday, 14-Jan-97 02:28:32 GMT
Last-modified: Friday, 10-Jan-97 21:32:02 GMT
Content-length: 13657
Content-type: text/html
</DOCHDR>
<!-- This document was created with HomeSite v2.0 Beta 2 -->
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">

<HTML>
<HEAD>
	<TITLE>Larval Fish Biology - Publications by Lee A. Fuiman</TITLE>
</HEAD>

<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<CENTER><B><I><FONT SIZE="+2" FACE="Garamond">Publications by Lee A. Fuiman</FONT></I></B></CENTER>
<HR>
<UL>
<LI>Fuiman, L.A., editor.  (in press).  Dynamic morphology, physiology, and behaviour of fish larvae.  Marine and Freshwater Behaviour and Physiology.

<P><P><LI>Duffy, J.T., C.E. Epifanio, and L.A. Fuiman.  (in press).  Mortality rates imposed by three scyphozoans on red drum (<I>Sciaenops ocellatus</I>) larvae in field enclosures.  Journal of Experimental Marine Biology and Ecology.

<P><LI>Fuiman, L.A. and D.M. Higgs.  (in press).  Ontogeny, growth, and the recruitment process.  In: R.C. Chambers and E.A. Trippel, eds.  Early life history and recruitment in fish populations.  Chapman and Hall.

<P>
<HR>
<P><LI>Higgs, D.M. and L.A. Fuiman.  1996.  Ontogeny of visual and mechanosensory structure and function in Atlantic menhaden <I>Brevoortia tyrannus</I>. Journal of Experimental Biology 199:2619-2629.

<P><LI>Higgs, D.M., and L.A. Fuiman.  1996.  Light intensity and schooling behaviour in larval gulf menhaden.  Journal of Fish Biology 48:979-991.

<P><LI>Fuiman, L.A., and G.R. Hoff.  1995.  Natural variation in elemental composition of sagittae from red drum.  Journal of Fish Biology 47:940-955.

<P><LI>Fuiman, L.A.  1995.  Book review: Early life history of fish: an energetics apporach.   Copeia 1995(3):747-748.

<P><LI>Hoff, G.R., and L.A. Fuiman.  1995.  Environmentally induced variation in elemental composition of red drum (<I>Sciaenops ocellatus</I>) otoliths.  Bulletin of Marine Science 56(2):578-591.

<P><LI>Fuiman, L.A.  1994.  The interplay of ontogeny and scaling in the interactions of fish larvae and their predators.  Journal of Fish Biology 45(supplement A):55-79.

<P><LI>Fuiman, L.A., and A.E. Magurran.  1994.  Development of predator defences in fishes.  Reviews in Fish Biology and Fisheries 4:145-183.

<P><LI>Fuiman, L.A., and R.S. Batty.  1994.  Susceptibility of Atlantic herring and plaice larvae to predation by juvenile cod and herring at two constant temperatures.  Journal of Fish Biology 44:23-34.

<P><LI>Fuiman, L.A., editor.  1993.  Water Quality and the Early Life Stages of Fishes.  American Fisheries Society Symposium 14.  172pp.

<P><LI>Hunter, J.R., N.C.-H. Lo, and L.A. Fuiman, editors.  1993.  Advances in the early life history of fishes.  Part 2. Ichthyoplankton methods for estimating fish biomass.  Bulletin of Marine Science 53:723-935.

<P><LI>Moser, H.G., P.E. Smith, and L.A. Fuiman, editors.  1993.  Advances in the early life history of fishes.  Part 1. Larval fish assemblages and ocean boundaries.  Bulletin of Marine Science 53:283-722.

<P><LI>Hoff, G.R., and L.A. Fuiman.  1993.  Morphometry and composition of red drum otoliths: changes associated with temperature, somatic growth rate, and age.  Comparative Biochemistry and Physiology 106A:209-219.

<P><LI>Fuiman, L.A.  1993.  Development of predator evasion in Atlantic herring, <I>Clupea harengus</I> L.  Animal Behaviour 45:1101-1116.

<P><LI>Fuiman, L.A., and D.R. Ottey.  1993.  Temperature effects on spontaneous behavior of larval and juvenile red drum <I>Sciaenops ocellatus</I>, and implications for foraging.  Fishery Bulletin  91:23-35. 

<P><LI>Fuiman, L.A.  1991.  Book review: Description and Identification of Razorback, Flannelmouth, White, Utah, Bluehead, and Mountain Sucker Larvae and Early Juveniles.  Copeia 1991(3):860-861.

<P><LI>Fuiman, L.A.  1991.  Influence of temperature on evasive responses of Atlantic herring larvae attacked by yearling herring.  Journal of Fish Biology 39(1):93-102.

<P><LI>Blaxter, J.H.S., and L.A. Fuiman.  1990.  The role of the sensory systems of herring larvae in evading predatory fishes.  Journal of the Marine Biological Association of the United Kingdom 70:413-427.

<P><LI>Fuiman, L.A., and J.C. Gamble.  1989.  Influence of experimental manipulations on predation of herring larvae by juvenile herring in large enclosures.  Rapports et Procs-Verbeaux des Runions, Conseil International pour L'Exploration de la Mer 191:359-365.

<P><LI>Fuiman, L.A., and P. Thomas.  1989.  Book review: Fish physiology, Volume XI. The physiology of developing fish. Part A. Eggs and Larvae. Part B. Viviparity and posthatching juveniles.  Transactions of the American Fisheries Society 118:455-458.

<P><LI>Blaxter, J.H.S., and L.A. Fuiman.  1989.  Function of the free neuromasts of marine teleost larvae.  Pages 481-499.  In: S. Coombs, P. Grner, and H. Mnz, eds.  The mechanosensory lateral line: neurobiology and evolution.  Springer-Verlag, New York.

<P><LI>Fuiman, L.A.  1989.  Vulnerability of Atlantic herring larvae to predation by yearling herring.  Marine Ecology Progress Series 51:291-299.

<P><LI>Fuiman, L.A., and J.C. Gamble.  1988.  Predation by Atlantic herring, sprat, and sandeels on herring larvae in large enclosures.  Marine Ecology Progress Series 44:1-6.

<P><LI>Fuiman, L.A., and P.W. Webb.  1988.  Ontogeny of routine swimming activity and performance in zebra danios (Teleostei: Cyprinidae).  Animal Behaviour 36:250-261.

<P><LI>Gamble, J.C., and L.A. Fuiman.  1987.  Evaluation of in situ enclosures during a study of the importance of starvation to the vulnerability of herring larvae to a piscine predator.  Journal of Experimental Marine Biology and Ecology 113:91-103.

<P><LI>Foster, N.R., and L.A. Fuiman.  1987.  Notes on the behavior and early life history of captive lyre gobies, <I>Evorthodus lyricus</I>.  Bulletin of Marine Science 41(1):27-35.

<P><LI>Miller, R.R., and L.A. Fuiman.  1987.  Description and conservation status of <I>Cyprinodon macularius eremus</I>, a new subspecies of pupfish from Organ Pipe Cactus National Monument, Arizona.  Copeia 1987(3):593-609.

<P><LI>Fuiman, L.A.  1987.  [Book review:]  Early life histories of fishes: new developmental, ecological and evolutionary perspectives.  Copeia 1987(2):534-537.

<P><LI>Fuiman, L.A.  1986.  Swimming mechanics and the environmental biology of fishes.  Environmental Biology of Fishes 17(3):235-237.  (Book Review).

<P><LI>Fuiman, L.A.  1986.  Burst-swimming performance of larval zebra danios and the effects of diel temperature fluctuations.  Transactions of the American Fisheries Society 115:143-148.

<P><LI>Fuiman, L.A.  1985.  Contributions of developmental characters to a phylogeny of catostomid fishes, with comments on heterochrony.  Copeia 1985(4):833-846.

<P><LI>Strauss, R.E., and L.A. Fuiman.  1985.  Quantitative comparisons of body form and allometry in larval and adult Pacific sculpins (Teleostei: Cottidae).  Canadian Journal of Zoology 63:1582-1589.

<P><LI>Fuiman, L.A.  1984.  Ostariophysi: development and relationships.  Pages 126-137, in: H.G. Moser, D.M. Cohen, M.P. Fahay, A.W.  Kendall, Jr., W.J. Richards, and S.L. Richardson, editors.  Ontogeny and systematics of fishes.  Special Publication No. 1, Am

<P><LI>Fuiman, L.A.  1984.  [Book review:]  Guide to the early stages of marine fishes occurring in the western North Atlantic Ocean, Cape Hatteras to the southern Scotian Shelf.  Copeia 1984(2):556-557.

<P><LI>Fuiman, L.A.  1983.  Analysis of egg and larval characters for their use in the systematics of ostariophysan fishes.  Doctoral dissertation.  University of Michigan, Ann Arbor, Michigan.  186 pp.

<P><LI>Fuiman, L.A.  1983.  Growth gradients in fish larvae.  Journal of Fish Biology 23(1):117-123.

<P><LI>Fuiman, L.A., J.V. Conner, B.F. Lathrop, G.L. Buynak, D.E. Snyder, and J.J. Loos.  1983.  State of the art of identification for cyprinid fish larvae from eastern North America.  Transactions of the American Fisheries Society 112(2B):319-332.

<P><LI>Fuiman, L.A.  1982.  Family Sciaenidae, drums.  Pages 649-655.  In: N. A. Auer, editor.  Identification of larval fishes of the Great Lakes basin with emphasis on the Lake Michigan drainage. Great Lakes Fishery Commission, Ann Arbor, Michigan. Special Publication 82-3. 744 pp.

<P><LI>Fuiman, L.A.  1982.  Family Percichthyidae, temperate basses.  Pages 510-523.  In: N. A. Auer, editor.  Identification of larval fishes of the Great Lakes basin with emphasis on the Lake Michigan drainage. Great Lakes Fishery Commission, Ann Arbor, Michigan. Special Publication 82-3. 744 pp.

<P><LI>Fuiman, L.A.  1982.  Family Catostomidae, suckers.  Pages 345-435.  In: N. A. Auer, editor.  Identification of larval fishes of the Great Lakes basin with emphasis on the Lake Michigan drainage. Great Lakes Fishery Commission, Ann Arbor, Michigan. Special Publication 82-3. 744 pp.

<P><LI>Heufelder, G.R., and L.A. Fuiman.  1982.  Family Cyprinidae, carps and minnows.  Pages 174-344.  In: N. A. Auer, editor.  Identification of larval fishes of the Great Lakes basin with emphasis on the Lake Michigan drainage. Great Lakes Fishery Commission, Ann Arbor, Michigan. Special Publication 82-3. 744 pp.

<P><LI>Fuiman, L.A.  1982.  Family Esocidae, pikes.  Pages 155-173.  In: N. A. Auer, editor.  Identification of larval fishes of the Great Lakes basin with emphasis on the Lake Michigan drainage.  Great Lakes Fishery Commission, Ann Arbor, Michigan. Special Publication 82-3. 744 pp.

<P><LI>Fuiman, L.A.  1982.  Family Petromyzontidae, lampreys.  Pages 23-37.  In: N.A. Auer, ed. Identification of larval fishes of the Great Lakes basin with emphasis on the Lake Michigan drainage.  Great Lakes Fishery Commission, Ann Arbor, Michigan.  Special Publication 82-3. 744 pp.

<P><LI>Fuiman, L.A. 1982.  Correspondence of myomeres and vertebrae and their natural variability during the first year of life in yellow perch.  Pages 56-59, In: C.F. Bryan, J.V. Conner, and F.M. Truesdale, editors.  Proceedings of the Fifth Annual Larval Fish Conference.  Louisiana Cooperative Fishery Research Unit, Louisiana State University, Baton Rouge, Louisiana.  86 pp.

<P><LI>Fritzsche, R.A., and L.A. Fuiman.  Osteichthyes.  Pages 858-944.  In: S. P. Parker, editor.  Synopsis and Classification of Living Organisms.  2 volumes.  McGraw-Hill Book Company, New York.  2398 pp.

<P><LI>Fritzsche, R.A., and L.A. Fuiman.  1982.  Agnatha.  Pages 830-831.  In: S. P. Parker, editor.  Synopsis and Classification of Living Organisms.  2 volumes.  McGraw-Hill Book Company, New York.  2398 pp.

<P><LI>Fuiman, L.A. and J.P. Baker.  1981.  Larval stages of the lake chub, <I>Couesius plumbeus</I>.  Canadian Journal of Zoology 59(2):218-224.

<P><LI>Fuiman, L.A. and J.R. Trojnar.  1980.  Factors affecting egg diameter of white suckers (<I>Catostomus commersoni</I>).  Copeia 1980(4):699-704.

<P><LI>Fuiman, L.A., editor.  1980.  Proceedings of the Fourth Annual Larval Fish Conference.  U.S. Fish and Wildlife Service, Biological Services Program, National Power Plant Team, FWS/OBS-80/43. 179 pp.

<P><LI>Fuiman, L.A. and D.C. Witman.  1979.  Descriptions and comparisons of catostomid fish larvae: <I>Catostomus catostomus</I> and <I>Moxostoma erythrurum</I>.  Transactions of the American Fisheries Society 108(6):604-619.

<P><LI>Fuiman, L.A.  1979.  Descriptions and comparisons of catostomid fish larvae: northern Atlantic drainage species.  Transactions of the American Fisheries Society 108(6):560-603.

<P><LI>Loos, J.J., L.A. Fuiman, E.K. Jankowski and N.R. Foster. 1979.  Notes on early life histories of cyprinoid fishes of the upper Potomac River.  Pages 93-139, In: R. Wallus and C.W. Voigtlander, editors.  Proceedings of a Workshop on Freshwater Larval Fishes.  Tennessee Valley Authority.  Norris, Tennessee.  241 pp.

<P><LI>Fuiman, L.A. and L. Corazza. 1979.  Morphometry and allometry: implications for larval fish taxonomy.  Pages 1-19, In: R. Wallus and C.W. Voigtlander, editors.  Proceedings of a Workshop on Freshwater Larval Fishes.  Tennessee Valley Authority.  Norris, Tennessee.  241 pp.

<P><LI>Fuiman, L.A.  1979.  Materials for a description of lake chubsucker (<I>Erimyzon sucetta</I>) larvae.  Pages 92-99, in: R.D. Hoyt, editor.  Proceedings of the Third Symposium on Larval Fish.  Western Kentucky University. 236 pp.

<P><LI>Loos, J.J. and L.A. Fuiman. 1978.  Subordinate taxa of the genus <I>Notropis</I>: a preliminary comparative survey of their developmental traits.  Pages 1-50, In: L.L. Olmsted, editor.  Proceedings of the First Symposium on Freshwater Larval Fish.  Southeastern Electric Exchange.  251 pp.

<P><LI>Fuiman, L.A. and J.J. Loos.  1978.  Morphological changes during the larval development of the cutlips minnow, <I>Exoglossum maxillingua</I>.  Transactions of the American Fisheries Society 107(4):605-612.

<P><LI>Fuiman, L.A.  1978.  Descriptions and comparisons of northeastern catostomid fish larvae.  Master's thesis.  Cornell University, Ithaca, New York.  110pp.

<P><LI>Fuiman, L.A. and J.J. Loos.  1977.  Identifying characters of the early development of the daces, <I>Rhinichthys atratulus</I> and <I>R. cataractae</I> (Osteichthyes: Cyprinidae).  Proceedings of the Academy of Natural Sciences of Philadelphia 129(2):23-32.

<P><LI>Fuiman, L.A.  1976.  Notes on the early development of the sea raven, <I>Hemitripterus americanus</I>.  Fishery Bulletin 74(2):467-470.
</UL>

<HR> 
<P><IMG
SRC="../../wideshot.gif" ALT="[Visitors Center]" HSPACE="5" BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-59</DOCNO>
<DOCOLDNO>IA027-000287-B040-11</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/thomas/publications.htm 192.138.168.29 19970114023452 text/html 27381
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Tuesday, 14-Jan-97 02:43:43 GMT
Last-modified: Wednesday, 13-Nov-96 22:21:20 GMT
Content-length: 27187
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Reproductive Endocrinology - Publications by Peter Thomas</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">

<CENTER><P><!-- This document was created with HomeSite v2.0 Beta 2 --><B><I><FONT
FACE="Garamond"><FONT SIZE=+2>Publications
by Peter Thomas</FONT></FONT></I></B>
<HR></P></CENTER>

<UL>
<P><LI>Zhu, Y. and P. Thomas. (in press). Effects of somatolactin on melanosome
aggregation in the melanophores of red drum (Sciaenops ocellatus) scales.
Genral and Comparative Endocrinology.</LI>

<P><LI>Thomas, P., D. Breckenridge-Miller and C. Detweiler. (in press). Binding
characteristics and regulation of the 17,20 , 21-trihydroxy-4-pregnen-3-one
(20 -S) receptor on testicular and sperm plasma membranes of spotted seatrout
(Cynoscion nebulosus). Fish Physiology and Biochemistry.</LI>

<P><LI>Ungerer, J. and P. Thomas. (in press). Role of the very low density
lipoproteins in the accumulation of o,p'-DDT in fish ovaries during gonadal
recrudescence. Aquatic Toxicology.</LI>

<P><LI>Khan, I.A. and P. Thomas. (in press). Melatonin influences gonadotropin
II secretion in the Atlantic croaker (Micropogonias undulatus). General
and Comparative Endocrinology.</LI>

<P><LI>Pinter, J. and P. Thomas. (in press). The ovarian progestogen receptor
in the spotted seatrout, Cynoscion nebulosus, demonstrates steroid specificity
intermediate between progesterone and glucocorticoid receptors in other
vertebrates. Journal of Steroid Biochemistry and Molecular Biology.</LI>

<P><LI>King, V, W., S. Ghosh, P. Thomas, and C.V. Sullivan. (in press). A
receptor for the oocyte maturation-inducing hormone 17 ,20 ,21-trihydroxy-4-pregnen-3-one
(20 -S) on ovarian membranes of striped bass. Biology of Reproduction.
</LI>

<P>
<HR></P>

<P><LI>Zhu, Y. and P. Thomas. 1996. Red drum somatolactin: development of
a homologous radioimmunoassay and plasma levels after exposure to stressors
or various backgrounds. General and Comparative Endocrinology 99:275-288.</LI>

<P><LI>Khan, I. and P. Thomas. 1996. Disruption of neuroendocrine function
in Atlantic croaker exposed to Aroclor 1254. Marine Environmental Research
42:145-149.</LI>

<P><LI>Ungerer, J. and P. Thomas. 1996. Transport and accumulation of organochlorines
in the ovaries of Atlantic croaker (Micropogonias undulatus). Marine Environmental
Research 42:167-171.</LI>

<P><LI>Zhu, Y. and P. Thomas. 1996. Elevations of somatolactin in plasma and
pituitaries and increased -MSH cell activity in red drum exposed to black
background and decreased illumination. General and Comparative Endocrinology
101:21-31.</LI>

<P><LI>Pinter, J. and P. Thomas. 1995. Studies of the nuclear progestogen
receptor in the ovary of the spotted seatrout: regulation of the final
stages of ovarian development. In: Proceedings of the Fifth International
Symposium on the Reproductive Physiology of Fish. pp. 302-304. Eds. F.W.
Goetz and P. Thomas. The University of Texas at Austin, Printing Department,
Austin, TX, USA.</LI>

<P><LI>Yoshizaki, G., W. Jin, R. Pati&ntilde;o and P. Thomas. 1995. Connexin
genes, gap junctions, and ovarian maturational competence. In: Proceedings
of the Fifth International Symposium on the Reproductive Physiology of
Fish. pp. 342-344. Eds. F.W. Goetz and P. Thomas. The University of Texas
at Austin, Printing Department, Austin, TX, USA.</LI>

<P><LI>Zhu, Y. and P. Thomas. 1995. Red drum somatolactin: development of
a homologous radioimmunoassay and plasma levels after exposure to stressors
or various backgrounds. General and Comparative Endocrinology 99:275-288.</LI>

<P><LI>Pinter, J. and P. Thomas. 1995. Characterization of a progestogen receptor
in the ovary of the spotted seatrout, Cynoscion nebulosus. Biology of Reproduction.
52:667-675.</LI>

<P><LI>Thomas, P. and L. Budiantara. 1995. Reproductive life history stages
sensitive to oil and naphthalene in Atlantic croaker. Marine Environmental
Research 39:147-150.</LI>

<P><LI>Ghosh, S. and P. Thomas. 1995. Antagonistic effects of xenobiotics
on steroid-induced final maturation of Atlantic croaker oocytes in vitro.
Marine Environmental Research 39:159-163.</LI>

<P><LI>Ghosh, P. and P. Thomas. 1995. Binding of metals to red drum vitellogenin
and incorporation into oocytes. Marine Environmental Research 39:165-168.</LI>

<P><LI>Laidley, C.W. and P. Thomas. 1994. Partial characterization of a sex-steroid
binding protein in the spotted seatrout (Cynoscion nebulosus). Biology
of Reproduction 51:982-992.</LI>

<P><LI>Thomas, P., P.A. Copeland and J.A. Prentice. 1994. Preliminary observations
on the reproductive physiology of female orangemouth corvina in captivity.
Journal of the World Aquaculture Society 25(2):214-224.</LI>

<P><LI>King, W.V., P. Thomas and C.V. Sullivan. 1994. Hormonal regulation
of final maturation of striped bass oocytes in vitro. Gen. Comp. Endocrinol.
96:223-233.</LI>

<P><LI>Thomas, P. 1994. Hormonal control of final oocyte maturation in sciaenid
fishes. In Perspectives in Comparative Endocrinology. K.G. Davey, R.E.
Peter and S.S. Tobe (eds.), pp. 619-625. Canadian Journal of Zoology.</LI>

<P><LI>Thomas, P., K.N. Baer and R.B. White. 1994. Isolation and partial characterization
of metallothionein in the liver of the red-eared turtle (Trachemys scripta)
following intraperitoneal administration of cadmium. Comparative Biochemistry
and Physiology, Part C 107:221-226.</LI>

<P><LI>King, William V., P. Thomas, R.M. Harrell, R.G. Hodson, and C.V. Sullivan.
1994. Plasma levels of gonadal steroids during final oocyte maturation
of striped bass, Morone saxatilis L. General and Comparative Endocrinology
95:178-191.</LI>

<P><LI>Khan, I.A. and P. Thomas. 1994. Seasonal and daily variations in the
plasma gonadotropin II response to a LHRH analog and serotonin in Atlantic
croaker (Micropogonias undulatus): Evidence for mediation by 5-HT2 receptors.
The Journal of Experimental Zoology 269:531-537.</LI>

<P><LI>Yoshizaki, G., R. Pati&ntilde;o and P. Thomas. 1994. Connexin messenger
ribonucleic acids in the ovary of Atlantic croaker: Molecular cloning and
characterization, hormonal control, and correlation with appearance of
oocyte maturational competence. Bio. Repr. 51:493-503.</LI>

<P><LI>Barry, T.P., P. Thomas and G.V. Callard. 1993. Stage-related production
of 21-hydroxylated progestins by the dogfish (Squalus acanthias) testis.
Journal of Experimental Zoology 265:522-532.</LI>

<P><LI>Copeland, P.A. and P. Thomas. 1993. Isolation of gonadotropin subunits
and evidence for two distinct gonadotropins in Atlantic croaker (Micropogonias
Undulatus). General and Comparative Endocrinology 91:115-125.</LI>

<P><LI>Godwin, J.R. and P. Thomas. 1993. Sex change and steroid profiles in
the protandrous anemonefish Amhipion melanopus (Pomacentridae, Teleostei).
General and Comparative Endocrinology 91:144-157.</LI>

<P><LI>Khan, I.A. and P. Thomas. 1993. Immunocytochemical localization of
serotonin and gonadotropin-releasing hormone in the brain and pituitary
gland of the Atlantic croaker, Micropogonias undulatus. General and Comparative
Endocrinology 91:167-180.</LI>

<P><LI>Singh, H. and P. Thomas. 1993. Mechanism of stimulatory action of growth
hormone on ovarian steroidogenesis in spotted seatrout, Cynoscion nebulosus.
General and Comparative Endocrinology 89:341-353.</LI>

<P><LI>Thomas, P. 1993. Effects of cadmium on gonadotropin secretion from
Atlantic croaker pituitaries incubated in vitro. Marine Environmental Research
35:141-145.</LI>

<P><LI>Thomas, P. and C.R. Arnold. 1993. Environmental and hormonal induction
of gonadal recrudescence and spawning in red drum, spotted seatrout and
some other sciaenid fishes. In Recent Advances in Aquaculture IV. pp. 31-42.
Eds. J.F. Muir and R.J. Roberts. Blackwell Scientific Publications, Oxford.</LI>

<P><LI>Thomas, P. and J. Smith. 1993. Binding of xenobiotics to the estrogen
receptor of spotted seatrout: A screening assay for potential estrogenic
effects. Marine Environmental Research 35:147-151.</LI>

<P><LI>Thomas, P. and H.W. Wofford. 1993. Effects of cadmium and aroclor 1254
on lipid peroxidation, glutathione peroxidase activity, and selected antioxidants
in Atlantic croaker tissues. Aquatic Toxicology 27:159-178.</LI>

<P><LI>York, W.S., R. Pati&ntilde;o and P. Thomas. 1993. Ultrastructural changes
in follicle cell-oocyte associations during development and maturation
of the ovarian follicle in Atlantic croaker. General and Comparative Endocrinology
92:402-418.</LI>

<P><LI>Cameron, J.N. and P. Thomas. 1992. Calcitonin-like immunoreactivity
in the blue crab: tissue distribution, variations in the molt cycle, and
partial characterization. Journal of Experimental Zoology 262:279-286.</LI>

<P><LI>Copeland, P.A. and P. Thomas. 1992. Isolation of maturational gonadotropin
subunits from spotted seatrout (Cynoscion nebulosus) and development of
a beta subunit-directed radioimmunoassay for gonadotropin measurement in
sciaenid fish. General and Comparative Endocrinology 88:100-110.</LI>

<P><LI>Khan, I.A. and P. Thomas. 1992. Stimulatory effects of serotonin on
maturational gonadotropin release in the Atlantic croaker, Micropogonias
undulatus. General and Comparative Endocrinology 88:388-396.</LI>

<P><LI>Thomas, P. and M.J. Juedes. 1992. Influence of lead on the glutathione
status of Atlantic croaker tissues. Aquatic Toxicology 23:11-30.</LI>

<P><LI>White, R.B. and P. Thomas. 1992. Adrenal-kidney and gonadal steroidogenesis
during sexual differentiation of a reptile with temperature-dependent sex
determination. General and Comparative Endocrinology 88:10-19.</LI>

<P><LI>White, R.B. and P. Thomas. 1992. Stimulation of in vitro steroidogenesis
by pituitary hormones in a turtle (Trachemys scripta) within the temperature-sensitive
period for sex determination. Biology of Reproduction 47:952-959.</LI>

<P><LI>White, R.B. and P. Thomas. 1992. Whole-body and plasma concentrations
of steroids in the turtle, Trachemys scripta, before, during, and after
the temperature-sensitive period for sex determination. Journal of Experimental
Zoology 264:159-166.</LI>

<P><LI>Baer, K.N. and P. Thomas. 1991. Isolation of novel metal-binding proteins
distinct from metallothionein from spotted seatrout (Cynoscion nebulosus)
and Atlantic croaker (Micropogonias undulatus) ovaries. Marine Biology
108:31-37.</LI>

<P><LI>LaFleur, G.L. and P. Thomas. 1991. Evidence for a role of Na+, K+ -
ATPase in the hydration of Atlantic croaker and spotted seatrout oocytes
during final maturation. Journal Experimental Zoology 258:126-136. </LI>

<P><LI>Smith, J.S. and P. Thomas. 1991. Changes in hepatic estrogen-receptor
concentrations during the annual reproductive and ovarian cycles of a marine
teleost, the spotted seatrout Cynoscion nebulosus. General and Comparative
Endocrinology 81:234-245.</LI>

<P><LI>Spies, R.B., J.J. Stegeman, D.W. Rice, Jr., B. Woodin, P. Thomas, J.E.
Hose, J.N. Cross and M. Prieto. 1991. Sublethal responses of Platichthys
stellatus to organic contamination in San Francisco Bay with emphasis on
reproduction. In Biomarkers of Environmental Contamination. pp. 87-122.
Lewis Publishers, Inc. </LI>

<P><LI>Thomas, P. 1991. Endocrine control of final oocyte maturation in sciaenid
fishes. In Current Themes in Comparative Endocrinology. pp. 12-14. Eds.
R.N. Saxena et al. Proceedings of the Second Congress of the Asia and Oceania
Society for Comparative Endocrinology. Delhi University Press, New Delhi.</LI>

<P><LI>Thomas, P. and R. Pati&ntilde;o. 1991. Changes in 17 ,20 ,21-trihydroxy-4-pregnen-3-one
membrane receptor concentrations in ovaries of spotted seatrout during
final oocyte maturation. In Proceedings 4th International Symposium on
Reproductive Physiology of Fish. pp. 122-124. Eds. A.P. Scott, J. Sumpter,
D. Kime and M.S. Rolge. University of East Anglia.</LI>

<P><LI>Thomas, P. and L. Robertson. 1991. Plasma cortisol and glucose stress
responses of red drum (Sciaenops ocellatus) to handling and shallow water
stressors and anesthesia with MS-222, quinaldine sulfate and metomidate.
Aquaculture 96:69-86</LI>

<P><LI>Yan, H.Y. and P. Thomas. 1991. Histochemical and immunocytochemical
identification of the pituitary cell types in three sciaenid fishes: Atlantic
croaker (Micropogonias undulatus), spotted seatrout (Cynoscion nebulosus)
and red drum (Sciaenops ocellatus). General and Comparative Endocrinology
84:389-400.</LI>

<P><LI>Zakon, H.H., P. Thomas and H-Y. Hong. 1991. Electric organ discharge
frequencies and plasma sex steroid levels during gonadal recrudescence
in a natural population of Sternopygus macrurus. Journal Comparative Physiology
169:492-499.</LI>

<P><LI>Baer, K.N. and P. Thomas. 1990. Influence of capture stress, salinity
and reproductive status on zinc associated with metallothionein-like proteins
in the livers of three marine teleost species. Marine Environmental Research
29:277-287.</LI>

<P><LI>Landsman, R.E., C.F. Harding, P. Moller and P. Thomas. 1990. The effects
of androgens and estrogen on the external morphology and electric organ
discharge waveform of Gnathonemus petersii (Mormyridae, Teleostei). Hormones
and Behavior 24:532-553.</LI>

<P><LI>Pajor, A.M., J.J. Stegeman, P. Thomas and B.R. Woodin. 1990. Feminization
of the hepatic microsomal cytochrome P-450 system in brook trout by estradiol,
testosterone and pituitary factors. Journal of Experimental Zoology 253:
51-60.</LI>

<P><LI>Pati&ntilde;o, R. and P. Thomas. 1990. Characterization of membrane
receptor activity for 17 ,20 ,21-trihydroxy-4-pregnen-3-one in ovaries
of spotted seatrout (Cynoscion nebulosus). General and Comparative Endocrinology
78:204-217.</LI>

<P><LI>Pati&ntilde;o, R. and P. Thomas. 1990. Effects of gonadotropin on ovarian
intrafollicular processes during the development of oocyte maturational
competence in a teleost, the Atlantic croaker: Evidence for two distinct
stages of gonadotropic control of final oocyte maturation. Biology of Reproduction
43:818-827.</LI>

<P><LI>Pati&ntilde;o, R. and P. Thomas. 1990. Gonadotropin stimulates 17 ,20
,21-trihydroxy-4-pregnen-3-one production from endogenous substrates in
Atlantic croaker ovarian follicles undergoing final maturation in vitro.
General and Comparative Endocrinology 78:474-478.</LI>

<P><LI>Pati&ntilde;o, R. and P. Thomas. 1990. Induction of maturation of Atlantic
croaker oocytes by 17 ,20 ,21-trihydroxy-4-pregnen-3-one in vitro: consideration
of some biological and experimental variables. Journal of Experimental
Zoology 255:97-109.</LI>

<P><LI>Smith, J.S. and P. Thomas. 1990. Binding characteristics of the hepatic
estrogen receptor of the spotted seatrout, Cynoscion nebulosus. General
and Comparative Endocrinology 77:29-42.</LI>

<P><LI>Thomas, P. 1990. Biochemical and molecular responses of fish to stressors
and their potential use in environmental monitoring. Transactions of the
American Fisheries Society, Symposium 8:9-28.</LI>

<P><LI>Thomas, P. 1990. Teleost model for studying the effects of chemicals
on female reproductive endocrine function. Journal of Experimental Zoology
(Supplement 4):126-128.</LI>

<P><LI>Zakon, H.H., H.Y. Yan and P. Thomas. 1990. Human chorionic gonadotropin-induced
shifts in the electrosensory and motor systems of the weakly electric fish
Sternopygus. Journal of Neurobiology 21:826-833.</LI>

<P><LI>Baer, K.N. and P. Thomas. 1989. Purification and isolation of a non-metallothionein
Zn-binding protein from spotted seatrout (Cynoscion nebulosus) oocytes.
Marine Environmental Research 28: 157-161.</LI>

<P><LI>Copeland, P.A. and P. Thomas. 1989. Control of gonadotropin release
in the Atlantic croaker: evidence for lack of dopaminergic inhibition.
General and Comparative Endocrinology 74:474-483.</LI>

<P><LI>Copeland, P.A. and P. Thomas. 1989. Purification of maturational gonadotropin
from Atlantic croaker (Micropogonias undulatus) and development of a homologous
radioimmunoassay. General and Comparative Endocrinology 73:425-441.</LI>

<P><LI>MacKenzie, D.S., P. Thomas and S.M. Farrar. 1989. Seasonal changes
in thyroid and reproductive steroid hormones in female channel catfish
(Ictalurus punctatus) in pond culture. Aquaculture 78:63-80.</LI>

<P><LI>Thomas, P. 1989. Effects of Aroclor 1254 and cadmium on reproductive
endocrine function and ovarian growth in Atlantic croaker. Marine Environmental
Research 28:499-503.</LI>

<P><LI>Thomas, P. and N.W. Boyd. 1989. Dietary administration of a LHRH analog
induces successful spawning of spotted seatrout (Cynoscion nebulosus).
Aquaculture 80:363-370.</LI>

<P><LI>Thomas, P. and J.M. Trant. 1989. Evidence that 17 ,20 ,21-trihydroxy-4-pregnen-3-one
is a maturation-inducing steroid in spotted seatrout. Fish Physiology and
Biochemistry 7:185-191.</LI>

<P><LI>Trant, J.M. and P. Thomas. 1989. Changes in ovarian steroidogenesis
in vitro associated with final maturation of Atlantic croaker oocytes.
General and Comparative Endocrinology 75:405-412.</LI>

<P><LI>Trant, J.M. and P. Thomas. 1989. Isolation of a novel maturation-inducing
steroid produced in vitro by ovaries of Atlantic croaker. General and Comparative
Endocrinology 75:397-404.</LI>

<P><LI>Brown-Peterson, N. and P. Thomas. 1988. Differing reproductive characteristics
of temperate and subtropical groups of Cynoscion nebulosus. Contributions
in Marine Science 30 (Suppl.):71-77.</LI>

<P><LI>Brown-Peterson, N., P. Thomas and C.R. Arnold. 1988. Reproductive biology
of the spotted seatrout, Cynoscion nebulosus, in South Texas. Fisheries
Bulletin 86(2):373-388.</LI>

<P><LI>Copeland, P.A. and P. Thomas. 1988. The measurement of plasma vitellogenin
levels in a marine teleost, the spotted seatrout (Cynoscion nebulosus)
by homologous radioimmunoassay. Comparative Biochemistry and Physiology
B 91(1):17-23.</LI>

<P><LI>Lewis, D.H. and P. Thomas. 1988. Assessing immunocompetence of red
drum. Contributions in Marine Science 30 (Suppl.):153-156.</LI>

<P><LI>Robertson, L., P. Thomas and C.R. Arnold. 1988. Plasma cortisol and
secondary stress responses of cultured red drum (Sciaenops ocellatus) to
several transportation procedures. Aquaculture 68:115-130.</LI>

<P><LI>Singh, H., R.W. Griffith, A. Takahashi, H. Kawauchi, P. Thomas and
J.J. Stegeman. 1988. Regulation of gonadal steroidogenesis in Fundulus
heteroclitus by recombinant salmon growth hormone. General and Comparative
Endocrinology 72:144-153.</LI>

<P><LI>Sorensen, E.M.B. and P. Thomas. 1988. Selenium accumulation, reproductive
status, and histopathological changes in environmentally exposed redear
sunfish. Archives of Toxicology 61:324-329.</LI>

<P><LI>Thomas, P. 1988. Reproductive endocrine function in female Atlantic
croaker exposed to xenobiotics. Marine Environmental Research 24:179-183.</LI>

<P><LI>Thomas, P. and N. Boyd. 1988. Induced spawning of spotted seatrout,
red drum and orangemouth corvina (family: Sciaenidae) with luteinizing
hormone-releasing hormone analog injection. Contributions in Marine Science
30 (Suppl.):43-47.</LI>

<P><LI>Thomas, P., M. Westerman, P.F. Dehn, E. Nowicki, G.J. Holt and C.R.
Arnold. 1988. Growth of juvenile red drum: adenylate metabolism, RNA-DNA
ratio and effects of growth hormone. Contributions in Marine Science 30
(Suppl.):29-35.</LI>

<P><LI>Trant, J.M. and P. Thomas. 1988. Structure-activity relationships of
steroids in inducing germinal vesicle breakdown of Atlantic croaker oocytes
in vitro. General and Comparative Endocrinology 71:307-317.</LI>

<P><LI>Wofford, H.W. and P. Thomas. 1988. Effect of xenobiotics on peroxidation
of microsomal lipids from striped mullet (Mugil cephalus) and Atlantic
croaker (Micropogonias undulatus). Marine Environmental Research 24:285-2889.</LI>

<P><LI>Wofford, H.W. and P. Thomas. 1988. Peroxidation of mullet and rat liver
lipids in vitro: Effects of pyridine nucleotides, iron, incubation buffer,
and xenobiotics. Comparative Biochemistry Physiology 89C(2):201-205.</LI>

<P><LI>Yan, H.Y. and P. Thomas. 1988. Changes in prolactin cell size and chloride
cell number in young red drum (Sciaenops ocellatus) during salinity adaptation.
Contributions in Marine Science 30 (Suppl.):157-164.</LI>

<P><LI>Prentice, J.A. and P. Thomas. 1987. Successful spawning of orangemouth
corvina following des-Gly10, [D-Ala6]-luteinizing hormone-releasing hormone
(1-9) ethylamide and pimozide injection. Progressive Fish Culturist 49:66-69.</LI>

<P><LI>Robertson, L., P. Thomas, C.R. Arnold and J.M. Trant. 1987. Plasma
cortisol and secondary stress responses of red drum (Sciaenops ocellatus)
to handling, transport, rearing density and an outbreak of disease. Progressive
Fish Culturist 49:1-12.</LI>

<P><LI>Thomas, P. 1987. Influence of some environmental variables on the ascorbic
acid status of mullet, Mugil cephalus Linn, tissues. III. Effects of exposure
to oil. Journal of Fish Biology 30:485-494.</LI>

<P><LI>Thomas, P., R.S. Carr and J.M. Neff. 1987. Biochemical responses and
alterations of tissue ascorbic acid and glutathione content. In Pollutant
Studies in Marine Animals. pp. 155-180. Eds. C.S. Giam and L.E. Ray. CRC
Press.</LI>

<P><LI>Thomas, P. and D.H. Lewis. 1987. Effect of cortisol on immunity in
red drum, Sciaenops ocellatus. Journal of Fish Biology 31(Suppl. A):123-127.</LI>

<P><LI>Wanshu, H. and P. Thomas. 1987. The in vitro effects of steroids, human
chorionic gonadotropin and cyanoketone on germinal vesicle breakdown of
striped mullet (Mugil cephalus) oocytes. Chinese Journal of Oceanology
and Limnology 5:1-8.</LI>

<P><LI>Trant, J.M., P. Thomas and C.H.L. Shackleton. 1986. Identification
of 17 ,20 ,21-trihydroxy-4-pregnen-3-one as the major ovarian steroid produced
by the teleost (Micropogonias undulatus) during final oocyte maturation.
Steroids 47:89-99.</LI>

<P><LI>Steele, C.W., D.W.M. Owens, A.D. Scarfe and P. Thomas. 1985. Behavioral
assessment of the sublethal effects of aquatic pollutants. Marine Pollution
Bulletin 16(6):221-224.</LI>

<P><LI>Thomas, P., M.B. Bally and J.M. Neff. 1985. Influence of some environmental
variables on the ascorbic acid status of mullet (Mugil cephalus Linn.)
tissues. II. Seasonal fluctuations and biosynthetic ability. Journal of
Fish Biology 27:47-57.</LI>

<P><LI>Thomas, P. and M.J. Juedes. 1985. Altered glutathione status in Atlantic
croaker (Micropogonias undulatus) exposed to lead. Marine Environmental
Research 17:192-195.</LI>

<P><LI>Thomas, P. and J.M. Neff. 1985. Plasma corticosteroid and glucose responses
to pollutants in striped mullet: different effects of naphthalene, benzo[a]pyrene
and cadmium exposure. In Marine Pollution and Physiology: Recent Advances.
pp. 63-82. Eds. A. Calabrese, F.P. Thurberg, F.J. Vernberg and W.B. Vernberg.
University of South Carolina Press.</LI>

<P><LI>Wofford, H.W. and P. Thomas. 1985. Comparison of microsomal lipid peroxidation
in fish and rats. Marine Environmental Research 17:215-217.</LI>

<P><LI>Thomas, P. 1984. Influence of some environmental variables on the ascorbic
acid status of mullet (Mugil cephalus Linn.) tissues: 1. Effect of salinity,
capture-stress and temperature. Journal of Fish Biology 25:711-720.</LI>

<P><LI>Thomas, P. and J.M. Neff. 1984. Effects of a pollutant and other environmental
variables on the ascorbic acid content of fish tissues. Marine Environmental
Research 14:489-491.</LI>

<P><LI>Thomas, P. and H.W. Wofford. 1984. Effects of metals and organic compounds
on hepatic glutathione, cysteine and acid soluble thiol levels in mullet
(Mugil cephalus L.) Toxicology Applied Pharmacology 76:172-182.</LI>

<P><LI>Thomas, P. and H.W. Wofford. 1984. Elevated acid soluble thiol content
in fish hepatic tissue: a response to pollutants. Marine Environmental
Research 14:486-488.</LI>

<P><LI>Thomas, P. and H.W. Wofford. 1984. High-performance liquid chromatography
of corticosteroids in vertebrate plasma: assay of cortisol in mullet and
corticosterone in the rat. Comparative Biochemistry and Physiology 78(2):473-479.</LI>

<P><LI>Wofford, H.W. and P. Thomas. 1984. Interactions of cadmium with sulfhydryl-containing
compounds in striped mullet (Mugil cephalus L.). Marine Environmental Research
14:119-137.</LI>

<P><LI>Carr, R.S., M.B. Bally, P. Thomas and J.M. Neff. 1983. Comparison of
methods for the determination of ascorbic acid in animal tissues. Analytical
Chemistry 55:1229-1232.</LI>

<P><LI>Kamstra, G.K., P. Thomas and Janet Sadow. 1983. Evaluation of changes
in the secretion of corticotrophin releasing activity using the isolated
rat hypothalamus incubated in vitro. Journal of Endocrinology 97:291-300.</LI>

<P><LI>Carr, R.S., P. Thomas and J.M. Neff. 1982. A simple spectrophotometric
technique for the determination of pentachlorophenol in water. Bulletin
Environmental Contamination and Toxicology 28:477-479.</LI>

<P><LI>Stegeman, J.J., A.M. Pajor and P. Thomas. 1982. Influence of estradiol
and testosterone on cytochrome P-450 and monooxygenase activity in immature
brook trout (Salvelinus fontinalis). Biochemical Pharmacology 31:3979-3989.</LI>

<P><LI>Thomas, P., M. Bally and J.M. Neff. 1982. Ascorbic acid status of mullet
(Mugil cephalus Linn.) exposed to cadmium. Journal of Fish Biology 20:183-196.</LI>

<P><LI>Thomas, P., H.W. Wofford and J.M. Neff. 1982. Effect of cadmium on
glutathione content of mullet (Mugil cephalus) tissues. In Pollution and
Physiology of Marine Organisms. pp. 109-125. Eds. A Calabrese, F.P. Thurberg,
F.J. Vernberg and W.B. Vernberg. Academic Press, N.Y.</LI>

<P><LI>Thomas, P., R.S. Carr and J.M. Neff. 1981. Biochemical responses of
mullet (Mugil cephalus) and polychaete worms Nereis virens to pentachlorophenol.
In Biological Monitoring of Marine Pollutants. pp. 73-103. Eds. A. Calabrese,
F.P. Thurberg, F.J. Vernberg and W.B. Vernberg. Academic Press, N.Y.</LI>

<P><LI>Thomas, P., H.W. Wofford and J.M. Neff. 1981. Biochemical stress responses
of striped mullet (Mugil cephalus L.) to fluorene analogs. Aquatic Toxicology:
329-342.</LI>

<P><LI>Thomas, P., B. Woodin and J.M. Neff. 1980. Biochemical responses of
striped mullet (Mugil cephalus) to oil exposure. I. Acute responses-interrenal
activation and secondary stress responses. Marine Biology 59:141-149.</LI>

<P><LI>Ishii, S., P. Thomas and S. Nakamura. 1973. Morphometric classification
of the neurosecretory granules in the rat pars nervosa. Z. Zellforsch 146:463-471.</LI>
</UL>

<P>
<HR></P>

<P><IMG SRC="../wideshot.gif" ALT="[Visitors Center]" HSPACE=5 BORDER=1 HEIGHT=75
WIDTH=225 ALIGN=ABSCENTER><A
HREF="http://wwwutmsi.zo.utexas.edu/index.htm">Return
to MSI Home Page </A></P>

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-60</DOCNO>
<DOCOLDNO>IA027-000287-B040-197</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/staff/afamos/TS-JOS96.htm 192.138.168.29 19970114023807 text/html 1740
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Tuesday, 14-Jan-97 02:47:57 GMT
Last-modified: Wednesday, 13-Nov-96 22:33:20 GMT
Content-length: 1547
Content-type: text/html
</DOCHDR>
<BODY TEXT= black BACKGROUND="../../images/chalk.gif">
<CENTER><IMG  SRC="ts-jos96.gif" BORDER=3></CENTER><BR>
The graph shows the predicted and recorded tides at the UTMSI Pier
Laboratory tide gage located off the South Jetty of the Aransas Pass (27
50.3'N; 097 03.0'W) which connects Corpus Christi Bay to the Gulf of
Mexico.  The graph covers a 14-day period starting 30 September 1996 during which
high tides from Tropical Storm Josephine caused considerable coastal
flooding and beach erosion.  The peak high came at 0158 CDT 07 October
1996 with a level of 3' 1" above Mean Sea Level (MSL).  At that time
Josephine still bore the ignominious name "Tropical Depression #10", but
even so, erosion from this storm produced the most beach erosion on
Mustang Island since Hurricane Allen in August 1980, slightly greater than
September 1988's Hurricane Gilbert erosion.<BR>
<BR>
The tides are referenced to MSL.  Note that almost all of October's tides
are above MSL.  October has the highest astronomical tides of the
year.  Note also that the storm-elevated water level remained high
for nearly a week and that it fortunately arrived as the
astronomical tides were in a diminishing period.  One week earlier
or later and an additional foot of water would have done even
greater damage.
<HR> 
<P><IMG
SRC="file:///E|/NETSCAPE/ns-home/docs/wideshot.gif" ALT="[Visitors Center]" HSPACE="5"
BORDER="1" HEIGHT="75" WIDTH="225" ALIGN="ABSCENTER"><A
HREF="../../index.htm">Return to MSI Home Page </A></P> 
<P>
</P>
<HR> 
</DOC>
<DOC>
<DOCNO>WT01-B18-61</DOCNO>
<DOCOLDNO>IA026-000281-B007-183</DOCOLDNO>
<DOCHDR>
http://msi20.zo.utexas.edu:80/ 192.138.168.29 19970113200330 text/html 2935
HTTP/1.0 200 OK
Server: Netscape-Communications/1.12
Date: Monday, 13-Jan-97 20:14:01 GMT
Last-modified: Friday, 10-Jan-97 15:03:14 GMT
Content-length: 2746
Content-type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Marine Science Institute - University of Texas at Austin
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" BACKGROUND="../../images/chalk.gif">

<CENTER><P><A NAME="top_home"></A><IMG SRC="images/banner.gif" ALT="[UTMSI Banner]" HEIGHT=61 WIDTH=600 ALIGN=BOTTOM>
<IMG SRC="wideshot.gif" ALT="[Visitors Center]" BORDER=3 HEIGHT=198 WIDTH=597></P></CENTER>

<P><I>Department of Marine Science, The University of Texas at Austin,
Marine Science Institute, 750 Channelview Drive, Port Aransas, Texas 78373</I></P>

<P>Our web pages contain many color photographs intended to give you a
flavor of the Marine Science Institute. You may wish to disable the image
autoload feature of your browser for faster viewing.</P>

<P><I>Last updated: January 10, 1997 by Lee A. Fuiman and Scott A. Holt</I>
<HR>
<CENTER><A HREF="mainmap.map"><IMG ISMAP SRC="mainmap.gif" HEIGHT=44 WIDTH=522></A></CENTER></P>

<P><B><FONT FACE="Brush Script MT"><FONT COLOR="#FF0000"><FONT SIZE=+3><A HREF="current/whatnew.htm">What's
New</A></FONT></FONT></FONT></B> on the UTMSI Web Site</P>

<DL>
<DT><A HREF="academic/acadmain.htm"><FONT SIZE="+2" COLOR="Red">Academic Programs</FONT></A> </DT>

<DD>Description of graduate, undergraduate, and summer programs at MSI</DD>
<DD><B>Online application for summer program at MSI</B></DD>

<DT><A HREF="staff/pers1995.htm"><FONT SIZE="+2" COLOR="Red">Faculty and Staff</FONT></A> </DT>

<DD>Research, academic, and administrative staff </DD>

<DT><A HREF="mes/mesdesc.htm"><FONT SIZE="+2" COLOR="Red">Marine Education Services</FONT></A> </DT>

<DD>Public outreach programs for K-12, teacher training, Mustang Island
Elderhostel </DD>

<DT><A HREF="geninfo.htm"><FONT SIZE="+2" COLOR="Red">General Information</FONT></A> </DT>

<DD>An introduction to the Institute, its history, physical facilities,
research programs, boats, and outreach activities </DD>

<DT><A HREF="current/currmain.htm"><FONT SIZE="+2" COLOR="Red">Current Events and Activities</FONT></A> </DT>

<DD>Boy Scouts' Oceanography Day, 50 Year Celebration, recent research
results and ongoing projects, seminars, R/V Longhorn and R/V Katy schedule,
tide predictions, and current activities at MSI </DD>

<DT><A HREF="hornspec.htm"><FONT SIZE="+2" COLOR="Red">Ships - <I>R/V LONGHORN </I></FONT></A><A HREF="katy.htm"><FONT SIZE="+2" COLOR="Red">and <I>R/V KATY</I> </FONT></A></DT>

<DD>Information and specifications
</DD>
</DL>
<HR>
<I>Send comments about this site to <A HREF="mailto:sholt@utmsi.zo.utexas.edu">Scott
Holt</A></I>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-62</DOCNO>
<DOCOLDNO>IA021-000230-B029-245</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/index.html 198.68.7.46 19970107213204 text/html 1189
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:32:09 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1018
Last-modified: Wed, 14 Aug 1996 00:13:15 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE>Welcome to Corvallis Disposal Company On-Line</TITLE>
	<META PROAXIS NAME="Corvallis Disposal On-Line">
</HEAD>
<BODY BGCOLOR="#f1e8ba" TEXT="#503624" ALINK="#ff0000" LINK="#d72748" VLINK=
"#ad525f">
<H1><CENTER><BR>
Welcome to <BR>
Corvallis Disposal Online </CENTER>
</H1>
<P><CENTER><BR>
</CENTER>
<H2><CENTER><A HREF="http://www.corvallis.disposal.com/frames/entry.html">Enter
using Frames</A> <BR>
<BR>
<A HREF="http://www.corvallis.disposal.com/no_frame/waste.html">No Frames</A></CENTER>
</H2>
<H4><CENTER></CENTER>
</H4>
<P><CENTER><IMG SRC="frames/images/spacer.gif" WIDTH="152" HEIGHT="102"
NATURALSIZEFLAG="0" ALIGN=bottom><BR>
<A HREF="http://home.netscape.com/comprod/mirror/index.html"><IMG SRC="frames/images/netscape.gif"
WIDTH="88" HEIGHT="31" ALIGN=bottom NATURALSIZEFLAG="3"><BR>
<BR>
</A><B>This site is best viewed using Netscape 2.0 or higher.<BR>
<A HREF="http://home.netscape.com/comprod/mirror/index.html">Click here
to download.<BR>
</A></B></CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-63</DOCNO>
<DOCOLDNO>IA021-000230-B029-170</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/ 198.68.7.46 19970107213129 text/html 1189
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:31:33 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1018
Last-modified: Wed, 14 Aug 1996 00:13:15 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE>Welcome to Corvallis Disposal Company On-Line</TITLE>
	<META PROAXIS NAME="Corvallis Disposal On-Line">
</HEAD>
<BODY BGCOLOR="#f1e8ba" TEXT="#503624" ALINK="#ff0000" LINK="#d72748" VLINK=
"#ad525f">
<H1><CENTER><BR>
Welcome to <BR>
Corvallis Disposal Online </CENTER>
</H1>
<P><CENTER><BR>
</CENTER>
<H2><CENTER><A HREF="http://www.corvallis.disposal.com/frames/entry.html">Enter
using Frames</A> <BR>
<BR>
<A HREF="http://www.corvallis.disposal.com/no_frame/waste.html">No Frames</A></CENTER>
</H2>
<H4><CENTER></CENTER>
</H4>
<P><CENTER><IMG SRC="frames/images/spacer.gif" WIDTH="152" HEIGHT="102"
NATURALSIZEFLAG="0" ALIGN=bottom><BR>
<A HREF="http://home.netscape.com/comprod/mirror/index.html"><IMG SRC="frames/images/netscape.gif"
WIDTH="88" HEIGHT="31" ALIGN=bottom NATURALSIZEFLAG="3"><BR>
<BR>
</A><B>This site is best viewed using Netscape 2.0 or higher.<BR>
<A HREF="http://home.netscape.com/comprod/mirror/index.html">Click here
to download.<BR>
</A></B></CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-64</DOCNO>
<DOCOLDNO>IA021-000230-B029-188</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/frames/entry.html 198.68.7.46 19970107213137 text/html 461
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:31:41 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 291
Last-modified: Mon, 24 Jun 1996 23:41:46 GMT
</DOCHDR>
<html>

<title>Corvallis Disposal: Welcome </title>


<frameset rows="78,*">
<frame src="header.html" marginwidth=0 marginheight=0 noresize 
scrolling="no" name="header">
<frame src="navbar.html" marginwidth=0 marginheight=0 name="bottom">

</frameset>

<noframes>


</noframes>

</html>



</DOC>
<DOC>
<DOCNO>WT01-B18-65</DOCNO>
<DOCOLDNO>IA021-000230-B029-310</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/form.html 198.68.7.46 19970107213235 text/html 2356
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:32:36 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2185
Last-modified: Mon, 24 Jun 1996 23:45:57 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE>Contact Corvallis Disposal On-Line</TITLE>
</HEAD>
<BODY BGCOLOR="#f9f9f9">
<FORM ACTION="/cgi-bin/formmail?info@corvallis.disposal.com" 
ENCTYPE="x-www-form-encoded"
METHOD="POST">
<H1><TABLE> <TR><TD valign=top></H1>
<IMG SRC="../frames/images/mail_nav.gif" BORDER="0" WIDTH="200" HEIGHT=
"350" ALIGN=bottom></TD><TD valign=top 
cellpadding=5> <FONT size=4><A NAME="top"></A><H1><CENTER>Contact 
Corvallis Disposal for more 
information!</FONT></TD></TR></TABLE></CENTER></H1>We invite your 
questions and comments. Please submit your inquiries with the form below: 
<PRE>Your Name:
<INPUT NAME="name" TYPE="text" SIZE="32" MAXLENGTH="40">
Your Company:
<INPUT NAME="Company" TYPE="text" SIZE="30">
Your E-mail address:
<INPUT NAME="email" TYPE="text" SIZE="26" MAXLENGTH="40">
Your daytime phone number:
<INPUT NAME="phone" TYPE="text" SIZE="23" MAXLENGTH="20">
Your fax number:
<INPUT NAME="fax number" TYPE="text" SIZE="23" MAXLENGTH="40">
Your mailing address:
<TEXTAREA NAME="your address-street/box,city" ROWS="4" COLS="43"
></TEXTAREA>
Your service address:
<TEXTAREA NAME="service address-street,city" ROWS="4" COLS="43"
></TEXTAREA>

Your comments/questions:
<TEXTAREA NAME="comments" ROWS="7" COLS="42"
></TEXTAREA>

<SELECT NAME="contact type" MULTIPLE SIZE="3">
<OPTION>I would like to be contacted by e-mail
<OPTION>I would like to be contacted by regular mail
<OPTION>I would like to be contacted by phone
</SELECT></PRE><H4>(Hold down <I>Control</I> or <I>Command</I> to select 
more than one option.) </H4><P><CENTER><INPUT
TYPE="submit" VALUE="Send to Corvallis Disposal"><INPUT TYPE="reset" VALUE=
"Oops, let me try again!"><HR>
<A HREF="../index.html">HOME</A> 
| <A HREF="recycle.html">RECYCLING</A> 
| <A HREF="compost.html">COMPOSTING</A> 
| <A HREF="waste.html">SERVICES</A> 
| <A areainfo.html">COMMUNITY INFORMATION</A>
| <A HREF="request.html">REQUEST SERVICES</A></CENTER><br>
Corvallis Disposal &amp; Recycling Company<br>
110 NE Walnut Blvd.<br>
Corvallis, OR 97330<br>
(541) 754-0444<br><CENTER>
this site created by <A HREF="mailto:paperworks@proaxis.com">Paperworks 
Design</A>, Corvallis, OR 
</CENTER></FORM></BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-66</DOCNO>
<DOCOLDNO>IA021-000230-B029-267</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/recycle.html 198.68.7.46 19970107213215 text/html 13680
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:32:17 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 13508
Last-modified: Tue, 31 Dec 1996 17:39:48 GMT
</DOCHDR>
<HTML>
<HEAD>
   <TITLE>Everything you wanted to know about recycling...</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFE5" background="../frames/images/arr_back.gif">

<P><BR>

<TABLE BORDER=0 CELLPADDING=1 WIDTH="100%">
   <TR>
      <TD VALIGN=top>
         <P><A NAME="rec_top"></A><MAP NAME="recycnav_map"><AREA SHAPE=polygon COORDS="10,98,10,147,111,147,111,114,59,114,10,98"
                           HREF="recycle.html#glass"><AREA SHAPE=rect 
                           COORDS="10,148,111,185"
                           HREF="recycle.html#metal"><AREA SHAPE=rect 
                           COORDS="10,186,129,241"
                           HREF="recycle.html#plastic"><AREA SHAPE=rect 
                           COORDS="10,242,129,280"
                           HREF="recycle.html#paper"><AREA SHAPE=rect 
                           COORDS="10,281,111,330"
                           HREF="recycle.html#motoroil"><AREA SHAPE=rect 
                           COORDS="132,119,182,330"
                           HREF="recycle.html#locations"></MAP><A HREF="a href="
         : /imurl / /frames _frame /recycle.html /recycln.map /no http " /images /www.corvallis.disposal.com><IMG ISMAP
         SRC="../frames/images/recycnav.gif" WIDTH=200 HEIGHT=350
         BORDER=0 ALIGN=bottom
         usemap="#recycnav_map" hspace="10"></A>
      </TD><TD VALIGN=top cellpadding=5>
         <P>Corvallis Disposal is dedicated to the concept and
         practice of environmental preservation. We are constantly
         seeking new technologies and services which will not only
         preserve our environment, but provide more efficient and
         economical collection, recycling, and disposal of waste
         materials.<BR>
         
         <BR>
         
         By recycling, less energy is required than when using virgin
         resources, both in the initial extraction of resources and
         in manufacturing new products. Recycling conserves valuable
         natural resources and saves millions of dollars of valuable
         materials that would otherwise be buried in landfills. For
         the environment, processing recyclables into new goods
         produces far less air, water and land pollution.<BR>
         
         <BR>
         
         Recycling costs money, but it is still a good investment.
         The revenue derived by selling your recyclable materials
         offsets about 20% of the costs of offering the service.
         These short-termed costs are offset by long-term gains of
         saving resources, energy and landfill space. By changing our
         destructive habits we will begin to sustain a healthier
         environment and preserve our finite resources for future
         generations. This is why Corvallis Disposal has made a
         commitment to recycling. Please become a part of this
         growing endeavor. <NOBR></P>
         
         <P ALIGN=CENTER><A HREF="#yarddebris">Yard Debris</A> |
         <A HREF="#paper">Paper Products</A> |
         <A HREF="#glass">Glass</A> | <A HREF="#metal">Metals</A> |
         <WBR><A HREF="#motoroil">Motor Oil</A> |
         <A HREF="#plastic">Plastics</A> |
         <A HREF="#locations">Recycling Locations</NOBR></A>
      </TD></TR>
</TABLE></P>

<P ALIGN=CENTER><A HREF="../index.html">HOME</A> |
<A HREF="recycle.html">RECYCLING</A> |
<A HREF="compost.html">COMPOSTING</A> |
<A HREF="waste.html">SERVICES</A> | <A HREF="form.html">ASK US</A>
<A HREF="areainfo.html">COMMUNITY INFORMATION</A>|
<A HREF="request.html">REQUEST SERVICES</A></P>

<P><HR></P>

<H2><A NAME="yarddebris"></A>Yard Debris Recycling &amp;
<A HREF="compost.html">Composters</A></H2>

<P>City residents of Corvallis, Philomath, and Adair Village: If you
choose, a yard debris container can be delivered to regular garbage
service customers, by request. These containers will be emptied every
other week on your regular garbage day. Containers must be placed at
curbside to be emptied. If you prefer to
<A HREF="compost.html">compost</A> your own yard debris, we will
supply you with a <A HREF="compost.html">composter</A> instead. Yard
Debris - Defined as: Lawn clippings, brush, limbs, tree trimmings,
prunings. Not acceptable: Dirt/gravel, paper/ plastic trash, metal or
rubber objects, stumps / logs, rocks / bricks. SUBURBAN residents: We
have <A HREF="compost.html">composters</A> available.
<A HREF="#rec_top">BACK TO THE TOP</A><HR><A NAME="paper"></A><IMG
SRC="../frames/images/sm_paper.gif" ALT="Paper Products" WIDTH=120
HEIGHT=60 ALIGN=top><BR>

</P>

<H3>Newspapers</H3>

<P>Anything that comes in your newspaper can be recycled with your
newspaper. Stack in easily handled untied stacks. Please do not mix
newspaper with magazines, cardboard or paper bags.</P>

<H3>Corrugated (3-layer) Cardboard &amp; Brown Paperbags</H3>

<P>Flatten, and place at curbside. Remove all wire and plastic. Waxed
cardboard cannot be recycled. Recycle brown paper bags with your
cardboard. Recycle cereal boxes and shoe boxes with your mixed paper
(see below).</P>

<H3>Mixed Paper consists of:</H3>

<P>These three can be mixed in one brown paper bag.</P>

<H3>Sorted Household Mail</H3>

<P>White and pastel colored paper, envelopes, window envelopes,
pamphlets and brochures. Staples are okay. <BR>

<B><FONT COLOR="#AF0000">NO</FONT></B> construction paper, tissue
paper, books, paper towels, tape, food or gum wrappers.</P>

<H3>Paperboard (Flatten)</H3>

<P>Cereal type boxes (remove liners), shoe boxes, 6 &amp; 12 pack
beverage boxes, paper egg cartons, paper tubes ( i.e. paper towel).
</P>

<P>Please do not include: ice cream boxes, milk cartons, foil-lined
boxes, coffee cups, any container from the frozen or refrigerated
food sections.</P>

<H3>Magazines</H3>

<P>Shiny coated magazines and catalogs. <A HREF="#rec_top">BACK TO
THE TOP</A><HR><A NAME="motoroil"></A><IMG
SRC="../frames/images/sm_oil.gif" ALT="Used Motor Oil" WIDTH=94
HEIGHT=60 ALIGN=top><BR>

<BR>

Pour motor oil into non-breakable containers with tight fitting
screw-on caps (bleach or milk jugs).<STRONG> No paint thinner, gas or
other hazardous liquids. </STRONG><A HREF="#rec_top">BACK TO THE
TOP</A><HR><A NAME="glass"></A><IMG
SRC="../frames/images/sm_glass.gif" ALT="Glass" WIDTH=120 HEIGHT=60
ALIGN=top><BR>

<BR>

Sorted by color (clear, green, brown) in separate bags. Bottles and
jars only (please rinse). Labels do not need to be removed. Recycle
the lids from jars with your tin. <STRONG> No window glass, light
bulbs, pyrex or ceramics. </STRONG><A HREF="#rec_top">BACK TO THE
TOP</A><HR></P>

<H2><A NAME="metal"></A><IMG SRC="../frames/images/sm_metal.gif"
ALT="Tin Cans/Aluminum" WIDTH=120 HEIGHT=60 ALIGN=top><BR>

<BR>

Tin Cans/Aluminum</H2>

<P>Remove label, top and bottom. Rinse clean and flatten whenever
possible. Rounded end cans do not need to be flattened. Foil, TV
dinner trays and beverage cans are all accepted. <STRONG> No
appliances or scrap metal. </STRONG><A HREF="#rec_top">BACK TO THE
TOP</A><HR><A NAME="plastic"></A><IMG
SRC="../frames/images/sm_plast.gif" ALT="Plastics" WIDTH=120
HEIGHT=60 ALIGN=top><BR>

<BR>

</P>

<H3>Bottle and tub shaped rigid plastic containers only</H3>

<P>Why can we only recycle bottle &amp; tub shaped plastics? The
Garten Foundation in Salem (where we take our plastics), has a new
Plastics Recovery Facility (PRF) which is the first in the world able
to sort plastic bottles and tubs with all seven plastic resin code
numbers. Previously, the only way to recycle plastics was to keep
each resin code number separate from the time it's picked up to the
time it goes to market. This PRF can not only take all 7 resin code
numbers but can take them mingled together! But only if they are
bottle or tub shaped. The system that separates the plastics by resin
code can only "see" these shapes. Bags, trays, etc. are impossible
for this system to sort.</P>

<H3>Examples of Recyclable Plastic Containers <TABLE BORDER=0
CELLSPACING=5 CELLPADDING=5 WIDTH="100%">
   <TR>
      <TD>
         <P>Kitchen </H3></P>
         
         <UL>
            <LI>Milk
            
            <LI>Soda
            
            <LI>Water
            
            <LI>Juice
            
            <LI>Yogurt &amp; Margarine
            
            <LI>Ketchup &amp; Syrup
            
            <LI>Cooking Oils
         </UL>
         
         <H3>Bathroom</H3>
         
         <UL>
            <LI>Shampoo
            
            <LI>Conditioner
            
            <LI>Lotions
         </UL>
      </TD><TD>
         <P>Household Cleaners</H3></P>
         
         <UL>
            <LI>Dish Detergent
            
            <LI>Window Cleaner
            
            <LI>Kitchen &amp; Bath Cleaner
         </UL>
         
         <H3>Automotive</H3>
         
         <UL>
            <LI>Windshield Washer
            
            <LI>Antifreeze
         </UL>
         
         <H3>Laundry</H3>
         
         <UL>
            <LI>Liquid Detergent
            
            <LI>Fabric Softener
            
            <LI>Bleach
         </UL>
      </TD></TR>
</TABLE></H3>

<H3></UL><A HREF="#rec_top">BACK TO THE TOP</A><HR></H3>

<H2>Do Not Put These Items In The Recycling Bin</H2>

<H3><I><STRONG>(Even a Small Amount of Contaminants Can Ruin an
Entire Shipment of Recyclable Plastics)</STRONG></I></H3>

<UL>
   <LI>Lids, Caps and Spray Pumps
   
   <LI>Bags or Wraps
   
   <LI>Pails (Ice cream)
   
   <LI>Food Storage, Freezer Containers (Tupperware)
   
   <LI>Containers - 5 Gallons or Larger
   
   <LI>Flower Pots and Garden Plastics
   
   <LI>Trays, Microwave Dishes
   
   <LI>Hazardous Waste containers (Pesticides, Herbicides, Solvents,
   Motor Oil, Paints, Adhesives)
   
   <LI>Styrofoam (Please enclose in a bag and put in trash).
</UL>

<H3><HR></H3>

<H1 ALIGN=CENTER>If In Doubt, Throw It Out...</H1>

<H2 ALIGN=CENTER>Unrecyclables Will Be Left In Your Recycle Bins!
</H2>

<H3><HR></H3>

<H2><I>Why do I need to sort my recycling?</I></H2>

<H3><I>Separating each commodity in your bin is important because
each commodity needs to go into a separate compartment on our trucks.
When the truck is full, each compartment is emptied into large boxes
at our site and are then hauled to markets where they are recycled.
Our drivers cannot sort everyone's bin because that would require
spending extra time at each stop which would mean we would need to
quadruple (or more) the number of recycling drivers we have! And that
would mean higher rates for our customers.</I><BR>

<BR>

Corvallis Disposal 's recycling program has experienced strong growth
during the past 5 years, as indicated by this graph:<BR>

<IMG SRC="../frames/images/chart.gif" WIDTH=246 HEIGHT=267
ALIGN=bottom><BR>

The large increase from 1992 to 1993 can be attributed to the start
of mixed paper recycling and curbside yard debris recycling.<HR>
</H3>

<H2>Some helpful links:</H2>

<DIR>
   <LI><B><A HREF="http://www.plasticsresource.com/">American
   Plastics Council</A></B>
   
   <LI><B><A HREF="http://www.gpi.org/">Glass Recycling
   Institute</A></B>
   
   <LI><B><A HREF="http://www.best.COM/~dillon/recycle/">The Consumer
   Recycling Resources Guide</A></B>
   
   <P>Includes instructions for recycling items we don't take
   locally.</P>
   
   <P><BR>
   
   </P>
   

   <LI><B><A HREF="http://www.econet.apc.org/econet/en.issues.html/">EcoNet
   - Environmental Issues Resource Center</A></B>
   
   <LI><B><A HREF="http://es.inel.gov/index.html/">Enviro$en$e</A>
   </B>
</DIR>

<H3><HR><A NAME="locations"></A><IMG
SRC="../frames/images/sm_locat.gif" ALT="LOCATIONS" WIDTH=222
HEIGHT=54 ALIGN=top><BR>

</H3>

<H2>When</H2>

<H3><BR>

Your recyclable materials are collected each week on your regular
garbage pick-up day. Please have your recycling bins to the street by
7 a.m.<BR>

</H3>

<H2>Where</H2>

<H3><BR>

If you wish to drop off your recyclables, the following sites are
available for you to do so: <TABLE BORDER=0 CELLSPACING=5
CELLPADDING=5 WIDTH="100%">
   <TR>
      <TD>
         <P>Corvallis Disposal 110 N.E. Walnut Blvd., Corvallis
         <I>Drop off anytime.</I>
      </TD><TD>
         <P>Processing &amp; Recovery Center 10 mi. north of
         Corvallis, Hwy 99W, Right on Camp Adair Rd. for 1 mile
         <I>Mon.-Sat., 8am-5pm; Sun. Noon-5pm</I>
      </TD></TR>
   <TR>
      <TD>
         <P>First Alternative CO-OP 1007 S.W. 3rd St., Corvallis
         <I>Drop off anytime.</I>
      </TD><TD>
         <P>Alsea Recycle Center Alsea Fire Station
      </TD></TR>
   <TR>
      <TD>
         <P>Monroe Transfer Station Monroe, OR
      </TD><TD>
         <P>Greenberry Store 29974 Hwy. 99W
      </TD></TR>
   <TR>
      <TD>
         <P>Blodgett across Hwy. from Blodgett Store
      </TD><TD>
         <P>Kings Valley School
      </TD></TR>
   <TR>
      <TD>
         <P>Pioneer Village
      </TD><TD>
         <P>Alpine Store
      </TD></TR>
</TABLE></H3>

<H3>Other recycling services available: Office Paper Recycling,
Commercial Recycling and Multi-family Recycling.
<A HREF="#rec_top">BACK TO THE TOP</A></H3>

<H3 ALIGN=CENTER><A HREF="../index.html">HOME</A> |
<A HREF="compost.html">COMPOSTING</A> |
<A HREF="waste.html">SERVICES</A> | <A HREF="form.html">ASK US</A>
<A HREF="areainfo.html">COMMUNITY INFORMATION</A> |
<A HREF="request.html">REQUEST SERVICES</A><BR>

this site created by
<A HREF="mailto:paperworks@proaxis.com">Paperworks Design</A>,
Corvallis, OR</H3>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-67</DOCNO>
<DOCOLDNO>IA021-000230-B029-286</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/compost.html 198.68.7.46 19970107213224 text/html 6250
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:32:26 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 6079
Last-modified: Mon, 24 Jun 1996 23:45:52 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE>Composting Information Page</TITLE>
</HEAD>
<BODY BGCOLOR="#ffffc7">

<TABLE>
<TR>
<TD ROWSPAN=5 valign=center>
<MAP NAME="compost_map">

<AREA SHAPE=rect COORDS="20,312 144,329"
HREF="compost.html#problems">

<AREA SHAPE=rect COORDS="20,296 144,311"
HREF="compost.html#method">

<AREA SHAPE=rect COORDS="20,285 144,295"
HREF="compost.html#notto">

<AREA SHAPE=rect COORDS="20,267 144,284"
HREF="compost.html#whatto">

<AREA SHAPE=rect COORDS="20,250 144,266"
HREF="compost.html#uses">
</MAP>
<a href="http://www.corvallis.disposal.com/frames/images/compostn.map/IMURL/
http://www.corvallis.disposal.com/no_frame/compost.html">
<img src="../frames/images/comp_nav.gif" border="0" WIDTH="200"
HEIGHT="350" HSPACE="10" ALIGN=bottom ISMAP USEMAP="#compost_map"></a>
</TD>

<TD valign=center cellpadding="10">
<A NAME="top"></A><A HREF="#uses">
<H3>Uses for Compost</H3></A>
</TD>
<TR><TD><A HREF="#whatto"><H3>What to Compost</H3></A></TD></TR> 
<TR><TD><A HREF="#notto"><H3>What not to Compost</H3></A></TD></TR>
<TR><TD><A HREF="#method"><H3>Composting Methods</H3></A></TD></TR>
<TR><TD><A HREF="#problems"><H3>Composting Problems</H3></A></TD></TR>
</TABLE>
<CENTER>
<A HREF="../index.html">HOME</A> 
| <A HREF="recycle.html">RECYCLING</A> 
| <A HREF="compost.html">COMPOSTING</A> 
| <A HREF="waste.html">SERVICES</A> 
| <A HREF="form.html">ASK US</A> 
| <A HREF="areainfo.html">COMMUNITY INFORMATION</A>
| <A HREF="request.html">REQUEST SERVICES</A>
</CENTER>
<H1>Did you know?...</H1><UL><LI>Food waste and yard debris make up about 25% of our 
garbage. <LI>Grass clippings and leaves can take years to decompose in the 
landfill. </UL>
<HR><A NAME="uses"></A><H1>Uses For Compost</H1>Compost contains nutrients 
and holds nutrients in the soil until plants can use them, but is not a 
substitute for fertilizers. <H2><I>As A Soil Amendment</I></H2>Mix compost 
into vegetable and flower gardens each year before planting <H2><I>As A 
Potting Mixture</I></H2>Add one part compost to two parts commercial 
potting soil, or make your own mixture by using equal parts of compost and 
sand or perlite. <A HREF="#top">BACK TO THE TOP</A><HR> <A
NAME="whatto"></A><H1>What To Compost</H1><UL><LI>Grass clippings 
<LI>Leaves <LI>Flowers <LI>Old plants <LI>Twigs <LI>Old potting soil </UL>
<A HREF="#top">BACK TO THE TOP</A><HR> <BR><A NAME="notto"></A><H1>What NOT To 
Compost</H1><UL><LI>Diseased plants <LI>Weeds with seeds <LI>Invasive 
weeds like quack grass or morning glory <LI>Pet feces <LI>Dead animals 
<LI>Meat or fish parts <LI>Dairy products such as milk, butter, or cheese 
<LI>Grease, cooking oil, or oily foods </UL><BR>
<A HREF="#top">BACK TO THE TOP</A><HR> <A NAME="method"></A><H1>How To 
Compost</H1><H2>Soil Saver</H2><H3><I>HOT COMPOSTING (Compost 
Turning)</I></H3><UL><LI>Rich compost is created when you alternate layers 
of organic waste. It is easiest to estimate this ratio by alternating 
layers of &quot;green stuff&quot; and &quot;brown stuff&quot; as the 
compost pile is built. Example: A layer of grass clippings (&quot;green 
stuff&quot;) twice as thick as a layer of brown leaves (&quot;brown 
stuff&quot;) is a good ratio. <LI>Keep the material as moist as a 
squeezed-out sponge. Occasional watering may be required to moisten the 
pile if it becomes too dry. <LI>Turn the material (at least 4-5 times 
during the summer) with a pitchfork, shovel or compost turner so it's well 
aerated. You can turn the pile once a week but more frequent turning will 
inhibit composting. <LI>Your compost is ready to use when it is a dark 
brown or black color, crumbly, humus-rich top soil, with the sweet aroma 
of the good earth. </UL>
<H2>Gedye Bin</H2><H3><I>CLOSED-AIR COMPOSTING</I></H3><BR><UL><LI>Closed-air 
composting uses bins, sometimes called digesters, that have solid sides 
and tight-fitting lids to conserve moisture and hold in any unpleasant 
odors. This type of holding bin is good for composting vegetable or fruit 
scraps. <LI>Place bin in a sunny location if possible. <LI>Fork the ground 
underneath the bin so earthworms and soil organisms can begin their work. 
<LI>Don't turn the contents. If they dry out, add more water. If they 
become soggy, add dry ingredients. <LI>Spread a thin layer of dry leaves 
or soil over every 6 to 8 inches of waste to control odors and ensure an 
adequate bacteria supply. <LI>Your compost is ready to use when it is a 
dark brown or black color, crumbly, humus-rich top soil, with the sweet 
aroma of the good earth. </UL>
<H3>A link for more information: <A 
HREF="http://net.indra.com/~topsoil/Compost_Menu.html">Composting</A></H3><BR><A 
HREF="#top">BACK TO THE TOP</A> <HR><BR><A
NAME="problems"></A><H1>Problems</H1><BR><H2><I>Will my composter attract 
flies?</I></H2>Not if you dig your food scraps into the compost or cover 
any food scraps or &quot;green stuff&quot; with a layer of soil or 
&quot;brown stuff.&quot; <H2><BR><I>Will my composter attract animals or 
rodents?</I></H2><BR>To prevent the attraction of animals, do not add meat 
products, dairy products, fat or fish to your composter. Again, cover food 
scraps with soil or &quot;brown stuff.&quot; Lay a sheet of hardware cloth 
or rabbit cage wire on the ground beneath your composter to keep rodents 
out. <H2><BR><I>Why does my composter smell like ammonia?</I></H2><BR>You have too 
much &quot;green stuff.&quot; Add more&quot;brown stuff.&quot; <BR><H2><I>Why 
does my composter smell rotten?</I></H2><BR>There is too much moisture in the 
composter. Turn the pile and add porous material such as leaves or 
sawdust.<BR> <A HREF="#top">BACK TO THE TOP </A><BR>
<P><CENTER><A HREF="../index.html">HOME</A> 
| <A HREF="recycle.html">RECYCLING</A> 
| <A HREF="compost.html">COMPOSTING</A> 
| <A HREF="waste.html">SERVICES</A> 
| <A HREF="form.html">ASK US</A><BR> 
| <A HREF="areainfo.html">COMMUNITY INFORMATION</A>
| <A HREF="request.html">REQUEST SERVICES</A><BR>
<BR>this site created by <A 
HREF="mailto:paperworks@proaxis.com">Paperworks Design</A>, Corvallis, 
OR</CENTER></BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-68</DOCNO>
<DOCOLDNO>IA021-000230-B029-211</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/waste.html 198.68.7.46 19970107213150 text/html 9993
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:31:51 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 9822
Last-modified: Mon, 24 Jun 1996 23:46:11 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE>Waste Disposal Information</TITLE>
</HEAD>
<BODY BGCOLOR="#ffffe3">
<H3><TABLE> <TR><TD valign=top></H3>
<MAP NAME="serv_map"> <AREA SHAPE=rect COORDS="20,312 144,329"
HREF="waste.html#indust"> <AREA SHAPE=rect COORDS="20,296 144,311"
HREF="waste.html#resident"> <AREA SHAPE=rect COORDS="20,285 144,295"
HREF="waste.html#commerc"> <AREA SHAPE=rect COORDS="20,267 144,284"
HREF="waste.html#doanddont"> <AREA SHAPE=rect COORDS="20,250 144,266"
HREF="waste.html#reduce"> </MAP> 
<A HREF="wastenav.map/IMURL/http://www.corvallis.disposal.com/no_frame/waste.html">
<IMG SRC="../frames/images/wastenav.gif" BORDER="0" WIDTH="200" HEIGHT="350" 
ALIGN=bottom ISMAP USEMAP="#serv_map"></A>
<H3></TD><TD valign=top cellpadding="15"> <FONT size=4>There's more to successful
solid-waste disposal than &quot;picking up the garbage.&quot; It has to
be done in a manner that satisfies not only the individual customer, but
also the community and the environment.<BR>
<BR>
At Corvallis Disposal, our service includes regular garbage pick-up, recycling,
and several types of specialized containers and services. We strive to employ
the latest equipment and handling methods for safe, and efficient removal
of solid waste.<BR>
<BR>
In the &quot;perfect&quot; waste-management system, there would be no waste;
every article of refuse could be reclaimed, just as in nature. Corvallis
Disposal will always aim for that level of efficiency, and we welcome your
suggestions for improving our service.</FONT></TD></TR></TABLE> </H3>
<P><CENTER><A HREF="../index.html">HOME</A>
| <A HREF="recycle.html">RECYCLING</A>
| <A HREF="compost.html">COMPOSTING</A>
| <A HREF="waste.html">SERVICES</A> 
| <A HREF="form.html">ASKUS</A>
<BR><A HREF="areainfo.html">COMMUNITY INFORMATION</A> 
| <A HREF="request.html">REQUEST SERVICES</A><BR></CENTER>
<P>
<H1><A NAME="resident"></A>Services</H1>
<H2>Residential</H2>
<UL>
<LI>Weekly or on-call garbage collection 
<LI>Weekly curbside collection of recyclables (available in most areas)
<LI>Bi-weekly collection of yard debris (available in most areas) 
<LI>Composters 
<LI>Special pick-up of bulky items such as appliances and furniture 
<LI>Temporary dumpsters for cleanup projects
</UL>
<H2>Regular Can Service</H2>
Our regular service is collecting one can per residence once a week - unless
otherwise directed. Either permanent, temporary or off-schedule pick-up
service may be arranged by calling during regular business hours. <BR>
<BR>
We require a metal or plastic container (preferably metal), with handles
and a close-fitting cover, also with a handle. The container should have
a maximum capacity of 32 gallons and a loaded weight not exceeding 60 pounds.
Overweight cans constitute a hazard to the person lifting the load; therefore,
we assess an extra charge. 
<H2>Residential Cart Service</H2>
Beginning April 1, 1996, we will offer a 35-gallon garbage cart, available
to Corvallis, Adair Village, and Philomath city residents, with a few areas
excepted. These carts are collected using an 'automated' truck, and consequently
must be placed at the curb for collection. Corvallis Disposal provides the
cart at no additional charge, and will provide replacements or repairs to
the cart as needed.<BR>
<BR>
Collections begin at 7:00 am, so it may be convenient for you to set your
refuse out the evening before pick-up day.<BR>
We appreciate the placement of cans for quick, safe access. Also, please
keep pets secured on pick-up day. 
<H3>Service Rates</H3>
Monthly rates, based on one pick-up per week for Corvallis, Adair Village,
and Philomath: 
<DL>
<DT>One 32-gallon can $10.35 
<DT>Two 32-gallon cans $19.35 
<DT>Extra/occasional can $ 3.00 per extra can 
<DT>One 35-gallon cart $10.35 
<DT>One 90-gallon cart $17.20 
</DL>
<I>Rates for suburban areas are slightly higher.</I> 
<H3>Will Call Service</H3>
For the customer who needs less than 1 can picked up each week. Please call
our office to schedule a pick-up. The rate below applies to each pick-up.
<DIR>
<LI>Two 32-gallon cans:$ 5.90 
<LI>Suburban rate: Two 32-gallon cans:$ 6.25 
</DIR>
<BR>
<HR>
<H2>Moving</H2>
When you move from one location to another within our service area, be sure
to notify us in advance so your service can continue without interruption.
If you move out of the area, a call to the office will terminate your service.
<H2>Vacation</H2>
When vacation plans call for being away for more than three weeks, your
account will be given proper credit if we are notified in advance. 
<H2>Holiday Collection Schedule</H2>
The people who pick up your garbage each week will not be working on THANKSGIVING,
CHRISTMAS or NEW YEAR'S DAY. On these three holidays, our scheduled pick-ups
will be a day late for the holiday and all days for the balance of the week.
<H2>Curbside Recycling </H2>
We provide 2 recycle bins per household to sort your recyclables. Place
at curb on your garbage day by 7:00 A.M.<BR>
<BR>
<HR><A NAME="commerc"></A>
<H2>Commercial</H2>
<DIR>
<LI>Regularly scheduled garbage collection 
<LI>Recycling programs to meet the needs of each business. Including cardboard,
office paper, cans, bottles, etc.<HR> 
</DIR>
<H1><A NAME="indust"></A></H1>
<H2>Industrial</H2>
<UL>
<LI>Drop boxes for garbage or recycling 
<LI>Recycling programs to meet the needs of each business. Including cardboard,
office paper, woodwaste, etc. 
</UL>
<BR>
<BR>
<HR><A NAME="doanddont"></A>
<H1>PLEASE DO NOT put these items in your trash: </H1>
<UL>
<LI><STRONG>medical sharps ( i.e. needles, lancets, syringes) 
<LI>any liquid waste 
<LI>hazardous waste (i.e. anything labeled poison or caustic) 
<LI>large appliances</STRONG> 
</UL>
<BR>
<HR>
<H2><A HREF="areainfo.html#calen">Annual Events</A></H2>
Each year we have several scheduled events. These include: Spring Clean-Up
Day; Household Hazardous Waste Collection event; Leaf Collection for several
weeks in the fall; and Christmas Tree Collection for 2 weeks after Christmas.
These events are available for no additional charge, with the exact <A HREF="areainfo.html#calen">dates</A>
announced in advance each year. 
<H2>Clean-Up Services</H2>
If you have an accumulation of refuse material and no way of removing it
yourself, let us handle it. We will load and haul away piles of yard debris,
tree cuttings and building material. Call today for rates or an on-site
estimate. 
<H2>Loaner Containers</H2>
When there's too much for your household refuse can, we can provide a container
to match the job. Call ahead to reserve your container for the day(s) you
need it.<BR>
<BR>
1 1/2 yard container (9 can equivalent) $19.75/empty (Plus $3.90/week rent)
<BR>
<HR><A NAME="reduce"></A>
<H1>Helpful Hints for Reducing Toxic Waste:</H1>
<H2>Household Toxic Waste </H2>
As a consumer you may assume a product is safe if it is offered for sale.
Unfortunately, many household products contain hazardous ingredients that
can be harmful when you use them or dispose of them improperly.<BR>
<P><CENTER><B>Common Hazardous Products</B></CENTER>
<UL>
<LI>Oil Based Paints 
<LI>Solvent-based Paint Thinners 
<LI>Furniture and Floor Polishes 
<LI>Lawn Fertilizers 
<LI>Drain Openers 
<LI>Mothballs 
<LI>Pesticides 
<LI>Motor Oil 
<LI>Bug Sprays 
<LI>Smoke Detectors (Should be returned to the manufacturer at their address
on base of detector) 
</UL>
<BR>
<BR>
<BR>
<B>Look for These Key Words &amp; Symbols:</B><BR>
Flammable/Combustible<BR>
Can easily be set on fire<BR>
<BR>
Corrosive/Caustic <BR>
Can burn and destroy living tissue<BR>
<BR>
Radioactive <BR>
Can damage and destroy cells and chromosomes<BR>
<BR>
Toxic/Poisonous <BR>
Capable of causing injury or death from ingestion, <BR>
inhalation or absorption<BR>
<BR>
Explosive/Reactive <BR>
Can detonate or explode from exposure to heat,<BR>
sudden shock or pressure<BR>
<BR>
<B>Consider Alternative Products<BR>
<BR>
</B><I>Buy Only What You Need</I><BR>
If you have leftovers, pass them on to someone else.<BR>
<BR>
<I>If You Are Pregnant Avoid Hazardous Products</I><BR>
Many chemicals are not tested for their effects on the unborn fetus. 
<H2>Non-Toxic Alternatives </H2>
<H4>Outdoor Pesticides</H4>
<UL>
<LI>Use natural predators such as ladybugs, ground beetles, lacewings, praying
mantis &amp; spiders. 
<LI>Set traps to collect insects such as wet newspapers, stones, flat boards,
lettuce, spinach leaves &amp; grapefruit rinds. 
<LI>Use companion planting. 
</UL>
<H4>Drain Cleaner</H4>
<UL>
<LI>Prevent clogged drain by pouring boiling water down drain periodically.
<LI>Plunger followed by handful of baking soda with 1/2 cup vinegar; cover
drain &amp; let sit for 15 minutes followed by 2 quarts boiling water. 
<LI>Use mechanical snake. 
</UL>
<H4>Disinfectants</H4>
<UL>
<LI>Use 1 teaspoon bleach mixed with 1 gallon water. 
<LI>Use ammonia. 
</UL>
<H4>Oven Cleaner</H4>
<UL>
<LI>Sprinkle salt or baking soda on fresh spills when they're warm and scrape
them off when oven cools. 
<LI>Line bottom of oven with foil (check oven warranty about foil use).
</UL>
<H4>Air Freshener</H4>
<UL>
<LI>Ventilation is the best air freshener. 
<LI>Open box of baking soda. 
</UL>
<H4>Tile Cleaner</H4>
<UL>
<LI>Scrub with baking soda. 
</UL>
<H4>Indoor Insect Spray</H4>
<UL>
<LI>Screen in windows &amp; doors. 
<LI>Promptly put discarded food into covered containers. 
<LI>Keep kitty litter box clean &amp; isolated. 
<LI>Use flypaper or flyswatter. 
</UL>
<P><CENTER><A HREF="../index.html">HOME</A>
| <A HREF="recycle.html">RECYCLING</A> | <A HREF="compost.html">COMPOSTING</A>
| <A HREF="waste.html">SERVICES</A> | <A HREF="form.html">ASK US</A><BR>
<A HREF="areainfo.html">COMMUNITY INFORMATION</A> 
| <A HREF="request.html">REQUEST SERVICES</A><BR><BR>
<BR>
<BR>
this site created by <A HREF="mailto:paperworks@proaxis.com">Paperworks
Design</A>, Corvallis, OR</CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-69</DOCNO>
<DOCOLDNO>IA021-000230-B029-356</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/request.html 198.68.7.46 19970107213254 text/html 986
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:32:57 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 816
Last-modified: Mon, 24 Jun 1996 23:46:04 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE>Contact Corvallis Disposal On-Line</TITLE>
</HEAD>
<BODY BGCOLOR="#f9f9f9">

<IMG SRC="../frames/images/reqestnv.gif" BORDER="0" WIDTH="200" HEIGHT=
"350" ALIGN="left" HSPACE="15" VSPACE="10"><A NAME="top"></A><CENTER>
<H1>Request Services 
from Corvallis Disposal</H1><FONT size=5><br>
<A HREF="res_form.html">RESIDENTIAL SERVICES</A><br><br>
<A HREF="com_form.html">COMMERCIAL SERVICES</A></FONT><br></CENTER>

<BR clear=left>
<CENTER><A HREF="../index.html">HOME</A> 
| <A HREF="recycle.html">RECYCLING</A> 
| <A HREF="compost.html">COMPOSTING</A> 
| <A HREF="waste.html">SERVICES</A> 
| <A HREF="areainfo.html">COMMUNITY INFORMATION</A>
<br><br>
Corvallis Disposal &amp; Recycling Company<br>
110 NE Walnut Blvd.<br>
Corvallis, OR 97330<br>
(541) 754-0444</CENTER></FORM></BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-70</DOCNO>
<DOCOLDNO>IA021-000230-B029-333</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/areainfo.html 198.68.7.46 19970107213244 text/html 3888
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:32:47 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 3717
Last-modified: Mon, 24 Jun 1996 23:45:49 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE>Corvallis Disposal's newsletter and links to our community</TITLE>
</HEAD>
<BODY BGCOLOR="#cee8fb">
<TABLE> <TR><TD valign=top><MAP NAME="comm_map"> 
<AREA SHAPE=rect COORDS="51,277 151,294" HREF="newsletr.html" >
<AREA SHAPE=rect COORDS="17,297 86,312" HREF="areainfo.html#util" > 
<AREA SHAPE=rect COORDS="17,318 107,334" HREF="areainfo.html#gov" > 
<AREA SHAPE=rect COORDS="109,297 176,312" HREF="areainfo.html#schools" > 
<AREA SHAPE=rect COORDS="109,318 183,334" HREF="areainfo.html#calen" ></MAP>
<A HREF="areainfo.html">
<IMG SRC="../frames/images/communav.gif" BORDER="0" WIDTH="200" HEIGHT="350"  ALIGN=bottom ISMAP
USEMAP="#comm_map"></A></TD><TD valign=top cellpadding=5> 
<H1>Calendar of Events</H1>
<CENTER><H3>Check out our <A HREF="newsletr.html">newsletter!</A></H3>
<P><A HREF="../index.html">HOME</A><BR>
<A HREF="recycle.html">RECYCLING</A>
<BR><A HREF="compost.html">COMPOSTING</A>
<BR><A HREF="waste.html">SERVICES</A>
<BR><A HREF="form.html">ASK US</A>
<BR><A HREF="request.html">REQUEST
SERVICES</A><BR>
<BR></TD></TR></TABLE>
<A NAME="calen"></A>
<H2>Free Community Events sponsored by Corvallis Disposal<HR></H2>
<A NAME="calen"></A><BR>
<H3>Upcoming Household Hazardous Waste Collections in our area</H3><BR>
<B>Lebanon</B><BR>
September 28, 1996<BR>
Call 928-2551 after 7/1/96 for location and times<BR><BR>
<B>Harrisburg</B><BR>
October 5, 1996<BR>
Call 928-2551 after 7/1/96 for location and times<BR><BR>
<B>Albany</B><BR>
October 18 &amp; 19, 1996<BR>
<A HREF="http://www.sanitation.com">Albany Lebanon Sanitation</A><BR>
1214 Montgomery St. South<BR>
928-2551<BR><BR>
<TABLE BORDER=1 CELLPADDING=5><BR>
<TR><TH>Yes<BR></TH><TH>No<BR></TH></TR><BR>
<TR><TD>Anything labeled caution, danger, flammable, etc. Examples include:
paints, pesticides, explosives, radioactive waste, poisons, antifreeze, 
paint thinner, and batteries.<BR></TD><TD>Waste generated from a business (unless pre-registered, 
call for details), Empty Containers (they may be put in your trash)<BR></TD></TR></TABLE><BR>
Metro Recycling in Portland operates hazardous waste collection sites 7 
days a week. For information: 503-234-3000<BR><BR>
<B>For information on events held statewide: DEQ 1-800-732-9253</B><BR><BR>
<HR>
<H3>Leaf Collection <BR>
November 4 through January 3</H3>
Corvallis Disposal will collect leaves in Corvallis, Philomath, and Adair
if swept into the street. These are picked up on the same day as your garbage
day. These leaves are made into compost at the Processing and Recovery Center
(PRC) 745-5831.<BR>
<HR>
<H3>Christmas Tree Collection <BR>
December 30 through January 10 </H3>
Christmas trees will be collected curbside in Corvallis, Philomath, and
Adair and turned into compost at the Processing and Recovery Center (PRC)
745-5831. Trees should be free of tinsel and flocking. Customers outside
of these areas can have their trees picked for no charge by their garbage
route. You can also drop off your tree for recycling at Corvallis Disposal
or the Philomath Fire Department.<BR><HR><BR>
<A NAME="schools"></A>
<H2>School Information</H2>
<A HREF="http://www.corvallis.k12.or.us">Corvallis Schools  
K-12</A><BR><HR><BR>
<A NAME="gov"></A><H2>Community and Government</H2>
City of Corvallis community homepage called <A 
HREF="http://www.orst.edu/cornet">CORNET</A><BR><HR><BR>
<P><CENTER><A HREF="../index.html">HOME</A> |
<A HREF="recycle.html">RECYCLING</A>
| <A HREF="compost.html">COMPOSTING</A>
| <A HREF="waste.html">SERVICES</A>
| <A HREF="form.html">ASK US</A>
| <A HREF="request.html">REQUEST SERVICES</A><BR>
<BR>
<BR>
this site created by <A HREF="mailto:paperworks@proaxis.com">Paperworks
Design</A>, Corvallis, OR</CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-71</DOCNO>
<DOCOLDNO>IA021-000230-B030-5</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/res_form.html 198.68.7.46 19970107213333 text/html 7486
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:33:38 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 7315
Last-modified: Tue, 25 Jun 1996 17:18:03 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE>Residential Service Request Form</TITLE>
</HEAD>
<BODY BGCOLOR="#f7fbfd">
<FORM ACTION="/cgi-bin/formmail?info@corvallis.disposal.com" ENCTYPE="x-www-form-encoded"
METHOD="POST">
<P><CENTER><A NAME="top"></A><IMG SRC="../frames/images/reqestnv.gif" BORDER=
"0" WIDTH="200" HEIGHT="350" ALIGN="LEFT" HSPACE=15 VSPACE=10></CENTER>
<H1><CENTER>Residential Service Request Form</CENTER>
</H1>
<H4>If you wish to start residential garbage service at your home or apartment,
please contact Corvallis Disposal by telephone at 754-0444, Monday thru
Friday, 8 am to 5 pm.</H4>
<BR>
<BR>
<H3>You can now request services from Corvallis Disposal on line.</H3><BR><BR>
Services are arranged in two categories: 
<DIR>
  <LI>Delivery Services - get a cart, dumpster, or other container for use.<BR>
<BR>
  <LI>Pickup Services - have a container or other item emptied or taken away. 
</DIR><BR><BR><BR>
<CENTER><A HREF="../index.html">HOME</A> 
| <A HREF="recycle.html">RECYCLING</A> 
| <A HREF="compost.html">COMPOSTING</A> 
| <A HREF="waste.html">SERVICES</A> 
| <A HREF="areainfo.html">COMMUNITY INFORMATION</A></CENTER>
<BR CLEAR=LEFT>
<H2>1. All requests require your name, address, and phone number.</H2>
<TABLE border="0"> <TR><TD>Name:<BR>
</TD><TD><INPUT NAME="name" TYPE="text" SIZE="30"></TD></TR> <TR><TD>Service
Address:<BR>
</TD> <TD><INPUT NAME="service address" TYPE="text" SIZE="30"></TD></TR>
<TR><TD>City:<BR>
</TD><TD><INPUT NAME="city" TYPE="text" SIZE="30"></TD></TR> <TR><TD>Phone
Number:<BR>
</TD><TD><INPUT NAME="phone no." TYPE="text" SIZE="30"></TD></TR>
<TR><TD>e-mail (optional):<BR>
</TD><TD><INPUT NAME="email" TYPE="text" SIZE="30"></TD></TR></TABLE>
<H2>2. Please select one type of service:</H2>
<H4><A HREF="#deliver">Delivery</A> -get a cart, dumpster, or other container from
Corvallis Disposal<BR>
<BR>
<A HREF="#pickup">Pickup</A>- have a container or other item emptied or taken away</H4>
<H2><HR></H2>
<H1><CENTER><A NAME="deliver"></A>Delivery Services</CENTER>
</H1>
<H2>I need:</H2>
<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="automated cart requested">
A automated cart delivered to my house<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="yard debris cart requested">
A yard debris cart delivered to my house<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="composter requested"> A composter
delivered to my house<BR>
1 <INPUT TYPE="checkbox" NAME="checkbox" VALUE="1 red recycling bin requested">
2 <INPUT TYPE="checkbox" NAME="checkbox" VALUE="2 red recycling bins requested">
Red recycling bin(s) delivered to my house<BR>
other:<INPUT NAME="other request" TYPE="text" SIZE="30"><BR>
<BR>
<INPUT NAME="submit" TYPE="submit" VALUE="Submit a request for delivery"><INPUT
NAME="name" TYPE="reset" VALUE="Clear Form"><BR>
<BR>
<A HREF="#top">Back to the top of this form.</A> 
<H2><HR>For temporary dumpster service: </H2>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="request for a 1.5 yard 
dumpster">1.5 cu. yard dumpster (small blue container, 6 ft. long, 4 ft tall, 3 ft wide)
$3.90/ week minimum rental + $19.75 per empty. The container will be delivered
within 2 working days, unless you live in a rural area.<BR>
<BR>
<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="request for a 30 yard dumpster">30
cu. yard dumpster (22 feet long, 6 ft tall, 8 ft wide) $120 each time it
is hauled to the landfill ($145 outside city limits), $20 per ton, $8 per day rental charge (5 days
no rental charge, no rent charged on weekends).<BR>
This container will be delivered within 2 working days. If you would like
it delivered at a later date, please specify in the special instructions:<BR>
<BR>
<TABLE border="0"> <TR><TD>Your billing address:</TD><TD><INPUT NAME="billing address"
TYPE="text" SIZE="30"></TD></TR><BR>
<TR><TD>Where shall we set this container?<BR>(in your driveway, in the 
street, etc.)</TD><TD><TEXTAREA NAME="location to set container"
ROWS="6" COLS="32"
></TEXTAREA></TD></TR><BR>
<TR><TD>Special Instructions:</TD><TD><TEXTAREA NAME="special instructions:"
ROWS="7" COLS="27"
></TEXTAREA></TD></TR></TABLE><BR>
<BR>
<BR>
<INPUT NAME="submit" TYPE="submit" VALUE="Submit a request for delivery">
<INPUT NAME="name" TYPE="reset" VALUE="Clear Form"><BR>
<BR>
<A HREF="#top">Back to the top of this form.</A> 
<H2><HR></H2>
<H1><CENTER><A NAME="pickup"></A>Pickup Services</CENTER>
</H1>
<H2>I need:</H2>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="on-call customer needs can emptied">
A garbage can emptied at my house (I'm an on-call customer)<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="yard debris cart emptied">
A yard debris cart taken away<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="composter removed">A composter
taken away<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="please empty a 1.5 yard dumpster">1.5
cu. yard dumpster emptied   ($19.75 per empty)<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="please empty and remove a 1.5 yard dumpster">1.5
cu. yard dumpster emptied <I>and  </I>taken away <BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="please empty a 30-yard 
dumpster">30 cu. yard dumpster emptied  ($120 each time it is hauled to the landfill, 
$145 outside city limits, $20 per ton, $8 per day rental charge)<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="please empty and remove a 30-yard dumpster">30
cu. yard dumpster emptied <I>and</I>  taken away<BR>
Other: <INPUT NAME="other pickup" TYPE="text" SIZE="30"><BR>
<BR>
Please do not put into these containers: hazardous wastes (such as paint,
pesticides, solvents), tires, liquids, medical waste, metal appliances (such
as stoves, refrigerators, etc.)<BR>
<BR>
<BR>
<INPUT NAME="submit" TYPE="submit" VALUE="Submit a request for pickup"><INPUT
NAME="name" TYPE="reset" VALUE="Clear Form"><BR>
<BR>
<A HREF="#top">Back to the top of this form.</A> <BR>
<BR>
<HR>
<H1><CENTER>Special Pickup Service Request</CENTER>
</H1>
<H4><INPUT TYPE="checkbox" NAME="checkbox" VALUE="pickup a pile of debris or large item">
Special Pickup of a pile of debris or a large item (sofa, mattress, etc.).<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="pickup large metal appliance">
I have a large metal appliance (such as a stove, refrigerator, etc.)<BR>
Other:<INPUT NAME="other pickup" TYPE="text" SIZE="30"> </H4>
<TABLE border="0"> 
<TR><TD>Type of debris (yard debris, fencing, stove,
sofa, etc.):<BR>
</TD><TD><INPUT NAME="type of debris" TYPE="text" SIZE="30"></TD></TR> 
<TR><TD>Where
will this pile/item be sitting? <BR>
</TD><TD><TEXTAREA NAME="location of pile/item" ROWS="3" COLS="40"
></TEXTAREA></TD></TR> <BR>
<TR><TD>Special instructions:<BR>
</TD><TD><TEXTAREA NAME="special instructions" ROWS="4" COLS="39"
></TEXTAREA></TD></TR><TR><TD colspan="2">Your pick up will occur within
2 working days. Metal appliances are picked up on Thursdays.<BR>
</TD></TR> </TABLE> <BR>
<INPUT NAME="submit" TYPE="submit" VALUE="Submit a request for pickup"><INPUT
NAME="name" TYPE="reset" VALUE="Clear Form"><BR>
<BR>
<A HREF="#top">Back to the top of this form.</A><BR>
<P><CENTER><A HREF="../index.html">HOME</A> | <A HREF="recycle.html">RECYCLING</A>
| <A HREF="compost.html">COMPOSTING</A> | <A HREF="waste.html">SERVICES</A>
| <A HREF="form.html">ASK US</A> | <A HREF="request.html">REQUEST SERVICES</A></CENTER>
</FORM>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-72</DOCNO>
<DOCOLDNO>IA021-000230-B030-26</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/com_form.html 198.68.7.46 19970107213347 text/html 6093
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:33:46 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 5922
Last-modified: Tue, 25 Jun 1996 17:18:00 GMT
</DOCHDR>
<HTML>
<HEAD>
    <TITLE>Commercial/Industrial Service Request Form</TITLE>
</HEAD>
<BODY BGCOLOR="#f7fbfd">
<FORM ACTION="/cgi-bin/formmail?info@corvallis.disposal.com" ENCTYPE="x-www-form-encoded"
METHOD="POST">
<P><CENTER><A NAME="top"></A><IMG SRC="../frames/images/reqestnv.gif" BORDER=
"0" WIDTH="200" HEIGHT="350" ALIGN="LEFT" HSPACE=15 VSPACE=10 NATURALSIZEFLAG=
"0"></CENTER>
<H1><CENTER>Commercial Service Request Form</CENTER>
</H1>
<H4>If you wish to start commercial service at your business, please contact
Corvallis Disposal by telephone at 754-0444, Monday thru Friday, 8 am to
5 pm.</H4>
<BR>
<BR>
You can now request services from Corvallis Disposal on line. <BR>
Services are arranged in two categories: 
<DIR>
  <LI>Delivery Services - get a cart, dumpster, or other container for use.<BR>
<BR>
  <LI>Pickup Services - have a container or other item emptied or taken away. 
</DIR><BR><BR><BR>
<CENTER><A HREF="../index.html">HOME</A> 
| <A HREF="recycle.html">RECYCLING</A> 
| <A HREF="compost.html">COMPOSTING</A> 
| <A HREF="waste.html">SERVICES</A> 
| <A HREF="areainfo.html">COMMUNITY INFORMATION</A></CENTER>
<BR CLEAR=LEFT>
<H2>1. All requests require your name, address, and phone number.</H2>
<TABLE border="0"> <TR><TD>Name:<BR>
</TD><TD><INPUT NAME="name" TYPE="text" SIZE="30"></TD></TR> 
<TR><TD>Business Name:<BR>
</TD><TD><INPUT NAME="business" TYPE="text" SIZE="30"></TD></TR> 
<TR><TD>Service Address:<BR>
</TD><TD><INPUT NAME="service address" TYPE="text" SIZE="30"></TD></TR>
<TR><TD>City:<BR>
</TD><TD><INPUT NAME="city" TYPE="text" SIZE="30"></TD></TR> 
<TR><TD>Phone Number:<BR>
</TD><TD><INPUT NAME="phone" TYPE="text" SIZE="30"></TD></TR>
<TR><TD>e-mail (optional):<BR>
</TD><TD><INPUT NAME="email" TYPE="text" SIZE="30"></TD></TR> </TABLE> 
<H2>2. Please select one type of service:</H2>
<H4><A HREF="#deliver">Delivery</A> - get a cart, dumpster, or other container from
Corvallis Disposal<BR>
<BR>
<A HREF="#pickup">Pickup</A> - have a container emptied or taken away</H4>
<H2><HR></H2>
<H1><CENTER><A NAME="deliver"></A>Delivery Services</CENTER>
</H1>
<H2>I need:</H2>
<BR>
1 <INPUT TYPE="checkbox" NAME="checkbox" VALUE="1 red recycling bin requested">
2 <INPUT TYPE="checkbox" NAME="checkbox" VALUE="2 red recycling bins requested">
Red recycling bin(s) delivered to my business<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="office paper recycling setup requested">
Office paper recycling setup delivered to my business<BR>
Other: <INPUT NAME="other delivery requested" TYPE="text" SIZE="30">
<BR>
Temporary dumpsters: <BR>
<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="request for a 1.5 yard dumpster">1.5
cu. yard dumpster (small blue container, 6 ft. long, 4 ft tall, 3 ft wide)
$3.90/ week min. rental + $19.75 per empty. The container will be delivered
within 2 working days, unless in a rural area.<BR>
<BR>
<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="request for a 30 yard dumpster">30
cu. yard dumpster (22 feet long, 6 ft tall, 8 ft wide) $120 each time it
is hauled to the landfill, ($145 outside city limits), $20 per ton, $8 per day rental charge (5 days
no rental charge, no rent charged on weekends). <BR>
This container will be delivered within 2 working days. If you would like
it delivered at a later date, please specify in the special instructions:<BR>
<BR>
<TABLE border="0"> <TR><TD>Your billing address:</TD><TD><INPUT NAME="name"
TYPE="text" SIZE="30"></TD></TR><BR>
<TR><TD>Where shall we set this container?<BR>(in a driveway, etc.)</TD><TD><TEXTAREA NAME="name"
ROWS="6" COLS="32"
></TEXTAREA></TD></TR><BR>
<TR><TD>Special Instructions:</TD><TD><TEXTAREA NAME="name" ROWS="7" COLS=
"27"
></TEXTAREA></TD></TR></TABLE><BR>
<BR>
<BR>
<INPUT NAME="submit" TYPE="submit" VALUE="Submit a request for delivery">
<INPUT NAME="name" TYPE="reset" VALUE="Clear Form"><BR>
<BR>
<A HREF="#top">Back to the top of this form.</A> 
<H2><HR></H2>
<H1><CENTER><A NAME="pickup"></A>Pickup Services</CENTER>
</H1>
<H2>I need:</H2>
<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="request office paper picked up">Office
paper picked up<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="composter requested">Dumpster
emptied at my business. <BR>
Special instructions:<TEXTAREA NAME="special instructions" ROWS="4" COLS=
"42"
></TEXTAREA><BR>
<BR>
<INPUT NAME="submit" TYPE="submit" VALUE="Submit a request for pickup"><INPUT
NAME="name" TYPE="reset" VALUE="Clear Form"><BR>
<BR>
<A HREF="#top">Back to the top of this form.</A> 
<H2><HR></H2>
<H1><CENTER>Special Pickup Service Request</CENTER>
</H1>
<H4><INPUT TYPE="checkbox" NAME="checkbox" VALUE="pickup of pile of debris or large item">
Special Pickup of a pile of debris or a large item (sofa, mattress, etc.).<BR>
<INPUT TYPE="checkbox" NAME="checkbox" VALUE="pickup of large metal appliance">
I have a large metal appliance (such as a stove, refrigerator, etc.) </H4>
<TABLE border="0"> <TR><TD>Type of debris (yard debris, fencing, stove,
sofa, etc.):<BR>
</TD><TD><INPUT NAME="type of debris" TYPE="text" SIZE="30"></TD></TR> <TR><TD>Where
will this pile/item be sitting? <BR>
</TD><TD><TEXTAREA NAME="location of pile/item" ROWS="3" COLS="40"
></TEXTAREA></TD></TR><BR>
<TR><TD>Special instructions:<BR>
</TD><TD><TEXTAREA NAME="special instructions" ROWS="4" COLS="39"
></TEXTAREA></TD></TR><TR><TD colspan="2">Your pickup will occur within
2 working days. Metal appliances are picked up on Thursdays.<BR>
</TD></TR></TABLE> <BR>
<INPUT NAME="submit" TYPE="submit" VALUE="Submit a request for pickup"><INPUT
NAME="name" TYPE="reset" VALUE="Clear Form"><BR>
<BR>
<A HREF="#top">Back to the top of this form.</A><BR>
<P><CENTER><A HREF="../index.html">HOME</A> | <A HREF="recycle.html">RECYCLING</A>
| <A HREF="compost.html">COMPOSTING</A> | <A HREF="waste.html">SERVICES</A>
| <A HREF="form.html">ASK US</A> | <A HREF="request.html">REQUEST SERVICES</A></CENTER>
</FORM>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-73</DOCNO>
<DOCOLDNO>IA021-000230-B029-420</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/newsletr.html 198.68.7.46 19970107213326 text/html 12342
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:33:28 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 12170
Last-modified: Fri, 06 Dec 1996 21:43:23 GMT
</DOCHDR>
<HTML>
<HEAD>
   <TITLE>Corvallis Disposal's newsletter and links to our
   community</TITLE>
</HEAD>
<BODY BGCOLOR="#EFEFD9">

<P><TABLE BORDER=0 CELLPADDING=1 WIDTH="100%">
   <TR>
      <TD VALIGN=top>
         <P><MAP NAME="comm_map"><AREA SHAPE=rect COORDS="51,277 151,294" HREF="newsletr.html" ><AREA SHAPE=rect COORDS="17,297 86,312" HREF="areainfo.html#util" ><AREA SHAPE=rect COORDS="17,318 107,334" HREF="areainfo.html#gov" ><AREA SHAPE=rect COORDS="109,297 176,312" HREF="areainfo.html#schools" ><AREA SHAPE=rect COORDS="109,318 183,334" HREF="areainfo.html#calen" ></MAP><A HREF="http://www.corvallis.disposal.com/no_frame/areainfo.html"><IMG ISMAP
         SRC="../frames/images/communav.gif" WIDTH=200 HEIGHT=350
         BORDER=0 ALIGN=bottom usemap=#comm_map></A>
      </TD><TD cellpadding=5>
         <P ALIGN=CENTER><IMG SRC="../frames/images/recycit2.gif"
         WIDTH=200 HEIGHT=137 ALIGN=bottom hspace=15>
      </TD></TR>
</TABLE></P>

<P><BODY BGCOLOR="#f6faf6"></P>

<H1 ALIGN=CENTER><FONT COLOR="#AF0000">Corvallis Disposal
Perspectives - Fall 1996</FONT></H1>

<P ALIGN=CENTER><FONT COLOR="#AF0000">In this issue:<BR>

</FONT><FONT COLOR="#AF0000"><A HREF="#collect">Leaf
Collection</A></FONT><FONT COLOR="#AF0000"> |
</FONT><FONT COLOR="#AF0000"><A HREF="#tips">Leaf Collection
Tips</A></FONT><FONT COLOR="#AF0000"> |
</FONT><FONT COLOR="#AF0000"><A HREF="#load">Get a Load of
Leaves</A></FONT><FONT COLOR="#AF0000"> |
</FONT><FONT COLOR="#AF0000"><A HREF="#sched">Holiday
Schedule</A></FONT><FONT COLOR="#AF0000"> |
</FONT><FONT COLOR="#AF0000"><A HREF="#compost">Leaf
Compost</A></FONT><FONT COLOR="#AF0000"><BR>

</FONT><FONT COLOR="#AF0000"><A HREF="backnews.html">Back issues of
Recycle It!</A></FONT></P>

<P><FONT SIZE=5 COLOR="#AF0000"><A NAME="collect"></A>Leaf Collection
on City Streets</FONT></P>

<P>Corvallis Disposal's annual leaf collection program has begun, and
will continue through January 3.</P>

<P><B>Corvallis:</B> During this time, residents within the city
limits of Corvallis can place their leaves in curbed streets for
pick-up each week on garbage collection day.</P>

<P>In order to prevent blockage of bike lanes, we plan to collect
leaves every week-day from those streets in the central part of the
city that have major bike paths. Please try to avoid putting your
leaves directly in the bike lanes.</P>

<P><B>Philomath:</B> In Philomath, leaves will be collected from all
streets within the city limits on one day only - Thursday, December
5. Please have your leaves in the street by 7:00 in the morning.</P>

<P><B>Tangent &amp; Adair Village:</B> For those of you who live in
Tangent or Adair Village, remember to use your yard-debris cart or
composter for leaf disposal. This service is provided free with your
weekly garbage service. Please give us a call if you don't have one
yet.</P>

<P><B>Other Areas:</B> Many of you who live outside of the above
areas will likely use your leaves for mulching, composting or
burning. If you want to though, you can take them to the Processing
and Recovery Center. They charge two dollars per cubic yard of leaves
that you drop off.</P>

<P>Please give them a call at 745-2018 if you have any questions.
<FONT COLOR="#AF0000"><A HREF="#top">TOP</A></FONT></P>

<P>&nbsp;</P>

<P><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=5 WIDTH="100%">
   <TR>
      <TD>
         <P ALIGN=CENTER><IMG SRC="../frames/images/leaves1.jpg"
         WIDTH=200 HEIGHT=140 ALIGN=bottom>
      </TD><TD>
         <P ALIGN=CENTER><IMG SRC="../frames/images/leaves2.jpg"
         WIDTH=200 HEIGHT=141 ALIGN=bottom>
      </TD></TR>
   <TR>
      <TH>
         <P ALIGN=LEFT>Leaf piles that are placed in the street are
         scooped up by Corvallis Disposal's tractor...
      </TH><TH>
         <P ALIGN=LEFT>...then dropped into a truck, to be taken to
         the recycling center.
      </TH></TR>
</TABLE></P>

<P>&nbsp;</P>

<P ALIGN=CENTER><TABLE BORDER=0 CELLPADDING=1 WIDTH="60%">
   <TR>
      <TD>
         <P ALIGN=CENTER><B><FONT SIZE=4 COLOR="#AF0000"><A NAME="tips"></A>Tips
         to Make Sure your Leaves are Collected</FONT></B>
      </TD></TR>
   <TR>
      <TD>
         <UL>
            <LI><FONT SIZE=4>Place leaves in the gutter at least 14
            inches from the curb (this allows drainage along your
            street, and gives the equipment enough room to collect
            all the leaves).</FONT>
            
            <LI><FONT SIZE=4>Place you leaves in a spot that will not
            be blocked by parked vehicles (10 ft. from the nearest
            vehicle).</FONT>
            
            <LI><FONT SIZE=4>Leaves only please - branches and other
            yard debris cannot go into this pile.</FONT>
            
            <LI><FONT SIZE=4>Please have your leaves in the street by
            7:00 a.m. on your garbage day.
            </FONT><FONT COLOR="#AF0000"><A HREF="#top">TOP</A></FONT>
         
         </UL>
      </TD></TR>
</TABLE></P>

<P><FONT SIZE=5 COLOR="#AF0000"><A NAME="load"></A>Get a Load of
Leaves </FONT></P>

<P><FONT SIZE=4>If you would like to have a truck-load of leaves
delivered to your home or business, simply call our office with your
name and address. There is no charge.</FONT></P>

<P><B><FONT SIZE=4>Please remember:</FONT></B></P>

<UL>
   <LI><FONT SIZE=4>We deliver full loads of leaves only (enough to
   fill a single-car garage) and cannot guarantee the types of leaves
   you will receive.</FONT>
   
   <LI><FONT SIZE=4>The leaves come off the ground and out of yards,
   so there may be some yard-type debris mixed in.</FONT>
   
   <LI><FONT SIZE=4>We try to deliver in the most efficient manner
   possible, so it may be several days before your leaves are
   delivered.
   </FONT><FONT COLOR="#AF0000"><A HREF="#top">TOP</A></FONT>
</UL>

<P>&nbsp;</P>

<P><TABLE BORDER=1 CELLPADDING=5 WIDTH="100%">
   <TR>
      <TD COLSPAN=3>
         <P ALIGN=CENTER><B><FONT SIZE=5 COLOR="#AF0000"><A NAME="sched"></A>Holiday
         Schedule</FONT></B></P>
         
         <P>If your regular garbage pick-up day is on Wednesday,
         Thursday or Friday, you will be affected by this year's
         Holiday Schedule. Our drivers take off only three holidays
         per year: Thanksgiving, Christmas and New Years Day. We will
         be working on Saturdays during these weeks to get those of
         you who are usually serviced on Friday.
      </TD></TR>
   <TR>
      <TH VALIGN=bottom>
         <P><FONT COLOR="#AF0000">For the Week of </FONT>
      </TH><TH VALIGN=bottom>
         <P><FONT COLOR="#AF0000">If your regular pick-up day
         is...</FONT>
      </TH><TH VALIGN=bottom>
         <P><FONT COLOR="#AF0000">This week it will be picked up
         on...</FONT>
      </TH></TR>
   <TR>
      <TD ROWSPAN=3>
         <P><B><FONT SIZE=4>Thanksgiving</FONT></B></P>
         
         <P><B><FONT SIZE=4>Nov. 28th</FONT></B>
      </TD><TD>
         <P ALIGN=CENTER>Monday/Tuesday/Wednesday (Nov. 25-27)
      </TD><TD>
         <P ALIGN=CENTER>Regular Schedule
      </TD></TR>
   <TR><TD>
         <P ALIGN=CENTER>Thursday (Nov. 28)
      </TD><TD>
         <P ALIGN=CENTER>Friday (Nov. 29)
      </TD></TR>
   <TR><TD>
         <P ALIGN=CENTER>Friday (Nov. 29)
      </TD><TD>
         <P ALIGN=CENTER>Saturday (Nov. 30)
      </TD></TR>
   <TR>
      <TD ROWSPAN=4>
         <P><B><FONT SIZE=4>Christmas</FONT></B></P>
         
         <P><B><FONT SIZE=4>Dec. 25th</FONT></B>
      </TD><TD>
         <P ALIGN=CENTER>Monday / Tuesday (Dec. 23 &amp; 24)
      </TD><TD>
         <P ALIGN=CENTER>Regular Schedule
      </TD></TR>
   <TR><TD>
         <P ALIGN=CENTER>Wednesday (Dec. 25)
      </TD><TD>
         <P ALIGN=CENTER>Thursday (Dec. 26)
      </TD></TR>
   <TR><TD>
         <P ALIGN=CENTER>Thursday (Dec. 26)
      </TD><TD>
         <P ALIGN=CENTER>Friday (Dec. 27)
      </TD></TR>
   <TR><TD>
         <P ALIGN=CENTER>Friday (Dec. 27)
      </TD><TD>
         <P ALIGN=CENTER>Saturday (Dec. 28)
      </TD></TR>
   <TR>
      <TD ROWSPAN=4>
         <P><B><FONT SIZE=4>New Years Day</FONT></B></P>
         
         <P><B><FONT SIZE=4>Jan. 1st</FONT></B>
      </TD><TD>
         <P ALIGN=CENTER>Monday / Tuesday (Dec. 30 &amp; 31)
      </TD><TD>
         <P ALIGN=CENTER>Regular Schedule
      </TD></TR>
   <TR><TD>
         <P ALIGN=CENTER>Wednesday (Jan. 1)
      </TD><TD>
         <P ALIGN=CENTER>Thursday (Jan. 2)
      </TD></TR>
   <TR><TD>
         <P ALIGN=CENTER>Thursday (Jan. 2)
      </TD><TD>
         <P ALIGN=CENTER>Friday (Jan 3)
      </TD></TR>
   <TR><TD>
         <P ALIGN=CENTER>Friday (Jan 3)
      </TD><TD>
         <P ALIGN=CENTER>Saturday (Jan 4)
      </TD></TR>
</TABLE></P>

<P><FONT COLOR="#AF0000"><A HREF="#top">TOP</A></FONT><FONT COLOR="#AF0000">
</FONT></P>

<P><FONT SIZE=5 COLOR="#AF0000">&nbsp;</FONT></P>

<P><FONT SIZE=5 COLOR="#AF0000"><A NAME="compost"></A>Your Leaves
Help Make Compost</FONT></P>

<P>The leaves and yard debris collected by Corvallis Disposal are
eventually returned to area gardens as nutrient-rich compost.</P>

<P>CDC drivers deliver truck loads of leaves and yard debris to the
Processing and Recovery Center (PRC) located off Highway 99 about ten
miles north of Corvallis.</P>

<P>Here, the leaves are stacked in piles and left untouched for about
four months. The mixed yard debris is spread out in long rows, then
covered with tarps to reduce leaching of nutrients by rainwater.</P>

<P>Next spring, the leaves from this fall will be mixed together with
fresh yard debris and run through a shredder. The mixed ratio is 20%
leaves to 80% green yard debris.</P>

<P>This shredded mixture is put in piles and turned twice weekly.
After about 100 days - with the help of nature's decomposers
(bacteria, fungi, insects, etc.) - the pile turns into a rich
compost.</P>

<P>It is high in carbon which provides energy for organisms, and in
nitrogen which is necessary for cell development. Compost also helps
loosen clay soils, aides in moisture retention, and generally
provides a healthy growing environment for plants.</P>

<P>The PRC's compost can be purchased for $8 per cubic yard.
(745-2018) <FONT COLOR="#AF0000"><A HREF="#top">TOP</A></FONT></P>

<P ALIGN=CENTER><HR WIDTH="10%"></P>

<P ALIGN=CENTER><B><FONT COLOR="#006D00">Corvallis Disposal expects
to recycle 600 cubic yards of Christmas trees this year. </FONT></B>
</P>

<P ALIGN=CENTER><B><FONT COLOR="#006D00">That's about 200 pickup
truck loads.</FONT></B></P>

<P><HR WIDTH="10%"><B><FONT SIZE=5 COLOR="#AF0000">Holiday
Recycling</FONT></B></P>

<P>Wrapping paper &amp; cards can be recycled with your paperboard
&amp; household mail mix <B>(NO foil, plastic or tissue paper
please).</B></P>

<P>Christmas trees will be picked up on your garbage day from
December 30 through January 10. If your tree is clean of all
flocking, tinsel, etc. and you put it at the curb, we will recycle
it. Otherwise, we will throw it away as garbage free of charge.</P>

<P ALIGN=CENTER><FONT COLOR="#AF0000"><A HREF="#collect">Leaf
Collection</A></FONT><FONT COLOR="#AF0000"> |
</FONT><FONT COLOR="#AF0000"><A HREF="#tips">Leaf Collection
Tips</A></FONT><FONT COLOR="#AF0000"> |
</FONT><FONT COLOR="#AF0000"><A HREF="#load">Get a Load of
Leaves</A></FONT><FONT COLOR="#AF0000"> |
</FONT><FONT COLOR="#AF0000"><A HREF="#sched">Holiday
Schedule</A></FONT><FONT COLOR="#AF0000"> |
</FONT><FONT COLOR="#AF0000"><A HREF="#compost">Leaf
Compost</A></FONT><FONT COLOR="#AF0000"><BR>

</FONT><FONT COLOR="#AF0000"><A HREF="backnews.html">Back issues of
Recycle It!</A></FONT></P>

<P ALIGN=CENTER><HR WIDTH="10%"></P>

<P>Editor: Renee Harber<BR>

Contributing Writers: Jeff Andrews, Carol Dion, Bronwyn Evans, Pam
Wald<BR>

<BR>

<HR WIDTH="10%"></P>

<P>RECYCLE IT! is published on a quarterly, or as-needed basis, by
Corvallis Disposal &amp; Recycling Company.</P>

<P ALIGN=CENTER><A HREF="../index.html">HOME</A> |
<A HREF="recycle.html">RECYCLING</A> |
<A HREF="compost.html">COMPOSTING</A> |
<A HREF="waste.html">SERVICES</A> | <A HREF="form.html">ASK US</A> |
<A HREF="request.html">REQUEST SERVICES</A></P>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-74</DOCNO>
<DOCOLDNO>IA021-000230-B030-49</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/backnews.html 198.68.7.46 19970107213358 text/html 1735
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:33:59 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1564
Last-modified: Tue, 03 Dec 1996 20:30:29 GMT
</DOCHDR>
<HTML>
<HEAD>
   <TITLE>Corvallis Disposal's newsletter and links to our
   community</TITLE>
</HEAD>
<BODY BGCOLOR="#EFEFD9">

<P><TABLE BORDER=0 CELLPADDING=1 WIDTH="100%">
   <TR>
      <TD VALIGN=top>
         <P><MAP NAME="comm_map"><AREA SHAPE=rect COORDS="51,277 151,294" HREF="newsletr.html" ><AREA SHAPE=rect COORDS="17,297 86,312" HREF="areainfo.html#util" ><AREA SHAPE=rect COORDS="17,318 107,334" HREF="areainfo.html#gov" ><AREA SHAPE=rect COORDS="109,297 176,312" HREF="areainfo.html#schools" ><AREA SHAPE=rect COORDS="109,318 183,334" HREF="areainfo.html#calen" ></MAP><A HREF="http://www.corvallis.disposal.com/no_frame/areainfo.html"><IMG ISMAP
         SRC="../frames/images/communav.gif" WIDTH=200 HEIGHT=350
         BORDER=0 ALIGN=bottom usemap=#comm_map></A>
      </TD><TD cellpadding=5>
         <P ALIGN=CENTER><IMG SRC="../frames/images/recycit2.gif"
         WIDTH=200 HEIGHT=137 ALIGN=bottom hspace=15>
      </TD></TR>
</TABLE></P>

<P><BODY BGCOLOR="#f6faf6"></P>

<H1 ALIGN=CENTER><FONT COLOR="#AF0000">Corvallis Disposal
Perspectives - Index</FONT></H1>

<P ALIGN=CENTER><B><FONT SIZE=5><A HREF="news96sm.html">Summer
1996</A></FONT><FONT SIZE=5>    
</FONT><FONT SIZE=5><A HREF="newsletr.html">Current
Issue</A></FONT></B></P>

<BLOCKQUOTE><P>&nbsp;</P></BLOCKQUOTE>

<P ALIGN=CENTER><A HREF="../index.html">HOME</A> |
<A HREF="recycle.html">RECYCLING</A> |
<A HREF="compost.html">COMPOSTING</A> |
<A HREF="waste.html">SERVICES</A> | <A HREF="form.html">ASK US</A> |
<A HREF="request.html">REQUEST SERVICES</A></P>
</BODY>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-75</DOCNO>
<DOCOLDNO>IA021-000230-B030-74</DOCOLDNO>
<DOCHDR>
http://www.corvallis.disposal.com:80/no_frame/news96sm.html 198.68.7.46 19970107213408 text/html 8521
HTTP/1.0 200 OK
Date: Tue, 07 Jan 1997 21:34:10 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 8350
Last-modified: Tue, 03 Dec 1996 20:25:01 GMT
</DOCHDR>
<HTML>
<HEAD>
   <TITLE>Corvallis Disposal's newsletter and links to our
   community</TITLE>
   <X-SAS-WINDOW TOP=40 BOTTOM=619 LEFT=161 RIGHT=691>
</HEAD>
<BODY BGCOLOR="#EFEFD9">

<P><TABLE BORDER=0 CELLPADDING=1 WIDTH="100%">
   <TR>
      <TD VALIGN=top>
         <P><MAP NAME="comm_map"><AREA SHAPE=rect COORDS="51,277 151,294" HREF="newsletr.html" ><AREA SHAPE=rect COORDS="17,297 86,312" HREF="areainfo.html#util" ><AREA SHAPE=rect COORDS="17,318 107,334" HREF="areainfo.html#gov" ><AREA SHAPE=rect COORDS="109,297 176,312" HREF="areainfo.html#schools" ><AREA SHAPE=rect COORDS="109,318 183,334" HREF="areainfo.html#calen" ></MAP><A HREF="http://www.corvallis.disposal.com/no_frame/areainfo.html"><IMG ISMAP
         SRC="../frames/images/communav.gif" WIDTH=200 HEIGHT=350
         BORDER=0 ALIGN=bottom usemap=#comm_map></A>
      </TD><TD cellpadding=5>
         <P ALIGN=CENTER><IMG SRC="../frames/images/recycit2.gif"
         WIDTH=200 HEIGHT=137 ALIGN=bottom hspace=15>
      </TD></TR>
</TABLE></P>

<P><BODY BGCOLOR="#f6faf6">
<H1><FONT COLOR="#AF0000">Corvallis Disposal Perspectives</FONT></H1></P><br>

<H2>History of Recycling in Benton County</H2>

<P><IMG SRC="../frames/images/chart2.gif" WIDTH=360 HEIGHT=229
 ALIGN=right>You may not have
realized it, but May marked an important anniversary for Corvallis
and Benton County. Sixteen years ago, Corvallis and Philomath
residents demonstrated their commitment to reduce the amount of
garbage going to the landfill by participating in the state's first
curbside recycling program.</P>

<P>Since that time, Tangent and Monroe residents have also joined the
ranks of curbside recyclers. Whether recycling at curbside or
bringing materials to a recycling center, residents throughout the
county have sorted their recyclables with such vigor that Benton
County continues to have one of the highest recovery rates in the
state (35%) - second only to Portland (39%).</P>

<P><FONT SIZE=5 COLOR="#AF0000">How We Got Here </FONT></P>

<P>In January 1990, Corvallis Disposal distributed more than 10,000
red recycling bins. By the end of the year, 40% more people were
recycling, and the amount of recyclables collected was almost twice
that of the previous year. This huge increase in recycling resulted
in a 10% decrease in the amount of garbage dumped into the landfill.
</P>

<P>Each time a new item is added to the list of recyclables, a
greater amount of waste is recovered for recycling.</P>

<P>The large increase in 1993 (see graph) is due to the addition of
mixed paper and yard debris recycling. These two items make up the
majority of household waste, and therefore, offer great potential for
recycling.</P>

<P><TABLE BORDER=1 CELLPADDING=1 WIDTH="100%">
   <TR>
      <TD COLSPAN=2>
         <H2 ALIGN=CENTER><FONT COLOR="#AF0000">Curbside Recycling
         Program </FONT></H2>
      </TD></TR>
   <TR>
      <TD>
         <P><B>May 1980</B></P>
         
         <P>&nbsp;
      </TD><TD>
         <P>Curbside recycling began in Corvallis &amp; Philomath
         (glass, tin, cardboard, newspaper, motor oil and aluminum)
      </TD></TR>
   <TR>
      <TD>
         <P><B>January 1990</B>
      </TD><TD>
         <P>Plastics (#1 and 2) recycling began
      </TD></TR>
   <TR>
      <TD>
         <P><B>October 1990</B>
      </TD><TD>
         <P>Magazine recycling began
      </TD></TR>
   <TR>
      <TD>
         <P><B>February 1993</B>
      </TD><TD>
         <P>Mixed paper added to curbside recycling
      </TD></TR>
   <TR>
      <TD>
         <P><B>April 1993</B>
      </TD><TD>
         <P>Yard debris recycling and composting
      </TD></TR>
   <TR>
      <TD>
         <P><B>February 1995</B>
      </TD><TD>
         <P>Mixed plastics (all bottles or tubs)
      </TD></TR>
</TABLE></P>

<P><FONT SIZE=5 COLOR="#AF0000">Where We're Going</FONT></P>

<P>In 1991, the Oregon Legislature established waste recovery goals
for each county. Benton County's goal was to recycle 30% of its waste
by 1995. We reached this mark in 1993-two years early.</P>

<P>We are now aiming for the statewide goal of recycling half of our
garbage by the year 2000. To reach this goal, we need to continue
adding to the list of acceptable items, but, more importantly, we
need to make recycling easier to do. Corvallis Disposal staff are
evaluating a number of different collection systems that might make
it easier for all to recycle a larger percentage of their waste.</P>

<P>We are also working with businesses to enhance their recycling
programs. In his new role as business resource person, Clint Hilton
will help businesses reach their optimal level of garbage and
recycling service. Pam Wald continues to coordinate the recycling
education program for schools and community groups.</P>

<P>If you have any comments or questions on recycling, you can either
send us a note, call our office, or E-mail us at
mail@disposal.com<HR></P>

<H2><FONT SIZE=6>The Plastic Loop </FONT></H2>

<P>After your recyclable plastic bottles and tubs are picked up at
the curb, they are taken to Source Recycling in Albany.</P>

<P>Source Recycling bales an average of 60,000 pounds of used plastic
containers every month. Once baled, the plastics are sent to the
Garten Foundation in Salem, where they're sorted via a high-tech
computerized system. It quickly and effectively sorts plastic bottles
and tubs according to resin type and color.</P>

<P>However, because of the system's design, lids and containers
smaller than six ounces will simply fall through the cracks_and
plastic bags will clog up the sorter's gears. Also, bags, styrofoam
and clam shell containers are made of a type of plastic that our
markets are not currently interested in buying. For these reasons, we
are not taking lids, bags, clam shells, styrofoam and very small
containers.</P>

<P>Manufacturers purchase the sorted, used plastics to make recycled
products, such as non-food containers, plastic lumber and clothing.
</P>

<H2><HR>It's OK to Mix Your Plastics</H2>

<UL>
   <LI>Bottle-shaped containers larger than six ounces (please remove
   the lids)
   
   <LI>Round food tubs up to two gallons (please remove the lids)
   
   <LI>NO motor-oil and pesticide containers, for health and safety
   reasons
</UL>

<H2><HR><IMG SRC="../frames/images/cdccart.jpg" WIDTH=180 HEIGHT=226
 ALIGN=left>Automated Cart
Update</H2>

<P>Many Corvallis and Philomath residents have made the switch to
using a new automated garbage cart instead of a can. If you would
like to join them, please give us a call.</P>

<P ALIGN=CENTER>~~~~~~~~~~~~~~~~~</P>

<UL>
   <LI>Two Sizes Available: 35 or 90 gallon.
   
   <LI>35 gallon cart costs the same as one-can service; 90 gallon
   cart is $17.20 per month.
   
   <LI>Carts must be at the street by 7:00 a.m. on your garbage day.
   
   <LI>This service is currently offered on most Corvallis and
   Philomath streets, and will be introduced into many suburban areas
   over the next six months.
</UL>
<br clear=all>

<H2><HR></H2>

<H2>Yard Debris Recycling</H2>

<P>&nbsp;</P>

<P>If you are a busy gardener this summer, one yard debris cart may
not seem like enough to hold all the lawn clippings and shrub
trimmings that your yard is producing.</P>

<P>While we can not lessen your work load, a second yard cart may
solve your disposal problem. The cost is $4 per month.</P>

<P>And, be sure to let us know if you would like another yard-debris
calendar to help you keep track of your pick-up days.</P>

<P><HR></P>
<center>
<P ALIGN=CENTER>The total amount of yard debris collected by
Corvallis Disposal since 1993 is enough to cover 17 football fields
three feet deep.</P>

<P ALIGN=CENTER><HR>Would your group or school like to arrange a
visit from our recycling coordinator?</P>

<P ALIGN=CENTER>Call Pam at 754-0445 ext. 204</P>
</center>
<P>&nbsp;</P>

<P><HR>Editor-in-Chief: Renee Harber<BR>

Contributing Writers: Jeff Andrews, Carol Dion, Bronwyn Evans, Pam
Wald<BR>

<BR>

<HR>RECYCLE IT! is published on a quarterly, or as-needed basis, by
Corvallis Disposal &amp; Recycling Company.</P>

<P ALIGN=CENTER><A HREF="../index.html">HOME</A> |
<A HREF="recycle.html">RECYCLING</A> |
<A HREF="compost.html">COMPOSTING</A> |
<A HREF="waste.html">SERVICES</A> | <A HREF="form.html">ASK US</A> |
<A HREF="request.html">REQUEST SERVICES</A></P>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-76</DOCNO>
<DOCOLDNO>IA097-001038-B024-322</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/index.html 206.119.148.29 19970215060554 text/html 7136
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:22:02 GMT
Last-modified: Wednesday, 24-Jul-96 19:09:32 GMT
Content-length: 6949
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Services Home Page</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR> Learn about the Medical Search Service offered by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>







<H1 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=369 HEIGHT=129 

ALT="Schine On Line Services" 

SRC="logo.gif">

</H1>



<H2 ALIGN=CENTER>Is the Second Best Treatment<BR>Good Enough for You?</H2>



<HR>



<H2 ALIGN=CENTER>

	<A NAME="If the President Had Cancer...">

		<A HREF="garybook.html">

<I>If the President Had Cancer...</I>

		</A>

	</A>

</H2>



<H4 ALIGN=CENTER>by <A NAME="Gary Schine">

		<A HREF="gstory.html">

Gary Schine</H4></A></A>







<H4>If the president were diagnosed with cancer...</H4>



<P><DD>...Doctors and researchers would search for the latest information available on treatments that could save him.  Top experts would be summoned to the White House.  The president would be treated with the best and latest available.  He would be given the best opportunity to defeat that cancer, to survive, and to return to good health.

</P>



<P>For the rest of us it's chancy.  You may get the best available or you may not.  While teams of physicians and researchers would search the literature to make sure a president or a senator got the best there is, the same would not be done for you or for me.  Most of us assume that our doctor is up-to-date on the latest treatments.  However, the facts are that this assumption is as naive as it is comfortable.</P>



<P><STRONG>There is a very real chance that a potentially lifesaving treatment exists that your doctor does not know about.  You simply don't know unless you have the latest information on your illness.</STRONG></P>



<HR WIDTH=100%>



<H3 ALIGN=CENTER>Computers:  Pipeline to Better 

Treatment</H3>



<P>Not too many years ago, searching for medical developments required a major medical library, volumes of heavy directories, and weeks of time.</P>



<P><STRONG>Today it is possible to search thousands of medical journals in minutes, using online medical databases.</STRONG></P>



<P><STRONG>Through database searching, anyone can learn about the latest developments in treatment for any illness </STRONG>--and <STRONG>you may learn about it months before your doctor does.</STRONG>  It is hardly an exaggeration to say your life may be saved by finding the latest information.

<P>The information contained in these databases is <A HREF="selfhelp.html">not accessible</A> from the World Wide Web; they are subscription-only, government databases which are far from user-friendly.  However, the researchers at Schine On-Line Services have been trained to navigate these databases in search of this potentially life-saving information.  Don't leave a stone unturned; let the professionals at Schine On-Line Services help you find all your treatment options!

</P></P>





<HR WIDTH=100%>



<H3 ALIGN=CENTER>

Is the Second Best Treatment<BR> Good Enough for You?

</H3>



<H4 ALIGN=CENTER>

<A HREF="overview.html">An Overview of Schine On-Line Services</A>

</H4>



<P>Schine On-Line Services, Inc., founded by cancer survivor <A HREF="gstory.html">Gary Schine</A>, author of <A HREF="garybook.html">Cancer Cure</A>, gathers information on any and all types of cancer or other illness directly for clients.  Our researchers have extensive on-line experience, training from the National Library of Medicine, and other medical database training.  We can search the databases for you and provide a report of the current developments in treatment and <A HREF="ctrials.html">clinical trials</A> of your particular illness.</P>



<HR WIDTH=100%>



<H3 ALIGN=CENTER>

"Can Information Cure Cancer?"

</H3>



<H4 ALIGN=CENTER>by <A HREF="gstory.html">Gary Schine</A></H4>



<P>I was 38 years old when I learned I had a rare form of leukemia.  The cancer would kill me, my oncologist warned, because there simply was no cure.  He tried to persuade me to take comfort in the fact that it would probably progress slowly; but all I could think about were my two small kids who I'd be leaving behind, and my wife who would have to bring them up alone.</P>



<P>Today, over five years later, I am cancer free.  I expect to stay that way, and the oncologists familiar with my condition expect the same.  I owe my cure to my own efforts in researching and finding the latest information on treating my illness --a newly developed treatment that my doctor knew nothing about.</P>





<HR WIDTH=100%>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>

	</TD>

</TR>

</TABLE>

</BODY>

</HTML>




</DOC>
<DOC>
<DOCNO>WT01-B18-77</DOCNO>
<DOCOLDNO>IA097-001038-B024-95</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/overview.html 206.119.148.29 19970215060418 text/html 10052
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:20:24 GMT
Last-modified: Wednesday, 24-Jul-96 19:09:52 GMT
Content-length: 9865
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Svces:  Overview</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>



<H1 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=369 HEIGHT=129 

ALT="Schine On Line Services" 

SRC="logo.gif">

</H1>



<H1 ALIGN=CENTER>An Overview of Services</H1>



<HR>



<P>Schine On-Line Services, Inc., founded by cancer survivor <A HREF="gstory.html">Gary Schine</A>, gathers information on any and all types of cancer or other illness directly for clients.  Our researchers have extensive on-line experience and training from the National Library of Medicine and from other medical database providers.  We can search the databases for you and provide a report of the current developments and <A HREF="ctrials.html">clinical trials</A> for your particular illness.

<P>
<A NAME="legit"><CENTER><B>Are We Legitimate?</B></CENTER></A>

<P>People with cancer are particularly vulnerable to con men, snake oil salesmen, and well-intentioned practitioners of dubious therapies.  You are well advised to carefully check out any offer of treatment help before spending your money, or wasting time and effort on a useless therapeutic dead-end.
<P>Schine On-line Service is a legitimate company offering a legitimate services to persons with serious illness.  By all means check us out-- you don't have to take out word for it.  We belong to the <B>Better Business Bureau</B>.  That means that we have agreed to abide by a stringent code of business ethics as set forth by the BBB.  It also means that you can easily get information on our legitimacy from the BBB by calling 401-785-1212.  You will find our record to be unblemished.

<P>You can also check us out by reading about us in the following publications:
<UL>
<LI><I>Family Circle</I> (April 25, 1995)
<LI><I>Business Week</I> (February 20, 1995)
<LI><I>Men's Fitness</I> (June, 1995)
<LI><I>American Health</I> (June, 1995)
<LI><I>Chicago Tribune</I> (June 6, 1995)
</UL>
<P>Of course, Gary Schine's book <A HREF="garybook.html">Cancer Cure</A> details the rationale behind empowering yourself with information.
<P>We run an information service for people with cancer or other serious illness.  We believe that those facing illness need comprehensive and current  information on their treatment possibilities in order to make informed treatment decisions-- decisions that can literally involve life vs. death.  We believe that in some cases, the  information we provide  can  and does save lives.  However, we candidly admit that the information we provide may not lead to any changes in treatment and may serve to confirm that you are already getting the best that is available.

<P>If you are looking for comprehensive and very current treatment information specific to your illness, please call us!  If you are looking for promises of miracles, we unfortunately can not deliver.

<P>We hope to hear from you.
</P>


<HR WIDTH=75%>



<A NAME="search"><H2 ALIGN=CENTER>Comprehensive Reports</H2></A>



<H3>Our comprehensive, computer-searched reports include:</H3>



<UL>

	<LI>a layperson overview of your illness (from PDQ)

	<LI>a technical overview of your illness (from PDQ physician section) 

	<LI>a listing of current clinical trials for your illness (from PDQ)

	<UL>

		<LI>details including names, addresses, and phone numbers for the person and organization leading each clinical trial listed

		<LI>names of all doctors and institutions in your region authorized to administer each clinical trial

		</UL>

	<LI>the latest treatment-related developments for your illness from  over 3,000 medical and scientific journals, from the USA and abroad (including the researcher's name and institution)

	<LI>the latest information on treatment and other resources from the National Organization for Rare Disorders (NORD) if available

	<LI>a list of medical libraries in your area for follow-up research.

</UL>



<P>A typical report for cancer is between 80 and 200 pages, and for non-cancer illnesses between 50 and 120 pages.  Compiling a report currently costs &#36;189.00.</P>





<H4 ALIGN=CENTER>Feel free to examine an abridged 

<A NAME="Sample Report">

	<A HREF="demorept.html">

Sample Report

	</A>

</A>

 compiled by Schine On-Line Services.

</H4>



<HR WIDTH=75%>



<H2 ALIGN=CENTER>Monthly Updating Service</H2>



<P>New developments in medicine are taking place all the time.  It is not an exaggeration to say that next month or the month after a new development that can save your life will be reported.  For this reason, Schine On-Line Services, Inc. also offers a monthly updating service.</P>



<P>At the beginning of each month, we check the latest month's entries to Cancerlit or Medline, and check on clinical trials added to PDQ.  All relevant findings and new clinical trial information is promptly mailed to every client subscribing to the updating service.</P>



<HR WIDTH=75%>



<H2 ALIGN=CENTER>Some Responses to Schine On-Line Services</H2>



<P ALIGN=CENTER><I>Thank you so very much for your wonderful service.<BR>

I am now on a new treatment that we found in your report.<BR>

Your report has been a lifesaver in both a literal and figurative sense.</I><BR>

-Karen Snellings, Chatsworth, CA</P>



<P ALIGN=CENTER><I>My doctor read your report and found a new treatment for me.<BR>

The information in your report changed my treatment and my life.</I><BR>

-Jeanne Theberge, New York, NY</P>



<P ALIGN=CENTER><I>You made a most significant difference<BR>

 in the lives of a great number of individuals with cancer.</I><BR>

-Judy Gerner, Anderson Support Network<BR>

M.D. Anderson Cancer Center, Houston</P>



<P ALIGN=CENTER><I>I was about to enter a clinical trial that my doctor was recommending.<BR>

Thanks to information in your report which had several negative and no positive reports of this treatment,<BR>

 I decided against this trial.  I'm so glad I contacted you.  Keep up the good work!</I><BR>

-Robert Ash, Kansas City, MO</P>

	



<P ALIGN=CENTER><I>Your report resulted in a complete change of treatment protocol<BR>

 which is currently proving effective.</I><BR>

-Martha Olden, Durham, NC</P>



<P ALIGN=CENTER>(note: some names have been changed)</P>



<HR WIDTH=75%>



<H2 ALIGN=CENTER><A NAME="do this myself">"Can I do this myself on the World Wide Web?"</H2>



<P ALIGN=CENTER>You may be wondering..."Can I do my own search on the World Wide Web?"</A><BR>  Please see our section on the pros and cons of <A HREF="selfhelp.html">do-it-yourself searching</A> on the Internet.</P>





<HR WIDTH=75%>



<H2 ALIGN=CENTER>To Reach Us</H2>



<P>If you are interested in having us do on-line searching for you or want more information about our search services, contact us right away.  We will be happy to discuss our services with you.  You can also submit your <A HREF="srchord.html">order online</A>, as well as make a <A HREF="contact.html">request</A> for additional information!</P>



<H3 ALIGN=CENTER>

Schine On-Line Services, Inc.<BR>

39 Brenton Avenue<BR>

Providence, RI  02906

</H3>

<H2 ALIGN=CENTER>

1 (800) FIND CURE

</H2>

<H4 ALIGN=CENTER>

1 (800) 346-3287<BR>

1 (401) 751-0120

</H4>

<H3 ALIGN=CENTER>

<A HREF="mailto:schine@findcure.com">schine@findcure.com</A>

</H3>



<P ALIGN=CENTER>Schine On-Line Services is a member of the Better Business Bureau (401-785-1212).</P>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR WIDTH=75%>



<H3 ALIGN=CENTER>Return to <A HREF="index.html">Schine On-Line Home Page</A></H3>





<HR>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>



</TD>

</TR>

</TABLE>

</BODY>

</HTML>




</DOC>
<DOC>
<DOCNO>WT01-B18-78</DOCNO>
<DOCOLDNO>IA097-001038-B024-120</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/srchord.html 206.119.148.29 19970215060435 text/html 7968
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:20:42 GMT
Last-modified: Friday, 27-Sep-96 22:17:06 GMT
Content-length: 7784
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Svces:  Overview</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<FORM METHOD="POST" ACTION="http://www.tiac.net/cgi-bin/guest-book.cgi">



<INPUT TYPE=hidden NAME="Hemail" VALUE="schine@findcure.com">

<INPUT TYPE=hidden NAME="Hurl" VALUE="http://www.findcure.com/">

<INPUT TYPE=hidden NAME="Hpagename" VALUE="The SOLS Home Page">

<INPUT TYPE=hidden NAME="Hthankyou" VALUE="Thank you for your order!">

<INPUT TYPE=hidden NAME="Himage" VALUE="http://www.findcure.com/logo.gif">

<INPUT TYPE=hidden NAME="Hsubject" VALUE="An Order from the SOLS Website!">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn about the Medical Search Service offered by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>



<H1 ALIGN=CENTER>Medical Search Order Form</H1>



<HR width=75%>



<P>Schine On-Line Services, Inc., founded by cancer survivor <A HREF="gstory.html">Gary Schine</A>, gathers information on any and all types of cancer or other illness directly for clients.  Our researchers have extensive on-line experience and training from the National Library of Medicine and from other medical database providers.  We can search the databases for you and provide a report of the current developments and <A HREF="ctrials.html">clinical trials</A> for your particular illness.</P>



<HR WIDTH=75%>



<A NAME="search"><H2 ALIGN=CENTER>Comprehensive Reports</H2></A>



<H3>Our comprehensive, computer-searched reports include:</H3>



<UL>

	<LI>a layperson overview of your illness (from PDQ)

	<LI>a technical overview of your illness (from PDQ physician section) 

	<LI>a listing of current clinical trials for your illness (from PDQ)

	<UL>

		<LI>details including names, addresses, and phone numbers for the person and organization leading each clinical trial listed

		<LI>names of all doctors and institutions in your region authorized to administer each clinical trial

		</UL>

	<LI>the latest treatment-related developments for your illness from  over 3,000 medical and scientific journals, from the USA and abroad (including the researcher's name and institution)

	<LI>the latest information on treatment and other resources from the National Organization for Rare Disorders (NORD) if available

	<LI>a list of medical libraries in your area for follow-up research.

</UL>



<P>A typical report for cancer is between 80 and 200 pages, and for non-cancer illnesses between 50 and 120 pages.  Compiling a report currently costs &#36;189.00 ($4.00 Shipping &amp; Handling).</P>





<H4 ALIGN=CENTER>Feel free to examine an abridged 

<A NAME="Sample Report">

	<A HREF="demorept.html">

Sample Report

	</A>

</A>

 compiled by Schine On-Line Services.

</H4>



<HR WIDTH=75%>



<H2 ALIGN=CENTER>Monthly Updating Service</H2>



<P>New developments in medicine are taking place all the time.  It is not an exaggeration to say that next month or the month after a new development that can save your life will be reported.  For this reason, Schine On-Line Services, Inc. also offers a monthly updating service.</P>



<P>At the beginning of each month, we check the latest month's entries to Cancerlit or Medline, and check on clinical trials added to PDQ.  All relevant findings and new clinical trial information is promptly mailed to every client subscribing to the updating service.</P>



<HR WIDTH=75%>

<H2 ALIGN=CENTER>Search Order Form</H2>
<H4 ALIGN=CENTER>Alternately, you can <A HREF="fax.html">FAX</A> us your order.</H4>

<P ALIGN=CENTER><FONT SIZE=4><B>Please supply us with the following information<BR> so that we may process your order.</B></FONT><P>

<PRE>
Name...........<INPUT TYPE=TEXT NAME="name" SIZE=40>
Title..........<INPUT TYPE=TEXT NAME="title" SIZE=40>
Address........<INPUT NAME="mailing_address1" SIZE=40>
               <INPUT NAME="mailing_address2" SIZE=40>
City...........<INPUT TYPE=TEXT NAME="city" SIZE=15> State..<INPUT TYPE=TEXT NAME="state" SIZE=3> Zip:<INPUT TYPE=TEXT NAME="zip" SIZE=7>
Phone..........<INPUT TYPE=TEXT NAME="phone" SIZE=15> Fax....<INPUT TYPE=TEXT NAME="fax" SIZE=16>
E-mail.........<INPUT TYPE=TEXT NAME="email_address" SIZE=40>
Diagnosis......<INPUT TYPE=TEXT NAME="diagnosis" SIZE=40>
Stage(If Known)<INPUT TYPE=TEXT NAME="stage" SIZE=40>
Age............<INPUT TYPE=TEXT NAME="age" SIZE=15> Male....<INPUT TYPE=RADIO NAME="sex" VALUE=male> Female....<INPUT TYPE=RADIO NAME="sex" VALUE=female>
Credit Card #..<INPUT TYPE=TEXT NAME="card_number" SIZE=15> Expiration...<INPUT TYPE=TEXT NAME="expiration" SIZE=10>
               <INPUT TYPE=radio NAME="card_type" VALUE=Visa>Visa                    <INPUT TYPE=radio NAME="card_type" VALUE=Master Card>Master Card
               <INPUT TYPE=radio NAME="card_type" VALUE=American Express>American Express        <INPUT TYPE=radio NAME="card_type" VALUE=Discover>Discover


Special Shipping/Handling Requests:

  <TEXTAREA NAME="special_handling" COLS=51 ROWS=3></TEXTAREA>
</PRE>



<P><CENTER><A NAME="subscribe"></A><INPUT TYPE="submit" VALUE="Submit Order"><INPUT TYPE="reset" VALUE="Clear Order Form"></CENTER>



<H3 ALIGN=CENTER>

Schine On-Line Services, Inc.<BR>

39 Brenton Avenue<BR>

Providence, RI  02906

</H3>

<H2 ALIGN=CENTER>

1 (800) FIND CURE

</H2>

<H4 ALIGN=CENTER>

1 (800) 346-3287<BR>

1 (401) 751-0120

</H4>

<H3 ALIGN=CENTER>

<A HREF="mailto:schine@findcure.com">schine@findcure.com</A>

</H3>



<P ALIGN=CENTER>Schine On-Line Services is a member of the Better Business Bureau (tel: 401-785-1212).</P>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR WIDTH=75%>



<H3 ALIGN=CENTER>Return to <A HREF="index.html">Schine On-Line Home Page</A></H3>





<HR>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>



</TD>

</TR>

</TABLE>

</BODY>

</HTML>






</DOC>
<DOC>
<DOCNO>WT01-B18-79</DOCNO>
<DOCOLDNO>IA097-001038-B024-144</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/ctrials.html 206.119.148.29 19970215060448 text/html 5651
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:20:55 GMT
Last-modified: Tuesday, 10-Dec-96 05:52:42 GMT
Content-length: 5466
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On Line Svces:  Clinical Trials</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn about the Medical Search Service offered by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>


	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>



<HR SIZE=6 WIDTH=75%>



<H1 ALIGN=CENTER>Clinical Trials:</H1>



<H2 ALIGN=CENTER>New Hope for Persons with Cancer</H2>



<HR SIZE=6 WIDTH=75%>



<H2 ALIGN=CENTER>

<A NAME="New Clinical Trials"><A HREF="newclntr.html">77 New Clinical Trials Announced in December</A></A>

</H2>





<P ALIGN=CENTER><STRONG>Be sure to check this site for monthly updates on recently announced clinical trials.</STRONG></P>





<P>Many of us view clinical trials as the use of human guinea pigs in medical experimentation with more for harm than good.  The reality is that far more people are helped than hurt by U.S. clinical trials, and all participants must by fully informed of their prospects and risks.</P>



<H3>Clinical trials in this country are divided into three phases:</H3>



<DL COMPACT>

<DT><STRONG>Phase I.</STRONG>

	<DD>In this first phase, drugs (or other treatments) that have been comprehensively tested on animals are first administered to humans.  Because the drug is new and unproved, it is only offered to people who have no other reasonable options; that is, nothing to lose.



<DT><STRONG>Phase II.</STRONG>

	<DD>A drug that has been phase I tested and shows clear signs of effectiveness without undue risk is admitted to this phase.  It is offered to a broader group of patients to better establish its value as a new treatment.



<DT><STRONG>Phase III.</STRONG>

	<DD>Here, a new treatment is compared to existing treatments, or to no treatment at all.  In phase III, some patients receive the new treatment, while others receive a more conventional treatment or a placebo (which is not a treatment, but appears to be one).  If a treatment is clearly safer and more effective than the alternatives, the FDA will sometimes allow this phase of testing to be ommitted, putting the treatment on the fast track to full approval.

</DL>



<P>By nature, clinical trials are at the cutting edge of medicine.  Tomorrow's standard treatments are found in today's trials.  While not all clinical trials lead to improvement in one's illness, many do.</P>





<HR SIZE=4 WIDTH=75%>



<H4>For more information on clinical trials and other aspects of cancer treatment, visit any one of the following sites:</H4>



<UL>

	<LI>

<A HREF="http://www.cancerguide.org">

Steve Dunn:  CancerGuide

</A>

	<LI>

<A HREF="http://www.nci.nih.gov/">

National Cancer Institute

</A>

	<LI>

<A HREF="http://wwwicic.nci.nih.gov/">

International Cancer Information Center

</A>

	<LI>

<A HREF="http://www.oncolink.upenn.edu/">

Oncolink

</A>

	<LI>

<A HREF="http://utmdacc.uth.tmc.edu/">

MD Anderson

</A>

	<LI>

<A HREF="gopher://gopher.nih.gov/11/clin/cancernet">

CancerNet (gopher menu)

</A>

	<LI>

<A HREF="http://imsdd.meb.uni-bonn.de/cancernet/cancernet.html">

CancerNet (www server)

</A>

</UL>





<H3 ALIGN=CENTER>

Return to 

	<A HREF="index.html">

Schine On-Line Home Page

	</A>

</H3>



<H3 ALIGN=CENTER>

See an  

	<A HREF="overview.html">

Overview of Schine On-Line Services

	</A>

</H3>





<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR SIZE=3>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>



</TD>

</TR>

</TABLE>

</BODY>

</HTML>






</DOC>
<DOC>
<DOCNO>WT01-B18-80</DOCNO>
<DOCOLDNO>IA097-001038-B024-161</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/garybook.html 206.119.148.29 19970215060500 text/html 11380
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:21:06 GMT
Last-modified: Wednesday, 24-Jul-96 19:09:17 GMT
Content-length: 11192
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Gary Schine:  Cancer Cure</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn about the Medical Search Service offered by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>


	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>





<HR SIZE=6>



<table cellpadding=0 border=0 width=100%>

<tr>



<td align=center valign=center width=50%>

<H1>Cancer Cure

</H1><h3>Previously published as <I>If the President Had Cancer...</I></h3>

<H2>Cancer Cure:  How to find and get the best there is.</H2>

<H2>by <A HREF="gstory.html">Gary Schine</A></H2>

</td>



<td align=center valign=center width=50%>

<img align=center 

src="book.gif" 

ALT="Book Picture"

 border=2>

</td>



</tr>

</table>



<HR SIZE=6>







<P ALIGN=CENTER><I>"A fine guide and reference source<BR> from someone who has lived the experience<BR> and learned how to teach others.</I><BR>-Bernie Siegel, M.D.</P>



<P ALIGN=CENTER><I>"An important resource for anyone facing the cancer challenge."</I><BR>-Judy Gerner, Director, The Anderson Network<BR>MD Anderson Cancer Center</P>



<P ALIGN=CENTER><I>"I shudder to think what would happen<BR> if I didn't read <STRONG>If the President Had Cancer.</STRONG><BR>  My father owes however many years he has left to this book."</I><BR>-Jill Bortman, Lincoln, RI</P>







<HR SIZE=3 WIDTH=75%>



<P><STRONG>Medical science has come a long way in treating cancer.</STRONG><BR>  Developments and discoveries continue to come very rapidly.  Research and experimentation is constantly taking place at hundreds of hospitals, clinics, and universities throughout the country and the world.</P>



<P><STRONG>However, people in need often don&#39;t get the best care because they are ignorant about their disease and its treatment alternatives.</STRONG><BR>

Too many patients assume that their doctor is fully abreast of all the latest information about their condition and its treatment.  Further, too many patients are afraid to challenge their doctor&#39;s knowledge or his status as the undisputed decision maker.</P>



<P><STRONG>Because developments come so rapidly, it is simply naive to assume that every doctor is up-to-date on every kind of cancer and treatment.</STRONG><BR>

When your life is at stake, the fear of challenging or even insulting the doctor by questioning his knowledge or recommendations simply must be overcome.</P>



<P><STRONG>You must get the best information available and assert your right to make decisions that will impact upon your survival and your quality of life.</STRONG><BR>

This book will show you how to find the information you need to have, how to use it to your advantage, and how to deal with a medical establishment that does not encourage patients to exercise their rights to learn and decide.</P>







<HR SIZE=6 WIDTH=75%>



<H3>

<P>Specifically, this book will show you how to:</P>



<UL>

	<LI><A HREF="selfhelp.html">Access the Latest Information,</A> both on and off the World Wide Web

	<LI>Ask Your Doctor the Right Questions

	<LI><A NAME="Second Opinion">

			<A HREF="2ndopine.html">Get a Second Opinion</A>

		</A>



	<LI>Find Out about 

		<A NAME="Clinical Trials">

			<A HREF="ctrials.html">Clinical Trials</A>

		</A>



	<LI>Use Contacts

	<LI>Find Out a Doctor&#39;s Qualifications and Abilities

	<LI>Anticipate and Overcome Obstacles

</UL>

</H3>







<HR SIZE=6 WIDTH=75%>



<H3 ALIGN=CENTER>Table of Contents</H3>



<PRE>

1.  Introduction............................................1

            What This Guide Is Meant to Do..................5

2.  Finding Basic Information...............................9

            National Cancer Institute.......................9

            Cancer and Health Associations.................13

            Medical Textbooks..............................14

3.  Evaluating Your Doctor.................................15

            Certifications.................................15

            Board Certification............................15

            Know Your Doctor's Background..................16

4.  Questions to Ask Your Doctor...........................19

            Suggested Questions - Illness and Treatment....20

            Questions Regarding Tests......................25

5.  Your Medical Records...................................27

            Why You Need Your Records......................27

            Where Your Records Are.........................28

            Access to Your Records.........................29

            Obtaining Your Records.........................30

            Examining Your Records.........................33

6.  Getting a Second Opinion...............................35

            Why the Reluctance to Get a Second Opinion?....36

            Why a Second Opinion Is Necessary..............37

            Where to Get Your Second Opinion...............38

7.  Clinical Trials and Medical Research...................45

            Science Versus Supposition.....................46

            Scientific Research............................47

            How Clinical Trials Work.......................49

8.  Information Regarding Alternative Medicine.............57

            What Are Alternative Medicines?................57

            The Scientific Method & Alternative Medicine...58

            Finding Information on Alternative Medicine....59

9.  Finding the Latest Information Available

                              About Your Illness...........63

            Organization of This Section...................63

            Libraries......................................64

            Computers and Research.........................66

            Accessing the Databases........................80

            Chapter Conclusion.............................94

10.  Cancer Information on the Internet....................97

            Searching Capabilities.........................97

            Uncontrolled Access............................98

            Searching on the World Wide Web................99

            Using Search Engines..........................100

            Available Internet Offerings..................100

            Usegroups on the Internet.....................102


11.  Having the Research Done For You.....................105

            Schine On-Line Services.......................105

            Doing Your Own Research Versus

                        Having It Done For You............107

12.  Conclusion...........................................109

Epilogue..................................................111

Appendix I.   Glossary....................................113

Appendix II.  NCI Designated Cancer Centers...............130

Appendix III. NCI Free Publications.......................138

Appendix IV.  Associations for Cancer Patients 

                                    and Survivors.........146

Appendix V.   Selected References.........................171



Index.....................................................175</PRE>







<HR SIZE=6 WIDTH=75%>



<P>This book is not meant to be an indictment of doctors.  Many of the criticisms lodged at physicians may result from the expectations that we as patients have for those who are advising and treating us.  Too often we expect them to have all the answers and solutions.  We demand not only technical expertise in medicine, but also flawless interpersonal and communications skills, a sophisticated understanding of psychology, unlimited availability, and a potpourri of superhuman abilities.  Sometimes, when doctors behave in ways that we consider arrogant, they are merely reflecting the image that patients have demanded they fulfill.</P>



<P>Furthermore, this book does not advocate so-called <A NAME="alternatives">

	<A HREF="cures.html">alternatives</A>

</A>

 like foreign treatments of dubious scientific merit, cure by miracle diet, or cure by positive thinking.  Indeed, Gary Schine was treated and apparently cured by traditionally trained physicians with the skill to administer the latest drugs that were developed by traditional medical research.</P>







<HR SIZE=6 WIDTH=75%>



<P ALIGN=CENTER><STRONG>Book Price:  &#36;13 at most major bookstores.</STRONG></P>


<P ALIGN=CENTER><STRONG>You can also order a copy of <I>Cancer Cure</I> <BR>online at <A HREF="http://www.amazon.com/">www.amazon.com</A>, or by calling Schine On-Line Services directly at 1 (800) FIND CURE.</STRONG></P>







<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

Return to 

	<A HREF="index.html">

Schine On-Line Home Page

	</A>

</H3>



<H3 ALIGN=CENTER>

If you are interested in having us do online searching for you,<BR>

please see the  

	<A HREF="overview.html">

Overview of Schine On-Line Services

	</A>

</H3>





<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR SIZE=3>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>



</TD>

</TR>

</TABLE>



</BODY>

</HTML>








</DOC>
<DOC>
<DOCNO>WT01-B18-81</DOCNO>
<DOCOLDNO>IA097-001038-B024-200</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/gstory.html 206.119.148.29 19970215060511 text/html 9814
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:21:18 GMT
Last-modified: Tuesday, 10-Dec-96 05:59:57 GMT
Content-length: 9629
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Svces:  Gary's Story</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn about the Medical Search Service offered by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<P>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>



<HR SIZE=4>



<table cellpadding=0 border=0 width=100%>

<tr>



<td align=center valign=center width=50%>

<H1>Can Information Cure Cancer?

</H1><br>

<H2>Gary Schine's Story</H2><br>

</td>



<td align=center valign=center width=50%>

<img align=center 

src="gpic75.jpg" 

ALT="Gary's Picture"

 border=1>

</td>



</tr>

</table>



<HR SIZE=4>







<P><STRONG><FONT SIZE="+2">&quot;You have a lymphoproliferative disorder,&quot;</FONT></STRONG> the doctor told me.  I had no idea what that meant, and the doctor knew it.  He was just beginning to break the news to me gently and I guess that was the approach that worked best for him.</P>



<P>As the story unfolded it became clear that my depressed iron level noted at a recent blood drive had nothing to do with poor diet as I had naively surmised.  I won&#39;t pretend to remember everything that Dr. Telder&#42; said at that meeting but I clearly remember a few words like malignancy and leukemia and a few phrases of advice like &quot;make sure your health insurance and life insurance policies are paid up.&quot;  Mostly I remember thinking about my two year old daughter and my seven year old son growing up without a father and about 

my wife having to support them, raise them, and explain what happened to daddy all by herself.  &quot;This can&#39;t be real,&quot; I thought.  &quot;I&#39;m only 38; how can I have cancer?&quot;  It was very real indeed.</P>



<P>The doctor had a little encouraging news by our next meeting two weeks later.  He had completed his diagnostic tests and explained that I had hairy cell leukemia, a rare form of the disease.  It could have been worse, in that HCL progresses relatively slowly.  &quot;Why I&#39;ve seen people with HCL live for ten years,&quot; he told me.  To keep me alive would require major surgery, a splenectomy.  That might buy me a few years of relatively trouble free life.  Then I might start on a drug called interferon which would manage the illness but not cure it.  Interferon comes with side effects such as periodic flu-like symptoms and loss of mental concentration abilities.  &quot;There is no cure,&quot; the doctor cautioned.  &quot;What we want to do is lessen the severity and slow down the progress of the leukemia.&quot;</P>



<P>In the meantime my already compromised immune system would deteriorate further, my constant fatigue would get worse, and I might eventually be susceptible to spontaneous external and internal bleeding.</P>



<P>That was eighteen months ago.  <STRONG>Things are different now.</STRONG>  This morning I braved the 26 degree cold and ran 2 1/2 miles as I do on most mornings.  Back then, I had difficulty walking two flights of stairs.  I&#39;m working full 8 hour days now.  I could easily work more but I don&#39;t because I want to spend time with my kids.  One thing my experience taught me is how important it is to spend time with them.  Last year I could hardly stay awake for eight hours without a nap.  My immune system is as capable as it ever was, and spontaneous bleeding is no longer a threat.  There is simply no evidence of cancer to be found in my body.</P>



<P>You see, despite Dr. Telder&#39;s predictions, I am, by all indications cured of my incurable disease.  <STRONG>The doctor simply was unaware of the latest developments in the treatment</STRONG> of HCL.  He did not know about two recent treatments that were much more effective than his antiquated treatment proposal of splenectomy followed by interferon.</P>



<P>The treatment that I chose was developed and administered at Scripps Clinic and Research Foundation in La Jolla, California.  The treatment, a chemotherapy agent called 2-chlorodeoxyadenosine (2-CDA), involved a seven day intravenous infusion.  While the drug had short term side effects like nausea, fever, and flu-like symptoms, there are no known long term side effects.  Two weeks after the treatment I returned from California to my home in Rhode Island able to carry on my life, albeit on an abbreviated schedule.  Two months after my return I was working full time, exercising for the first time in years, and feeling like a new person.  While I have no guarantees, I have been given every reason to believe I will neither suffer a relapse nor later side effects from the treatment.</P>



<P><STRONG>Once I independently set out to learn about my illness, finding this treatment was not difficult.</STRONG>  Through a call to the local chapter of the <A HREF="http://www.leukemia.org/">Leukemia Society of America,</A> I learned that there was a treatment for HCL in clinical trial.  A bit of simple research uncovered a technical report about 2-CDA in the venerable <I>New England Journal of Medicine</I> and a lay-person summary of the technical report in the equally venerable <I>Wall Street Journal.</I>  Both articles appeared three months previous to my diagnosis.</P>



<P><STRONG>Had I not set out to find information on my own, had I not been assertive in seeking and getting the best treatment available, the prognosis offered by Dr. Telder would have been fulfilled.</STRONG></P>



<P><STRONG>Every person with a serious illness has the responsibility to be informed about that illness and its treatment options.  The seriously ill patient must take responsibility for doing all he can to prolong his life and to strive for the best quality of life possible.</STRONG>  As my experience shows, relying solely on one&#39;s doctor will not always be adequate.  It takes some research and study and some assertiveness to assure that you know what the choices are and to make those choices based on the best information possible.</P>



<P>Clearly my own efforts resulted in a home run; I found a cure for an illness that was supposed to be debilitating and fatal.  In my case (at least in retrospect) it was all black and white, there was a bad choice and a much better choice.  Not every cancer sufferer will be so fortunate or have choices so clearly contrasted as I did.  However, many patients will have choices as to how to battle the formidable enemy called cancer.  To know how to make the best choices, indeed to know what the choices are, you need to become informed.  You need also to use that information to derive the power you will need to give yourself the best chance possible.</P>



<P>&#42;The name "Dr. Telder" is fictitious.  Any resemblance to any person's actual name is unintended and coincidental.</P>



<HR SIZE=4 WIDTH=75%>



<P>Following his experiences, Gary Schine founded a search service to provide information about the latest research and treatments available for other persons faced with a serious illness.</P>



<P>Please see our <A HREF="overview.html">Overview of Services</A> page for details about the services provided by Schine On-Line, Inc.  If you are interested in having us do an on-line search, or would like to know more about the our search services, please feel free to <A HREF="contact.html">contact us.</A></P>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

Return to 

	<A HREF="index.html">

Schine On-Line Home Page

	</A>

</H3>



<H3 ALIGN=CENTER>

See an  

	<A HREF="overview.html">

Overview of Schine On-Line Services

	</A>

</H3>





<HR SIZE=3>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>



</TD>

</TR>

</TABLE>

</BODY>

</HTML>






</DOC>
<DOC>
<DOCNO>WT01-B18-82</DOCNO>
<DOCOLDNO>IA097-001038-B024-224</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/selfhelp.html 206.119.148.29 19970215060520 text/html 9069
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:21:27 GMT
Last-modified: Wednesday, 24-Jul-96 19:09:59 GMT
Content-length: 8882
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

	<TITLE>

Schine On-Line Svces:  Can I Do This Myself?

	</TITLE>

</HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn about the Medical Search Service offered by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>



<HR SIZE=6>



<H1 ALIGN=CENTER>Can I Get All the Information About My Illness on the Web?</H1>

<H2 ALIGN=CENTER>(Why Do I Need You?)</H2>



<HR SIZE=6>



<H3 ALIGN=CENTER>The Web offers a great deal of information for just about any type of illness.<BR>

However, it does not offer access to the key databases<BR>

for up-to-date medical developments in cancer treatment.</H3>



<P><STRONG>The National Library of Medicine's Cancerlit and Medline databases are available only to subscribers who pay usage fees.</STRONG>  The National Cancer Institute's Clinical Trials database too, is not accessible via the World Wide Web.  However, the PDQ overview sections (for patients and for medical professionals) are available on the Web by accessing <A HREF="http://imsdd.meb.uni-bonn.de/cancernet/cancernet.html">Cancernet.</A></P>



<P>Someday, the National Library of Medicine may develop user friendly software and  make their databases free to use on the Net.  Someday, the PDQ Clinical database may be free to use.  However, as of today both databases require subscriptions and user fees, and the former <STRONG>also requires knowledge of an esoteric command language for effective searching.</STRONG></P>



<H4>The promise of the Net is real to be sure.  However, it is not yet the omnipotent information gathering tool that it is cracked up to be.  It can be very useful for finding medical information as long as one understands its current pitfalls and its limitations:</H4>





<HR SIZE=3 WIDTH=75%>



<H2 ALIGN=CENTER>Searching Capabilities</H2>

<H3 ALIGN=CENTER>From <A HREF="garybook.html"><I>Cancer Cure</I></A> by <A HREF="gstory.html">Gary Schine</A></H3>



<P><STRONG>Key benefits of the sophisticated medical databases (like Medline and Cancerlit) include their deliberate and meticulous indexing.</STRONG>  Medical librarians  dissect articles categorizing them by controlled vocabulary terms-- sometimes twenty or thirty such terms for one article.  This indexing makes it possible to search with reasonable precision.  If I wanted to find articles on, for example, multiple myeloma treatment, published in 1995 through 1996, involving the use of radiation therapy, I could easily limit to these parameters (as well as to many others).  The database would dutifully provide exactly the information that I requested.</P>



<P><STRONG>The Internet has no such trained indexers.</STRONG>  No Net indexing to date can hold a candle to the indexing done by the staffs of Medline, Cancerlit or by other controlled databases.  The Internet, particularly the World Wide Web, does offer <I>search engines</I> that utilize keyword search capabilities.  That means a Web user can ask one of the search engines for information on "multiple myeloma".  Such a request would pull up hundreds of retrievals.  However, their usability and relevance would be hit or miss, in that they might include items on the treatment of multiple myeloma as well as reviews of novels where a character within suffers from the illness, to the obituary of people who succumbed to the illness.</P>



<P>While such a search might well produce a host of <I>false hits,</I> or items that match the technical search criteria but do not match the search goals, it might very well miss important information that does not meet the keyword criteria.  For example, multiple myeloma is a type of a plasma cell neoplasm.  An article on treatment of all plasma cell neoplasms that does not specifically mention multiple myeloma would be missed by a keyword-based search engine.</P>





<P>The Internet is to controlled medical databases what a book flea market is to a research library.  You may find some wonderful bits of information, but <STRONG>you cannot assume that you have done a systematic search merely by surfing the Net using your illness as  a key word search term.</STRONG>  Further, evaluating information found--sifting the quackery from the legitimate science-- can be as difficult as it is important.</P>





<HR SIZE=3 WIDTH=75%>



<H2 ALIGN=CENTER>Uncontrolled Access to the Internet</H2>



<P>A key advantage of the Internet in general is a key drawback, when it comes to seeking out information as important as treatment of a serious illness.  The Net is essentially an electronic democracy where anyone can post and present to the public pretty much whatever he or she would like.  <STRONG>No one acts as editor or review committee.</STRONG>  If I want to announce on the World Wide Web that a new brand of grape juice cures colon cancer, I can easily do so, as can anyone else with Net access.  What's more, my posting on grape juice would be on apparently equal footing with postings from the world's most venerable medical journals.  In point of fact, there are quacks selling all sorts of snake oil on the Net, further increasing its perils as an information gathering tool.</P>



<P><STRONG>The general public, however, is not able to add to the controlled medical databases.  Entries are controlled by strict parameters,</STRONG> essentially limited to medical and scientific journals, and related publications and documents.  Further, source and reference information which adheres to scientific and academic documentation standards  is included in the medical databases.  Virtually all the medical information in medical databases is referenced and documented such that a user can readily  know where that information came from and who provided it.  If such reference information is provided with items found on the Internet it is for the most part voluntary and unverified.</P>



<P><STRONG>The Net can be quite useful for finding anecdotal information, for finding emotional support from those who have been there, and for pointing one in the direction of available resources.  Currently, it is not a great resource for systematically searching out documented scientific studies or legitimate clinical trials.</STRONG></P>





<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

Back to 

	<A HREF="overview.html#do this myself">

Overview of Schine On-Line Services

	</A>

</H3>



<H3 ALIGN=CENTER>

Return to 

	<A HREF="index.html">

Schine On-Line Home Page

	</A>

</H3>





<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR SIZE=3>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>



</TD>

</TR>

</TABLE>

</BODY>

</HTML>




</DOC>
<DOC>
<DOCNO>WT01-B18-83</DOCNO>
<DOCOLDNO>IA097-001038-B024-267</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/demorept.html 206.119.148.29 19970215060535 text/html 30740
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:21:40 GMT
Last-modified: Monday, 17-Jun-96 15:59:38 GMT
Content-length: 30555
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Svces: Sample Report</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF>

<HR SIZE=4 WIDTH=75%>



<H1 ALIGN=CENTER>Schine On-Line Services</H1>

<H2 ALIGN=CENTER>Sample Report</H2>



<HR SIZE=4 WIDTH=75%>



<PRE>





TABLE OF CONTENTS FOR ACTUAL REPORT



This is the actual table of contents from a report on Renal Cell 

Carcinoma (Kidney Cancer).  Only a few passages of the full report are 

included in this sample.





Introduction to Report...........................................3

The Best Doctor..................................................5

If The President Had Cancer......................................6

1a. Outline of Renal Cell Carcinoma..............................6

1b. Technical Outline of Renal Cell Carcinoma...................11

2a. Current Clinical Trials (from PDQ)..........................21

How Clinical Trials Work........................................21

2b. Clinical Trials Listing.....................................24

2c. Clinical Trials Available,  LA, MS, TX, AL.................139

3. Latest Findings From Cancerlit/Medline......................140

4. Information on Alternative and Non-Traditional Medicine

 in Regards to Renal Cell Carcinoma............................183

5. Latest Information From The National Organization of Rare

 Disorders.....................................................186

6. Medical Libraries in Your Area (zip code 704)...............189









Schine On-line Services serves only as a clearinghouse for health and 

medical information.



We do not provide medical services or perform or assist in the 

performance of medical diagnosis or treatment of any kind.  For medical 

advice, diagnoses, or treatment, consult a competent and licensed 

physician.



While we make every attempt to provide a thorough search service, we 

cannot guarantee that our searches are complete or definitive.  We 

assume no liability for the contents of any information within this 

report.  We can not be responsible for any negligent act or omission in 

connection with this literature search or in the selection of any 

literature.  Reliance upon any information within, is at the users own 

risk.  Again, for medical advice, diagnoses, or treatment, consult a 

competent and licensed physician.









INTRODUCTION TO REPORT





NOTE: This is the actual introduction to the report



This report contains information on the latest treatments and on related 

current findings for Renal Cell Carcinoma, particularly (but not 

exclusively) recurred RCC.  It was gathered from a number of computer 

databases.  It is divided into sections as described below.







SECTION 1a. Outline of  Renal Cell Carcinoma



This section is a strait-forward summary of Renal Cell Carcinoma in lay 

person language.  It includes a general introduction that will help you 

understand your condition as well as information on staging , and 

prognosis.  This section  is from the National Cancer Institutes 

Physicians Data Query (PDQ) database.







SECTION 1b. Technical Outline of  Renal Cell Carcinoma



This section, also from PDQ, is a more technical and more detailed 

summary of Renal Cell Carcinoma.  It is designed for physicians and 

other medical professionals.  While non-physicians will probably not be 

able to understand this section in its entirety, much of the information 

can be understood by a lay person prepared to read it carefully.  A good 

medical dictionary might be helpful for this section and for most of the 

following sections.







SECTION 2. Current and Recent Clinical Trials



This section contains specific details on current clinical trials for 

Renal Cell Carcinoma.  



There are well over 1000 clinical trials taking place in the United 

States at any given time.  Reputable clinical trials take place in other 

nation's throughout the world as well.  In this and in virtually all 

other nations, a new treatment must be extensively tested and evaluated 

in laboratories and then on animals, before it is used for humans.  



This sections begins with a brief explanation of clinical trials.







SECTION 3. Latest Findings from Cancerlit, Renal Cell Carcinoma



This section contains references and summary information from recent 

studies involving Renal Cell Carcinoma.  This information can be useful 

to:



a. examine the reported effectiveness of clinical trials (such as those 

found in section II. of this report)



b. evaluate the effectiveness of a treatment or treatments that your 

doctor is proposing.  For example, it is one thing to be told by your 

doctor that your chances for complete remission are pretty good with 

treatment XYZ but another to read that a in recent study of 50 people 

with Renal Cell Carcinoma who were treated with XYZ, 75% achieved 

complete remission at 6 months.



c. compare effectiveness and risk of one treatment option to another.  

This is useful in deciding whether the treatment that your doctor is 

proposing is more or less effective than other standard treatments or 

treatments in clinical trial that may be available.



Note that the final line on each summary (starting with AD) indicates 

the institution where that particular report came from.  Cancerlit 

includes information from the USA and the entire world.







SECTION 4. Information on Alternative and Non-Traditional Medicine in 

Regards to Renal Cell Carcinoma.



This section, from the Cancerlit Database, includes  research findings  

available specifically for non-traditional treatments and related 

reports dealing with Renal Cell Carcinoma or related cancers.  The 

following types of medicine were searched (by National Library of 

Medicine Medical Subject Headings and text word where no MESH heading 

was available).





Alternative Medicine			Medicine, Herbal

Medicine, African Traditional		Medicine, Oriental Traditional

Medicine, Arabic			Medicine, Ayurvedic

Homeopathy				drugs, Chinese Herbal

Chiropractic				antineoplaston (S Burzynski)

bovine cartilage			shark cartilage



Note that only items specifically indexed under one of these heading 

will be retrieved as part of this section.   Also, we do not limit our 

search to human treatment and clinical experimentation here as we do in 

the previous sections because people often want to know about early 

stage (pre-human trial) alternative medicine experimentation.  Other 

treatment reports that fall under the domain of alternative or non-

traditional may be included in one of the previous sections.







SECTION 5. Information from National Organization of Rare Disorders 

(NORD)



NORD is a non-profit organization dedicated to identifying, controlling, 

and curing rare or Orphan Diseases.  The information it offers includes 

overviews, new treatments, and sources of further information for many 

rare (and some not-so-rare) cancers.  The organization is largely 

supported by pharmaceutical companies so not surprisingly, most of the 

treatments are drug based.  



If we found Renal Cell Carcinoma in the NORD database, their information 

is included in this section.







SECTION 6. Medical Libraries In Your Area



There are many medical libraries and general libraries with medical 

sections.  Some of these libraries in your area and their addresses  are 

listed in this section.



Medical libraries are designed more for medical professionals than for 

patients.  Their policies on use by the public vary so it is worth 

checking before taking a long trip only to be denied access.  



Medical libraries are the best place to search for the full text of 

articles that are included in this report in summary (abstract) fashion.  

The libraries listed here work with the National Library of Medicines 

system of sharing resources.  This means that any one of them should be 

able to track down any journal referenced by the NLM (Cancerlit section 

of this report).  Whether they will use their sharing capabilities for 

you depends on the libraries policies.







.c2.  THE BEST DOCTOR



People with cancer often ask, "Who is the best doctor for my illness?"  

Unfortunately, there is no easy answer to this question.  However, it is 

fair to reason that a doctor whose name comes up several times in this 

report is well versed and up to date on Renal Cell Carcinoma.  That is, 

if Dr. John Doe is participating in several clinical trials (section 2 

and/or has published several articles on this illness (section 3 or 4), 

Dr. Doe is very likely to be an expert on the treatment of Renal Cell 

Carcinoma.  The clinical trials listings include the names, addresses, 

and phone numbers for listed participants.







.c2.If The President Had Cancer...



If The President Had Cancer  is a step by step guide for patients who 

want to make sure they get the best care available and who want to take 

more control of their care.  It includes information on finding 

information, getting a second opinion from top specialists in your type 

of cancer, questions to ask your doctor, and more.  For further 

information, see the enclosed brochure.

 







1a. OUTLINE OF RENAL CELL CARCINOMA 



  

                      DESCRIPTION

-- What is renal cell cancer? --



Renal cell cancer (also called cancer of the kidney or renal 

adenocarcinoma) is

a disease in which cancer (malignant) cells are found in certain tissues 

of the

kidney.  Renal cell cancer is one of the less common kinds of cancer.  

It

occurs more often in men than in women....



In an actual report, thisoverview continues for several pages.  







1b. TECHNICAL OUTLINE OF RENAL CELL CARCINOMA



 DIAGNOSIS #1 OF 1                      10/19/95 12:0                       

                               RENAL CELL CANCER

                                   PROGNOSIS

Renal cell cancer, also called renal adenocarcinoma, or hypernephroma, 

can often be cured if it is diagnosed and treated when still localized 

to the kidney and to immediately surrounding tissue.  The probability of 

cure is directly related to the stage or degree of tumor dissemination.  

Even when regional lymphatics or blood vessels are involved with tumor, 

a significant number of patients can achieve prolonged survival and 

probable cure.....  



In an actual report, this technical overview continues for several 

pages.  







.c.2a. CURRENT CLINICAL TRIALS (from PDQ) 

 



.c2.  HOW CLINICAL TRIALS WORK



Virtually all U.S. clinical trials are performed only with the approval 

of the US Food and Drug Administration (FDA) and according to strict FDA 

guidelines.  Also, most clinical trials must first be approved by an 

Institutional Review Board (IRB) at the institution where the trial is 

to take place.  The IRB, which is composed of physicians, scientists, 

and others reviews the study to assure that it is well designed and that 

it includes appropriate safeguards for the patients, and that the 

potential benefits outweigh the potential risks.  Clinical trials are 

carefully reviewed for medical ethics, patient safety, and scientific 

merit by the organization that is sponsoring the research.  As with the 

practice of medicine in general, a key ethical tenant must be observed: 

nothing shall be done to a patient that will knowingly do any harm that 

is not outweighed by a greater benefit.



A clinical trial must have a clear and potentially helpful purpose with 

clear evaluation criteria and clear steps in its administration.  In 

many instances effectiveness in destroying or abating cancer relative to 

standard therapies is being tested.  In some cases effectiveness of two 

or more drugs has been proven to be similar but relative toxicities need 

to be evaluated.



While the heavy scrutiny that a clinical trial receives does not 

guarantee that every trial is absolutely safe, it is at least very 

significant protection against carelessness and undue risk under the 

circumstances.  In all cases you will receive information about the 

potential benefits and hazards and you will not be admitted to a 

clinical trial until and unless you consent in writing to be part of 

that trial.  Even with your written consent, you can leave the clinical 

trial at any time and for any reason or for no reason at all.







CLINICAL TRIAL PHASES



Trials in cancer research in this country are designed in 4 phases with 

each phase building upon what was learned in the previous phase.  Not 

all trials make it through all 4 phases if the value is called into 

question by early data.  Also, some clinical trials are allowed to 

forego phases 3 if earlier results are particularly promising.  Each 

clinical trial listed in this report lists which phase it is currently 

in.  The phases are outlined as follows:



Phase I



In this phase a new drug is first administered to humans.  Because the 

drug is new to humans, risks are highest here.  Part of the researchers 

job is to determine the best way to administer the drug, appropriate 

dosage, and of course to carefully monitor side effects.  Only people 

with advanced disease who could not be helped by other known treatment 

are typically allowed to participate in this potentially perilous phase.



Phase II



In this phase, access is opened up to more patients.  Patients with 

related forms of cancer may be admitted into trials that have 

successfully passed through phase I without undue side effects.



Phase III



The key to this phase is comparison of the new treatment with other 

treatments.  The group getting the new treatment is called the treatment 

group and the group getting the standard treatment is called the control 

group.  Where there is no existing treatment, some patients get the 

treatment and the control group gets no treatment at all.  This is 

typically done through randomization  meaning patients are randomly 

assigned to the treatment or control group. While this is good science 

it unfortunately means some patients get a treatment that may not be as 

good as other patients are getting.  For this reason, the FDA sometimes 

permits this phase to be skipped if there is clear evidence that the 

investigational treatment is better than the existing alternatives (or 

lack thereof).



Phase IV



A treatment that makes it into phase IV has pretty much proven its 

value.  Although the FDA continues to monitor its benefits and toxicity,  

it becomes a standard treatment option until and unless new data 

uncovers unforeseen problems.  Sometimes it is used in conjunction with 

other proven drugs, and sometimes it is initially approved for use if 

established treatments have not been effective with a particular 

patient.



Before a drug is approved by the FDA as a standard treatment, that 

agency  reviews all the clinical trial data.  This is a lengthy process 

taking at least a year and sometimes much more.  In fact, it can easily 

take 5 to 10 years from the point where an investigational drug is first 

administered to a patient to the time it is fully approved by the FDA.







NCI GROUP C TREATMENT PROTOCOLS



Group C treatments are drugs provided to physicians by the NCI for 

treatment of individual patients.  Drugs in this category have been FDA 

approved for treatment of specific cancers.  They have passed through 

extensive clinical trials (at lease through phase II.) and show 

considerable promise.  If all goes according to expectation, these drugs 

will soon be approved for commercialization.







INFORMATION ON EACH TRIAL



Each trial description contains the following information:



-name of institution(s) where trial is taking place

-name of at least one researcher (participant) involved in the study

-address of participant(s)  and institution including the lead 

organization in all cases.  Also, the names and addresses of 

participants in your state and nearby states are included in a separate 

list following the first listing.

-entry criteria (physical characteristics such as age, condition, 

gender, etc. for eligibility to participate as a patient)

-status- all clinical trials listed here are active

-Objectives- The medical objectives are detailed in each summary 

contained in the report.  Note that these are the objectives from a 

research point-of-view, not for your point of view as a person with 

cancer.  Your objective is clearer and simpler-- to either fully or 

partially cure your illness.  Dont be put off by the cold scientific 

language of the description of the objective.  The improvement of 

quality of life for the patient is understood as the human objective and 

does not need stating in the scientific summary of objectives.



-Summary-  Finally, each trial listed has a summary that describes the 

trial itself in a few paragraphs.  Again, this is written for medical 

professionals but it will give you an idea of what you will go through 

if you enter any of the trials listed. 





FOREIGN CLINICAL TRIALS



It is possible that one or more current clinical trials are not included 

in the PDQ database and therefore are not listed in this section.  This 

is especially likely for clinical trials taking place outside the U.S, 

even though a number of foreign trials are included. 







GETTING MORE INFORMATION ON CLINICAL TRIALS



Dont hesitate to ask your doctor to  call or write one of the 

researchers (listed as participants in each description) for further 

information about the trial and about your own eligibility for 

participating.  If your doctor is hesitant, by all means contact the 

researchers yourself.



Section III.  (Latest Findings From Cancerlit) of this report contains 

information on recent studies involving Renal Cell Carcinoma.  Some of 

that information may include results of the clinical trials mentioned in 

the PDQ list of trials.





If the President Had Cancer (available through Schine On-line Services) 

contains more details on clinical trials.



note: This listing contains clinical trials taking place worldwide.  

Following this listing, those clinical trials from this complete list 

that are available in your state and nearby states are listed separately 

with the names of local participants.







2b. CLINICAL TRIALS LISTING



NOTE:    There were a total of 53 clinical trials listed in this 

particular report (for a person age 48 with recurred Renal Cell 

Carcinoma ).  One is included here as an example.



NOTE: This listing includes trials which may be available to persons age 

48 with recurred Renal Cell Carcinoma.



NOTE: Details regarding dosages are not included.  Note that the same 

trials may use different dosages in different combinations.  Information 

on dosages for any trials will be forwarded at no additional charge, 

upon your request.





SAMPLE 1 OF 37 CLINICAL TRIAL LISTINGS





TREATMENT TRIAL PROTOCOL #1 OF 53              10/19/95 12:0               

                         MSKCC-91065A2  NCI-T91-0107C

Phase I Study of Intraperitoneal EDAM with or without Systemic or Oral 

CF in

Patients with Advanced Malignancies Principally Confined to the 

Peritoneal

Cavity (Summary Last Modified 01/92)

STATUS: Active   AGE RANGE: 18 and over



                                  OBJECTIVES

OBJECTIVES:

I.  Evaluate the safety and pharmacology of edatrexate (EDAM) 

administered by the intraperitoneal route.



II.  Define the MTD of EDAM when administered by the intraperitoneal 

route with or without the oral/systemic administration of leucovorin.



III.  Determine, in a preliminary manner, whether there is evidence of 

antineoplastic activity for EDAM against tumors principally confined to 

the peritoneal cavity when administered by the intraperitoneal route.



                            PROTOCOL ENTRY CRITERIA

PROTOCOL ENTRY CRITERIA:



--Disease Characteristics--



Histologically confirmed advanced cancer either principally confined to 

the peritoneal cavity or for which the major symptomatic disease 

manifestation is in the peritoneal cavity (e.g., symptomatic ascites)



Disease must be considered incurable by surgery, radiotherapy, or 

standard chemotherapy, or patient must have failed standard therapy or 

refused therapy of proven merit



Measurable or evaluable disease not required



--Prior/Concurrent Therapy--



Biologic therapy:

  Not specified



Chemotherapy:

  Maximum of 2 prior chemotherapy regimens (including a maximum of 1 

prior intraperitoneal regimen) allowed.  Prior local difficulties with 

any prior intraperitoneal chemotherapy (e.g., abdominal pain, 

excessively slow treatment instillation) exclude. At least 4 weeks since 

myelosuppressive chemotherapy (6 weeks for nitrosoureas or mitomycin).  

Recovery from marrow-toxic effects of prior chemotherapy required.



Endocrine therapy:

  Not specified



Radiotherapy:

  At least 4 weeks since prior radiotherapy to major bone marrow-

containing sites



Surgery:

  Not specified



--Patient Characteristics--



Age:

  18 and over



Performance status:

  Karnofsky 50-100%



Life expectancy:

  At least 8 weeks



Hematopoietic:

  WBC at least 3,500

  Platelets at least 100,000



Hepatic:

  Bilirubin no greater than 2.0 mg/dl



Renal:

  Creatinine less than 2.0 mg/dl





              PROTOCOL CHAIRPERSONS

Leonard Bruce Saltz   Chair   Ph: 212-639-2501

  Memorial Sloan-Kettering Cancer Center

  1275 York Avenue

  New York, NY  10021

    Memorial Sloan-Kettering Cancer Center  Primary lead  MSKCC-91065A2







 

2c. Clinical Trials Available,  LA, MS, TX, AL



note:   This section lists the clinical trials available in your region 

of the country (or world).  In this case, our client lives in Lousiana 

so we searched all clinical trials with participating organizations in 

any of the statesin his region.  Of course the lead organization for all 

the trials listed in the database is included in the section above (with 

name, address, phone number, etc.).  One of the two trials available in 

the region is listed here as a sample.



This listing includes the trials listed above (Section 2b) that are 

available in your region.  Details on each trial listed here can be 

found in Section 2b.



This listing includes the trials listed above (2b) that are available in 

your region.  Details on each trial listed here can be found in (2b).



TREATMENT TRIAL PROTOCOL #1 OF 2               10/19/95 12:0               

                          AIS-1061-9320  NCI-V95-0689

Phase II/III Randomized Study of CD8+ TIL/IL-2 for Metastatic Renal Cell

Carcinoma (Summary Last Modified 09/95)

STATUS: Active   AGE RANGE: 18 and over



                                 PARTICIPANTS

Brent F. Treiger   Chair   Ph: 408-982-3966

  Applied Immune Sciences, Inc.

  5301 Patrick Henry Drive

  Santa Clara, CA  95054-1114

    Applied Immune Sciences, Inc.  Primary lead  AIS-1061-9320



Seth P. Lerner   Principal Investigator   Ph: 713-798-4001

  Scurlock Towers

  Suite 1035

  6560 Fannin

  Houston, TX  77030

    Department of Urology

     Houston  Texas



Robert P. Whitehead   Principal Investigator   Ph: 806-743-3155

  Texas Tech University

  Health Science Center

  Division of Oncology Hematology

  3601 Fourth Street

  Lubbock, TX  79430

    Health Science Center

     Lubbock  Texas



Douglas W. Orr   Principal Investigator   Ph: 214-692-3800

  Texas Oncology, P.A.

  8115 Preston Road

  Suite 300

  Dallas, TX  75248

    Texas Oncology, P.A.

     Dallas  Texas

John J. Nemunaitis   Co-Principal Investigator   Ph: 214-824-3396

  Director, Clinical Research

  Texas Oncology, P.A.

  Suite 250

  3310 Live Oak

  Dallas, TX  75204

    Texas Oncology, P.A.

     Dallas  Texas









3. Latest Findings From Cancerlit/Medline



Note: This section contains very recent studies and reports on the 

treatment of Renal Cell Carcinoma.  This important information can help 

you evaluate different  treatment options and make treatment choices 

based upon hard scientific  information (i.e. which treatment seems to 

offer a higher possibility of full  cure, which has the lowest risk of 

adverse effects, etc.).  Also, if there have been recent breakthroughs 

in the treatment of your illness, this section  is likely to contain 

that late-breaking information.  It is not easy for a lay person to 

understand this information, but it can increase your chances of long  

term survival.  We advise clients to read through the studies and circle 

those that look promising.  With the appropriate items circled, take the 

report to your doctor for help in determining which of the items are 

worth following up on.  One of fifty-five treatment reports is included 

in this sample.  This information is not available through Cancernet, 

Oncolink or any other free on-line services.



SAMPLE 1 of 77 treatment reports





1

UI  - 95382620

AU  - Wada T

AU  - Nishiyama K

AU  - Maeda M

AU  - Hara S

AU  - Tanaka N

AU  - Yasutomi M

AU  - Kurita T

TI  - Combined chemoendocrine treatment with tegafur and tamoxifen for 

advanced renal cell carcinoma.

AB  - Ten patients with advanced renal cell carcinoma were given 

combined chemoendocrine treatment with tegafur and tamoxifen.

      Patients were orally administered 800 mg/body tegafur and 20 

mg/body tamoxifen daily. One patient was assessed as CR, three as PR, 

two as NC and four as PD. One out of two patients with estrogen receptor 

(ER)-positive tumors and three out of four patients with ER-negative 

tumors responded favorably to this treatment.  Side effects observed 

during treatment included nausea and vomiting (Grade I in three patients 

and Grade II in five), leukopenia (Grade II in four patients and Grade 

III in two), Grade II liver dysfunction in two patients, and slight 

pigmentation in two patients.  This treatment can be considered 

efficacious for renal cell carcinoma. 

AD - First Department of Surgery, Kinki University School of Medicine, 

Osaka, Japan.

SO  - Anticancer Res 1995 Jul-Aug;15(4):1581-4









4. Information on Alternative and Non-Traditional Medicine in Regards to 

Renal Cell Carcinoma



Note that only items specifically indexed under one of the headings 

noted in the introduction for section 4, will be retrieved as part of 

this section.  Also, we do not limit our search to human treatment and 

clinical experimentation here as we do in the previous sections because 

people often want to know about early stage (pre-human trial) 

alternative medicine experimentation.  Other treatment reports that fall 

under the domain of alternative or non-traditional may be included in 

one of the previous sections.





SAMPLE 1 of 6 reports of non-traditional treatment for this illness.





1

SI  - MEDL/95111534

AU  - Lau BH

AU  - Ruckle HC

AU  - Botolazzo T

AU  - Lui PD

TI  - Chinese medicinal herbs inhibit growth of murine renal cell

      carcinoma.

SO  - Cancer Biother; 9(2):153-61 1994

AB  - Tumors are known to produce factors suppressing immune functions.  

We previously showed that a murine renal cell carcinoma (Renca) 

suppressed macrophage function in vitro and that this suppression was 

abolished by co-incubation with extracts of two Chinese medicinal herbs.  

We now report that these phytochemicals are capable of inhibiting growth 

of Renca in vivo.  BALB/c mice were transplanted intraperitoneally (IP) 

with 1-2 x 10(5) Renca cells.  One day after tumor transplant, mice were 

randomized into two groups.  One group was treated IP, daily for 10 

days, with 100 microliters of phytochemicals containing 500 micrograms 

each of Astragalus membranaceus and Ligustrum lucidum, while the other 

group received saline as controls.  A cure rate of 57% was obtained with 

these phytochemicals when the initial tumor load was 2 x 10(5), and 100% 

when the initial tumor load was 1 x 10(5).  Additional experiments were 

performed to investigate the mechanisms involved in this protection.  

Splenic macrophages from tumor-bearing mice were shown to have depressed 

chemiluminescent oxidative burst activity, and this depression was 

restored with phytochemical treatment.  Splenocytes from mice 

transplanted with Renca responded less favorably to interleukin-2 (IL-2) 

in generating lymphokine-activated killer (LAK) cells; again this 

depression was restored with phytochemical treatment.  Our data suggest 

that these phytochemicals may have exerted their antitumor effects via 

augmentation of phagocyte and LAK cell activities.

AD  - Department of Microbiology, School of Medicine, Loma Linda 

University, California 92350.







5. Latest Information From The National Organization of Rare Disorders



note: This section contains overview information, some summary 

information on therapy, and information on organizations helpful to 

people with the illness in question.   The NORD information is not 

included in this sample report.





6. Medical Libraries in Your Area (zip code 7011-)





note:  This section lists medical libraries in your area (by zip code).  

This is useful information for additional research, for finding actual 

articles abstracted in this report, etc.  This section usually contains 

3-20 librarylistings.



SAMPLE 2 of 18 listings (for zip codes starting with 7011):





1

NA  - NEW ORLEANS ADOLESCENT HOSPITAL

NA  - LIBRARY ILL

AD  - 210 STATE STREET NEW ORLEANS LA 70118

LB  - 70118F

DU  - NON-ACTIVE





2

NA  - TULANE MEDICAL SCHOOL DEPARTMENT OF ORTHOPAEDICS

NA  - JACK K WICKSTROM MEMORIAL ORTHOPAEDIC LIBRARY

AD  - 1430 TULANE AVENUE ROOM 2001 NEW ORLEANS LA 70112

LB  - 70112F

DU  - NON-ACTIVE









.......End of sample report.......



</PRE>





<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

Back to 

	<A HREF="overview.html#Sample Report">

Overview of Schine On-Line Services

	</A>

</H3>



<H3 ALIGN=CENTER>

Return to 

	<A HREF="index.html">

Schine On-Line Home Page

	</A>

</H3>





<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR SIZE=3>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>



</BODY>

</HTML>



</DOC>
<DOC>
<DOCNO>WT01-B18-84</DOCNO>
<DOCOLDNO>IA097-001038-B024-293</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/contact.html 206.119.148.29 19970215060545 text/html 5187
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:21:54 GMT
Last-modified: Wednesday, 24-Jul-96 19:09:03 GMT
Content-length: 5000
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Clinical Trial Info. Request</TITLE></HEAD>

<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<FORM METHOD="POST" ACTION="http://www.tiac.net/cgi-bin/guest-book.cgi">



<INPUT TYPE=hidden NAME="Hemail" VALUE="schine@findcure.com">
<INPUT TYPE=hidden NAME="Hurl" VALUE="http://www.findcure.com/">
<INPUT TYPE=hidden NAME="Hpagename" VALUE="The SOLS Home Page">
<INPUT TYPE=hidden NAME="Hthankyou" VALUE="Thank you for your order!">
<INPUT TYPE=hidden NAME="Himage" VALUE="http://www.findcure.com/logo.gif">
<INPUT TYPE=hidden NAME="Hsubject" VALUE="A Clinical Trials Information Request from the SOLS Website!">





<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Are We Legitimate?  Learn about the Medical Search Service offerd by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD VALIGN=TOP FONTSIZE=3>

<H1 ALIGN=CENTER>Clinical Trial Listings</H1>

<H3 ALIGN=CENTER>What Are YOUR Options?</H3>

<P>Developments  in cancer treatment come so rapidly that breakthroughs are

almost commonplace.  Are there breakthroughs in treating your illness?

Tell us your diagnosis and we will research the number of clinical trials

currently active and accepting patients with your illness.  We'll also

check the medical literature to find out how many articles have been

published in recent months dealing specifically with treating your illness.



<P>We hope you'll order a complete search from us in the future, however, this offer is without cost or

obligation.



<P>Either fill out the form below, send us an <A HREF="mailto:schine@findcure.com">E-Mail</A>, or call us at 1-800-FINDCURE.



<P ALIGN=CENTER><FONT SIZE=4><B>Please supply us with the following information<BR> so that we may respond to your request:</B></FONT><P>

<PRE>

Name.............<INPUT TYPE=TEXT NAME="name" SIZE=30>
Mailing Address..<INPUT TYPE=TEXT NAME="mailing_address1" SIZE=30>
                 <INPUT TYPE=TEXT NAME="mailing_address2" SIZE=30>
Diagnosis........<INPUT TYPE=TEXT NAME="diagnosis" SIZE=30>
Stage (If Known).<INPUT TYPE=TEXT NAME="stage" SIZE=15> Age...<INPUT TYPE=TEXT NAME="age" SIZE=7> 
City.............<INPUT TYPE=TEXT NAME="city" SIZE=30>
State............<INPUT TYPE=TEXT NAME="state" SIZE=11> Zip...<INPUT TYPE=TEXT NAME="zip" SIZE=11>
Phone............<INPUT TYPE=TEXT NAME="phone" SIZE=11> Fax...<INPUT TYPE=TEXT NAME="fax" SIZE=11>
E-mail...........<INPUT TYPE=TEXT NAME="email_address" SIZE=30>

Would you Prefer to Be Contacted by:

         E-Mail<INPUT TYPE=RADIO NAME="email_response">     Telephone<INPUT TYPE=RADIO NAME="telephone_response">     Fax<INPUT TYPE=RADIO NAME="fax_response">
</PRE>



<P><CENTER><A NAME="subscribe"></A><INPUT TYPE="submit" VALUE="Submit"><INPUT TYPE="reset" VALUE="Clear Form"></CENTER>



<HR>

<H3 ALIGN=CENTER>

Schine On-Line Services, Inc.<BR>

39 Brenton Avenue<BR>

Providence, RI  02906

</H3>

<H2 ALIGN=CENTER>

1 (800) FIND CURE

</H2>

<H4 ALIGN=CENTER>

1 (800) 346-3287<BR>

1 (401) 751-0120

</H4>

<H3 ALIGN=CENTER>

<A HREF="mailto:schine@findcure.com">schine@findcure.com</A>

</H3>



<HR>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>



<HR>



<H3 ALIGN=CENTER>Return to <A HREF="index.html">Schine On-Line Home Page</A></H3>





<HR>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>

</TD>

</TR>

</TABLE>

</BODY>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-85</DOCNO>
<DOCOLDNO>IA097-001038-B024-342</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/fax.html 206.119.148.29 19970215060602 text/html 3228
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:22:11 GMT
Last-modified: Friday, 27-Sep-96 22:17:02 GMT
Content-length: 3044
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Svces:  Fax Search Order</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF>

<FORM METHOD="POST" ACTION="http://www.tiac.net/cgi-bin/guest-book.cgi">

<INPUT TYPE=hidden NAME="Hemail" VALUE="schine@findcure.com">
<INPUT TYPE=hidden NAME="Hurl" VALUE="http://www.findcure.com/">
<INPUT TYPE=hidden NAME="Hpagename" VALUE="The SOLS Home Page">
<INPUT TYPE=hidden NAME="Hthankyou" VALUE="Thank you for your order!">
<INPUT TYPE=hidden NAME="Himage" VALUE="http://www.findcure.com/logo.gif">
<INPUT TYPE=hidden NAME="Hsubject" VALUE="An Order from the SOLS Website!">

<H2 ALIGN=CENTER>Fax Order Form</H2>
<P ALIGN=CENTER><FONT SIZE=4>Simply print out a copy of this page,<BR> fill in the requested information, <BR>and fax it to Schine Online Services at <BR><B>401-751-7955.</B></FONT>
<P ALIGN=CENTER>We will confirm your order and process it immediately afterwards.
<P>
<HR>

<CENTER>
<PRE>
Name...........<INPUT TYPE=TEXT NAME="name" SIZE=40>
Title..........<INPUT TYPE=TEXT NAME="title" SIZE=40>
Address........<INPUT NAME="mailing_address1" SIZE=40>
               <INPUT NAME="mailing_address2" SIZE=40>
City...........<INPUT TYPE=TEXT NAME="city" SIZE=15> State..<INPUT TYPE=TEXT NAME="state" SIZE=3> Zip:<INPUT TYPE=TEXT NAME="zip" SIZE=7>
Phone..........<INPUT TYPE=TEXT NAME="phone" SIZE=15> Fax....<INPUT TYPE=TEXT NAME="fax" SIZE=16>
E-mail.........<INPUT TYPE=TEXT NAME="email_address" SIZE=40>
Diagnosis......<INPUT TYPE=TEXT NAME="diagnosis" SIZE=40>
Stage(If Known)<INPUT TYPE=TEXT NAME="stage" SIZE=40>
Age............<INPUT TYPE=TEXT NAME="age" SIZE=15> Male....<INPUT TYPE=RADIO NAME="sex" VALUE=male> Female....<INPUT TYPE=RADIO NAME="sex" VALUE=female>
Credit Card #..<INPUT TYPE=TEXT NAME="card_number" SIZE=15> Expiration...<INPUT TYPE=TEXT NAME="expiration" SIZE=10>
              <INPUT TYPE=radio NAME="card_type" VALUE=Visa>Visa                    <INPUT TYPE=radio NAME="card_type" VALUE=Master Card>Master Card
           <INPUT TYPE=radio NAME="card_type" VALUE=American Express>American Express        <INPUT TYPE=radio NAME="card_type" VALUE=Discover>Discover


Special Shipping/Handling Requests:

  <TEXTAREA NAME="special_handling" COLS=51 ROWS=3></TEXTAREA>
</PRE>
</CENTER>

<HR>
<H3 ALIGN=CENTER>

Schine On-Line Services, Inc.<BR>

39 Brenton Avenue<BR>

Providence, RI  02906

</H3>

<H2 ALIGN=CENTER>

1 (800) FIND CURE

</H2>

<H4 ALIGN=CENTER>

1 (800) 346-3287<BR>

1 (401) 751-0120

</H4>

<H3 ALIGN=CENTER>

<A HREF="mailto:schine@findcure.com">schine@findcure.com</A>

</H3>



<P ALIGN=CENTER>Schine On-Line Services is a member of the Better Business Bureau (tel: 401-785-1212).</P>












<H3 ALIGN=CENTER>Return to <A HREF="index.html">Schine On-Line Home Page</A></H3>





<HR>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-86</DOCNO>
<DOCOLDNO>IA097-001038-B024-389</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/newclntr.html 206.119.148.29 19970215060622 text/html 61401
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:22:21 GMT
Last-modified: Tuesday, 10-Dec-96 05:52:55 GMT
Content-length: 61215
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Svces:  New Clinical Trials</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF>

<HR SIZE=4 WIDTH=75%>

<H1 ALIGN=CENTER>New Clinical Trials</H1>

<H2 ALIGN=CENTER>Announced in PDQ for the Month of December, 1996</H2>

<HR SIZE=4 WIDTH=75%>

<PRE>
TREATMENT TRIAL PROTOCOL #1 OF 77              12/09/96 11:5               
                        3AC-USC-11S-96-1  NCI-V96-1059
Phase I Pilot Study of Cryosurgical Ablation of Soft Tissue Sarcomas of the
Extremity (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: no age specified

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
Lawrence Menendez   Chair   Ph: 213-242-5830
  USC/Norris Comprehensive Cancer Center
  University of Southern California School of Medicine
  1510 San Pablo Street, Suite 322
  Los Angeles, CA  90033-4608
    USC/Norris Comprehensive Cancer Center  Primary lead  3AC-USC-11S-96-1






TREATMENT TRIAL PROTOCOL #2 OF 77              12/09/96 11:5               
                            AMC-002  NCI-T96-0042H
Phase II Study of Oral 9-cis-Retinoic Acid for AIDS-Related Kaposi's Sarcoma
(Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI CTEP-approved, NCI grant supported

                             PROTOCOL CHAIRPERSONS
Steven A. Miles   Chair   Ph: 310-206-8359
  UCLA Clinical AIDS Research and Education (CARE) Center
  University of California Los Angeles Medical Center
  Room BH 412C CHS
  10833 Le Conte Avenue
  Los Angeles, CA  90024
    AID Associated Malignancies Clincal Trials Consortium  Primary lead  AMC-002
Alvin E. Friedman-Kien   Co-Chair   Ph: 212-263-5314
  New York University Medical Center
  Department of Microbiology and Dermatology
  550 First Avenue
  New York, NY  10016
    AID Associated Malignancies Clincal Trials Consortium  Primary lead  AMC-002






TREATMENT TRIAL PROTOCOL #3 OF 77              12/09/96 11:5               
                        BIH-96-02-03-0619  NCI-V96-1036
Phase II Pilot Study of Bicalutamide Alone and in Combination with
Aminoglutethimide and Hydrocortisone for Advanced Androgen-Independent
Prostate Cancer (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: over 18

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Robin Joyce   Chair   Ph: 617-667-1401
  Beth Israel Hospital
  Shapiro Clinical Center
  Division of Hematology/Oncology
  330 Brookline Avenue
  Boston, MA  02215
    Beth Israel Hospital  Primary lead  BIH-96-02-03-0619






TREATMENT TRIAL PROTOCOL #4 OF 77              12/09/96 11:5               
                               C-9333  CLB-9333
Phase III Randomized Study of Carboplatin/Paclitaxel vs No Adjuvant
Chemotherapy After Resection of Stage I (T2N0) non-Small Cell Lung Cancer
(Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Richard L. Schilsky   Chair   Ph: 312-702-6180
  University of Chicago Cancer Research Center
  MC 1140
  5841 South Maryland Avenue
  Chicago, IL  60637-1470
    Cancer and Leukemia Group B  Primary lead  C-9333






TREATMENT TRIAL PROTOCOL #5 OF 77              12/09/96 11:5               
                         CAN-NCIC-IND100  NCI-V96-1067
Phase II Study of Topotecan and Etoposide in Refractory/Relapsed Acute Myeloid
Leukemia (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 to 70

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Michael Crump   Chair   Ph: 416-340-3793
  Toronto General Hospital
  M-L 2-018
  200 Elizabeth Street
  Toronto, Ontario  M5G 2C4
  Canada
    NCIC-Clinical Trials Group  Primary lead  CAN-NCIC-IND100






TREATMENT TRIAL PROTOCOL #6 OF 77              12/09/96 11:5               
                         CAN-NCIC-IND95  NCI-V96-1064
Phase II Study of Gemcitabine/Cisplatin in Inoperable, Locally Advanced or
Metastatic Transitional Cell Carcinoma of the Urothelial Tract (Summary Last
Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Malcolm J. Moore   Chair   Ph: 416-946-2263
  Ontario Cancer Institute
  Princess Margaret Hospital
  Department of Medicine
  610 University Avenue
  Toronto, Ontario  M4X 1K9
  Canada
    NCIC-Clinical Trials Group  Primary lead  CAN-NCIC-IND95






TREATMENT TRIAL PROTOCOL #7 OF 77              12/09/96 11:5               
                         CAN-NCIC-IND96  NCI-V96-1065
Phase I Study of BMS-182751 (a Platinum Compound) plus Etoposide in Advanced
Nonhematologic Malignancies (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 to physiologic 75

                                  SPONSORSHIP
non-US clinical trials group, pharmaceutical

                             PROTOCOL CHAIRPERSONS
Glenwood Dillon Goss   Chair   Ph: 613-737-6792
  Ottawa Regional Cancer Center, General Division
  Ontario Cancer Treatment and Research Foundation
  Ottawa General Hospital
  501 Smyth Road
  Ottawa, Ontario  K1H 8L6
  Canada
    NCIC-Clinical Trials Group  Primary lead  CAN-NCIC-IND96






TREATMENT TRIAL PROTOCOL #8 OF 77              12/09/96 11:5               
                         CAN-NCIC-IND97  NCI-V96-1068
Phase II Study of DPPE (a Tamoxifen Analogue) and Doxorubicin for Advanced
Breast Cancer (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 to 75

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Kong Eng Khoo   Chair   Ph: 204-787-2241
  Manitoba Cancer Treatment and Research Foundation
  100 Olivia Street
  Winnipeg, Manitoba  R3E 0V9
  Canada
    NCIC-Clinical Trials Group  Primary lead  CAN-NCIC-IND97






TREATMENT TRIAL PROTOCOL #9 OF 77              12/09/96 11:5               
                         CAN-NCIC-IND98  NCI-V96-1066
Phase I Study of Doxorubicin/ICI D1694 for Inoperable, Locally Advanced or
Metastatic Gastric Cancer (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 to 75

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Georg Bjarnason   Chair   Ph: 416-480-4928
  Toronto Sunnybrook Regional Cancer Centre
  2075 Bayview Avenue
  Toronto, Ontario  M4N 3M5
  Canada
    NCIC-Clinical Trials Group  Primary lead  CAN-NCIC-IND98






TREATMENT TRIAL PROTOCOL #10 OF 77              12/09/96 11:5              
                          CAN-NCIC-MA14  NCI-V96-1060
Phase III Randomized Study of Adjuvant Therapy with Tamoxifen Alone vs
Tamoxifen plus Octreotide in Postmenopausal Women with Stage I/II/III Breast
Cancer (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: postmenopausal

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Michael N. Pollak   Chair   Ph: 514-340-8222
  Jewish General Hospital
  3755 Cote Sainte Catherine Road
  Montreal, Quebec  H3T 1E2
  Canada
    NCIC-Clinical Trials Group  Primary lead  CAN-NCIC-MA14






TREATMENT TRIAL PROTOCOL #11 OF 77              12/09/96 11:5              
                          CAN-NCIC-MA15  NCI-V96-1063
Phase I/II Study of Docetaxel/Epirubicin with and without G-CSF as First-Line
Therapy for Metastatic Breast Cancer (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 16 and over

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Maureen E. Trudeau   Chair   Ph: 416-323-6303
  Women's College Hospital
  Suite 518
  60 Grosvenor Street
  Suite 522
  Toronto, Ontario  M5S 1B6
  Canada
    NCIC-Clinical Trials Group  Primary lead  CAN-NCIC-MA15






TREATMENT TRIAL PROTOCOL #12 OF 77              12/09/96 11:5              
                          CCCWFU-74196  NCI-V96-1080
Phase II Pilot Study of Radiotherapy plus Fluorouracil in Stage I/II Breast
Cancer Treated by Lumpectomy with or without Adjuvant Chemotherapy (Summary
Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
Carolyn C. Ferree   Chair   Ph: 910-716-4981
  Bowman Gray School of Medicine
  Medical Center Boulevard
  Winston-Salem, NC  27157
    Comprehensive Cancer Center of Wake Forest University, Bowman Gray School of
    Primary lead  CCCWFU-74196






TREATMENT TRIAL PROTOCOL #13 OF 77              12/09/96 11:5              
                          CCCWFU-98195  NCI-V96-1082
Phase III Randomized Study of Quality of Life in Postmenopausal Women with
Resectable Stage II/IIIA Breast Cancer Treated with Adjuvant Tamoxifen Alone
or in Combination with Cyclophosphamide/Methotrexate/Fluorouracil (Summary
Last Modified 12/96)
STATUS: Active   AGE RANGE: 70 and over

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
Gretchen Kimmick   Chair   Ph: 910-716-7975
  Comprehensive Cancer Center of Wake Forest University, Bowman Gray School of
  Medicine
  Medical Center Boulevard
  Winston-Salem, NC  27157-1082
    Comprehensive Cancer Center of Wake Forest University, Bowman Gray School of
    Primary lead  CCCWFU-98195






TREATMENT TRIAL PROTOCOL #14 OF 77              12/09/96 11:5              
                                   CCG-0936
Phase I Study of Intravenous Vinorelbine in Pediatric Patients with Previously
Treated Leukemia, Lymphoma, or Solid Tumors (Summary Last Modified 07/96)
STATUS: Active   AGE RANGE: under 21

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Timothy Madden   Chair   Ph: 713-794-4800
  University of Texas - M.D. Anderson Cancer Center
  Department of Experimental Pediatrics
  1515 Holcombe Boulevard
  Houston, TX  77030
    Children's Cancer Group  Primary lead  CCG-0936






TREATMENT TRIAL PROTOCOL #15 OF 77              12/09/96 11:5              
                                   CCG-0943
Phase I Study of CI-958 (a Synthetic Intercalating Agent) for Recurrent
Pediatric Solid Tumors and Lymphomas (Summary Last Modified 05/95)
STATUS: Active   AGE RANGE: 21 and under

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Carola Arndt   Chair   Ph: 507-284-3903
  Mayo Clinic
  Department of Pediatrics
  200 First Street Southwest
  Rochester, MN  55905
    Children's Cancer Group  Primary lead  CCG-0943






TREATMENT TRIAL PROTOCOL #16 OF 77              12/09/96 11:5              
                           CINJ-M-1373  NCI-V94-0484
Phase I/II Study of Hemodynamically Isolated Intrahepatic Infusion of DOX for
Liver Cancer (Summary Last Modified 11/94)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Thanjavur Subramanian Ravikumar   Chair   Ph: 908-235-6793
  Associate Director
  Cancer Institute of New Jersey
  Robert Wood Johnson Medical School
  Chief of Surgical Oncology
  303 George Street
  Suite 501
  New Brunswick, NJ  08901
    Cancer Institute of New Jersey  Primary lead  CINJ-M-1373






TREATMENT TRIAL PROTOCOL #17 OF 77              12/09/96 11:5              
                          CMC-09-95-14B  NCI-V96-1039
Phase II Pilot Study of Interleukin-2 and Interferon alfa in Metastatic Renal
Cell Carcinoma (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Richard L. White, Jr.   Chair   Ph: 704-355-3809
  Carolinas Medical Center
  Department of General Surgery Research
  C/O Paula Muehlbauer
  Blumenthal Cancer Center
  P.O. Box 32861
  1000 Blythe Boulevard
  Charlotte, NC  28232-2861
    Carolinas Medical Center  Primary lead  CMC-09-95-14B






TREATMENT TRIAL PROTOCOL #18 OF 77              12/09/96 11:5              
                          CMC-09-95-15B  NCI-V96-1038
Phase II Pilot Study of Low-Dose Interleukin-2 for Metastatic Renal Cell
Carcinoma (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Richard L. White, Jr.   Chair   Ph: 704-355-3809
  Carolinas Medical Center
  Department of General Surgery Research
  C/O Paula Muehlbauer
  Blumenthal Cancer Center
  P.O. Box 32861
  1000 Blythe Boulevard
  Charlotte, NC  28232-2861
    Carolinas Medical Center  Primary lead  CMC-09-95-15B






TREATMENT TRIAL PROTOCOL #19 OF 77              12/09/96 11:5              
                          CMC-09-95-16B  NCI-V96-1037
Phase II Study of Interleukin-2 in Metastatic Melanoma (Summary Last Modified
12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Richard L. White, Jr.   Chair   Ph: 704-355-3809
  Carolinas Medical Center
  Department of General Surgery Research
  C/O Paula Muehlbauer
  Blumenthal Cancer Center
  P.O. Box 32861
  1000 Blythe Boulevard
  Charlotte, NC  28232-2861
    Carolinas Medical Center  Primary lead  CMC-09-95-16B






TREATMENT TRIAL PROTOCOL #20 OF 77              12/09/96 11:5              
                          DUT-KWF-CKVO-9411  EU-96025
Phase III Randomized Study of Thoracic Radiotherapy with vs without
Concomitant Carboplatin for Locally Advanced non-Small Cell Lung Cancer
(Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 to 75

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Hendricus Groen   Chair   Ph: 31-50-3612357
  Academisch Ziekenhuis Groningen
  Hanzeplein 1
  9713 EZ Groningen, Netherlands
    Academisch Ziekenhuis Groningen  Primary lead  DUT-KWF-CKVO-9411






TREATMENT TRIAL PROTOCOL #21 OF 77              12/09/96 11:5              
                                    E-1196
Phase II Study of Doxorubicin/Docetaxel for Advanced Breast Cancer (Summary
Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 to 70

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Robert L. Comis   Chair   Ph: 215-955-4652
  Thomas Jefferson University Hospital
  Jefferson Cancer Center
  Suite 1014
  1025 Walnut Street
  Philadelphia, PA  19107-5099
    Eastern Cooperative Oncology Group  Primary lead  E-1196
George W. Sledge   Co-Chair   Ph: 317-635-7401
  Indiana University Hospitals
  Department of Oncology, Room 1730
  550 North University Boulevard
  Indianapolis, IN  46202
    Eastern Cooperative Oncology Group  Primary lead  E-1196






TREATMENT TRIAL PROTOCOL #22 OF 77              12/09/96 11:5              
                                    E-2296
Phase I Study of Radiotherapy plus Fluorouracil and Gemcitabine in Recurrent,
Residual, and Unresectable Pancreatic Adenocarcinoma (Summary Last Modified
12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Robert L. Comis   Chair   Ph: 215-955-4652
  Thomas Jefferson University Hospital
  Jefferson Cancer Center
  Suite 1014
  1025 Walnut Street
  Philadelphia, PA  19107-5099
    Eastern Cooperative Oncology Group  Primary lead  E-2296
David J. Vaughn   Co-Chair   Ph: 215-349-8140
  University of Pennsylvania Cancer Center
  6 Penn Tower
  3400 Spruce Street
  Philadelphia, PA  19104
    Eastern Cooperative Oncology Group  Primary lead  E-2296






TREATMENT TRIAL PROTOCOL #23 OF 77              12/09/96 11:5              
                                    E-5995
Phase II Study of 2-Chlorodeoxyadenosine in Relapsed or Refractory Acute
Myeloid Leukemia (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: no age specified

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Robert L. Comis   Chair   Ph: 215-955-4652
  Thomas Jefferson University Hospital
  Jefferson Cancer Center
  Suite 1014
  1025 Walnut Street
  Philadelphia, PA  19107-5099
    Eastern Cooperative Oncology Group  Primary lead  E-5995
Martin Stuart Tallman   Co-Chair   Ph: 312-908-8697
  Northwestern University Hematology/Oncology
  Suite 700
  233 East Erie Street
  Chicago, IL  60611
    Eastern Cooperative Oncology Group  Primary lead  E-5995






TREATMENT TRIAL PROTOCOL #24 OF 77              12/09/96 11:5              
                             E-8592  NCI-P96-0076
Phase III Randomized Study of Bleomycin vs Doxycycline vs Talc for Malignant
Pleural Effusions (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program, NCI DCPC cancer control study

                             PROTOCOL CHAIRPERSONS
Robert L. Comis   Chair   Ph: 215-955-4652
  Thomas Jefferson University Hospital
  Jefferson Cancer Center
  Suite 1014
  1025 Walnut Street
  Philadelphia, PA  19107-5099
    Eastern Cooperative Oncology Group  Primary lead  E-8592
Norman J. Snow   Co-Chair   Ph: 216-778-5461
  MetroHealth Medical Center
  Department of Surgery
  2500 MetroHealth Drive
  Cleveland, OH  44109-1998
    Eastern Cooperative Oncology Group  Primary lead  E-8592

Michael J. O'Connell   Chair   Ph: 507-284-3903
  Mayo Clinic
  Department of Oncology
  200 First Street Southwest
  Rochester, MN  55905
    North Central Cancer Treatment Group  Secondary lead  NCCTG-942853






TREATMENT TRIAL PROTOCOL #25 OF 77              12/09/96 11:5              
                                  EORTC-10925
Phase III Randomized Study of Internal Mammary and Medial Supraclavicular
Lymph Node Chain Irradiation vs No Further Therapy in Resected Stage I/II/III
Breast Cancer (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 75 and under

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
H. Struikmans   Chair   Ph: 30-2506266
  Academisch Ziekenhuis Utrecht
  Heidelberglaan, 100
  3508 GA Utrecht, Netherlands
    EORTC Breast Cancer Cooperative Group  Primary lead  EORTC-10925

Walter F. Van den Bogaert   Chair   Ph: 32-16346903
  University Hospital Gasthuisberg
  Department of Radiotherapy
  Department of Senology
  Herestraat 49
  U.Z. Gasthuisberg
  B-3000 Leuven, Belgium
    EORTC Radiotherapy Cooperative Group  Secondary lead  EORTC-22922






TREATMENT TRIAL PROTOCOL #26 OF 77              12/09/96 11:5              
                             FRE-CPC014  EU-96009
Phase III Randomized Study of Induction Combination Chemotherapy with Two
Different Doses of Cyclophosphamide Followed by Alternating Chemotherapy and
Radiotherapy in Limited Stage Small Cell Lung Cancer (Summary Last Modified
12/96)
STATUS: Active   AGE RANGE: under 70

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Thierry Le Chevalier   Chair   Ph: 33-1-42-11-43-22
  Institut Gustave Roussy
  Department of Medecine
  39 Rue Camille Desmoulins
  F-94805 Villejuif Cedex, France
    Institut Gustave Roussy  Primary lead  FRE-CPC014
Rodrigo Arriagada   Co-Chair   Ph: 562-206-14-00
  Instituto de Radiomedicina
  Vitacura
  Casilla 124
  Avenida Americo Vespucio Norte 1314
  Las Condes
  34 Santiago, Chile
    Institut Gustave Roussy  Primary lead  FRE-CPC014






TREATMENT TRIAL PROTOCOL #27 OF 77              12/09/96 11:5              
                         FRE-FNCLCC-PEGASE02  EU-96031
Phase II Study of High-Dose Cyclophosphamide/Doxorubicin/G-CSF Followed by
Cyclophosphamide/Doxorubicin/Fluorouracil with Peripheral Blood Stem Cell
Rescue in Inflammatory Breast Cancer (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 to 59

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Patrice Viens   Chair   Ph: 33-91-22-35-37
  Institut J. Paoli and I. Calmettes
  Marseille Institute of Cancer
  232 Bd. de Sainte Marguerite
  13273 Marseille Cedex 9, France
    Federation Nationale des Centres de Lutte Contre le Cancer  Primary lead
    FRE-FNCLCC-PEGASE02






TREATMENT TRIAL PROTOCOL #28 OF 77              12/09/96 11:5              
                         FRE-FNCLCC-PEGASE03  EU-96032
Phase III Randomized Study of Intensification with Cyclophosphamide/Thiotepa
(CHUT) with Autologous PBSC Support vs No Intensification in Locally Recurrent
or Metastatic Breast Cancer Responsive to Induction with
Epirubicin/Fluorouracil/Cyclophosphamide (FEC 100) (Summary Last Modified
12/96)
STATUS: Active   AGE RANGE: under 60

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Pierre Biron   Chair   Ph: 78-78-26-41
  Centre Leon Berard
  Departement de Chimiotherapie Intensive et Greffe de Moelle
  28 Rue Laennec
  69373 Lyon Cedex 08, France
    Federation Nationale des Centres de Lutte Contre le Cancer  Primary lead
    FRE-FNCLCC-PEGASE03






TREATMENT TRIAL PROTOCOL #29 OF 77              12/09/96 11:5              
                         FRE-FNCLCC-PEGASE04  EU-96033
Phase III Randomized Study of Consolidation with
Cyclophosphamide/Mitoxantrone/Melphalan Followed by Autologous Stem Cell
Rescue vs Conventional Chemotherapy for Metastatic Breast Cancer (Summary Last
Modified 12/96)
STATUS: Active   AGE RANGE: under 60

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Henri Hubert Roche   Chair   Ph: 33-61-42-42-42
  Centre Claudius Regaud
  20-24, rue du Pont Saint Pierre
  31052 Toulouse Cedex, France
    Federation Nationale des Centres de Lutte Contre le Cancer  Primary lead
    FRE-FNCLCC-PEGASE04






TREATMENT TRIAL PROTOCOL #30 OF 77              12/09/96 11:5              
                              GER-NB90  EU-96004
Phase III Nonrandomized Study of Therapy Based on Risk Group for Children and
Adolescents with Neuroblastoma (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: under 21

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Frank Berthold   Chair   Ph: 49-221-4784380
  Universitats-Klinik Medizinische
  Department of Pediatric Oncology
  Joseph-Stelzmann-Strasse 9
  D 50924 Cologne (Koln), Federal Republic of Germany
    Medizinische Universitaetsklinik I  Primary lead  GER-NB90






TREATMENT TRIAL PROTOCOL #31 OF 77              12/09/96 11:5              
                             GER-NB95-S  EU-96003
Phase II Study of Regression of Neuroblastoma in Infants (Summary Last
Modified 12/96)
STATUS: Active   AGE RANGE: under 1 year at diagnosis

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Frank Berthold   Chair   Ph: 49-221-4784380
  Universitats-Klinik Medizinische
  Department of Pediatric Oncology
  Joseph-Stelzmann-Strasse 9
  D 50924 Cologne (Koln), Federal Republic of Germany
    Medizinische Universitaetsklinik I  Primary lead  GER-NB95-S






TREATMENT TRIAL PROTOCOL #32 OF 77              12/09/96 11:5              
                                    GOG-160
Phase II Study of Monoclonal Antibody HER2 for Advanced Ovarian Cancer that
Overexpresses the HER2 Antigen (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: no age specified

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Michael A. Bookman   Chair   Ph: 215-728-2987
  Fox Chase Cancer Center
  7701 Burholme Avenue
  Philadelphia, PA  19111
    Gynecologic Oncology Group  Primary lead  GOG-160
Beth Y. Karlan   Co-Chair   Ph: 310-855-3302
  Cedars-Sinai Medical Center
  Suite 160W
  8700 Beverly Boulevard
  Los Angeles, CA  90048
    Gynecologic Oncology Group  Primary lead  GOG-160






TREATMENT TRIAL PROTOCOL #33 OF 77              12/09/96 11:5              
                           GUMC-34594  NCI-V96-0970
Phase I/II Pilot Study of Bispecific Antibody 520C9xH22 with GM-CSF for
Advanced Malignancies Expressing the HER-2/neu Antigen (Summary Last Modified
12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Michael John Hawkins   Chair   Ph: 202-687-8469
  Vincent T. Lombardi Cancer Research Center, Georgetown University Medical
  Center
  Division of Medical Oncology
  Podium Level
  3800 Reservoir Road NW
  Washington, DC  20007
    Vincent T. Lombardi Cancer Research Center, Georgetown University MedicalCen
    Primary lead  GUMC-34594






TREATMENT TRIAL PROTOCOL #34 OF 77              12/09/96 11:5              
                           GUMC-95061  NCI-V96-0969
Phase I Study of Crotoxin (a Noncovalent Heterodimeric Toxin) for Advanced
Carcinomas (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Michael John Hawkins   Chair   Ph: 202-687-8469
  Vincent T. Lombardi Cancer Research Center, Georgetown University Medical
  Center
  Division of Medical Oncology
  Podium Level
  3800 Reservoir Road NW
  Washington, DC  20007
    Vincent T. Lombardi Cancer Research Center, Georgetown University MedicalCen
    Primary lead  GUMC-95061






TREATMENT TRIAL PROTOCOL #35 OF 77              12/09/96 11:5              
                           GUMC-96087  NCI-V96-0968
Phase I Study of CEP-2563 Dihydrochloride (an Indolocarbazole) for Advanced
Solid Tumors (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
pharmaceutical

                             PROTOCOL CHAIRPERSONS
Michael John Hawkins   Chair   Ph: 202-687-8469
  Vincent T. Lombardi Cancer Research Center, Georgetown University Medical
  Center
  Division of Medical Oncology
  Podium Level
  3800 Reservoir Road NW
  Washington, DC  20007
    Vincent T. Lombardi Cancer Research Center, Georgetown University MedicalCen
    Primary lead  GUMC-96087






TREATMENT TRIAL PROTOCOL #36 OF 77              12/09/96 11:5              
              JHOC-NABTT-101-9601  NCI-T96-0052H  NABTT-101-9601
Phase I Open-Label, Multicenter Study of Intraoperative Implantation of
Polifeprosan 20 Wafers Containing Carmustine (GLIADEL) for Recurrent Malignant
Glioma (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI CTEP-approved, NCI grant supported

                             PROTOCOL CHAIRPERSONS
Alessandro Olivi   Chair   Ph: 410-955-3657
  Johns Hopkins Oncology Center
  Johns Hopkins Hospital
  600 North Wolfe Street
  Baltimore, MD  21205
    Johns Hopkins Oncology Center  Primary lead  JHOC-NABTT-101-9601






TREATMENT TRIAL PROTOCOL #37 OF 77              12/09/96 11:5              
                         LIGAND-L1057-33  NCI-V96-1052
Phase II Study of Oral 9-cis-Retinoic Acid for Advanced Hormone-Refractory
Prostate Cancer (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
pharmaceutical

                             PROTOCOL CHAIRPERSONS
Allen F. Gidner   Chair   Ph: 619-452-2345
  Ligand Pharmaceuticals, Inc.
  C/O Parexel International
  8910 University Center Lane, Suite 480
  San Diego, CA  92122-1085
    Ligand Pharmaceuticals, Inc.  Primary lead  LIGAND-L1057-33






TREATMENT TRIAL PROTOCOL #38 OF 77              12/09/96 11:5              
                           MAYO-907253  NCI-V96-1072
Phase II Study of Etoposide and Cisplatin in Recurrent Ependymomas (SummaryLast Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
Randolph S. Marks   Chair   Ph: 507-284-4137
  Mayo Clinical Cancer Center
  Mayo Clinic
  200 First Street Southwest
  Rochester, MN  55905
    Mayo Clinical Cancer Center  Primary lead  MAYO-907253






TREATMENT TRIAL PROTOCOL #39 OF 77              12/09/96 11:5              
                           MAYO-917202  NCI-V96-1073
Phase II Study of Octreotide for Meningioma and Meningeal Hemangiopericytoma
(Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
David W. Kimmel   Chair   Ph: 507-284-3903
  Mayo Clinic
  Department of Neurology
  200 First Street Southwest
  Rochester, MN  55905
    Mayo Clinical Cancer Center  Primary lead  MAYO-917202






TREATMENT TRIAL PROTOCOL #40 OF 77              12/09/96 11:5              
                           MAYO-936101  NCI-V96-1074
Phase II Study of I-MAP (Ifosfamide, Mitomycin, Doxorubicin, and Cisplatin)
with GM-CSF for Suboptimally Debulked Advanced Primary Ovarian Carcinoma and
Primary Peritoneal Carcinoma and Surgically Incurable Genital Carcinosarcomas
(Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
John H. Edmonson   Chair   Ph: 507-284-8413
  Mayo Clinic
  Department of Oncology
  200 First Street Southwest
  Rochester, MN  55905
    Mayo Clinical Cancer Center  Primary lead  MAYO-936101






TREATMENT TRIAL PROTOCOL #41 OF 77              12/09/96 11:5              
                           MAYO-937502  NCI-V96-1075
Phase II Study of Ifosfamide/Mitomycin/Doxorubicin/Cisplatin plus GM-CSF in
Advanced Sarcomas or Mesotheliomas (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
John H. Edmonson   Chair   Ph: 507-284-8413
  Mayo Clinic
  Department of Oncology
  200 First Street Southwest
  Rochester, MN  55905
    Mayo Clinical Cancer Center  Primary lead  MAYO-937502






TREATMENT TRIAL PROTOCOL #42 OF 77              12/09/96 11:5              
                           MAYO-937701  NCI-V96-1076
Phase II Study of Combination Chemotherapy with GM-CSF Support plus
Chemoradiotherapy Prior to Surgery as Function-Preserving Curative Therapy of
Primary Extremity Soft Tissue Sarcomas (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: over 18

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
John H. Edmonson   Chair   Ph: 507-284-8413
  Mayo Clinic
  Department of Oncology
  200 First Street Southwest
  Rochester, MN  55905
    Mayo Clinical Cancer Center  Primary lead  MAYO-937701






TREATMENT TRIAL PROTOCOL #43 OF 77              12/09/96 11:5              
                           MAYO-943001  NCI-V96-1077
Phase II Study of PSC 833 plus Doxorubicin in Metastatic Breast Cancer
Refractory to Anthracyclines or Anthracenediones (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: no age specified

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
Charles Erlichman   Chair   Ph: 507-284-3902
  Mayo Clinical Cancer Center
  Mayo Clinic
  200 First Street Southwest
  Rochester, MN  55905
    Mayo Clinical Cancer Center  Primary lead  MAYO-943001






TREATMENT TRIAL PROTOCOL #44 OF 77              12/09/96 11:5              
                           MAYO-945102  NCI-V96-1078
Phase II Study of Paclitaxel and Cisplatin in Advanced Urothelial Cancer
(Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
Patrick A. Burch   Chair   Ph: 507-284-8432
  Mayo Clinical Cancer Center
  Mayo Clinic
  Medical Oncology, East 12
  200 First Street Southwest
  Rochester, MN  55905
    Mayo Clinical Cancer Center  Primary lead  MAYO-945102






TREATMENT TRIAL PROTOCOL #45 OF 77              12/09/96 11:5              
                           MAYO-968001  NCI-V96-1079
Phase II Study of High-Dose Dexamethasone for Primary Systemic Amyloidosis
(Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
Morie Abraham Gertz   Chair   Ph: 507-284-4102
  Mayo Clinic
  W 10 B
  200 First Street Southwest
  Rochester, MN  55905
    Mayo Clinical Cancer Center  Primary lead  MAYO-968001






TREATMENT TRIAL PROTOCOL #46 OF 77              12/09/96 11:5              
                           MRC-LEUK-CML-IV  EU-96029
Phase III Randomized Study of Interferon alfa Alone vs Before and After
Idarubicin/Cytarabine and Autologous Stem Cell Transplantation for Newly
Diagnosed Chronic Myelogenous Leukemia in Chronic Phase (Summary Last Modified
12/96)
STATUS: Active   AGE RANGE: 18 to 60

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Ian M. Franklin   Chair   Ph: 0141-211-4672
  Royal Infirmary
  University of Glasgow
  Department of Medicine
  Alexandra Parade
  Glasgow G31 2ER, Scotland
  United Kingdom
    Medical Research Council's Working Party on Leukemia in Adults and Children
    Primary lead  MRC-LEUK-CML-IV

Hillard M. Lazarus   Chair   Ph: 216-844-3629
  Case Western Reserve University/Ireland Cancer Center
  University Hospitals of Cleveland
  Dept. of Medicine
  Division of Hematology/Oncology
  11100 Euclid Avenue
  Cleveland, OH  44106-5065
    Eastern Cooperative Oncology Group  Secondary lead  E-7995






TREATMENT TRIAL PROTOCOL #47 OF 77              12/09/96 11:5              
                           MRC-LEUK-CML-V  EU-96028
Phase III Randomized Study of Low- vs High-Dose Interferon alfa for Newly
Diagnosed Chronic Myelogenous Leukemia in Chronic Phase (Summary Last Modified
12/96)
STATUS: Active   AGE RANGE: adult

                                  SPONSORSHIP
non-US clinical trials group

                             PROTOCOL CHAIRPERSONS
Patricia Shepherd   Chair   Ph: 0131-537-1000
  Western General Hospital
  Crewe Road South
  Edinburgh EH4 2XU, Scotland
  United Kingdom
    Medical Research Council's Working Party on Leukemia in Adults and Children
    Primary lead  MRC-LEUK-CML-V
Jill M. Hows   Co-Chair   Ph: 117 950 50 50
  Southmead Hospital
  Westbury-on-Trym
  Bristol BS10 5NB, England
  United Kingdom
    Medical Research Council's Working Party on Leukemia in Adults and Children
    Primary lead  MRC-LEUK-CML-V






TREATMENT TRIAL PROTOCOL #48 OF 77              12/09/96 11:5              
                           MSKCC-96025  NCI-V96-0942
Phase I Pilot Study of Postoperative Oral UFT (Uracil and Tegafur in a 4:1
Molar Ratio) plus Leucovorin and Radiotherapy in Colorectal Cancer (Summary
Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
pharmaceutical

                             PROTOCOL CHAIRPERSONS
Bruce David Minsky   Chair   Ph: 212-639-6817
  Memorial Sloan-Kettering Cancer Center
  Department of Radiation Oncology
  1275 York Avenue
  New York, NY  10021
    Memorial Sloan-Kettering Cancer Center  Primary lead  MSKCC-96025






TREATMENT TRIAL PROTOCOL #49 OF 77              12/09/96 11:5              
                                 NCCTG-952053
Phase II Pilot Study of High-Dose Thoracic Radiotherapy plus Concomitant
Cisplatin/Etoposide in Limited Stage Small Cell Lung Cancer (Summary Last
Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: no age specified

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Michael J. O'Connell   Chair   Ph: 507-284-3903
  Mayo Clinic
  Department of Oncology
  200 First Street Southwest
  Rochester, MN  55905
    North Central Cancer Treatment Group  Primary lead  NCCTG-952053
William R. Noyes   Co-Chair   Ph: 608-263-8500
  University of Wisconsin Comprehensive Cancer Center
  K4/B100
  Radiation Oncology/Department of Human Oncology
  Clinical Science Center
  600 Highland Avenue
  Madison, WI  53792
    North Central Cancer Treatment Group  Primary lead  NCCTG-952053






TREATMENT TRIAL PROTOCOL #50 OF 77              12/09/96 11:5              
                                 NCCTG-952451
Phase II Study of Neoadjuvant Paclitaxel and Carboplatin in Resectable
non-Small Cell Lung Cancer (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Michael J. O'Connell   Chair   Ph: 507-284-3903
  Mayo Clinic
  Department of Oncology
  200 First Street Southwest
  Rochester, MN  55905
    North Central Cancer Treatment Group  Primary lead  NCCTG-952451
Philip J. Stella   Co-Chair   Ph: 313-434-4930
  Ann Arbor Hematology Oncology
  McAuley Cancer Care Building
  Suite C139
  5301 Huron River Drive
  Ypsilanti, MI  48197
    North Central Cancer Treatment Group  Primary lead  NCCTG-952451






TREATMENT TRIAL PROTOCOL #51 OF 77              12/09/96 11:5              
                                 NCCTG-952452
Phase II Study of Edatrexate/Vinblastine/Doxorubicin/Cisplatin with G-CSF in
Advanced non-Small Cell Lung Cancer (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Michael J. O'Connell   Chair   Ph: 507-284-3903
  Mayo Clinic
  Department of Oncology
  200 First Street Southwest
  Rochester, MN  55905
    North Central Cancer Treatment Group  Primary lead  NCCTG-952452
Ron James Kirschling   Co-Chair   Ph: 218-722-8364
  Duluth Clinic
  400 East Third Street
  Duluth, MN  55805-1983
    North Central Cancer Treatment Group  Primary lead  NCCTG-952452






TREATMENT TRIAL PROTOCOL #52 OF 77              12/09/96 11:5              
                          OSU-T96-0020  NCI-T96-0020H
Phase II Study of CI-980 in Untreated Extensive Stage Small Cell Lung Cancer
(Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: no age specified

                                  SPONSORSHIP
NCI-sponsored, NCI CTEP-approved, NCI grant supported

                             PROTOCOL CHAIRPERSONS
Timothy David Moore   Chair   Ph: 614-222-3300
  Central Ohio Medical Group
  497 East Town Street
  Columbus, OH  43215
    Ohio State Comprehensive Cancer Center - Arthur G. James Cancer Hospital and
    Primary lead  OSU-T96-0020






TREATMENT TRIAL PROTOCOL #53 OF 77              12/09/96 11:5              
                                   POG-9432
Phase II Study of Topotecan Followed by Radiotherapy in Newly Diagnosed
Intracranial Ependymoma (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 3 to 21 at diagnosis

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Sharon B. Murphy   Chair   Ph: 312-880-4584
  Chief, Division of Hematology/Oncology
  Children's Memorial Hospital, Chicago
  Box #30
  2300 Children's Plaza
  Chicago, IL  60614
    Pediatric Oncology Group  Primary lead  POG-9432






TREATMENT TRIAL PROTOCOL #54 OF 77              12/09/96 11:5              
                                   POG-9464
Phase II Study of Cyclophosphamide plus Topotecan in Children with Recurrent
or Refractory Solid Tumors (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 21 and under at diagnosis

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Robert L. Saylors   Chair   Ph: 501-320-1494
  Arkansas Children's Hospital
  800 Marshall Street
  Little Rock, AR  72202
    Pediatric Oncology Group  Primary lead  POG-9464






TREATMENT TRIAL PROTOCOL #55 OF 77              12/09/96 11:5              
                                   RTOG-9517
Phase I/II Study of Brachytherapy as the Sole Method of Radiotherapy in
Resected Stage I/II Breast Cancer (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: no age specified

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
James D. Cox   Chair   Ph: 713-792-3411
  University of Texas - M.D. Anderson Cancer Center
  1515 Holcombe Boulevard
  Houston, TX  77030
    Radiation Therapy Oncology Group  Primary lead  RTOG-9517






TREATMENT TRIAL PROTOCOL #56 OF 77              12/09/96 11:5              
                             RTOG-9601  RTOG-R9601
Phase III Randomized, Double-Blind Study of Radiotherapy with vs without
Bicalutamide in Patients with PSA Elevation Following Radical Prostatectomy
for pT3 N0 Carcinoma of the Prostate (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: no age specified

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
James D. Cox   Chair   Ph: 713-792-3411
  University of Texas - M.D. Anderson Cancer Center
  1515 Holcombe Boulevard
  Houston, TX  77030
    Radiation Therapy Oncology Group  Primary lead  RTOG-9601

Charles A. Coltman, Jr.   Chair   Ph: 210-616-5580
  Director
  San Antonio Cancer Institute
  Suite 1000
  8122 Datapoint Drive
  San Antonio, TX  78229-3264
    Southwest Oncology Group  Secondary lead  SWOG-R9601






TREATMENT TRIAL PROTOCOL #57 OF 77              12/09/96 11:5              
                                   RTOG-9609
Phase II Study of Paclitaxel/Etoposide/Cisplatin plus Accelerated
Hyperfractionated Thoracic Radiotherapy for Limited Stage Small Cell Lung
Cancer (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
James D. Cox   Chair   Ph: 713-792-3411
  University of Texas - M.D. Anderson Cancer Center
  1515 Holcombe Boulevard
  Houston, TX  77030
    Radiation Therapy Oncology Group  Primary lead  RTOG-9609






TREATMENT TRIAL PROTOCOL #58 OF 77              12/09/96 11:5              
                               S-9617  SWOG-9617
Phase I Study of Mitoxantrone/Etoposide/PSC 833 in Patients 56 Years of Age
and Over with Previously Untreated Acute Myeloid Leukemia (Summary Last
Modified 12/96)
STATUS: Active   AGE RANGE: 56 and over

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Thomas R. Chauncey   Chair   Ph: 206-764-2709
  University of Washington School of Medicine
  Box 358280
  Seattle, WA  98195
    Southwest Oncology Group  Primary lead  S-9617






TREATMENT TRIAL PROTOCOL #59 OF 77              12/09/96 11:5              
                               S-9628  SWOG-9628
Phase II Study of Dexamethasone/Interferon alfa for Primary Systemic
Amyloidosis (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: adult

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Madhav Dhodapkar   Chair   Ph: 501-686-5222
  Arkansas Cancer Research Center
  University of Arkansas for Medical Sciences
  Mail Slot 508
  4301 West Markham Street
  Little Rock, AR  72205
    Southwest Oncology Group  Primary lead  S-9628






TREATMENT TRIAL PROTOCOL #60 OF 77              12/09/96 11:5              
                                 SAFR-CT-HD-2
Phase III Randomized, Prospective Study of ChlVPP (CLB/VBL/PCB/PRED) with vs
without Radiotherapy for Patients with Responding Advanced Hodgkin's Disease
(Summary Last Modified 04/90)
STATUS: Active   AGE RANGE: 14 and over

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Nicolas Novitzky   Chair   Ph: 27-21-404-3073
  University of Cape Town School of Medicine
  Head, Department of Haematology
  Anzio Road, Observatory
  7925 Cape Town, Republic of South Africa
    University of Cape Town School of Medicine  Primary lead  SAFR-CT-HD-2






TREATMENT TRIAL PROTOCOL #61 OF 77              12/09/96 11:5              
          SCH-C94-105/I94-105  NCI-V95-0665  SCH-C94-105  SCH-I94-105
Phase III Randomized Study of Maintenance Therapy with IFN-A vs Placebo for
Intermediate- and High-Grade non-Hodgkin's Lymphoma in Complete or Partial
Remission Following Salvage Chemotherapy (Summary Last Modified 07/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
pharmaceutical

                             PROTOCOL CHAIRPERSONS
Heinrich H. Gerhartz   Chair   Ph: 
  Staedtische Kliniken Duisburg
  Zu den Rehwiesen 9
  D-47055 Duisburg, Federal Republic of Germany
    Schering-Plough Research Institute  Primary lead  SCH-C94-105/I94-105






TREATMENT TRIAL PROTOCOL #62 OF 77              12/09/96 11:5              
                        SFFCR-IND-45-952  NCI-V96-0998
Phase II Study of Oral Nitrocamptothecin in Advanced Pancreatic Adenocarcinoma
(Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
John S. Stehlin, Jr.   Chair   Ph: 713-652-3161
  Stehlin, deIpolyi Oncology Clinic
  1315 Calhoun, Suite 1800
  Houston, TX  77002
    Stehlin, deIpolyi Oncology Clinic  Primary lead  SFFCR-IND-45-952






TREATMENT TRIAL PROTOCOL #63 OF 77              12/09/96 11:5              
                        SJCRH-ANGEL-6387  NCI-V96-0971
Phase I Study of Neomycin Resistance Gene-Marked, Epstein-Barr Virus-Specific
Autologous Cytotoxic T-Lymphocytes in Relapsed Hodgkin's Disease (Summary Last
Modified 12/96)
STATUS: Active   AGE RANGE: any age

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Helen E. Heslop   Chair   Ph: 901-531-2529
  Saint Jude Children's Research Hospital
  332 North Lauderdale Street
  Memphis, TN  38105-2794
    Saint Jude Children's Research Hospital  Primary lead  SJCRH-ANGEL-6387






TREATMENT TRIAL PROTOCOL #64 OF 77              12/09/96 11:5              
                        SJCRH-ANGELA-6387  NCI-V96-0972
Phase I Study of Neomycin Resistance Gene-Marked, Epstein-Barr Virus-Specific
Autologous Cytotoxic T-Lymphocytes in Patients with Relapsed Hodgkin's Disease
Who Have Undergone Autologous Bone Marrow Transplantation (Summary Last
Modified 12/96)
STATUS: Active   AGE RANGE: any age

                                  SPONSORSHIP
Other/Unknown

                             PROTOCOL CHAIRPERSONS
Helen E. Heslop   Chair   Ph: 901-531-2529
  Saint Jude Children's Research Hospital
  332 North Lauderdale Street
  Memphis, TN  38105-2794
    Saint Jude Children's Research Hospital  Primary lead  SJCRH-ANGELA-6387






TREATMENT TRIAL PROTOCOL #65 OF 77              12/09/96 11:5              
                                   SWOG-9149
Phase II Study of CDDP Preceded by a 12-Hour Continuous Infusion of HU/ARA-C
in Adults with Malignant Glioma (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: adult

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Lode J. Swinnen   Chair   Ph: 708-327-3142
  Loyola University Medical Center
  Division of Hematology-Oncology
  2160 South First Avenue
  Maywood, IL  60153
    Southwest Oncology Group  Primary lead  SWOG-9149






TREATMENT TRIAL PROTOCOL #66 OF 77              12/09/96 11:5              
                                   SWOG-9430
Phase II Study of Complete Surgical Resection of Stage IV Melanoma (Summary
Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Charles A. Coltman, Jr.   Chair   Ph: 210-616-5580
  Director
  San Antonio Cancer Institute
  Suite 1000
  8122 Datapoint Drive
  San Antonio, TX  78229-3264
    Southwest Oncology Group  Primary lead  SWOG-9430






TREATMENT TRIAL PROTOCOL #67 OF 77              12/09/96 11:5              
                                   SWOG-9455
Phase II Study of Fluorouracil and Interferon alfa in Advanced Adenocarcinoma
of the Bladder (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI cooperative group program

                             PROTOCOL CHAIRPERSONS
Charles A. Coltman, Jr.   Chair   Ph: 210-616-5580
  Director
  San Antonio Cancer Institute
  Suite 1000
  8122 Datapoint Drive
  San Antonio, TX  78229-3264
    Southwest Oncology Group  Primary lead  SWOG-9455






TREATMENT TRIAL PROTOCOL #68 OF 77              12/09/96 11:5              
                           UCCRC-7889  NCI-T95-0074H
Phase II Study of Trimethylcolchicinic Acid (TMCA) in Hormone-Refractory
Prostate Cancer (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI CTEP-approved, NCI grant supported

                             PROTOCOL CHAIRPERSONS
John W. Kugler   Chair   Ph: 309-672-5681
  Oncology/Hematology Associates of Central Illinois, P.C.
  Suite 780
  900 Main Street
  Peoria, IL  61602
    University of Chicago Cancer Research Center  Primary lead  UCCRC-7889






TREATMENT TRIAL PROTOCOL #69 OF 77              12/09/96 11:5              
                           UCCRC-8233  NCI-T96-0039H
Phase II Study of CI-958 for Refractory or Recurrent Ovarian Cancer (Summary
Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI CTEP-approved, NCI grant supported

                             PROTOCOL CHAIRPERSONS
Gini Fleming   Chair   Ph: 312-702-6712
  University of Chicago Medical Center
  Department of Hematology/Oncology
  MC 2115
  5841 South Maryland Avenue
  Chicago, IL  60637-1470
    University of Chicago Cancer Research Center  Primary lead  UCCRC-8233






TREATMENT TRIAL PROTOCOL #70 OF 77              12/09/96 11:5              
                           UCCRC-8254  NCI-T96-0048H
Phase II Study of CI-980 for Hormone-Refractory Stage D2 Prostate Cancer
(Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: no age specified

                                  SPONSORSHIP
NCI-sponsored, NCI CTEP-approved, NCI grant supported

                             PROTOCOL CHAIRPERSONS
Juan C. Garcia   Chair   Ph: 219-237-1328
  Michiana Hematology/Oncology P.C.
  922 East Colfax
  South Bend, IN  46617
    University of Chicago Cancer Research Center  Primary lead  UCCRC-8254






TREATMENT TRIAL PROTOCOL #71 OF 77              12/09/96 11:5              
                           UNMC-07996  NCI-V96-0932
Phase II Study of Iodine-131-Labeled Monoclonal Antibody B1 in
Chemotherapy-Refractory Low-Grade B-Cell Lymphomas and Low-Grade Lymphomas
That Have Transformed to Higher Grade Histologies (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
pharmaceutical

                             PROTOCOL CHAIRPERSONS
Julie M. Vose   Chair   Ph: 402-559-5166
  University of Nebraska Medical Center
  Department of Internal Medicine
  Section of Oncology/Hematology
  600 South 42nd Street
  Omaha, NE  68198-3330
    University of Nebraska Medical Center  Primary lead  UNMC-07996






TREATMENT TRIAL PROTOCOL #72 OF 77              12/09/96 11:5              
                            UPCC-3394  NCI-H96-0976
Phase I Study of Stereotactic Injection of the Herpes Simplex Thymidine Kinase
Gene Followed by Intravenous Ganciclovir with and without Surgery for
Recurrent Malignant Glioma (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI grant supported

                             PROTOCOL CHAIRPERSONS
Jane B. Alavi   Chair   Ph: 215-662-6319
  Hospital of the University of Pennsylvania
  3400 Spruce Street
  Philadelphia, PA  19104
    University of Pennsylvania Cancer Center  Primary lead  UPCC-3394






TREATMENT TRIAL PROTOCOL #73 OF 77              12/09/96 11:5              
                          WCCC-CO-9691  NCI-T96-0050H
Phase I Study of Diethylhomospermine (a Synthetic Analogue of the Polyamine
Pathway) in Refractory Malignancies (Summary Last Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: 18 and over

                                  SPONSORSHIP
NCI-sponsored, NCI CTEP-approved, NCI grant supported

                             PROTOCOL CHAIRPERSONS
George Wilding   Chair   Ph: 608-265-8131
  University of Wisconsin Comprehensive Cancer Center
  K6/550 CSC
  Clinical Science Center
  600 Highland Avenue
  Madison, WI  53792
    University of Wisconsin Comprehensive Cancer Center  Primary lead
    WCCC-CO-9691






TREATMENT TRIAL PROTOCOL #74 OF 77              12/09/96 11:5              
                          YALE-HIC-8618  NCI-V96-1094
Phase II Study of High-Dose Carmustine/Etoposide/Cytarabine/Melphalan (BEAM)
Followed by PBSC or Isolated CD34+ PBSC Support in Aggressive, Chemosensitive
B-Cell non-Hodgkin's Lymphoma (Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: 18 to 70

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
Dennis L. Cooper   Chair   Ph: 203-785-6007
  Yale University School of Medicine
  Department of Internal Medicine
  Section of Medical Oncology
  333 Cedar Street
  New Haven, CT  06520-8064
    Yale Comprehensive Cancer Center  Primary lead  YALE-HIC-8618
Diane Krause   Co-Chair   Ph: 203-785-4095
  Yale Comprehensive Cancer Center
  333 Cedar Street
  New Haven, CT  06520-8028
    Yale Comprehensive Cancer Center  Primary lead  YALE-HIC-8618






TREATMENT TRIAL PROTOCOL #75 OF 77              12/09/96 11:5              
                          YALE-HIC-8752  NCI-V96-1093
Phase II Pilot Study of High-Dose Chemotherapy with Peripheral Stem Cell
Support for Stage III/IV Ovarian Epithelial Cancer (Summary Last Modified
12/96)
STATUS: Active   AGE RANGE: over 18

                                  SPONSORSHIP
NCI-sponsored, NCI-sponsored trial in cancer center

                             PROTOCOL CHAIRPERSONS
Thomas J. Rutherford   Chair   Ph: 203-785-6301
  Yale Comprehensive Cancer Center
  Room 332
  333 Cedar Street
  New Haven, CT  06520-8028
    Yale Comprehensive Cancer Center  Primary lead  YALE-HIC-8752
John R. Murren   Co-Chair   Ph: 203-785-6222
  Yale Comprehensive Cancer Center
  Department of Internal Medicine
  Section of Medical Oncology NSB 287
  333 Cedar Street
  New Haven, CT  06520-8028
    Yale Comprehensive Cancer Center  Primary lead  YALE-HIC-8752






TREATMENT TRIAL PROTOCOL #76 OF 77              12/09/96 11:5              
                         YALE-HIC-8895  NCI-T96-0064D
Phase I Study of Perillyl Alcohol for Refractory Malignancies (Summary Last
Modified 12/96)
STATUS: Approved - Not yet active   AGE RANGE: over 18

                                  SPONSORSHIP
NCI-sponsored, NCI CTEP-approved

                             PROTOCOL CHAIRPERSONS
John R. Murren   Chair   Ph: 203-785-6222
  Yale Comprehensive Cancer Center
  Department of Internal Medicine
  Section of Medical Oncology NSB 287
  333 Cedar Street
  New Haven, CT  06520-8028
    Yale Comprehensive Cancer Center  Primary lead  YALE-HIC-8895






TREATMENT TRIAL PROTOCOL #77 OF 77              12/09/96 11:5              
                       ZENECA-1033IL/0030  NCI-V96-1049
Phase III Randomized, Double-Blind Study of Anastrozole vs Tamoxifen as
First-Line Therapy in Postmenopausal Women with Advanced Breast Cancer
(Summary Last Modified 12/96)
STATUS: Active   AGE RANGE: no age specified

                                  SPONSORSHIP
pharmaceutical

                             PROTOCOL CHAIRPERSONS
Bernadette Matthews   Chair   Ph: 302-886-3241
  Zeneca Pharmaceuticals
  1800 Concord Pike
  P.O. Box 15437
  Wilmington, DE  19850-5437
    Zeneca Pharmaceuticals  Primary lead  ZENECA-1033IL/0030
Aman U. Buzdar   Co-Chair   Ph: 713-792-2817
  University of Texas - M.D. Anderson Cancer Center
  Box 56
  1515 Holcombe Boulevard
  Houston, TX  77030
    Zeneca Pharmaceuticals  Primary lead  ZENECA-1033IL/0030
</PRE>



<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

Back to 

	<A HREF="ctrials.html#New Clinical Trials">

Clinical Trials Information Page

	</A>

</H3>



<H3 ALIGN=CENTER>

Return to 

	<A HREF="index.html">

Schine On-Line Home Page

	</A>

</H3>



<H3 ALIGN=CENTER>

See an  

	<A HREF="overview.html">

Overview of Schine On-Line Services

	</A>

</H3>



<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR SIZE=3>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>





</BODY>

</HTML>




</DOC>
<DOC>
<DOCNO>WT01-B18-87</DOCNO>
<DOCOLDNO>IA097-001038-B024-413</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/2ndopine.html 206.119.148.29 19970215060631 text/html 7780
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:22:40 GMT
Last-modified: Wednesday, 24-Jul-96 19:08:45 GMT
Content-length: 7593
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Svces:  Second Opinions</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn about the Medical Search Service offered by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>


	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>



<HR SIZE=6 WIDTH=75%>



<H1 ALIGN=CENTER>Getting a Second Opinion:</H1>



<H2 ALIGN=CENTER>Why a Second Opinion is Necessary</H2>



<HR SIZE=6 WIDTH=75%>



<H4>A Physician Can't Be Up-to-Date on Every Development.</H4>



<P>Medicine is very much a high-technology field.  As with any high-tech field, evolutionary and revolutionary <STRONG>developments are constantly surfacing.</STRONG>  It is not fair to expect any practitioner to be up to date on every current development.</P>



<P>A doctor who is busy practicing medicine just doesn't have time to closely watch the ever changing field of medical research on behalf of every patient.  An article in the March 1992 issue of <I>Consumer Reports</I> cites a study by sociologist David Phillips of the University of California at San Diego that found <STRONG>most physicians initially get their information on new medical developments from the newspaper.</STRONG>  Only a few developments make it into the daily paper right away; many never do at all.</P>



<P><STRONG>It is quite possible that there is a better treatment available or in development about which your doctor simply does not know.</STRONG>  One possible way to find out if this is so in your case is simply to go to another doctor.</P>



<HR SIZE=6 WIDTH=75%>



<H2 ALIGN=CENTER>Where to Get Your Second Opinion</H2>



<HR SIZE=6 WIDTH=75%>



<P>The <A HREF="http://www.nci.nih.gov">National Cancer Institute</A> is the federal organization charged with the responsibility of coordinating government efforts toward fighting cancer.  With its nearly two billion dollar annual budget, the NCI sponsors research and clinical trials, collects and distributes cancer information, and sponsors other programs and activities to battle cancer.  Much of the research sponsored is carried out by other public and private organizations but with financial help from the NCI.</P>



<P>The NCI has designated twenty-eight hospitals and clinics as comprehensive cancer centers and thirteen as clinical cancer centers.  These centers have been recognized for their excellence in cancer treatment by the NCI.</P>



<P><STRONG>To be designated as a comprehensive cancer center, an institution must meet the following criteria:</STRONG></P>



<UL TYPE=SQUARE>

	<LI>must pass rigorous peer review

	<LI>must have a strong core of basic laboratory research in several scientific fields

	<LI>must have a record of innovative clinical research studies

	<LI>must have a strong program of clinical research and an ability to transfer research findings into clinical practice

	<LI>must maintain strong participation in NCI designated high-priority clinical trials

	<LI>must maintain significant levels of cancer prevention and control research

	<LI>must initiate outreach and educational activities

	<LI>must maintain cancer information services for patients and health professionals

</UL>



<P>The clinical cancer centers focus on both basic research and clinical research within each institution.  They frequently incorporate nearby affiliated clinical research institutions into their overall research programs.</P>



<P><STRONG>If you possibly can, get a second opinion from a designated comprehensive cancer center.</STRONG>  Failing that, a clinical cancer center would also be a good bet for a state of the art second opinion.  The designated centers are required to keep up to date on the latest information about cancer and to participate in cancer research and clinical trials.</P>



<P>Also, their staffs include research physicians as well as full time practitioners.  Research physicians tend to be up on the latest developments and the pros and cons of different treatment alternatives.  Also, <STRONG>researchers at NCI-designated facilities are more likely to seek out the latest information on a particular illness because they see that as part of their professional responsibility.  Practitioners, on the other hand, may tend to put a lower priority on keeping current with the latest research developments.</STRONG></P>



<P>Finally, it is important to note that there are many other excellent cancer treatment facilities that do not have the NCI recognition as either a comprehensive or clinical cancer center.  Other groups offer their own lists of quality cancer treatment institutions.  For example, a magazine for cancer survivors and patients called <I>Coping,</I> publishes an annual listing of what it considers to be the top one hundred institutions for cancer treatment in this country.</P>



<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

Back to 

	<A HREF="garybook.html#Second Opinion">

<I>Cancer Cure</I>

	</A>

 (Gary's Book)

</H3>



<H3 ALIGN=CENTER>

Return to 

	<A HREF="index.html">

Schine On-Line Home Page

	</A>

</H3>



<H3 ALIGN=CENTER>

See an  

	<A HREF="overview.html">

Overview of Schine On-Line Services

	</A>

</H3>





<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>



<HR SIZE=3>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>



</TD>

</TR>

</TABLE>



</BODY>

</HTML>










</DOC>
<DOC>
<DOCNO>WT01-B18-88</DOCNO>
<DOCOLDNO>IA097-001038-B024-433</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/cures.html 206.119.148.29 19970215060644 text/html 7139
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:22:52 GMT
Last-modified: Wednesday, 24-Jul-96 19:09:10 GMT
Content-length: 6952
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Svces:  &quot;Cures&quot;</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn about the Medical Search Service offered by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<P>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>


	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>







<HR SIZE=6>



<H1 ALIGN=CENTER>Science Versus Supposition</H1>



<H3 ALIGN=CENTER>An excerpt from <A HREF="garybook.html"><I>Cancer Cure</I></A>, by <A HREF="gstory.html">Gary Schine</A></H3>



<HR SIZE=6>





<P>"Not long ago I was listening to the car radio on a long drive home.  A gentleman was being interviewed on a talk show about how he cured himself of colon cancer.  This gentleman claimed he refused all medical treatment and instead went on a macrobiotic diet which completely eradicated his cancer.  Further, he was sure that most cancer sufferers could cure their disease through following his diet.</P>



<P>"Was his cancer really cured through his macrobiotic diet?  Maybe yes and maybe no.  If his cancer really did disappear, there could have been any number of factors that independently or in combination with other factors were responsible for his reversal of fortune.</P>



<P>"While it is entirely possible that the claimed disappearance of his cancer occurred concurrently with his macrobiotic diet, this in and of itself does not prove that his diet was the cause.  Likewise, one person being treated with a drug and having his cancer disappear concurrently with that treatment does not prove the drug was the cause.</P>



<P><STRONG>"The key to proving or at least indicating a viable cause and effect relationship lies in the scientific method of inquiry.</STRONG>  This first step of the scientific method involves isolating the substance or practice that is suspected of causing the outcome.  That is isoloating the variable --in this case the macrobiotic diet or the drug-- from all other variables that might be alternative causes of the outcome.  The scientific method also demands that results be duplicated several times before any reasonable cause and effect conclusions can be drawn.</P>



<P>"Some phenomena are easy to prove scientifically.  A healthy person's broken bone, if set properly, will heal.  Likewise an otherwise healthy person with any of several kinds of bacterial infections can be cured with antibiotics.  The value of these treatments are easy to prove because they are nearly 100% effective.  That is, if the appropriate antibiotic was administered to 1,000 otherwise healthy people with pneumococcal pneumonia foe example, nearly all of them would have their pneumonia quickly eradicated.  If another 1,000 people with pneumococcal pneumonia received no antibiotic, many of them would not recover.</P>



<P>"What's more, the effect of an antibiotic on various types of bacteria can be easily tested.  The drug will either kill or not kill the bacteria.</P>



<P>"With most cancer treatments though, the results are not nearly as clear.  It is not at all unusual for a treatment to be partially effective for some patients, completely effective for others, and ineffective for others still.  This makes the scientific proof much more complex than in a simple yes or no, all or nothing situation.</P>



<P><STRONG>"For any treatment claims to be considered valid, the same or similar results have to be achieved over and over again.</STRONG>  If 10 people with colon cancer switched to the same macrobiotic diet, received no other treatment, and 9 of the 10 saw their cancer disappear, that would be a reasonable indication the the diet was at least partly responsible.  If 1,000 people with colon cancer switched to the same macrobiotic diet and 900 of them saw their cancer disappear, that would be an even better indication that the diet was responsible.</P>



<P><STRONG>"All reputable science relies on the scientific method.</STRONG>  Whether the research is measuring the effectiveness of a new cancer treatment, the prospects of a political candidate, or consumer reaction to a new breakfast cereal, the principles of scientific inquiry remain the same.  While the methods differ, the underlying theory of research is quite straightforward."</P>



<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

Back to 

	<A HREF="garybook.html#alternatives">

<I>Cancer Cure</I>

	</A>

 (Gary's Book)

</H3>



<H3 ALIGN=CENTER>

Return to 

	<A HREF="index.html">

Schine On-Line Home Page

	</A>

</H3>



<H3 ALIGN=CENTER>

See an  

	<A HREF="overview.html">

Overview of Schine On-Line Services

	</A>

</H3>





<HR SIZE=3 WIDTH=75%>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR SIZE=3>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>



</TD>

</TR>

</TABLE>

</BODY>

</HTML>










</DOC>
<DOC>
<DOCNO>WT01-B18-89</DOCNO>
<DOCOLDNO>IA097-001038-B024-66</DOCOLDNO>
<DOCHDR>
http://www.findcure.com:80/ 206.119.148.29 19970215060408 text/html 7136
HTTP/1.0 200 OK
Server: Netscape-Commerce/1.1
Date: Saturday, 15-Feb-97 06:20:14 GMT
Last-modified: Wednesday, 24-Jul-96 19:09:32 GMT
Content-length: 6949
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD><TITLE>Schine On-Line Services Home Page</TITLE></HEAD>



<BODY BGCOLOR=#FFFFFF  BACKGROUND="bckgrnd.GIF">



<TABLE WIDTH=100% BORDER=0 CELLPADDING=10>

<TR>

	<TD VALIGN=TOP WIDTH=115 ALIGN=CENTER>

	<A HREF="overview.html"><IMG SRC="wand.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>An Overview of SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR> Learn about the Medical Search Service offered by SOLS</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="overview.html#legit" ><IMG SRC="question.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Are We Legitimate?</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>

Questions about SOLS?  Learn more about the legitimacy of our service.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="srchord.html"><IMG SRC="wwwsearch.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Medical Searches</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Order a Medical Search to learn all of your treatment options!</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="ctrials.html"><IMG SRC="ttube.gif" BORDER=0><IMG SRC="beaker.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>New Clinical Trials</B></FONT></A><BR><FONT COLOR=#FFFFFF SIZE=2> Learn about the new clinical trials begun this month.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="garybook.html" ><IMG SRC="ccure.GIF" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Cancer Cure</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Read some exerpts from Gary schine's book and learn how information helped save his life.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="gstory.html"><IMG SRC="gpicsm.JPG" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Gary's Story</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Learn how Gary Schine found a life-saving treatment when his doctor said there weren't any.</FONT>

	<HR NOSHADE>

	<P>

	<A HREF="mailto:schine@findcure.com" ><IMG SRC="mail.gif" BORDER=0><FONT COLOR=#FFFFFF SIZE=4><B><BR>Contact SOLS</B></FONT></A><FONT COLOR=#FFFFFF SIZE=2><BR>Do you have any questions about SOLS?  E-Mail us!</FONT>

	<HR NOSHADE>

	<P>

	</TD>

	<TD ALIGN=TOP FONTSIZE=3>







<H1 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=369 HEIGHT=129 

ALT="Schine On Line Services" 

SRC="logo.gif">

</H1>



<H2 ALIGN=CENTER>Is the Second Best Treatment<BR>Good Enough for You?</H2>



<HR>



<H2 ALIGN=CENTER>

	<A NAME="If the President Had Cancer...">

		<A HREF="garybook.html">

<I>If the President Had Cancer...</I>

		</A>

	</A>

</H2>



<H4 ALIGN=CENTER>by <A NAME="Gary Schine">

		<A HREF="gstory.html">

Gary Schine</H4></A></A>







<H4>If the president were diagnosed with cancer...</H4>



<P><DD>...Doctors and researchers would search for the latest information available on treatments that could save him.  Top experts would be summoned to the White House.  The president would be treated with the best and latest available.  He would be given the best opportunity to defeat that cancer, to survive, and to return to good health.

</P>



<P>For the rest of us it's chancy.  You may get the best available or you may not.  While teams of physicians and researchers would search the literature to make sure a president or a senator got the best there is, the same would not be done for you or for me.  Most of us assume that our doctor is up-to-date on the latest treatments.  However, the facts are that this assumption is as naive as it is comfortable.</P>



<P><STRONG>There is a very real chance that a potentially lifesaving treatment exists that your doctor does not know about.  You simply don't know unless you have the latest information on your illness.</STRONG></P>



<HR WIDTH=100%>



<H3 ALIGN=CENTER>Computers:  Pipeline to Better 

Treatment</H3>



<P>Not too many years ago, searching for medical developments required a major medical library, volumes of heavy directories, and weeks of time.</P>



<P><STRONG>Today it is possible to search thousands of medical journals in minutes, using online medical databases.</STRONG></P>



<P><STRONG>Through database searching, anyone can learn about the latest developments in treatment for any illness </STRONG>--and <STRONG>you may learn about it months before your doctor does.</STRONG>  It is hardly an exaggeration to say your life may be saved by finding the latest information.

<P>The information contained in these databases is <A HREF="selfhelp.html">not accessible</A> from the World Wide Web; they are subscription-only, government databases which are far from user-friendly.  However, the researchers at Schine On-Line Services have been trained to navigate these databases in search of this potentially life-saving information.  Don't leave a stone unturned; let the professionals at Schine On-Line Services help you find all your treatment options!

</P></P>





<HR WIDTH=100%>



<H3 ALIGN=CENTER>

Is the Second Best Treatment<BR> Good Enough for You?

</H3>



<H4 ALIGN=CENTER>

<A HREF="overview.html">An Overview of Schine On-Line Services</A>

</H4>



<P>Schine On-Line Services, Inc., founded by cancer survivor <A HREF="gstory.html">Gary Schine</A>, author of <A HREF="garybook.html">Cancer Cure</A>, gathers information on any and all types of cancer or other illness directly for clients.  Our researchers have extensive on-line experience, training from the National Library of Medicine, and other medical database training.  We can search the databases for you and provide a report of the current developments in treatment and <A HREF="ctrials.html">clinical trials</A> of your particular illness.</P>



<HR WIDTH=100%>



<H3 ALIGN=CENTER>

"Can Information Cure Cancer?"

</H3>



<H4 ALIGN=CENTER>by <A HREF="gstory.html">Gary Schine</A></H4>



<P>I was 38 years old when I learned I had a rare form of leukemia.  The cancer would kill me, my oncologist warned, because there simply was no cure.  He tried to persuade me to take comfort in the fact that it would probably progress slowly; but all I could think about were my two small kids who I'd be leaving behind, and my wife who would have to bring them up alone.</P>



<P>Today, over five years later, I am cancer free.  I expect to stay that way, and the oncologists familiar with my condition expect the same.  I owe my cure to my own efforts in researching and finding the latest information on treating my illness --a newly developed treatment that my doctor knew nothing about.</P>





<HR WIDTH=100%>



<H3 ALIGN=CENTER>

<IMG ALIGN=CENTER WIDTH=305 HEIGHT=75 

ALT="Schine On-Line Services:  1 (800) FIND CURE"

SRC="minilogo.gif">

</H3>





<HR>

<ADDRESS>

Text &#169; 1993-1996, Gary Schine<BR>

Web Site Designed by <A HREF="http://www.tiac.net/users/everlast/">Everlasting Designs</A>

</ADDRESS>

	</TD>

</TR>

</TABLE>

</BODY>

</HTML>




</DOC>
<DOC>
<DOCNO>WT01-B18-90</DOCNO>
<DOCOLDNO>IA062-000359-B043-213</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ 194.159.248.137 19970112015542 text/html 2627
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:55:41 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2455
Last-modified: Fri, 08 Nov 1996 09:42:42 GMT
</DOCHDR>
<html>
<head>
<title>ABPI Home Page</title>
</head>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/abpi_n2.gif alt= ABPI logo></td>
<td width=150></td>
<td width=150><img src=pics/abpi_n3.gif alt= ABPI Address></td>
<td width=100></td>
</table>
</center>

<p>

<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=support.htm>Technical Support</a></td>
<th width=200><a href=abpinews.htm>News</a></td>
<th width=100><a href=new.htm>What's New</a></td>
</tr>

<tr>
<th width=150><a href=#GI>Information</a></td>
<th width=150><a href=msintro.htm>Member Services</a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<center><h1>Welcome to the home pages of the<br>
Association of the British Pharmaceutical Industry (ABPI)</center></h1>

<p>

The ABPI is the trade association for more than a hundred companies in Britain producing prescription medicines.  Its member companies research, develop, manufacture and supply more than 90 per cent of the medicines prescribed through the UK's National Health Service (NHS).

<p>

The pharmaceutical industry carries out almost a third of all industrial research and development in the United Kingdom, spending more than 4 million a day, and is a major earner for Britain, with an annual trade surplus of just over 1,700 million.

<hr>

<center>
<h2><a name=GI>Information</a></h2>
</center>
Click on one of the following links to find out more about:

<ul>
<li><a href=abpiaddr.htm>the ABPI Address</a>
<li><a href=abpiobj.htm>the ABPI strategic objectives</a>
<li><a href=abpimem.htm>a list of the ABPI member companies</a><i> and links to their home pages</i>
</ul>

<hr>

<center>
<i>You are visitor number: <IMG SRC="http://www.demon.co.uk/cgi-bin/Counter.cgi?abpi.index.html"> to the ABPI Home Page since 16 February 1996.</i>
</center>

<hr>
This site is made possible by Eli Lilly European Regulatory Team (ELERT) of Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, United Kingdom.

<hr>
</body>
<address>
<h6>
Last Updated 7 November, 1996.<br>
Web Page by the <A HREF = "MAILTO:IA@ABPI.demon.co.uk">ABPI Webmaster</a> 
</h6>
</address>
<p>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-91</DOCNO>
<DOCOLDNO>IA062-000359-B043-236</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/support.htm 194.159.248.137 19970112015614 text/html 2341
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:56:14 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2169
Last-modified: Wed, 21 Aug 1996 12:08:37 GMT
</DOCHDR>
<html>
<head>
<title>ABPI Information</title>
</head>

<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/abpi_n2.gif alt= ABPI logo></td>
<td width=150></td>
<td width=150><img src=pics/abpi_n3.gif alt= ABPI Address></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<td with=150><center><i>Technical Support</i></center></td>
<th width=200><a href=abpinews.htm>News</a></td>
<th width=100><a href=new.htm>What's New</a></td>
</tr>

<tr>
<th width=150><a href=index.htm#GI>Information</a></td>
<th width=150><a href=msintro.htm>Member Services</a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>
<center><h2>ABPI Technical Support Information</h2></center>
The ABPI Internet pages are written in Hyper Text Markup Language (HTML) version 2. To enable anyone with a browser to use the pages to their full extent, no use has been made of special, nonstandard features of HTML as offered in the latest version of Netscape Navigator 2, <i>e.g.</i> frames and Java script.
<p>
However, if you have problems with the features presented in the various pages, errors in links, etc., please contact the <a href= MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a> by E-mail.
<p>
If you have any problems with the features offered in the Member Services area, please contact the <a href= MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a> by E-mail indicating the problem (<i>e.g.</i> password forgotten, etc.) in a short message providing your name, company name, address and telephone number, and the Webmaster will contact you as soon as possible.<br>

<hr>
<a href=http://www.abpi.org.uk><img align=middle border=0 src=pics/b_arrow.gif></a><a href=http://www.abpi.org.uk>ABPI Home Page</a>

<hr>

</body>
<address>
<h6>Last updated 21 August 1996<br>
Web Page by <a href= MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</address>
<p>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-92</DOCNO>
<DOCOLDNO>IA062-000359-B043-265</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/abpinews.htm 194.159.248.137 19970112015623 text/html 3577
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:56:28 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 3405
Last-modified: Wed, 21 Aug 1996 12:08:35 GMT
</DOCHDR>
<html>
<head>
<title>ABPI News</title>
</head>

<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/abpi_n2.gif alt= ABPI logo></td>
<td width=150></td>
<td width=150><img src=pics/abpi_n3.gif alt= ABPI Address></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=support.htm>Technical Support</a></td>
<td width=200><center><i>News</i><center></a></td>
<th width=100><a href=new.htm>What's New</a></td>
</tr>

<tr>
<th width=150><a href=index.htm#GI>Information</a></td>
<th width=150><a href=msintro.htm>Member Services</a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>


<center><h1>ABPI News</h1></center>

<p>

<center><h3>ABPI pages on the Internet</h3></center>
<p>

The ABPI launched a number of information pages on the Internet on 7 February 1996.  The aim of these pages is to explain the role and structure of the ABPI, and to provide information to companies.

<hr>

<h3><a href=docs/press06.htm>&#163;2 billion-plus trade surplus makes medicines Britain's second-biggest export earner</a></h3>

<P>

Britain's pharmaceutical industry earned well over &#163;2 billion
for the nation last year, putting it second only to the oil industry
as a net contributor to the UK economy, according to final figures
published on 2 May by the Association of the British Pharmaceutical
Industry (ABPI).

<P>

With pharmaceutical exports standing at nearly &#163;5 billion,
the positive balance of trade in medicines was &#163;2,133 million
- 25 per cent higher than the previous year, when it stood at
&#163;1,700 million. The figures push pharmaceuticals above power-generating
machinery into second place as a top earner for Britain.

<hr>

<h3><center><a href=docs/press05.htm>ABPI Annual Report published </a> </center></h3>

<p>

The pharmaceutical industry's spending on research and development
of new medicines in the UK soared to record levels last year,
figures published on 10 April by the Association of the
British Pharmaceutical Industry show.

<hr>

<center><h3><a href=docs/press04.htm>Epilepsy: outlook is good, says industry</a> </h3></center>

<p>

The number of people with epilepsy who have been seizure-free
for two years or more has doubled in the past 30 years thanks
to improvements in medicines and other factors, according to a
booklet launched on 23 April by the ABPI.

<hr>

<center><h3><a href=docs/press01.htm>Charting progress in the treatment of cancer</a></h3></center>

<p>

Important advances in the treatment of cancer are outlined in a new booklet, available from the ABPI.<i>Target Cancer</i> describes some of the research and clinical contributions to the anticancer battle currently being made by British-based pharmaceutical companies. 

<hr>

<a href=http://www.abpi.org.uk><img align=middle src=pics/b_arrow.gif border=0></a>
<a href=http://www.abpi.org.uk>Return to ABPI Home Page</a>

<hr>

</body>
<address>
<h6>Last updated 21 August 1996.<br>
Webpage by the <a href= MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</address>
<p>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-93</DOCNO>
<DOCOLDNO>IA062-000359-B043-286</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/new.htm 194.159.248.137 19970112015631 text/html 2116
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:56:37 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 1944
Last-modified: Fri, 08 Nov 1996 09:49:22 GMT
</DOCHDR>
<html>
<head>
<title>ABPI What's New</title>
</head>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/abpi_n2.gif alt= ABPI logo></td>
<td width=150></td>
<td width=150><img src=pics/abpi_n3.gif alt= ABPI Address></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=support.htm>Technical Support</a></td>
<th width=200><a href=abpinews.htm>News</a></td>
<td width=100><center><i>What's New</i></center></td>
</tr>

<tr>
<th width=150><a href=index.htm#GI>Information</a></td>
<th width=150><a href=msintro.htm>Member Services</a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<center><h2>What's New</h2></center>

<ul>

<li>7 November, 1996 </b><br><br>

There have been some additions to member companies with web pages. These include Amersham, CP Pharmaceuticals, Roche, SmithKline Beecham, and a new address for Pfizer.

There have also been additions to the links page (in the Member Services area).
<br><br>
<hr>
From September 1996, the ABPI Internet pages were divided into an open area, and a Member Services area, which includes information specifically for ABPI member companies.  <br><br>
Contact the ABPI webmaster by e-mail for the user ID and the password, as instructed in the <a href=msintro.htm>Member Services introduction area</a>.



</ul>

<hr>
<a href=http://www.abpi.org.uk><img align=middle border=0 src=pics/b_arrow.gif></a><a href=http://www.abpi.org.uk>ABPI Home Page</a>

<hr>

</body>
<address>
<h6>
Last updated 7 November, 1996.<br>
Web Page by the <A HREF = "MAILTO:IA@ABPI.demon.co.uk">ABPI Webmaster</a> 
</h6>
</address>
<p>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-94</DOCNO>
<DOCOLDNO>IA062-000359-B043-309</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/msintro.htm 194.159.248.137 19970112015639 text/html 2005
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:56:44 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 1833
Last-modified: Thu, 05 Sep 1996 10:37:10 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Member Services Intro</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/abpi_n2.gif alt= ABPI logo></td>
<td width=150></td>
<td width=150><img src=pics/abpi_n3.gif alt= ABPI Address></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=support.htm>Technical Support</a></td>
<th width=200><a href=abpinews.htm>News</a></td>
<th width=100><a href=new.htm>What's New</a></td>
</tr>

<tr>
<th width=150><a href=index.htm#GI>Information</a></td>
<td width=150><center><i>Member Services</i></center></a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

The Member Services area of the site is available only for members of the ABPI.  A password and user id are needed to enter this area, which can be obtained from the webmaster at the<a href= mailto:ia@abpi.demon.co.uk> ABPI</a>.  Please indicate in your e-mail your name, your company name and location, your telephone and fax number, and e-mail address.  The Webmaster will provide you with the user id and password.
<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>
<tr>
<th width=250><a href=members/memserv.htm>Member Services</a></td>
</tr>
</table>
</center>

<hr>

<a href=http://www.abpi.org.uk><img align=middle src=pics/b_arrow.gif border=0></a><a href=http://www.abpi.org.uk>ABPI Home Page</a>

<hr>

</body>
<address>
<h6>
Last Updated 05 September, 1996.<br>
Web Page by the <A HREF = "MAILTO:IA@ABPI.demon.co.uk">ABPI Webmaster</a> 
</h6>
</address>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-95</DOCNO>
<DOCOLDNO>IA062-000359-B043-330</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe.htm 194.159.248.137 19970112015703 text/html 2864
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:56:54 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2692
Last-modified: Fri, 06 Sep 1996 10:16:11 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>OHE Home Page</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohe/ohenews.htm>OHE News</a></td>
<th width=100><a href=ohe/whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=#GI>Information</a></td>
<th width=150><a href=#PUB>Publications</a></td>
<td width=200><center><i>OHE</i></center></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H1><CENTER>Welcome to the Pages of the<BR>

Office of Health Economics (OHE)</CENTER></H1>

<HR>
<a name=GI><center><h2>Information</h2></center></a>
The Office of Health Economics (OHE) was founded in 1962 by the Association of the British Pharmaceutical Industry (ABPI).
The OHE has established an international reputation for the acquisition and collation of health statistics and for its booklets, briefings, monographs, and compendiums.

<P>

The OHE studies and links medical, social and economic data from government, academic and pharmaceutical industry sources, and carries out a limited programme of original research. Its work is reviewed by an editorial board and advice and assistance is given by a panel of honorary advisors and many anonymous specialists who act as ad hoc referees on particular topics.

<HR>
<a name=PUB><center><h2>List of Publications</h2></center></a>
Click on one of the following topics to obtain a list of publications relating to the selected topic:

<UL>
<LI><A HREF=ohe/netschp.htm>Studies of Current Health Problems</A>
<LI><A HREF=ohe/netohed.htm>OHE Briefings</A> 
<LI><A HREF=ohe/netohes.htm>Reports of OHE Symposia</A> 
<LI><A HREF=ohe/netpham.htm>Pharmaceutical Health Monographs</A>
<LI><A HREF=ohe/netcomp.htm>Compendia</A> 
<LI><A HREF=ohe/netoheal.htm>OHE Annual Lectures </A>
</UL>

<HR>

Click <a href=heabpi.htm>here </a>to obtain information about the Health Economics Database launched by OHE and IFPMA.

<hr>

<a href=http://www.abpi.org.uk><IMG SRC=pics/b_arrow.gif ALIGN="BOTTOM" border=0></a> <a href=http://www.abpi.org.uk> ABPI Home Page</a>

<hr>
</body>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-96</DOCNO>
<DOCOLDNO>IA062-000359-B043-351</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/heabpi.htm 194.159.248.137 19970112015720 text/html 6581
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:57:21 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 6409
Last-modified: Wed, 21 Aug 1996 12:08:32 GMT
</DOCHDR>
<head>
<title>HEED Database</title>
</head>
<body bgcolor=#FFFFFF>

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/heed.gif border=0 alt=heed logo></td>
<td width=150></td>
<td width=150><img src=pics/ohe2.gif alt=address HEED></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=2000><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=100><a href=new.htm>What's New</a></td>
</tr>

<tr>
<th width=150><a href=#TOP>Topics</a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<td width=100><center><i>HEED</i></center></td>
</table>
</center>

<hr>

<center>
<b> NEW INDUSTRY- RUN HEALTH ECONOMICS DATABASE<br>
LAUNCHED BY OHE AND IFPMA </b>
</center>
<p>
A specialised data service using CD-ROM to help identify economic evaluations in health care has been launched by the Office of Health Economics (OHE) and the International Federation of Pharmaceutical Manufacturers Associations (IFPMA).
<p>
The service, known as HEED (a Health Economic Evaluations Database), is a database that contains information on health economics articles, in particular studies of cost-effectiveness (and other forms of economic evaluation), with objective analysis of key articles.
<p>
HEED now has more than 6,000 bibliographic references and 2,200 reviewed articles, building up through monthly updates to contain a comprehensive bibliography of all published economic literature.
<hr>
<center><h2><a name=TOP>Topics</h2></center>
<ul><i>
<li><a href=#content>Content</a>
<li><a href=#database>Searching the Database</a>
<li><a  href=#freports>Formatted Reports</a>
<li><a href=#acpan>Academic Panel</a>
<li><a href=#org>Organisation</a>
<li><a href=#info>More Information and Contact</a>
</i></ul>
<hr>
<a name=content><b>Content</b></a><br>
A monthly search of clinical and economic on-line databases is undertaken, combined with hand searching of the leading journals containing evaluation literature. Working papers from academic institutions and references from reviewed and other papers are also included.
<p>Reviews are undertaken of the selected key literature by researchers in academic institutions according to a structured format. In addition to providing an overview of the paper, they also provide additional information, such as ICD-9 and ATC Codes, type of economic evaluation, and type of data source for events and resources used. These categories can be searched on using the CD-ROM software.
<p>
<a name=database><b>Searching the Database</b></a><br>
HEED is very easy to use, even for beginners. There are no complex commands to learn and nearly all operations are simply 'point and click'. You will find that HEED has been designed for easy reference and frequent use. 
<p>With 54 fields to choose from, you can search the database by tailoring your search criteria to pick up only data of relevance to you. The search criteria are grouped into a number of subject groupings. Each subject grouping contains specific search criteria, which you can specify in any combination (in addition to wild card and Boolean functions) to search the database. You can modify and refine your search criteria to quickly access your search results in manageable quantities.  The subject groupings include:
<ul>
<li>Bibliographical details
<li>Study definitions
<li>Analysis and results
<li>Keywords
</ul>
<p>You will be able to search HEED using keywords or any combination of the search criteria that includes:              
<ul>
<li>Author name 
<li>Book/Journal name
<li>Countries applicable
<li>Publication dates 
<li>Publication status
<li>Study dates
<li>ATC classifications 
<li>Data Sources 
<li>Drug names
<li>ICD-9 classifications
<li>Non-drug technologies
<li>Technology assessed
<li>Type of article
<li>Type of economic evaluation
<li>Costs included
<li>Discounting
<li>Patient groups
<li>Sensitivity analysis
<li>Sources of clinical and economic information
<li>Sponsor
</ul>
<p>
You will be able to save your search criteria for use at a later date. 
<p>
<a name=freports><b>Formatted Reports </b></a><br>
The HEED CD-ROM reports will present the results of your search in a clear easy-to-read format.
<p>There are four default report formats:
<ul>
<li>Search Report
<li>Summary Report
<li>Brief Report
<li>Detailed Report
</ul>
<p>
The reports will present the results of your search at increasing levels of detail. The Detailed Report will additionally provide details of the study question, key results and, providing Copyright permission has been given by the article publisher, the article abstract in full.
<p>
Hypertext links are available so that you can access the ICD-9 and ATC sub-reports. You can  also design report  formats for your own specific requirements.
<p>
The results of your search can be directed to a printer at varying levels of detail. You can also export your search results to floppy disc in report or ASCII formats.
<p>
<a name=acpan><b> Academic Panel</a></b><br>
A panel of academic advisors is providing guidance on the search  and review processes.  The panel comprises Martin Buxton, Mike Drummond, Bernie O'Brien, Kevin Schulman, Bengt Jonsson, Frans Rutten, Joan Rovira and Akinori Hisashige.
<p>
<a name=org><b>Organisation</b></a><br>
HEED has been set up with finance from more than 20 companies in the USA, Europe and Japan, who comprise the Steering Group for the project. New industry subscribers will be included in a user group designed to ensure the service develops in accordance with industry needs.
<p>
<a name=info><b> For More Information</b><br>
For further information on the OHE-IFPMA Database please contact : <a HREF = "MAILTO:IA@ABPI.demon.co.uk">Gerry Crosbie</a>, Project Manager, OHE-IFPMA Database Ltd., 12 Whitehall, London SW1A 2DY 
<p>(<b> Tel </b>+44 171 930 3477  Ext. 1474 or<b> Fax </b>: +44 171 747 1419)
<hr>
<a href=http://www.abpi.org.uk><img align=middle src=pics/b_arrow.gif border=0></a><a href=http://www.abpi.org.uk>ABPI Home Page</a>
<hr>
</body>
<p><address>
<h6>
Last Updated 21 August, 1996.<br>
Web Page by the <a HREF = "MAILTO:IA@ABPI.demon.co.uk"><B> ABPI Webmaster</a>.
</Address>
</h6>
<p>
</DOC>
<DOC>
<DOCNO>WT01-B18-97</DOCNO>
<DOCOLDNO>IA062-000359-B043-380</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/abpiaddr.htm 194.159.248.137 19970112015732 text/html 1861
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:57:37 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 1689
Last-modified: Wed, 21 Aug 1996 12:08:36 GMT
</DOCHDR>
<html>

<head>
<title>ABPI Address</title>
</head>
<body bgcolor="#FFFFFF">


<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/abpi_n2.gif alt= ABPI logo></td>
<td width=150></td>
<td width=150><img src=pics/abpi_n3.gif alt= ABPI Address></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=support.htm>Technical Support</a></td>
<th width=200><a href=abpinews.htm>News</a></td>
<th width=100><a href=new.htm>What's New</a></td>
</tr>

<tr>
<th width=150><a href=index.htm#GI>Information</a></td>
<th width=150><a href=msintro.htm>Member Services</a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>
<center><h2>ABPI Address </h2></center>
<p>

<h3>Address: </h3><br>

The Association of the British Pharmaceutical Industry<br>
12 Whitehall<br>
London SW1A 2DY<br>
United Kingdom<br>
<p>
Phone: (+44) (0)171 930 3477<br>
Fax:   (+44) (0)171 747 1411<br>
Telex: 298916 ABPI G<br>
Internet site: <a href=http://www.abpi.org.uk>http://www.abpi.org.uk</a><br>
E-mail: <A HREF = "MAILTO:IA@ABPI.demon.co.uk">International Affairs, ABPI</a>

<hr>

<a href=http://www.abpi.org.uk><img align=middle src=pics/b_arrow.gif border=0></a><a href=http://www.abpi.org.uk>ABPI Home Page</a>

<hr>

</body>

<address>
<h6>
Last Updated 21 August, 1996.<br>
Web Page by the <A HREF = "MAILTO:IA@ABPI.demon.co.uk">ABPI Webmaster</a> 
</h6>
</address>
<p>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-98</DOCNO>
<DOCOLDNO>IA062-000359-B043-401</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/abpiobj.htm 194.159.248.137 19970112015809 text/html 3584
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:58:14 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 3412
Last-modified: Wed, 21 Aug 1996 12:08:33 GMT
</DOCHDR>
<html>
<head>
<title>ABPI and its Members</title>
</head>

<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/abpi_n2.gif alt= ABPI logo></td>
<td width=150></td>
<td width=150><img src=pics/abpi_n3.gif alt= ABPI Address></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=support.htm>Technical Support</a></td>
<th width=200><a href=abpinews.htm>News</a></td>
<th width=100><a href=new.htm>What's New</a></td>
</tr>

<tr>
<th width=150><a href=index.htm#GI>Information</a></td>
<th width=150><a href=msintro.htm>Member Services</a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<center>
<h1>ABPI and its Members</h1>
</center>

<p>

The Association of the British Pharmaceutical Industry (ABPI) is the trade association for more than a hundred companies in Britain producing prescription medicines.  Its member companies research, develop, manufacture and supply more than 90 per cent of the medicines prescribed through the National Health Service (NHS).

<p>

The main functions of the ABPI are to represent the pharmaceutical industry operating in the UK in a way that assures patients access to the best available medicines by creating a favourable political and economic environment that encourages innovative research and development, and affords fair commercial returns.

<p>

The strategic objectives of the ABPI are:<br>

<ul>
<li>to safeguard the interests of patients, and enhance the health of the nation, through effective use of medicines;<br>
<li>to promote the growth and success of its members and the international competitiveness and export performance of the industry;<br>
<li>to develop and promote the UK as an attractive R&D and manufacturing environment to encourage innovation;
<li>to ensure that the industry is recognised as an integral partner in the provision of healthcare.<br>
</ul>

<p>

These objectives will be achieved by:<br>

<ul>
<li>acting as the leading body in representing the industry view to governments and decision makers;<br>
<li>defining, prioritising and managing, on behalf of and with the participation of its membership, issues of strategic importance to the industry;<br>
<li>managing, at national level, the interface with the NHS on industry issues;<br>
<li>managing relationships and effective communication with government, professions, patients and the general public;
<li>facilitating information exchange among the membership and with related external groups;<br>
<li>taking a lead role in developing and implementing standards and codes of practice for the industry through self-regulation;<br>
<li>influencing legislation affecting the industry.
</ul>

<hr>

Click here for a list of the <a href=abpimem.htm>Members of the ABPI</a>

<hr>
<a href=http://www.abpi.org.uk><img align=middle src=pics/b_arrow.gif border=0 alt=back arrow></a><a href=http://www.abpi.org.uk>ABPI Home Page</a>

<hr>

</body>
<address>
<h6>
Last Updated 21 August 1996.<br>
Web Page by the <A HREF = "MAILTO:IA@ABPI.demon.co.uk">ABPI Webmaster</A>
</h6>
</address>
<p>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-99</DOCNO>
<DOCOLDNO>IA062-000359-B043-416</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/abpimem.htm 194.159.248.137 19970112015826 text/html 6572
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:58:31 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 6400
Last-modified: Fri, 08 Nov 1996 09:47:32 GMT
</DOCHDR>
<html>
<head>
<title>ABPI Members</title>
</head>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/abpi_n2.gif alt= ABPI logo></td>
<td width=150></td>
<td width=150><img src=pics/abpi_n3.gif alt= ABPI Address></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=support.htm>Technical Support</a></td>
<th width=200><a href=abpinews.htm>News</a></td>
<th width=100><a href=new.htm>What's New</a></td>
</tr>

<tr>
<th width=150><a href=index.htm#GI>Information</a></td>
<th width=150><a href=msintro.htm>Member Services</a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<center>
<h2>ABPI<br>
List of Member Companies</h2>
<h3>1995  -  1996</h3>
</center>

<hr>

<center>
<a href=#A>A</a>; <a href=#B>B</a>; <a href=#C>C</a>; <a href=#D>D</a>; <a href=#E>E</a>; <a href=#F>F</a>; <a href=#G>G</a>; <a href=#H>H</a>; <a href=#I>I</a>; <a href=#J>J</a>; <a href=#K>K</a>; <a href=#L>L</a>; <a href=#M>M</a>; <a href=#N>N</a>; <a href=#O>O</a>; <a href=#P>P</a>; <a href=#R>R</a>; <a href=#S>S</a>; <a href=#T>T</a>; <a href=#U>U</a>; <a href=#W>W</a>; <a href=#Y>Y</a>; <a href=#Z>Z</a>
</center>

<hr>

<a name=A><b>A</b></a><br>
<ul>
<li>Abbott Laboratories Limited
<li><a href=http://www.amersham.co.uk>Amersham International plc</a>
<li>Amgen Limited
<li>Approved Prescription Services Limited	
<li>Armour Pharmaceutical Company Limited
<li><a href=http://www.astra.com>Astra Pharmaceuticals Limited</a>
<li>Astra Charnwood
</ul>

<a name=B><b>B</b></a><br>
<ul>
<li>BASF plc
<li>Bayer plc
<li>Beecham Research Laboratories
<li>Bencard
<li>Berk Pharmaceuticals
<li>Biogen Limited
<li>Boehringer Ingelheim Limited
<li>Boehringer Mannheim UK (Pharmaceuticals) Limited
<li>The Boots Company plc
<li><A HREF="http://www.bms.com">Bristol-Myers Squibb Pharmaceuticals Ltd</a>
<li>Britannia Pharmaceuticals Limited
<li>British Biotech plc
</ul>

<a name=C><b>C</b></a><br>
<ul>
<li>Celltech Group plc
<li>Centeon Ltd
<li><a href=http://www.chugai.co.uk/>Chugai Pharma Europe Ltd</a>
<li><a href=http://www.ciba.com>Ciba-Geigy plc</a>
<li>Ciba Pharmaceutical
<li>Ciba Vision Lens Care Production Ltd 
<li>Arthur H Cox & Co. Limited
<li><a href=http://www.cppharma.co.uk>CP Pharmaceuticals Limited</a>
</ul>

<a name=D><b>D</b></a><br>
<ul>
<li>Daiichi Pharmaceuticals UK Limited
<li>Dista Products Limited
<li>Du Pont Pharmaceuticals Limited
</ul>

<a name=E><b>E</b></a><br>
<ul>
<li>Eisai Europe Limited
<li>Evans Medical Limited
</ul>
<a name=F><b>F</b></a><br>
<ul>
<li>Faulding Pharmaceuticals plc
<li>Fisons plc  -  Pharmaceutical Division
<li>Fujisawa Limited
</ul>

<a name=G><b>G</b></a><br>
<ul>
<li>Gensia Europe Limited
<li>Glaxo Wellcome Research and Development
<li><a href=http://www.glaxowellcome.co.uk>Glaxo Wellcome plc</a>
<li>Glaxo Wellcome Operations UK
<li>Glaxo Wellcome UK
</ul>

<a name=H><b>H</b></a><br>
<ul>
<li><a href=http://www.hoechst.com>Hoechst Roussel Limited</a>
</ul>

<a name=I><b>I</b></a><br>
<ul>
<li>Immuno Limited
<li>Ipsen International Limited
</ul>

<a name=J><b>J</b></a><br>
<ul>
<li>Janssen-Cilag Limited
</ul>

<a name=K><b>K</b></a><br>
<ul>
<li>Knoll Limited
</ul>

<a name=L><b>L</b></a><br>
<ul>
<li>Lagap Pharmaceuticals
<li>Leo Laboratories Limited
<li><a href=http://www.lilly.com>Eli Lilly and Company Limited</a>
<li>Lilly Industries Limited
<li>Lorex Synthelabo Ltd
</ul>

<a name=M><b>M</b></a><br>
<ul>
<li>3M Health Care Limited
<li>Marion Merell Dow Limited
<li>May & Baker
<li><a href=http://www.medeva.co.uk>Medeva plc</a>
<li>Medevale Pharmaservices Limited
<li>Merck and Lipha Pharmaceuticals
<li><a href=http://www.merck.com>Merck Sharp & Dohme Limited</a>
</ul>

<a name=N><b>N</b></a><br>
<ul>
<li>Norton Healthcare Limited
<li>Novex Pharma Limited
</ul>

<a name=O><b>O</b></a><br>
<ul>
<li>Organon Laboratories Limited
<li>Otsuka Pharmaceutical Co. Ltd
</ul>

<a name=P><b>P</b></a><br>
<ul>
<li>Parke Davis & Co. Limited
<li>Pasteur Merieux MSD Limited
<li><a href=http://www.pfizer.com/>Pfizer Limited</a>
<li>Proctor & Gamble Pharmaceuticals UK Limited
</ul>

<a name=R><b>R</b></a><br>
<ul>
<li>William Ransom & Son plc
<li>Regent-GM Laboratories Limited
<li>Rhone-Poulenc Rorer Limited
<li><a href=http://www.roche.com>Roche Products Limited</a>
<li>Rosemont Pharmaceuticals Limited
</ul>

<a name=S><b>S</b></a><br>
<ul>
<li><a href=http://www.med.umich.edu/trans/sandoz/>Sandoz Pharmaceuticals (UK) Limited</a>
<li>Sanofi Winthrop Limited
<li><a href=http://www.schering.co.uk/schering>Schering Health Care Limited</a>
<li>Schering-Plough Limited
<li>Schwarz Pharma Limited
<li><a href=http://www.monsanto.com/products/pharmaceutical/index.html>Searle</a>
<li>Smith & Nephew Healthcare Limited
<li>Smith & Nephew Medical Limited
<li><a href=http://www.sb.com/>SmithKline Beecham Pharmaceuticals</a>
<li>Solvay Healthcare Limited
<li>Speywood Pharmaceuticals Limited
<li>Steripak Limited
<li>Sterwin Medicines
<li>Stuart Pharmaceuticals
</ul>

<a name=T><b>T</b></a><br>
<ul>
<li>Takeda Euro R & D Centre
<li>Trinity Pharmaceuticals Limited
</ul>

<a name=U><b>U</b></a><br>
<ul>
<li>Upjohn Limited
</ul>

<a name=W><b>W</b></a><br>
<ul>
<li><A HREF="http://www.warner-lambert.com/">Warner Lambert (UK) Limited</a>
<li>Wyeth Lederle
<li>Wyeth Lederle UK (Export)
</ul>

<a name=Y><b>Y</b></a><br>
<ul>
<li>Yamanouchi UK Limited
<li>Yamanouchi Pharma Limited
</ul>

<a name=Z><b>Z</b></a><br>
<ul>
<li>Zeneca Pharmaceuticals
<li>Zeneca Pharma
</ul>

<hr>
<a href=abpiobj.htm><img align=middle border=0 src=pics/b_arrow.gif></a>
<a href=abpiobj.htm>ABPI and its Members</a>

<p>

<a href=http://www.abpi.org.uk><img align=middle border=0 src=pics/b_arrow.gif></a><a href=http://www.abpi.org.uk>ABPI Home Page</a>

<hr>
</body>
<address>
<h6>Last updated 7 November, 1996<br>
Web Page by <a href= MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</address>
<p>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-100</DOCNO>
<DOCOLDNO>IA062-000359-B044-1</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/index.htm 194.159.248.137 19970112015852 text/html 2627
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:58:57 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2455
Last-modified: Fri, 08 Nov 1996 09:42:42 GMT
</DOCHDR>
<html>
<head>
<title>ABPI Home Page</title>
</head>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td with=100></td>
<td width=150><img src=pics/abpi_n2.gif alt= ABPI logo></td>
<td width=150></td>
<td width=150><img src=pics/abpi_n3.gif alt= ABPI Address></td>
<td width=100></td>
</table>
</center>

<p>

<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=support.htm>Technical Support</a></td>
<th width=200><a href=abpinews.htm>News</a></td>
<th width=100><a href=new.htm>What's New</a></td>
</tr>

<tr>
<th width=150><a href=#GI>Information</a></td>
<th width=150><a href=msintro.htm>Member Services</a></td>
<th width=200><a href=ohe.htm>OHE</a></td>
<th width=100><a href=heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<center><h1>Welcome to the home pages of the<br>
Association of the British Pharmaceutical Industry (ABPI)</center></h1>

<p>

The ABPI is the trade association for more than a hundred companies in Britain producing prescription medicines.  Its member companies research, develop, manufacture and supply more than 90 per cent of the medicines prescribed through the UK's National Health Service (NHS).

<p>

The pharmaceutical industry carries out almost a third of all industrial research and development in the United Kingdom, spending more than 4 million a day, and is a major earner for Britain, with an annual trade surplus of just over 1,700 million.

<hr>

<center>
<h2><a name=GI>Information</a></h2>
</center>
Click on one of the following links to find out more about:

<ul>
<li><a href=abpiaddr.htm>the ABPI Address</a>
<li><a href=abpiobj.htm>the ABPI strategic objectives</a>
<li><a href=abpimem.htm>a list of the ABPI member companies</a><i> and links to their home pages</i>
</ul>

<hr>

<center>
<i>You are visitor number: <IMG SRC="http://www.demon.co.uk/cgi-bin/Counter.cgi?abpi.index.html"> to the ABPI Home Page since 16 February 1996.</i>
</center>

<hr>
This site is made possible by Eli Lilly European Regulatory Team (ELERT) of Eli Lilly and Company, Lilly Research Centre, Windlesham, Surrey, United Kingdom.

<hr>
</body>
<address>
<h6>
Last Updated 7 November, 1996.<br>
Web Page by the <A HREF = "MAILTO:IA@ABPI.demon.co.uk">ABPI Webmaster</a> 
</h6>
</address>
<p>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-101</DOCNO>
<DOCOLDNO>IA062-000359-B044-16</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/docs/press06.htm 194.159.248.137 19970112015900 text/html 3558
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:59:06 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 3386
Last-modified: Tue, 20 Aug 1996 09:32:53 GMT
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<TITLE>Press Release - Trade Surplus No 2</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="ABPI">
</HEAD>

<BODY>
<body text="#3300FF" bgcolor="#FFFFFF" link="#CC0000" vlink="#00FF00">

<P>
<CENTER>
<H3>&#163;2 billion-plus trade surplus makes medicines Britain's
second-biggest export earner</CENTER></H3>

<P>
Britain's pharmaceutical industry earned well over &#163;2 billion
for the nation last year, putting it second only to the oil industry
as a net contributor to the UK economy, according to final figures
published on 2 May by the Association of the British Pharmaceutical
Industry (ABPI).
<P>
With pharmaceutical exports standing at nearly &#163;5 billion,
the positive balance of trade in medicines was &#163;2,133 million
- 25 per cent higher than the previous year, when it stood at
&#163;1,700 million. The figures push pharmaceuticals above power-generating
machinery into second place as a top earner for Britain.
<P>
The figures show that exports of pharmaceuticals in 1995 were
worth &#163;4,935 million, compared with &#163;4,004 million the
previous year, while imports stood at &#163;2,802 million (&#163;2,304
million in 1994).
<P>
The results support the recent prediction by the Secretary of
State for Health, Mr Stephen Dorrell, that pharmaceuticals will
be as important for Britain in the next century as they have been
in recent years.
<P>
&quot;These figures reflect the strength of the British-based
pharmaceutical industry,&quot; said Dr Trevor Jones, Director-General
of the ABPI. &quot;They show the enormous contribution it makes
towards the wealth - as well as the health - of the nation when
given the scope to develop the long-term strategies essential
in a research-based industry. The benefit to Britain's economy
in jobs, foreign earnings and tax revenues is also worth &#163;2
billion a year.
<P>
&quot;Nevertheless, despite the undoubted success reflected in
the balance of trade surplus, imports of medicines are growing
almost as fast as exports. While there are clearly pressures on
funding healthcare in the UK, it is vital that any Government,
of whatever persuasion, continues to provide a stable environment
which looks to the long-term future of the industry.&quot;
<P>
Two of the biggest increases in the pharmaceutical balance of
trade surplus are to European Union countries and to the USA.
Exports to the EU rose to &#163;2,592 million in 1995 - a jump
of 38 per cent on 1994 when they were &#163;1,883 million - giving
a trade surplus of &#163;553 million, up 33 per cent from &#163;418
million. There was a 57 per cent jump in the trade surplus with
the USA, with the 1994 figure of &#163;212 million increasing
to &#163;333 million in 1995. This was due to a 46 per cent rise
in exports (&#163;619 million in 1995 from &#163;426 million in
1994).
<P>
Of other countries, the most dramatic rise is in the trade surplus
with Australia, where it more than doubled from 1994's &#163;57
million to reach &#163;117 million in 1995. This was largely due
to a 68 per cent rise in exports. 

<P>
<P>
<HR> 
<a href=abpinews.htm><img align=middle src=b_arrow.gif></a><a href=abpinews.htm>Return to ABPI News </a>
<hr>

</BODY>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-102</DOCNO>
<DOCOLDNO>IA062-000359-B044-40</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/docs/press05.htm 194.159.248.137 19970112015935 text/html 5618
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:59:23 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 5446
Last-modified: Tue, 20 Aug 1996 09:32:53 GMT
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<TITLE>Press Release - Trade Surplus</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="ABPI">
</HEAD>

<BODY>
<body text="#3300FF" bgcolor="#FFFFFF" link="#CC0000" vlink="#00FF00">

<P>
<CENTER><H3>MEDICINES RESEARCH AND TRADE SURPLUS BOTH HIT &#163;2 BILLION RECORD - NHS SPENDING ON MEDICINES IS LOW, SAYS INDUSTRY ANNUAL
REPORT</H3></CENTER>
<P>
The pharmaceutical industry's spending on research and development
of new medicines in the UK soared to record levels last year,
figures published on 10 April by the Association of the
British Pharmaceutical Industry show.
<P>
But the UK is near the bottom of the league table in terms of
the number of prescriptions written and their cost per head to
the NHS - an average of nine prescriptions a year at an average
cost of less than &#163;9.
<P>
Publishing its annual review, the ABPI predicted that the UK industry
would break the &#163;2 billion mark in terms of trade surplus
in medicines for 1995 - a record surplus with exports of more
than &#163;4 billion, making medicines one of the top three export
earners for Britain.
<P>
Latest figures for expenditure on UK research and development
by the pharmaceutical industry show that in 1995 it also reached
a record &#163;2 billion - more than &#163;5 million every day
- and represented about 20 per cent of the UK's total investment
in R&amp;D. An analysis of the R&amp;D record of all major British
companies over a four-year period put five pharmaceutical companies
in the top 15.
<P>
&quot;While we continue to make an enormous investment in the
fight against disease - the UK-based pharmaceutical industry is
offering real value for money, to the benefit of the NHS, patients
and taxpayers,&quot; said Dr Trevor Jones, Director-General of
the ABPI at the launch of the association's Annual Review.
<P>
&quot;However, these figures do pose the question, are we making
the most of our medicines?,&quot; said Dr Jones. &quot;Cheap prescribing
is by no means always good prescribing, and it is important that
the benefit of medicines, and not solely their cost, are taken
into account when deciding how best to treat patients.
<P>
&quot;There is no doubt that major advances in medicines would
be adopted more quickly if there were a shift towards evidence-based
analysis of health treatments, supported by firm, scientific proof
of their effectiveness, and we support moves towards this. Medicines
are a real winner.&quot;
<H3>INTERNATIONAL SUCCESS</H3>

<P>
The role played by the pharmaceutical industry in attracting inward
investment to Britain is also highlighted by the report. During
1995, the merger of two British firms, Glaxo and Wellcome, created
the world's largest pharmaceutical company by sales and Britain's
largest company by market capitalisation.
<P>
Sweden's Pharmacia and the American company Upjohn also merged
and decided to base their international headquarters in Britain.
&quot;Their decision emphasised confidence in the UK as the location
of choice for many pharmaceutical companies,&quot; said the ABPI's immediate past 
President, Dr Till Medinger.
<P>
&quot;Many overseas companies are seeking to increase their investment
in the UK, which has long been regarded as a centre of excellence
in the pharmaceutical world. The future opportunities for the
industry, linked to the spectacular advance of scientific knowledge
in biotechnology and genomics, are more exciting than ever.&quot;
<P>
Several overseas companies increased their investment in the UK,
as the process of rationalisation in the industry continued. Rh&ocirc;ne-Poulenc
Rorer acquired Fisons, after Astra had strengthened its UK research
base through the purchase of Fisons' research division, and BASF
took over Boots' prescription medicines manufacturing and research
business. There was a number of other mergers and acquisitions
in the industry.
<H3>PATIENT EMPOWERMENT</H3>

<P>
The industry's developing relationship with patients is reported
by the Review. To enable patients to take their rightful place
in the decision-making process for their own healthcare, the ABPI
and pharmaceutical companies recognise that they need to have
access to a full range of health information.
<P>
As well as the introduction of patient packs for prescription-only
medicines, complete with full patient information leaflets - a
three-year rolling programme began at the end of 1995 - the ABPI
also announced a new, voluntary scheme for its member companies
to make available more information to the public when a medicine
is licensed.
<P>
From January, companies have been opening up to the public for
the first time summaries of new licensing data submitted to the
Government as part of the medicines approval process, including
information on safety, side effects and the scientific basis on
which a medicine is approved.
<P>
&quot;For too long, the patient's voice has been disregarded and
I am delighted that the moves the ABPI has made to involve them
in the communication process have been greeted with such enthusiasm
by the patient groups,&quot; said Dr Medinger.

<P><P><HR> 
<a href=abpinews.htm><img align=middle src=b_arrow.gif></a><a href=abpinews.htm>Return to ABPI News </a>
<hr>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-103</DOCNO>
<DOCOLDNO>IA062-000359-B044-63</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/docs/press04.htm 194.159.248.137 19970112015949 text/html 5190
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 01:59:54 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 5018
Last-modified: Tue, 20 Aug 1996 09:32:53 GMT
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<TITLE>Press Release - Epilepsy </TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="International Affairs">
</HEAD>

<BODY>
<body text="#3300FF" bgcolor="#FFFFFF" link="#CC0000" vlink="#00FF00">

<P>
<CENTER><H3>EPILEPSY: OUTLOOK IS GOOD, SAYS INDUSTRY</H3></CENTER>

<P>
The number of people with epilepsy who have been seizure-free
for two years or more has doubled in the past 30 years thanks
to improvements in medicines and other factors, according to a
booklet launched on 23 April by the Association of the British Pharmaceutical
Industry (ABPI).
<P>
And the report stresses: &quot;It is probably not appropriate
to talk of 'cure' in people with active epilepsy, but the outlook
for most people is good.&quot;
<P>
Scientific studies show that, between 1950 and 1960, only 30 per
cent of people with epilepsy were seizure-free for a two-year
period, states the booklet, <I>Target Epilepsy</I>. Thirty years
later, this has risen to 60 per cent<I>.</I> 
<P>
&quot;As a medical problem, epilepsy is on a par with diabetes
- but funding remains one-twelfth that for diabetes, and specialist
clinics dealing with the disease have not been widely introduced,&quot;
said Dr Trevor Jones, Director-General of the ABPI, speaking at
the London launch of <I>Target Epilepsy</I>. &quot;Partly as a
response to this, many pharmaceutical companies working in this
field are providing a wide range of services for doctors, nurses
and people with epilepsy.
<P>
&quot;The UK-based pharmaceutical industry spends more than &#163;5
million a day on researching and developing new medicines, yet
its contribution to the fight against disease stretches well beyond
this. Working in co-operation with healthcare professionals and
with patients themselves are key elements in the industry's overall
strategy.&quot;
<P>
The second in a series of booklets designed to inform the general
public of the contribution being made by the UK-based pharmaceutical
industry towards treating healthcare, <I>Target Epilepsy</I> examines
the different forms the disease can take, what effect it has on
people, and some of the available treatments, especially anti-epileptic
medicines.
<P>
The search for such medicines has proved long and difficult. The
reasons for this include:
<UL>
<LI>No real indication as to the underlying causes of most cases
of epilepsy.
<LI>Insufficient understanding of brain function.
<LI>The realisation that epilepsy is not a single condition, but
a group of complex disorders.
</UL>

<P>
<I>Target Epilepsy</I> shows that the increase in the number of
people going two years or more without a seizure has come about
through better advice, improvements in the way medicines are used
and better population studies, as well as improved medication.
<P>
&quot;In those cases in which control has been achieved over several
years, a physician may gradually reduce and eventually discontinue
medication, and many such individuals will remain seizure-free
for the rest of their lives,&quot; the booklet says.
<P>
The booklet acknowledges that there are still more than 70,000
people with epilepsy in the UK who do not respond adequately to
available medicines, and much remains to be done. Nevertheless,
the overall message is optimistic, because about two-thirds of
people have their seizures controlled through the use of a single
medicine, and even more achieve control through a combination
of therapies.
<P>
The booklet goes on to describe the development of medicines over
the years, and explains how these work, addressing some difficult
challenges faced by scientists, such as how to get medicines into
the brain - a relatively inaccessible part of the body. And it
goes on to look at future developments.
<P>
&quot;There has recently been a notable growth of activity in
the field of epilepsy research, and much dedicated work over the
past 25 years has now come to fruition,&quot; the booklet says.
&quot;The result has been the introduction of new agents for partial
or generalised seizures or for those whose seizures are not adequately
controlled by traditional medicines,&quot; says the booklet. Four
entirely new medicines have been introduced in the past six years.
<P>
And the booklet adds: &quot;Other new products are in the pipeline,
but it is too soon to say whether they will represent major clinical
progress... But in the past few years, new medicines have made
huge progress in the treatment of epilepsy and the search for
the medicines of the future continues.&quot;
<P>
Researched and written by the medical writer, Dr Mike Hall, <I>Target
Epilepsy</I> is available free from the ABPI, 12 Whitehall, London
SW1A 2DY.
<P> 
<P>
<HR>
<a href=abpinews.htm><img align=middle src=b_arrow.gif></a><a href=abpinews.htm>Return to ABPI News </a>
<hr>
<p>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-104</DOCNO>
<DOCOLDNO>IA062-000359-B044-83</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/docs/press01.htm 194.159.248.137 19970112020021 text/html 7262
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:00:04 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 7090
Last-modified: Fri, 08 Nov 1996 09:51:01 GMT
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="International Affairs">
</HEAD>

<BODY>
<body text="#3300FF" bgcolor="#FFFFFF" link="#CC0000" vlink="#00FF00">

<center><H3>CHARTING PROGRESS IN TREATMENT OF CANCER</H3></center><br>

<P>
Important advances in the treatment of cancer are outlined in
a new booklet launched on 25 January in London by the Association
of the British Pharmaceutical Industry (ABPI).
<P>
The booklet, <i>Target Cancer</i>, describes some of the research and
clinical contributions to the anticancer battle currently being
made by British-based pharmaceutical companies.
<P>
Some 160,000 people die of cancer each year in the UK alone, and
the pharmaceutical industry plays a vital role in investigating
the disease. More money is invested into researching how cancer
works and how to treat it by the industry - which spends a total
of &#163;4 million a day on research and developing new medicines
- than the Government and charities combined, the booklet points
out.
<P>
&quot;The UK pharmaceutical industry has a worldwide reputation
for its research and development into cancers, as it does in many
other disease areas,&quot; said Dr Trevor Jones, Director-General
of the ABPI, who chaired the launch of the booklet. &quot;Yet
we are not in competition with the basic work of Government-funded
and charity-based scientists - rather we are working in full co-operation
and collaboration with them.&quot;
<P>
Nearly 50 new potential compounds in UK clinical trials for cancer
treatment or diagnosis are listed in the booklet, including more
than 30 non-biological treatments - the others are biological
products resulting from research in molecular biology. The first
category incorporates medicines to fight cancer in a variety of
areas, including breast cancer (six new medicines); large intestine
(six); prostate (five); lung (five); and leukaemias (three).
<P>
The rest are in other areas, including cancers of the ovaries,
pancreas, kidney, testes, stomach, head/neck, liver, and tumours
in various nervous tissue locations. Among the biological products
are stimulators of blood cell production in the bone marrow, bone
marrow protectors, immune stimulators and vaccine-type agents.
There are also three agents designed to break the resistance that
some tumours develop to medicines.
<P>
<i>Target Cancer</i> explains that one of the most serious problems facing
clinicians in the treatment of cancer is the development of resistance
to the medicines used. Studies in the USA have suggested that
90 per cent of the 1,400 people who die from cancer each day have
developed resistance at the time of their death.
<P>
Anti-cancer medicines need to accumulate inside cells to work.
Many cells that become resistant develop a mechanism for pumping
out anti-cancer medicines. Much research has therefore been directed
towards the discovery of compounds to prevent or reverse this
process, thereby enhancing the effectiveness of current medicines.
If this proves possible, one of the major problems facing physicians
is overcome.
<P>
Scientists have now identified many of the altered outer constituents
of cancer cells, raising the possibility that anti-cancer vaccines
can be made. New types of anti-cancer vaccine have been produced
and some are in early trials for solid tumours such as breast,
pancreas, large intestine, lung, prostate and skin cancer (melanoma).
<P>
However, the booklet suggests these products are more likely to
complement available therapies and boost other therapeutic measures
rather than replace them.
<P>
Among more conventional approaches, advances are being made in
areas, including:
<UL>
<LI>In <b>breast cancer</b> research, particular attention has been paid
to dealing with 'steroid-dependent' tumours, whose growth depends
on 'stimulation' by oestrogen. Developments are also being made
with an agent originally isolated from the bark of the Pacific
yew tree, but which can now be made synthetically.
<LI>Recent developments have resulted in improved survival rates
for patients in the advanced stages of <b>ovarian cancer</b>. A new class
of anti-cancer medicines has shown effectiveness in patients who
have not responded to some forms of conventional therapy.
<LI><b>Prostate</b> cancer and prostate enlargement - which often precedes
cancerous transformation - are a massive potential medical problem.
In Europe, there are some 19 million cases, with only about two
million receiving treatment. Several companies are developing
therapies to deal with both conditions.
<LI>Affecting both men and women, <b>cancer of the large intestine</b>
is one of the most frequent causes of death and is a tumour that
spreads easily, especially to the liver. Several companies have
made this a high-priority objective.
<LI>Established <b>lung cancer </b>is among the most difficult of all
cancers to treat. In an attempt to improve therapy, several companies
are investigating medicines aimed at targeting the tumours more
effectively.
</UL>

<P>
The booklet examines progress in the research into cancer being
made by the British-based industry in four main areas, although
the unique expertise of the industry lies in designing, synthesising
and testing new molecules. &quot;Some companies are British owned,
while others are subsidiaries of multinational organisations which
recognise the reputation of British medicine by basing their research
and development or clinical research facilities here,&quot; states
the booklet.
<P>
The booklet stresses there is clearly much more to be done in
the fight against cancer, and that many companies intend applying
gene therapy to many forms of cancer. &quot;If this happens, it
could herald the dawn of a new era of cancer treatment,&quot;
the booklet states.
<P>
The overall message of <i>Target Cancer</i> is encouraging. Increasingly,
there is greater openness about the causes and treatment of cancer
which will help to take the mystery out of the disease and remove
some of the fear still attached to it.
<P>
&quot;In the meantime, those who develop cancer should be aware
of the great progress that has been made - many tumours can be
cured and for those where this remains impossible, the duration
and quality of their lives can often be greatly increased,&quot;
the booklet says.
<P>
<i>Target Cancer </i> has been produced to inform the general public of
the contribution being made by the UK-based pharmaceutical industry
towards diagnosing and treating cancer. Researched and written
by Dr Mike Hall, a well-respected medical writer, the booklet
is available free from the ABPI, 12 Whitehall, London, SWIA 2DY, United Kingdom.
<p>
<p>
<hr>
<hr>
<a href=http://www.abpi.org.uk><img align=middle src=pics/b_arrow.gif border=0></a>
<a href=http://www.abpi.org.uk>Return to ABPI Home Page</a>
<p>
<hr>


</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-105</DOCNO>
<DOCOLDNO>IA062-000359-B044-142</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/ohenews.htm 194.159.248.137 19970112020059 text/html 1556
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:01:04 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 1384
Last-modified: Mon, 09 Sep 1996 10:09:30 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>OHE News</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<td width=200><center><i>OHE News</i></center></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>
<center><h1>OHE News</h1></center><br>

<h2>Listing of OHE Newsletter</h2><br>

<ul>
<li><a href=newslet.htm>OHE Newsletter - Spring 1996</a>
</ul>
<hr>

<a href=http://www.abpi.org.uk/ohe.htm><IMG SRC=../pics/b_arrow.gif ALIGN="BOTTOM" border=0></a> <a href=http://www.abpi.org.uk/ohe.htm>OHE Home Page</a>

<hr>
</body>
<ADDRESS>
<h6>Last Updated 09 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-106</DOCNO>
<DOCOLDNO>IA062-000359-B044-181</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/whatsnew.htm 194.159.248.137 19970112020114 text/html 2318
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:01:19 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2146
Last-modified: Fri, 06 Sep 1996 10:13:00 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>OHE What's New</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<td width=100><center><i>OHE What's New</i></center></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H1>OHE What's New</H1>
<HR>

Click on one of the following Topics to obtain the latest
information on the OHE's publications:

<UL>

<LI>The most recent publications

<UL>
<LI><a href=koblet.htm>Health Economics: An Introduction to Economic Evaluation</a>
<LI><a href=ryan.htm>Using Consumer Preferences in Health Care Decision Making:
the Application of Conjoint Analysis</a>
<LI><a href=sackett.htm>ONE Annual Lecture: The Doctor's (Ethical and Economic ) Dilemma</a>
</UL>

<LI>Forthcoming publications

<UL>
<LI><a href=dvt.htm>Deep Vein Thrombosis and Pulmonary Embolism</a>
<LI><a href=pcare.htm>The Future of Primary Care: Proceedings of a Conference</a>
</UL>

</UL>

<HR>

<P>

All publications are available from:

<P>

Mrs E Aulsford, Office of Health Economics,<BR>
12 Whitehall, London SW1A 2DY.<BR>
Tel: +44 (0)171 930 9203<BR>
Fax: +44 (0)171 747 1419.<BR>
<HR>

<P>
<A href=http://www.abpi.org.uk/ohe.htm><IMG SRC=../pics/b_arrow.gif ALIGN="BOTTOM" border=0></A>
<A href=http://www.abpi.org.uk/ohe.htm>OHE Home Page</A> 

<hr>

<ADDRESS>
Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</A>

</ADDRESS>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-107</DOCNO>
<DOCOLDNO>IA062-000359-B044-196</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/netschp.htm 194.159.248.137 19970112020123 text/html 2870
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:01:29 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2698
Last-modified: Fri, 06 Sep 1996 11:27:15 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Studies of Current Health Problems</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H1>Studies of Current Health Problems 
</H1>
<HR>

<UL>
<LI>AIDS: World policies &amp; problems (September 91)
<LI>Arthritis (March 92)
<LI>Asthma (February 90)
<LI>Born Imperfect (January 93)
<LI>Born Too Soon (January 93)
<LI>Cholesterol &amp; Coronary Heart Disease (February 91)
<LI>Chronic Venous Diseases of the Leg (Dec 92)
<LI>Cystic Fibrosis (March 86)
<LI>Dementia (September 92)
<LI>Depression (March 92)
<LI>Diabetes (October 89)
<LI>Diseases of the Prostate (September 95) &#163;7.50
<LI>Drug Misuse (April 92)
<LI>Dying With Dignity (February 91)
<LI>Eating Disorders (March 94)
<LI>Epilepsy (May 91)
<LI>Health: the Politicians Dilemma (June 86)
<LI>Health Care in China (September 88)
<LI>Mental Health in the 1990s (Dec 89)
<LI>Migraine (September 91)
<LI>Obesity (July 94) &#163;7.50
<LI>Organ Transplantation (July 91)
<LI>Osteoporosis (January 90)
<LI>Parkinson's Disease (October 91)
<LI>Patterns of Prescribing (January 91)
<LI>Stroke (June 88)
<LI>The AIDS Virus, forecasting the future (Dec 86)
</UL>
<HR>

<P>
All publications are priced at &#163;5.00 except for those indicated
with additional pricing details. Publications must be paid for
in advance, with cheques made payable to the OHE in Sterling.
<P>
The publications are available from:<BR>
<BR>
Mrs E Aulsford, Office of Health Economics,<BR>
12 Whitehall, London SW1A 2DY.<BR>
(Tel: 0171 930 9203; Fax: 0171 747 1419).<br>

<hr>

<a href=http://www.abpi.org.uk/ohe.htm><IMG SRC=../pics/b_arrow.gif border=0></a> <a href=http://www.abpi.org.uk/ohe.htm>OHE Home Page</a>

<hr>
</body>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-108</DOCNO>
<DOCOLDNO>IA062-000359-B044-213</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/netohed.htm 194.159.248.137 19970112020131 text/html 2320
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:01:37 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2148
Last-modified: Fri, 08 Nov 1996 10:00:09 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>OHE Briefings</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>
<H1>OHE Briefings </H1>
<HR>

<UL>
<LI>Economic Evaluation of Growth Hormone Therapy (Dec 91) Free
<LI>Handling Uncertainty in the Results of Economic Evaluation
(September 95)
<LI>Health Information ; The Consumer (May 94)
<LI>HIV &amp; AIDS in the UK (January 88) Free
<LI>Impact of Behavioural &amp; Biomedical Advance (November 94)
<LI>Impact of Unemployment on Health (June 93) &#163;2.00
<LI>The Economic Impact of Medicines (September 90) Free
<LI>Variations Between General Practitioners (July 90) Free
</UL>
<HR>

<P>
All publications are priced at &#163;5.00 except for those indicated
with additional pricing details. Publications must be paid for
in advance, with cheques made payable to the OHE in Sterling.
<P>
The publications are available from:<BR>
<BR>
Mrs E Aulsford, Office of Health Economics,<BR>
12 Whitehall, London SW1A 2DY.<BR>
(Tel: 0171 930 9203; Fax: 0171 747 1419). <br>

<hr>

<a href=http://www.abpi.org.uk/ohe.htm><IMG SRC=../pics/b_arrow.gif border=0></a> <a href=http://www.abpi.org.uk/ohe.htm>OHE Home Page</a>

<hr>
</body>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-109</DOCNO>
<DOCOLDNO>IA062-000359-B044-239</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/netohes.htm 194.159.248.137 19970112020203 text/html 2724
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:02:01 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2552
Last-modified: Fri, 06 Sep 1996 11:27:15 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Reports of OHE Symposia</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">
<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H1>Reports of OHE Symposia </H1>
<HR>

<UL>
<LI>A New NHS Act for 1996 (November 84)
<LI>AIDS in Africa: Meeting the Challenge (July 92)
<LI>Cost &amp; Benefits of Pharmaceutical Research (July 87)
<LI>Factors influencing clinical decisions in General Practice
(February 91) 7.50
<LI>Health, Education &amp; General Practice (1986)
<LI>Health Information and the Consumer (January 96) 10.00
<LI>Industrial Policy and the Pharmaceutical Industry (January
96) 10.00
<LI>Innvative Competition in Medicine (September 92) 7.50
<LI>Measuring the Benefits of Medicines: The Future Agenda (May
90) 7.50
<LI>People as Patients &amp; Patients as People (October 88)
<LI>Science in Medicine: How far has it advanced? (August 93) 7.50
<li>The Future on Primary Care: Proceedings of a Conference, edited by Jane Griffin. <img src=../pics/new-1.gif>
<LI>The Second Pharmacological Revolution (April 83) 7.50
</UL>
<HR>

<P>
All publications are priced at 5.00 except for those indicated
with additional pricing details. Publications must be paid for
in advance, with cheques made payable to the OHE in Sterling.
<P>
The publications are available from:<BR>
<BR>
Mrs E Aulsford, Office of Health Economics,<BR>
12 Whitehall, London SW1A 2DY.<BR>
(Tel: 0171 930 9203; Fax: 0171 747 1419).<BR>

<HR>

<a href=http://www.abpi.org.uk/ohe.htm><img src=../pics/b_arrow.gif border=0></a> <a href=http://www.abpi.org.uk/ohe.htm>OHE Home Page</a>

<hr>

</body>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-110</DOCNO>
<DOCOLDNO>IA062-000359-B044-274</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/netpham.htm 194.159.248.137 19970112020218 text/html 2777
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:02:23 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2605
Last-modified: Fri, 06 Sep 1996 11:36:45 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Pharmaceutical & Health Monographs</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H1>Pharmaceutical &amp; Health Monographs
</H1>
<HR>

<UL>
<li>Deep Vein Thrombosis and Pulmonary Embolism <img src=../pics/new-1.gif>
<LI>Economic Evaluation in the Development of Medicines (March
88)
<LI>Economics of Healthcare: A Level Schools Booklet (July 95)
1.00
<LI>Financing Health Care in the UK (November 95) 10.00
<li>Health Economics: An introduction to economic evaluation (August 96) 2.00 <img src=../pics/new-1.gif>
<LI>Hypothecated Health Taxes (November 95) 10.00
<LI>Innovative Chemical Extensions: the Economic basis of pharmaceutical
progress (March 88)
<LI>Issues in Development: A guide (May 83)
<LI>Managing The NHS (April 94) 10.00
<LI>Not What the Doctor Ordered (March 94) 10.00
<li>Using Consumer Preferences in Health Care Decision Making: the Application of Conjoint Analysis by Dr Mandy Ryan (September 96) 7.50 <img src=../pics/new-1.gif>
<LI>Value of the Pharmaceutial Industry to the Economy (June 95)
</UL>
<HR>

<P>
All publications are priced at 5.00 except for those indicated
with additional pricing details. Publications must be paid for
in advance, with cheques made payable to the OHE in Sterling.
<P>
The publications are available from:<BR>
<BR>
Mrs E Aulsford, Office of Health Economics,<BR>
12 Whitehall, London SW1A 2DY.<BR>
(Tel: 0171 930 9203; Fax: 0171 747 1419).<br>

<hr>

<a href=http://www.abpi.org.uk/ohe.htm><img src=../pics/b_arrow.gif border=0></a> <a href=http://www.abpi.org.uk/ohe.htm>OHE Home Page</a>

<hr>
</body>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-111</DOCNO>
<DOCOLDNO>IA062-000359-B044-303</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/netcomp.htm 194.159.248.137 19970112020304 text/html 1813
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:02:59 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 1641
Last-modified: Fri, 08 Nov 1996 10:00:09 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Compendia</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>
<H1>Compendia</H1>
<HR>

<UL>
<LI>Compendium of Health Statistics 9th Edition (February 95)
</UL>
<HR>

<P>
This publication is priced at 100.00 and must be paid for in advance,
with cheques made payable to the OHE in Sterling.
<P>
The publication is available from:<br>
<br>
Mrs E Aulsford, Office of Health Economics, <BR>
12 Whitehall, London SW1A 2DY.<BR>
(Tel: 0171 930 9203; Fax: 0171 747 1419).<br>

<hr>

<a href=http://www.abpi.org.uk/ohe.htm><IMG SRC=../pics/b_arrow.gif border=0></a> <a href=http://www.abpi.org.uk/ohe.htm>OHE Home Page</a>

<hr>
</body>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-112</DOCNO>
<DOCOLDNO>IA062-000359-B044-334</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/netoheal.htm 194.159.248.137 19970112020322 text/html 2000
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:03:28 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 1828
Last-modified: Fri, 06 Sep 1996 11:36:45 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>OHE Annual Lectures</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H1>OHE Annual Lectures</H1>
<HR>

<UL>
<LI>A Doctor Looks at Health Economics (October 94)
<LI>Healthcare as a Handicraft Industry (September 95)
<li>The Doctor's (Ethical and Economic) Dilemma by Professor David Sackett (September 96) <img src=../pics/new-1.gif>
</UL>
<HR>

<P>
These publications are priced at 5.00 and must be paid for in
advance, with cheques made payable to the OHE in Sterling.
<P>
The publications are available from:<br>
<br>
Mrs E Aulsford, Office of Health Economics,<BR>
12 Whitehall, London SW1A 2DY.<BR>
(Tel: 0171 930 9203; Fax: 0171 747 1419).<br>

<hr>

<a href=http://www.abpi.org.uk/ohe.htm><img src=../pics/b_arrow.gif border=0></a> <a href=http://www.abpi.org.uk/ohe.htm>OHE Home Page</a>

<hr>
</body>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-113</DOCNO>
<DOCOLDNO>IA063-000363-B030-56</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/newslet.htm 194.159.248.137 19970112020351 text/html 77689
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:03:49 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 77516
Last-modified: Mon, 09 Sep 1996 10:09:30 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>OHE Newsletter - Spring 96</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H1><center> OHE Newsletter - Spring 96</center></H1>

<P>
This newsletter is published by:<BR>
The Office of Health Economics <BR>
12 Whitehall <BR>
London SW1A 2DY <BR>
<B>Telephone</B> +44 (0)171-930 9203 <BR>
<B>Fax </B> +44 (0)171-747 1419 <BR>

<P>
The Office of Health Economics was founded in 1962 by the Association of the British Pharmaceutical Industry, with the following terms of reference: 

<UL>
<LI>To undertake research on the economic aspects of medical care.
<LI>To investigate other health and social problems. 
<LI>To collect data from other countries. 
<LI>To publish results, data and conclusions relevant to the above.
</UL>

<P>
<B>CONTENTS</B>

<UL>
<LI><a href=#sec1><B>Section 1</B></a> - OHE Publications in 1995/96 
<LI><a href=#sec2><B>Section 2</B></a> - Forthcoming OHE Publications - Spring 1996
<LI><a href=#sec3><B>Section 3</B></a> - Report on the Pharmaceutical Industry Health Economics Group 
<LI><a href=#sec4><B>Section 4</B></a> - Report on the 1996 OHE Annual Lecture 
<LI><a href=#sec5><B>Section 5</B></a>- Primary Care led purchasing in the NHS: fundholding and other models. Guest article by Professor Chris Ham of the Health Services Management Centre, University of Birmingham
<LI><a href=#sec6><B>Section 6 - </B></a>The Future of Primary Care . Guest article by Professor Martin Roland Director, National Primary Care Research and Development Centre, University of Manchester 
<LI><a href=#sec7><B>Section 7 -</B></a> Launch of OHE/IFPMA Database 
<LI><a href=#sec8><B>Section 8 - </B></a>OHE Compendium 
</UL>

<P>
<center><h2><a name=sec1><B>Section 1</B></h2></center>
<P>
<center><B>HEALTH INFORMATION AND THE CONSUMER</B></center>
<P>
`Health Information and the Consumer' is the collected papers from a conference, of the same name, held by the OHE in November 1994, edited by Jane Griffin.
<P>
Chapters in the book cover the following:

<UL>

<LI><B>The inverse care and the targeting of GP health promotion resources</B>. Dr Peter Toon (GP, Hackney and London Implementation Group) discusses the difficulties arising from the inequalities of access to GP care highlighted by a study of the patient health checks (introduced in 1990) which was conducted in Hackney. It was found that those most in need of care were least likely to
receive it and that such generalised health promotion campaigns fail to make a significant impact on risk factors (Smoking, diet, weight, alcohol consumption) and hence on morbidity, but simultaneously have a negative effect on quality of life of those who do take part by raising their anxiety. He argues that health promotion is to a large extent `the art of the possible' and, therefore, to set a health promotion agenda on the basis of the importance of various risk factors rather than their susceptibility to change is misguided.

<LI><B>The implications of marketing medicinal products to consumers</B>. Using the example of Zovirax and its switch from being a prescription only medicine to pharmacy sale, Noel Hall (formerly of Wellcome UK) finds that there are a number of lessons to be learned for all concerned: Manufacturers who are predominantly involved with the marketing of prescription only medicines have to continually remember that when they switch a product the customer is no longer the health professional but a consumer; the Pharmacy profession should carry out a major campaign to explain their role to consumers which might in turn lead consumers to recognise the value of information provided by pharmacists; and consumers need to take greater responsibility for understanding their own health problems, to read the patient information supplied with their medicine and to know where to go to obtain further information if necessary.

<LI><B>Medicines and the role of Patient Information Leaflets.</B>Dr Sharon Gibbs (Freelance Researcher and Writer) discusses the results of her research into patients knowledge about their medicines and the impact of patient information leaflets on their level of knowledge. She also reflects on the difficulties that pharmaceutical companies face when writing patient information leaflets in ensuring that the leaflets reach their target audience whilst at the same time containing sufficient information to comply with current legislation;

<LI><B>The legal implications of the provision of health information.</B> Diana Brahams (Practising Barrister and medico-legal correspondent, The Lancet) considers the legal implications for pharmacists and general practitioners in providing health information. Both doctors and pharmacists owe their patients a duty to act with reasonable skill and care but whilst under their new contracts GPs are required to provide information to promote a healthy lifestyle there is no such requirement in contracts for community pharmacists. Using the examples of real cases, Mrs Brahams discusses the legal relationship between the consumer and both professional groups and the possible pitfalls that might occur. 

<LI><B>The role of pharmacists in the provision of health information to the consumer</B>. This chapter takes the form of four papers by Dr Philip Brown (Publisher of SCRIP World Pharmaceutical News), Linda Stone (Community Pharmacist and a Past President of the Royal Pharmaceutical Society), Derek Prentice (Consumers' Association) and Dr Felicity Smith (Lecturer in Pharmacy Practice). From their different perspectives, the authors discuss whether pharmacists have a role in providing information to consumers and if so, are they currently fulfilling this responsibility in a way which meets the consumers needs. At the conference, this subject was then opened up to the audience to continue the debate and some of the discussion is included.

<LI><B>Patient's rights - a middle class phenomenon?</B> Rabbi Julia Neuberger (Chair of Camden and Islington Community Health Services NHS Trust) suggests that if the way in which health services were analysed it would be seen that most are provided to meet the needs of the professions providing the services rather than the patients who have to use them. She argues that the rise of
the patient's right movement was to some extent a response to this situation. Whilst for a variety of historical and sociological reasons this movement started off as a middle class phenomenon it could no longer be said that it was confined to any one section of society.

</UL>

<P>

<B>DISEASES OF THE PROSTATE</B>

<P>
This OHE report by Nick Marchant, published in September 1995, argued that a national screening programme for prostate cancer in men is not yet practicable.
<p>
Prostate cancer is a significant cause of illness and death amongst men. However, neither radiotherapy or radical prostatectomy, the two main treatments used for early stage prostate cancer, have had any significant effect on either life expectancy or quality of life. Indeed, no clinical trial has yet demonstrated increased survival for patients as a result of treatment. Because of this, the author believes there is little point in a national screening programme being introduced.
<P>
About 10 per cent of all malignant male cancers diagnosed in the UK each year are prostate cancer - only lung cancer has a higher rate. And the figure is rising. In 1992, there were 8,735 deaths attributable to prostate cancer, more than double the 4,313 in 1974. The burden of prostate cancer falls mainly on the elderly - only 206 of the deaths in 1992 occurred in men under 60. With
the numbers of older people in the country rising, the report points out that the number of deaths caused by prostate cancer is likely to rise - perhaps to as many as 18,500 by 2031.
<P>
The booklet also deals with all other forms of prostatic disease, especially benign prostatic hyperplasia (BPH). Symptoms include the desire to urinate during sleep, more often than normal, and pain during urination. There are about 78,000 new sufferers from BPH in the UK each year. Because symptoms build up gradually, many men accept BPH as part of the ageing process and suffer unnecessarily.
<P>
The past two decades have seen the development of a number of therapies for the treatment of BPH. Medicines and minimally-invasive therapies, as well as watchful waiting, are increasingly being regarded as realistic options to surgery. With effective treatment now available unnecessary suffering - especially in patients with milder forms of the disease - could be averted by increasing public
awareness.
<P>
<B>VALUE OF THE PHARMACEUTICAL INDUSTRY TO THE UK ECONOMY</B>
<P>
The &quot;Value of the Pharmaceutical Industry to the UK Economy&quot;, published by the OHE in the summer of 1995, sets out how the UK economy benefits from having resources employed in the UK based pharmaceutical industry rather than in other industry sectors.
Wherever possible these benefits are estimated.
<P>
The overall conclusion is that the value of the pharmaceutical industry to the UK economy in 1992 was around &#163;2 billion.
<P>
<B>How does the UK economy benefit ?</B> 

<UL>

<LI>Benefits to patients - Patients receive improved and more timely medicines as a result of medicines being developed in the UK.

<LI>R&amp;D spinoffs - Other industries, the NHS and universities, are able to produce better products and services, and/or lower unit costs as a result of improvements in the science knowledge
base derived from high levels of pharmaceutical R&amp;D.

<LI>Export profits - Higher profits from exported medicines benefit the UK economy in 2 ways:

<UL>
<LI>higher net profits to UK owners;
<LI>higher corporation tax revenues to the UK Exchequer.
</UL>

<LI>Employees' Wages - Higher wages paid in the industry, compared with other sectors, benefit the economy through:

<UL>
<LI>higher net earnings by UK workers;
<LI>higher income tax revenues to the UK Exchequer.
</UL>

<LI>Competitive Advantage in the global market drives better terms of trade, helping the UK trade balance.

</UL>

<P>
<B>How were these benefits measured ?</B> 
<P>
The estimates provided assume that no research or production facilities, nor corporate headquarters of pharmaceutical companies remain in the UK. The resources &quot;freed up&quot; are assumed to be
utilised in other sectors.
<P>
The paper focuses on the long term effects which would persist even after these resources could be re-employed, and so excludes any adjustment costs of retraining personnel or obsolescence of
assets.
<P>
The estimates also exclude payments between parties inside the UK (transfers). Only income increasing the purchasing power of the UK is included. In its simplest form this is income from abroad which adds to the wealth of the UK.
<P>
<B>INDUSTRIAL POLICY AND THE PHARMACEUTICAL INDUSTRY</B> 
<P>
This book, edited by Adrian Towse, brings together the proceedings of the Symposium held by the OHE in June 1994. It examines the practice of industrial policy in relation to the pharmaceutical
industry in Europe, Japan, and the USA, and elements of policy - supporting the science base, good purchasing, and attracting inward investment.
<P>
<B>George Yarrow</B>, of Hertford College, Oxford, examining the European Commission's Industrial Policy document argues a trade-off between innovative and price competition had to be recognised.  More price competition meant less innovative competition. It is the dynamic gains, from innovation, that are the source of real gain to society, hence the need for society to place the balance
between the two in the right place.
<P>
He noted the conflict between national government pricing policies and the creation of a single market through the free movement of product. This could lead to an export of price control. Parallel
trade would push prices down to those of the lowest priced Member State. Innovation would fall.
<P>
He argued that uniform prices are not the outcome of single markets.  Prices take account of factors such as volume and other customer characteristics. The way to improve the trade-off between innovative and price competition was to allow price differentials within a single market, through more sophisticated pricing mechanisms.  If this required some competition policy exemptions then they
should be negotiated.
<P>
<B>Professor Ian Neary</B> of the Contemporary Japan Centre, University of Essex, argued that the Japanese MHW had no industrial policy for the pharmaceutical industry. The fortunes of the industry
were a low priority for the MHW which had kept the pro-industrial policy MITI out of policy making. However, some of the top tier of Japanese companies would be internationally successful, in spite of lack of government sponsorship.
<P>
<B>Professor Scherer</B> of Harvard University noted that although there had been nothing in the USA that could be called an industrial policy, some Federal level policies were of significant benefit,
notably NIH spending of nearly $5bn per annum on research, and the Orphan Drug Act.
<P>
<B>Professor Trevor Jones</B>, Director-General of the ABPI noted that the UK had been a fruitful source of new pharmaceutical products because of the strong foundation of basic science upon which biomedical research is based, together with a long tradition of clinical science and practice in world renowned university hospitals, and the NHS. To maintain excellence in drug discovery and development, the UK needed policies to retain a strong science and medical base. This had to be matched with adequate funding, not only of research grants but of the fabric of university and institute
laboratories, many of which now showed marked signs of deterioration.  The restructuring of the Research Councils and the Technology Foresight exercise provided new impetus for further investment in biomedical R&amp;D. It would be important that it was not diluted in the competition for funds, and that building on strengths was a feature of allocation.
<P>
<B>Professor Henry Grabowski</B> of Duke University set out evidence from his work on the costs of R&amp;D and the returns or profitability of NCEs coming to market, commenting on the implications for policy makers wanting to use price control to keep purchasing costs down.
<P>
His 1991 study with DiMasi, Hansen, and Lasagna, produced a best estimate of $231m (in 1987 dollar) and 12 years to discover and develop a new drug. But whereas R&amp;D investment costs have been increasing further since then, product life cycles have been getting shorter as a result of faster follow-on from competing drugs, and increased generic competition when patents expire.
<P>
In his most recent study with Vernon, he found large variations in returns across NCEs. Whilst the top ten per cent of products earn more than five times the capitalised value of average R&amp;D
costs, only the top 30 per cent cover average R&amp;D costs (see Figure). The remaining 70 per cent will not typically cover any of the common discovery costs or the costs of failures. Hence blockbuster drugs motivate the R&amp;D process. As healthcare costs escalate, there is a risk that all countries will try to obtain the most innovative new pharmaceuticals at breakeven prices and try to leave the payments for drug R&amp;D to other countries.  Left unchecked, these developments could result in a drastic curtailment of global R&amp;D investment for new medicines, despite the exciting potential for scientific advances that now exist.
<P>
<B>Jeremy Holmes</B>, Managing Director of EAG, and Professor John Dunning looking at factors influencing the location of multinational investment decisions in the pharmaceutical industry. Of the four factors that influenced R&amp;D location, resource factors were most important for European firms, followed by market factors, drug and general regulatory factors. For US firms, market factors
were more important than resource factors. The most important resource factor for R&amp;D investment was the quality of a country's tertiary education system. It was difficult to overstate the importance f government policies in developing and upgrading the human capital base. Governments seeking to attract R&amp;D had to adopt &quot;holistic&quot; policies towards industrial competitiveness that recognised the links between policy on education, technology, industry tax and
employment.
<P>
Other contributors were Lois Quam, Vice President of Public Services at United Health Care (an edited version of her paper was included in OHE News 2) and Adrian Towse, OHE Director, of the Value of the UK-based pharmaceutical industry.

<P>
<B>Handling Uncertainty in the Results of Economic Evaluation</B>

<P>
This Briefing, by Andrew Briggs of Brunel University HERG, discusses how sensitivity analysis and other techniques for handling uncertainty can be used to give decision makers confidence in the robustness (or otherwise) of the results of an health economic evaluation of a medicine or other treatment.
<P>
He identifies four types of uncertainty, relating to: the data requirements of the study; the extrapolation of data or end points; the generalisability of results; and the choice of analytic method.
Although the use of statistical analysis to represent uncertainty is usual in clinical evaluation, it is not yet the method of choice for economic evaluations. The Briefing discusses four main types of sensitivity analysis (simple sensitivity analysis, extreme sensitivity analysis, threshold analysis, and probabilistic sensitivity analysis) and sets out guidelines for the choice of and presentation of sensitivity analysis.
<P>
<B>THE ECONOMICS OF HEALTH CARE</B> 
<P>
A booklet designed to help teachers and students apply economics to health care and to the challenges facing Britain's National Health Service has been distributed free to all secondary schools and colleges with A-level or equivalent courses in economics.  Additional copies have been supplied at a price of &#163;1. To date more than 6500 copies have been sent out.
<P>
The booklet, produced by the Office of Health Economics (OHE) and sponsored by the charities committee of Glaxo Wellcome, is entitled &quot;The Economics of Health Care&quot;. It supports
the new A-level syllabuses which place particular emphasis on the application of basic economic techniques to particular sectors of the economy.
<P>
The 50-page booklet comprises five units which examine: The problem of health care; How a free market approach to health care would work; The case against a free market; Health care in the UK; Some further questions.
<P>
As well as text, pictures and graph, the booklet contains activity boxes - suggesting related and follow-up projects which could be undertaken - as well as posing questions for the student to
consider. It comes with a full set of teachers' notes.  
<P>
<B>Hypothecated Health Taxes - An evaluation of recent proposals</B>
<P>
This report, by Andrew Jones and Alan Duncan of the University of York, examines the arguments put forward for the special tax which, its advocates claim, could increase the money available to the NHS while reducing political interference. Such ideas have been put forward for discussion by organisations including the Institute of Economic Affairs, the British Medical Association and the Liberal Democrats.
<P>
The report notes that in 1993-94, &#163;36 billion was spent on the NHS - about &#163;630 per head or &#163;1,500 per income tax payer. This would be equivalent to a &quot;health tax&quot; rate of 16p in the pound, cutting the present general income tax rate from 25p to 9p.
<P>
The criteria outlined in the report against which the proposed tax is measured are: efficiency; equity; stable but growing revenue base; transparency; responsiveness; flexibility; autonomy and accountability. The main challenge is to create a genuine link between the separate tax and the NHS expenditure, the report concludes.  Creating a separate NHS fund would help, but governments might
try to shift other expenditure on to the NHS so the fund would pay for that, too. Supporters of the earmarking would also need to set out the political mechanism by which the annual tax rate
would be set. These two issues will be examined in a future OHE report by the authors.
<P>
<B>Health Care As A Handicraft Industry</B>
<P>
The second annual OHE lecture was given by one of the worlds leading economists, Professor W J Baumol. In the lecture publication he states that Britain can and should spend more on the NHS.
<P>
He says that &quot;a major source of the health care cost disease can be traced to the differences in the productivity growth rates of the various parts of the typical developed economy. It is hardly
surprising that, while overall productivity in the industrial world has been growing rapidly, the pace of growth in different sectors has varied substantially.&quot;
<P>
He argues that health care is a &quot;handicraft&quot; industry. It &quot;cannot be fully automated and liberated from the requirement of a substantial residue of personal skill and attention&quot;.
There has been some rise in productivity but over longer periods it has been, and will be, far slower than the rate of productivity increase of the economy as a whole. That is why the share of GDP
devoted to health care will rise, irrespective of the impact of the aging of the population.
<P>
Professor Baumol argues that straight forward arithmetic suggests that over the next 50 years medical outlays may more than double their share of GDP. In the US health care expenditure could rise
from 12 per cent of GDP to 35 per cent. The UK currently spends 6.8 per cent of its GDP on health, a doubling would increase it to 14 per cent of GDP.
<P>
This may mean tax increases are necessary to pay for increases in NHS spending over time. It is a fiscal illusion that underlies the view that consumers as a group cannot afford to pay the rising
costs of health care. Economic growth means that we can afford more of everything - private and public consumption. However if taxes do not rise, the choice is to design a privately financed
ystem that provides high quality universal coverage, (he sets out eight goals to be achieved in such a design), or to allow a publicly funded service to be steadily eroded.
<P>
<B>Financing Health Care in the UK: A Discussion of NERA's
Prototype Model to Replace the NHS</B> 
<P>
This report, edited by Adrian Towse, is the result 0f an OHE symposium held in 1993 to discuss a major report Financing Health Care by the specialist economics consultancy NERA which included a prototype model for health care reform, which, in the UK, woud replace the NHS with a guaranteed health care package available to all, funded by compulsory income based contributions to a central insurance fund, with consumers then choosing which private insurer to use (the private insurer would be given a fixed sum by the central insurance fund), paying extra for services outside the guaranteed
health care package.
<P>
Professor A J Culyer argues that proposals to replace the NHS are fundamentally flawed. One of the UK's leading health economists, he argues that a private sector insurance scheme will raise administration costs, restrict access to services for those with chronic illnesses or low incomes, and is &quot;frankly naive about the workings of competitive insurance.&quot;
<P>
The NERA proposals are supported by William Laing in his contribution to the publication. He argues that consumers can exercise choice in health care, and that competition to provide a guaranteed health
care package will generate enormous improvements in the quality and efficiency of health care in the UK. He concludes that it is &quot;quite possible to imagine the ideas [the proposals] being part of the mainstream health policy debate in the UK in 5 to 10 years time ... the greatest attraction of the NERA proposals is the possibility that regulated competition might stimulate the emergence of radically new and more efficient health care delivery systems as part of the &quot;discovery&quot; process associated with competitive markets.&quot;
<P>
<center><h2><a name=sec2><B>Section 2 </B></h2></center>
<P>
<center><B>Forthcoming Publications</B></center>
<P>
<B>STIMULATING R&amp;D INTO NEW MEDICINES FOR LESS DEVELOPED
COUNTRIES</B> 
<P>
In December 1994 the OHE co-hosted a discussion meeting entitled &quot;Stimulating R&amp;D into new medicines for Less Developed Countries&quot;. This highly productive meeting was a joint venture with a Working Party of the WHO Ad Hoc Committee on Health Research Relating to Future Intervention Options headed by Prof. R. Feachem, now of the World Bank. The central aim of the meeting was to bring together a group individuals with industry backgrounds, along with appropriate academics and public policy makers to identify any barriers which were perceived to exist to the expeditious development of many new medicines needed in the poorer nations of the world.
<P>
The discussions raised a number of interesting points, including the following:

<UL>

<LI>Intellectual property protection may still be insufficient in many developing countries because of delayed implementation of GATT / TRIPS arrangements.

<LI>Effective demand in developing countries may be too low to generate a positive return on investment in which case subsidies of some form are likely to be necessary from the developed world.

<LI>Orphan Drug legislation could be used as a model on which to base intervention.

<LI>There may be a role for an international purchasing agency, set up and funded, partly, by developed countries

<LI>Companies already receive assistance with the set up and conduct of clinical trials in developing country environments.

<LI>The pattern of disease is changing and there will be greater convergence between developing and developing countries.

</UL>

<P>
These issues and others relating to the problem, in particular the potential role for Orphan Drug type legislation, are addressed in detail in a forthcoming OHE publication.

<P>
<B>DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM</B> 
<P>
In a report by Jane Griffin which looked at the problems caused by deep vein thrombosis and pulmonary embolism it was noted that approximately 10 per cent of all hospital deaths were due to pulmonary embolism (most fatal emboli arise from a deep vein thrombosis in the lower limb). DVT is preventable, and the report highlights the point that the most efficient way to prevent both fatal and
non-fatal thromboembolism is to use routine prophylaxis for moderate to high risk hospital patients. The report argues that not only would this course of action save lives but would also be cost-effective
in preventing non-fatal symptomatic thromboembolism, which requires investigation and treatment. The report questions why, in the light of all the supporting evidence, effective routine prophylaxis
is still not being used routinely.

<P>
Copies of the report will be available from late spring/summer 1996

<P>
<center><h2><a name=sec3><B>Section 3 </B></h2></center>
<P>
<center><B>PHARMACEUTICAL INDUSTRY HEALTH ECONOMICS GROUP</B></center>
<P>
The PIHEG met on September 19th to discuss &quot;Delivering Health Economics Information to NHS Decision Takers&quot;
<P>
<b> Professor John Gabbay</b>, Wessex Institute of Public Health, spoke from an NHS perspective on the use of cost-effectiveness evidence. He explained that with health-care spending increasing in every developed country the need for cost-effectiveness based evidence for clinical decision-making was becoming greater. Professor Gabbay focused upon the local initiative in which he is involved at the Wessex Institute of Public Health. This consists of a series of rapid research reviews, taking 2-3 months to complete, detailing various health technologies, each aimed at achieving an approximate
90% accuracy level. Each report is used to inform Wessex's Development Evaluation Committee about which health technologies to recommend to Health Commissions and Trusts in the Wessex region for use in contract setting. Health technologies are recommended for adoption or non-adoption on the basis of cost utility and the strength of evidence on which the cost utility was calculated.
<P>
Derek Smith, Chief Executive of Kings College Hospital, discussed his reasons for being sceptical over the role of health economics in NHS decision making. He viewed the absence of structures to
enable rigorous economic review as particularly significant. A variety of factors were cited as responsible for this situation:

<UL>

<LI>independence traditionally sought by NHS consultants
<LI>focus of purchasing in single year boxes
<LI>limited numbers of public health doctors
<LI>poor information and information flows
<LI>pressure to rationalise is not as strong in UK as in the US despite purchaser/provider split

</UL>

<P>
Despite the problems highlighted Derek Smith believes the changing health environment is likely to force change as a result of pressures on policy makers (ageing population/higher utilisation rates/diminishing government revenues/rising public expectations) and the system growing. Health economics seems sure to become a necessary and integral part of decision making.
<P>
Adrian Towse presented the results of a University of York survey of 90 GPs, &quot;Will GPs use evidence on cost-effectiveness&quot;.  The survey dealt with the need to identify and understand the
factors which determine whether or not an economic evaluation will impact upon a target audience. The target audience investigated in this case was GPs, both fundholders (FHGPs) and non-fundholders (NFHGPs). Results from the study indicated that the credibility that GPs attach to a study is dependent upon certain key criteria:

<UL>

<LI>SPONSOR - Industry sponsored studies have low credibility amongst GPs, whereas GP funded studies through BMA/RCGP have most credibility.
<LI>DECISION-MAKER INVOLVEMENT - A large increase in credibility would result with GP involvement. FHGPs rated this as more important than NFHGPs.
<LI>STUDY INVESTIGATOR - University Research Centres are seen as the most appropriate investigators and Patient Support Groups as the least appropriate.
<LI>MEDIUM OF DISSEMINATION - GPs rely heavily on journal reputation, with the Medical Journal / BMJ / Lancet carrying most credibility. Drug company mailings and drug representative visits carry the least.
<LI>METHODOLOGICAL QUALITY - Credibility increases if studies comply with an acceptable methodological framework.

</UL>

<P>
The survey suggests that economic evaluations will have an impact upon GPs, even when only modest economic consequences are identified. GPs appear to be a receptive and positive audience with a reasonable level of understanding. A lesson from the survey is that the impact of an economic evaluation can be maximised by tailoring the structure and dissemination of the study to the particular requirements and comprehension level of the target audience.

<P>
<center><h2><a name=sec4><B>Section 4</B></center></h2>
<P>
<center><B>1996 OHE ANNUAL LECTURE</B></center>
<P>
<I><B>David Sackett calls for Evidence-Based Medicine and Cost-Utility to Ration Care in the NHS</B></I> 
<P>
The 1996 Annual lecture was given by Professor David Sackett of the University of Oxford and the NHS R&amp;D Centre for Evidence Based Medicine, on February 13 at the Royal College of Physicians. The title of Professor Sackett's presentation was &quot;Evidence-Based Medicine, Cost Utility and the Physician &quot;. He discussed from a physician's point of view, the relationship between economics, with its concepts of cost-effectiveness and cost-utility, evidence -based medicine and the care of individual patients. The lecture was attended by approximately 250 people. A paper based on the presentation will be published later this year as part of the OHE Annual Lecture monograph series.
<P>
Professor David Sackett is the Director of the NHS R&amp;D Centre for Evidence-Based Medicine and Chair in Clinical Epidemiology at the Nuffield Department of Medicines, University of Oxford.
Prior to moving, to Oxford, in 1994, he worked at McMaster University in Canada, where he founded the Department of Clinical Epidemiology and Biostatistics, and served in turn, as Hospital Physician-in-Chief and University Head of the Division of Internal Medicine.
<P>
<B>Evidence-Based Medicine</B> 
<P>
Professor Sackett began by defining &quot;evidence-based medicine&quot; as &quot;the conscientious, explicit and judicious use of the current best evidence in making decisions about the care of individual patients&quot;.
<P>
The practice of evidence-based medicine requires the fusion of two different sorts of things. The first, the individual clinical expertise that gets better and better; second the best available external clinical evidence, access to which becomes worse and worse. By individual expertise we mean the increasing proficiency and judgement that individual clinicians acquire through clinical experience and clinical practice.
<P>
It is not &quot;cook-book medicine&quot;. External guidelines have to be integrated with individual clinical expertise in deciding whether and how it matches the patient's clinical state, predicament
and preferences, and thus whether it should be applied. 

<P>
<I><B>E-BM is not Cost Cutting</B></I> 
<P>
Evidence-based medicine is not cost-cutting medicine. There is afoot in many of the health professions a concern that evidence-based medicine will be hi-jacked by purchasers and managers, merely to cut the cost of health care for individual patients. This of course is a misunderstanding of what EBM is about because, if indeed it is directed toward the benefit of individual patients,
evidence-based medicine identifies and applies the most efficacious interventions to maximise their function, quantity and quality of life, and may raise rather than lower the cost of their care.
<P>
There is also a myth that most medicine is not evidence-based and huge savings can be made by cutting out this care, not to mention avoiding harm to patients. In one month we admitted 121
patients; we diagnosed 109; and discovered that the pundits had it upside down: that evidence-based care was provided to 82 per cent of our patients - slightly more than half on the basis of randomised trials, another third on the basis of convincing non-experimental evidence, and only about 18 per cent without substantial evidence.
<P>
<I><B>Tackling Conflicts</B></I> 
<P>
Conflicts that exist arise because I am striving to offer and provide manoeuvres that maximise my patient's utility. But in doing so I run the risk of using resources that ought to be going to optimising the mean cost utility to society. The opportunity cost of serving my patient's need may be to dis-serve some other patient's needs in a broader social context. The issue again is one of having to recognise that and sort out how to minimise it and what to do about it.
<P>
Individual clinicians comply with restrictions on access when they are judged to be valid for the patient in question and judged to be ethical in their construction. This requires disclosure to patients that &quot;yes, indeed, there is a manoeuvre&quot; and &quot;yes, on average it would improve your quality of life&quot; but that, given the rationing which has arguably existed ever since the first shaman found the first skull back in Palaeolithic times, a decision has been made by the health care system, by the public, by society, to restrict this; that that would be disclosed and, again, an offer made to link them to some other source. This would apply to manoeuvres which, although they would maximise my patient's utility, would conflict with distributive justice, and that I am a willing party to that group decision.
<P>
How can we minimise these areas of conflict? First, we can go after, and generate if we do not have it, more valid evidence to identify the ineffective manoeuvres now in use. The governmental papers suggest that perhaps 5 per cent of the &#163;20 million which was being spent in surgical services might be unnecessary.  Stopping that sort of activity frees up those resources for reallocation, more benefits both to the group and the individual patient, minimising the impacts of those differing points of view - minimising the conflict by increasing public confidence in an evidence-based and just health system.
<P>
With more and more valid cost utility information for use in policy-making, to identify the marginal cost per unit of health gain for the other manoeuvres, society can then decide whether to ration in an ordered fashion and draw a line or, through some other consensus development method, sort out which resources should or should not be made available. 
<P>
<center><h2><a name=sec5><B>Section 5</B></h2></center>
<P>
<center><B>Primary Care led purchasing in the NHS: Fundholding and other models</B></center>
<P>
<B>PROFESSOR C HAM</B>, Director, Health Services Management Centre, University of Birmingham 
<P>
In recent years there has been a shift of power within the Health Service. We have seen purchasers refocusing their activities, from the management of health care institutions and hospitals to thinking about the population, its health needs and how best they can use their resources to respond to those needs. In addition, dialogue has opened between health authorities and general practitioners,
combining a public health agenda with an interest in primary care.  A consequence of this shift in the balance of power has been to put specialists and secondary care providers in a more accountable
position, and to give purchasers, including GP fundholders, a greater capacity to exert leverage over how services are delivered This policy has been reinforced with recent measures to develop a primary care-led NHS.
<P>
There are two key components in this policy. One is the extension of fundholding; with three new options on the table, including &quot;total purchasing&quot; for a number of practices. The second
is the move to integrate district health authorities and Family Health Services Authorities in England and Wales from April 1996, bringing these two countries into line with Scotland and Northern Ireland where integration has existed for some time. These integrated authorities, will be expected to give priority to primary care, strengthening primary care provision and ensuring that all GPs,
not just fundholders, have influence over planning, purchasing and the commissioning of health care.
<P>
Starting with the two original models of purchasing: the population-centred approach, focused on the work of health authorities, and the more patient-oriented fundholding, what we have seen in practice is the rapid development of a range of mixed or hybrid models.
<P>
Fundholding has gone off into different directions with community fundholding, total purchasing, and the spontaneous emergence of multi-funds, with a new association which has been set up to bring
together the work of those multi-funds.
<P>
Starting from the population-centred model, we see health authorities developing a range of locality-based approaches to commissioning, trying to devolve and de-centralise their decision-making. We
see interest in practice-sensitive purchasing as health authorities try to get alongside individual practices, often developing notional budgets in the process. More strategically, we see the development of joint commissioning between health authorities and their local authority partners. This innovation and experimentation has not been driven from the centre but has evolved from the bottom up.  Managers, doctors and others have taken the opportunity to see how far they can test out these different approaches.
<P>
What does the evidence, such as it is, tell us about the likely effectiveness of these alternative purchasing models?
<P>
<B>The Effectiveness of Fundholding</B> 
<P>
Fundholding has had a number of effects. The UK experience certainly suggests that if you change the incentive structure facing primary care physicians they will change their clinical practices, not on the basis of good research evidence but because the way in which they are paid has changed. This is an important conclusion to draw, not just from fundholding but also from the 1990 GP contract and the impact that this had on health promotion, prevention work and other aspects of GPs' clinical activity.
<P>
What fundholding has done in particular is:

<OL>
<LI>Change in prescribing behaviour, producing more cost-effective prescribing, and increasing the use of generic drugs. GPs in fundholding practices have consequently often made savings in their drugs budgets.
<LI>Reduce waiting times for hospital appointments, both outpatient and inpatient, for the patients registered with fundholding practices. There has also been improved communication between general practitioners and their specialist colleagues. For example, improved discharge information getting back more quickly to GPs - a common complaint over many years.
<LI>Increase the range of services being delivered within primary care. Often the savings GPs have made, in prescribing budgets, for example, are redeployed to pay counsellors, physiotherapists,
and dieticians, to deliver care in the practice rather than referring patients to hospital to receive those services.
</OL>

<P>
Equally important, it should be acknowledged that the adverse effects of fundholding that I and many other people predicted do not seem to have materialised so far.

<OL>
<LI>The main danger anticipated was that fundholding would create an incentive for GPs to select patients. This does not appear to have happened, although the absence of research does not help
us make that judgement. The reason that risk selection has not materialised is that despite the intention in <I>Working for Patients</I> to establish budgets on a capitation basis, they have been set
on an historical basis, looking at what GPs have done in the past and therefore they have been relatively generous without creating a strong incentive to introduce risk selection.
<LI>The literature indicates that management and transaction costs appear to be relatively high in relation to fundholding, as compared with other models of purchasing. This is not just because of the
management allowances paid to fundholders, but more especially because of the additional workload for the NHS trusts in having to negotiate tailor-made contracts with a large number of small
purchasers.
<LI>The survey evidence appears to suggest that one of the main complaints GPs have about fundholding is the workload. This is unsurprising, given that taking on a budget will involve additional responsibilities. How long that can be sustained is an important question which needs to be addressed.
</OL>

<P>
The achievements of fundholders which I have mentioned have been thrown into sharper relief, by the fact that on the whole health authorities, following the population-centred purchasing model,were much slower to develop their role as purchasers. One reason for that is they were not encouraged to be very entrepreneurial in the early days. The emphasis was on steady state; the political line was to progress rather slowly.
<P>
Over time their impact has increased. They are now working with GPs in localities and through all sorts of other mechanisms. In the process, they are re-focusing their attention away from simply
the management of health care services to the public health agenda set out in <I>The Health of the Nation</I>. The emphasis is now on evidence-based medicine, ensuring cost-effectiveness in the
use of resources, and also the policy of a primary care-led NHS. 
<P>
The innovation we have seen in primary care has not been confined to GP fundholding. We are also seeing some very important developments in primary care provision and commissioning in non-fundholding practices. For example, the Lyme Community Care Unit in Dorset is achieving many of the same benefits that fundholding has done without actually going down that route.
<P>
<B>Assessing Models of Purchasing</B> 
<P>
What sense can we make of all of this, given incomplete evidence, a rapidly moving picture, and differential developments of the alternative models? We need to find a way of combining population
centred and patient-focused purchasing. The simple question who is the better purchaser, the health authority or the fundholder, is the wrong question to ask. The evidence suggests that health authorities are better at some aspects of purchasing, assessing community health care needs and working strategically with their partners in local authorities and in the voluntary sector. Equally,
GPs in fundholding and, to some extent, in non-fundholding practices are better at other aspects of purchasing. They are much closer to their patients. They have more direct experience of the quality
of care. They can respond to demands in a way which it will always be difficult to do for those who staff health authorities. The challenge is to combine the leverage of health authorities and the bite of fundholders to see if we can get the best of both of these different models of purchasing.
<P>
There is no guarantee that the sum of multiple purchasing decisions will add up to an appropriate pattern of service provision for people who are living in a given health district. Indeed, putting
it more forcibly and more bluntly, if we do not co-ordinate and synchronise purchasing decisions by health authorities on the one hand and fundholders on the other there is a real risk of instability and fragmentation. The ability to ensure good local access to comprehensive services will no longer be there because there is not the capacity in the service to plan and co-ordinate in the way we have become accustomed over the last 45 to 50 years.  So there needs to be &quot;synchronised purchasing&quot; in the new NHS. How that is to be achieved has never really been specified.
<P>
Turning to the future, fundholding is now seen as the preferred option for GPs but not the only option. There has been a shift in policy. It is quite likely, that fundholding will expand to cover perhaps 50 per cent of the population in England by next year, and maybe 60 per cent beyond that. It will be difficult to get beyond the 60 per cent figure because some GPs remain opposed to fundholding. Other options will therefore be needed.
<P>
Let us also recognise that, as the financial constraints in the health service tighten we may find not only further practices going into the scheme, but also some exits from fundholding. If the Government is serious about moving away from the current budget-setting method towards the capitation approach to fundholding, then over time that could mean some significant shifts for individual practices - both up and down. Under that system, the financial attractions to the losers of remaining as fundholders will diminish. It would also not be at all surprising if some practices felt that they had achieved what they wanted in two or three years of fundholding and decided to leave the scheme after that; especially if health authorities become better purchasers and they become more sensitive to GPs. The relative advantage of the different models may then change.
<P>
Despite the support and the momentum behind fundholding, it is probable that health authorities will continue to have an important role themselves as the direct purchasers. Whilst, they will also take on the more strategic, enabling role that has been prescribed for them, we are a long way from the position where health authorities will give up holding a budget and buying some services directly
for the populations they serve.
<P>
At the present time the proportion of the hospital and community health services' budget controlled by fundholders, and the proportion of the population covered by fundholders is relatively small compared
with the vast amount of resources still under the control of health authorities. The question is how will that change and how rapidly.  Speculating about two years down the track it might look something
like Figure 2. Total purchasers are in the left-hand column, GPs buying all services for their patients, covering perhaps 10 to 15 per cent of the population in England. Standard fundholding will expand because of the extensions to the services that GPs are purchasing, and we know that more practices will come in. Then we have the community fund holding option right at the end.  This is clearly not a precise scientific prediction. However, it does suggest that there will still be a considerable amount
of resources under the control of health authorities as direct purchasers. So for some time to come there will continue to be a role for health authorities, even with the current emphasis placed on the expansion and the development of GP fundholding.
<P>
What about a change of Government? Let me be bold here and suggest that it may not make that much difference. First of all, I do not think fundholding will be abolished overnight. If you are
a future Labour Secretary of State, it is unlikely that you would wish to antagonise a large number of GPs with a unilateral decision to get rid of fundholding. It is more likely that the policy will be geared towards encouraging GPs to leave fundholding of their own freewill and to participate in alternative GP commissioning models.
<P>
There would seem to be increasing convergence between the political parties. Labour's GP-commissioning model does not appear to be that different from the current policy, ie a primary care-led NHS. GPs who are already commissioning, under the umbrella of an integrated health authority seem to be operating in a way which would be rather similar to how they would function if there was
a change of Government in the next two years. The Labour Party has shifted its thinking. It is prepared to be discriminating in its response to present policies.
<P>
To summarise and conclude, what I am suggesting here is a convergence taking place; that there are some outstanding differences, but if you cut behind the smoke-screen of the political debate you
discover quite a lot of common ground now emerging, as both political parties begin perhaps to move towards a new consensus. There are some key challenges, however, which emerge whatever the political future may hold.

<OL>
<LI>There is a need to strengthen management capacity still further in primary care,. If we are expecting even more to happen in a primary care-led NHS, not only commissioning but also service
delivery and service provision, this will require a further investment in the management skills of all primary care staff, not just Gps.  We will have to find the resources to make that happen.
<LI>There is a serious problem of morale and motivation amongst GPs. We need to recognise this and find some ingenious ways of addressing this issue
<LI>There is a challenge for the new health authorities. The history and tradition of district health authorities has, until very recently, been in relation to secondary care and specialist services. There
is a risk that the Family Health Services Authority contribution will be swamped as the new appointments are made and as the new health authorities are established. We must avoid that and we
must ensure that there is a genuine primary care focus, not only in what health authorities say and in the plans they produce but in how they allocate resources.
</OL>

<P>
If we can meet these challenges then the idea of a primary care-led NHS will become a reality. If we cannot, then it is simply another of those nice phrases which we should dispose of in the dustbin
of political rhetoric.

<P>
<center><h2><a name=sec6><B>Section 6</B></h2></center>
<P>
<center><B>The Future of Primary Care</B></center>
<P>
<B>PROFESSOR MARTIN ROLAND</B> 
<P>
Director, National Primary Care Research and Development Centre, University of Manchester
<P>
General practice is the dominant discipline within UK primary care. The majority of primary care is delivered by general practice-based teams. Indeed, the role of general practice as the core primary
care discipline has been strengthened by the 1991 reforms, which have increasingly given purchasing power to GPs. In this article I comment on the future of general practice as the core primary care discipline, discussing two threats which are currently facing the generalist - from fragmentation within general practice itself and from the growing body of specialists working from within the
community. I discuss the challenge to general practice to define and assure the quality of care offered, and how finally set out a vision for the future of primary care in the UK.
<P>
<B>Risk of Fragmentation</B> 
<P>
The threat that primary care will become fragmented, making it more difficult to provide care of high quality relates to three current issues.

<OL>
<LI>How important is 24-hour responsibility to general practice?  Those with a pessimistic view of the future regard a separate night-time contract as the start of an inexorable chipping away at general practice, which will leave it unrecognisable as a distinct discipline. I do not share these fears. The experience of one comparable health care system, Denmark, is that splitting the out-of-hours contract from the day-time contract has proved a success. Personal continuity of the 5 per cent of care which occurs out of hours is not necessary for a high-quality primary health care service.
<LI>Defining a core of general practitioner services. The General Medical Services Committee of the BMA has this year produced a consultation document defining these. Although there may be a need to define the core of general practice, there is also a danger. We may lose sight of the fact that a large part of the case for the generalist is that the whole is greater than the sum of the parts. A definition of a core range of services may expose general practice to precisely the threats from which it is intended to protect it.
<LI>There are pressures for purchasers to look at sections of
general practice care and towards specific service contracts,
i.e. contracting from general practice. These are clearly going
to be a feature of primary care in the future.
</OL>

<P>
We should not be fearful of these developments. They mark the end of an era where general practice is an amorphous blob of care in which quality can be neither assessed nor assured. Back in 1983, the RCGP policy statement on quality said that each general practitioner should be able to say what services his practice provides for his patients, and each general practitioner should &quot;define specific objectives for the care of his patients and should monitor the extent to which these objectives are met.&quot;
<P>
Such service standards are not easy to set or to meet, but a profession which can lead with this sort of approach to the provision of care should have nothing to fear from contracts which define objectives
to be delivered for particular patient groups. If we are thinking about defining a core of general practice and thinking about contracting for elements of general practitioner care, one additional argument which needs to come into the discussion is whether the independent contractor status has outlived its value. An increasing number of younger GPs appear to be interested in a salaried service.
This is an issue which needs debate.
<P>

<B>Risk of Specialisation</B> 
<P>
A second possible threat to generalist care, is the risk of specialisation. I want to talk both about the risks of specialisation within general practice and the growth in community-based specialist care.
<P>
1) Specialisation within general practice comes in two forms.
<P>
a) The first is the employment of health professionals within the primary care team to carry out specific specialised tasks. The most obvious example here is the growth of the practice nurse.
Much has been written about this, especially on the other side of the Atlantic. Estimates range from 4 per cent to 85 per cent as the proportion of the generalist's work which could be done by nurses. I do not wish to defend the methodology of these studies, but there is at least the basis for a debate.
<P>
Indeed, in the UK many of the achievements within general practice in the past 10 years have been related to developments in practice nursing.
<P>
The last two practices that I worked in practice nurses trained as specialists in asthma and diabetes. I did not find my role as a general practitioner threatened. Indeed, I think that the greater threat to primary care comes from those who believe generalism means that the GP must be all things to all people.
<P>
b) The second form of specialisation within general practice, is the extent to which GPs themselves should become specialised within practices. This is an area where there has been very little public or professional debate. The fear within general practice is that once GPs start to become specialised this will mean the start of an inexorable slide, where the benefits of generalist care may be lost. The most obvious and perhaps least threatening areas for specialisation are those where particular technical
skills are required. So, for example, the capacity of a group practice to provide high-quality care may be enhanced if only one or two partners can use a slip lamp, insert an IUCD or carry out minor surgery. This is a crucial debate for the profession to have, and it will be particularly important to evaluate innovative models of practice.
<P>
2) I now want to discuss the possible threat from the growth in community-based specialist care.
<P>
An RCGP discussion paper describes a core general practice team of doctors, nurses and managers, sometimes including district nurses and health visitors. But what is the role of the other health professionals who are increasingly based in the community?
<P>
I believe the ever-increasing capacity for sub-specialist care to deliver effective interventions in community settings is one of the strongest reasons to protect the role of the generalist. Theodore Fox put it well over 30 years ago, saying:
<P>
&quot;<I>The more complex medicine becomes, the stronger the reasons why everyone should have a personal doctor who will take continuous responsibility for him, protecting him from the zealous specialist</I>.&quot;
<P>
The plethora of community-based specialists requires the coordinating function of a small core primary health care team. That, within the UK context, is the general practice-based team. What is unclear, however, is which of the other professional groups should provide direct access to patients. Few would argue that patients should not have direct access to dentists and pharmacists. However, it
is right, within the UK context, that access to community-based medical specialists continue to be by referral from GPs. Of course there are blurred edges. How should a specialist paediatric asthma clinic run by specialist asthma nurses interface with general practice? There are unresolved issues which need debate.
<P>
I now want to go on to discuss two challenges relating to the need to define and assure the quality of care offered
<P>

<B>The Need to Define Quality</B> 
<P>
There are a wide range of dimensions of quality. In relation to 20th century primary health care I would like to suggest six. 

<OL>
<LI>Access. One of the major strengths of the UK health care system is the fact that almost the entire population is registered with a general practitioner. In the move towards market orientation in the health service, it is extremely important that we guard against erosion of this principle, ensuring for example that fund-holding arrangements do not impair access to care for difficult or expensive
patients. A second element to access is ensuring you actually get to see the doctor.
<LI>Equity. On the whole, the NHS does not have a bad record of at least trying to distribute resources to where they are needed. One of the least attractive aspects of fund-holding has been that
it has led in some cases to a two-tier service. Sometimes this may result in an overall improvement in service, but we need to ensure that equity remains a fundamental principle in planning our health service.
<LI>Clinical care and performance. If there are threats to primary care disciplines from encroaching specialists, then primary care professionals need to be able to demonstrate that they have better
diagnostic skills, especially for undifferentiated, ill-structured problems, better management skills, especially for minor and moderately serious conditions and those with important psychosocial components, and provide better preventive care. Much time is spent thinking about the interface between primary and secondary care and the role of GPs in purchasing secondary care. It is very important that we do not neglect the core aspects of clinical care within general practice itself. Much is written about the role of the GP as gatekeeper, but we must not forget that the main job of the general practitioner is to look after his garden and not just to mind the gate. In looking at the quality of clinical care, we must not neglect important dimensions of quality because they are hard to measure. Haigh, Smith and Armstrong carried out work on large groups of patients, trying to identify the elements of quality which patients felt to be important. Top of the list was &quot;a doctor who listens&quot;. This ties in with concepts developed within general practice over the past 30 years that it is the quality of the individual consultation which is a key element of quality of care. An increasing amount of work from groups at St Thomas's, from John Howie's group in Edinburgh, shows that time is an essential element to quality of care. Good clinical care cannot be delivered in five minutes per patient. We must not forget that the quality of the individual clinical encounter is at the heart of medicine, and that primary care must be structured to allow sufficient time for the consultation. General practice must not choose performance indicators which are easily measured but ignore those which are key to good medical practice.
<LI>The range of services provided. There is a generally shared view that it would be desirable for a wide range of services to be provided cost-effectively from a base which is fairly close to the patient's home.
<LI>Anticipatory care. This is a weak link in primary care at present. Stott and Davies identify continuing care as one of the potential parts of all primary care consultations. The service is very demand-led, however, and practices are often not all that good at planning long-term care of chronic disease. Diabetes is perhaps the example to show that it can be done. Tudor-Hart wrote in 1983 that &quot;<I>Organised personal responsibility is the key to improved outcome</I>&quot;. Long-term management of chronic disease is often poorly coordinated, with communication between specialists and GPs that has changed little in the last 40 years, despite huge changes in the way in which care is provided. New ways of organising care for chronic illness are needed for the changing needs of our patient population.
<LI>Continuity of care. One of the questions about primary care in the future is whether the loss of continuity which results from working in larger teams is outweighed by the benefits that result. I do not think that continuity of care is always essential. However, there are occasions when personal care from one's own doctor becomes extremely important. We need to be able to describe those situations where continuity of care makes a real difference to outcome. Some of the developments I have described make personal continuity of care look seriously endangered. My belief is that personal continuity is a feature of NHS care that is worth vigorously defending.
</OL>

<P>
<B>The Need to Assure Quality</B> 
<P>
I move on from definitions of quality to assuring quality. As the emphasis on purchasing effective care in the NHS increases and as we start to experience health commissions purchasing care from the primary sector, quality assurance will become increasingly important. Audit is on the way out, being replaced by purchasing for quality - or some other suitable slogan. The message to the profession is clear: if they do not lead on this issue then they will be led, whether they like it or not. In the area where I work a novel collaboration between the local medical committee and the health authority has developed a range of quality standards to which the majority of Manchester practices working towards. There is a real opportunity over the next few years for professionals to work with Government and health authorities to define the important elements of quality and to determine how they can be delivered and assured.
<P>

<B>A Vision for the Future</B> 
<P>
I conclude with seven points which are my vision for a future which preserves the strengths of British primary care.

<OL>
<LI>A model of primary care based around the general practice team has served Britain well. It is a model which other countries are now seeking to emulate. This basic feature of the NHS does not need fixing.
<LI>It is difficult to operate a well-functioning team where there are more than 12 or so doctors and nurses. If care continues, as I believe it should, to be centred around a core general practice team, the team needs to find new ways of interacting and communicating with the increasing number of other professionals who, quite appropriately, are providing care from a community base.
<LI>The relationship between the health professional and his or her patient is key to providing high-quality patient care. Personal continuity is not always important but it is sometimes very important.
I am not suggesting that general practice should return to the days of Dr Finlay and Tannochbrae, but if we allow general practice to become like a department store then our patients will be the losers. We must remember this when developing quality indicators for general practice and, in particular, protect the time needed for the encounter between the doctor or nurse and his or her patient.
<LI>There are opportunities which are at present poorly realised for individual doctors or nurses within practices to develop specific skills. Specialisation within practices offers the opportunity to increase the range of services available. The amount of referral that occurs within practices could be increased. Fear that these developments will lead to a mini-specialoid service are probably overplayed.
<LI>The profession must seize the opportunity to define quality standards. There is a window of opportunity in the next few years that must be grasped.
<LI>Where expert advice is needed we need much better ways of communication. The growth in IT offers great opportunity for desktop decision support for GPs, which may enable them with confidence
to undertake the increasing amounts of care being asked of them. Telemedicine may offer opportunities for rapid access to brief specialist advice, which is notably lacking in the NHS at the
moment.
<LI>Finally, however models of purchasing develop in the NHS, I am sure that GPs need an important voice in the services provided for their patients. I am less convinced that GPs, whose main interest is personal care, are the best people to plan the health care of populations. I do not agree with those who believe that the future of public health medicine is somehow to become hybridised with general practice. Both disciplines have distinct contributions to make.
</OL>

<P>
The Government has correctly recognised the potential of a primary care-led NHS and the potential for general practice to take a leading role in that change. Yet as we have heard, perversely, at a time when general practice should be riding high, morale is lower than for many years. This is for many reasons, some of which we have heard, one of which is that a transfer of work to the primary sector has taken place without a comparable transfer of resources. Morale and resourcing need to be tackled. Adequately resourced, properly motivated, British primary care has the potential to become the envy of the world.
<P>

<center><h2><a name=sec7><B>Section 7</B></h2></center>
<P>
<center><B>HEALTH ECONOMICS DATABASE LAUNCHED BY OHE AND IFPMA</B></center>

<P>
A specialised data service using CD-ROM to help identify economic evaluations in health care was launched by the Office of Health Economics (OHE) and the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) in April 1995.
<P>
The service, known as HEED (a Health Economic Evaluations Database), is a database that contains information on health economics articles, in particular studies of cost-effectiveness (and other forms of economic evaluation), with objective analysis of key articles.
<P>
HEED now has more than 5,600 bibliographic references and 2,400 reviewed articles, building up through monthly updates to contain a comprehensive bibliography of all published economic literature.
<P>
<B>Content</B> 
<P>
A monthly search of clinical and economic on-line databases is undertaken, combined with hand searching of the leading journals containing evaluation literature. Working papers from academic
institutions and references from reviewed and other papers are also included.

<P>
Reviews are undertaken of the selected key literature by researchers in academic institutions according to a structured format. In addition to providing an overview of the paper, they also provide additional information, such as ICD-9 and ATC Codes, type of economic evaluation, and type of data source for events and resources used. These categories can be searched on using the CD-ROM software.
<P>

<B>Searching the Database</B> 
<P>
HEED is very easy to use, even for beginners. There are no complex commands to learn and nearly all operations are simply 'point and click'. HEED has been designed for easy reference and frequent use.

<P>
With 54 fields to choose from, the database can be searched by selecting only those search criteria of relevance. The search criteria are grouped into a number of subject groupings. Each subject grouping contains specific search criteria, which can be specified in any combination (in addition to wild card and Boolean functions) to search the database. The search criteria can be modified and refined to quickly access search results in manageable quantities.

<P>
The subject groupings include:

<UL>
<LI>Bibliographical details
<LI>Study definitions
<LI>Analysis and results
<LI>Keywords.
</UL>

<P>
It is also possible to search HEED using keywords or any combination of the search criteria that includes:

<UL>
<LI>Author name
<LI>Book/Journal name
<LI>Countries applicable
<LI>Publication dates
<LI>Publication status
<LI>Study dates
<LI>ATC classifications
<LI>Data Sources
<LI>Drug names
<LI>ICD-9 classifications
<LI>Non-drug technologies
<LI>Technology assessed
<LI>Type of article
<LI>Type of economic evaluation
<LI>Costs included
<LI>Discounting
<LI>Outcomes
<LI>Patient groups
<LI>Sensitivity analysis
<LI>Sources of clinical and economic information
<LI>Sponsor
</UL>

<P>
Search criteria can be saved for use at a later date.
<P>

<B>Formatted Reports</B> 
<P>
The HEED CD-ROM reports will present the results of searches in a clear easy-to-read format.
<P>
There are four default report formats:

<UL>
<LI>Search Report
<LI>Summary Report
<LI>Brief Report
<LI>Detailed Report.
</UL>

<P>
The reports will present the results of searches at increasing levels of detail. The Detailed Report will additionally provide details of the study question, key results and, providing copyright permission has been given by the article publisher, the article abstract in full.

<P>
Hypertext links are available so that the ICD-9 and ATC sub-reports can be accessed.
<P>

<B>Academic Panel</B> 
<P>
A panel of academic advisors is providing guidance on the search and review processes. The panel comprises Martin Buxton, Mike Drummond, Bernie O'Brien, Kevin Schulman, Bengt Jonsson, Frans
Rutten, Joan Rovira and Akinori Hisashige.
<P>

<B>Organisation</B> 
<P>
HEED has been set up with finance from more than 20 companies in the USA, Europe and Japan, who comprise the Steering Group for the project. New industry subscribers will be included in
a user group designed to ensure the service develops in accordance with industry needs.
<P>

<B>For More Information</B> 
<P>
For further information on the OHE-IFPMA Database please contact:<br>
Gerry Crosbie, Project Manager, <br>
OHE-IFPMA Database Ltd., <br>
12 Whitehall,<br>
London SW1A 2DY<br>
<B>Tel </B>+44 (0) 171 930 3477 Ext. 1474<br>
<B>Fax</B> +44 (0) 171 747 1419<br>

<P>
<center><h2><a name=sec8><B>Section 8</B></h2></center>
<P>

<center><B>OHE COMPENDIUM OF HEALTH STATISTICS</B></center>
<P>

<B>10th Edition 1996</B> 
<P>
The 10th edition of the Compendium of Health Statistics is currently being prepared by Sean McGuigan, who has recently taken over from Bob Chew as OHE Statistician.

<P>
Sean plans to have the Compendium ready by the third quarter of 1996.
<P>
Although the Compendium will broadly follow the form of its predecessors, users can expect to see improvements in several areas. There will be more information about data sources, graphical methods of data presentation will be improved and an index will be added. A recent market research exercise has provided many useful suggestions for development of the Compendium; as a result, several new data series will appear in the 10th edition. Sean would welcome any comments you may have on the Compendium.
<P>
He can be contacted on:
<P>
<B>Tel</B> +44 (0) 171 747 1418<br>
<B>Fax</B> +44 (0) 171 747 1419<br>

<P>
The 9th edition of the Compendium of Health Statistics was published in January 1995 as is available for purchase from the OHE.
<P>

<B>ORDER FORM</B> 
<P>
Diseases of the Prostate (&#163; 7.50)
<P>
Handling Uncertainty in the Results of Economic Evaluation (&#163;
5.00)
<P>
Health Information and the Consumer (&#163;10.00)
<P>
Industrial Policy and the Pharmaceutical Industry (&#163;10.00)
<P>
Value of the Pharmaceutical Industry to the Economy (&#163; 5.00)
<P>
Hypothecated Health Taxes (&#163;10.00)
<P>
Financing Health Care in the UK (&#163;10.00)
<P>
Healthcare as a Handicraft Industry (&#163; 5.00)

<P>
I would like an annual subscription to the OHE publications (&#163;20.00
UK, &#163;25.00 non-UK)

<P>
Please send me:

<UL>
<LI>an OHE publications list
<LI>details of the next PIHEG meeting (NB only industry representatives are eligible to attend)
<LI>details of the OHE Compendium of Health Statistics.
</UL>

<P>
<B>IF YOU ARE ORDERING PUBLICATIONS PLEASE ENCLOSE A CHEQUE MADE
PAYABLE TO ABPI</B> 
<P>
NAME________________________________________________________________
<P>
POSITION_____________________________________________________________
<P>
COMPANY/ORGANISATION____________________________________________
<P>
______________________________________________________________________
<P>
ADDRESS_____________________________________________________________
<P>
______________________________________________________________________
<P>
______________________________________________________________________

</BODY>

<hr>
<a href=http://www.abpi.org.uk/ohe.htm><IMG SRC=../pics/b_arrow.gif  border=0></a> <a href=http://www.abpi.org.uk/ohe.htm> OHE Home Page</a>

<hr>
</body>
<ADDRESS>
<h6>Last Updated 09 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
<p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-114</DOCNO>
<DOCOLDNO>IA063-000363-B030-77</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/koblet.htm 194.159.248.137 19970112020414 text/html 2453
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:04:18 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 2281
Last-modified: Fri, 06 Sep 1996 11:09:24 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Health Economics: Koblet</TITLE>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H2>Health Economics: An Introduction to Economic Evaluation 
</H2><HR>

This new guide to health economics, by Gisela Kobelt, Director of the
Pharmacia and Upjohn Corporate Management Centre in London, explains 
how economic assessments of medical technology are performed. Despite the increasing importance of economic evaluations the knowledge of these new techniques, and their potential
use and inherent difficulties, is still limited both within the pharmaceutical industry and among the industry's customer's. This guide should be useful, therefore, for non-specialists,
working in the pharmaceutical industry, and for users of this kind of information, such as physicians, pharmacists and managers. Its intention is to provide a short, easy-to-read, overview on economic evaluation and some insight into the techniques used, illustrated with simple examples.

<HR>

This publication is available from:

<P>
Mrs E Aulsford, Office of Health Economics,<br>
12, Whitehall, London SW1A 2DY.<br>
Tel: +44 (0)171 930 9203<BR>
Fax: +44 (0)171 747 1419<br>
<P>
<hr>
<A HREF=netpham.htm><IMG SRC=../pics/b_arrow.gif border=0></a><A HREF=netpham.htm>Pharmaceutical &amp; Health Monographs Page</A>

</BODY>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-115</DOCNO>
<DOCOLDNO>IA063-000363-B030-88</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/ryan.htm 194.159.248.137 19970112020425 text/html 3191
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:04:29 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 3019
Last-modified: Fri, 06 Sep 1996 11:09:24 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Using Consumer Preferences </TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<P>
<H2>Using Consumer Preferences in Health Care  Decision Making: the Application of Conjoint Analysis by Dr Mandy Ryan</H2><br>
<H3>ASK PATIENTS WHAT SERVICES THE NHS SHOULD PROVIDE</H3>
<P>
Patients should be asked which services the NHS should provide more of - and which should be provided less - in a way that can
be used by NHS doctors and managers, according to this OHE report by Dr Mandy Ryan.
<P>
NHS purchasers are under pressure to consult the public about NHS priorities, and hospitals want to know what matters to patients.
 This report proposes the use of a technique known as conjoint analysis which is commonly used in the private sector and in other
parts of the public sector.  It can be used to ask the real questions facing hard-pressed doctors and managers, and provide a genuine
public input into NHS decision-making.  Conjoint analysis provides this information by asking individuals to make choices between
different aspects of service and types of service.
<P>
By structuring the questions carefully, the strength of preferences can be established across a wide range of different services.
 Crucially, people have to indicate what they will give up to have more of something else.
<P>
The report criticises public opinion surveys and patient satisfaction surveys as too general to enable NHS purchasers to incorporate
into their everyday decision-making.  The views of the author are supported in an earlier study for the Treasury by a team of
academics from the University of Brunel, who argued for this technique to be widely used in the public sector.

<HR>

This publication is available from:
<P>
Mrs E Aulsford, Office of Health Economics,<BR>
12, Whitehall, London SW1A 2DY.<BR>
Tel: +44 (0)171 930 9203<BR>
Fax: +44 (0)171 747 1419</BR>
<P>
<hr>

<A HREF=netpham.htm><img src=../pics/b_arrow.gif></a><A HREF=netpham.htm>Pharmaceutical &amp; Health Monographs Page</A>

</BODY>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
</HTML>



</DOC>
<DOC>
<DOCNO>WT01-B18-116</DOCNO>
<DOCOLDNO>IA063-000363-B030-120</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/sackett.htm 194.159.248.137 19970112020438 text/html 3338
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:04:41 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 3166
Last-modified: Fri, 06 Sep 1996 11:09:24 GMT
</DOCHDR>
<HTML>

<HEAD>

<TITLE>OHE ANNUAL LECTURE 1996</TITLE>
</HEAD>

<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H2>OHE ANNUAL LECTURE 1996</H2>

<H3>The Doctor's (Ethical and Economic) Dilemma by Professor David
Sackett</H3>
<HR>

In the 1996 OHE Annual Lecture, Professor David Sackett, Director
of the NHS Centre for Evidence-Based Medicine, discusses the conflicts
that arise between a doctor's responsibilities to provide the
best care for his or her patient and to serve society at a time
when NHS resource constraints mean difficult choices have to be
made. Using five examples of (suitably anonymised) encounters
with patients, in some of which he has personally faced ethical
dilemmas, he concludes by setting out six strategies that the
NHS can follow to minimise conflict. These are: 
<p>
<OL>
<LI><B>eliminating useless or harmful clinical manoeuvres</B>,
by expanding patient-centred research and applying the results;
<LI><B>expanding effective, cost-saving clinical manoeuvres</B>,
notably preventing illnesses that are expensive to treat;
<LI><B>use equally effective but less expensive alternative clinical
manoeuvres</B>, for example by prescribing cheaper but equally
effective &quot;generic&quot; drugs;
<LI><B>determine and apply the cost-utility properties of clinical
manoeuvres</B>. Reliable evidence of cost-effectiveness is essential
for setting group priorities for treatment;
<LI><B>inform the public</B>. People should be informed that NHS
care can be evidence-based. A well informed public may want more
health spending on an NHS delivering effective care;
<LI><B>be explicit about the presence and nature of conflicts</B>.
By recognising that genuine ethical dilemmas will arise, clinicians
and managers can tackle them openly (respecting patient confidentiality)
in a problem solving mode.
</OL>
<HR>

This publication is available from:
<p>

Mrs E Aulsford, Office of Health Economics,<br>
12, Whitehall, London SW1A 2DY.<br>
Tel: +44 (0)171 930 9203<BR>
Fax: +44 (0)171 747 1419<br>
<P>
<hr>

</BODY>
<A HREF=netoheal.htm><img src=../pics/b_arrow.gif></a><A HREF=netoheal.htm>OHE Lectures Page</A>

<hr>

</BODY>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
</HTML>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-117</DOCNO>
<DOCOLDNO>IA063-000363-B030-156</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/dvt.htm 194.159.248.137 19970112020516 text/html 3686
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:04:55 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 3514
Last-modified: Fri, 06 Sep 1996 11:09:24 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Deep Vein Thrombosis and Pulmonary Embolism</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H2>Deep Vein Thrombosis and Pulmonary Embolism</H2>
<HR>

In this OHE report Jane Griffen outlines how post-surgical deep vein thrombosis (DVT) and pulmonary embolism (PE) are estimated
to have cost the National Health Service between &#163;205 and &#163;225 million in 1993. This estimate does not include the
costs incurred by the patients and their families. Indeed, if all the patients at high risk of developing a post-surgical DVT
(ie. those aged over 45 years and undergoing an operation associated with a high incidence of thrombosis) had received adequate prophylaxis the NHS would have made a cost saving of between &#163;35 and &#163;85 million and the number of deaths due to post surgical pulmonary embolism would probably have been reduced by more than 400, according to this analysis.

Yet, despite the fact that the major risk factors for DVT of age, immobility and certain forms of surgery are well known
among the medical profession and have been recognised for many years, less than half (46 per cent) of high risk surgical patients
appear to be receiving any form of prophylaxis. For some patients, particularly those undergoing brain surgery, it is possible that
the risks of using thrombolytic prophylaxis, such as excessive bleeding, outweigh the benefits of preventing deep vein thrombosis.
However, there are other non-pharmaceutical methods of prophylaxis such as elasticated stockings and according to the sample quoted
in the National Confidential Enquiry into Perioperative Deaths (CEPOD, 1995), only 17 per cent of neurosurgery patients were
given these.

The use of thrombolytic prophylaxis for the prevention of DVT provides a classic example of clinical and cost-effectiveness
evidence about a therapy not being put into practice. At a time when evidence-based medicine is receiving considerable emphasis
in the NHS, it would appear from this research, that much could be achieved in terms of cost savings and health gain if prophylactic
measures were implemented for surgical patients at high risk of developing a DVT.
<HR>

This publication is available from:

<P>
Mrs E Aulsford, Office of Health Economics,<br>
12, Whitehall, London SW1A 2DY.<br>
Tel: +44 (0)171 930 9203<BR>
Fax: +44 (0)171 747 1419<br>
<P>

<hr>
<A HREF=netpham.htm><img src=../pics/b_arrow.gif border=0></a><A HREF=netpham.htm>Pharmaceutical &amp; Health Monographs Page</A>

<hr>
</BODY>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-118</DOCNO>
<DOCOLDNO>IA063-000363-B030-186</DOCOLDNO>
<DOCHDR>
http://www.abpi.org.uk:80/ohe/pcare.htm 194.159.248.137 19970112020551 text/html 3645
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 02:05:52 GMT
Server: Apache/0.8.14
Content-type: text/html
Content-length: 3473
Last-modified: Fri, 06 Sep 1996 10:46:10 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Primary Care Proceedings</TITLE>
</HEAD>
<body bgcolor="#FFFFFF">

<center>
<table border=0 cellspacing=0 cellpadding=5>

<tr>
<td width=75></td>
<td width=150><img src=../pics/logoohe.gif></td>
<td width=100></td>
<td width=200><img src=../pics/ohe2.gif></td>
<td width=100></td>
</table>
</center>

<p>
<center>
<table border=2 cellspacing=0 cellpadding=5>

<tr>
<th width=150><a href= mailto:ia@abpi.demon.co.uk>Feedback</a></td>
<th with=150><a href=http://www.abpi.org.uk>ABPI</a></td>
<th width=200><a href=ohenews.htm>OHE News</a></td>
<th width=100><a href=whatsnew.htm>OHE What's New</a></td>
</tr>

<tr>
<th width=150><a href=../ohe.htm#GI>Information</a></td>
<th width=150><a href=../ohe.htm#PUB>Publications</a></td>
<th width=200><a href=../ohe.htm>OHE</a></td>
<th width=100><a href=../heabpi.htm>HEED</a></td>
</table>
</center>

<hr>

<H2>The Future of Primary Care: Proceedings of a Conference, edited by Jane Griffin</H2>
<HR>

This stimulating OHE book, edited by Jane Griffin, reports a series of papers presented at a conference in October 1995 on the future of general practice. Its purpose was not only to try to explain this fascinating paradox between political influence and job satisfaction, but to look to the future. We are about to witness a watershed in the history of primary health care in the UK and perhaps elsewhere. The pressures on a socialist health care system from consumer expectation and public spending constraint are not reversible.
There is no way back to the country practice of Dr Finlay. General practice has been elevated to centre stage to deal with these
pressures, and if it is to survive, it must move forward and seize its opportunity.
<P>
The contributors to the conference were from overseas as well as from the UK. They were asked to give their view on the way
forward for general practice from an international perspective. They dealt with an impressive range of issues from comparison
of the effect of primary care on the performance of national health care systems to the importance of continuity of care to the individual
patient. They presented an impressive array of information on the organisation and funding of primary care systems in Europe
and North America.
<P>
In the book Professor Starfield discusses the characteristics of a strong primary care system, which, she argues, are accessibility,
continuity of care, comprehensiveness, and coordination. Dr Makela, Professor van der Zee and Professor Light look at the systems
which have arisen in Finland, the Netherlands and the United States, respectively. Other important issues addressed are the future
of fundholding by Professor Ham and the causes of and solutions to low GP morale, by Professor Mant and Mr Towse. In the final
chapter, Professor Roland sets out his vision as to how the dangers of fragmentation and the challenges to define and assure quality
of care can be met.
<hr>

This publication is available from:

<P>
Mrs E Aulsford, Office of Health Economics,<br>
12, Whitehall, London SW1A 2DY.<br>
Tel: +44 (0)171 930 9203<BR>
Fax: +44 (0)171 747 1419<br>
<P>

<hr>
<A HREF=netohes.htm><img src=../pics/b_arrow.gif></a><A HREF=netohes.htm>Reports of OHE Symposia Page</A>

<hr>
</BODY>
<ADDRESS>
<h6>Last Updated 06 September 1996<BR>
Web Page by the <A HREF=MAILTO:IA@ABPI.demon.co.uk>ABPI Webmaster</a>
</h6>
</ADDRESS>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-119</DOCNO>
<DOCOLDNO>IA026-000276-B034-216</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/ 198.77.86.203 19970113171111 text/html 2233
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:13:17 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2062
Last-modified: Mon, 17 Jun 1996 20:07:20 GMT
</DOCHDR>
<HTML><HEAD>
<TITLE>The Energy Foundation</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<CENTER><IMG SRC="grf/logo.gif" ALT="Energy Foundation Logo" ALIGN=BOTTOM WIDTH="398" HEIGHT="176"></CENTER>
<CENTER><H1>Our Mission</H1></CENTER>
<BR>
<BLOCKQUOTE>
<IMG SRC="./grf/dcI.gif" ALT="I" ALIGN=left WIDTH="32" HEIGHT="56">
n January 1991, after a series of consultations with
many of the nation's leading scientists, policy-makers,
business leaders, and analysts, the staffs and boards of
The John D. and Catherine T. MacArthur Foundation, The
Pew Charitable Trusts, and The Rockefeller Foundation
created the Energy Foundation. <STRONG>Its mission is to assist
in the nation's transition to a sustainable energy
future by promoting energy efficiency and renewable
energy.</STRONG><P>

The Energy Foundation has a dual character: It functions
primarily as a grant-maker, but when it determines there
is an unmet need in the field, it may convene workshops,
commission papers, or take other direct initiatives. The
foundation also draws from and contributes to related
programs of The John D. and Catherine T. MacArthur
Foundation, The Pew Charitable Trusts, and The
Rockefeller Foundation. It has a budget of $10 million
per year.<p>

<A NAME="toc"></A>
<BLOCKQUOTE>
<A HREF="grants/index.html"><IMG border=0 SRC="./grf/blt.gif"><b>Grant Programs and Guidelines</b></a><br>
<A HREF="grants/grantees.html"><IMG border=0 SRC="./grf/blt.gif"><b>Grantee List</b></a><br>
<A HREF="essay/index.html"><IMG border=0 SRC="./grf/blt.gif"><b>Essay from the Executive Director</b></a><br>
<A HREF="sites.html"><IMG border=0 SRC="./grf/blt.gif"><b>Energy-Related WWW Sites</b></a><br>
<A HREF="reports/index.html"><IMG border=0 SRC="./grf/blt.gif"><b>Special Energy Foundation or Grantee Reports</b></A><br>
</BLOCKQUOTE></BLOCKQUOTE>
<hr>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>
</BODY>
</HTML>


</DOC>
<DOC>
<DOCNO>WT01-B18-120</DOCNO>
<DOCOLDNO>IA026-000276-B034-241</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/index.html 198.77.86.203 19970113171120 text/html 1838
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:13:25 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1667
Last-modified: Mon, 17 Jun 1996 20:16:53 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>"Programs and Grants"</TITLE>
</HEAD>
<BODY bgcolor="#ffffff">
<a href = "../index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<BLOCKQUOTE>

<H2>Programs and Grants</H2>
The Energy Foundation awards grants and takes direct
initiatives in five areas: <P>
<BLOCKQUOTE><img src="../grf/blt.gif" alt="*"><A HREF="utilities/index.html"><B>Utilities</B></A>, <br>
<img src="../grf/blt.gif" alt="*"><A HREF="buildings/index.html"><B>Buildings</B></A>, <br>
<img src="../grf/blt.gif" alt="*"><A HREF="transport/index.html"><B>Transportation</B></A>, <br>
<img src="../grf/blt.gif" alt="*"><A HREF="renew/index.html"><B>Renewable Energy</B></A>, and <br>
<img src="../grf/blt.gif" alt="*"><A HREF="integrated/index.html"><B>Integrated Issues</B></A>. <br>
</BLOCKQUOTE><P>
Its geographic focus is the United States, with special
emphasis on regional initiatives.
<P>
In this section we describe our programs and illustrate
them with the grants given in 1992, 1993, and 1994. Thus
far, a total of 281 grants worth $30,915,038 (over four
years) have been made to 132 organizations.
<P>
<B><A HREF="./guidelines.html">Application Information</A></B> and <B><A HREF="./application.html">Forms</A></B> are also available.

</BLOCKQUOTE>


</BODY>
<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-121</DOCNO>
<DOCOLDNO>IA026-000276-B034-268</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/grantees.html 198.77.86.203 19970113171137 text/html 22563
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:13:40 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 22391
Last-modified: Mon, 17 Jun 1996 20:04:03 GMT
</DOCHDR>
<HTML><HEAD><TITLE>Energy Foundation Grantees</TITLE></HEAD><BODY bgcolor="#FFFFFF"><a href = "../index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a><br clear=all><BLOCKQUOTE><H2>Energy Foundation Grantees, Alphabetically</H2><CENTER><TABLE><tr><TD><A HREF="#0-9"><B>0-9</B></A></TD><TD><A HREF="#A"><B>A</B></A></TD><TD><A HREF="#B"><B>B</B></A></TD><TD><A HREF="#C"><B>C</B></A></TD><TD><A HREF="#D"><B>D</B></A></TD><TD><A HREF="#E"><B>E</B></A></TD><TD><A HREF="#F"><B>F</B></A></TD><TD><A HREF="#G"><B>G</B></A></TD><TD><A HREF="#H"><B>H</B></A></TD><TD><A HREF="#I"><B>I</B></A></TD><TD><A HREF="#K"><B>K</B></A></TD></TR><TR><TD align=right><A HREF="#L"><B>L</B></A></TD><TD><A HREF="#M"><B>M</B></A></TD><TD><A HREF="#N"><B>N</B></A></TD><TD><A HREF="#O"><B>O</B></A></TD><TD><A HREF="#P"><B>P</B></A></TD><TD><A HREF="#Q"><B>Q</B></A></TD><TD><A HREF="#R"><B>R</B></A></TD><TD><A HREF="#S"><B>S</B></A></TD><TD><A HREF="#T"><B>T</B></A></TD><TD><A HREF="#U"><B>U</B></A></TD><TD><A HREF="#W"><B>W</B></A></TD></tr></TABLE></CENTER><A NAME="0-9"><h3>0-9</h3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>1000 Friends of Florida, </STRONG>Tallahassee, Florida<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>1000 Friends of Oregon, </STRONG>Portland, Oregon<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>20/20 Vision Education Fund, </STRONG>Washington, D.C.<A NAME="A"><h3>A</h3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>AeroVironment, Inc., </STRONG>Monrovia, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Alaska Center for the Environment, </STRONG>Anchorage, Alaska<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Alaska Conservation Foundation, </STRONG>Anchorage, Alaska<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Alliance for Affordable Energy, </STRONG>New Orleans, Louisiana<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Alliance to Save Energy, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Alliance to Save Energy,</STRONG> Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Alliance to Save Energy/President's Commission on Environmental Quality, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Academy of Arts and Sciences, </STRONG>Cambridge, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Council for an Energy-Efficient Economy, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Council for an Energy-Efficient Economy, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Council for an Energy-Efficient Economy, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Council for an Energy-Efficient Economy, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Institute of Architects/ Association of Collegiate Schools of Architecture,</STRONG> Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Lung Association of California, </STRONG>Redondo Beach, California<BR><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Lung Association, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Planning Association, </STRONG>Tallahassee, Florida<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>American Society of Heating, Refrigerating, and Air Conditioning Engineers, </STRONG>Atlanta, Georgia<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Arizona Center for Law in the Public Interest, </STRONG>Tucson, Arizona<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Audubon Society of Portland, </STRONG>Portland, Oregon<A NAME="B"><H3>B</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Bicycle Federation of America, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Business and Professional People for the Public Interest, </STRONG>Chicago, Illinois<A NAME="C"><H3>C</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>CALPIRG Charitable Trust, </STRONG>Santa Barbara, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>California/Nevada Community <DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Calthorpe Associates, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Campaign for a Prosperous Georgia, </STRONG>Atlanta, Georgia<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Center for Auto Safety, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Center for Clean Air Policy, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Center for Energy Efficiency and Renewable Technologies Research<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Center for Energy Efficiency and Renewable Technologies, </STRONG>Sacramento, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Center for Neighborhood Technology, </STRONG>Chicago, Illinois<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Center for Resource Management, </STRONG>Salt Lake City, Utah<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Citizens Conservation Corporation, </STRONG><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Citizens Energy Coalition Education Fund, </STRONG>Indianapolis, Indiana<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Citizens Fund, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Clean Air Council, </STRONG>Philadelphia, Pennsylvania<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Colorado Public Interest ,</STRONG>Research Foundation<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Conservation Law Foundation, </STRONG>Boston, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Conservation Law Foundation, </STRONG>Boston, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Conservation Law Foundation, </STRONG>Boston, Massachusetts<A NAME="D"><H3>D</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Demand-Side Management Training Institute, </STRONG>Bala Cynwyd, Pennsylvania<A NAME="E"><H3>E</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Earth Island Institute, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Earth Island Institute, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Eley Associates, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Energy Conservation Association, </STRONG>Denver, Colorado<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Energy Conservation Coalition, </STRONG>Takoma Park, Maryland<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Energy Rated Homes of America, </STRONG>Little Rock, Arkansas<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Environmental Action Foundation, </STRONG>Takoma Park, Maryland<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Environmental Action Foundation, </STRONG>Takoma Park, Maryland<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Environmental Defense Fund, <DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Environmental Defense Fund, </STRONG>New York, New York<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Environmental Defense FundTexas, </STRONG>Austin, Texas<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Environmental Law and Policy Center of the Midwest, </STRONG>Chicago, Illinois<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Environmental Law and Policy Center of the Midwest, </STRONG>Chicago, Illinois<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Environmental and Energy Study Institute, </STRONG>Washington, D.C.<A NAME="F"><H3>F</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Friends of the Earth, </STRONG>Washington, D.C.<A NAME="G"><H3>G</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Georgia Citizens Fund, </STRONG>Atlanta, Georgia<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Golden Gate National Park Association, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Green Seal, </STRONG>Washington, D.C.<A NAME="H"><H3>H</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Home Energy Ratings of Ohio Foundation, </STRONG>Columbus, Ohio<A NAME="I"><H3>I</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Institute for Transportation and the Environment, </STRONG>Seattle, Washington<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>International Institute for Energy Conservation, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Island Press, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Izaak Walton League of America, </STRONG>Minneapolis, Minnesota<A NAME="K"><H3>K</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Kearns & West, Inc., </STRONG>San Francisco, California<A NAME="L"><H3>L</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Land and Water Fund of the Rockies, </STRONG>Boulder, Colorado<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Land and Water Fund of the Rockies, </STRONG>Boulder, Colorado</STRONG><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Latino Issues Forum, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Legal Environmental Assistance Foundation, </STRONG>Tallahassee, Florida<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Local Government Commission, </STRONG>Sacramento, California<A NAME="M"><H3>M</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>MIT Solar Electric Vehicle Club, </STRONG>Cambridge, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Mainewatch, </STRONG>Hallowell, Maine<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Maryland Energy Administration, </STRONG>Annapolis, Maryland<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Michigan United Conservation Clubs, </STRONG>Lansing, Michigan<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Mid-Atlantic Energy Efficiency Project, </STRONG>Newark, New Jersey<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Minnesotans for an Energy-Efficient Economy, </STRONG>Minneapolis, Minnesota<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Montana Environmental Information Center, </STRONG>Helena, Montana<A NAME="N"><H3>N</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>NESCAUM Air Quality Foundation for Assessment, Research, and Education, </STRONG>Boston, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>National Academy of Sciences, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>National Association of State Utility Consumer Advocates, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>National Audubon Society, </STRONG>Sacramento, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>National Conference of State Legislatures, </STRONG>Denver, Colorado<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>National Consumer Law Center, </STRONG>Boston, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Natural Resources Council of Maine, </STRONG>Augusta, Maine<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Natural Resources Defense Council, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Natural Resources Defense Council, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Natural Resources Defense Council, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Natural Resources Defense Council, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>New York University, Stern School of Business, </STRONG>New York, New York<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Northeast Alternative Vehicle Consortium, </STRONG>Boston, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Northeast Sustainable Energy Association, </STRONG>Greenfield, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Northeast-Midwest Institute, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Northwest Conservation Act Coalition, </STRONG>Seattle, Washington<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Northwest Conservation Act Coalition, </STRONG>Seattle, Washington<A NAME="O"><H3>O</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Ohio Environmental Council, </STRONG>Columbus, Ohio<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>On the Ground, </STRONG>Berkeley, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Open Space Institute, </STRONG>New York, New York<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Opportunity Council, </STRONG>Bellingham, Washington<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Oregon Environmental Council, </STRONG>Portland, Oregon<A NAME="P"><H3>P</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Pace University School of Law, Center for Environmental Legal Studies, </STRONG>White Plains, New York<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Pace University, School of Law, Center for Environmental Legal Studies, </STRONG>White Plains, New York<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Pace University, School of Law, Center for Environmental Legal Studies, </STRONG>White Plains, New York<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Policy Initiatives Group, </STRONG>Portland, Oregon<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Princeton University, Center for Energy and Environmental Studies, </STRONG>Princeton, New Jersey<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Public Citizen, </STRONG>Washington, D.C.<A NAME="Q"><H3>Q</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>QLF/Atlantic Center for the Environment, </STRONG>Montpelier, Vermont<A NAME="R"><H3>R</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Rails to Trails Conservancy, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Regional Renewable Energy Project, </STRONG>Portland, Oregon<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Regulatory Assistance Project, </STRONG>Gardiner, Maine<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Rocky Mountain Institute, </STRONG>Snowmass, Colorado<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Rocky Mountain Institute, </STRONG>Snowmass, Colorado<A NAME="S"><H3>S</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Safe Energy Communication Council, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Safe Energy Communication Council, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Sensible Transportation Options for People, </STRONG>Tigard, Oregon<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Sierra Club Foundation, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Sierra Club Foundation, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Sierra Club Legal Defense Fund, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Southern Environmental Law Center, </STRONG>Charlottesville, Virginia<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Spokane Neighborhood Action Programs, </STRONG>Spokane, Washington<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Surface Transportation Policy Project, </STRONG>Washington, D.C. <A NAME="T"><H3>T</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Tellus Institute/Boston, Massachusetts, </STRONG><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Tennessee Valley Energy Reform Coalition, </STRONG>Nashville, Tennessee<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Texas Citizen Fund, </STRONG>Austin, Texas<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Texas Citizen Fund, </STRONG>Austin, Texas<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Texas Legal Services Center, </STRONG>Austin, Texas<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Texas Ratepayers Organization to Save Energy (R.O.S.E.), </STRONG>Austin, Texas<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Tides Foundation, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Tides Foundation/Capital Forum Account, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Tides Foundation/Capital Forum Account, </STRONG>San Francisco, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Transportation Alternatives, </STRONG>New York, New York<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Transportation Legal Task Force, </STRONG>(c/o Environmental Defense Fund)<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Tri-State Transportation Campaign (c/o New York Community Trust), </STRONG><A NAME="U"><H3>U</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Union of Concerned Scientists, </STRONG>Cambridge, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Union of Concerned Scientists, </STRONG>Cambridge, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>University of California at Berkeley, Department of Architecture, </STRONG>Berkeley, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>University of California at Berkeley, Energy Resources Group, </STRONG>Berkeley, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>University of California at Davis, </STRONG>Davis, California<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>University of Maryland at College Park, <DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>University of Maryland at College Park, Center for Global Change, </STRONG>College Park, Maryland<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>University of Maryland, </STRONG>College Park, Maryland<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>University of Pennsylvania, </STRONG>Philadelphia, Pennsylvania<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>University of Texas at Austin, Center for Energy Studies, </STRONG>Austin, Texas<A NAME="W"><H3>W</H3></A><DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>WalkBoston, </STRONG>Boston, Massachusetts<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Wisconsin Public Utility Institute, </STRONG>Madison, Wisconsin<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Wisconsin's Environmental Decade, </STRONG>Madison, Wisconsin<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>World Resources Institute, </STRONG>Washington, D.C.<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../grf/b2.gif"><STRONG>Worldwatch Institute, </STRONG>Washington, D.C.</BODY></BLOCKQUOTE><a href = "../index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a><br clear=all><hr><A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-122</DOCNO>
<DOCOLDNO>IA026-000276-B034-297</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/index.html 198.77.86.203 19970113171200 text/html 1708
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:13:53 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1537
Last-modified: Mon, 17 Jun 1996 20:08:46 GMT
</DOCHDR>

<HTML>
<HEAD>
<TITLE>"Essay from the Executive Director"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "../index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>
<H2>Essay from the Executive Director</H2>

<BR>

<CENTER>

<NOBR><A HREF="start.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Start Essay" SRC="MAPTL1.gif"></A><A HREF="cars.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Build Better Cars" SRC="MAPTR1.gif"></A></NOBR><BR><NOBR><A HREF="city.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Change the City" SRC="MAPML1.gif"></A><A HREF="fuels.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Switch to Better Fuels" SRC="MAPMR1.gif"></A></NOBR><BR><NOBR><A HREF="altmodes.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Promote Other Modes" SRC="MAPBL1.gif"></A><A HREF="conclusion.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Conclusion" SRC="MAPBR1.gif"></A></NOBR><BR>

</CENTER>

<P>


</BODY>
<a href = "../index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>
<hr>

<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-123</DOCNO>
<DOCOLDNO>IA026-000276-B034-333</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/sites.html 198.77.86.203 19970113171247 text/html 4585
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:14:36 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4414
Last-modified: Mon, 17 Jun 1996 20:04:28 GMT
</DOCHDR>
<HTML><HEAD><TITLE>Energy Related WWW Sites</TITLE></HEAD><BODY bgcolor="#FFFFFF"><a href = "./index.html#toc"><img align=right border=0 src="./grf/up.gif" alt = "[ Up ]"></a><br clear=all><H2>Energy Related WWW Sites</H2>This is a sampling of 'entry points' for renewable and efficienct energy information on the World Wide Web. This list is in no way comprehensive,and will change periodically.<ul><p><li> <B>The US DOE Energy Efficiency and Renewable Energy Network</B><br>       EE/RE news from the DOE's national labs. Broad and complete.        <br><a href="http://www.eren.doe.gov/"><b>http://www.eren.doe.gov/</B></a><p><li> <B>Association of Energy Services Professionals</B><br>       The Association of Energy Services Professionals (formerly the Association of Demand-Side Management Professionals) is an association ofnearly 2,000 utility executives, consultants, manufacturers, researchers, government regulators, and others concerned with promoting energy efficiency and value.        <br><a href="http://www.dnai.com:80/AESP/"><b>http://www.dnai.com:80/AESP/</b></a><p><li> <B>California Energy Commission Home Page</B><br>       Programs of the California Energy Commission, including policy, case studies, and export program. Limited gopher site.        <br><a href="http://resources.agency.ca.gov/cechomepage.html"><b>http://resources.agency.ca.gov/cechomepage.html</b></a><p><li> <B>Electric Vehicle Sites on the We</B>b        A comprehensive listing of EV info online, including academic, commercial, and government sites. Sponsored by the GreenWheels electric vehicle company.        <br><a href="http://northshore.shore.net/~kester/websites.html"><b>http://northshore.shore.net/~kester/websites.html</b></a><p><li> <B>Critical Mass Energy Project</B><br>       Fantastic resource for sustainable energy activists, containing background literature, congressional testimony, fact sheets, and publication lists for a variety of energy related topics, as well as chronicles of current energy-related legislative events.        <br><a href="http://www.essential.org/CMEP/"><b>http://www.essential.org/CMEP/</b></a><p><li> <B>Energy Yellow Pages</B><br>       A comprehensive directory of renewable energy companies, trade associations, research organizations, educational programs and publications. Standard listings are available at no charge, expanded ones available for a fee.        <br><a href="http://www.ccnet.com/~nep/yellow.htm"><b>http://www.ccnet.com/~nep/yellow.htm</b></a><p><li> <B>Sun At Work In Europe</B><br>       Sun At Work In Europe (SAWIE) is a quarterly publication which aims to provide an overview of the development and applications of renewable energy technology, particularly solar energy, in a European context.        <br><a href="http://sun1.bham.ac.uk/thorntme/sawie.html"><b>http://sun1.bham.ac.uk/thorntme/sawie.html</b></a><p><li> <B>"the Source" for Renewable Energy</B><br>       Comprehensive directory of businesses who manufacture, distribute or service renewable energy products, organized by geographic location, by business type, and by product type. <br>       <a href="http://www.rmii.com/theSource/renewableEnergy/"><b>http://www.rmii.com/theSource/renewableEnergy/</b></a><p><li><B>EnergyOnline</B><br>       Business and Regulatory Information on the Energy Industry, with an emphasis on Electric       Industry Restructuring. Effectively structured, with lots of annotated legislation, reports,       etc., including a discussion forum. <br>       <a href="http://www.energyonline.com"><b>http://www.energyonline.com</b></a><p><li><B>The Electronic Lobbyist</b><br>Automated form for sending E-Mail in support of wind,biomass, solar, and hydro energy to your Congressman/woman<br><a href="http://www.netcom.com/~stevie2/budget.html"><b>http://www.netcom.com/~stevie2/budget.html</b></a></ul><a href = "./index.html#toc"><img align=right border=0 src="./grf/up.gif" alt = "[ Up ]"></a><br clear=all></BODY><hr><p align=right><A HREF="http://www.ef.org/"><IMG border=0 SRC="./grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-124</DOCNO>
<DOCOLDNO>IA026-000276-B035-22</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/index.html 198.77.86.203 19970113171315 text/html 2245
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:15:21 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2074
Last-modified: Mon, 17 Jun 1996 20:05:38 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>Boosting Prosperity: Index</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">

<BLOCKQUOTE>

<a href = "../index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<BLOCKQUOTE><CENTER>
<FONT SIZE="+3">Boosting Prosperity:</FONT><hr>
<FONT SIZE="+1"><i>Reducing the Threat of Global Climate Change Through Sustainable Energy 
Investments</i></FONT></h3>
</CENTER>
</BLOCKQUOTE>
<br><br>
<BLOCKQUOTE>

<TABLE>
</td></tr><tr><td colspan=2>	<B><A HREF="execsumm/index.html">Executive Summary</A></b><br>
</td></tr><tr><td colspan=2>	<B><A HREF="Intro/index.html">Introduction</A></b><br>
</td></tr><tr><td align=right>		<B>I. </B></td><td><B><A HREF="I/index.html">Industrial Energy Efficiency Successes</A> </b><br>
</td></tr><tr><td align=right>		<B>II.</B> </td><td><B><A HREF="II/index.html">The Utility Industry: Efficiency Successes</A></b><br>
</td></tr><tr><td align=right>		<B>III.</B> </td><td><B><A HREF="III/index.html">Energy Use in Buildings: Progress in Efficiency Design, Retrofit </A></b><br>
</td></tr><tr><td align=right>		<B>IV.</B> </td><td><B><A HREF="IV/index.html">Transportation</A></b><br>
</td></tr><tr><td align=right>		<B>V.</B> </td><td><B><A HREF="V/index.html">Renewables: Coming of Age</A></b><br>
</td></tr><tr><td colspan=2>	<B><A HREF="companies.html">Business Case Study Index</A></b><br>
</td></tr><tr><td colspan=2>	<B><A HREF="graphics.html">List of Graphics</A></b><br>
</td></tr><tr><td colspan=2>	<B><A HREF="ordering.html">Ordering Information</A></b><br>

</TABLE>
</BLOCKQUOTE>

<a href = "../index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

</BLOCKQUOTE>

</BODY>
<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40">
</A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-125</DOCNO>
<DOCOLDNO>IA026-000276-B035-77</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/utilities/index.html 198.77.86.203 19970113171335 text/html 3082
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:15:39 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2911
Last-modified: Mon, 17 Jun 1996 20:22:53 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>"Utilities"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>

<H1>Utilities</H1>
<H4>The Energy Foundation will support efforts to spread
regulatory and market models wherein a utility's most
profitable mix of power sources-energy efficiency,
renewable energy, and fossil fuel power plants-is the
one with the lowest long-term costs. The foundation is
particularly concerned that consumers and low-income
constituents be represented in this process.</H4>

Power generation by electric utilities in the United
States takes a severe toll on the environment. U.S.
power plants discharge two-thirds of the country's
sulfur dioxide emissions, one-third of its carbon
dioxide emissions, one-third of its nitrogen oxide
emissions, and half of its nuclear waste. To compound
these problems, rising use of electricity, up 3 percent
in 1994, is creating demand for new fossil-fuel plants.
<P>
Energy-efficient alternatives in this sector are
particularly compelling. The Electric Power Research
Institute estimates that 23 percent of all U.S.
electricity consumption could be saved for less than 3
cents per kilowatt-hour-less than the cost of generating
that electricity. Over time, between a third and a half
of U.S. electricity consumption could be saved through
energy efficiency. Electric utilities, given proper
incentives, could finance these improvements for
industrial, commercial, and residential consumers. 
<P>
In New England, New York, California, Wisconsin, and the
Pacific Northwest, pioneering reforms in utility
regulation have made it profitable for utility companies
to meet electricity demand through energy efficiency
rather than through power plant construction. Both
consumers and utilities benefit from these investments,
establishing a 'win-win' collaboration among utilities,
businesses, consumers, and environmentalists.

<p>
<A HREF="grants.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Grant Recipients</B></A><br>
<A HREF="../guidelines.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Guidelines</B></A><br>
<A HREF="../application.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Forms</B></A>



</BODY>
</BLOCKQUOTE>
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-126</DOCNO>
<DOCOLDNO>IA026-000276-B035-116</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/buildings/index.html 198.77.86.203 19970113171401 text/html 2890
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:16:02 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2719
Last-modified: Mon, 17 Jun 1996 20:22:34 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>"Buildings"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>

<H1>Buildings</H1>
<H4>The Energy Foundation will support innovative programs to encourage greater energy efficiency in buildings. The foundation is particularly interested in efforts to improve building codes and ensure compliance, in the development of financing mechanisms and incentives, and in efforts to ensure that architects make energy integral to building design. </H4>

Large savings in energy can be realized through improvements in the insulation, heating, cooling, and lighting of residential and commercial buildings. More than one-third of U.S. energy is used to heat, cool, and light our living and working spaces. If these buildings were built and operated with off-the-shelf, cost-effective, high-efficiency technologies, energy consumption could be cut by 50 to 80 percent. Studies at Lawrence Berkeley Laboratory suggest that it costs little more to build an efficient office building than an inefficient one. 
<P>
These potential benefits are rarely realized.  Most people and corporations fail to consider the benefits of energy-efficiency improvements over the life of the technology and thus are discouraged by their higher initial costs. The best window now on the market, for example, insulates four times as well as its double-paned predecessor. Because it costs 30 percent more, its benefits are routinely ignored. Landlords and developers make structural energy decisions, but they are not directly affected by the higher energy bills paid by renters and buyers. Architects and builders have difficulty keeping up-to-date with new efficiency technologies.
<p>
<A HREF="grants.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Grant Recipients</B></A><br>
<A HREF="../guidelines.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Guidelines</B></A><br>
<A HREF="../application.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Forms</B></A>


</BODY>
</BLOCKQUOTE>
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-127</DOCNO>
<DOCOLDNO>IA026-000276-B035-137</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/transport/index.html 198.77.86.203 19970113171411 text/html 3223
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:16:16 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 3052
Last-modified: Mon, 17 Jun 1996 20:22:57 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>"Transportation"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>

<H1>Transportation</H1>
<H4>The Energy Foundation will support regional transportation reform through analysis, policy research, regulatory work, and advocacy. The foundation will explore policy options that promote alternatives to increased single-occupancy vehicle use and to new highway construction. The foundation will also support analysis and advocacy to promote increased vehicle fuel efficiency.</H4>

Transportation accounts for a third of all energy use in the United States and is responsible for nearly 30 percent of total U.S. carbon emissions. Cars and trucks alone consume 63 percent of all petroleum in the country. To make matters worse, the number of vehicle miles traveled in the U.S. is climbing at twice the rate of population growth.
<P>
Yet the transportation sector has tremendous potential for efficiency gains. The average fuel efficiency of new cars sold in the U.S. doubled between 1973 and 1987, largely due to federal standards. New automobile models have been developed that are more than three times as fuel-efficient as today's average. Advanced vehicle propulsion technologies are progressing, spurred especially by innovative policy in California. 
<P>
New transportation planning approaches also show promise. Public transit, improved bicycle facilities, high-occupancy vehicle lanes, pedestrian-oriented design, and an expanding array of transportation-control measures provide mobility while reducing environmental damage. 
<P>
The 1991 Intermodal Surface Transportation Efficiency Act (ISTEA) gives states unprecedented flexibility in how they allocate more than $150 billion in federal transportation dollars. Coupled with the Clean Air Act Amendments of 1990, which require state transportation plans to show compliance with federal air quality standards, ISTEA now allows metropolitan regions to harness substantial funding for alternatives to new highway construction.

<p>
<A HREF="grants.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Grant Recipients</B></A><br>
<A HREF="../guidelines.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Guidelines</B></A><br>
<A HREF="../application.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Forms</B></A>


</BODY>
</BLOCKQUOTE>
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-128</DOCNO>
<DOCOLDNO>IA026-000276-B035-165</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/renew/index.html 198.77.86.203 19970113171426 text/html 3013
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:16:30 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2842
Last-modified: Mon, 17 Jun 1996 20:23:01 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>"Renewable Energy"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>


<H1>Renewable Energy</H1>
<H4>The Energy Foundation will support policy research and advocacy to accelerate the commercialization of renewable energy. The foundation is especially interested in regional initiatives to encourage utility investments in renewable energy through scenario-building, regulatory work, and advocacy. The foundation may also support research and education to build the analytic base for new federal and state policies.</H4>

Renewable energy technologies-wind, solar-thermal, photovoltaics, and biomass-made major advances in the past decade. With forward-looking policies they could play a strong role in meeting future U.S. energy needs. Renewable energy costs have dropped several-fold while reliability and performance have improved dramatically. The cost of wind-generated electricity in the U.S. dropped from 25 cents per kilowatt-hour in 1980 to 5 cents per kilowatt-hour in 1994, which is cheaper than coal and competitive with natural gas. The cost curves for utility-scale solar-thermal and photovoltaic plants show similar downward trends. Increased production would further reduce costs.
<P>
A few states have taken the lead in removing regulatory and financial barriers to renewable energy development. In 1994, Minnesota called on utilities to build over 800 megawatts - equivalent to a coal plant - of renewable energy projects, to ensure, in part, that a stronger renewable energy industry will develop. Utilities in Texas, California, Oregon, Massachusetts, and New York have committed to renewable energy projects. In each case, policy-makers realized that renewable energy is a viable source of power whose future availability depends on today's support.

<p>
<A HREF="grants.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Grant Recipients</B></A><br>
<A HREF="../guidelines.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Guidelines</B></A><br>
<A HREF="../application.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Forms</B></A>



</BODY>
</BLOCKQUOTE>
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-129</DOCNO>
<DOCOLDNO>IA026-000276-B035-197</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/integrated/index.html 198.77.86.203 19970113171507 text/html 2907
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:16:52 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2736
Last-modified: Mon, 17 Jun 1996 20:23:06 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>"Integrated Issues"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>

<H1>Integrated Issues</H1>
<H4>The Energy Foundation will look for opportunities to deepen our understanding of the economics of energy use and its relationship to the health of the economy. The foundation will support development and implementation of federal, state, and regional policies that remove barriers to energy efficiency and renewable energy. The foundation will also work to see that changes in energy policy do not hurt those who are traditionally underrepresented in policy-making.</H4>

While energy efficiency and renewable energy are typically addressed within particular sectors of energy use-e.g., transportation, buildings, utilities-many aspects of the energy problem demand a broader perspective. 
<P>
Understanding and correcting the market failures that prevent society from capturing the benefits of energy efficiency requires insight into economics and finance: How can we build economic systems that recognize the depletable nature of natural resources and the environment? What are the financial barriers embedded in federal and state tax codes that slow energy efficiency and the development of renewable energy? 
<P>
Social and institutional questions, too, loom large: What kind of impacts do energy policies have on low-income and minority communities? How can we ensure that energy policy is not regressive or undemocratic? 
<P>
Thinking about the long-term energy future of the nation also demands an integrated perspective. How far can energy efficiency and renewable energy take this country? What are the employment impacts of different energy policies?

<p>
<A HREF="grants.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Grant Recipients</B></A><br>
<A HREF="../guidelines.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Guidelines</B></A><br>
<A HREF="../application.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Application Forms</B></A>




</BODY>
</BLOCKQUOTE>
<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-130</DOCNO>
<DOCOLDNO>IA026-000276-B035-278</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/start.html 198.77.86.203 19970113171612 text/html 8998
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:18:17 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 8827
Last-modified: Mon, 17 Jun 1996 20:12:24 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE></TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<HTML>
<HEAD>
<TITLE>"Essay from the Executive Director"</TITLE>
</HEAD>
<BODY>
<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<blockquote>

<H1>Solving the Transportation Crisis</H1>

<BLOCKQUOTE>
<H3><I><hr>An essay from the executive director<hr></I></H3>
</BLOCKQUOTE>

Baseball, hot dogs, apple pie, and Chevrolet. That old
GM slogan is not so much a sales pitch as a true
reflection of our national culture. The American love
affair with     the automobile is so pervasive and the
car is such an integral part of our economy, it has come
to shape our productivity, our social lives, our
landscape, and even our self-esteem.
<P>
Americans have more than one car per licensed driver. We
drive those cars more than ever-2.23 trillion miles per
year-and the number of miles the average car travels per
year is growing twice as fast as the population. 
<P>
And no wonder. The car offers greater mobility than any
other sort of transport, in a culture where mobility is
increasingly mandatory. It also offers a large measure
of comfort, safety, power, and style. We can go where we
want, when we want, without exposing ourselves to the
harsh elements of nature or the criminal elements of
society. These are crucial amenities.
<P>
But the love affair with the car, like all obsessions,
has its costs. Any knuckle-biting commuter, stuck in her
thousandth traffic jam, can testify about the automobile
population crisis. All those hours spent in traffic cost
us economically and emotionally: They assess a
multibillion-dollar toll on our productivity, and they
steal time we might otherwise spend enjoying other
aspects of life, like family and friends.
<P>
Our cities, especially younger cities, are given over to
the car (two-thirds of Los Angeles is paved!). Dads and
moms who must spend hours chauffeuring their kids to and
from school, sports, and friends' houses can readily
understand how the very mobility of the car has
restricted access and choice for those who cannot drive.
Of course it is children, the elderly, and the poor who
know this trapped feeling most poignantly.
<P>
And the environment--from the smoggy air in L.A. to the
oil-fouled shores of Prince William Sound, from the
toxic earth around Louisiana's refineries to the noise
that is so much a part of New York City's
ambience--continues to bear the brunt of the auto.
Perhaps the ultimate sacrifice is our kids' lungs, which
now operate at a 15 percent diminished capacity in Los
Angeles and which are increasingly susceptible to
disease.
<P>
Even our national security is at stake. The last two
decades have brought us two oil crises and one oil war,
but the nation's appetite for oil still grows. Close to
half the oil this nation consumes is imported from
abroad, the largest proportion ever.
<P>
<IMG HEIGHT=439 WIDTH=341 ALIGN=right ALT="Figure of 
Energy Consumption by Highway Vehicles" SRC="figure1.gif">

These problems are getting worse. This graph suggests
that the next oil crisis is only a matter of time and,
as we all know, decisions made in crisis are usually not
the wisest.

<P>
What can be done? Is there no way to keep the benefits
of the car without jeopardizing our cities, our health,
our national security, and our peace of mind? Do we have
to choose between a healthy downtown and a prosperous
Detroit, between decent neighborhoods for our kids and
mobility for ourselves, between breathing clean air and
getting to work?
<P>
This essay argues that the transportation crisis is
solvable, that it is possible to build livable cities
and functioning transportation systems that do not
sacrifice individual mobility.
The ideas that follow are collected from innovative
thinkers around the world. Many of these ideas
constitute a fundamental departure from past policies
and mechanisms of governance, but without such changes,
we will simply drive ourselves from one crisis to the
next. 
<PBR CLEAR=all>
<A HREF="transportation.html">The Energy Foundation's
transportation program</A> is designed to test and
promote these solutions. Our grants have two broad aims:
To refocus spending on our transportation infrastructure
so that more economically efficient and environmentally
benign choices are made, and to spur innovation of and
markets for cleaner vehicle technologies. We are under
no illusion that either task will be easy, but we
believe that, together, such policies will create more
transportation choices, fewer environmental problems,
and more livable towns and cities.
<P>
The graphic that guides readers through this essay
illustrates the range of solutions proposed for these
problems.
<P>
<A NAME="two">Each </A>policy has some potential, but
each has profound limitations.  Consider, for example,
the position of people who focus their energies on
raising fuel economy.  Raising automobile fuel mileage
has already doubled the efficiency of new cars
<I>(see figure 2)</I>. Why not double
it again, and skip the hard work of trying to stem
vehicle miles traveled?

<BLOCKQUOTE>

<TABLE>

	<TR>
<TH colspan=2>Figure 2: U.S. Auto Fleet and CAFE standards</TH>
</TR>
<TR>

	<TD valign=top>
<IMG SRC="./figure2.gif" ALIGN=BOTTOM WIDTH="308" 
ALT="Figure of U.S. Auto Fleet and CAFE standards" HEIGHT="362">
 
	</TD>

	<TD>
	<H4><I><hr>People who labor in the transportation
field tend to become fixated on one or another favored
policy. Automakers argue that  market signals should
steer their decisions. Safety and environmental
advocates counter that regulations have successfully led
to safer and cleaner cars. Transit authorities despair
of the $300 billion in costs that private autos impose
on society while railroads, subways, and buses languish
for lack of funding. And those who care about the form
of traditional towns--the village square, the
neighborhood shop, and streets safe for children--rail
against sprawl and Wal-Marts and strip malls.
<hr></I></H4>
	</TD>
</TR>
</TABLE>
</BLOCKQUOTE>
<P>
Why not?  Because the extraordinary rise in the
distances we drive and the number of trips we take has
absorbed all the gains we have made in fuel efficiency
during the last 15 years <I>(see
figures 3 and 4)</I>. Only if the growth in miles
traveled can be stemmed will raising fuel efficiency
standards and moving to ultra-clean, ultra-efficient
cars render major improvements.


<BLOCKQUOTE>

<TABLE>
<tr> <th colspan=2>Figure 3</th></tr> 
<tr> <td> 
<IMG WIDTH=298 HEIGHT=427 ALIGN=right VSPACE=5 HSPACE=5
ALT="Figure of Highway  Miles Traveled" SRC="figure3.gif">
</td> <td width=150> 
<H3><I><hr>The answer lies in these graphs.
<p>
The extraordinary rise in the distances we
drive and the number of trips we take has
absorbed all the gains we have made in fuel efficiency
during the last 15 years. 
<hr></I></H3></td> </tr>


<tr> <th colspan=2>Figure 4</th></tr> <td> 
<IMG WIDTH=314 HEIGHT=410 ALIGN=right ALT="Figure of
Vehicle Miles Traveled per capita"SRC="figure4.gif">
</td> <td width=150> 
<H3><I><hr>Only if the growth in miles
traveled can be stemmed will raising
fuel-efficiency standards and moving to ultra-clean,
ultra-efficient cars render major improvements.
<hr></I></H3></td> </tr> </table>


</BLOCKQUOTE><P>
<STRONG>
The real potential for change, then, lies in integrating
solutions. This essay looks, in turn, at improvements to
the auto, changes in fuels, changing land-use patterns,
and new approaches to building and running the
transportation infrastructure.</STRONG>
<BR CLEAR=all><P>
<BR>


</blockquote>
<CENTER>

<NOBR>
<A HREF="start.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Start Essay" SRC="MAPTL1on.gif"></A><A HREF="cars.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Build Better Cars" SRC="MAPTR1.gif"></A><BR><A HREF="city.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Change the City" SRC="MAPML1.gif"></A><A HREF="fuels.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Switch to Better Fuels" SRC="MAPMR1.gif"></A><BR><A HREF="altmodes.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Promote Other Modes" SRC="MAPBL1.gif"></A><A HREF="conclusion.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Conclusion" SRC="MAPBR1.gif"></A><BR>

</CENTER>

<P>


<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>


</BODY>
</HTML>



</BODY>
<hr>
<p align=right>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT></A>
<font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-131</DOCNO>
<DOCOLDNO>IA026-000276-B035-341</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/cars.html 198.77.86.203 19970113171643 text/html 4130
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:18:47 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 3959
Last-modified: Mon, 17 Jun 1996 20:13:48 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>"Build Better Cars"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">

<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>
<blockquote>

<H1>Build Better Cars</H1>

<BLOCKQUOTE><H3><I><hr>Analysts argue that a complete reinvention of the
automobile is in order -- which would result in a 100
mpg "hypercar."<hr></I></H3></BLOCKQUOTE>

During the 1973 oil crisis, policy-makers took a hard
look at the nation's energy appetite and found that
transportation consumed more than half the nation's oil.
New cars averaged only 13 miles per gallon. Despite
protests from automakers, Congress passed the Corporate
Average Fuel Economy (CAFE) standards, which required
automakers to improve that figure to 27.5 miles per
gallon by 1988. This policy--which doubled new car-fuel
economy--ultimately resulted in less industry
dislocation than Detroit assumed; indeed, it is credited
in many quarters with spurring the technological
revitalization of the U.S. auto industry. The CAFE law
also marks the only  success so far in addressing energy
use in U.S. automobiles.
<P>
What is the potential for extending CAFE standards
again, to 55 mpg by 2005? Many independent engineers
point to cars on the road that get 50 mpg, and indeed
most automakers have built prototype cars that get more
than 100 mpg, without sacrificing performance. Doubling
the fuel economy of the nation's fleet would halve its
consumption of oil, all but eliminating the need for oil
imports.
<P>
Automakers have vigorously, and so far successfully,
resisted such legislation. They argue that customers
want larger cars with more powerful engines, and,
barring a boost in gasoline prices, fuel efficiency is
just not what customers are looking for. Because
legislators are sensitive to the economic importance of
the auto industry and wary of interventions in the
market, it is probably fair to say that in the absence
of another oil crisis, auto fuel-efficiency standards
will stagnate. CAFE worked once, but there is little
chance it will be tried again in the near future.
<P>
One team of analysts, Amory and Hunter Lovins of Rocky
Mountain Institute, argues that a complete reinvention
of the automobile is in order, and that only such a
thorough redesign can push us beyond the CAFE debate <A
HREF = "hypercar.html" name="hyp">(see "Moving toward the
'hypercar'")</A>. Their concepts should lead to cars
that get more than 100 mpg, with drastically reduced
pollution, noise, and required maintenance. If such
"hypercars" were developed, their non-fuel
attributes--safety, reliability, nimbleness, and lower
cost--could induce customer demand. The fuel savings
would be a free byproduct.
</blockquote>
<P>
<BR>

<CENTER>

<A HREF="start.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Start Essay" SRC="MAPTL1.gif"></A><A HREF="cars.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Build Better Cars" SRC="MAPTR1on.gif"></A><BR><A HREF="city.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Change the City" SRC="MAPML1.gif"></A><A HREF="fuels.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Switch to Better Fuels" SRC="MAPMR1.gif"></A><BR><A HREF="altmodes.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Promote Other Modes" SRC="MAPBL1.gif"></A><A HREF="conclusion.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Conclusion" SRC="MAPBR1.gif"></A>

</CENTER>

<P>


<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>



</BODY>
<hr>
<p align=right>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT></A>
<font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-132</DOCNO>
<DOCOLDNO>IA026-000276-B036-12</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/city.html 198.77.86.203 19970113171655 text/html 10745
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:19:00 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 10573
Last-modified: Mon, 17 Jun 1996 20:13:32 GMT
</DOCHDR>
<HTML><HEAD>
<TITLE>"Change the City"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<BLOCKQUOTE><H1>Change the City</H1>

<BLOCKQUOTE><H3><I><hr>If streets are well laid-out and destinations are
brought closer; people can get around without having to
drive.<hr></I></H3>
</BLOCKQUOTE>

Enough with the car. What about the cities and suburbs
where the car is driven? No amount of new auto
technology or cleaner fuels will relieve congestion,
make towns more accessible to those without cars,
encourage people to interact with their neighbors,
rebuild communities, or preserve open space and
agricultural land. The pattern of U.S. metropolitan
growth needs to be examined--and the further one
projects ahead, the more important that pattern becomes.
<P>
American communities are in the middle of a revolution.
In the first part of this century, the nation moved from
being an agricultural society, in which most people
lived on farms, to one in which the population was split
between farms and cities. In the second half of the
century, there was a vast migration from both the urban
areas and rural areas to the suburbs. The United States
is now primarily a suburban economy, with more than half
the population living in suburbs.
<P>
The automobile made suburbs possible, and the auto
continues to dominate the suburban form. The average
American household makes more than 10 car trips per day.
It is the norm for American families to do their
shopping, go to school or work, enjoy sports, and
commune with friends and families in a 40-mile radius of
their home. (Note that a 40-mile circle contains 1,200
square miles!) This easy access to remote destinations
means that it is commensurably less important to have
friends or shops or schools or work nearby. The auto has
made it possible to pay little attention to the quality
of local resources, since substitutes can be found a 15-
or 30-minute drive away. Access has been decoupled from
location.
<P>
That decoupling has both good and bad consequences. The
benefits of a broader base of options include access to
better jobs, better or cheaper homes, more schools, more
sports facilities, and more shopping. The downside is
that local resources are neglected. Why pay taxes to
support a local park when you can drive to a state park?
Why strive to protect downtown jobs when you don't work
downtown or shop downtown?
<P>
The car also makes the idea of the "common good" more
abstract and remote. A village square or a local school
is the only option in a car-less world; everyone has an
interest in keeping that square clean and that school
healthy. The auto makes the square just one of dozens of
options for public space, and because that square is
supported by local taxes, it often seems to be the most
expensive of the lot. The country is thus in the midst
of abandoning the "public sphere"--parks, public
schools, and even public services like police
protection--in favor of  the "private sphere," with
gated suburbs, private recreation clubs, private
schools, and private 
security forces.
<P>
Some of the most creative thinkers--conservative and
liberal--argue that it is time to reinvent the suburb
and rethink the urban core. Town planners, architects,
and economists are converging around a practical and
positive vision of the metropolis. Three themes dominate
their work:

<UL>
<LI> The destinies of suburbs and urban cores cannot
be separated; policies must be developed that serve the
greater metropolis.

<LI> The most successful cities are those where local
values and local commitment are manifest. Good policies
make it easier for citizens to contribute to their
communities.

<LI> Land-use patterns-the physical form of a
neighborhood-have a profound (and underappreciated)
impact on social interactions, neighborliness, and sense
of community.
</UL>

These ideas can easily be made tangible and practical.
For example, 20 years ago, Oregon required every city to
develop an "urban growth boundary" to contain and focus
future development. As a result, cities such as Portland
have managed to avoid much of the sprawl and related
urban blight that characterize so many cities. The
simple act of drawing a boundary around the metropolis
has united the downtown and suburban concerns, and it
has preserved farmland, reduced demands for auto travel,
and made transit systems viable. Downtown businesses
know that the boundary keeps them within a reasonable
range of the region's shoppers and workers. Most
developers happily trade geographic limitations for the
certainty of knowing where they can build and where they
cannot. Suburbanites appreciate the relative lack of
congestion, since they are not immediately surrounded by
suburbs even farther out. Growth is directed to land
inside the boundary:  this "infill" development means
that light rail is fast becoming a viable option for
Portland commuters.
<P>
Not every city has the political impetus to draw a
boundary around itself, but other measures can have a
similar impact. Lowering regulatory barriers for
development within metropolitan boundaries, while
raising them for development beyond, can funnel most
development to where it should occur. If cities and
suburbs were to collaborate on tax policies-or even
establish tax-base sharing, as Minneapolis-St. Paul has
done-they could avoid the ultimately debilitating game
of bidding for development with lower taxes. By
rethinking and coordinating development and tax
policies, a city and its suburbs can both emerge as
winners, rather than one prospering only at the other's
expense.
<P>
An urban-growth boundary implies infill development and
mixed use, which can themselves be a boon. Space and
quiet are the great virtues of suburbia, but these often
come at the cost of easy access to stores, restaurants,
and schools. By mixing these uses with housing, suburbs
become communities. If streets are laid out well and
destinations are nearby, kids can walk or bike to the
store or school. Families can walk to a park instead of
driving. A number of regions have started this repair
work, including the city of Pasadena and San Diego
County.
<P>
Good infill and mixed-use development get at the heart
of the transportation dilemma. Two California suburbs
illustrate how such changes lead to dramatically
different automobile use. Rockridge is a traditional
suburb near Berkeley, with a grid-street layout and a
mix of shops, schools, parks, and houses. Danville, in
Contra Costa County, is composed of arterials, feeders,
and culs-de-sac, and has only housing. Danville
households put twice as many miles on their cars as
their Rockridge counterparts. The policy question, then,
is: Do we build more Danvilles on more farmland, or do
we fill in, and in the process make current suburbs more
livable?
<P>
Infill has another great bonus. Transit systems like
light rail require a certain minimum housing density to
be useful-they become cost-effective only when there are
enough potential riders along each stretch of the route.
Transit will become feasible in many of today's suburbs
with judicious infill. 
<P>
Finally, the topography of our cities and suburbs
matters a great deal. Old housing projects-modernist
glass and concrete towers surrounded by parking lots-are
dehumanizing; it is no surprise that so many are reduced
to shambles in a few years. Strip malls and shopping
centers can have a similar dehumanizing effect. There is
no way to walk to most malls--they tend to be removed
from neighborhoods and surrounded by wide, busy streets
and highways--or to browse on a strip mall. The auto
becomes the only way to get to and from these centers.
<P>
By taking great care with the relationships among
houses, streets, parks, schools, and commercial centers,
town planners and developers can reverse or reduce such
car dependency. Good walkable or bikeable connections
between houses and schools are cheap and obvious ways to
breathe life into a town even as they reduce auto use.
Some towns are turning to "pedestrian-oriented
development" and "transit-oriented development" to
reintroduce people into a town's fabric. To make a town
pedestrian friendly, planners use "traffic calming,"
which is the generic term for narrowing streets,
building 
speed bumps, giving predominance to pedestrians in
intersections, and similar measures. Parking lots are
tucked behind shops, instead of vice versa.
Transit-friendly developments incorporate the same
concepts, but they are clustered developments--with
greater density-located near transit stops. In Chicago's
West Side, for example, the Center for Neighborhood
Technology is helping redevelop an urban area as a
transit-oriented development <A HREF =
"neighborhood.html" name="neighbor">(see "Reclaiming a
neighborhood")</A>. 
<P>
Besides creating a more enjoyable town or community,
making streets and destinations accessible to
pedestrians tends to raise the value of real estate in a
community. It turns out that people like to live in
towns with walkable destinations and schools a quick
bike ride away. This added value, if coupled with the
reduced regulatory burdens described above, could be the
spur that moves development past cookie-cutter sprawl.
</BLOCKQUOTE><P>
<BR>

<CENTER>
<NOBR><A HREF="start.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Start Essay" SRC="MAPTL1.gif"></A><A HREF="cars.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Build Better Cars" SRC="MAPTR1.gif"></A></NOBR><BR><NOBR><A HREF="city.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Change the City" SRC="MAPML1on.gif"></A><A HREF="fuels.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Switch to Better Fuels" SRC="MAPMR1.gif"></A></NOBR><BR><NOBR><A HREF="altmodes.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Promote Other Modes" SRC="MAPBL1.gif"></A><A HREF="conclusion.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Conclusion" SRC="MAPBR1.gif"></A></NOBR><BR>
</CENTER>

<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

</BODY>
<hr>
<p align=right>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT></A>
<font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-133</DOCNO>
<DOCOLDNO>IA026-000276-B036-34</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/fuels.html 198.77.86.203 19970113171715 text/html 6009
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:19:10 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 5838
Last-modified: Mon, 17 Jun 1996 20:13:13 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>"Switch to Better Fuels"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<BLOCKQUOTE><H1>Switch to Better Fuels</H1>

<BLOCKQUOTE><H3><I><hr>In the next decade, only electric cars are likely
both to be economically viable and to meet the
zero-emission standard.<hr></I></H3></BLOCKQUOTE>

Whether we hope to reduce oil consumption or tailpipe
emissions, it is natural to look at the fuel supply for
relief. There is a host of possible alternatives to
conventional gasoline, ranging from the close cousins
(reformulated gasoline or compressed natural gas) to
those more exotic in source but not in use (such as
ethanol derived from specially grown crops, called
biomass), to those requiring a redesign of the
automobile (electric cars or hydrogen fuel cells). 
<P>
Here, the classic policy dilemma of radical versus
incremental reforms becomes apparent: Easy, but small
improvements can be had from moderate shifts to cleaner
fossil fuels. Larger contributions will be possible if
the nation can stomach the more difficult switch to
well-designed biomass programs. And truly revolutionary
changes are possible only if automakers begin with a
clean sheet of paper.
<P>
The last two options on the better-fuels section of our
map--electric cars and fuel-cell cars--have captured the
attention of air quality officials in California and the
Northeast, where air pollution is so bad that almost
everyone agrees that big changes are necessary.
California has required car manufacturers to sell an
increasing fraction of zero-emission vehicles, or ZEVs,
beginning with 2 percent of new cars in the state in
1998 (an estimated 31,000 vehicles) and growing to 10
percent by 2003.
<P>
Although, in a decade or so, vehicles that run on fuel
cells should also become available, in the short run,
only electric cars are likely both to be economically
viable and to meet the zero-emission standard. The
primary limitation of electric cars is the battery,
which holds much less energy than gasoline does. This
translates into reduced driving range and reduced
performance. Against that limitation, electric cars
offer reduced maintenance, lower driving costs, higher
energy efficiency, quieter operation, and, most
important, drastically less pollution. And, as batteries
become more effective energy carriers, the problems with
range will lessen.
<P>
The California regulation promoting electric vehicles
has greatly invigorated research and development on
electric car technologies in small companies, university
labs, and auto manufacturers. There has been a greater
advance in control systems, drive components, and
batteries in the last three years than in the previous
two decades.
<P>
But the regulation has also inspired opposition from
automakers, who worry they will be compelled to build
expensive, poorly performing cars for which there is no
market. Electric car advocates note that auto companies
used the same arguments against regulations for seat
belts, collapsible steering columns, air bags, and
fuel-efficiency standards, all of which have been
remarkably successful. Auto companies rebut that
electric vehicles are a more fundamental change than
previous requirements.
<P>
The California regulations are clearly steering the
economy into uncharted territory: It is too early to
predict how zero-emission vehicles will perform or to
gauge their potential market. It is clearly not too
early, though, to look for ways to boost the market for
electric cars and ensure that society reaps the benefits
of this newly invigorated technology. California has
started that work by offering a variety of tax
incentives for alternative-fuel vehicles. Policy-makers
should also consider other ways to make electric cars
especially attractive. Cities and states could, for
example, allow operators of electric vehicles to:
<UL><LI> Park for free
<LI> Use high-occupancy vehicle lanes
<LI> Pay reduced tolls
<LI> Receive a tax credit
<LI> Obtain reduced-rate electricity for night-time charging.
</UL>
Every one of these policies--especially the ZEV
mandate--arouses controversy, since they all constitute
some regulatory interference in the market. But the auto
itself has impacts beyond the market: Remember the oil
crises, the environmental destruction, and the hours
spent in congestion. And of course the infrastructure on
which the auto depends--highways, streets, and even
tax-subsidized mortgages--is built and maintained "beyond the market."
<P>
</BLOCKQUOTE><BR>

<CENTER>

<NOBR><A HREF="start.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Start Essay" SRC="MAPTL1.gif"></A><A HREF="cars.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Build Better Cars" SRC="MAPTR1.gif"></A></NOBR><BR><NOBR><A HREF="city.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Change the City" SRC="MAPML1.gif"></A><A HREF="fuels.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Switch to Better Fuels" SRC="MAPMR1on.gif"></A></NOBR><BR><NOBR><A HREF="altmodes.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Promote Other Modes" SRC="MAPBL1.gif"></A><A HREF="conclusion.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Conclusion" SRC="MAPBR1.gif"></A></NOBR><BR>

</CENTER>
<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

</BODY>
<hr>
<p align=right>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT></A>
<font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-134</DOCNO>
<DOCOLDNO>IA026-000276-B036-68</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/altmodes.html 198.77.86.203 19970113171801 text/html 7783
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:20:02 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 7612
Last-modified: Mon, 17 Jun 1996 20:13:58 GMT
</DOCHDR>
<HTML><HEAD>
<TITLE>"Promote Other Modes "</TITLE>
</HEAD>

<BODY bgcolor="#FFFFFF">
<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<BLOCKQUOTE><H1>Promote Other Modes</H1>

<BLOCKQUOTE><H3><hr><I>If drivers were charged directly for using roads,
there would be fewer traffic jams, less pollution, and
greater incentive to use transit systems.<hr></I></H3></BLOCKQUOTE>

Anyone who is a serious transit rider knows the virtues
of a car. Cars are ready when you are; they go where you
are going. Buses, subways, and light rail instead force
you to operate on their schedule and route. It is no
wonder that many transit systems are in a death spiral:
declining use results in reduced revenue, which leads to
worse service and further declining use.
<P>
The decline in transit mirrors the huge public
investments in highways and auto facilities. Since the
1950s, federal policies--ranging from the Interstate
Highway Act to mortgage tax deductions--have induced
sprawl at the expense of the city. The imbalance between
the car and its alternatives needs to be righted. 
<P>
As this essay describes, the very popularity of the car
is limiting its usefulness, both for those stuck in
endless congestion and for those who cannot drive but
must live and work in an automobile topography. 
<P>
One short-term and two long-term strategies will make
transit attractive. First, system managers and local
political leaders need to inject funds into public
transit to make it safer, cleaner, and more reliable.
The New York City subway system has recently undergone
such a transition: Trains are, on the whole, now free of
graffiti. They are safer, cleaner, and more dependable.
Certainly the New York subway system still needs
improvement, but the trend is in the right direction.
New York's commuter trains have shown even more
improvement. In other cities, such as Philadelphia and
Chicago, supreme effort should be made to prevent the
dismantling of existing systems, which would be
extremely expensive to replace.
<P>
The longer-run solutions tie into the previous section
of this essay and the one following. The form of the
metropolis ultimately limits the usefulness of the
transit system. It is difficult or impossible to build
transit systems that economically serve low-density
developments; rebuilding cities through infill
development makes transit systems viable. Perhaps more
importantly, good transit systems can induce
"transit-oriented development," which inverts the
public-transit death spiral.
<P>
Finally, we have to consider the economic signals that
car drivers and transit users face. Purchasing a car and
paying for its insurance are the two largest costs of
driving. Those costs are fixed whether the car is used a
little or a lot. The costs that vary with auto use--such
as oil, tires, and tolls--amount to only 20 percent of
automobile operating costs. Once someone buys a car, it
costs them very little to drive it.
<P>
Transit is the opposite. Tickets for the bus, subway, or
train are usually purchased for every ride. Even if the
total cost of using transit is less than that of owning
and driving a car, the marginal costs are often much
higher.
<P>
To give more accurate price signals, good public policy
would shift auto expenses from the fixed to the variable
column. For example, insurance could be paid on a
per-mile basis, with the information taken from annual
odometer readings. The varying price would more
accurately reflect the varying risk--which, after all,
grows with every mile driven. Similar ideas have been
proposed for congestion. Users now pay nothing to use
most roads, so there is no incentive to use them
judiciously. If some general taxes were reduced in
exchange for "congestion pricing"--charging drivers
directly for using roads--there would be far fewer
traffic jams, less pollution, and less waste.
<P>
Perhaps the most important inaccurate price signal is
that for gasoline which, at one-fourth European levels,
fails to account for the pollution it leaves when
burned, or the wars it sparks in the Mideast. These
"external" costs--estimated by some at more than $300
billion per year--are now borne by children with lung
disease and farmers with stunted crops, not by those who
benefit from the cheap gas.  If pollution were taxed
directly, it would be possible to reduce other taxes
while cleaning the air.
<P>
All the policies described in this essay would more
naturally fall into place if prices accurately reflected
true costs <A HREF = "truecosts.html" name="true">(see "The true
costs of driving.")</A>. Cleaner cars and cleaner fuels
would become cheaper. Driving to distant suburbs would
be more expensive, and the value of pedestrian-friendly
communities would rise. Transit would become a more
economical choice.  But there are great forces
maintaining the current price system. Americans  are
used to cheap gas and distrustful of taxing politicians.
And it would be profoundly unfair to change price
signals if those changes left the poor worse off.
<P>
Many sound arguments exist for using better price
signals to resolve the transportation dilemma. General
Motors and Chrysler have advocated higher gas taxes as a
wiser solution than fuel-efficiency standards. The
National Academy of Sciences believes that congestion
pricing--charging for the use of highways during peak
traffic hours--would save billions of dollars.
Environmentalists have long argued that polluters should
pay for the damage they cause.
<P> 
But commuters do not understand the reasons for charging
for a road their tax dollars already built. And for
lower-income citizens, any policy that raises the cost
of living is a direct threat to their livelihood.
<P>
Better price signals are conceptually elegant, but they
have so far failed virtually every political test.
Unless policies can be designed so that they produce
benefits-such as income tax relief-directly to those
paying the new fees, they have little chance of being
enacted. The challenge, then, is to create pricing
policies that are an integral part of tax reform. Such
policies must not impose new burdens on the poor or
middle class: indeed, when they are truly economically
efficient, they should generate net benefits that can
then be distributed to different income classes.
<P>
<BR>
</BLOCKQUOTE>
<CENTER><NOBR><A HREF="start.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Start Essay" SRC="MAPTL1.gif"></A><A HREF="cars.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Build Better Cars" SRC="MAPTR1.gif"></A></NOBR><BR><NOBR><A HREF="city.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Change the City" SRC="MAPML1.gif"></A><A HREF="fuels.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Switch to Better Fuels" SRC="MAPMR1.gif"></A></NOBR><BR><NOBR><A HREF="altmodes.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Promote Other Modes" SRC="MAPBL1on.gif"></A><A HREF="conclusion.html"><IMG WIDTH=152 HEIGHT=149 BORDER=0 HSPACE=0 VSPACE=0 ALT="Conclusion" SRC="MAPBR1.gif"></A></NOBR><BR>
</CENTER>
<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

</BODY>
<hr>
<p align=right>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT></A>
<font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-135</DOCNO>
<DOCOLDNO>IA026-000276-B036-90</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/conclusion.html 198.77.86.203 19970113171810 text/html 3092
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:20:16 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2921
Last-modified: Mon, 17 Jun 1996 20:13:22 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>"Conclusion"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">

<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>


<BLOCKQUOTE><H1>Conclusion</H1>
The American metropolis is at a turning point. In many
cities, the very convenience of the car has begun to
turn on itself, as congestion keeps those 100
mile-per-hour cars crawling along at 10 or 15 miles per
hour. In Los Angeles, average highway speed is only 28
miles per hour, and it is projected to slow to 18 mph
early in the next century. The real, grisly glimpse of a
car-saturated 
future lies in today's Bangkok, where car toilets are
becoming popular, since commutes can take many hours.
<P>
It is possible to reverse the trends that are locking us
in cars and isolating us in our own communities. It will
take major policy changes and a willingness to abandon
parochial concerns; instead we need to embrace an
approach that integrates a broad range of solutions.
Perhaps most important, reviving the American metropolis
will require courage, will, and a collective vision; we
need a sense that it is possible to shape our common
destiny.
<P>
The staff and board of the Energy Foundation recognize
the difficulty of changing the transportation system,
and we understand how tightly our economy and mobility
are interwoven. But we are committed to supporting
efforts that can solve difficult problems without making
others worse, that can untangle the gridlock on the
street and in the legislatures, and that can help make
the nation's cities and communities more livable.
<P>
<H5>Hal Harvey<BR>
Executive Director</H5>
<P>
</BLOCKQUOTE>
<BR>

<CENTER>
<NOBR><A HREF="start.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Start Essay" SRC="MAPTL1.gif"></A><A HREF="cars.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Build Better Cars" SRC="MAPTR1.gif"></A></NOBR><BR><NOBR><A HREF="city.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Change the City" SRC="MAPML1.gif"></A><A HREF="fuels.html"><IMG WIDTH=152 HEIGHT=139 BORDER=0 HSPACE=0 VSPACE=0 ALT="Switch to Better Fuels" SRC="MAPMR1.gif"></A></NOBR><BR><NOBR><A HREF="altmodes.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Promote Other Modes" SRC="MAPBL1.gif"></A><A HREF="conclusion.html"><IMG WIDTH=152 HEIGHT=148 BORDER=0 HSPACE=0 VSPACE=0 ALT="Conclusion" SRC="MAPBR1on.gif"></A></NOBR><BR>
</CENTER>

<a href = "./index.html#toc"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

</BODY>
<hr>
<p align=right>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT></A>
<font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-136</DOCNO>
<DOCOLDNO>IA026-000277-B023-203</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/execsumm/index.html 198.77.86.203 19970113171835 text/html 30581
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:20:26 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 30409
Last-modified: Mon, 17 Jun 1996 18:21:17 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY  bgcolor="#FFFFFF">

<blockquote>

<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<BLOCKQUOTE><CENTER>
<FONT SIZE="+3">Boosting Prosperity:</FONT><hr>
<FONT SIZE="+1"><i>Reducing the Threat of Global Climate Change Through Sustainable Energy 
Investments</i></FONT></h3>
</CENTER>
</BLOCKQUOTE>
<br><br>

<IMG SRC="../../grf/dcT.gif" ALT="T" ALIGN=LEFT WIDTH="56" HEIGHT="56">
he Intergovernmental Panel on Climate Change (IPCC), an
international group of 2,500 climate scientists
assembled under the authority of the United Nations to
monitor global climate, recently released a report
documenting the causal link between human activity and
global climate change.  The IPCC report declares that
the 6 billion metric tons of carbon emitted into the
atmosphere globally each year are indeed heating the
planet. Because economic growth and energy consumption
have historically marched in lockstep, there is great
concern that policy measures aimed at reducing
fossil-fuel use could constrain future prosperity.  <p>
     Fortunately, the world need not choose between
catastrophic climate change and 
economic growth. A host of new technologies offers the
means to simultaneously boost the economy and reduce
greenhouse gas emissions. So while some argue that
cutting U.S. carbon dioxide emissions could be a costly
drag on the economy, this report provides dozens of case
studies that show the opposite: the reduction of carbon
dioxide emissions can be a beneficial side effect of
profitable business choices.

<P ALIGN=CENTER><I>Sponsored by Rockefeller Brothers Fund<br>
and the Energy Foundation<br><br>
January 1996</I></P>

<h3>A. Energy Efficiency and Renewable Energy Increase
Economic Growth While Decreasing the Threat of Global
Climate Change</h3><p>
<p>
History shows that the United States can increase
economic growth while cutting energy consumption. Figure
1 shows that from 1973 to 1986, Gross Domestic Product
(GDP) grew 35 percent while the energy consumed per unit
of GDP fell to 2.4 percent per year. <p>

<BLOCKQUOTE><hr><a href="../img/ExecSum-Fig-1.gif"><img align=left src="../t/ExecSum-Fig-1.gif"></a><p>
<h4><I>Figure 1: <br>Energy Efficiency: Decoupling Economic Growth from Energy Consumption
<br clear=all><hr></I></h4></BLOCKQUOTE>

     By the end of this period, Americans were saving
over $150 billion each year through improved energy
efficiency, and had avoided a 50 percent cumulative
increase in carbon emissions. <p>
     Figure 2 shows that moderating energy use is
fundamental to solving the global climate change
dilemma.<p>

<BLOCKQUOTE><hr><a href="../img/ExecSum-Fig-2.gif"><img align=left src="../t/ExecSum-Fig-2.gif"></a><p>
<h4><I>Figure 2:<br>Sources of Emissions Driving Climate Change<br clear=all><hr></I></h4>
</BLOCKQUOTE>
     Since 1986, however, low fossil fuel prices in the
U.S. have encouraged an increase in energy consumption.
Today, Americans spend $505 billion per year on energy,
and U.S. carbon emissions have reached an all-time high:
1,394 million metric tons in 1994, accounting for 25
percent of the global total. Unless decision- makers
place greater emphasis on efficiency and renewable
energy, these trends will continue. The U.S. Department
of Energy (DOE) projects that with current trends and
policies, energy use could increase to about 104
quadrillion Btu (quads) per year by 2010, up from 85
quads today. Given this rise in demand and resultant
increases in energy prices, this could translate to a
national energy bill in 2010 of about $950 billion
 -  and an increase in carbon emissions of 17
percent.<p>
     At a global summit held in Rio de Janeiro in 1992,
the United States was one of 154 nations and the
European Community to sign the United Nations Framework
Convention on Climate Change. The framework stipulates
international commitments to cut greenhouse gas
emissions, including carbon dioxide emissions, to 1990
levels. Despite this commitment, as Figure 3 shows, U.S.
carbon emissions are continuing to grow at about one
percent per year.<p>

<BLOCKQUOTE><hr>
<a href="../img/ExecSum-Fig-3.gif"><img align=left src="../t/ExecSum-Fig-3.gif"></a><p>
<h4><I>Figure 3:<br>Carbon Emission Trends<br clear=all><hr></I></h4>
</BLOCKQUOTE>

<h3>B. Energy Efficiency and Renewable Energy Markets Are
Growing Rapidly, and Creating Jobs</h3><p>
<p>
The United States has barely scratched the surface of
energy-saving opportunities available in the economy.
The global market for energy efficiency has grown to
over $80 billion annually, and is expected to reach
$115-140 billion annually by 2015. The American Council
for an Energy-Efficient Economy (ACEEE) estimates that
U.S. efficiency improvements consistent with a 2.4
percent annual reduction in national energy intensity
(the rate achieved in the U.S. during 1973-1986) could
create a 
net increase of nearly 500,000 jobs by the year 2000,
and nearly 1.1 million new jobs by 2010. (Energy
intensity measures energy use per dollar of GDP, and
reflects how efficiently goods and services are
produced.) The majority of new jobs nationwide would be
created as money saved on power bills is recirculated
into the economy and spent on additional products and
services.<p>
     Investments in energy efficiency 
can lower consumers' energy bills, reduce energy costs,
cut oil imports, increase the net number of jobs, and
boost incomes  -  all while cutting carbon dioxide
emissions and reducing the threat of global climate
change.<P>



<h3>C. Numerous Case Studies Demonstrate That Carbon Dioxide
Emissions Can Be Cut While Adding to U.S. Prosperity</h3><p>

When they invest in energy efficiency, U.S. businesses
improve their bottom line by lowering their energy
bills, and boost their productivity and increase their
competitiveness  -  all while cutting greenhouse
emissions.

<h4>1. Industrial Energy-Efficiency Successes</h4>

U.S. industries spend $121 billion per year on energy
and consume about a quarter of all U.S. energy. Several
studies show that industry could cut its energy
intensity by 11 to 38 percent between now and the year
2015. When businesses improve their manufacturing
processes to use energy and raw materials more
efficiently, productivity, profitability, and employment
often increase. At the same time, carbon dioxide
emissions and environmental compliance costs typically
fall.
<p>
 <B>3M Corporation.</B> 3M has cut its energy use per
unit of production in half over the last 20 years,
reducing overall emissions by one-third. The company has
worked aggressively to achieve an ambitious but
practical corporate goal: cut energy use per unit of
production and per square foot of building space by 20

percent. It has pledged to implement all energy-saving
projects with a 15 percent or greater return on
investment (a payback period of six to seven years).
Energy cost-cutting has made the company more
competitive and more productive. 3M is also marketing a
new "dual cure coating" process that is used for
aircraft topcoats and primers, and for coatings for the
backing of high-temperature electrical tape. The new
coatings could eliminate an estimated 236,000 metric
tons of volatile organic compounds (VOCs) annually
 -  7.5 percent of U.S. total emissions. Because the
new process requires less energy, it could also reduce
carbon dioxide emissions by an estimated 2 million
metric tons a year. By 2010, the cumulative energy
savings could be greater than all the electricity used
in all the commercial establishments in the state of
Iowa in 1995.<P>
 <B>Dow Chemical.</B> Dow Chemical's Louisiana Division,
whose 2,400 employees in more than 20 plants make
chemicals such as propylene, began a yearly contest in
1982 to find energy-saving projects that paid for
themselves in one year and that required a capital
investment of less than $200,000. The first year, the
contest produced 27 winning projects that required a
total capital investment of $1.7 million and produced an
average return on investment of 173 percent. The 1983
contest had 32 winning projects requiring a total
capital investment of $2.2 million and providing a 340
percent return on investment  -  producing an annual,
ongoing savings of $7.5 million. The yearly contest was
so successful that Dow changed the rules to eliminate
the $200,000 limit and to include savings from all kinds
of waste reduction, 
not just energy. For 575 projects implemented throughout
the 1980s, the average return was 204 percent (audited).
After ten years and nearly 700 projects, the 1992
contest had 109 winning entries that enjoyed an average
return of 305 percent; the 1993 
contest generated 140 projects with an average return of
298 percent.<p>
<h4>2. Utility Industry Efficiency Successes</h4> <p>
<p>
America's utilities provide roughly $260 billion each
year in energy services to homes, businesses and
industries
  -  a figure that represents 
5.2 percent of the gross national product (GNP). At the
same time, U.S. utilities emitted approximately 500
million metric tons of carbon in 1993, or about 36
percent of the annual U.S. total. This figure has
dropped from where it would have been had n
ot a wide array of electric utility energy-saving
programs saved the U.S. economy billions of dollars. 
<p>
     From 1989 to 1993, utility investments in
energy-efficiency programs tripled to about $3 billion
per year. These investments reduced national generation
in 1993 by 44,000 gigawatt-hours, 1.6 percent of total
U.S. generation. These savings cut consumers' utility
bills by nearly $4 billion that year, while reducing
carbon dioxide emissions by approximately 27.8 million
metric tons.<p>
     Utility efficiency programs in California provided
net benefits of $2.2 billion during the period from 1990
to 1994. In 1994, the average cost of saved
kilowatt-hours was less than 2 cents per kilowatt-hour
 -  less than the wholesale price of power produced
by the cheapest new generating plant. New York utility
programs delivered $1.4 billion in net benefits to
customers between 1990 to 1994. In the Pacific
Northwest, efficiency programs during 1995 saved more
than 900 average megawatts of electricity at an average
cost of 2 to 2-1/2 cents per kilowatt-hour, saving
retail consumers 
$2 billion. The efforts avoided more than 5.35 million
metric tons of carbon dioxide emissions. In Wisconsin,
utilities achieved a cumulative reduction in energy
demand from 1988 to 1994 of 2,959 gigawatt-hours, while
reducing carbon dioxide emissions by 1.8 million metric
tons. From 1995 through 2013, projections show,
Wisconsin utility efficiency programs could reduce
electricity usage by 5,152 gigawatt-hours, preventing
more than 3.1 million metric tons of carbon dioxide
emissions. In Massachusetts, programs at three major
utilities delivered net benefits of nearly $400 million
between 1990 and 1993.<p>
     Market uncertainties due to proposed utility
industry restructuring are currently causing utilities
to cut back on all long-term investments, including
efficiency. However, the newest utility restructuring
models  -  from California and New England  - 
indicate that energy efficiency investments will
continue. The most 
profitable course for future, still-regulated
distribution companies will be to select the lowest-cost
option to meet energy needs. A recent report projects
that utility efficiency programs will deliver 3 percent
of electricity demand annually by the year 2000,
avoiding 45 million metric tons of carbon dioxide
emissions.<p>
<p>
<h4>3. Efficiency Successes in Buildings, Equipment, and Appliances</h4><p>
<p>
The U.S. could cut energy consumption in buildings by 33
to 50 percent by the year 2015, simply by investing in
cost-effective, commercially available tech- nologies.
Substantial progress in building efficiency has been
made already. Improved building codes, energy-efficient
designs, retrofits, and improved equipment and
appliances have stabilized energy intensity in the
commercial sector, and have reduced energy intensity in
residences. Offices and homes now get the same
services
  -  lights, heating, air-conditioning  -  using
less energy than in the past. But much more energy waste
can be trimmed.<p>

<H4>a. Successful Building Design</H4><p>
Energy design decisions are long-lasting. The median
lifetime for commercial buildings is between 50 and 70
years. The potential for savings is high. A 
reasonably attainable 30 percent improvement in U.S.
building efficiency would reduce energy bills by $75
billion annually in 15 years.<p>
     Energy-efficient building and office design can
significantly increase worker productivity. By improving
lighting, heating, and cooling, workers are made more
comfortable and productive. An increase of 1 percent in
productivity can provide savings that exceed a company's
entire energy bill.<P>
 <B>Lockheed Missiles and Space Company.</B> One of the
most successful examples of efficient design for a
commercial office 
building is Lockheed Missiles and Space Company's
Building 157 in Sunnyvale, California. A central atrium
in the 600,000 square-foot office brings daylight deep
into the building, saving Lockheed about 75 percent on
its lighting bill. Since daylight generates less heat
than office lights, peak air-conditioning has been cut
substantially. Overall, the building runs with about
half the energy costs of a typical building of similar
size. Although the energy-efficient improvements added
roughly $2 million to the building's $50 million capital
costs, the energy savings, worth nearly $500,000 per
year, paid for themselves in a little more than four
years. More important, however, have been productivity
improvements. Russell Robinson, manager of Facility
Interior Development, reports that productivity is up
 while absenteeism has declined. According to Don
Aitken, chairman of the Department of Environmental
Studies at nearby San Jose State University, "Lockheed
moved a known population of workers into the building
and absenteeism dropped 15 percent." Aitken led numerous
tours of Building 157 after it opened, and was told by
Lockheed officials that the reduced absenteeism paid 100
percent of the extra cost of the building in the first
year. The architect, Lee Windheim, has learned that
productivity rose 15 percent on the first major contract
done in the building.
<p>
<H4>b. Lighting Retrofits</H4><p>
Lighting accounts for 19 percent of all electricity sold
in the U.S. and costs consumers nearly $40 billion per
year. The best light bulbs on the market use only a
quarter as much energy as conventional 
incandescent light bulbs and last ten times longer, each
preventing the burning of as much as 400 pounds of coal,
and saving consumers more than $35 net on their
electricity bills over the life of the improved bulb.
<p>
     If energy-efficient lighting were installed
everywhere profitable to do so, America's demand for
electricity would drop by more than 10 percent. This
would result in annual reductions of 
1.3 million metric tons of sulfur dioxide, 600,000
metric tons of nitrogen oxides, and 202 million metric
tons of carbon dioxide. That's a reduction in carbon
dioxide emissions equivalent to taking 44.5 million cars
off the road. These reductions represent 12 percent of
all U.S. utility emissions.
<p>
 <B>Boeing Corporation.</B> Boeing has been a participant
in the Environmental Protection Agency (EPA) Green
Lights program to promote energy-efficient lighting.
Lighting upgrades have cut electricity use by 25 to 90
percent in several million square feet of Boeing's
facilities, with a 53 percent annual return on
investment. Boeing's upgrades have saved 130,000
megawatt-hours, have paid for themselves in just two
years, and have cut carbon dioxide emissions by 18,070
metric tons per year. They have 
also reduced annual emissions of other air pollutants,
including sulfur dioxide (down 4,536 metric tons) and
nitrogen oxides (down 1,815 metric tons). The new
lighting has improved workers' abilities to detect
manufacturing defects by 20 percent. According to
Lawrence Friedman, Boeing's conservation manager, the
savings from catching errors early,while difficult to
measure, are estimated to exceed greatly the cost of the
energy-efficient upgrades.<P>
<H4>c. Efficient Appliances and Equipment</H4><p>
Appliance and equipment standards are saving consumers
$1.9 billion annually, and ultimately will save
consumers $132 billion net over the lifetime of products
purchased by 2030, providing a ratio of total benefits
to costs of 3-to-1. Past and necessary future appliance
and equipment standards could cut residential
electricity use 7 percent by the year 2015, saving about
80,000 gigawatt-hours and 21,000 megawatts annually, and
avoiding approximately 50.6 million metric tons of
carbon dioxide per year. <p>
<p>
 <B>Whirlpool's "Golden Carrot"&#129; Super-Efficient
Refrigerator.</B> Refrigerators consume 20 percent of all
residential electricity, and average about 685
kilowatt-hours per refrigerator each year. To encourage
manufacturers to develop and market
refrigerator-freezers that are substantially more
efficient, a group of electric utilities formed a
consortium  -  the Super Efficient Refrigerator
Program, Inc. (SERP)  -  that put up a $30 million
pot of incentive money. In June 1993, SERP selected two
semi-finalists - including Whirlpool.  As shown in
Figure 4, energy and carbon savings from the Golden
Carrot&#129; refrigerator are substantial. Compared to
an owner of a 1978 model, each owner of a Golden
Carrot
&#129; refrigerator saves $135 per year in electricity
while cutting carbon emissions by two-thirds.
<p>

<BLOCKQUOTE><hr>
<a href="../img/ExecSum-Fig-4a.gif"><img align=left src="../t/ExecSum-Fig-4a.gif"></a><p>
<h4><I>Figure 4a:<br>New Golden Carrot Whirlpool Design Reduces Comsumer Costs...<br clear=all></I></h4>
<p>
<br><a href="../img/ExecSum-Fig-4b.gif">
<img align=right src="../t/ExecSum-Fig-4b.gif"></a>
<h4><I>Figure 4b:<br>...And Carbon Emissions<br clear=all><hr></I></h4>
</BLOCKQUOTE>

 <B>Lawrence Berkeley National Laboratory.</B> The U.S.
Department of Energy program at the Lawrence Berkeley
National Laboratory (LBNL) has made enormous
contributions to national energy efficiency by
contributing to the development of electronic ballasts
and low emissivity, or "Low-E," windows. Electronic
ballasts, virtually unknown in the mid-1970s when LBNL's
research began, now capture a 24-percent share of the
ballast market. Cumulative energy savings attributable
to electronic ballasts from 1988 to 1993 total $400
million. By 2015, use of electronic ballasts could avoid
environmental emissions of approximately 157,000 metric
tons of sulfur dioxide, 144,000 metric tons of nitrogen
oxides, and 73 million metric tons of carbon dioxide.
Today, Low-E windows have captured 36 percent of the
U.S. windows market, boasting $600 million in annual
sales.      By 1993, the cumulative energy savings to
the U.S. was $760 million, and will reach $17 billion by
the year 2015. By that year, Low-E windows are projected to prevent, through
avoided electricity generation, 142,000 metric tons of
sulfur dioxide, 129,000 metric tons of nitrogen oxides,
and more than 64 million metric tons of carbon dioxide
emissions.
     Energy-efficient building codes, building designs,
retrofit investments, and equipment and appliance
standards all contribute to greater business
competitiveness and economic growth  -  while helping
to avoid carbon dioxide emissions.<P>
<h4>4. Successes in the Transportation Sector</h4><p>
<p>
The combustion of fossil fuels in America's
transportation sector consumed 35 percent of the
nation's energy in 1990 and produced more than 32
percent of U.S. carbon dioxide emissions. 
Transportation will be the fastest growing source of
U.S. carbon dioxide emissions over the long term  - 
by far  -  unless Americans take aggressive steps to
build efficiency into transportation systems.<p>
     Two-thirds of total U.S. oil consumption goes to
transportation, and each day Americans use 4 million
more barrels of oil for transportation than the U.S.
produces. The United States imports half the petroleum
it uses, a fact that contributed $56 billion 
to the U.S. trade deficit in 1994, and the trend is
upward. The gap between what we use and what we produce
is projected to rise to 9 million barrels per day by 
the year 2010. Dependence on oil imports threatens U.S.
national security, making our economy vulnerable to
foreign cartels, price swings, supply disruptions, and
foreign wars.<p>
     Transportation energy use accounts 
for about half of all air pollution emissions in the
U.S. and more than 80 percent of air pollution in
cities. Highway vehicles alone account for 26 percent of
U.S. emissions of VOCs, 32 percent of nitrogen oxides,
and 62 percent of total carbon monoxide. 
The American Lung Association estimates that
America spends $50 billion each year on health care as a
direct result of air pollution.<p>
     Fortunately, fuel efficiency has improved
substantially in the transportation sector during the
last 20 years, and efficiency gains are far from
exhausted. <P>
 <B>Federal Corporate Automobile Fuel Efficiency
(CAFE)</B> requirements for new vehicles are one of the
major energy-policy success stories of the past 20
years. CAFE standards doubled automobile fuel efficiency
from 14 miles per gallon (mpg) to 27 mpg between 1975
and 1985. The standards, which have not been improved
since the mid-1980s, are presently saving nearly 3
million barrels of oil per day  -  which corresponds
to $50 billion of consumer savings and 150 million
metric tons of greenhouse gas emissions avoided
annually.<p>
     As shown in Figure 5, working prototypes could
easily double vehicle 
fuel efficiency, while electric and hybrid-electric
vehicles  -  if incentives are created to spur market
development  -  could usher in a new age of clean
transportation, powered by renewables-derived
electricity.<p>

<BLOCKQUOTE><hr>
<a href="../img/ExecSum-Fig-5.gif"><img align=left src="../t/ExecSum-Fig-5.gif"></a><p>
<h4><I>Figure 5:<br>Efficient Prototype Vehicles<br clear=all><hr></I></h4>
</BLOCKQUOTE>

<p>
 <B>General Motors Corporation</B>. Many manufacturers
are moving ahead with electric vehicle production.
General Motors originally unveiled its Impact model in
1990. The Impact, with a composite body and stiff
aluminum frame, incorporates an advanced electric motor,
electronic controls, regenerative braking, and
aerodynamic streamlining. The energy cost of running an
Impact is only a quarter that of a gasoline-powered car.
The driving range is about 100 miles using its 1,100
pounds of lead-acid batteries. Those who have
test-driven the Impact have given it rave reviews for
its quiet ride, maneuverability, and rapid acceleration.
Even counting the emissions from the power plants used
to charge it, the Impact produces two-thirds less
pollution than California will allow under its 1998
ultra-low emission standard, and 72 percent less carbon
dioxide than is emitted by a 1994 Ford Taurus.<p>
<h4>5. Renewable Energy: Coming of Age</h4><p>
<p>
Efficiency reduces consumption while maintaining or
improving the services provided by energy. Renewable
energy could supply new power needs with no carbon
emissions. Renewable energy technologies
  -  wind, photovoltaics, solar-thermal, and
geothermal
  -  have made major advances in the past decade.
Figure 6 highlights the dramatic drop in renewable
energy costs. <p>

<BLOCKQUOTE><hr>
<a href="../img/ExecSum-Fig-6.gif"><img align=left src="../t/ExecSum-Fig-6.gif"></a><p>
<h4><I>Figure 6:<br> Renewable Energy Costs are Dropping<br clear=all><hr>
</I></h4>
</BLOCKQUOTE>

     For example, the cost of wind-generated electricity
in the U.S. dropped from 25 cents per kilowatt-hour in
1984 to less than 5 cents per kilowatt-hour today. The
cost curves for solar-thermal and photovoltaic utility
plants show similar downward trends. Increased
production would further reduce costs. 
If pollution and social costs from fossil fuel use were
to be internalized in fossil fuel prices, many
renewables today would be cheaper than fossil fuels. <p>
     At the same time, reliability has improved
markedly, and renewable capacity is expected to grow. A
recent study projects that existing renewable 
technologies could supply roughly one-quarter of our
current energy use by 2010.<p>
     The advancement of wind energy is a convincing
success story. U.S. wind resources are large enough to
supply more than 4.4 billion megawatt-hours
  -  more than 1-1/2 times the total amount of
electricity used in the United States. At least
thirty-seven states have commercial wind energy
potential. The wind industry is producing utility-scale
turbines that are significantly less costly and far more
reliable than earlier generation turbines. Utility
contracts for wind power have been signed recently for a
levelized price of less than 4 cents per kilowatt-hour
 -  competitive with fossil sources and cheaper than
nuclear. Wind has enormous advantages over fossil fuels,
including minimal future costs subject to inflation, and
low operating and maintenance costs. Wind energy is one
of the least costly sources of new electrical generation
and is competitive with new plants fired with 
fossil fuels.<p>
<p>
 <B>Kenetech Corporation.</B> U.S. Windpower, Inc. formed
Kenetech Corporation, based in San Francisco, in 1986 as
a holding company. Kenetech, the world's largest wind
company, has more than 800 employees. It manufactures
and sells one of the most advanced wind turbines in the
world, the variable speed Model 33M-VS. This turbine is
able to deliver electricity at less than 5 cents per
kilowatt-hour, making it economically competitive with
traditional fossil-fuel energy sources. Kenetech
operates an installed base of approximately 4,400 wind
turbines, most of which are in the United States. In
California, Kenetech generated 659,131 megawatt-hours of
electricity in 1993, offsetting 226,082 metric tons of
carbon dioxide emissions that would otherwise have been
generated by California's average mix.<p>
     Photovoltaic (PV) power is another promising
renewable technology. PVs use semiconductor technology
to convert sunlight directly into electricity without
the need for turbines, generators, or any other moving
parts. PV production costs have fallen more than 50-fold
during the last 20 years, and PVs generate power today
at an average cost of 25 to 50 cents per kilowatt-hour
for grid-connected applications. At these prices, PV
applications are mainly cost-effective for off-the-grid
uses in remote locations and for specialized grid
situations where distribution and transmission expansion
costs can be avoided. For example, PV arrays situated at
generating substations to support a utility's
transmission and distribution system, and PV arrays at
residential and commercial centers, have the potential
to manage demand for electricity by shaving utility peak
loads. Overall costs are reduced and carbon emissions
avoided. <P>
 <B>Amoco/Enron Solar.</B> The domestic PV industry
received a boost in January 1995 when Amoco Corp., which
owns Solarex, the largest U.S. manufacturer and marketer
of PV systems, launched a joint venture with Enron
Corp., the nation's largest natural gas company.
Together, they propose to build a $25 million facility
to manufacture PV modules and a $150 million,
100-megawatt PV-powered generating plant in Nevada that
they maintain will be able to sell power profitably for
5.5 cents per kilowatt-hour (escalating at 3 percent
annually over 30 years). Production at the plant  - 
which each year will manufacture large-area,
multijunction amorphous silicon modules with capacity in
excess of 10 megawatts  -  is scheduled to begin in
1996.<P>
<h3>D. Conclusion</h3><p>
<p>
The successes reviewed in this report not only save
dollars and boost economic performance, but also cut
carbon dioxide emissions and reduce the threat of global
climate change. Our nation can grow economically, add
jobs, and become more internationally competitive while
cutting greenhouse gas emissions. <p>
     The task ahead is not simple, however. While the
market has captured many efficiency and renewable energy
successes, a host of market barriers to efficiency
investments persists.  For example, although efficiency
and renewable energy technologies are often cheaper on a
life-cycle basis, their up-front costs are typically
higher than less-efficient products.  Public policies
that provide consumers with life-cycle product
information could help overcome this market failure. 
Similarly, because it takes up-front capital to invest
in improved efficiency, public policies that promote
financing and technical assistance can facilitate
investment.  Although the focus of this report is on
efficiency and renewable energy success stories, given
the market hurdles to efficiency investments, utility
efficiency programs and public policy incentives are
crucial to encourage energy efficiency.  The effects of
tighter environmental regulations and the prospect of
higher fossil energy prices will increasingly make
efficiency investments a prudent pursuit for all
businesses.<p>
     Michael Porter, a professor at the Harvard Business
School, notes that "the underlying cause of sustained
national advantage is improvement and innovation." The
compelling conclusion of the case studies in this
report, coupled with the solid economic, employment,
public health, and pollution-reduction benefits reviewed
in each, support a strategic vision for U.S. energy
policy: Energy efficiency and renewable energy can add
to U.S. prosperity while cutting U.S. carbon dioxide
emissions and reducing the threat of global climate
change.
</blockquote>

</BODY>

<a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40">
</A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>


</DOC>
<DOC>
<DOCNO>WT01-B18-137</DOCNO>
<DOCOLDNO>IA026-000277-B023-345</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/Intro/index.html 198.77.86.203 19970113172026 text/html 6208
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:22:04 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 6037
Last-modified: Mon, 17 Jun 1996 20:26:14 GMT
</DOCHDR>
<HTML><HEAD><TITLE>Boosting Prosperity: Introduction</TITLE></HEAD><BODY bgcolor="#FFFFFF"><BLOCKQUOTE><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><BLOCKQUOTE><CENTER><FONT SIZE="+2">Boosting Prosperity:</FONT><hr><FONT SIZE="+1"><i>Reducing the Threat of Global Climate Change Through Sustainable Energy Investments</i></FONT></H2></CENTER></BLOCKQUOTE><br><br><IMG SRC="../../grf/dcT.gif" ALT="T" ALIGN=left WIDTH="56" HEIGHT="56">he Intergovernmental Panel on Climate Change (IPCC), an international group of 2,500 climate scientists assembled under the authority of the United Nations to monitor global climate, recently documented the causal link between human activity and global climate change. The IPCC report declares that the 6 billion metric tons of carbon emitted into the atmosphere globally each year are indeed heating the planet. Because economic growth and energy consumption have historically marched in lockstep, there is great concern that policy measures aimed at reducing fossil-fuel use could constrain future prosperity. <BR><p>     Fortunately, the world need not choose between catastrophic climate change and economic growth. A host of new technologies offers the means to simultaneously boost the economy and reduce greenhouse gas emissions. U.S. businesses, municipalities, and educational institutions are finding that investments in energy efficiency cut power bills and provide a rapid payback, while reducing carbon dioxide emissions. So while some argue that cutting U.S. carbon dioxide emissions would be a costly drag on the economy,<a href="#1"  NAME="r1">[ 1 ]</A> </a>this report shows dozens of examples of how carbon dioxide reductions are often a beneficial side effect of profitable, energy-saving business choices.<BR><p>     Energy efficiency<a href="#2" NAME="r2">[ 2</a> ] </a>can increase profitability and competitiveness by lowering the cost of doing business. When businesses improve their manufacturing processes to use energy and raw materials more efficiently, carbon dioxide emissions and environmental compliance costs fall while profitability, productivity, and competitiveness improve, creating jobs.<p><a href="A.html"><b>A. Energy Efficiency and Renewable Energy Reduce the Threat of Global Climate Change While Fueling Economic Growth     </b></a><p><a href="B.html"><b>B. Energy Efficiency Does Not Mean Reduced Economic Growth     </b></a><p><a href="C.html"><b>C. Energy Efficiency and Renewables Markets Are Rapidly Growing, and Creating Jobs     </b></a><p><a href="D.html"><b>D. Successes Demonstrate That Cutting Carbon Dioxide Emissions Can Add to U.S. Prosperity     </b></a><p><!--text--><hr><font size =-1><P><A HREF="#r1"  NAME="1">1.</a> Working Group III of the Intergovernmental Panel on Climate Change (IPCC) has been charged with assessing the economic costs of climate change. Some have argued for the use of "top-down" macroeconomic models, which look at aggregated statistical data, and claim that carbon dioxide emission controls could cost the U.S. economy 1 to 2 percent of GDP annually. On the other hand, "bottom-up" computer models find the opposite conclusion, that carbon dioxide emission controls could actually grow the economy by 1 to 2 percent annually through increased energy and economic efficiency, enhancing profitability, productivity, and new job creation.<BR><p>     Advocates for the "top down" models claim that it would be more cost-effective to delay implementation of carbon controls until current capital infrastructure and investments reach the end of their life-cycle. This argument, however, suffers in two respects. First, it fails to account for ecological reality: carbon dioxide continuously accumulates in the atmosphere, so emission reductions sooner are more valuable than reductions later. Second, it reflects an outmoded business philosophy. As discussed below, the businesses that will thrive in an increasingly competitive global economy are those that recognize the necessity of constant reinvestment in efficient production and productivity improvements. Energy efficiency investments will assist companies in becoming more productive and competitive, while helping the U.S. meet its international carbon dioxide reduction obligations. <I>See</I> Cutter Information, Corp., "IPCC Debates Economic Models," <I>Global Environmental Change Report</I>, Vol. VII, No. 17, pp. 1-3 (Arlington, MA: September 8, 1995); Quinn, B., "Boosting Productivity While Protecting the Environment," <I>Area Development</I>, pp. 39-44 (July 1995); <I>see also</I> Porter, M. and Van der Linde, C., "Green <I>and</I> Competitive: Ending the Stalemate," <I>Harvard Business Review</I>, pp. 120-134 (Boston, MA: September-October, 1995).<BR><P><A NAME="2"  HREF="#r2">2.</a> Energy efficiency refers to obtaining greater benefits from a resource by investing in more efficient end-use products - such as compact fluorescent light bulbs, high-efficiency motors and drives, or more-efficient heating systems. Hopkins, M., and Jones, T., <I>Getting in Gear: How Energy Efficiency Can Help Smaller Manufacturers Compete in the Global Marketplace,</I> p. 6 (Washington, D.C: Alliance to Save Energy, January 1995).<BR></font><p><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all></BLOCKQUOTE></BODY><hr><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-138</DOCNO>
<DOCOLDNO>IA026-000277-B023-377</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/I/index.html 198.77.86.203 19970113172043 text/html 1556
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:22:49 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1385
Last-modified: Mon, 17 Jun 1996 20:26:53 GMT
</DOCHDR>
<HTML><HEAD><TITLE>I. Industrial Energy Efficiency Successes   </TITLE></HEAD><BODY bgcolor="#FFFFFF"><BLOCKQUOTE><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><H2>I. Industrial Energy Efficiency Successes   </H2>  <A HREF="intro.html"><B>Introduction</B></A><p><a href="A.html"><b>A. Energy-Efficiency Investments Can Boost Productivity While Reducing Industrial Waste Materials  </b></a><p><a href="B.html"><b>B.<I> </I>Energy-Efficiency Investments Can Improve Competitiveness     </b></a><p><a href="C.html"><b>C.<I> </I>Energy-Efficiency Investments Can Create Jobs     </b></a><p><a href="D.html"><b>D.<I> </I>Conclusion     </b></a><p><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all></BLOCKQUOTE></BODY><hr><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-139</DOCNO>
<DOCOLDNO>IA026-000277-B023-397</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/index.html 198.77.86.203 19970113172052 text/html 2277
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:22:58 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2106
Last-modified: Mon, 17 Jun 1996 20:26:46 GMT
</DOCHDR>
<HTML><HEAD><TITLE>II. The Utility Industry: Efficiency Successes</TITLE></HEAD><BODY bgcolor="#FFFFFF"><BLOCKQUOTE><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><H2>II. The Utility Industry: <br>Efficiency Successes</H2>   <A HREF="intro.html"><B>Introduction</B> </A> <p><a href="A.html"><b>A.<I> </I>Utility Efficiency Has Improved Markedly     </b></a><p><a href="B.html"><b>B. Integrated Resource Planning Has Been a Demonstrated Success     </b></a><p><a href="C.html"><b>C. Demand-Side Management Programs Have Been Successful Nationwide     </b></a><p><BLOCKQUOTE><a href="C1.html"><I><b>1. California DSM Successes     </b></I></a><p><a href="C2.html"><I><b>2. Pacific Northwest DSM Successes     </b></I></a><p><a href="C3.html"><I><b>3. New England DSM Successes     </b></I></a><p><a href="C4.html"><I><b>4. New York DSM Successes     </b></I></a><p><a href="C5.html"><I><b>5. Wisconsin DSM Successes     </b></I></a><p></BLOCKQUOTE><a href="D.html"><b>D. Federal Initiatives Continue to Spur Efficiency Successes     </b></a><p><a href="E.html"><b>E. DSM Programs Could Become an Essential Utility Service in a Restructured Utility Industry</b></a><p>     <a href="F.html"><b>F. Industrial Efficiency Services Will Exemplify Efficiency Programs in a Restructured Industry</b></a><p>     <a href="G.html"><b>G. Conclusion     </b></a><p><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all></BLOCKQUOTE></BODY><hr><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-140</DOCNO>
<DOCOLDNO>IA026-000277-B024-11</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/index.html 198.77.86.203 19970113172108 text/html 2780
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:23:06 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2609
Last-modified: Mon, 17 Jun 1996 20:26:38 GMT
</DOCHDR>
<HTML><HEAD><TITLE>Energy Use in Buildings</TITLE></HEAD><BODY bgcolor="#FFFFFF"><BLOCKQUOTE><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><H2>III. Energy Use in Buildings: <br>Progress in Efficiency Design, <br>Retrofit  Investments, and <br>Equipment and Appliance Standards</H2>     <A HREF="intro.html"><B>Introduction</B></A><p><a href="A.html"><b>A. Energy-Efficient Design Is Demonstrating Dramatic Energy Savings     </b></a><p><BLOCKQUOTE><a href="A1.html"><b><I>1. Energy-Efficient Building Design Can Significantly Improve Worker Productivity</I>  </b></a>   <p><a href="A2.html"><b><I>2. Building Codes Offer Substantial Energy Savings</I>     </b></a><p></BLOCKQUOTE><a href="B.html"><b>B. Energy-Efficient Retrofits Are a Source of Energy Savings Waiting to be Mined </b></a>    <p><BLOCKQUOTE><a href="B1.html"><b><I>1. Building Retrofits Cut Energy Bills While Improving Worker Comfort and Productivity</I>   </b></a>  <p><a href="B2.html"><b><I>2. Lighting Retrofits Cut Error Rates and Improve Productivity</I>     </b></a><p><a href="B3.html"><b><I>3. Home Energy Rating Systems (HERS) Provide Important Consumer Information</I></b></a>     <p><a href="B4.html"><b><I>4. Energy Efficient Mortgages (EEMs) Can Provide Necessary Retrofit Financing</I></b></a>     <p><a href="B5.html"><b><I>5. Energy Services Companies Provide Retrofit Services With Immediate Energy Savings</I> </b></a>    <p></BLOCKQUOTE><a href="C.html"><b>C. Energy-Efficient Appliances and Equipment Provide Significant Energy Savings </b></a>    <p><BLOCKQUOTE><a href="C1.html"><b>1. Whirlpool's "Golden Carrot" - Super-Efficient Refrigerator     </b></a><p><a href="C2.html"><b>2. Energy-Efficient Windows     </b></a><p><a href="C3.html"><b>3. Energy-Efficient Equipment Labeling     </b></a><p></BLOCKQUOTE><a href="D.html"><b>D. Conclusion     </b></a><p><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all></BLOCKQUOTE></BODY><hr><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-141</DOCNO>
<DOCOLDNO>IA026-000277-B024-39</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/index.html 198.77.86.203 19970113172119 text/html 2820
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:23:26 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2649
Last-modified: Mon, 17 Jun 1996 20:26:33 GMT
</DOCHDR>
<HTML><HEAD><TITLE>IV. Transportation </TITLE></HEAD><BODY bgcolor="#FFFFFF"><BLOCKQUOTE><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><H2>IV. Transportation </H2>    <A HREF="intro.html"><B>Introduction</B></A><p><a href="A.html"><b>A. Fuel-Efficiency Improvements in Internal Combustion Engines Cost-Effectively Reduce Air Pollution, Including Carbon Dioxide Emissions     </b></a><p><BLOCKQUOTE><a href="A1.html"><b>1. Internal Combustion Engine Efficiency Has Improved     </b></a><p><a href="A2.html"><b>2. Corporate Average Fuel Efficiency Standards Are a Significant Success     </b></a><p><a href="A3.html"><b>3. Accelerated Vehicle Retirement Programs Can Improve Air Quality     </b></a><p><a href="A4.html"><b>4. Materials Improvements Are Cutting Vehicle Weight and Increasing Efficiency     </b></a><p><a href="A5.html"><b>5. Vehicle Emissions Reduction Technologies Have Successfully Cut Emissions     </b></a><p></BLOCKQUOTE><a href="B1.html"><b>B. New Vehicle Technologies are Ushering In an Era of More Efficient Transportation     </b></a><p><BLOCKQUOTE><a href="B1.html"><b>1. Technology Incentives Spur Markets For Efficient Vehicles     </b></a><p><a href="B2.html"><b>2. New Low-Emission and Zero-Emission Vehicles Could Revolutionize Transportation     </b></a><p><BLOCKQUOTE><a href="B2a.html"><b>a. Electric Vehicles     </b></a><p><a href="B2b.html"><b>b. Hybrid-Electric Vehicles     </b></a><p><a href="B2c.html"><b>c. Fuel Cells     </b></a><p></BLOCKQUOTE></BLOCKQUOTE><a href="C.html"><b>C.<I> </I>Improving the Efficiency of Other Transportation Modes Reduces Carbon Dioxide Emissions While Improving Competitiveness     </b></a><p><BLOCKQUOTE><a href="C.html#air"><b>1. Air Transport     </b></a><p></BLOCKQUOTE><a href="D.html"><b>D. Long-Term Solutions Must Include Improved Urban Design     </b></a><p><a href="E.html"><b>E. Conclusion     </b></a><p><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all></BLOCKQUOTE></BODY><hr><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-142</DOCNO>
<DOCOLDNO>IA026-000277-B024-61</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/index.html 198.77.86.203 19970113172134 text/html 1959
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:23:37 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1788
Last-modified: Mon, 17 Jun 1996 20:26:28 GMT
</DOCHDR>
<HTML><HEAD><TITLE>Renewables: Coming of Age</TITLE></HEAD><BODY bgcolor="#FFFFFF"><BLOCKQUOTE><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><H2>V. Renewables: Coming of Age</H2><A HREF="intro.html"><B>Introduction</B></A><p><a href="A.html"><b>A. Renewables Technologies Have Made Major Advances     </b></a><p><a href="B.html"><b>B. Renewable Energy Has Become Reliable     </b></a><p><a href="C.html"><b>C. The Growth of Renewables Depends on Several Factors     </b></a><p><a href="D.html"><b>D. Four Promising Renewables Industries     </b></a><p><BLOCKQUOTE><a href="D1.html"><b>1. Wind Power     </b></a><p><a href="D2.html"><b>2. Photovoltaics     </b></a><p><a href="D3.html"><b>3. Solar Thermal     </b></a><p><BLOCKQUOTE><a href="D3a.html"><b>a. Parabolic Troughs     </b></a><p><a href="D3b.html"><b>b. Central Receivers     </b></a><p><a href="D3c.html"><b>c. Parabolic Dishes     </b></a><p></BLOCKQUOTE><a href="D4.html"><b>4. Geothermal     </b></a><p></BLOCKQUOTE><a href="E.html"><b>E. Conclusion     </b></a><p><a href = "intro.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "../index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all></BLOCKQUOTE></BODY><hr><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></P></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-143</DOCNO>
<DOCOLDNO>IA026-000277-B024-102</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/companies.html 198.77.86.203 19970113172153 text/html 12277
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:23:56 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 12105
Last-modified: Mon, 17 Jun 1996 18:31:48 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>Business Case Study Index</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<BLOCKQUOTE>

<a href = "./index.html"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<H2>Business Case Study Index</H2>
<ul>
<li>American Lung Association   <BR>
<UL>
	<LI><i><A HREF = "IV/D.html#AmericanLungAssociation">Chicago's Community Green Line Initiative</A></i>
	<LI><i><A HREF = "IV/intro.html#AmericanLungAssociation">Transportation</a></i>
</UL>
<li><A HREF = "III/B2.html#AmocoOil">Amoco Oil</A>  <BR>
<li><A HREF = "V/D2.html#Amoco/Enron Solar">Amoco/Enron Solar</A><BR>
<li>AT&T <BR>
<UL>
	<LI><i><A HREF = "II/D.html#AT&T">Federal Initiatives</A></i>
	<LI><i><A HREF = "III/B2.html#AT&T">Lighting Retrofits</a></i>   
</UL>
<li><A HRE F= "V/D1.html#BattellePacificNorthwestLaboratory">Battelle Pacific Northwest Laboratory </A><BR>
<li>Bechtel    <BR>
<UL>
	<LI><i><A HREF = "V/B.html#Bechtel">Renewable Energy Has Become Reliable</a></i>
	<LI><i><A HREF = "V/D3b.html#Bechtel">Central Receivers</a></i>
</UL>
<li><A HREF = "III/B2.html#BellAtlantic">Bell Atlantic </A>    <BR>
<li><A HREF = "I/B.html#BigBearStores">Big Bear Stores</A>    <BR>
<li><A HREF = "II/C1.html#BlueDiamondAlmonds">Blue Diamond Almonds</A>
<li><A HREF = "III/B2.html#Boeing">Boeing</A>     <BR>
<li>Bonneville Power Administration
<UL>
	<LI><i><A HREF = "II/C2.html#BonnevillePowerAdministration">Pacific Northwest DSM Successes</A></i> <BR>
	<LI><i><A HREF = "II/F.html#BonnevillePowerAdministration">Industrial Efficiency Services</A></i>
</UL>
<li>Boston Edison Company     <BR>
<UL>
	<LI><i><A HREF="V/D2.html#BostonEdisonCompany">Photovoltaics</A></i>
	<LI><i><A HREF="I/B.html#BostonEdisonCompany">Energy-Efficiency Investments Can Improve Competitiveness</A></i>
</UL>
<li><A HREF = "I/B.html#BreyersCompany">Breyers Company, The</a><BR>
<li><A HREF = "I/A.html#BrushWellman">Brush Wellman, Inc.</a><BR>
<li><A HREF = "II/C3.html#BurlingtonElectricDepartment">Burlington Electric Department</a> <BR>
<li><A HREF = "V/D4.html#CaliforniaEnergyCompany, Inc.">California Energy Company, Inc.</a><BR>
<li><A HREF = "IV/B2.html#Calstart,Inc.">Calstart, Inc.</a><BR>
<li><A HREF = "IV/A3.html#ChevronCorporation">Chevron Corporation</a><BR>
<li><A HREF = "I/B.html#ChrisErhartFoundryandMachineCompany">Chris Erhart Foundry and Machine Company</a> <BR>
<li>Chrysler Corporation <BR>
<UL>
	<LI><i><A HREF = "I/A.html#ChryslerCorporation">Energy-Efficiency Investments</a></i><BR>
	<LI><i><A HREF = "IV/B2c.html#ChryslerCorporation">Fuel Cells</a></i><BR>
</UL>
<li><A HREF = "I/B.html#CincinnatiGasElectric">Cincinnati Gas & Electric</a><BR>
<li><A HREF = "IV/B2a.html#Clean,IntelligentTransportation,Inc.">Clean, Intelligent Transportation, Inc.</a><BR>
<li><A HREF = "IV/D.html#CommunityGreenLineInitiative,Chicago">Community Green Line Initiative, Chicago</a><BR>
<li><A HREF = "III/B2.html#CompaqComputerCorporation">Compaq Computer Corporation</a><BR>
<li><A HREF = "II/C4.html#ConsolidatedEdison">Consolidated Edison</a><BR>
<li><A HREF = "I/C.html#CraneValves">Crane Valves</a><BR>
<li><A HREF = "V/D3c.html#CumminsEngineCo.">Cummins Engine Co.</a><BR>
<li><A HREF = "V/D3c.html#CumminsPowerGeneration,Inc.">Cummins Power Generation, Inc.</a><BR>
<li><A HREF = "IV/B2c.html#Daimler-Benz">Daimler-Benz</a><BR>
<li><A HREF = "I/C.html#DowChemical">Dow Chemical</a><BR>
<li><A HREF = "II/D.html#Dupont">Dupont</a><BR>
<li><A HREF = "IV/B2c.html#EnergyPartners">Energy Partners</a><BR>
<li><A HREF = "III/B3.html#EnergyRatedHomesofAmerica">Energy Rated Homes of America </a><BR>
<li><A HREF = "V/B.html#EnergyWorks">EnergyWorks</a><BR>
<li><A HREF = "V/D2.html#EnronCorporation">Enron Corporation</a><BR>
<li><A HREF = "III/B4.html#FannieMae">Fannie Mae</a><BR>
<li><A HREF = "V/D1.html#FloWindCorporation">FloWind Corporation</a><BR>
<li><A HREF = "IV/B2c.html#FordMotorCorporation">Ford Motor Corporation</a><BR>
<li><A HREF = "III/B4.html#FreddieMac">Freddie Mac</a><BR>
<li><A HREF = "III/C1.html#Frigidaire ">Frigidaire</a><BR>
<li><A HREF = "Intro/C.html#GeneralElectric">General Electric</a><BR>
<li><A HREF = "IV/B2a.html#GeneralMotorsCorporation">General Motors Corporation</a><BR>
<li><A HREF = "IV/B2c.html#GeorgetownUniversity">Georgetown University</a><BR>
<li><A HREF = "II/C5.html#GoodwillIndustries">Goodwill Industries</a><BR>
<li><A HREF = "II/C3.html#GraniteStateElectric">Granite State Electric</a><BR>
<li><A HREF = "II/F.html#GreenfieldIndustries">Greenfield Industries</a><BR>
<li><A HREF = "I/A.html#Haskell-LemonConstructionCompany">Haskell-Lemon Construction Company</a><BR>
<li><A HREF = "I/A.html#Hill-RomCompany">Hill-Rom Company</a><BR>
<li><A HREF = "II/F.html#HolnamCompany">Holnam Company</a><BR>
<li><A HREF = "IV/A1.html#HondaMotorsCorporation">Honda Motors Corporation</a><BR>
<li>Honeywell, Inc.
<UL>
	<LI><I><A HREF = "III/B1.html#Honeywell,Inc.">Building Retrofits</a></I><BR>
	<LI><I><A HREF = "III/B5.html#Honeywell,Inc.">Energy Services Companies</a></I><BR>
</UL>
<li><A HREF = "III/B2.html#HydeTools">Hyde Tools</a></I><BR>
<li><A HREF = "II/C1.html#Intel">Intel</a></I><BR>
<li><A HREF = "I/C.html#IowaEnergyCenter">Iowa Energy Center</a></I><BR>
<li><A HREF = "III/B1.html#J.C.Penney">J.C. Penney</a></I><BR>
<li><A HREF = "III/B2.html#Johnson&Johnson">Johnson & Johnson</a></I><BR>
<li><A HREF = "I/C.html#KellyCompany,The">Kelly Company, The</a></I><BR>
<li><A HREF = "V/D1.html#KenetechCorporation">Kenetech Corporation</a></I><BR>
<li>Lawrence Berkeley National Laboratory <BR>
<UL>
	<LI><I><A HREF = "III/B2.html#LawrenceBerkeleyNationalLaboratory">Lighting Retrofits</a></I><BR>
	<LI><I><A HREF = "III/C2.html#LawrenceBerkeleyNationalLaboratory">Energy-Efficient Windows</a></I><BR>
</UL>
<li><A HREF = "III/B2.html#LockheedMartinDefenseSystems">Lockheed Martin Defense Systems</a><BR>
<li><A HREF = "III/A1.html#LockheedMissilesandSpaceCompany">Lockheed Missiles and Space Company</a><BR>
<li><A HREF = "III/B2.html#LongsDrugStores">Longs Drug Stores</a><BR>
<li><A HREF = "II/C5.html#MadisonGasandElectric">Madison Gas and Electric</a><BR>
<li><A HREF = "V/D4.html#MagmaPowerCo.">Magma Power Co.</a><BR>
<li><A HREF = "I/B.html#Mar-Jac,Inc.">Mar-Jac, Inc.</a><BR>
<li><A HREF = "III/B2.html#MarriottMarquisHotel">Marriott Marquis Hotel</a><BR>
<li>Massachusetts Electric Company    <BR>
<UL>
	<LI><I><A HREF = "I/C.html#MassachusettsElectricCompany">Energy-Efficiency Investments</a></I><BR>
	<LI><I><A HREF = "II/C3.html#MassachusettsElectricCompany">New England DSM Successes</a></I><BR>
</UL>
<li><A HREF = "III/B2.html#MassachusettsInstituteofTechnology">Massachusetts Institute of Technology</a><BR>
<li><A HREF = "III/B2.html#McDonald'sCorporation">McDonald's Corporation</a><BR>
<li><A HREF = "IV/D.html#MetroLink,St.Louis">MetroLink, St. Louis</a><BR>
<li><A HREF = "IV/B2b.html#MitsubishiMotors">Mitsubishi Motors</a><BR>
<li><A HREF = "III/B1.html#MobilCorporation">Mobil Corporation</a><BR>
<li><A HREF = "II/C3.html#NarragansettElectric">Narragansett Electric</a><BR>
<li>National Renewable Energy Laboratory
<UL>
	<LI><I><A HREF = "V/B.html#NationalRenewableEnergyLaboratory">Renewable Energy Has Become Reliable</a></I><BR>
	<LI><I><A HREF = "V/D1.html#NationalRenewableEnergyLaboratory">Wind Power</a></I><BR>
</UL>
<li><A HREF = "III/B2.html#NewYorkPowerAuthority">New York Power Authority</a><BR>
<li><A HREF = "III/B2.html#Nike,Inc.">Nike, Inc.</a><BR>
<li>Oak Ridge National Laboratory
<UL>
	<LI><I><A HREF = "II/D.html#OakRidgeNationalLaboratory">Federal Initiatives Continue to Spur Efficiency Successes</a></I><BR>
	<LI><I><A HREF = "IV/A4.html#OakRidgeNationalLaboratory">Materials Improvements</a></I><BR>
</UL>
<li>Pacific Gas and Electric
<UL>
	<LI><I><A HREF = "V/B.html#PacificGasandElectric">Renewable Energy Has Become Reliable</a></I><BR>
	<LI><I><A HREF = "V/D2.html#PacificGasandElectric">Photovoltaics</a></I><BR>
	<LI><I><A HREF = "V/D4.html#PacificGasandElectric">Geothermal</a></I><BR>
</UL>
<li><A HREF = "V/B.html#Pacificorp">Pacificorp</a><BR>
<li><A HREF = "III/B2.html#ParkeIndustries,Inc.">Parke Industries, Inc.</a><BR>
<li><A HREF = "III/B2.html#PennsylvaniaPower&Light">Pennsylvania Power & Light</a><BR>
<li><A HREF = "II/C2.html#PortlandEnergyOffice">Portland Energy Office</a><BR>
<li><A HREF = "III/B1.html#PotomacElectricPowerCompany">Potomac Electric Power Company</a><BR>
<li><A HREF = "II/C2.html#PugetSoundPower&Light">Puget Sound Power & Light</a><BR>
<li><A HREF = "III/A1.html#RensselaerPolytechnicInstitute">Rensselaer Polytechnic Institute</a><BR>
<li>Sacramento Municipal Utility District<BR>
<UL>
	<LI><I><A HREF = "II/C1.html#SacramentoMunicipalUtilityDistrict">California DSM Successes</a></i>
	<LI><A HREF="V/D2.html#SacramentoMunicipalUtilityDistrict"><I>Photovoltaics</I></A>
</UL>
<li>Sandia National Laboratories    <BR>
<UL>
	<LI><I><A HREF = "V/D1.html#SandiaNationalLaboratories">Wind Power</a></I><BR>
	<LI><I><A HREF = "V/D3a.html#SandiaNationalLaboratories">Parabolic Troughs</a></I><BR>
</UL>
<li><A HREF = "II/C2.html#SeattleCityLight">Seattle City Light</a><BR>
<li><A HREF = "III/B2.html#ShellOil">Shell Oil</a><BR>
<li><A HREF = "V/D2.html#SiemensSolarIndustries">Siemens Solar Industries</a><BR>
<li><A HREF = "V/D2.html#Solarex">Solarex</a><BR>
<li><A HREF = "IV/B2a.html#SolectriaCorporation">Solectria Corporation</a><BR>
<li><A HREF = "I/C.html#SouthwireCompany,The">Southwire Company, The</a><BR>
<li>Southern California Edison     <BR>
<UL>
	<LI><I><A HREF = "II/C1.html#SouthernCaliforniaEdison">California DSM Successes</a></I><BR>
	<LI><I><A HREF = "V/D3b.html#SouthernCaliforniaEdison">Central Receivers</a></I><BR>
	<LI><I><A HREF = "V/D4.html#SouthernCaliforniaEdison">Geothermal</a></I><BR>
</UL>
<li><A HREF = "Intro/C.html#StaberIndustries">Staber Industries</a><BR>
<li><A HREF = "III/C1.html#SuperEfficientRefrigeratorProgram,Inc.">Super Efficient Refrigerator Program, Inc.</a><BR>
<li><A HREF = "III/B1.html#TargetStores">Target Stores</a><BR>
<li><A HREF = "III/B2.html#TennesseeValleyAuthority">Tennessee Valley Authority</a><BR>
<li><A HREF = "I/A.html#3MCorporation">3M Corporation</a><BR>
<li><A HREF = "IV/A3.html#TotalPetroleumCompany">Total Petroleum Company</a><BR>
<li><A HREF = "V/D1.html#U.S.Windpower,Inc.">U.S. Windpower, Inc.</a><BR>
<li><A HREF = "III/B2.html#U.S.X.Corporation/U.S.SteelGroup">U.S.X. Corporation/U.S. Steel Group</a><BR>
<li><A HREF = "III/B2.html#UnitedAirlines">United Airlines</a><BR>
<li><A HREF = "III/B2.html#UniversityofCaliforniaatBerkeley">University of California at Berkeley</a><BR>
<li><A HREF = "III/A1.html#Wal-Mart">Wal-Mart</a><BR>
<li><A HREF = "II/C2.html#WashingtonPublicPowerSupplySystem">Washington Public Power Supply System</a><BR>
<li>Washington Times, The    <BR>
<UL>
	<LI><I><A HREF = "III/B1.html#WashingtonTimes,The">Building Retrofits Cut Energy Bills</a></I><BR>
	<LI><I><A HREF = "III/B2.html#WashingtonTimes,The">Lighting Retrofits</a></I><BR>
</UL>
<li><A HREF = "III/A1.html#WestBendMutualInsuranceCompany">West Bend Mutual Insurance Company</a><BR>
<li><A HREF = "II/F.html#WesternMassachusettsElectric">Western Massachusetts Electric</a><BR>
<li><A HREF = "III/C1.html#Whirlpool">Whirlpool</a><BR>
<li>Wisconsin Electric     <BR>
<UL>
	<LI><I><A HREF = "II/C5.html#WisconsinElectric">Wisconsin DSM Successes</a></I><BR>
	<LI><I><A HREF = "II/F.html#WisconsinElectric">Industrial Efficiency Services</a></I><BR>
</UL>
<li><A HREF = "III/B2.html#WorldTradeCenter">World Trade Center</a><BR>
<li><A HREF = "V/D1.html#ZondSystems,Inc.">Zond Systems, Inc.</a><BR>
</ul>


</BLOCKQUOTE>
</BODY>

<a href = "./index.html"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40">
</A>

<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-144</DOCNO>
<DOCOLDNO>IA026-000277-B024-155</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/graphics.html 198.77.86.203 19970113172308 text/html 4347
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:24:57 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4176
Last-modified: Mon, 17 Jun 1996 18:36:27 GMT
</DOCHDR>
<HTML><HEAD><TITLE>List of Available Images</TITLE></HEAD><BODY bgcolor="#FFFFFF"><BLOCKQUOTE><a href = "./index.html"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a><br clear=all><H2>List of Available Images</H2><table cellpadding=5 ><tr><td align=middle valign=top><a href="img/Bldgs-stds.gif"><img src="t/Bldgs-stds.gif"></a><p><FONT SIZE="-1">Life-Cycle Energy and Economic Benefits of Selected Appliance Standards</FONT></td><td align=middle valign=top><a href="img/Bldgs-volume.gif"><img src="t/Bldgs-volume.gif"></a><p><FONT SIZE="-1">Refrigerator Electricity Use and Volume</FONT></td><td align=middle valign=top><a href="img/ExecSum-Fig-1.gif"><img src="t/ExecSum-Fig-1.gif"></a><p><FONT SIZE="-1">Energy Efficiency: Decoupling Economic Growth from Energy Consumption</FONT></td><td align=middle valign=top><a href="img/ExecSum-Fig-2.gif"><img src="t/ExecSum-Fig-2.gif"></a><p><FONT SIZE="-1">Sources of Emissions Driving Climate Change</FONT></td></tr><tr><td align=middle valign=top><a href="img/ExecSum-Fig-3.gif"><img src="t/ExecSum-Fig-3.gif"></a><p><FONT SIZE="-1">Carbon Emission Trends</FONT></td><td align=middle valign=top><a href="img/ExecSum-Fig-4a.gif"><img src="t/ExecSum-Fig-4a.gif"></a><p><FONT SIZE="-1">New Golden Carrot Whirlpool Design Reduces Comsumer Costs...</FONT></td><td align=middle valign=top><a href="img/ExecSum-Fig-4b.gif"><img src="t/ExecSum-Fig-4b.gif"></a><p><FONT SIZE="-1">...And Carbon Emissions</FONT></td><td align=middle valign=top><a href="img/ExecSum-Fig-5.gif"><img src="t/ExecSum-Fig-5.gif"></a><p><FONT SIZE="-1">Efficient Prototype Vehicles</FONT></td></tr><tr><td align=middle valign=top><a href="img/ExecSum-Fig-6.gif"><img src="t/ExecSum-Fig-6.gif"></a><p><FONT SIZE="-1">Renewable Energy Costs are Dropping</FONT></td><td align=middle valign=top><a href="img/Ind-Exp.gif"><img src="t/Ind-Exp.gif"></a><p><FONT SIZE="-1">Energy Expenditures in Manufacturing, 1991</FONT></td><td align=middle valign=top><a href="img/Ind-manu.gif"><img src="t/Ind-manu.gif"></a><p><FONT SIZE="-1">Percentage of Manufacturing Energy Consumption by Industry</FONT></td><td align=middle valign=top><a href="img/Ind-SavingsPot.gif"><img src="t/Ind-SavingsPot.gif"></a><p><FONT SIZE="-1">High and Low Efficiency Savings Potential</FONT></td></tr><tr><td align=middle valign=top><a href="img/Renew-Pv.gif"><img src="t/Renew-Pv.gif"></a><p><FONT SIZE="-1">Photovoltaic Conversion Efficiency</FONT></td><td align=middle valign=top><a href="img/Renew-Windp.gif"><img src="t/Renew-Windp.gif"></a><p><FONT SIZE="-1">U.S. Wind energy Potential</FONT></td><td align=middle valign=top><a href="img/Tpo-VMT-a.gif"><img src="t/Tpo-VMT-a.gif"></a><p><FONT SIZE="-1">Vehicle Miles Traveled are Projected to Rise</FONT></td><td align=middle valign=top><a href="img/Tpo-VMT-b.gif"><img src="t/Tpo-VMT-b.gif"></a><p><FONT SIZE="-1">Automobile Efficiency Standards are Flat</FONT></td></tr><tr><td align=middle valign=top><a href="img/Tpo-VMT-c.gif"><img src="t/Tpo-VMT-c.gif"></a><p><FONT SIZE="-1">Thus, Gasoline Consumption is Expected to Rise</FONT></td><td align=middle valign=top><a href="img/Util-CaDSM.gif"><img src="t/Util-CaDSM.gif"></a><p><FONT SIZE="-1">Chart 6: Costs and Savings California DSM Programs</FONT></td><td align=middle valign=top><a href="img/Util-TotE.gif"><img src="t/Util-TotE.gif"></a><p><FONT SIZE="-1">U.S. Utilities' Contribution to Total Air Consumption</FONT></td><td align=middle valign=top><a href="img/Utl-NewE.gif"><img src="t/Utl-NewE.gif"></a><p><FONT SIZE="-1">Chart 7: Benefits of New England DSM Programs</FONT></td></tr></tAble></BLOCKQUOTE></BODY><a href = "./index.html"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a><br clear=all><hr><A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</a><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-145</DOCNO>
<DOCOLDNO>IA026-000277-B024-182</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/ordering.html 198.77.86.203 19970113172328 text/html 1457
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:25:33 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1286
Last-modified: Mon, 17 Jun 1996 18:29:29 GMT
</DOCHDR>
<HTML><HEAD><TITLE>Ordering this Report</TITLE></HEAD><BODY bgcolor="#FFFFFF"><a href = "./index.html"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a><br clear=all><BLOCKQUOTE><H2>Ordering this Report</H2>A printed copy of this report is available from the American Council for an Energy Efficient Economy (ACEEE).<P>Ordering information can be found on their Web site by following this link:<p><B><A HREF="http://solstice.crest.org/efficiency/aceee/pubs/e963.htm">http://solstice.crest.org/efficiency/aceee/pubs/e963.htm</A></B><p>...or you may contact them directly at:<p><B>American Council for an Energy-Efficient Economy<br>2140 Shattuck Avenue, Suite 202, Berkeley, California 94704 -- (510) 549-9914<br>1001 Connecticut Avenue, Suite 801, Washington, D.C. 20036 -- (202) 429-8873<br><A HREF="mailto:aceee@ix.netcom.com">aceee@ix.netcom.com</A></B></BLOCKQUOTE></BODY><hr><A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-146</DOCNO>
<DOCOLDNO>IA026-000277-B024-308</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/utilities/grants.html 198.77.86.203 19970113172505 text/html 29827
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:26:48 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 29655
Last-modified: Mon, 17 Jun 1996 19:28:26 GMT
</DOCHDR>

<HTML><HEAD>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>

<TITLE>"Grants in Utilities"</TITLE>
<H1>Grants in Utilities</H1>

<DL>

<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Alliance for Affordable Energy, </STRONG>New Orleans, Louisiana

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif"> 
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support an education, research, and advocacy project that will promote least-cost planning in the Deep South (Renewable and Efficient Energy Project/REEP).<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Council for an Energy-Efficient Economy, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $10,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To advise a study in Florida that will review past experience with efficiency standards and utility demand-side management (DSM) programs over the previous decade, identify electricity efficiency measures, and investigate DSM options available in Florida.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $150,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To continue demand-side management (DSM) utility work, including design of 'market transformation' programs for utility DSM; research and analysis of DSM/IRP issues; and examination potential for new supply-side efficiency.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Planning Association, </STRONG>Tallahassee, Florida

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $90,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To bring together a 'Coalition for an Energy-Efficient Florida,' with the goal of educating the environmental community, policy-makers, the media, and organizations about sound energy strategies in the state of Florida.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>California/Nevada Community 
Action Association, </STRONG>Sacramento, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $40,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To re-establish a strong presence in the regulatory process at the California PUC to ensure representation of low-income customers.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Campaign for a Prosperous Georgia, </STRONG>Atlanta, Georgia

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $35,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $80,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote large-scale utility energy efficiency programs within the state and to launch public education and organizing campaigns to support those efforts.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Center for Clean Air Policy, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote increased utility investment in energy efficiency programs. To collaborate with utilities 
in the design of effective demand-side management (DSM) programs that meet the Clean Air Act compliance plans in Ohio.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $40,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To provide expert testimony on low-income demand-side management (DSM) training for low-income advocates, to undertake technical analysis on low-income DSM, and to develop an energy end-use survey for low-income households in Ohio.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $25,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To create the regulatory and policy environment in Ohio for a transition to a sustainable energy future.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Center for Energy Efficiency and Renewable Technologies, </STRONG>Sacramento, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $45,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To supplement CEERT's work on electric utility industry restructuring models that promote 
efficiency and renewable energy.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Citizens Energy Coalition Education Fund, </STRONG>Indianapolis, Indiana

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote efficiency as an alternative to new power plant construction and as a least-cost Clean Air Act compliance strategy. To encourage comprehensive residential demand-side management (DSM) programs, and ensure that low-income DSM programs are included in utility DSM spending in the state of Indiana.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Conservation Law Foundation, </STRONG>Boston, Massachusetts

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $850,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To research new policies and regulatory models to articulate and implement a power system for New England that meets energy service needs without endangering the economy, ecosystems, or public health.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $114,500<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To supplement CLF's work building New England regulatory models that promote energy efficiency and renewable energy.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Demand-Side Management Training Institute, </STRONG>Bala Cynwyd, Pennsylvania

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $30,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To do market research to devise the best training program for DSM personnel.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Energy Conservation Association, </STRONG>Denver, Colorado

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $35,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $40,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote demand-side management and low-income energy assistance programs.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Environmental Action Foundation, </STRONG>Takoma Park, Maryland

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $14,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 9 Months<BR>
1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $80,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To work on the Tennessee Valley Authority Accountability Campaign, which will design and promote efficiency programs in the Tennessee Valley region.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Environmental Defense Fund, 
Texas Office, </STRONG>Austin, Texas

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $70,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To advocate for regulatory reform by removing disincentives to utility energy efficiency programs and to push for aggressive utility investments in efficiency.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To reform the Texas utility regulatory process with the goal of institutionalizing energy efficiency.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Environmental Law and Policy Center of the Midwest, </STRONG>Chicago, Illinois

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To launch a policy and technical-support center for a multistate Midwest energy efficiency effort. The new center will coordinate regional strategies, support state groups, and spearhead independent interventions in the six-state region surrounding the Great Lakes.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Kearns & West, Inc., </STRONG>San Francisco, California

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $15,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 4 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To conduct a market research study with electric and gas utilities to determine the level of support and acceptable costs for Lawrence Berkeley Livermore's DEEP project.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Land and Water Fund of the Rockies, </STRONG>Boulder, Colorado

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $225,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote utility regulatory reform before state utility commissions in Colorado, New Mexico, Utah, Arizona, and Nevada, and to promote better implementation of Western Area Power Administration's (WAPA) statutory responsibilities regarding energy efficiency and renewable energy.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $15,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support work on a sustainable energy plan for the Rocky Mountain area.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Latino Issues Forum, </STRONG>San Francisco, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $8,500<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop an educational and participation program in the electric industry deregulation process for low-income constituents.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Legal Environmental Assistance Foundation, </STRONG>Tallahassee, Florida

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $275,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the Energy Advocacy Program, which works to move Florida utilities toward major investments in energy efficiency.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Michigan United Conservation Clubs, </STRONG>Lansing, Michigan

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $120,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To analyze utility plans and build an alternative scenario with increased efficiency that offers lower economic and environmental costs for rate-payers in Michigan.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $75,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support integrated resource planning and demand-side management in Michigan.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Mid-Atlantic Energy Efficiency Project, </STRONG>Newark, New Jersey

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote regulatory changes that encourage energy efficiency in the Mid-Atlantic region, particularly in New Jersey and Pennsylvania.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>National Association of State Utility Consumer Advocates, </STRONG>Washington, D.C.

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $21,295<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To investigate the opportunities for a grant from the U.S. Department of Energy to conduct policy research on electricity issues.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>National Conference of State Legislatures, </STRONG>Denver, Colorado

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $37,500<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 18 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To provide customized, on-site training on energy efficiency and renewable energy to state legislators and their staffs.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>National Consumer Law Center, </STRONG>Boston, Massachusetts

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $75,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $80,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To build the baseline of knowledge of the low-income/equity concerns surrounding the utility regulatory-reform agenda.  The assistance would include legal and technical support for low-income groups to prepare materials for regulatory proceedings as well as strategic advice for such groups.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $5,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To fund expenses for DSM advocates to attend the Low-Income DSM Advocates Retreat.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Natural Resources Defense Council, </STRONG>San Francisco, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $850,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote regulations and market mechanisms that make a utility's least-cost mix of resources its most profitable course of action.

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $33,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To upgrade NRDC's obsolete computer system.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Northwest Conservation Act Coalition, </STRONG>Seattle, Washington

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $250,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To expand its promotion of regulations that make efficiency profitable in the Pacific Northwest.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Ohio Environmental Council, </STRONG>Columbus, Ohio

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $125,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To create the regulatory and policy environment within Ohio to make a transition to a sustainable energy future.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Opportunity Council, </STRONG>Bellingham, Washington

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $15,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To participate in the Puget Power collaborative to ensure that low-income concerns are represented.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Pace University, School of Law, Center for Environmental Legal Studies, </STRONG>White Plains, New York

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $525,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To continue work in utility efficiency in New York and Florida.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Policy Initiatives Group, </STRONG>Portland, Oregon

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $13,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To ensure that energy efficiency and renewable energy concerns are addressed in Bonneville Power Authority's long-term power sales negotiations.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Regulatory Assistance Project, </STRONG>Gardiner, Maine

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $39,886<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To assist state legislators in understanding the value of electric utility development of energy conservation and renewable resources and the threat posed to development of these resources by legislation permitting retail wheeling.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $259,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To educate public utility commissioners about integrated resource planning, energy efficiency, and renewable energy.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Safe Energy Communication Council, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $28,200<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To conduct energy-outreach tours with a utility executive to communicate examples of utility success stories to other utility executives, policy-makers, politicians, and the press.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Southern Environmental Law Center, </STRONG>Charlottesville, Virginia

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote the regulatory-reform model in the Southern region-Virginia, North Carolina, South Carolina, Alabama, Georgia, and Tennessee-in order to promote utility investments in energy efficiency.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $75,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To improve the efficiency with which electricity is used in the Southeast by promoting greater utility reliance on energy efficiency.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $275,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote utility energy efficiency programs in Georgia, Virginia, and North Carolina, and broaden the coalition pushing for energy- efficiency regulations.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Spokane Neighborhood Action Programs, </STRONG>Spokane, Washington

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $15,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To write and distribute an Energy Advocates' Handbook for environmentalists and consumers interested in affecting Pacific Northwest energy policy.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Tennessee Valley Energy Reform Coalition, </STRONG>Nashville, Tennessee

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $11,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 9 Months<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $20,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To work on the Tennessee Valley Authority Accountability Campaign, which will design and promote efficiency programs in the Tennessee Valley region.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $13,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To provide for management consultant assistance to discuss TVERC management and strategies.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Texas Citizen Fund, </STRONG>Austin, Texas

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $110,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 18 Months<BR>
1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To build jointly a 'Texas Energy Coalition' that educates the environmental community, policy-makers, the media, and others about the advantages of energy efficiency for Texas.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Texas Legal Services Center, </STRONG>Austin, Texas

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $35,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $40,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To organize statewide forums on energy conservation and address the needs of low-income customers in Texas.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Texas Ratepayers Organization to Save Energy (R.O.S.E.), </STRONG>Austin, Texas

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $11,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To cover start-up costs for Texas R.O.S.E., an organization that will encourage energy conservation and efficiency in Texas through interventions, policy analysis, and consumer education.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Tides Foundation, </STRONG>San Francisco, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $120,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To form partnerships between companies and utilities to enhance competitiveness while reducing energy use.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $103,050<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To launch a media and public education campaign to protect environmental and consumer interests in electric utility restructuring.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>University of Texas at Austin, Center for Energy Studies, </STRONG>Austin, Texas

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $25,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To study the technical and achievable potential of residential, commercial, and industrial energy efficiency in Texas.<P>
</dl>
<A HREF="index.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Programs</B></A>


</BODY>
</BLOCKQUOTE>
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-147</DOCNO>
<DOCOLDNO>IA026-000276-B035-229</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/guidelines.html 198.77.86.203 19970113171542 text/html 5272
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:17:41 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 5101
Last-modified: Mon, 17 Jun 1996 20:19:53 GMT
</DOCHDR>
<HTML><HEAD><TITLE>General Application Information</TITLE></HEAD><BODY bgcolor="#FFFFFF"><a href = "./index.html"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a><br clear=all>     <H1>     General Application Information</H1><hr><BLOCKQUOTE><H3>What Are the Limitations on Foundation Grants?</H3><ul>    <li>   The foundation makes grants to nonprofit charitable organizations classified as 501(c)(3) public charities by the Internal       Revenue Service. The foundation does not support individuals or for-profit organizations.    <li>   The foundation does not support local projects, unless they have been consciously designed for further replication or have broad       regional or national implications. The foundation's geographic focus is the United States, with special emphasis on regional initiatives.    <li>   The foundation does not make grants intended to support candidates for political office, to influence legislation, or to support        sectarian or religious purposes.    <li>   The foundation does not fund the research and development of technology (e.g., funds to develop hybrid automobiles or       commercialization of an invention).    <li>   The foundation does not fund demonstration projects (e.g., model solar homes).    <li>   The foundation does not fund community energy projects.    <li>   The foundation does not fund endowments or debt reduction, nor does it make general-support grants. The foundation does      not support annual fund-raising campaigns or capital construction. The foundation does not support the planning,       renovation, maintenance, retrofit, or purchase of buildings; the purchase of equipment; or the acquisition of land, even if the      intent is to save energy.</ul><H3>How to Apply for a Grant</H3>    Because the foundation's funding priorities are specialized, we recommend that all applicants carefully review these guidelines. If    you are not sure whether your project fits the guidelines, we encourage you to write a brief letter of inquiry describing the project,    its purpose, and the amount you are requesting. We will notify you if a full proposal is warranted.     If you are confident that your project fits within the guidelines, we do not require a letter of inquiry. Please send us the applica-     tion form (last page), one copy of your proposal, and the supporting documents listed below.<H3>The Proposal</H3>     We have no fixed format for proposals. Use the form that best conveys the strengths of your project.     In general, a complete proposal includes the following:<ul>    <li>   the attached application form as a cover sheet    <li>   a clear statement of the need(s) or problem(s) to be addressed    <li>   target decision-maker(s)    <li>   strategy    <li>   timeline    <li>   results you expect from your project    <li>   project budget - including a brief explanation of the budget, a list of other sources of actual and potential funding for the            project, and a description of plans to secure additional funding    <li>   how you will determine whether your project is successful    <li>   history of organization, including mission and goals</ul><H3>Supporting Documents</H3>    To consider a proposal for funding, we need the following documents:<ul>    <li>   organization budget    <li>   most recent audited financial statements    <li>   IRS letter certifying tax-exempt status    <li>   current annual report    <li>   list of board of directors and officers    <li>   resumes of key personnel involved in project</ul><H3>Deadlines</H3>    The foundation's Board of Directors meets three times a year (the first week of March, the last week of June, and the first week of    November). We accept proposals on a continuous basis. There are no specific deadlines. However, in order to consider a proposal    for inclusion in a specific docket, we need to receive proposals approximately twelve weeks in advance of the next board     meeting. Please keep in mind that it takes approximately four weeks to review proposals and inquiries and to contact you with a    response. <H3>For More Information Contact:</H3>     The Energy Foundation<br>       Presidio Building 1012, 2nd Floor, Torney Avenue<br>       P.O. Box 29905<br>       San Francisco, CA 94129-0905<br>       (415) 561-6700 (telephone)<br>       (415) 561-6709 (fax)<br>       <A HREF="mailto:energyfund@ef.org">energyfund@ef.org</A> (e-mail)<br>       <A HREF="http://www.ef.org/">http://www.ef.org/</A> (web page)<br></BLOCKQUOTE><a href = "./index.html"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a><br clear=all><hr><A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-148</DOCNO>
<DOCOLDNO>IA026-000276-B035-255</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/application.html 198.77.86.203 19970113171600 text/html 2430
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:18:03 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2259
Last-modified: Mon, 17 Jun 1996 20:19:40 GMT
</DOCHDR>
<HTML><HEAD><TITLE>Application Form</TITLE></HEAD><BODY bgcolor="#FFFFFF"><a href = "./index.html"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a><br clear=all><table><tr><td valign=top width=400><H1><I>Application Form</I></H1><I>Please print out, complete and submit this form<br>with your proposal and supporting documents.</I></td> <td><FONT SIZE="-1">     The Energy Foundation<br>       Presidio Building 1012, 2nd Floor, Torney Avenue<br>       P.O. Box 29905<br>       San Francisco, CA 94129-0905<br>       (415) 561-6700 (telephone)<br>       (415) 561-6709 (fax)<br>       <A HREF="mailto:energyfund@ef.org">energyfund@ef.org</A> (e-mail)<br>       <A HREF="http://www.ef.org/">http://www.ef.org/</A> (web page)<br></FONT></td> </tr> </table>Date of Application:<hr>Organization:<hr>Address:<hr>Telephone:<hr>Fax:<hr>E-mail:<hr>Date of Incorporation (Month/Year):<hr><form>Tax Status:  <INPUT TYPE="checkbox">501(c)(3)<INPUT TYPE="checkbox">Other</form>Primary Contact Person:<hr>Title:<hr>Telephone:<hr>Fax:<hr>Total organization budget:<hr>Total project budget:<hr>Amount requested from the Energy Foundation:<hr>For what duration:<hr><TABLE><tr> <td width=400 valign=top> Other sources of funding for the project:<br><br><br><br><br><br><br><br></td> <td rowspan=2 valign=top> <FORM ACTION="" METHOD=POST>Sector (please check)<br><INPUT TYPE="checkbox">Utilities<br><INPUT TYPE="checkbox">Transportation<br><INPUT TYPE="checkbox">Buildings<br><INPUT TYPE="checkbox">Renewable Energy<br><INPUT TYPE="checkbox">Integrated Issues<br></FORM></td> </tr><tr> <td width=400 valign=top>  Other proposals pending; with whom:<br><br><br><br><br><br><br><br></td> </tr> </TABLE><a href = "./index.html"><img align=right border=0 src="../grf/up.gif" alt = "[ Up ]"></a><br clear=all></BODY><hr><A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A><p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-149</DOCNO>
<DOCOLDNO>IA026-000277-B025-22</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/buildings/grants.html 198.77.86.203 19970113172536 text/html 10858
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:27:38 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 10686
Last-modified: Mon, 17 Jun 1996 19:28:47 GMT
</DOCHDR>

<HTML><HEAD>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>

<TITLE>"Grants in Buildings"</TITLE>
<H1>Grants in Buildings</H1>
<DL>

<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Alliance to Save Energy,</STRONG> Washington, D.C.

<DD><EM>1994 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $215,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To continue work on residential building codes and coordinate with NDRC and ACEEE on refining codes, pushing for state adoption, and improving code compliances.<BR>

<EM>1994 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $200,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the Building Codes Assistance Project.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote residential energy-efficiency financing mechanisms.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Council for an Energy-Efficient Economy, </STRONG>Washington, D.C.

<DD><EM>1994 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $208,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To continue ACEEE's program to increase equipment efficiency and to work on building codes.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Institute of Architects/ Association of Collegiate Schools of Architecture,</STRONG> Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To produce and distribute An Architect's Guide To Energy Conserving Products and Systems. By providing a one-stop guide to efficient products, this catalog will reduce the information gap facing architects who want to improve building energy performance.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Society of Heating, Refrigerating, and Air Conditioning Engineers, </STRONG>Atlanta, Georgia

<DD><EM>
1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To accelerate adoption of new residential energy conservation standards by states and model code agencies and to educate users in implementation of the standard, ASHRAE 90.2.<P>



<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Citizens Conservation Corporation, </STRONG>
Boston, Massachusetts

<DD><EM>1992 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $43,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $40,000 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $37,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To educate members of public-housing authorities, which pay an annual public utility bill of $1.3 billion, about the new Housing and Urban Development regulations that provide incentives for energy efficiency. To build a coalition to advocate for the purchase of energy-efficient appliances and equipment for public housing.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Eley Associates, </STRONG>San Francisco, California

<DD><EM>1994 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $15,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support energy performance contracting for city of Oakland administration buildings.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Energy Rated Homes of America, </STRONG>Little Rock, Arkansas

<DD><EM>1992 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $5,000 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 9 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">
To support a national conference on Home Energy Rating Systems and Energy-Efficient Mortgages.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Golden Gate National Park Association, </STRONG>San Francisco, California

<DD><EM>1992 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a least-cost energy plan for the San Francisco-based Presidio, which would be used to direct infrastructure investment. Using the results of the Presidio to produce a report for federal facilities managers on energy-efficiency upgrades.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Green Seal, </STRONG>Washington, D.C.

<DD><EM>1992 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1994 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop standards for lighting products, windows and other building products, and major appliances, which would allow consumers to make informed choices about the energy and environmental impacts of products.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Home Energy Ratings of Ohio Foundation, </STRONG>Columbus, Ohio

<DD><EM>1994 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $10,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Weeks</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a conference on residential energy- efficiency services.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Montana Environmental Information Center, </STRONG>Helena, Montana

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $2,520<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To participate in a collaborative effort on energy building codes in Montana that would produce a new building code for the state.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Natural Resources Defense Council, </STRONG>San Francisco, California

<DD><EM>1994 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $208,000 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To continue to work for the adoption of energy-efficient codes for appliances and buildings.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Pace University, School of Law, Center for Environmental Legal Studies, </STRONG>White Plains, New York

<DD><EM>1992 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $2,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote energy-efficient new construction in the rebuilding of South Florida's homes and businesses after Hurricane Andrew.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Rocky Mountain Institute, </STRONG>Snowmass, Colorado

<DD><EM>1992 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $44,275<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994  <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To implement a pilot project to encourage real estate investors to pursue energy efficiency in commercial buildings.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>University of California at Berkeley, Department of Architecture, </STRONG>Berkeley, California

<DD><EM>1992 <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $338,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1994  <IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $351,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop a curriculum of resource modules and case studies on energy-efficient and environmentally responsible design, called the Vital Signs Curriculum Materials Project, for undergraduate and graduate students majoring in architecture.<P>

</DL>

<A HREF="index.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Programs</B></A>



</BODY>
</BLOCKQUOTE>
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-150</DOCNO>
<DOCOLDNO>IA026-000277-B025-70</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/transport/grants.html 198.77.86.203 19970113172555 text/html 38868
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:27:53 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 38696
Last-modified: Mon, 17 Jun 1996 19:28:17 GMT
</DOCHDR>

<HTML><HEAD>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>

<TITLE>"Grants in Transportation"</TITLE>
<H1>Grants in Transportation</H1>
<DL>

<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>1000 Friends of Florida, </STRONG>Tallahassee, Florida

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote transportation reform work in Florida.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>1000 Friends of Oregon, </STRONG>Portland, Oregon

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $110,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $200,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $220,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To build an integrated land-use/transportation model for the Portland area that can demonstrate sound land-use alternatives to a proposed $200 million bypass freeway. To further develop key aspects of the integrated land-use/transportation/ air-quality model.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $37,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To conduct a public information and education program to promote public involvement in Portland Metro's ''Region 2040,'' a Portland regional growth planning project concerning transportation, air quality, water quality, and green spaces.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>20/20 Vision Education Fund, </STRONG>Washington, D.C.

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $8,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To run a short-term citizen campaign in Pennsylvania and Connecticut for adoption of the California Low Emission Vehicle plan in the Northeast.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>AeroVironment, Inc., </STRONG>Monrovia, California

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $25,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To hold a workshop called ''Jumpstart'' focused on the niche opportunities for small electric vehicles.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Alaska Center for the Environment, </STRONG>Anchorage, Alaska

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $60,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote alternative and efficient transportation in Alaska.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Alaska Conservation Foundation, </STRONG>Anchorage, Alaska

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $25,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To address the tremendous influx of ISTEA funds into Alaska, which may be used to open wild lands to logging and mining rather than solving transportation problems.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Academy of Arts and Sciences, </STRONG>Cambridge, Massachusetts

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To convene a working group of academics, business people, government officials, and advocates to
consider the future of urban transportation. The group will make broad policy recommendations
to make the automobile more compatible with other social goals, and will consider land-use and urban-planning options to reduce auto dependence.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a seminar series on land-use strategies.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Council for an Energy-Efficient Economy, </STRONG>Washington, D.C.

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $205,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To work toward increasing vehicle fuel efficiency through both ''command and control'' and market incentives, to examine methods to reduce carbon dioxide emissions, and to produce technical reports on vehicle technology.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Lung Association, </STRONG>Washington, D.C.

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To form a coalition to promote the adoption of the California Low Emission Vehicle regulations in other states.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $41,200<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a media campaign on the Ozone Transport Commission's position on the proposed Low Emission Vehicle regulations.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Lung Association of California, </STRONG>Redondo Beach, California<BR>

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To analyze proposals from the South Coast Air Quality Management District, produce a manual on clean air for the 18 California American Lung Association chapters, and support outreach efforts within the community of health professionals.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote work on sound transportation policy and clean air issues in the Los Angeles area.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Arizona Center for Law in the Public Interest, </STRONG>Tucson, Arizona

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $75,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote transportation alternatives for Phoenix that reduce vehicle miles traveled and comply with environmental mandates.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Audubon Society of Portland, </STRONG>Portland, Oregon

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $13,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To conduct a public information and education program to promote public involvement in Portland Metro's ''Region 2040,'' a Portland regional growth planning project concerning transportation, air quality, and land use.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Bicycle Federation of America, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To build a national, regional, and technical base to make bicycle and pedestrian facilities a more integral part of state and metropolitan transportation plans. The grant will also support smaller grants to local groups working on these issues.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Business and Professional People for the Public Interest, </STRONG>Chicago, Illinois

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $105,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $175,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop a coalition of local organizations that will push transportation policy-makers to integrate air-quality concerns into transportation plans and to evaluate state transportation proposals.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>CALPIRG Charitable Trust, </STRONG>Santa Barbara, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $35,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a public education campaign to garner support for the Zero Emission Vehicle mandate.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Calthorpe Associates, </STRONG>San Francisco, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 18 Months</EM><BR>
<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To hold a meeting to build consensus around new planning principles for the reduction of suburban sprawl and the promotion of infill development.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Center for Auto Safety, </STRONG>Washington, D.C.

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support research on fuel efficiency and economic incentives and to be a participant in the Clinton administration's Climate Action Roundtable to take place in 1994.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Center for Neighborhood Technology, </STRONG>Chicago, Illinois

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $150,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote the Sustainable Transportation Program to provide clean, equitable mobility of Chicagoans within the city and region, and to minimize transportation needs by promoting investments that strengthen the inner city and create local jobs, amenities and services.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Citizens Fund, </STRONG>Washington, D.C.

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $26,500
Duration: 7 Months</EM><BR>
<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote alternative forms of transportation at the state and local level in Georgia.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop a diverse coalition capable of combining research, policy analysis, public education, constituency-building, and public participation to impact regional and state transportation issues.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Clean Air Council, </STRONG>Philadelphia, Pennsylvania

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To provide direct assistance, educational forums, and educational materials for the public and policy- makers on the connection between transportation and energy in order to steer federal highway funds toward public transit.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Colorado Public Interest ,</STRONG>Research Foundation
Denver, Colorado

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $40,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote transportation reform in the Denver area to reduce projected increase of vehicle miles traveled and promote alternative transportation modes.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Conservation Law Foundation, </STRONG>Boston, Massachusetts

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $275,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote policies that better reflect an understanding of the costs associated with various modes of transportation.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Earth Island Institute, </STRONG>San Francisco, California

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $5,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote transportation/land-use planning research on the field of energy policy as it affects low-income citizens and communities of color.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To create a socially just and ecologically sustainable transportation plan for developing the Bayshore Corridor in the Bayview/Hunters Point District in San Francisco.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Energy Conservation Coalition, </STRONG>Takoma Park, Maryland

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $8,550<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To convene a strategic planning retreat for transportation advocates to determine their 1992 agenda.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Environmental Defense Fund, </STRONG>New York, New York

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $417,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To strengthen the administration of the Clean Air Act Amendment and ISTEA at federal and regional (N.Y., N.J., Conn.) levels.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $8,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To analyze data affecting the LEV/ZEV program in New York State.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the Transportation Legal Task Force.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $120,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support work on Intelligent Vehicle Highway Systems emphasizing sustainable transportation and community systems.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Environmental Law and Policy Center of the Midwest, </STRONG>Chicago, Illinois

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $150,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To analyze the potential of a Midwest Highspeed Rail Network Project from an environment and energy perspective and to advocate for highspeed rail where it is justified.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $12,500<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop a set of guidelines for an accelerated retirement-of-vehicles program.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Georgia Citizens Fund, </STRONG>Atlanta, Georgia

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $150,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the Georgia Transportation Alliance to combine research, policy development, public education, constituency building, and public participation to impact the regional and state transportation planning process.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Institute for Transportation and the Environment, </STRONG>Seattle, Washington

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $20,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop a least-cost transportation planning model and apply it to the Puget Sound regional transit system.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>International Institute for Energy Conservation, </STRONG>Washington, D.C.

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop an integrated transportation planning framework.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Island Press, </STRONG>Washington, D.C.

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $15,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To market and distribute ''At Road's End: Transportation and Land-Use Choices for Communities.''<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Local Government Commission, </STRONG>Sacramento, California

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $23,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the newsletter Livable Places Update; to hold a conference covering the benefits of mixed-use development, existing mixed-use growth, and pedestrian- and transit-oriented land-use planning; and to stimulate local government effort in the Los Angeles Basin toward land-use planning strategies that will reduce dependence on the automobile.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To establish a ''Center for Resource-Efficient Land Use'' with a target group of those who have direct responsibility for making land-use decisions.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>MIT Solar Electric Vehicle Club, </STRONG>Cambridge, Massachusetts

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $25,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote educational programs and conduct research on fuel cells in automobiles.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>National Academy of Sciences, </STRONG>Washington, D.C.

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To conduct research on sustainable transportation to facilitate a better understanding of the goals that should be driving research and policy directions.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>National Audubon Society, </STRONG>Sacramento, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $20,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To conduct a campaign to promote widespread support of the Zero Emission Vehicle mandate.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Natural Resources Council of Maine, </STRONG>Augusta, Maine

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To devise a transportation plan within a collaborative rule-making process that gives preference to the least-cost and least-polluting options that meet Maine's transportation needs.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Natural Resources Defense Council, </STRONG>San Francisco, California

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $15,500<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To study the effects of a mandated increase in fuel efficiency on American automobile manufacturers and to assess alternatives.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $328,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To continue work to increase vehicle fuel efficiency, protect the Zero Emission Vehicle mandate in California, and press for transportation reform in the Los Angeles Basin.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $10,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To host a National Strategy Meeting to devise an action plan for clean air, transportation, and energy issues in the coming year.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>NESCAUM Air Quality Foundation for Assessment, Research, and Education, </STRONG>Boston, Massachusetts

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $30,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To bring together stakeholders in the Northeast in support of market-based initiatives to reduce pollution due to transportation.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Northeast Alternative Vehicle Consortium, </STRONG>Boston, Massachusetts

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $20,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To provide NAVC and its constituents with strategic policy and technical assistance to support a desirable conclusion to the U.S. EPA proceedings on the Ozone Transport Commission's Low Emission Vehicle recommendation.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Northeast Sustainable Energy Association, </STRONG>Greenfield, Massachusetts

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $3,500<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a Northeast Zero Emission Vehicle public education campaign.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Oregon Environmental Council, </STRONG>Portland, Oregon

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $40,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To implement congestion pricing policies, already adopted in principle by the city of Portland.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>QLF/Atlantic Center for the Environment, </STRONG>Montpelier, Vermont

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $5,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop, publish, and distribute policy recommendations of the Northeast Cold Climate Electric Vehicle Management Program.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Rails to Trails Conservancy, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $200,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote energy-efficient transportation in federal transportation policies and to promote innovations in the Transportation Research Board.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Rocky Mountain Institute, </STRONG>Snowmass, Colorado

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the economic and cultural analysis needed to promote advanced transportation.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Sensible Transportation Options for People, </STRONG>Tigard, Oregon

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the Decision Empowerment Campaign to conduct outreach and education to foster the region-wide debate about the Western Bypass freeway around Portland and the lutraq alternative.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Sierra Club Foundation, </STRONG>San Francisco, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a fuel-efficiency campaign coordinated with the Clinton administration's Climate Action Roundtable.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Sierra Club Legal Defense Fund, </STRONG>San Francisco, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $225,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To work on federal Clean Air Act conformity regulations and to ensure their enforcement at the local level.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Surface Transportation Policy Project, </STRONG>Washington, D.C. 

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $225,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $125,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To assist state planners to use federal money for less polluting and less energy-intensive modes of transport.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $20,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support training for grassroots transportation reform advocates.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Tides Foundation/Capital Forum Account, </STRONG>San Francisco, California

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $6,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To organize a conference to support California's Zero Emission Vehicle mandate.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $26,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a public awareness campaign about the Zero Emission Vehicle mandate that also addresses the concerns of community-based organizations.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Transportation Alternatives, </STRONG>New York, New York

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $11,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To print and distribute the Bicycle Blueprint: Making Cycling a Mainstream Transportation Option in New York City.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Transportation Legal Task Force, </STRONG>(c/o Environmental Defense Fund)
New York, New York

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To launch a national strategy to build the legal precedents and evidentiary record for transportation reform and take on cases in several cities to establish the practice under the Clean Air Act amendments. This is a joint project of Environmental Defense Fund, the Natural Resources Defense Council, the Sierra Club Legal Defense Fund, and the Conservation Law Foundation.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Tri-State Transportation Campaign (c/o New York Community Trust), </STRONG>
New York, New York

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $400,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $20,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a regionwide campaign to redirect federal and state dollars from the expansion of highways to more community friendly and enviro-nmentally sound transportation initiatives. This grant is made up of smaller grants to local groups.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Union of Concerned Scientists, </STRONG>Cambridge, Massachusetts

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support an analysis of policies for promoting clean, efficient vehicle technologies and fuels, and market-based incentives that reduce vehicle miles traveled.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>University of California at Davis, </STRONG>Davis, California

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $135,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support an in-residence transportation fellowship program and a short course for professionals on the relationship between transportation, energy, and the environment.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>University of Maryland, </STRONG>College Park, Maryland

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $10,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To advise the Energy Development Council on a transportation efficiency study.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>University of Pennsylvania, </STRONG>Philadelphia, Pennsylvania

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $85,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To launch an analysis of urban transportation policies in the U.S. with a comparison with countries that have demonstrated success with innovative policies, and to specify several measures and actions to build better transportation systems.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>WalkBoston, </STRONG>Boston, Massachusetts

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $20,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To ensure that the final design of the Boston Central Artery/Tunnel incorporates safe pedestrian corridors.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>World Resources Institute, </STRONG>Washington, D.C.

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $10,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To release a video that addresses misapprehensions that prejudice consumers against electric vehicles.<P>
</dl>
<A HREF="index.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Programs</B></A>


</BODY>
</BLOCKQUOTE>
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-151</DOCNO>
<DOCOLDNO>IA026-000277-B026-202</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/renew/grants.html 198.77.86.203 19970113173150 text/html 12301
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:33:39 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 12129
Last-modified: Mon, 17 Jun 1996 19:28:33 GMT
</DOCHDR>

<HTML><HEAD>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>

<TITLE>"Grants in Renewable Energy"</TITLE>
<H1>Grants in Renewable Energy</H1>

<DL>

<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Center for Resource Management, </STRONG>Salt Lake City, Utah

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To convene a conference of utility executives, government officials, and advocates with the goal of finding common ground on general development principles for renewable energy.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Center for Energy Efficiency and Renewable Technologies Research
and Education Fund, </STRONG>Sacramento, California

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To continue regulatory intervention to push renewable energy in California; export strategies to Nevada, Arizona, and Utah; and help educate renewable energy campaigns in Texas, the Southwest, the Pacific Northwest, the Upper Midwest, and New England.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Conservation Law Foundation, </STRONG>Boston, Massachusetts

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $18,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop a more focused advocacy effort to advance renewable energy in New England.<BR>

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $144,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To investigate the potential for a joint New England sustainable-energy campaign.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Environmental Defense FundTexas, </STRONG>Austin, Texas

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $200,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To expand the use of renewable energy in Texas through legal advocacy.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Izaak Walton League of America, </STRONG>Minneapolis, Minnesota

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $6,400<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To evaluate the political, strategic, and technical opportunities and obstacles to advancing wind energy and other renewables in the Great Plains.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Land and Water Fund of the Rockies, </STRONG>Boulder, Colorado</STRONG>

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $25,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 9 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote education on energy and environmental externalities; to mobilize organizations in New Mexico for involvement in public-service commission hearings; and to promote conversion of Southwestern coal-fired plants to natural gas/solar hybrids.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $150,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To build the legal and technical arguments for renewables in the Southwest and push those arguments in various utility forums. To prepare a renewable vision that lays out the region's potential and the policies to achieve it, and use the vision to begin organizing a political constituency for renewable energy.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Mainewatch, </STRONG>Hallowell, Maine

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $25,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To analyze the technical and economic impact of the renewable energy industry in New England, with special attention to renewable development job creation.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Minnesotans for an Energy-Efficient Economy, </STRONG>Minneapolis, Minnesota

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $140,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote renewable energy in Minnesota as part of the Upper Midwest Campaign.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Natural Resources Defense Council, </STRONG>San Francisco, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $212,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To work for the acquisition of new renewable energy resources in New York, California, and the Pacific Northwest.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Northwest Conservation Act Coalition, </STRONG>Seattle, Washington

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop legal and technical arguments for renewable energy and, through the Renewable Northwest Project, promote them in utility and regional planning forums.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Princeton University, Center for Energy and Environmental Studies, </STRONG>Princeton, New Jersey

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $275,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To research key questions about substantially expanded wind energy; to determine how integrating different renewable energy technologies can overcome problems of intermittency; to examine the merits of biogas gasifier/turbine combinations; and to examine different hydrogen and fuel-cell strategies for transportation.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>
Regional Renewable Energy Project, </STRONG>Portland, Oregon

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $17,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 18 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To educate environmental and public interest groups in the Pacific Northwest about the state of renewable energy technology and its potential in the PNW.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Safe Energy Communication Council, </STRONG>Washington, D.C.

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $58,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To launch Phase II of SECC education and outreach project.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Texas Citizen Fund, </STRONG>Austin, Texas

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To build a constituency to advance renewable energy in Texas.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Union of Concerned Scientists, </STRONG>Cambridge, Massachusetts

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $442,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To encourage development of renewable sources of energy on a large scale through technical analyses; strengthening regional, state, and local organizations; and work to expand the federal role in renewable energy commercialization.<BR>

1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $156,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To investigate the potential for a joint New England sustainable energy campaign.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>University of Maryland at College Park, Center for Global Change, </STRONG>College Park, Maryland

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $40,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop a strategic business plan for a renewable energy policy center.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Wisconsin Public Utility Institute, </STRONG>Madison, Wisconsin

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $10,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To convene a Sustainable Biomass Energy Workshop that would bring together stake-holders in Wisconsin to evaluate a biomass energy future for the state.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Wisconsin's Environmental Decade, </STRONG>Madison, Wisconsin

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $60,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To develop a 'Green Energy Plan,' which is part of the DSM/renewables strategy in the Midwest.
</dl>
<A HREF="index.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Programs</B></A>


</BODY>
</BLOCKQUOTE>
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-152</DOCNO>
<DOCOLDNO>IA026-000277-B026-250</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/grants/integrated/grants.html 198.77.86.203 19970113173254 text/html 14993
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:34:48 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 14821
Last-modified: Mon, 17 Jun 1996 19:43:24 GMT
</DOCHDR>

<HTML><HEAD>
</HEAD>
<BODY bgcolor="#FFFFFF">
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all><BLOCKQUOTE>


<TITLE>"Grants in Integrated Issues"</TITLE>
<H1>Grants in Integrated Issues</H1>

<DL>

<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Alliance to Save Energy, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $125,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To examine the energy implications of federal and state tax codes that determine how energy-efficiency and renewable energy investments fare; and to recommend an energy tax package to further economic, security, environmental, and equity goals.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $14,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To conduct a national telephone poll on opinions about current and future energy policy in the U.S.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $595,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support full implementation of the Energy Policy Act, educate policy-makers about the impact of federal policy choices, reform federal energy subsidies, and evaluate federal energy tax options.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif">
<STRONG>Alliance to Save Energy/President's Commission on Environmental Quality, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $25,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the energy-efficiency implementation activities of the President's Commission on Environmental Quality.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>American Council for an Energy-Efficient Economy, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $12,500<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To analyze the job impacts of investing in energy efficiency and renewable technologies. A special focus is on the job impacts of increased Corporate Average Fuel Economy (CAFE) standards.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $150,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote industrial technologies and process innovations that increase energy efficiency and reduce emissions in an economically attractive way.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $170,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To create an Energy Efficiency and Economic Development Program to research economic and employment opportunities associated with energy- efficiency initiatives.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Earth Island Institute, </STRONG>San Francisco, California

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $24,290<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 9 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To prepare and disseminate a policy-makers' guide on the findings, methodology, and limitations of more than a dozen major studies on the costs of reducing fossil carbon emissions. The report will emphasize practical options for governments.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $100,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the Social and Ecological Justice Transportation Improvement Project to address transportation issues in the region.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Environmental Action Foundation, </STRONG>Takoma Park, Maryland

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $55,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the Energy and Equity Roundtable.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Environmental and Energy Study Institute, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $30,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the 'Congressional Environmental Leadership Initiative' to educate the 1993 Congress about environmental priorities and innovative policies that can protect the environment and spur the economy.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Friends of the Earth, </STRONG>Washington, D.C.

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $5,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 6 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote environmental tax reform in Minnesota.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $85,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To do research and educate the public on green-tax options in Minnesota.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Maryland Energy Administration, </STRONG>Annapolis, Maryland

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $5,600<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 3 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a conference titled 'Financing Energy Conservation' for county and municipal officials interested in funding local energy-conservation projects.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>New York University, Stern School of Business, </STRONG>New York, New York

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year<BR>
1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To fund a series of teaching materials on energy, sustainable ecology, and the economy for business school students.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Northeast-Midwest Institute, </STRONG>Washington, D.C.

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $150,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To promote energy efficiency in industry.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>On the Ground, </STRONG>Berkeley, California

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $21,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To build circulation for On the Ground.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Open Space Institute, </STRONG>New York, New York

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support the Energy Task Force to develop a long-term energy policy plan for the Clinton administration.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Pace University School of Law, Center for Environmental Legal Studies, </STRONG>White Plains, New York

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $75,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To carry out an analysis of the potential of carbon taxes in the state of New York.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Public Citizen, </STRONG>Washington, D.C.

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $2,822<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To print additional copies of 'A Sustainable Energy Blueprint,' 'The Sustainable Energy Budget,' and 'A Sustainable Energy Blueprint: A National Opinion Poll.'<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Sierra Club Foundation, </STRONG>San Francisco, California

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $8,800<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To convene a conference on state-level Clean Air Act implementation programs.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Tellus Institute/Boston, Massachusetts, </STRONG>

<DD><EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $75,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To update and publish 'America's Energy Choices II.'<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Tides Foundation/Capital Forum Account, </STRONG>San Francisco, California

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $25,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To organize a conference that brings together business, government, and environmental leaders to explore market incentives and environmental protection in the energy and air-quality fields.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a campaign to increase support for energy efficiency and renewable energy.<BR>

<EM>1994<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $13,500<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 9 Months</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To publicize the 'Lean and Clean Management,' a book about the benefits of industrial investments in energy efficiency.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>University of California at Berkeley, Energy Resources Group, </STRONG>Berkeley, California

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $300,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 2 Years</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC=b6yellow.gif>To support the expansion of an interdisciplinary program that trains graduate students in energy-resources development and national security issues. To ensure faculty involvement in policy-making arenas.<BR>

<EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $20,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To design an 'Annual Review of Energy Efficiency,' including detailed sector-by-sector analyses of the industrialized countries, that will enable policy-makers and analysts to choose the best policies from different countries.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>University of Maryland at College Park, 
Center for Global Change, </STRONG>College Park, Maryland

<DD><EM>1993<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $24,500<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To support a study of the effects of energy taxes on the competitiveness of U.S. industries.<P>


<DT><IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b2.gif"><STRONG>Worldwatch Institute, </STRONG>Washington, D.C.

<DD><EM>1992<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Amount: $50,000<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/s2.gif">
Duration: 1 Year</EM><BR>

<IMG ALIGN=baseline WIDTH=16 HEIGHT=16 SRC="../../grf/b6.gif">To publish a book that paints a vision of a sustainable-energy future that depends heavily on energy efficiency and renewable energy technologies.<P>

</DL>


<A HREF="index.html"><IMG SRC="../../grf/blt.gif" ALT="*" border=0 ALIGN=bottom WIDTH="19" HEIGHT="18">
<B>Programs</B></A>


</BODY>
</BLOCKQUOTE>
<a href = "./index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<br clear=all>

<hr>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT WIDTH="116" HEIGHT="40"></A>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-153</DOCNO>
<DOCOLDNO>IA026-000277-B028-19</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/Intro/A.html 198.77.86.203 19970113173959 text/html 6475
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:41:43 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 6304
Last-modified: Tue, 18 Jun 1996 22:22:54 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF">
<a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a>
<a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<a href = "index.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a>
<br clear=all>
<!--end head-->
<title>Energy Efficiency and Renewable Energy Reduce the Threat of 
Global Climate Change</title><table><tr><td><blockquote>
<H2><I>A. </I>Energy Efficiency and Renewable Energy Reduce the Threat of 
Global Climate Change While Fueling Economic Growth<BR></H2>

<BR>
Energy-related carbon emissions in the United States have reached an 
all-time high. Emissions resulting from the nation's use of fossil fuels 
climbed to 1,394 million metric tons in 1994, an increase of 24 million 
metric tons (1.8 percent) over 1993 levels, and of 56 million metric tons 
(4.2 percent) compared with 1990 levels.<a href="#3" name="r3"> [ 3 ] </a>But this growth in carbon 
emissions can be reversed. A national energy strategy that emphasizes 
energy efficiency and renewable energy could remedy the threat posed by 
global climate change.<BR>

<BLOCKQUOTE><hr>
<a href = "../img/ExecSum-Fig-3.gif"><img src = "../t/ExecSum-Fig-3.gif"
 alt = "Chart 1:Carbon Emission Trends" align=left></a>
<h3><I>Chart 1: Carbon Emission Trends</I></h3><br clear=all><hr></BLOCKQUOTE>


<p>     Numerous studies have examined the impact of a national energy 
strategy that emphasizes greater energy efficiency. <I>America's Energy 
Choices</I>,<a href="#4" name="r4"> [ 4 ] </a>for example, showed that vigorous adoption of cost-effective 
energy efficiency and renewable energy measures could cut national energy 
usage in 2030 by nearly 50 percent.<B> </B>Those same measures could 
dramatically reduce our nation's petroleum dependence, save consumers more 
than $2 trillion net over the next 40 years, and cut carbon dioxide 
emissions in 2030 by more than 70 percent (relative to emissions in 
1988).<a href="#5" name="r5"> [ 5 ] </a>The Electric Power Research Institute (EPRI) estimates that 23 
percent of all U.S. electricity consumption could be saved for less than 3 
cents per kilowatt-hour - which is less than the cost of generating 
that electricity.<a href="#6" name="r6"> [ 6 ] </a>



<!--text-->

<hr><font size =-1>

<P><A NAME="3"  HREF="#r3">3.</a> Geller, H. and Morris, H., <I>U.S. Carbon Emissions Continue to Climb in 
1994,</I> p. 1 (Washington, D.C.: American Council for an Energy-Efficient 
Economy, June 1, 1995).<BR>
<P><A NAME="4"  HREF="#r4">4.</a> Union of Concerned Scientists, Alliance to Save Energy, American Council 
for an Energy-Efficient Economy, and Natural Resources Defense Council, 
<I>America's Energy Choices: Investing in a Strong Economy and a Clean 
Environment</I> (Washington, D.C.: 1991); Geller, H., DeCicco, J., and 
Laitner, S., <I>Energy Efficiency and Job Creation: The Employment and 
Income Benefits from Investing in Energy Conserving Technologies</I>, p. 
ii (Washington, D.C.: American Council for an Energy-Efficient Economy, 
October 1992).<BR>
<p>     Investments in energy efficiency offer significant environmental 
improvements <I>and</I> economic gains. If the U.S. was to adopt the 
program laid out in <I>America's Energy Choices</I>, by the year 2010 
America could:<BR><ul>
 <LI>     Reduce annual electricity generation by 27 percent;<BR>
 <LI>     Decrease the need for new generating facilities by more than 50 
percent;<BR>
 <LI>     Reduce emissions of carbon dioxide in the utility sector by 33 
percent and nitrogen oxides by 12 percent;<BR>
 <LI>     Reduce the total amount paid for electricity by 18 percent (a 
savings of $50 billion in 1992 dollars); and<BR>
 <LI>     Increase annual consumption of goods and services other than 
electricity by $45 billion.<BR>
</ul>
All this could be accomplished without a loss of jobs or increased 
inflation, and with a cumulative savings of $211 billion off the nation's 
electric bill. Union of Concerned Scientists, et al., <I>America's Energy 
Choices: Investing in a Strong Economy and a Clean Environment</I> 
(Washington, D.C.: 1991); Moscovitch, E., "DSM in the Broader Economy: The 
Economic Impacts of Utility Efficiency Programs," <I>The Electricity 
Journal</I>, Vol. 7, No. 4, p. 15 (Seattle, WA: May 1994).<BR>
<P><A NAME="5"  HREF="#r5">5.</a> Union of Concerned Scientists, et al., <I>America's Energy Choices: 
Investing in a Strong Economy and a Clean Environment</I> (Washington, 
D.C.: 1991).<BR>
<P><A NAME="6"  HREF="#r6">6.</a> Other studies have also shown that the U.S. materials economy is only 
about 10 to 15 percent efficient - or even lower. Robert U. Ayres 
estimates that roughly 94 percent of the materials used in the U.S. 
manufacturing sector are converted to waste. This implies a net efficiency 
of only 6 percent. The vast volume of resource waste means a large 
environmental impact. It also means a higher cost of goods and services. 
Claassen, R., and Girifalco, L., "Materials for Energy Utilization," 
<I>Scientific American</I>, pp. 103-117 (October 1986); Ayres, R., 
"Industrial Metabolism," <I>Technology and Environment</I>, (Washington, 
D.C.: National Academy Press, 1987), as cited in Laitner, S., et al., 
<I>Environment and Jobs: The Employment Impact of Federal Environmental 
Investments,</I> Research Report No. 95-02, pp. 29-30 (Washington, D.C.: 
National Commission for Employment Policy, April 1995). <BR>




<!--footnotes-->


</font>
</blockquote>
</td>


<td align = center width =150>

<!--images here-->


</td></tr>
</table>





<!--start foot-->
<p align=right><a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a>
<a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a>
<a href = "index.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a>
<br clear=all><hr>
<p align=right><font size=-1>
<a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>
Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-154</DOCNO>
<DOCOLDNO>IA026-000277-B028-58</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/Intro/B.html 198.77.86.203 19970113174024 text/html 5759
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:42:27 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 5588
Last-modified: Mon, 17 Jun 1996 00:26:00 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Energy Efficiency Does Not Mean Reduced Economic Growth</title>
<table><tr><td><blockquote>
<H2><I>B. </I>Energy Efficiency Does Not Mean Reduced Economic Growth</H2>
<BR>

<BR>
Prior to 1973, U.S. energy consumption and the Gross National Product 
(GNP) seemed to be inexorably linked. But more recent history shows that 
energy consumption can be reduced during economic expansion. From 1973 to 
1986, GNP grew 35 percent while the energy consumed per unit of GDP 
<I>fell</I> to 2.4 percent per year. Some 26.6 "quads"<a href="#7" name="r7"> [ 7 ] </a>of anticipated 
energy usage per year, worth $150 billion, never materialized - mostly 
due to improved energy efficiency.<a href="#8" name="r8"> [ 8 ] </a>A 50 percent increase in carbon 
dioxide emissions was thus avoided during this period.<BR>

<BLOCKQUOTE><hr><a href = "../img/ExecSum-Fig-1.gif">
<img src = "../t/ExecSum-Fig-1.gif" align=left 
alt = "Chart 2: Energy Efficiency: Decoupling Economic
Growth from Energy Consumption"></a>
<h3><I>Chart 2: Energy Efficiency: Decoupling Economic
Growth from Energy Consumption</I><br clear=all><hr></h3>
</BLOCKQUOTE>

<p>     The United States now uses about 85 quads of primary energy annually, 
resulting in a national energy bill of $505 billion per year.<a href="#9" name="r9"> [ 9 ] </a>The U.S. 
Department of Energy (DOE) projects that with current trends and policies, 
energy use will increase to about 104 quads per year by 2010. Given this 
rise in demand and resultant increases in prices, our national energy bill 
in 2010 is projected to reach about $950 billion.<a href="#10" name="r10"> [ 10 ] </a>Increasing energy use 
creates a host of problems besides higher dollar outlays, including 
greater oil imports (DOE forecasts a 68 percent increase between 1990 and 
2010) and greater pollutant emissions (DOE forecasts an 17 percent 
increase in carbon emissions between 1993 and 2010).<a href="#11" name="r11"> [ 11 ] </a>
<p>     Vigorous energy-efficiency improvements could lower consumers' energy 
bills and reduce the cost of energy services, cut oil imports, reduce 
pollutant emissions, create a net increase in jobs, <I>and</I> boost 
individual incomes.<BR>

<!--text-->

<hr><font size =-1>





<!--footnotes-->
<P><A NAME="7"  HREF="#r7">7.</a> A "quad" is one quadrillion British thermal units (Btu) of energy. The 
entire U.S. consumed 88.5 quads in 1994. Approximate equivalents to 1 quad 
include: (1) the amount of gasoline that will enable the average car to 
travel 170 billion miles; (2) the amount of energy in 6 billion cubic feet 
of hardwood; or (3) the primary energy that will meet the needs of 3 
million average Americans for 1 year. United States Department of Energy, 
<I>Sustainable Energy Strategy: Clean and Secure Energy for a Competitive 
Economy,</I> p. 9 (Washington, D.C.: National Energy Policy Plan, U.S. 
Government Printing Office, July 1995); Rosenfeld, A., and Ward, E., 
"Energy Use in Buildings," <I>The Energy-Environment Connection,</I> 
Hollander, J., ed., p. 225 (Washington, D.C.: Island Press, 1992).<BR>
<P><A NAME="8"  HREF="#r8">8.</a> United States Congress, Office of Technology Assessment, <I>Building 
Energy Efficiency</I>, OTA-E-518, p. 13 (Washington, D.C.: U.S. Government 
Printing Office, May 1992). Although part of the improvement in U.S. 
energy intensity can be attributed to structural shifts in the economy 
(such as from manufacturing to services) and interfuel substitution, 
approximately three-quarters was due to improved energy efficiency. 
Schipper, L., Howarth, R., and Geller, H., <I>United States Energy Use 
From 1973 to 1987: The Impacts of Improved Efficiency,</I> p. 458 
(Washington, D.C.: American Council For an Energy-Efficient Economy, 
1990).<BR>
<P><A NAME="9"  HREF="#r9">9.</a> United States Department of Energy, <I>Sustainable Energy Strategy: 
Clean and Secure Energy For a Competitive Economy,</I> National Energy 
Policy Plan, ISBN 0-16-048183-X, p. 2 (Washington, D.C.: July 1995). <BR>
<P><A NAME="10"  HREF="#r10">10.</a> United States Department of Energy,<I> Annual Energy Outlook 1992: With 
Projection Through 2010,</I> DOE/EIA-0383(92) (Washington, D.C.: Energy 
Information Administration, January 1992).<BR>
<P><A NAME="11"  HREF="#r11">11.</a> United States Department of Energy, <I>Annual Energy Outlook 1995: With 
Projections to 2010, </I>DOE/EIA-0383(95), p. 11 (Washington, D.C.: Energy 
Information Administration, January 1995). <BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>

<!--start foot--><p align=right><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-155</DOCNO>
<DOCOLDNO>IA026-000277-B028-88</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/Intro/C.html 198.77.86.203 19970113174036 text/html 4870
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:42:42 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4699
Last-modified: Mon, 17 Jun 1996 00:26:01 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Energy Efficiency and Renewables Markets Are Rapidly 
Growing</title>
<table><tr><td><blockquote>

<H2><I>C. </I>Energy Efficiency and Renewables Markets Are Rapidly 
Growing, and Creating Jobs</H2>
<BR>
<B><BR>
</B>Energy-efficiency and renewables-technology markets are growing 
rapidly and generating thousands of jobs nationwide. The American Council 
for an Energy-Efficient Economy (ACEEE) estimates that efficiency 
improvements consistent with a 2.4 percent annual reduction in national 
energy usage (the rate achieved in the U.S. during 1973-1986) could create 
a net increase of nearly 500,000 jobs by the year 2000 and nearly 1.1 
million new jobs by 2010.<a href="#12" name="r12"> [ 12 ] </a>
<p>     A recent study has found that in Ohio alone as many as 63,000 jobs 
could be created by the year 2010 through energy-efficiency investments 
and the manufacture of energy-efficiency products.<a href="#13" name="r13"> [ 13 ] </a>For example, new jobs 
have been created at <B><I><A NAME="StaberIndustries">Staber Industries<a></B></I> in Groveport, Ohio, 
which makes energy-saving clothes washers, and at <B><I><A NAME="GeneralElectric">General Electric<a></B></I> in Circleville, Ohio, which makes compact fluorescent 
light bulbs. The majority of new jobs nationwide would be created as money 
saved on power bills is recirculated into the economy and spent on 
additional products and services.<a href="#14" name="r14"> [ 14 ] </a>
<p>     Current energy efficiency markets are already sizable. The global 
energy efficiency market is now in excess of $80 billion per year, and is 
projected to reach $115-140 billion annually by 2015.<a href="#15" name="r15"> [ 15 ] </a>
Energy efficiency and environmental technology markets are large and 
growing all over the world.<a href="#16" name="r16"> [ 16 ] </a>
<BR>



<!--text-->

<hr><font size =-1>





<!--footnotes-->
<P><A NAME="12"  HREF="#r12">12.</a> Geller, H., DeCicco, J., and Laitner, S., <I>Energy Efficiency and Job 
Creation: The Employment and Income Benefits from Investing in Energy 
Conserving Technologies</I>, p. 45 (Washington, D.C.: American Council for 
an Energy-Efficient Economy, October 1992).<BR>
<P><A NAME="13"  HREF="#r13">13.</a> Laitner, S., et al., <I>Energy Efficiency as an Investment in Ohio's 
Economic Future</I>, p. v (Washington, D.C.: American Council for an 
Energy-Efficient Economy, November 1994).<BR>
<P><A NAME="14"  HREF="#r14">14.</a> Walker, K., et al., <I>Power Boosters: Ohio's Energy Efficiency Success 
Stories</I>, p. 7 (Washington, D.C.: Safe Energy Communication Council, 
1995).<BR>
<BR>
<P><A NAME="15"  HREF="#r15">15.</a> Hagler Bailly Consulting, Inc., <I>The Global Market for Energy 
Efficiency,</I> pp. ii-iii (Arlington, VA: 1995).<BR>
<P><A NAME="16"  HREF="#r16">16.</a> The global market for energy efficiency and environmental products and 
services is currently estimated to be $425 billion. Estimates of the scale 
of these markets vary widely, primarily because there is no agreement on 
which industries and technologies to include. The U.S. market for 
pollution avoidance and remediation alone is $134 billion per year. United 
States Department of Energy, "Energy Efficiency and Renewable Energy 
Benefits," <I>Fact Sheet</I>, p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995); Laitner, S., et al., 
<I>Environment and Jobs: The Employment Impact of Federal Environmental 
Investments,</I> Research Report No. 95-02, pp. ii-iii (Washington, D.C.: 
National Commission for Employment Policy, April 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-156</DOCNO>
<DOCOLDNO>IA026-000277-B028-124</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/Intro/D.html 198.77.86.203 19970113174058 text/html 5522
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:43:00 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 5351
Last-modified: Mon, 17 Jun 1996 00:26:01 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->


<title>Cutting Carbon Dioxide Emissions Can 
Add to U.S. Prosperity</title>
<table><tr><td><blockquote>



<H2><I>D. </I>Successes Demonstrate That Cutting Carbon Dioxide Emissions Can 
Add to U.S. Prosperity</H2>
<BR>
<BR>
This report documents how U.S. businesses and individuals are increasing 
their bottom lines while improving economic prosperity, employment, and 
public health - and cutting greenhouse emissions.<BR>
<BR>
 <p>     <B>
<H3>Chapter I</H3>
</B> reviews energy-efficiency success stories in 
the industrial sector, stories that demonstrate how companies that set out 
to cut electricity bills also improved worker productivity and became more 
competitive.<BR>
 <p>     <B>
<H3>Chapter II</H3>
</B> assesses a wide array of energy-saving 
electric utility programs and federal energy-efficiency programs that have 
saved the U.S. economy billions of dollars.<BR>
 <p>     <B>
<H3>Chapter III</H3>
</B> reviews gains in the energy-efficient design 
of commercial buildings and residences nationwide, and assesses ongoing 
innovations that could lead to improved building codes. It discusses 
commercial and residential energy-efficiency retrofit 
successes - including lighting upgrades - as well as efficiency 
gains in the design of appliances and equipment.<BR>
 <p>     <B>
<H3>Chapter IV</H3>
</B> reviews the transportation sector and the 
improvement in fuel efficiency over the last 20 years. It goes on to 
discuss how new automobile engines that are now available could double 
vehicle fuel efficiency, while electric and hybrid-electric 
vehicles - given incentives that would spur market 
development - could usher in a new age of clean transportation, powered 
by renewables-derived electricity.<BR>
 <p>     <B>
<H3>Chapter V</H3>
</B> reviews recent successes in renewable energy, 
including a drop in the cost per kilowatt-hour of wind, photovoltaic, 
solar thermal, and geothermal power. Wind can now compete head-to-head 
with fossil fuels.<BR>
<BR>
<p>     All of the successes reviewed in this report not only save dollars 
and add to U.S. economic strength, but also cut carbon dioxide emissions 
and reduce the threat of global climate change. Our nation can grow 
economically, add jobs, and become more internationally competitive while 
cutting greenhouse gas emissions. <BR>
<p>     The task ahead is not simple, however. While the market has captured 
many efficiency and renewable energy successes, a host of market barriers 
to efficiency investments persists.  For example, although efficiency and 
renewable energy technologies are often cheaper on a life-cycle basis, 
their up-front costs are typically higher than less-efficient products.  
Public policies that provide consumers with life-cycle product information 
could help overcome this market failure.  Similarly, because it takes 
up-front capital to invest in improved efficiency, public policies that 
promote financing and technical assistance can facilitate investment.  
Although the focus of this report is on efficiency and renewable energy 
success stories, given the market hurdles to efficiency investments, 
utility efficiency programs and public policy incentives are crucial to 
encourage energy efficiency.  The effects of tighter environmental 
regulations and the prospect of higher energy prices will increasingly 
make efficiency investments a prudent pursuit for all businesses.<BR>
<p>     Michael Porter, a professor at the Harvard Business School, notes 
that "the underlying cause of sustained national advantage is improvement 
and innovation."<a href="#17" name="r17"> [ 17 ] </a>The following case studies -  coupled with the solid 
economic, employment, public health and pollution-reduction benefits 
reviewed in each - establish the need for a strategic vision for U.S. 
energy policy: energy efficiency and renewable energy can add to U.S. 
prosperity while cutting U.S. carbon dioxide emissions, reducing the 
threat of global climate change.








<!--text-->

<hr><font size =-1>





<!--footnotes-->
<P><A NAME="17"  HREF="#r17">17.</a> Porter, M., <I>The Competitive Advantage of Nations</I>, p. 652 (New 
York, NY: The Free Press, 1990), as cited in Laitner, S., et al., 
<I>Environment and Jobs: The Employment Impact of Federal Environmental 
Investments,</I> Research Report No. 95-02, p. 32 (Washington, D.C.: 
National Commission for Employment Policy, April 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-157</DOCNO>
<DOCOLDNO>IA026-000277-B028-207</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/I/intro.html 198.77.86.203 19970113174234 text/html 6849
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:44:24 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 6678
Last-modified: Mon, 17 Jun 1996 00:27:58 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><!--end head-->
<title>Industrial Energy Efficiency
 Successes</title>
<table><tr><td><blockquote>


<H1>I. Industrial Energy Efficiency
 Successes<BR></H1>

<BR>
U.S. industries spend $121 billion per year on energy, consuming about a 
quarter of all U.S. energy.<a href="#18" name="r18"> [ 18 ] </a>While manufacturers account for roughly half 
of that annual bill ($61.1 billion in 1991), they are responsible for 85 
percent of U.S. industrial carbon dioxide emissions - approximately 504 
million metric tons annually. Efficiency improvements in the manufacturing 
process can reduce these emissions, cut consumption, and improve a 
company's bottom line.<a href="#19" name="r19"> [ 19 ] </a>

<BLOCKQUOTE><hr>
<a href = "../img/Ind-manu.gif"><img src = "../t/Ind-manu.gif"
 alt = "Percentage of Manufacturing Energy Consumption
by Industry" align=left></a><h3><I>Percentage of Manufacturing Energy Consumption
by Industry <br clear=all><hr></I></h3>
</BLOCKQUOTE>


<p>     According to several studies, the annual energy savings that could be 
attained by U.S. industry over the next two decades ranges from 11 to 27 
percent of the demand that would otherwise occur, and potential savings by 
2015 may reach as high as 38 percent.<a href="#20" name="r20"> [ 20 ] </a>These improvements depend, 
however, on the design and implementation of new policies and programs to 
stimulate more energy efficiency. Finding ways to encourage the 
installation of technologies such as high-efficiency motors,<a href="#21" name="r21"> [ 21 ] </a>
computerized controls, industry-specific technologies, and cogeneration 
units could result in avoided energy consumption of 59 quads a year by 
2010 - a savings worth $183 billion in 1994 dollars.<a href="#22" name="r22"> [ 22 ] </a><BR>



<!--text-->

<hr><font size =-1>





<!--footnotes-->
<P><A NAME="18"  HREF="#r18">18.</a> United States Department of Energy, "Why Industrial Energy Use 
Matters," <I>Fact Sheet,</I> p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995). <BR>
<P><A NAME="19"  HREF="#r19">19.</a> The industrial sector includes manufacturing, mining, agriculture, and 
construction. Manufacturing is the largest component of the industrial 
sector, and accounts for about a quarter of total national electricity 
consumption. Including system losses in electric generation, manufacturing 
consumption was 20 quads in 1991, and accounted for 37 percent of total 
U.S. carbon dioxide emissions. Elliott, R. Neal, <I>Electricity 
Consumption and the Potential for Electric Energy Savings in the 
Manufacturing Sector,</I> pp. iii, 2 (Washington, D.C.: American Council 
for an Energy-Efficient Economy, April 1994); United States Department of 
Energy, "Why Industrial Energy Use Matters," <I>Fact Sheet,</I> p. 1 
(Washington, D.C.: Office of Energy Efficiency and Renewable Energy, 
1995). <BR>
<P><A NAME="20"  HREF="#r20">20.</a> According to one market-based scenario, total energy use in the 
industrial sector could be reduced by 12 percent by 2010 and 18 percent by 
2030 from baseline projections. <I>See America's Energy Choices</I>, pp. 
65-66. The DOE has estimated that <I>technical</I> industrial energy 
savings potential in the year 2010 is 27 percent, and <I>achievable</I> 
industrial energy savings potential in the year 2010 is 13 percent. 
Congress' Office of Technology Assessment estimates that the potential 
industrial savings in the year 2015 is between 11 and 37 percent. An Oak 
Ridge National Laboratory report estimates that the cost-effective 
industrial fuel (non-electric) savings potential is 11 percent in the year 
2010. <I>See</I> Hopkins, M., and Jones, T., <I>Getting in Gear: How 
Energy Efficiency Can Help Smaller Manufacturers Compete in the Global 
Marketplace,</I> p. 58, n. 21 (Washington, D.C.: Alliance to Save Energy, 
January 1995). The American Council for an Energy-Efficient Economy 
estimates that 14 to 38 percent of total electricity consumption can be 
saved through an orderly upgrade of equipment at the time of equipment 
failure, process modernization, or new construction. Process optimization 
and redesign would significantly increase this conservation potential. 
Elliott, R. Neal, <I>Electricity Consumption and the Potential for 
Electric Energy Savings in the Manufacturing Sector, </I>p. iii 
(Washington, D.C.: American Council for an Energy-Efficient Economy, April 
1994).<BR>
<P><A NAME="21"  HREF="#r21">21.</a> More than 80 percent of the energy savings available to U.S. industry 
comes from electric motor systems improvements. Lighting and process 
improvements contribute slightly less than 10 percent. More than 33 
percent of the energy savings available from motor systems improvements 
comes from the application of adjustable speed drives, with another 25 
percent coming from improved drivetrain, electricity supply, and 
maintenance practices. Another 17 percent of electricity savings available 
from motors is estimated to come from installing more efficient motors. In 
fact, manufacturers spend about $30 billion annually to operate 40 million 
electric motors - which consume 70 percent of all energy in a typical 
manufacturing facility. These costs could be cut nearly in half with 
efficient motor systems. Elliott, R. Neal, <I>Electricity Consumption and 
the Potential for Electric Energy Savings in the Manufacturing Sector,</I> 
pp. iii, 2 (Washington, D.C.: American Council for an Energy-Efficient 
Economy, April 1994).<BR>
<P><A NAME="22"  HREF="#r22">22.</a> Hopkins, M., and Jones, T., <I>Getting in Gear: How Energy Efficiency 
Can Help Smaller Manufacturers Compete in the Global Marketplace,</I> p. 
18, (Washington, D.C.: Alliance to Save Energy, January 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>






<!--start foot--><p align=right><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-158</DOCNO>
<DOCOLDNO>IA026-000277-B028-240</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/I/A.html 198.77.86.203 19970113174248 text/html 19085
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:44:53 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 18913
Last-modified: Mon, 17 Jun 1996 00:28:00 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Energy-Efficiency Investments Can Boost Productivity</title>
<table><tr><td><blockquote>



<H2><I>A. </I>Energy-Efficiency Investments Can Boost Productivity While 
Reducing Industrial Waste Materials</H2>

<BR>
Inefficient industrial energy use is closely related to the generation of 
industrial waste materials. Industry is responsible for producing more 
than 544 million metric tons of hazardous wastes and approximately 11.8 
billion metric tons of solid wastes each year.<a href="#23" name="r23"> [ 23 ] </a>Industry spends 
approximately $45 billion each year to meet emissions control 
requirements.<a href="#24" name="r24"> [ 24 ] </a>Minimizing the generation of waste materials, and 
transforming wastes into feedstocks, could reduce the nation's primary 
energy requirement by as much as 6 quads per year.<a href="#25" name="r25"> [ 25 ] </a>Energy efficiency 
technologies and processes, when installed "pre-end-of-the-pipe," can 
prevent pollution before it occurs, lowering production costs and thereby 
freeing capital for more productive purposes. <BR>

<BLOCKQUOTE><hr><a href = "../img/Ind-SavingsPot.gif"><img align=left 
src = "../t/Ind-SavingsPot.gif"
 alt = "High and Low Efficiency Savings Potential
in the Manufacturing Sector"></a><H3><I>High and Low Efficiency Savings Potential
in the Manufacturing Sector<br clear=all><hr></I></H3>
</BLOCKQUOTE>
<p>     Both energy use and pollution are <I>controllable</I> costs. Although 
energy is typically a small percentage of total production costs,<a href="#26" name="r26"> [ 26 ] </a>other 
production costs - such as wages, work rules, materials costs, and 
disposal charges - are often more difficult to control. Controlling 
energy and waste cuts the operating budget and can have an enormous impact 
on a company's bottom line.<a href="#27" name="r27"> [ 27 ] </a>In many cases, the energy savings embodied 
in new technologies capable of reducing environmental emissions is 
sufficient to pay for upgrades - regardless of such other benefits as 
improved product quality or productivity. Energy efficiency should be a 
fundamental component of all manufacturers' environmental programs - to 
help them meet today's environmental regulations and tomorrow's more 
stringent standards.<a href="#28" name="r28"> [ 28 ] </a>
<B><I><p>     <A NAME="3MCorporation">3M Corporation<a>.</B></I> Often cited as one of the 
best-run companies in the world, 3M - based in St. Paul, 
Minnesota - has reduced its energy use per unit of production by 
one-half over the last 20 years, and in the process has reduced overall 
emissions by one-third. The company has achieved greater returns through 
energy-efficiency improvements than through alternative cost-cutting 
measures, and has pledged to implement all energy-saving projects with a 
15 percent or greater return on investment (a payback period of six to 
seven years). It has aggressively pursued a corporate goal to further cut 
energy use per unit of production and per square foot of building space by 
20 percent from 1990 through 1995.<a href="#29" name="r29"> [ 29 ] </a>Energy cost-cutting has made the 
company both more competitive and productive.<BR>
<p>    <p>      3M is also marketing a new "dual cure coating" process, a 
low-solvent technique that uses light to cure coatings. It is used for 
aircraft topcoats and primers, and for coatings for the backing of 
high-temperature electrical tape. The process produces superior physical 
properties with minimal volatile organic compound (VOC) emissions.<a href="#30" name="r30"> [ <a href="#30" name="r30"> [ 30 ] </a>] </a>Based 
on a conservative projection of 10 percent market penetration, the new 
coatings could eliminate an estimated 236,000 metric tons of VOCs 
annually - 7.5 percent of the U.S. total. This energy-efficient process 
will also reduce carbon dioxide emissions by an estimated 2 million metric 
tons a year. By the year 2010, 3M's new coatings could save an estimated 
25 trillion Btu of energy - more than all the electricity used in all 
the commercial establishments in the state of Iowa in 1995.<a href="#31" name="r31"> [ 31 ] </a>
<B><I> <p>     <A NAME="Haskell-LemonConstructionCompany">Haskell-Lemon Construction Company<a>.</B></I> Haskell-Lemon 
Construction Company of Oklahoma City, Oklahoma manufactures asphalt 
paving products. Mixing hot asphalt can waste, in the form of exhaust 
steam, as much as 60 percent of the energy used in various stages of the 
mixing process. In 1989, Haskell-Lemon installed a heat-recovery system at 
one of three asphalt hot-mix plants to recover the waste steam, speed the 
manufacturing process, and reduce energy costs.<BR>
<p>    <p>      Haskell-Lemon personnel tested the system for two months and 
documented the energy savings. The new system reduced fuel requirements by 
30 percent and increased production by as much as 40 percent. Emissions 
decreased by 50 percent because some toxic fumes that previously escaped 
with evaporating steam were condensed in the heat-recovery process. The 
heat-recovery system cost $100,000. Annual energy savings ranged between 
$20,000 and $30,000, depending on the cost of fuel, and thus the internal 
rate of return on the heat-recovery system was 20 to 33 percent.<a href="#32" name="r32"> [ 32 ] </a>
<p>    <p>      If all 4,500 hot-mix plants in the United States used the same 
heat-recovery process as Haskell-Lemon, the industry could save $250 
million in energy costs each year. In 1991, the Haskell-Lemon project was 
selected for the DOE's Sixth National Awards Program for Energy 
Innovation.<a href="#33" name="r33"> [ 33 ] </a>
<p>    <p>      DOE's Energy Analysis and Diagnostic Center/Industrial 
Assessment Center (EADC/IAC) has issued several energy-saving 
recommendations for companies that mix asphalt paving. By installing the 
six most frequently recommended efficiency improvements,<a href="#34" name="r34"> [ 34 ] </a>each asphalt 
mixing company would spend an average of $54,393 and save $37,186 annually 
in reduced energy bills - while cutting carbon dioxide emissions each 
year by 652 metric tons.<a href="#35" name="r35"> [ 35 ] </a><P>
<BR>
<B><I> <p>     <A NAME="Hill-RomCompany">Hill-Rom Company<a>.</B></I> Hill-Rom Company of Batesville, 
Indiana manufactures furniture and medical equipment. To address high 
energy costs in the mid-1980s, as well as a number of engineering 
problems, Hill-Rom installed a monitoring system for production equipment 
and an integrated maintenance control center. It saved $180,000 in energy 
costs by replacing inefficient space heaters with new high-efficiency 
heaters, installing a lighting control system, replacing manual motor 
starters on the ventilation system, and replacing manual heating, 
ventilation, and air conditioning (HVAC) controls with direct networked 
controls.<a href="#36" name="r36"> [ 36 ] </a><BR>
<p>    <p>      The new monitoring systems improved productivity. The plant has 
been able to shorten maintenance response time, reduce machine downtime, 
and improve plant environmental conditions. The labor and material savings 
attributable to the systems amounted to $430,000 in 1990. Taken together, 
the direct energy savings and productivity savings enabled Hill-Rom to pay 
back its $424,300 investment in fewer than eight months.<a href="#37" name="r37"> [ 37 ] </a>
<p>    <p>      In Hill-Rom's industry, the DOE's EADC/IAC program audited 12 
smaller-sized furniture manufacturing plants. The program identified 68 
energy-saving measures.<a href="#38" name="r38"> [ 38 ] </a>The average cost of implementing the six most 
common recommendations was $3,770 per plant, and they yielded an average 
annual energy savings of $5,459 while cutting annual carbon dioxide 
emissions by 69 metric tons.<a href="#39" name="r39"> [ 39 ] </a>
<BR>
<BR>
<B><I> <p>     <A NAME="BrushWellman"> Brush Wellman, Inc.</a></B></I> In 1991, perchloroethylene 
(PCE) spilled from a storage tank at Brush Wellman, Inc.'s facility in 
Elmore, Ohio. The spill contaminated groundwater and surrounding soils. 
Brush Wellman, a manufacturer of beryllium and beryllium alloy products, 
had relied on PCE as a cleaning solvent. But faced with a $1.49 million 
clean-up tab, the company set out to end the threat of spills and find 
alternatives to PCE cleaning systems.<a href="#40" name="r40"> [ 40 ] </a><BR>
<p>    <p>      Brush Wellman's solution was to install a high-energy, 
dense-fluid cleaning system that uses nonhazardous (when not emitted as a 
greenhouse gas) carbon dioxide. The new cleaning process saved energy when 
compared with the previous system. Natural gas savings amounted to 31.66 
million cubic feet per year, and electricity savings were 323 
megawatt-hours annually.<a href="#41" name="r41"> [ 41 ] </a>The entire PCE waste stream was eliminated. All 
told, the new system cost $1.23 million while saving $282,000 per year in 
the costs of PCE solvent, steam, electricity, water, waste disposal, and 
maintenance. The payback period was just over 4 years. The new cleaning 
process has many potential applications: any metal-machining or 
product-processing company could adapt the system.<a href="#42" name="r42"> [ 42 ] </a>Besides the 
substantial annual energy savings, Brush Wellman's new cleaning system 
reduces overall carbon dioxide emissions from avoided electricity usage by 
1,640 metric tons each year.<a href="#43" name="r43"> [ 43 ] </a>
<BR>
<B><I> <p>     <A NAME="ChryslerCorporation">Chrysler Corporation</a>.</B></I> U.S. automobile 
manufacturers are seeking better paint-application systems to replace 
liquid spray-paint systems, which are major sources of VOC emissions. 
Chrysler Corporation's Newark, New Jersey assembly plant generates more 
than 83 metric tons of VOCs per year. Chrysler is developing powder 
coatings that could eventually replace liquid spray-paint systems in 
automobile manufacturing. Chrysler is installing and testing a full-body 
powder-paint antichip system<a href="#44" name="r44"> [ 44 ] </a>at its Newark facility.<a href="#45" name="r45"> [ 45 ] </a>The new system 
will save 24.3 billion Btu of energy per year by eliminating the old 
system's incinerator for the VOCs, and an additional 22.2 billion Btu per 
year by lowering the paint booth air heating requirements. The system 
virtually eliminates VOCs and nitrogen oxides emissions, and cuts carbon 
dioxide emissions by 2,951 metric tons annually. The system also uses 
paint more efficiently, eliminating 95 percent of the sludge waste that 
had to be landfilled under the old spray-paint system. Chrysler will save 
nearly $4 million per year from reduced material use, energy consumption, 
and waste disposal. This savings, combined with the superior performance 
of the powder-painted surfaces, could enhance the competitiveness of U.S. 
automotive manufacturers.<a href="#46" name="r46"> [ 46 ] </a>
<p>     <BR>



<!--text-->

<hr><font size =-1>





<!--footnotes-->
<P><A NAME="23"  HREF="#r23">23.</a> Bartsch, C., and DeVaul, D., <I>Utilities and Manufacturers: Pioneering 
Partnerships and Their Lessons for the 21st Century, </I>p. 20 
(Washington, D.C.: Northeast-Midwest Institute, 1994).<BR>
<p><a name="24" href="#r24">24</a> United States Department of Energy, "Why Industrial Energy Use 
Matters," <I>Fact Sheet,</I> p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995).<BR>
<P><A NAME="25"  HREF="#r25">25.</a> Bartsch, C., and DeVaul, D., <I>Utilities and Manufacturers: Pioneering 
Partnerships and Their Lessons for the 21st Century, </I>p. 20 
(Washington, D.C.: Northeast-Midwest Institute, 1994).<BR>
<P><A NAME="26"  HREF="#r26">26.</a> Despite the size of the manufacturing sector's electricity 
expenditures, these expenditures only represent an average of 1.2 percent 
of the value of manufactured goods. In a few industries - such as 
aluminum and industrial gases - electricity purchases are more than 20 
percent of the value of the manufactured products. In other industries 
like food processing, transportation equipment, and apparel, electricity 
purchases are less than 1 percent of the value of shipments. Elliott, R. 
Neal, <I>Electricity Consumption and the Potential for Electric Energy 
Savings in the Manufacturing Sector,</I> pp. iii, 2 (Washington, D.C.: 
American Council for an Energy-Efficient Economy, April 1994); United 
States Department of Energy, "Why Industrial Energy Use Matters," <I>Fact 
Sheet,</I> p. 1 (Washington, D.C.: Office of Energy Efficiency and 
Renewable Energy, 1995).<BR>
<P><A NAME="27"  HREF="#r27">27.</a> <I>See </I>Hopkins, M., and Jones, T., <I>Getting in Gear: How Energy 
Efficiency Can Help Smaller Manufacturers Compete in the Global 
Marketplace,</I> p. 39, (Washington, D.C.: Alliance to Save Energy, 
January 1995).<BR>
<P><A NAME="28"  HREF="#r28">28.</a> <I>Id., </I>p. 40.<BR>
<P><A NAME="29"  HREF="#r29">29.</a> <I>Id., </I>p. 5.<BR>
<P><A NAME="30"  HREF="#r30">30.</a> VOCs from 3M's process are below California's stringent standards. 
United States Department of Energy, "Dual Cure Coatings: 3M, St. Paul, 
Minnesota," <I>Case Studies</I>, p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995).<BR>
<P><A NAME="31"  HREF="#r31">31.</a> United States Department of Energy, "Dual Cure Coatings: 3M, St. Paul, 
Minnesota," <I>Case Studies</I>, p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995).<BR>
<P><A NAME="32"  HREF="#r32">32.</a> Hopkins, M., and Jones, T., <I>Getting in Gear: How Energy Efficiency 
Can Help Smaller Manufacturers Compete in the Global Marketplace,</I> p. 
15, (Washington, D.C.: Alliance to Save Energy, January 1995).<BR>
<P><A NAME="33"  HREF="#r33">33.</a> <I>Id.<BR>
</I>34 The EADC/IAC recommendations for asphalt paving mixing companies 
include: insulate bare tanks, vessels, lines and process equipment; adjust 
(tune) burners for optimal air/fuel ratio; replace motors with 
energy-efficient motors; use higher efficiency, lower wattage lamps or 
ballasts in existing fixtures; use waste heat from hot flue gases to 
preheat combustion air; and install automatic stack dampers. <I>Id.,</I> 
p. 14.<BR>
<P><A NAME="35"  HREF="#r35">35.</a> <I>Id.</I> After auditing ten smaller-sized asphalt manufacturing 
plants, the EADC/IAC program identified an average of more than $278,000 
in annual energy-saving measures. The recommended energy-efficiency 
investments average a one-year payback and have saved 18,542 
megawatt-hours of power, preventing about 11,116 metric tons of carbon 
emissions. <I>Id.</I> <BR>
<P><A NAME="36"  HREF="#r36">36.</a> <I>Id.,</I> p. 33.<BR>
<P><A NAME="37"  HREF="#r37">37.</a> <I>Id.</I><BR>
<P><A NAME="38"  HREF="#r38">38.</a> The six most common recommendations included: use higher 
efficiency, lower wattage lamps or ballasts in existing fixtures; install 
compressor air intakes in the coolest locations; eliminate leaks in lines 
and valves carrying compressed air or other gases; convert to more 
efficient light sources (e.g., fluorescent for incandescent) where 
acceptable; adjust (tune) burners for optimal air/fuel ratio; replace 
motors with energy-efficient motors; reduce operating time of equipment to 
the minimum required, and turn off during idle periods. <I>Id., </I>p. 
32.<BR>
<P><A NAME="39"  HREF="#r39">39.</a> <I>Id. </I><BR>
<P><A NAME="40"  HREF="#r40">40.</a> United States Department of Energy, United States Environmental 
Protection Agency, <I>Metals Cleaning System Using CO2 Cuts Grease, 
Protects Workers</I>, DOE/CH10093-339, DE94006940 (Washington, D.C.: 
National Industrial Competitiveness through Energy, Environment & 
Economics (NICE3), September 1994).<BR>
<P><A NAME="41"  HREF="#r41">41.</a> <I>Id. </I><BR>
<P><A NAME="42"  HREF="#r42">42.</a> Metal machining or processing companies could adapt the carbon dioxide 
dense-fluid system if they are currently using PCE or other chlorinated 
solvents to clean long rod, bar, and tube products, small machined parts, 
electronic components and connectors, or intricately-shaped products.<BR>
<P><A NAME="43"  HREF="#r43">43.</a> United States Department of Energy, U.S. Environmental Protection 
Agency, <I>Metals Cleaning System Using CO2 Cuts Grease, Protects 
Workers</I>, DOE/CH10093-339, DE94006940 (Washington, D.C.: National 
Industrial Competitiveness through Energy, Environment & Economics 
(NICE3), September 1994).<BR>
<P><A NAME="44"  HREF="#r44">44.</a> With the powder-paint system, primer coats are applied in powder form. 
Electrostatic attraction between the powder and the vehicle surface keeps 
the coating on the surface until the powder is polymerized in a bake oven 
at 325&#176; F. The resulting surfaces are harder, and thus more resistant 
to chipping, and have a higher luster than liquid-painted vehicles. United 
States Department of Energy, United States Environmental Protection 
Agency, <I>Powder Paint System Improves Automobile Coatings, Boosts 
Environment</I>, DOE/CH10093-338, DE94006939 (Washington, D.C.: National 
Industrial Competitiveness through Energy, Environment & Economics 
(NICE3), September 1994).<BR>
<P><A NAME="45"  HREF="#r45">45.</a> The facility is located in a "severe non-attainment" area for VOCs 
under the Clean Air Act, and must demonstrate a 15 percent reduction in 
emissions by 1996. United States Department of Energy, United States 
Environmental Protection Agency, <I>Powder Paint System Improves 
Automobile Coatings, Boosts Environment</I>, DOE/CH10093-338, DE94006939 
(Washington, D.C.: National Industrial Competitiveness through Energy, 
Environment & Economics (NICE3), September 1994).<BR>
<P><A NAME="46"  HREF="#r46">46.</a> <I>Id.</I><BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>




<!--start foot--><p align=right><a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-159</DOCNO>
<DOCOLDNO>IA026-000277-B028-277</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/I/B.html 198.77.86.203 19970113174307 text/html 10825
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:45:11 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 10653
Last-modified: Mon, 17 Jun 1996 00:28:00 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Energy-Efficiency Investments Can Improve Competitiveness</title>
<table><tr><td><blockquote>

<H2><I>B. </I>Energy-Efficiency Investments Can Improve Competitiveness <BR>
<BR></H2>

The relatively low industrial energy prices in the United States are 
considered key competitive advantages in the global marketplace. However, 
these low prices also mean that U.S. manufacturers may place less 
importance on energy efficiency than do their competitors in Europe and 
Japan. This difference is illustrated in the selling prices of many 
products; one expert estimates that 5 percent of the difference in price 
between similar Japanese and American products is the result of more 
efficient energy use in Japanese plants.<a href="#47" name="r47"> [ 47 ] </a>U.S. industry can use energy 
efficiency to its competitive advantage.<BR>
<BR>
<B><I> <p>     The <A NAME="BreyersCompany"> Breyers Company</a>.</B> </I>
In New England, public 
utilities have helped local businesses and industries compete and expand 
by investing more than $500 million in energy efficiency since 1987. The 
efficiency expenditures have lowered the energy bills of these companies, 
and have benefited the utilities by delaying the need to build expensive 
new generation plants.<a href="#48" name="r48"> [ 48 ] </a>When the Breyers Company ice cream plant in 
Framingham, Massachusetts was having difficulty staying competitive, 
<B><I><A NAME="BostonEdisonCompany">Boston Edison Company</a>,</B></I> the local utility, helped it install 
energy-efficiency improvements. The joint investment in energy-efficient 
refrigeration, heat-recovery systems, motors, and lighting reduced the 
plant's electricity use by 12.5 million kilowatt-hours (enough to power 
2,000 homes) while simultaneously improving product quality and adding new 
jobs.<a href="#49" name="r49"> [ 49 ] </a>The electricity savings cut annual carbon dioxide emissions by 
more than 8,275 metric tons.<a href="#50" name="r50"> [ 50 ] </a>
<BR>
<B><I> <p>     <A NAME="BigBearStores">Big Bear Stores </a>.</B></I> The Big Bear Stores grocery 
chain in Ohio and West Virginia has aggressively cut electricity bills by 
installing computer-controlled refrigeration and freezer display cases, 
lighting, and ventilation systems. Waste heat from the refrigeration units 
helps heat both the stores and hot water. Freezers, refrigerated display 
cases, and air-conditioning systems all use high-efficiency motors and 
compressors. Company-wide, electrical costs per square foot have decreased 
by approximately 15 percent, saving the company $1 million per year and 
helping it price its foods more competitively.<a href="#51" name="r51"> [ 51 ] </a>
<BR>
<B><I> <p>     <A NAME="Mar-Jac,Inc.">Mar-Jac, Inc.<a></B></I> Mar-Jac, Inc. is a poultry 
processor in Gainesville, Georgia that employs 550 people. Processing 
poultry requires water heated to between 120&#176; and 130&#176; F. The 
company used three natural gas-fired boilers to supply steam to the heat 
exchangers that heated the water. The boilers' low efficiency resulted in 
high energy costs, and maintenance was difficult and expensive.<a href="#52" name="r52"> [ 52 ] </a><BR>
<p>    <p>      In 1988, the plant manager replaced the three steam boilers with 
two new water heaters capable of supplying water at up to 180&#176; F, and 
installed a new direct-fired gas water heater as well. Both process 
improvements resulted in substantial energy savings. The new system cost 
$210,000, but reduced gas consumption by 40 percent - resulting in a 
payback of less than 3 years. The process manufacturing investments 
improved safety, reduced the possibility of blowing a boiler, and lowered 
maintenance costs while cutting emissions.<a href="#53" name="r53"> [ 53 ] </a>
<p>    <p>      The DOE's EADC/IAC conducts free energy audits at small- and 
medium-sized manufacturing plants around the country. These audits have 
resulted in an estimated energy savings of $517 million (94 trillion Btu), 
at a total cost to taxpayers of $27 million. EADC/IAC has issued 
energy-saving recommendations for various businesses, including poultry 
processors. By installing even the six most recommended efficiency 
improvements, each poultry processor would spend an average of $7,912 
while saving $13,495 annually in reduced energy bills - and cutting 
carbon dioxide emissions each year by 304 metric tons. <a href="#54" name="r54"> [ 54 ] </a><P>
<B><I> <p>     <A NAME="ChrisErhartFoundryandMachineCompany"> Chris Erhart Foundry and Machine Company</a>.</B></I> Erhart 
Foundry in Cincinnati, Ohio produces iron castings for customers 
throughout the Midwest. The foundry has been in business for 140 years, 
but since the 1980s, the plant's effort to improve energy efficiency has 
been a "constant battle," says Dan Erhart. Energy comprises 15 to 20 
percent of total operating costs, and any reduction in consumption goes to 
improving the company's competitive position in the industry.<a href="#55" name="r55"> [ 55 ] </a><BR>
<p>    <p>      In the early 1990s, Erhart called in <B><I><A NAME="CincinnatiGasElectric"> Cincinnati Gas  Electric </a></B></I> (CG&E) for an energy audit. Based on CG&E 
recommendations, Erhart replaced the foundry's 500 incandescent fixtures 
with high pressure sodium fixtures that provided twice as much light while 
using a third less energy.<a href="#56" name="r56"> [ 56 ] </a>
<p>    <p>      Erhart's biggest investment, however, was a change in its 
foundry process. The company installed a computer controller on its 
800-kilowatt induction furnace. Employees had been manually monitoring the 
furnace temperature, which made it extremely difficult to control demand. 
The controller is now reducing energy bills by 182 kilowatts per 
month - a 23 percent reduction - which saves $22,000 a year. The 
computer, which allows operation during off-peak hours and reduces the 
load during on-peak hours, paid for itself in six months. The energy 
savings shave 4 percent off Erhart's operating costs - a boon to 
productivity and competitiveness.<a href="#57" name="r57"> [ 57 ] </a>
<BR>







<!--text-->

<hr><font size =-1>





<!--footnotes-->
<P><A NAME="47"  HREF="#r47">47.</a> In many Japanese plants, <I>every employee</I> is expected to minimize 
energy usage. Hopkins, M., and Jones, T., <I>Getting in Gear: How Energy 
Efficiency Can Help Smaller Manufacturers Compete in the Global 
Marketplace,</I> pp. 17, 58 n. 12 (Washington, D.C.: Alliance to Save 
Energy, January 1995). Other experts argue, however, that although 
Japanese industries are 25 percent less energy intensive, they pay more 
for their energy. Energy use times price may be about equal for the U.S. 
and Japan. Wolf, J., personal correspondence, December 5, 1995 (notes on 
file with the author).<BR>
<P><A NAME="48"  HREF="#r48">48.</a> New England Policy Council, <I>Power to Spare II: Energy Efficiency and 
New England's Economic Recovery</I>, p. 11 (Boston, MA: Conservation Law 
Foundation, et al., June 1992).<BR>
<P>
<P><A NAME="49"  HREF="#r49">49.</a> Elliott, R. Neal, <I>Electricity Consumption and the Potential for 
Electric Energy Savings in the Manufacturing Sector</I>, pp. 13-14 
(Washington, D.C.: American Council for an Energy-Efficient Economy, 
1994); <I>see also </I>C. Bartsch and D. DeVaul, <I>Utilities and 
Manufacturers: Pioneering Partnerships and Their Lessons for the 21st 
Century</I>, pp. 50-57 (Washington, D.C.: Northeast-Midwest Institute, 
1994); Romm, J., <I>Lean and Clean Management: How to Boost Profits and 
Productivity by Reducing Pollution</I>, p. 60 (New York, NY:  Kodansha 
America, 1994).<BR>
<P><A NAME="50"  HREF="#r50">50.</a> This carbon dioxide reduction figure uses a DOE emissions factor of 
0.662 metric tons/MWh for the state of Massachusetts. United States 
Department of Energy<I>, Voluntary Reporting of Greenhouse Gases: 
Reporting Form and Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, 
Appendix F ("Adjusted Electricity Emission Factors by State") (Washington, 
D.C.: Energy Information Administration, June 1995).<BR>
<P><A NAME="51"  HREF="#r51">51.</a> Walker, K., et al., <I>Power Boosters: Ohio's Energy Efficiency Success 
Stories</I>, pp. 11-12 (Washington, D.C.: Safe Energy Communication 
Council, 1995).<BR>
<P><A NAME="52"  HREF="#r52">52.</a> Hopkins, M., and Jones, T., <I>Getting in Gear: How Energy Efficiency 
Can Help Smaller Manufacturers Compete in the Global Marketplace,</I> p. 
11 (Washington, D.C.: Alliance to Save Energy, January 1995).<BR>
<P><A NAME="53"  HREF="#r53">53.</a> Mar-Jar, Inc., and many manufacturers, do not divulge energy 
consumption information for competitive reasons. Obtaining carbon dioxide 
reduction data is thereby not possible. <I>Id.<BR>
</I>54 The EADC/IAC recommendations for poultry processors include: use 
higher efficiency, lower wattage lamps or ballasts in existing fixtures; 
replace motors with energy-efficient motors; adjust (tune) burners for 
optimal air/fuel ratios; insulate bare tanks, vessels, lines, and process 
equipment; install, upgrade, or repair insulation on steam lines; and 
repair and eliminate leaks in steam lines and valves. <I>Id., </I>p. 
10.<BR>
<P><A NAME="55"  HREF="#r55">55.</a> Walker, K., et al., <I>Power Boosters: Ohio's Energy Efficiency Success 
Stories</I>, pp. 20-21 (Washington, D.C.: Safe Energy Communication 
Council, 1995).<BR>
<P><A NAME="56"  HREF="#r56">56.</a> <I>Id. </I><BR>
<P><A NAME="57"  HREF="#r57">57.</a> <I>Id. <BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-160</DOCNO>
<DOCOLDNO>IA026-000277-B028-328</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/I/C.html 198.77.86.203 19970113174338 text/html 11348
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:45:37 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 11176
Last-modified: Mon, 17 Jun 1996 00:28:01 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Energy-Efficiency Investments Can Create Jobs</title>
<table><tr><td><blockquote>


<H2><i>C. </I>Energy-Efficiency Investments Can Create Jobs</H2>

Energy efficiency cuts costs, increases productivity, and reduces 
pollution - while saving and often creating jobs. Implementing 
efficiency measures that are cost effective on a life-cycle basis leads to 
more jobs, higher personal incomes, and a higher GDP for the United 
States.<a href="#58" name="r58"> [ 58 ] </a>A number of case studies demonstrate how companies have 
benefited economically - and in some cases have even been turned 
around, by investing in energy efficiency.<BR>
<BR>
<B><I> <p>     <A NAME="SouthwireCompany,The">Southwire Company <a>.</B></I> 
The Southwire Company, 
headquartered at Carrollton, Georgia, is a large manufacturer of copper 
rod, cable and wire. Southwire had soaring energy costs in the early 
1980s, when its energy bills reached 20 percent of overhead and were 
rising. Profit margins were dropping, and the company had to lay off 1,000 
of its 4,000 workers.<a href="#59" name="r59"> [ 59 ] </a><BR>
<p>    <p>      Between 1981 and 1988, however, a comprehensive efficiency 
program saved Southwire $40 million in energy costs. Efficiency measures 
included a particularly successful motor efficiency program. The program 
focused on the life-cycle costs of motors, comparing the costs of 
rewinding older motors with the costs of buying new, high-efficiency 
motors. Southwire purchased high-efficiency motors whenever the net 
present value of the energy savings over five years exceeded the financing 
costs. To minimize downtime, the company then stocked the motors in 
preparation for their replacement. In addition, plant operators shut off 
many motors during peak demand times to avoid excess energy costs. The $40 
million in energy savings cut overhead from 20 to 13 percent and turned 
Southwire into a profitable company.<a href="#60" name="r60"> [ 60 ] </a>
<BR>
<B><I> <p>     The <A NAME="KellyCompany,The">Kelly Company <a>.</B></I> As a leading manufacturer of 
injection molded and structural foam parts for the paint and hardware 
industries, The Kelly Company of Clinton, Massachusetts was a productive 
and profitable player in its industry for many years. But in the 
mid-1980s, the national recession and international competition brought 
the manufacturer to the brink of financial disaster and jeopardized the 
livelihoods of its 65 employees.<a href="#61" name="r61"> [ 61 ] </a><BR>
<p>    <p>      Seeking to cut costs without cutting jobs, the company focused 
on reducing electricity costs, its third largest operating expense. With 
the assistance of <B><I><A NAME="MassachusettsElectricCompany">Massachusetts Electric Company<a></B></I> and the 
Massachusetts Industrial Services Program, Kelly installed variable-speed 
drives on injection molding machines, process cooling system improvements 
that included new high-efficiency pumps, and premium efficient grinders to 
reuse waste material generated by the injection molding machines. Kelly's 
electricity costs dropped 20 percent, saving $83,000 per year and enabling 
the company to expand product lines and add personnel. The efficiency 
improvements cut sulfur dioxide emissions by 7 metric tons and carbon 
dioxide emissions by 659 metric tons annually.<a href="#62" name="r62"> [ 62 ] </a>
<B><I> <p>     <A NAME="CraneValves">Crane Valves</a>.</B></I> In the face of strong foreign 
competition undercutting the foundry business, Crane Valves of Washington, 
Iowa needed to cut manufacturing costs to save jobs. Assisted by the Metal 
Casting Center at the University of Northern Iowa, Crane-Washington 
implemented a "total assessment audit" of its plant. The audit brought in 
six public- and private-sector organizations with expertise in energy 
efficiency, productivity improvement, and waste reduction. The audit 
catalyzed a total quality management program that delineated a host of 
capital and non-capital improvement initiatives - all of which focused 
on energy-use efficiencies, productivity improvements, and process 
management. The audit assessed energy use in all process cycles, including 
the materials, equipment, and tooling cycles of foundry operations. <BR>
<p>    <p>      With funding from the <B><I><A NAME="IowaEnergyCenter">Iowa Energy Center <a></B></I> in Ames, 
Crane-Washington launched a demonstration project at its facility that 
could serve as a model for the entire foundry industry. The results are 
striking: kilowatt-hours per ton of materials were slashed by 29 percent; 
scrap was cut by 39 percent; error rates dropped by 28 percent; and the 
number of labor-hours per ton of poured materials fell 27 percent. All 
this while productivity soared: the average tons per day of materials 
poured increased an astounding 78 percent, while the number of good molds 
poured daily increased 42 percent. To top it off, new jobs increased by 30 
percent from November 1993 through October 1994.<a href="#63" name="r63"> [ 63 ] </a>
<B><I> <p>     <A NAME="DowChemical">Dow Chemical<a>. </B></I>Often the best efficiency 
investments begin with employee suggestions, which, when implemented 
systematically, can bolster productivity and expand the company, creating 
jobs. Dow Chemical's Louisiana Division, whose 2,400 employees in more 
than 20 plants produce chemicals like propylene, began a yearly contest in 
1982 to find energy-saving projects that paid for themselves in one year 
(a return on investment of more than 100 percent) and that required a 
capital investment of less than $200,000.<a href="#64" name="r64"> [ 64 ] </a><BR>
<p>    <p>      The first year, the program had 27 winning projects that 
required a total capital investment of $1.7 million with an average return 
on investment of 173 percent. Dow's energy manager, Kenneth Nelson, 
reported that after the first 27 projects "many people felt there couldn't 
be others with such high returns." The skeptics were wrong. The 1983 
contest had 32 winners. The projects they suggested required a total 
capital investment of $2.2 million and provided a 340 percent return on 
investment - producing savings for the company of $7.5 million in the 
first year and every year after that.<a href="#65" name="r65"> [ 65 ] </a><BR>
<p>    <p>      The yearly contest was so successful that Dow eliminated the 
$200,000 limit and included savings from all kinds of waste reduction, not 
just energy. Winning suggestions included more efficient pumps and 
installation of heat exchangers to salvage waste heat. Others involved 
sophisticated process redesign. An ethic of "continuous process 
improvement" began to pervade the company. Employees received engraved 
plaques in a formal awards ceremony, and in addition, were often rewarded 
by their supervisors through job performance raises. <BR>
<p>    <p>      For 575 projects throughout the 1980s, the average return was 
204 percent (audited). After ten years and nearly 700 projects, the 1992 
contest had 109 winning projects with an average return of 305 percent, 
and the 1993 contest had 140 projects with an average return of 298 
percent.<a href="#66" name="r66"> [ 66 ] </a>
<p>     <BR>






<hr><font size =-1>





<!--footnotes-->
<P><A NAME="58"  HREF="#r58">58.</a> The positive employment and income results of efficiency 
investments are due primarily to the relatively low number of jobs in the 
energy sectors (coal, oil, and gas extraction, fuel refining, and electric 
and gas utilities) compared to the economy as a whole. Conserving energy 
reduces the energy bills paid by consumers and businesses, thereby 
enabling greater purchases of non-energy goods, equipment, and services. 
The result is a shift of economic activity away from energy supply 
industries and towards sectors of the economy that employ more workers per 
dollar received.<BR>
<p>     Less than 10 percent of the net jobs created are associated with 
direct investment in efficiency measures while more than 90 percent are 
associated with re-spending energy bill savings. The largest absolute 
increase in jobs is in the construction, retail trade and services 
industries, as these sectors install energy-efficiency measures and gain 
new business orders from the re-spending of energy bill savings.<BR>
<p>     Productivity improvements in the oil and gas extraction industries 
are likely to lead to a reduction of 200,000 jobs in this sector by 2010. 
Individual companies in the fossil-fuel sector may be able to reduce 
adverse jobs impacts by diversifying into the energy efficiency and 
renewable energy fields. Geller, H., DeCicco, J., and Laitner, S., 
<I>Energy Efficiency and Job Creation: The Employment and Income Benefits 
from Investing in Energy Conserving Technologies</I>, pp. iii-iv 
(Washington, D.C.: American Council for an Energy-Efficient Economy, 
October 1992).<BR>
<P><A NAME="59"  HREF="#r59">59.</a> Romm, J., <I>Lean and Clean Management: How to Boost Profits and 
Productivity by Reducing Pollution</I>, pp. 152-153 (New York, NY: 
Kodansha America, 1994). <BR>
<P><A NAME="60"  HREF="#r60">60.</a> <I>Id. <BR>
</I><P><A NAME="62"  HREF="#r62">62.</a> U.S. Environmental Protection Agency, and U.S. Department of 
Energy,<I> The Climate Wise Program Opportunities Assessment Guide: 
Turning Energy Efficiency and Environmental Performance Into a Corporate 
Asset</I>, Version 1.0, p. 17 (Washington, D.C.: October 1995).<BR>
<P><A NAME="62"  HREF="#r62">62.</a> <I>Id. <BR>
</I><P><A NAME="64"  HREF="#r64">64.</a> The Metal Casting Center, <I>Turning the Corner at 
Crane-Washington</I>, pp. ii-iii, 1-18 (Cedar Falls, Iowa: University of 
Northern Iowa, 1995).<BR>
<P><A NAME="64"  HREF="#r64">64.</a> Romm, J., <I>Lean and Clean Management: How to Boost Profits and 
Productivity by Reducing Pollution,</I> pp. 42-43 (New York, NY: Kodansha 
International, October 1994).<BR>
<P><A NAME="65"  HREF="#r65">65.</a> <I>Id. </I><BR>
<P><A NAME="66"  HREF="#r66">66.</a> <I>Id. </I><BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-161</DOCNO>
<DOCOLDNO>IA026-000277-B028-366</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/I/D.html 198.77.86.203 19970113174412 text/html 2200
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:46:17 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2029
Last-modified: Mon, 17 Jun 1996 16:07:27 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Conclusion</title>
<table><tr><td><blockquote>


<H2><I>D. </I>Conclusion<I></H2>

</I><BR>
The best industrial efficiency programs start with employee suggestions, 
which subsequently must be supported by determined management and by 
federal, local, or utility financing and technical support. Communicating 
to plant staff members that energy efficiency is a priority and 
encouraging them to identify energy-saving opportunities taps the know-how 
of those closest to the manufacturing process - which can have 
extraordinary results.<BR>
<p>     A key lesson from these industrial case studies is that process 
manufacturing efficiency improvements require a pervasive ethic of 
constant feedback from all members of a business. Efficiency improvements 
are rarely one-shot investments. Continuous improvement in energy 
efficiency and waste reduction can boost productivity and 
competitiveness - while empowering employees. It takes people - not 
just technology - to save energy, expand a business, and improve the 
environment at the same time.





<font size =-1>





<!--footnotes-->


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-162</DOCNO>
<DOCOLDNO>IA026-000277-B028-390</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/intro.html 198.77.86.203 19970113174425 text/html 2636
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:46:29 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2465
Last-modified: Mon, 17 Jun 1996 00:29:47 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><!--end head--><title>The Utility Industry</title>
<table><tr><td><blockquote>

<H1>II. The Utility Industry: Efficiency 
Successes<BR></H1>

<BR>
America's utilities provide roughly $260 billion each year in energy 
services to homes, businesses and industries - 5.2 percent of the gross 
national product.<a href="#67" name="r67"> [ 67 ] </a>Electric and gas utilities have capital assets worth 
$790 billion.<a href="#68" name="r68"> [ 68 ] </a>Energy production and consumption by utilities involves 
enormous environmental costs: the nation's electric utilities released 
approximately 500 million metric tons of carbon in 1993, which is about 36 
percent of the annual U.S. total.<a href="#69" name="r69"> [ 69 ] </a><BR>
<BR>

<BLOCKQUOTE><hr>
<a href = "../img/Util-TotE.gif"><img src = "../t/Util-TotE.gif"
 alt = "Chart 5: U.S. Utilities' Contribution to Total Air
Consumption" align=left></a><H3><I>Chart 5: U.S. Utilities' Contribution to Total Air
Consumption<br clear=all><hr></I></H3>
</BLOCKQUOTE>


<hr><font size =-1>





<!--footnotes-->
<P><A NAME="67"  HREF="#r67">67.</a> United States Department of Energy, "Why Utility Energy Use Matters," 
<I>Fact Sheet</I>, p. 1 (Washington, D.C.: Office of Energy Efficiency and 
Renewable Energy, 1995).<BR>
<P><A NAME="68"  HREF="#r68">68.</a> <I>Id. </I><BR>
<P><A NAME="69"  HREF="#r69">69.</a> United States Department of Energy, <I>Annual Energy Outlook 1995 With 
Projections to 2010</I>, DOE/EIA-0383(95), p. 11 (Washington, D.C.: Energy 
Information Administration, January 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>



<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-163</DOCNO>
<DOCOLDNO>IA026-000277-B029-29</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/A.html 198.77.86.203 19970113174450 text/html 3560
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:46:55 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 3389
Last-modified: Mon, 17 Jun 1996 00:29:48 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Utility Efficiency Has Improved Markedly</title>
<table><tr><td><blockquote>

<H2><I>A. </I>Utility Efficiency Has Improved Markedly<BR>
<BR></H2>

During the past two decades, the utility sector has made significant 
progress in improving electric energy efficiency. Between 1960 and 1973, 
U.S. electricity use grew at an average rate of 7.3 percent per year, 
almost double the 4 percent growth per year in GDP.<a href="#70" name="r70"> [ 70 ] </a>Between 1973 and 
1986, however, growth in electricity use fell to 2.4 percent per year. 
Some 26.6 quads of anticipated energy usage per year never materialized, 
mostly due to improved energy efficiency.<a href="#71" name="r71"> [ 71 ] </a>Greater efficiency was caused 
by a combination of factors, including structural changes in the U.S. 
economy (including the shift from manufacturing to services), changes in 
electricity and fossil-fuel prices, development and commercialization of 
new energy-efficient products and services, government energy-efficiency 
programs, and utility demand-side management (DSM) programs.<a href="#72" name="r72"> [ 72 ] </a><BR>
<BR>



<!--text-->

<hr><font size =-1>





<!--footnotes-->
<A NAME="70"  HREF="#r70">70.</a> United States Department of Energy, <I>Annual Energy Review 1992,</I> 
DOE/EIA-0384(92) (Washington, D.C.: Energy Information Administration, 
June 1993).<BR>
<P><A NAME="71"  HREF="#r71">71.</a> Rosenfeld, A., and Ward, E., "Energy Use in Buildings," <I>The 
Energy-Environment Connection,</I> Hollander, J., ed., p. 225 (Washington, 
D.C.: Island Press, 1992).<BR>
<P><A NAME="72"  HREF="#r72">72.</a> DSM programs improve the efficiency with which customers use 
electricity, and also affect the timing of that use (e.g., by shifting it 
away from high-cost, peak times). Utilities run such programs for two 
primary reasons. One is to improve customer service. The second is to 
acquire resources that, just like power plants, can meet customer 
energy-service needs. DSM programs are often less expensive and 
environmentally cleaner than power plants. Hirst, E., and Eto, J., 
<I>Justification for Electric-Utility Energy-Efficiency Programs,</I> 
ORNL/CON-419, LBNL-37593, p. 1 (Oak Ridge, TN: Oak Ridge National 
Laboratory, August 1995).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-164</DOCNO>
<DOCOLDNO>IA026-000277-B029-57</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/B.html 198.77.86.203 19970113174503 text/html 2851
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:47:09 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2680
Last-modified: Mon, 17 Jun 1996 00:29:49 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Integrated Resource Planning</title>
<table><tr><td><blockquote>


<H2><I>B. </I>Integrated Resource Planning Has Been a Demonstrated Success</H2>

<BR>
During the past five years, federal, state, and public utility commission 
regulators have adopted regulations that successfully promote energy 
efficiency and renewables development. Among these successes has been 
adoption of a regulatory model known as "integrated resource planning" 
(IRP), or least-cost energy planning. Initially mandated in California in 
1990, IRP involves ranking all energy sources, including improvements in 
energy efficiency, by cost. An energy-efficiency improvement must be 
implemented first - before the acquisition of new generating 
capacity - if the improvement costs less per kilowatt-hour 
<I>avoided</I> than new supply would cost.<BR>
<p>     Although most states now claim to have adopted IRP procedures to some 
degree, only 10 have a regulatory framework that genuinely ensures that 
DSM can compete on an equal footing with supply options.<a href="#73" name="r73"> [ 73 ] </a>





<hr><font size =-1>





<!--footnotes-->
<P><A NAME="73"  HREF="#r73">73.</a> These include four states that decouple profits from sales volume (CA, 
MT, NY, and WA), and six states that have other unconditional lost-revenue 
recovery mechanisms (CT, MA, NH, OR, PA, and VT). Geller, H., et al., 
<I>Bridging the Gap: Initiatives to Achieve President Clinton's Climate 
Commitment</I>, p. 14 (Washington, D.C.: American Council for and 
Energy-Efficient Economy, April 22, 1994).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-165</DOCNO>
<DOCOLDNO>IA026-000277-B029-90</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/C.html 198.77.86.203 19970113174520 text/html 5932
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:47:25 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 5761
Last-modified: Mon, 17 Jun 1996 00:29:49 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Regional Demand-Side Management Programs</title>
<table><tr><td><blockquote>

<H2><I>C. </I>Regional Demand-Side Management Programs Have Been Successful 
Nationwide<BR></H2>

<BR>
In response to IRP policies, billions of utility dollars have been 
diverted away from building new generation capacity. The money instead has 
gone into DSM programs to reduce demand. From 1990 to 1994, utility 
investments in DSM programs and energy efficiency tripled to $3 billion 
per year. These investments reduced national generation 2 percent per 
year, while consumers saved nearly $4 billion annually on their utility 
bills. A 1993 EPRI survey of most U.S. DSM programs<a href="#74" name="r74"> [ 74 ] </a>found that the 
programs save electricity at an average cost of just 2.1 cents per 
kilowatt-hour.<a href="#75" name="r75"> [ 75 ] </a>Utility spending on DSM programs increased dramatically 
between 1989 and 1993, growing from 0.5 to 1.5 percent of utility 
operating revenues. In 1993, U.S. electric utilities spent $2.8 billion on 
DSM programs.<a href="#76" name="r76"> [ 76 ] </a>These expenditures paid substantial benefits, including 
electricity reductions in 1993 of 44,000 gigawatt-hours and peak demand 
reductions of 40,000 megawatts. These reductions are equivalent to 1.6 
percent of annual electricity sales and 6.8 percent of summer peak demand, 
and reduced U.S. carbon dioxide emissions by approximately 27.8 million 
metric tons.<a href="#77" name="r77"> [ 77 ] </a>In 1994, utility DSM programs cut potential summer peak 
demand by 7 percent and annual electricity use by 2 percent nationwide.<BR>
<p>     Despite current uncertainties in utility markets due to industry 
restructuring, DSM programs are expected to expand, and could reduce 
national electricity demand by 3 percent annually by the year 2000. This 
continued expansion could reduce electricity generation by 71,000 
gigawatt-hours in the year 2000, preventing 44.9 million metric tons of 
carbon dioxide emissions annually.<a href="#78" name="r78"> [ 78 ] </a><BR>
<p>     Over the last decade of incorporating IRP into utility planning, 
literally hundreds of utility DSM programs have emerged. Utilities used 
DSM to retain customers, to increase market share, and to enhance 
profitability by improving customer services. DSM programs will become 
even more important in a restructured utility industry, as still-regulated 
distribution companies will select the low-cost option for providing 
energy needs. The following success stories, categorized by region, 
demonstrate the financial savings - and substantial environmental and 
health benefits - of utility efficiency programs.<P>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="74"  HREF="#r74">74.</a> The Electric Power Research Institute is a utility-funded organization 
in Palo Alto, California.<BR>
<P><A NAME="75"  HREF="#r75">75.</a> Hadley, S., and Hirst, E., <I>Utility DSM Programs from 1989 through 
1998: Continuation or Crossroads?, </I>ORNL/CON-405 (Oak Ridge, TN: Oak 
Ridge National Laboratory, February 1995), cited in Hirst, E., and Eto, 
J., <I>Justification for Electric-Utility Energy-Efficiency Programs,</I> 
ORNL/CON-419, LBNL-37593, p. 1 (Oak Ridge, TN: Oak Ridge National 
Laboratory, August 1995).<BR>
<P><A NAME="76"  HREF="#r76">76.</a> <I>Id. </I><BR>
<P><A NAME="77"  HREF="#r77">77.</a> This carbon dioxide reduction data uses a national average for 
electricity, given the actual fuel share in 1993, of 0.6332 metric tons 
per megawatt-hour (MWh). In the future, avoided emissions will depend on 
the actual displacement of future and/or existing plants. Laitner, S., 
Economic Research Associates (Arlington, VA: December 5, 1995).<BR>
<P><A NAME="78"  HREF="#r78">78.</a> Hirst, E. and Eto, J., <I>Justification for Electric-Utility 
Energy-Efficiency Programs, </I>ORNL/CON-419, LBNL-37593 (Oak Ridge, TN: 
Oak Ridge National Laboratory, August 1995); Geller, et al., <I>Bridging 
the Gap: Initiatives to Achieve President Clinton's Climate 
Commitment,</I> pp. 15-16 (Washington, D.C.: American Council for an 
Energy-Efficient Economy, April 22, 1994), citing Hirst, E., 
<I>Electric-Utility DSM-Program Costs and Effects: 1991 to 2001</I> (Oak 
Ridge, TN: Oak Ridge National Laboratory, May 1993). This carbon dioxide 
reduction data uses a national average for electricity, given the actual 
fuel share in 1993, of 0.6332 metric tons per megawatt-hour (MWh). In the 
future, avoided emissions will depend on the actual displacement of future 
and/or existing plants. Laitner, S., Economic Research Associates 
(Arlington, VA: December 5, 1995).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "C1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-166</DOCNO>
<DOCOLDNO>IA026-000277-B029-124</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/C1.html 198.77.86.203 19970113174535 text/html 14423
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:47:39 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 14251
Last-modified: Mon, 17 Jun 1996 00:29:50 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>California DSM Successes</title>
<table><tr><td><blockquote>



<H3>1. California DSM Successes<BR>
<BR></H3>

DSM programs in California provided net life-cycle benefits of $2.2 
billion during the period 1990 to 1994.<a href="#79" name="r79"> [ 79 ] </a>In 1994, the average cost of 
saved kilowatt-hours was less than two cents per kilowatt-hour.<a href="#80" name="r80"> [ 80 ] </a>By 1994, 
California DSM programs were saving   1 percent of system consumption each 
year - and companies and residences were not even touching the limits 
of their efficiency capacity.<a href="#81" name="r81"> [ 81 ] </a><P>

<BLOCKQUOTE><hr><a href = "../img/Util-CaDSM.gif"><img src = "../t/Util-CaDSM.gif"
 alt = "Chart 6: Costs and Savings California DSM Programs" align=left></a>
<h3><I>Chart 6: Costs and Savings California DSM Programs<br clear=all><hr></I></h3>
</BLOCKQUOTE>

<B><I> <p>     Pacific Gas and Electric</I>.</B> Pacific Gas and 
Electric (PG&E), California's largest utility, was one of the first in the 
country to implement utility efficiency programs. PG&E's Direct Assistance 
programs, over their ten-year history, have weatherized more than 600,000 
low-income homes with attic insulation, weather stripping, shower heads, 
caulking, water heater blankets, and duct wraps, at a total program cost 
of $245 million.<a href="#82" name="r82"> [ 82 ] </a>In addition, since 1987, the program has replaced more 
than 90,000 appliances - primarily refrigerators that exceed federal 
appliance efficiency standards, but also furnaces, evaporative coolers, 
and water heaters - with energy-efficient models at no charge to 
low-income customers. It also installed more than 70,000 compact 
fluorescent lamps. In 1992, the programs saved 16,283 megawatt-hours of 
electricity, which prevented 5,585 metric tons of carbon dioxide 
emissions. Over their life-cycle, however, the efficiency installations 
from 1987 through 1992 saved 1,901 gigawatt-hours, resulting in a 
cumulative reduction in carbon dioxide emissions of 652,000 metric 
tons.<a href="#83" name="r83"> [ 83 ] </a>
<p>         PG&E's Model Energy Communities Pilot Project targeted the 
Antioch/Brentwood area northeast of Oakland, California, which was slated 
for construction of a new substation to handle a spike in demand when 
homeowners concurrently switched on air conditioners at the end of summer 
workdays. PG&E installed innovative demand-side management technologies 
that targeted this specific community, including compact fluorescent 
bulbs, low-flow shower heads, shell improvements, duct repair, insulation, 
sun screens, and air-conditioner tune-ups. PG&E also downsized 
air-conditioner units to better fit room conditions.<a href="#84" name="r84"> [ 84 ] </a>At a cost of $8.9 
million, PG&E saved 4,322 megawatt-hours of electricity between 1991 and 
1993, which prevented 1,482 metric tons of carbon dioxide emissions. Over 
the life-cycle of the energy saving installations, 86.4 gigawatt-hours are 
expected to be saved, corresponding to a cumulative carbon dioxide 
reduction of nearly 30,000 metric tons.<a href="#85" name="r85"> [ 85 ] </a>
<B><I> <p>     <A NAME="SouthernCaliforniaEdison">Southern California Edison<a></I>.</B> Southern California 
Edison (SCE) created one of the more innovative lighting DSM programs when 
it awarded compact fluorescent lamp manufacturers wholesale rebates of $5 
per unit, creating a "downstream" price reduction at the retail level. 
Because retailers traditionally double or treble their wholesale costs, 
customer rebates reached as high as $15 with each $5-per-bulb 
manufacturer's rebate. The wholesale rebates spurred manufacturer 
participation, while bulk rebates allowed SCE to stipulate performance 
specifications during manufacturing, including minimum efficiency 
requirements for each bulb. SCE achieved high participation by both 
residential and commercial consumers, while transforming the market away 
from old, inefficient incandescent lighting.<a href="#86" name="r86"> [ 86 ] </a>Residences saved 101,057 
megawatt-hours of electricity annually because of the program, a reduction 
in demand that cut carbon dioxide emissions by 34,650 metric tons each 
year. Carbon dioxide reductions over the life-cycle of the new bulbs will 
total 225,300 metric tons. Commercial customers saved 118,979 
megawatt-hours per year, with annual carbon dioxide reductions of 40,800 
metric tons and life-cycle reductions of 265,250 metric tons.<a href="#87" name="r87"> [ 87 ] </a>The 
combined cost of the residential and commercial programs from 1992 through 
1994 was $14,425,429. <P>
<B><I> <p>     <A NAME="SacramentoMunicipalUtilityDistrict">Sacramento Municipal Utility District<a></I>.</B> The 
Sacramento Municipal Utility District (SMUD) is a case study of an 
impressive utility turnaround. On the heels of a voter referendum to shut 
down its Rancho Seco nuclear power plant in the late 1980s, SMUD closed 
the plant and ushered in a new era at the utility. SMUD set out to secure 
800 megawatts from DSM programs and 400 megawatts from renewable energy 
sources. Under the leadership of David Freeman, SMUD boosted its DSM 
budget from $3.8 million to $38 million in 1991.<BR>
<p>    <p>      By 1993, SMUD's Energy-Efficient Refrigerators program, for 
example, had resulted in purchases of more than 70,000 energy-efficient 
refrigerators while 63,000 old, inefficient refrigerators were collected 
and recycled. SMUD's Direct Investment Program has provided electric-heat 
customers with almost 15,000 energy-efficiency measures for free. 
Participants in the Residential Peak Corps Program, SMUD's leading 
load-management program, have installed 96,130 air-conditioning cyclers. 
Participants in the Shade Tree Program have planted 109,000 trees, and 
1,200 solar water heaters have been installed through the Solar Domestic 
Water Heater Program, which SMUD has expanded to promote rooftop solar 
photovoltaics. Equally impressive results have accrued from SMUD's 
commercial and industrial retrofit programs.<a href="#88" name="r88"> [ 88 ] </a><BR>
<p>    <p>      These programs saved, in 1993, 96.4 gigawatt-hours of 
electricity - which avoided 33,000 metric tons of carbon dioxide 
emissions in that year. During the life-cycle of SMUD's DSM and 
renewable-energy programs, including all efficiency installations made 
between 1978 and 1993, 4,039 gigawatt-hours will be saved, including 309 
megawatts of capacity savings, at a total cost of $196 million. That 
represents a reduction of 1.38 million metric tons of carbon dioxide 
emissions.<a href="#89" name="r89"> [ 89 ] </a>
<p>    <p>      SMUD helped one of its industrial customers, <B><I><A NAME="BlueDiamondAlmonds">Blue Diamond Almonds</a>,</B></I> become significantly more energy efficient. Blue Diamond 
installed energy-efficient lighting in its warehouses and offices, saving 
$52,000 annually. Heating equipment upgrades added another $18,000 in 
annual energy savings. A similar SMUD-supported energy-efficiency program 
for <B><I><A NAME="Intel">Intel<a>, </B></I>the large semi-conductor manufacturer, convinced 
the company to expand its operations in Sacramento, adding 250 jobs.<a href="#90" name="r90"> [ 90 ] </a>
<B><I> <p>     California Energy Commission</B></I>. The California 
Energy Commission (CEC) seeks to cut the energy demand of local government 
facilities through its "Energy Partnership Program," which provides 
technical and financial assistance for energy upgrades at city and county 
facilities throughout California. The program has supplied technical 
assistance to existing public facilities, providing efficiency upgrades 
(compact fluorescent lamps, ballasts, occupancy sensors, thermostat 
controls, energy management systems, variable frequency drives, HVAC 
improvements) to city halls, administration buildings, libraries, fire and 
police departments, jails, hospitals, and wastewater treatment plants. CEC 
facilitates project financing through its own revolving loan fund, federal 
funds, utility assistance, energy service companies, or other outside 
funding sources.<a href="#91" name="r91"> [ 91 ] </a>The Energy Partnership Program has been a dramatic 
success, saving 15.7 gigawatt-hours of electricity in 1992 at a cost of 
$6.5 million, while preventing 5,385 metric tons of carbon dioxide 
emissions. Cumulative savings include 165.9 gigawatt-hours from upgrades 
installed from 1989 through 1993, avoiding 56,900 metric tons of carbon 
dioxide emissions at a total cost of $17.3 million.<a href="#92" name="r92"> [ 92 ] </a>
<p>     <BR>





<hr><font size =-1>





<!--footnotes-->

<P><A NAME="79"  HREF="#r79">79.</a> Miller, P., <I>Presentation Before CPUC Full Panel Hearing on 
Restructuring</I>, R. 94-04-031, p. 2 (September 8, 1995). Net benefits 
from the 1990 through 1992 programs totaled $1.4 billion (D.93-09-078), 
while net benefits from 1993 were $0.4 billion (D.94-12-021). Utility 
applications for 1994 estimate net benefits also at $0.4 billion 
(applications 95-04-038, 95-04-041, 95-04-046, and 95-04-050).<BR>
<P><A NAME="80"  HREF="#r80">80.</a> Hirst, E., Cavanagh, R., & Miller, P., <I>The Future of DSM in a 
Restructured U.S. Electricity Industry</I> (publication forthcoming, 
1995). This is the full, amortized cost to the utilities of a 
kilowatt-hour at the meter - with no credit for peak savings - and 
is considerably lower than any other energy resource available in 
California. Miller, P., <I>Presentation Before CPUC Full Panel Hearing on 
Restructuring</I>, R. 94-04-031, p. 2 (September 8, 1995).<BR>
<P><A NAME="81"  HREF="#r81">81.</a> Hirst, E., Cavanagh, R., & Miller, P., <I>The Future of DSM in a 
Restructured U.S. Electricity Industry</I>, p. 2 (publication forthcoming, 
1995).<BR>
<P><A NAME="82"  HREF="#r82">82.</a> The Results Center, <I>Pacific Gas & Electric: Direct Assistance 
Programs</I>, Profile #75, p. 2 (Aspen, CO: IRT Environment, Inc., 
1993).<BR>
<P><A NAME="83"  HREF="#r83">83.</a> This carbon dioxide reduction data uses a DOE emissions factor for 
California of 0.343 metric tons/MWh. United States Department of 
Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="84"  HREF="#r84">84.</a> The Results Center, <I>Pacific Gas & Electric: Model Energy Communities 
Program</I>, Profile #81, p. 2 (Aspen, CO: IRT Environment, Inc., 
1994).<BR>
<P><A NAME="85"  HREF="#r85">85.</a> This carbon dioxide reduction data uses a DOE emissions factor for 
California of 0.343 metric tons/MWh. United States Department of 
Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="86"  HREF="#r86">86.</a> The Results Center, <I>Southern California Edison: CFB and CFL 
Manufacturer's Rebates</I>, Profile #113 (Aspen, CO: IRT Environment, 
Inc., 1994).<BR>
<P><A NAME="87"  HREF="#r87">87.</a> This carbon dioxide reduction data uses a DOE emissions factor for 
California of 0.343 metric tons/MWh. United States Department of 
Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="88"  HREF="#r88">88.</a> The Results Center, <I>Sacramento Municipal Utility District: 
Comprehensive Municipal DSM</I>, Profile #91 (Aspen, CO: IRT Environment, 
Inc., 1994).<BR>
<P><A NAME="89"  HREF="#r89">89.</a> This carbon dioxide reduction data uses a DOE emissions factor for 
California of 0.343 metric tons/MWh. United States Department of 
Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="90"  HREF="#r90">90.</a> United States Department of Energy, "Sacramento Municipal Utility 
District," <I>Case Studies</I>, p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995).<BR>
<P><A NAME="91"  HREF="#r91">91.</a> The Results Center, <I>California Energy Commission: Energy Partnership 
Program</I>, Profile #64, p. 2 (Aspen, CO: IRT Environment, Inc., 
1993).<BR>
<P><A NAME="92"  HREF="#r92">92.</a> This carbon dioxide reduction data uses a DOE emissions factor for 
California of 0.343 metric tons/MWh. United States Department of 
Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->
</td></tr>
</table>



<!--start foot--><p align=right><a href = "C2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-167</DOCNO>
<DOCOLDNO>IA026-000277-B029-159</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/C2.html 198.77.86.203 19970113174549 text/html 17293
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:47:54 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 17121
Last-modified: Mon, 17 Jun 1996 00:29:51 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Pacific Northwest DSM Successes</title>
<table><tr><td><blockquote>

<H3>2. Pacific Northwest DSM Successes</H3>

<BR>
In 1995, the Pacific Northwest (Washington, Oregon, Idaho, and Montana) 
was enjoying nearly 900 average megawatts of electricity savings as a 
result of DSM efforts - annual savings equivalent to the power output 
of four good-sized gas-fired combustion turbines. Conserved energy totaled 
over 50,000 gigawatt-hours in 1995 at an average cost of 2 to 2-1/2 cents 
per kilowatt-hour - well below the next most costly resource 
alternative available. These DSM programs were saving retail consumers $2 
billion per year while avoiding carbon dioxide emissions of approximately 
5.35 million metric tons annually.<a href="#93" name="r93"> [ 93 ] </a><BR>
<p>     <BR>
<B><I> <p>     <A NAME="PortlandEnergyOffice">Portland Energy Office<a>. </B></I>In 1993, Portland, Oregon 
became the first U.S. city to adopt a local carbon dioxide reduction 
strategy, committing to reduce its carbon dioxide emissions by 20 percent 
below 1988 baselines by the year 2010. This target is a greater reduction 
than the United States committed to under the 1992 Framework Convention on 
Climate Change.<a href="#94" name="r94"> [ 94 ] </a>
<p>    <p>      Portland's "Multifamily Energy Savings" program, initiated in 
1987, exemplifies the city's long-standing commitment to energy 
efficiency. It is intended to target the split incentive between landlord 
and tenants - where tenants typically pay utility bills, leaving 
landlords little incentive to make efficiency improvements. The program 
encourages retrofits by marketing existing efficiency services - such 
as utility audits, rebates and loans, plus state tax credits - to 
building owners. By promoting a diverse package of financial incentives, 
the program has made building owners in Portland surprisingly receptive to 
investing in energy-efficiency measures like windows, insulation, common 
area lighting, water heaters, air sealing, and heating system 
improvements. To date, the program has weatherized more than 11,050 
apartment units, producing savings of approximately 1,200 kilowatt-hours 
annually per unit. The highly successful program saved 1,412 
megawatt-hours (avoiding 151 metric tons of carbon dioxide) in 1993 alone, 
and should save 375,570 megawatt-hours over the projected life-cycle of 
the improvements (avoiding 40,186 metric tons of carbon dioxide). It 
achieved these savings at a cost of less than 1 cent per kilowatt-hour 
saved.<a href="#95" name="r95"> [ 95 ] </a>
<B><I> <p>     <A NAME="BonnevillePowerAdministration">Bonneville Power Administration </a></B></I>. The city of 
Ashland, Oregon developed one of America's premier resource conservation 
initiatives in a small community. The city's Conservation Division worked 
with the Bonneville Power Administration - the region's wholesale power 
supplier - to implement a range of energy-efficiency measures, for both 
new construction and retrofits, that conserve electricity, gas and water, 
and reduce waste. The measures include weatherization, "Good Cents" new 
homes, showerheads, and composting. More than half the savings have been 
generated in the residential sector, lowering customers' bills and 
improving occupants' comfort. Ashland has also addressed the land-use 
implications of development, and has implemented a comprehensive set of 
land-use ordinances to minimize negative aspects of development. For 
example, the city rewards resource efficiency in new developments by 
issuing "conservation bonuses" that allow developers to build more units 
than normal, increasing density while easing travel, sprawl, and demands 
on gasoline and air quality. Ashland's comprehensive resource-efficiency 
approach has created nearly 10,000 megawatt-hours in annual savings while 
cutting carbon dioxide emissions by 1,070 metric tons annually. Cumulative 
savings from 1980 through 1994 come to 66,000 megawatt-hours of 
electricity and 7,062 metric tons of carbon dioxide emissions. Over the 
life-cycle of the efficiency installations, more 26,000 metric tons of 
carbon dioxide will be saved.<a href="#96" name="r96"> [ 96 ] </a>
<p>    <p>      Bonneville's "WaterWise" program is an agricultural initiative 
that involves a comprehensive effort to conserve irrigation water and 
energy while improving crop yields, thanks to the precision application of 
water. WaterWise provides technical, financial and informational services 
to farmers east of the Cascade Mountains in Washington and Oregon. The 
program focuses on irrigation system testing and design work, hardware 
retrofits (including low pressure, mainline, and pump modification 
equipment), and irrigation management, and it provides farmers with 
detailed information on weather patterns and evapotranspiration rates for 
optimal crop watering. For an investment of $24.5 million, Bonneville has 
saved 506.3 gigawatt-hours of electricity over the decade 1983 through 
1993 - which corresponds to a carbon dioxide emissions savings of more 
than 61,250 metric tons. Over the life-cycle of the improvements installed 
during that decade, 1,419 gigawatt-hours will be saved, reducing carbon 
dioxide emissions by 171,700 metric tons.<a href="#97" name="r97"> [ 97 ] </a>
<p>    <p>      Bonneville Power administered an Aluminum Smelter Conservation/ 
Modernization program in the late 1980s that was responsible for enormous 
energy savings. The ten primary smelters in Bonneville's service territory 
consume one-third of all Bonneville power - 15 percent of all 
electricity used in the Northwest (sold by Bonneville and other 
utilities). Aluminum production is a highly electricity-intensive 
industry, with electricity purchases comprising roughly 25 percent of 
operating costs. The objective of the Conservation/ Modernization program 
was to encourage smelters to improve the efficiency of their industrial 
processes, both to remain competitive and to free up electric supply for 
other Northwest uses. Bonneville paid the smelters incentive payments for 
baseline efficiency improvements equal to half a cent per kilowatt-hour 
saved over a 10-year period, which is about one-third of the cost of 
efficiency improvements. The program has achieved electricity savings of 
4.1 percent of total industrial sales - equal to 1,057.8 gigawatt-hours 
saved per year, and 225,311 metric tons of carbon dioxide emissions 
reduced annually.<a href="#98" name="r98"> [ 98 ] </a>
<B><I> <p>     <A NAME="PugetSoundPower&Light">Puget Sound Power & Light</a></B>.</I> Puget Power's 
"Commercial and Industrial Electricity Conservation Service," begun in 
late 1978, was one of the first DSM programs to be offered to the 
commercial sector. Puget's philosophy has been to provide valuable 
customer services while controlling load growth. Puget's staff includes a 
highly-trained cadre of engineers with the technical expertise necessary 
to analyze commercial and industrial facilities. Their analyses have taken 
a whole-facility, customized approach; they look at all facets of 
electricity use and assess efficiency upgrades, including process systems, 
the building envelope, space conditioning, lighting applications, and 
water heating improvements. Puget uses a total resource cost basis for 
measuring cost effectiveness, and pays for upgrades based on the utility's 
avoided cost, a value that reflects the full life-cycle of each 
improvement. Typical incentive payments equal 60 to 80 percent of 
customers' total installation costs - a level that significantly 
exceeds most utility rebate programs. Puget generally ends up paying out 
about half its avoided cost. For instance, in 1992 the program cost an 
average of 3.3 cents per kilowatt-hour, while its avoided cost for 
measures with an average life-cycle of 15 years was 6.5 cents per 
kilowatt-hour. Efficiency improvements installed during 1992 saved 122 
gigawatt-hours in that year (16,958 metric tons of carbon dioxide saved) 
at a cost of $25.5 million, with life-cycle energy savings from those 
improvements totaling 1,823 gigawatt-hours, which should cut carbon 
dioxide emissions by 253,397 metric tons. Since the program began, the 
life-cycle savings of improvements installed between 1978 and 1992 are 
6,356 gigawatt-hours at a total cost of $101.25 million, avoiding 883,484 
metric tons of carbon dioxide emissions.<a href="#99" name="r99"> [ 99 ] </a>
<B><I><BR>
 <p>     <A NAME="SeattleCityLight">Seattle City Light<a></B>.</I> Seattle City Light, one of the 
nation's largest municipal utilities, reinforces the notion that utilities 
can effectively offer DSM services in regions characterized by low power 
rates. In 1993, Seattle City Light budgeted a precedent-setting 9.1 
percent of gross revenues for DSM. The utility's early emphasis on energy 
efficiency, however, came only after a lawsuit overturned the utility's 
planned investment in the <A NAME="WashingtonPublicPowerSupplySystem">Washington Public Power Supply System<a> (WPPSS), a 
proposed series of nuclear plants. The WPPSS decision changed the 
utility's course, prodding it to become one of the nation's leaders in 
energy efficiency.<BR>
<p>    <p>      Seattle City Light's comprehensive DSM programs cover the 
residential, commercial and industrial sectors, and have included 
weatherization, lighting, energy-efficient water heaters, and water 
efficiency measures, as well as industrial and commercial efficiency 
improvements for motors and HVAC systems. This success has been supported 
by the Bonneville Power Administration, which over time has funded nearly 
one-quarter of Seattle City Light's DSM expenditures. In 1993, efficiency 
improvements installed that year cut energy demand by 52,629 
megawatt-hours (producing a carbon dioxide reduction of 7,315 metric 
tons), which will save 885,294 megawatt-hours over the life-cycle of those 
improvements (reducing carbon dioxide emissions by 123,055 metric tons). 
Cumulatively, since the DSM programs began in 1978, Seattle City Light 
efficiency programs have saved 2,454,256 megawatt-hours (341,141 metric 
tons of carbon dioxide). Over the life-cycle of the installations, 
7,380,743 megawatt-hours will be saved - for a total life-cycle carbon 
dioxide reduction of 1,025,923 metric tons.<BR>
<a href="#100" name="r100"> [ 100 ] </a>





<hr><font size =-1>





<!--footnotes-->

<P><A NAME="93"  HREF="#r93">93.</a> Northwest Power Planning Council data, November 9, 1995. Carbon dioxide 
reduction data uses a DOE emission factor of 0.107, which is the lowest 
emission factor in the Northwest region (for the state of Oregon). Thus 
the figure understates the actual carbon dioxide reduction amount. United 
States Department of Energy<I>, Voluntary Reporting of Greenhouse Gases: 
Reporting Form and Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, 
Appendix F ("Adjusted Electricity Emission Factors by State") (Washington, 
D.C.: Energy Information Administration, June 1995); state electric 
generation capacity data is from Freedman, M., <I>Renewable Energy 
Sourcebook </I>(Washington, D.C.: Public Citizen, April 18. 1995).<BR>
<P><A NAME="94"  HREF="#r94">94.</a> U.N. General Assembly, "United Nations Framework Convention on Climate 
Change," A/AC.237/18 (Part II)/Add.1 and A/AC.237/18 (Part 
II)/Add.1/Corr.1 (United Nations, 1992). With the fiftieth ratification 
filed with the Convention's Secretariat, the FCCC entered into force on 
March 21, 1994. See note 116 and accompanying text.<BR>
<P><A NAME="95"  HREF="#r95">95.</a> The Results Center, <I>Portland Energy Office: Multifamily Energy 
Savings Program</I>, Profile #104 (Aspen, CO: IRT Environment, Inc., 
1994). Carbon dioxide reduction data uses a DOE emissions factor for 
Oregon of 0.107 metric tons/MWh. United States Department of Energy<I>, 
Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="96"  HREF="#r96">96.</a> The Results Center, <I>The City of Ashland: Comprehensive Conservation 
Programs</I>, Profile #115 (Aspen, CO: IRT Environment, Inc., 1994). 
Carbon dioxide reduction data uses a DOE emissions factor for Oregon of 
0.107 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>
<P><A NAME="97"  HREF="#r97">97.</a> The Results Center, <I>Bonneville Power Administration: WaterWise 
Program, </I>Profile #85 (Aspen, CO: IRT Environment, Inc., 1994). Carbon 
dioxide reduction data uses an average emission factor for Washington and 
Oregon of 0.132 metric tons/MWh, weighted by the electric generation 
capacity of each state, and assumes efficiency measures were evenly 
distributed between the two states. United States Department of Energy<I>, 
Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995); state electric generation 
capacity data is from Freedman, M., <I>Renewable Energy Sourcebook 
</I>(Washington, D.C.: Public Citizen, April 18, 1995).<BR>
<P><A NAME="98"  HREF="#r98">98.</a> Jordan, J., and Nadel, S., <I>Industrial Demand-Side Management 
Programs: What's Happened, What Works, What's Needed,</I> pp. 22-24 
(Washington, D.C.: American Council for an Energy-Efficient Economy, March 
1993). Carbon dioxide reduction data uses a DOE-derived average emission 
factor for WA, OR, ID and MT of 0.213 metric tons/MWh, weighted by the 
electric generation capacity of each Pacific Northwest state, and assumes 
efficiency measures for the aluminum smelters are distributed evenly among 
the four states. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.:Energy Information Administration, 
June 1995); state electric generation capacity data is from Freedman, M., 
<I>Renewable Energy Sourcebook </I>(Washington, D.C.: Public Citizen, 
April 18, 1995). Bonneville is currently transferring responsibility for 
most conservation investments to its retail utility customers. Cavanagh, 
R., personal correspondence (New York, NY: Natural Resources Defense 
Council, December 5, 1995) (notes on file with the author).<BR>
<P><A NAME="99"  HREF="#r99">99.</a> The Results Center, <I>Puget Sound Power & Light: Commercial & 
Industrial Electricity Conservation Service, </I>Profile #74 (Aspen, CO: 
IRT Environment, Inc., 1993). Carbon dioxide reduction data uses a DOE 
emissions factor for Washington State of 0.139 metric tons/MWh. United 
States Department of Energy<I>, Voluntary Reporting of Greenhouse Gases: 
Reporting Form and Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, 
Appendix F ("Adjusted Electricity Emission Factors by State") (Washington, 
D.C.: Energy Information Administration, June 1995).<BR>
<P><A NAME="100"  HREF="#r100">100.</a> The Results Center, <I>Seattle City Light: Comprehensive Municipal 
DSM, </I>Profile #103 (Aspen, CO: IRT Environment, Inc., 1994). Carbon 
dioxide reduction data uses a DOE emission factor for Washington State of 
0.139 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "C3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-168</DOCNO>
<DOCOLDNO>IA026-000277-B029-185</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/C3.html 198.77.86.203 19970113174622 text/html 9264
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:48:06 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 9093
Last-modified: Mon, 17 Jun 1996 00:29:51 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C4.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>New England DSM Successes</title>
<table><tr><td><blockquote>

<H3>3. New England DSM Successes</H3>


In 1990, New England Electric System earned $8.3 million, a 12 percent 
return, on DSM programs. By 1991, New England utilities' DSM expenditures 
had increased to about $300 million annually, with the majority of those 
expenditures targeted for energy efficiency rather than load management. 
These investments have resulted in significant economic, environmental, 
and energy-security benefits. For example, in 1991, utility DSM 
investments in New England:<P>
<ul>
 <li>     were saving 2,169 gigawatt-hours of energy annually, enough to 
heat and power the New Haven metropolitan area;<p>
 <li>     produced energy-efficiency improvements that will lower net 
electric bills by approximately $250 million over their life cycle;<p>
 <li>     saved the equivalent of 3.7 million barrels of oil;<p>
 <li>     avoided emissions of 11,800 metric tons of sulfur dioxide;<p>
 <li>     avoided emissions of 5,000 metric tons of nitrogen oxides; 
and,<p>
 <li>     avoided emissions of 1.8 million metric tons of carbon 
dioxide.<a href="#101" name="r101"> [ 101 ] </a>
</ul>
<p>     Three of the largest utilities in Massachusetts have worked 
collaboratively with environmental and consumer groups to design and 
implement DSM programs. From 1990 through 1993, investments in DSM by 
these utilities grew, such that by 1993, DSM outlays reached 5 percent of 
annual utility retail revenues. During that four-year period, investments 
totaled $540 million, including both utility and participant costs, for 
measures that produced energy savings at an average life-cycle cost of 3.8 
cents per kilowatt-hour. The life-cycle savings total 14,091 
gigawatt-hours and provide 267 megawatts of summer peak reductions. Carbon 
dioxide reductions over the life cycle of the measures total 9.3 million 
metric tons.<a href="#102" name="r102"> [ 102 ] </a>In 1994, the DSM programs of these three utilities 
accounted for about 3 percent of customer energy requirements. The net 
value of customer savings exceeded $843 million, including environmental 
benefits ($398 million if environmental externalities are excluded). The 
energy-efficiency investments have helped to defer investments in 
additional capacity.<a href="#103" name="r103"> [ 103 ] </a>

<BLOCKQUOTE><hr>
<a href = "../img/Utl-NewE.gif"><img src = "../t/Utl-NewE.gif"
 alt = "Chart 7: Benefits of New England DSM Programs" align=left></a>
 <h3><I>Chart 7: Benefits of New England DSM Programs<br clear=all><hr></I></h3>
</BLOCKQUOTE>

<B><I> <p>     <A NAME="NewEnglandElectricSystem">New England Electric System<a></B>.</I> In 1987, New England 
Electric System, which comprises three utilities - 
<B><I><A NAME="MassachusettsElectricCompany">Massachusetts Electric Company<a>, 
<A NAME="NarragansettElectric">Narragansett Electric<a>,</B></I> and 
<B><I><A NAME="GraniteStateElectric">Granite State Electric<a></B></I> - 
initiated its "Design 2000" program, which focuses 
on implementing efficiency upgrades at the time customers install new 
electrical equipment during the normal course of business. These "time 
dependent" opportunities occur during new construction, renovation, and 
when failed equipment is replaced. Design 2000 pays essentially all 
out-of-pocket expenses associated with the efficiency upgrades, which 
include lighting, motors and drives, HVAC upgrades, food-service and 
industrial-process improvements, and custom measures that employ emerging 
technologies - and then provides the participant with lower electricity 
bills. Energy savings from 1993 efficiency upgrades alone were 28,972 
megawatt-hours (saving 15,935 metric tons of carbon dioxide emissions), 
while the life-cycle savings of the measures installed in that year will 
be 416,276 megawatt-hours (a carbon dioxide emissions reduction of 228,952 
metric tons). Cumulatively since 1989, 66,220 megawatt-hours have been 
saved (preventing 36,421 metric tons of carbon dioxide emissions), while 
the life-cycle energy savings of upgrades to date will be 923,374 
megawatt-hours (avoiding carbon dioxide emissions of 530,017 metric tons). 
The Design 2000 program has saved New England Electric 14.16 megawatts of 
new capacity at a total, cumulative program cost of $21.3 million.<a href="#104" name="r104"> [ 104 ] </a>
<B><I> <p>     <A NAME="BurlingtonElectricDepartment"> Burlington Electric Department</a></B>.</I> Burlington has 
served the residents of Burlington, Vermont with a mix of electricity and 
energy-efficiency services since the late 1970s. At that time, it 
responded to the oil shocks by introducing its first energy-efficiency 
programs. More recently, local concerns over power purchases from 
Hydro-Quebec and its controversial James Bay development prompted 
Burlington voters to pass an $11 million bond issue to catalyze DSM 
programs. The utility introduced a "Smartlight" leasing program for 
compact fluorescent lamps, and promoted a program to convert electric 
resistance heating to other fuels in order to reduce winter peak load. Six 
other programs offer customers a comprehensive package of DSM options. 
Cumulative energy savings from 1991 through 1993 totaled 33,944 
megawatt-hours (preventing 2,444 metric tons of carbon dioxide emissions), 
and over the life cycle of these installations will save 290,183 
megawatt-hours (preventing 20,893 metric tons of carbon dioxide 
emissions).<a href="#105" name="r105"> [ 105 ] </a>
<p>     <BR>





<hr><font size =-1>





<!--footnotes-->
<P><A NAME="101"  HREF="#r101">101.</a> Conservation Law Foundation, <I>Power to Spare II: Energy Efficiency 
and New England's Economic Recovery</I>, p. 7 (Boston, MA: June 1992).<BR>
<P><A NAME="102"  HREF="#r102">102.</a> This carbon dioxide reduction data uses a DOE emission factor for 
Massachusetts of 0.662 metric tons/MWh. United States Department of 
Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="103"  HREF="#r103">103.</a> Coakley, S., and Schlegel, J., <I>Comparing Electric Utility DSM 
Planning and Evaluation Estimates in Massachusetts: Are We Getting What We 
Planned For?,</I> p. 303 (Chicago, IL: International Energy Program 
Evaluation Conference, August 23, 1995).<BR>
<P><A NAME="104"  HREF="#r104">104.</a> The Results Center, <I>New England Electric System: Design 2000, 
</I>Profile #92 (Aspen, CO: IRT Environment, Inc., 1994). Carbon dioxide 
reduction data uses a DOE-derived, average emission factor for 
Massachusetts, Rhode Island and New Hampshire of 0.574 metric tons/MWh, 
weighted by the electric generation capacities of these New England 
states, and assumes efficiency measures are installed evenly among the 
three states. United States Department of Energy<I>, Voluntary Reporting 
of Greenhouse Gases: Reporting Form and Instructions</I>, Form EIA-1605EZ, 
OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission Factors by 
State") (Washington, D.C.: Energy Information Administration, June 1995); 
electric generation capacity data is from Freedman, M., <I>Renewable 
Energy Sourcebook </I>(Washington, D.C.: Public Citizen, April 18, 
1995).<BR>
<P><A NAME="105"  HREF="#r105">105.</a> The Results Center, <I>Burlington Electric Department: Comprehensive 
Municipal DSM,</I> Profile, #98 (Aspen, Co.: IRT Environment, Inc., 1994). 
Carbon dioxide reduction data uses a DOE emission factor for Vermont of 
0.072 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>




<!--start foot--><p align=right><a href = "C4.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-169</DOCNO>
<DOCOLDNO>IA026-000277-B029-222</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/C4.html 198.77.86.203 19970113174649 text/html 6193
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:48:44 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 6022
Last-modified: Mon, 17 Jun 1996 00:29:52 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C5.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->

<title>New York DSM Successes</title>
<table><tr><td><blockquote>



<H3>4. New York DSM Successes<BR>
 </H3>
     
DSM programs in New York provided net life-cycle energy savings to 
customers of $1.4 billion during the period 1990 to 1994.<a href="#106" name="r106"> [ 106 ] </a>
<BR>
<B><I> <p>     <A NAME="ConsolidatedEdison">Consolidated Edison</a>. </B></I>Consolidated Edison's 
"Commercial & Industrial Efficient Lighting Incentives Program" provides 
commercial and industrial customers with lighting rebates of 25 cents per 
watt of lighting load removed for fluorescent ballast upgrades.  Lighting 
control devices are rebated at 10 cents per watt of connected lighting 
load.  Under the Shared Energy Savings financing approach, Con Edison 
provides up-front installation costs with customer repayment derived from 
energy savings over a payback period of up to five years.  Under this 
approach, Con Edison recovers its costs while customers receive the 
benefits of an immediate positive cash flow from energy savings without 
any capital outlay requirements.  From 1990 through 1994, the program 
achieved approximately 1,251 gigawatt-hours of annualized energy savings 
and 311 megawatts of system peak reductions, cutting carbon dioxide 
emissions by 587,970 metric tons.<a href="#107" name="r107"> [ 107 ] </a>
<p>     Con Edison's "Commercial & Industrial High Efficiency Motor Incentive 
Program" encourages commercial and industrial customers to install 
high-efficiency electric motors and variable frequency drives (VFDs).  Con 
Edison pays $10 per horsepower for motors meeting the utility's minimum 
efficiency standards, which fully offsets the differential equipment cost 
incurred by customers.  The current incentive level for VFDs is either $50 
or $90 per horsepower depending upon the pump and fan HVAC application.  
Here again, a Shared Energy Savings approach is offered as an alternative 
to rebates.  From 1990 through 1994, this successful program saved 
approximately 137 gigawatt-hours in annualized energy and reduced the 
system peak by approximately 5 megawatts, and cut carbon dioxide emissions 
by 64,390 metric tons.<BR>
<p>     Con Edison's "Dealer Incentive Programs" are point-of-purchase 
incentive programs for retail businesses that sell energy-efficient 
appliances and equipment.  Con Edison encourages retail salespeople and 
their managers to sell high-efficiency units, such as air conditioners and 
refrigerators, by awarding credits which are redeemable for merchandise or 
travel.  No direct incentives are offered to customers.  The program is 
transforming the appliance and equipment market: appliance dealers have 
substantially increased their stock of highly-efficient appliances. From 
1990 through 1994, this and other of Con Edison's residential DSM programs 
have saved approximately 60 gigawatt-hours in annualized energy and 
reduced the system peak by approximately 28 megawatts, cutting carbon 
dioxide emissions by 28,200 metric tons.<BR>
<p>     Other Con Edison DSM programs include the "Commercial & Industrial 
High-Efficiency Electric Space Conditioning Incentive Program," "Steam 
Air-Conditioning Program," "Commercial & Industrial Customized 
Energy-Efficiency Program," "Curtailable Electric Service Program," 
"Residential Compact Fluorescent Program," and "Residential Submetering 
Program."  Con Edison's DSM programs have saved over 1,800 gigawatt-hours 
on an annualized basis during the 1990-1994 period, with associated peak 
demand savings of about 585 megawatts.  The programs have avoided 846,000 
metric tons of carbon dioxide emissions.<a href="#108" name="r108"> [ 108 ] </a>
<p>      <BR>


<hr><font size =-1>





<!--footnotes-->
<P><A NAME="106"  HREF="#r106">106.</a> New York Public Service Commission, <I>Energy Conservation Fact 
Sheet</I> (Pace University Center for Environmental Legal Studies, 
September 1994).<BR>
<P><A NAME="107"  HREF="#r107">107.</a> Consolidated Edison, corporate data (December 19, 1995).  Carbon 
dioxide reduction data uses an emission factor of 0.470 metric tons/MWh 
for the state of New York.  United States Department of Energy, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>
<P><A NAME="108"  HREF="#r108">108.</a> Consolidated Edison, corporate data (December 19, 1995).  Carbon 
dioxide reduction data uses an emission factor of 0.470 metric tons/MWh 
for the state of New York.  United States Department of Energy, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>






</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "C5.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-170</DOCNO>
<DOCOLDNO>IA026-000277-B029-261</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/C5.html 198.77.86.203 19970113174703 text/html 6573
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:49:08 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 6402
Last-modified: Mon, 17 Jun 1996 00:29:52 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C4.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Wisconsin DSM Successes</title>
<table><tr><td><blockquote>

<H3>5. Wisconsin DSM Successes</H3>
Wisconsin utilities achieved a cumulative reduction in energy demand from 
1988 to 1994 of 2,959 gigawatt-hours, which avoided 1.8 million metric 
tons of carbon dioxide emissions. In 1994 alone, Wisconsin's DSM programs 
saved 549 gigawatts, which cut carbon dioxide emissions in that year by 
334,000 metric tons. Such savings are projected to continue, albeit at a 
declining rate, primarily due to uncertainties surrounding utility 
industry restructuring. Savings in 1995 are projected to be 451 
gigawatt-hours, cutting carbon dioxide emissions by 274,000 metric tons. 
Cumulatively from 1995 through 2013, projections show that Wisconsin DSM 
programs could reduce electricity usage by 5,152 gigawatt-hours, which 
could prevent more than 3.1 million metric tons of carbon dioxide 
emissions. <a href="#109" name="r109"> [ 109 ] </a>
<p>     <BR>
<B><I> <p>     <A NAME="WisconsinElectric">Wisconsin Electric<a></B>.</I> Wisconsin Electric assists in 
providing energy-efficient, affordable housing for low- and 
moderate-income families. Through several innovative grant and loan 
programs, Wisconsin Electric seeks to instill an energy-efficiency ethic 
among low-income housing providers, community- based service agencies, and 
low-income energy customers. Projects have included installing 
energy-efficient fluorescent lights and refrigerators in a newly renovated 
emergency shelter in Milwaukee, in 13 low-income apartments in a recently 
converted building that had been a vacant elementary school, and in 18 
transitional housing units in a joint project with the Milwaukee YWCA. The 
lighting retrofit saves the YWCA more than 15,000 kilowatts annually, and 
prevents more than 9 metric tons of carbon dioxide emissions each year. 
Wisconsin Electric also installed electric energy-efficiency measures in 
<B><I><A NAME="GoodwillIndustries">Goodwill Industries<a></B></I> facilities that annually save an 
estimated $33,000 in electric bills. Another project teamed Wisconsin 
Electric with the Milwaukee Housing Authority to upgrade the electrical 
efficiency of 527 public housing units. Wisconsin Electric programs target 
low-income customers who do not have the financial resources to invest in 
energy conservation measures. Through these programs, Wisconsin Electric 
has cut energy demand by more than 4.4 million kilo-watt 
hours - preventing some 2,680 metric tons of carbon dioxide 
emissions.<a href="#110" name="r110"> [ 110 ] </a>
<BR>
<B><I> <p>     <A NAME="MadisonGasandElectric">Madison Gas and Electric<a></B>.</I> A small, investor-owned 
utility that sells both electricity and gas, Madison Gas and Electric 
(MGE) has been a pioneer in DSM programs. A 1991 DOE study found MGE to be 
one of nine leading utilities nationally in the delivery of rebate 
programs. Through its "Residential Lighting Program," MGE has been able to 
shift the Madison market away from incandescent lighting and into a 
reliable market for high-efficiency products, achieving maximum customer 
and utility energy savings at the least cost. For instance, in 1990 there 
were only four retailers in MGE service territory selling six models of 
compact fluorescent lamps. Now there are 62 retailers (out of 100 total 
retailers) selling a total of 63 models of compact fluorescents. MGE 
distributes rebate coupons for $5 or $10 off eligible lighting measures, 
and $15 or $30 off other measures, to both end-use customers and to retail 
stores. MGE offers to pay 50 percent of retailer costs for cooperative 
energy-efficient lighting advertising. MGE provides lists of retailers 
stocking compact fluorescents to its customers, and assists with in-store 
displays. Sales have skyrocketed so much that MGE has been able to slowly 
phase-out rebates and move toward consumer education to continue high 
sales volumes. Cumulative energy savings since 1990 are 23,799 
megawatt-hours, saving 738 kilowatts of capacity, and avoiding 14,494 
metric tons of carbon dioxide emissions at a program cost of $1.5 
million.<a href="#111" name="r111"> [ 111 ] </a>
<P>
<BR>






<hr><font size =-1>





<!--footnotes-->

<P><A NAME="109"  HREF="#r109">109.</a> Public Service Commission of Wisconsin, <I>The Future of Wisconsin's 
Electric Power Industry: Environmental Impact Statement, Volume I</I>, PSC 
Docket 05-EI-114, p. 99 (October 1995). Carbon dioxide reduction data uses 
an emission factor of 0.609 metric tons/MWh for the state of Wisconsin. 
United States Department of Energy<I>, Voluntary Reporting of Greenhouse 
Gases: Reporting Form and Instructions</I>, Form EIA-1605EZ, OMB No. 
1905-0194, Appendix F ("Adjusted Electricity Emission Factors by State") 
(Washington, D.C.: Energy Information Administration, June 1995).<BR>
<P><A NAME="110"  HREF="#r110">110.</a> Carbon dioxide reduction data uses a DOE emission factor of 0.609 
metric tons/MWh for the state of Wisconsin. United States Department of 
Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C4.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-171</DOCNO>
<DOCOLDNO>IA026-000277-B029-298</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/D.html 198.77.86.203 19970113174801 text/html 15476
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:49:56 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 15304
Last-modified: Mon, 17 Jun 1996 00:29:53 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "E.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C5.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Federal Initiatives</title>
<table><tr><td><blockquote>

<H2><I>D. </I>Federal Initiatives Continue to Spur Efficiency Successes</H2>

<BR>
Federal and state support for efficiency programs has been critical to the 
success of programs nationwide. According to the Congressional Research 
Service, the federal government has spent a total of $5.7 billion on 
energy-efficiency research and development since 1973. Technologies 
advanced by these efforts have saved American homeowners and businesses 
$226 billion, and will save billions more over the life cycle of the 
efficiency <BR>
improvements.<a href="#112" name="r112"> [ 112 ] </a>Several of the federal program success stories are 
reviewed below.<BR>
<BR>
 <p>     <B><I>U.S. Environmental Protection Agency and U.S. Department of 
Energy "Climate Wise" Program.</B></I> Administered jointly by the EPA and 
DOE, the Climate Wise program is a voluntary program that works with 
businesses (with a focus on manufacturing firms) to install cost-effective 
energy efficiency and pollution prevention strategies. Climate Wise 
participants currently represent almost 4 percent of U.S. industrial 
energy use. <BR>
<p>    <p>      By joining Climate Wise, businesses agree to initiate, expand, 
or accelerate a set of cost-effective measures to improve efficiency, 
including (1) improving equipment and manufacturing process efficiencies, 
(2) utilizing fuel switching and improved management practices, (3) 
integrating efficiency into new product design and manufacturing, and (4) 
participation in other federal voluntary programs, such as Green Lights 
(to install efficient lighting), Motor Challenge (to improve motor 
efficiencies), Waste Wi$e (to integrate waste reduction strategies), and 
NICE3 (to demonstrate energy-efficient, pollution-preventing 
technologies). Companies that have initiated Climate Wise programs have 
achieved significant economic and environmental benefits. By the year 
2000, current Climate Wise companies expect to save more than $80 million 
annually.<BR>
<p>    <p>      In return for their participation, Climate Wise companies 
receive technical assistance from federal agencies and national 
laboratories, utilities, trade associations, and state and local energy, 
pollution prevention, and economic development offices. 
Business-to-business exchange workshops facilitate replication of 
successful efficiency models. Financial assistance can be arranged through 
guaranteed loans, low-interest buy-downs from state providers, state tax 
credits, utility programs, and private-sector financing opportunities. 
Climate Wise "showcases" projects and businesses that demonstrate 
significant greenhouse gas emissions reductions, and sponsors media 
events, awards programs, and other promotional activities.<a href="#113" name="r113"> [ 113 ] </a>
<B><p>     <I><A NAME="Dupont">Dupont<a>,</B></I> headquartered in Wilmington, Delaware, has 
installed energy-efficiency improvements through the Climate Wise Program 
that are currently saving $31 million annually. Dupont estimates that 
further energy-efficiency improvements, including fuel switching, improved 
steam balance and waste heat reductions, will reduce carbon dioxide 
emissions by 18 million metric tons annually by the year 2000 from 1990 
emission levels.<a href="#114" name="r114"> [ 114 ] </a>
<B><p>     <I><A NAME="AT&T">AT&T</a>,</B></I> in Basking Ridge, New Jersey, is installing 
efficiency improvements through the Climate Wise program projected to save 
the company $50 million each year and offset 154,000 metric tons of carbon 
dioxide annually by the year 2000.<a href="#115" name="r115"> [ 115 ] </a>
<BR>
<B><I> <p>     U.S. Department of Energy "Climate Challenge" 
Program</B>.</I> The United States was one of 154 nations and the European 
Community to sign the United Nations Framework Convention on Climate 
Change (FCCC) in Rio de Janeiro in 1992.<a href="#116" name="r116"> [ 116 ] </a>Domestic implementation of the 
U.S. commitment - which is to reduce U.S. greenhouse-gas emissions to 
1990 levels by the year 2000 - follows mostly voluntary measures set 
forth in President Clinton's Climate Change Action Plan. The plan, issued 
in October 1993, seeks 108 million metric tons of carbon dioxide 
reductions and calls on electric utilities to provide much of those 
reductions.<a href="#117" name="r117"> [ 117 ] </a>
<p>    <p>      Climate Challenge is the primary element of the plan that 
directly involves electric utilities. As of March 1995, 79 utilities, 
representing more than half of U.S. electricity generation, had signed 
agreements with DOE to participate in Climate Challenge, pledging to 
reduce carbon dioxide emissions by 41 million metric tons by the year 
2000. DSM programs account for 18 percent of the reductions planned in 
Climate Challenge.<a href="#118" name="r118"> [ 118 ] </a>
<P>
<BR>
<B><I> <p>     Federal Energy Management Program (FEMP).</B></I> As the 
world's largest consumer of goods and services, the federal government has 
a major impact on the marketplace. Energy consumption by the federal 
government can be reduced substantially through energy-efficiency 
measures. FEMP coordinates the reduction effort. If all agencies 
implemented the FEMP requirements of the Energy Policy Act of 1992 (EPAct) 
and Executive Order 12902,<a href="#119" name="r119"> [ 119 ] </a>the agencies would save as much as $400 
million annually by 2000 and $1 billion annually by 2005.<a href="#120" name="r120"> [ 120 ] </a>FEMP has 
successfully cut net energy consumption by 20 percent in four federal 
agencies (Energy, Interior, Justice, and the Federal Emergency Management 
Agency), and by 10 percent in six more (Agriculture, Defense, 
Transportation, Veterans Affairs, General Services Administration, and 
NASA). One of FEMP's strengths is its ability to attract outside resources 
to aid in the task of saving energy; the program leverages about $3 in 
savings for every dollar of taxpayer expenditures.<a href="#121" name="r121"> [ 121 ] </a>FEMP's efforts have 
cut the equivalent of 3 million metric tons of carbon dioxide 
emissions.<a href="#122" name="r122"> [ 122 ] </a>
<B><I> <p>     U.S. Department of Energy "Weatherization Assistance 
Program</B>.<B>"</B></I> The DOE's Weatherization Assistance Program (WAP) 
provides, through state energy offices, grants to community-based service 
providers for weatherization of low-income family residences, particularly 
those housing children, the elderly, and disabled family members. Since 
its inception in 1976, WAP has lowered the energy costs of more than 4.4 
million homes, saving the equivalent of 12 million barrels of oil. A 
typical family served by the program has an annual income of $7,641, and 
as a result of the program, saved 18.2 percent off their annual heating 
costs. State and local agencies have leveraged more than $200 million each 
year to increase the number of assisted homes to about 225,000 annually. 
In fiscal year 1996, WAP is slated to weatherize an additional 116,145 
homes. A 1990 <A NAME="OakRidgeNationalLaboratory">Oak Ridge National Laboratory.<a> study determined that for 
every dollar invested by DOE in WAP, $1.72 in energy savings results. WAP 
is also responsible for substantial job creation - 52 jobs for every $1 
million of federal funds invested, plus another 22 indirect jobs.<a href="#123" name="r123"> [ 123 ] </a>
<BR>
<B><I> <p>     State Energy Conservation Program</B>.</I> The 
federally-supported State Energy Conservation Program (SECP) provides the 
resources for many of the services provided by state energy offices. SECP 
funds are used nationwide for energy training, waste minimization, 
recycling, home energy rating systems, computerized bus routings to save 
energy, energy emergency planning, promotion of natural gas vehicles, and 
many other activities. Many states use SECP funds to provide technical 
assistance to businesses and industries for reducing their energy 
consumption, thus reducing associated costs.<a href="#124" name="r124"> [ 124 ] </a>
<B><I> <p>     Institutional Conservation Program</B>.</I> The 
Institutional Conservation Program (ICP) provides matching funds and 
technical assistance to schools and hospitals for energy-saving capital 
improvements for buildings, equipment, mechanical systems, and controls. 
Approximately 65,000 buildings - 22 percent of all eligible structures 
in the country - have had energy improvements through ICP. DOE 
estimates the cumulative energy cost savings directly attributable to 
ICP-supported retrofits totaled $4.1 billion through 1991. The ICP 
typically provides 50 percent of the efficiency investment costs, which 
are matched either by state or private sources. The average project takes 
three years to generate a positive cash flow from energy savings, but the 
annual return on investment is then greater than 33 percent. In addition, 
the projects generate substantial employment opportunities in the 
construction industry.<BR>
<p>     <BR>
These federal energy-efficiency programs make it possible for numerous 
state and local agencies to provide the technical and financial capacity 
for residential, commercial and industrial DSM programs. The nationwide 
efficiency effort has reduced national energy use; if the United States 
were still consuming energy as intensively as it did in 1973, it would 
have consumed approximately 116 quads in 1992 instead of the 85.5 quads 
actually consumed. This reduction in energy use represents a savings in 
energy costs to the American consumer of approximately $170 billion.<a href="#125" name="r125"> [ 125 ] </a>
Federal energy-efficiency investments have been critical - and 
successful. Still greater financial and environmental gains could result 
from far-sighted national policies that bolster energy-efficiency and DSM 
budgets.<P>





<hr><font size =-1>





<!--footnotes-->
<P><A NAME="112">112.</a>The Results Center, <I>Madison Gas & Electric: Residential Lighting 
Program Niagara Mohawk Power Corporation: Commercial/Industrial Lighting 
Rebate, </I>Profile #69 (Aspen, CO: IRT Environment, Inc., 1993). Carbon 
dioxide reduction data uses an emission factor of 0.609 metric tons/MWh 
for the state of Wisconsin. United States Department of Energy<I>, 
Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="112"  HREF="#r112">112.</a> Sustainable Energy Budget Coalition, <I>Penny Wise, Pound Fuelish: 
Congressional Energy Budget Proposals, a State-By-State Analysis,</I> pp. 
4-5 (Tacoma Park, MD: June 1, 1995). These savings figures do not count 
the reduction in pollution, oil imports, and threat of climate change 
reduced by federal efficiency investments. The same Congressional Research 
Service study found that the U.S. annual trade deficit would be $16 
billion larger were it not for these federal investments. <I>Id.</I><BR>
<P><A NAME="113"  HREF="#r113">113.</a> United States Environmental Protection Agency and United States 
Department of Energy, <I>The Climate Wise Partnership Agreement and Action 
Plan</I>, pp. 1-6 (Washington, D.C.: EPA Office of Policy, Planning and 
Evaluation, DOE Office of Energy Efficiency and Renewable Energy, 
1994).<BR>
<P><A NAME="114"  HREF="#r114">114.</a> <I>Id., </I>p. 7.<BR>
<P><A NAME="115"  HREF="#r115">115.</a> <I>Id.</I><BR>
<P><A NAME="116"  HREF="#r116">116.</a> U.N. General Assembly, "United Nations Framework Convention on Climate 
Change," A/AC.237/18 (Part II)/Add.1 and A/AC.237/18 (Part 
II)/Add.1/Corr.1 (United Nations, 1992). <BR>
<P><A NAME="117"  HREF="#r117">117.</a> Clinton, President William J., and Gore, Vice President Albert, Jr., 
<I>The Climate Change Action Plan</I>, DOE/PO-0011-2, p. 5 (Washington, 
D.C.: October, 1993).<BR>
<P><A NAME="118"  HREF="#r118">118.</a> United States Department of Energy, <I>Energy for Today and Tomorrow: 
Investments for a Strong America, </I>Fiscal Year 1996 Budget-in-Brief, p. 
13 (Washington, D.C.: Office of Energy Efficiency & Renewable Energy, 
1995); Hirst, E., & Eto, J., <I>Justification for Electric-Utility 
Energy-Efficiency Programs</I>, ORNL/CON-419, LBNL-37593, p. 19 (Oak 
Ridge, TN: Oak Ridge National Laboratory, August 1995).<BR>
<P><A NAME="119"  HREF="#r119">119.</a> Federal agencies are directed to reduce their energy consumption by 30 
percent, compared to their 1985 consumption levels, by 2005. Energy Policy 
Act of 1992, Pub. L. No. 102-486, 106 Stat. 2776 (1992), 42 U.S.C.A. 
&#167;&#167; 13201-556 (West Supp. 1994) (EPAct). Executive Order 12902 
assigned responsibility for coordinating agency compliance efforts to the 
DOE's FEMP program.<BR>
<P><A NAME="120"  HREF="#r120">120.</a> Sustainable Energy Budget Coalition, <I>Penny Wise, Pound Fuelish: 
Congressional Energy Budget Proposals, a State-By-State Analysis,</I> p. 
24 (Tacoma Park, MD: June 1, 1995).<BR>
<P><A NAME="121"  HREF="#r121">121.</a> <I>Id.</I><BR>
<P><A NAME="122"  HREF="#r122">122.</a> United States Department of Energy, <I>Energy for Today and Tomorrow: 
Investments for a Strong America, </I>Fiscal Year 1996 Budget-in-Brief, p. 
16 (Washington, D.C.: Office of Energy Efficiency & Renewable Energy, 
1995).<BR>
<P><A NAME="123"  HREF="#r123">123.</a> Sustainable Energy Budget Coalition, <I>Penny Wise, Pound Fuelish: 
Congressional Energy Budget Proposals, a State-By-State Analysis,</I> pp. 
23-24 (Tacoma Park, MD: June 1, 1995); United States Department of Energy, 
<I>Energy for Today and Tomorrow: Investments for a Strong America, 
</I>Fiscal Year 1996 Budget-in-Brief, p. 13 (Washington, D.C.: Office of 
Energy Efficiency & Renewable Energy, 1995).<BR>
<P><A NAME="124"  HREF="#r124">124.</a> Sustainable Energy Budget Coalition, <I>Penny Wise, Pound Fuelish: 
Congressional Energy Budget Proposals, a State-By-State Analysis,</I> p. 
24 (Tacoma Park, MD: June 1, 1995).<BR>
<P><A NAME="125"  HREF="#r125">125.</a> <I>Id., </I>pp. 19-20.<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "E.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C5.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-172</DOCNO>
<DOCOLDNO>IA026-000277-B029-327</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/E.html 198.77.86.203 19970113174817 text/html 5649
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:50:20 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 5478
Last-modified: Mon, 17 Jun 1996 00:29:54 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "F.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>DSM Programs Could Become an Essential Utility Service</title>
<table><tr><td><blockquote>


<H2><I>E. </I>DSM Programs Could Become an Essential Utility Service in a 
Restructured Utility Industry<BR></H2>

<BR>
The utility industry is in the middle of a major restructuring. Adoption 
of the National Energy Policy Act of 1992 (EPAct)<a href="#126" name="r126"> [ 126 ] </a>has, by deregulating 
electricity sales among wholesale power buyers, stimulated a competitive 
wholesale power market while leaving end-user deregulation to the 
states.<a href="#127" name="r127"> [ 127 ] </a>Although the prospect of increased competition is leading some 
utilities to reduce or eliminate their DSM programs (because these 
programs often increase electricity prices), on a national level, DSM 
expenditures by utilities are projected to rise steadily through 1998.<a href="#128" name="r128"> [ 128 ] </a>
Utilities are likely to refocus their DSM programs on customer service and 
customer productivity in an effort to retain market share and to gain new 
customers.<a href="#129" name="r129"> [ 129 ] </a>
<p>     The transition to competitive markets is a window of opportunity for 
improved energy efficiency and renewables development. The bottom line is 
that the new industry structure should be <I>more efficient</I> - both 
economically and in terms of environmental protection. Enhanced 
competition and environmental protection need not be enemies. 
Restructuring and re-regulation of the utility industry must incorporate 
efficiency and renewables development if the United States is to meet its 
international obligations to reduce the threat of global climate 
change.<P>
<BR>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="126"  HREF="#r126">126.</a> Energy Policy Act of 1992, Pub. L. No. 102-486, 106 Stat. 2776 (1992), 
42 U.S.C.A. &#167;&#167; 13201-556 (West Supp. 1994) (EPAct). Title XVI of 
EPAct, titled "Global Climate Change," set forth a number of targets 
designed to promote a national least-cost energy strategy, including:<BR>
(a) A 30 percent increase in energy efficiency by 2010, based upon 1988 
levels;(b) A 75 percent increase in the use of renewable energy by 2005, 
based upon 1988 levels;(c) A reduction in U.S. oil consumption from 40 
percent to 35 percent of total energ<BR>
y use by 2005.<BR>
<P><A NAME="127"  HREF="#r127">127.</a> There are important reasons to restructure the present 
vertically-integrated utilities, and spin off generation, transmission, 
and distribution as separate legal entities&#173;including conflicts of 
interest among the three functions. For example, the business purpose of 
generation companies will be to maintain as much market share as possible 
within current retail service territories. On the other hand, distribution 
companies in a restructured industry - which provide hook-up services 
to end users -  will seek to influence the generation portfolios that 
serve many, if not all, of their customers. Distribution companies will be 
in the energy services business, and will seek to provide a mix of energy 
resources as demanded by end-use customers. The portfolio provided by 
distribution companies may well include a mix that maximizes energy 
efficiency and renewables over more polluting generation sources. If the 
distribution companies help in any way to select the winners in an 
increasingly competitive generation marketplace, distribution's ownership 
of some of the generation competitors is a fundamental conflict of 
interest. Divestiture is perhaps the only solution. The utility industry 
would ultimately be comprised of independent electricity distribution, 
transmission, and generation companies. <I>See</I> Cavanagh, R., 
<I>Restructuring for Sustainability: Energy-Efficiency Solutions in the 
New Electric Services Industry</I>, pp. 8-9 (New York, NY: Natural 
Resources Defense Council, October 16, 1995).<BR>
<P><A NAME="128"  HREF="#r128">128.</a> Hirst, E., and Hadley, S., "The DSM Sky Hasn't Fallen Yet," <I>The 
Electricity Journal</I>, Vol. 7, No. 10, p. 79 (Seattle, WA: December 
1994).<BR>
<P><A NAME="129"  HREF="#r129">129.</a> Hirst, E., and Eto, E., <I>Justification for Electric-Utility 
Energy-Efficiency Programs</I>, ORNL/CON-419, LBNL-37593, pp. 48-49 (Oak 
Ridge, TN: Oak Ridge National Laboratory, August 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "F.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-173</DOCNO>
<DOCOLDNO>IA026-000277-B029-366</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/F.html 198.77.86.203 19970113174857 text/html 12710
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:50:54 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 12538
Last-modified: Mon, 17 Jun 1996 00:29:55 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "G.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "E.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Industrial Efficiency Services Will Exemplify Efficiency Programs</title>
<table><tr><td><blockquote>


<H2><I>F. </I>Industrial Efficiency Services Will Exemplify Efficiency Programs 
in a Restructured Industry</H2>

<BR>
Implementing effective industrial efficiency programs requires specialized 
expertise. By far, the greatest energy-efficiency savings are gleaned from 
changes in the industrial process. Process equipment and manufacturing 
configurations account for a whopping 90 percent of a typical industrial 
firm's overall energy use. <BR>
<p>     Many utilities hesitate to invest the time and effort required to 
locate trained assessors capable of evaluating different types of 
manufacturing operations. Utilities, however, have a compelling reason to 
target industry: industrial firms consume roughly 25 percent of all energy 
consumed in the United States.<a href="#130" name="r130"> [ 130 ] </a><BR>
<p>     A number of case studies demonstrate that utility-industry 
partnerships can deliver efficiency improvements to the industrial process 
which save money, increase production, while reducing emissions. By 
bundling energy-efficiency <I>services</I> with power sales to their 
largest customers - services that include assistance with process 
manufacturing improvements that streamline operations and save on utility 
bills<a href="#131" name="r131"> [ 131 ] </a>#139;industries stay put, jobs remain in the local area, and 
utilities improve their customer relations. Industrial DSM programs will 
be a key component of utility restructuring. As the following examples 
attest, successful industrial DSM programs are already underway in several 
regions.<BR>
<BR>
<B><I> <p>     <A NAME="WesternMassachusettsElectric">Western Massachusetts Electric<a>.</B></I> Western 
Massachusetts Electric serves 810 industrial customers, which make up 27.1 
percent of its load. The utility, strapped with high rates due to the cost 
of bringing a nuclear power plant on line, had, on average in 1992, the 
third-highest electrical rates in Massachusetts - 8.9 cents per 
kilowatt-hour for industrial customers. But Western Massachusetts Electric 
now works directly with its industrial customers to find solutions to its 
high rates and to enhance customer competitiveness.<a href="#132" name="r132"> [ 132 ] </a>
<p>    <p>      For example, <B><I><A NAME="GreenfieldIndustries">Greenfield Industries<a>,</B></I> a machine tool 
manufacturer and a Western Massachusetts Electric customer, had to cut 
costs and improve competitiveness if it was to remain in business. The 
utility stepped in with technical advice, and partnered with Greenfield to 
restructure the production line. The utility first offered to pay for a 
walk-through assessment of the plant, and subsequently subcontracted out a 
more detailed energy assessment, and it split the costs with Greenfield. 
Most of the measures recommended in the assessment were then implemented 
by the subcontractor, including new vacuum furnaces and monitoring plans. 
The utility paid an incentive rebate based on an avoided cost of 5 cents 
per kilowatt-hour. The rebate was enough to ensure that Greenfield's 
expenses for the retrofits paid for themselves from energy savings over 
just two years. Greenfield spent roughly $2 million on the new furnaces 
and plant reorganization, which included moving from a production process 
design that used 300,000 square feet across nine floors to one that 
utilized only 60,000 square feet an one floor. As a result of the 
improvements, Greenfield's production has risen 25 percent, market share 
has expanded, product quality has improved, and scrap rates have declined 
sharply. The firm estimates that 90 percent of its improved outlook is due 
to the process efficiency improvements - made possible by Western 
Massachusetts Electric. Greenfield's annual energy costs have fallen from 
$1 million to less than $400,000. The two new vacuum furnaces alone cut 
electricity consumption by 82 percent; the old furnaces consumed 1.8 
million kilowatt-hours annually, while the new furnaces use 314,300 
kilowatts per year, which means that carbon dioxide emissions decreased by 
984 metric tons annually.<a href="#133" name="r133"> [ 133 ] </a>
<p>    <p>      The process efficiency improvements also eliminated 
manufacturing steps required by the old system, which necessitated the use 
of chlorofluorocarbons as well as cyanide. In fact, the utility 
partnership helped the company essentially eliminate hazardous waste 
generation. Productivity is up; managers have hired two new employees and 
expect to hire 12 to 16 more in the near future. In sum, the 
utility-industry partnership increased dramatically the facility's energy 
efficiency, reduced its generation of hazardous wastes, and improved 
productivity substantially. Equally important, employees are committed to 
continuous process improvements in production and in reducing waste. The 
change in employee outlook builds an enhanced pride in the company, and 
further spurs productivity.<a href="#134" name="r134"> [ 134 ] </a><P>
<B><I> <p>     <A NAME="WisconsinElectric">Wisconsin Electric<a>.</B></I> Wisconsin Electric's "Smart 
Money for Business" program offers commercial and industrial customers 
zero-to-low interest loans or cash rebates for installing qualifying 
energy-efficiency measures. Prescriptive rebates are available for 
lighting, motor, HVAC, and refrigeration measures, while custom incentives 
are available for process-related improvements and are negotiated with 
each participant (between 15 and 30 percent of a custom project's total 
costs are typically covered by the incentive). Utility engineers 
communicate with process-level plant personnel, marketing the program to 
them; larger projects involve senior management of both the utility and 
customer simultaneously. More than half of all Wisconsin Electric's 
industrial customers have received rebates or loans through the Smart 
Money program. The utility has found that personal, one-on-one contact 
with the customer while providing technical expertise is essential to 
successful process-oriented programs. The program has reduced the 
utility's sales to industrial customers by 2.5 percent, at a levelized 
cost of 2.1 cents per kilowatt-hour saved. From 1987 through October 1993, 
Wisconsin Electric's cumulative electricity savings were 357,600 
megawatt-hours, deferring 71.7 megawatts of capacity and cutting carbon 
dioxide emissions by 217,778 metric tons.<a href="#135" name="r135"> [ 135 ] </a>
<B><I> <p>     <A NAME="BonnevillePowerAdministration">Bonneville Power Administration </a>. </B></I> Bonneville's 
decentralized, flexible "Energy $avings Plan" seeks to form partnerships 
with industrial customers and tailor process efficiency improvements to 
their needs. For example, the <B><I><A NAME="HolnamCompany">Holnam Company<a>,</B></I> a cement 
manufacturer in Seattle, sought to reduce its rising energy costs to 
compete in an increasingly competitive market for cement in the Pacific 
Northwest. Based on an assessment and plant evaluation sponsored by 
Bonneville, Holnam carried out four energy-efficiency projects, at a total 
cost of $248,232. Bonneville reimbursed the company $115,615 to account 
for the saved energy. The four projects, all of which targeted the 
production process, included kiln drive motors, kiln stack gas 
precipitators, cooler grate drive motors, and cooler fan motors. They will 
save a projected 1,782 megawatt-hours, or 3.4 kilowatt-hours per ton of 
cement, annually - improving productivity. These savings cut carbon 
dioxide emissions by 248 metric tons annually.<a href="#136" name="r136"> [ 136 ] </a>Most important, the 
partnership has established a flexible mechanism for future process 
efficiency improvements.<BR>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="130"  HREF="#r130">130.</a> United States Department of Energy, "Why Industrial Energy Use 
Matters," <I>Fact </I>Sheet, p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995); Bartsch, C., and DeVaul, D., 
<I>Utilities and Manufacturers: Pioneering Partnerships and Their Lessons 
for the 21st Century, </I>p. 3 (Washington, D.C.: Northeast-Midwest 
Institute, 1994).<BR>
<P><A NAME="131"  HREF="#r131">131.</a> Industrial DSM programs typically offer direct rebates for the 
installation of energy-efficient measures related to the following: 
motors, lighting, HVAC systems, steam traps, adjustable speed drives 
(ASDs), and compressed air systems.<BR>
<P><A NAME="132"  HREF="#r132">132.</a> Bartsch, C., and DeVaul, D., <I>Utilities and Manufacturers: 
Pioneering Partnerships and Their Lessons for the 21st Century,</I> pp. 5, 
57-62 (Washington, D.C.: Northeast-Midwest Institute, 1994).<BR>
<P><A NAME="133"  HREF="#r133">133.</a> <I>Id. </I>Carbon dioxide reduction data uses an emission factor of 
0.662 metric tons/MWh for the state of Massachusetts. United States 
Department of Energy<I>, Voluntary Reporting of Greenhouse Gases: 
Reporting Form and Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, 
Appendix F ("Adjusted Electricity Emission Factors by State") (Washington, 
D.C.: Energy Information Administration, June 1995).<BR>
<P><A NAME="134"  HREF="#r134">134.</a> Bartsch, C., and DeVaul, D., <I>Utilities and Manufacturers: 
Pioneering Partnerships and Their Lessons for the 21st Century,</I> pp. 5, 
57-62 (Washington, D.C.: Northeast-Midwest Institute, 1994). Carbon 
dioxide reduction data uses an emission factor of 0.662 metric tons/MWh 
for the state of Massachusetts. United States Department of Energy<I>, 
Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="135"  HREF="#r135">135.</a> Nadel, S., and Jordan, J., <I>Designing Industrial DSM Programs That 
Work, </I>pp. 16-17 (Washington, D.C.: American Council for an 
Energy-Efficient Economy, December 1993); Jordan, J., and Nadel, S., 
<I>Industrial Demand-Side Management Programs: What's Happened, What 
Works, What's Needed,</I> pp. 36-38 (Washington, D.C.: American Council 
for an Energy-Efficient Economy, March 1993); carbon dioxide reduction 
data uses an emission factor of 0.609 metric tons/MWh for the state of 
Wisconsin, provided by the United States Department of Energy<I>, 
Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="136"  HREF="#r136">136.</a> Bartsch, C., and DeVaul, D., <I>Utilities and Manufacturers: 
Pioneering Partnerships and Their Lessons for the 21st Century,</I> pp. 
62-66 (Washington, D.C.: Northeast-Midwest Institute, 1994). Carbon 
dioxide reduction data uses an emission factor of 0.139 metric tons/MWh 
for the state of Washington. United States Department of Energy<I>, 
Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "G.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "E.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-174</DOCNO>
<DOCOLDNO>IA026-000277-B029-401</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/II/G.html 198.77.86.203 19970113174914 text/html 1750
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:51:20 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1579
Last-modified: Mon, 17 Jun 1996 00:29:56 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "F.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Conclusion</title>
<table><tr><td><blockquote>


<H2><I>G. </I>Conclusion</H2>

<BR>
In the future, regulated local distribution companies are likely to 
continue to deliver energy-efficiency services to customers, as will a 
host of unregulated energy-service companies, equipment vendors, and power 
marketers. These changes in DSM-program orientation and delivery, however, 
are unlikely to alter significantly the rationale behind DSM programs. 
Regardless of the future structure of the utility industry, energy 
efficiency is an important asset: efficiency cuts customers' bills, 
reduces system costs, and cuts emissions.<BR>






<!--footnotes-->


</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "F.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-175</DOCNO>
<DOCOLDNO>IA026-000277-B030-46</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/intro.html 198.77.86.203 19970113174959 text/html 7883
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:52:01 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 7712
Last-modified: Mon, 17 Jun 1996 00:30:13 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><!--end head--><title>Energy Use in Buildings</title>
<table><tr><td><blockquote>


<H1>III. Energy Use in Buildings: Progress in Efficiency Design, Retrofit 
Investments, and Equipment and Appliance Standards</H1>
<BR>
<BR>
The energy-efficiency of most of America's residences and commercial 
buildings could be substantially improved. In 1989, U.S. buildings 
consumed 36 percent of total U.S. energy at a cost of $200 billion.<a href="#137" name="r137"> [ 137 ] </a>
That's more than what was consumed by transportation or industry. 
Residences spent $120 billion on energy bills, while commercial buildings 
(offices, stores, schools, hospitals) spent nearly $80 billion.<a href="#138" name="r138"> [ 138 ] </a>The 
energy consumed by U.S. buildings causes more than 450 million metric tons 
of annual carbon dioxide emissions - 33 percent of the U.S. total and 
about 8 percent of <I>global</I> annual emissions.<a href="#139" name="r139"> [ 139 ] </a>
<p>     The United States could cut building energy consumption by 33 to 50 
percent by the year 2015 if it invested in cost-effective, commercially 
available energy-saving technologies.<a href="#140" name="r140"> [ 140 ] </a>Substantial progress has been 
made. Energy-efficient building designs, retrofits, equipment, and 
appliances have <I>stabilized</I> energy intensity in the commercial 
sector,<a href="#141" name="r141"> [ 141 ] </a>and have <I>reduced</I> energy intensity in residences.<a href="#142" name="r142"> [ 142 ] </a>
<p>     The buildings sector, however, presents distinct policy challenges 
for capturing efficiency savings. Buildings occupants are often not 
owners - which undermines incentives to invest in efficiency and 
creates a market imperfection that is difficult to overcome.<a href="#143" name="r143"> [ 143 ] </a>Energy 
costs over a building's 50- to 70-year useful life are comparable to 
initial construction costs. Similarly, the life-cycle energy costs of 
equipment and appliances are often many times greater than their initial 
cost. Because markets focus more on the first costs than the full 
life-cycle costs of new buildings, retrofits, equipment, and appliances, 
public policy must correct these market failures through a combination of 
intelligent regulation and market incentives. <P>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="137"  HREF="#r137">137.</a> U.S. buildings consumed about 31.5 "quads" in 1989. Rosenfeld, A., and 
Ward, E., "Energy Use in Buildings," <I>The Energy-Environment 
Connection,</I> Hollander, J., ed., p. 223 (Washington, D.C.: Island 
Press, 1992).<BR>
<P><A NAME="138"  HREF="#r138">138.</a> <I>Id.</I><BR>
<P><A NAME="139"  HREF="#r139">139.</a> United States Department of Energy, "Why Building Efficiency Matters," 
<I>Fact Sheet</I>, p. 1 (Washington, D.C.: Office of Energy Efficiency and 
Renewable Energy, 1995).<BR>
<P><A NAME="140"  HREF="#r140">140.</a> United States Congress, Office of Technology Assessment, <I>Building 
Energy Efficiency,</I> OTA-E-518, p. 3 (Washington, D.C.: U.S. Government 
Printing Office, May 1992).<BR>
<A HREF="#r141" NAME="141">141</A>.Commercial buildings used 12.9 quads of energy at a cost of $68 billion 
in 1989. Despite growth in the number of energy-intensive commercial 
buildings (the commercial building stock, as measured by total square 
footage, grew more than 50 percent from 1970 to 1989), and increases in 
air conditioning and other equipment, energy intensity (energy use per 
square foot per year) stayed flat in the commercial sector from 1970 to 
1990. Improved energy-efficiency technologies helped dampen the growth in 
energy use through improved windows and shells, greater use of ceiling and 
wall insulation, more efficient heating, ventilation and air-conditioning 
(HVAC) equipment, better lighting systems, and other technologies. Future 
commercial energy use, despite expected continued expansion of commercial 
office space, is also projected to remain flat. Investments in commercial 
building technologies with a positive net present value to the consumer 
could cut building energy use from 29.7 quads today to 28 quads by 2015, 
corresponding to an annual energy savings of 14 quads by 2015 - worth 
$80 billion at today's energy prices. United States Congress, Office of 
Technology Assessment, <I>Building Energy Efficiency,</I> OTA-E-518, pp. 
3, 21-32 (Washington, D.C.: U.S. Government Printing Office, May 1992).<BR>

<P><A NAME="142" HREF="#r142">142.</a>Americans consumed 16.8 quads of energy in residential buildings 
(including single-family dwellings) in 1989. Space heating is responsible 
for almost half of total residential energy use, followed by water 
heating, refrigerators and freezers, air conditioning, and lights. 
Although total residential energy use increased from 1970 to 1989, 
primarily due to a 45 million increase in U.S. population over that 
period, energy intensity (energy consumed per household per year) actually 
<I>decreased</I> by 15 percent in the same period. The reasons for the 
decrease include:<BR>
<ul>
<li>     Retrofitting older homes with energy-efficiency technologies. From 
1983 to 1988, about 26 million owner-occupied U.S. households added storm 
windows and/or doors, and 17 million added insulation. <BR>
<li>     Greater use of energy-efficient building practices in newer houses. 
New houses built in 1985 installed far more insulation than did houses 
built in 1973, including 46 percent greater R-value (insulation heat 
retention) in ceilings, 20 percent more R-value in exterior walls, 60 
percent more R-value in floor insulation, and 68 percent fewer single-pane 
windows.<BR>
<li>     Improved equipment and appliance efficiency. 
</ul><BR>
Assuming the recent decrease in residential energy intensity continues, an 
annual residential consumption of 15.6 quads by 2010 is possible. United 
States Congress, Office of Technology Assessment, <I>Building Energy 
Efficiency</I>, OTA-E-518, pp. 3, 15, 18, 31 (Washington, D.C.: U.S. 
Government Printing Office, May 1992).<BR>
<P><A NAME="143"  HREF="#r143">143.</a> Individual homeowners also often fail to make efficiency investments 
because of a variety of market barriers, including uncertainty regarding 
the savings that will result from specific measures, uncertainty regarding 
how long they will own or occupy the home, uncertainty regarding the 
resale market value of the efficiency improvements, and lack of capital. 
In addition, renters are often responsible for utility bills but are not 
in a position to make capital improvements. Geller, H., et al., 
<I>Bridging the Gap: Initiatives to Achieve President Clinton's Climate 
Commitment</I>, p. 13 (Washington, D.C.: American Council for an 
Energy-Efficient Economy, April 22, 1994).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-176</DOCNO>
<DOCOLDNO>IA026-000277-B030-79</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/A.html 198.77.86.203 19970113175024 text/html 2365
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:52:26 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2194
Last-modified: Mon, 17 Jun 1996 00:30:13 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Energy-Efficient Design</title>
<table><tr><td><blockquote>

<H2><I>A. </I>Energy-Efficient Design Is Demonstrating Dramatic Energy 
Savings</H2>
<BR>
Energy decisions made when constructing buildings are long-lasting. The 
median lifetime for commercial buildings is between 50 and 70 years, far 
longer than most power plants.<a href="#144" name="r144"> [ 144 ] </a>The potential for savings is high. A 
reasonably-attainable 30 percent improvement in U.S. building efficiency 
would reduce energy bills by $75 billion annually in 15 years.<a href="#145" name="r145"> [ 145 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="144"  HREF="#r144">144.</a> United States Department of Energy, "Why Building Efficiency Matters," 
<I>Fact Sheet</I>, p. 1 (Washington, D.C.: Office of Energy Efficiency and 
Renewable Energy, 1995).<BR>
<P><A NAME="145"  HREF="#r145">145.</a> United States Department of Energy, "Why Building Efficiency Matters," 
<I>Fact Sheet</I>, p. 1 (Washington, D.C.: Office of Energy Efficiency and 
Renewable Energy, 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "A1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-177</DOCNO>
<DOCOLDNO>IA026-000277-B030-107</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/A1.html 198.77.86.203 19970113175113 text/html 8921
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:52:59 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 8750
Last-modified: Mon, 17 Jun 1996 00:30:14 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title> Energy-Efficient Building Design</title>
<table><tr><td><blockquote>


<H3>1. Energy-Efficient Building Design Can Significantly Improve Worker 
Productivity</H3>
<BR>
<B><BR>
</B>Numerous examples demonstrate that energy-efficient building and 
office design can significantly increase worker productivity. By improving 
lighting, heating, and cooling, workers can be made more comfortable and 
productive. An increase of 1 percent in p<BR>
roductivity can provide savings to a company that exceed its entire energy 
bill.<a href="#146" name="r146"> [ 146 ] </a>
<B><I> <p>     <A NAME="LockheedMissilesandSpaceCompany">Lockheed Missiles and Space Company<a>.</B></I> One of the 
most successful examples of efficient office-building design is Lockheed 
Missiles and Space Company's Building 157 in Sunnyvale, California.<a href="#147" name="r147"> [ 147 ] </a>The 
600,000 square-foot office building, designed by the architectural firm 
Leo A. Daly, brings daylight deep into the building. A central atrium runs 
top to bottom; the building's 2,700 engineers and support staff consider 
it the building's most attractive feature. Exterior "light shelves" on the 
south facade operate as sunshades or as reflectors depending on the 
season; in summer, they bounce light onto the interior ceiling to maximize 
interior light, while in the winter, when the sun's angle is lower, they 
diffuse reflected light and reduce glare. The overall design separates 
ambient and task lighting, with daylight supplying most of the ambient 
lighting and task lighting fixtures supplementing each workstation. 
Continuously dimmable fluorescents with photocell sensors maintain a 
constant level of light automatically and save even more energy. The open 
office layout was designed to foster the interaction, and the comfort, of 
the engineers and staff. Employees rave about the building.<BR>
<p>    <p>      Daylighting has saved Lockheed about 75 percent on its lighting 
bill. Since daylight generates less heat than office lights, the design 
features cut peak air-conditioning substantially. Overall, the building 
runs with about half the energy costs of a typical building of similar 
size. Although the energy-efficient improvements added roughly $2 million 
to the building's $50 million capital costs, the energy savings are worth 
nearly $500,000 per year, and paid for themselves in a little more than 
four years.<BR>
<p>    <p>      More important, however, have been productivity improvements. 
Russell Robinson, manager of facility interior development, reports that 
productivity is up while absenteeism is down. Lockheed considers 
productivity data to be proprietary, but according to Don Aitken, chairman 
of the Department of Environmental Studies at nearby San Jose State 
University, "Lockheed moved a known population of workers into the 
building and absenteeism dropped 15 percent." Aitken led numerous tours of 
Building 157 after it opened, and was told by Lockheed officials that the 
reduced absenteeism paid 100 percent of the extra cost of the building in 
the first year. The architect, Lee Windheim, reports that Lockheed 
officials told him that productivity rose 15 percent on the first major 
contract done in the building. Apparently, top Lockheed officials told 
Aitken that they believe they won a very competitive $1.5 billion defense 
contract on the basis of their improved productivity - and that the 
profits from that contract alone paid for the entire building.<a href="#148" name="r148"> [ 148 ] </a>
<B><I> <p>     <A NAME="WestBendMutualInsuranceCompany">West Bend Mutual Insurance Company<a>.</B></I> Another 
example of improved productivity through energy-efficient design involves 
West Bend Mutual Insurance Company's new 150,000-square-foot headquarters 
in West Bend, Wisconsin. The building is the subject of one of the most 
carefully documented increases in productivity due to green design.<a href="#149" name="r149"> [ 149 ] </a>
<p>    <p>      The building incorporates a number of energy-saving design 
features, including an energy-efficient lighting system (including task 
lighting and occupancy sensors), efficient windows, shell insulation, and 
a more efficient heating, ventilation, and air-conditioning (HVAC) system. 
It uses a thermal-storage system that makes ice overnight to help cool the 
building during the day. Offices all have individual temperature and 
airflow controls. Perhaps the most innovative feature of the building is 
its "environmentally responsive workstations" (ERWs). Workers in 
open-office areas are given direct, individual control over temperature 
and airflow via radiant heaters and vents built directly into their 
furniture and controlled by a panel on their desks. The control panel also 
provides direct control of task lighting and white-noise levels. A motion 
sensor in each workstation turns the station off when the worker leaves 
the space and turns it back on when he or she returns.<BR>
<p>    <p>      West Bend Mutual Insurance's old building had used $2.16 of 
annual electricity costs per square foot. The annual electricity costs in 
the new building are $1.32 per square foot - a 39 percent reduction. 
Furthermore, the <A NAME="RensselaerPolytechnicInstitute">Rensselaer Polytechnic Institute<a> (RPI) in Troy, New York 
conducted a detailed study of productivity in the old building in the 26 
weeks before the move and in the new building for 24 weeks after the move. 
The conclusion of the RPI study: "The combined effect of the new building 
and ERWs produced a statistically significant median increase in 
productivity of approximately 16 percent over productivity in the old 
building."<a href="#150" name="r150"> [ 150 ] </a>Although a significant portion of the productivity increase 
derived from the ERWs, analysis shows that the majority of the 
productivity increase came from the building's energy-efficient design and 
systems.1<a href="#151" name="r151"> [ 151 ] </a>
<BR>
<B><I> <p>     <A NAME="Wal-Mart">Wal-Mart<a>. </B></I>Wal-Mart's prototype "Eco-Mart" in 
Lawrence, Kansas incorporates several energy-efficient design features 
that have produced several interesting surprises for Wal-Mart management. 
Although the Eco-Mart design includes a glass arch at the entrance for 
daylighting, an efficient lighting system, an HVAC system that utilizes 
ice-storage, and special light-monitoring skylights, it includes a design 
flaw: only half the store is daylit. Interestingly, departments located in 
the daylit half of the store are considerably more productive. Sales in 
the daylit areas are higher than any other department in the Eco-Mart. 
They are also significantly higher than the same departments in other 
Wal-Mart stores. Wal-Mart is implementing many of the Eco-Mart measures in 
new construction for other stores and is retrofitting already-built stores 
with various energy-efficiency measures.<a href="#152" name="r152"> [ 152 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="146"  HREF="#r146">146.</a> Romm, J., and Browning, W., <I>Greening the Building and the Bottom 
Line: Increasing Productivity Through Energy-Efficient Design,</I> p. 1 
(Snowmass, CO: Rocky Mountain Institute, December 1994).<BR>
<P><A NAME="147"  HREF="#r147">147.</a> <I>Id., </I>pp 8-9.<BR>
<P><A NAME="148"  HREF="#r148">148.</a> <I>Id.</I><BR>
<P><A NAME="149"  HREF="#r149">149.</a> <I>Id., </I>p 10.<BR>
<P><A NAME="150"  HREF="#r150">150.</a> <I>Id.</I><BR>
<P><A NAME="151"  HREF="#r151">151.</a> <I>Id.</I><BR>
<P><A NAME="152"  HREF="#r152">152.</a> <I>Id., p. 11.</I><BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "A2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-178</DOCNO>
<DOCOLDNO>IA026-000277-B030-142</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/A2.html 198.77.86.203 19970113175141 text/html 8828
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:53:39 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 8657
Last-modified: Mon, 17 Jun 1996 00:30:15 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Building Codes Offer Substantial Energy Savings</title>
<table><tr><td><blockquote>

<H3><I>2. Building Codes Offer Substantial Energy Savings</H3>
 </I><BR>
<BR>
Building codes are cutting U.S. energy consumption substantially. By the 
year 2000, improved residential and commercial building codes could cut 
electricity use by 14,000 gigawatt-hours,<a href="#153" name="r153"> [ 153 ] </a>reducing nationwide carbon 
dioxide emissions by some 8.86 million metric tons.<a href="#154" name="r154"> [ 154 ] </a>
<p>     Since the 1970s, private engineering societies, government agencies, 
and code official organizations have promulgated a number of model 
building codes that include energy-efficiency standards. The Energy Policy 
Act of 1992 requires states to adopt commercial building standards that 
meet or exceed the American Society of Heating, Refrigeration and 
Air-conditioning Engineers (ASHRAE) model standard for commercial 
buildings. However, states are only required to <I>consider</I> adopting 
such standards for <I>residential</I> buildings.<a href="#155" name="r155"> [ 155 ] </a>A considerable gap 
remains between what is possible for energy-efficient and economical 
building construction and actual practice. <BR>
<p>     The ASHRAE commercial building standards in effect nationally are 
expected to reduce energy bills by $2.1 billion annually by 2010.<a href="#156" name="r156"> [ 156 ] </a>
Improved commercial building codes slated for adoption by ASHRAE could cut 
carbon dioxide emissions by 1 million metric tons per year by the year 
2000 and 11.2 million metric tons annually by 2010.<a href="#157" name="r157"> [ 157 ] </a>
<p>     New homes have been built with designs that use half or less of the 
energy consumed in older homes. Every year, about 1 million new houses are 
built in America. Each represent a one-time opportunity: many energy 
efficiency designs and installations that are easy and inexpensive to 
include in new dwellings are difficult or expensive to add later as 
retrofits. Building codes are needed to "raise the floor" for energy 
efficiency in new homes. <P>
<B><I> <p>     The Model Energy Code. </B></I>Adoption of a widely 
accepted residential model energy standard - the Model Energy Code 
(MEC) of the Council of American Building Officials (CABO) - could save 
500,000 megawatt-hours of energy in every year's new housing 
stock - enough to power another 65,000 to 70,000 single-family homes 
each year. Carbon dioxide emissions could be cut by 316,600 metric tons 
every year.<a href="#158" name="r158"> [ 158 ] </a>Cumulatively, the energy savings from ten years of housing 
starts could total 3.6 quads of energy over a 50-year span - which 
highlights the importance of capturing energy-efficiency opportunities at 
the time of construction.<a href="#159" name="r159"> [ 159 ] </a>If Congress would require adoption of the MEC 
at the state level, as well as improved code compliance and enforcement 
procedures,<a href="#160" name="r160"> [ 160 ] </a>carbon dioxide emissions could be cut by 600,000 metric 
tons by the year 2000 and 3.8 million metric tons by the year 2010.<a href="#161" name="r161"> [ 161 ] </a>
<p>     The MEC's added energy efficiency would be cost-effective. Although 
energy-efficiency installations can increase construction costs, energy 
savings would outweigh costs by 3-to-1 over a 30-year period. Every MEC 
home's annual energy bill would be reduced, on average, by $150, more than 
the average increase in mortgage payments of around $90. Thus, the actual 
"payback" to the average home buyer is almost immediate.<a href="#162" name="r162"> [ 162 ] </a>
<BR>





<hr><font size =-1>





<!--footnotes-->
<A HREF="#r153" NAME="153">153</A> Geller, H. and Nadel, S., <I>Implications of the Energy Policy Act of 
1992 for Utility Demand-Side Management Efforts</I> (Washington, D.C.: 
American Council for an Energy-Efficient Economy, March 1993).<BR>
<P><A NAME="154" HREF="#r154">154.</a>This carbon dioxide reduction data uses a national average for 
electricity, given the actual fuel share in 1993, of 0.6332 metric tons 
per megawatt-hour (MWh). In the future, avoided emissions will depend on 
the actual displacement of future and/or existing plants. Laitner, S., 
Economic Research Associates (Arlington, VA: December 5, 1995).<BR>
<P><A NAME="155"  HREF="#r155">155.</a> Energy Policy Act of 1992, Pub. L. No. 102-486, 106 Stat. 2776 (1992), 
42 U.S.C.A. &#167;&#167; 13201-556 (West Supp. 1994).<BR>
<P><A NAME="156" HREF="#r156">156.</a> United States Department of Energy, <I>Sustainable Energy Strategy: 
Clean and Secure Energy for a Competitive Economy,</I> p. 26 (Washington, 
D.C.: National Energy Policy Plan, U.S. Government Printing Office, July 
1995).<BR>
<P><A NAME="157" HREF="#r157">157.</a> Geller, H., et al., <I>Bridging the Gap: Initiatives to Achieve 
President Clinton's Climate Commitment</I>, p. 13 (Washington, D.C.: 
American Council for an Energy-Efficient Economy, April 22, 1994).<BR>
<P><A NAME="159" HREF="#r159">159.</a>This carbon dioxide reduction data uses a national average for 
electricity, given the actual fuel share in 1993, of 0.6332 metric tons 
per megawatt-hour (MWh). In the future, avoided emissions will depend on 
the actual displacement of future and/or existing plants. Laitner, S., 
Economic Research Associates (Arlington, VA: December 5, 1995). <BR>
<P><A NAME="159"  HREF="#r159">159.</a> Howard, B., and Prindle, W., <I>Better Building Codes For Energy 
Efficiency</I>, p. iii (Washington, D.C.: The Alliance to Save Energy, 
September 1991).<BR>
<P><A NAME="160"  HREF="#r160">160.</a> Adoption of building codes, to be effective, must be supplemented with 
compliance and enforcement measures, including (1) training and education 
for designers, builders, owners, and code officials, (2) enforcement 
support, including inspections, and (3) quality assurance and evaluation. 
Smith, L. and Nadel, S., <I>Energy Code Compliance</I>, pp. 22-24 
(Washington, D.C.: American Council for an Energy-Efficient Economy, 
August 1995).<BR>
<P><A NAME="161"  HREF="#r161">161.</a> Geller, H., et al., <I>Bridging the Gap: Initiatives to Achieve 
President Clinton's Climate Commitment</I>, p. 13 (Washington, D.C.: 
American Council for an Energy-Efficient Economy, April 22, 1994).<BR>
<BR>
<P><A NAME="162"  HREF="#r162">162.</a> Howard, B., and Prindle, W., <I>Better Building Codes For Energy 
Efficiency</I>, p. iii (Washington, D.C.: The Alliance to Save Energy, 
September 1991). The 1995 MEC code was recently adopted by the Building 
Officials and Code Administrators, Inc. (BOCA) as the energy-conservation 
provisions for the National Building and Mechanical Codes. This action 
replaces a reference to the MEC or ASHRAE Standards 90A and 90B as 
compliance alternatives. Those states (primarily in the Midwest, 
Mid-Atlantic, and Northeast) that refer in their state codes to BOCA 
standards will remove the reference to the ASHRAE standards (which are 
more than 15 years old and have been superseded by newer standards 
referenced in the newest MEC). Thus, the latest Model Energy Code will be 
included in the next published edition of the BOCA codes. Several states, 
including Virginia, Oklahoma, and New Jersey, by law adopt the newest 
edition of the BOCA codes when they become available. Building Codes 
Assistance Project, <I>Announcing a BCAP Success: BOCA Adopts the Latest 
Edition of the Model Energy Code, </I>p. 1 (Washington, D.C.: 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-179</DOCNO>
<DOCOLDNO>IA026-000277-B030-245</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/B.html 198.77.86.203 19970113175244 text/html 2372
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:54:42 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2201
Last-modified: Mon, 17 Jun 1996 00:30:15 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>>Energy-Efficient Retrofits Are a Source of Energy Savings</title>
<table><tr><td><blockquote>


<H2><I>B. </I>Energy-Efficient Retrofits Are a Source of Energy Savings 
Waiting to be Mined<BR></H2>

<BR>
Retrofits of existing buildings are a source of efficiency waiting to be 
mined. Eighty percent of U.S. commercial buildings were built prior to 
1979 and contain obsolete energy systems.<a href="#163" name="r163"> [ 163 ] </a>
 A full-scale retrofit 
generally calls for replacing lighting and HVAC system components, 
improving maintenance procedures, and installing computerized controls. 
Windows may be either replaced or coated with low-emissivity films, and 
sensors can be placed to monitor temperature and humidity, with the 
information fed into microcomputers to control the indoor climate.<BR>
<P>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="163"  HREF="#r163">163.</a> United States Department of Energy, "Why Building Efficiency Matters," 
<I>Fact Sheet</I>, p. 1 (Washington, D.C.: Office of Energy Efficiency and 
Renewable Energy, 1995).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "B1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-180</DOCNO>
<DOCOLDNO>IA026-000277-B030-286</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/B1.html 198.77.86.203 19970113175301 text/html 10292
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:55:06 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 10120
Last-modified: Mon, 17 Jun 1996 00:30:16 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Building Retrofits Cut Energy Bills</title><table><tr><td><blockquote><H3>1. Building Retrofits Cut Energy Bills While Improving Worker Comfort and Productivity</H3><BR><BR>Energy-efficiency retrofits for existing buildings and residences have attractive economic returns. For example, a three-year payback, which is typical in lighting retrofits, is an internal rate of return of 33 percent - generally superior to the results of financial managers for personal investments. Retrofits typically cut energy use by 50 cents or more per square foot of commercial space, a significant reduction in overhead.<a href="#164" name="r164"> [ 164 ] </a><p>     The greatest gains, however, are found - somewhat surprisingly - in improved worker productivity that often results from efficiency improvements.<a href="#165" name="r165"> [ 165 ] </a>Because labor costs dwarf energy costs per square foot, productivity gains often are the prime motivator for businesses to improve energy efficiency.<a href="#166" name="r166"> [ 166 ] </a>In the following examples, companies set out to cut energy and maintenance expenditures through energy-efficiency retrofits. Gains in worker productivity were often an unintended, added benefit of the energy efficiency investments.<a href="#167" name="r167"> [ 167 ] </a><BR><B><I> <p>     Main Post Office, Reno, Nevada. </B></I>In 1986, mail sorters at the Main Post Office in Reno, Nevada became the most productive in the western region of the United States. A $300,000 lighting retrofit, which included a lowered ceiling that made the room easier to heat and cool, boosted productivity more than 6 percent annually. The rate of sorting errors by machine operators dropped to 0.1 percent  - the lowest error rate in the western region. The annual energy and maintenance savings came to about $50,000 - a six-year payback. The productivity gains, however, were worth $400,000 to $500,000 per year, and paid for the entire renovation in less than a year.<a href="#168" name="r168"> [ 168 ] </a><BR><B><I> <p>     DOE's James Forrestal Building.</B></I> The U.S. government spends $9 billion each year on energy for federal buildings, operations, and employee transport. Federal agencies are required by law to reduce their energy use by 30 percent in the next decade (from 1985 consumption levels).<a href="#169" name="r169"> [ 169 ] </a>The goal is to save $400 million annually by the year 2000, and $1 billion a year by 2005. The DOE has made strides toward this goal, starting with its own headquarters, the James Forrestal Building in Washington, D.C. Lighting upgrades in 1994 cut energy bills by two-thirds. Because the retrofits produce higher quality light, worker comfort and productivity has increased. The cost of the project, $1.36 million, was paid for with a <B><I><A NAME="PotomacElectricPowerCompany">Potomac Electric Power Company<a></B></I> utility rebate plus private-sector financing from an energy-service company (ESCo). The ESCo will recover its investment from the anticipated 63 percent savings in lighting consumption. The reduced electricity demand cuts pollution emissions in the local utility service area by 27 metric tons of sulfur dioxide, 14 metric tons of nitrous oxide, and more than 3,600 metric tons of carbon dioxide.<a href="#170" name="r170"> [ 170 ] </a><BR><B><I> <p>     City of Phoenix's Energy Management Program.</B></I> Municipalities and school districts have improved productivity through energy-efficiency retrofits. The Energy Management Program for the city of Phoenix, Arizona installed energy-efficiency measures in 300 municipal buildings - including an airport, water and waste treatment plants, offices, libraries, and fire and police stations - saving the city $22.8 million over 16 years, plus far greater savings in worker productivity improvements. Energy savings over this period exceeded 290,000 megawatt hours, cutting carbon dioxide emissions by approximately 105,000 metric tons.<a href="#171" name="r171"> [ 171 ] </a><B><I>EPA's Energy Star Buildings Program.</B></I> In April 1995, EPA launched a comprehensive, nationwide strategy for maximizing energy-efficiency in existing buildings. EPA's "Energy Star Buildings" program is underway in twenty-four "showcase" buildings nationwide, and includes buildings owned by <B><I><A NAME="Honeywell,Inc.">Honeywell, Inc.<a>, Inc., <A NAME="J.C.Penney">J.C. Penney<a>, <A NAME="MobilCorporation">Mobil Corporation<a>, <A NAME="TargetStores">Target Stores<a>, <A NAME="WashingtonTimes,The">Washington Times </a>,</B></I> and others. <BR><p>     The program involves a five-stage upgrade strategy that capitalizes on system interactions to maximize energy savings at minimum cost. After upgrading to energy-efficient lighting (stage 1), participants tune up building systems (stage 2) and reduce heating and cooling loads (stage 3). Participants then improve fans and air-handling systems (state 4) and improve heating and cooling equipment (stage 5). Upgrades are staged so that heating and cooling loads are reduced before major HVAC equipment upgrades are initiated. This staged approach provides immediate energy cost savings and ensures proper load matching when upgrading major equipment in the latter stages of the strategy.<BR><p>     Results in the showcase buildings have been impressive. On average, participants are reducing their energy use by 35 percent and earning a 58 percent return on their investment. By the year 2000, the Energy Star Buildings program could lower annual U.S. buildings energy expenditures from today's $70 billion annually to about $42 billion.<a href="#172" name="r172"> [ 172 ] </a><hr><font size =-1><!--footnotes--><P><A NAME="164"  HREF="#r164">164.</a> These gains are typically tiny compared to the cost of employees, which is greater than the total energy and operating costs of a building. A 1990 national survey of large office buildings measured average electricity costs at $1.53 per square foot. Maintenance and repairs add another $1.37 per square foot. Labor, on the other hand, costs on average $130 per square foot - 72 times the energy costs. Thus, an increase of 1 percent in productivity can nearly offset a company's entire annual energy expenditures. Romm, J., and Browning, W., <I>Greening the Building and the Bottom Line: Increasing Productivity Through Energy-Efficient Design,</I> p. 3 (Snowmass, CO: Rocky Mountain Institute, December 1994).<BR><P><A NAME="165"  HREF="#r165">165.</a> Productivity is measured by Joe Romm, Special Assistant for Policy and Planning to the Deputy Secretary of Energy, in terms of production rate, quality of production, and changes in absenteeism. These productivity factors can be improved by fewer distractions from eye strain or poor thermal comfort, and similar variables. <I>Id.</I><BR><P><A NAME="166"  HREF="#r166">166.</a> United States Department of Energy, "Why Building Efficiency Matters," <I>Fact Sheet</I>, p. 1 (Washington, D.C.: Office of Energy Efficiency and Renewable Energy, 1995).<BR><P><A NAME="167"  HREF="#r167">167.</a> The energy-efficiency investments were not undertaken for energy <I>conservation</I>, but rather to increase energy <I>efficiency</I>. Conservation implies reduced services; energy efficiency means providing the same or better energy services using less energy. In general, building efficiency upgrades provide more pleasing light, more reliable production, and greater comfort and control. Romm, J., <I>Lean and Clean Management: How to Boost Profits and Productivity by Reducing Pollution,</I> pp. 72-73 (New York: Kodansha America, 1994). <BR><P><A NAME="168"  HREF="#r168">168.</a> <I>Id., </I>pp. xv-xviii.<BR><P><A NAME="169"  HREF="#r169">169.</a> Energy Policy Act of 1992, Pub. L. No. 102-486, 106 Stat. 2776, 42 U.S.C.A. &#167;&#167; 13201-556 (West Supp., 1994) (EPAct). <BR><P><A NAME="170"  HREF="#r170">170.</a> United States Department of Energy, "Forrestal Relighting Initiative," <I>Case Studies,</I> p. 1 (Washington, D.C.: Office of Energy Efficiency and Renewable Energy, 1995).<BR><P><A NAME="171"  HREF="#r171">171.</a> The Results Center, <I>The City of Phoenix: Energy Management Program</I>, Profile Brief #118 (Basalt, CO: IRT Environment, 1994). Carbon dioxide reduction data uses a DOE emission factor for Arizona of 0.362 metric tons/MWh. United States Department of Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission Factors by State") (Washington, D.C.: Energy Information Administration, June 1995).<BR><P><A NAME="172"  HREF="#r172">172.</a> United States Environmental Protection Agency, <I>Green Lights: Fourth Annual Report</I>, EPA 430-R-95-004, pp. 24-25 (Washington, D.C.: Office of Air and Radiation, June 1995).<BR></font></blockquote></td><td align = center width =150><!--images here--></td></tr></table><!--start foot--><p align=right><a href = "B2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-181</DOCNO>
<DOCOLDNO>IA026-000277-B030-334</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/B2.html 198.77.86.203 19970113175344 text/html 47032
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:55:21 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 46860
Last-modified: Mon, 17 Jun 1996 00:30:17 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->

<title>Lighting Retrofits Cut Error Rates and Improve Productivity</title>
<table><tr><td><blockquote><H3>2. Lighting Retrofits Cut Error Rates and Improve Productivity</H3>
<BR>
<BR>
Lighting accounts for 19 percent of all electricity sold in the United 
States.<a href="#173" name="r173"> [ 173 ] </a>Every kilowatt-hour of lighting not used prevents emissions of 
5.8 grams of sulfur dioxide, 2.5 grams of nitrogen oxides, and 1.5 pounds 
of carbon dioxide.<a href="#174" name="r174"> [ 174 ] </a>The best light bulbs on the market use only a 
quarter as much energy as conventional incandescent light bulbs and last 
ten times longer, preventing the burning of up to 400 pounds of coal, and 
saving consumers a net $35 on their electricity bills over the life of the 
improved bulb. <BR>
<p>     If energy-efficient lighting were installed everywhere profitable, 
America's demand for electricity would drop by more than 10 percent. This 
would result in annual emission reductions of 1.3 million metric tons of 
sulfur dioxide, 600,000 metric tons of nitrogen oxides, and 202 million 
metric tons of carbon dioxide. Those reductions would be equivalent to 
taking 44.5 million cars off the road,<a href="#175" name="r175"> [ 175 ] </a>and represent 12 percent of all 
U.S. utility emissions.<a href="#176" name="r176"> [ 176 ] </a><P>
<B><I> <p>     EPA's Green Lights Program.</B></I> Although lighting 
represents only about 10 percent of the available electricity savings 
potential in the U.S. economy, lighting represents one of the easiest ways 
to save electricity.<a href="#177" name="r177"> [ 177 ] </a>The Environmental Protection Agency's "Green 
Lights" Program has brought together more than 1,600 organizations<a href="#178" name="r178"> [ 178 ] </a>to 
upgrade their lighting with state-of-the-art technologies. In 1994, Green 
Lights participants saved more than 1 million megawatt-hours of 
electricity, which reduced electricity bills by more than $92 million<a href="#179" name="r179"> [ 179 ] </a>
and cut carbon dioxide emissions by approximately 633,200 metric tons.<a href="#180" name="r180"> [ 180 ] </a>
The typical Green Lights upgrade yields an after-tax internal rate of 
return of 20 to 40 percent. Unanticipated benefits often include increased 
employee productivity and morale improvements from better lighting 
quality. Full implementation of Green Lights upgrades by current 
participants could save $15.8 billion and 12.2 million megawatt-hours of 
electricity annually, while cutting carbon dioxide emissions by more than 
7.7 million metric tons per year.<a href="#181" name="r181"> [ 181 ] </a>If that $15.8 billion were reinvested 
in jobs and enhanced productivity, by the year 2000, Green Lights could 
result in more than 220,000 new jobs.<a href="#182" name="r182"> [ 182 ] </a>
<BR>
<p>     <B><I><A NAME="LawrenceBerkeleyNationalLaboratory">Lawrence Berkeley National Laboratory<a>.</B></I> Since the 
mid-1970s, the DOE has invested some $70 million at Lawrence Berkeley 
National Laboratory (LBNL) for research and development of advanced 
energy-efficient building technologies, software, and standards. That 
investment has helped spawn a $2.4 billion U.S. market for key 
products - including energy-efficient lighting. <BR>
<p>    <p>      Lighting costs U.S. businesses and consumers nearly $40 billion 
each year. The strategic use of federal research dollars can trim billions 
from this annual bill. LBNL's early work on the electronic ballast 
illustrates the potential payoff from lighting research and working with 
industry. <BR>
<p>    <p>      The electronic ballast has developed from a laboratory curiosity 
to a highly successful energy-efficient lighting technology. By 1993, 
electronic ballasts had captured 23 percent of total ballast sales. They 
will likely replace magnetic ballasts in more than 75 percent of 
applications by 2015 because of utility and other incentive programs and 
federal programs and standards. The federal investment in electronic 
ballast research and development is about $3 million. Cumulative energy 
savings attributable to electronic ballasts from 1988 to 1993 alone were 
$400 million. Businesses and consumers will ultimately save a net $700 
million from electronic ballasts installed through 1993, which could grow 
to $13 billion for technologies installed through the year 2015. By 2015, 
electronic ballast technology could avoid 142,400 metric tons of sulfur 
dioxide, 130,600 metric tons of nitrogen oxides, and 66.2 million metric 
tons of carbon dioxide.<a href="#183" name="r183"> [ 183 ] </a>
<BR>
<B><I> <p>     <A NAME="Boeing">Boeing</A>.</B></I> Substantial inroads have been made in 
cutting lighting electricity demand. For example, Boeing, headquartered in 
Renton, Washington, has been an EPA Green Lights participant. Lighting 
upgrades have cut electricity use by 25 to 90 percent in several million 
square feet of its facilities, with a 53 percent annual return on 
investment. Boeing's upgrades have saved 130,000 megawatt-hours, have paid 
for themselves in just two years, and have cut carbon dioxide emissions by 
18,070 metric tons per year. Other air pollutants have also been reduced, 
including 4,536 metric tons of sulfur dioxide and 1,815 metric tons of 
nitrogen oxides each year. The new lighting has improved workers' 
abilities to detect defects by 20 percent. The savings from catching 
errors early, according to Lawrence Friedman, Boeing's conservation 
manager, while difficult to measure, are estimated to exceed greatly the 
cost of the energy-efficient upgrades.<a href="#184" name="r184"> [ 184 ] </a>
<BR>
<B><I> <p>     <A NAME="PennsylvaniaPower&Light">Pennsylvania Power & Light<a>. </B></I>Pennsylvania Power & 
Light's drafting engineers had been working in a 12,775-square-foot room 
prone to "veiling reflections," a form of indirect glare. A lighting 
upgrade - consisting of high-efficiency lamps and ballasts fitted with 
parabolic louvers to reduce glare - in a 2,275-square-foot portion of 
the shop floor brought impressive results. Building superintendent Russell 
Allen notes, "Generally speaking &#138; we converted from general lighting 
to task lighting. As a result, more of the light is directed specifically 
to work areas and less is applied to circulation areas, creating more 
variance in lighting levels which upgrades the appearance of the space." 
The total net cost of the lighting upgrade was $8,362. Energy use dropped 
69 percent, and annual operating costs fell 73 percent from $2,800 to 
$765. With these savings, the investment would have paid for itself in 4.1 
years, a 24-percent return. But the resulting 13.2 percent boost in 
productivity, worth $42,240 a year, turned a 24 percent return on 
investment into a 540 percent return with payback in just 69 days. 
Absenteeism and error rates dropped and morale rose, changes worth at 
least another $50,000 per year. All told, the return on investment 
exceeded 1,000 percent.<a href="#185" name="r185"> [ 185 ] </a>
<BR>
<BR>
<B><I> <p>     <A NAME="AT&T">AT&T</a>. </B></I>AT&T in Columbus, Ohio slashed its energy 
costs by $4.5 million over 14 years by installing state-of-the-art metal 
halide light bulbs, improving insulation, and installing variable-speed 
drives on heating, ventilation, and air-conditioning fans.<a href="#186" name="r186"> [ 186 ] </a>The light 
bulb retrofits alone saved roughly 1,000 megawatt-hours of electricity per 
year - which slashed electricity bills 50 percent - while increasing 
light levels 70 percent. Workers in assembly areas, where small parts are 
handled, reported that they can see better now that old-style fluorescent 
lighting has been replaced with metal halide bulbs. Assembly errors have 
dropped, resulting in a marked improvement in productivity. The lighting 
retrofits alone cut carbon dioxide emissions by 820 metric tons annually. 
<a href="#187" name="r187"> [ 187 ] </a>
<B><I> <p>     <A NAME="HydeTools">Hyde Tools<a>. </B></I>Hyde Tools, a Massachusetts-based 
manufacturer of cutting blades, installed a lighting upgrade of 
sodium-vapor and metal-halide bulbs in the early 1990s. The retrofit cost 
$98,000 (including labor), with $48,000 of that covered by the local 
utility. Annual energy savings came to $48,000, yielding a payback of 
about one year. Substantial productivity improvements resulted 
unexpectedly. Doug DeVries, the company's purchasing manager, initially 
installed the upgrade in only a small portion of the factory floor. At 
first, several workers complained because the new lights cast an orange 
hue. After six months, he gave workers the option of restoring the 
original lighting on the principle that no amount of energy saved would be 
worth making his operators dissatisfied. But according to DeVries, "When 
we experimented by turning the old fluorescent lights back on after six 
months, there was a near riot of disapproval." The new lights had made it 
possible to see tiny specks of dirt on each blade during their 
manufacture. Unless detected, the dirt caused product defects. With the 
new lighting, DeVries says, "The quality of work improved significantly 
because we could see things we couldn't see before." DeVries estimates 
that the improved quality was worth another $25,000 a year to the company. 
DeVries notes that every dollar saved on the shop floor is worth $10 in 
direct sales - and thus the improved quality from the efficient 
lighting was the equivalent of a $250,000 increase in sales.<a href="#188" name="r188"> [ 188 ] </a>
<B><I><BR>
 <p>     <A NAME="UnitedAirlines">United Airlines<a>. </B></I>The United Airlines Maintenance 
Operations Center at San Francisco International Airport could save an 
estimated $100,000 annually due to a lighting retrofit recently completed 
by <A NAME="ParkeIndustries,Inc.">Parke Industries, Inc.<a> United wanted to improve productivity in an 
important maintenance and repair area by enhancing the quality of light. 
Workers in this area regularly service aircraft, parts and components for 
the airline's entire fleet flying both domestic and international routes. 
The lighting project is expected to cut 1,022 megawatt-hours of 
electricity annually, saving $51,000 off annual electric bills - about 
half the original $100,000 annual operating cost. The project payback is 
1.09 years. Additional benefits include another $48,000 in savings from 
reduced maintenance requirements. Carbon dioxide emissions could be cut by 
350 metric tons each year.<a href="#189" name="r189"> [ 189 ] </a>
<B><I> <p>     The <A NAME="WorldTradeCenter">World Trade Center<a>. </B></I>New York's World Trade 
Center is receiving a $1,826,000 lighting retrofit. The <B><I><A NAME="NewYorkPowerAuthority">New York Power Authority<a></B></I>y High-Efficiency Light Program is providing an 
$834,000 cash incentive and is offering a shared savings deal on the 
$991,000 balance. Yearly demand and consumption of electricity will be 
reduced by approximately 828 kilowatts and 5,121 megawatt-hours, resulting 
in an annual savings of nearly $330,000 while reducing annual carbon 
dioxide emissions by 2,406 metric tons.<a href="#190" name="r190"> [ 190 ] </a>
<B><I> <p>     <A NAME="LockheedMartinDefenseSystems">Lockheed Martin Defense Systems <a> </B></I>Lockheed Martin 
Defense Systems in Pittsfield, Massachusetts upgraded more than 8,000 
assorted fluorescent fixtures to high-efficiency electronic ballasts and 
energy-efficient T-8 lamps, saving 3,400 megawatt-hours of electricity per 
year and reducing annual energy bills by $188,100 (a 113 percent internal 
rate of return). Carbon dioxide emissions were reduced by 2,250 metric 
tons per year, which is equivalent to taking 496 cars off the road each 
year.<a href="#191" name="r191"> [ 191 ] </a>
<BR>
<B><I> <p>     Ashton Elementary School.</B></I> Ashton Elementary 
School in Sarasota, Florida retrofitted its lighting from 4,444 T-12s and 
20 incandescent lamps to 2,222 T-8s and 20 compact twin-tube lamps, which 
improved the quality of classroom light while reducing electricity 
consumption by 246 megawatt-hours per year at a savings of $17,236 - an 
annual internal rate of return of 50 percent. Carbon dioxide emissions 
were cut by 144 metric tons annually, equivalent to taking 32 cars off the 
road per year.<a href="#192" name="r192"> [ 192 ] </a>
<P>
<B><I> <p>     <A NAME="ShellOil">Shell Oil<a>. </B></I>Shell Oil implemented a lighting 
upgrade at its Anacortes, Washington refinery, replacing 7,730 150-watt 
incandescent lamps with 7,520 70-watt high pressure sodiums and 240 T-8 
lamps. The retrofit cut electricity demand by 1,803 megawatt-hours per 
year, saving $127,346 in energy costs - a 25.5 percent internal rate of 
return. Greater efficiency from the lighting upgrade reduced annual carbon 
dioxide emissions by 250 metric tons, equivalent to taking 55 cars off the 
road each year.<a href="#193" name="r193"> [ 193 ] </a>
<B><I> <p>     <A NAME="UniversityofCaliforniaatBerkeley">University of California at Berkeley<a>. </B></I>University 
of California at Berkeley's five-year, $6 million lighting upgrade project 
renovated the lighting in 60 campus buildings by installing 91,000 
high-efficiency ballasts, 18,000 reflectors, and 3,000 occupancy sensors. 
Electricity saved amounted to 12,116 megawatt-hours each year, at an 
energy cost savings of $909,000 annually - a 20 percent internal rate 
of return. Annual carbon dioxide emissions were reduced by 4,156 metric 
tons, equivalent to taking 915 cars off the road each year.<a href="#194" name="r194"> [ 194 ] </a>
<BR>
<B><I> <p>     <A NAME="TennesseeValleyAuthority">Tennessee Valley Authority<a>. </B></I>The Tennessee Valley 
Authority set an example for other public agencies by replacing 524 
incandescent fixtures with compact fluorescents and 190 incandescent exit 
signs with LED exit signs at its Knoxville Office Complex. TVA also 
replaced 9,400 old fluorescent fixtures with T-8 lamps, electronic 
ballasts, and parabolic lenses and installed 1,200 occupancy sensors to 
control lighting. The upgrade cut TVA's electricity demand by 3,100 
megawatt-hours, saving $210,000 each year while reducing annual carbon 
dioxide emissions by 1,879 metric tons - equivalent to removing 414 
cars from the road each year.<a href="#195" name="r195"> [ 195 ] </a>
<B><I> <p>     <A NAME="Nike,Inc.">Nike, Inc.<a> </B></I>Nike upgraded 1,545 T-12 lamps to 
1,545 8-foot T-8 lamps, all with electronic ballasts, at its Western 
Division Distribution Center in Wilsonville, Oregon. It also upgraded 44 
exit signs from 20-watt incandescent lamps to 2-watt LEDs. After the 
upgrade, Nike found it was spending half the amount on energy while 
getting twice the lighting level. Electricity demand dropped by 331 
megawatt-hours per year, saving $16,553. Annual pollution reduction 
benefits included 22 metric tons of sulfur dioxide, 13 metric tons of 
nitrogen oxides, and 35 metric tons of carbon dioxide. Said Nike, "There 
are always ways to <I>Just Do It </I>better."<a href="#196" name="r196"> [ 196 ] </a>
<BR>
<B><I> <p>     <A NAME="CompaqComputerCorporation">Compaq Computer Corporation </a>. </B></I>Employees at Compaq 
Computer's Houston, Texas headquarters were pleased with a lighting 
upgrade that reduced both glare and reflections, while saving money and 
reducing the company's environmental impact. The company retrofitted older 
fixtures with two 40-watt enhanced T-10, 3,700 lumens, 80 CRI with 
24,000-hour life. Lighting energy usage fell 39 percent. Overall 
electricity consumption dropped by 1,307 megawatt-hours per year, saving 
$83,493 annually in energy costs. Annual pollution reduction benefits 
included 193 metric tons of sulfur dioxide, 120 metric tons of nitrogen 
oxides, and 920 metric tons of carbon dioxide emissions.<a href="#197" name="r197"> [ 197 ] </a><P>
<B><I> <p>     <A NAME="AmocoOil">Amoco Oil</a>. </B></I>In early 1993, Amoco decided it would 
install 10,300 T-8 lamps, 105 energy-efficient exit sign lamps, and 500 
occupancy sensors in its Tulsa Research Center in Tulsa, Oklahoma. Energy 
savings totaled 1,197 megawatt-hours per year, a cost savings of $124,883 
annually. Pollution reduction benefits include 34 metric tons of sulfur 
dioxide, 46 metric tons of nitrogen oxides, and 907 metric tons of carbon 
dioxide each year.<a href="#198" name="r198"> [ 198 ] </a>
<B><I> <p>     <A NAME="WashingtonTimes,The">Washington Times<a>. </B></I>The Washington Times 
upgraded its headquarters facility in Washington, D.C. with 6,360 T-8's, 
1,151 compact fluorescents, 145 occupancy sensors, 409 halogen PAR lamps, 
and 153 LED exit signs. According to one receptionist, "I no longer feel 
heat on my head all day long. The light bulbs . . . are much cooler and 
give off better light than before. These lights have cured my headaches." 
Electricity savings annually amounted to 1,085 megawatt-hours and $72,810 
per year. Annual pollution-reduction benefits included 244 metric tons of 
sulfur dioxide, 77 metric tons of nitrogen oxides, and 1,293 metric tons 
of carbon dioxide.<a href="#199" name="r199"> [ 199 ] </a>
<B><I> <p>     Bell Atlantic. </B></I><A NAME="BellAtlantic">Bell Atlantic </a>retrofitted all 
fluorescent fixtures at its Data Center in Richmond, Virginia with T-8's 
and electronic ballasts, and installed a variable voltage dimming system 
to reduce glare and enable a constant light output. Air-conditioning 
energy outlays dropped by 273 megawatt-hours due to the new, cooler 
lighting. Total electricity usage fell by 1,600 megawatt-hours, saving 
$109,000 each year. Annual pollution reduction benefits include 443 metric 
tons of sulfur dioxide, 141 metric tons of nitrogen oxides, and 803 metric 
tons of carbon dioxide emissions.<a href="#200" name="r200"> [ 200 ] </a>
<B><I> <p>     <A NAME="McDonald'sCorporation">McDonald's Corporation<a>. </B></I>McDonald's Corporation is 
engaged in a nationwide effort to upgrade existing 4-lamp fluorescent 
fixtures with T-8 lamps and electronic ballasts. The average results for 
one McDonald's restaurant, based on a sample of more than 200 stores in 
the northeastern United States, include electricity reductions of 30 
megawatt-hours at a savings of $2,260 per year - reflecting a 38 
percent internal rate of return. Carbon dioxide reductions total 19 metric 
tons per store annually, equivalent to taking 4 cars off the road per 
year. In the words of Joe Megacz, corporate utilities manager, "The energy 
savings numbers per store may be modest, but when you multiply them by the 
1,500 company-owned restaurants we have committed to the Green Lights 
program, the total becomes significant."<a href="#201" name="r201"> [ 201 ] </a>
<B><I> <p>     Provo, Utah's City Hall. </B></I>The city of Provo, 
Utah - which developed the first prototype hydrogen-powered 
mass-transit bus back in 1974 - upgraded its City Hall with a 
combination of T-8s, compact fluorescents, and high-pressure sodium lamps. 
The result saves 709 megawatt-hours of electricity each year and reduces 
the city's electricity cost $36,678 annually, reflecting a 22 percent 
internal rate of return. The lessened electricity demand prevents 640 
metric tons of annual carbon dioxide emissions. In the words of Alan 
Dewitt, Provo facility manager, "[w]e are committed to energy efficiency 
as a <I>city</I>. By making our buildings more efficient, we have become a 
model for citizens throughout the community."<a href="#202" name="r202"> [ 202 ] </a>
<P>
<B><I> <p>     <A NAME="MarriottMarquisHotel">Marriott Marquis Hotel<a>. </B></I>The New York Marriott 
Marquis Hotel has extensively upgraded its 1,825,726-square- foot 
facility. The upgrade included the addition of an Energy Management 
System. Guest room upgrades alone replaced 10,009 incandescent lamps with 
compact quad-tube lamps. Total annual electricity reductions were 2,556 
megawatt-hours, which saves $190,033 each year - an internal rate of 
return of 100 percent. Carbon dioxide emissions were cut by 1,201 metric 
tons each year, equivalent to taking 264 cars off the road per year. 
According to Ed Pietzak, director of engineering, "The hotel used less 
electricity in 1994 than it did in 1986, despite the guest room occupancy 
rates <I>increasing</I> from 64.8 percent to over 90 percent&#138; The 
experience of the hotel shows that even with relatively new facilities and 
increasing occupancy rates, significant savings can be achieved."<a href="#203" name="r203"> [ 203 ] </a>
<BR>
<B><I> <p>     <A NAME="LongsDrugStores">Longs Drug Stores<a>. </B></I>Longs Drug Stores in Hilo, 
Hawaii upgraded from T-12s and incandescents to T-8s and compact twin-tube 
lamps. The store's management also installed occupancy sensors and 
reflectors. Electricity usage has dropped by 31,974 megawatt-hours per 
year, saving $3,453,166 annually, which represents an 83 percent internal 
rate of return. Annual carbon dioxide emissions have been reduced by 
21,966 metric tons. David Alexander, facilities manager, says, "It became 
apparent after our upgrades that we not only saved the expected energy, 
but also that the visual acuity of our customers and employees was 
dramatically improved. After upgrading our store's lighting, we learned 
that saving energy in lighting does not have to mean working in a 
cave."<a href="#204" name="r204"> [ 204 ] </a>
<B><I> <p>     <A NAME="U.S.X.Corporation/U.S.SteelGroup">U.S.X. Corporation/U.S. Steel Group<a>.</B></I> U.S.X. 
Corporation/U.S. Steel Group listened to employees' suggestions to upgrade 
to section lighting and timers in the company's Caster Spares Building in 
Gary, Indiana. The workers designed a lighting system that saves the Gary 
plant $120,892 annually while cutting electricity usage by 2,628 
megawatt-hours per year. The upgrade changed 748 400-watt mercury vapor 
lamps to 403 600-watt high pressure sodium lamps, which operate 87 percent 
fewer hours per year under timed switching devices. Annual pollution 
reduction benefits include 784 metric tons of sulfur dioxide, 264 metric 
tons of nitrogen oxides, and 2,588 metric tons of carbon dioxide. Tim 
Briney, plant coordinator at the Gary plant, had this to say: "We listen 
to the workers in our facilities. And they wanted to upgrade their 
lighting."<a href="#205" name="r205"> [ 205 ] </a>
<B><I> <p>     The County of San Diego. </B></I>San Diego County, 
California sought to upgrade lighting in as many of its 610 buildings as 
possible. In the words of Tom DuMont, deputy director of facility 
services, "Our experience has demonstrated that the commitment and 
involvement of directors and top managers provide the momentum to start 
and maintain an aggressive, major relighting program, and to ensure that 
the financial benefits are well understood by executive, financial, and 
administrative officials." At its Operations Center Annex, the county 
upgraded a combination of T-12s and incandescent lamps to T-8s and compact 
quad-tubes, saving 1,063 megawatt-hours and $99,009 annually. 
Pollution-reduction benefits include 22 metric tons of sulfur dioxide, 30 
metric tons of nitrogen oxides, and 365 metric tons of carbon dioxide 
emissions annually.<a href="#206" name="r206"> [ 206 ] </a>
<B><I> <p>     <A NAME="MassachusettsInstituteofTechnology">Massachusetts Institute of Technology<a>. </B></I>The 
Massachusetts Institute of Technology in Cambridge, Massachusetts upgraded 
campus lighting with approximately 225,000 T-8 lamps, 100,000 electronic 
ballasts, 3,000 reflectors and 2,500 new fixtures. Electricity demand 
dropped by 12,278 megawatt-hours per year, saving $982,241 annually - a 
13 percent internal rate of return. William Wohlfarth, P.E., senior 
electrical engineer for the school, noted that the upgrade was "well 
received by facility users. The improved color rendition was observed 
immediately, and people noted better depth perception and clearer, cleaner 
spaces. My advice to other organizations is to spend time obtaining good 
initial surveys and accurate run hours. Also, you should standardize on 
upgrade materials as much as practical, and negotiate large quantity 
material prices." MIT's upgrade avoids 8,128 metric tons of carbon dioxide 
emissions annually, equivalent to taking 1,790 cars off the road each 
year.<a href="#207" name="r207"> [ 207 ] </a>
<B><I> <p>     <A NAME="Johnson&Johnson">Johnson & Johnson<a>. </B></I>At Johnson & Johnson's McNeil 
Consumer Products Company in Fort Washington, Pennsylvania, nearly all 
buildings received lighting upgrades, including buildings performing such 
diverse functions as manufacturing, product packaging, administration, 
research, warehousing, food service, and child development. The light 
quality has greatly improved and maintenance has been reduced. By 
converting all 6,000 inefficient fluorescents to T-8s and T-10s, all 
incandescents to compact fluorescents, and all exit signs to LED or 
compact fluorescents, the facility is saving 1,373 megawatt-hours per year 
and cutting its energy bills by $107,574 annually. Pollution reduction 
benefits include 8 metric tons of sulfur dioxide, 3.7 metric tons of 
nitrogen oxides, and 800 metric tons of carbon dioxide each year. 
Spokesman Mike Vlasic notes that "with the money we are saving . . . we 
have expanded into other energy saving products - such as motion 
sensors and exit lights - and enhanced our energy management 
system."<a href="#208" name="r208"> [ 208 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="173"  HREF="#r173">173.</a> Geller, H. and Nadel, S., "Market Transformation Strategies to Promote 
End-Use Efficiency," <I>Annual Review of Energy and Environment </I>19, p. 
308 (Washington, D.C.: American Council for an Energy-Efficient Economy, 
1994).<BR>
<P><A NAME="174"  HREF="#r174">174.</a> United States Environmental Protection Agency, <I>Green Lights: An 
Enlightened Approach to Energy Efficiency and Pollution Prevention,</I> 
EPA 430-K-93-001, p. 3 (Washington, D.C.: July 1993).<BR>
<P><A NAME="175"  HREF="#r175">175.</a> Car removals assume an annual average carbon dioxide emission per car 
of 4.54 metric tons, based on 22 pounds of CO2 per gallon, a U.S. fleet 
average of 19.2 mpg, 15.6 gallons per tank, 300 miles traveled per tank, 
and 8,800 average miles driven per year (29.33 tanks of gasoline per 
year). Forty million cars is equivalent to about a quarter of the U.S. 
fleet. <I>See </I>United States Environmental Protection Agency, <I>Green 
Lights: An Enlightened Approach to Energy Efficiency and Pollution 
Prevention,</I> EPA 430-K-93-001, p. 3 (Washington, D.C.: Office of Air 
and Radiation, July 1993); United States Environmental Protection Agency, 
<I>Green Lights: Fourth Annual Report,</I> EPA 430-R-95-004, p. 2 
(Washington, D.C.: Office of Air and Radiation, June 1995).<BR>
<P><A NAME="176"  HREF="#r176">176.</a> United States Environmental Protection Agency, <I>Green Lights: An 
Enlightened Approach to Energy Efficiency and Pollution Prevention,</I> 
EPA 430-K-93-001, p. 3 (Washington, D.C.: July 1993).<BR>
<P><A NAME="177"  HREF="#r177">177.</a> The overall savings potential as a fraction of end use is 20 to 40 
percent, and lighting represents more than 15 percent of total electricity 
consumption in some industry groups like textiles, printing, apparel, and 
furniture. Elliott, R. Neal, <I>Electricity Consumption and the Potential 
for Electric Energy Savings in the Manufacturing Sector,</I> p. iv 
(Washington, D.C.: American Council for an Energy-Efficient Economy, April 
1994).<BR>
<P><A NAME="178"  HREF="#r178">178.</a> Green Lights participants include major corporations in the oil, 
pharmaceutical, retail, and industrial sectors, hotels and restaurants, 
newspapers and cable networks, universities and school districts, 
hospitals and insurance companies, financial institutions and real estate 
firms, federal, state and local government agencies and offices, as well 
as nonprofit groups. EPA provides a package of networking, technical, and 
marketing tools, at no cost, that are designed to ensure that lighting 
upgrades will result in the greatest possible energy savings. Included is 
a financing registry to help participants manage the up-front costs of 
converting their lighting, including an extensive database of 
utility-sponsored financial assistance and a directory of energy service 
companies (ESCos) that finance lighting-efficiency upgrades through 
leasing, shared savings, guaranteed savings, and other financing 
techniques. United States Environmental Protection Agency, <I>Green 
Lights: An Enlightened Approach to Energy Efficiency and Pollution 
Prevention,</I> EPA 430-K-93-001, pp. 8-9 (Washington, D.C.: July 
1993).<BR>
<P><A NAME="179"  HREF="#r179">179.</a> <I>Id. </I><BR>
<P><A NAME="180" href=180>180.</a>This carbon dioxide reduction data uses a national average for 
electricity, given the actual fuel share in 1993, of 0.6332 metric tons 
per megawatt-hour (MWh). In the future, avoided emissions will depend on 
the actual displacement of future and/or existing plants. Laitner, S., 
Economic Research Associates (Arlington, VA: December 5, 1995).<BR>
<P><A NAME="181"  HREF="#r181">181.</a> This carbon dioxide reduction data uses a national average for 
electricity, given the actual fuel share in 1993, of 0.6332 metric tons 
per megawatt-hour (MWh). In the future, avoided emissions will depend on 
the actual displacement of future and/or existing plants. Laitner, S., 
Economic Research Associates (Arlington, VA: December 5, 1995); United 
States Environmental Protection Agency, <I>Green Lights: An Enlightened 
Approach to Energy Efficiency and Pollution Prevention,</I> EPA 
430-K-93-001, p. 17 (Washington, D.C.: July 1993).<BR>
<P><A NAME="182"  HREF="#r182">182.</a> United States Environmental Protection Agency, <I>Green Lights: An 
Enlightened Approach to Energy Efficiency and Pollution Prevention,</I> 
EPA 430-K-93-001, p. 17 (Washington, D.C.: July 1993).<BR>
<P><A NAME="183"  HREF="#r183">183.</a> Lawrence Berkeley National Laboratory, <I>From the Lab to the 
Marketplace</I> (Berkeley, CA: Energy & Environment Division, 1994).<BR>
<P><A NAME="184"  HREF="#r184">184.</a> Romm, J., <I>Lean and Clean Management: How to Boost Profits and 
Productivity by Reducing Pollution</I>, pp. 74-75 (New York: Kodansha 
America, 1994); Laitner, S., <I>Energy Efficiency Investments as a 
Productivity Strategy for the United States: An Overview</I>, pp. 4-5 
(Alexandria, VA: Economic Research Associates, June 1995). Carbon 
reduction data uses a DOE emission factor for Washington of 0.139 metric 
tons/MWh. United States Department of Energy<I>, Voluntary Reporting of 
Greenhouse Gases: Reporting Form and Instructions</I>, Form EIA-1605EZ, 
OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission Factors by 
State") (Washington, D.C.: Energy Information Administration, June 
1995).<BR>
1995. Romm, J., and Browning, W., <I>Greening the Building and the Bottom 
Line: Increasing Productivity Through Energy-Efficient Design,</I> pp. 6-7 
(Snowmass, CO: Rocky Mountain Institute, 1994).<BR>
<P><A NAME="186"  HREF="#r186">186.</a> <I>Id.</I>, p. 10.<BR>
<P><A NAME="187"  HREF="#r187">187.</a> <I>Id.</I> Carbon dioxide reduction data derives from a DOE emission 
factor for Ohio of 0.820 metric tons/MWh. United States Department of 
Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>
<P><A NAME="188"  HREF="#r188">188.</a> Romm, J., and Browning, W., <I>Greening the Building and the Bottom 
Line: Increasing Productivity Through Energy-Efficient Design,</I> p. 6 
(Snowmass, CO: Rocky Mountain Institute, 1994).<BR>
<P><A NAME="189"  HREF="#r189">189.</a> "United Airlines Energy Savings Soar With Retrofit," <I>Lighting 
Management & Maintenance</I>, Vol. 23, No. 6, p. 8 (Princeton Junction, 
NJ: CMA Publications, July 1995). The carbon dioxide reduction data uses a 
DOE emissions factor for California of 0.343 metric tons/MWh. United 
States Department of Energy<I>, Voluntary Reporting of Greenhouse Gases: 
Reporting Form and Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, 
Appendix F ("Adjusted Electricity Emission Factors by State") (Washington, 
D.C.: Energy Information Administration, June 1995).<BR>
<P><A NAME="190"  HREF="#r190">190.</a> CMA Publications, "Sica Electrical to Retrofit the World Trade 
Center," <I>Lighting Management & Maintenance</I>, Vol. 23, No. 6, p. 8 
(Princeton Junction, NJ: July 1995). Carbon dioxide reduction data uses a 
DOE emission factor for New York of 0.470 metric tons/MWh. United States 
Department of Energy<I>, Voluntary Reporting of Greenhouse Gases: 
Reporting Form and Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, 
Appendix F ("Adjusted Electricity Emission Factors by State") (Washington, 
D.C.: Energy Information Administration, June 1995).<BR>
<P><A NAME="191"  HREF="#r191">191.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Massachusetts 
of 0.662 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). Car removals assume annual average carbon dioxide emissions 
per car of 4.54 metric tons, based on 22 pounds of CO2 per gallon, a U.S. 
fleet average of 19.2 mpg, 15.6 gallons per tank, 300 miles traveled per 
tank, and 8,800 average miles driven per year (29.33 tanks of gasoline per 
year).<BR>
<BR>
<P><A NAME="192"  HREF="#r192">192.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Florida of 
0.587 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). Car removals assume annual average carbon dioxide emissions 
per car of 4.54 metric tons, based on 22 pounds of CO2 per gallon, a U.S. 
fleet average of 19.2 mpg, 15.6 gallons per tank, 300 miles traveled per 
tank, and 8,800 average miles driven per year (29.33 tanks of gasoline per 
year).<BR>
<P><A NAME="193"  HREF="#r193">193.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Washington of 
0.139 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). Car removals assume annual average carbon dioxide emissions 
per car of 4.54 metric tons, based on 22 pounds of CO2 per gallon, a U.S. 
fleet average of 19.2 mpg, 15.6 gallons per tank, 300 miles traveled per 
tank, and 8,800 average miles driven per year (29.33 tanks of gasoline per 
year).<BR>
<P><A NAME="194"  HREF="#r194">194.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for California of 
0.343 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). Car removals assume annual average carbon dioxide emissions 
per car of 4.54 metric tons, based on 22 pounds of CO2 per gallon, a U.S. 
fleet average of 19.2 mpg, 15.6 gallons per tank, 300 miles traveled per 
tank, and 8,800 average miles driven per year (29.33 tanks of gasoline per 
year).<BR>
<P><A NAME="195"  HREF="#r195">195.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Tennessee of 
0.606 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). Car removals assume annual average carbon dioxide emissions 
per car of 4.54 metric tons, based on 22 pounds of CO2 per gallon, a U.S. 
fleet average of 19.2 mpg, 15.6 gallons per tank, 300 miles traveled per 
tank, and 8,800 average miles driven per year (29.33 tanks of gasoline per 
year).<BR>
<P><A NAME="196"  HREF="#r196">196.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Oregon of 
0.107 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). <BR>
<P><A NAME="197"  HREF="#r197">197.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Texas of 
0.704 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). <BR>
<BR>
<P><A NAME="198"  HREF="#r198">198.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Oklahoma of 
0.758 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). <BR>
<P><A NAME="199"  HREF="#r199">199.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Washington, 
D.C. of 1.192 metric tons/MWh. United States Department of Energy<I>, 
Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995). <BR>
<P><A NAME="200"  HREF="#r200">200.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Virginia of 
0.502 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). <BR>
<P><A NAME="201"  HREF="#r201">201.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). This 
carbon dioxide reduction data uses a national average for electricity, 
given the actual fuel share in 1993, of 0.6332 metric tons per 
megawatt-hour (MWh). In the future, avoided emissions will depend on the 
actual displacement of future and/or existing plants. Laitner, S., 
Economic Research Associates (Arlington, VA: December 5, 1995). Car 
removals assume annual average carbon dioxide emissions per car of 4.54 
metric tons, based on 22 pounds of CO2 per gallon, a U.S. fleet average of 
19.2 mpg, 15.6 gallons per tank, 300 miles traveled per tank, and 8,800 
average miles driven per year (29.33 tanks of gasoline per year).<BR>
<P><A NAME="202"  HREF="#r202">202.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Utah of 0.903 
metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). <BR>
<P><A NAME="203"  HREF="#r203">203.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for New York of 
0.470 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). Car removals assume annual average carbon dioxide emissions 
per car of 4.54 metric tons, based on 22 pounds of CO2 per gallon, a U.S. 
fleet average of 19.2 mpg, 15.6 gallons per tank, 300 miles traveled per 
tank, and 8,800 average miles driven per year (29.33 tanks of gasoline per 
year).<BR>
<P><A NAME="204"  HREF="#r204">204.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Hawaii of 
0.687 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). <BR>
<P><A NAME="205"  HREF="#r205">205.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Indiana of 
0.985 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). <BR>
<P><A NAME="206"  HREF="#r206">206.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for California of 
0.343 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>
<P><A NAME="207"  HREF="#r207">207.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington., D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Massachusetts 
of 0.662 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). Car removals assume annual average carbon dioxide emissions 
per car of 4.54 metric tons, based on 22 pounds of CO2 per gallon, a U.S. 
fleet average of 19.2 mpg, 15.6 gallons per tank, 300 miles traveled per 
tank, and 8,800 average miles driven per year (29.33 tanks of gasoline per 
year).<BR>
<P><A NAME="208"  HREF="#r208">208.</a> United States Environmental Protection Agency, Green Lights Profile 
(Washington, D.C.: Atmospheric Pollution Prevention Division, 1995). 
Carbon dioxide reduction data uses a DOE emission factor for Pennsylvania 
of 0.583 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995). <BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "B3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-182</DOCNO>
<DOCOLDNO>IA026-000277-B031-99</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/B3.html 198.77.86.203 19970113175459 text/html 8379
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:57:06 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 8208
Last-modified: Mon, 17 Jun 1996 00:30:19 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B4.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Home Energy Rating Systems </title>
<table><tr><td><blockquote>


<H3>3. Home Energy Rating Systems (HERS) Provide Important Consumer 
Information</H3>

<BR>
Every year, 3.5 million homes in America change hands. Every transfer 
offers an opportunity to retrofit homes with energy-efficiency measures. 
When buying a home, consumers typically only have enough information to 
base their decision on the home's first costs. But the life-cycle energy 
costs of a home, like a car or appliance, are important values that make a 
substantial difference in the real cost - and value - of a home.<P>
<B><I> <p>     DOE's Five-Star Rating Program.</I> </B>The U.S. DOE has 
developed a uniform home energy rating system that evaluates the 
efficiency of residences on a 100-point scale. The most efficient house 
receives 100 points ("five stars plus"), indicating a home that is roughly 
two times as efficient as one built to the specifications of the 1993 
Model Energy Code.209 In mid-1995, DOE proposed the program as a national 
standard, with voluntary adoption left to the states. States should be 
encouraged to implement the program, which will offer buyers essential 
information about the life-cycle energy costs of a potential home 
purchase.<p>      <BR>
<p>    <p>      Uniform Home Energy Rating Systems (HERS), nationwide, will 
remove market barriers to financing for energy-efficiency investments. The 
real estate industry, and most consumers, fail to recognize the life-cycle 
market value of efficiency investments. Lenders are generally unwilling to 
loan more dollars for more efficient houses, even though those households 
have greater disposable income due to lower energy bills. Uniform 
efficiency ratings will help standardize the real estate efficiency 
market, enabling lenders and utilities to expand energy loan programs and 
increase consumer demand.<a href="#210" name="r210"> [ 210 ] </a>
<B><I> <p>     <A NAME="EnergyRatedHomesofAmerica">Energy Rated Homes of America <a> </B></I>The private sector 
has also taken on HERS. "Energy Rated Homes of America" also uses a 
100-point scale and provides an "as-is" rating for each home it 
evaluates.<a href="#211" name="r211"> [ 211 ] </a>An "improvement-options" rating is also provided, which 
indicates how the home would rate, and the potential savings, if fully 
detailed retrofit measures were installed. Thus the process of rating a 
home not only provides a score, but provides the home owner with 
cost-effective, suggested improvements. The funds necessary to carry out 
these improvements can be added to mortgages - discussed 
below - allowing inefficient homes to be upgraded and the cost of 
improvements financed over the life of the loan.<a href="#212" name="r212"> [ 212 ] </a>
<B><I> <p>     The Austin, Texas "Energy Star Program."</B></I> Austin's 
Energy Star Program is a similar new-home HERS program. The rating 
compares a particular energy-efficient home to the same home if it were 
built to minimum code standards. A one-star home<a href="#213" name="r213"> [ 213 ] </a>saves approximately 6 
percent more energy than the base (code-built) home; a two-star home<a href="#214" name="r214"> [ 214 ] </a>
saves about 15 percent; and a three-star home<a href="#215" name="r215"> [ 215 ] </a>represents more than 23 
percent energy savings. Austin has marketed the Energy Star Program 
especially toward volume builders, who typically are conscious of small 
incremental cost increases per unit and historically have been less 
inclined to meet efficiency levels much above code requirements. Austin 
has been able to get more than 40 builders to join the Energy Star 
Program - a majority of the builders in the Austin area. The builders 
have become so actively involved in the program that, according to Doug 
Seiter, Energy Star Program manager for the city, they are "changing their 
design plans just to get better ratings. They've been joining because it 
makes them competitive."<a href="#216" name="r216"> [ 216 ] </a>In the 12 months preceding October 1, 1990, 
the program had given Energy Star ratings to 622 homes, representing 50 to 
60 percent of that year's new residential building stock. These homes 
saved more than 1 million kilowatt-hours that year - enough electricity 
to serve more than 100 homes for a year. Projected electricity savings are 
estimated to be $143,060, an average of $230 per home. Just these 622 
homes saved 704 metric tons of carbon dioxide emissions during 1990.<a href="#217" name="r217"> [ 217 ] </a>
<P>
<BR>
<BR>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="209"  HREF="#r209">209.</a> Unfortunately, the House and Senate have each passed legislation that 
would prohibit DOE from conducting any buildings-oriented rulemaking, 
including HERS. Verdict, M., "DOE Proposes New Guidelines for Home Energy 
Ratings Based on Five-Star Program," <I>Alliance Update</I>, p. 8  
(Washington, D.C.: Alliance to Save Energy, Summer 1995).<BR>
<P><A NAME="210"  HREF="#r210">210.</a> <I>Id. </I><BR>
<P><A NAME="211"  HREF="#r211">211.</a> The rating system evaluates these home-efficiency measures: compact 
fluorescent lights; water heater tank wraps; ceiling, floor, and pipe 
insulation; efficient refrigerators and freezers; high-efficiency space 
and water heating equipment; air leakage reduction and controls. The 
Results Center, Inc., <I>Energy Rated Homes of America: Uniform Energy 
Rating System,</I> Profile Brief #90, p. 2 (Basalt, CO: IRT Environment, 
1994).<BR>
<P><A NAME="212"  HREF="#r212">212.</a> <I>Id.  </I>Increased availability of uniform ratings would enable 
lenders and utilities to expand their energy loan programs much more 
rapidly and help increase consumer demand. <BR>
<P><A NAME="213"  HREF="#r213">213.</a> A one-star home includes increased heating and cooling efficiencies, 
somewhat higher insulation levels, and improved shading coefficients on 
windows (solar screens).<BR>
<P><A NAME="214"  HREF="#r214">214.</a> Two-star homes include reduced air infiltration, improved shading 
techniques, higher equipment efficiencies, and higher insulation 
values.<BR>
<P><A NAME="215"  HREF="#r215">215.</a> Three-star homes typically take the total design of the home into 
account for maximum energy advantage, as well as optimum efficiencies. 
These ratings apply to both all-electric and multifuel homes. The Alliance 
to Save Energy, "A Star-Quality Rating Program in Austin,"<I>Reaching For 
the Stars: Shining Examples of Success in Energy-Efficient Housing,</I> p. 
19 (Washington, D.C.: March 1991).<BR>
<P><A NAME="216"  HREF="#r216">216.</a> <I>Id.</I><BR>
<P><A NAME="217"  HREF="#r217">217.</a> This carbon dioxide reduction figure uses a DOE emissions factor of 
0.704 for the state of Texas. United States Department of Energy<I>, 
Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>




<!--start foot--><p align=right><a href = "B4.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-183</DOCNO>
<DOCOLDNO>IA026-000277-B031-172</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/B4.html 198.77.86.203 19970113175627 text/html 6454
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:57:22 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 6283
Last-modified: Mon, 17 Jun 1996 00:30:19 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B5.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title> Energy Efficient Mortgages</title>
<table><tr><td><blockquote>



<H3>4. Energy Efficient Mortgages (EEMs) Can Provide Necessary Retrofit 
Financing</H3>

<BR>
The Federal Housing Administration, Fannie Mae, Freddie Mac, various 
lenders, and numerous utilities have introduced new financing products for 
energy-efficiency upgrades. Home buyers are being encouraged to install 
efficiency improvements at the time of purchase through Energy Efficient 
Mortgages (EEMs) - which provide financing for efficiency upgrades as 
part of a home mortgage package. EEMs allow home buyers to automatically 
qualify for a larger mortgage to pay for efficiency 
improvements - improvements which then more than pay for the added cost 
of the mortgage through energy savings. Lenders provide EEMS under the 
rationale that the mortgagee will have greater disposable income from 
savings on utility bills and can therefore afford a greater monthly 
mortgage payment.<a href="#218" name="r218"> [ 218 ] </a>
<B><I> <p>     The Federal Housing Administration.</B></I> The Federal 
Housing Administration (FHA) is authorized by the Energy Policy Act of 
1992 to offer up to $8,000 above the qualifying loan amount for 
cost-effective219 efficiency retrofit measures at the time of home resale. 
In October 1995, the FHA announced that it is expanding its EEM program 
nationwide. The FHA EEM will apply not only to retrofits but also to new 
construction.<a href="#220" name="r220"> [ 220 ] </a>A borrower can finance through the mortgage 100 percent 
of the cost of eligible energy-efficient improvements - which may 
include energy-saving equipment as well as active and passive solar 
technologies - without an appraisal of the energy improvements and 
without further credit qualification of the borrower.<a href="#221" name="r221"> [ 221 ] </a>
<B><I> <p>     <A NAME="FannieMae">Fannie Mae <a> and <A NAME="FreddieMac">Freddie Mac<a>.</B></I> In Colorado, Fannie 
Mae and Freddie Mac have a loan program that allows borrowers to finance 
energy upgrades in both new homes and resales as long as the increase is 
less than or equal to the present-value calculation of the rated energy 
savings. Both Fannie Mae and Freddie Mac have expressed an interest in 
taking the program nationwide. Under Fannie Mae's Community Home Buyers 
Program, purchasers with incomes at or below the national median can 
finance efficiency upgrades with a 3 percent down payment. Freddie Mac has 
a similar program known as the Affordable Gold Program that reduces the 
cash required for the down payment. These programs qualify low or median 
income home buyers for energy-efficient homes using cash from utility 
rebate programs as part of their down payment.<a href="#222" name="r222"> [ 222 ] </a>
<B><I> <p>     Pacific Gas and Electric.</B></I> In California, Pacific 
Gas and Electric has teamed with three lenders to automatically qualify 
buyers for an additional 10 percent mortgage, at below-market interest 
rates, for homes that are rated 10 to 25 percent more efficient than the 
California state energy code. Loan demand has exceeded all expectations. 
The lenders involved are now marketing these new incentives nationwide to 
utilities and ratings organizations interested in promoting 
energy-efficiency financing.<a href="#223" name="r223"> [ 223 ] </a>
<p>    <p>      Fannie Mae is pilot testing an unsecured home-improvement loan 
at below-market interest for up to $15,000 with the same California 
utility. This energy loan program is operated with a utility partner and a 
third-party consumer loan originator. If successful, Fannie Mae says it 
will take the program nationwide.<a href="#224" name="r224"> [ 224 ] </a>
<P>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="218"  HREF="#r218">218.</a> Geller, H., et al., <I>Bridging the Gap: Initiatives to Achieve 
President Clinton's Climate Commitment</I>, p. 10 (Washington, D.C.: 
American Council for an Energy-Efficient Economy, April 22, 1994).<BR>
<P><A NAME="219"  HREF="#r219">219.</a> To be cost-effective, the total cost of the energy-efficient 
improvements (including maintenance costs) must be less than the total 
present value of the energy saved over the useful life of the 
improvements. United States Department of Housing and Urban Development, 
<I>Single Family Loan Production - Expansion of the Energy Efficient 
Mortgage Program</I>, Mortgagee Letter 95-46 (Washington, D.C.: Office of 
the Assistant Secretary for Housing, Federal Housing Commissioner, October 
6, 1995).<BR>
<P><A NAME="220"  HREF="#r220">220.</a> For new construction, the energy improvements must be over and above 
those required for compliance with the current FHA energy conservation 
standards for new construction (which are the CABO 1992 Model Energy 
Code). <I>Id.</I> <BR>
<P><A NAME="221"  HREF="#r221">221.</a> <I>Id.</I><BR>
<P><A NAME="222"  HREF="#r222">222.</a> Verdict, M., <I>Selling Home Buyers on Energy Loan Programs</I>, p. 2 
(Washington, D.C.: Alliance to Save Energy, 1995).<BR>
<P><A NAME="223"  HREF="#r223">223.</a> <I>Id.</I><BR>
<P><A NAME="224"  HREF="#r224">224.</a> <I>Id. </I><BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "B5.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-184</DOCNO>
<DOCOLDNO>IA026-000277-B031-200</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/B5.html 198.77.86.203 19970113175649 text/html 6200
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:58:55 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 6029
Last-modified: Mon, 17 Jun 1996 00:30:20 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B4.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title> Energy Services Companies Provide Retrofit Services</title>
<table><tr><td><blockquote>

<H3>5. Energy Services Companies Provide Retrofit Services With Immediate 
Energy Savings</H3>
<BR>
<BR>
Efforts to improve energy efficiency in buildings are often obstructed by 
the divergent priorities and incentives of the building industry. Lack of 
coordination between architects, building engineers and subcontractors, 
lenders, owners, tenants, and the operations and maintenance staffs of 
large commercial buildings often results in a failure to capture potential 
energy efficiency savings.<a href="#225" name="r225"> [ 225 ] </a>
<p>     Energy Services Companies (ESCos) are in the business of designing 
and installing energy-efficiency systems in buildings, typically on a 
performance contract basis. Performance contracts allow businesses and 
building owners to upgrade their facilities without sacrificing scarce 
financial resources up front. ESCo performance contracts guarantee a 
positive financial return from efficiency upgrades throughout the contract 
term. ESCos often bundle their services with private bank financing 
packages that provide a net positive cash flow from energy savings from 
day one of efficiency installations. <BR>
<p>     ESCos typically conduct an initial audit of a building, and then 
implement a multi-stage retrofit involving lighting upgrades, automation 
and control systems, temperature control systems, improved HVAC systems, 
building envelope and windows upgrades, and microprocessor-based energy 
management control systems for monitoring overall system efficiency. 
Additional ESCo services include indoor air quality diagnostics, 
chlorofluorocarbon (CFC) replacement, maintenance of equipment and 
controls, and on-site training of employees in order to optimize building 
performance and energy savings.<a href="#226" name="r226"> [ 226 ] </a>
<p>     <B><I><A NAME="Honeywell,Inc.">Honeywell, Inc.<a>, Inc.</B></I> Honeywell, headquartered in 
Minneapolis, Minnesota, is the largest U.S. ESCo. Honeywell has 
retrofitted buildings and facilities throughout the U.S. with 
energy-efficiency technologies and processes, including federal, state and 
local governments, schools, hospitals, commercial buildings and 
industries. Honeywell uses performance contracting, and bundles its 
services with private bank financing that guarantees a neutral or positive 
cash flow from efficiency upgrades. Most often, actual energy savings far 
exceed the performance guarantee, with all additional energy savings 
accruing to the customer.<BR>
<p>    <p>      In 1990, Honeywell contracted with the City of Seattle, 
Washington to install efficiency upgrades in the Seattle Municipal 
Building. Honeywell replaced old lighting with new electronic ballasts and 
T-8 fluorescent lamps. Automated centralized lighting controls and 
occupancy sensors reduced the hourly energy used for lighting from 400 
kilowatt-hours to 224 kilowatt-hours. To improve poor indoor air quality, 
Honeywell installed a new high-efficiency air filtration system and new 
fan coil units. In the first two years, the upgrades cut building energy 
use by 2,483 megawatt-hours - an energy savings of 62 percent. These 
savings avoided 345 metric tons of carbon dioxide emissions annually, 
equivalent to removing 76 cars from the road.<a href="#227" name="r227"> [ 227 ] </a>
<p>     ESCos will play an increasing role in the future, both in the 
buildings sector and in a restructured utility industry, because of their 
ability to package capital with design expertise, serving to improve their 
clients' bottom line. Government facilities, private businesses, public 
housing and potentially private residences can benefit from ESCo 
services.<BR>
<BR>




<hr><font size =-1>





<!--footnotes-->

<P><A NAME="225"  HREF="#r225">225.</a> Rosenfeld, A., and Ward, E., "Energy Use in Buildings," <I>The 
Energy-Environment Connection</I>, Hollander, J., ed., pp. 235-36 
(Washington, D.C.: Island Press, 1992).<BR>
<P><A NAME="226"  HREF="#r226">226.</a> Honeywell, Inc., "Performance Contracting," <I>Smart Building Energy 
Management</I>, forthcoming.<BR>
<P><A NAME="227"  HREF="#r227">227.</a> <I>Id. </I>Carbon dioxide reduction data uses a DOE emission factor 
for Washington of 0.139 metric tons/MWh. United States Department of 
Energy<I>, Voluntary Reporting of Greenhouse Gases: Reporting Form and 
Instructions</I>, Form EIA-1605EZ, OMB No. 1905-0194, Appendix F 
("Adjusted Electricity Emission Factors by State") (Washington, D.C.: 
Energy Information Administration, June 1995). Car removals assume annual 
average carbon dioxide emissions per car of 4.54 metric tons, based on 22 
pounds of CO2 per gallon, a U.S. fleet average of 19.2 mpg, 15.6 gallons 
per tank, 300 miles traveled per tank, and 8,800 average miles driven per 
year (29.33 tanks of gasoline per year).<BR>
</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B4.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-185</DOCNO>
<DOCOLDNO>IA026-000277-B031-217</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/C.html 198.77.86.203 19970113175706 text/html 4235
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:59:08 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4064
Last-modified: Mon, 17 Jun 1996 00:30:21 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B5.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Energy-Efficient Appliances and Equipment</title>
<table><tr><td><blockquote>




<H2><I>C. </I>Energy-Efficient Appliances and Equipment Provide Significant 
Energy Savings</H2>
<BR>
<BR>
During the late 1970s and early 1980s, a number of states established 
efficiency standards for major home appliances, and appliance 
manufacturers petitioned the federal government to establish uniform 
preemptive national standards. These were enacted as the National 
Appliance Energy Conservation Act of 1987. There are now national 
efficiency standards for most categories of home appliances and equipment. 
The U.S. DOE periodically reviews and updates these standards. Although 
efficiency measures add a small extra cost to products, the efficiency 
standards are set at levels where the extra costs are rapidly offset by 
energy savings.<a href="#228" name="r228"> [ 228 ] </a><BR>

<BLOCKQUOTE>
<hr>
<a href = "../img/Bldgs-stds.gif"><img src = "../t/Bldgs-stds.gif"
 alt = "Chart 8: Life-Cycle Energy and Economic Benefits
 of Selected Appliance Standards" align=left></a>
 <h3><I>Chart 8: Life-Cycle Energy and Economic Benefits
 of Selected Appliance Standards<br clear=all><hr></I></h3>
</BLOCKQUOTE>
<p>     Residential appliance standards alone are already saving consumers 
$1.9 billion annually, and ultimately will save consumers $132 billion net 
over the lifetime of products purchased by 2030, providing a ratio of 
total benefits to costs of 3-to-1.<a href="#229" name="r229"> [ 229 ] </a>Past and necessary future appliance 
and equipment standards could cut residential electricity use 7 percent by 
the year 2015, saving about 80,000 gigawatt-hours and 21,000 megawatts of 
capacity annually<a href="#230" name="r230"> [ 230 ] </a> - which represents approximately 50.6 million 
metric tons of carbon dioxide reductions per year.<a href="#231" name="r231"> [ 231 ] </a>



<hr><font size =-1>





<!--footnotes-->
<P><A NAME="228"  HREF="#r228">228.</a> United States Department of Energy, <I>Sustainable Energy Strategy: 
Clean and Secure Energy for a Competitive Economy,</I> pp. 26-27 
(Washington, D.C.: National Energy Policy Plan, U.S. Government Printing 
Office, July 1995).<BR>
<P><A NAME="229"  HREF="#r229">229.</a> Lawrence Berkeley National Laboratory, <I>From the Lab to the 
Marketplace</I> (Berkeley, CA: Energy & Environment Division, 1994).<BR>
<P><A NAME="230"  HREF="#r230">230.</a> McMahon, J., Turiel, I., and Geller, H., "National Impacts of 
Appliance Standards," <I>Energy and Buildings</I> (forthcoming).<BR>
<P><A NAME="231"  HREF="#r231">231.</a> This carbon dioxide reduction data uses a national average for 
electricity, given the actual fuel share in 1993, of 0.6332 metric tons 
per megawatt-hour (MWh). In the future, avoided emissions will depend on 
the actual displacement of future and/or existing plants. Laitner, S., 
Economic Research Associates (Arlington, VA: December 5, 1995). <BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>




<!--start foot--><p align=right><a href = "C1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B5.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-186</DOCNO>
<DOCOLDNO>IA026-000277-B031-251</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/C1.html 198.77.86.203 19970113175718 text/html 8099
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:59:23 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 7928
Last-modified: Mon, 17 Jun 1996 00:30:22 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Whirlpool's "Golden Carrot"&#129; Super-Efficient Refrigerator</title>
<table><tr><td><blockquote>


<H3>1. Whirlpool's "Golden Carrot"&#129; Super-Efficient Refrigerator </H3>
<BR>
<BR>
One of the most creative and impressive new technology-forcing incentives 
is the "Golden Carrot"&#129; Super-Efficient Refrigerator program.<a href="#232" name="r232"> [ 232 ] </a>
Refrigerators consume 20 percent of all residential electricity, and 
average about 685 kilowatt-hours per refrigerator each year.<a href="#233" name="r233"> [ 233 ] </a>To 
encourage manufacturers to develop and market refrigerator-freezers that 
are substantially more efficient than the 1993 standards, and also to 
influence the next round of federal standards, a group of electric 
utilities formed a consortium - the <A NAME="SuperEfficientRefrigeratorProgram,Inc.">Super Efficient Refrigerator Program, Inc.<a> (SERP).<a href="#234" name="r234"> [ 234 ] </a>In July 1992, SERP issued a Request for Proposals 
to refrigerator manufacturers asking them to design, manufacture, and sell 
the most energy-efficient refrigerator possible - while competing for a 
$30 million pot of incentive money. The manufacturer who promised the most 
energy savings at the lowest cost per kilowatt-hour saved was to win the 
entire pot (provided that the manufacturer can sell enough qualifying 
models within the service areas of the participating utilities). To be 
eligible, bids had to be for CFC-free designs. In October 1992, SERP 
received fourteen bids, including a number of bids from major 
manufacturers. In December 1992, it selected two 
semi-finalists - <B><I><A NAME="Frigidaire">Frigidaire<a>s</B></I> and <B><I><A NAME="Whirlpool">Whirlpool<a></B></I>. 
These manufacturers then built prototype units and submitted them to SERP 
for testing. Both prototypes used roughly 40 percent less energy than 
required under the 1993 federal efficiency standards. SERP selected a 
single winner in June 1993 - Whirlpool. The $30 million prize will be 
paid as the efficient Whirlpool refrigerators are delivered to retail 
stores within the service areas of participating utilities.<a href="#235" name="r235"> [ 235 ] </a>

<BLOCKQUOTE>
<hr>
<a href = "../img/ExecSum-Fig-4a.gif"><img src = "../t/ExecSum-Fig-4a.gif"
 alt = "Chart 9a, 9b: New Golden Carrot Whirlpool Design 
Reduces Comsumer costs." align=left></a>
<h3><I>New Golden Carrot Whirlpool Design Reduces Comsumer Costs...<br clear=all></I></h3>
 <p>
<a href = "../img/ExecSum-Fig-4b.gif"><img src = "../t/ExecSum-Fig-4b.gif" align=right></a>
<br><h3><I>...And Carbon Emissions<br clear=all><hr></I></h3>
</BLOCKQUOTE>


<p>     Energy savings from the Golden Carrot&#129; program are substantial. 
About 25,000 SERP refrigerators were sold in 1994, providing savings of 
7,100 megawatt-hours of energy and 1.6 megawatts of capacity - and 
cutting carbon dioxide emissions by about 4,495 metric tons. Over the 
life-cycle of those 25,000 refrigerators, 135,375 megawatt-hours will be 
saved, cutting carbon dioxide emissions by approximately 85,719 metric 
tons.<a href="#236" name="r236"> [ 236 ] </a>Once the program's 250,000 refrigerators enter the market as 
planned, the program could result in direct annual energy savings of 
96,000 megawatt-hours (a capacity equivalent of 16 megawatts) and 1.83 
million life-cycle megawatt-hours - cutting carbon dioxide emissions by 
about 60,787 metric tons each year and by about 1,158,756 metric tons over 
the life cycle of the refrigerators.<a href="#237" name="r237"> [ 237 ] </a>

<BLOCKQUOTE>
<hr>
<a href = "../img/Bldgs-volume.gif"><img src = "../t/Bldgs-volume.gif"
 alt = "Chart 10: Refrigerator Electricity Use and Volume" align=left></a>
 <h3><I>Chart 10: Refrigerator Electricity Use and Volume<br clear=all><hr></I></h3>
</BLOCKQUOTE>

<p>     The indirect effects of the program, however, produced the greatest 
benefit. Because of the program, the entire market for refrigerators could 
be transformed; Whirlpool's competitors are also now developing more 
efficient refrigerators.<a href="#238" name="r238"> [ 238 ] </a>The Golden Carrot&#129; concept could be 
replicated to encourage improved efficiency designs for buildings, 
equipment, and appliances. Federal, state, and local governments could 
form partnerships with local utilities, manufacturers, and other 
interested parties to encourage improved efficiency through similar 
incentive schemes for technology demonstration and marketing.<BR>





<hr><font size =-1>





<!--footnotes-->
<P><A NAME="232"  HREF="#r232">232.</a> The program was crafted by the U.S. Environmental Protection Agency, 
the Natural Resources Defense Council, the American Council for an 
Energy-Efficient Economy, Pacific Gas and Electric, and Southern 
California Edison.<BR>
<P><A NAME="233"  HREF="#r233">233.</a> The average rated electricity consumption of new refrigerators 
declined from about 1,725 kilowatt-hours per year in 1972 to around 685 
kilowatt-hours per year in 1993. Geller, H. and Nadel, S., "Market 
Transformation Strategies to Promote End-Use Efficiency," <I>Annual Review 
of Energy and Environment</I> 19, p. 305 (Washington, D.C.: American 
Council for an Energy-Efficient Economy, 1994).<BR>
<P><A NAME="234"  HREF="#r234">234.</a> Nadel, S., et al., <I>Emerging Technologies to Improve Energy 
Efficiency in the Residential & Commercial Sectors</I>, p. 16 (Washington, 
D.C.: American Council for an Energy-Efficient Economy, February 1993).<BR>
<P><A NAME="235"  HREF="#r235">235.</a> United States Environmental Protection Agency, <I>Green Lights: An 
Enlightened Approach to Energy Efficiency and Pollution Prevention,</I> 
EPA 430-K-93-001, p. 15 (Washington, D.C.: July 1993).<BR>
<P><A NAME="236"  HREF="#r236">236.</a> This carbon dioxide reduction data uses a national average for 
electricity, given the actual fuel share in 1993, of 0.6332 metric tons 
per megawatt-hour (MWh). In the future, avoided emissions will depend on 
the actual displacement of future and/or existing plants. Laitner, S., 
Economic Research Associates (Arlington, VA: December 5, 1995).<BR>
<P><A NAME="237"  HREF="#r237">237.</a> The Results Center, <I>Super Efficient Refrigerator Program</I>, 
Profile Brief #106 (Basalt, CO: IRT Environment, 1994). This carbon 
dioxide reduction data uses a national average for electricity, given the 
actual fuel share in 1993, of 0.6332 metric tons per megawatt-hour (MWh). 
In the future, avoided emissions will depend on the actual displacement of 
future and/or existing plants. Laitner, S., Economic Research Associates 
(Arlington, VA: December 5, 1995).<BR>
<P><A NAME="238"  HREF="#r238">238.</a> The Results Center, <I>Super Efficient Refrigerator Program</I>, 
Profile Brief #106 (Basalt, CO: IRT Environment, 199

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

 
</td></tr>
</table>




<!--start foot--><p align=right><a href = "C2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-187</DOCNO>
<DOCOLDNO>IA026-000277-B031-284</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/C2.html 198.77.86.203 19970113175741 text/html 3126
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:59:35 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2955
Last-modified: Mon, 17 Jun 1996 00:30:23 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title> Energy-Efficient Windows</title>
<table><tr><td><blockquote>

<H3>2. Energy-Efficient Windows</H3>

<B><BR>
</B>Residential and commercial windows in the United States leak as much 
heat every year as is produced from the annual output of the Alaskan 
pipeline - approximately 1.8 billion barrels of oil per day costing $25 
billion.<a href="#239" name="r239"> [ 239 ] </a><P>
<B><I><P>
 <p>     <A NAME="LawrenceBerkeleyNationalLaboratory">Lawrence Berkeley National Laboratory<a>. </B></I>The DOE's 
program at the LBNL has made an enormous contribution to national energy 
efficiency through its development of low emissivity, or "Low-E," windows, 
which use a special coating to reduce heat loss by 35 percent. LBNL helped 
private businesses develop prototype coatings and new, low-cost, thin-film 
deposition processes. Today, Low-E windows have captured 36 percent of the 
U.S. windows market with $600 million in annual sales. By 1993, the 
cumulative energy savings to the United States was $760 million, and 
cumulative savings will reach $17 billion by the year 2015. By that year, 
Low-E windows are projected to be preventing, through avoided electricity 
generation, 142,000 metric tons of sulfur dioxide, 129,000 metric tons of 
nitrous oxide, and more than 64 million metric tons of carbon dioxide 
emissions.<a href="#240" name="r240"> [ 240 ] </a>
<P>
<BR>





<hr><font size =-1>





<!--footnotes-->

<P><A NAME="239"  HREF="#r239">239.</a> Rosenfeld, A., and Ward, E., "Energy Use in Buildings," <I>The 
Energy-Environment Connection,</I> Hollander, J., ed., p. 242 (Washington, 
D.C.: Island Press, 1992).<BR>
<P><A NAME="240"  HREF="#r240">240.</a> United States Department of Energy, "Low-E Windows," <I>Case 
Studies</I>, p. 1 (Washington, D.C.: Office of Energy Efficiency and 
Renewable Energy, 1995).<BR>
</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>




<!--start foot--><p align=right><a href = "C3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-188</DOCNO>
<DOCOLDNO>IA026-000277-B032-37</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/C3.html 198.77.86.203 19970113175811 text/html 2665
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:00:14 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2494
Last-modified: Mon, 17 Jun 1996 00:30:23 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title> Energy-Efficient Equipment Labeling</title>
<table><tr><td><blockquote>
<H3><I>3. Energy-Efficient Equipment Labeling</H3>
 </I><BR>
<BR>
<B><I> <p>     EPA's "Energy Star" Program. </B></I>EPA's "Energy Star" 
equipment program affixes a readily-identifiable energy-efficiency label 
to office equipment that meets certain specifications for energy savings. 
The label is currently used by personal computer, monitor, printer, 
copier, and fax machine manufacturers whose products offer a low-power 
"sleep" mode when not in use (with no loss in performance) and can awaken 
automatically when needed. <BR>
<p>    <p>      Computer systems consume 5 percent of all commercial 
electricity - a percentage that could grow to 10 percent by the year 
2000. Some 30 to 40 percent of all computers are left on at night and over 
weekends. On an average day, computers are active less than 20 percent of 
the time.<a href="#241" name="r241"> [ 241 ] </a>By using Energy Star equipment, an office with 100 PCs and 
monitors, 20 printers, and 10 fax machines could save about $3,800 per 
year.<P>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="241"  HREF="#r241">241.</a> United States Environmental Protection Agency, <I>Green Lights: An 
Enlightened Approach to Energy Efficiency and Pollution Prevention,</I> 
EPA 430-K-93-001, p. 15 (Washington, D.C.: July 1993).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-189</DOCNO>
<DOCOLDNO>IA026-000277-B032-76</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/III/D.html 198.77.86.203 19970113175849 text/html 2038
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:00:47 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1867
Last-modified: Mon, 17 Jun 1996 00:30:24 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Conclusion</title>
<table><tr><td><blockquote>
<H2><I>D. </I>Conclusion</H2>
<BR>
<BR>
Much more could be done to improve the energy efficiency of America's 
buildings, residences, appliances, and equipment. Fifty percent of large 
businesses that spend at least $100,000 annually on energy bills invest in 
energy efficiency only when paybacks are 2 years or less. This is 
equivalent to demanding better than 50 percent annual returns on financial 
investments. Energy-efficiency investments simply make good sense: they 
offer returns superior to those of most financial instruments, and they 
often improve worker comfort while significantly increasing productivity. 
Energy-efficient building designs, retrofit investments, and equipment and 
appliance standards all contribute to greater business competitiveness and 
economic growth - while preventing carbon dioxide emissions.<BR>





<font size =-1>





<!--footnotes-->


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>




<!--start foot--><p align=right><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-190</DOCNO>
<DOCOLDNO>IA026-000277-B032-107</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/intro.html 198.77.86.203 19970113175907 text/html 7696
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:01:11 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 7525
Last-modified: Mon, 17 Jun 1996 00:30:48 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><!--end head-->
<title>Transportation</title>
<table><tr><td><blockquote>


<H1>IV. Transportation</H1>
<BR>
<BR>
The combustion of fossil fuels by the U.S. transportation sector consumed 
35 percent of the nation's energy in 1990 and produced more than 32 
percent of U.S. carbon dioxide emissions.<a href="#242" name="r242"> [ 242 ] </a>Transportation will be the 
fastest-growing source of U.S. carbon dioxide emissions over the long 
term - by far - unless Americans take aggressive steps to build 
efficiency into transportation systems.<a href="#243" name="r243"> [ 243 ] </a>
<p>     Two-thirds of total U.S. oil consumption goes to transportation.<a href="#244" name="r244"> [ 244 ] </a>
Transportation is the only sector of the U.S. economy that is totally 
dependent on oil. Oil consumption by transportation has profound 
implications for national security. Each day, Americans use 4 million more 
barrels of oil for transportation than the United States produces. The 
United States imports more than half the petroleum it uses, and those 
imports contributed $56 billion to the U.S. trade deficit in 1994.<a href="#245" name="r245"> [ 245 ] </a>The 
United States is importing more oil than ever before, and the trend is 
upward. The gap between what we use and what we produce is projected to 
rise to 9 million barrels per day by the year 2010.<a href="#246" name="r246"> [ 246 ] </a>Dependence on oil 
imports threatens U.S. national security.<a href="#247" name="r247"> [ 247 ] </a>It makes our economy 
vulnerable to foreign cartels, price swings, supply disruptions, and 
foreign wars.<BR>
<p>     Transportation energy use accounts for about half of all air 
pollution emissions in the United States and more than 80 percent of air 
pollution in cities.<a href="#248" name="r248"> [ 248 ] </a>Highway vehicles alone account for 26 percent of 
U.S. emissions of volatile organic compounds (VOCs), 32 percent of 
nitrogen oxides, and 62 percent of total carbon monoxide.<a href="#249" name="r249"> [ 249 ] </a>Emissions of 
these hydrocarbon vapor emissions are tied to gasoline use. Hydrocarbon 
by-products of gasoline consumption react with nitrogen oxides to form 
ground-level ozone, a major air pollutant that aggravates asthma and 
causes other respiratory problems. The <A NAME="AmericanLungAssociation">American Lung Association</a> (ALA) 
estimates that the United States spends $50 billion each year on health 
care as a direct result of air pollution.<a href="#250" name="r250"> [ 250 ] </a>
<p>     Every tank of gasoline consumed by an automobile produces between 240 
and 400 pounds of carbon dioxide when burned.<a href="#251" name="r251"> [ 251 ] </a>Every pound emitted 
accumulates in the atmosphere for between 50 and 200 years.<a href="#252" name="r252"> [ 252 ] </a>The United 
States emits almost as much carbon dioxide from the transport sector as 
Eastern Europe, Southeast Asia, China, Africa, Latin America, and the 
Middle East combined.<a href="#253" name="r253"> [ 253 ] </a>




<hr><font size =-1>





<!--footnotes-->


<P><A NAME="242"  HREF="#r242">242.</a> Clinton, President W., and Gore, Vice President A., <I>The Climate 
Change Action Plan</I>, DOE/PO-0011-2, p. 17 (Washington, D.C.: October 
1993); United States Department of Energy, "Why Transportation Energy 
Matters," <I>Fact Sheet,</I> p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995).<BR>
<P><A NAME="243"  HREF="#r243">243.</a> Clinton, President W., and Gore, Vice President A., <I>The Climate 
Change Action Plan</I>, DOE/PO-0011-2, p. 17 (Washington, D.C.: October 
1993).<BR>
<BR>
<P><A NAME="244"  HREF="#r244">244.</a> Fulkerson, W., <I>et al.</I>, "Energy Technology R & D: What Could 
Make a Difference?" ORNL-6541/V1, Part 1: Synthesis Report, p. 20 (Oak 
Ridge, TN: Oak Ridge National Laboratory, May 1989).<BR>
<P><A NAME="245"  HREF="#r245">245.</a> Brown, M. and Vaughan, K., <I>Science and Technology for a Sustainable 
Energy Future: Accomplishments of the Energy Efficiency and Renewable 
Energy Program at Oak Ridge National Laboratory</I>, ORNL/CON-410, p. 35 
(Oak Ridge, TN: Oak Ridge National Laboratory, March 1995); United States 
Department of Energy, "Why Should We Care About Sustainable Energy?" 
<I>Fact Sheet</I>, p. 2 (Washington, D.C.: Office of Energy Efficiency and 
Renewable Energy, 1995).<BR>
<P><A NAME="246"  HREF="#r246">246.</a> United States Department of Energy, "Why Transportation Energy 
Matters," <I>Fact Sheet,</I> p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995). <BR>
<P><A NAME="247"  HREF="#r247">247.</a> United States Department of Energy, Office of Technical and Financial 
Assistance, <I>America's Best: Outstanding State Energy Grant 
Projects</I>, DOE/CH 10093-149, DE92010586, p. 10 (Golden, CO: National 
Renewable Energy Laboratory, August 1992). <BR>
<P><A NAME="248"  HREF="#r248">248.</a> United States Department of Energy, "Why Transportation Energy 
Matters," <I>Fact Sheet,</I> p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995).<BR>
<P><A NAME="249"  HREF="#r249">249.</a> United States Department of Energy, <I>Sustainable Energy Strategy: 
Clean and Secure Energy For a Competitive Economy,</I> National Energy 
Policy Plan, ISBN 0-16-048183-X, p. 20 (Washington, D.C.: July 1995). Six 
criteria pollutants addressed in the Clean Air Act are related to 
transportation sources: (1) ground level ozone (smog precursors such as 
volatile organic compounds (VOCs) and oxides of nitrogen (NOx)), (2) 
carbon monoxide, (3) particulate matter less than 10 microns in diameter 
(PM-10), (4) nitrogen dioxide, (5) sulfur dioxide, and (6) lead.<BR>
<P><A NAME="250"  HREF="#r250">250.</a> United States Department of Energy, "Why Transportation Energy 
Matters," <I>Fact Sheet,</I> p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995).<BR>
<P><A NAME="251"  HREF="#r251">251.</a> Walsh, M., "Motor Vehicles and Global Warming," <I>Global Warming: The 
Greenpeace Report, </I>Leggett, J., ed., p. 261 (Oxford University Press: 
1990). Each gallon of gasoline consumed emits about 22 pounds of carbon 
dioxide. <I>Id.</I> at 284.<BR>
<P><A NAME="252"  HREF="#r252">252.</a> National Academy of Sciences, <I>Policy Implications of Greenhouse 
Warming</I>, p. 11 (Washington, D.C.: National Academy Press, 1991).<BR>
<P><A NAME="253"  HREF="#r253">253.</a> Walsh, M., "Motor Vehicles and Global Warming," <I>Global Warming: The 
Greenpeace Report, </I>Leggett, J., ed., pp. 261-62 (Oxford University 
Press: 1990).<BR>
</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>




<!--start foot--><p align=right><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-191</DOCNO>
<DOCOLDNO>IA026-000277-B032-138</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/A.html 198.77.86.203 19970113175920 text/html 2283
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:01:27 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2112
Last-modified: Mon, 17 Jun 1996 00:30:48 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Fuel-Efficiency Improvements in Internal Combustion Engines</title>
<table><tr><td><blockquote>

<H2>A. Fuel-Efficiency Improvements in Internal Combustion Engines 
Cost-Effectively Reduce Air Pollution, Including Carbon Dioxide Emissions </H2>

<BR>
<BR>
A huge potential exists for increased energy efficiency in transportation, 
which would benefit our national economy, national security, global 
industrial competitiveness, and the environment. Great strides have been 
made since 1970 in improving fuel efficiency and in reducing air pollutant 
emissions. Perhaps more than any other sector of the economy, however, 
transportation stands to gain the most from a concerted, national effort 
to mobilize efficiency improvements. Increasing transportation efficiency 
requires a duel strategy of building more-efficient vehicles while 
increasing the options for alternative modes of mobility - including 
transit, biking, and walking.<BR>




<font size =-1>





<!--footnotes-->


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "A1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-192</DOCNO>
<DOCOLDNO>IA026-000277-B032-161</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/A1.html 198.77.86.203 19970113175934 text/html 6726
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:01:37 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 6555
Last-modified: Mon, 17 Jun 1996 00:30:49 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Internal Combustion Engine Efficiency Has Improved</title>
<table><tr><td><blockquote>

<H3>1. Internal Combustion Engine Efficiency Has Improved</H3>
<BR>
<BR>
Only about 13 percent of the energy consumed by today's vehicles actually 
propels them forward.<a href="#255" name="r255"> [ 255 ]</a>
Each year U.S. drivers spend $77 billion on
gasoline and oil for their vehicles - with the bulk of each gallon of 
gasoline discharged through the tailpipe as waste exhaust.<a href="#256" name="r256"> [ 256 ] </a>Much of this 
energy need not be wasted.<BR>
<p>     The increase in automobile fuel efficiency already achieved is an 
important transportation success. The technology exists, however, to 
substantially improve fuel efficiency in internal combustion engines. The 
most efficient cars now on the road achieve more than 45 miles per gallon 
(mpg). Commercial prototypes boast more than 70 mpg <I>in the city</I>.<a href="#257" name="r257"> [ 257 ] </a>
Technology exists to raise average new-car fuel economy 65 percent, from 
28 to 46 miles per gallon, by 2005. A comparable increase can be made for 
light trucks.<a href="#258" name="r258"> [ 258 ] </a>Phasing these improvements into U.S. cars and light 
trucks over the next 10 years could save 2.8 million barrels of oil per 
day by 2010. These savings are larger than the supplies expected from 
exploiting reserves offshore or in the Arctic National Wildlife Refuge.<a href="#259" name="r259"> [ 259 ] </a>
<BR>

<BLOCKQUOTE>
<hr>
<a href = "../img/ExecSum-Fig-5.gif"><img src = "../t/ExecSum-Fig-5.gif" 
alt = "Chart 11: Efficient Prototype Vehicles" align=left></a>
<h3><I>Chart 11: Efficient Prototype Vehicles,<br clear=all><hr></I></h3>
</BLOCKQUOTE>
<p>     Because carbon dioxide emissions are proportional to fuel 
consumption, higher fuel economy means lower greenhouse gas emissions. If 
a 6 percent annual improvement trajectory in new vehicle fuel economy is 
started in 1996, annual greenhouse gas emissions could be reduced by 27 
million metric tons in 2000 and by 152 million metric tons in 2010.<a href="#260" name="r260"> [ 260 ] </a>
<p>     These savings would be on top of substantial progress already 
obtained in integrating energy efficiency into automobiles, including 
passenger cars and light trucks, over the past two decades. Automobiles 
required 40 percent less energy per vehicle-mile in 1990 than in 1970.<a href="#261" name="r261"> [ 261 ] </a>
These efficiency gains are due in large part to technology-forcing 
regulations, especially federal Corporate Average Fuel Efficiency (CAFE) 
standards, as well as greater consumer acceptability and affordability of 
smaller vehicles. Between 1970 and 1990, the annual amount of fuel used 
per automobile declined by 25 percent.<a href="#262" name="r262"> [ 262 ] </a><BR>

<BR>
 <p>     <B><I><A NAME="HondaMotorsCorporation">Honda Motors Corporation<a>. </B></I>Honda has introduced a 
new high-efficiency Civic HX Coupe that meets the California low-emission 
vehicle (LEV) standard several years before the requirement goes into 
effect. The vehicle's continuously variable transmission (CVT) and 
lean-burn 1.6 liter engine give the vehicle up to 25 percent greater 
mileage over conventional automatics, at an economical price.<a href="#263" name="r263"> [ 263 ] </a>
<P>




<hr><font size =-1>





<!--footnotes-->

<P><A NAME="254"  HREF="#r254">254.</a> Sperling, D., "Gearing Up For Electric Cars," <I>Issues in Science and 
Technology</I>, Vol. XI, No. 2, p. 34 (Dallas, TX: National Academy of 
Sciences, Winter 1994-95).<BR>
<P><A NAME="255"  HREF="#r255">255.</a> United States Department of Energy, "Why Transportation Energy 
Matters," <I>Fact Sheet,</I> p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995).<BR>
<P><A NAME="256"  HREF="#r256">256.</a> United States Department of Energy, Office of Technical and Financial 
Assistance, <I>America's Best: Outstanding State Energy Grant 
Projects</I>, DOE/CH 10093-149, DE92010586, p. 10 (Golden, CO: National 
Renewable Energy Laboratory, August 1992). <BR>
<P><A NAME="257"  HREF="#r257">257.</a> Natural Resources Defense Council, Inc., <I>Cooling the Greenhouse: 
Vital First Steps to Combat Global Warming,</I> p. 31 (Washington, D.C.: 
1989).<BR>
<P><A NAME="258"  HREF="#r258">258.</a> DeCicco, J., and Ross, M., "Improving Automotive Efficiency," 
<I>Scientific American</I>, p. 55 (December 1994).<BR>
<P><A NAME="259"  HREF="#r259">259.</a> <I>Id. </I><BR>
<P><A NAME="260"  HREF="#r260">260.</a> Geller, H., et al., <I>Bridging the Gap: Initiatives to Achieve 
President Clinton's Climate Commitment, </I>p. 5 (Washington, D.C.: 
American Council For an Energy-Efficient Economy, April 22, 1994).<BR>
<P><A NAME="261"  HREF="#r261">261.</a> Because total vehicle miles driven increased by 90 percent since 1970, 
total fuel used by automobiles and light trucks has increased by 45 
percent over the 20-year period. <I>Trends in Transportation Energy Use 
and Emissions,</I> Background Paper, p. 2 (November 1994).<BR>
<P><A NAME="262"  HREF="#r262">262.</a> <I>Id. </I>In the same period, however, the number of miles traveled 
per gallon increased by 45 percent.<BR>
<P><A NAME="263"  HREF="#r263">263.</a> McCosh, D., "Lean, Mean, and Green: A Low-Cost, High-Tech Approach to 
Safety and Lower Emissions," <I>Popular Science</I>, p. 65 (New York, NY: 
Times-Mirror, November 1995).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "A2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-193</DOCNO>
<DOCOLDNO>IA026-000277-B032-187</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/A2.html 198.77.86.203 19970113175948 text/html 3013
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:01:53 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2842
Last-modified: Mon, 17 Jun 1996 00:30:49 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Corporate Average Fuel Efficiency Standards Are a Significant 
Success</title>
<table><tr><td><blockquote>


<H3>2. Corporate Average Fuel Efficiency Standards Are a Significant 
Success</H3>
<BR>
<BR>
Federal CAFE fuel-efficiency requirements for new vehicles are one of the 
major energy policy success stories of the past 20 years. CAFE standards 
doubled automobile fuel efficiency from 14 mpg to 27 mpg between 
1975 and 1985. The standards are presently saving nearly 3 million barrels 
of oil per day - corresponding to $50 billion of consumer savings and 
150 million metric tons of greenhouse gas emissions avoided annually.<a
href="#264" name="r264"> [ 264 ] </a>
<BR>
<p>     Although average fuel economy for new cars has not improved since the 
mid-1980's, the technology has improved substantially during this time. 
Because CAFE standards failed to keep pace with engine-efficiency 
improvements, automobile manufacturers used the technological improvements 
to increase vehicle power rather than vehicle efficiency. With foresight 
and the right policies, improved engine technology is ready to increase 
fuel efficiency, thereby reducing carbon dioxide emissions and U.S. 
dependence on foreign oil.<BR>




<hr><font size =-1>





<!--footnotes-->

<P><A NAME="264"  HREF="#r264">264.</a> Geller, H., et al., <I>Bridging the Gap: Initiatives to Achieve 
President Clinton's Climate Commitment, </I>p. 5 (Washington, D.C.: 
American Council For an Energy-Efficient Economy, April 22, 1994), citing 
DeCicco, J., <I>Savings from CAFE: Projections of the Future Oil Savings 
from Light Vehicle Fuel Economy Standards</I> (Washington, D.C.: American 
Council For an Energy-Efficient Economy, May 1992).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>




<!--start foot--><p align=right><a href = "A3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-194</DOCNO>
<DOCOLDNO>IA026-000277-B032-229</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/A3.html 198.77.86.203 19970113180005 text/html 5089
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:02:09 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4918
Last-modified: Mon, 17 Jun 1996 00:30:49 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A4.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Accelerated Vehicle Retirement Programs Can Improve Air Quality</title>
<table><tr><td><blockquote>



<H3>3. Accelerated Vehicle Retirement Programs Can Improve Air Quality</H3>
<BR>
<BR>
As cars age, emissions can rise dramatically, sometimes increasing more 
than a hundredfold after only a few years. "Super-emitters" of air 
pollution are those 10 percent or so of cars and light trucks that account 
for half of all vehicle emissions. They also tend to reduce dramatically 
the average fuel efficiency of the U.S. fleet. Despite the federal 27.5 
mpg CAFE standard, the fleet average is only 19.2 mpg, primarily due to 
continued use of older, less efficient vehicles.<a href="#265" name="r265"> [ 265 ] </a><BR>
<p>     Accelerated vehicle retirement programs have been getting these 
older, more polluting vehicles off the road. In some jurisdictions, 
industrial sources are able to meet their Clean Air Act obligations more 
cheaply by buying and scrapping super-emitters than by installing 
pollution-control equipment. <BR>
<BR>
<p>     <B><I><A NAME="ChevronCorporation">Chevron Corporation</a>.</B></I> In Southern California, Chevron 
Corporation is purchasing and dismantling 4,200 pre-1975 model-year cars 
under California's Rule 1610, which awards mobile source emissions credits 
to stationary source polluters that operate scrapping programs. Chevron 
plans to use the credits to forestall required installation of 
vapor-recovery technology at one of its off-shore oil terminals.<a href="#266" name="r266"> [ 266 ] </a><P>
<p>     <B><I><A NAME="TotalPetroleumCompany">Total Petroleum Company<a>.</B></I> Total Petroleum Company in 
Denver, Colorado is scrapping 300 pre-1982 cars and repairing another 300 
post-1982 models. The Denver Regional Air Quality District subjects each 
car to emissions testing prior to scrapping, and bases the number of 
pollution permits to be awarded to Total Petroleum on verified pollution 
reductions. The program targets cars that have been: (1) waived from the 
state's tailpipe inspection; (2) reported on a state "smoking vehicle 
hotline," where motorists are encouraged to inform the state of cars that 
exhibit signs of high emissions; and (3) deemed to be high emitters by 
remote sensing technology.<a href="#267" name="r267"> [ 267 ] </a>Total Petroleum is paying $1,000 for all 
scrapped cars and up to $500 for repairs to emissions-related parts.<BR>
<BR>


<hr><font size =-1>





<!--footnotes-->

<P><A NAME="265"  HREF="#r265">265.</a> Super-emitters tend to be older vehicles, but some are relatively new 
vehicles with poorly maintained engines, defective emission-control 
equipment, or emission controls that have been tampered with. Sperling, 
D., <I>Future Drive: Electric Vehicles and Sustainable Transportation</I>, 
p. 16 (Washington, D.C.: Island Press, 1995).<BR>
<P><A NAME="266"  HREF="#r266">266.</a> Kallen, R., et al., <I>Components of a Model Accelerated Vehicle 
Retirement Program</I>, p. 27 (Chicago, IL: Environmental Law and Policy 
Center, March 27, 1995). AVR programs must be designed such that net 
emissions are actually reduced. Some past programs have awarded pollution 
permits too liberally, having failed to determine whether the older, 
scrapped vehicles had been recently driven, and how much.<BR>
<P><A NAME="267"  HREF="#r267">267.</a> Remote sensing is considered by some as the cutting edge of AVR. A 
remote sensor projects a beam of infrared light across the road to a 
detector. The exhaust from a passing car alters the beam, and the 
resulting fluctuations measure carbon monoxide and nitrogen oxide 
emissions. Kallen, R., et al., <I>Components of a Model Accelerated 
Vehicle Retirement Program</I>, p. 28 (Chicago, IL: Environmental Law and 
Policy Center, March 27, 1995). <BR>
</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "A4.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-195</DOCNO>
<DOCOLDNO>IA026-000277-B032-259</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/A4.html 198.77.86.203 19970113180017 text/html 2892
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:02:22 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2721
Last-modified: Mon, 17 Jun 1996 00:30:50 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A5.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Materials Improvements Are Cutting Vehicle Weight and Increasing 
Efficiency</title>
<table><tr><td><blockquote>
<H3>4. Materials Improvements Are Cutting Vehicle Weight and Increasing 
Efficiency</H3>
<BR>
<BR>
Many automakers have argued that raising mileage levels through more 
stringent CAFE standards means cutting car weight, size, and safety. But 
improvements in aluminum and plastic composites promise lighter, 
higher-mileage cars that will be just as big, safe, and powerful as 
today's models.<P>
<p>     <B><I><A NAME="OakRidgeNationalLaboratory">Oak Ridge National Laboratory.</a></B></I>. The Oak Ridge National 
Laboratory in Oak Ridge, Tennessee coordinates a Lightweight Materials 
Program to develop cost-effective materials and technologies that will aid 
in automobile weight reduction while meeting or exceeding safety 
standards. The program also seeks to reduce the overall environmental 
impact of automobiles by minimizing process waste and increasing 
recyclability. A 25 percent weight reduction in current vehicles would 
save about 13 percent of total U.S. gasoline consumption, reducing carbon 
dioxide emissions by about 92 million metric tons per year.<a href="#268" name="r268"> [ 268 ]
</a>
<BR>




<hr><font size =-1>





<!--footnotes-->

<P><A NAME="268"  HREF="#r268">268.</a> Brown, M. and Vaughan, K., <I>Science and Technology for a Sustainable 
Energy Future: Accomplishments of the Energy Efficiency and Renewable 
Energy Program at Oak Ridge National Laboratory</I>, ORNL/CON-410, pp. 
42-43 (Oak Ridge, TN: Oak Ridge National Laboratory, March 1995).<BR>
</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "A5.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-196</DOCNO>
<DOCOLDNO>IA026-000277-B032-284</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/A5.html 198.77.86.203 19970113180026 text/html 4738
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:02:32 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4567
Last-modified: Mon, 17 Jun 1996 00:30:50 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A4.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Vehicle Emissions Reduction Technologies Have Successfully Cut 
Emissions</title>
<table><tr><td><blockquote>

<H3>5. Vehicle Emissions Reduction Technologies Have Successfully Cut 
Emissions</H3>
<BR>
<BR>
New cars in the early 1990s emitted only about one-fourth as much 
pollution as uncontrolled vehicles of the 1960s.<a href="#269" name="r269"> [ 269 ] </a>This progress
has been
due primarily to federal uniform standards for new-car emissions.<a href="#270" name="r270"> [ 270 ] </a>These 
standards have spurred the development of numerous technologies, including 
cleaner fuels, advances in pollution-control technologies such as 
catalytic converters and electronic fuel-injection systems, better vehicle 
maintenance technologies, and inspection standards. Lead, for example, has 
been virtually eliminated from motor vehicle exhaust through the 
introduction of cleaner fuels.<BR>

<BLOCKQUOTE><hr>
<a href = "../img/Tpo-VMT-a.gif"><img src = "../t/Tpo-VMT-a.gif"
 alt = "Charts 12a: Vehicle Miles Traveled" align=left></a>
<h3><I>Charts 12a: Vehicle Miles Traveled are Projected to Rise<br clear=all></I></h3>
<p>
<a href = "../img/Tpo-VMT-b.gif"><img src = "../t/Tpo-VMT-b.gif"
 alt = "Charts 12a: Vehicle Miles Traveled" align=right></a>
<br><h3><I>Automobile Efficiency Standards are Flat<br clear=all></I></h3>
<p>
<a href = "../img/Tpo-VMT-c.gif"><img src = "../t/Tpo-VMT-c.gif"
 alt = "Charts 12a: Vehicle Miles Traveled" align=left></a>
<br><h3><I>Thus, Gasoline Consumption is Expected to Rise<br clear=all><hr></I></h3>

</BLOCKQUOTE>
<p>     Despite vast reductions in tailpipe emissions, automobiles are still 
a primary source of urban air pollution. This is because people are 
driving more - racking up 43 percent more vehicles miles traveled (VMT) 
each year.<a href="#271" name="r271"> [ 271 ] </a>Increases in the number of vehicle miles traveled has more 
than offset increases in average vehicle fuel economy. Every American 
travels, on average, nearly 8,800 miles each year in a car or light truck, 
and the rate of increase in per capita VMT is growing at more than 2 
percent per year.<a href="#272" name="r272"> [ 272 ] </a>In the absence of additional efficiency standards, 
total end-use carbon emissions in the transport sector are projected to 
increase by 90.7 million metric tons between 1990 and 2010, because growth 
in personal and freight travel is projected to outpace fuel-efficiency 
improvements.<a href="#273" name="r273"> [ 273 ] </a><P>





<hr><font size =-1>





<!--footnotes-->
<P><A NAME="269"  HREF="#r269">269.</a>
Sperling, D., <I>Future Drive: Electric Vehicles and Sustainable 
Transportation</I>, p. 18 (Washington, D.C.: Island Press, 1995).<BR>
<P><A NAME="270"  HREF="#r270">270.</a> <I>Id., </I>pp. 18-19.<BR>
<P><A NAME="271"  HREF="#r271">271.</a> United States Department of Energy, "Why Transportation Energy 
Matters," <I>Fact Sheet</I>, p. 1 (Washington, D.C.: Office of Energy 
Efficiency and Renewable Energy, 1995).<BR>
<P><A NAME="272"  HREF="#r272">272.</a> United States Department of Energy, <I>Sustainable Energy Strategy: 
Clean and Secure Energy For a Competitive Economy,</I> National Energy 
Policy Plan, ISBN 0-16-0481833-X, p. 20 (Washington, D.C.: July 1995).<BR>
<P><A NAME="273"  HREF="#r273">273.</a> United States Department of Energy, <I>Annual Energy Outlook 1994 With 
Projections to 2010,</I> DE94-005938, p. 19 (Oak Ridge, TN: January 
1994).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>





<!--start foot--><p align=right><a href = "B1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A4.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-197</DOCNO>
<DOCOLDNO>IA026-000277-B033-11</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/B1.html 198.77.86.203 19970113180045 text/html 4343
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:02:43 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4172
Last-modified: Mon, 17 Jun 1996 00:30:51 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A5.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>New Vehicle Technologies</title>
<table><tr><td><blockquote>


<H2><I>B. </I>New Vehicle Technologies are Ushering In an Era of More 
Efficient Transportation</H2>
<P>

<H3>1. Technology Incentives Spur Markets For Efficient Vehicles</H3>
<BR>
<BR>
Faced with increasing vehicle emissions and the prospect of failing to 
attain federal Clean Air Act standards, several U.S. jurisdictions are 
implementing policies that require greater vehicle efficiency. <P>
<p>     <B><I>The California Air Resources Board. </B></I>The California 
Air Resources Board (CARB) has galvanized a low-emission vehicle (LEV) and 
zero-emission vehicle (ZEV) market in California by requiring automobile 
manufacturers to include at least 2 percent zero emission vehicles in 
their 1998 vehicle sales (an estimated 31,000 vehicles). Sales must rise 
to 5 percent by the year 2001 and 10 percent in 2003.<a href="#274" name="r274"> [ 274 ] </a><BR>
<p>    <p>      <BR>
The level of overall ZEV investment, in both human and financial terms, 
has been remarkable, reaching as high as $500 million by some estimates. 
The California ZEV program has the capacity to create a trillion-dollar 
industry of environmentally clean transportation products that will create 
millions of jobs and investment opportunities in the United States and 
around the world. The California ZEV mandate has been embraced by Vermont, 
Massachusetts, and New York, and is being seriously considered by a number 
of other states.<a href="#275" name="r275"> [ 275 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->

<P><A NAME="274"  HREF="#r274">274.</a> Companies subject to the ZEV requirements are "major" automakers 
selling more than 35,000 vehicles per year in California. The companies 
include General Motors, Ford, Toyota, Chrysler, Honda, Nissan, and Mazda. 
In 2003, the threshold will drop to 3,000 sales per year, which will 
affect most European companies and smaller Japanese companies. Sperling, 
D., <I>Future Drive: Electric Vehicles and Sustainable Transportation</I>, 
pp. 38-39 (Washington, D.C.: Island Press, 1995).<p>     An important lure 
for all these companies is the ability to sell ZEV credits. For each 
vehicle sold, the California Air Resources Board will provide the company 
with a ZEV credit. Credits can be sold t<BR>
o any of the Big Seven manufacturers. Because the fine for not selling a 
ZEV is $5,000, and the loss per vehicle is expected to be greater than 
$5,000 per vehicle initially, the Big Seven should be willing to pay up to 
$5,000 for each vehicle credit. The trading of ZEV credits could be 
attractive to all concerned. It allows a company such as General Motors to 
meet part (or all) of its ZEV responsibilities without paying an 
embarrassing fine and without incurring large losses. And it provides 
small, cash-strapped electric vehicle companies with a substantial cash 
subsidy for every vehicle sold, even small neighborhood electric cars. 
<I>Id.,</I> p. 43.<BR>
<P><A NAME="275"  HREF="#r275">275.</a> <I>Id., </I>p. 39.<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "B2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A5.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-198</DOCNO>
<DOCOLDNO>IA026-000277-B033-63</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/B2.html 198.77.86.203 19970113180132 text/html 3865
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:03:37 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 3694
Last-modified: Mon, 17 Jun 1996 00:30:51 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B2a.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->

<title>New Low-Emission and Zero-Emission Vehicles</title>
<table><tr><td><blockquote>
<H3>2. New Low-Emission and Zero-Emission Vehicles Could Revolutionize 
Transportation</H3>
<BR>
<BR>
More than a dozen companies are deploying LEV and ZEV vehicles, 
anticipating a potentially huge future market. The new designs may be 
three to five times as efficient as today's, and reduce emissions of 
regulated pollutants by at least 95 percent. Carbon dioxide emissions 
could decline by 75 to 90 percent.<a href="#276" name="r276"> [ 276 ] </a><P>
<p>     <B><I><A NAME="Calstart,Inc."> Calstart, Inc.</a> </B></I>Calstart is a public-private 
consortium founded in 1992 to help California companies foster an advanced 
transportation industry by arranging for grants, marketing their products, 
and sharing information. It is a leading player in the state's efforts to 
support LEV and ZEV vehicles. More than 150 member companies have joined 
forces and are developing advanced transportation technologies. Thus far, 
member companies have deployed an aluminum chassis for electric vehicles, 
opened one of the largest production sites for natural gas vehicles, 
developed the first electric-natural gas hybrid vehicles, developed the 
first electric-natural gas hybrid bus, and introduced the nation's first 
electric school bus. Through June 1995, the member companies had created 
1,655 jobs.<a href="#277" name="r277"> [ 277 ] </a>
<BR>
<p>     <B><I>DOE's "Clean Cities" Program. </B></I>The U.S. DOE "Clean 
Cities" program has successfully expanded the use of vehicles that use 
alternative fuels in 34 communities that have received a Clean Cities 
designation. Clean Cities communities intend to have more than 60,000 
alternative fuel vehicles in use by the end of 1996, and will establish 
700 refueling and maintenance facilities.<a href="#278" name="r278"> [ 278 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="276"  HREF="#r276">276.</a> Flavin, C., and Lenssen, N., <I>Power Surge: Guide to the Coming 
Energy Revolution, </I>Worldwatch Environmental Alert Series, p. 197 (New 
York, NY: W.W. Norton, 1994).<BR>
<P><A NAME="277"  HREF="#r277">277.</a> Flanigan, J., "Chance at a Clean Start: Zero-Emission Car Mandate 
Needs to Be More Flexible," <I>The Los Angeles Times</I>, p. D6 (June 7, 
1995).<BR>
<P><A NAME="278"  HREF="#r278">278.</a> United States Department of Energy, "Programs Targeted For Urban 
Centers and Municipalities," <I>Fact Sheet,</I> p. 1 (Washington, D.C.: 
Office of Energy Efficiency and Renewable Energy, 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "B2a.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-199</DOCNO>
<DOCOLDNO>IA026-000277-B033-93</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/B2a.html 198.77.86.203 19970113180146 text/html 9781
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:03:52 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 9610
Last-modified: Mon, 17 Jun 1996 00:30:52 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B2b.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Electric Vehicles</title>
<table><tr><td><blockquote>

<H4>a. Electric Vehicles</H4>
<BR>
</B>Electric vehicles are the closest thing to a nonpolluting 
transportation medium. Their only adverse effects on the environment would 
be linked to the generation of electricity to charge their batteries and, 
possibly, to disposal of the batteries (although recycling may dispel this 
concern).<a href="#279" name="r279"> [ 279 ] </a>Although the initial price of electric cars will likely be 
higher than the price of internal combustion engine vehicles, electric 
vehicles will have lower overall life-cycle costs.<a href="#280" name="r280"> [ 280 ] </a>Inadequate 
batteries, at present, are the only significant obstacle to widespread 
use.<a href="#281" name="r281"> [ 281 ] </a><P>
<B><p>     <I>South Coast Air Quality Management District (SCAQMD), 
California.</B></I> In July 1995, SCAQMD unveiled a two-year "Electric 
Vehicle Incentive" program to help bring electric vehicles to the market. 
Beginning in 1996, SCAQMD will offer a $5,000 discount for motorists 
purchasing an electric vehicle, up to a total of 1,200 vehicles. The 
vehicles will be required to meet certain minimum performance 
specifications and all federal motor vehicle safety standards. In addition 
to this program, SCAQMD will use an additional $1 million to encourage the 
development of electric vehicle corridors. Under this program, groups of 
three or more clustered cities along designated corridors can apply for 
matching funds to help develop electric vehicle infrastructure.<BR>
<B><BR>
</B><p>     <B><I><A NAME="GeneralMotorsCorporation">General Motors Corporation<a>. </B></I>Many manufacturers 
are moving ahead with electric vehicle production. General Motors 
originally unveiled its "Impact" model in 1990.<a href="#282" name="r282"> [ 282 ] </a>The Impact, with a 
composite body and stiff aluminum frame, incorporates an advanced electric 
motor, electronic controls, regenerative braking, and aerodynamic 
streamlining. The energy cost of running an Impact is only a quarter that 
of a gasoline-powered car. The driving range, however, is limited to about 
100 miles by its 1,100 pounds of lead-acid batteries.<a href="#283" name="r283"> [ 283 ] </a>Nevertheless, 
those who have test-driven an Impact have on the whole given it rave 
reviews for its quiet ride, maneuverability, and rapid acceleration.<a href="#284" name="r284"> [ 284 ] </a>
Even counting the emissions from the power plants used to charge it, the 
Impact produces two-thirds less pollution than California will allow under 
its 1998 ultra-low emission standard,285 and 72 percent less carbon 
dioxide than is emitted by a 1994 Ford Taurus.<a href="#286" name="r286"> [ 286 ] </a>
<BR>
<p>     <B><I><A NAME="Clean,IntelligentTransportation,Inc."> Clean, Intelligent Transportation, Inc </a>. (CITI).</B></I> 
Calstart and a Norwegian consortium joined forces recently and unveiled a 
personal electric car designed for affordability, with a sticker price of 
less than $10,000. The new company, Clean, Intelligent Transportation, 
Inc., will bring the new car, the PIVCO CITI, to California, and plans to 
begin manufacturing there by late 1996 or early 1997. The car is a roomy 
two-passenger vehicle that will be marketed as a commuter car for use as a 
family's second car to be used primarily for commuting and running errands 
around town. The car will run at freeway speeds, includes air 
conditioning, and will, with its dual air-bags, meet U.S. safety 
standards. The car will have a range of 60 to 80 miles between 
charges.<a href="#287" name="r287"> [ 287 ] </a>
<p>     <BR>
<p>     <B><I><A NAME="SolectriaCorporation">Solectria Corporation<a>. </B></I>Solectria, of Wilmington, 
Massachusetts, has produced a lightweight electric sedan with the standard 
features typical of sedans on the market today. With its aerodynamic 
styling, the new <I>Sunrise</I> sedan incorporates a state-of-the-art AC 
induction drive system and a driving range of 120 miles per charge, using 
advanced lead-acid batteries. (Enhanced range is expected as superior 
battery technologies are introduced in the future. A <I>Sunrise</I> 
prototype using a nickel metal-hydride battery has logged 238 miles in 
mixed city-highway driving without stopping for a charge.) The two-door, 
four-passenger electric vehicle includes power brakes, dual air bags, 
cruise control, automatic battery thermal management for winter driving, 
efficient electric air conditioning/heating, and a sophisticated onboard 
battery charging and monitoring system. The car accelerates from zero to 
30 mph in 6 seconds, zero to 60 mph in 17 seconds, and maintains a 
cruising speed of 75 mph. The vehicle is projected to cost $20,000 at a 
mass-production level of 20,000 units, and will be available in 1998. Over 
the past 6 years, Solectria vehicles have consistently achieved top honors 
for efficiency, range and performance.<a href="#288" name="r288"> [ 288 ] </a>
<B>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="279"  HREF="#r279">279.</a> More electric vehicles does not necessarily mean more power plants. 
Batteries can be recharged during off-peak hours when excess generating 
capacity is available. The prospect of recharging at night presents 
electric utilities with an opportunity to operate more efficiently by 
allowing them to draw power from otherwise idle capacity. Sperling, D., 
<I>Future Drive: Electric Vehicles and Sustainable Transportation</I>, p. 
58 (Washington, D.C.: Island Press, 1995). <BR>
<P><A NAME="280"  HREF="#r280">280.</a> <I>Id., </I>pp. 55-56.<BR>
<P><A NAME="281"  HREF="#r281">281.</a> Zetsche, D., "The Automobile: Clean and Customized," <I>Scientific 
American</I>, Vol. 273, No. 3, p. 105 (New York, NY: September 1995). The 
vehicle battery market is not yet mature. The most expensive component in 
the electric driveline is the battery. Currently available lead-acid 
batteries last less than two years and 20,000 miles and do not store 
enough energy to power a full-size vehicle very far or fast. But major 
improvements are expected, especially as the California ZEV mandate 
approaches in 1998. <I>See</I> <I>Id., </I>pp. 48-49.<BR>
<P><A NAME="282"  HREF="#r282">282.</a> Flavin, C., and Lenssen, N., <I>Power Surge: Guide to the Coming 
Energy Revolution, </I>Worldwatch Environmental Alert Series, pp. 199-200 
(New York, NY: W.W. Norton, 1994).<BR>
<P><A NAME="283"  HREF="#r283">283.</a> <I>Id., </I>p. 203. Researchers see a potential to increase the energy 
storage capacity of lead-acid batteries by 50 percent or more, while other 
research teams are seeking to adapt the more efficient but costlier 
nickel-cadmium and lithium batteries used in computers and other 
electronic devices. A 1994 study by the California Air Resources Board 
suggests that battery technology continues to advance rapidly, and that by 
the end of this decade new batteries may double the 60- to 100-mile range 
typical of today's electric cars. In the longer run, still lower costs and 
greater storage capacities are within reach. <I>Id.,</I> pp. 211-12.<BR>
<P><A NAME="284"  HREF="#r284">284.</a> GM test-drivers have driven the car at over 170 miles per hour - a 
record for electric cars. <I>Id.,</I> p. 203. An early Impact prototype 
accelerated to 60 mph in eight seconds, faster than Nissan's 300ZX sports 
car. <I>Popular Science</I> described it as "possibly the best-handling 
and best-performing small car that GM has ever turned out." McCosh, S., 
"We Drive the World's Best Electric Car," <I>Popular Science</I>, Vol. 
244, No. 1, pp. 52-56 (January 1994).<BR>
<P><A NAME="285"  HREF="#r285">285.</a> Flavin, C., and Lenssen, N., <I>Power Surge: Guide to the Coming 
Energy Revolution, </I>Worldwatch Environmental Alert Series, p. 203 (New 
York, NY:  W.W. Norton, 1994).<BR>
<P><A NAME="286"  HREF="#r286">286.</a> Ford Taurus emissions are based on a 50,000-mile urban/suburban 
testing cycle. Impact emissions are based on the current California 
electricity generation mix. <I>Id., </I>pp. 206-07.<BR>
<P><A NAME="287"  HREF="#r287">287.</a> Calstart, Inc., "PIVCO and CALSTART Roll Out $10,000 Electric Commuter 
Car," <I>The CALSTART Connection,</I> Vol. 3, No. 4, p. 1 (Burbank, CA: 
August-October 1995).<BR>
<P><A NAME="288"  HREF="#r288">288.</a> Solectria Corporation, <I>Sunrise Specifications</I>, corporate 
marketing materials<I> </I>(Wilmington, MA: 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "B2b.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-200</DOCNO>
<DOCOLDNO>IA026-000277-B033-132</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/B2b.html 198.77.86.203 19970113180232 text/html 3351
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:04:23 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 3180
Last-modified: Mon, 17 Jun 1996 00:30:52 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B2c.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2a.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Hybrid-Electric Vehicles</title>
<table><tr><td><blockquote>

<B>
<H4>b. Hybrid-Electric Vehicles</H4>
<BR>
</B>Hybrid-electric vehicles are another promising technology that could 
increase the efficiency of automobiles, retaining most of the 
environmental advantages of a battery-powered model without the huge 
quantity of batteries that weigh down pure electric vehicles. 
Hybrid-electrics have both a battery-powered electric motor and a small 
combustion engine, which are used either separately or together, depending 
on the driving situation. In some modes, the engine runs continuously, 
efficiently and relatively cleanly, charging the batteries and greatly 
extending the vehicle's range. This advantage has prompted renewed 
interest in hybrids, with most large automakers developing models to meet 
either the zero-emission vehicle or ultra-low emission vehicle standards 
that take effect in some regions in the next three to six years.<a href="#289" name="r289"> [ 289 ] </a><BR>
<BR>
<p>     <B><I><A NAME="MitsubishiMotors">Mitsubishi Motors<a>.</B></I> Mitsubishi has come out with a 
prototype hybrid-electric vehicle that can attain top speeds of 95 miles 
per hour. Running on the battery alone, the vehicle achieves zero local 
emissions. When stored energy levels fall, a gasoline engine/generator 
takes over to provide wheel power while simultaneously recharging the 
battery. The vehicle's driving range is 150 miles on one tank of gasoline. 
Ford and GM are both working on advanced hybrid vehicles in programs 
cofunded by the U.S. DOE.<a href="#290" name="r290"> [ 290 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->


<P><A NAME="289"  HREF="#r289">289.</a> Zetsche, D., "The Automobile: Clean and Customized," <I>Scientific 
American</I>, Vol. 273, No. 3, p. 105 (New York, NY: September 1995).<BR>
<P><A NAME="290"  HREF="#r290">290.</a> Flavin, C., and Lenssen, N., <I>Power Surge: Guide to the Coming 
Energy Revolution, </I>Worldwatch Environmental Alert Series, p. 205 (New 
York, NY: W.W. Norton, 1994).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "B2c.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2a.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-201</DOCNO>
<DOCOLDNO>IA026-000277-B033-160</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/B2c.html 198.77.86.203 19970113180248 text/html 6493
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:04:52 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 6322
Last-modified: Mon, 17 Jun 1996 00:30:53 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2b.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Fuel Cells</title>
<table><tr><td><blockquote>

<B>
<H4>c. Fuel Cells</H4>
<BR>
</B>Fuel cells could represent a whole new era in transportation 
technology, and a significant advance over both internal combustion and 
battery-powered vehicles. NASA employed fuel cells in the Apollo 
spacecrafts and space shuttles; using them to power automobiles, however, 
could become their most important application. Fuel cells transform 
hydrogen and oxygen into electricity. In an automobile, a fuel cell's 
power train would consist of a storage tank that holds hydrogen or a 
hydrogen-carrying fuel such as methanol, a fuel cell system that converts 
the fuel into electricity, and an electric motor. Given their greater 
efficiency and lower operating costs, fuel cell vehicles are likely to 
have lower life-cycle costs than gasoline or battery-powered 
vehicles.<a href="#291" name="r291"> [ 291 ] </a>
<p>     Fuel-cell vehicles would have many advantages, including zero 
emissions, quiet operation, long range, and unparalleled energy 
efficiency. Fuel cells run on methanol, natural gas, or petroleum - and 
would dramatically reduce pollution and cut greenhouse gas emissions and 
energy consumption by at least half.<a href="#292" name="r292"> [ 292 ] </a>The greatest promise involves 
powering future fuel cell vehicles with solar-derived hydrogen.<a href="#293" name="r293"> [ 293 ] </a>
<p>     Three fuel cell buses have been built under the supervision of 
<B><I><A NAME="GeorgetownUniversity">Georgetown University<a></B></I> with funding from the U.S. DOE. All 
three are powered by methanol, a phosphoric-acid fuel cell made by Fuji 
Electric, and a nickel-cadmium battery available for peak-power needs, 
such as hard accelerations and climbing steep hills. Several smaller fuel 
cell vehicles are under construction as well. In late 1993, <B><I><A NAME="EnergyPartners">Energy Partners<a></B></I>, a start-up company in Florida, rolled out a fuel cell 
car running on compressed hydrogen. <B><I><A NAME="Daimler-Benz">Daimler-Benz<a> </B></I>unveiled a 
van running on a fuel cell and hydrogen in April 1994. <B><I>General 
Motors</B></I> is building a methanol fuel cell car to be completed by 
1996. In mid-1994, the U.S. DOE announced contract awards of $13.8 million 
to <B><I><A NAME="FordMotorCorporation">Ford Motor Corporation <a></B></I> and $15 million to <B><I><A NAME="ChryslerCorporation">Chrysler Corporation</a></B></I> to develop 
fuel cells for light-duty vehicles. Both intend to use hydrogen as the 
on-board fuel.<a href="#294" name="r294"> [ 294 ] </a><BR>
<BR>
<p>     <B><I>The City of Palm Desert, California.</B></I> Palm Desert is 
participating in a $4.23 million-dollar multi-organization project to 
build and test eight fuel cell-powered electric vehicles during the next 
three years. These vehicles will run on hydrogen that will be produced by 
a solar photovoltaic array near Palm Desert's City Hall and a wind turbine 
north of the city. Unlike battery-powered vehicles, which may be 
associated with some air pollution from the electricity generation plants, 
these vehicles will truly have zero emissions.<a href="#295" name="r295"> [ 295 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="291"  HREF="#r291">291.</a> The cost of fuel-cell vehicles is sensitive to the type of fuel used. 
The life-cycle costs of fuel-cell cars powered by solar hydrogen may be 
somewhat greater than those of comparable gasoline cars, while fuel cells 
powered by natural gas probably would be cheapest. Sperling, D., <I>Future 
Drive: Electric Vehicles and Sustainable Transportation</I>, p. 93 
(Washington, D.C.: Island Press, 1995).<BR>
<P><A NAME="292"  HREF="#r292">292.</a> <I>Id., </I>p. 89.<BR>
<P><A NAME="293"  HREF="#r293">293.</a> Solar hydrogen is hydrogen made by electrolytically splitting water 
using solar cells. The technology is still expensive. However, Joan Ogden 
and Robert Williams of Princeton University have argued that rapid 
advances in solar technology make inexpensive solar electricity a 
possibility. They predict that the cost of solar hydrogen in the early 
years of the next century, including all distribution and retail mark-ups 
(but not taxes), could be between $2.25 and $3.25 per gasoline-equivalent 
gallon. Because fuel cells are more than twice as energy efficient as 
internal combustion engines, the relatively high cost of solar hydrogen 
is, from the vehicle user's perspective, more than halved, bringing fuel 
costs within a commercially viable range.<p>     

The ideal 
 place for producing solar hydrogen is in sunny locations such as the 
American Southwest. If all the cars and trucks in the U.S. were fueled 
with hydrogen in 2010, only 1 percent of U.S. deserts - equivalent to 
0.1 percent of the total U.S. land area - would be needed to produce 
the hydrogen. <I>Id., </I>p. 90.<BR>
<P><A NAME="294"  HREF="#r294">294.</a> <I>Id., </I>pp. 85-86.<BR>
<P><A NAME="295"  HREF="#r295">295.</a> Atwood, S., "Hydrogen Fuel Cell Vehicles to be Tested in Palm Desert," 
<I>AQMD Advisor</I>, Vol. 3, No. 1, p. 5 (Diamond Bar, CA: South Coast Air 
Quality Management District, November 1995).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2b.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-202</DOCNO>
<DOCOLDNO>IA026-000277-B033-184</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/C.html 198.77.86.203 19970113180304 text/html 3025
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:05:07 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2854
Last-modified: Mon, 17 Jun 1996 00:30:53 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2c.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Improving the Efficiency of Other Transportation Modes</title>
<table><tr><td><blockquote>

<H2><I>C. </I>Improving the Efficiency of Other Transportation Modes Reduces 
Carbon Dioxide Emissions While Improving Competitiveness</H2>
<P>
Energy efficiency has improved the way the United States transports 
commercial products, and the way public transit moves people. Efficiency 
reduces costs, thereby increasing competitiveness at the same time that it 
reduces carbon dioxide emissions.<P>
<H3><A NAME="air">1. Air Transport</A></H3>

In 1993, air transport accounted for 13.5 percent of total U.S. 
transportation energy use. This figure is expected to rise to 15.5 percent 
in 2010. Efficiency gains in air transport are a clear success. Over the 
past 20 years, air transport has achieved the largest improvements among 
all transport modes - halving energy use per passenger-mile. In the 
past, fuel costs exceeded 40 percent of an airline's direct operating 
costs. Those airlines that have adopted cost-effective efficiency 
technologies have managed to remain competitive while cutting fuel to 15 
to 20 percent of operating costs. Despite these gains in fuel efficiency, 
the expected rise in passenger miles traveled means that U.S. air 
transport carbon dioxide emissions are expected to rise from about 475 
million metric tons today to between 650 and 1,100 million metric tons in 
2015.<a href="#296" name="r296"> [ 296 ] </a><BR>
</I><BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="296"  HREF="#r296">296.</a> Greene, D., <I>Commercial Air Transport Energy Use and Emissions: Is 
Technology Enough? </I>DE-AC05-84OR21400, pp. 3, 21-22 (Oak Ridge, TN: Oak 
Ridge National Laboratory, August 3, 1995).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>




<!--start foot--><p align=right><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B2c.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-203</DOCNO>
<DOCOLDNO>IA026-000277-B033-218</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/D.html 198.77.86.203 19970113180340 text/html 7765
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:05:26 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 7594
Last-modified: Mon, 17 Jun 1996 00:30:54 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "E.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Long-Term Solutions Must Include Improved Urban Design</title>
<table><tr><td><blockquote>
<H2><I>D. </I>Long-Term Solutions Must Include Improved Urban Design</H2>
<P>
For the last 40 years, urban form has revolved around the automobile. 
Engineers have designed roadways to enhance vehicle speeds, rather than 
pedestrian safety. In many suburban developments, the sidewalk has 
disappeared altogether. Shopping centers are often set far from 
residential areas. Catering to patrons who arrive by automobile, they 
provided excessive parking, limited pedestrian assess, and no bicycle 
facilities. <BR>
<p>     America has become a nation where the automobile seems necessary to 
accomplish daily tasks and leisure pursuits. Road systems are often unable 
to keep up with demand and congestion continues to worsen. The spatial 
separation between jobs, homes, stores, and recreation is increasing. 
Those segments of our society that do not drive have been marginalized 
from mainstream society and employment opportunities.<BR>
<p>     If the United States is to seriously address carbon dioxide emissions 
in the transportation sector, it will be necessary to reorient our urban 
design toward people rather than cars. Urban structures cannot be changed 
overnight. However, there are signs that efforts to improve urban design 
have already begun. The goal is to create more livable communities. The 
side benefit will be cleaner air and reduced carbon dioxide emissions.<P>
<p>     <B><I><A NAME="MetroLink,St.Louis">MetroLink, St. Louis<a>.</B></I> One urban design success story 
is St. Louis' light-rail system, MetroLink. Using federal highway funds 
for construction, the system opened in 1993, 32 years after the city's 
last commuter rail line closed. Careful planning, implementation, and 
promotion have made MetroLink a model transit and land-use planning 
success. <BR>
<p>    <p>      MetroLink is an economic boon to the city, and people find they 
both like and <I>use</I> the rail line. It has reduced traffic on St. 
Louis' most congested freeways and lowered demand for downtown parking 
facilities. MetroLink uses less energy per mile and produces less air 
pollution per passenger-mile than automobiles. The system reached its 
five-year ridership goal in its first year. The citizens of St. Louis 
approved a sales tax increase to expand MetroLink and improve other 
transit services. <BR>
<p>    <p>      The most significant factor in MetroLink's success is its 
land-use planning approach: St. Louis uses a radial corridor land-use 
pattern. Radial patterns lend themselves to transit development because 
population densities in the corridors tend to be high, increasing chances 
that ridership, too, will be higher than it would be in cities with grid 
development patterns. Also, radial corridor cities tend to have a lot of 
magnets - shopping centers, museums, and sports arenas - within 
walking distance of transit stations. MetroLink facilitates a resurgence 
of a land-use pattern more widely known before the age of the 
automobile - the American village land-use pattern - where most 
daily conveniences were located within walking distance. This pattern 
could prevail for land-use planning in the 21st century.<a href="#297" name="r297"> [ 297 ] </a>
<B><BR>
</B><p>     <B><I>Chicago's <A NAME="CommunityGreenLineInitiative,Chicago">Community Green Line Initiative, Chicago </a></I>. </B>The 
Community Green Line Initiative is a planned community-based 
transit-oriented development centered around the Pulaski Street Station in 
Chicago. The Pulaski Street Station is part of what used to be the Lake 
Street Elevated Line - now the Green Line - one of Chicago's 
historic elevated transit lines. In 1994, the line shut down for a 
two-year reconstruction project, which will include building or renovating 
28 transit stations. <BR>
<p>     Within a half mile of the Green Line live 118,000 people - a 
population similar to a small city. Only half of these households have 
access to a car. Members of the community developed the Green Line 
Initiative to boost transit ridership, reduce automobile dependence, stem 
the abandonment of buildings, and increase job opportunities - all 
while contributing to regional air quality goals. West Garfield, the 
community surrounding Pulaski Station, has suffered greatly from 
development patterns that favor sprawl, structural disinvestment, and 
suburban infrastructure funding - all patterns that continue to 
contribute to the social and economic disintegration of inner cities 
across the United States. The Community Green Line Initiative has 
encouraged citizen involvement in planning, and seeks to upgrade the 
neighborhoods surrounding the Green Line by making the area an attractive 
place to live, work, raise families, and shop. New jobs will be 
created - within walking distance of workers' homes. The land-use plan 
calls for rebuilding neighborhood density with new housing, revitalizing 
the neighborhood economy with retail and commercial development, and 
creating new public parks. <BR>
<p>    <p>      The Green Line Initiative has taken advantage of federal funds 
made available through the Intermodal Surface Transportation Efficiency 
Act (ISTEA), which mandates broad changes in the way transportation 
decisions are made and funded, and the Congestion Mitigation and Air 
Quality Program (CMAQ), a component of ISTEA, which provides funds for 
projects that reduce traffic congestion and improve air quality. To help 
the initiative qualify for these funds, the <A NAME="AmericanLungAssociation">American Lung Association</a> 
(ALA) projected the air quality impacts of the project. According to the 
ALA, the Green Line Initiative will eliminate 17.5 percent of vehicle 
trips to work and 20 percent of all other trips, thereby saving 1,556 
vehicle miles traveled every day. These reductions could cut ozone 
precursors, including VOCs, by 6.9 metric tons, and nitrogen oxides by 
2.75 metric tons per year.<a href="#298" name="r298"> [ 298 ] </a>
<P>
<BR>






<hr><font size =-1>





<!--footnotes-->

<P><A NAME="297"  HREF="#r297">297.</a> Warren, W., "Why Success in St. Louis?" <I>TR News 180</I>, pp. 22-26 
(September-October 1995).<BR>
<P><A NAME="298"  HREF="#r298">298.</a> Freedberg, M., "Community Green Line Initiative," <I>Opportunities in 
Neighborhood Technology</I>, pp. 1-12 (Chicago, IL: Center for 
Neighborhood Technology, 1995).<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>



<!--start foot--><p align=right><a href = "E.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-204</DOCNO>
<DOCOLDNO>IA026-000277-B033-248</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/IV/E.html 198.77.86.203 19970113180358 text/html 3199
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:06:04 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 3028
Last-modified: Mon, 17 Jun 1996 00:30:56 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Conclusion</title>
<table><tr><td><blockquote>


<H2><I>E. </I>Conclusion</H2>

Transportation will be the fastest-growing source of U.S. carbon dioxide 
emissions over the long term - by far - unless Americans take 
aggressive steps to build efficiency into transportation systems. 
Transportation is the only sector of the U.S. economy that is virtually 
totally dependent on oil. America is importing more oil than ever before, 
and the trend is upward. Transportation accounts for about half of all air 
pollution emissions in the United States, and more than 80 percent of air 
pollution in cities. Every tank of gasoline consumed by an automobile 
produces up to 400 pounds of carbon dioxide emissions.<BR>
<p>     Solutions to these transportation problems are within reach; what is 
needed is the political will to tackle them. Internal combustion engines 
are becoming increasingly efficient. Federal CAFE standards have doubled 
automobile fuel efficiency, saving nearly 3 million barrels of oil every 
day. Programs are helping retire older, more polluting vehicles from the 
road, while emissions-reduction technologies in new vehicles are being 
improved.<BR>
<p>     A revolution is underway in the transportation sector - the 
development of new low-emission and zero-emission vehicle technologies. 
The California Air Resources Board has implemented LEV and ZEV vehicle 
standards, which will take effect in 1998, that should spur a potential 
trillion-dollar market for environmentally clean automobiles. Several 
electric vehicle and hybrid-electric vehicle manufacturers are gearing up 
for mass production.<BR>
<p>     If the United States is going to seriously reduce carbon dioxide 
emissions in the transportation sector, however, long term solutions must 
include a reassessment of land-use planning. Communities nationwide are 
seeking to redesign urban structures around people, rather than around 
traffic. Several new urban designs maximize the benefits of locating 
conveniences within walking or bicycling distance.<BR>
<BR>



<font size =-1>





<!--footnotes-->


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>




<!--start foot--><p align=right><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-205</DOCNO>
<DOCOLDNO>IA026-000277-B033-269</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/intro.html 198.77.86.203 19970113180411 text/html 5088
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:06:14 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4917
Last-modified: Mon, 17 Jun 1996 16:47:32 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><!--end head--><title>Renewables</title><table><tr><td><blockquote><H1>IV. Renewables: Coming of Age</H1><BR><BR>Renewable energy technologies - wind, photovoltaics, solar-thermal, and geothermal<a href="#299" name="r299"> [ 299 ] </a> - have made major advances in the past decade, and are rapidly becoming a means of minimizing the costs of providing energy services. Renewables can assist utilities with environmental regulatory compliance, protect ratepayers from fluctuations in fossil-fuel prices, diversify the energy supply mix, improve air quality, cut public health costs, and improve local economies as a result of market demands for, and export of, cleaner technologies.<a href="#300" name="r300"> [ 300 ] </a><BR><BLOCKQUOTE><hr><a href = "../img/ExecSum-Fig-6.gif"><img src = "../t/ExecSum-Fig-6.gif" alt = "Chart 12: Renewable Energy Costs are Dropping" align=left></a> <h3><I>Chart 12: Renewable Energy Costs are Dropping<br clear=all><hr></I></h3></BLOCKQUOTE><p>     Renewable energy costs have dropped while reliability and performance have improved dramatically. For example, the cost of wind-generated electricity in the United States dropped from 25 cents per kilowatt-hour in 1984 to less than 5 cents per kilowatt-hour today.<a href="#301" name="r301"> [ 301 ] </a>The cost curves for solar-thermal and photovoltaic utility plants show similar downward trends. Increased production would further reduce costs.<a href="#302" name="r302"> [ 302 ] </a>If pollution and social costs from fossil use were to be internalized in fossil prices, many renewables today would be cheaper than fossil fuels. With support from forward-looking public policies, renewables could play a strong role in meeting future U.S. energy needs.<P><hr><font size =-1><!--footnotes--><P><A NAME="299"  HREF="#r299">299.</a> Renewables also include hydroelectric and biomass. Substantial potential for hydroelectric capacity expansion exists in the U.S., particularly in the Northeast. Although biomass provides some 5 percent of U.S. total energy use (including electricity generation, space heating with wood, and transportation fuels such as ethanol and methanol), biomass employs the combustion process, creating air emissions that include carbon dioxide. Biomass feedstock management can offset these emissions by sequestering carbon dioxide as feedstocks grow, and the use of biomass in place of fossil fuels can involve a net decrease in overall carbon dioxide emissions.<BR><BR><P><A NAME="300"  HREF="#r300">300.</a> Hamrin, J., and Rader, N., <I>Investing in the Future: A Regulator's Guide to Renewables</I>, p. 7 (Washington, D.C.: The National Association of Regulatory Utility Commissioners, February 1993).<BR><P><A NAME="301"  HREF="#r301">301.</a> In June 1995, Northern States Power announced a winning levelized bid price of 3 cents per kilowatt-hour for development of a 100-megawatt wind project. Swezey, B., and Wan, Y., <I>The True Cost of Renewables: An Analytic Response to the Coal Industry's Attack on Renewable Energy</I>, NREL/TP-462-20032, p. 14, n. 8 (Golden, CO: National Renewable Energy Laboratory, October 1995), citing National Renewable Energy Laboratory, <I>State Renewable Energy News</I> (Summer 1995).<BR><P><A NAME="302"  HREF="#r302">302.</a> An analysis of energy futures performed by Shell International notes that renewables costs will continue to fall as production increases. The key question for renewables is not whether costs will fall, but "the speed at which market opportunities will appear, to enable renewables to move down their cost curves." Grunwald, E.J., <I>Energy in the Long Term</I> (Shell International Petroleum Co., Ltd., undated), cited in Swezey, B., and Wan, Y., <I>The True Cost of Renewables: An Analytic Response to the Coal Industry's Attack on Renewable Energy</I>, NREL/TP-462-20032, p. 2, n. 1 (Golden, CO: National Renewable Energy Laboratory, October 1995).<BR></font></blockquote></td><td align = center width =150><!--images here--></td></tr></table><!--start foot--><p align=right><a href = "A.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-206</DOCNO>
<DOCOLDNO>IA026-000277-B033-297</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/A.html 198.77.86.203 19970113180431 text/html 4319
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:06:36 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4148
Last-modified: Mon, 17 Jun 1996 00:31:15 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Renewables Technologies Have Made Major Advances</title>
<table><tr><td><blockquote>


<H2><I>A. </I>Renewables Technologies Have Made Major Advances</H2>
<BR>
<BR>
When Congress enacted the 1978 Public Utility Regulatory Policies Act 
(PURPA),<a href="#303" name="r303"> [ 303 ] </a>it required utilities to buy renewables-generated power at the 
utility's "avoided costs"<a href="#304" name="r304"> [ 304 ] </a> - which sparked the first major deployment 
of renewable energy in the U.S. market. Since then, approximately 12,000 
megawatts of nonhydroelectric renewables have come on line. Several 
states, particularly California, have encouraged the development and 
deployment of renewable resources, and have experimented with a variety of 
mechanisms to push renewables into the marketplace. <BR>
<p>     The costs of renewables have dropped, allowing them to compete with 
more conventional power generation. The U.S. DOE projects a continued drop 
in prices. At the same time, renewable capacity is expected to grow. By 
2005, renewable capacity in the United States could increase to 4,180 
megawatts of wind, 260 megawatts of photovoltaics, 3,440 megawatts of 
geothermal, and 12,500 megawatts of biomass and municipal solid waste 
energy.<a href="#305" name="r305"> [ 305 ] </a>U.S. export opportunities for renewables and efficiency 
technologies have become one of the fastest-growing economic sectors.<a href="#306" name="r306"> [ 306 ] </a>
<P>





<hr><font size =-1>





<!--footnotes-->
<P><A NAME="303"  HREF="#r303">303.</a> Public Utility Regulatory Policies Act of 1978, Pub. L. No. 95-617, 92 
Stat. 3117 (1978), 16 U.S.C. &#167; 2601, <I>et seq</I>. (1982) 
(PURPA).<BR>
<P><A NAME="304"  HREF="#r304">304.</a> Avoided costs are measured as the amount the utility would have had to 
spend to provide the capacity and energy itself. Utilities are able to 
pass through the cost of purchased power to ratepayers, creating an 
incentive for utilities to engage in demonstration and commercialization 
of renewables. PURPA demonstrated that competition in generation is both 
viable and beneficial and has led to an expanding renewable energy 
sector.<BR>
<P><A NAME="305"  HREF="#r305">305.</a> Rosenzweig, R., "The Federal Interest in Electric Restructuring," 
<I>Public Utilities Fortnightly, </I>Vol. 133, No. 20, p. 18 (Vienna, VA: 
November 1, 1995).<BR>
<P><A NAME="306"  HREF="#r306">306.</a> Internationally, India has committed to install 2,000 megawatts of 
renewable energy by 2000, and China has featured renewable energy in its 
Agenda 21 - a plan developed to achieve the objectives established by 
the Framework Convention on Climate Change. India and China alone will 
account for 35 percent of incremental electricity demand between 1993 and 
2010, requiring $450 billion in capital. Because research and development 
has driven down their costs, renewable technologies will have an 
opportunity to compete against conventional technologies in international 
markets. <I>Id. </I><BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>




<!--start foot--><p align=right><a href = "B.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "intro.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-207</DOCNO>
<DOCOLDNO>IA026-000277-B033-326</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/B.html 198.77.86.203 19970113180458 text/html 4729
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:06:58 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 4558
Last-modified: Mon, 17 Jun 1996 00:31:15 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Renewable Energy Has Become Reliable</title>
<table><tr><td><blockquote>

<H2><I>B. </I>Renewable Energy Has Become Reliable</H2>
<BR>
<BR>
The reliability of renewables has improved markedly. Although renewables 
by their nature provide power intermittently (when the sun shines or the 
wind blows), technological improvements have made renewable energy highly 
reliable. For example, new models of wind turbines are up and running 95 
percent of the time the wind blows. Many renewable technologies can 
generate electricity as part of base load or are otherwise dispatchable; 
geothermal units can have capacity factors greater than 90 percent.<a href="#307" name="r307"> [ 307 ] </a>For 
comparison, the average capacity factor for all operating coal-fired power 
plants in the United States was 60 percent from 1990 to 1994. A recent 
<A NAME="NationalRenewableEnergyLaboratory">National Renewable Energy Laboratory<a> study suggests that intermittent 
generation load levels of at  least 10 percent (and perhaps as high as 20 
percent) can be accommodated with no adverse system impacts.<a href="#308" name="r308"> [ 308 ] </a>In 
California, <A NAME="PacificGasandElectric">Pacific Gas and Electric <a> uses wind to supply as much as 7 
percent of its system load - 5 percent during peak hours - with no 
adverse effects.<BR>
 <p>     <B><I><A NAME="EnergyWorks">EnergyWorks </a>. </B></I><A NAME="Bechtel">Bechtel</a> recently joined forces with 
<A NAME="Pacificorp">Pacificorp<a> of Portland, Oregon to form EnergyWorks, a joint venture based 
in Landover, Maryland to develop, finance, own, and operate small, 
renewable energy systems, including solar, wind, and hybrid energy 
systems. Bechtel's president, John D. Carter, sees the venture as an 
opportunity in an increasing global shift toward renewables. EnergyWorks' 
president and CEO Jeffrey W. Eckel notes, "The use of new renewable energy 
technologies is growing at a rate between 10 and 20 percent annually in a 
number of markets," including foreign markets. The EnergyWorks venture 
reflects the growing economic viability of renewable energy.<BR>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="307"  HREF="#r307">307.</a> Capacity factor is the amount of load achieved by operating a given 
generation source, and is a measure of dependability. Solar- and 
wind-based projects, without storage, typically have capacity factors of 
20 to 30 percent because they operate only when the sun shines or the wind 
blows. Swezey, B., and Wan, Y., <I>The True Cost of Renewables: An 
Analytic Response to the Coal Industry's Attack on Renewable Energy</I>, 
NREL/TP-462-20032, pp. 2-4 (Golden, CO: National Renewable Energy 
Laboratory, October 1995).<BR>
<P><A NAME="308"  HREF="#r308">308.</a> When power from intermittent resources is not available, other 
generators on the system are called on to supply the power. At low 
renewables penetration levels, this situation is much like the normal 
utility system response to load fluctuations. At higher renewables 
penetration levels, a utility might have to provide additional 
dispatchable capacity to compensate for both normal load fluctuations and 
the output variations of the intermittent renewables generators. Research 
shows that intermittent penetration levels above 10 percent are entirely 
feasible, with any technical limits being a function of the specific 
utility system characteristics.<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "C.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "A.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-208</DOCNO>
<DOCOLDNO>IA026-000277-B034-28</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/C.html 198.77.86.203 19970113180515 text/html 7284
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:07:19 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 7113
Last-modified: Mon, 17 Jun 1996 00:31:16 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>The Growth of Renewables Depends on Several Factors</title>
<table><tr><td><blockquote>
<H2><I>C. </I>The Growth of Renewables Depends on Several Factors</H2>
<BR>
<BR>
Several factors affect renewable electricity development, including:<BR>
<BR>
<B><I> <p>     Prices of competing fuels, especially natural 
gas</B></I>. The current and forecasted price of natural gas and other 
fossil fuels will continue to influence the business climate for 
renewables, affecting utility power purchases, the competitiveness of 
renewables in bidding solicitations, and the availability of private 
investment capital and government support. Deploying renewables has high 
up-front capital costs, but typically extremely low operating costs 
because there are no fuel costs. On a life-cycle basis, renewables often 
have lower costs.<a href="#309" name="r309"> [ 309 ] </a>Nevertheless, at present, natural gas beats 
renewables on a first-cost, short-term basis. Modular natural gas 
facilities currently produce electricity at around 3 cents per 
kilowatt-hour, or less. Although fossil prices, including natural gas 
prices, will inevitably rise, it is uncertain when.<a href="#310" name="r310"> [ 310 ] </a>
<BR>
<B><I> <p>     Evolving electric power regulation</B></I>. Because 
renewables have difficulty competing with natural gas on a first-cost 
basis, regulatory treatment is critical to the future development of 
renewable electricity. Legislative incentives and regulatory policies 
favoring renewables have been responsible for the bulk of purchase 
contracts awarded to renewable electricity developers to date. Just ten 
states have accounted for more than 70 percent of U.S. renewables 
development (excluding hydropower development by utilities), which shows 
the importance of state utility regulatory policy.<a href="#311" name="r311"> [ 311 ] </a>P>
<B><I> <p>     Environmental externalities</B>.</I> A key question in 
the utility industry restructuring debate is whether, or how, the price of 
fossil fuels will be adjusted to account for the environmental and social 
costs associated with their extraction and combustion. At present, these 
externalities are not fully incorporated into market prices. Since 
renewable electricity technologies consume less water and generate much 
less air pollution, hazardous waste, and carbon dioxide emissions, they 
would see wider use in markets that internalize the environmental costs of 
energy production. According to the National Renewable Energy Laboratory, 
as of early 1994, 29 states and the District of Columbia required electric 
utilities to consider environmental externalities in their resource 
planning processes. Seven of these states - California, Massachusetts, 
Minnesota, Nevada, New York, Oregon and Wisconsin - have developed 
monetary values for pollutant emissions. The momentum toward quantifying 
and incorporating the costs of environmental externalities, however, has 
recently stalled.<a href="#312" name="r312"> [ 312 ] </a>P>
<B><I> <p>     Future Cost Curves of Renewables.</I> </B>Further cost 
reductions could greatly enhance the market penetration of renewables. 
Reductions in the price of renewables are dependent, however, on the 
willingness and the ability of private industry, the federal government, 
and electric utilities to continue to fund technological research, 
demonstration, and commercialization programs. Regulatory uncertainty and 
overcapacity in the market have slowed needed investments in renewables, 
while Congress is scrutinizing the U.S. DOE's budget and is even 
considering abolishing the department altogether.<a href="#313" name="r313"> [ 313 ] </a>P>
<B><I> <p>     Foreign Competition. </B></I>Although the United States 
has pioneered most renewable electricity technologies, the foreign rate of 
development for these technologies is beginning to surpass the U.S. 
pace.<a href="#314" name="r314"> [ 314 ] </a>If the U.S. market continues to be inhospitable, it may force 
renewables development overseas. If the United States fails to develop 
aggressively its own renewables market through public incentives, the 
future U.S. energy infrastructure could become dominated by foreign 
firms.<BR>
<P>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="309"  HREF="#r309">309.</a> Wind project developers have been signing contracts to deliver 
electricity at prices as low as 4 cents per kilowatt-hour in a contract's 
first year, and wind developer Zond Systems just signed a contract for 3 
cents per kilowatt-hour levelized over 30 years. Geothermal and 
small-scale hydro plants can produce electricity for between 4.5 and 7 
cents per kilowatt-hour. Even the more expensive photovoltaics systems 
(which convert sunlight to electricity) have seen costs fall to around $7 
a watt for grid-connected systems, down from $30 a watt for experimental 
systems in the early 1980s, and now produce electricity for between 25 and 
50 cents a kilowatt-hour. Williams, S., and Bateman, B., "Despite Improved 
Performance and Lower Costs, U.S. Renewable Power in a Slump," News 
Release, p. 2 (Washington, D.C.: Investor Responsibility Research Center, 
August 2, 1995). <BR>
<P><A NAME="310"  HREF="#r310">310.</a> Williams, S., and Bateman, B., <I>Power Plays: Profiles of America's 
Independent Renewable Electricity Developers</I>, pp. 4, 30 (Washington, 
D.C.: Investor Responsibility Research Center, 1995).<BR>
<P><A NAME="311"  HREF="#r311">311.</a> <I>Id., </I>p. 4.<BR>
<P><A NAME="312"  HREF="#r312">312.</a> The Massachusetts Supreme Court and an administrative law judge in New 
York recently struck down those states' externality rules or values, and 
Nevada is reconsidering its values for environmental externalities. 
California says it also plans to reform or repeal its externality values 
in the near future. <I>Id., </I>pp. 4-5.<BR>
<P><A NAME="313"  HREF="#r313">313.</a> <I>Id., </I>p. 5.<BR>
<P><A NAME="314"  HREF="#r314">314.</a> <I>Id.</I><BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "D.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "B.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-209</DOCNO>
<DOCOLDNO>IA026-000277-B034-58</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/D.html 198.77.86.203 19970113180530 text/html 1889
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:07:35 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1718
Last-modified: Mon, 17 Jun 1996 00:31:16 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Four Promising Renewables Industries</title>
<table><tr><td><blockquote>

<H2><I>D. </I>Four Promising Renewables Industries</H2>
<BR>
<BR>
Despite current impediments, continued technological development and 
inevitable increases in fossil energy prices could make renewable sources 
the fastest growing - and perhaps the dominant - source of power in 
the 21st century. Reviewed below are four renewable industries - wind, 
photovoltaics, solar thermal, and geothermal - for which the near-term 
viability of commercial deployment vary widely. <BR>
<P>




<hr><font size =-1>





<!--footnotes-->


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "D1.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "C.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-210</DOCNO>
<DOCOLDNO>IA026-000277-B034-98</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/D1.html 198.77.86.203 19970113180705 text/html 19950
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:08:22 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 19778
Last-modified: Mon, 17 Jun 1996 00:31:17 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Wind Power</title>
<table><tr><td><blockquote>

<H3>1. Wind Power</H3>
<BR>
<BR>
The advancement of wind energy is a convincing success story. The wind 
industry is producing utility-scale turbines that are significantly less 
costly and far more reliable than earlier generation turbines. Newer 
turbines are routinely available for generation more than 95 percent of 
the time, and utility contracts for wind power have been signed recently 
for a levelized price of less than 4 cents per kilowatt-hour - a price 
that is competitive with fossil sources and cheaper than nuclear.<a href="#315" name="r315"> [ 315 ] </a>Wind 
has enormous advantages over fossil fuels, including minimal future costs 
subject to inflation<a href="#316" name="r316"> [ 316 ] </a>and low operating and maintenance costs.<a href="#317" name="r317"> [ 317 ] </a>Wind 
energy is one of the least costly sources of new electrical generation and 
is competitive with new fossil fuel-fired plants.<a href="#318" name="r318"> [ 318 ] </a>

<BLOCKQUOTE>
<hr>
<a href = "../img/Renew-Windp.gif"><img src = "../t/Renew-Windp.gif"
 alt = "Chart 14: U.S. Wind energy Potential" align=left></a>
 <h3><I>Chart 14: U.S. Wind energy Potential<br clear=all><hr></I></h3>
</BLOCKQUOTE>
<p>     Wind power has another advantage - its modularity. Wind turbines 
individually cost a fraction of what a conventional power plant costs, and 
a generator can install as many wind turbines as it needs, when it needs 
them, and with lead times of about one year.<a href="#319" name="r319"> [ 319 ] </a>
<p>     The cost of wind energy ranks well below all other energy sources 
when measuring rational, economic costs.<a href="#320" name="r320"> [ 320 ] </a>
<p>     In spite of wind energy's declining costs, the market still presents 
numerous barriers. As utilities turn to market mechanisms, such as 
bidding, to determine the type of power plants that will be built, wind 
energy's beneficial attributes are being ignored in the "dash to natural 
gas" - the mid-1990s fuel of choice.<a href="#321" name="r321"> [ 321 ] </a>The market should discount 
future cost projections of fossil fuel-fired technologies because of price 
volatility.<a href="#322" name="r322"> [ 322 ] </a><BR>
<p>     At the end of 1994, 1,717 megawatts of wind capacity had been 
installed in the United States, producing around 3.5 million 
megawatt-hours per year. (Using wind to provide 3.5 million megawatt-hours 
of U.S. generation avoids about 2.2 million metric tons of carbon dioxide 
emissions annually.<a href="#323" name="r323"> [ 323 ] </a> The bulk of this capacity was installed in the 
mid-to-late 1980s. Far greater growth of wind installations has occurred 
in foreign markets. Europe accounted for 80 percent of the wind industry's 
sales in 1993, and Germany alone accounted for nearly half of worldwide 
wind capacity installed in 1994. Worldwide grid-connected wind energy 
capacity was 3,657 megawatts at the end of 1994, and generated more than 6 
million megawatt-hours of electricity.<a href="#324" name="r324"> [ 324 ] </a>
<p>     The U.S. wind resource is large enough to supply more than 4.4 
billion megawatt-hours - more than 1.5 times the total amount of 
electricity used in the United States.<a href="#325" name="r325"> [ 325 ] </a>A 1990 Battelle Pacific 
Northwest Laboratory study concluded that available wind technology under 
tight land use restrictions could economically produce 20 percent of the 
electrical needs of the contiguous United States on just 0.6 percent of 
the land.<a href="#326" name="r326"> [ 326 ] </a>Although wind power (without storage) is an intermittent 
resource, meteorologists have become reasonably accurate in predicting the 
energy profile of a wind resource in sites with good wind data.<a href="#327" name="r327"> [ 327 ] </a>
<BR>
 
<B><I><BR>
 <p>     <A NAME="KenetechCorporation">Kenetech Corporation<a>.</B></I> Kenetech Corporation, based in 
San Francisco, was formed in 1986 as the holding company for <A NAME="U.S.Windpower,Inc.">U.S. Windpower, Inc.<a><a href="#328" name="r328"> [ 328 ] </a>Kenetech, with more than 800 employees, is the world's 
largest wind company. It manufacturers and sells one of the most advanced 
wind turbines in the world, the variable speed Model 33M-VS. This turbine 
delivers electricity at less than 5 cents per kilowatt-hour, making it 
economically competitive with traditional fossil-fuel energy sources. 
Variable-speed turbines capture a higher percentage of available energy 
than did earlier designs, and rotate faster as wind speeds pick up to 
maintain steady power output to the utility grid. Kenetech is the only 
U.S. wind turbine manufacturer that is producing utility-scale turbines on 
a volume basis. Kenetech operates an installed base of around 4,400 wind 
turbines, most of which are in the United States. <BR>
<p>    <p>      An example of one ongoing Kenetech project is the Sacramento 
Municipal Utility District (SMUD) five-megawatt wind project, which began 
operation in 1994 using Kenetech turbines. The project produced energy at 
4.3 cents per kilowatt-hour in its first year (non-inclusive of federal 
energy production incentive payments).<a href="#329" name="r329"> [ 329 ] </a>Kenetech provided SMUD with 
guarantees that its turbines would operate at 28 percent of capacity over 
two years and that the project will annually produce 121.7 
gigawatt-hours - which offsets 41,743 metric tons of carbon dioxide 
from California's average annual <BR>
generation.<a href="#330" name="r330"> [ 330 ] </a>SMUD has an option to expand the plant size to 100 
megawatts.<a href="#331" name="r331"> [ 331 ] </a><BR>
<p>    <p>      Overall in California, Kenetech generated 659,131 megawatt-hours 
of electricity in 1993, offsetting 226,082 metric tons of carbon dioxide 
emissions that would otherwise have been generated by California's average 
mix.<a href="#332" name="r332"> [ 332 ] </a>
<B><I> <p>    <A NAME="FloWindCorporation">FloWind Corporation <a></B></I> FloWind, based in San 
Rafael, California, develops wind plants and manufactures and designs wind 
turbines. The company operates two wind farms with more than 860 turbines 
in the Altamont and Tehachapi Passes in California. FloWind pioneered 
commercial development of a vertical axis wind turbine (VAWT), and also 
has exclusive marketing rights to a 275-kilowatt horizontal axis turbine 
designed by Robert Lynette and Advanced Wind Turbine - the AWT-26. <BR>
<p>    <p>      During 1993, the company invested substantially in research and 
development for a new generation VAWT - a 17-meter "extended height to 
diameter" VAWT. FloWind began testing prototypes of this 300-kilowatt 
turbine in Tehachapi in early 1994 and plans to upgrade substantial 
portions of its two wind plants with the new turbine design. FloWind's 
VAWT design was developed in part with <A NAME="SandiaNationalLaboratories">Sandia National Laboratories<a>. Using 
a $3.2 million cost-shared research agreement with the DOE, FloWind 
conducted a study of possible advancements in the VAWT technology, and 
integrated a number of improvements that capture more wind energy and 
bring down costs.<a href="#333" name="r333"> [ 333 ] </a>Commercial production of the turbine is slated for 
1995. <BR>
<p>    <p>      FloWind has grown into a company with 100 employees and annual 
wind turbine sales of $66 million, including $47 million in sales to 
India.<a href="#334" name="r334"> [ 334 ] </a>The total installed capacity of the more than 860 turbines 
operated by FloWind is around 140 megawatts, including 94 megawatts from 
turbines it owns. In 1993, FloWind generated 170,499 megawatt-hours of 
electricity in California,<a href="#335" name="r335"> [ 335 ] </a>offsetting 58,481 metric tons of carbon 
dioxide emissions that otherwise would have been emitted by California's 
average generation mix.<a href="#336" name="r336"> [ 336 ] </a>P>
<B><I> <p>     <A NAME="ZondSystems,Inc.">Zond Systems, Inc.<a></B></I> Zond Systems, with 
headquarters in Tehachapi, California, is the second-largest producer of 
wind-generated electricity in the world. Zond's five operating wind 
facilities in California have a total generating capacity of about 260 
megawatts. The company also has designed the largest U.S.-made turbine, 
rated at 500 kilowatts. The 500 kilowatt turbine - the Z-40 -  is a 
three-bladed, upwind, 40-meter rotor diameter machine developed with 
assistance from the <A NAME="NationalRenewableEnergyLaboratory">National Renewable Energy Laboratory<a> Zond installed 
one Z-40 in Tehachapi Pass, California, in 1994. <BR>
<p>    <p>      In February 1994, the DOE agreed to provide Zond with a $1 
million grant under the government's Value Engineered Turbine Program. 
Zond will use the funds to produce a prototype Z-40, test it in the field 
and release it for commercial production. Zond says it plans to begin 
building its first wind-power plant with Z-40 turbines in 1995.<a href="#337" name="r337"> [ 337 ] </a><BR>
<p>    <p>      Zond generated 578,172 megawatt-hours of electricity in 
California in 1993,<a href="#338" name="r338"> [ 338 ] </a>which offset 198,313 metric tons of carbon dioxide 
that otherwise would have been emitted by California's average generation 
mix.<a href="#339" name="r339"> [ 339 ] </a>





<hr><font size =-1>





<!--footnotes-->
<P><A NAME="315"  HREF="#r315">315.</a> <I>Id., </I>p. 255.<BR>
<P><A NAME="316"  HREF="#r316">316.</a> Gipe, P., "Wind Energy's Declining Costs," <I>Solar Today</I>, Vol. 9, 
No. 6, p. 23 (Boulder, CO: The American Solar Energy Society, 
November/December 1995).<BR>
<P><A NAME="317"  HREF="#r317">317.</a> The cost of operating and maintaining wind turbines is about half a 
cent per kilowatt-hour. This is half the cost of coal and nuclear plant 
operations, maintenance, and fuel, and about one-third the cost of that 
for gas-fired plants. The installed capacity cost of new turbines in 
commercial-scale projects of 10 to 20 megawatts ranged from $800 to $1,000 
per kilowatt in 1994. The American Wind Energy Association expects that 
the industry will reduce installed costs to around $750 per kilowatt by 
the year 2000. <I>Id., </I>pp. 23-24, 262.<BR>
<P><A NAME="318"  HREF="#r318">318.</a> <I>Id., </I>p. 24. The difference in cost between decommissioning 
nuclear power plants and wind power plants is substantial, but often 
ignored. For example, decommissioning the damaged Unit 2 reactor at Three 
Mile Island will cost more than $1 billion when completed, nearly as much 
as it cost to build the plant. Overall, decommissioning nuclear plants 
will cost from $0.3 billion to as much as $3 billion per 1000-megawatt 
reactor in 1985 dollars, or $300 to $3,000 per kilowatt. Wind plants, in 
comparison, are sustainable, and can be upgraded indefinitely. If 
decommissioning were necessary for some reason, it would cost about $3,000 
to $5,500 per turbine, or $30 to $55 per kilowatt - at least six times 
less than nuclear. The turbine's salvage value would likely offset much of 
this. <I>Id.</I><BR>
<BR>
<P><A NAME="319"  HREF="#r319">319.</a> A 50-megawatt wind facility typically is completed in 18 months. 
<I>Id., </I>p. 24. A study by Los Alamos Laboratory found that "utilities 
could afford to pay as much as four times more in overnight construction 
costs for five-year lead-time plants than for 15-year lead-time plants." 
According to Oak Ridge National Laboratory, building a series of power 
plants with short lead times would cut the price of electricity 18 percent 
over the 15-year period considered, or 1.3 cents per kilowatt hour, 
relative to building one 600-megawatt coal-fired power plant over four 
years. <I>Id.</I>, pp. 24-25.<BR>
<P>
<P><A NAME="320"  HREF="#r320">320.</a> <I>Id., </I>p. 25. Michael DeAngelis and Sam Rashkin of the California 
Energy Commission's research and development office performed an analysis 
of the hidden costs associated with all electric generation sources, and 
concluded that oil combustion, nuclear fission, fuel cells, and coal have 
among the highest costs, while efficiency, wind, biomass, hydroelectric 
and solar thermal electric are among the lowest-cost technologies.<BR>
<P><A NAME="321"  HREF="#r321">321.</a> <I>Id. </I>A survey by the National Renewable Energy Laboratory (NREL) 
found that competitive bidding in most states has a "systematic bias 
against renewables" because of the emphasis on using "proven" 
(traditional) technologies, the undervaluation of environmental costs, and 
the exclusion of fuel-price uncertainty for fossil fuel plants.<BR>
<P><A NAME="322"  HREF="#r322">322.</a> By de-emphasizing the price volatility of fossil fuels, the cost of 
energy for conventional energy sources appears lower in early years than 
that for technologies with high capital costs but low fuel costs, like 
those of renewables.  <I>Id.</I><BR>
<P><A NAME="323"  HREF="#r323">323.</a> This carbon dioxide reduction data uses a national average for 
electricity, given the actual fuel share in 1993, of 0.6332 metric tons 
per megawatt-hour (MWh). In the future, avoided emissions will depend on 
the actual displacement of future and/or existing plants. Laitner, S., 
Economic Research Associates (Arlington, VA: December 5, 1995).<BR>
<P><A NAME="324"  HREF="#r324">324.</a> Williams, S., and Bateman, B., <I>Power Plays: Profiles of America's 
Independent Renewable Electricity Developers</I>, p. 255 (Washington, 
D.C.: Investor Responsibility Research Center, 1995).<BR>
<P><A NAME="325"  HREF="#r325">325.</a> This figure derives from a 1990 <A NAME="BattellePacificNorthwestLaboratory ">Battelle Pacific Northwest Laboratory </a>
study, which assumed that, in windy areas of the 37 states most suitable 
for utility-scale wind development, 90 percent of range lands, 70 percent 
of agricultural land, and 50 percent of forest ridge crests would be 
available for energy production, while urban areas and environmentally 
protected lands would be excluded. Wind development is compatible with 
other uses, and preserves land for rural uses; much of the range and 
agricultural lands still would be available for grazing and farming 
because wind power development (including roads, turbine and transformer 
pads, and service buildings) occupies only 5 to 10 percent of the total 
land area for a project. <I>Id., </I>pp. 259, 272.<BR>
<P><A NAME="326"  HREF="#r326">326.</a> <I>Id., </I>p. 260.<BR>
<P><A NAME="327"  HREF="#r327">327.</a> Kenetech is confident enough in its wind resource data to offer power 
output guarantees for wind-power plants that it is selling to the 
Sacramento Municipal Utility District and PacifiCorp.  <I>Id.</I><BR>
<P><A NAME="328"  HREF="#r328">328.</a> McGraw Hill, "Kenetech," <I>125 Independent Power Companies: Profiles 
of Industry Players and Projects</I>, p. 72 (1994).<BR>
<P><A NAME="329"  HREF="#r329">329.</a> Tax incentives available to the wind industry include a 10-year energy 
production tax credit of 1.5 cents per kilowatt-hour (inflation-adjusted) 
for wind projects brought on-line between 1994 and 1999 and a five-year 
depreciation for wind equipment. Williams, S., and Bateman, B., <I>Power 
Plays: Profiles of America's Independent Renewable Electricity 
Developers</I>, pp. 262-63, 266 (Washington, D.C.: Investor Responsibility 
Research Center, 1995).<BR>
<P><A NAME="330"  HREF="#r330">330.</a> This carbon dioxide data uses a DOE emissions factor for California of 
0.343 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>
<P><A NAME="331"  HREF="#r331">331.</a> Williams, S., and Bateman, B., <I>Power Plays: Profiles of America's 
Independent Renewable Electricity Developers</I>, pp. 284-86 (Washington, 
D.C.: Investor Responsibility Research Center, 1995).<BR>
<P><A NAME="332"  HREF="#r332">332.</a> This carbon dioxide data uses a DOE emissions factor for California of 
0.343 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>
<P><A NAME="333"  HREF="#r333">333.</a> Williams, S., and Bateman, B., <I>Power Plays: Profiles of America's 
Independent Renewable Electricity Developers</I>, pp. 281-83 (Washington, 
D.C.: Investor Responsibility Research Center, 1995).<BR>
<P><A NAME="334"  HREF="#r334">334.</a> United States Department of Energy, "Energy Pioneer: FloWind," <I>Fact 
Sheet</I>, p. 1 (Washington, D.C.: Office of Energy Efficiency and 
Renewable Energy, 1995).<BR>
<P><A NAME="335"  HREF="#r335">335.</a> California Energy Commission Performance Data, cited in Williams, S., 
and Bateman, B., <I>Power Plays: Profiles of America's Independent 
Renewable Electricity Developers</I>, pp. 283-84 (Washington, D.C.: 
Investor Responsibility Research Center, 1995).<BR>
<P><A NAME="336"  HREF="#r336">336.</a> This carbon dioxide data uses a DOE emissions factor for California of 
0.343 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>
<P><A NAME="337"  HREF="#r337">337.</a> Williams, S., and Bateman, B., <I>Power Plays: Profiles of America's 
Independent Renewable Electricity Developers</I>, pp. 304-09 (Washington, 
D.C.: Investor Responsibility Research Center, 1995).<BR>
<P><A NAME="338"  HREF="#r338">338.</a> California Energy Commission Performance Data, cited in Williams, S., 
and Bateman, B., <I>Power Plays: Profiles of America's Independent 
Renewable Electricity Developers</I>, pp. 308-09 (Washington, D.C.: 
Investor Responsibility Research Center, 1995).<BR>
<P><A NAME="339"  HREF="#r339">339.</a> This carbon dioxide data uses a DOE emissions factor for California of 
0.343 metric tons/MWh. United States Department of Energy<I>, Voluntary 
Reporting of Greenhouse Gases: Reporting Form and Instructions</I>, Form 
EIA-1605EZ, OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission 
Factors by State") (Washington, D.C.: Energy Information Administration, 
June 1995).<BR>
</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->

</td></tr>
</table>




<!--start foot--><p align=right><a href = "D2.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-211</DOCNO>
<DOCOLDNO>IA026-000277-B034-131</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/D2.html 198.77.86.203 19970113180743 text/html 10597
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:09:45 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 10425
Last-modified: Mon, 17 Jun 1996 00:31:18 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Photovoltaics</title>
<table><tr><td><blockquote>
<H3>2. Photovoltaics</H3>
<BR>
<BR>
Photovoltaic (PV) power uses semiconductor technology to convert sunlight 
directly into electricity without the need for turbines, generators or any 
other moving parts. Photovoltaics' rapid evolution has been tied to 
advancements in solid state physics and, like the computer industry, its 
future development could revolutionize the way we live.<a href="#340" name="r340"> [ 340 ] </a>
<p>     Photovoltaics' inherently modular technology lends itself to a wide 
variety of applications, ranging from hand-held calculators to rooftop 
generating systems and central station power plants. Because of this 
flexibility, and because PV systems can be used in diffuse or direct light 
in all climates - including every state in the U.S. - PV technology 
appears to have the greatest potential of all renewable resources.<a href="#341" name="r341"> [ 341 ] </a>

<BLOCKQUOTE>
<hr>
<a href = "../img/Renew-Pv.gif"><img src = "../t/Renew-Pv.gif"
 alt = "Chart 15: Photovoltaic Conversion Efficiency" align=left></a>
 <h3><I>Chart 15: Photovoltaic Conversion Efficiency<br clear=all><hr></I></h3>
</BLOCKQUOTE>

<p>     PV production costs have fallen more than fiftyfold over the last 20 
years, and generate power today at an average cost of 25 to 50 cents per 
kilowatt-hour for grid-connected applications. Grid-connected PV systems 
cost about $5 to $7 per watt to manufacture. At these prices, 
cost-effective PV applications are mainly for off-the-grid uses in remote 
locations where power is needed for water pumping, refrigeration, 
lighting, and communications. However, PVs can be cost-effective in 
specialized grid situations. For example, PV arrays sited at generating 
substations to support a utility's transmission and distribution system, 
and PV arrays sited at residential and commercial centers, have the 
potential to manage demand for electricity by shaving utility peak 
loads.<BR>
<p>     The <B><I><A NAME="BostonEdisonCompany">Boston Edison Company</a></B></I> has found cost-effective 
applications for PVs, even at today's prices. The Union of Concerned 
Scientists, in an extensive study, concluded that as much as 31 percent of 
Boston Edison's electricity could be supplied by renewables, including 
PVs. Boston Edison's break-even cost of supplying electricity (without 
adding in externalities) is $5.20 per watt - within the current cost 
range of PVs. PV technology has matured to the point where it can be 
cost-effective when transmission expansion is necessary, and can play an 
important role in utility transmission and distribution planning.<a href="#342" name="r342"> [ 342 ] </a>
<p>     As of 1994, the U.S. had just 18 megawatts of grid-connected PV 
installed capacity, and 25 megawatts of additional PV in stand-alone 
applications.<a href="#343" name="r343"> [ 343 ] </a>These numbers are expected to climb. Chart 15  shows the 
five principal PV technologies currently under development, and their 
present and projected efficiencies. With prices dropping, PV generation is 
likely to become a major source of clean power by the turn of the 
century.<P>

<B><I> <p>     <A NAME="Amoco/Enron Solar">Amoco/Enron Solar</a>.</B></I> The domestic PV industry 
received a boost in January 1995 when Amoco Corp., which owns 
<A NAME="Solarex">Solarex<a> - the largest U.S. manufacturer and marketer of PV 
systems - launched a joint venture with <A NAME="EnronCorporation">Enron Corporation <a>, the nation's 
largest natural gas company. Together, they propose to build a $25 million 
manufacturing facility to produce PV modules and a $150 million, 
100-megawatt PV generating plant in Nevada that they maintain will be able 
to sell power profitably for 5.5 cents per kilowatt-hour (escalating by 3 
percent annually over 30 years).<a href="#344" name="r344"> [ 344 ] </a>When production begins in 1996, the 
plant will manufacture in excess of 10 megawatts of large-area 
multijunction amorphous silicon modules annually.<P>
<B><I> <p>     The <A NAME="SacramentoMunicipalUtilityDistrict">Sacramento Municipal Utility District</A>.</B></I> The 
Sacramento Municipal Utility District (SMUD) is perhaps the utility most 
committed to solar energy in the country. SMUD has implemented a wide 
range of solar technologies, including 2 megawatts of PV arrays located at 
its retired Rancho Seco nuclear power plant, 600 kilowatts of PV arrays at 
its Hedge substation (where it has developed a highly cost-effective 
single-axis mounting strategy), PV electric vehicle recharging stations, 
and rooftop solar collectors for residential and commercial customers.<BR>
<p>    <p>      <BR>
SMUD's "PV Pioneers" program has installed 4-kilowatt PV panels, 
manufactured by Siemens Solar, on customers' roofs, at a cost of $7.07 per 
peak watt. These customers seem eager to pay a premium for the 
satisfaction of generating and consuming clean, renewable electricity.<a href="#345" name="r345"> [ 345 ] </a>
SMUD has installed more than 240 systems in Sacramento's residential 
neighborhoods, allowing the utility to gain valuable insights into 
decentralized generation, whereby customers also become generators, 
feeding small increments of power into the fingers of the distribution 
network where it is often needed most.<BR>
<p>    <p>      SMUD's PV programs produced 63,971 megawatt-hours of cumulative 
power between 1986 and 1994. This electricity output, had it been produced 
by California's average mix, would have pumped 21,942 metric tons of 
carbon dioxide into the atmosphere.<a href="#346" name="r346"> [ 346 ] </a>Instead, it was emissions-free.<P>
<B><I> <p>     <A NAME="SiemensSolarIndustries">Siemens Solar Industries<a>.</B></I> The leading U.S. PV 
producer, Siemens Solar, based in Camarillo, California, shipped 
approximately 15 megawatts of PV modules in 1994, and 12.5 megawatts of PV 
modules in 1993, representing more than half of all U.S. PV shipments and 
21 percent of the global market. In February 1995, the company announced 
its intent to increase production capacity by nearly 50 percent. Its core 
technology is single crystalline solar cells, but Siemens Solar also is 
developing copper indium diselenide thin-film cells. <BR>
<p>    <p>      Siemens Solar has also installed several grid-support systems. 
One is a 500-kilowatt PV installation at <A NAME="PacificGasandElectric">Pacific Gas and Electric <a>
Company's Kerman, California substation, which places the power generation 
source closer to the point of demand, reducing transmission and 
distribution costs. A second system, for the Sacramento Municipal Utility 
District, includes four-kilowatt residential rooftop systems and a 
200-kilowatt single axis tracking PV system for transmission and 
distribution support. Siemens Solar is also providing Southern California 
Edison Co. with off-grid systems.<a href="#347" name="r347"> [ 347 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->


<P><A NAME="340"  HREF="#r340">340.</a> Williams, S., and Bateman, B., <I>Power Plays: Profiles of America's 
Independent Renewable Electricity Developers</I>, p. 391 (Washington, 
D.C.: Investor Responsibility Research Center, 1995).<BR>
<P><A NAME="341"  HREF="#r341">341.</a> <I>Id.</I><BR>
<P><A NAME="342"  HREF="#r342">342.</a> Chandler, D., "Solar, Wind Units Seen as Boon to Ratepayers," <I>The 
Boston Globe</I> (August 8, 1995); Oppenheim, J., <I>Renewable Energy 
Technology Analysis</I>, p. 1 (Brookline, MA: Pace University School of 
Law, Energy Project Center, August 16, 1995).<BR>
<P><A NAME="343"  HREF="#r343">343.</a> Solar Energy Industries Association data, cited in Williams, S., and 
Bateman, B., <I>Power Plays: Profiles of America's Independent Renewable 
Electricity Developers</I>, p. 391 (Washington, D.C.: Investor 
Responsibility Research Center, 1995).<BR>
<P><A NAME="344"  HREF="#r344">344.</a> Williams, S., and Bateman, B., <I>Power Plays: Profiles of America's 
Independent Renewable Electricity Developers</I>, p. 391 (Washington, 
D.C.: Investor Responsibility Research Center, 1995).<BR>
<P><A NAME="345"  HREF="#r345">345.</a> Fully 26 percent of SMUD customers are willing to pay a premium for PV 
power generated on their own rooftops. Seventy percent were willing to 
participate in a "green pricing" program in which they would pay more on 
their monthly utility bills so that SMUD could establish a "Clean Energy" 
program.<BR>
<P><A NAME="346"  HREF="#r346">346.</a> The Results Center, <I>Sacramento Municipal Utility District: Solar 
Photovoltaics Program</I>, Profile #111 (Aspen, CO: IRT Environment, Inc., 
1994). Carbon dioxide reduction data uses a DOE emissions factor of 0.343 
for California. United States Department of Energy<I>, Voluntary Reporting 
of Greenhouse Gases: Reporting Form and Instructions</I>, Form EIA-1605EZ, 
OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission Factors by 
State") (Washington, D.C.: Energy Information Administration, June 
1995).<BR>
<P><A NAME="347"  HREF="#r347">347.</a> Williams, S., and Bateman, B., <I>Power Plays: Profiles of America's 
Independent Renewable Electricity Developers</I>, pp. 437-39 (Washington, 
D.C.: Investor Responsibility Research Center, 1995). <BR>
</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->
</td></tr>
</table>




<!--start foot--><p align=right><a href = "D3.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D1.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-212</DOCNO>
<DOCOLDNO>IA026-000277-B034-158</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/D3.html 198.77.86.203 19970113180754 text/html 1901
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:10:02 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1730
Last-modified: Mon, 17 Jun 1996 00:31:18 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D3a.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><HTML><HEAD><TITLE>Solar Thermal</TITLE></HEAD><BODY bgcolor="#FFFFFF"><table><tr><td><blockquote><H3><I>3</I>. Solar Thermal</H3>Solar thermal systems convert energy from sunlight to thermal energy,which can either be used directly as heat energy or converted intoelectricity. Three solar thermal electric technologies - parabolic troughs,central receivers, and parabolic dishes - are being developed in the United States today. All three technologies use tracking mirrors to reflect and concentrate sunlightonto a central receiver, where the conversion to high temperature thermal energy takes place.</font></blockquote></td><td align = center width =150><!--images here--></td></tr></table><!--start foot--><p align=right><a href = "D3a.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D2.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-213</DOCNO>
<DOCOLDNO>IA026-000277-B034-177</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/D3a.html 198.77.86.203 19970113180805 text/html 3284
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:10:10 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 3113
Last-modified: Mon, 17 Jun 1996 00:31:19 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D3b.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Parabolic Troughs</title>
<table><tr><td><blockquote>

<H4>a. Parabolic Troughs<I><BR>
</B></I></H4>
Of the three technologies, only parabolic troughs have been 
developed to commercial scale.<a href="#348" name="r348"> [ 348 ] </a>Luz International, Ltd. installed 
parabolic trough technology at nine plants between 1984 and 1990. To 
finance the plants, Luz used federal and California tax incentives, 
international tax incentives for equipment purchases, and favorable power 
purchase agreements. Although Luz is now out of business, other owners are 
still operating its solar thermal plants, selling power to Southern 
California Edison. While Luz was operating the plants, it dramatically 
reduced generation costs from nearly 25 cents per kilowatt-hour in 1984 to 
around 9 cents per kilowatt-hour in 1989. <A NAME="SandiaNationalLaboratories">Sandia National Laboratories<a> 
estimates that new parabolic trough plants could produce electricity for 8 
to 14 cents per kilowatt-hour, depending on tax incentives and plant 
size.<a href="#349" name="r349"> [ 349 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->

<P><A NAME="348"  HREF="#r348">348.</a> Parabolic troughs consist of long rows of concentrators that are 
curved in only one dimension, forming troughs. The troughs are mounted on 
a single-axis tracking system that tracks the sun from east to west. They 
are lined with a reflective surface that focuses the sun's energy onto a 
pipe located along the trough's focal line. A heat transfer fluid is 
circulated through the pipes and then pumped to a central storage area, 
where it passes through a heat exchanger. The heat is then transferred to 
a working fluid, usually water, which is flashed into steam to drive a 
conventional steam turbine. <BR>
<I>Id., </I>p. 451.<BR>
<P><A NAME="349"  HREF="#r349">349.</a> Without favorable tax treatment, a parabolic trough system would 
generate electricity for about 17 cents per kilowatt-hour today. 
<I>Id.</I><BR>
</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "D3b.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D3.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-214</DOCNO>
<DOCOLDNO>IA026-000277-B034-212</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/D3b.html 198.77.86.203 19970113180844 text/html 4057
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:10:34 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 3886
Last-modified: Mon, 17 Jun 1996 00:31:19 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D3c.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D3a.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head-->
<title>Central Receivers</title>
<table><tr><td><blockquote>

<B> 
<H4><p>b. Central Receivers<BR>
</B></H4>
The second solar thermal technology, central receivers - or 
"power towers" - have yet to be demonstrated on a commercial scale.<a href="#350" name="r350"> [ 350 ] </a>
However, a 10-megawatt plant is scheduled to begin operation in early 1996 
and continue through 1998. The project, known as Solar Two, is a 
partnership between the U.S. DOE and a consortium led by <A NAME="SouthernCaliforniaEdison">Southern California Edison<a>. The project is upgrading a prior 10-megawatt 
demonstration system, known as Solar One, that produced more than 35,000 
megawatt-hours of electricity at an installed capacity cost of 
approximately $14,000 per kilowatt-hour.<a href="#351" name="r351"> [ 351 ] </a>The new system is expected to 
do better, and will use a molten salt thermal storage system, enabling it 
to assist Southern California Edison's peak demand period by extending 
electricity generation into the early evening hours.<BR>
<B><I><BR>
 <p>     <A NAME="Bechtel ">Bechtel</a> Corporation.</B></I> Bechtel, with headquarters in San 
Francisco, is the project team manager for Solar Two, the 10-megawatt 
central receiver "power tower" project sponsored by a consortium of 15 
companies and utilities, as well as the U.S. DOE. The consortium and the 
DOE will split the total cost of the project, estimated to be $48.5 
million. Bechtel designed the Solar Two system, which basically converts 
the Solar One facility in Daggett, California from a pressurized 
water/steam receiver and oil/rock storage system to a molten nitrate salt 
receiver and thermal storage system. Solar Two will be able to collect and 
store solar heat in molten salt during the day and then generate 
electricity with it during cloudy periods or in the early evening, during 
peak demand. Construction began on Solar Two in November 1994. The 
consortium hopes to bring Solar Two on-line in late 1995 and to complete 
testing in 1998. The sponsors of Solar Two also contracted with Bechtel to 
develop a plan to commercialize the technology.<a href="#352" name="r352"> [ 352 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->

<P><A NAME="350"  HREF="#r350">350.</a> Central receiver technology consists of a fixed receiver mounted on a 
tower surrounded by a large array of mirrors, known as heliostats. The 
heliostats track the sun and reflect its rays onto the receiver, which 
absorbs the heat. Within the receiver, a fluid absorbs the receiver's heat 
energy and then is transported from the receiver to a turbine generator or 
a storage tank. <I>Id., </I>p. 454.<BR>
<P><A NAME="351"  HREF="#r351">351.</a> <I>Id., </I>pp. 454-55.<BR>
 352 <I>Id., </I>p. 467.<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "D3c.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D3a.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-215</DOCNO>
<DOCOLDNO>IA026-000277-B034-248</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/D3c.html 198.77.86.203 19970113180908 text/html 3736
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:11:08 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 3565
Last-modified: Mon, 17 Jun 1996 00:31:20 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "D4.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D3b.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Parabolic Dishes</title>
<table><tr><td><blockquote>     <B>
<p>     <H4>c. Parabolic Dishes</H4>
<p>     <BR>
</B>The third solar thermal technology, parabolic-dish generating systems, 
achieve the highest performance of the three solar thermal designs in 
terms of annually collected energy and absorption of peak sunlight.<a href="#353" name="r353"> [ 353 ] </a>
During the past 15 years, about eight systems ranging in size from a few 
kilowatts to 50 kilowatts have been built and operated in the United 
States, although recent development has largely been confined to industry 
and government cost-shared research and development. The DOE is investing 
in a utility-scale joint venture to develop a 25-kilowatt system that 
utilizes advanced Stirling engines at the concentrator focal point. The 
DOE hopes to spark commercialization of dish/Stirling systems, and expects 
the systems eventually to achieve capital costs of $1,500 per 
kilowatt-hour (for systems augmented by fossil fuels) and a levelized 
energy cost of 6 cents per kilowatt-hour.<a href="#354" name="r354"> [ 354 ] </a><P>
<B><I> <p>     <A NAME="Cummins Power Generation, Inc.">Cummins Power Generation, Inc.<a></B></I> Cummins Power 
Generation (CPG) is a subsidiary of <A NAME="CumminsEngineCo.">Cummins Engine Co.</a> of Columbus, 
Indiana. CPG is America's foremost producer of dish/Stirling systems. CPG 
is developing two systems - a <BR>
7-kilowatt and a 25-kilowatt system -  both of which were selected by 
the U.S. DOE's Joint Venture Program for commercial demonstration. Under 
both contracts, CPG's systems will employ a free-piston Stirling engine 
driven directly by high heater head temperatures of 675&#176; Celsius. The 
entire structure of parabolic dishes will track the sun as it moves.<BR>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="353"  HREF="#r353">353.</a> Parabolic dish generating systems consist of parabolic-shaped 
point-focus concentrators that reflect solar energy onto a receiver 
mounted at the focal point. Parabolic dishes typically use dozens of 
curved reflective panels made of glass or laminated films, mounted on a 
structure that tracks the sun. When the concentrated sunlight hits the 
receiver, it is either directly utilized by a heat engine, or used to heat 
a fluid that is transmitted to a central engine. <I>Id., </I>p. 457.<BR>
<P><A NAME="354"  HREF="#r354">354.</a> <I>Id., </I>pp. 457-58.<BR>


</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "D4.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D3b.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-216</DOCNO>
<DOCOLDNO>IA026-000277-B034-281</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/D4.html 198.77.86.203 19970113180923 text/html 7909
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:11:25 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 7738
Last-modified: Mon, 17 Jun 1996 00:31:20 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "E.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D3c.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><title>Geothermal</title>
<table><tr><td><blockquote>
<H3>4. Geothermal</H3>
<BR>
<BR>
Geothermal energy is heat stored beneath the earth's surface. The amount 
of heat ultimately recoverable is dependent on the technology available to 
tap it. Some geothermal sites may be developed in a sustainable manner so 
that the heat withdrawn equals the heat being replaced naturally. 
Practically speaking, potential geothermal resources are so large that 
they are not considered depletable.<a href="#355" name="r355"> [ 355 ] </a>
<p>     Geothermal power has been in commercial production since about 1960, 
with the United States leading the world with more than 3,000 megawatts of 
installed capacity.<a href="#356" name="r356"> [ 356 ] </a>Since the early 1990s, however, geothermal 
development has been hindered by slumping U.S. energy markets in the West, 
where most of today's usable domestic geothermal resources are located. 
Despite a drop in geothermal electricity costs to between 4.5 and 7 cents 
per kilowatt-hour, low natural gas prices have made it difficult for 
geothermal to compete.<a href="#357" name="r357"> [ 357 ] </a>Nevertheless, because gas prices eventually will 
rise, geothermal resources have a tremendous potential to provide clean 
and sustainable energy in the future.<P>
<B><I> <p>    <A NAME="PacificGasandElectric">Pacific Gas and Electric <a>.</B></I> Electric 
utilities, primarily Pacific Gas and Electric (PG&E), were the first in 
the United States to build geothermal generating facilities. PG&E owns 
about three-quarters of the capacity of The Geysers, a 35-square-mile dry 
steam field in Northern California, that has an infrastructure investment 
of about $3.5 billion. The Geysers has about 500 wells, most of which are 
6,000 to 10,000 feet deep, tapping into a steam reservoir whose 
temperatures exceed 220&#176; Celsius. The field has been in production 
since 1960, but began to decline in 1988, when it reached a peak output of 
2,000 megawatts.<a href="#358" name="r358"> [ 358 ] </a><BR>
<p>    <p>      PG&E has found geothermal to be highly economical. The first ten 
PG&E power plants at The Geysers - completed between 1960 and 
1974 - were all built for less than $200 per kilowatt. In the late 
1970s, however, the cost of new plants at The Geysers started to rise 
because less desirable sites were used. Two PG&E units brought on-line in 
1985 had an average capital cost of about $1,400 per kilowatt. More recent 
projects had an average capital cost of about $2,500 per kilowatt. <BR>
<p>     Despite the production decline at The Geysers, geothermal remains one 
of PG&E's lowest-cost sources of power over the life of the facilities, 
and in 1994 represented around 10 percent of PG&E's thermal generating 
capacity.<a href="#359" name="r359"> [ 359 ] </a>P>
<B><I> <p>     <A NAME="CaliforniaEnergyCompany, Inc."> California Energy Company, Inc.</a></B></I> California Energy 
Company, based in Omaha, Nebraska, is the world's largest independent 
geothermal power company, with operations in the United States, the 
Philippines, and Indonesia. The company operates 13 geothermal facilities 
with a total capacity of 575 megawatts, has contracted to provide over 
1,500 megawatts in the future, and has projects under construction 
totaling another 540 megawatts.<a href="#360" name="r360"> [ 360 ] </a><BR>
<p>    <p>      In 1990, the California Energy Company received the National 
Environmental Achievement Award for its 288-megawatt Coso project at the 
U.S. Naval Weapons Center in Inyo County, California. The company plans to 
expand this facility - a nine-unit steam geothermal complex - to 
around 600 megawatts. <BR>
<p>    <p>      In 1995, California Energy acquired <B><I><A NAME="MagmaPowerCo.">Magma Power Co.<a> 
Co.,</B></I> another leader in the geothermal industry, and made it a 
wholly-owned subsidiary. Magma Power operates seven power plants (three 
purchased from Unocal in 1993) totaling 264 megawatts in the Salton Sea 
Known Geothermal Area in California's Imperial Valley.361 In 1993, 
California Energy sold 4,103 megawatt-hours of its geothermal electricity 
to <A NAME="SouthernCaliforniaEdison">Southern California Edison<a>. This geothermal electricity offset 1,407 
metric tons of carbon dioxide that otherwise would have been emitted by 
California's average generation mix.<a href="#362" name="r362"> [ 362 ] </a>
<BR>




<hr><font size =-1>





<!--footnotes-->
<P><A NAME="355"  HREF="#r355">355.</a> <I>Id., </I>pp. 185-86.<BR>
<P><A NAME="356"  HREF="#r356">356.</a> <I>Id., </I>p. 185.<BR>
<P><A NAME="357"  HREF="#r357">357.</a> <I>Id., </I>pp. 185-86.<BR>
<P><A NAME="358"  HREF="#r358">358.</a> In 1994, production stood at about 1,250 megawatts. Field operators 
expect an additional 50 percent decline over the next 20 years, to about 
600 megawatts. Although industry estimates that only about 5 percent of 
the field's geothermal heat has been tapped, the decline stems from 
depletion of fluid in the field. Over-building has contributed to the 
fluid decline, as well as the practice of reinjecting only about 20 
percent of the fluid used in production (the other 80 percent is 
evaporated in cooling towers). By adding fluid from external sources, 
including reinjecting most of the produced fluid and modifying power plant 
design, The Geysers could supply at least several hundred megawatts of 
electricity for another 50 years. <I>Id., </I>p. 188.<BR>
<P><A NAME="359"  HREF="#r359">359.</a> <I>Id.</I><BR>
<P><A NAME="360"  HREF="#r360">360.</a> Weisgall, J., California Energy Company, Inc., personal correspondence 
(Washington, D.C.: December 11, 1995) (notes on file with the author).<BR>
<BR>
<P><A NAME="361"  HREF="#r361">361.</a> Williams, S., and Bateman, B., <I>Power Plays: Profiles of America's 
Independent Renewable Electricity Developers</I>, pp. 210-13 (Washington, 
D.C.: Investor Responsibility Research Center, 1995). <BR>
362Southern California Edison power purchase data from Williams, S., and 
Bateman, B., <I>Power Plays: Profiles of America's Independent Renewable 
Electricity Developers</I>, p. 216 (Washington, D.C.: Investor 
Responsibility Research Center, 1995). This carbon dioxide reduction data 
is derived from a DOE emissions factor of 0.343 metric tons/MWh for 
California. United States Department of Energy<I>, Voluntary Reporting of 
Greenhouse Gases: Reporting Form and Instructions</I>, Form EIA-1605EZ, 
OMB No. 1905-0194, Appendix F ("Adjusted Electricity Emission Factors by 
State") (Washington, D.C.: Energy Information Administration, June 
1995).<BR>

</font>
</blockquote>
</td>


<td align = center width =150>


<!--images here-->


</td></tr>
</table>



<!--start foot--><p align=right><a href = "E.html"><img align=right border=0 src="../../grf/next.gif" alt = "[ Next ]"></a><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D3c.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-217</DOCNO>
<DOCOLDNO>IA026-000277-B035-15</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/reports/V/E.html 198.77.86.203 19970113180944 text/html 1828
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 18:11:48 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 1657
Last-modified: Mon, 17 Jun 1996 00:31:21 GMT
</DOCHDR>
<html><BODY bgcolor="#FFFFFF"><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D4.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><!--end head--><H2><I>E. </I>Conclusion</H2>
<BR>
<BR>
Renewables will be a key component of any national strategy to cut carbon 
dioxide emissions and reduce the threat of global climate change. 
Renewables costs have fallen steeply and are expected to drop further. 
Wind energy is already nearly cost-competitive with fossil 
generation - even when the high social and environmental costs of 
fossil fuels are not added to their prices. Photovoltaics are already 
cost-effective for certain transmission and distribution expansion 
applications, and are often the best option for off-grid generation. Solar 
thermal technologies continue to improve thanks to prudent federal 
government assistance, and offer promise as large-scale, centralized 
generation facilities. Geothermal is a proven technology yet to tap its 
vast geographic potential.<BR>


<!--start foot--><p align=right><a href = "index.html"><img align=right border=0 src="../../grf/up.gif" alt = "[ Up ]"></a><a href = "D4.html"><img align=right border=0 src="../../grf/back.gif" alt = "[ Back ]"></a><br clear=all><hr><p align=right><font size=-1><a href="http://www.ef.org/"><img src="../../grf/efhome.gif" alt="EF Home" align=left border=0></a>Copyright (c) 1996 the Energy Foundation<br><A HREF="mailto:ef@ef.org">Comments & Questions</A><br>Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A></font></p></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-218</DOCNO>
<DOCOLDNO>IA026-000276-B035-48</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/index.html 198.77.86.203 19970113171325 text/html 2233
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:15:30 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2062
Last-modified: Mon, 17 Jun 1996 20:07:20 GMT
</DOCHDR>
<HTML><HEAD>
<TITLE>The Energy Foundation</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<CENTER><IMG SRC="grf/logo.gif" ALT="Energy Foundation Logo" ALIGN=BOTTOM WIDTH="398" HEIGHT="176"></CENTER>
<CENTER><H1>Our Mission</H1></CENTER>
<BR>
<BLOCKQUOTE>
<IMG SRC="./grf/dcI.gif" ALT="I" ALIGN=left WIDTH="32" HEIGHT="56">
n January 1991, after a series of consultations with
many of the nation's leading scientists, policy-makers,
business leaders, and analysts, the staffs and boards of
The John D. and Catherine T. MacArthur Foundation, The
Pew Charitable Trusts, and The Rockefeller Foundation
created the Energy Foundation. <STRONG>Its mission is to assist
in the nation's transition to a sustainable energy
future by promoting energy efficiency and renewable
energy.</STRONG><P>

The Energy Foundation has a dual character: It functions
primarily as a grant-maker, but when it determines there
is an unmet need in the field, it may convene workshops,
commission papers, or take other direct initiatives. The
foundation also draws from and contributes to related
programs of The John D. and Catherine T. MacArthur
Foundation, The Pew Charitable Trusts, and The
Rockefeller Foundation. It has a budget of $10 million
per year.<p>

<A NAME="toc"></A>
<BLOCKQUOTE>
<A HREF="grants/index.html"><IMG border=0 SRC="./grf/blt.gif"><b>Grant Programs and Guidelines</b></a><br>
<A HREF="grants/grantees.html"><IMG border=0 SRC="./grf/blt.gif"><b>Grantee List</b></a><br>
<A HREF="essay/index.html"><IMG border=0 SRC="./grf/blt.gif"><b>Essay from the Executive Director</b></a><br>
<A HREF="sites.html"><IMG border=0 SRC="./grf/blt.gif"><b>Energy-Related WWW Sites</b></a><br>
<A HREF="reports/index.html"><IMG border=0 SRC="./grf/blt.gif"><b>Special Energy Foundation or Grantee Reports</b></A><br>
</BLOCKQUOTE></BLOCKQUOTE>
<hr>
<p align=right><font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>
</BODY>
</HTML>


</DOC>
<DOC>
<DOCNO>WT01-B18-219</DOCNO>
<DOCOLDNO>IA026-000277-B026-368</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/hypercar.html 198.77.86.203 19970113173438 text/html 3092
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:36:44 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2921
Last-modified: Mon, 17 Jun 1996 17:15:27 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE></TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<TITLE>"Moving Toward the 'Hypercar'"</TITLE>

<BLOCKQUOTE>
<H1>Moving toward the "hypercar."</H1>

<IMG SRC="hypcar.gif" HEIGHT=144 WIDTH=138 align=left hspace=12>
<br><br><br><H3>Analysts argue that a complete <br>
reinvention of the automobile is in order -<br>
which would result in a 100 mpg "hypercar".
</H3>
<br clear=all>


On Sept. 29, 1993, the Big Three automakers committed to
developing a triple-efficiency "clean car" prototype
within a decade. A really efficient car, however, can't
be made by pursuing incremental refinements to a
fundamentally obsolete concept of the automobile. A
leapfrog is needed, is now feasible, and can far surpass
the 1993 goal. Striking technological innovations have
been made that, artfully integrated, can yield safe,
affordable and otherwise superior cars getting hundreds
of miles per gallon.
<P>
Accelerating today's heavy steel cars requires engines
so large that their efficiency is halved: only 15-20
percent of the gasoline's energy is available to move
the car, and only 1 percent available to move the
driver. Almost all of the lost power heats the tires and
road, the brakes, and the air pushed aside by the car.
<P>
The key to the super-efficient "hypercar" is first to
make it ultralight. Advanced composite materials can cut
total weight three- to four-fold while improving safety.
Sleeker streamlining can cut aerodynamic drag while
better tires and lowered weight will reduce tire and
road loss. Once this ultralight strategy has largely
eliminated unrecoverable energy losses, the remaining
loss of wheelpower is braking. But if the wheels are
driven by special electric motors, those motors can act
as electronic brakes that convert motion back into
useful electricity. 
<P>
A long driving range can then be achieved by burning any
liquid or gaseous fuel, in a tiny onboard engine or
other powerplant, to make electricity to run the
wheel-motors. 
A few batteries can temporarily store and reuse
recovered braking energy. This "hybrid" technology
combines the best of gasoline and electric cars.
<P>
Combining these approaches yields extraordinary
synergies. Adding hybrid-electric drive to an ordinary
production car increases its efficiency by one-third to
one-half. Making an ordinary car ultralight doubles its
efficiency. But doing both together can boost a car's
efficiency by about tenfold.

<H5>Amory B. and L. Hunter Lovins<BR>
Rocky Mountain Institute</H5>
<P>
<A HREF="cars.html#hyp"><EM>Return to Essay</EM></A>
</BLOCKQUOTE><P>




</BODY>
<hr>
<p align=right>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT></A>
<font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-220</DOCNO>
<DOCOLDNO>IA026-000277-B027-158</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/truecosts.html 198.77.86.203 19970113173652 text/html 2551
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:38:53 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2380
Last-modified: Mon, 17 Jun 1996 17:14:29 GMT
</DOCHDR>

<HTML><HEAD>
<TITLE>"The True Costs of Driving"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">

<BLOCKQUOTE><H1>The true costs of driving.</H1>

<IMG SRC="busNcar.gif" HEIGHT=216 WIDTH=162 align=left><br><br><br><br>
<H3>If drivers were charged directly for using roads,
there would be fewer traffic jams, less pollution, and
greater incentive to use transit systems.</H3>
<br clear=all>


 A treacherous gap has opened between our perception
that driving costs almost nothing, and the reality of
the enormous cost we actually pay to drive.<P>

Gasoline prices have been at a post-World War II low,
and efficient cars stretch gasoline dollars. We often
enjoy "free" parking and rarely pay tolls. Most car
ownership costs-purchase price, fees, and
insurance-don't go up the more we drive.
<P>
But driving costs are actually high and they are
growing. The true costs of driving are detailed in a
report commissioned by the Conservation Law Foundation,
released in May 1994. For each form of transportation,
researchers at Apogee Research Inc., a leading
consulting firm, tallied personal expenses, government
costs, and environmental and other impacts.
<P>
The conclusions: Parking costs as much as 24 cents per
mile of solo driving, in land, maintenance, and tax
breaks. Ignoring damage to crops, plant and animal life,
and buildings, air pollution costs 7 to 11 cents per
mile. Accident costs not covered by insurance add 1 to 6
cents. Personal expenses like insurance add 40 to 67
cents. And if one considers government spending, tax
breaks, and the trade effects of dependence on foreign
oil, gas costs half again the pump price.<P>
     In the Boston region, solo driving costs 81 cents
to 94 cents per mile, and that doesn't include many
unquantifiable expenses, like the costs of sprawl and
oil spills. By comparison, the costs of transit ranges
from 29 to 64 cents per mile; carpooling from 34 to 41
cents; and walking or bicycling from 13 to 14 cents.
<P>
<A HREF="altmodes.html#true"><EM>Return to Essay</EM></A>
</BLOCKQUOTE>
</BODY>
<hr>
<p align=right>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT></A>
<font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-221</DOCNO>
<DOCOLDNO>IA026-000277-B027-3</DOCOLDNO>
<DOCHDR>
http://www.ef.org:80/essay/neighborhood.html 198.77.86.203 19970113173510 text/html 2741
HTTP/1.0 200 OK
Date: Mon, 13 Jan 1997 17:37:13 GMT
Server: Apache/1.1.0
Content-type: text/html
Content-length: 2570
Last-modified: Mon, 17 Jun 1996 17:15:27 GMT
</DOCHDR>
<HTML><HEAD>
<TITLE>"Reclaiming A Neighborhood"</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<HEAD>
<BLOCKQUOTE><H1>Reclaiming a neighborhood.</H1> 

<IMG SRC="biker.gif" HEIGHT=137 WIDTH=144 align=left><br><br><br>
<H3>If streets are well laid-out and destinations are
brought closer, people can get around without having to
drive.</H3>
<br clear=all>
At the turn of the century, West Garfield was a thriving
community on Chicago's West Side, offering jobs, easy
transportation, and a regional park. But today the
median household income of its declining population is
only $15,102, and 40 percent of the neighborhood lots
are vacant.<P>

Things are improving, though. Garfield Park is being 
refurbished, a regional library has opened, and the Lake
Street El Coalition stopped the Chicago Transit
Authority from shutting down the elevated train line
that serves the neighborhood. In 1993, the coalition
advanced an ambitious plan, assembled by the
<STRONG>Center for Neighborhood Technology</STRONG>
(CNT), to use Pulaski Station on the Green Line as the
centerpiece of a pedestrian-friendly, transit-based
redevelopment model designed to boost ridership by
increasing density and encouraging sustainable economic
development.<P>

Specifics of the plan include on-site policing, child
care, retail stores, and business offices at Pulaski
Station, which would become an intermodal hub with a
shuttle to the nearby commercial strip, and with bicycle
lockers, traffic calming, and a pedestrian-oriented
shopping strip. In-filling would provide greater housing
variety, while technical and financial assistance would
help retain manufacturing jobs. Lake Street would be
designated a "green industrial area" to recruit
environmental businesses.<P>

The project should save more than 1,500 vehicle miles
traveled per day. Because the Lake Michigan area has not
attained national air quality standards, the project
qualified for a $4  million capital grant through the
federal transportation act. Because this project will
help clean the air, CNT was able to secure demonstration
funds for similar plans at four other inner-city Green
Line stations.<P>

<A HREF="city.html#neighbor"><EM>Return to Essay</EM></A>

</BLOCKQUOTE>


</BODY>
<hr>
<p align=right>
<A HREF="http://www.ef.org/"><IMG border=0 SRC="../grf/efhome.gif" ALT="EF Home Page" ALIGN=LEFT></A>
<font size=-1>Copyright (c) 1996 the Energy Foundation<br>
<A HREF="mailto:ef@ef.org">Comments & Questions</A><br>
Web Development by <A HREF="http://www.crest.org/common/crestinfo.html">CREST</A>
</font></p>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-222</DOCNO>
<DOCOLDNO>IA087-000632-B013-141</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/pr01.htm 206.61.184.43 19970122090520 text/html 3951
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:05:13 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Monday, 16-Dec-96 04:58:33 GMT
Content-length: 3736
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>DrugLibrary.org Press Release 1</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body background="images/whttxtr2.jpg" bgcolor="#f2f2f2"
stylesrc="_private/style.htm">
<!--webbot bot="Include" tag="BODY"
u-include="_private/logo.htm" startspan -->

<p align="center"><font color="#0000FF"><font size="5"><em>DRCNet
Online Library of Drug Policy </em></font></font></p>
<!--webbot bot="Include" endspan i-checksum="58446" -->

<h1> Press Release 1</h1>
<!--webbot bot="Include" tag="BODY"
u-include="_private/navbar.htm" startspan -->

<p><a href="index.htm"><img src="images/bhome.gif"
alt="[Home Icon]" border="0" width="56" height="14"></a><a
href="news.htm"><img src="images/bnews.gif"
alt="[What's New Icon]" border="0" width="58" height="14"></a><a
href="toc.htm"><img src="images/btoc.gif" alt="[TOC Icon]"
border="0" width="60" height="14"></a><a href="feedback.htm"><img
src="images/bfeed.gif" alt="[Feedback Icon]" border="0"
width="59" height="14"></a><a
href="http://www.druglibrary.org/srchform.html"><img
src="images/bsrch.gif" alt="[Search Icon]" border="0" width="58"
height="14"></a></p>
<!--webbot bot="Include" endspan i-checksum="35058" -->

<p> <img src="images/undercon.gif" alt="[Under Construction]"
border="0" width="40" height="38"></p>

<p> <strong><em>FOR IMMEDIATE RELEASE</em></strong></p>

<hr>

<h1>Title of Announcement</h1>

<h3><em>Subtitle of announcement</em></h3>

<p> <strong>Today's Date</strong> -- This is the body of the
announcement ...</p>

<hr>

<p> <em>For More Information Contact:</em><br>
<br>
<!--webbot bot="Substitution" s-variable="CompanyLongName"
startspan -->DRCNet Online Library of Drug Policy<!--webbot
bot="Substitution" endspan i-checksum="25634" --><br>
<!--webbot bot="Substitution" s-variable="CompanyAddress"
startspan -->P.O. Box 1430<!--webbot bot="Substitution" endspan
i-checksum="27458" --><br>
Tel: <!--webbot bot="Substitution" s-variable="CompanyPhone"
startspan -->805-251-4140<!--webbot bot="Substitution" endspan
i-checksum="12858" --><br>
FAX: <!--webbot bot="Substitution" s-variable="CompanyFAX"
startspan -->805-251-4140<!--webbot bot="Substitution" endspan
i-checksum="12858" --><br>
Internet: <a href="mailto:schaffer@smartlink.net"><!--webbot
bot="Substitution" s-variable="CompanyEmail" startspan -->schaffer@smartlink.net<!--webbot
bot="Substitution" endspan i-checksum="61567" --></a><br>
</p>
<!--webbot bot="Include" tag="BODY"
u-include="_private/navbar.htm" startspan -->

<p><a href="index.htm"><img src="images/bhome.gif"
alt="[Home Icon]" border="0" width="56" height="14"></a><a
href="news.htm"><img src="images/bnews.gif"
alt="[What's New Icon]" border="0" width="58" height="14"></a><a
href="toc.htm"><img src="images/btoc.gif" alt="[TOC Icon]"
border="0" width="60" height="14"></a><a href="feedback.htm"><img
src="images/bfeed.gif" alt="[Feedback Icon]" border="0"
width="59" height="14"></a><a
href="http://www.druglibrary.org/srchform.html"><img
src="images/bsrch.gif" alt="[Search Icon]" border="0" width="58"
height="14"></a></p>
<!--webbot bot="Include" endspan i-checksum="35058" -->

<h5> Send mail to <a href="mailto:schaffer@smartlink.net"><!--webbot
bot="Substitution" s-variable="CompanyWebmaster" startspan -->schaffer@smartlink.net<!--webbot
bot="Substitution" endspan i-checksum="61567" --></a> with
questions or comments about this web site.<br>
Last modified: <!--webbot bot="TimeStamp" s-type="EDITED"
s-format="%B %d, %Y" startspan -->August 20, 1996<!--webbot
bot="TimeStamp" endspan i-checksum="22495" --></h5>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-223</DOCNO>
<DOCOLDNO>IA087-000632-B013-192</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/pr02.htm 206.61.184.43 19970122090553 text/html 3951
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:05:47 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Monday, 16-Dec-96 04:58:30 GMT
Content-length: 3736
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>DrugLibrary.org Press Release 2</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body background="images/whttxtr2.jpg" bgcolor="#f2f2f2"
stylesrc="_private/style.htm">
<!--webbot bot="Include" tag="BODY"
u-include="_private/logo.htm" startspan -->

<p align="center"><font color="#0000FF"><font size="5"><em>DRCNet
Online Library of Drug Policy </em></font></font></p>
<!--webbot bot="Include" endspan i-checksum="58446" -->

<h1> Press Release 2</h1>
<!--webbot bot="Include" tag="BODY"
u-include="_private/navbar.htm" startspan -->

<p><a href="index.htm"><img src="images/bhome.gif"
alt="[Home Icon]" border="0" width="56" height="14"></a><a
href="news.htm"><img src="images/bnews.gif"
alt="[What's New Icon]" border="0" width="58" height="14"></a><a
href="toc.htm"><img src="images/btoc.gif" alt="[TOC Icon]"
border="0" width="60" height="14"></a><a href="feedback.htm"><img
src="images/bfeed.gif" alt="[Feedback Icon]" border="0"
width="59" height="14"></a><a
href="http://www.druglibrary.org/srchform.html"><img
src="images/bsrch.gif" alt="[Search Icon]" border="0" width="58"
height="14"></a></p>
<!--webbot bot="Include" endspan i-checksum="35058" -->

<p> <img src="images/undercon.gif" alt="[Under Construction]"
border="0" width="40" height="38"></p>

<p> <strong><em>FOR IMMEDIATE RELEASE</em></strong></p>

<hr>

<h1>Title of Announcement</h1>

<h3><em>Subtitle of announcement</em></h3>

<p> <strong>Today's Date</strong> -- This is the body of the
announcement ...</p>

<hr>

<p> <em>For More Information Contact:</em><br>
<br>
<!--webbot bot="Substitution" s-variable="CompanyLongName"
startspan -->DRCNet Online Library of Drug Policy<!--webbot
bot="Substitution" endspan i-checksum="25634" --><br>
<!--webbot bot="Substitution" s-variable="CompanyAddress"
startspan -->P.O. Box 1430<!--webbot bot="Substitution" endspan
i-checksum="27458" --><br>
Tel: <!--webbot bot="Substitution" s-variable="CompanyPhone"
startspan -->805-251-4140<!--webbot bot="Substitution" endspan
i-checksum="12858" --><br>
FAX: <!--webbot bot="Substitution" s-variable="CompanyFAX"
startspan -->805-251-4140<!--webbot bot="Substitution" endspan
i-checksum="12858" --><br>
Internet: <a href="mailto:schaffer@smartlink.net"><!--webbot
bot="Substitution" s-variable="CompanyEmail" startspan -->schaffer@smartlink.net<!--webbot
bot="Substitution" endspan i-checksum="61567" --></a><br>
</p>
<!--webbot bot="Include" tag="BODY"
u-include="_private/navbar.htm" startspan -->

<p><a href="index.htm"><img src="images/bhome.gif"
alt="[Home Icon]" border="0" width="56" height="14"></a><a
href="news.htm"><img src="images/bnews.gif"
alt="[What's New Icon]" border="0" width="58" height="14"></a><a
href="toc.htm"><img src="images/btoc.gif" alt="[TOC Icon]"
border="0" width="60" height="14"></a><a href="feedback.htm"><img
src="images/bfeed.gif" alt="[Feedback Icon]" border="0"
width="59" height="14"></a><a
href="http://www.druglibrary.org/srchform.html"><img
src="images/bsrch.gif" alt="[Search Icon]" border="0" width="58"
height="14"></a></p>
<!--webbot bot="Include" endspan i-checksum="35058" -->

<h5> Send mail to <a href="mailto:schaffer@smartlink.net"><!--webbot
bot="Substitution" s-variable="CompanyWebmaster" startspan -->schaffer@smartlink.net<!--webbot
bot="Substitution" endspan i-checksum="61567" --></a> with
questions or comments about this web site.<br>
Last modified: <!--webbot bot="TimeStamp" s-type="EDITED"
s-format="%B %d, %Y" startspan -->August 20, 1996<!--webbot
bot="TimeStamp" endspan i-checksum="22495" --></h5>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-224</DOCNO>
<DOCOLDNO>IA087-000632-B013-220</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/pr03.htm 206.61.184.43 19970122090604 text/html 3951
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:05:56 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Monday, 16-Dec-96 04:58:27 GMT
Content-length: 3736
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>DrugLibrary.org Press Release 3</title>
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body background="images/whttxtr2.jpg" bgcolor="#f2f2f2"
stylesrc="_private/style.htm">
<!--webbot bot="Include" tag="BODY"
u-include="_private/logo.htm" startspan -->

<p align="center"><font color="#0000FF"><font size="5"><em>DRCNet
Online Library of Drug Policy </em></font></font></p>
<!--webbot bot="Include" endspan i-checksum="58446" -->

<h1> Press Release 3</h1>
<!--webbot bot="Include" tag="BODY"
u-include="_private/navbar.htm" startspan -->

<p><a href="index.htm"><img src="images/bhome.gif"
alt="[Home Icon]" border="0" width="56" height="14"></a><a
href="news.htm"><img src="images/bnews.gif"
alt="[What's New Icon]" border="0" width="58" height="14"></a><a
href="toc.htm"><img src="images/btoc.gif" alt="[TOC Icon]"
border="0" width="60" height="14"></a><a href="feedback.htm"><img
src="images/bfeed.gif" alt="[Feedback Icon]" border="0"
width="59" height="14"></a><a
href="http://www.druglibrary.org/srchform.html"><img
src="images/bsrch.gif" alt="[Search Icon]" border="0" width="58"
height="14"></a></p>
<!--webbot bot="Include" endspan i-checksum="35058" -->

<p> <img src="images/undercon.gif" alt="[Under Construction]"
border="0" width="40" height="38"></p>

<p> <strong><em>FOR IMMEDIATE RELEASE</em></strong></p>

<hr>

<h1>Title of Announcement</h1>

<h3><em>Subtitle of announcement</em></h3>

<p> <strong>Today's Date</strong> -- This is the body of the
announcement ...</p>

<hr>

<p> <em>For More Information Contact:</em><br>
<br>
<!--webbot bot="Substitution" s-variable="CompanyLongName"
startspan -->DRCNet Online Library of Drug Policy<!--webbot
bot="Substitution" endspan i-checksum="25634" --><br>
<!--webbot bot="Substitution" s-variable="CompanyAddress"
startspan -->P.O. Box 1430<!--webbot bot="Substitution" endspan
i-checksum="27458" --><br>
Tel: <!--webbot bot="Substitution" s-variable="CompanyPhone"
startspan -->805-251-4140<!--webbot bot="Substitution" endspan
i-checksum="12858" --><br>
FAX: <!--webbot bot="Substitution" s-variable="CompanyFAX"
startspan -->805-251-4140<!--webbot bot="Substitution" endspan
i-checksum="12858" --><br>
Internet: <a href="mailto:schaffer@smartlink.net"><!--webbot
bot="Substitution" s-variable="CompanyEmail" startspan -->schaffer@smartlink.net<!--webbot
bot="Substitution" endspan i-checksum="61567" --></a><br>
</p>
<!--webbot bot="Include" tag="BODY"
u-include="_private/navbar.htm" startspan -->

<p><a href="index.htm"><img src="images/bhome.gif"
alt="[Home Icon]" border="0" width="56" height="14"></a><a
href="news.htm"><img src="images/bnews.gif"
alt="[What's New Icon]" border="0" width="58" height="14"></a><a
href="toc.htm"><img src="images/btoc.gif" alt="[TOC Icon]"
border="0" width="60" height="14"></a><a href="feedback.htm"><img
src="images/bfeed.gif" alt="[Feedback Icon]" border="0"
width="59" height="14"></a><a
href="http://www.druglibrary.org/srchform.html"><img
src="images/bsrch.gif" alt="[Search Icon]" border="0" width="58"
height="14"></a></p>
<!--webbot bot="Include" endspan i-checksum="35058" -->

<h5> Send mail to <a href="mailto:schaffer@smartlink.net"><!--webbot
bot="Substitution" s-variable="CompanyWebmaster" startspan -->schaffer@smartlink.net<!--webbot
bot="Substitution" endspan i-checksum="61567" --></a> with
questions or comments about this web site.<br>
Last modified: <!--webbot bot="TimeStamp" s-type="EDITED"
s-format="%B %d, %Y" startspan -->August 20, 1996<!--webbot
bot="TimeStamp" endspan i-checksum="22495" --></h5>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-225</DOCNO>
<DOCOLDNO>IA087-000632-B013-168</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/search.htm 206.61.184.43 19970122090544 text/html 3461
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:05:37 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Monday, 16-Dec-96 04:58:21 GMT
Content-length: 3246
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>DrugLibrary.org Text Search Page</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 2.0">
</head>

<body background="images/whttxtr2.jpg" bgcolor="#f2f2f2"
stylesrc="_private/style.htm">
<!--webbot bot="Include" u-include="_private/logo.htm"
tag="BODY" startspan -->

<p align="center"><font color="#0000FF"><font size="5"><em>DRCNet
Online Library of Drug Policy </em></font></font></p>
<!--webbot bot="Include" endspan i-checksum="58446" -->

<p><img src="images/hsrch.gif" alt="[Page Banner Image]"
align="bottom" width="472" height="48"> </p>
<!--webbot bot="Include" tag="BODY"
u-include="_private/navbar.htm" startspan -->

<p><a href="index.htm"><img src="images/bhome.gif"
alt="[Home Icon]" border="0" width="56" height="14"></a><a
href="news.htm"><img src="images/bnews.gif"
alt="[What's New Icon]" border="0" width="58" height="14"></a><a
href="toc.htm"><img src="images/btoc.gif" alt="[TOC Icon]"
border="0" width="60" height="14"></a><a href="feedback.htm"><img
src="images/bfeed.gif" alt="[Feedback Icon]" border="0"
width="59" height="14"></a><a
href="http://www.druglibrary.org/srchform.html"><img
src="images/bsrch.gif" alt="[Search Icon]" border="0" width="58"
height="14"></a></p>
<!--webbot bot="Include" endspan i-checksum="35058" -->

<p>You may search our web site for all documents containing
matching words or patterns.</p>
<!--webbot bot="Search" s-index="All" s-dsn="default"
s-fields="TimeStamp,DocumentK" s-text="Search for:" i-size="20"
s-submit="Start Search" s-clear="Reset" startspan -->

<form action="_vti_bin/shtml.exe/search.htm" method="POST">
    <input type="hidden" name="VTI-GROUP" value="0"><p><b>Search
    for: </b><input type="text" name="search" size="20" value></p>
    <p><input type="submit" value="Start Search"><input
    type="reset" value="Reset"></p>
</form>
<!--webbot bot="Search" endspan i-checksum="35488" --><!--webbot
bot="Include" tag="BODY" u-include="_private/navbar.htm"
startspan -->

<p><a href="index.htm"><img src="images/bhome.gif"
alt="[Home Icon]" border="0" width="56" height="14"></a><a
href="news.htm"><img src="images/bnews.gif"
alt="[What's New Icon]" border="0" width="58" height="14"></a><a
href="toc.htm"><img src="images/btoc.gif" alt="[TOC Icon]"
border="0" width="60" height="14"></a><a href="feedback.htm"><img
src="images/bfeed.gif" alt="[Feedback Icon]" border="0"
width="59" height="14"></a><a
href="http://www.druglibrary.org/srchform.html"><img
src="images/bsrch.gif" alt="[Search Icon]" border="0" width="58"
height="14"></a></p>
<!--webbot bot="Include" endspan i-checksum="35058" -->

<h5>Send mail to <a href="mailto:schaffer@smartlink.net"><!--webbot
bot="Substitution" s-variable="CompanyWebmaster" startspan -->schaffer@smartlink.net<!--webbot
bot="Substitution" endspan i-checksum="61567" --></a> with
questions or comments about this web site.<br>
Last modified: <!--webbot bot="TimeStamp" s-type="EDITED"
s-format="%B %d, %Y" startspan -->September 30, 1996<!--webbot
bot="TimeStamp" endspan i-checksum="39056" --></h5>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-226</DOCNO>
<DOCOLDNO>IA087-000632-B039-223</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/ceoma.html 206.61.184.43 19970122071613 text/html 3128
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:16:08 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:01:05 GMT
Content-length: 2913
</DOCHDR>
<html>
<head>
   <title>Carl E. Olsen's Marijuana Archive</title>
   <meta name="GENERATOR" content="Mozilla/3.0b3Gold (Win32)">
</head>
<body bgcolor="#FFFFFF" link="#0000FF" vlink="#FF0000" alink="#FF00FF">
<!---Another DosRios Page 03-18-96 --->
<table BORDER="0" CELLPADDING="0" CELLSPACING="0" VALIGN="TOP">
<tr>
<td>
<img src="carl-ia.jpg" border=0 height=372 width=400 align=top>
</td>
<td align="top">
<h1 align=center><b>Welcome to my Marijuana Archive!</b></h1>
<center><p>
<a href="http://www.pointcom.com/"><img src="5perclgt.gif" border=0 height=118 width=120 align=bottom></a><a href="http://www.eff.org/blueribbon.html"><img src="blu_ribn.gif" border=0 height=110 width=70 align=top></a></p></center>
</td>
</tr>
</table><p>
<hr>Since June 10 1996 I have had <img src="/cgi-bin/Count.cgi?df=olsen.index.html.count" alt="graphic counter" border=0 >visitorsto this page (not including the sub-pages)... <hr></p>
<H2><IMG SRC=reddot.gif> <A href="DEA/dea.html">Olsen v. DEA (No. 94-1605)</A></H2>
<H2><IMG SRC=reddot.gif> <A href="MEDICAL/medical.html">Marijuana as a Medicine</A></H2>
<H2><IMG SRC=reddot.gif> <A href="COPTIC/coptic.html">Ethiopian Zion Coptic Church</A></H2>
<H2><IMG SRC=reddot.gif> <A href="RELIGION/religion.html">Free exercise of religion</A></H2>
<H2><IMG SRC=reddot.gif> <A href="HEMP/hemp.html">Hemp as an Industrial and Food Resource</A></H2>
<H2><IMG SRC=reddot.gif> <A href="DPF/dpf.html">Drug Policy Forum of Iowa</A></H2>
<H2><IMG SRC=reddot.gif> <A href="NORML/norml.html">Iowa NORML</A></H2>
<H2><IMG SRC=reddot.gif> <A href="LPI/lpi.html">Libertarian Party of Iowa</A></H2>
<H2><IMG SRC=reddot.gif> <A href="WAR/war.html">The War on Drugs</A></H2>
<H2><IMG SRC=reddot.gif> <A href="COMMON/common.html">Emergency War Powers</A></H2>
<H2><IMG SRC=reddot.gif> <A href="LINKS/links.html">Links to other sources of information</A></H2>
<hr><table cellspacing=5 cellpadding=5><tr><td><a href="http://www.druglibrary.org/"><img src="drcglobe.gif" border=0 height=90 width=100></a></td><td><h3><a href="http://www.druglibrary.org/" target="_top">Schaffer DRCNet:</a><p><a href="http://www.druglibrary.org/" target="_top"> World's LargestOnline Drug Policy Information Center</a><h3></p></td></tr></table>
<center><hr width="100%" ><font SIZE=+4>Want to get active?<br>Here's how:<br><a href="http://www.drcnet.org/map/">Media Awareness Project (MAP)</a></font></center>
<hr width="100%" >Special thanks to our host:
<h2><img src="reddot.gif" border=0 height=14 width=14><a href="http://www.calyx.com/">Calyx Internet Access</a></h2><p>
<hr></p><h4>Please send your comments regarding this page to: <a href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a></h4><p><hr></p><address>Carl E. Olsen - carl@mail.commonlink.com<br>P.O. Box 4091, Des Moines, IA 50333<br>(515) 262-6957 voice and fax </address><p><hr></p></body></html>
</DOC>
<DOC>
<DOCNO>WT01-B18-227</DOCNO>
<DOCOLDNO>IA087-000632-B039-242</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/dea.html 206.61.184.43 19970122071625 text/html 4453
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:16:15 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:15 GMT
Content-length: 4238
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="AUTHOR" content="Carl E. Olsen">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Olsen v. DEA, No. 94-1605 (Marijuana Scheduling)</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" link="#0000FF"
vlink="#800080" alink="#FF0000">

<h1>Olsen v. DEA, No. 94-1605 <br>
U.S. Court of Appeals, D.C. Circuit</h1>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="mckinney.html">Interview with Laurence O. McKinney - July
20, 1991</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="bonner-1.html">Olsen's Letter to the DEA - July 21, 1992</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="bonner-2.html">Administrator Bonner's response to Olsen's
Letter - August 17, 1992</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="bonner-3.html">Olsen's Petition to Reschedule Marijuana - September
6, 1992</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="bonner-4.html">Olsen's Statement of Grounds for
Rescheduling - September 6, 1992</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="bonner-5.html">DEA's Final Ruling - October 23, 1992</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="davis-1.html">FDA's Letter to Olsen - June 13, 1993</a> </h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="BRIEF/brief.html">Olsen's Brief to the U.S. Court of
Appeals - August 3, 1993</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="remand-m.html">DEA's Motion for Remand - September 15, 1993</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="remand-r.html">Olsen's Response to Motion for Remand -
September 21, 1993</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="dea-hark.html">DEA's Letter to U.S. Senator Tom Harkin - November
17, 1993</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="dea-gras.html">DEA's Letter to U.S. Senator Charles
Grassley - November 23, 1993</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="davis-2.html">FDA's Letter to Olsen - December 2, 1993</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="ruling.html">DEA's Final Ruling - May 16, 1994</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="issues.html">Olsen's Statement of the Issues to be raised
on Review - October 2, 1994</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="shulgin.html">THC Chemistry by Alexander Shulgin - January
21, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="order.html">ORDER of the Court - August 25, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="BRIEF2/brief2.html">Olsen's Brief to the U.S. Court of
Appeals - September 18, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="dea95-1.html">DEA's Brief to the U.S. Court of Appeals -
November 6, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="reply95.html">Olsen's Reply Brief to the U.S. Court of
Appeals - December 4, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="order2.html">ORDER of the Court - September 19, 1996</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="order3.html">ORDER of the Court - October 3, 1996</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="allison.html">Preparatory notes for U.S. Supreme Court
review - November 22, 1996</a></h4>

<hr>

<address>
    Carl E. Olsen - carl@mail.commonlink.com<br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 262-6957 voice and fax 
</address>

<hr>

<p><a href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a> </p>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-228</DOCNO>
<DOCOLDNO>IA087-000632-B042-179</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/medical.html 206.61.184.43 19970122072343 text/html 9025
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:23:36 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:49 GMT
Content-length: 8810
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Marijuana as a Medicine</title>
</head>

<body bgcolor="#FFFFFF" link="#0000FF" vlink="#FF0000"
alink="#FF00FF">

<h1 align="center">Marijuana as a medicine <img
src="../images/medmj.gif" align="absmiddle" width="64"
height="72"></h1>

<hr>

<h4 align="center"><blink>NEW</blink><br>
<a href="caprop215.html">Proposition 215 - California Voters
Legalize Medical Marijuana by 56% to 44%</a><br>
<a href="azprop200.html">Proposition 200 - Arizona Voters
Legalize Medical Marijuana by 65% to 35%</a></h4>

<hr>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="IOWA/iowa.html">Iowans for Medical Marijuana</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="HELMERS/helmers.html">State of Iowa v. Allen Helmers</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="../DPF/dpf.html">Drug Policy Forum of Iowa - Iowa
candidates support medical marijuana</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="ACT/act.html">The Alliance for Cannabis Therapeutics</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="POT/pot.html">Patients Out of Time - Marijuana as Medicine</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="YOUNG/young.html">DEA Judge Francis L. Young's ruling -
September 6, 1988</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="jenks.html">Jenks v. State, 582 So.2d 676 - Florida, June
13, 1991</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="safer.html">CBS Sixty Minutes (&quot;Smoking to Live&quot;)
- December 1, 1991</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="spyker.html">Declaration of Dr. Daniel Spyker, Food and
Drug Admin. - June 16, 1993</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="monkey.html">National Center for Toxicological Research -
Arkansas Times - September 16, 1993</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="paule.html">National Center for Toxicological Research -
Published Journal Articles</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="grubor00.html">Grubor v. Pennsylvania - February 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="leshner.html">Nat'l Institute on Drug Abuse (NIDA) rejects
AIDS/marijuana study - April 19, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="abrams.html">AIDS researcher, Dr. Donald Abrams, is
critical of NIDA ruling - April 28, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="west.html">San Jose Mercury News - May 14, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="lester.html">Journal of the American Medical Association -
June 21, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="nida.html">Nat'l Institute on Drug Abuse Anti-Marijuana
Conference - July 18, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="seeley.html">Ralph Seeley v. The State of Washington -
August 25, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="nejm.html">New England Jounal of Medicine - Sept. 7, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="grubor.html">Grubor v. Pennsylvania - October 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="apha.html">American Public Health Association - November
1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="hr2618.html">H.R. 2618 - therapeutic use of marijuana -
Nov. 10, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="lancet.html">The Lancet - November 11, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="weld.html">The Boston Globe - Pot, a balm to some, faces
new hurdle - Nov. 25, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="pate.html">Potential medical uses of Cannabis, by David W.
Pate - December 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="bmj.html">British Medical Journal - December 23-30, 1995</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="washing.html">State of Washington funds medical marijuana
study - March 8, 1996</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="cbd.html">Cannabidiol: The Wonder Drug of the 21st Century?
- May 25, 1996</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="../DEA/dea.html">Olsen v. DEA - U.S. Court of Appeals -
October 1996</a></h4>

<hr>

<h1>Links to other sources of information</h1>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.gnv.fdt.net/~jrdawson/lawsuit.htm">Compassionate
Class Action for Medicalization of Marijuana</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.acu.org/">Americans for Compassionate Use</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.medicalmarijuana.org/">Compassionate Use Act of
1996</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.prop215.org/">Medical Marijuana Initiative
Proposition 215</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www2.alpworld.com/HEALTH/Prop_215/index.html">Steve
Kubby's Medical Marijuana Page (Proposition 215)</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.trvnet.net/~mmcmahon/">George McMahon, One of
eight patients in the federal medical marijuana program</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.majority.com">Republicans for Medical Marijuana
in California</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.natlnorml.org/medical/medmj.shtml">National
NORML's Medical Marijuana Page</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.calyx.com/~normlca/medical.html">NORML Canada's
Medical Marijuana Page</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.calyx.net/~schaffer/medical_mj.htm">Cliff
Schaffer's Medical Marijuana Page</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.mpp.org/~mpp/MAPS.html">Rick Doblin, MAPS,
responds to NIDA ruling - April 27, 1995</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.soros.org/lindesmith/exposing/exposing.html">Exposing
Marijuana Myths - The Lindesmith Center</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.dts.org/BRXCGBC/">Berkeley's Rx. Cannabis
Growers and Buyers Club</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.newday.com/cgi-bin/NewDay/showfilm?Let_Our_People_Grow">Let
Our People Grow - a film by Suzanne Girot</a></h4>

<hr>

<p align="center"><a href="http://www.pointcom.com/"><img
src="../images/5perclgt.gif" width="120" height="118"></a> </p>

<hr>

<p>This site has been reviewed and rated by The McKinley Group's
professional editorial team, and listed in Magellan, a
comprehensive Internet directory of over 1.5 million sites and
40,000 reviews.</p>

<p align="center"><a href="http://www.mckinley.com/"><img
src="../images/backlink.gif" width="66" height="70"></a> </p>

<form action="http://www.mckinley.com/mckinley-cgi/iopcode.pl"
method="POST">
    <p><b>Enter Query: </b><input type="text" size="45"
    name="query"> <input type="submit" value="Search Magellan"> </p>
    <p><a
    href="http://www.mckinley.com/mckinley-cgi/advsearch.pl">(Click
    here for search options)</a> </p>
    <hr>
    <address>
        Carl E. Olsen - carl@mail.commonlink.com<br>
        P.O. Box 4091, Des Moines, IA 50333<br>
        (515) 262-6957 voice and fax 
    </address>
    <hr>
    <h4>Please send your comments regarding this page to: <a
    href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a></h4>
    <hr>
</form>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-229</DOCNO>
<DOCOLDNO>IA087-000632-B043-131</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/COPTIC/coptic.html 206.61.184.43 19970122072527 text/html 3076
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:25:15 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:07:15 GMT
Content-length: 2861
</DOCHDR>
<html>

<head>
<title>Ethiopian Zion Coptic Church</title>
<meta name="AUTHOR" contents="Olsen, Carl">
<meta name="DATE" contents="1996">
<meta name="SUMMARY" contents="sacramental marijuana">
<meta name="KEYWORDS" contents="Coptic, Rastafari, ganja">
</head>

<body bgcolor="#FFFFFF" link="#0000FF" vlink="#FF0000"
alink="#FF00FF">

<h1>Ethiopian Zion Coptic Church</h1>

<h4><img src="../images/reddot.gif"> <a href="wells2.html">History
of the Ethiopian Zion Coptic Church by Walter Wells (1978)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="wells1.html">Letter
from Walter Wells to the Miami Herald (1978)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="GARVEY/garvey.html">The
Opinions of Marcus Garvey</a></h4>

<h4><img src="../images/reddot.gif"> <a href="sixtymin.html">CBS
Sixty Minutes (&quot;Holy Smoke&quot;) (October 28, 1979)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="tropic.html">Tropic
Magazine (&quot;Louv Story&quot;) (August 2, 1981)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="cir-11th.html">United
States v. Middleton, 690 F.2d 820 (11th Cir. 1982)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="cir-1st.html">United
States v. Rush, 738 F.2d 497 (1st Cir. 1984)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="court-ia.html">State
v. Olsen, No. 171-69079 (Iowa July 18, 1984)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="ginsburg.html">Olsen
v. DEA, 878 F.2d 1458 (D.C. Cir. 1989)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="MAZUR/mazur.html">Notre
Dame Journal of Law, Ethics &amp; Public Policy (Vol 5, No. 3,
1991)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="ganjaman.html">Panama
City News Herald (&quot;The Ganja Man&quot;) (September 4, 1994)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="peck.html">Appellant's
Brief, California v. Peck, No. E016630 (April 4, 1996)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="peck-rb.html">Respondent's
Brief, California v. Peck, No. E016630 (June 4, 1996)</a></h4>

<h4><img src="../images/reddot.gif"> <a href="mikuriya.html">So
much for the First Amendment, by Todd Mikuriya (April 21, 1996)</a></h4>

<hr>
<center>

<h3><a href="LETTERS/letters.html">CORRESPONDENCE</a></h3>
</center>

<hr>

<h1>Links to other sources of information</h1>

<h4><img src="../images/purpcube.gif"> <a
href="http://home.earthlink.net/~tkezele">Our Church Home Page</a></h4>

<h4><img src="../images/purpcube.gif"> <a
href="http://www.magmacom.com/~ourchrch/">Our Church (Canada)</a></h4>

<hr>

<address>
    Carl E. Olsen - <a href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a><br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 262-6957 voice and fax 
</address>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-230</DOCNO>
<DOCOLDNO>IA087-000631-B004-28</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/RELIGION/religion.html 206.61.184.43 19970122073621 text/html 2344
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:35:58 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:38:17 GMT
Content-length: 2129
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="AUTHOR" content="Carl E. Olsen">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Free Exercise of Religion</title>
</head>

<body bgcolor="#000000" text="#FFFFFF" link="#00FF66"
vlink="#00FFFF" alink="#FF3300">

<h1>Free exercise of religion</h1>

<p><img src="../images/reddot.gif" width="14" height="14"> <a
href="boyll.html">New Mexico Court protects peyote use by
non-Indian: 1991</a> </p>

<p><img src="../images/reddot.gif" width="14" height="14"> <a
href="rfra.html">Religious Freedom Restoration Act (RFRA) of 1993</a> </p>

<p><img src="../images/reddot.gif" width="14" height="14"> <a
href="airfaa.html">American Indian Religious Freedom Act
Amendments (AIRFAA) of 1994</a> </p>

<p><img src="../images/reddot.gif" width="14" height="14"> <a
href="103-675.html">Legislative History of AIRFAA: House Report
103-675</a> </p>

<p><img src="../images/reddot.gif" width="14" height="14"> <a
href="flores.html">Texas Court rules RFRA unconstitutional: March
13, 1995</a> </p>

<p><img src="../images/reddot.gif" width="14" height="14"> <a
href="BROWN/brown.html">United States v. Tom Brown - July 18,
1995</a></p>

<p><img src="../images/reddot.gif" width="14" height="14"> <a
href="BROWN/brown-04.html">United States v. Tom Brown - December
12, 1995</a></p>

<p><img src="../images/reddot.gif" width="14" height="14"> <a
href="flores2.html">High Court To Rule on Religion Law - October
16, 1996</a></p>

<hr>

<h1>Links to other sources of information</h1>

<p><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.student.lu.se/~reh94sve/sven.html">The Christian
Link Collection</a></p>

<hr>

<address>
    Carl E. Olsen - carlolsen@mail.commonlink.com<br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 262-6957 voice and fax 
</address>

<hr>

<p><a href="mailto:carlolsen@mail.commonlink.com">carlolsen@mail.commonlink.com</a> </p>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-231</DOCNO>
<DOCOLDNO>IA087-000631-B005-133</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/HEMP/hemp.html 206.61.184.43 19970122073941 text/html 4768
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:39:31 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:25:45 GMT
Content-length: 4553
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Hemp as an Industrial and Food Resource</title>
</head>

<body bgcolor="#FFFFFF" link="#0000FF" vlink="#FF0000"
alink="#FF00FF">

<h1 align="center">Hemp as an Industrial and Food Resource</h1>

<hr>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="IHA/iha.html">International Hemp Association</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="fuel.html">Irish have high hopes for cannabis, fuel of the
future</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="CROP/crop.html">Hemp as a crop for Missouri farmers (1991)</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="biblio.html">Hemp Bibliography by Eric Skidmore</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="rose-001.html">Hemp Foods ... Beyond the Soybean</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="newhempr.html">Boulder Hemp Initiative Project - Industrial
Hemp</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="register.html">Des Moines Register: Revival of hemp
industry at hand? (July 7, 1996)</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="fiber.html">Hemp Fiber</a></h4>

<hr>

<h1>Links to other Sources of Information</h1>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.hemptimes.com/hspp/index.html">Hemp, Science
&amp; Public Policy by Jon Gettman</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.welcomehome.org/cohip.html">Colorado Hemp
Initiative Project</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://pressenter.pressenter.com/~davewest/AAmyhomepage.htm">Dr.
Dave's Hemp Archives</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.indirect.com/www/chaptrk/cha1.html">Coalition
for Hemp Awareness Hemp Page</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.hempbc.com/Overview.html">An Overview of
hempbc.com</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.crl.com/~hemplady/">HempWorld Magazine</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.wwdc.com:80/~hemp/">Chris Clay's Hemp Nation
HeadQuarters (Canada)</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://fub46.zedat.fu-berlin.de:8080/~dawn/hemp/hemp9100.htm">Hemp
Museum - Berlin</a></h4>

<hr>

<h1>Commercial Links</h1>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.hempery.com">Ohio Hempery</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://fornits.com/curiosity/insthemp/here.html">The
Institute for Hemp</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://ecolution.com/">ECOLUTION Cyber Hemp</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.dlcwest.com/~barbaron/hemp.html">Highwear Hemp
Clothing</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.compulink.co.uk/~hemp/">New Earth -- HEMP</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.efn.org/~gordon_k/HungryBear.html">Hungry Bear
Hemp Foods Home Page</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.leonardo.net/frameworks/clients/hemptdr/hemptdrhtml/hemptdr.html">HEMP
TRADERS' HOME PAGE: Hemp fabrics, Hemp textiles</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.rella.com/">HempRella</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.nootopia.com/hoh/">House of Hemp</a></h4>

<hr>

<h4>Please send your comments regarding this page to: <a
href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a></h4>

<hr>

<address>
    Carl E. Olsen - carlolsen@mail.commonlink.com<br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 243-7351 voice and fax 
</address>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-232</DOCNO>
<DOCOLDNO>IA087-000631-B011-6</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DPF/dpf.html 206.61.184.43 19970122075237 text/html 1335
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:52:28 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:13:02 GMT
Content-length: 1120
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Drug Policy Forum of Iowa</title>
</head>

<body bgcolor="#FFFFFF" link="#0000FF" vlink="#FF0000"
alink="#FF00FF">

<h1>Drug Policy Forum of Iowa</h1>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="SURVEY/survey.html">1996 Survey of Candidates' Views on
Drug Policy</a></h4>

<hr>

<h1>Links to other sources of information</h1>

<p><h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.niad.nl/fc1uk.htm">Dutch Cannabis Policy</a></h4></p>

<p><h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.olywa.net/when/main.html">Compare Legal Drugs
with Illegal Drugs</a></h4></p>

<hr>

<address>
    Carl E. Olsen - <a href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a><br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 262-6957 voice and fax 
</address>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-233</DOCNO>
<DOCOLDNO>IA087-000631-B046-130</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/NORML/norml.html 206.61.184.43 19970122082150 text/html 2791
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 08:21:42 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:36:24 GMT
Content-length: 2576
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="author" content="Iowa NORML">
<meta name="date" content="1996">
<meta name="summary" content="Iowa NORML's Web Site">
<meta name="keywords"
content="NORML, Marijuana, marijuana, Cannabis, cannabis, Hemp, hemp">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Iowa NORML</title>
</head>

<body bgcolor="#FFFFFF" link="#0000FF" vlink="#FF00FF"
alink="#FF0000">

<p align="center"><font size="7"><b>Iowa NORML</b></font> <br>
<font size="4">Affiliate of the</font> <br>
<a href="http://www.natlnorml.org/"><font size="5"><b>National
Organization for the Reform of Marijuana Laws</b></font></a><font
size="5"><b> </b></font></p>

<h3 align="center">Post Office Box 4091 <br>
Des Moines, Iowa 50333 <br>
phone (515) 262-6957 / fax (515) 262-6957 <br>
http://www.commonlink.com/~olsen/NORML/norml.html <br>
<a href="mailto:iowanorml@commonlink.com">iowanorml@commonlink.com</a></h3>

<hr>

<h4><img src="../images/reddot.gif" width="14" height="14"><a
href="WEEKLY96/weekly96.html">1996 National NORML's Weekly Media
Releases</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"><a
href="WEEKLY95/weekly95.html">1995 National NORML's Weekly Media
Releases</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"><a
href="LAWS/laws.html">Iowa Legislation and Judicial Rulings</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"><a
href="PETITIONS/petitions.html">Petitions to Reschedule Marijuana</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"><a
href="QCHC/qchc.html">Quad Cities Hemp Coalition</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"><a
href="LETTERS/letters.html">Letters from Politicians, Readers and
P.O.W.s</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"><a
href="LINKS/links.html">Links to other NORML groups and
information</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"><a
href="/~olsen/">Carl E. Olsen's Marijuana Archive</a></h4>

<hr>

<h4>Please send your comments regarding this page to: <a
href="mailto:iowanorml@commonlink.com">iowanorml@commonlink.com</a></h4>

<hr>

<address>
    Carl E. Olsen - <a href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a> <br>
    P.O. Box 4091, Des Moines, IA 50333 <br>
    (515) 262-6957 voice and fax 
</address>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-234</DOCNO>
<DOCOLDNO>IA087-000632-B011-90</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/LPI/lpi.html 206.61.184.43 19970122085728 text/html 1674
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 08:57:23 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:48:04 GMT
Content-length: 1459
</DOCHDR>
<HTML>
<HEAD><TITLE>Libertarian Party of Iowa</TITLE>
</HEAD>
<BODY BGCOLOR="#800000" TEXT="#FFFF00" LINK="#00FF00" VLINK="#FF0000" ALINK="#FF00FF">
<BASEFONT SIZE=+1>
<CENTER><FONT SIZE=+3><B>Libertarian Party of Iowa
<BR>(LPI)</B></FONT></CENTER>
<BR><CENTER><FONT  SIZE=+2><B>Reaching your LPI Officers</B></FONT></CENTER>
<BR><FONT SIZE=+1 FACE="Arial, Helvetica">Libertarian Party of Iowa
<BR>P.O. Box 7256
<BR>Des Moines, Iowa 50309</FONT>
<BR>
<FONT FACE="Arial, Helvetica"><UL>
<LI>Libertarians in Action
<BR> State Newsletter
<BR>P.O. Box 1041
<BR>Waterloo, Iowa 50704
<P><LI>Dick Kruse
<BR>Chair
<BR>P.O. Box 2282
<BR>Ames, Iowa 50010-2282
<BR>515-268-1962
<P><LI>Tim Hird
<BR>Treasurer
<BR>P.O. Box 7256
<BR>Des Moines, Iowa 50309
<BR>515-285-7942
<P><LI>Carl Olsen
<BR>Secretary
<BR>P.O. Box 4091
<BR>Des Moines, Iowa 50333
<BR>515-262-6957
<P><LI>Randy Herod
<BR>News Letter Editor
<BR>P.O. Box 1041
<BR>Waterloo, Iowa 50704
<BR>319-235-9660
<P><LI>John Hartog
<BR>Executive Committee
<BR>515-262-4660
<P><LI>Gerald Carroll
<BR>Executive Committee
<BR>319-354-2433
<P><LI>Mark Hagerman
<BR>Executive Committee
<BR>515-277-3204
</FONT></UL></h4>
<CENTER><H4><A HREF="links.html">LIBERTARIAN LINKS</A></H4></CENTER>
<address>Carl E. Olsen - <A HREF=mailto:carl@dsmnet.com>carl@dsmnet.com</A>
<br>P.O. Box 4091, Des Moines, IA 50333
<br>(515) 262-6957 voice and fax
</address><hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-235</DOCNO>
<DOCOLDNO>IA087-000632-B011-145</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/WAR/war.html 206.61.184.43 19970122085809 text/html 6086
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 08:57:58 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:42:16 GMT
Content-length: 5871
</DOCHDR>
<html>

<head>
<title>War on Drugs</title>
</head>

<body bgcolor="#FFFFFF" link="#0000FF" vlink="#FF0000"
alink="#FF00FF">

<h1>The War on Drugs</h1>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="../images/reefer.jpg">1930s &quot;Reefer
Madness&quot; poster</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="ketchika.html">Alaska trial court overrules
marijuana law (Oct. 29, 1993)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="conrad.html">Chris Conrad (May 12, 1995)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="ERIC/eric.html">Eric Sterling (May 15, 1995)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="padavich.html">Christopher F. Padavich (June
26, 1995)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="paul.html">Paul Westmoreland (July 4, 1995)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="brown-01.html">Tom Brown - Our Church (July
31, 1995)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="sense.html">A common-sense judge - Des Moines
Regisiter Editorial (Sept. 5, 1995)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="trimble.html">DARE cop busted for meth - Des
Moines Regisiter (January 2, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="trimble1.html">DARE cop busted for meth #2 -
Des Moines Regisiter (January 3, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="trimble2.html">DARE cop busted for meth #3 -
Des Moines Regisiter (January 3, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="roderick.html">Roderick T. Harvey (January
21, 1996)</a></h4>

<h4><img src="../images/gr_ball.gif" border="0"><a
href="http://www.quaker.org/fj/wink.html">Getting Off Drugs: The
Legalization Option (February 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="afraid.html">Who will protect children from
legalized drugs? (February 21, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="bridge.html">It doesn't mean you could buy
'coke' at Hy-Vee (March 1, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="johnnie1.html">Johnnie Clements (March 3,
1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="johnnie2.html">Johnnie Clements (March 18,
1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="jack01.html">Jack Johnson (March 24, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="harvey02.html">Roderick T. Harvey (April 2,
1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="jack02.html">Jack Johnson (April 11, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="trimble3.html">Officer fired for drugs put on
probation (May 17, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="trimble4.html">Trimble sentence a travesty of
justice (May 25, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="trimble5.html">'No justice' in Trimble
sentence, critics say (May 28, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="trimble6.html">Trimble sentence may seem
unfair (June 1, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="trimble7.html">State legislator wants change
regarding judges (June 1, 1996)</a></h4>

<h4><img src="../images/reddot.gif" border="0" height="14"
width="14"><a href="brown-02.html">Tom Brown (June 18,
1996)</a></h4>

<hr>

<h1>Links to other sources of information</h1>

<h4><img src="../images/purpcube.gif" border="0" height="18"
width="18"><a href="http://www.drcnet.org/map/">Media Awareness
Project (MAP)</a></h4>

<h4><img src="../images/purpcube.gif" border="0" height="18"
width="18"><a href="http://www.xs4all.nl/~mlap/special/wod.html">The
Drug War is Lost - National Review (Feb. 12, 1996)</a> </h4>

<h4><img src="../images/purpcube.gif" border="0" height="18"
width="18"><a
href="http://www.xs4all.nl/~mlap/debate/nanahas.html">Commentary
on Gabriel Nahas</a> </h4>

<h4><img src="../images/purpcube.gif" border="0" height="18"
width="18"><a href="http://www.undcp.org/index.html">United
Nations International Drug Control Programme</a> </h4>

<h4><img src="../images/purpcube.gif" border="0" height="18"
width="18"><a href="http://www.drcnet.org/">Drug Reform
Coordination Network (DRCNet)</a> </h4>

<h4><img src="../images/purpcube.gif" border="0" height="18"
width="18"><a href="http://www.calyx.com/~schaffer/">Cliff
Schaffer's web pages</a> </h4>

<h4><img src="../images/purpcube.gif" border="0" height="18"
width="18"><a
href="http://www.calyx.com/~schaffer/LIBRARY/basicfax.html">Cliff
Schaffer's Basic Facts document</a> </h4>

<h4><img src="../images/purpcube.gif" border="0" height="18"
width="18"><a
href="http://www.service.com/PAW/morgue/cover/1995_May_31.COVER31.html">Former
San Jose Police Chief Joe McNamara (May 31, 1995)</a> </h4>

<hr>

<address>
    Carl E. Olsen - carl@mail.commonlink.com <br>
    P.O. Box 4091, Des Moines, IA 50333 <br>
    (515) 262-6957 voice and fax 
</address>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-236</DOCNO>
<DOCOLDNO>IA087-000632-B012-445</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/COMMON/common.html 206.61.184.43 19970122090338 text/html 2224
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:03:30 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:02:40 GMT
Content-length: 2009
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Emergency War Powers</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" link="#0000FF"
vlink="#800080" alink="#FF0000">

<h1 align="center">Emergency War Powers</h1>

<hr>

<h4>The Privilege of the Writ of Habeas Corpus shall not be suspended, unless
when in Cases of Rebellion or Invasion the public Safety may require
it.<br>
<i>U.S. Constitution, Article 1, Section 9, Clause 2</i></h4>

<hr>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="factfict.html">Constitution: Fact or Fiction</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="report.html">War and Emergency Powers</a></h4>

<h4><img src="../images/reddot.gif" width="14" height="14"> <a
href="12usc95b.html">12 USC  95b (1995)</a> </h4>

<hr>

<h1>Links to other sources of information</h1>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://afcomm.metronet.com/afc/index.html">American Freedom
Coaliton</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.iquest.net/~rjtavel/">Indiana's Fully Informed
Jury Association</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://users.aol.com/dritus/apn.htm">American Patriot
Network</a></h4>

<h4><img src="../images/purpcube.gif" width="18" height="18"> <a
href="http://www.primenet.com/~slack/fija/fijaf.html">The SoapBox
FIJA Page</a></h4>

<hr>

<address>
    Carl E. Olsen - carlolsen@mail.commonlink.com<br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 262-6957 voice and fax 
</address>

<hr>

<h4>Please send your comments regarding this page to: <a
href="mailto:carlolsen@mail.commonlink.com">carlolsen@mail.commonlink.com</a></h4>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-237</DOCNO>
<DOCOLDNO>IA087-000632-B013-93</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/LINKS/links.html 206.61.184.43 19970122090456 text/html 6882
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 09:04:44 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:27:07 GMT
Content-length: 6667
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Links to other sources</title>
</head>

<body bgcolor="#FFFFFF" link="#0000FF" vlink="#FF0000"
alink="#FF00FF">

<h1>Links to other sources of information:</h1>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.calyx.com/~schaffer/">Cliff Schaffer's Home Page</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.drcnet.org/">Drug Reform Coordination Network
(DRCNet)</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.lap.nl/drugtext.html">Foundation for Drug Policy
&amp; Human Rights - The Netherlands</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.drugtext.org/">Foundation for Drug Policy &amp;
Human Rights - USA</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.natlnorml.org/">National Organization for the
Reform of Marijuana Laws</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.xs4all.nl/~mlap/norml.html">Mario Lap's NORML
Home Page</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.niad.nl/fc1uk.htm">Dutch Cannabis Policy</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.drcnet.org/map/">Media Awareness Project (MAP)</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.mpp.org/~mpp/">Marijuana Policy Project</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://gnv.fdt.net/~jrdawson/">James Dawson's Freedom Page</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.maps.org/">Multidisciplinary Association for
Psychedelic Studies</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.famm.org/">Families Against Mandatory Minimums
(F.A.M.M.)</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.fear.org/">Forfeiture Endangers American Rights
(F.E.A.R.)</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.gatewood.com/">Gatewood Galbraith's Home Page</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://csp.org/csp/">Council on Spiritual Practices</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://emporium.turnpike.net/~jnr/think.htm">Jim Rosenfield
- &quot;Think For Yourself&quot;</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://hyperreal.com/drugs/">Hyperreal Drug Information
Archives</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://fox.nstn.ca/~eoscapel/cfdp/cfdp.html">Canadian
Foundation for Drug Policy</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://sunsite.unc.edu/warstop/warstop.html">WARSTOP</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.paranoia.com/~fraterk/">Psychedelic Tabby Cabal</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.acu.org/~acu/">Californians for Compassionate
Use</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.wwdc.com:80/~hemp/">Chris Clay's Hemp Nation
HeadQuarters (Canada)</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://wl.iglou.com/hippie/pot_info.htm">Michrel L.
Standefer's Marijuana Information Page Hippie@iglou.com</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www-unix.oit.umass.edu:80/~verdant/">UMASS Cannabis
Reform Coalition</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.winternet.com/~grp/">Minnesota Grassroots Party</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.csuchico.edu/pot/">Chico Cannabis Club Home Page</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://snowcrest.net/swtlight/">HOLY SMOKE</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.hemp.net/hipws/hipws.html">Hemp Initiative
Projects of Washington State</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://home.earthlink.net/~tkezele">Our Church Home Page</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.asis.com/~edenson/">Civil Liberties Monitoring
Project</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.iquest.net/~rjtavel/">Indiana's Fully Informed
Jury Association</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.efn.org/~charlesg/4:20.html">The 4:20 Page ...
Earth Day is 4:20 ... 4:20 is Earth Day</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.calyx.com/~normlca/">NORML Canada</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.theflow.nl/">The Flow - Hemp Internet</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.cp.duluth.mn.us/~brandonc/reform.html">The Drug
Policy Reform Page</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.hempery.com">Ohio Hempery</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.cybershopping.net/a/azenterprises/">A-Z
Enterprises specializes in herbs that help you pass any drug test</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.thebc.com/">TheBC</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="http://www.eff.org/govt.html">Links to Government Servers
and Information</a></h4>

<h4><img src="../images/cyancube.gif" width="18" height="18"> <a
href="finer.html">Pot Stories From The Net</a></h4>

<hr>

<address>
    Carl E. Olsen - <a href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a><br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 243-7351 voice and fax 
</address>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-238</DOCNO>
<DOCOLDNO>IA087-000632-B039-268</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/mckinney.html 206.61.184.43 19970122071635 text/html 24977
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:16:26 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:12:25 GMT
Content-length: 24761
</DOCHDR>
<HTML>
<CENTER><H4>
TELEPHONE INTERVIEW WITH LAURENCE MCKINNEY<BR>
CAMBRIDGE PHARMACEUTICAL LABORATORIES, INC.<BR>
POST OFFICE BOX 748<BR>
CAMBRIDGE, MASSACHUSETTS 02139<BR>
(617) 868-9386<BR>
JULY 20, 1991</H4></CENTER> 
<PRE> 
  OLSEN:   What's the difference between synthetic THC and 
natural THC? 
 
  MCKINNEY:   Molecularly speaking, there's no difference at all.   
The only difference between getting THC out of the plant, is when 
you get it out of the plant, the residuals, the impurities, are 
all these dismissive molecules, which are other plant molecules, 
of course.   When you make synthetic THC, the only residual 
impurity, quote-unquote, is delta-8 THC, so Marinol's technically 
95% THC and 5% delta-8 THC, whereas marijuana is 5% THC and 95% 
plant material which apparently has no effect, because every time 
people give all this testimony and talk about the effects of 
smoking marijuana, or whatever, whenever they talk about the 
effects, the effects are identical from the effects of taking 
THC. 
 
  OLSEN:   You said there's never been any ..., you know, when 
people talk about marijuana, they're talking about THC, because 
none of the other chemicals have ever been tested. 
 
  MCKINNEY:   Exactly.  Well, it's not that they haven't been 
tested, they've been tested, but there's been no real indication 
that they have an effect to the extent that it changes the effect 
of smoking marijuana.  In other words, there's never been a test 
on any of the other drugs that are in marijuana that indicated 
they have dramatic enough effects that they would be changing the 
effect of THC.  Say, maybe, there was, you know, 2% water in your 
orange juice, it wouldn't do a lot of difference to the orange 
juice.  It would be slightly diluted, but you wouldn't taste any 
difference, and you wouldn't feel any difference.  So, what's 
happening is, the government charges, which are totally specious, 
is that there are these other things in marijuana, sure, but not 
one of these other things in marijuana has been shown to be 
dangerous or problematical, nor has it ever been shown that those 
experiencing the effects of marijuana are experiencing the 
effects of anything else but THC. 
 
  OLSEN:   What about the argument that smoking marijuana is bad 
because it's smoke? 
 
  MCKINNEY:   That, per se, is silly, because the National Cancer 
Institute will tell you that unless you smoke more than four 
cigarettes a day, there's no determination that you're moving 
towards lung damage, and very few people are smoking more than 
four joints a day. 
 
  OLSEN:  Is there anything different about marijuana smoke than 
tobacco smoke 
 
  MCKINNEY:  No.  Actually, marijuana does have a slightly 
tarrier smoke.  It's about 30% to 40% tarrier, but, again, we go 
down to how many joints a day. 
 
  OLSEN:  What about the bronchodilator and bronchoconstrictor 
things? 
 
  MCKINNEY:  That has to do with the effects of THC on the smooth 
muscle.  Initially, it acts as a stimulator, which causes smooth 
muscle to contract, which gives you that feeling of your 
diaphragm getting tight, or people say that smoke is expanding.  
That's ridiculous.  Smoke is not expanding their diaphragm, it's 
contracting.  It's because it effects all smooth muscle 
immediately, making it contract. 
 
  OLSEN:  Well, they say marijuana's like a bronchodilator, and 
tobacco is a bronchoconstrictor. 
 
  MCKINNEY:  Who say? 
 
  OLSEN:  I've read this over and over again. 
 
  MCKINNEY:   Yeah, well, there's a lot of things.  People used 
to say you could bury your dope in the ground, it would get full 
of mold and everything.  There's a lot of bullshit around in this 
business, because there's so many people 
 
  OLSEN:  I've also heard that it was good for migraines, because 
it expanded the blood vessels in the brain. 
 
  MCKINNEY:  Well, that's complete bullshit, because there's 
nothing that's going to give you a headache faster than expanding 
the blood vessels in the brain.  In fact, the two kinds of 
headaches that we normally have, one is caused by constriction of 
the muscles in the neck which drops the blood pressure in the 
brain, the other is caused by exhaustion which by making the 
smooth muscles relax ... 
 
  OLSEN:  Well, it was described to me as the migraine or the 
headache comes from constricting of the blood vessels, cutting 
off the supply of oxygen to the brain. 
 
  MCKINNEY:  No.  No, not at all.  If you cut off the blood 
supply to the brain, you'd be dead.  It just drops the blood 
pressure slightly. 
 
  OLSEN:  Well, just restricting the flow, I mean, somewhat. 
 
  MCKINNEY:  Restricting the flow drops the blood pressure, 
doesn't it? 
 
  OLSEN:  I don't know. 
 
  MCKINNEY:  Well, let's face it.  You've got X amount of blood 
pressure, and you put less blood in.  Come on. 
 
  OLSEN:  Yeah.  I don't know.  It was described to me as being a 
reduction in oxygen. 
 
  MCKINNEY:  By a licensed physician who had a knowledge of 
cardiovascular things, or some marijuana advocate?  Let's get 
straight here.  Who are we talking to, experts or Merlins? 
 
  OLSEN:  No.  I just heard this.  I'm just checking it out. 
 
  MCKINNEY:  Don't believe a thing you hear, unless the guy who 
is saying it . 
 
  OLSEN:  Well, I don't believe a thing I hear.  I repeat it as 
being something I heard, and that's all the value I give it. 
 
  MCKINNEY:  Between you and me, I won't pass along anything.  
Ever since I've been in the drug education business, since 1970, 
I always check it out with the medical journals before I repeat 
anything. 
 
  OLSEN:  Well, of course, well, I just thought I'd check with 
you, since you're that kind of a person. 
 
  MCKINNEY:  Well, here's the word.  THC from a plant and THC 
from a vat are absolutely identical.  However, since that's the 
case, and since no one smoking marijuana has ever described the 
symptoms of smoking marijuana as being different from those of 
having an effect of THC, we are really putting people in jail for 
an alternative administration of a legal drug, and that's what I 
keep saying.  If you vaporize a plant to get your THC molecules, 
even though they re mixed with a lot of other crap, sure, it's 
ineffective, but it's simply an alternative mode of 
administration.  And the Drug Enforcement Administration has to 
admit that people smoking marijuana are self-medicating 
themselves with THC.  And if you talk about self-medication, 
instead of getting high, and you talked about self-medication 
with crude THC, rather than smoking a doobie, now you re talking 
about using this wonder drug that everyone says is so safe. 
 
  OLSEN:  Yeah.  Yeah, OK, tell me now, what are the two 
chemicals that are used to make THC synthetically. 
 
  MCKINNEY:  Olivitol and paramenthadianol , And you react the 
two, and I'm not certain how you react the two, I mean, that's 
the part I don't know.  Do you put it in a pressure cooker?  Do 
you put it in a special apparatus?  Do you do this?  Do you do 
that?  I'm not sure.  But you react the two together.  It is 
being done at Norac Industries owned by Chester, Dr.  Chester, 
McCluskey in Azusa, California.  I mean, this is something that 
ought to he fun.  You could get a sort of a tour of the lab.  You 
could get all the marijuana activists out to Azusa and stand 
around the place where they make the THC. 
 
  OLSEN:  Yeah.  I'm interested in where they get these two 
chemicals from, too. 
 
  MCKINNEY:  They get it from Sandoz in New Jersey. 
 
  OLSEN:  And do you have any idea how Sandoz gets it? 
 
  MCKINNEY:  They make it. 
 
  OLSEN:  OK.  And do you have any idea how they make it? 
 
  MCKINNEY:  Yeah, from a lot of other stuff.  I think they start 
with gallac acid.  I'm not certain, but I think they start with 
gallac acid.  I'm not sure, but the thing is, someone told me ...  
Carl Nocka is the man who makes it. 
 
  OLSEN:  OK.  Got his address? 
 
  MCKINNEY:  Carl Nocka is the man who makes the olivitol for 
Sandoz.  I believe it's Sandoz, in their chemical division.  He 
describes the process of making olivitol as mouse milk. 
 
  OLSEN:  OK.  Is there any way I could find out from this guy, 
or from anybody else, exactly where the organic compounds come 
from?  What do they start out with?  Where do they get the plant 
material or the mineral material? 
 
  MCKINNEY:  There's no plant material. 
 
  OLSEN:  Well, where do they get the minerals from then, to 
start this whole process? 
 
  MCKINNEY:  Well, they usually get them out of the ground. 
 
  OLSEN:  Yeah.  And what are they?  What are the minerals? 
 
  MCKINNEY:  Well, it comes down to probably atoms of carbon and 
nitrogen, and things like that.  You see, when you talk about 
biosynthesis, it means the plant, using its own clever bits of 
iona this and iona that, is shifting the molecules back and 
forth.  Let's also recall that the plant doesn't make 
tetrahydrocannabinol (THC), it makes tetrahydrocannabinolic acid 
and then it has to be decarboxylated by heat.  Now, the other way 
of making THC is to make cannabidiol and then reverse isomerize 
it, which the isomerizer never did do, into THC.  That's the 
Razdan process.  You see, the thing is, that when you're making 
THC, if you let the reaction go too far, you end up with 
cannabidiol.  And, what the Razdan process locked into, the fact 
was, take it all the way to cannabidiol and then turn the 
cannabidiol into THC.  That's how they do Razdan THC, which is 
the stuff that Harry Pars wanted to put on the market.  Remember, 
THC can be made by anybody for nausea, it can't be made by anyone 
else excepting Unimed for weight gain. 
 
  OLSEN:  OK.  Why? 
 
  MCKINNEY:  Why?  Because they got an orphan drug from the 
United States government, a monopoly.  That's why this whole 
thing started.  Kapoor, an Indian fellow with $200 million, took 
over Unimed and then he got an orphan drug for weight gain, and 
pushed forward with a lot of government pressure, and they opened 
up the market in Europe by having the UN change their OKs on THC. 
 
  OLSEN:  OK.  What's an orphan drug? 
 
  MCKINNEY:  Orphan drug means when a drug supposedly has so 
little market that making the ..., the expense of creating an FDA 
passable version of the drug would exceed the money that a person 
was going to make from it.  It's called an orphan drug.  That 
means that nobody really wants to make it, because it's not 
profitable enough.  So, in order to induce a company to make an 
orphan drug, the government gives one company a monopoly.  So, 
Unimed has a monopoly.  The interesting thing about Unimed is 
that it's owned by an Indian named John Kapoor who lives in 
Chicago, but it's distributed by Roxane Laboratories which is 
wholly, privately, owned by the German drug cartel Boehringer-
Ingelheim, which means that the profits from this drug are going 
to Germany.  And, the people who make the olivitol are Sandoz.  
It's a Swiss company.  So, the profits from the manufacture of 
the raw ingredients go to Switzerland.  All the money from this 
wonderful drug goes out of the United States, increasing our 
deficit.  If we grew it in this country and made it, it would be 
American THC.  This is sold by the Germans, with ingredients made 
by the Swiss.  And we could do it all ourselves.  The original 
work was done by Arthur D. Little and was picked up by Unimed 
back in 1983, because no one else wanted to make it.  The 
capsules are made by Banner Laboratories in Los Angeles.  So, the 
THC, pure THC, is shipped from Norac to Banner, Banner puts it 
into capsules and ships it to the Cleveland, Ohio, warehouse of 
Roxane Laboratories. 
 
  OLSEN:  How do you think that the government can keep marijuana 
illegal then? 
 
  MCKINNEY:  Well, because, you see, the law, as was written by 
John Mitchell, is the Controlled Substances Act.  If it was the 
Controlled Drug Act, we'd have a real problem, because in modern 
day we don't think of a drug as being a collection of substances, 
but as being a specific molecule.  But, by calling it a 
Controlled Substances Act, you can play all sorts of legal 
rubbery games like saying that cocaine is in Schedule 2, because 
there's a medical use for cocaine, but crack is in Schedule 1. 
 
  OLSEN:  And the coca plant is in Schedule 2. 
 
  MCKINNEY:  Yes.  But, what I'm trying to point out is, although 
cocaine is in Schedule 2, and they can't get it out of Schedule 
2, to make more money for the police and the Justice Department, 
crack is in Schedule 1, which means there is no medical 
intervention, it's all in the hands of the police, although, 
chemically speaking, crack and cocaine are precisely the same.  
It's simply another form of it.  And that's why I say you have 
the Controlled Substances Act.  That's how you can have the 
entire peyote plant in that category, or the entire marijuana 
plant, because it's a substance.  THC is in Schedule 2.  
Marijuana is in Schedule 1.  It's in Schedule I supposedly 
because it contains a drug called THC which is in Schedule 2.  
However, if you take the THC out of marijuana, it's still in 
Schedule 1, even though its got its drug taken out of it, because 
it's the marijuana that's the controlled substance, and that is 
the trick to a controlled substance.  They could make Scotch Tape 
into a controlled substance. 
 
  OLSEN:  Why is marijuana then, without THC, in Schedule I and 
tobacco is legal? 
 
  MCKINNEY:  Because, in Schedule I in the Controlled Substances 
Act they define a number of different items, and marijuana is 
defined as the leaves and the flowering tops and everything made 
of the marijuana plant.  That's the legal definition. 
 
  OLSEN:  But how can you call it due process, I mean, how is it 
fair that a classification include something and doesn't include 
something else, when they both fit the same definition? 
 
  MCKINNEY:  No one ever said the body of law in any country is 
particularly good.  In Arabia, they chop your head off.  I mean, 
let's face it, the laws are never anything but the current 
reflection of popular political opinion.  So, what you're looking 
at here is a drug which is itself, at 95%, considered to be a 
wonder drug, safe, never been an overdose.  OK?  But, at 5% in a 
plant, it's in the same category as heroin.  In other words, when 
it's 20 or 30 times more potent, it's legal.  But, when it's so 
crude, when it's in its crudest form, it's like saying gasoline 
and crude oil ... 
 
  OLSEN:  Well, aren't they saying, because of the fact that it's 
only 5% and it's mixed with all this other stuff, that that's why 
it's worse that the 95% pure? 
 
  MCKINNEY:  Well, what they're saying, whenever you try to make 
marijuana into Schedule 2, is that there are all these other 
things which haven't been tested.  They make you put marijuana 
through the same test you'd put THC through, which is to say, 
what are the impurities?," and of course there are 423 molecules 
in marijuana, only one of them is THC.  So, if you take out the 
THC, how many impurities have you got?  422.  That's how they do 
it.  Because, normally, when you make a drug, you've got to test 
the impurities and see if they're OK, and see if they have any 
effect.  Can you imagine anyone wanting to test 422 other 
molecules?  Now, the only thing I have, there's been a change in 
the generic drug laws that says you don't have to duplicate the 
entire procedure, but you do have to make it equivalent, its got 
to have the same effect.  And when the FDA told us that they 
didn't care where you got THC from, as long as it was 95% pure, 
there was some question there.  But what it comes right down to 
is that nobody in the marijuana movement, including Richard 
Dennis, wants to put their money behind the one simple routine 
that would change everything, which I've been talking about for 
the last four years, which is a very simple movement to change 
the definition of marijuana in the rule books.  All you have to 
do is include tetrahydrocannabinol (THC) as one of the legal 
products of the plant, along with hemp seed and hemp cloth and 
hemp this and hemp that, and the whole thing would fall apart 
immediately, because then you would have the anomaly of a plant 
which had its active ingredient removed still being in Schedule 
1.  It would fall apart on its own ridiculousness.  And yet ... 
 
  OLSEN:  In other words, you're saying that it would be looked 
at like tobacco? 
 
  MCKINNEY:  Yeah.  I mean, it wouldn't be looked at like 
tobacco.  Suppose that you had a lemon, and vitamin C was legal, 
but lemons were illegal because they had vitamin C, and a lemon 
was defined as everything that comes off the lemon tree. 
 
  OLSEN:  Yeah.  Well, you re saying marijuana is illegal because 
it has THC in it. 
 
  MCKINNEY:  I'm saying that the way that the government keeps 
marijuana illegal is by broadcasting the idea that marijuana 
contains a dangerous drug.  The dangerous drug they refer to is 
THC at 5%.  On the other side of their mouth, they're calling THC 
a safe and harmless drug at 95%.  In other words, when the THC is 
in sesame oil, which is the only other ingredient in Marinol, 
surrounded by a gelatin capsule, it's a wonder drug.  When the 
THC is in a hemp stalk, surrounded by hemp fibers, it's Schedule 
I criminal, and how it would be illegal for us to hack our way 
into there and pull the legal drug out.  You see, to us, to our 
way of thinking, and our argument all along, we're going into a 
plant to pull out something legal, and we're calling the plant 
illegal because its got the legal stuff in it.  It doesn't make 
any sense.  You can simply say that the people smoking marijuana 
are self-medicating themselves with the effects of THC, which are 
found by the government to be safe, efficacious, and absolutely 
harmless.  There's never been an overdose, there's never been a 
death.  And they're just people who have, you know, nausea maybe?  
Who knows, maybe they want to gain weight.  Fine, let them self-
medicate.  Why can't they medicate by taking it out of the plant?  
It's like saying you've got to have pure synthetic maple syrup, 
you can't tap a tree. 
 
  OLSEN:  So, is there another way to get THC out of marijuana 
besides smoking it, and without refining it? 
 
  MCKINNEY:  No. 
 
  OLSEN:  Is there some way to use the raw marijuana at home, 
does it have to go through some ... 
 
  MCKINNEY:  You can't get pure THC out of it. 
 
  OLSEN:  You can't? 
 
  MCKINNEY:  You can't.  No.  You can get maybe a solution as 
high as 65% or 75%, you can.  That's about as high as you con go.  
The reason it costs nearly as much to make natural THC is because 
there's so much more gunk to clear out with the liquid 
chromatograms.  When you've only got two molecules to separate, 
it's not so hard.  When you've got 400 to separate, it's harder. 
 
  OLSEN:  It would be more expensive to make THC from a plant 
than it would be to ...? 
 
  MCKINNEY:  As expensive.  Until you get into serious large 
production, there's no real advantage.  The one thing that's the 
biggest advantage is you don't have to rely on a lot of complex 
expensive chemicals made by a lot of complex expensive companies.  
When Carl Nocka said that making olivitol was mouse milk, what he 
meant was it takes a hell of a lot of whatever they use to make 
it out of to make a little bit.  It's a very low yield process.  
That's why olivitol costs $1,000 a kilogram.  Very expensive.  
Now, in the making of THC from the raw materials, it costs a lot 
more to refine it, but the raw materials are cheaper.  You see, 
the liquid chromatogram uses packed columns of silica gel which 
will retard certain molecules and let other molecules go through.  
And what happens is that it retards the cannabinoids say, but 
then eventually the little granules in the tube become all 
clogged up with what they're trying to sieve out.  And the 
problem is because there's so many similar molecules to THC in 
the gunk, that you can't run the solution through the tubes more 
than two or three times and it's all gunked up.  And, silica gel 
costs $150 to $250 a kilogram.  It's like sand.  It's specially 
treated sand, for all intents and purposes.  But the fact is, 
it's expensive, and when you have a synthetic, which only has 
delta-9 and delta-8, you can see it's a lot easier to separate 
them.  Still, the most expensive part of making the synthetic is 
separating the delta-9 so you end up with a 95% solution. 
 
  OLSEN:  You have to do this no matter how you make it, right? 
 
  MCKINNEY:  You always have to go to the liquid chromatogram for 
the last stage.  The thing is, when you make it synthetically, 
you end up with an 80% solution, and there are only two molecules 
in that solution.  In the making of natural , you end up with a 
75% solution, 25% of which is made up of 420 different other 
things.  However, generically speaking, this may not be as 
important if it's shown that tests have no differences in the 
effect.  The only reason that Perdue-Frederick dropped that is 
because there wasn't enough sales of the synthetic.  Otherwise, 
they would have backed us with the natural. 
 
  OLSEN:  They would have kept testing? 
 
  MCKINNEY:   They would have backed us with the natural.  They 
didn't test.  They never got to that stage.  But the funny thing 
is that, of course, if they push the synthetic enough, or course, 
other people will come in line and start working with the 
natural, hopefully.  And, if they're going to make the natural, 
they're going to have to make it out of the plant, and the plant 
will have to drop to Schedule 2, as all precursors of Schedule 2 
drugs have to be in the same schedule.  You can't have a 
precursor of a drug in a higher schedule than the drug itself. 
 
  OLSEN:  What is a precursor?  You mean the plant? 
 
  MCKINNEY:  The plant, the poppy. 
 
  OLSEN:  The coca plant? 
 
  MCKINNEY:   Yeah.  The poppy plant is in Schedule 2, opium 
poppy.  And, if, say, for instance, if mescaline became legal, 
they'd have to put peyote in Schedule 2 for the same reason.  And 
that's why I keep saying, if we can only get natural THC into 
Schedule 2, it would force marijuana into Schedule 2.  But the 
nutniks in the marijuana reform movement are all a bunch of ex-
hippies sitting around rolling doobies on the back porch and 
gazing at the sun and saying, "Oh wow!"  They're not realizing 
there are two important things to do.  First, it's very easy to 
change the definition if it looks like you're doing it to keep 
marijuana away from people.  And by simply slipping in a 
definitional change in the marijuana definition in the law, state 
by state, you can slip that through the legislatures with no one 
getting excited, because they wouldn't understand what you were 
really doing.  It sounds like you're, you know, bringing the 
definition up to date, because in 1985 THC became legal, 
therefore, THC is defined as the psychoactive drug in marijuana, 
and that's the way it's defined in the Physician's Desk 
Reference, the PDR. 
 
  OLSEN:  Well, you know, Iowa's law says that marijuana's in 
both Schedule I and Schedule 2.  Schedule I says it has no 
medical use, and Schedule 2 says it does, and what you just said 
would be a way to solve, to make the Iowa law make sense and 
accomplish exactly what they tried to accomplish without making 
it look like a bunch of idiots wrote it. 
 
  MCKINNEY:  You can change the definition so that marijuana is 
illegal, excepting for the products, and one of those products 
would be pure, it could be pharmaceutically pure THC. 
 
  OLSEN:  Which would be Schedule 2. 
 
  MCKINNEY:  Yeah.  Now, the legislatures and the lawmakers know 
if anyone wouldn't realize what they were doing by changing that 
to make it clear that only pharmaceutically pure THC from the 
marijuana plant would be considered legal, but the rest of it's 
no good, it sounds like you're making it impossible for someone 
to do this, but whet they are doing is that they're making 
marijuana the precursor of a legal drug. 
 
CARL ERIC OLSEN 
(515) 243-7351
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-239</DOCNO>
<DOCOLDNO>IA087-000632-B040-28</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/bonner-1.html 206.61.184.43 19970122071653 text/html 2037
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:16:41 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:40 GMT
Content-length: 1822
</DOCHDR>
<HTML>
<PRE>
     Post Office Box 4091  
     Des Moines, Iowa 50333  
     July 21, 1992  

Robert C. Bonner, Administrator  
Drug Enforcement Administration  
Washington, D.C. 20537  

Dear Mr. Bonner:  

     I just finished reading your decision on the Marijuana 
Rescheduling Petition, 57 FR 10499 (March 26, 1992).  Your 
explanation of the scheduling criteria in the Controlled 
Substances Act (CSA) left me confused.  By your definition, a 
substance in Schedule II is a scientifically established chemical 
compound capable of reproduction in standardized dosages.  Of 
course, marijuana is not such a substance, it is a plant, not a 
drug.  

     Although you made no mention of the fact, the coca plant, 
from which cocaine is made, and the opium plant, from which 
morphine and heroin are made, are both in Schedule II of the CSA.  
As I was reading your decision, I wondered how these two plants 
can be in Schedule II.  These plants are subject to the same 
variances in chemistry as the marijuana plant.  It seems like you 
are treating marijuana unfairly.  

     If Congress intended to rely on scientifically established 
chemistry and reproducible dosages, why did Congress include the 
coca and opium plants in Schedule II?  

     It seems to me that these plants should not be included in 
the CSA at all, because they will never fit into your definition 
of drugs, and I think your definition is correct as far as it 
goes.  However, since Congress has decided to include them in the 
CSA, your definition is inadequate to explain them.  I hope you 
will correct your definition, and not simply ignore this apparent 
inconsistency.  

     Thank you for your attention.  

     Sincerely,  
     Carl Eric Olsen  
     (515) 243-7351 
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-240</DOCNO>
<DOCOLDNO>IA087-000632-B040-61</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/bonner-2.html 206.61.184.43 19970122071715 text/html 2321
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:17:05 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:36 GMT
Content-length: 2106
</DOCHDR>
<HTML>
<PRE>
August 17, 1992  

Dear Mr. Olsen:  

     This is in response to your letter of July 21, 1992, 
regarding my decision with respect to the Marijuana Rescheduling 
Petition.  

     Your letter correctly states that one of the factors to be 
considered in determining whether a substance has a currently 
accepted medical use in treatment is that it is a scientifically 
established chemical compound capable of reproduction in 
standardized dosages.  While you are also correct in noting that 
Congress placed coca and opium plant materials in Schedule II, 
your attempt to analogize those substances to marijuana, and to 
find inconsistency in their scheduling, fails.  

     In placing coca leaves and opium plant material in Schedule 
II, Congress was very much aware that these plant materials have 
historically been recognized as the source for a variety of 
accepted and useful medications.  Neither of these plants are 
used medicinally as plant material.  In both instances, the 
medically active alkaloids are extracted from the plant material 
after which pharmaceutical compounds capable of reproduction in 
standardized dosages are produced.  These compounds are the 
medications which may then be lawfully marketed in the United 
States.  While indigenous populations in various parts of the 
world brew coca teas, chew coca leaves, and smoke opium for 
various purposes, these practices are not permitted in the United 
States under the Controlled Substances Act.  

     Unlike pharmaceuticals derived from opium and coca leaves, 
the petition to reschedule marijuana did not involve the 
scheduling of any medically useful compound to be extracted from 
the plant material.  Instead, the petition involved unsupported 
claims for the medical use of smoked marijuana.  There is, 
therefore, no inconsistency in my finding that such claims did 
not make a case for accepted medical use in treatment in the 
United States.  

     Very truly yours,  

     Robert C. Bonner  
     Administrator of Drug Enforcement
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-241</DOCNO>
<DOCOLDNO>IA087-000632-B040-87</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/bonner-3.html 206.61.184.43 19970122071726 text/html 1213
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:17:17 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:33 GMT
Content-length: 999
</DOCHDR>
<HTML>
<PRE>
     Post Office Box 4091  
     Des Moines, Iowa 50333  
     September 6, 1992  

Robert C. Bonner, Administrator  
DrugEnforcement Administration  
Washington, D.C. 20537  

Dear Mr. Bonner:  

     Carl Eric Olsen hereby petitions the Administrator to 
reschedule marijuana from Schedule I to Schedule II of the 
Controlled Substances Act (CSA) pursuant to Section 201 of the 
CSA, Public Law 91-513, 21 U.S.C.  811 and 21 C.F.R.  1307.03.  

     Attached hereto and constituting a part of this petition is 
a statement of the grounds upon which petitioner relies for the 
proposed rescheduling.  

     Five copies of this petition are provided pursuant to 21 
C.F.R.  1308.44(b).  

     All notices regarding this petition should be addressed to:  

     Carl Eric Olsen  
     Post Office Box 4091  
     Des Moines, Iowa 50333  
     (515) 243-7351  

     Sincerely yours,  

     Carl Eric Olsen  
     (515) 243-7351 
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-242</DOCNO>
<DOCOLDNO>IA087-000632-B040-111</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/bonner-4.html 206.61.184.43 19970122071751 text/html 4461
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:17:34 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:31 GMT
Content-length: 4246
</DOCHDR>
<HTML>
<PRE>
     PETITIONER'S STATEMENT OF GROUNDS FOR RESCHEDULING 
 
     The Controlled Substances Act (CSA), 21 U.S.C.  801 et 
seq., contains five schedules, the first of which (Schedule I) 
contains substances which have no medical use in treatment in the 
United States, and the final four of which (Schedules II through 
V) contain substances which have medical use in treatment in the 
United States but which are available only by a physician's 
prescription.  Marijuana is currently in Schedule I of the CSA. 

     On March 26, 1992, the Administrator made a final decision 
in a marijuana rescheduling petition, DEA No. 86-22, rejecting 
the finding of an administrative law judge that marijuana has 
medical use in treatment in the United States, and rejecting the 
administrative law judge's recommendation that marijuana be moved 
to Schedule II of the CSA.  57 FR 10499. 

     The essence of the decision was that marijuana is a plant 
and not a drug.  The Administrator argued that the chemistry of 
the marijuana plant is complex, varies from plant to plant, and 
is incapable of reproduction in standardized dosages (attributes 
common to all plants), and that a drug is a scientifically 
established chemical compound capable of reproduction in 
standardized dosages. 

     The Administrator's decision has been appealed to the United 
States Court of Appeals for the District of Columbia by several 
parties seeking medical access to marijuana plants. 

     According to the Administrator, "the petition to reschedule 
marijuana did not involve the scheduling of any medically useful 
compound to be extracted from the plant material."  The 
Administrator went on the say, "the petition involved unsupported 
claims for medical use of smoked marijuana."  See Exhibit A. 

     As for other plants in Schedule II, the Administrator said, 
"In placing coca leaves and opium plant material in Schedule II, 
Congress was very much aware that these plant materials have 
historically been recognized as the source for a variety of 
accepted and useful medications."  The Administrator went on to 
say, "Neither of these plants are used medicinally as plant 
material."  See Exhibit A. 

     It must follow from the Administrator's explanation that 
marijuana need not have an accepted medical use in treatment in 
the United States in order to be rescheduled from Schedule I to 
Schedule II of the CSA, it only needs to be shown that marijuana 
is a source for an accepted and useful medication. 

     On October 11, 1985, the Administrator proposed to 
reschedule dronabinol to Schedule II of the CSA.  50 FR 42186 
(October 18, 1985); 21 C.F.R.  1308.12(f)(1) (1991).  Dronabinol 
is the synthetic equivalent of the isomer of delta-9-
tetrahydrocannabinol which is the principle psychoactive 
substance present in Cannabis Sativa L., marijuana.  50 FR 42186 
(October 18, 1985). 

     Dronabinol is the U.S. Adopted Name (USAN) for the substance 
(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-
dibenzo [b,d] pyran-1-ol or (-)-delta-9-(trans)-
tetrahydrocannabinol, the principle psychoactive substance in 
Cannabis sativa L., marijuana.  50 FR 42186 (October 18, 1985).  
It has the empirical formula C21H30O2 with molecular weight of 
314.45.  1989 Physician's Desk Reference, page 1859.   

     On May 24, 1991, the United Nations Economic and Social 
Council (ESCOR) rescheduled delta-9-tetrahydrocannabinol from 
Schedule I to Schedule II of the 1971 Convention on Psychotropic 
Substances.  U.N. Doc. E/CN.7/1991/26.  Report of the Commission 
on Narcotic Drugs on its thirty-fourth session, U.N. Doc. 
E/1991/24, Supp. No. 4.  The United States is a party to that 
international convention pursuant to the Psychotropic Substances 
Act of 1978 (Pub. L. 95-633, November 10, 1978).  50 FR 42186 
(October 18, 1985). 

     Since marijuana is now a source for an accepted and useful 
medication, it must now be moved from Schedule I to Schedule II 
of the CSA. 
 
     Respectfully submitted, 

     Carl Eric Olsen 
     Post Office Box 4091 
     Des Moines, Iowa 50333 
     (515) 243-7351
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-243</DOCNO>
<DOCOLDNO>IA087-000632-B040-143</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/bonner-5.html 206.61.184.43 19970122071805 text/html 2078
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:17:56 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:28 GMT
Content-length: 1863
</DOCHDR>
<HTML>
<PRE>
October 23, 1992  

Dear Mr. Olsen:  

     This is in response to your petition to reschedule marijuana 
from Schedule I to Schedule II of the Controlled Substances Act.  
The crux of your petition is that marijuana itself need not have 
an accepted medical use in treatment in the United States if it 
is shown that marijuana is the source of an accepted and useful 
medication.  To that end, you argue that marijuana should be 
rescheduled as a source of delta-9-tetrahydrocannabinol because 
dronabinol, the synthetic form of the same isomer, is controlled 
in Schedule II.  

     In a final rule published on May 13, 1986, then 
Administrator John C. Lawn placed a very specific substance, 
synthetic dronabinol in sesame oil and encapsulated in soft 
gelatin capsules, in Schedule II.  Administrator Lawn's action 
did not involve the rescheduling of delta-9-tetrahydrocannabinol 
itself, nor did it include any form of dronabinol other than the 
synthetic.  Accordingly, pursuant to 21 C.F.R.  1308.44(c), your 
petition to reschedule marijuana is not accepted.  

     Since I am not accepting your petition on the grounds that 
dronabinol is a wholly synthetic substance, not obtained from 
marijuana, it is unnecessary for me to consider the broader 
question of whether the rescheduling of marijuana would be 
appropriate if accepted medications were indeed obtained from 
that source.  As you are well aware, the issue of whether 
marijuana itself has any accepted medical use is pending before 
the United States Court of Appeals for the District of Columbia 
Circuit.  We are confident that the Court will find no merit in 
the petition and that it will affirm my ruling in that case.  

     Very truly yours,  

     Robert C. Bonner  
     Administrator of Drug Enforcement
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-244</DOCNO>
<DOCOLDNO>IA087-000632-B040-166</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/davis-1.html 206.61.184.43 19970122071815 text/html 1509
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:18:08 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:25 GMT
Content-length: 1294
</DOCHDR>
<HTML>
<PRE>
July 13, 1993  

Dear Mr. Olsen:  

     This replies to your May 13, 1993, letter asking several 
questions about drugs.  

     It is true that a good many drugs useful in therapeutics can 
be extracted from herbs.  Some drugs have an animal origin, e.g., 
many hormones.  A synthetic drug is a drug that is made by 
chemically combining various starting materials to make the 
desired product.  The product is then identical in all respects 
to the product isolated from a plant source.  Such a product can 
be marketed under the same name.  For example, cortisone is 
synthesized from a yam that grows in Mexico and it is identical 
to cortisone extracted from adrenal tissue.  

     A synthetic drug would be in the same schedule as its 
naturally occurring twin.  For example, synthetic lysergic acid 
amide is in the same schedule as lysergic acid amide derived from 
the plant source.  

     Please let me know if I can be of further assistance on drug 
matters.  

     Sincerely yours,  

     Harold Davis  
     Consumer Safety Officer  
     CDER Executive Secretariat Staff (HFD-8)  
     Center for Drug Evaluation and Research 
     Food and Drug Administration
     5600 Fishers Lane
     Rockville, Maryland
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-245</DOCNO>
<DOCOLDNO>IA087-000632-B040-195</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/BRIEF/brief.html 206.61.184.43 19970122071837 text/html 1474
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:18:23 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:09:58 GMT
Content-length: 1259
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="AUTHOR" content="Carl E. Olsen">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Petitioner's Brief - August 4, 1993</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" link="#0000FF"
vlink="#FF00FF" alink="#FF0000">

<h4 align="center">IN THE UNITED STATES COURT OF APPEALS<br>
FOR THE DISTRICT OF COLUMBIA CIRCUIT<br>
No. 93-1109<br>
CARL ERIC OLSEN<br>
Petitioner,<br>
v.<br>
DRUG ENFORCEMENT ADMINISTRATION<br>
Respondent.<br>
Petition for Review of an order of the<br>
Drug Enforcement Administration<br>
Petitioner's Brief<br>
August 4, 1993</h4>

<h4><img src="../../images/REDDOT.GIF" width="14" height="14"> <a
href="brief-01.html">Petitioner's Brief to the U.S. Court of
Appeals (Part 1)</a> </h4>

<h4><img src="../../images/REDDOT.GIF" width="14" height="14"> <a
href="brief-02.html">Petitioner's Brief to the U.S. Court of
Appeals (Part 2)</a> </h4>

<hr>

<address>
    Carl E. Olsen - carlolsen@mail.commonlink.com<br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 243-7351 voice and fax 
</address>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-246</DOCNO>
<DOCOLDNO>IA087-000632-B041-53</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/remand-m.html 206.61.184.43 19970122071918 text/html 3445
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:19:05 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:12:10 GMT
Content-length: 3230
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="Carl E. Olsen">
</HEAD>

<BODY>

<PRE>
                 IN THE UNITED STATES COURT OF APPEALS
                  FOR THE DISTRICT OF COLUMBIA CIRCUIT

______________________________________
                                      )
CARL ERIC OLSEN,                      )
                                      )
                       Petitioner,    )
                                      )
     v.                               )                     No. 93-1109
                                      )
DRUG ENFORCEMENT ADMINISTRATION,      )
                                      )
                       Respondent.    ) 
______________________________________)


                           MOTION FOR REMAND  


     The Drug Enforcement Administration, respondent in the above-

captioned appeal, hereby moves this Court to remand the action to the 

Administrator of the Drug Enforcement Administration.  In support of 

this motion and as the basis therefore, respondent states as follows:  

     1.   On September 6, 1992, appellant Olsen filed a petition with 

the Administrator requesting that marijuana be rescheduled from 

Schedule I to Schedule II of the Controlled Substances Act.  In 

support of this petition, appellant filed a statement of grounds for 

rescheduling in compliance with 21 C.F.R. &#167; 1308.44(b)(B).  

     2.   On October 23, 1992, the Administrator responded to 

appellant's petition by refusing to accept that petition for filing. 

Prior to rejecting the petition for filing the Administrator took no 

action to review the grounds upon which appellant relied in that 

petition.  

     3.   Pursuant to the 21 C.F.R. &#167; 1308.44(c), respondent is 

required to accept the petition for filing absent some defect in 

format.  As this requirement was not met, respondent now requests this 

Court to remand the matter so that respondent may accept appellant's 

petition for filing and review that petition in accordance with 

regulations.  See NORML v. Ingersoll, 497 F.2d 654 (D.C. Cir. 1974).  

     4.   Respondent makes this motion in the interests of fairness 

and judicial economy and not with the intent of causing unnecessary 

delay.  Therefore, respondent respectfully requests this Court to 

order the Administrator upon remand to accept appellant's petition for 

filing and to make a ruling upon the matter within 90 days of the date 

of this Court's final order in the related cases of Alliance for 

Cannabis Therapeutics v. Drug Enforcement Administration, No. 92-1168 

and Drug Policy Foundation v. Drug Enforcement Administration, No. 92-

1179.  Both of these cases are scheduled for oral argument on October 

1, 1993.

     Respectfully submitted,  

     Lena D. Mitchell  
     Trial Attorney  
     Narcotic and Dangerous Drug Section  
     U.S. Department of Justice
     Criminal Division
     P.O. Box 27312
     Washington, D.C.  20530 

September 15, 1993
</PRE>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-247</DOCNO>
<DOCOLDNO>IA087-000632-B041-79</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/remand-r.html 206.61.184.43 19970122071936 text/html 5283
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:19:27 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:12:07 GMT
Content-length: 5068
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="Carl E. Olsen">
</HEAD>

<BODY>

<PRE>
                 IN THE UNITED STATES COURT OF APPEALS
                  FOR THE DISTRICT OF COLUMBIA CIRCUIT

______________________________________
                                      )
CARL ERIC OLSEN,                      )
                                      )
                       Petitioner,    )
                                      )
     v.                               )                     No. 93-1109
                                      )
DRUG ENFORCEMENT ADMINISTRATION,      )
                                      )
                       Respondent.    ) 
______________________________________)


                       RESPONSE TO MOTION FOR REMAND  


     I, Carl Eric Olsen, petitioner in the above-captioned petition for 

review of a final administrative order, hereby respond to the 

respondent's Motion for Remand to the Administrator of the Drug 

Enforcement Administration, and state as follows:  

     1.   On September 6, 1992, I filed a petition with the Administrator 

requesting that marijuana be rescheduled from Schedule I to Schedule II 

of the Controlled Substances Act.  In support of this petition, I filed a 

statement of grounds for rescheduling in compliance with 21 C.F.R. &#167; 

1308.44(b)(B).  

     2.   On October 23, 1992, the Administrator responded by refusing to 

accept my petition for filing and by ruling on its merits.  Contrary to 

what the respondent says in paragraph two of the Motion for Remand, the 

Administrator did review the grounds upon which I relied and did make a 

ruling on the merits of my petition.

     3.   Pursuant to the 21 C.F.R. &#167; 1308.44(c), respondent is required 

to accept a petition for filing absent some defect in format.  As the 

respondent now admits, this requirement was not met, and respondent now 

claims it is requesting this Court to remand the matter so that it may 

accept my petition for filing in accordance with regulations.  However, 

since the respondent ruled on the merits of my petition, it is 

questionable whether the respondent actually refused to accept my petition 

for filing.  

     4.   Respondent claims to make the Motion for Remand in the interests 

of fairness and judicial economy and not with the intent of causing 

unnecessary delay.  However, the respondent fails to mention that the Drug 

Enforcement Administration (DEA) has been developing a pattern of 

unfairness, waste of judicial resources and unnecessary delay.  The 

respondent mentions one example in the Motion for Remand, NORML v. 

Ingersoll, 497 F.2d 654 (D.C. Cir. 1974), but fails to mention another 

case where a petition was not accepted for filing, Carl Eric Olsen v. 

Drug Enforcement Administration, 878 F.2d 1458 (D.C. Cir 1989).  Between 

1983 and 1985, I filed several petitions which the DEA refused to accept, 

until a mandamus action was filed in the U.S. District Court.  Id. 878 

F.2d at 1459.  Then, after review of the DEA's denial of the petition on 

its merits was sought, the DEA asked this Court &quot;to remand the matter for 

renewed agency consideration.&quot;  Id. 878 F.2d at 1460.  This is exactly 

what the DEA is doing now.  

     5.   Since the DEA has already ruled on the merits of my petition, 

the only possible reason for a remand would be because the DEA didn't make 

a reasonable decision on the merits of my petition and now wants to hold 

an administrative hearing before an administrative law judge to correct 

its error.  If the DEA simply plans to deny the petition again after it is 

accepted for filing, then there is no reason for a remand, because a final 

ruling has already been made and such a remand would simply be a waste of 

judicial resources and an unnecessary delay.  

     6.   Respondent now requests this Court to order the Administrator 

upon remand to accept my petition for filing and to make a ruling upon the 

matter within 90 days of the date of this Court's final order in the 

related cases of Alliance for Cannabis Therapeutics v. Drug Enforcement 

Administration, No. 92-1168 and Drug Policy Foundation v. Drug Enforcement 

Administration, No. 92-1179.  Both of these cases are scheduled for oral 

argument on October 1, 1993.  I strongly oppose my case being delayed for 

these two cases.  The grounds upon which I seek rescheduling are entirely 

unrelated to the grounds relied upon in these two cases, and, if this 

Court decides to remand this matter, I think this Court should set a time 

frame that is unrelated to them.  

     Respectfully submitted,  

     Carl E. Olsen, pro se  
     Post Office Box 4091  
     Des Moines, Iowa 50333

September 19, 1993 
</PRE>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-248</DOCNO>
<DOCOLDNO>IA087-000632-B041-99</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/dea-hark.html 206.61.184.43 19970122071943 text/html 1956
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:19:37 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:18 GMT
Content-length: 1741
</DOCHDR>
<HTML>
<PRE>
November 17, 1993  

Dear Senator Harkin:  

     This is in response to your letter of October 12, 1993, on 
behalf of your constituent, Mr. Carl E. Olsen.  

     Pursuant to 21 U.S.C.  811, and interested party can 
petition the DEA to reschedule a controlled substance.  When such 
a petition is filed with the Drug Enforcement Administration, it 
is carefully evaluated to determine whether the petition meets 
the requirements of 21 C.F.R.  1308.44.  Section (b) of that 
regulation requires that the petition conform to the format 
provided and also specifies that four copies be filed.  If the 
petition is accepted for filing, the Administrator will evaluate 
the petition on its merits.  If the petition is not accepted for 
filing, because it is either lacking in the regulatory 
requirements or not readily understood, the Administrator will 
notify the petitioner of his decision and reasons thereof.  21 
C.F.R.  1308.44(c).  A copy of the regulation has been provided 
for your convenience.  

     As you are aware, your constituent has appealed the DEA's 
nonacceptance of his petition to the United States Court of 
Appeals for the District of Columbia.  In that case, the DEA has 
asked for a remand of the action in order that the Administrator 
may accept Mr. Olsen's petition for filing and review that 
petition on its merits.  The DEA is constrained from commenting 
further on the merits of Mr. Olsen's case since it is currently 
pending before the court of appeals.  

     I hope the foregoing will assist you in responding to your 
constituent.  

     Sincerely,  

     Stephen H. Greene  
     Acting Administrator of Drug Enforcement 
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-249</DOCNO>
<DOCOLDNO>IA087-000632-B041-122</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/dea-gras.html 206.61.184.43 19970122072000 text/html 2357
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:19:44 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:20 GMT
Content-length: 2142
</DOCHDR>
<HTML>
<PRE>
November 23, 1993  

Dear Senator Grassley:  

     This is in response to your letter of October 25, 1993, on 
behalf of your constituent, Mr. Carl E. Olsen.  

     As you are aware, your constituent has appealed the Drug 
Enforcement Administration's (DEA) nonacceptance of his petition 
to reschedule marijuana from Schedule I to Schedule II of the 
Controlled Substances Act to the United States Court of Appeals 
for the District of Columbia.  Pursuant to 21 U.S.C.  811, and 
interested party can petition the DEA to reschedule a controlled 
substance.  When such a petition is filed with the Drug 
Enforcement Administration, it is carefully evaluated to 
determine whether the petition meets the requirements of 21 
C.F.R.  1308.44.  Section (b) of that regulation requires that 
the petition conform to the format provided and be readily 
understood.  If the petition is accepted for filing, the 
Administrator will evaluate the petition on its merits.  If the 
petition is not accepted for filing, the Administrator will 
notify the petitioner of his decision and reasons thereof.  21 
C.F.R.  1308.44(c).  A copy of the regulation has been provided 
for your convenience.  

     Despite Mr. Olsen's contentions, the Administrator did not 
review the grounds upon which Mr. Olsen relied in his petition 
before refusing to accept his petition.  However, DEA has 
recognized that the requirement that a petition be accepted for 
filing absent some ambiguity or some defect in format was not met 
in this matter.  Therefore, in the pending case before the Court 
of Appeals, DEA has asked for a remand of the action in order 
that the Administrator may accept Mr. Olsen's petition for filing 
and review that petition on its merits.  The DEA is constrained 
from commenting further on the merits of Mr. Olsen's case since 
it is currently pending before the court of appeals.  

     I hope the foregoing will assist you in responding to your 
constituent.  

     Sincerely,  

     Stephen H. Greene  
     Acting Administrator of Drug Enforcement 
</PRE>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-250</DOCNO>
<DOCOLDNO>IA087-000632-B041-146</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/davis-2.html 206.61.184.43 19970122072020 text/html 1553
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:20:13 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:23 GMT
Content-length: 1338
</DOCHDR>
<HTML>
<PRE>
December 2, 1993  

Dear Mr. Olsen:  

     This replies to your July 21, 1993, letter concerning 
synthetic dronabinol (delta-9-THC).  

     In respect to the naturally extracted and synthetically 
manufactured dronabinol, the Drug Enforcement Agency has 
promulgated the enclosed regulation.  Please note that 
tetrahydrocannabinol is a Schedule I substance, but dronabinol, 
synthetic, in sesame oil and in a soft gelatin capsule, is a U.S. 
Food and Drug Administration approved drug product and is a 
Schedule II substance.  Both marijuana and tetrahydrocannabinol 
are Schedule I substances.  

     With respect to your other questions on marijuana, the 
original chemical researcher was Dr. Roger Adams of the 
University of Illinois chemistry department.  The pharmacology of 
the compounds was investigated by Dr. Seigried Lowe of the 
University of Utah.  A review of marijuana is given on page 549-
553 of Goodman and Gilman's The Pharmacological Basis of 
Therapeutics, 8th Edition, Pergamon Press, 1990.  

     Sincerely yours,  

     Harold Davis  
     Consumer Safety Officer  
     CDER Executive Secretariat Staff (HFD-8)  
     Center for Drug Evaluation and Research
     Food and Drug Administration
     5600 Fishers Lane
     Rockville, Maryland
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-251</DOCNO>
<DOCOLDNO>IA087-000632-B041-172</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/ruling.html 206.61.184.43 19970122072033 text/html 15033
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:20:22 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:54 GMT
Content-length: 14817
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="Carl E. Olsen">
</HEAD>

<BODY>

<PRE>
                   UNITED STATES DEPARTMENT OF JUSTICE

                     Drug Enforcement Administration

______________________________
In the Matter of              )
                              )
                              )
PETITION OF CARL ERIC OLSEN   )                On Remand From the
                              )                United States Court
                              )                of Appeals for the
                              )                District of Columbia
______________________________)                Circuit, No. 93-1109


                               FINAL ORDER


     This order is issued pursuant to an Order dated December 9, 1993, 

from the United States Court of Appeals for the District of Columbia 

Circuit which remanded the matter of a petition from Carl Eric Olsen to 

the Drug Enforcement Administration (DEA) for a ruling by the agency.

     On September 6, 1992, Carl Eric Olsen (Petitioner) of Des Moines, 

Iowa, submitted a petition requesting that the controlled substance 

marijuana, be rescheduled from Schedule I to Schedule II of the 

Controlled Substances Act of 1970 (CSA).  The Petitioner's grounds 

were based on his evaluation of two prior rescheduling actions by the 

Administrator.  See Rescheduling of Synthetic Dronabinol in Sesame Oil 

and Encapsulated in Soft Gelatin Capsules, 51 Fed. Reg. 17476 (1986) and 

Marijuana Rescheduling Petition, 57 Fed. Reg. 10499 (1992).  On October 

23, 1992, the-Administrator of Drug Enforcement, Robert C. Bonner, 

declined to accept his petition.  The Petitioner subsequently filed for 

review of then-Administrator Bonner's decision with the United States 

Court of Appeals for the District of Columbia
</PRE>
<HR>

<PRE>
Circuit.  The matter was remanded by Order of that Court to the DEA for a 

ruling.  Pursuant to that Court's Order, and 21 C.F.R. &#167; 1308.44(c), the 

Deputy Administrator of the Drug Enforcement Administration has 

considered the matters before him and thereby renders his final decision.

     In his Petition for rescheduling, the Petitioner alleged that 

marijuana need not have an accepted medical use in treatment in the 

United States in order to be rescheduled from Schedule I, but &quot;it only 

needs to be shown that marijuana is a source for an accepted and useful 

medication&quot;.  This contention was based on Petitioner's own analogies 

drawn from an earlier DEA marijuana rescheduling case, 57 Fed. Reg. 10499 

(1992), and subsequent written statements made to the Petitioner by then-

Administrator Bonner regarding coca leaves and opium plant material; and 

the Petitioner's incorrect contention that the DEA proposed to reschedule 

dronabinol in a proposed rulemaking.  See Rescheduling of Synthetic 

Dronabinol in Sesame Oil and Encapsulated in Soft Gelatin Capsules, 50 

Fed. Reg. 42186 (1985).  It appears that Petitioner contends that this 

rescheduling action included delta-9-tetrahydrocannabinol (delta-9-THC), 

an ingredient in marijuana, and concluded that &quot;since marijuana is now a 

source for an accepted and useful medication, it must now be rescheduled 

from Schedule I to Schedule II of the CSA&quot;.

     The Deputy Administrator finds, for the reasons stated herein, that 

the grounds upon which the Petitioner relies are not 


                                     2
</PRE>
<HR>

<PRE>
sufficient to justify the initiation of proceedings for the transfer of 

marijuana from Schedule I to Schedule II of the CSA. 

     In July 1992, the Petitioner wrote then-Administrator Bonner 

regarding his final order of March 26, 1992, (57 Fed. Reg. 10499), in 

which the Administrator declined to reschedule marijuana to Schedule II, 

and the apparent &quot;unfair&quot; classification of the marijuana plant as a 

Schedule I substance, while coca and opium plants remained in Schedule 

II.  Then-Administrator Bonner replied by letter on August 17, 1992, and 

distinguished the pharmaceuticals or derivative compounds from each 

plant.  Apparently, the Petitioner then created a theory, that given 

that the Schedule II opium and coca plants were a source for accepted 

medication, then if marijuana plants were a source for accepted 

medications it should also be a Schedule II substance.  To further his 

argument, the Petitioner pointed to the rescheduled drug, which he 

called dronabinol, as having its source in marijuana.  The Petitioner 

also alluded to inconsistencies of scheduling of delta-9-THC, a 

component of marijuana, between the CSA and certain multilateral 

international agreements.

     When the CSA was created, Congress specified the initial scheduling 

of controlled substances and the criteria by which controlled substances 

could be rescheduled.  21 U.S.C. &#167;&#167; 811-812.  The DEA is bound, by law, 

to follow this mandate.  Congress placed both the tetrahydrocannabinols, 

which includes delta-9-THC, and the plant marijuana into Schedule I when 

it enacted the


                                    3
</PRE>
<HR>

<PRE>
CSA.  See Pub. L. 91-513, &#167; 202(c), Schedule I (c)(17) and (c)(10). 

Similarly, Congress placed opium poppy and straw and coca leaves into 

Schedule II.  See Pub. L. 91-513, &#167; 202(c), Schedule II (a)(3) and 

 (a)(4).  The legislative history indicates that marijuana was placed 

into Schedule I on its own merits and not because delta-9-THC could be 

extracted from it.  H.R. Rep. No. 1444, 91st Cong., 2d Sess., pt. 1, at 

12 (1970).

     Whether or not marijuana is a source of delta-9-THC is irrelevant to 

the status of marijuana under the CSA.  With regard to the classification 

of controlled substances, the Attorney General may, by rule, add to the 

established schedules or transfer between such schedules and drug or 

other substance if [s]he finds that such drug or other substance has a 

potential for abuse, and makes with respect to such drug or other 

substance the findings prescribed by subsection (b) of Section 812 for 

the schedule in which such drug is to be placed.  21 U.S.C. &#167; 811(a)(1). 

The Attorney General has delegated this authority to the Administrator, 

who has redelegated it to the Deputy Administrator.  See 28 C.F.R. &#167;&#167; 

0.100(b) and 0.104.  (59 Fed. Reg. 23637 (May 6, 1994)).

     In order for a substance to be placed into Schedule II, the 

Attorney General must find that:  &quot;(A) The drug or other substance has a 

high potential for abuse.  (B) The drug or other substance has a 

currently accepted medical use in treatment in the United States or a 

currently accepted medical use with severe restrictions.  (C) Abuse of 

the drug or other substance may lead


                                    4
</PRE>
<HR>

<PRE>
 to severe psychological or physical dependence.&quot;  21 U.S.C. &#167; 812(b)(2).

     Then-Administrator John C. Lawn previously determined that marijuana 

does not have a currently accepted medical use in treatment in the United 

States and as a result must remain in Schedule I.  See Marijuana 

Rescheduling Petition, 54 Fed. Reg. 53767 (1989).  Then-Administrator 

Lawn's final order was appealed to the United States Circuit Court of 

Appeals for the D.C. Circuit which returned the matter to the DEA for an 

explanation of the factors relied upon in determining &quot;currently accepted 

medical use&quot;.  See Alliance for Cannabis Therapeutics v. DEA, 930 F.2d 

936 (D.C. Cir. 1991).

     In response to the remand, then-Administrator Bonner issued a final 

order in which he determined that for a substance to have a &quot;currently 

accepted medical use&quot; the following must exist: 

     a.   the drug's chemistry must be known and reproducible; 

     b.   there must be adequate safety studies; 

     c.   there must be adequate and well-controlled studies proving 

          efficacy; 

     d.   the drug must be accepted by qualified experts; and

     e.   the scientific evidence must be widely available. 

Then-Administrator Bonner concluded that marijuana failed to meet all 

elements of the five-part test and, therefore, did not meet the 

statutorily prescribed criteria for a Schedule II substance. 

Marijuana Rescheduling Petition, 57 Fed. Reg. 10499 (1992); See 


                                  5
</PRE>
<HR>

<PRE>
Alliance for Cannabis Therapeutics v. DEA, et al., 15 F.3d 1131 (D.C. 

Cir. 1994) upholding the Administrator's decision. 

     Accordingly, the Deputy Administrator concludes that the 

Petitioner's contention that marijuana need not have an accepted 

medical use in treatment in the United States in order to be 

rescheduled from Schedule I to Schedule II of the CSA is not in 

accordance with law.  DEA may only move a drug from Schedule I if 

there is a finding of &quot;currently accepted medical use in treatment in 

the United States&quot;.

     Although delta-9-THC is the principle psychoactive ingredient in 

marijuana, it can be synthesized and exist as a chemical. Delta-9-THC 

is a generic term which refers to four separate chemicals and two 

mixtures of chemicals, i.e., four stereochemical variants of the 

parent substance and two racemates.  One of the stereochemical 

variants, the (-) delta-9-trans-THC isomer, is the principle 

psychoactive ingredient in Cannabis sativa, L., or marijuana.  That 

isomer is also the ingredient in a pharmaceutical product which has 

been shown to be safe and effective as an anti-emetic for certain 

patients receiving cancer chemotherapy, and is identified chemically 

as (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-

dibenzo[b,d]-pyran-1-ol.  The International Nonproprietary name (INN) 

and the U.S. Adopted Name (USAN) for that isomer of delta-9-THC is 

dronabinol. 

     With the development of scientific and medical evidence that 

demonstrated that a pharmaceutical product which contained


                                  6
</PRE>
<HR>

<PRE>
dronabinol was safe and effective for the treatment of nausea and 

vomiting associated with cancer chemotherapy in certain patients, 

then-Administrator John C. Lawn rescheduled this pharmaceutical 

product from Schedule I to Schedule II. See 51 Fed. Reg. 17476 

 (1986).  Only the pharmaceutical product was transferred from 

Schedule I to Schedule II, i.e., &quot;dronabinol (synthetic) in sesame 

oil and encapsulated in soft gelatin capsules in a U.S. Food and Drug 

Administration approved drug product&quot;.  No rescheduling action was 

taken with regard to (-) delta-9-trans-THC, i.e., dronabinol, which 

remains in Schedule I of the CSA. Tetrahydrocannabinols, including 

delta-9-THC, one of the synthetic equivalents of the substances 

contained in the plant or resinous extractives of Cannabis 

(marijuana) are listed at 21 C.F.R. &#167; 1308.11(d)(25). 

     Tetrahydrocannabinols and all their isomers, including delta-9-

THC, are also the subject of control by international agreement under 

the United Nations Convention on Psychotropic Substances, 1971, 

February 21, 1971, 32 U.S.T. 543, T.I.A.S. 9725, 1019 U.N.T.S. 175. 

Cannabis, cannabis resin and extracts and tinctures of cannabis are 

regulated as Schedule I substances under the United Nations Single 

Convention on Narcotic Drugs, 1961, March 30, 1961, 18 U.S.T. 1407, 

T.I.A.S. 6298, 520 U.N.T.S. 204. The United States is a party to both 

conventions.

     Then-Administrator Lawn also discussed the United States 

international obligations in his Dronabinol in Sesame Oil and 

Encapsulated in a Soft Gelatin Capsule, rescheduling action. 


                                  7
</PRE>
<HR>

<PRE>
See 51 Fed. Reg. 17476 (1986). Since Article 7 of the Convention on 

Psychotropic Substances, 1971 has strict prohibitions on activities 

involving Schedule I drugs, in 1987, the United States Government 

initiated an action to have delta-9-THC transferred to Schedule II to 

allow the pharmaceutical product to be marketed. See U.N. Doc. 

E/CN.7/1990/4.  Such a transfer was not inconsistent with the 

substance delta-9-THC remaining in the CSA Schedule I. Under Article 

23 of the Convention on Psychotropic Substances, 1971, a party may 

adopt more strict or severe measures of control if desirable or 

necessary for the protection of the public health and welfare. 

     Under the CSA, the regulation of chemicals and the plant 

material are distinct from each other. The classification of delta-9-

THC has no bearing on the classification of marijuana. Under the CSA, 

a proposed change in the schedule of either a tetrahydrocannabinol or 

the plant marijuana requires the Attorney General to proceed 

independently. 

     Petitioner apparently does not wish to look to the clear 

construct of the Controlled Substances Act, but to pose alternative 

theories of the Act.  Under the CSA, drugs or other substances may be 

treated and classified differently, according to the enumerated 

statutory criteria. 21 U.S.C. &#167; 812(b). 

     The Deputy Administrator reaffirms that marijuana does not have 

a currently accepted medical use in treatment in the United States 

and is thus appropriately listed as a Schedule I controlled 

substance. The Deputy Administrator finds nothing to


                                  8
</PRE>
<HR>

<PRE>
support the petitioner's contention that since marijuana, coca, and 

opium are all plant materials they must be treated alike in the CSA. 

The Deputy Administrator further finds that the rescheduling of the 

pharmaceutical product &quot;dronabinol (synthetic) in sesame oil and 

encapsulated in a soft gelatin capsule in a U.S. Food and Drug 

Administration approved drug product&quot;, which contains the synthetic 

chemical ingredient (-) delta-9-trans-THC, did not require that 

either the plant marijuana or substance delta-9-THC be similarly 

rescheduled. The Petitioner's request is denied. 

      Stephen H. Greene
      Deputy Administrator

Dated: May 16, 1994 


                                  9
</PRE>

<P>
 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-252</DOCNO>
<DOCOLDNO>IA087-000632-B041-190</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/issues.html 206.61.184.43 19970122072041 text/html 2992
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:20:35 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:12:28 GMT
Content-length: 2777
</DOCHDR>
<html>
<pre>
                UNITED STATES COURT OF APPEALS
                 DISTRICT OF COLUMBIA CIRCUIT
________________________________________________________________

CARL ERIC OLSEN,

          Petitioner,                    No. 94-1605

     -vs-

DRUG ENFORCEMENT ADMINISTRATION,         PETITIONER'S STATEMENT
                                         OF THE ISSUES
          Respondent.
________________________________________________________________

     The Petitioner raises the following issues to be decided by

the Court:

     1.   Whether the Drug Enforcement Administration (DEA) 

Administrator erred in ruling that the DEA may only move 

marijuana from Schedule I of the Controlled Substances Act (CSA) 

if there is a finding of "currently accepted medical use in 

treatment in the United States."

     2.   Whether this court's ruling in Alliance for Cannabis 

Therapeutics v. DEA, 930 F.2d 936 (D.C. Cir. 1991) (upholding the 

DEA's decision not to move marijuana from Schedule I to Schedule 

II of the CSA, based on the lack of marijuana's "currently 

accepted medical use in treatment in the United States"), 

effectively overruled this court's prior ruling in National 

Organization for the Reform of Marijuana Laws v. DEA, 559 F.2d 

735 (D.C. Cir. 1977) (finding that marijuana could be moved to 

Schedule II without having a "currently accepted medical use in 

treatment in the United States").

     3.   Whether the Administrator of the DEA erred in ruling 

that the principal psychoactive ingredient in Cannabis sativa, L. 

(marijuana), the (-) delta-9-trans-THC isomer of delta-9-THC 

(dronabinol), 21 C.F.R.  1308.12(f)(1), remains in Schedule I, 

while the identical substance becomes a Schedule II substance 

when it is contained in a Food and Drug Administration (FDA) 

approved drug product (Marinol) "in sesame oil and encapsulated 

in a soft gelatin capsule."

     4.   Whether the Administrator of the DEA erred in ruling 

that the regulation of chemicals and their plant material sources 

are distinct from, and have no relationship to, each other.

     5.   Whether the Administrator of the DEA erred in ruling 

that the placement of marijuana in the CSA has no relationship to 

the scheduling of delta-9-THC, contrary to this court's ruling in 

United States v. Watson, 514 F.2d 201 (D.C. Cir. 1975).  

     6.   Whether the Administrator of the DEA erred in ruling 

that plant materials are not treated consistently in the CSA.

     Respectfully submitted,

     ___________________________________
     Carl E. Olsen
     Post Office Box 4091
     Des Moines, Iowa 50333
     (515) 243-7351
</pre>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-253</DOCNO>
<DOCOLDNO>IA087-000632-B041-212</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/shulgin.html 206.61.184.43 19970122072054 text/html 8615
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:20:45 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:49 GMT
Content-length: 8400
</DOCHDR>
<HTML>
<PRE>
Date: Sat, 21 Jan 1995
From: (Alexander T. Shulgin)
To: carlolsen@dsmnet.com
Subject: old letters


Hi:

I think these are the two files that you wanted.  It is awful 
to lose stuff from the hard disk, when there is no one else to 
blame.

----------------

olsen-01.ats

----------------

Hello Carl:

Thanks for the letter.  Let me see if I can answer your questions 
without waiving my hands around.

(1)  How many isomers are there of the THC molecule?

There is delta-1 THC (using a different numbering system, this is 
also known as delta-9 THC).  It has two asymmetric centers, and 
so it can exist in a trans- or as a cis-form (known as 
stereoisomers) and each of these forms is resolvable into a 
dextro- and a levo-component (known as optical isomers).  Putting 
this into a box form, you have:


                    trans-pair (stereo)         cis-pair (stereo)


     dextro-           d-(trans)-delta-1          d-(cis)-delta-1
     (optical)              THC **                     THC


     levo-             l-(trans)-delta-1          l-(cis)-delta-1
     (optical)              THC *                      THC


which adds up to four isomers.

There is also delta-6 THC (same as delta-1(6) THC or, with a 
different numbering systems delta-8 THC).  Using the same square 
as with the delta-1 isomer, we have:


                    trans-pair (stereo)         cis-pair (stereo)


     dextro-           d-(trans)-delta-6          d-(cis)-delta-6
     (optical)              THC                        THC


     levo-             l-(trans)-delta-6          l-(cis)-delta-6
     (optical)              THC                        THC



which totals another four isomers.

There is a third isomer explicitly named in the law, not a 
natural material, but a laboratory product that had been studied 
in the early days of the chemistry of these compounds.  This is 
called delta-3,4 THC (or delta-6a,10a THC with the other 
numbering system).  Here the two optically active carbon atoms 
that allowed the cis-trans argument now carry the double bond 
(the meaning of the term delta) but a new optically active site 
has been opened up at the 1- (9-) position.  So there can be a 
dextro-form and a levo-form (optical isomers) but no cis- or 
trans-pairs.  This totals to another two isomers.  Thus the 
answer to your first question, there are ten possible isomers of 
THC to be considered in the halls of law enforcement.

(2)  What is an isomer?

That depends upon who you ask, and in what context.  Literally, 
iso- means the "same", and -mer is from meros, meaning "part."  
In common chemical usage, it is generally taken to mean that the 
same atoms are there (in terms of which elements and how many of 
them), but they are just hooked up differently.  And when there 
are describing (or limiting) prefixes, they emphasize just how 
these different hookups are most readily recognized.  
     
Stereoisomers are distinguished by the differences in shape.  
Think of a hand in a five-fingered rubber glove, making all kinds 
of different forms, but always with the same amount of hand 
inside the glove.  A fist shape and a splayed finger shape would 
be stereoisomers.

Optical isomers are distinguished by their mirror-image 
relationships.  Two molecules not superimposable but are in every 
other way identical.  Put a rubber glove on your right hand, and 
another on your left.  They are identical, except that cannot be 
superimposed.  One is the mirror reflection of the other.

Positional isomers are defined as have certain groups as being 
over there rather than over here.  Consider a conventional rubber 
glove (the thumb-shaped covering at position one) and then 
another with the thumb position where the third finger usually 
is, and the third finger position at the thumb's location.  These 
are positional isomers, with the finger positions being the 
rearranged factor.

The authors of the law, and thus the DEA, are quite inconsistent 
in the use of this term.  Since you have the Controlled 
Substances Manual, check out the first full paragraph on page 226 
for some insight into this confusion (page 212 if you have the 
first edition).

(3)  Is delta-9 THC an isomer, or does it have isomers of its 
own?


Look up at the first box.  All for named items are isomers of 
delta-9 THC (the trans- and cis-pairs, and the optical isomers of 
each pair).  Thus delta-9 THC can exist in any of four isomeric 
forms.  This is pretty close to saying that delta-9 THC has its 
own isomers.

But, in common parlance, the term delta-9 THC is very often used 
for the natural component of cannabis, the active component, and 
this is explicitly the trans, levo-isomer of delta-9 THC.  This 
is the lower left isomer in that box, the one marked with a "*".  
If this is the sense in which the term delta-9 THC is used (and 
it is so used frequently and casually) then it is an isomer, the 
natural isomer, the one with the * above.

The answer to this question depends exactly on what the asker has 
in mind when he uses the term delta-9 (or, delta-1) THC.  
Remember, that the two names are synonymous.

One final caveat.  The delta-9 THC that is the material used in 
the Schedule II drug known as Dronabinol is something yet 
different than any of these.  It is a synthetic material, and is 
isolated as the trans- material, but I do not believe that it is 
resolved into its optical isomers.  Thus, in this context, delta-
9 THC is a 50:50 mixture of l-(trans)-delta-9 THC and d-(trans)-
delta-9 THC.  This is a 50:50 mixture of the one * and the two ** 
things in the first box above. 

To summarize:

When the term delta-1 (delta-9) THC is used to represent the 
active factor of cannabis, it is the isomer with the one *.

When the term delta-1 (delta-9) THC is used to represent the 
active component in the Schedule II drug, it is a 50:50 mixture 
of the one * and two ** isomers.  

When the term delta-1 (delta-9) THC is used to represent the 
chemical concept without stereo- or optical-designations, then 
the term embraces all four isomers in that first box.  

Hope this helps.  It is a one hour lecture distilled down into a 
ten minute note.

Sasha

---------------------

olsen-02.ats

---------------------

Hi Carl:

I have just now been looking with more care at the package insert
that accompanies the commercial Marinol, Dronabinol, and also the

PDR, and both of them give the chemical name as:

(6a-R-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-
dibenzo[b,d]pyran-1-ol

and the Merck index refers to these commercial drugs as

(-)-delta1-3,4-trans-form

I had assumed, without checking, that the synthetic material was 
the racemate (the two trans isomers in the first of the diagrams 
I sent you.  But the letter "R" in the first name, and the minus
sign "-" in the second name, both attest to the fact that the
synthetic drug (the component of the schedule II item) is indeed
a single isomer.  Thus the term delta-1 THC (delta-9 THC) means 
not three things, but only two.  As a general term, it can be all 
four of those isomers, individually or collectively.  As a 
botanical term, it is the one specific isomer in that collection, 
the l-trans delta-1 isomer (the first "l" is the letter ell, as 
the first letter of levo, or rotating to the left and the second 
is the number "1").  And so is the synthetic.  

And, as to your other question, no, the two isomers cannot be 
isolated from the plant, as only one is there.  

To summarize:

     l-trans- (the letter ell)
     levo-trans
     6a-R-trans
     
all refer to the natural (as well as the synthetic) delta-1 THC, 
that is apparently prepared from optically active starting
materials.

     dl-trans
     racemic trans
     6a without the R but with the trans

all refer to an optically inactive form of delta-1 THC, still
trans, but containing an isomer that is not found in nature, and
that is not in the drug Marinol.

     delta-1 THC can refer to any or all of the four isomers, 
both trans and cis, both levo and dextro.

Sorry about the wrong assumption above.  Hope this makes 
everything clearer.

Sasha
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-254</DOCNO>
<DOCOLDNO>IA087-000632-B041-234</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/order.html 206.61.184.43 19970122072109 text/html 1880
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:21:02 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:12:18 GMT
Content-length: 1665
</DOCHDR>
<HTML>
<PRE><CENTER>UNITED STATES COURT OF APPEALS
DISTRICT OF COLUMBIA CIRCUIT</CENTER>

No. 94-1605                           September Term, 1994
                                      United States Court of Appeals
                                      for the District of Columbia Circuit
Carl Eric Olsen, Petitioner           FILED AUG 25 1995
v.
Drug Enforcement Administration, Respondent

<CENTER>O R D E R</CENTER><BR>
     It appearing that the above case may fall within the intent and
purpose of Rule 34(j) of the Circuit Rules of this Court and may also
meet one or more of the criteria set forth in that rule, it is ORDERED,
sua sponte, that a briefing schedule be established as follows:

          Appellant(s)/Petitioner(s) Brief and Appendix           10/6/95

          Appellee(s)/Respondent(s) Brief                         11/6/95

          Appellant(s)/Petitioner(s) Reply Brief                  11/20/95

     This notice does not preclude the court, after examination of the
briefs, from setting this case for oral argument.  If this case is
accorded 34(j) treatment, an order will be issued disclosing the panel
prior to decision on the merits of the case.

     All parties should include the following phrase on any pleading or
brief hereinafter filed in this case:  "CASE BEING CONSIDERED FOR
TREATMENT PURSUANT TO RULE 34(j) OF THE GENERAL RULES".

                             FOR THE COURT:
                             Mark J. Langer, Clerk

                             BY:
                             Mary Anne McMain, Deputy Clerk


Order 93-34j (April 1992/Jan 1994)
</PRE>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-255</DOCNO>
<DOCOLDNO>IA087-000632-B041-260</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/BRIEF2/brief2.html 206.61.184.43 19970122072136 text/html 1206
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:21:14 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:09:22 GMT
Content-length: 992
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Petitioner's Brief - September 18, 1995</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" link="#0000FF"
vlink="#FF00FF" alink="#FF0000">

<h4 align="center">IN THE UNITED STATES COURT OF APPEALS<br>
FOR THE DISTRICT OF COLUMBIA CIRCUIT<br>
No. 94-1605</h4>

<p align="center">CARL ERIC OLSEN, Petitioner,<br>
v.<br>
DRUG ENFORCEMENT ADMINISTRATION, Respondent.</p>

<p align="center">Petition for Review of an order of the<br>
Drug Enforcement Administration<br>
Petitioner's Brief</p>

<h4 align="center"><a href="brief2-1.html">Click here for part 1</a><br>
<a href="brief2-2.html">Click here for part 2</a> </h4>

<pre>
					Carl Eric Olsen, Pro se
					Post Office Box 4091
					Des Moines, Iowa 50333
					(515) 262-6957
</pre>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-256</DOCNO>
<DOCOLDNO>IA087-000632-B042-40</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/dea95-1.html 206.61.184.43 19970122072220 text/html 28490
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:22:10 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:10 GMT
Content-length: 28274
</DOCHDR>
<html>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#C000C0">
<pre><b>
_________________________________________________________________
_________________________________________________________________
              CASE BEING CONSIDERED FOR TREATMENT
          PURSUANT TO RULE 34(j) OF THE GENERAL RULES

             IN THE UNITED STATES COURT OF APPEALS
              FOR THE DISTRICT OF COLUMBIA CIRCUIT
                     ______________________

                          No. 94-1605
                     ______________________

                        CARL ERIC OLSEN,

                           Petitioner,

                                v.

                 DRUG ENFORCEMENT ADMINISTRATION,

                           Respondent.
                     ______________________

              PETITION FOR REVIEW OF AN ORDER OF THE
                 DRUG ENFORCEMENT ADMINISTRATION
                     ______________________

                    BRIEF FOR THE RESPONDENT
                     ______________________

                         JOHN C. KEENEY
                           Acting Assistant Attorney General
                         THERESA M.B. VAN VLIET
                           Chief
                         LENA WATKINS
                         JOHN J. FARLEY
                           Trial Attorneys
                           Narcotic and Dangerous Drug Section
                           Criminal Division
                           U.S. Department of Justice
                           P.O. Box 27312, Central Station
                           Washington, D.C. 20038
                           (202) 514-0917

OF COUNSEL:

DENNIS F. HOFFMAN
Drug Enforcement Administration

_________________________________________________________________
_________________________________________________________________
</b>
<HR>
                        <B>TABLE OF CONTENTS</B>

                                                             <B>PAGE</B>

TABLE OF AUTHORITIES  . . . . . . . . . . . . . . . . . . . .  ii

CERTIFICATE AS TO PARTIES, RULINGS, AND RELATED CASES . . . .   v

GLOSSARY  . . . . . . . . . . . . . . . . . . . . . . . . . .  vi

STATEMENT OF THE ISSUE  . . . . . . . . . . . . . . . . . . .   1

STATUTES AND REGULATIONS  . . . . . . . . . . . . . . . . . .   1

STATEMENT OF THE CASE . . . . . . . . . . . . . . . . . . . .   2
     I.   STATUTORY AND REGULATORY BACKGROUND . . . . . . . .   2
     II.  THE CURRENT PROCEEDINGS . . . . . . . . . . . . . .   5

SUMMARY OF THE ARGUMENT . . . . . . . . . . . . . . . . . . .   8

ARGUMENT  . . . . . . . . . . . . . . . . . . . . . . . . . .   9
     I.   STANDARD OF REVIEW  . . . . . . . . . . . . . . . .   9

     II.  CONGRESS, DEA, AND THE COURTS HAVE ALL FOUND THAT
          MARIHUANA IS PROPERLY IN SCHEDULE I OF THE CSA AND
          MUST REMAIN THERE UNTIL IT SATISFIES THE CRITERIA
          IN 21 U.S.C. 812(b).  . . . . . . . . . . . . . . .  10

     III. DEA PROPERLY FOUND THAT THE PETITION WAS NOT
          SUFFICIENT TO JUSTIFY ADDITIONAL RESCHEDULING
          PROCEEDINGS BECAUSE THE PETITION WAS PREMISED ON
          THE INCORRECT BELIEF THAT A SCHEDULE I DRUG MUST
          BE RESCHEDULED IF IT IS THE SOURCE OF AN ACCEPTED
          AND USEFUL MEDICATION.  . . . . . . . . . . . . . .  13

          A.   THE PETITIONER'S ARGUMENT  . . . . . . . . . .  13

          B.   THE CSA DOES NOT MANDATE THAT A SCHEDULE I
               DRUG MUST BE RESCHEDULED IF IT IS THE SOURCE
               OF AN ACCEPTED AND USEFUL MEDICATION BUT
               REQUIRES DEA TO MAKE INDIVIDUAL FINDINGS
               ABOUT A PARTICULAR DRUG PRIOR TO RESCHEDULING
               IT.  . . . . . . . . . . . . . . . . . . . . .  14

     IV.  THE ADMINISTRATOR PROPERLY DENIED THE PETITION
          BECAUSE IT RELIED ON THE INCORRECT ASSUMPTION THAT
          DRONABINOL HAS BEEN MOVED TO SCHEDULE II WHEN IN
          FACT ONLY A SINGLE PHARMACEUTICAL PRODUCT HAS BEEN
          MOVED TO SCHEDULE II. . . . . . . . . . . . . . . .  19

CONCLUSION  . . . . . . . . . . . . . . . . . . . . . . . . .  23


                                ii
<hr>
                       <B>TABLE OF AUTHORITIES</B>

<B>CASES                                                        PAGE</B>

Alliance for Cannabis Therapeutics v. Drug Enforcement
     Administration, 15 F.3d 1131 (D.C. Cir. 1994)  . 3,16,18,19*

Alliance for Cannabis Therapeutics v. Drug Enforcement
   Administration, 930 F.2d 936 (D.C. Cir. 1991)  . . . . 2,3,16*

Chevron U.S.A., Inc. v. Natural Resources Defense Council,
     Inc., 467 U.S. 837 (1984)  . . . . . . . . . . . .  10,16,17

Cutler v. Hayes, 818 F.2d 879 (D.C. Cir. 1987)  . . . . . . 21,22

Fertilizer Institute v. United States Environmental
   Protection Agency, 935 F.2d 1303 (D.C. Cir. 1991)  . . . .  22

Grinspoon v. Drug Enforcement Admin., 828 F.2d 881
     (lst Cir. 1987)  . . . . . . . . . . . . . . . . . . . .  21

Independent Insurance Agents of America, Inc. v. Ludwig,
     997 F.2d 958 (D.C. Cir. 1993)  . . . . . . . . . . . . .  18

National Organization for the Reform of Marijuana Laws v.
     Bell, 488 F. Supp. 123 (D.D.C. 1980) . . . . .  12,14,16,19*

National organization for the Reform of Marijuana Laws v.
   Drug Enforcement Admin., 559 F.2d 735 (D.C. Cir. 1977) .  3,16

National Organization for the Reform of Marijuana Laws v.
     Ingersoll, 497 F.2d 654 (D.C. Cir. 1974) . . . . . . . . . 3

Olsen v. Drug Enforcement Admin., 776 F.2d 267 (llth Cir.
     1985), cert. denied, 475 U.S. 1030 (1986)  . . . . . . . . 7

Olsen v. Iowa, 808 F.2d 652 (8th Cir. 1986) . . . . . . . . . . 6

Olsen v. State, Civ. No. 83-301-E, 1986 WL 4045 (S.D. Iowa
     March 19, 1986)  . . . . . . . . . . . . . . . . . . . . . 6

Randolph-Sheppard Vendors of America v. Weinberger, 795 F.2d
     90 (D.C. Cir. 1986)  . . . . . . . . . . . . . . . . . 21-22

State v. Olsen, 315 N.W.2d 1 (Iowa 1982)  . . . . . . . . . . . 6

USAA Federal Savings Bank v. McLaughlin, 849 F.2d 1505
     (D.C. Cir. 1988) . . . . . . . . . . . . . . . . . . . .  18

____________________

     *  Authorities chiefly relied upon.

                               iii
<hr>
United States v. Fogarty, 692 F.2d 542 (8th Cir. 1982),
     cert. denied, 460 U.S. 1040 (1983) . . . . . . . . . . 12,16

United States v. Greene, 892 F.2d 453 (6th Cir. 1989), cert.
     denied, 495 U.S. 935 (1990)  . . . . . . . . . . . . . .  12

United States v. Middleton, 690 F.2d 820 (11th Cir. 1982),
     cert. denied, 460 U.S. 1051 (1983) . . . . . . . . . . .  12

United States v. Rush, 738 F.2d 497 (lst Cir. 1984), cert.
     denied, 470 U.S. 1004 (1985) . . . . . . . . . . . . . . . 6

United States v. Walton, 514 F.2d 201 (D.C. Cir. 1975)  . . .  15

United States v. Whitley, 734 F.2d 1129 (6th Cir. 1984) . . .  18

<B>REGULATIONS</B>

21 C.F.R.:
     1307.03  . . . . . . . . . . . . . . . . . . . . . . . . . 6
     1308.11  . . . . . . . . . . . . . . . . . . . . .  16-17,20
     1308.12  . . . . . . . . . . . . . . . . . . . . . . . .  20
     1308.44  . . . . . . . . . . . . . . . . . . . . . . .  9-10

28 C.F.R.:
     0.100(b) . . . . . . . . . . . . . . . . . . . . . . . . . 3
     0.104  . . . . . . . . . . . . . . . . . . . . . . . . . . 3

50 Fed. Reg. 42,186 . . . . . . . . . . . . . . . . . . . . 19,21

51 Fed. Reg. 17,476 . . . . . . . . . . . . . . . . . . .  20,21*

51 Fed. Reg. 22,946 . . . . . . . . . . . . . . . . . . . . . . 3

54 Fed. Reg. 53,767 . . . . . . . . . . . . . . . . . . . 3,6,16*

57 Fed. Reg. 10,499 . . . . . . . . . . . . . . . . .  3,4,16,20*

58 Fed. Reg. 25,790 . . . . . . . . . . . . . . . . . . . . .  16

<B>STATUTES</B>

5 U.S.C.:
     706  . . . . . . . . . . . . . . . . . . . . . . . . . 10,26

21 U.S.C.:
     811  . . . . . . . . . . . . . . . . . . . . 2,6,9,10,12,15*
     812  . . . . . . . . . . . . . . . . . . .  2,4,10,14-17,21*
     877  . . . . . . . . . . . . . . . . . . . . . . . . .  8,10
____________________

     *  Authorities chiefly relied upon.

                                iv
<hr>
<B>MISCELLANEOUS</B>

H. Rep. No. 1444, 81st Cong., 2nd Sess., reprinted in 1970
  U.S.C.C.A.N. 4566 . . . . . . . . . . . . . . . . . . . . 11-12

                                     v
  
     <B>CERTIFICATE AS TO PARTIES, RULINGS, AND RELATED CASES</B>


<b>A.   Parties and Amici</b>

     All parties, intervenors, and amici appearing before the

agency and in this court are listed in the Petitioner's Brief.


<b>B.   Rulings Under Review</b>

     References to the ruling at issue appear in the Petitioner's

Brief.  The ruling is reproduced on pages 17-25 of the

Petitioner's Appendix.


<b>C.   Related Cases</b>

     This matter was previously before this court in Olsen v.

Drug Enforcement Admin., No. 93-1109 (D.C. Cir. Dec. 9, 1993).

In that case, the court granted DEA's motion for remand.

     References to related cases in the Petitioner's Brief

accurately identify cases before this court that previously

addressed the scheduling of marihuana.  Another case addressing

the scheduling of marihuana is National Org. for the Reform of

Marijuana Laws v. Bell, 488 F. Supp. 123 (D.D.C. 1980) (three

judge court).

                                vi
<hr>
                             <b>GLOSSARY</b>

CSA - Controlled Substances Act, 21 U.S.C. 801 et seq.

DEA - U.S. Drug Enforcement Administration

FDA - U.S. Food and Drug Administration

HEW - U.S. Department of Health, Education, and Welfare

THC - tetrahydrocannabinol

                               vii
<hr>
              CASE BEING CONSIDERED FOR TREATMENT
          PURSUANT TO RULE 34(j) OF THE GENERAL RULES

             IN THE UNITED STATES COURT OF APPEALS
              FOR THE DISTRICT OF COLUMBIA CIRCUIT
                     ______________________

                          No. 94-1605
                     ______________________

                        CARL ERIC OLSEN,

                           Petitioner,

                                v.

                 DRUG ENFORCEMENT ADMINISTRATION,

                           Respondent.
                     ______________________

              PETITION FOR REVIEW OF AN ORDER OF THE
                 DRUG ENFORCEMENT ADMINISTRATION
                     ______________________

                    BRIEF FOR THE RESPONDENT
                     ______________________
   
                     <B>STATEMENT OF THE ISSUE</B>

     Whether the Drug Enforcement Administration properly

rejected the petitioner's theory that marihuana plants should be

moved from Schedule I to Schedule II of the Controlled Substances

Act because marihuana plants are a source of an accepted and

useful medication when the petitioner's theory was based solely

upon language in an informal letter and was contradicted directly

by the plain language of the Controlled Substances Act.

                     <B>STATUTES AND REGULATIONS</B>

     Except for those already included in the Addendum to the

Petitioner's Brief, the pertinent statutes and regulations are

set forth in an addendum bound with this brief.

                                1
<HR>
                       STATEMENT OF THE CASE

I.   STATUTORY AND REGULATORY BACKGROUND

     In response to the growing drug problem in the United

States, Congress in 1970 passed the Controlled Substances Act, <a href="http://www.law.cornell.edu/uscode/21/801.html">21

U.S.C. 801 <i>et seq.</i></a> ("CSA").  The CSA classifies various hazardous

drugs into five schedules.  <i>Id</i>. <a href="http://www.law.cornell.edu/uscode/21/812.html">812</a>.  Restrictions upon use and

access to a particular drug vary based upon the drug's schedule

status in the CSA.  Drugs in Schedule I are subject to more

severe restrictions than drugs in the other schedules.  See

<i>Alliance for Cannabis Therapeutics</i> v. <i>Drug Enforcement Admin.</i>,

930 F.2d 936, 937 (D.C. Cir. 1991).  Congress placed marihuana in

Schedule I of the CSA.<A HREF="#1">1</A>  21 U.S.C. 812(c), Schedule I(c)(10).

     Although Congress made the initial scheduling decisions, the

CSA specifically permits the Attorney General to add a substance

to a schedule, transfer a substance from one schedule to another

or remove a substance from the schedules entirely.  <i>Id</i>. <a href="http://www.law.cornell.edu/uscode/21/811.html">811</a>(a).

The Attorney General may only transfer a substance to a different

schedule if she "finds that such drug or other substance has a

potential for abuse" and makes findings that the drug or

substance meets the requirements for the new schedule.  <i>Id</i>.  The

findings required for placing a substance in a particular

schedule are listed in 21 U.S.C. 812(b).  The Attorney General

has delegated the authority to reschedule controlled substances

____________________

     <A NAME="1">1</A>    The substance is called "marihuana" in the CSA and the
respondent will use that spelling throughout this brief.
However, where the spelling "marijuana" is used in a quoted
passage, the spelling has not been changed.

                                2
<HR>
to the Administrator of the Drug Enforcement Administration

("DEA").  28 C.F.R. 0.100(b).  The Drug Enforcement Administrator

("Administrator") has further delegated this authority to the

Deputy Administrator.  28 C.F.R. 0.104.

     For over 20 years, various groups and individuals have asked

DEA to exercise its authority to move marihuana from Schedule I

to a less restrictive schedule or to remove marihuana from the

CSA schedules entirely.  See <i>Alliance for Cannabis Therapeutics</i>

v. <i>Drug Enforcement Admin.</i>, 15 F.3d 1131 (D.C. Cir. 1994);

<i>Alliance for Cannabis Therapeutics</i>, 930 F.2d at 937; <i>National

Org. for the Reform of Marijuana Laws</i> v. <i>Drug Enforcement Admin.</i>,

559 F.2d 735 (D.C. Cir. 1977); <i>National Org. for the Reform of

Marijuana Laws</i> v. <i>Ingersoll</i>, 497 F.2d 654 (D.C. Cir. 1974).

Despite these efforts, in March of 1992, the Administrator issued

a final order denying a petition to reschedule marihuana from

Schedule I to Schedule II of the CSA.  See 57 Fed. Reg. 10,499

(1992).<A HREF="#2">2</A>

     The Administrator relied upon the language of the CSA in

____________________

     <A NAME="2">2</A>    DEA's review of the rescheduling petition was quite
extensive.  DEA issued a notice of a hearing on the rescheduling
petition in 1986.  See 51 Fed. Reg. 22,946 (1986).  After
hearings before an administrative law judge, the Administrator
issued findings of fact and conclusions of law that determined
that marihuana should not be moved from Schedule I because the
marihuana plant has no currently accepted medical use and because
it is not safe for use, even under medical supervision.  See 54
Fed. Reg. 53,767, 53,784 (1989).  On appeal, this court generally
upheld the Administrator's decision but remanded the matter for
clarification.  See <i>Alliance for Cannabis Therapeutics</i>, 930 F.2d
at 940-941.  On remand, the Administrator again found that
marihuana plants should remain in Schedule I.  See 57 Fed. Reg.
at 10,507-10,508.  The latter decision was affirmed by this Court
in <i>Alliance for Cannabis Therapeutics</i>, 15 F.3d at 1137.

                                3
<HR>
making his determination.  Under the CSA, a drug or substance may

not be placed in Schedule II absent findings that:

     (A)  The drug or other substance has a high
          potential for abuse.

     (B)  The drug or other substance has a currently
          accepted medical use in treatment in the
          United States or a currently accepted medical
          use with severe restrictions.

     (C)  Abuse of the drug or other substances may
          lead to severe psychological or physical
          dependence.

21 U.S.C. 812(b)(2)(A)-(C).

     In the Administrator's final order, he concluded that the

marihuana plant had no currently accepted medical use and thus

could not be placed in schedule II.  57 Fed. Reg. at 10,499.

The Administrator applied a five-part test for determining

whether a substance had a currently accepted medical use:

     (1)  the drug's chemistry must be known and reproducible;

     (2)  there must be adequate safety studies;

     (3)  there must be adequate and well-controlled
          studies proving efficacy;

     (4)  the drug must be accepted by qualified experts; and

     (5)  the scientific evidence must be widely available.

57 Fed. Reg. at 10,504-10,507.  After reviewing the evidence in

the record, the Administrator found that marihuana could not

satisfy a single one of these criteria.  <i>Id</i>. at 10,507.  These

findings, as well as other findings of fact and conclusions of

law, resulted in the denial of the marihuana rescheduling

petition.

                                4
<HR>
<B>II.  THE CURRENT PROCEEDINGS</B>

     On July 21, 1992, the petitioner sent a letter to then-

Administrator Robert C. Bonner in which he raised several 

questions about the Administrator's final order.  In the letter, 

the petitioner appeared to agree with the Administrator's finding

that marihuana, as a plant, failed to satisfy the first part of

the test for determining a currently accepted medical use because

a plant such as marihuana is not a scientifically established

compound capable of reproduction in standard dosages.  A. 1.<A HREF="#3">3</A>

The petitioner's letter then asked why coca and opium plants (the

sources of cocaine, morphine, and heroin) were placed in Schedule

II.  <I>Id</I>.  If, the petitioner reasoned, coca and opium plants are

subject to the same scientific variances as marihuana plants,

then DEA is "treating marijuana unfairly."  <I>Id</I>.  The petitioner

suggested either removing all plants from the CSA schedules

because they "will never fit into your definition of drugs" or

changing the definition to account for the inconsistency in the

treatment of the different plants.  <I>Id</I>.

     On August 17, 1992, Administrator Bonner sent the petitioner

a response to his letter.  A. 5.  In the response, the

Administrator rejected the petitioner's attempt to analogize

marihuana plants to coca and opium plants.  <I>Id</I>.  The

Administrator explained that when Congress placed coca leaves and

opium plant materials in Schedule II, it was aware that these

____________________

     <A NAME="3">3</A>    "A." references are to the bound appendix submitted by
the petitioner with his brief.

                                5
<HR>
plants had been recognized historically as the source for a

variety of accepted and useful medications.  <I>Id</I>.  The plants

contain medically active alkaloids that can be extracted and used

to produce pharmaceutical compounds capable of reproduction in

standardized doses.  <I>Id</I>.  In contrast, the Administrator pointed

out that the recent attempts to reschedule marihuana were not

grounded on claims that medically useful compounds could be

extracted from marihuana, but rather that smoking marihuana

itself produced medical benefits.  <I>Id</I>.  Thus, the Administrator

found the scheduling decisions to be reconcilable.  <I>Id</I>. at 5-6.

     The petitioner, proceeding t)ro se, then filed a formal

request for the rescheduling of marihuana pursuant to 21 U.S.C.

811 and 21 C.F.R. 1307.03.<A HREF="#4">4</A>  A. 2-4.  In his petition, he drew

an analogy from language in the Administrator's letter of August

17, 1992.  He reasoned that if coca leaves and opium plants could

be placed in Schedule II because they are sources of accepted and

____________________

     <A NAME="4">4</A>    The petitioner has frequently litigated issues related
to the legal treatment of marihana.  He challenged several
criminal convictions by arguing that marihuana smoking was
protected by the free exercise clause of the First Amendment and
the equal protection clause of the Fourteenth Amendment.  See
<I>Olsen</I> v. <I>Iowa</I>, 808 F.2d 652, 653 (8th Cir. 1986); <I>United States</I>
v. <I>Rush</I>, 738 F.2d 497, 511-513 (lst Cir. 1984), cert. denied, 470
U.S. 1004 (1985); <I>State</I> v. <I>Olsen</I>, 315 N.W.2d 1, 7-9 (Iowa 1982).
Additionally, the petitioner has brought numerous civil actions
seeking to obtain judicial authorization to use marihuana.  See
<I>Olsen</I> v. <I>Drug Enforcement Admin.</I>, 878 F.2d 1458, 1461-1465 (D.C.
Cir. 1989), cert. denied, 495 U.S. 906 (1990); <I>Olsen</I> v. <I>Drug</I>
<I>Enforcement Admin.</I>, 776 F.2d 267, 268 (llth Cir. 1985), cert.
denied, 475 U.S. 1030 (1986); <I>Olsen</I> v. <I>State</I>, Civ.  No. 83-301-E,
1986 WL 4045, at *1 (S.D. Iowa March 19, 1986).  The petitioner
also participated in the administrative proceedings where the DEA
considered a petition to reschedule marihuana from Schedule I to
Schedule II of the CSA.  See 54 Fed. Reg. at 53,767.

                                6
<HR>
useful medications, then marihuana plants could be placed in

schedule II if marihuana is shown to be "a source for an accepted

and useful medication."  A. 3.  The petitioner then noted that

dronabinol, a synthetic equivalent of the isomer which is the

principle psychoactive substance in marihuana, has been

rescheduled to Schedule II.  <I>Id</I>.  Because marihuana is the source

of an accepted and useful medication, dronabinol, the petitioner

reasoned that marihuana must be moved to Schedule II of the CSA.

Id. at 4.  The petitioner then requested that the Administrator

reschedule marihuana from Schedule I to Schedule II of the CSA.

Id. at 2.<A HREF="#5">5</A>

     The Administrator initially refused to accept the

rescheduling petition because dronabinol is a wholly synthetic

substance and is not obtained from marihuana.  A. 7.  However,

after the petitioner appealed, DEA voluntarily asked this court

to remand the petition for a ruling.  This court remanded the

petition in an Order dated December 9, 1993.  See <I>Olsen</I> v. <I>Drug</I>

<I>Enforcement Admin.</I>, No. 93-1109 (D.C. Cir. Dec. 9, 1993).

     On May 16, 1994, Deputy Administrator Stephen H. Greene

issued a nine-page final order denying the petition.  A. 17.  The

final order explained that Congress placed marihuana in Schedule

I.  A. 19-20.  It rejected the petitioner's analogy, finding that

marihuana can only be moved from Schedule I if there is a finding

that marihuana has a "currently accepted medical use in treatment

____________________

      <A NAME="5">5</A>    The petitioner did not ask DEA to reschedule any other
substances.

                                7
<HR>
in the United States."  A. 22.  The order acknowledged that (-)

delta-9-trans-THC isomer, the principal psychoactive ingredient

in marihuana, is also the ingredient in a pharmaceutical product

that has proven to be a safe and effective anti-emetic for

patients receiving cancer chemotherapy.  <I>Id</I>.  However, the order

noted that only a very specific synthetic dronabinol product was

rescheduled to Schedule II -- "dronabinol ("synthetic) in sesame

oil and encapsulated in a soft gelatin capsule" in a drug product

approved by the Food and Drug Administration ("FDA").  A. 23.

The order further stated that the regulation of plants and

chemicals under the CSA is distinct and that the CSA requires the

independent evaluation of each individual controlled substance.

A. 24.  The final order reaffirmed that marihuana plants have no

currently accepted medical use in treatment and found that the

rescheduling of one pharmaceutical product did not require DEA to

transfer marihuana plants or any other substance to Schedule II.

A. 24-25.

     The petitioner has appealed the final order to this court

pursuant to 21 U.S.C. 877.

                     <B>SUMMARY OF THE ARGUMENT</B>

     Congress placed marihuana in Schedule I of the CSA and this

decision has been consistently approved by the courts.  The

petitioner is incorrect in asserting that marihuana must be moved

from Schedule I to Schedule II if it is a source of an accepted

and useful medication.  The plain language of the CSA requires

that a substance itself must have a currently accepted medical

                                8
<HR>
use before it may be moved from Schedule I to Schedule II.  The

petitioner has failed to provide any evidence to suggest that the

marihuana plant itself has a currently accepted medical use.

Under the CSA, the rescheduling of synthetic dronabinol in a

pharmaceutical product has no effect on the scheduling of the

marihuana plant.  Thus, the petitioner's request for rescheduling

failed to raise any issue that justified the initiation of

rescheduling proceedings.

     The petitioner is also incorrect in asserting that

dronabinol was moved from Schedule I to Schedule II.  Only one

specific pharmaceutical product containing synthetic dronabinol

has been moved to Schedule II: synthetic dronabinol in sesame oil

and encapsulated in a soft gelatin capsule in a FDA-approved drug

product.  Although the petitioner now seeks to challenge the

legality of the rule rescheduling this pharmaceutical product and

argues that dronabinol should have been rescheduled in its

entirety, he did not raise these issues before DEA.  These

issues should not be considered for the first time by this court.

                            <B>ARGUMENT</B>

<B>I.   STANDARD OF REVIEW</B>

     Any interested person may submit a petition to DEA

requesting that DEA reschedule a controlled substance. 21 U.S.C.

811(a); 21 C.F.R. 1308.44(a).  However, a petition that is

accepted for filing "may be denied by the Administrator within a

reasonable time thereafter if he finds the grounds upon which the

petitioner relies are not sufficient to justify the initiation of

                                9
<HR>
proceedings."  21 C.F.R. 1308.44(c).  The Administrator relied

upon this provision in denying the petition in the instant case.

A. 18-19.

     In reviewing the Administrator's decision, findings of fact,

"if supported by substantial evidence, shall be conclusive."  21

U.S.C. 877.  Additionally, DEA's action may be set aside if it

was arbitrary, capricious, an abuse of discretion or contrary to

law.  5 U.S.C. 706.  However, when reviewing an administrative

agency's interpretation of a statute, the court must give effect

to the unambiguously expressed intent of Congress.  Chevron

U.S.A., Inc. v. Natural Resources Defense Council, Inc., 467 U.S.

837, 842-843 (1984).  If the statute is silent or ambiguous, the

court is to determine whether the agency's interpretation is

based upon a permissible construction of the statute.  Id. at

843.  The court may not substitute its own judgment for a

reasonable interpretation made by the administrator of an agency.

Id. at 844.

<B>II.  CONGRESS, DEA, AND THE COURTS HAVE ALL FOUND THAT
     MARIHUANA IS PROPERLY IN SCHEDULE I OF THE CSA AND MUST
     REMAIN THERE UNTIL IT SATISFIES THE CRITERIA IN 21
     U.S.C. 812(b).</B>

     Congress made the initial decision to place marihuana in

Schedule I.  21 U.S.C. 811(c).  This decision was made after

careful consideration.  The legislative history of the CSA

demonstrates that Congress was sensitive to the arguments of

                                10
</PRE><HR>
<h3>Click here for <a href="dea95-2.html">part 2</a></h3>
</BODY></HTML>








</DOC>
<DOC>
<DOCNO>WT01-B18-257</DOCNO>
<DOCOLDNO>IA087-000632-B042-87</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/reply95.html 206.61.184.43 19970122072243 text/html 34741
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:22:36 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:12:03 GMT
Content-length: 34525
</DOCHDR>
<html>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#C000C0">
<pre><b>                              CASE BEING CONSIDERED FOR TREATMENT
                      PURSUANT TO RULE 35(j) OF THE GENERAL RULES




              IN THE UNITED STATES COURT OF APPEALS
               FOR THE DISTRICT OF COLUMBIA CIRCUIT
_________________________________________________________________

                           No. 94-1605
_________________________________________________________________


                         CARL ERIC OLSEN

                           Petitioner,

                               v.

                 DRUG ENFORCEMENT ADMINISTRATION

                           Respondent.

_________________________________________________________________

              Petition for Review of an order of the
                 Drug Enforcement Administration
_________________________________________________________________

                     Petitioner's Reply Brief
_________________________________________________________________


                              Carl Eric Olsen, Pro se
                              Post Office Box 4091
                              Des Moines, Iowa 50333
                             (515) 262-6957</b>
<hr>                        <b>TABLE OF CONTENTS</b>
                                                             <b>Page</b>

TABLE OF CONTENTS ...........................................   i

TABLE OF AUTHORITIES ........................................   i

STATUTES AND REGULATIONS ....................................  ii

ARGUMENT ....................................................   1

FAILURE TO FOLLOW PROPER ADMINISTRATIVE PROCEDURE ...........  14

CONCLUSION ..................................................  15

REQUEST FOR ORAL ARGUMENT ...................................  16

CERTIFICATE OF SERVICE ......................................  16


                       <b>TABLE OF AUTHORITIES</b>
<b>CASES                                                        Page</b>

*<i>Alliance for Cannabis Therapeutics v. 
  Drug Enforcement Administration</i>, 
  930 F.2d 936 (D.C. Cir. 1991) ............. 4, 7, 9, 10, 11, 13

<i>Alliance for Cannabis Therapeutics v. 
  Drug Enforcement Administration</i>, 
  15 F.3d 1131 (D.C. Cir. 1994) ........................... 7, 11

<i>Carl Eric Olsen v. Drug Enforcement Administration</i>,
  776 F.2d 267 (11th Cir. 1985) .............................. 14

<i>Carl Eric Olsen v. Drug Enforcement Administration</i>,
  979 F.2d 1458 (D.C. Cir. 1989) .......................... 14-15

<i>Carl Eric Olsen v. Drug Enforcement Administration</i>,
  No. 93-1109 (D.C. Cir. Dec. 9, 1993) ....................... 15

<i>Chevron U.S.A., Inc. v. 
  Natural Resources Defense Council, Inc.</i>, 467 U.S.
  837, 104 S.Ct. 2778, 81 L.Ed.2d 694 (1984) ................ 7-8

*<i>Grinspoon v. Drug Enforcement Administration</i>,
  828 F.2d 881 (1st Cir. 1987) ........................ 9, 10, 13
____________________
     *    Authorities chiefly relied upon


                              - i -
<hr>*<i>National Organization for the Reform of Marijuana Laws v.
  Drug Enforcement Administration</i>,
  559 F.2d 735 (D.C. Cir. 1977) ..................... 4, 5, 7, 10

*<i>National Organization for the Reform of Marijuana Laws v.
  Ingersoll</i>, 497 F.2d 654 (D.C. Cir. 1974) ................... 14

<i>United States v. Moore</i>, 423 U.S. 122 (1972) ................... 6

*<i>United States v. Walton</i>, 514 F.2d 201 
  (D.C. Cir. 1975) .................................... 4, 10, 11


<b>STATUTES</b>

21 U.S.C.  812 ............................................... 7

21 U.S.C.  812(b)(2) ......................................... 6


<b>FEDERAL REGULATIONS</b>

21 C.F.R.  1307.03 .......................................... 15 

21 C.F.R.  1308.11 .......................................... 13

21 C.F.R.  1308.11(f)(1) ................................. 9, 14

21 C.F.R.  1308.11(d)(25) .................................... 3

21 C.F.R.  1308.12 .......................................... 13

50 Fed. Reg. 42,185 (1985) ................................ 2, 13

51 Fed. Reg. 17,476 (1986) ................................ 3, 13

57 Fed. Reg. 10,499 (1992) .................................... 6


<b>INTERNATIONAL OBLIGATIONS</b>

Convention on Psychotropic Substances, 1971 ................... 3

Official Records of the Economic and Social Council,
  1991, Supp. No. 4 ........................................... 3



____________________
     *    Authorities chiefly relied upon.


                               - ii -
<hr><b>MISCELLANEOUS</b>

Executive Order 12919 (June 3, 1994) .......................... 6

1993 Physician's Desk Reference ............................... 2

Psychotropic Substances Act, Pub. L. 95-633,
  Nov. 10, 1978, 92 Stat. 2768 ................................ 4

Marihuana Tax Act, Aug. 2, 1937, 50 Stat. 551 ................ 10


                             - iii -
<hr>              IN THE UNITED STATES COURT OF APPEALS
               FOR THE DISTRICT OF COLUMBIA CIRCUIT
_________________________________________________________________

                           No. 94-1605
_________________________________________________________________


                         CARL ERIC OLSEN

                           Petitioner,

                               v.

                 DRUG ENFORCEMENT ADMINISTRATION

                           Respondent.

_________________________________________________________________

             Petition for Review of an order of the
                 Drug Enforcement Administration
_________________________________________________________________

                    Petitioner's Reply Brief
_________________________________________________________________


                            <b>ARGUMENT</b>

     The Drug Enforcement Administration (DEA) claims that the  

issue of whether (-)-delta-9-(trans)-tetrahydrocannabinol (also 

known as levo-trans-delta-9-tetrahydrocannabinol) has been, or 

should have been, rescheduled to Schedule II of the Controlled 

Substances Act is being raised for the first time in this 

petition for judicial review.  This objection is without merit.  

The matter of the scheduling of (-)-delta-9-(trans)-

tetrahydrocannabinol<a href="#1">1</a> was implicit in the original petition for 

rescheduling of marijuana.



____________________
	<a name="1">1</a> Throughout the remainder of this brief, the abreviation 
"THC" will be used in place of the term "tetrahydrocannabinol."


                              - 1 -
<hr>     There are four isomers of delta-9-THC: (1) levo-(trans)-

delta-9-THC; (2) levo-(cis)-delta-9-THC; (3) dextro-(trans)-

delta-9-THC; and (4) dextro-(cis)-delta-9-THC.  Of these four, 

only one is found naturally occurring in the marijuana plant: 

levo-(trans)-delta-9-THC (also known as (-)-delta-9-(trans)-

THC).<a href="#2">2</a>  Levo-(trans)-delta-9-THC is also the only one of the 

four isomers that is active (or psychoactive).  This isomer is 

the same isomer found in the commercial product Marinol.  This 

isomer has also been given the U.S. Adopted Name (USAN) of 

dronabinol.

     In the petitioner's brief which accompanied the original 

petition to the DEA, A. 3-4,<a href="#3">3</a> a substance by the name of 

dronabinol was clearly identified.  A DEA proposal to reschedule 

dronabinol to Schedule II of the Controlled Substances Act was 

also cited in the orignal brief filed with the DEA by the 

petitioner.  50 Fed. Reg. 42,186 (Oct. 18, 1985).  According to 

the DEA and the Physician's Desk Reference, this substance is 

clearly identified as "the principle psychoactive substance in 

Cannabis sativa L., marijuana."  1989 Physician's Desk Reference, 

page 1859.  In other words, dronabinol can be made synthetically 

or extracted from marijuana, the plant in which it occurs 

naturally.  Dronabinol is exactly the same no matter whether it 

is produced synthetically in a test tube, or extracted from a 

marijuana plant.  This is an important distinction, because 
____________________
     <a name="2">2</a>    Another name for this isomer is levo-(trans)-delta-1-
THC, or (-)-delta-1-(trans)-THC.
     <a name="3">3</a>    "A." references are to the bound appendix submitted by 
the petitioner with his brief.


                              - 2 -
<hr>dronabinol is not exclusively a semi-synthetic substance like 

heroin,<a href="#4">4</a> or a synthetic substance like alphacetylmethadol.<a href="#5">5</a> 

     Of course, the actual substance which was later rescheduled 

was not dronabinol, but rather "dronabinol (synthetic) in sesame 

oil and encapsulated in a soft gelatin capsule."  51 Fed. Reg. 

17,476 (1986).  However, this combination of drug and food 

substances was not mentioned in the petitioner's brief which was 

attached to the original petition filed with the DEA.  The reason 

this combination was not mentioned was because sesame oil and 

soft gelatin capsules are foods.  Sesame oil is not added for 

purpose of diluting dronabinol, nor does encapsulation in gelatin 

capsules change the strength or potency of dronabinol.

     The original brief filed with the DEA also referred to an 

international treaty, the <i>Convention on Psychotropic Substances</i>, 

February 21, 1971, 32 U.S.T. 543, T.I.A.S. 9725, 1019 U.N.T.S. 

175, which was amended at the request of the United States in 

1991, and which included the rescheduling of all the 

stereochemical variants of THC.<a href="#6">6</a>  E/1991/24 E/CN.7/1991/26, 24 

May 1991.  The United States is bound by this treaty and the 

____________________
     <a name="4">4</a>    Pursuant to a telphone conversation of November 27, 
1995, with John P. Morgan, Professor of Pharmacology, City 
Univerity of New York, Medical School, Room J903, 138th Street at 
Convent Avenue, New York, New York 10031; telephone (212) 650-
8255.  Professor Morgan stated that heroin does not occur 
naturally in the opium poppy.  Heroin is a semi-synthetic 
derivative of morphine.
     <a name="5">5</a>    <i>Id</i>. Professor Morgan, footnote 4, supra.  Professor 
Morgan also stated that alphacetylmethadol is not a naturally 
occuring substances.  It is made synthetically.
     <a name="6">6</a>    This international rescheduling included all four 
isomers of delta-9-THC, along with all other forms of THC found 
in the plant, e.g., those found in 21 C.F.R.  1308.11(d)(25).


                              - 3 -
<hr>amendment pursuant to the <i>Psychotropic Substances Act</i>, Pub. L. 

95-633, November 10, 1978.  This international rescheduling 

procedure allowed the United States to reschedule dronabinol, 

although the DEA is claiming that only the specific isomer 

dronabinol (and only when made synthetically) in sesame oil and 

encapsulated in a soft gelatin capsule was actually rescheduled.

     The petitioner's original petition and brief did not tell 

the DEA that rescheduling of dronabinol was being sought, because 

it was implicit in the argument that marijuana should be 

rescheduled.  The petitioner argued that dronabinol had already 

been rescheduled to Schedule II, and, therefore, marijuana is now 

the source of a Schedule II substance, dronabinol.  Contrary to 

the DEA's assertions, this issue is not being raised for the 

first time on judicial review.  The DEA could have asked for 

clarification, if it was unsure of the grounds for the petition.

     The fact that no cite case law was cited in the Petitioner's 

original brief does not mean that none existed.  All of the ideas 

expressed in the petitioner's original petition and brief were 

taken from prior decisions of this court in <i>United States v.</i> 

<i>Walton</i>, 514 F.2d 201 (D.C. Cir. 1975), <i>National Organization for</i> 

<i>the Reform of Marijuana Laws v. Drug Enforcement Administration</i>, 

559 F.2d. 735 (D.C. Cir. 1977), and <i>Alliance for Cannabis</i> 

<i>Therapeutics v. Drug Enforcement Administration</i>, 930 F.2d 936 

(D.C. Cir. 1991).  There is nothing original about these 

arguments, as they were all presented by this court in these 

three cases.


                              - 4 -
<hr>     On page 3 of its brief, the DEA talks about 20 years of 

rescheduling petitions, all of which have been appealed and 

denied.  The DEA fails to mention that none of these previous 

petitions raised the issue presented here.  In all of the cases 

cited by the DEA, the petitioners were seeking either 

recreational, medical, or sacramental use of the marijuana plant, 

in its natural form.  The matter presently before this court 

seeks none of these, and that's why the issue presented here has 

never been raised before, even though it was invited by this 

court in <i>National Organization for the Reform of Marijuana Laws</i> 

<i>v. Drug Enforcement Administration</i>, 559 F.2d 735, 748 (D.C. Cir. 

1977).

     If this case is successful in transferring marijuana from 

Schedule I to Schedule II of the Controlled Substances Act (CSA), 

the most that could be hoped for is that dronabinol could be 

extracted from marijuana, rather than being made entirely 

synthetically.  Both cocaine and morphine can be made 

synthetically, but neither of them are commonly made that way.  

It is more economical to extract cocaine and morphine from their 

natural sources (the plants they come from, coca and opium 

poppy).<a href="#7">7</a>  The trend is to go with extraction, rather than 

synthesis.

     The United States government currently grows marijuana under 

contract with the University of Mississippi, and it could easily 
____________________
     <a name="7">7</a>    <i>Id</i>. Professor Morgan, footnote 4, supra.  Professor 
Morgan also stated that aspirin is not even made synthetically, 
because it's cheaper to extract it from it's natural plant 
source.


                              - 5 -
<hr>license others to manufacture marijuana for the purpose of 

extracting dronabinol.  In 1942, the federal government actually 

exempted farmers from military service if they agreed to grow 

marijuana for the production of hemp fiber during World War II.  

Marijuana is still mentioned as a strategic military resource in 

Section 901(e) of the Executive Order 12919 of June 3, 1994 

(National Defense Industrial Resources Preparedness).

     The penalties for illegal possession of a Schedule II 

substance are no different from those for illegal possession of a 

Schedule I substance.  Therefore, there is no valid enforcement 

concern for the Drug Enforcement Administration, because the 

DEA's mission is strictly one of enforcement.  <i>United States v.</i> 

<i>Moore</i>, 423 U.S. 122, 135 (1972).  As the DEA Administrator stated 

in 1992, "Clearly, the Controlled Substances Act does not 

authorize the Attorney General, nor by delegation the DEA 

Administrator, to make the ultimate decision as to whether a drug 

should be used as medicine."  57 Fed. Reg. 10,499, 10,505 (March 

26, 1992).  Rescheduling marijuana from Schedule I to Schedule II 

would not set any precedent for further rescheduling, nor would 

it lead to increased drug diversion when the strict Schedule II 

requirements for manufacture are met.<a href="#8">8</a> 

     Although the DEA in its brief continually refers to the 

statutory criteria for scheduling set forth in 21 U.S.C.  

812(b)(2) Schedule II, and is quick to point out that marijuana 

____________________
     <a name="8">8</a>    Manufacturers would be required to meet the same 
standards as those currently employed by the federal government's 
marijuana farm at the University of Mississippi.


                              - 6 -
<hr>fails to satisfy any of them, it completely sweeps under the rug 

the fact that coca and opium poppy, both Schedule II substances, 

also fail to satisfy any of them.  The DEA refers to the plain 

meaning of the statute, but fails to explain this obvious 

inconsistency between its argument and the plain wording of the 

statute.  Congress was clearly using other factors to determine 

scheduling, which this court properly recognized in 1977.  <i>Id</i>. 

<i>NORML v. DEA</i>, 559 F.2d at 748.

     To be fair, the DEA has admitted there is an inconsistency 

in its argument.  In footnote 9, on page 16 of its brief, the DEA 

admits that some courts, including this one, have found that the 

scheduling criteria in 21 U.S.C.  812 are neither cumulative nor 

exclusive.  However, the DEA gives two reasons why these doubts 

should be resolved in its favor.

     First, the DEA claims that the dicta in these cases were 

overruled by this court's decisions in <i>Alliance for Cannabis</i> 

<i>Therapeutics v. Drug Enforcement Administration</i>, 15 F.3d 1131, 

1133 (D.C. Cir. 1991), and <i>Alliance for Cannabis Therapeutics v.</i> 

<i>Drug Enforcement Administration</i>, 930 F.2d 936, 938-940 (D.C. Cir. 

1994).  The problem with the DEA's reasoning is that the issue in 

this case was not raised by the <i>Alliance for Cannabis</i> 

<i>Therapeutics</i> cases, and, therefore, it is not res judicata in 

this matter.

     The second argument given by the DEA is that this court 

should give deference to the DEA's interpretation of the statute 

because of the guidelines for statutory interpretation 

articulated by the U.S. Supreme Court in <i>Chevron , U.S.A, Inc. v.</i> 


                              - 7 -
<hr><i>Natural Resources Defense Council, Inc.</i>, 467 U.S. 837 (1984).  

Again, the problem with this reasoning is that <i>Chevron</i> requires 

this court to first look at the plain meaning of the statute.  

This court must first resolve the inconsistency of the scheduling 

of coca and opium poppy under the statute.  According to the 

DEA's reasoning, neither coca and opium poppy could be scheduled 

in Schedule II of the statute.  The DEA has never moved to 

correct this inconsistency by attempting to reschedule coca and 

opium poppy to Schedule I.  Therefore, it is obvious that the DEA 

has failed to properly interpret the statute in this matter.

     The DEA admits that, in drafting the statute, Congress was 

aware that coca and opium poppy were the sources of accepted 

medicines, but fails to acknowledge that this creates an 

additional scheduling criterion (being the natural plant source 

of an accepted medicine), and that Congress was equally aware 

that marijuana was not the source of any accepted medicine at the 

time the Controlled Substances Act was written.  Things have 

changed.  Marijuana is now the source of an accepted medicine, 

even though the DEA makes an artificial distinction between the 

synthetic and the naturally extracted equivalent of the drug.  

Coca and opium poppy are the evidence that Congress did not 

consider the scheduling of plants and their included chemicals to 

be distinct, and the DEA half-heartedly admits as much.<a href="#9">9</a> 
____________________
     <a name="9">9</a>    It is important to note that coca, opium, and marijuana 
plants are not only the source of accepted medicines, but those 
medicines are all the principle psychoactive drugs contained 
within those plants.  In other words, these plants are only 
medically active (psychoactive) to the extent they contain these 
drugs.  Of course, that is not to say that these plants have no 


                              - 8 -
<hr>     There is no difference between a synthetic drug and its 

naturally extracted twin.  By definition, a synthetic molecule 

must be identical to its natural equivalent.  The Food and Drug 

Administration verifies this fact.  A. 16.  Synthetic dronabinol 

and the (-)-delta-9-(trans)-THC found in the marijuana plant are 

the same thing.  The DEA is saying that only synthetic dronabinol 

in sesame oil and encapsulated in soft gelatin capsules has been 

rescheduled, and the Code of Federal Regulations actually 

distinguishes (wrongly) synthetic from naturally occurring 

dronabinol (as if synthetic and naturally occurring drugs were 

not the exact same thing).  21 C.F.R.  1308.11(f)(1).  However, 

the DEA is saying that dronabinol itself was not transferred from 

Schedule I to Schedule II of the CSA.  The DEA claims that only a 

pharmaceutical product, dronabinol (synthetic) in sesame oil and 

encapsulated in soft gelatin capsules, was transferred to 

Schedule II.

     On page 21 of its brief, the DEA briefly mentions <i>Grinspoon</i> 

<i>v. Drug Enforcement Administration</i>, 828 F.2d 881, 891-892 (1st 

Cir. 1987), but completely fails to mention its subsequent 

approval by this court in <i>Alliance for Cannabis Therapeutics v.</i> 

<i>Drug Enforcement Administration</i>, 930 F.2d 936, 939-940 (D.C. Cir. 

1991).  The <i>Grinspoon</i> court held that the DEA cannot rely on FDA 

marketing approval in making scheduling decisions.  While it is 

true, as the DEA points out in footnote 13, on page 21 of its 

brief, that FDA marketing approval is sufficient to establish 
_________________________________________________________________
other medicinal qualities, just none that are presently 
recognized by the medical profession.


                              - 9 -
<hr>accepted medical use, the DEA fails to acknowledge that lack of 

FDA marketing approval does not necessitate a finding that the 

substance has no medical use.  <i>Alliance</i>, 930 F.2d at 939; 

<i>Grinspoon</i>, 828 F.2d at 891.  As this court wrote in 1977,

     If, as respondent contends, a determination that the 
     substance has no accepted medical use ends the inquiry, 
     then presumably Congress would have spelled that out in 
     its procedural guidelines.  Its failure to do so 
     indicates an intent to reserve to HEW a finely tuned 
     balancing process involving several medical and 
     scientific considerations.

<i>NORML</i>, 559 F.2d at 748.  It would be ludicrous to assume that 

dronabinol has no medical value unless it is in sesame oil and 

encapsulated in soft gelatin capsules, or that it would have no 

medical value if it were extracted from a marijuana plant.

     It is interesting to note in footnote 7, on page 11, and, 

again on page 14 of the DEA's brief, that the DEA recognizes that 

Congress had strong doubts about placing marijuana in Schedule I 

and fully intended that further research would clarify this 

matter.  Further research has indeed revealed that marijuana has 

at least as much therapeutic value as coca and opium poppy.  

     It is also disturbing how the DEA ignores the holdings in 

<i>United States v. Walton</i>, 514 F.2d 201 (D.C. Cir. 1975).  This 

court specifically held that marijuana was illegal only to the 

extent that it contained THC.  This court interpreted the plain 

meaning of the statute, as well as its history in the <i>Marihuana</i> 

<i>Tax Act</i> of 1937, and determined that it was plain from the face 

of the statute that THC<a href="#10">10</a> was the controlling factor in 
____________________
     <a name="10">10</a>   The term "THC", as used by this court, referred to 
dronabinol, since it is the only isomer of delta-9-THC which is 


                              - 10 -
<hr>marijuana's scheduling.  The DEA seems to think this holding has 

been overruled by subsequent decisions in <i>Alliance for Cannabis</i> 

<i>Therapeutics v. DEA</i>, 930 F.2d 936, and <i>Alliance for Cannabis</i> 

<i>Therapeutics v. DEA</i>, 15 F.3d 1131.  Again, the issues raised were 

not the same, and neither of the <i>Alliance</i> rulings are res 

judicata as to the issue presented here.

     In footnote 10, on page 16 of its brief, the DEA makes an 

interesting analogy to a substance by the name of levo-

alphacetylmethadol.  This is a great analogy, because it's almost 

exactly the same situation as we have with levo-(trans)-delta-9-

THC.  The other three isomers of delta-9-THC are psychoactively 

inactive.  In other words, they have little, if any, medical 

value, which means that it's highly unlikely they will ever be 

rescheduled to Schedule II (or below) under the DEA's currently 

proposed (and faulty) standards.  It also means they have 

practically no abuse potential, which means that it's highly 

unlikely they would have ever been scheduled in Schedule I (or 

any schedule) if it had not been for their psychoactive 

counterpart (dronabinol).  As this court noted in <i>Walton</i>, it was 

the psychoactive isomer of delta-9-THC that caused marijuana to 

be outlawed in the first place.<a href="#11">11</a>  If none of the isomers of 

delta-9-THC were psychoactive, it would be highly unlikely that 

_________________________________________________________________
present in the marijuana plant, and it is the only form of THC 
which is psychoactive.
     <a name="11">11</a>   At the time <i>Walton</i> was decided, the term THC was used 
as if it were the same thing as dronabinol, because the levo-
(trans) isomer is the only isomer of delta-9-THC that is actually 
produced by the plant.  The other isomers can only be produced in 
a chemical laboratory.


                              - 11 -
<hr>Congress would ever have even thought of outlawing marijuana.  

Without the psychoactive isomer of delta-9-THC, marijuana is just 

another weed.

     Marijuana is the source of dronabinol, and not the source of 

the other three isomers of delta-9-THC.  Practically speaking, it 

is the levo-(trans) isomer of delta-9-THC that we are speaking of 

when we refer to delta-9-THC.  In the DEA's analogy, 

alphacetylmethadol would be the equivalent of delta-9-THC, and 

levo-alphacetylmethadol would be the equivalent of dronabinol.  

     Alphacetylmethadol doesn't come from a plant, it's made 

synthetically.<a href="#12">12</a>  If alphacetylmethadol came from a plant, that 

plant would only be controlled to the extent that it contained 

the psychoactive substance levo-alphacetylmethadol and not the 

other isomers of alphacetylmethadol which are psychoactively 

inactive.<a href="#13">13</a>  The difference between alphacetylmethadol and 

marijuana is that the former comes from a test tube and the 

latter comes from a seed.  The genesis of alphacetylmetadol is a 

test tube and the genesis of delta-9-THC is a plant.  The 

precedent for the treatment of plants has already been 

established by Congress in drafting the Controlled Substances 

Act.  The analogy breaks down, because alphacetylmethadol does 

not come from a plant.  Both alphacetylmethadol and the three 

non-dronabinol isomers of delta-9-THC can only be made 

synthetically.  However, dronabinol is produced either 


____________________
     <a name="12">12</a>   <i>Id</i>. Professor Morgan, footnote 4, supra.
     <a name="13">13</a>   <i>Id</i>. Professor Morgan, footnote 4, supra.


                              - 12 -
<hr>synthetically or by a plant, while levo-alphacetylmethadol can 

only be made synthetically.

     One last point that should be mentioned again is that the 

DEA originally sought to reschedule dronabinol itself.  50 Fed. 

Reg. 42,186 (Oct. 18, 1985).  On page 19 of the DEA's brief, the 

DEA incorrectly states that this proposal was only for synthetic 

dronabinol in sesame oil and encapsulated in a soft gelatin 

capsule.  The original proposal was for dronabinol itself, not a 

U.S. Food and Drug Administration approved product.  The actual 

rescheduling order changed the rescheduling to "dronabinol in 

sesame oil and encapsulated in soft gelatin capsules."  51 Fed. 

Reg. 17,476 (1986).  This is not difficult to understand, because 

this action was prior to the 1987 ruling in <i>Grinspoon v. Drug</i> 

<i>Enforcement Administration</i>, 828 F.2d 881, 891-892 (1st Cir. 

1987), where the First Circuit ruled that the DEA could not rely 

solely on FDA marketing approval in making scheduling decisions.  

This court approved the holding of the <i>Grinspoon</i> court in 

<i>Alliance for Cannabis Therapeutics v. Drug Enforcement</i> 

<i>Administration</i>, 930 F.2d 936, 939-940 (D.C. Cir. 1991).

     The DEA's assertion that dronabinol was not rescheduled, 

along with its assertion that marijuana is not the source of an 

accepted medicine are false.  Evidence of the DEA's error is the 

list of controlled substances contained in Schedule I and 

Schedule II in the Code of Federal Regulations at 21 C.F.R.  

1308.11 and 1308.12.  Dronabinol is the only substance that 

contains the following added language:



                              - 13 -
<hr>     (synthetic) in sesame oil and encapsulated in a soft 
     gelating capsule in a U.S. Food and Drug Administration 
     approved drug product

21 C.F.R.  1308.11(f)(1).  Every other substance in Schedule I 

and Schedule II is identified only by its chemical name.<a href="#14">14</a>  The 

addition of sesame oil and gelatin capsules does nothing to 

change the nature of the substance dronabinol.  In the 

petitioner's brief attached to the original petition filed with 

the DEA, the substance identified is dronabinol, not a U.S. Food 

and Drug Administration approved product.


     
        <b>FAILURE TO FOLLOW PROPER ADMINISTRATIVE PROCEDURE</b>

     Since the DEA is concerned about following proper 

administrative procedure, it should be noted that the DEA has 

failed to follow proper administrative procedure on numerous 

occasions, particularly in four cases (three in which the 

petitioner has been a party).  <i>National Organization for the</i> 

<i>Reform of Marijuana Laws v. Ingersoll</i>, 497 F.2d 654 (D.C. Cir. 

1974) (case remanded because DEA refused to accept a rescheduling 

petition); <i>Carl Eric Olsen v. Drug Enforcement Administration</i>, 

776 F.2d 267 (11th Cir. 1985) (DEA scolded for refusing to 

respond to a rescheduling petition); <i>Carl Eric Olsen v. Drug</i> 
____________________
     <a name="14">14</a>   Admittedly, there is some cross-scheduling of 
substances in the lower schedules (e.g., codeine is in Schedule 
II, while codeine diluted to "not more than 200 milligrams of 
codeine per 100 milliliters or per 100 grams" is in Schedule V), 
but such cross-scheduling involves diluted forms of the same 
drug.  It is important to note that codeine is in Schedule II, 
not Schedule I, because it has medical use.  To suggest that 
codeine be included in Schedule I unless it is in sesame oil and 
encapsulated in soft gelatin capsules would be absurd.  It is 
also important to note that there is no cross-scheduling between 
Schedule I and Schedule II (with the exception of dronabinol).


                              - 14 -
<hr><i>Enforcement Administration</i>, 878 F.2d 1458 (D.C. Cir. 1989) 

(petitioner had to file for a writ of mandamus to compel the DEA 

to accept a rescheduling petition, and case later remanded 

because DEA failed to properly address the issues raised); <i>Carl</i> 

<i>Eric Olsen v. Drug Enforcement Administration</i>, No. 93-1109 (D.C. 

Cir. Dec. 9, 1993) (case remanded because DEA refused to accept a 

rescheduling petition).  This record shows that the DEA has made 

a consistent effort to obstruct justice and deny petitioners the 

first amendment constitutional right to petition government for a 

redress of grievances.


                           <b>CONCLUSION</b>

     The regulations of the DEA clearly state that a petition to 

reschedule can be brought by any interested party.  21 C.F.R.  

1307.03.  It is important that citizens be encouraged to keep an 

eye on government officials; in fact, it is a civil duty.  It is 

not the function of the government to keep the citizen from 

falling into error; it is the function of the citizen to keep the 

government from falling into error.

     The DEA improperly failed to reschedule marijuana and 

dronabinol when it rescheduled the pharmaceutical equivalent of 

dronabinol.  The DEA improperly refused to reschedule marijuana 

when this error was brought to its attention.  The appropriate 

remedy is for this court to order that marijuana and dronabinol 

are both included within Schedule II of the Controlled Substances 

Act of 1970.



                              - 15 -
<HR>                    <b>REQUEST FOR ORAL ARGUMENT</b>

     The petitioner respectfully requests that he be granted oral 

argument in this matter.

                              Respectfully submitted,

                              ___________________________________

                              Carl Eric Olsen, pro se
                              Post Office Box 4091
                              Des Moines, Iowa 50333
                              (515) 262-6957


                     <b>CERTIFICATE OF SERVICE</b>

     I hereby certify that two copies of the foregoing 

Petitioner's Reply Brief were mailed by first class mail on this 

28th day of November, 1995, to:

     John F. Farley
     Trial Attorney
     Narcotics and Dangerous Drug Section
     Criminal Division
     U.S. Department of Justice
     P.O. Box 27312, Central Station
     Washington, D.C. 20038

                              ___________________________________

                              Carl Eric Olsen, pro se



                              - 16 -</pre></BODY></html>
</DOC>
<DOC>
<DOCNO>WT01-B18-258</DOCNO>
<DOCOLDNO>IA087-000632-B042-103</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/order2.html 206.61.184.43 19970122072255 text/html 1625
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:22:48 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:12:16 GMT
Content-length: 1410
</DOCHDR>
<HTML>
<HEAD><TITLE>U.S. Court of Appeals for the D.C. Circuit (Sept. 19, 1996)</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#C000C0">
<FONT SIZE=+3 FACE="Lincoln"><CENTER><B>United States Court of Appeals</B></CENTER></FONT>
<FONT SIZE=-2 FACE="Arial, Helvetica"><CENTER><B><BIG>F</BIG></B>OR <B><BIG>T</BIG></B>HE <B><BIG>D</BIG></B>ISTRICT OF <B><BIG>C</BIG></B>OLUMBIA <B><BIG>C</BIG></B>IRCUIT</CENTER></FONT>
<CENTER><B>______</B></CENTER>
<BR>
<FONT SIZE=+1 FACE="Arial, Helvetica"><B>No. 94-1605<SPACER TYPE=HORIZONTAL SIZE=300>September Term, 1996</B></FONT>
<BR><BR><FONT FACE="Arial, Helvetica">
<BR>Carl Eric Olsen,
<BR><SPACER TYPE=HORIZONTAL SIZE=100>Petitioner
<BR><BR>
<BR><DD>v.
<BR>
<BR>Drug Enforcement Administration,
<BR><SPACER TYPE=HORIZONTAL SIZE=100>Respondent
<BR><BR>
<BR>
<DD><B>BEFORE</B>:&nbsp;  Williams, Sentelle, and Henderson, Circuit Judges
<BR><BR><BR>
<CENTER><B><U>ORDER</U></B></CENTER>
<BR>
<DD>The court concludes, on its own motion, that oral argument will not assist the court in this case.&nbsp;  Accordingly, the court will dispose of the petition for review without oral argument on the basis of the record and the presentations in the briefs.&nbsp;  <U>See</U> D.C. C<SMALL>IR.</SMALL> R<SMALL>ULE</SMALL> 34(j).
<BR>
<BR><CENTER><B><U>Per Curiam</U></B></CENTER>
<BR><BR>
<BR>FILED SEP 19 1996
</FONT></BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-259</DOCNO>
<DOCOLDNO>IA087-000632-B042-127</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/order3.html 206.61.184.43 19970122072314 text/html 2239
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:23:03 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:12:13 GMT
Content-length: 2024
</DOCHDR>
<HTML>
<HEAD><TITLE>U.S. Court of Appeals for the D.C. Circuit (Oct. 3, 1996)</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#C000C0">
<FONT SIZE=+3 FACE="Lincoln"><CENTER><B>United States Court of Appeals</B></CENTER></FONT>
<FONT SIZE=-2 FACE="Arial, Helvetica"><CENTER><B><BIG>F</BIG></B>OR <B><BIG>T</BIG></B>HE <B><BIG>D</BIG></B>ISTRICT OF <B><BIG>C</BIG></B>OLUMBIA <B><BIG>C</BIG></B>IRCUIT</CENTER></FONT>
<CENTER><B>______</B></CENTER>
<BR>
<FONT SIZE=+1 FACE="Arial, Helvetica"><B>No. 94-1605<SPACER TYPE=HORIZONTAL SIZE=300>September Term, 1996</B></FONT>
<BR><BR><FONT FACE="Arial, Helvetica">
<BR>Carl Eric Olsen,
<BR><SPACER TYPE=HORIZONTAL SIZE=100>Petitioner
<BR><BR>
<BR><DD>v.
<BR>
<BR>Drug Enforcement Administration,
<BR><SPACER TYPE=HORIZONTAL SIZE=100>Respondent
<BR><BR>
<BR>
<CENTER><B>PETITION FOR REVIEW OF AN ORDER OF THE<BR>
DRUG ENFORCEMENT ADMINISTRATION</B></CENTER>
<BR><BR>
<BR>
<DD><B>BEFORE</B>:&nbsp;  Williams, Sentelle, and Henderson, Circuit Judges
<BR><BR><BR>
<CENTER><B><U>J U D G M E N T</U></B></CENTER>
<BR>
<DD>This petition for review was considered on the record from an order of the Drug Enforcement Administration and on the briefs filed by the parties.&nbsp;  The court has determined that the issues presented occasion no need for an opinion.&nbsp;  <U>See</U> D.C. C<SMALL>IR.</SMALL> R<SMALL>ULE</SMALL> 36(b).&nbsp;  It is
<BR>
<BR><DD><B>ORDERED</B> and <B>ADJUDGED</B> that the petition for review be denied.&nbsp;  Petitioner's rescheduling request was not supported by grounds sufficient to justify the initiation of rescheduling proceedings.&nbsp;  <U>See</U> 21 C.F.R. &sect; 1308.44(c).
<BR>
<BR><DD>The Clerk is directed to withhold issuance of the mandate herein until seven days after disposition of any timely petition for rehearing.&nbsp;  <U>See</U> D.C. C<SMALL>IR.</SMALL> R<SMALL>ULE</SMALL> 41.
<BR>
<BR><CENTER><B><U>Per Curiam</U></B></CENTER>
<BR><BR>
<BR>FILED OCT 03 1996
</FONT></BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-260</DOCNO>
<DOCOLDNO>IA087-000632-B042-158</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/DEA/allison.html 206.61.184.43 19970122072334 text/html 11506
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:23:23 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:11:45 GMT
Content-length: 11290
</DOCHDR>
<HTML>
<HEAD><TITLE>Kubiak, Allison - November 22, 1996</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#800080" ALINK="#FF0000"><BASEFONT SIZE="4">
Carl,
<BR>
<BR>Here is a copy of Allison Kubiak's memo regarding your case.
<BR>All the best...LEH
<BR>
<BR>TO: L. Hirsch
<BR>FROM: A. Kubiak
<BR>RE: Review of Administrative Decisions Under the APA
<BR>_______________________________________________________________________
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">The following information is a rough overview of the standard of review we will use to show the administrator's decision was made unfairly.&nbsp; Interestingly, none of the squibs I read noted that an administrator's decision, made arbitrarily and capriciously, violated a person's due process rights.&nbsp;  I think this is because a decision improperly made in violation of the APA is not a constitutional violation per se.

<BR><SPACER TYPE="HORIZONTAL" SIZE="50">There are other possible causes of action which we may want to pursue.&nbsp;  One area which crosses over into the APA issue is whether or not the administrator's decision was made in violation of the statute itself.&nbsp;  According to the clear language of the statute the administrator is not to make the decision to reschedule without getting binding advice from HHS.&nbsp;  It is not clear to me in this case that such advice was ever obtained regarding the difference between synthetic and actual delta-9-THC.&nbsp;  Carl's argument that HHS has impliedly recommended moving 'true' THC to schedule 2 thru its
allowance of Marinol on schedule 2 is persuasive.&nbsp;  Unfortunately, there is case precedent which treats the synthetic compound differently from the real thing.

<BR><SPACER TYPE="HORIZONTAL" SIZE="50">It seems that a good equal protection argument could be gleaned from this confusion.&nbsp;  I have not really figured it out yet but I am thinking along the lines of an argument that Marinol users and 'compassionate use' patients are similarly situated groups being treated dissimilarly with for no rationally related government purpose.&nbsp;  If we could construct an argument that the compassionate use patients have a significant liberty interest at stake (ie. the possibility of prosecution as opposed to the Marinol users), we may elevate the argument to a strict scrutiny plateau.&nbsp;  All of these ideas are far beyond the scope of Carl's argument.&nbsp;  Even so, they may be worthwhile to include should we get lucky.

<BR><SPACER TYPE="HORIZONTAL" SIZE="50">The following is a general guide which covers the basics of administrative review.&nbsp;  It is neither exhaustive nor complete!&nbsp;  I just thought you might want a little refresher course on administrative law for our conversation.&nbsp;  I
hope to start building small, detailed and exhaustive memorandum on each
aspect of our petition.&nbsp;  We should discuss how to break the argument 
section into small parts addressing each test under the standard of review.&nbsp;  I asked Ryan to get copies of NORML's petition so that we don't end up duplicating their work.&nbsp;  While they are using the same standard, their factual approach is different.&nbsp;  If either of us were to get cert. granted, I would guess the court would pull in the other petition as well.
<BR>
<BR>STANDARD OF REVIEW
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">In determining the reviewability of an agency action, the court must strike a balance between the goal of efficient agency action and the value of judicial review in ensuring the rationality and fairness of agency decision making.&nbsp;  <U>Natural Resources Defense Council, Inc. v. SEC.</U>, 606 F.2d 1031 (1979).
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">It is the duty of the reviewing court to determine whether the course followed by the agency is consistent with the constitutional mandate from Congress on which it acted.&nbsp;  The court must then justify and explain any departure from prior norms.&nbsp;  <U>Scott Paper Co. v. U.S.</U>, 372 F.Supp. 721, <U>aff'd</U>, 419 U.S. 807 (1979).
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">The standard of judicial review of an agency action is based upon the scope of review outlined in 10(e) of the Administrative Procedures Act (5 USCS 706) and assuming that the statutory procedures are met and that the constitutional provisions have been complied with, a reviewing court is limited to a determination of whether the agency substantially complied with its statutory and regulatory procedures, whether its factual determinations were supported by substantial evidence and whether its actions were arbitrary, capricious or an abuse of discretion.&nbsp;  <U>Albert v. Chafee</U>, 571 F.2d 1063 (1978).
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">In review under this statute the court must inquire whether the agency action was within the scope of the agencies authority, whether agency conformed to its procedural requirements, and whether the decision was arbitrary, capricious, abuse of discretion or otherwise not in accordance with the law.&nbsp;  The third inquiry requires that the court consider whether the decision was based on consideration of relevant factors and whether there has been a clear error of judgement.&nbsp;  <U>PPG Industries Inc. v. Harrison</U>, 587 F.2d 237 (CA 5 1979), <U>reh'g den.</U>, 591 F.2d 102, <U>revrs'd on other grounds</U>, 446 
US 578.
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">In reviewing challenged actions, the court must first determine whether a government official whose actions are being challenged followed necessary procedural requirements in reaching and implementing his challenged decision.&nbsp;  Secondly, the courts must inquire whether the government official acted within the scope of his authority, that is, whether the decision was within the range of judgments he could legally make, whether they properly construed the limits of his authority and whether there is evidence before him sufficient to render it possible for him to reasonably believe the actions he took were ultimately within the limits of his authority.&nbsp;  Finally, a court must consider whether the decision was arbitrary, capricious or an abuse of discretion.&nbsp;  This implies that the decision must have been based on good faith consideration of relevant factors and whether there was a clear 
error of judgement.&nbsp;  <U>Movement Against Destruction v. Trainor</U>, 400 F.Supp. 533 (1975).
<BR>
<BR>--STATUTORY INTERPRETATION
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">Statutory interpretation by an agency of statutes within its mandate is reviewable under the arbitrary and capricious standard and is not entitled great deference.&nbsp;  <U>Local School Board of Educ. v. Geauga County MHA</U>, 732 F.2d 505 (1982).&nbsp;  This is due to the consideration that the court is equally (if not more so) qualified to interpret the law.&nbsp;  <U>Matzke v. Block</U>, 732 F.2d 
799 (1983).*&nbsp;  See long negative case history.
<BR>
<BR>OTHER STANDARDS
<BR>
<BR>Clearly Erroneous Test:
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">In applying the arbitrary and Capricious test the court must consider whether the decision was based on consideration of relevant factors and whether there has been a clear error in judgement.&nbsp;  <U>Bowman Transportation Inc. v. Arkansas Best Freight System</U>, 419 U.S. 281 (1974).
<BR>
<BR>Rational Basis Test:
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">Under the aforementioned tests, there may be a careful inquiry into facts, the ultimate scope of review is a narrow one, namely that the administrator's decision was a rational one.&nbsp;  See <U>Id</U>.
<BR>
<BR>ARBITRARY AND CAPRICIOUS
<BR>
<BR>In General:
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">Under section 706 the court is not permitted to substitute its own judgement for that of an agency.&nbsp;  The standards require the courts inquiry must be searching and careful.&nbsp;  The court must insure both that the agency has adequately considered all relevant factors and that it has demonstrated rational connections between facts found and the choices made and the court must examine the procedures employed by the agency in reaching its decision to insure that those procedures comply with applicable statutory and constitutional requirements.&nbsp;  <U>United States Lines Inc. v. Federal Maritime
Com.</U>, 584 F.2d 519 (1978).&nbsp;  The arbitrary and capricious standard is applicable to both the situation where the agency has decided to act as 
well as to the situation where the agency has decided not to act.&nbsp;  <U>NRDC v. SEC</U>, 432 F.Supp.1190 (1977).
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">The burden to overcome the presumption that the agency's action was rational is placed on the complaining party.&nbsp;  <U>Great Salt Lake Minerals & Chemical Corp. v. Marsh</U>, 96 F.Supp. 548 (1984).
<BR>
<BR>Construction of Standard:
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">Agency rule meets the standard where it entirely fails to consider important aspects of the problem or offers explanations for its decision which run counter to evidence before an agency or offers an explanation so implausible that the agency could not ascribe to difference in review.&nbsp;  <U>Motor Vehicle Mfrs. Asso. v. State Farm Met. Auto. Ins. Co.</U>, 463 U.S. 29 (1983).
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">In order to have an action set aside the challenging party must prove that it was willful and unreasoning action without consideration and in disregard of facts or circumstances of case.&nbsp;  <U>Moore v. Curtis</U>, 736 F.2d 1260 (1984).
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">A decision is arbitrary where the agency relies on factors not intended by Congress, entirely ignores important aspects of the problem, explains its decision in a manner contrary to the evidence before it or reaches a decision so implausible that it cannot be subscribed to difference in view.&nbsp;  <U>Bedford County Hospital v. HHS</U>, 769 F.2d 1017 (1985).
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">Support for agencies action must appear in the record.&nbsp;  <U>National Welfare Rights Org. v. Mathews</U>, 533 F.2d 637 (1976).
<BR><BR>
<BR>STANDING:
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">5 USCS 702 does not create substantive rights, and there is therefore no right to sue for violation of APA in absence of a relative statute.&nbsp;  <U>Alvarez Mendez v. Stock</U>, 941 F.2d 956 (1991).
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">In cases arising under the APA standing requires that the plaintiff show challenged action has caused injury in fact.&nbsp;  A claim is defeated where claim of injury is threatened rather than actual and risk of injury need not be certain as opposed to contingent.&nbsp;  <U>Idaho Conservation League v. Mumma</U>, 956
F.2d 1058 (1992).
<BR>
<BR><SPACER TYPE="HORIZONTAL" SIZE="50">Review is permitted only in cases brought by a person whose putative injuries are within the zone of interests sought to be protected by the statute in question.&nbsp;  <U>INS. v. Legalization Assistance Project of the LA County Fed'n of Labor</U>, 114 S.Ct. 422 (1993).
</BODY></HTML>


</DOC>
<DOC>
<DOCNO>WT01-B18-261</DOCNO>
<DOCOLDNO>IA087-000632-B042-208</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/caprop215.html 206.61.184.43 19970122072357 text/html 4138
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:23:50 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:04 GMT
Content-length: 3923
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>California Proposition 215</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" link="#0000FF"
vlink="#800080" alink="#FF0000">

<p align="center"><a href="http://www.prop215.org/prop215.html"><tt>http://www.prop215.org/prop215.html<br>
</tt></a><a href="http://Vote96.ss.ca.gov/Vote96/html/BP/215.htm"><tt>http://Vote96.ss.ca.gov/Vote96/html/BP/215.htm</tt></a></p>

<p align="center"><tt>vote totals for California propositions</tt><a
href="http://Vote96.ss.ca.gov/Vote96/html/vote/prop/page.961113073101.html"><tt><br>
http://Vote96.ss.ca.gov/Vote96/html/vote/prop/page.961113073101.html<br>
</tt></a></p>

<p align="center"><tt>Proposition 215</tt></p>

<p align="center"><tt>Medical Marijuana Intiative</tt></p>

<p><tt>Section 1. Section 11362.5 is added to the Health and
Safety Code, to read:</tt></p>

<blockquote>
    <p><tt>11362.5. (a) This section shall be known and may be
    cited as the Compassionate Use Act of 1996.<br>
    <br>
    (b) (l) The people of the State of California hereby find and declare
    that the purposes of the Compassionate Use Act of 1996 are as
    follows:</tt></p>
    <blockquote>
        <p><tt>(A) To ensure that seriously ill Californians have
        the right to obtain and use marijuana for medical
        purposes where that medical use is deemed appropriate and
        has been recommended by a physician who has determined
        that the person's health would benefit from the use of
        marijuana in the treatment of cancer, anorexia, AIDS,
        chronic pain, spasticity, glaucoma, arthritis, migraine, or
        any other illness for which marijuana provides relief.<br>
        <br>
        (B) To ensure that patients and their primary caregivers
        who obtain and use marijuana for medical purposes upon
        the recommendation of a physician are not subject to
        criminal prosecution or sanction.<br>
        <br>
        (C) To encourage the federal and state governments to
        implement a plan to provide for the safe and affordable
        distribution of marijuana to all patients in medical need
        of marijuana.</tt></p>
    </blockquote>
    <p><tt>(2) Nothing in this act shall be construed to
    supersede legislation prohibiting persons from engaging in
    conduct that endangers others, nor to condone the diversion
    of marijuana for nonmedical purposes.</tt></p>
    <p><tt>(c) Notwithstanding any other provision of law, no
    physician in this state shall be punished, or denied any
    right or privilege, for having recommended marijuana to a
    patient for medical purposes.<br>
    <br>
    (d) Section 11357, relating to the possession of marijuana, and
    Section 11358, relating to the cultivation of marijuana, shall
    not apply to a patient, or to a patient's primary caregiver,
    who possesses or cultivates marijuana for the personal
    medical purposes of the patient upon the written or oral
    recommendation or approval of a physician.<br>
    <br>
    (e) For the purposes of this section, &quot;primary
    caregiver&quot; means the individual designated by the person
    exempted under this act who has consistently assumed
    responsibility for the housing, health, or safety of that
    person.</tt></p>
</blockquote>

<p><tt>Sec. 2. If any provision of this measure or the
application thereof to any person or circumstance is held
invalid, that invalidity shall not affect other provisions or
applications of the measure which can be given effect without the
invalid provision or application, and to this end the provisions
of this measure are severable.<br>
</tt></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-262</DOCNO>
<DOCOLDNO>IA087-000632-B042-230</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/azprop200.html 206.61.184.43 19970122072406 text/html 26437
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:23:59 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:15 GMT
Content-length: 26221
</DOCHDR>
<HTML>
<HEAD><TITLE>Arizona Proposition 200</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#800080" ALINK="#FF0000">
<TT>
<CENTER><A HREF=http://www.sosaz.com/1996BallotProps.htm>http://www.sosaz.com/1996BallotProps.htm</A></CENTER>

<P><CENTER>PROPOSITION 200</CENTER>

<P><CENTER>OFFICIAL TITLE</CENTER>

<P><CENTER>AN INITIATIVE MEASURE</CENTER>

<P>AMENDING TITLE 13, TITLE 41, AND TITLE 42, OF THE ARIZONA REVISED STATUTES; AMENDING TITLE 41, CHAPTER 11, BY ADDING 41-1604.16; RELATING TO ESTABLISHMENT OF THE ARIZONA PARENTS COMMISSION ON DRUG EDUCATION AND PREVENTION; AMENDING TITLE 41, CHAPTER 11, BY ADDING 41-1604.14; RELATING TO PERSONS NOT ELIGIBLE FOR PAROLE; AMENDING TITLE 13, CHAPTER 13, BY AMENDING 13-3412 AND ADDING 13-3412.01; RELATING TO PERMISSIBLE USE OF CONTROLLED SUBSTANCES BY SERIOUSLY ILL OR TERMINALLY ILL PATIENTS; AMENDING TITLE 41, CHAPTER 11, BY ADDING 41-1604.15 AND AMENDING TITLE 31, CHAPTER 3, BY ADDING 31-411.01; RELATING TO PAROLE FOR PERSONS CONVICTED OF PERSONAL POSSESSION OR USE OF CONTROLLED SUBSTANCES; AMENDING TITLE 13, CHAPTER 9, BY ADDING 13-901.01; RELATING TO PROBATION FOR PERSONS CONVICTED OF PERSONAL POSSESSION OR USE OF CONTROLLED SUBSTANCES AND BY  ADDING 13-901.02; RELATING TO THE ESTABLISHMENT OF THE DRUG TREATMENT AND EDUCATION FUND; AND AMENDING TITLE 42, CHAPTER 12, BY ADDING 42-1204.01; RELATING TO LUXURY PRIVILEGE TAXES; AND PROVIDING FOR SEVERABILITY.

<P><CENTER>TEXT OF PROPOSED AMENDMENT</CENTER>

<P>Be it enacted by the people of the State of Arizona: The following amendments are proposed to become valid when approved by a majority of the qualified electors voting thereon and upon proclamation pursuant thereto by the Governor of the State of Arizona.

<P>Section 1. TITLE

<P>THIS ACT SHALL BE KNOWN AND MAY BE CITED AS THE "DRUG MEDICALIZATION, PREVENTION, AND CONTROL ACT OF 1996."

<P>Section 2. FINDINGS AND DECLARATIONS

<P>THE PEOPLE OF THE STATE OF ARIZONA FIND AND DECLARE THE FOLLOWING:
<OL>
<LI> ARIZONA'S CURRENT APPROACH TO DRUG CONTROL NEEDS TO BE STRENGTHENED.
     THIS IS EVIDENCED BY THE FACT THAT, ACCORDING TO THE ARIZONA CRIMINAL
     JUSTICE COMMISSION, BETWEEN 1991 AND 1993 MARIJUANA USE DOUBLED AMONG
     ELEMENTARY SCHOOL STUDENTS AND, BETWEEN 1990 AND 1993 QUADRUPLED AMONG
     MIDDLE-SCHOOL STUDENTS. IN ADDITION TO ACTIVELY ENFORCING OUR CRIMINAL
     LAWS AGAINST DRUGS, WE NEED TO MEDICALIZE ARIZONA'S DRUG CONTROL
     POLICY: RECOGNIZING THAT DRUG ABUSE IS A PUBLIC HEALTH PROBLEM AND
     TREATING ABUSE AS A DISEASE. THUS, DRUG TREATMENT AND PREVENTION MUST
     BE EXPANDED.
<LI> WE MUST ALSO TOUGHEN ARIZONA'S LAWS AGAINST VIOLENT CRIMINALS ON DRUGS.
     ANY PERSON WHO COMMITS A VIOLENT CRIME WHILE UNDER THE INFLUENCE OF
     ILLEGAL DRUGS SHOULD SERVE 100% OF HIS OR HER SENTENCE WITH ABSOLUTELY
     NO EARLY RELEASE.
<LI> THOUSANDS OF ARIZONANS SUFFER FROM DEBILITATING DISEASES SUCH AS
     GLAUCOMA, MULTIPLE SCLEROSIS, CANCER, AND AIDS, BUT CANNOT HAVE ACCESS
     TO THE NECESSARY DRUGS THEY NEED. ALLOWING DOCTORS TO PRESCRIBE
     SCHEDULE I CONTROLLED SUBSTANCES COULD SAVE VICTIMS OF THESE DISEASES
     FROM LOSS OF SIGHT, LOSS OF PHYSICAL CAPACITY, AND GREATLY REDUCE THE
     PAIN AND SUFFERING OF THE SERIOUSLY ILL AND TERMINALLY ILL.
<LI> THE DRUG PROBLEMS OF NON-VIOLENT PERSONS WHO ARE CONVICTED OF PERSONAL
     POSSESSION OR USE OF DRUGS ARE BEST HANDLED THROUGH COURT-SUPERVISED
     DRUG TREATMENT AND EDUCATION PROGRAMS. THESE PROGRAMS ARE MORE
     EFFECTIVE THAN LOCKING NON-VIOLENT OFFENDERS UP IN A COSTLY PRISON.
     PILOT PROGRAMS IN ARIZONA THAT PROVIDE TREATMENT ALTERNATIVES TO PRISON
     FOR LOW LEVEL DRUG OFFENDERS HAVE A 73% SUCCESS RATE AND COST ROUGHLY
     1/8 AS MUCH AS PRISON. OVER THE NEXT DECADE HUNDREDS OF MILLIONS OF
     DOLLARS CAN BE SAVED BY USING MANDATORY DRUG TREATMENT AND EDUCATION
     PROGRAMS AS AN ALTERNATIVE TO PRISON.
<LI> VIOLENT OFFENDERS ARE NOT ADEQUATELY PUNISHED DUE TO THE PRISON
     OVER-CROWDING CRISIS IN ARIZONA. PLACING NON-VIOLENT PERSONS WHO ARE
     CONVICTED OF PERSONAL POSSESSION OR USE OF DRUGS IN COURT-SUPERVISED
     DRUG TREATMENT AND EDUCATION PROGRAMS WILL FREE UP SPACE IN OUR PRISONS
     SO THAT THERE IS ROOM TO INCARCERATE VIOLENT OFFENDERS AND DRUG
     DEALERS.
<LI> THE MISSING LINK IN DRUG EDUCATION AND PREVENTION IS PARENTAL
     INVOLVEMENT. THE TAX DOLLARS SAVED BY ELIMINATING PRISON TIME FOR
     NON-VIOLENT PERSONS CONVICTED OF PERSONAL POSSESSION OR USE OF DRUGS
     SHOULD BE USED FOR DRUG TREATMENT AND EDUCATION, TARGETED AT PROGRAMS
     THAT INCREASE PARENTAL INVOLVEMENT IN THEIR CHILDREN'S DRUG-EDUCATION.
</OL>
<P>Section 3. PURPOSE AND INTENT

<P>THE PEOPLE OF THE STATE OF ARIZONA DECLARE THEIR PURPOSES TO BE AS FOLLOWS:
<OL>
<LI> TO REQUIRE THAT ANY PERSON WHO COMMITS A VIOLENT CRIME UNDER THE
     INFLUENCE OF DRUGS SERVE 100 PERCENT OF HIS OR HER SENTENCE AND NOT BE
     ELIGIBLE FOR PAROLE OR ANY FORM OF EARLY RELEASE.
<LI> TO PERMIT DOCTORS TO PRESCRIBE SCHEDULE I CONTROLLED SUBSTANCES TO
     TREAT A DISEASE, OR TO RELIEVE THE PAIN AND SUFFERING OF SERIOUSLY ILL
     AND TERMINALLY ILL PATIENTS.
<LI> TO REQUIRE THAT NON-VIOLENT PERSONS CONVICTED OF PERSONAL POSSESSION OR
     USE OF DRUGS SUCCESSFULLY UNDERGO COURT-SUPERVISED MANDATORY DRUG
     TREATMENT PROGRAMS AND PROBATION.
<LI> TO REQUIRE THAT NON-VIOLENT PERSONS CURRENTLY IN PRISON FOR PERSONAL
     POSSESSION OR USE OF ILLEGAL DRUGS, AND NOT SERVING A CONCURRENT
     SENTENCE FOR ANOTHER CRIME, OR PREVIOUSLY CONVICTED OR SENTENCED OR
     SUBJECT TO SENTENCING UNDER ANY HABITUAL CRIMINAL STATUTE IN ANY
     JURISDICTION IN THE UNITED STATES, BE MADE ELIGIBLE FOR IMMEDIATE
     PAROLE AND DRUG TREATMENT, EDUCATION AND COMMUNITY SERVICE.
<LI> TO FREE UP SPACE IN OUR PRISONS TO PROVIDE ROOM FOR VIOLENT OFFENDERS.
<LI> TO EXPAND THE SUCCESS OF PILOT DRUG INTERVENTION PROGRAMS WHICH DIVERT
     DRUG OFFENDERS FROM PRISON TO DRUG TREATMENT, EDUCATION, AND
     COUNSELING.
</OL>
<P>Section 4.

<P>Title 41, Chapter 11, Arizona Revised Statutes, is amended by adding
41-1604.16 to read as follows:

<P>41-1604.16. ARIZONA PARENTS COMMISSION ON DRUG EDUCATION AND PREVENTION.
<OL>
<LI> THE ARIZONA PARENTS COMMISSION ON DRUG EDUCATION AND PREVENTION IS
     HEREBY CREATED. THE COMMISSION SHALL CONSIST OF NINE (9) MEMBERS. THE
     MEMBERS OF THE COMMISSION SHALL BE APPOINTED BY THE GOVERNOR WITHIN
     SIXTY (60) DAYS OF THE EFFECTIVE DATE OF THIS ACT AND SHALL SERVE A TWO
     YEAR TERM. OF THE NINE MEMBERS, FIVE SHALL BE PARENTS WITH CHILDREN
     CURRENTLY ENROLLED IN AN ARIZONA SCHOOL, ONE SHALL BE A REPRESENTATIVE
     OF A LAW ENFORCEMENT AGENCY, ONE SHALL BE AN EDUCATOR IN A LOCAL SCHOOL
     DISTRICT, ONE SHALL BE A REPRESENTATIVE OF A COUNTY PROBATION
     DEPARTMENT, AND ONE SHALL BE A REPRESENTATIVE OF THE DRUG EDUCATION AND
     TREATMENT COMMUNITY.
<LI> EACH MEMBER SHALL BE APPOINTED FOR A TERM OF TWO YEARS. THE MEMBERS
     SHALL RECEIVE NO PAY, BUT MAY BE REIMBURSED FOR ACTUAL EXPENSES
     INCURRED ON COMMISSION BUSINESS.
<LI> THE COMMISSION SHALL FUND PROGRAMS THAT WILL INCREASE AND ENHANCE
     PARENTAL INVOLVEMENT AND WILL INCREASE EDUCATION ABOUT THE SERIOUS
     RISKS AND PUBLIC HEALTH PROBLEMS CAUSED BY THE ABUSE OF ALCOHOL AND
     CONTROLLED SUBSTANCES.
<LI> THE COMMISSION SHALL CONTRACT FOR ADMINISTRATIVE AND PROFESSIONAL
     SERVICES WITH A NOT FOR PROFIT ORGANIZATION OR GOVERNMENT ENTITY WITH
     EXPERTISE IN SUBSTANCE ABUSE EDUCATION AND PREVENTION.
</OL>
<P>Section 5.

<P>Title 41, Chapter 11, Arizona Revised Statutes, is amended by adding
41-1604.14 to read as follows:

<P>4l-1604.14. PAROLE NONELIGIBILITY; VIOLENT CRIME; INFLUENCE OF CONTROLLED SUBSTANCE; DEFINITION
<OL>
<LI> NOTWITHSTANDING ANY LAW TO THE CONTRARY, ANY PERSON CONVICTED OF A
     VIOLENT CRIME COMMITTED WHILE UNDER THE INFLUENCE OF A CONTROLLED
     SUBSTANCE IN VIOLATION OF THE PROVISIONS TITLE 13, CHAPTER 34, IS
     NONELIGIBLE FOR PAROLE AND MUST SERVE 100 PERCENT OF HIS OR HER
     SENTENCE IN PRISON. PURSUANT TO 41-1604.09, THE DIRECTOR SHALL INCLUDE
     ANY SUCH PERSON IN THE CLASSES OF NON-ELIGIBILITY REQUIRED TO BE
     ESTABLISHED BY THE DIRECTOR.
<LI> FOR THE PURPOSE OF THIS SECTION, A VIOLENT CRIME INCLUDES ANY CRIMINAL
     ACT WHICH RESULTS IN DEATH OR PHYSICAL INJURY OR ANY CRIMINAL USE OF
     WEAPONS OR DANGEROUS INSTRUMENTS.
</OL>
<P>Section 6.

<P>Title 13, Chapter 13, 13-3412, Arizona Revised Statutes, is amended as
follows:

<P>13-3412. Exceptions and exemptions; burden of proof; privileged
communications.
<OL>
<LI> The provisions of 13-3402, 13-3403, 13-3404, 13-3404.01 and 13-3405
     through 13-3409 do not apply to:
<OL>     
     <LI> Manufacturers, wholesalers, pharmacies and pharmacists under the
          provisions of 32-1921 and 32-1961.
     <LI> Medical practitioners, pharmacies and pharmacists while acting in
          the course of their professional practice, in good faith and in
          accordance with generally accepted medical standards.
     <LI> Persons who lawfully acquire and use such drugs only for
          scientific purposes.
     <LI> Officers and employees of the United States, this state or a
          political subdivision of the United States or this state, while
          acting in the course of their official duties.
     <LI> An employee or agent of a person described in paragraphs 1 through
          4 of this subsection, and a registered nurse or medical technician
          under the supervision of a medical practitioner, while such
          employee, agent, nurse or technician is acting in the course of
          professional practice or employment, and not on his own account.
     <LI> A common or contract carrier or warehouseman, or an employee of
          such carrier or warehouseman, whose possession of such drugs is in
          the usual course of business or employment.
     <LI> Persons lawfully in possession or control of controlled substances
          authorized by title 36, chapter 27.
     <LI> Persons who sell any non-narcotic substance that under the federal
          food, drug and cosmetic act may lawfully be sold over the counter
          without a prescription.
     <LI> THE RECEIPT, POSSESSION OR USE, OF A CONTROLLED SUBSTANCE INCLUDED
          IN SCHEDULE I OF 36-2512, BY ANY SERIOUSLY ILL OR TERMINALLY ILL
          PATIENT, PURSUANT TO THE PRESCRIPTION OF A DOCTOR IN COMPLIANCE
          WITH THE PROVISIONS OF 13-3412.01.
</OL>
<LI> In any complaint, information or indictment and in any action or
     proceeding brought for the enforcement of any provision of this chapter
     the burden of proof of any such exception, excuse, defense or exemption
     is on the defendant.
<LI> In addition to other exceptions to the physician-patient privilege,
     information communicated to a physician in an effort to procure
     unlawfully a prescription-only, dangerous or narcotic drug, or to
     procure unlawfully the administration of such drug, is not a privileged
     communication.
</OL>
<P>Section 7.

<P>Title 13, Chapter 13, Arizona Revised Statutes, is amended by adding
13-3412.01 to read as follows:

<P>13-3412.01. PRESCRIBING CONTROLLED SUBSTANCES INCLUDED IN SCHEDULE I OF
36-2512 FOR SERIOUSLY ILL AND TERMINALLY ILL PATIENTS
<OL>
<LI> NOTWITHSTANDING ANY LAW TO THE CONTRARY, ANY MEDICAL DOCTOR LICENSED TO
     PRACTICE IN ARIZONA MAY PRESCRIBE A CONTROLLED SUBSTANCE INCLUDED IN
     SCHEDULE I OF 36-2512 TO TREAT A DISEASE, OR TO RELIEVE THE PAIN AND
     SUFFERING OF A SERIOUSLY ILL PATIENT OR TERMINALLY ILL PATIENT, SUBJECT
     TO THE PROVISIONS OF 13-3412.01. IN PRESCRIBING SUCH A CONTROLLED
     SUBSTANCE, THE MEDICAL DOCTOR SHALL COMPLY WITH PROFESSIONAL MEDICAL
     STANDARDS.
<LI> NOTWITHSTANDING ANY LAW TO THE CONTRARY, A MEDICAL DOCTOR MUST DOCUMENT
     THAT SCIENTIFIC RESEARCH EXISTS WHICH SUPPORTS THE USE OF A CONTROLLED
     SUBSTANCE LISTED IN SCHEDULE I OF 36-2512 TO TREAT A DISEASE, OR TO
     RELIEVE THE PAIN AND SUFFERING OF A SERIOUSLY ILL PATIENT OR TERMINALLY
     ILL PATIENT BEFORE PRESCRIBING THE CONTROLLED SUBSTANCE. A MEDICAL
     DOCTOR PRESCRIBING A CONTROLLED SUBSTANCE INCLUDED IN SCHEDULE I OF
     36-2512 TO TREAT A DISEASE, OR TO RELIEVE THE PAIN AND SUFFERING OF A
     SERIOUSLY ILL PATIENT OR TERMINALLY ILL PATIENT, MUST OBTAIN THE
     WRITTEN OPINION OF A SECOND MEDICAL DOCTOR THAT THE PRESCRIBING OF THE
     CONTROLLED SUBSTANCE IS APPROPRIATE TO TREAT A DISEASE OR TO RELIEVE
     THE PAIN AND SUFFERING OF A SERIOUSLY ILL PATIENT OR TERMINALLY ILL
     PATIENT. THE WRITTEN OPINION OF THE SECOND MEDICAL DOCTOR SHALL BE KEPT
     IN THE PATIENT'S OFFICIAL MEDICAL FILE. BEFORE PRESCRIBING THE
     CONTROLLED SUBSTANCE INCLUDED IN SCHEDULE I OF 36-2512 THE MEDICAL
     DOCTOR SHALL RECEIVE IN WRITING THE CONSENT OF THE PATIENT.
<LI> ANY FAILURE TO COMPLY WT. THE PROVISIONS OF THIS SECTION MAY BE THE
     SUBJECT OF INVESTIGATION AND APPROPRIATE DISCIPLINING ACTION BY THE
     BOARD OF MEDICAL EXAMINERS.
</OL>
<P>Section 8.

<P>Title 41, Chapter 11, Arizona Revised Statutes, is amended by adding
4l-1604.15 to read as follows:

<P>41-1604.15. PAROLE ELIGIBILITY FOR PERSONS PREVIOUSLY CONVICTED OF PERSONAL POSSESSION OR USE OF A CONTROLLED SUBSTANCE
<OL>
<LI> NOTWITHSTANDING ANY LAW TO THE CONTRARY, IF A PRISONER HAS BEEN
     CONVICTED OF THE PERSONAL POSSESSION OR USE OF A CONTROLLED SUBSTANCE
     AS DEFINED IN 36-2501, AND IS NOT CONCURRENTLY SERVING ANOTHER
     SENTENCE, THE PRISONER SHALL BE ELIGIBLE FOR PAROLE.
<LI> ANY PERSON WHO HAS PREVIOUSLY BEEN CONVICTED OF A VIOLENT CRIME AS
     DEFINED IN 41-1604.14, SUBSECTION B OR HAS PREVIOUSLY BEEN CONVICTED,
     SENTENCED OR SUBJECT TO SENTENCING UNDER ANY HABITUAL CRIMINAL STATUTE
     IN ANY JURISDICTION IN THE UNITED STATES, SHALL NOT BE ELIGIBLE FOR
     PAROLE PURSUANT TO THE PROVISIONS OF THIS SECTION.
<LI> PERSONAL POSSESSION OR USE OF A CONTROLLED SUBSTANCE PURSUANT TO THIS
     ACT SHALL NOT INCLUDE POSSESSION FOR SALE, PRODUCTION, MANUFACTURING,
     OR TRANSPORTATION FOR SALE OF ANY CONTROLLED SUBSTANCE.
<LI> WITHIN NINETY (90) DAYS OF THE EFFECTIVE DATE OF THIS ACT, THE DIRECTOR
     OF THE STATE DEPARTMENT OF CORRECTIONS SHALL PREPARE A LIST WHICH
     IDENTIFIES EACH PERSON WHO IS ELIGIBLE FOR PAROLE PURSUANT TO THE
     PROVISIONS OF THIS SECTION, AND DELIVER THE LIST TO THE BOARD OF
     EXECUTIVE CLEMENCY.
</OL>
<P>Section 9.

<P>Title 31, Chapter 3, Arizona Revised Statutes, is amended by adding
31-411.01 to read as follows:

<P>31-411.01. PAROLE FOR PERSONS PREVIOUSLY CONVICTED OF PERSONAL POSSESSION OR USE OF A CONTROLLED SUBSTANCE; TREATMENT; PREVENTION; EDUCATION; TERMINATION OF PAROLE
<OL>
<LI> NOTWITHSTANDING ANY LAW TO THE CONTRARY, EVERY PRISONER WHO IS ELIGIBLE
     FOR PAROLE PURSUANT TO THE PROVISIONS OF 41-1604.15 SHALL BE RELEASED
     UPON PAROLE, PROVIDED, HOWEVER THAT IF THE BOARD OF EXECUTIVE CLEMENCY
     DETERMINES THAT A PRISONER SO ELIGIBLE WOULD BE A DANGER TO THE GENERAL
     PUBLIC, THAT PRISONER SHALL NOT BE RELEASED UPON PAROLE.
<LI> AS TO EACH PRISONER RELEASED UPON PAROLE PURSUANT TO THE PROVISIONS OF
     THIS SECTION, THE BOARD SHALL ORDER THAT AS A CONDITION OF PAROLE THE
     PERSON BE REQUIRED TO PARTICIPATE IN AN APPROPRIATE DRUG TREATMENT OR
     EDUCATION PROGRAM ADMINISTERED BY A QUALIFIED AGENCY OR ORGANIZATION
     THAT PROVIDES SUCH TREATMENTS TO PERSONS WHO ABUSE CONTROLLED
     SUBSTANCES. EACH PERSON ENROLLED IN A DRUG TREATMENT OR EDUCATION
     PROGRAM SHALL BE REQUIRED TO PAY FOR HIS OR HER PARTICIPATION IN THE
     PROGRAM TO THE EXTENT OF HIS OR HER FINANCIAL ABILITY.
<LI> EACH PERSON RELEASED UPON PAROLE PURSUANT TO THE PROVISIONS OF THIS
     SECTION SHALL REMAIN ON PAROLE UNLESS THE BOARD REVOKES PAROLE OR
     GRANTS AN ABSOLUTE DISCHARGE FROM PAROLE OR UNTIL THE PRISONER REACHES
     HIS OR HER INDIVIDUAL EARNED RELEASE CREDIT DATE PURSUANT TO
     41-1604.10. WHEN THE PRISONER REACHES HIS OR HER INDIVIDUAL EARNED
     RELEASE CREDIT DATE, HIS OR HER PAROLE SHALL BE TERMINATED AND HE OR
     SHE SHALL NO LONGER BE UNDER THE AUTHORITY OF THE BOARD.
</OL>
<P>Section 10.

<P>Title 13, Chapter 9, Arizona Revised Statutes, is amended by adding
13-901.01 to read as follows:

<P>13-901.01. PROBATION FOR PERSONS CONVICTED OF PERSONAL POSSESSION AND USE OF CONTROLLED SUBSTANCES; TREATMENT; PREVENTION; EDUCATION
<OL>
<LI> NOTWITHSTANDING ANY LAW TO THE CONTRARY, ANY PERSON WHO IS CONVICTED OF
     THE PERSONAL POSSESSION OR USE OF A CONTROLLED SUBSTANCE AS DEFINED IN
     36-2501 SHALL BE ELIGIBLE FOR PROBATION. THE COURT SHALL SUSPEND THE
     IMPOSITION OR EXECUTION OF SENTENCE AND PLACE SUCH PERSON ON PROBATION.
<LI> ANY PERSON WHO HAS BEEN CONVICTED OF OR INDICTED FOR A VIOLENT CRIME AS
     DEFINED 41-1604.14, SUBSECTION B SHALL NOT BE ELIGIBLE FOR PROBATION
     AS PROVIDED FOR IN THIS SECTION, BUT INSTEAD SHALL BE SENTENCED
     PURSUANT TO THE OTHER PROVISIONS OF TITLE 13, CHAPTER 34.
<LI> PERSONAL POSSESSION OR USE OF A CONTROLLED SUBSTANCE PURSUANT TO THIS
     ACT SHALL NOT INCLUDE POSSESSION FOR SALE, PRODUCTION, MANUFACTURING,
     OR TRANSPORTATION FOR SALE OF ANY CONTROLLED SUBSTANCE.
<LI> IF A PERSON IS CONVICTED OF PERSONAL POSSESSION OR USE OF A CONTROLLED
     SUBSTANCE AS DEFINED IN 36-2501, AS A CONDITION OF PROBATION, THE
     COURT SHALL REQUIRE PARTICIPATION IN AN APPROPRIATE DRUG TREATMENT OR
     EDUCATION PROGRAM ADMINISTERED BY A QUALIFIED AGENCY OR ORGANIZATION
     THAT PROVIDES SUCH PROGRAMS TO PERSONS WHO ABUSE CONTROLLED SUBSTANCES.
     EACH PERSON ENROLLED IN A DRUG TREATMENT OR EDUCATION PROGRAM SHALL BE
     REQUIRED TO PAY FOR HIS OR HER PARTICIPATION IN THE PROGRAM TO THE
     EXTENT OF HIS OR HER FINANCIAL ABILITY.
<LI> A PERSON WHO HAS BEEN PLACED ON PROBATION UNDER THE PROVISIONS OF THIS
     SECTION, WHO IS DETERMINED BY THE COURT TO BE IN VIOLATION OF HIS OR
     HER PROBATION SHALL HAVE NEW CONDITIONS OF PROBATION ESTABLISHED IN THE
     FOLLOWING MANNER: THE COURT SHALL SELECT THE ADDITIONAL CONDITIONS IT
     DEEMS NECESSARY, INCLUDING INTENSIFIED DRUG TREATMENT, COMMUNITY
     SERVICE, INTENSIVE PROBATION, HOME ARREST, OR ANY OTHER SUCH SANCTIONS
     SHORT OF INCARCERATION.
<LI> IF PERSON IS CONVICTED A SECOND TIME OF PERSONAL POSSESSION OR USE OF A
     CONTROLLED SUBSTANCE AS DEFINED IN 36-2501, THE COURT MAY INCLUDE
     ADDITIONAL CONDITIONS OF PROBATION IT DEEMS NECESSARY, INCLUDING
     INTENSIFIED DRUG TREATMENT, COMMUNITY SERVICE, INTENSIVE PROBATION,
     HOME ARREST, OR ANY OTHER ACTION WITHIN THE JURISDICTION OF THE COURT.
<LI> A PERSON WHO HAS BEEN CONVICTED THREE TIMES OF PERSONAL POSSESSION OR
     USE OF A CONTROLLED SUBSTANCE AS DEFINED IN 36-2501 SHALL NOT BE
     ELIGIBLE FOR PROBATION UNDER THE PROVISIONS OF THIS SECTION, BUT
     INSTEAD SHALL BE SENTENCED PURSUANT TO THE OTHER PROVISIONS OF TITLE
     13, CHAPTER 34.
</OL>
<P>Section 11.

<P>Title 13, Chapter 9, Arizona Revised Statutes, is amended by adding
13-901.02 to read as follows:

<P>13-901.02. DRUG TREATMENT AND EDUCATION FUND
<OL>
<LI> THERE IS HEREBY CREATED A SPECIAL FUND WHICH SHALL BE CALLED THE DRUG
     TREATMENT AND EDUCATION FUND IN THE ADMINISTRATIVE OFFICE OF SUPREME
     COURT.
<LI> FIFTY (50) PERCENT OF THE MONIES DEPOSITED IN THE DRUG TREATMENT AND
     EDUCATION FUND SHALL BE DISTRIBUTED BY THE ADMINISTRATIVE OFFICE OF THE
     SUPREME COURT TO THE SUPERIOR COURT PROBATION DEPARTMENTS TO COVER THE
     COSTS OF PLACING PERSONS IN DRUG EDUCATION AND TREATMENT PROGRAMS
     ADMINISTERED BY A QUALIFIED AGENCY OR ORGANIZATION THAT PROVIDES SUCH
     PROGRAMS TO PERSONS WHO ABUSE CONTROLLED SUBSTANCES. SUCH MONIES SHALL
     BE ALLOCATED TO SUPERIOR COURT PROBATION DEPARTMENTS ACCORDING TO A
     FORMULA BASED ON PROBATION CASELOAD TO BE ESTABLISHED BY THE
     ADMINISTRATIVE OFFICE OF THE SUPREME COURT.
<LI> FIFTY (50) PERCENT OF THE MONIES DEPOSITED IN THE DRUG TREATMENT AND
     EDUCATION FUND SHALL BE TRANSFERRED TO THE ARIZONA PARENTS COMMISSION
     ON DRUG EDUCATION AND PREVENTION ESTABLISHED PURSUANT TO 41-1604.16.
<LI> THE ADMINISTRATIVE OFFICE OF THE SUPREME COURT SHALL CAUSE TO BE
     PREPARED AT THE END OF EACH FISCAL YEAR AFTER 1997 AN ACCOUNTABILITY
     REPORT CARD THAT DETAILS THE COST SAVINGS REALIZED FROM THE DIVERSION
     OF PERSONS FROM PRISONS TO PROBATION. A COPY OF THE REPORT SHALL BE
     SUBMITTED TO THE GOVERNOR AND THE LEGISLATURE, AND A COPY OF THE REPORT
     SHALL BE SENT TO EACH PUBLIC LIBRARY IN THE STATE. THE ADMINISTRATIVE
     OFFICE OF THE SUPREME COURT SHALL RECEIVE REIMBURSEMENT FROM THE DRUG
     TREATMENT AND EDUCATION FUND FOR ANY ADMINISTRATIVE COSTS IT INCURS IN
     THE IMPLEMENTATION OF THIS ACT.
</OL>
<P>Section 12.

<P>Title 42, Chapter 12 is amended by adding 42-1204.01 as follows:

<P>42-1204.01. LUXURY PRIVILEGES TAX; PURPOSE; DRUG TREATMENT AND EDUCATION
FUND; DEPARTMENT OF CORRECTIONS REVOLVING FUND
<OL>
<LI> NOTWITHSTANDING ANY LAW TO THE CONTRARY, SEVEN (7) PERCENT OF THE
     MONIES COLLECTED BETWEEN JANUARY 1, 1997 AND DECEMBER 31, 1999,
     PURSUANT TO 42-1204 SUBSECTION A, PARAGRAPH 1, AND EIGHTEEN (18)
     PERCENT OF MONIES COLLECTED BETWEEN JANUARY 1, 1997 AND DECEMBER 31,
     1999, PURSUANT TO SUBSECTION A, PARAGRAPHS 2, 3, AND 4, SHALL BE
     DEPOSITED IN THE DRUG TREATMENT AND EDUCATION FUND ESTABLISHED PURSUANT
     TO 13-902.02.
<LI> NOTWITHSTANDING ANY LAW TO THE CONTRARY, THREE (3) PERCENT OF THE
     MONIES COLLECTED BETWEEN JANUARY 1, 1997 AND DECEMBER 31, 1999,
     PURSUANT TO SECTION 42-1204 SUBSECTION A, PARAGRAPH 1, AND SEVEN (7)
     PERCENT OF MONIES COLLECTED BETWEEN JANUARY 1, 1997 AND DECEMBER 31,
     1999, PURSUANT TO SUBSECTION A, PARAGRAPHS 2, 3. AND 4, SHALL BE
     DEPOSITED IN A SEPARATE REVOLVING FUND OF THE DEPARTMENT OF CORRECTIONS
     FOR PAYMENT OF THE EXPENSES OF IMPLEMENTING THE PROVISIONS OF
     31-411.01, AND SHALL NOT REVERT TO THE STATE GENERAL FUND IF
     UNEXPENDED AT THE CLOSE OF THE FISCAL YEAR.
<LI> NOTWITHSTANDING ANY LAW TO THE CONTRARY, TEN (10) PERCENT OF THE MONIES
     COLLECTED AFTER DECEMBER 31, 1999 PURSUANT TO 42-1204 SUBSECTION A,
     PARAGRAPH 1, AND TWENTY FIVE (25) PERCENT OF THE MONIES COLLECTED AFTER
     DECEMBER 31, 1999 PURSUANT TO SUBSECTION A, PARAGRAPHS 2, 3, AND 4,
     SHALL BE DEPOSITED IN THE DRUG TREATMENT AND EDUCATION FUND ESTABLISHED
     PURSUANT TO 13-902.02.
</OL>
<P>Section 13. Severability

<P>If any provision of this Act, or part thereof, is for any reason held to be invalid or unconstitutional, the remaining sections shall not be affected
but shall remain in full force and effect, and to this end the provisions of
the Act are severable.

<P><CENTER>ANALYSIS BY LEGISLATIVE COUNCIL</CENTER>

<P><CENTER>(In compliance with A.R.S. section 19-124)</CENTER>

<P>Proposition 200 would require that certain persons who are convicted of drug offenses be sentenced as follows:
<OL>
<LI> Require that persons who commit violent crimes while under the influence of drugs serve 100% of their sentences, without eligibility for parole.
<P>
<LI> Require that persons who have been convicted before the proposition
passes of the personal possession or use of a controlled substance such as
marijuana and who are serving their sentence in prison be released on
parole. A person is released on parole after serving time in jail or prison,
is under the supervision of a parole officer and may have his parole revoked
if any condition of parole is violated. The State Department of Corrections
would be required to establish a procedure for paroling these persons. The
Board of Executive Clemency would be required to release these persons
unless the Board determines that a person would be a danger to the general
public. Persons who are released on parole would be required to participate
in drug treatment or education.
<P>
<LI> Require that persons who are convicted after the proposition passes of
the personal possession or use of a controlled substance such as marijuana
be eligible for probation. A person who is sentenced to probation does not
serve any time in jail or prison, is under the supervision of a probation
officer and remains free as long as the person continues his good behavior.
A person on probation would be required to participate in a drug treatment
or education program.
</OL>
<P>Proposition 200 would allow medical doctors to prescribe a controlled
substance such as marijuana to treat a disease or to relieve the pain and
suffering of a seriously or terminally ill patient. The doctor must be able
to document that scientific research supports the use of the controlled
substance and must obtain a written opinion from a second doctor that
prescribing the controlled substance is appropriate. A patient who receives,
possesses or uses a controlled substance as prescribed by a doctor would not
be subject to criminal penalties.

<P>Proposition 200 would establish the Drug Treatment and Education Fund. These monies would come from a percentage of the luxury tax on alcohol, cigarettes and other tobacco products. 50% of these monies would be transferred to Superior Court probation departments to cover the costs of placing persons in drug education and treatment programs. The remaining 50% of the monies would be transferred to the Arizona Parents Commission on Drug Education and Prevention.

<P>Proposition 200 would establish an Arizona Parents Commission on Drug
Education and Prevention. The Commission would be responsible for funding
programs that increase and enhance parental involvement in drug education
and treatment.
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-263</DOCNO>
<DOCOLDNO>IA087-000627-B022-216</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/IOWA/iowa.html 206.61.184.43 19970122053918 text/html 5762
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:39:08 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:53:17 GMT
Content-length: 5547
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Iowans for Medical Marijuana</title>
</head>

<body bgcolor="#000000" text="#FFFFFF" link="#00FF66"
vlink="#00FFFF" alink="#FF3300">

<h1 align="center">Iowans for Medical Marijuana</h1>

<h3 align="center">Post Office Box 4091<br>
Des Moines, Iowa 50333<br>
(515) 262-6957 voice &amp; fax</h3>

<hr>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="/~olsen/MEDICAL/medical.html">Carl E. Olsen's Medical
Marijuana Page</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="../HELMERS/helmers.html">State of Iowa v. Allen Helmers</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="cityview.html">Cityview - The forbidden cure - November 13,
1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="dmreg.html">Des Moines Register endorses medical marijuana
- November 11, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="olsonsb.html">The Olsons' letter to the Des Moines Register
- November 7, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="smithc.html">Curt Smith's letter to the Des Moines Register
- October 24, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="grassley.html">Grassley, Charles, U.S. Senator - October
30, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="rally.html">October 6 Rally protesting persecution of
medical patients</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="nussle.html">Letter from U.S. Rep. Jim Nussle - September
6, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="olsen-03.html">Carl Olsen's letter to the Partnership for a
Drug Free Iowa - September 5, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="dale-01.html">Letter from the Partnership for a Drug Free
Iowa - September 4, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="harkin01.html">Letter from U.S. Senator Tom Harkin - August
29, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="fallon.html">State Representative Ed Fallon - August 26,
1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="olsen-02.html">Carl Olsen's letter to the Partnership for a
Drug Free Iowa - August 17, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="olsen-01.html">Carl Olsen's letter to U.S. Senator Tom
Harkin - August 9, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="result96.html">Preliminary Results of 1996 Medical
Marijuana Legislative Survey</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="gregg.html">Ryan Gregg - July 15, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="survey97.html">1997 Iowa Legislative Survey</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="ganske02.html">Letter from Congressman Greg Ganske - April
1, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="ganske.html">U.S. Congressman Greg Ganske - December 13,
1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="hughes.html">Former Governor and U.S. Senator Harold Hughes
- July 17, 1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="wright.html">Professor R. Dean Wright, Ph.D. - July 17,
1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="norris.html">Senate Intern Larisa Thomas-Norris - July 13,
1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="lind.html">State Senator Jim Lind - June 7, 1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="crocker.html">State Permit to hold Medical Marijuana
Meeting - June 2, 1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="pharmacy.html">Iowa Board of Pharmacy Examiners opposes
marijuana resolution - March 10, 1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="resolut.html">Proposed Medical Marijuana Resolution - died
in committee on February 21, 1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="reform.html">Proposed Medical Marijuana Resolution Faces
Opposition by Iowa Medical Society</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="survey.html">1995 Iowa Legislative Survey</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="pleas.html">State v. Pleas - Pottawattamie County, June 16,
1994</a></h4>

<hr>

<address>
    Carl E. Olsen - carlolsen@mail.commonlink.com<br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 262-6957 voice and fax 
</address>

<hr>

<h4>Please send your comments regarding this page to: <a
href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a></h4>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-264</DOCNO>
<DOCOLDNO>IA087-000627-B023-11</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/HELMERS/helmers.html 206.61.184.43 19970122053937 text/html 2642
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:39:31 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:50:54 GMT
Content-length: 2427
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>State of Iowa v. Allen Helmers</title>
</head>

<body bgcolor="#000000" text="#FFFFFF" link="#00FF66"
vlink="#00FFFF" alink="#FF3300">

<h1 align="center">State of Iowa v. Allen Helmers</h1>

<hr>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="helmers5.html">Medicinal marijuana hearing delayed -
October 27, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="helmers4.html">Des Moines rally supports Waterloo man -
October 7, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="gram.html">Karon Gram letter to the editor- September 24,
1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="davis.html"><strong>Cindy Davis letter to the editor -
September 22, 1996</strong></a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="cox.html">Joleen Cox letter to the editor - September 19,
1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="helmers3.html">Judge delays probation hearing - September
17, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="casella1.html">Letter from Denise Casella - September 10,
1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="olsen-01.html">Carl Olsen's letter to the court - August
28, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="helmers2.html">Looking for relief, Waterloo Courier -
August 28, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="helmers1.html">Statement of Allen Helmers - July 8, 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="verduyn.html">Statement of Dr. W. H. Verduyn - July 2, 1996</a></h4>

<hr>

<address>
    Carl E. Olsen - carlolsen@mail.commonlink.com<br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 262-6957 voice and fax 
</address>

<hr>

<h4>Please send your comments regarding this page to: <a
href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a></h4>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-265</DOCNO>
<DOCOLDNO>IA087-000627-B028-95</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/ACT/act.html 206.61.184.43 19970122055533 text/html 1962
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:55:23 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:49:10 GMT
Content-length: 1747
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Alliance for Cannabis Therapeutics</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" link="#0000FF"
vlink="#800080" alink="#FF0000">

<h1 align="center">Alliance for Cannabis Therapeutics</h1>

<h2 align="center">Post Office Box 21210<br>
Kalorama Station<br>
Washington, D.C. 20009</h2>

<hr>

<h4 align="left"><img src="../../images/reddot.gif" width="14"
height="14"> <a href="virginia.html">Virginia Nurses Back
Pot-by-Prescription (Spring 1995)</a> </h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="australi.html">Medical Marijuana in Australia (Spring 1995)</a> </h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="scientis.html">Scientists advocate marijuana for the ill
(Spring 1995)</a> </h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="leganews.html">Legal News (Spring 1995)</a> </h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="states.html">Legislative Tallies for States Recognizing
Marijuana's Medical Value</a> </h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="cases.html">Significant Legal Cases</a> </h4>

<hr>

<address>
    Carl E. Olsen - carlolsen@mail.commonlink.com<br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 262-6957 voice and fax 
</address>

<hr>

<h4>Please send your comments regarding this page to: <a
href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a></h4>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-266</DOCNO>
<DOCOLDNO>IA087-000627-B028-286</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/POT/pot.html 206.61.184.43 19970122055846 text/html 3457
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:58:13 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 17:57:27 GMT
Content-length: 3242
</DOCHDR>
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Patients Out of Time - Cannabis as Medicine</title>
</head>

<body bgcolor="#FFFFFF" link="#0000FF" vlink="#FF0000"
alink="#FF00FF">

<h5 align="center"><font color="#FF0000" size="7"><b>Patients Out
of Time</b></font><font size="7"><b> <br>
</b></font><font color="#008080" size="6"><b>Cannabis as Medicine</b></font><font
size="6"><b> <br>
</b></font><font size="3">Fish Pond Plantation, 1472 Fish Pond
Road, Howardsville, VA 24562 <br>
Electronic Bulletin Board (804) 263-8237<br>
email </font><a href="mailto:Mary_Lynn@patient.win.net"><font
size="3">Mary_Lynn@patient.win.net</font></a></h5>

<hr>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="ana.html">American Nurses Association - October 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="marylynn.html">Press Release - March 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="pot-002.html">Organizations Supporting Access to
Therapeutic Cannabis - March 1996</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="cna.html">California Nurses Association - September 21,
1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="nysna.html">New York State Nurses Association - June 29,
1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="nnsaposi.html">National Nurses Society on Addictions
Position Paper -May 1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="vnaposit.html">Virginia Nurses Association Position Paper -
March 1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="ptpolicy.html">Official Policy Statement of Patients Out of
Time - January 1995</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="vnaresol.html">Resolution of the Virginia Nurses
Association - October 7, 1994</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="cma.html">California Medical Association, 1992 &amp; 1994</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="perspect.html">Perspectives on Addictions Nursing - June
1993</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="therapeu.html">Therapeutic Cannabis References</a></h4>

<h4><img src="../../images/reddot.gif" width="14" height="14"> <a
href="misuse.html">Misuse of Research</a></h4>

<hr>

<h4 align="center"><a href="http://www.trvnet.net/~mmcmahon/">George
McMahon</a>, one of eight patients in the federal medical
marijuana program and a founding member of Patients Out of Time</h4>

<hr>

<address>
    Carl E. Olsen - carl@mail.commonlink.com <br>
    P.O. Box 4091, Des Moines, IA 50333 <br>
    (515) 262-6957 voice and fax 
</address>

<hr>

<h4>Please send your comments regarding this page to: <a
href="mailto:carl@mail.commonlink.com">carl@mail.commonlink.com</a></h4>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-267</DOCNO>
<DOCOLDNO>IA087-000627-B021-202</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/YOUNG/young.html 206.61.184.43 19970122053617 text/html 1432
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 05:35:59 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:02:57 GMT
Content-length: 1217
</DOCHDR>
<html>

<head>
<title>Francis L. Young</title>
<meta name="AUTHOR" content="Carl E. Olsen">
</head>

<body bgcolor="000000" text="FFFFFF" link="00FF66" vlink="00FFFF"
alink="FF3300">
<center>

<h4>UNITED STATES DEPARTMENT OF JUSTICE<br>
Drug Enforcement Administration<br>
In The Matter Of<br>
MARIJUANA RESCHEDULING PETITION<br>
Docket No. 86-22<br>
OPINION AND RECOMMENDED RULING, FINDINGS OF<br>
FACT, CONCLUSIONS OF LAW AND DECISION OF<br>
ADMINISTRATIVE LAW JUDGE<br>
FRANCIS L. YOUNG, Administrative Law Judge<br>
DATED: SEPTEMBER 6, 1988</h4>
</center>


<h4><img src="../../images/reddot.gif"> <a href="young1.html">Judge
Young's ruling (Pages 1-15)</a> </h4>

<h4> <img src="../../images/reddot.gif"> <a href="young2.html">Judge
Young's ruling (Pages 16-34)</a> </h4>

<h4> <img src="../../images/reddot.gif"> <a href="young3.html">Judge
Young's ruling (Pages 35-52)</a> </h4>

<h4> <img src="../../images/reddot.gif"> <a href="young4.html">Judge
Young's ruling (Pages 53-69)</a> </h4>

<hr>

<address>
    Carl E. Olsen - carl@mail.commonlink.com<br>
    P.O. Box 4091, Des Moines, IA 50333<br>
    (515) 262-6957 voice and fax 
</address>

<hr>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-268</DOCNO>
<DOCOLDNO>IA087-000628-B024-248</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/jenks.html 206.61.184.43 19970122060426 text/html 17164
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:04:07 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:05:05 GMT
Content-length: 16948
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<DD><TITLE>JENKS v. FLORIDA, 582 So.2d 676 (Fla.App. 1 Dist. 1991)</TITLE>
<DD><META NAME="AUTHOR" CONTENT="District Court of Appeal of Florida, First Division">
<DD><META NAME="SUMMARY" CONTENT="statute defining cannabis as Schedule I substance did not preclude defense of medical necessity, and defendants established medical necessity defense">
<DD><META NAME="KEYWORDS" CONTENT="Cannabis, cannabis, Marijuana, marijuana">
<DD><META NAME="GENERATOR" CONTENT="Mozilla/3.0b5aGold (Win95; I) [Netscape]">
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#FF0000" ALINK="#FF00FF">
582 SOUTHERN REPORTER, 2d SERIES 676 <P>
<TT>
<DD>Kenneth L. JENKS and Barbara J. Jenks, Appellants, 
<DD>&nbsp;&nbsp;v. 
<DD>STATE of Florida, Appellee. 
<P>
<DD>No. 90-2462. 
<P>
<DD>District Court of Appeal of Florida, First District.
<P>
<DD>June 18, 1991. 
<BR>
<BR>
<BR>
<DD>Defendants were convicted in the Circuit Court, Bay County, 
Clinton Foster, J., of cultivating cannabis and possession of 
drug paraphernalia, and they appealed.&nbsp; The District Court of 
Appeal, Ervin, J., held that: (1) statute defining cannabis as 
Schedule I substance did not preclude defense of medical 
necessity, and (2) defendants established medical necessity 
defense. 
<P>
<DD>Reversed. 
<P>
<DD>Nimmons, J., dissented. 
<P>
1.&nbsp; Drugs and Narcotics 78 
<DD>Statute defining cannabis as Schedule I substance did not 
preclude defense of medical necessity raised by defendant's 
charged with cultivating cannabis and possession of drug 
paraphernalia, who allegedly used marijuana to treat nausea which 
they suffered in connection with their contraction of acquired 
immune deficiency syndrome (AIDS).&nbsp; West's F.S.A. &sect; 893.03(1)(d). 
<P></TT>
JENKS v. STATE Fla. 677 
<BR>Cite as 582 So.2d 676 (Fla.App. 1 Dist. 1991) 
<TT><P>
2.&nbsp; Drugs and Narcotics 78 
<DD>Defendants charged with cultivating cannabis and possession of 
drug paraphernalia established medical necessity defense; medical 
expert and physician testified that no other drug or treatment 
was available that would effectively eliminate or diminish nausea 
suffered by defendants, who had contracted acquired immune 
deficiency syndrome (AIDS), and defendants established that if 
their nausea was not controlled, their lives were in danger.&nbsp;  
West's F.S.A. &sect;&sect; 893.13, 893.147. 
<P>
3.&nbsp; Drugs and Narcotics 78 
<DD>Elements of medical necessity defense to use of controlled 
substance are: that defendant did not intentionally bring about 
circumstances which precipitated unlawful act; that defendant 
could not accomplish same objective using less offensive 
alternative available to defendant; and that evil sought to be 
avoided was more heinous than unlawful act perpetrated to avoid 
it. 
<P>
<DD>John F. Daniel, of Daniel &amp; Komarek, Chartered, Panama 
City, for appellants. 
<P>
<DD>Robert A. Butterworth, Atty. Gen., and Gypsy Bailey, Asst. 
Atty. Gen., Tallahassee, for appellee. 
<P>
<DD>ON MOTION FOR REHEARING 
<P>
<DD>ERVIN, Judge. 
<P>
<DD>We substitute the following opinion for Jenks v. State, 16 
F.L.W. D1070, 1991 WL 61786 (Fla. 1st DCA Apr. 16, 1991). 
<P>
<DD>Kenneth and Barbara Jenks appeal their convictions for 
cultivation of marijuana and possession of drug paraphernalia, 
contending that the trial court erred in refusing to recognize 
their defense of medical necessity.&nbsp; We agree and reverse. 
<P>
<DD>Kenneth Jenks inherited hemophilia from his mother, and 
contracted the acquired immune deficiency syndrome (AIDS) virus 
from a blood transfusion in 1980.&nbsp; He unknowingly passed it to 
his wife, Barbara Jenks.&nbsp; Mrs. Jenks' health began to decline 
rapidly.&nbsp; Her weight dropped from 150 to 112 pounds during a 
three week period as a result of constant vomiting, and she was 
hospitalized at least six times for two to three weeks at a time.  
Although she had been prescribed over a half-dozen oral 
medications for nausea, none of them worked.&nbsp; When given shots for 
nausea, she was left in a stupor and unable to function.&nbsp; Like 
wise, when Mr. Jenks started AZT treatment, he was not able to 
eat because the medication left him constantly nauseous.&nbsp; He also 
lost weight, although not as dramatically as his wife. 
<P>
<DD>When the Jenks began participating in a support group 
sponsored by the Bay County Health Department, a group member 
told them how marijuana had helped him.&nbsp; Although initially 
reluctant, Mr. and Mrs. Jenks tried marijuana and found that they 
were able to retain their AIDS medications, eat, gain weight, 
maintain their health, and stay out of the hospital.&nbsp; They asked 
their treating physician about prescribing the drug, but were 
unable to obtain a legal prescription.&nbsp; The Jenks decided to grow 
two marijuana plants to insure its availability, avoid the 
expense of buying it on the street, and reduce the possibility of 
arrest. 
<P>
<DD>On March 29, 1990, the Jenks were arrested and charged with 
manufacturing (cultivating) cannabis, pursuant to Section 893.13, 
Florida Statutes (1989), and possession of drug paraphernalia, a 
violation of Section 893.147, Florida Statutes (1989).&nbsp; The Jenks 
admitted to cultivating the marijuana and advised officers at the 
scene that they each had AIDS and used the marijuana to relieve 
their symptoms. 
<P>
<DD>The Jenks waived their right to a jury trial and agreed that 
the bench trial should center on their defense of medical 
necessity.&nbsp; Because their physician, Thomas Sunnenberg, was not 
available to testify, the parties stipulated that Dr. 
Sunnenberg's testimony would be, in part: 
<BLOCKQUOTE>
<DD>Defense witness, THOMAS D. SUNNENBERG, M.D. ... will testify as follows: 
<P>
<DD>*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;* 
<P>
<DD>8.&nbsp; That he has been unable to find any effective drug for treating the defendants' nausea. 
</BLOCKQUOTE></TT>
582 SOUTHERN REPORTER, 2d SERIES 678 
<TT><BLOCKQUOTE>
<DD>9.&nbsp; That the nausea is so debilitating that if it is not controlled, the defendants could die. 
<P>
<DD>10.&nbsp; That if he could legally prescribe Cannabis Sativa as a drug to control their nausea he would. 
<P>
<DD>11.&nbsp; That the only drug that controls their nausea is Cannabis Sativa. 
<P>
<DD>12.&nbsp; That he is presently seeking access to legal Cannabis Sativa through the Food and Drug Administration under the Compassionate Investigational New Drug Program (IND) for the Jenks. 
</BLOCKQUOTE>
At trial, the defense also presented two expert witnesses, Robert 
Randall, who suffers from glaucoma and who successfully asserted 
the defense of medical necessity against a charge of marijuana 
cultivation in 1976,* and Dr. Daniel Dansak of Alabama, who has 
treated over fifty patients who have used marijuana to alleviate 
both disease symptoms and side-effects of medication. 
<P>
<DD>The trial judge rejected the defense of medical necessity, 
found the Jenks guilty of manufacturing marijuana, and withheld 
adjudication of guilt, placing the Jenks on one year of 
unsupervised probation.  He ordered the Jenks to perform 500 
hours of community service, to be discharged only by "providing 
care, comfort and concern for each other." 
<P>
<DD>The necessity defense has been formulated as follows: 
<BLOCKQUOTE>
<DD>The pressure of natural physical forces sometimes confronts a person in an emergency with a choice of two evils: either he may violate the literal terms of the criminal law and thus produce a harmful result, or he may comply with those terms and thus produce a greater or equal or lesser amount of harm.&nbsp; For reasons of social policy, if the harm which will result from compliance with the law is greater than that which will result from violation of it, he is by virtue of the defense of necessity justified in 
violating it. 
</BLOCKQUOTE>
W.R. LaFave &amp  A.W. Scott, Jr., 1 Substantive Criminal Law &sect; 
5.4, at 627 (1986) (hereinafter LaFave &amp; Scott).&nbsp; Or, as 
stated by Justice Holmes, "'Detached reflection cannot be 
expected in the presence of an uplifted knife.'"&nbsp; Arnolds &amp;  
Garland, The Defense of Necessity in Criminal Law: The Right to 
Choose the Lesser Evil, 65 J.Crim.L. &amp; Criminology 289, 290 
(1974) (hereinafter Arnolds &amp; Garland) (quoting Brown v. 
United States, 256 U.S. 335, 41 S.Ct. 501, 65 L.Ed. 961 (1921)). 
<P>
<DD>Although there is no specific legislative acceptance of the 
necessity defense in Florida, we conclude that the defense was 
recognized at common law and that there has been no clearly 
expressed legislative rejection of such defense.&nbsp; The necessity 
defense was articulated as early as 1551 in Reninger v. Fagossa, 
1 Plowd. 1, 19, 75 Eng.Rep. 1, 29-30 (1551): "[W]here the words 
of [the law] are broken to avoid greater inconvenience, or 
through necessity, or by compulsion," the law has not been 
broken.&nbsp;  Arnolds &amp; Garland, at 291.&nbsp; The authors state that 
the defense is poorly developed in Anglo-American jurisprudence 
because there are so few cases dealing with it, "probably because 
these cases are not often prosecuted."&nbsp; In any event, they 
indicate that although there is some disagreement on this, "it 
seems clear that necessity was a defense at common law."&nbsp; Arnolds 
&amp; Garland, at 290.&nbsp; The authors cite a number of pre-1776 
cases involving the necessity defense.&nbsp; Arnolds &amp; Garland, at 
291 n. 29.* 
<P>
<DD>Consequently, we consider that Florida has adopted the 
necessity defense pursuant to Section 2.01, Florida Statutes 
(1989), which provides: 
<BLOCKQUOTE>
<DD>The common and statute laws of England which are of a general and not a 
local nature ... are declared to be of force in this state; provided, the said statutes and common law be not inconsistent with the Constitution and laws of the United States and the acts of the Legislature of this state. 
</BLOCKQUOTE></TT>
JENKS v. STATE Fla. 679 
<BR>Cite as 582 So.2d 676 (Fla.App. 1 Dist. 1991) 
<TT><P>
<DD>The medical-necessity defense is merely a more particular 
application of the necessity defense, See, e.g., LaFave &amp;  
Scott at &sect; 5.4(c)7, at 631-33; G.E. Torcia, 1 Wharton's Criminal 
Law &sect; 88 (1978); 22 C.J.S. Criminal Law &sect; 50 (1989).&nbsp; In fact, in Bavero v. State, 347 So.2d 781 (Fla. 1st DCA 1977), this court 
recognized the defense of medical necessity there asserted by a 
prison escapee.&nbsp; Accord State v. Alcantaro, 407 So.2d 922, 924 
(Fla. 1st DCA 1981) ("Medical necessity was recognized as an 
arguable defense by this court in Bavero v. State[.]"), review 
denied, 413 So.2d 875 (Fla.1982). 
<P>
<DD>[1]&nbsp; Although the state conceded at oral argument that the 
necessity defense exists in Florida's common law, the state 
nevertheless contends that Section 893.03, Florida Statutes 
(1989), is inconsistent with and therefore precludes the defense 
in the case at bar.&nbsp; We disagree.&nbsp; Section 893.03(1) provides: 
<BLOCKQUOTE>
<DD>SCHEDULE 1.&nbsp; A substance in Schedule I has a high potential for abuse and has no currently accepted medical use in treatment in the United States and in its use under medical supervision does not meet accepted safety standards except for such uses provided for in s. 402.36.&nbsp; The following substances are controlled in Schedule I: 
<P>
<DD>*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;* 
<P>
<DD>(c)4.&nbsp; Cannabis. 
</BLOCKQUOTE>
(Footnote omitted.)  However, subsection (1)(d) provides, 
<BLOCKQUOTE>
<DD>Notwithstanding the aforementioned fact that Schedule I substances have no currently accepted medical use, the Legislature recognizes that certain substances are currently accepted for certain limited medical uses in treatment in the United States but have a high potential for abuse. 
</BLOCKQUOTE>
The state argues that section 893.03 permits no medical uses of 
marijuana whatsoever.&nbsp; In fact, all that subsection (1) states is 
that marijuana is not generally available for medical use.  
Subsection (1)(d), however, clearly indicates that Schedule I 
substances may be subject to limited medical uses.&nbsp; It is well 
established that a statute should not be construed as abrogating 
the common law unless it speaks unequivocally, and should not be 
interpreted to displace common law more than is necessary.&nbsp;  
Carlile v. Game &amp; Fresh Water Fish Comm'n, 354 So.2d 362, 364 
(Fla.1977) (quoting 30 Fla.Jur. Statutes &sect; 130 (rev. ed. 1974); 
State v. Egan, 287 So.2d 1, 6-7 (Fla.1973); Sullivan v. 
Leatherman, 48 So.2d 836, 838 (Fla.1950) (en banc).&nbsp; We conclude 
that section 893.03 does not preclude the defense of medical 
necessity under the particular facts of this case. 
<P>
<DD>[2, 3] Moreover, we conclude that the Jenks met their burden 
of establishing this defense at trial.&nbsp; The elements of the 
defense have previously been addressed by trial courts in United 
States v. Randall, 104 Daily Wash.L.Rep. 2249 (Super.Ct.D.C. Nov. 
24, 1976), and in Florida in State v. Mussika, 14 F.L.W. 1 (Fla. 
17th Cir.Ct. Dec. 28, 1988), which both involved the medically 
necessary use of marijuana by people with glaucoma.&nbsp; Those 
elements are as follows: 1. That the defendant did not 
intentionally bring about the circumstance which precipitated the 
unlawful act; 2. That the defendant could not accomplish the same objective using a less offensive alternative available to the 
defendant; and 3. That the evil sought to be avoided was more 
heinous than the unlawful act perpetrated to avoid it. 
<P>
<DD>As applied to the case at bar, the Jenks obviously did not 
intend to contract AIDS. Furthermore, the Jenks' medical expert 
and physician testified that no drug or treatment is available 
that would effectively eliminate or diminish the Jenks' nausea.* 
Finally, the Jenks established that if their nausea was not 
controlled, their lives were 
</TT><P>
582 SOUTHERN REPORTER, 2d SERIES 680 
<P><TT>
in danger.*&nbsp; The state put on no evidence that contradicted the 
Jenks, and the trial court had no authority to reject the 
witnesses' testimony.&nbsp; Based upon these facts, we conclude the 
trial court erred in reject ing the Jenks' defense and in 
convicting them as charged. 
<P>
<DD>REVERSED with directions that judgment of acquittal be 
entered. 
<P>
<DD>ZEHMER, J., concurs. 
<P>
<DD>NIMMONS, J., dissents without written opinion. 
<P></TT>
FOOTNOTES: 
<P>
1.&nbsp; United States v. Randall, 104 Daily Wash.L. Rep. 2249 
(Super.Ct.D.C. Nov. 24. 1976). 
<P>
2.&nbsp; Other pre-1776 cases are cited in Note, "Necessity: The Right 
to Present a Recognized Defense," 21 N.Eng.L.Rev. 779, 781-83 
(1985-86). 
<P>
3.&nbsp; Dr. Sunnenberg testified by stipulation that "he has been 
unable to find any effective drug for treating the defendants' 
nausea," and that "the only drug that controls their nausea is 
Cannabis Sativa."&nbsp; Dr. Dansak testified that there is a drug, 
Raglan, that is "a little more effective than marijuana," but 
that it must be given intravenously in "fairly whopping doses," 
thus creating problems with infections, particularly in AIDS 
patients. 
<P>
4.&nbsp; The Jenks described their constant vomiting and weight loss 
at the hearing.&nbsp; Dr. Sunnenberg stated in his stipulated 
testimony that his patients' "nausea is so debilitating that if 
it is not controlled, the defendants could die." 
<P>
589 SOUTHERN REPORTER, 2d SERIES 292 
<P><TT>
SUPREME COURT 
<P>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Docket&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Appeal from 
<BR>Title&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Number&nbsp;&nbsp;&nbsp;&nbsp;Date&nbsp;&nbsp;&nbsp;&nbsp;Disposition&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Citation 
<P>
State v. Jenks&nbsp;&nbsp;&nbsp;&nbsp;78165&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10/8/91&nbsp;Rev. den.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1st DCA 582 So.2d 676 
<P>
Review of this decision was denied by the Supreme Court of 
Florida on October 8, 1991, affirming the decision of the Florida 
District Court of Appeals for the First District. 
</TT>
</BODY> 
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-269</DOCNO>
<DOCOLDNO>IA087-000628-B024-270</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/safer.html 206.61.184.43 19970122060440 text/html 16251
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:04:32 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:06:23 GMT
Content-length: 16035
</DOCHDR>
<html>
<pre>
CBS NEWS - 60 MINUTES 
Volume XXIV, Number 11 
</pre>
<pre> 
     December 1, 1991 
</pre>
<pre> 
     MORLEY SAFER: [voice-over] What you are watching is quite rare.  
This man and his wife are smoking marijuana, but legal marijuana.  They 
are among only 14 people in the United States who have had it prescribed 
by their doctors.  Applications have to go through the DEA, the FDA, and 
the National Institute of Drug Abuse, and if all approve, the legal 
marijuana grown on a government farm in Mississippi is sent to the 
patient's pharmacist, a month's supply of cigarettes at a time. 
</pre>
<pre> 
     Smoking to Live 
</pre>
<pre> 
     SAFER:  Marijuana is not good for you.  It's an axiom.  But for some 
people, marijuana could be the difference between life and death.  That's 
what they and their doctors say.  The doctors prescribe it and the 
patients smoke it to live. 
     What you are watching is quite rare.  This man and his wife are 
smoking marijuana, but legal marijuana.  They are among only 14 people in 
the United States who had it prescribed by their doctors.  For Ken and 
Barbara Jenks, marijuana is but one more of the myriad of prescription 
drugs they must take every day. 
          [interviewing] How often do you smoke these?:
     BARBARA JENKS:  We usually smoke - well, I usually smoke at least 
three to four a day. 
     SAFER:  What would happen to you physically, both of you, if you 
went for a couple of days without these? 
     KEN JENKS:  We'd throw up all the time. 
     Mrs. JENKS:  I would get sick to my stomach. 
     Mr. JENKS:  I mean, you couldn't - you get sick, and then you can't 
take your medicine, so 
     Mrs. JENKS:  I wouldn't be able to eat. 
     Mr. JENKS:  - and then you can't eat, so, I mean, the weight - and 
then you'd start losing weight, so, I mean - 
     Mrs. JENKS:  Having AIDS is like a wasting syndrome, you know, with 
     the virus and everything.  The smell of food, the - just even 
thinking about food just makes you nauseated. 
     SAFER:  [voice-over] Ken and Barbara Jenks are dying.  He is a 
hemophiliac.  Eleven years ago, he was given blood contaminated by the 
AIDS virus.  He unknowingly infected his wife.  They are both too sick to 
work.  They live on disability, barely able to cope.  Without the 
marijuana, they would probably be dead, would have wasted away because of 
the nausea brought on by their chemotherapy. 
     Before they got marijuana legally, they bought it on the street, or 
grew it, until last year, when police burst into their trailer in Panama 
City, Florida, and got the goods on them: two marijuana plants. 
     Mr. JENKS:  And then they started, you know, going through my house, 
I mean, just dumping drawers and tearing the cabinets up. 
SAFER:  [voice-over] The police thought they were onto something big when 
they found a suitcase filled with syringes and other drug paraphernalia. 
     Mr. JENKS:  I mean, they were going berserk. 
SAFER:  [voice-over] Ken tried to convince them that the syringes and the 
pills were prescribed by doctors.  He did not tell them that marijuana 
was the only medicine that enabled them to take the chemotherapy without 
being violently ill. 
     Mrs. JENKS:  You're talking to somebody that never wanted to take an 
aspirin for a headache.  It's - it's a relief to know that there's 
something that you can smoke to relieve the nausea from taking all the 
medications that you're on. 
     SAFER:  [voice-over] The Jenks were charged with growing marijuana 
and possession of drug paraphernalia.  In court, their lawyer, John 
Daniel, tried to prove that for the Jenks, marijuana was a medical 
necessity. 
          [interviewing] Did the prosecution present any counterevidence?
     JOHN DANIEL:  None whatsoever, sir.  In fact, they even stipulated 
in Kenny and Barbara's case that it was beneficial for them and that they 
would die without it. 
     SAFER:  The prosecution conceded that? 
     Mr. DANIEL:  Yes, sir. 
     SAFER:  But you lost the case because you couldn't prove medical 
necessity, so that doesn't jibe somehow. 
     Mr. DANIEL:  Judge Foster said there is no such doctrine as medical 
necessity in Florida, that it's a matter for the legislature to 
promulgate a statute that says that it is or is not. 
     SAFER:  But the judge was not an unsympathetic judge.
     Mr. DANIEL:  Super judge.  The sweetest sentence I've had in 20 
years of criminal defense work.
     SAFER:  [voice-over] The judge found them guilty, but sentenced them 
to 500 hours of community service.  Their only task?  To look after each 
other. 
     As decent as the sentence was, the Jenks were outraged that they 
were still considered criminals.  They decided to appeal. 
     Mr. DANIEL:  Kenny and Barbara said, "Go for it.  We're going to be 
gone soon.  There's going to be people following in our footprints and in 
our pain and suffering, and there needs to be some law made one way or 
the other on it."  That's why they took it up on appeal, and I'm glad to 
do it for them.
     SAFER:  Why?  They're not exactly the wealthiest clients in the 
world.
     Mr. DANIEL:  No.  I'm not exactly charging them, sir. 
     SAFER:  [voice-over] The DEA classifies marijuana as a highly 
dangerous drug, in the same class as heroin and LSD.  And the only way to 
get it legally is to face a bureaucratic jungle, three of them.  
Applications have to go through the DEA, the FDA and the National 
Institute of Drug Abuse, and if all approve, the legal marijuana, grown 
on a government farm in Mississippi, is sent to the patient's pharmacist, 
a month's supply of cigarettes at a time. 
     Robert Randall was the first American to gain legal access to 
marijuana for medical use.  He was diagnosed with glaucoma in 1972.  
Doctors told him he had three to five years before he would go blind.  
One evening, he tried a marijuana cigarette. 
     ROBERT RANDALL:  It was a bit like a "Eureka!" experience.  I mean, 
I had known in college that if I smoked marijuana, what the doctors then 
called "eyestrain" seemed to diminish, but I had never put all the pieces 
together, and suddenly they came together.  The next morning I woke up 
and thought that I was crazy.  It's crazy to believe that an illegal drug 
is going to prolong your sight, when all the modern pharmaceuticals have 
failed to do so. 
     SAFER:  [voice-over] Randall is still on prescription drugs, but his 
doctors found that the essential drug in relieving the intense eye 
pressure of glaucoma was marijuana, which he's been smoking for 15 years.  
But getting it legally was not easy. 
     Mr. RANDALL:  It took 14 months from the time of my arrest.  I had 
to go  through - 
     SAFER:  You were arrested for possession? 
     Mr. RANDALL:  I was arrested for growing four marijuana plants.  I 
had to go through two controlled medical studies that were really 
unnecessary.  They simply demonstrated to others what I already knew to 
be the case.  And then I had to wait around for many months while a bunch 
of bureaucrats, who were really not very excited about this idea, decided 
whether or not I would go blind.  It's a very uncomfortable, frightening 
situation to be in. 
     SAFER:  [voice-over] Only 14 people are now able to get marijuana 
legally from the government.  It took the Jenks almost nine months to get 
their first prescription.  Many doctors are reluctant to make the effort, 
fearing that the ramifications of even applying for marijuana will affect 
their reputations. 
          [interviewing] The Jenks' own doctor, who prescribes marijuana 
for them, won't come on and talk about it. 
     Mr. DANIEL:  A junkie doctor.  He doesn't want to be called that.  I 
understand that.  He could - it could also be, "I'm afraid I'll have all 
of these people coming out of the woodwork saying, 'Oh, I've got a back 
pain, Doctor, how about giving me 400 joints?'"  I can understand that. 
     SAFER:  [voice-over] But many doctors say their reluctance to apply 
for a prescription has nothing to do with bureaucracy.  Dr. Richard 
Gralla, who heads the Department of Oncology at the Ochsner Clinic in New 
Orleans, told us that the scientific studies do not show marijuana as 
effective as other drugs, despite the claims of Randall and other 
patients. 
     Dr. RICHARD GRALLA:  There are testimonials for almost any medicine, 
and in fact, sometimes testimonials are the germ of a good idea, the 
beginning of a good idea.  Unfortunately, more often than not, they're 
just that, they're just testimonials. 
     SAFER:  [voice-over] But Dr. Lester Grinspoon, who practices 
psychiatry at Harvard University, disagrees.  He's one of the first 
physicians to take a stand on using marijuana as medical treatment. 
     Dr. LESTER GRINSPOON:  It is very useful for the treatment of the 
nausea and vomiting which accompanies the use of some chemotherapeutic 
substances for the treatment of some cancers. 
     SAFER:  [voice-over] Dr. Grinspoon knows it from the most personal 
kind of experience.  His son had leukemia and died, but during the 
chemothernpy Grinspoon feels it was the marijuana that was keeping young 
Danny alive. 
     Dr. GRINSPOON:  He would be so tense before he took the medicine, 
because he knew what was going to follow, and what followed was eight 
hours of first vomiting, and then retching.  It's very, very, difficult.  
He got to the point where he said, "I'm not going to take the medicine 
anymore."
     SAFER:  How old was he? 
     Dr. GRINSPOON:  He was 15. 
     SAFER:  [voice-over] His wife bought some marijuana near a local 
high school.  At Danny's next treatment, Grinspoon was amazed. 
     Dr. GRINSPOON:  It was absolutely stunning, the difference that this 
made.  He was relaxed, he had the treatment, he not only did not have 
nausea and vomiting, but he asked if he could get a submarine sandwich on 
the way home.  I was really dumbfounded.  I then called the doctor, Dr. 
Jaffe, who was taking care of him, and told him what had happened, and so 
the next time he smoked cannabis right in the treatment room at the 
Children's Hospital.  Same thing, not a bit of discomfort, ate 
afterwards, and it was then that Dr. Jaffe and I went to the head of the 
Children's Hospital, Dr. Frye, and suggested that maybe this bore some 
kind of systematic looking into.  And that, in fact, led to the Salan 
study, which first established that this is useful in the treatment of 
the nausea and vomiting of cancer chemotherapy. 
     SAFER:  But the DEA has maintained for years that marijuana has no 
therapeutic value, that it's a dangerous drug that must remain illegal.  
However, no one from the DEA would come on this broadcast and respond to 
the scientific evidence of those who say otherwise. 
     Three years ago, the DEA's administrative law judge, Francis Young, 
wrote of marijuana, "In light of the evidence, it would be unreasonable, 
arbitrary and capricious for the DEA to stand between those sufferers and 
the benefits of this substance."  But the DEA rejected its own judge's 
opinion and stands firm that doctors shall not prescribe marijuana. 
     [voice-over] Except, of course, for those few who are willing to go 
through the agonizingly long process of applying.  Desperate patients say 
they would rather live by buying marijuana illegally than die by playing 
by the rules.  Dr. Ivan Silverberg hears that all the time from his 
cancer patients in San Francisco. 
     Dr. IVAN SILVERBERG:  I have yet to hear of a patient who can't find 
it.  I have heard loud and clear from patients who resent having to go on 
the street when they're feeling sick, when they're nauseated, when 
they've lost 40 and 50, 60 pounds, to try and buy a drug from somebody 
without knowing whether that drug is adulterated because it comes off the 
street, of having to face the possibility that the person they're buying 
it from is an undercover policeman.  I think all these things are wrong. 
     SAFER:  [voice-over] But Silverberg says if he had to fill out that 
mountain of paperwork every time a patient needed marijuana, he wouldn't 
have time to treat his patients. 
          [interviewing] Why has the DEA dug its heels in on this and 
will not allow the general prescribing of marijuana by physicians when 
you can prescribe much more dangerous, much more habit-forming drugs?
     Dr. SILVERBERG:  You're absolutely correct.  I think morphine, for 
example, Demerol, are far more hazardous drugs, in my opinion, than 
marijuana.  I think part of it is an entrenched bureaucracy that doesn't 
want to admit it's wrong.
     Dr. GRALLA:  Even if it were available in 10 minutes down in the 
pharmacy, I'd be reluctant to write it.  It has nothing to do with it - 
the political issues that we have in drugs and the drug problem in the 
United States.  It's the fact that in my own experience in using 
cannabinoids - in my patients' experience, who have smoked marijuana, 
neither marijuana nor the cannabinoids measure up to those drugs that I 
have. 
     SAFER:  [voice-over] Among those drugs is Zofran, which has been on 
the market only for the past few months.  By all accounts, it works 
wonderfully. 
     Dr. SILVERBERG:  Zofran is a most effective drug which is said to 
have an 80 percent response rate, by their definition.  It costs $600 a 
day.
     SAFER:  And the patient has to have it administered in the hospital?
     Dr. SILVERBERG:  Or in a full - in an ambulatory care center where 
he's there, essentially, the whole day. 
     SAFER:  [voice-over] If marijuana is as effective as Doctors 
Silverberg and Grinspoon say it is, why haven't the drug companies tried 
to get government approval for it? 
     Dr. GRINSPOON:  You can't patent marijuana, it's a plant.  They 
can't make any money.  No way.  You see, in our country, the way drugs 
come into being, a drug company gets hold of a chemical, somebody 
discovered it has some sort of effect, they review it, they decide is it 
worth trying to do it. They have to invest between $80 and $100 million 
to get it from chemical to drug on the shelf.  But then they get an 
exclusive patent for 17 years, and they can earn a lot of money.  How 
could they possibly do this with cannabis? 
     SAFER:  [voice-over] For the Jenks, marijuana has made their 
troubled lives tolerable, and to the doubters they say - 
     Mrs. JENKS:  Do I look like a junkie? 
     Mr. JENKS:  Do I?  I mean - 
     Mrs. JENKS:  I wish I didn't have to take the medication that I - I 
wish I didn't even have to smoke marijuana. 
     Mr. JENKS:  Yeah.  It'd be nice to be to be free of drugs and 
disease, but we're not.  I mean, we need drugs.  I can't help that.  I 
mean, I've been taking drugs my whole life, and it hasn't made a junkie 
out of me.
     SAFER:  Do you ever agonize over, "Why me?  Why us?"
     Mr. JENKS:  At first. 
     Mrs. JENKS:  At first we did. 
     Mr. JENKS:  But then, I mean, for me it was easier.  I mean, I've 
been dealing with disease since I was six months old, so it was just like 
fuel to the fire.  I mean, you know, it was just one more thing.
     Mrs. JENKS:  He blamed himself because I had gotten it, and I don't 
blame him, because he - you know, I love him, he's my husband.
     Mr. JENKS:  You know, these are the cards you got dealt.  You've 
just got to play 'em or fold, kind of. 
     SAFER:  The Jenks eventually won their appeal and their criminal 
convictions were overturned.  The Public Health Service is not accepting 
any new applications into the program for marijuana prescriptions and 
it's considering closing it down entirely, regardless of what patients 
say. 
</pre>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-270</DOCNO>
<DOCOLDNO>IA087-000628-B024-295</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/spyker.html 206.61.184.43 19970122060458 text/html 8584
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:04:45 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:05:45 GMT
Content-length: 8369
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="Carl E. Olsen">
</HEAD>

<BODY>

<PRE>
                       UNITED STATES DISTRICT COURT
                       FOR THE DISTRICT OF COLUMBIA

LADD HUFFMAN,
Plaintiff,
v.                                                Civil No. 93-0237 NHJ
FOOD AND DRUG ADMINISTRATION,
Defendant. 

                DECLARATION OF DANIEL A. SPYKER, Ph.D., M.D. 

I, Dr. Daniel A. Spyker, do hereby declare the following:

     1.   I am a Medical Officer in the Pilot Drug Evaluation Staff, 
Center for Drug Evaluation and Research, United States Food and Drug 
Administration (FDA).  I have held this position since August 1990. 

     2.   In my position as Medical Officer, I am engaged fulltime in 
the evaluation of clinical drug trials, proposed and completed, in 
support of investigational new drug applications (INDs) and new drug 
applications submitted to the FDA under the Federal Food, Drug, and 
Cosmetic Act (the Act).  Since October 1990, I have been responsible for 
the review and follow-up of INDs relating to marijuana, including a 
number of single-patient INDs from physicians requesting therapeutic 
marijuana for their patients. 

     3.   A single-patient IND for marijuana, an unapproved new drug 
under the Act, allows a physician to receive and dispense the drug as an 
investigational drug for use in one specific patient.  Because marijuana 
is not a drug approved by the FDA, distribution of marijuana outside the 
IND process is in violation of the Act.

     4.   While FDA processes and allows single-patient INDs for 
investigational drugs to proceed, FDA does not supply the drugs.  In the 
case of single-patient INDs for marijuana, the marijuana is provided by 
the National Institute on Drug Abuse, Public Health Service, Department 
of Health and Human Services, pursuant to its authority under the Public 
Health Service Act.  Before the National Institute on Drug Abuse can 
supply marijuana to the sponsoring physician for a single-patient IND, 
because the drug is regulated under the Controlled Substances Act, the 
physician must apply to and receive approval from the Drug Enforcement 
Administration, the Department of Justice, to receive and dispense the 
marijuana.  When the Drug Enforcement Administration issues a 
registration for the physician to receive the marijuana, it provides the 
order form which must be presented to the National Institute on Drug 
Abuse for shipment of the marijuana. 

     5.   When a single-patient IND for marijuana is received by the 
Center for Drug Evaluation and Research, it is forwarded to the Pilot 
Drug Evaluation Staff for review.  The IND is assigned to a consumer 
safety officer who distributes copies to the reviewing chemist, 
pharmacologist, and medical officer.  These reviewers decide whether it 
is safe for the study proposed in the IND to proceed.

     6.   The Center for Drug Evaluation and Research received a single-
patient IND for marijuana for Ladd Huffman on January 2, 1991.  The IND 
was submitted by Patricia J. Harrison, M.D.  The IND was received by the 
Pilot Drug Evaluation Staff on January 7, 1991.  The consumer safety 
officer distributed the IND to the reviewers.  The pharmacology review 
was completed on January 10, 1991, and it determined that it was safe 
for the IND to proceed.  The chemistry review was completed on January 
11, 1991, and it determined that it was safe for the IND to proceed.

     7.   I called the sponsoring physician, Dr. Harrison, on January 11, 
1991, to discuss the requirements for the IND and to request the 
submission of additional information. 

     8.   I completed the medical review of the IND for Ladd Huffman on 
January 16, 1991, and determined that it was safe for the IND to proceed. 
On January 25, 1991, I received the information I had requested from Dr. 
Harrison.

     9.   On March 8, 1991, I issued a letter to Dr. Harrison advising 
her that the IND for Ladd Huffman could proceed. 

     10.  In June 1991, the Pilot Drug Evaluation Staff was advised that 
the Assistant Secretary for Health, Department of Health and Human 
Services, had decided to consider whether the National Institute on Drug 
Abuse would continue to supply marijuana for single-patient INDs. 

     11.  In March 1992, the Pilot Drug Evaluation Staff was advised that 
the Secretary of the Department of Health and Human Services had made a 
decision that the National Institute on Drug Abuse would not provide 
marijuana for single-patient INDs except to those patients who were 
receiving marijuana at the time.  This group receiving marijuana 
included patients whose INDs FDA has already reviewed and allowed to 
proceed, whose physicians had received approval to receive the marijuana 
from the Drug Enforcement Administration and for whom the National 
Institute on Drug Abuse had shipped marijuana upon receipt of the Drug 
Enforcement Administration order form submitted by the physicians.

     12.  As I understand it, the March 1992 decision of the Secretary of 
Health and Human Services not to provide marijuana to additional single 
patient INDs was based on a number of considerations including the health 
concerns of providing patients with potentially harmful substances, and 
the fact that existing medical evidence does not support additional 
research on smoked marijuana to treat disease in single patient studies.  
For those patients who had already received marijuana, marijuana would 
continue to be supplied while their physicians, with assistance from the 
Department of Health and Human Services, explored alternative therapies.  
Through attrition among this patient group, the Department of Health and 
Human Services would eventually achieve its ultimate goal of not 
supplying marijuana for any patients under single-patient INDs. 

     13.  As I understand from the National Institute on Drug Abuse, 
shipments began in August 1991 for the last person to receive marijuana 
under a single-patient IND.

     14.  As I understand from the Drug Enforcement Administration, that 
agency received an application from Dr. Harrison to receive and dispense 
marijuana for Ladd Huffman on August 19, 1991, but no registration to 
receive marijuana was issued.  Since Dr. Harrison had not received 
approval to receive and dispense marijuana for Ladd Huffman from the Drug 
Enforcement Administration, the National Institute on Drug Abuse had not 
shipped any marijuana for Ladd Huffman.  Therefore, under the March 1992 
decision of the Secretary, the National Institute on Drug Abuse would not 
supply marijuana for Ladd Huffman's single-patient IND.

     15.  There were 27 additional single-patient INDs that FDA had 
allowed to proceed which had not received marijuana.  Under the 
Secretary's March 1992 decision, marijuana would not be supplied for 
these INDs by the National Institute on Drug Abuse. 

     16.  In March 1992, as a result of the Secretary's decision, I 
contacted the sponsoring physicians of the INDs for Ladd Huffman and 
other patients who were not already receiving marijuana to advise them 
that the National Institute on Drug Abuse would not supply marijuana for 
their single-patient INDs.  I also advised the sponsoring physicians of 
other treatment options for their patients' conditions and the 
availability of referrals to experts at the National Institutes of 
Health, Public Health Service, Department of Health and Human Services. 
The single-patient INDs for these individuals were cancelled.

     17.  FDA cannot disclose information regarding patients receiving 
marijuana under single-patient INDs without such patients' consent. 

     Pursuant to 28 U.S.C. &#167; 1746, I declare under penalty of perjury 
that, to the best of my knowledge and belief, the foregoing is true and 
correct. 

     Executed on: June 16, 1993, at Rockville, MD. 

Daniel A. Spyker, PhD, M.D.
Medical Officer
Pilot Drug Evaluation Staff
Center for Drug Evaluation	
and Research
United States Food and Drug	
Administration 
</PRE>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-271</DOCNO>
<DOCOLDNO>IA087-000628-B024-323</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/monkey.html 206.61.184.43 19970122060534 text/html 15364
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:05:20 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:36 GMT
Content-length: 15148
</DOCHDR>
<html>
<pre>
The Arkansas Times, September 16, 1993 
REEFER MADNESS 
While courts send users to prison, scientists at NCTR find little to 
support dangers of pot. 
</pre>
<pre> 
POT'S TAB IN THE  
WAR ON DRUGS  
</pre>
<pre> 
The investment:  
     * Federal matching funds for the "war on drugs" in Arkansas totaled 
$4.6 million in 1992. 
     * State and local agencies kicked in another $1.8 million. 
     * The Arkansas National Guard received $1.3 million to assist in 
marijuana eradication. 
     * An unknown additional amount of money was generated for drug 
investigations by the sale of confiscated property. 
     * No figures are available for the cost of prosecuting drug cases 
and incarcerating offenders.   
</pre>
<pre> 
The return:  
     * 42 percent of all arrests for the sale and manufacture of drugs in 
1992 were for selling or growing marijuana. 
     * And 62 percent of all arrests for possession of drugs were for 
possession of marijuana. 
</pre>
<pre> 
By Mara Leveritt  
     The monkeys smoked a joint a day.  
     Actually, they didn't recline in their cages, puffing a hand-rolled 
reefer.  This being a scientific experiment, funded by the powerful 
National Institute on Drug Abuse, the process was more carefully 
controlled.  The monkeys were fitted with masks through which marijuana 
smoke, machine-puffed in carefully measured doses, was passed into their 
nostrils. 
     The experiment, performed at the National Center for Toxicological 
Research near Pine Bluff, was designed to test whether chronic marijuana 
use caused brain damage.  It lasted for several years, with the most 
intensive phase, during which monkeys were exposed to heavy doses of 
marijuana smoke, occurring from 1984 to 1985. 
     Reports on the study's findings continue to be published in 
pharmacology and toxicology journals.  But beyond those tight scientific 
circles, the results of the NCTR experiment, the most extensive of its 
kind yet conducted, have gone almost entirely unnoticed. 
     That's not surprising, perhaps.  In a world where the political 
majority has shown little tolerance for marijuana, the test results are 
explosive. 
     The experiment discovered no adverse impact from marijuana on 
monkeys' general health, no sign that heavy exposure to marijuana smoke 
caused lung cancer, and, with one exception, no long-term effects on the 
animals' behavior from exposure to marijuana. 
     Before the NCTR study, the largest experiment examining the effects 
of marijuana on primates was one conducted at the Stanford Research 
Institute.  That experiment, focusing on the brain's electrical activity 
under the influence of marijuana, involved 16 monkeys. 
     By contrast, the experiment at NCTR used 62 monkeys, all rhesus 
males.  In 1983, the animals were all approximately two to three years 
old, the monkey equivalent of teen-agers. 
     For one year before the start of the experiment, the monkeys were 
trained to play "games" designed to test their perception of the passage 
of time and their ability to discern left from right.  Only after they 
were proficient did the exposure to marijuana begin. 
     Toxicologists divided the monkeys into four groups.  Every day for a 
year, 16 monkeys each received what Dr. Merle Paule, head of NCTR's 
Behavioral Toxicology Laboratory and Primate Research Facility, called "a 
pretty heavy exposure" to marijuana, the human equivalent, Paule said, of 
"four or five joints a day." 
     Another group of 16 smoked the same amount of marijuana, but only 
two days per week.  Staffers called them the "weekend smokers." 
     A third group was administered smoke from cigarettes identical to 
the others, except that the psychoactive component of THC had been 
removed.  And a fourth group received no smoke exposure at all. 
     The monkeys smoked for a year, then they were monitored and tested 
for another year. 
     Dr. William Slikker, acting director of NCTR's Division of 
Neurotoxicology, explained that the study generated so much data, it has 
taken time to compile it and the results have been released gradually, in 
several reports since the experiment was ended. 
     In 1991, the journal Fundamental and Applied Toxicology published a 
report on the effects of marijuana on the monkeys' general health.  
Slikker was the lead writer, with Paule (pronounced Paul) and other NCTR 
researchers listed as collaborators. 
     That report concluded, "The general health of the monkeys was not 
compromised by a year of marijuana smoke exposure as indicated by weight 
gain, carboxyhemoglobin and clinical chemistry/hematology values. 
     "Most clinical parameters ... did not show any treatment-related 
changes, and those few that did were of small magnitude, transient in 
nature, and were not different at the end of the five-month postdosing 
period." 
     Last week, in his office at NCTR, Paule explained the health study's 
results in more casual terms.  "There's just nothing there," he said.  
"They were all fine." 
     Last year, the journal Toxicology Letters published a report by 
another group of NCTR researchers on the effects of marijuana on the 
lungs of the monkeys who smoked.  Seven months after the last exposure to 
marijuana smoke, some of the monkeys were killed and their bodies 
autopsied.  Scientists examined the lungs for signs of disturbances 
called "carcinogen-DNA adducts," considered to be one of the early 
indications of cancer. 
     The writers of that study reported that although their findings were 
not conclusive, they were "at variance with earlier work suggesting that 
fractions of marijuana smoke are highly genotoxic." 
     The seven authors noted that, "It has been suggested that marijuana 
smoking is a proximal cause of respiratory cancer.  However, these 
intimations have not been borne out by epidemiological investigations, 
which is surprising considering the widespread use of marijuana." 
     Moreover, the journal article noted: "The data presented here 
suggest that seven months after the last smoke exposure, there is not 
evidence of increased marijuana smoke-induced carcinogen-DNA adducts in 
the lungs of exposed monkeys." 
     Paule's informal interpretation: "If it's not there, it's probably 
not too terrible." 
     (The researchers discount the claim that as marijuana has become 
increasingly potent, due to refined horticultural techniques, it has also 
become more dangerous.  Other studies, they say, have demonstrated that 
smokers inhale only to the point of inebriation, so that persons smoking 
stronger marijuana smoke considerably less of it.) 
     Late last year, Paule himself was the lead author of a report 
published in The Journal of Pharmacology and Experimental Therapeutics.  
It dealt with marijuana's effect on behavior. 
     This report's findings were more complex.  
     Before the monkeys were started on their year-long smoke exposure, 
Slikker, Paule and other scientists, conducted a short-term study to 
determine the immediate effect of THC on the animals; in other words, how 
they reacted when they were "high." 
     They found two areas of apparent impact.  One was the monkey's 
short-term memory.  "That's a function that's very sensitive," Paule 
explained, "but only on an acute basis.  If you test them the next day, 
you see no residual effect on those behaviors." 
     The monkeys sense of time also appeared disrupted.  Monkeys, it 
turns out, are as good as humans at estimating the passage of time.  
Members of both species to equally well at a test that requires them, for 
instance, to press down on a lever for more than 10 seconds but not 
longer than 14 seconds. 
     Marijuana has been shown to affect human's ability to perform the 
test at normal levels, and the monkeys were no different.  "That time-
estimation behavior is exquisitely sensitive to marijuana," Paule said, 
"even at very low doses." 
     The NCTR study corroborated human studies showing that time seems to 
stretch out for many subjects under the influence of marijuana.  In the 
monkeys' response to the time-perception test, Paule explained, "what 
they said was that eight seconds feels like ten." 
     That phenomenon too, however, quickly dissipated.  Testing the next 
day showed the monkeys' time perception restored to its normal acuity. 
     The main thrust of the study, however, concerned the long-term 
effects of exposure to marijuana.  To study that, the animals were tested 
for cognitive function and motivation 23 hours after each marijuana 
exposure. 
     The cognitive test involved four lights and two levers.  The monkeys 
were taught that when they saw a red or a yellow light, they were to hit 
a lever on their left in order to receive a food pellet.  If a blue or a 
green light came on, they would get the pellet by hitting a lever on 
their right. 
     The researchers wanted to see if the animals scored any differently 
23 hours after exposure to marijuana than they had before receiving the 
drug.  "On that test," Paule said, "their performance was unaffected." 
     The test of motivation, however, showed a definite pattern of 
change.  This test required the monkeys to put forth an increasing amount 
of effort to get food.  Since a decrease in motivation or "work ethic" 
has been described as one of the effects of smoking marijuana, the 
researchers wanted to see "how much effort the monkeys were willing to 
put out," as compared to the nonsmoking control group. 
     Their paychecks were banana-flavored food pellets.  For the first 
pellet, the monkeys had only to depress a lever once.  They had to hit it 
twice to get the second pellet.  And for a third pellet, they had to pump 
the lever three times. 
     Here, the group exposed to THC showed a clear unwillingness to get 
worked up about work.  Paule pointed out that during the year the test 
was being conducted, the monkeys were passing from adolescence into 
adulthood, a time for them, as for humans, he said, when "the work ethic 
normally goes way up." 
     But that improvement didn't show up in the marijuana-smokers.  While 
the nonsmoking monkeys showed a willingness to work harder and harder as 
the year progressed, the marijuana groups stayed at adolescent levels. 
     "Our interpretation of this is that marijuana smoking in monkeys 
does produce something akin to an amotivational syndrome," Paule said.  
He added, however, that the phenomenon may have occurred precisely 
because the monkeys were at the critical and deliberately chosen stage of 
adolescence when the NCTR test was conducted. 
     Because marijuana use is high among teenagers, depressed motivation 
at that stage in life can have serious effects.  But marijuana may not 
have the same effect on adults. 
     "We did a search of the literature," Paule said, "and we found that 
those studies that tried to find amotivational syndrome in adults could 
not find one.  It only appears in adolescence.  Chances are, if we'd done 
these studies in adults, we wouldn't have seen this effect.  And the good 
news is that, even among adolescents, when the exposure to marijuana was 
stopped, their motivation jumped right back up to normal levels." 
     "It took two to three months for them to recover to full values, but 
they did recover and they recovered fully." 
     Paule noted two other findings related to the motivational test.  
One was that the willingness to work appeared to be equally affected in 
both the daily and weekend smokers.  "That totally surprised us," he 
said. 
     Another finding worthy of note was that, as in most areas of life, 
one monkey proved to be an exception.  As Paule put it, he seemed to go 
"blooey" under the influence of marijuana. 
     "Unlike the others, we found that this one particular animal was 
severely disrupted by chronic marijuana exposure on the discrimination 
task.  And he never recovered full from the amotivational syndrome.  We 
have no understanding of why.  Everything else about him tested normal." 
     That one monkey represents a warning.  As Paule cautioned, "There 
appears to be tremendous individual variation in susceptibility to 
marijuana." 
     Also of interest in the NCTR study, in light of U.S. criminal 
sanctions against marijuana, is the researchers' observation that the 
animals exposed to marijuana never posed a threat to their handlers. 
     "I've never seen anything that suggests marijuana is responsible for 
an increase in any violent behavior," Paule said, adding, "I would say 
that the perceived risk to marijuana is probably overstated." 
     That's the scientist speaking.  Here's the father.  Asked what he 
would tell his 9-year-old son about the risks of smoking marijuana, this 
was Paule's answer: "I'd tell him he probably shouldn't smoke dope before 
he becomes an adult." 
</pre>
<pre> 
POT RESEARCH LID ABOUT TO BLOW OPEN 
     Dr. Don McMillan, chairman of the Department of Pharmacology at the 
University of Arkansas at Little Rock, is also the school's Wilbur D. 
Mills professor of Alcoholism and Drug Abuse Prevention.  He led a major 
study into human tolerance of marijuana in the early part of his career, 
and more recently served as an advisor to the researchers at NCTR in 
planning of their study of marijuana's effects on monkeys. 
     After years during which he said marijuana research was "stalled," 
McMillan is once again excited about developments in the field. 
     "It looks like the whole lid on marijuana research is about to blow 
wide open," he said in a recent interview.  "I think we're going to know 
a tremendous amount more about the mechanism of action and how it works 
on the brain in the next two years." 
     As marijuana is studied further, its effects, especially relative to 
other, legal drugs, will also become better understood.  For example, 
marijuana is ranked with heroin and LSD as a Schedule I drug.  The 
federal government rates its potential for abuse higher than the risk of 
abusing cocaine, morphine, PCP, or methadone. 
     Asked about that, McMillan said, "The thing you have to remember is 
that that schedule is a legal classification, not a medical one." 
     He said the medical understanding of marijuana is that it poses a 
lower risk to society and individual health than that of two legal drugs 
-- alcohol and tobacco. 
     "Marijuana is probably less harmful than either of those -- but of 
course, there's still a lot we don't know about it." 
</pre>
<pre>
     The Arkansas Times, September 16, 1993, pp. 11-12 
</pre>
<pre> 
(reprinted with permission from the Arkansas Times) 
Arkansas Times, Alan Leveritt - Publisher, Max Brantley - Editor 
201 East Markham Street, 200 Heritage Center West 
P.O. Box 34010, Little Rock, Arkansas 72203 
Telephone: (501) 375-2985 
</pre>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-272</DOCNO>
<DOCOLDNO>IA087-000628-B024-346</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/paule.html 206.61.184.43 19970122060550 text/html 5446
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:05:43 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:06:27 GMT
Content-length: 5231
</DOCHDR>
<HTML>
<PRE>
ACUTE EFFECTS OF MARIJUANA SMOKE ON COMPLEX OPERANT BEHAVIOR IN RHESUS 
MONKEYS, by Gene E. Schultze, D. E. McMillan, John R. Bailey, Andrew C. 
Scallet, Syed F. Ali, William Slikker, Jr, and Merle G. Paule.  Life 
Science, Vol. 45, pp. 465-475 (1989) 
 
Effects of Chronic Delta-9-Tetrahydrocannabinol (THC) Administration on 
Neurotransmitter Concentrations and Receptor Binding in the Rat Brain, by 
S. F. Ali, G. D. Newport, A. C. Scallet, K. W. Gee, M. G. Paule, R. M. 
Brown and W. Slikker, Jr.  NeuroToxicology, Vol. 10, pp. 491-500 (1989) 
 
CHRONIC MARIJUANA (MJ) SMOKING AND URINARY CORTISOL (UC) EXCRETION IN THE 
MONKEY, by M. G. Paule, J. R. Bailey, A. C. Scallet, S. F. Ali & W. 
Slikker, Jr.  Proc. West. Pharmacol. Soc., Vol. 32, p. 189 (1989) 
 
EFFECT OF CHRONIC DELTA-9-TETRAHYDROCANNABINOL (THC) ON PYRAMIDAL NEURON 
SIZE AND SYNAPTIC DENSITY IN RAT HIPPOCAMPUS, by W. Slikker, Jr., A. C. 
Scallet, E. Uemura, A. Andrews, S. F. Ali, D. E. McMillan, M. G. Paule, 
and R. M. Brown.  Marijuana '87, pp. 377-382 
 
THE INFLUENCE OF ANESTHESIA, PREGNANCY AND SEX ON THE PLASMA DISPOSITION 
OF DELTA-9-TETRAHYDROCANNABINOL, AND 11-NOR-9-CARBOXY-DELTA-9-
TETRAHYDROCANNABINOL IN THE RHESUS MONKEY, by Merle G. Paule, John R. 
Bailey and William Slikker, Jr.  Marijuana '87, pp. 315-320 
 
ESTIMATION OF PLASMA DELTA-9-TETRAHYDROCANNABINOL (THC) LEVELS BY 
CARBOXYHEMOGLOBIN MEASUREMENT IN RHESUS MONKEYS AFTER EXPOSURE TO 
MARIJUANA SMOKE FROM CIGARETTES OF KNOWN THC CONTENT, by Merle G. Paule, 
John R. Bailey, William Slikker, Jr. and Roger M. Brown.  Marijuana '87, 
pp. 259-262 
 
Acute Effects of Delta-9-Tetrahydrocannabinol in Rhesus Monkeys as 
Measured by Performance in a Battery of Complex Operant Tests, by Gene E. 
Schultze, D. E. McMillan, John R. Bailey, Andrew Scallet, Syed F. Ali, 
William Slikker, Jr. and Merle G. Paule.  The Journal of Pharmacology and 
Experimental Therapeutics, pp. 178-186 (1988) 
 
Morphometric studies of the rat hippocampus following chronic delta-9-
tetrahydrocannabinol (THC), by A. C. Scallet, E. Uemura, A. Andrews, S. 
F. Ali, D. E. McMillan, M. G. Paule, R. M. Brown and W. Slikker, Jr.  
Brain Research, Vol. 436, pp. 193-198 (1987) 
 
Fetal Disposition of Delta-9-Tetrahydrocannabinol (THC) during Late 
Pregnancy in the Rhesus Monkey, by J. R. Bailey, H. C. Cunny, M. G. Paule 
and W. Slikker, Jr.  Toxicology and Applied Pharmacology, Vol. 90, pp. 
315-321 (1987) 
 
PLASMA DISTRIBUTION OF DELTA-9-TETRAHYDROCANNABINOL (THC) IN THE RHESUS 
MONKEY AFTER MARIJUANA SMOKE EXPOSURE, By M. G. Paule, J. H. Bailey, C. 
M. Fogle, M. P. Gillam, W. Slikker, Jr. & R. M. Brown.  Proc. West. 
Pharmacol. Soc., Vol. 30, pp. 397-399 (1987) 
 
Behavioral, Neurochemical, and Neurohistorical Effects of Chronic 
Marijuana Smoke Exposure in the Nonhuman Primate.  
Marijuana/Cannabinoids: Neurobiology and Neurophysiology, edited by Laura 
Murphy and Andrzej Bartke, CRC Press (1992), pp. 219-273.  ISBN 0-8493-
7931-8 
 
Chronic Marijuana Smoke Exposure in the Rhesus Monkey I Plasma 
Cannabinoid and Blood Carboxyhemoglobin Concentrations and Clinical 
Chemistry Parameters, by William Slikker, Jr., Merle G. Paule, Syed F. 
Ali, Andrew C. Scallet, and John R. Bailey.  Fundamental and Applied 
Toxicology, Vol. 17, pp. 321-334 (1991) 
 
Chronic Marijuana Smoke Exposure in the Rhesus Monkey II Effects on 
Progressive Ratio and Conditioned Position Responding, by Merle G. Paule, 
Richard R. Allen, John R. Bailey, Andrew C. Scallet, Syed F. Ali, Roger 
M. Brown and William Slikker, Jr.  The Journal of Pharmacology and 
Experimental Therapeutics, Vol. 260, pp. 210-222 (1992) 
 
No increase in carcinogen-DNA adducts in the lungs of monkeys exposed 
chronically to marijuana smoke, by Glenn Talaska, Marlene Schamer, John 
R. Bailey, Syed F. Ali, Andrew C. Scallet, William Slikker, Jr. and Merle 
G. Paule.  Toxicology Letters, Vol. 63, pp. 321-332 (1992) 
 
Effects of Chronic Delta-9-THC Treatment of Cardiac Beta-Adrenoceptors in 
Rats, by Eric B. Evans, Ernst Seifen, Richard H. Kennedy, Ronny 
Kafiluddi, Merle G. Paule, Andrew C. Scallet, Syed F. Ali and William 
Slikker, Jr.  Pharmacology Biochemistry & Behavior, Vol. 28, pp. 171-174 
(1987) 
 
Chronic Marijuana Smoke Exposure in the Rhesus Monkey IV Neurochemical 
Effects and Comparison to Acute and Chronic Exposure to Delta-9-
Tetrahydrocannabinol (THC) in Rats, by Syed F. Ali, Glenn D. Newport, 
Andrew C. Scallet, Merle G. Paule, John R. Bailey and William Slikker, 
Jr. Pharmacology Biochemistry & Behavior, Vol. 40, pp. 677-682 (1991) 
 
Chronic exposure to Delta-9-tetrahydrocannabinol fails to irreversibly 
alter brain cannabinoid receptors, by Tracy M. Westlake, Allyn C. 
Howlett, Syed F. Ali, Merle G. Paule, Andrew C. Scallet and William 
Slikker, Jr.  Brain Research, Vol. 544, pp. 145-149 (1991) 
 
This list has been provided by Merle G. Paule, Ph.D., HFT-132, Department 
of Health and Human Services, Public Health Service, Food and Drug 
Administration, National Center for Toxicological Research, 3900 NCTR 
Drive, Jefferson, Arkansas 72079-9502, (501) 543-7000.
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-273</DOCNO>
<DOCOLDNO>IA087-000632-B043-25</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/grubor00.html 206.61.184.43 19970122072432 text/html 12846
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:24:11 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:05:20 GMT
Content-length: 12630
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>Grubor v. Pennsylvania - February 1995</title>
</head>

<body bgcolor="#FFFFFF" text="#000000" link="#0000FF"
vlink="#800080" alink="#FF0000">

<h4 align="center">IN THE SUPREME COURT OF PENNSYLVANIA<br>
SITTING AT PITTSBURGH</h4>

<hr>

<h4 align="center">DOCKET: 75 W.D. ALLOCATUR DOCKET '95</h4>

<hr>

<h4 align="center">JOHN M. GRUBOR, Petitioner</h4>

<h4 align="center">vs.</h4>

<h4 align="center">COMMONWEALTH OF PENNSYLVANIA<br>
DEPARTMENT OF TRANSPORTATION<br>
BUREAU OF DRIVER LICENSING, Respondent</h4>

<hr>

<h4 align="center">ALLOCATUR PETITION FOR ALLOWANCE OF APPEAL</h4>

<hr>

<h4 align="center">PETITION FOR ALLOWANCE OF APPEAL<br>
FROM THE ORDER OF THE COMMONWEALTH COURT OF PENNSYLVANIA<br>
DATED JANUARY 10, 1995, AT DOCKET NO: 2607 C.D. 1992,<br>
WHICH ORDER AFFIRMED A FINAL ORDER DATED NOVEMBER 4, 1992,<br>
BY THE COURT OF COMMON PLEAS OF ALLEGHENY COUNTY<br>
AT DOCKET NUMBER S.A. 1675 OF 1992</h4>

<hr>

<h4 align="center">FILED PRO SE, BY:</h4>

<h4 align="center">JOHN M. GRUBOR, J.D.<br>
P.O. BOX 114<br>
E. McKEESPORT, PA. 15035</h4>

<h4 align="center">(412) 855-2594</h4>

<hr>

<h4 align="center">RECEIVED<br>
FEB 7 1995<br>
SUPREME COURT<br>
WESTERN DISTRICT</h4>

<hr>

<p align="center"><b><u>ALLOCATUR PETITION FOR ALLOWANCE OF
APPEAL</u></b></p>

<p>AND NOW comes the PETITIONER, John M. Grubor, J.D., <u>pro</u> <u>se</u>,
pleading for Allocatur Allowance of Appeal as follows:</p>

<p>Petitioner pleads for relief from the <u>PER CURIAM</u> order
of the Commonwealth Court dated January 10, 1995, the text of
which was:</p>

<p align="center">&quot;<u>0 R D E R</u> </p>

<blockquote>
    <p>NOW, January 10, 1995, upon consideration of appellant's
    nunc pro tunc petition for reconsideration based on after
    acquired evidence, the petition is denied.&quot;</p>
</blockquote>

<p>The aforementioned Order followed a previous &quot;<u>OPINION
NOT REPORTED</u> MEMORANDUM OPINION BY JUDGE McGINLEY FILED:
October 28, 1994&quot; and an Order attached thereto. The
complete opinion and Order are attached hereto and marked as &quot;Exhibit
II.&quot;</p>

<p>For the purpose of clarifying the issues (see &quot;Questions
presented for review&quot;) a proposed Petition for Certiorari
has been attached as &quot;Exhibit I.&quot;</p>

<p>The lower court order has been attached hereto and marked as
&quot;Exhibit III.&quot;</p>

<p>The verbatim text of the first statute at issue has been
attached hereto and marked as &quot;Exhibit IV.&quot;</p>

<p>The verbatim text of the second statute at issue has been
attached hereto and marked a &quot;Exhibit V.&quot;</p>

<p align="center">1 </p>

<hr>

<p align="center"><u>QUESTIONS PRESENTED FOR REVIEW</u></p>

<p>The circumstances of this case involve the bona fide medical
use of a controlled substance for a life threatening medical
necessity (deadly seizures), which was justified under section
503 of the Crimes Code, and which justification should be a
complete defense to all other sanctions. The suspension of the
Defendant's Driver's License in the instant case is the Political
Subjugation of Medicine, which is an issue of immediate public
importance, justifying this Honorable Court's assumption of
plenary jurisdiction.</p>

<p>The three main questions presented for review by this
Honorable Court are questions of substance not heretofore
determined by this Honorable Court. There are two other questions
which this Court has &quot;apparently ruled upon&quot; but which
are included in the proposed PETITION FOR CERTIORARI contained in
the Appendix of this pleading. The two other questions are
subsidiary questions fairly comprised within the three main
questions and shall not be discussed in this pleading. However,
argument on the two other questions, as set forth in paragraphs
one and two of the aforementioned CERTIORARI, is hereby reserved
for subsequent pleadings and oral argument. The three main
questions are as follows:</p>

<p>A. Whether the commonwealth can suspend the driver's license
of Defendant, who is a bona tide medical user of a controlled
substance, for a plea bargain to a crime which had nothing to do
with the Motor Vehicle Code.</p>

<p>B. Whether the Commonwealth can refuse to consider the
issuance of an occupational Limited License to the Defendant.</p>

<p>C. Whether the Defendant was denied his constitutional right
to Procedural Due Process by being required to present his entire
case to the lower court in five minutes.</p>

<p align="center">2 </p>

<hr>

<p align="center"><u>STATEMENT OF THE CASE</u></p>

<p>This case involves the bona fide medical use of a controlled
substance for a life threatening medical necessity. After having
bloody nocturnal Epileptic seizures for almost five years, the
PETITIONER (Defendant) began using the only substance that could
stop his seizures, Cannabis. Defendant was treated with Dilantin
and other drugs by three Neurologists for 4 1/2 years, but the
conventional drugs prescribed by the Physicians did not stop the
Defendant's bloody nocturnal episodes.</p>

<p>In 1986, Defendant read in the medical literature that
Cannabis (&quot;Marijuana&quot; in Spanish) was known to be the
only substance to actually &quot;stop&quot; Epileptic seizures.
Defendant was in fear of death from his nocturnal Epileptic
seizures for two reasons. The first was the possibility of ending
a seizure &quot;on his back&quot; and thereby suffocating on the
&quot;swallowing of the tongue&quot; effect. But he was also
fearing death from &quot;drowning on his own blood.&quot; On many
a morning, Defendant woke up with blood all over his pillow and
sheets. His tongue was severely bitten into on both sides and the taste
of blood would last for days. Sometimes it would take weeks for
the tongue to heal and the pain resulting from the back spasms
during the seizures would last for months.</p>

<p>Because Defendant had no other legal alternative, he began
using Cannabis for his life threatening medical necessity in
1986. His actions were and continue to be justified under the
criteria set forth in section 503 of the Crimes Code. Defendant
has had no seizures for nine years and his termination of the use
of the controlled substance is not Medically indicated.</p>

<p>In 1988, at the St. Louis University Medical School, and in
1989, at the National Institute of Mental Health, cannabinoid
receptors were discovered and located in the human brain. This
new evidence gave the answer as to why Cannabis was so effective</p>

<p align="center">3 </p>

<hr>

<p>in the treatment of Epilepsy. We already knew why the miracle
drug cannabis was effective in Glaucoma, AIDS, Cancer, Asthma and
other diseases, but the existence and location of the brain receptors
now explained it's tremendous effectiveness in Epilepsy,
Parkinson's Disease, Multiple Sclerosis and other spastic
disorders. It seemed that the law should recognize these new
medical developments, but it did not. Instead, politicians caused
the POLITICAL SUBJUGATION OF MEDICINE.</p>

<p>In 1989, with George Bush playing &quot;tough on crime,&quot;
the &quot;Federal Mandates&quot; came in like gangbusters. The
mandates required the States to pass these new laws in order to
get the new &quot;Federal Money.&quot; The two statutes at issue
in the instant case are the results of the &quot;Federal Mandates.&quot;
No one paid any attention to the needs of the Medical Necessity
Users.</p>

<p>In March of 1992, Defendant plead guilty to the possession of
1/3 ounce of cannabis in return for &quot;one year probation and
no other penalty.&quot; Defendant never knew or was told of the
mandatory driver's license suspension during the court Colloquy.
When the Bureau of Motor Vehicles tried to suspend Defendant's
Driver's license in April of 1992, Defendant filed a Statutory
Appeal in the Allegheny County Common Pleas Court.</p>

<p>On November 4, 1992, the lower court dismissed Defendant's
Appeal and Defendant filed a timely appeal to the commonwealth
court. (The lower court order is attached hereto as &quot;Exhibit III.&quot;)
Oral Argument was not granted by the commonwealth Court and a
written &quot;OPINION NOT REPORTED MEMORANDUM OPINION&quot; was
filed by the commonwealth court on October 28, 1994. (Exhibit
II.) After consideration of a Petition for Reconsideration, the
Commonwealth Court denied same on January 10, 1995.</p>

<p>A timely Allocatur Petition for Allowance of Appeal was filed
and is presently at issue before this Honorable Court.</p>

<p align="center">4 </p>

<hr>

<p align="center"><u>REASONS FOR ALLOWANCE OF APPEAL</u></p>

<p>This may be the most important case this Honorable Supreme
Court has ever considered, because it deals with the Political
Subjugation of Medicine. This recently identified PSM phenomenon
has caused an increase in the crime problem, the drug problem and
the domestic violence/abuse problems in the last seven years. In
essence, an overwhelming issue of immediate public importance is
at hand: This Honorable Court is obligated to be a non-political
entity, and it must therefore consider and rule upon this PSM
which has invaded the Legislative and Executive branches of
Government. If the Judiciary does not do it's duty, then we lose
our only hope for a decent Government: The Statutes at issue in
the instant case were passed without the slightest regard for the
then current medical information, a prime example of the
Political Subjugation of Medicine. All three main questions
presented for review in the instant case are ramifications of
this PSM and are questions of substance not heretofore determined
by this Honorable Court.</p>

<p>The Petitioner is a member of a &quot;suspect class&quot; of
Medical Necessity users of the Controlled substance Cannabis, who
deserve &quot;greater protection&quot; than other offenders,
because their actions are Justified under section 503 of the
Crimes Code. This &quot;suspect class&quot; involves millions of
people in this commonwealth who use Cannabis daily for Epilepsy,
Glaucoma, AIDS, Cancer, Asthma, Parkinson's Disease, Multiple
Sclerosis, Emphysema, Muscular Dystrophy and other diseases, and who's
driver's licenses are put in jeopardy by their medical
necessities.</p>

<p>WHEREFORE, Petitioner respectfully prays to this Honorable
Court for Allocatur, Permission for Appeal and for oral argument.</p>

<p>Respectfully Submitted, by: John M. Grubor, pro se, PETITIONER</p>

<p align="center">5 </p>

<hr>

<p>&quot;Proposed Pleading&quot; (not to form):</p>

<p align="center"><b><u>IN THE SUPREME COURT OF THE UNITED STATES</u></b></p>

<p align="center"><b><u>PETITI0N FOR CERTIORARI</u></b></p>

<p>Questions to be presented to the Court:</p>

<p>1. Whether a State may rule that a sanction passed under a
&quot;Crimes Code&quot; is merely a &quot;civil penalty.&quot;
(thereby denying the consideration of constitutional rights
applicability to the sanction).</p>

<p>2. Whether a State may deny Due Process to a Defendant who has
executed a plea bargain by later demanding additional penalties
(license suspension and over $10,000 in costs) which were not disclosed
to the Defendant at the time of the Court colloquy. (Defendant
would not have plead guilty if he had known of the driver's
license suspension)</p>

<p>3. Whether a Defendant in a Driver's license suspension case
is denied Procedural Due Process by being required to present his
entire defense in five minutes in a courtroom that was a
&quot;joke&quot; because of apparent case fixing by the tipstaff.</p>

<p>4. Whether a State may take away ones liberty (driver's
license suspension) because of a Defendant's use (justified under
503 of crimes code) of a controlled substance which had nothing to
do with an automobile or the Motor vehicle Code.</p>

<p>5. Whether a State may refuse to consider the issuance of an
occupational Limited License to those individuals in the suspect
class of Medical Necessity Users of a controlled Substance who's actions
are justified within the definitions set forth in Section 503 of
the Uniform Crimes Code.</p>

<p align="center">Exhibit I. </p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT01-B18-274</DOCNO>
<DOCOLDNO>IA087-000628-B024-375</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/leshner.html 206.61.184.43 19970122060613 text/html 3005
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:06:00 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:56 GMT
Content-length: 2790
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="Carl E. Olsen">
</HEAD>

<BODY>

<PRE>
Department of Health &amp; Human Services
Public Health Service
National Institutes of Health
National Institute on Drug Abuse
5600 Fishers Lane
Rockville, Maryland 20857



April 19, 1995

Donald I. Abrams, M.D.
Chairman, Community Consortium
Assistant Director AIDS Program
San Francisco General Hospital
Professor of Clinical Medicine
Unervisity of California San Francisco
995 Potrero  Avenue
Building 80, Ward 84
San Francisco, California 94110

Dear Dr. Abrams:

We have reviewed your request that the NIH supply marijuana for a study 
of the effects of smoked marijuana on weight changes in persons with 
HIV-related wasting syndrome.  Unfortunately, we have determined that we 
cannot comply with your request.

As you know, decisions for the commitment of limited NIH resources are 
based upon scientific principles, so as to ensure the most effictive use 
of our research resources.  Our decision here is based upon issues of 
design, scientific merit and rationale.  We believe that your study will 
not adequately answer the question posed.

Although the study propose seeks to make a dose-effect comparison of 
smoked marijuana to delta-9-tetrahydrocannabinol (THC), there is no real 
dosing control.  The marijuana is to be taken home and there is no 
requirement and way to ensure that the subjects smoke all available 
materials on any fixed schedule.  Additionally, that they are given a 
two-week supply of marijuana at one time further confounds the study 
design.  Thus, we believe the dose-effect component is confounded since 
the study cannot correlate variability in weight gain with dosage.

We also believe the study lacks adequate sample size to make any 
inferences regarding the dose-effect relationship.  We base our 
conclusion on an analogous study performed by the National Institute on 
Allergy and Infectious Diseases that compared megestrol and THC in 56 
subject [sic] with AIDS-related wasting syndrome but still lacked 
inferential power.  Another counfounding variable not adequately 
controlled for in your proposed study is diet.  Neither the total daily 
caloric intake nor the percentages of the composition of the foodstuffs 
is assessed.

We sincerely share your hope that new treatments will be found swiftly 
to improve the quality and prolong the lives of patients suffering from 
this terrible disease.  As you know, a great deal of NIH research 
support is directed toward this end.

Sincerely,
[signed]
Alan I. Leshner, Ph.D.
Director 
</PRE>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-275</DOCNO>
<DOCOLDNO>IA087-000628-B025-18</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/abrams.html 206.61.184.43 19970122060626 text/html 8986
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:06:19 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:27 GMT
Content-length: 8771
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="Carl E. Olsen">
</HEAD>

<BODY>

<PRE>
University Of Califoria, San Francisco
School of Medicine
Please address reply to the undersigned at:
UCSF AIDS Program
San Francisco General Hospital
995 Potrero Avenue
Building 80, Ward 84
San Francisco, California 94110


April 28, 1995

Alan I. Leshner, Ph.D
Director
National Institute on Drug Abuse
5600 Fishers Lane
Rockville, Maryland 20857

Dear Dr. Leshner,

I am writing in response to your letter of April 19 regarding my 
request that NIDA consider supplying marijuana for the Community 
Consortium's proposed study in patients with HIV-related wasting 
syndrome.  I was not only disappointed by the flat out rejection of 
the request, but also by the way this matter has been handled by your 
Institute from the onset.  To receive the first communication from 
your office nine months after we sent the initial submission is 
offensive and insulting.  I realize that this has been a very 
difficult decision for you to make because of all the nonscientific 
issues involved, but I am certainly not used to having no 
communication at all for nine months from someone with whom I had 
corresponded on an official matter.  The apparent abscence of any 
possibility to discuss your concerns and to modify the protocol 
appropriately so that we may work together for the benefit of our 
patients is also unacceptable in my opinion. 

The National Institute on Drug Abuse has not been the first body to 
review our proposed pilot study.  It has been reviewed and approved 
by the Committee on Human Research of the University of California, 
San Francisco, as well as by our own Scientific Advisory Committee 
and Community Advisory Forum.  In addition, the study has been 
approved (pending location of the source of inhaled marijuana) by the 
California Research Advisory Panel.  The US Food and Drug 
Administration has also been involved since the onset in developing 
the trial and has strongly influenced the study's design.  The 
General Clinical Research Center at San Francisco General Hospital 
has agreed to collaborate in the study by providing dietary 
counseling and monitoring of patients, as well as performing the 
state-of-the-art composition measurements we intend to perform. 
Collaborating investigators at Chiron Corporation were also eager to
participate in this study by donating their newly developed 
technology to assess HIV viral burden in patients randomized to 
receive marijuana.  Hence, your concerns about the scientific merit 
of the study have not been shared by a number of competent reviewers 
and investigators.

To respond to your concerns in a timely manner, I will address each 
issue you raise in turn.  However, it is important to stress that 
this trial was designed as a pilot study to determine the feasibility 
of conducting a larger study and, in particular, the sample size 
required to evaluate the efficacy of inhaled marijuana.  As you know, 
the use of a pilot study in clinical research is a well-established 
procedure.  I am sure you would agree that it is a prudent strategy 
to conduct a small pilot trial of inhaled marijuana prior to launching
the definitive efficacy trial that would require a much larger sample 
size.

We fully appreciate that the current pilot study would not be 
adequate to &quot;make any inferences regarding the dose-effect 
relationship.&quot;  However, we would be able to determine whether a dose 
was associated with an intolerable rate of side effects, and that 
dose would then be eliminated from a larger efficacy trial.  As 
indicated in the protocol, we plan to do intensive monitoring of 
pulmonary and immune function as well as HIV viral load in our 
patients.  If we saw that inhalation of marijuana was detrimental to 
any of these parameters, that information would be crucial to share 
with others in order to protect the safety of patients who are 
already using inhaled marijuana (from other sources).  The current 
pilot study certainly should be large enough (with 30 patients 
smoking marijuana) to assess such possible detrimental effects.

The Community Consortium conducts community-based clinical trials of 
treatments that are being widely used by the patient population and, 
as I am sure you are aware, individuals with access are currently 
utilizing inhaled marijuana.  Our aim is to assess the impact of 
treatments that we study in &quot;real world&quot; situations.  As you know, 
with whatever drug one studies in a clinical trial, we can never be 
truly certain that patients are consuming 100% of their assigned 
doses.  Even for treatment of Pneumococcal pneumonia, very few 
patients treated actually complete their full course of penicillin. 
Similarly, zidovudine (AZT) was approved as the first antiretroviral 
agent for treating HIV infectioin, and we know that compliance in 
those trials was not 100%.  In our study, we plan to ask patients to 
quantitate how much of their allotted marijuana they smoked on any 
given day.  We also plan to have patients return any unused marijuana 
so we can assess how much they actually usilized.  Whether they 
actually smoked all that they were given at each visit is irrelevant 
when an intent-to-treat analysis is utilized for data analysis.

Your concerns about total daily caloric intake and &quot;the percentages 
of the composition of the foodstuffs&quot; are a bit extreme, in my 
opinion, but do not present insurmountable problems for us.  As the 
General Clinical Research Center at San Francisco General Hospital is 
our collaborating site where patients will go to be taught how to use 
the water pipe for inhalation, and where they will return for all of 
their follow-up evaluations, obtaining this dietary information is 
certainly possible.  In fact, this is the sort of information that 
the GCRC specializes in collecting!  Though we could add this 
requirement, it would be a major inconvience to these already ill 
patients to ask them to collect this information on a daily basis 
during the trial.  Of course, another option is to admit all patients 
on the study to the GCR for the duration of their participation in 
the study, so that all intake and output can be accurately assessed. 
Once again, however, that is not how patients would be living while 
they utilized the intervention in the real world, so the value of 
data obtained in this fashion is, in my mind, unclear.  It certainly 
does not reflect the &quot;real world&quot; usage.

As an AIDS investigator who has worked closely with National 
Institutes of Health and the US Food and Drug Administration for the 
past 14 years of this epidemic, I must tell you that dealing with 
your Institute has been the worst experience of my career!  The lack 
of any official communication for nine months is unheard of, even in 
the most cumbersome of government bureaucracies.  In fact, I was so 
shocked to finally receive your communication that I failed to detach 
the green postcard to verify receipt.  I apologize to you, and to 
your staff who called for three consecutive days to make sure the 
letter had arrived.

Finally, the &quot;sincerity&quot; with which you share my &quot;hope that new 
treatments will be found swiftly&quot; feels so hypocritical that it makes 
me cringe.  Believe it or not, I wish I had never needed to approach 
NIDA with this request.  The Community Consortium had a source of 
marijuana established for this study from the onset.  Unfortunately, 
the source was foreign and the FDA advised us that the DEA was having 
difficulty with the importation issue and suggested we contact you. 
(The DEA has also been less than forthcoming in responding to my 
request for a Schedule I license sent to them April 15, 1994.)

Obviously, your letter leaves no door open for further discussion as 
to how this pilot study could be modified so that we could work 
together.  Hence, I will not bother you further.  Your letter will be 
widely distributed.  You had an opportunity to do a service to the 
community of people living with AIDS.  You and your Institute failed. 
In the words of the AIDS activist community: SHAME!

Sincerely,

[signed]

Donald I. Abrams, M.D.
Chairman, Community Consortium
Assistant Director, AIDS Program
San Francisco General Hospital
Professor of Clinical Medicine
University of California San Francisco

cc: Philip R. Lee, MD
    Harold E. Varmus, MD 
</PRE>

</BODY>

</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-276</DOCNO>
<DOCOLDNO>IA087-000628-B025-51</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/west.html 206.61.184.43 19970122060640 text/html 30307
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:06:29 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:06:45 GMT
Content-length: 30091
</DOCHDR>
<HTML>
<PRE>
WEST / SAN JOSE MERCURY NEWS / MAY 14, 1995 
 
Marijuana is said to relieve the suffering of people with cancer, 
AIDS and other diseases.  But are our drug laws Nipping 
Compassion in the Bud? 
 
Cover story: Reefer madness 
By Tracie Cone 
 
[picture] 
 
They are law-abiding citizens, but they or someone they love are 
suffering from grave illnesses, and pharmaceuticals don't ease 
the pain.  So they come to places like the Cannabis Buyers Club.  
Above, Hazel Rodgers signs up a new patient, Danny O'Dell, who 
came from Texas. 
 
Reefer MADNESS 
Story by Tracie Cone 
 
Law-abiding regular folks descend into a netherworld to get 
relief for themselves or others with grave diseases.  Why 
morphine and not marijuana? 
 
IT'S DUSK ON THE HIGHWAY, the time when the sun disappears and 
the dwindling light makes objects hard to discern.  I see a car 
growing larger in my rearview mirror, but what's that on the 
roof?  It registers: a police car-with lights and siren off for a 
sneak attack.  My heart pounds so hard my throat hurts.  I clutch 
my steering wheel with 
sweaty palms. 
   I decide I've been under surveillance since I broke state and 
federal law 15 minutes earlier in Santa Cruz.  My trunk holds 
marijuana amid golf clubs and dry cleaning.  Who would buy the 
story that I'm taking it to a sick friend? 
   Yet I am.  She is waiting at home, her gut churning from her 
latest round of cancer treatment, and this is the substance she 
prays will finally bring relief.  We had read of people who smoke 
marijuana to ease the nausea of chemotherapy.  She decided to try 
it after her prescription medication caused near-deadly 
complications. 
   The prospect of jail is viewed as just another indignity to 
people who are dying and will try anything to feel good again.  
When a life is at stake, the rule books often get chucked, no 
matter how law-abiding the person may be. 
   "What have I got to lose?" she had asked. 
   Near the Pajaro River, I poise my hand on my blink- 
 
POT 
 
er.  Maybe a final act of traffic-law compliance will make the 
police go easy on me. 
   The car rides my bumper for a second, then pulls to the left 
and darts past.  It's only a Honda Accord with a ski rack on the 
top.  I sigh at the trick played by my paranoid brain and drive 
home under the comforting cover of darkness. 
 
POSSESSING MARIJUANA makes criminals out people who use it to 
reverse the "wasting syndrome" of AIDS, relax spastic muscles, 
stifle epileptic seizures or ease the symptoms of a dozen other 
ailments.  It is a misdemeanor in California to possess less than 
an ounce.  People who deliver it to ailing friends are committing 
a felony. 
   These users rarely fit the law-enforcement profile.  They're 
not social misfits looking for a legal way to get high.  It is 
not a "gateway" to the land of LSD and crack cocaine.  They are 
simply doing what many sick people have done since ancient 
Egyptians smoked the leaves to cure headaches. 
   Studies have shown that the THC in marijuana, along with some 
combination of its 460 known compounds, eases nausea in 
chemotherapy patients and reduces eye pressure in people 
suffering from blinding glaucoma. 
   Yet the federal Government, spending billions in a popular war 
on drugs, halted all research that might prove whether the plant 
is more effective with some people than synthetic drugs on the 
market. 
   It's absurd that medical decisions are being made by 
politicians," says Dr. Arnold Jeffe, a Santa Cruz physician.  
"It's so crazy that this has become such a big deal when, really, 
it's not a big deal at all." 
   Politics made marijuana illegal in 1937 and politics might 
soon put it legally back in doctors' hands.  San Jose Assemblyman 
John Vasconcellos has introduced a compassionate-use bill that 
would allow sick people to use marijuana. 
   "If people are in pain they ought to be able to use marijuana 
to relieve their pain," Vasconcellos said.  "It's none of the 
government's business in the first place." 
   Should the bill fail, the San Francisco-based group 
Californians for Compassionate Use has hired a political 
consultant to get the issue on the November 1996 ballot. 
   The proposition would make Californians the first in the 
country to decide a medical marijuana law, and the group -- AIDS 
activists skilled in the art of lobbying and sick people who 
depend on the drug -- believes the referendum has a chance. 
   They are encouraged by a recent statewide survey they 
commissioned showing that while few Californians want to make 
marijuana legal, 66 percent of the 750 randomly questioned 
respondents would support a law allowing sick people to use it 
with a doctor's prescription. 
   The law would turn Salinas retirees Dorothy 
 
14 / MAY 14, 1995 / W E S T 
 
and Richard Haskell into law-abiding citizens again.  They 
provide marijuana to their 44-year-old daughter, Vicki, who has 
liver cancer. 
   "Umm, we just want it for, well, medicinal purposes," Dorothy 
Haskell said.  "It breaks our hearts to see our daughter suffer." 
 
FOR 25 YEARS the medical marijuana battle has been waged politely 
by people with glaucoma and cancer.  Now it is becoming the 
vocal, in-your-face fight of AIDS patients who say marijuana's 
appetite-inducing side effect keeps them from wasting away.  AIDS 
activists just might succeed where others have not: They already 
have forced the Food and Drug Administration to make experimental 
drugs available years ahead of schedule. 
   "I've been very conscious of the difference between AIDS 
patients and cancer and glaucoma patients," says Robert Randall 
of the non-profit Alliance for Cannabis Therapeutics, based in 
Washington, D.C.  "AIDS patients tend to be a part of a powerful, 
organized community of people who are suffering.  They look out 
for each other." 
   AIDS activists were a big part of successful marijuana 
referendums in San Francisco and Santa Cruz counties.  Eighty 
percent of voters in San Francisco, and 77 percent in Santa Cruz, 
approved resolutions supporting the use of pot for medical 
reasons. 
   Medical marijuana advocates want to modify a law that has been 
in place since 1970.  That's when the FDA and Drug Enforcement 
Agency ruled that the peace movement's drug of choice is as 
useless to medical science as LSD and heroin.  All three became 
classified as Schedule 1 narcotics -- drugs with no known medical 
use. 
   Morphine, cocaine and even Marinol -- a synthetic derivative 
of marijuana's Delta-9-Tetrahydrocannabinol (THC) -- are Schedule 
2, which means doctors can prescribe them.  Medical marijuana 
advocates argue that Marinol often doesn't work as well as the 
real thing -- especially in a vomiting patient -- and want the 
plant moved to Schedule 2. 
   In April 300 people -- many sick or dying, on crutches and in 
wheelchairs, in suits and leather, Gray Panthers and gay 
activists -- gathered on the steps of the U.S. Federal Building 
in San Francisco to draw attention to the fight. 
   "This is our Stonewall!" shouted referendum leader Dennis 
Peron, comparing the marijuana battle to New York's historic gay 
freedom struggle.  "They are not going to drive us back into our 
closets.  I think back to '65 when cops were dragging our friends 
to jail -- and now cops want to take AIDS patients to jail." 
   With TV cameras rolling and tour buses creeping by, they dared 
the DEA to arrest them all. 
   Martin Simmons, 32, scooted his wheelchair to the front of the 
crowd and screamed the chant: 
   Racist, sexist, anti-gay 
   DEA, go away. 
   "I'm dying," Simmons, an AIDS patient, said afterward.  "F--- 
the law." 
 
RICHARD AND DOROTHY HASKELL are proof that need is the thing most 
likely to convince someone with anti-drug views to accept medical 
marijuana.  My friend had never even seen marijuana. 
   I often drove her to the hospital and witnessed the horrendous 
nausea she suffered after treatment.  Prescription drugs were 
supposed to settle her stomach, but every day we stopped two or 
three times on the way home for her dry heaves to pass.  At home, 
she vomited more.  She lost the desire to eat and quickly dropped 
15 pounds, which in turn made her too weak to withstand strong 
treatment. 
   This is what cancer sufferers say about anti-nausea drugs such 
as Zofran (which costs $600 a dose) and Torecan: The side effects 
can be worse than the problems they're designed to prevent.  
Sometimes, it's a headache, stupor or insomnia.  My friend's 
pharmaceutical, besides not curing her nausea, constipated her. 
   In most people, that would be uncomfortable but not deadly.  
But doctors continued giving her the toxic chemical they hoped 
would kill her cancer cells, and it wasn't leaving her body.  In 
the car beside me one evening, after a violent burst of dry 
heaves, she stopped breathing.  I beat on her chest, screamed 
frantically and started CPR: 
   "Please breathe.  Come back.  Please don't die." 
   She didn't die, and later I told her about my aunt who had 
smoked pot while undergoing chemotherapy for liver cancer.  My 
friend has a medicine cabinet full of painkillers, but had never 
tried an illegal drug.  Now she was desperate. 
   I asked friends about buying marijuana on the black market 
which, law enforcement should be happy to hear, doesn't seem as 
active as it was a decade ago.  Instead I found the medical 
marijua-

na underground. 
 
MY FIRST VISIT was with Scott Imler, who runs Citizens for 
Medical Marijuana in Santa Cruz. 
   On the cramped top floor of an old downtown Victorian, Imler 
dispenses advice and marijuana to people he believes are sincere.  
It helps if they have a note from their doctor -- and almost all 
the patients Imler helps do.  He keeps records on a computer, and 
a stash in the closet.  He sent me home with a good supply of 
prime sinsemilla buds. 
   Imler, 37, used to be a special education teacher.  He grew 
pot in the late '80s to supply sick friends in San Francisco.  In 
1992, after sheriffs deputies seized his crop, he worked to pass 
the Santa Cruz County compassionate-use referendum. 
   Dennis Peron of San Francisco sold marijuana in the 1960s and 
'70s as the drug culture thrived.  In the late '80s he discovered 
a higher purpose for law-breaking when his lover, dying of AIDS, 
used marijuana to stimulate his appetite.  Looking respectable 
with Gap clothes and a gray banker-style haircut, Peron now sells 
marijuana to sick people who can afford it, and gives it to those 
who can't at his Cannabis Buyers Club, an illegal reefer pharmacy 
in the city's Castro district. 
   Peron founded the statewide referendum group earlier this year 
and counts on his buyers club members for support.  One Friday in 
April, however, Peron abruptly closed the doors after he received 
a tip: The Drug Enforcement Agency would bust him that afternoon.  
He quickly organized the protest outside the Federal Building 
because customers were returning to dark Tenderloin street 
corners or Dolores Park to find supplies. 
   "I haven't eaten in days, I can't sleep," Martin Simmons said.  
"I don't know what else to do." 
   Valerie and Mike Corral of Davenport began growing marijuana 
20 years ago, after reading that it could control Valerie's 
epileptic seizures.  Now they grow enough to share with about a 
dozen people, all of them dying, who find them by word-of-mouth.  
With her bobbed hair, slacks and pumps, Valerie, 42, looks more 
Junior Leaguer than pot grower. 
   Once a week at her mountaintop cabin, she hunches over a 
tattered "Joy of Cooking" and modifies the traditional Butter 
Thin cookie recipe.  Using marijuana instead of flour, she 
produces a green cookie that will  induce the same effect as 
smoked marijuana after it meanders through the digestive system. 
   Santa Cruz County Sheriffs deputies have arrested Corral twice 
and destroyed her plants.  Yet even the prospect of prison does 
not stop her. 
   "There's not a person who could violate me more than a 
seizure, so I have no fear of cops," she says. 
   May is planting time, and Valerie and Mike are preparing the 
greenhouse.  They plant "Luther Burbank style," growing 100 
seedlings, but keeping only the five or six female plants that 
develop the bushy foliage they're looking for.  They might net 15 
pounds in a season. 
   "We've learned how to grow healthy plants and get a high 
yield," says Mike, who has collected seeds for 20 years.  "It's 
genetics." 
   One recipient of their pot is Bill Shanteau, 44, a Cabrillo 
College instructor who is in the final stages of colon cancer.  
He waits in bed for the weekly delivery that brings physical, 
psychological and psychokinetic relief.  Yes, sometimes Shanteau 
just wants to get high. 
   "The point is," Shanteau says, "marijuana is a major agent in 
keeping me interested in life.  Besides restoring my appetite, 
it's like a hot tub for the brain.  It stimulates me 
intellectually.  It keeps me focused in the moment instead of me 
sitting here thinking I'm dying tomorrow.  I hate to think what 
my life would be like right now if I didn't have it." 
   Shanteau's desire to get high complicates the issue.  
Marijuana doesn't only ease nausea in sick people; it also makes 
them high.  This troubles pot foes, who see the potential for 
abuse and distrust the motives of the people who are pushing 
medical marijuana.  Last year in Sacramento, a woman publicly 
lashed out at Valerie Corral: 
   "She said, 'You People just want to feel good,'" Corral 
recalls.  "And I said, 'Yeah?  So?  What's the crime in a sick 
person wanting to feel good?'" 
 
TOM GORMAN OF SACRAMENTO cringes when people say anything good 
about marijuana.  A member of the California Narcotics Officers 
Association, Gorman says that stories of medical miracles are 
propaganda from people who want to decriminalize drugs. 
   "If you were dying of cancer," says the 27-year veteran of law 
enforcement, you'd probably grasp at anything.  But smoking 
anything is not good for you.  What we're doing in the '90s is 
the exact same thing we did in the '70s -- we're romanticizing 
drugs.  Once you get a soft attitude, kids get the impression 
it's not so bad." 
   Gov. Pete Wilson agrees.  In 1994 he vetoed a medical 
marijuana bill passed by the Legislature.  An aide says Wilson 
will veto the Vasconcellos bill if it lands on his desk. 
   "The governor believes it would serve no useful purposes" says 
spokesman Jesus Arredondo, "when the FDA has already concluded 
that marijuana is not good." 
   The California Medical Association says marijuana, used under 
a doctor's order, is often beneficial.  The American Medical 
Association, the only group originally to speak against Congress' 
1937 ban, has not taken a stand, but supports more research. 
   The American Bar Association, the National Association of 
Attorneys General and the Conference of Episcopal Bishops are 
among the groups calling for the repeal of laws against medical 
marijuana.  Legislators in 35 states, including California, have 
passed non-binding resolutions supporting its use. 
   From the '40s through the '60s, as science refined 
pharmaceutical drugs, the medical community began thinking of 
herbs and botanical treatments as old-fashioned.  But in the 
'70s, recreational users inadvertently discovered marijuana's 
value to modern medicine; researchers reported that cancer 
patients they had treated felt better after using the drug. 
   Robert Randall of the Alliance for Cannabis Therapeutics has 
glaucoma.  In 1976, after a lawsuit and weeks of tests at the 
Jules Stein Eye Institute at UCLA, he became the first person in 
the United States to receive marijuana from the federal 
government.  By then he was nearly blind and the tests showed 
that only marijuana -- not any prescription drug -- would lower 
his eye pressure and save his sight.  The government, he says, 
had had that information since 1971. 
   "The prospect that an easily grown plant can ease human 
suffering should be a cause for celebration," he says.  "The 
problem is, we don't live in a sane society." 
   Randall says he smokes pot every day.  He still has limited 
eyesight. 
   From 1978 to 1986, New Mexico health officials tested 
marijuana on cancer patients who were not helped by other anti-
nausea treatment; 90 percent reported improvement.  A study in 
New York showed that 78 percent of 56 cancer patients who didn't 
respond to other drugs felt better after smoking marijuana.  The 
study, published in 1988, also tested the synthetic THC:  One-
third of the patients who did not feel better using it did show 
improvement after smoking marijuana. 
   By 1991, the federal government, still denying marijuana's 
benefits, was shipping it to 12 people suffering from cancer 
nausea, glaucoma, chronic pain and muscle spasms associated with 
multiple sclerosis.  Randall encouraged people with AIDS to 
apply, as he had, for an application to use an unproven drug.  It 
was a program established by Jimmy Carter after Randall's case 
became public. 
   Meanwhile, doctors began accepting the use of medical 
marijuana.  A 1991 study by Rick Doblin, a Ph.D. candidate at 
Harvard's Kennedy School, found that 44 percent of the 1,000 
cancer specialists who responded to a nationwide survey have told 
patients that marijuana could relieve nausea.  More than half of 
the oncologists surveyed said it should be available by 
prescription. 
   Some doctors believe that not telling their patients is cruel. 
   "I have patients who say that it helps them, and I recommend 
it to patients," says Dr. Leff, 53, of Santa Cruz, who was 
Cincinnati's Drug and Alcohol Abuse director in the early 1970s.  
"[Recommending marijuana] is not unusual.  It's only a big deal 
to people with religious or moralistic views about the drug." 
   The FDA, swamped with thousands of unproven drug applications, 
had approved about two dozen more patients by late 1991.  But the 
Public Health Service under George Bush quietly stopped approving 
new participants and ended all marijuana research programs.  The 
patients already approved but still waiting for marijuana were 
out of luck.  Today the government provides marijuana to only 
eight of the original 12 patients. (The other four have died.) 
   "There was a sense, with so many people applying, that we 
wouldn't have enough marijuana to provide," said Rayford Kytle of 
the PHS, which grows a small crop in Mississippi. 
   The PHS supported the Bush administration decision by saying 
that smoking marijuana, like cigarettes, can cause lung cancer.  
The PHS further warned that smoking it can compromise immune 
systems already made fragile by AIDS or other diseases.  And 
being under the influence can cause anxiety. 
   Bill Clinton, who says he tried marijuana but didn't inhale, 
has upheld the ban.  His administration added a provision, 
however, that allows research into medical benefits. 
   Dr. Donald Abrams, assistant director of the AIDS project at 
San Francisco General Hospital, sought approval to study 
marijuana's effects on the wasting syndrome associated with AIDS.  
"The study would not only see whether it's effective, but whether 
it's harmful," Abrams says. 
 
W E S T / MAY 14, 1995 / 17 
 
POT 
 
   He hoped to study 40 people -- too few to settle the marijuana 
question but enough to determine whether more research is 
warranted.  He applied to the FDA, the DEA and a state agency 
that oversees California university research programs.  The state 
approved the study and the FDA signed off after insisting on 
numerous chances.  On April 15, 1994, Abrams crossed what he 
thought would be the final hurdle when he paid the DEA for a 
license to distribute a Schedule I drug.  The DEA cashed the 
check, but has yet to approve the research. 
   "Everything I hear is from unofficial channels," Abrams said.  
"They said they didn't trust my research, or they questioned my 
credibility.  Nobody can give me a direct answer on why this is 
taking so long." 
   A federal health official offered this reason: "It' s too 
volatile an issue with the anti-drug people.  It's a shame they 
can't distinguish between a small group of medically needy people 
and drug abusers." 
   Abrams' struggle has had an unfortunate side effect: It has 
discouraged others from applying. 
   "Political pressure has demoralized researchers," Doblin says.  
"It has made it hard to get money for research.  If Donald 
doesn't get permission, nobody is going to try." 
   Few issues besides abortion produce such distrust between 
camps.  Marijuana opponents say we can't say "no" to most drugs 
but "yes" to one.  They say there are enough medications on the 
market to provide relief.  Few politicians want to be viewed as 
being soft on drugs. 
   The marijuana proponents counter that the government policy is 
set by pharmaceutical manufacturers who stand to lose billions of 
dollars in anti-nausea drug sales to a plant they cannot patent.  
Proponents say medical professionals not bureaucrats, should 
decide health-care issues. 
   "They're probably right," says the federal health official, 
who asked for anonymity, "but until people convince their 
congressional representatives that the law needs to be changed, 
nothing will be done." 
   In 1988, after two years of public hearings, the DEA's own 
chief administrative law judge said the drug agency should 
rewrite its marijuana policy. 
   "It would be unreasonable, arbitrary and capricious for DEA to 
continue to stand between those sufferers and the benefit of this 
substance in light of the evidence of this record," Judge Francis 
L. Young said. 
 
MY FRIEND, who has never smoked a cigarette, didn't know how to 
inhale her marijuana.  We made a pipe by rolling aluminum foil 
into a tube, then bending one end up slightly.  We rolled some 
into joints. 
   After smoking a few puffs, or eating one of Corral's cookies, 
my friend had little nausea.  She could eat real food again. 
   In four weeks she regained her weight.  Her face was full, her 
cheeks pink.  Her eyes, which often seemed dull and half closed, 
were open and bright.  We drove home from the hospital without 
ever stopping again. 
   "If the government wants to find out whether marijuana can 
stop cancer patients and AIDS sufferers from throwing up and 
losing weight -- put them on a scale," Randall says. 
   Dorothy and Richard Haskell decided in March that breaking the 
law was preferable to watching Vicki suffer. 
   "We were always anti-drug," Dorothy says.  "It just wasn't the 
way we lived." 
   Vicki's pain medication had stopped working.  She couldn't 
sleep or keep food down.  The Haskells read about medical 
marijuana but didn't know where to find any until they read an 
article in which Imler was quoted. 
   When the Haskells stepped inside Imler's headquarters, they 
looked as if one more worry would break them.  From the parlor 
wafted the click of typewriter keys as Ed Frey, attorney and 
former D.A. candidate, worked in his office.  Imler gets free 
office space and a small salary to work as Frey's assistant.  The 
couple stammered nervously. 
   "Anyone who has ever had a child can tell you why we're here," 
Dorothy said.  "It breaks our hearts to see our daughter suffer." 
   "I just want her to be able to sleep, she's in so much pain," 
Richard said.  "It's our daughter, so as far as I'm concerned, 
I'm not doing anything illegal." 
   All day, Imler helps people like the Haskells, fields phone 
calls, teaches clients to grow pot for themselves, and solicits 
donations. 
   "We have an uneasy accommodation with local law enforcement 
here," he says.  "They know we're here, but so far we've been 
lucky." 
   Politicians know the voters in Santa Cruz County believe sick 
people should be allowed marijuana if they want it.  And Santa 
Cruz police say they are aware that medical marijuana proponents 
are active in town, but they are too busy to investigate the 
movement. 
   "We don't have enough personnel to enjoy the luxury of sitting 
around and wondering what they're doing," says deputy police 
chief Jeff Locke.  "But our feeling is still that it's against 
the law." 
   In March, Imler received a letter from Dr. Stephen Stein, 
medical director of the County of Santa Cruz Health Services 
Agency, asking him to provide marijuana to an AIDS patient. 
   "[The patient] reports using marijuana to treat symptoms of 
nausea and anorexia," Stein wrote.  "I have no objection to him 
using it for this purpose." 
   The local attitude makes District Attorney Art Danner wonder 
whether prosecuting a medical marijuana case would waste 
taxpayers money.  That's part of the reason he has declined to 
prosecute Valerie Corral both times sheriffs deputies arrested 
her. 
   A trial would cost thousands, and a loss would demoralize law 
enforcement. 
   "Hers was a difficult case," he says.  "I don't think I could 
get a jury to convict her.  It's a difficult situation here.  On 
the one hand, we have a lot of terminally ill people using it.  
On the other hand, we don't want everyone with a headache to use 
it." 
   Danner, a member of the National Association of District 
Attorneys' Executive Committee, has asked the group to take up 
the issue at its annual convention in July. 
   "I suggested we take a good look at the research and see 
whether it should be moved from the legal to medical 
jurisdiction," Danner says.  "I got a lot of interest from other 
D.A.s whose constituents are talking to them about this issue.  
They were more interested than I thought they'd be." 
   About the time the district attorneys meet, members of 
Californians for Compassionate Use will begin collecting the 
signatures of 433,000 registered voters.  The drive is being 
conducted by Ken Masterton, a political consultant who qualified 
recent successful propositions protecting mountain lions and 
increasing the tobacco tax. 
 
THE HASKELLS were unaware of the various political movements when 
they visited Imler in March. 
   To them, marijuana was a last resort; a trip to the downtown 
head shop for a pipe too strange to consider. 
   "Uh, no, please, we can't go in there," Dorothy begged. 
 
continued on page 22 
 
POT 
 
continued from page 19 
 
   Imler gave them joints instead of a pipe.  Richard held the 
sealed envelope and folded it in half.  He searched his pockets 
for a paper clip and nervously affixed the halves together.  He 
put the package in his pocket and realized the group had been 
watching him fumble. 
   "Oh, I don't know what I'm doing," he said. 
   Before leaving for their own nerve-racked drive home, the 
Haskells gave Imler a $50 bill.  It is a huge donation for a 
shoestring operation dependent upon the kindness of strangers.  
Timing was good.  Donations of pot and money are off.  Imler's 
stash has been of such bad quality lately that even home health-
care nurses have called to complain. 
   Back in Salinas, Vicki, who has two high school-age sons, 
attempted to try the marijuana.  Stigma proved a powerful 
deterrent. 
   "She didn't want to do it in front of her kids," Dorothy 
Haskell said.  "She's back in the hospital now, trying to get her 
pain medication  regulated.  I don't think she gave it a chance 
because she thought it was really wrong.  I even took a couple of 
puffs myself so she would think it was OK.  If your child is 
involved, you'll do anything." 
 
IN MID-APRIL Vicki Haskell turned worse.  After trying every pain 
medication prescribed by her doctor, she smoked the marijuana.  
After weeks of insomnia, she was able to sleep through the night.  
On April 12, Richard and Dorothy drove back to Santa Cruz to get 
more. 
   "Every time someone like that leaves, I say, Now I know why 
we're here," Imler says. 
   Dennis Peron reopened the buyers club a week after he closed 
it.  Martin Simmons was among the 1,500 first-day customers.  
Peron hopes drug agents won't show, and the DEA's Mike Herald 
declined to confirm whether Peron is being investigated.  If the 
DEA comes knocking, Peron threatens, agents will have to arrest 
all 4,000 members. 
   "Tell the jail to stock up on catheters and medical 
equipment," he says.  "The jail is going to be full of sick 
people. 
   Randall says the marijuana fight reminds him of the struggles 
of Galileo, the 16th-century astronomer.  Galileo saw craters on 
the moon, but the church replied the moon is perfect.  Look 
through the telescope, Galileo implored.  But the church said: 
No, it's an instrument of the devil. 
   "On the one hand, I'm more optimistic now than I've ever 
been," Randall says.  "AIDS patients have revitalized this 
movement around the world.  Still, bureaucrats resist, even under 
overwhelming evidence they are destroying people's lives." 
   And that, says Randall, is true reefer madness. 
   My friend recently learned that she is cancer-free for the 
first time in a decade.  Her doctor said part of the reason is 
that she kept on weight. 
   "You kept your strength up," he told her, "which allowed you 
to withstand the high doses.  I'm trying to determine what 
combination of chemicals may have caused that." 
   She hopes that someday she will find the courage to tell him. 
 
TRACIE CONE is a staff writer for West. 
 
Scott Imler has a toll-free number: (800) 355-0289.
</PRE>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-277</DOCNO>
<DOCOLDNO>IA087-000628-B025-88</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/lester.html 206.61.184.43 19970122060654 text/html 13483
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:06:43 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:53 GMT
Content-length: 13267
</DOCHDR>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>

<HEAD>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z">
<META NAME="AUTHOR" CONTENT="Carl E. Olsen">
</HEAD>

<BODY>

<H3>Commentary</H3>

<H2>Marihuana as Medicine</H2>

<H3>A Plea for Reconsideration</H3>

<P>
BETWEEN 1840 and 1900, European and American medical journals
published more than 100 articles on the therapeutic use of the
drug known then as Cannabis indica (or Indian hemp) and now as
marihuana. It was recommended as an appetite stimulant, muscle
relaxant, analgesic, hypnotic, and anticonvulsant. As late as
1913 Sir William Osler recommended it as the most satisfactory
remedy for migraine.
<P>
Today the 5000-year medical history of cannabis has been almost
forgotten. Its use declined in the early 20th century because
the potency of preparations was variable, responses to oral ingestion
were erratic, and alternatives became available -- injectable
opiates and, later, synthetic drugs such as aspirin and barbiturates.
In the United States, the final blow was struck by the Marihuana
Tax Act of 1937. Designed to prevent nonmedical use, this law
made cannabis so difficult to obtain for medical purposes that
it was removed from the pharmacopeia. It is now confined to Schedule
I under the Controlled Substances Act as a drug that has a high
potential for abuse, lacks an accepted medical use, and is unsafe
for use under medical supervision.
<P>
In 1972 the National Organization for the Reform of Marijuana
Laws petitioned the Bureau of Narcotics and Dangerous Drugs, later
renamed the Drug Enforcement Administration (DEA), to transfer
marihuana to Schedule II so that it could be legally prescribed.
As the proceedings continued, other parties joined, including
the Physicians Association for AIDS [acquired immunodeficiency
syndrome] Care. It was only in 1986, after many years of legal
maneuvering, that the DEA acceded to the demand for the public
hearings required by law. During the hearings, which lasted 2
years, many patients and physicians testified, and thousands of
pages of documentation were introduced. In 1988 the DEA's own
administrative law judge, Francis L. Young, declared that marihuana
in its natural form fulfilled the legal requirement of currently
accepted medical use in treatment in the United States. He added
that it was &quot;one of the safest therapeutically active substances
known to man.&quot; His order that the marihuana plant be transferred
to Schedule II was overruled, not by any medical authority, but
by the DEA itself, which issued a final rejection of all pleas
for reclassification in Mach 1992.
<P>
Meanwhile, a few patients have been able to obtain marihuana legally
for therapeutic purposes. Since 1978, legislation permitting patients
with certain disorders to use marihuana with a physician's approval
has been enacted in 36 states. Although federal regulations and
procedures made the laws difficult to implement, 10 states eventually
established formal marihuana research programs to seek Food and
Drug Administration (FDA) approval for Investigational New Drug
(IND) applications. These programs were later abandoned, mainly
because the bureaucratic burden on physicians and patients became
intolerable.
<P>
Growing demand also forced the FDA to Institute an Individual
Treatment IND (commonly referred to as a Compassionate IND) for
the use of physicians whose patients needed marihuana because
no other drug would produce the same therapeutic effect. The application
process was made enormously complicated, and most physicians did
not want to become involved, especially since many believed there
was some stigma attached to prescribing cannabis. Between 1976
and 1988 the government reluctantly awarded about a half dozen
Compassionate INDs for the use of marihuana. In 1989 the FDA was
deluged with new applications from people with AIDS, and the number
granted rose to 34 within a year. In June 1991, the Public Health
Service announced that the program would be suspended because
it undercut the administration's opposition to the use of illegal
drugs. After that no new Compassionate INDs were granted, and
the program was discontinued in March 1992. Eight patients are
still receiving marihuana under the original program; for everyone
else it is officially a forbidden medicine.
<P>
And yet physicians and patients in increasing numbers continue
to relearn through personal experience the lessons of the 19th
century. Many people know that marihuana is now being used illegally
for the nausea and vomiting induced by chemotherapy. Some know
that it lowers intraocular pressure in glaucoma. Patients have
found it useful as an anticonvulsant, as a muscle relaxant in
spastic disorders, and as an appetite stimulant in the wasting
syndrome of human immunodeficiency virus infection. It is also
being used to relieve phantom limb pain, menstrual cramps, and
other types of chronic pain, including (as Osler might have predicted)
migraine.2 Polls and voter referenda have repeatedly indicated
that the vast majority of Americans think marihuana should be
medically available.
<P>
One of marihuana's greatest advantages as a medicine is its remarkable
safety. It has little effect on major physiological functions.
There is no known case of a lethal overdose; on the basis of animal
models, the ratio of lethal to effective dose is estimated as
40,000 to 1. By comparison, the ratio is between 3 and 50 to 1
for secobarbital and between 4 and 10 to 1 for ethanol. Marihuana
is also far less addictive and far less subject to abuse than
many drugs now used as muscle re- <HR>

<H5>From the Department of Psychiatry, Harvard Medical School,
and the Massachusetts Mental Health Center, Boston.</H5>

<H5>Reprint requests to Harvard Medical School, 74 Fenwood Rd,
Boston, MA 02115 (Dr Grinspoon).</H5>
<HR>

<H4>JAMA, June 21, 1995 -- Vol. 273, No. 23 1875</H4>
<HR>

<P>
laxants, hypnotics, and analgesics. The chief legitimate concern
is the effect of smoking on the lungs. Cannabis smoke carries
even more tars and other particulate matter than tobacco smoke.
But the amount smoked is much less, especially in medical use,
and once marihuana is an openly recognized medicine, solutions
may be found. Water pipes are a partial answer; ultimately a technology
for the inhalation of cannabinoid vapors could be developed. Even
If smoking continued, legal availability would make it easier
to take precautions against aspergilli and other pathogens. At
present, the greatest danger in medical use of marihuana is its
illegality, which imposes much anxiety and expense on suffering
people, forces them to bargain with illicit drug dealers, and
exposes them to the threat of criminal prosecution.
<P>
The main active substance in cannabis, [delta-9]-tetrahydrocannabinol
([delta-9]-THC), has been available for limited purposes as a
Schedule II synthetic drug since 1985. This medicine, dronabinol
(Marinol), taken orally in capsule form, is sometimes said to
obviate the need for medical marihuana. Patients and physicians
who have tried both disagree. The dosage and duration of action
of marihuana are easier to control, and other cannabinoids in
the marihuana plant may modify the action of [delta-9]-THC. The
development of cannabinoids in pure form should certainly be encouraged,
but the time and resources required are great and at present unavailable.
In these circumstances, further isolation, testing, and development
of individual cannabinoids should not be considered a substitute
for meeting the immediate needs of suffering people.
<P>
Although it is often objected that the medical usefulness of marihuana
has not been demonstrated by controlled studies, several informal
experiments involving large numbers of subjects suggest an advantage
for marihuana over oral [delta-9]-THC and other medicines. For
example, from 1978 through 1986 the state research program in
New Mexico provided marihuana or synthetic [delta-9]-THC to about
250 cancer patients receiving chemotherapy after conventional
medications failed to control their nausea and vomiting. A physician
who worked with the program testified at a DEA hearing that for
these patients marihuana was clearly superior to both chlorpromazine
and synthetic [delta-9]-THC.3 It is true that we do not have studies
controlled according to the standards required by the FDA -- chiefly
because legal, bureaucratic, and financial obstacles are constantly
put in the way. The situation is ironical, since so much research
has been done on marihuana, often in unsuccessful attempts to
prove its dangerous and addictive character, that we know more
about it than about most prescription drugs.
<P>
Physicians should offer more encouragement to controlled research,
but it too has limitations. Individual therapeutic responses can
be obscured by the statistical results of group experiments in
which there is little effort to identify the specific features
of a patient that affect the drug response. Furthermore, much
of our knowledge of synthetic medicines as well as plant derivatives
comes from anecdotal evidence. For example, as early as 1976 several
small, methodologically imperfect, and relatively obscure studies
had shown that taking an aspirin a day could prevent a second
heart attack. In 1988 a large-scale experiment demonstrated dramatic
effects. This story is suggestive, because marihuana, like aspirin,
is a substance known to be unusually safe and to have enormous
potential health benefits.
<P>
Cannabis can also bring about immediate relief of suffering measurable
in a study with only one subject. In the experimental method known
as the single patient randomized trial, active and placebo treatments
are administered randomly in alternation or succession to a patient.
The method is often useful when large scale controlled studies
are impossible or inappropriate because the disorder is rare,
the patient is atypical, or the response to the treatment is idiosyncratic.
Many patients, either deliberately or because of unreliable supplies,
have informally carried out somewhat similar experiments by alternating
periods of cannabis use with periods of no use in the treatment
of various disorders.2(pp.133-135)
<P>
The American Medical Association was one of the few organizations
that raised a voice in opposition to the Marihuana Tax Act of
1937, yet today most physicians seem to take little active interest
in the subject, and their silence is often cited by those who
are determined that marihuana shall remain a forbidden medicine.
Meanwhile, many physicians pretend to ignore the fact that their
patients with cancer, AIDS, or multiple sclerosis are smoking
marihuana for relief; some quietly encourage them. In a 1990 survey,
44% of oncologists said they had suggested that a patient smoke
marihuana for relief of the nausea induced by chemotherapy.4 If
marihuana were actually unsafe for use even under medical supervision,
as its Schedule I status explicitly affirms, this recommendation
would be unthinkable. It is time for physicians to acknowledge
more openly that the present classification is scientifically,
legally, and morally wrong.
<P>
Physicians have both a right and a duty to be skeptical about
therapeutic claims for any substance, but only after putting aside
fears and doubts connected with the stigma of illicit nonmedical
drug use. Advocates of medical use of marihuana are sometimes
charged with using medicine as a wedge to open a way for &quot;recreational&quot;
use. The accusation is false as applied to its target, but expresses
in a distorted form a truth about some opponents of medical marihuana;
they will not admit that it can be a safe and effective medicine
largely because they are stubbornly committed to exaggerating
its dangers when used for nonmedical purposes.
<P>
We are not asking readers for immediate agreement with our affirmation
that marihuana is medically useful, but we hope they will do more
to encourage open and legal exploration of its potential. The
ostensible indifference of physicians should no longer be used
as a justification for keeping this medicine in the shadows.
<UL>
<LI>Lester Grinspoon, MD
<LI>James B. Bakalar, JD
</UL>
<HR>

<H5>1. In the Matter of Marijuana Rescheduling Petition, Docket
86-22, Opinion, Recommended Ruling, Findings of Fact, Conclusions
of Law, and Decision of Administrative Law Judge, September 6,
1988. Washington, DC: Drug Enforcement Agency; 1988.</H5>

<H5>2. Grinspoon L., Bakalar J. Marihuana, the Forbidden Medicine.
New Haven, Conn.: Yale University Press; 1993.</H5>

<H5>3. In the Matter of Marijuana Rescheduling Petition, Docket
86-22, Affidavit of Daniel Daneac, M.D. Washington, DC: Drug Enforcement
Agency; 1987.</H5>

<H5>4. Doblin R., Kleiman M.A.R. Marihuana as anti-emetic medicine:
a survey of oncologists' attitudes and experiences. J Clin Oncol,
1991;9:1275-1290. </H5>
<HR>

<H4>1876 JAMA, June 21, 1995 -- Vol. 273, No. 23</H4>
<HR>

<P>
 
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-278</DOCNO>
<DOCOLDNO>IA087-000628-B025-119</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/nida.html 206.61.184.43 19970122060710 text/html 8007
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:06:56 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:06:37 GMT
Content-length: 7792
</DOCHDR>
<HTML>
<PRE>
                                         Public Health Service
DEPARTMENT OF HEALTH & HUMAN SERVICES    National Institutes of Health
                                         National Institute on Drug Abuse
                                         5600 Fishers Lane
                                         Rockville, Maryland 20857


Dear Colleague:

I am very pleased to invite you to attend the National conference on 
Marijuana Use:  Prevention, Treatment, and Researh, sponsored by the 
National Institute on Drug Abuse (NIDA), National Institutes of Health 
(NIH).  This is the first national conference to focus on providing 
scientifically based information on marijuana to dispel myths, increase 
public awareness of the rising trends in marijuana use, and educate the 
public about the consequences of marijuana use, especially for young 
people.  Another purpose is to educate the drug abuse prevention and 
treatment communities about research results that can assist in prevention 
and treatment efforts.

This conference is one of the principal elements in the Marijuana 
Prevention Initiative, which the Secretary of the U.S. Department of 
Health and Human Services, Donna Shalala, announced last December when she 
released the results of the 1994 Monitoring the Future study.  It responds 
to the significant upturns in marijuana use among 8th, 10th, and 12th 
grade students.

The conference will present outcomes of NIDA/NIH research that focus on:  
Extent of the Problem; What Marijuana Is, What It Does, and Where It Acts; 
Consequenses of Marijuana Use; and Research-Based Prevention and Treatment 
Approaches.  Scientists, the public, and practitioners will exchange 
information that can be disseminated through the media, national 
organizations, educators, juvenile justice authorities, and State and 
local antidrug coalitions.

We are very concerned about the significant increased use of marijuana, 
especially by young people.  This conference will synthesize and begin to 
disseminate scientifically accurate information about the consequences of 
marijuana use.  We know it will be useful to all who attend.

I encourage you to attend the conference.

                                    Sincerely,
                                    Alan I. Leshner, Ph.D.
                                    Director
</PRE>
<HR>
<PRE>
               National Institute on Drug Abuse
             National Conference on Marijuana Use:
              Prevention, Treatment and Research

Tuesday, July 18, 1995
 5:00 p.m. - 7:00 p.m.     CONFERENCE REGISTRATION

Wednesday, July 19, 1995
 7:30 a.m.                 CONFERENCE REGISTRATION/
                           CONTINENTAL BREAKFAST

 8:45 a.m.- 10:00 a.m.     OPENING SESSION
                           Welcome and Remarks
                              Alan I. Leshner, Ph.D.
                              Director
                              National Institute on Drug Abuse
                           Keynote Addresses
                           The Department's Marijuana Prevention
                            Initiative
                              Donna Shalala, Ph.D.
                              Secretary of Health and Human Services

                           Marijuana Use and the National Drug
                           Control Strategy
                              Lee P. Brown, Ph.D.
                              Director
                              Office of National Drug Confrol Policy

10:00 a.m.- 10:45 a.m.     Changing Trends, Patterns and Nature of
                           Marijuana Use

                           National Marijuana Media Campaign

10:45 a.m. - 11:00 a.m.    BREAK

11:00 a.m. - 11:30 a.m.    Marijuana: What It Is and What It Does

11:30 a.m. - 12:30 p.m.    Effects of Marijuana on the Body

12:30 p.m. - 2:00 p.m.     LUNCHEON

 2:00 p.m. - 3:15 p.m.     Consequences of Marijuana Use

 3:15 p.m. - 3:30 p.m.     BREAK

 3:30 p.m. - 4:30 p.m.     Concurrent Workshops

 4:30 p.m. - 5:30 p.m.     Antecedents to Marijuana Use and
                           Familial Transmission

 5:30 p.m. - 6:15 p.m.     The Natural History of Marijuana Use:
                           From Initiation to Dependence

 6:30 p.m. - 7:30 p.m.     RECEPTION
</PRE>
<HR>
<PRE>
Thursday, July 20, 1995
 7:00 a.m. - 8:30 a.m.     CONTINENTAL BREAKFAST

 8:30 a.m. - 9:45 a.m.     Preventing Marijuana Use

 9:45 a.m.- 10:00 a.m.     BREAK

10:00 a.m. - 11:00 a.m.    Treatment Strategies for Marijuana Use:
                           Adults and Adolescents

11:00 a.m. - 12:00 p.m.    Relationship Between Marijuana Use
                           and the Use of Other Drugs, and Other
                           Antisocial Problem Behaviors

12:00 p.m. - 1:00 p.m.     LUNCH (on your own)

 1:00 p.m. - 2:00 p.m.     Concurrent Worhshops

 2:00 p.m. - 3:00 p.m.     Behavioral Effects: Motivation,
                           Cognition, Intellectual Performance

 3:00 p.m. - 3:15 p.m.     BREAK

 3:15 p.m. - 4:30 p.m.     Marijuana Use and Performance

 4:30 p.m. - 5:00 p.m.     CLOSING SESSION

                     Conference Location:
                  Crystal City Marriott Hotel
                 1999 Jefferson Davis Highway
                     Arlington, VA 22202
                        703/413-5500

Registration Fee:  The registration fee for the conference is $75.00.
After June 30, 1995 registration fee will be $100.00.  This fee covers
continental breakfast each morning, lunch and reception on Wednesday,
and a copy of the Proceedings.

Credits:  CEU credits will be accepted through the Georgetown University
Hospital.  Applications will be available at the conference.

Confirmation:  A registratIon confirmation package will be sent to
registrants by Circle Solutions for all registrations received before
July 5, 1995.

Cancellation Policy:  All cancellatIons must be in writing.  Full refunds
will be made if request is postmarked on or before July 10, 1995.  After
that date, no portion of the registratIon fee can be refunded.  Refunds
will be mailed 30 days after the conference.
</PRE>
<HR>
<PRE>
Lodging:  Special room rates have been negotiated at the Crystal City
Marriott Hotel.

Rates:  Single $114.00      Double $114.00
Cutoff Date:  Friday, June 30, 1995.  After this date the conference rate
may not be available.

Reservations:  Call 703/413-5500 and indicate to the reservationist that
you are attending the National Institute on Drug Abuse, National
Marijuana Conference.

Confirmation:  The Crystal City Marriott will send you a written
confirmation of your hotel reservation only if requested.  We advise you
to request a written confirmation and obtain a confirmation number
from the reservationist when you make the reservation.

Travel:  You are welcome to consider Cahan Travel Management (CTM),
subcontracted to Circle Solutions, Inc., to make your travel arrangements.
CTM has negotiated special rates for this conference.  Tickets must be
purchased seven days in advance.

To book your flights with CTM please call our travel agents Mary
Maybach or Christine Adams, at 800/356-3174 or 703/893-3240 between
9:00 a.m. and 5:00 p.m. eastern time.



For further logistical information contact:

          Karen Tyler-Barnes
          Logistics Coordinator
          Circle Solutions, Inc.
          9201 Greensboro Drive, Suite 600
          McLean, VA 22102

          703/821-8955 ext. 440
          703/921-2098 (fax)
          <A HREF="mailto:CIRCCONF@dgs.dgsys.com">CIRCCONF@DGS.DGSYS.COM</A> (Internet)
</PRE>
</HTML>


</DOC>
<DOC>
<DOCNO>WT01-B18-279</DOCNO>
<DOCOLDNO>IA087-000628-B025-151</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/seeley.html 206.61.184.43 19970122060749 text/html 812
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:07:16 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:05:50 GMT
Content-length: 598
</DOCHDR>
<HTML><H4><CENTER>SUPERIOR COURT OF THE STATE OF WASHINGTON<BR>
COUNTY OF PIERCE<BR>
No. 94-2-11862-1<P>
RALPH SEELEY, Plaintiff,<BR>
vs.<BR>
THE STATE OF WASHINGTON, Defendant.<P>
PLAINTIFF'S BRIEF SUPPORTING SUMMARY JUDGMENT OF DECLARATION<BR>
THAT LISTING MARIJUANA AS "SCHEDULE I" UNDER RCW 69.50.204<BR>
IS A VIOLATION OF THE WASHINGTON CONSTITUTION<P>
<A HREF = "seeley-1.html">Click here for part 1</A><BR>
<A HREF = "seeley-2.html">Click here for part 2</A></CENTER></H4>
<PRE>
					RALPH SEELEY, WSBA 22469
                                        (pro se)
</PRE>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-280</DOCNO>
<DOCOLDNO>IA087-000628-B025-235</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/nejm.html 206.61.184.43 19970122060842 text/html 7957
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:08:34 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:31 GMT
Content-length: 7742
</DOCHDR>
<HTML>
<HEAD>
<TITLE>THE NEW ENGLAND JOURNAL OF MEDICINE, Sept. 7, 1995, Page 670</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" VLINK="#FF0000" ALINK="#FF00FF">
<FONT SIZE=+2><CENTER><B>MARIJUANA, THE AIDS WASTING SYNDROME,
<BR>AND THE U.S. GOVERNMENT</B></CENTER></FONT> 
 
<FONT SIZE=+1><P><DD><I>To the Editor:</I>&nbsp;  Evidence of the therapeutic value and limited toxicity of marijuana in the treatment of various symptoms and syndromes is rapidly accumulating.&nbsp;  Patients with glaucoma, migraine, epilepsy, multiple sclerosis paraplegia, quadriplegia, the AIDS wasting syndrome, or nausea and vomiting due to chemotherapy for cancer have risked severe penalties to acquire cannabis, because they find it more useful than legally available medicines.<SUP><SMALL><A HREF="#1">1</A>,<A HREF="#2">2</A></SMALL></SUP>&nbsp;  The U.S. government has consistently refused to permit prescription sales of marijuana, insisting that the evidence of its safety and efficacy is inadequate. 
<BR><DD>In response to a lawsuit brought by advocates of the medical use of marijuana, an administrative law judge with the Drug Enforcement Administration (DEA) recommended in 1988 that the federal legal classification of marijuana be changed so that physicians can prescribe     it.<SUP><SMALL><A HREF="#3">3</A></SMALL></SUP>&nbsp;  The DEA did not implement the recommendation.&nbsp;  In 1992, Richard Bonner, then DEA administrator, offered this suggestion: "Those who insist that marihuana has medical uses would serve society better by promoting or sponsoring more legitimate scientific research, rather than throwing their time, money, and rhetoric into lobbying, public relations campaigns, and perennial litigation."<SUP><SMALL><A HREF="#4">4</A></SMALL></SUP> 
<BR><DD>Encouraged by this declaration, Donald Abrams, of the University of California, San Francisco, sought permission to conduct a privately financed pilot study comparing three potencies of inhaled marijuana (high, medium, and low) with oral delta-9-tetrahydrocannabinol (dronabinol) capsules, which are available by prescription in the United States, for the treatment of weight loss associated with the AIDS wasting syndrome.&nbsp;  Dr. Abrams's protocol (Investigational New Drug No. 43,542) was designed in consultation with the Food and Drug Administration (FDA) and approved by the FDA, the University of California, San Francisco, institutional review board, the California Research Advisory Panel, and the scientific advisory committee of the San Francisco Community Consortium. 
<BR><DD>Unfortunately, the U.S. government will not allow Dr. Abrams to obtain a legal supply of marijuana.&nbsp;  The DEA refused to permit him to import marijuana from Hortapharm, a company licensed by the government of the Netherlands to cultivate cannabis for botanical and pharmaceutical research.&nbsp;  The National Institute on Drug Abuse (NIDA), which controls the domestic supply of marijuana for clinical research, rejected Dr. Abrams's request in April 1995.&nbsp;  The letter of rejection, from NIDA director Alan I. Leshner, was sent nine months after Dr. Abrams had submitted his request. 
<BR><DD>Given the limited sources of support for research on marijuana 
(pharmaceutical companies, for example, are not interested in supporting such research), the U.S. government by now should have taken note of the increasingly persuasive therapeutic claims and sponsored its own clinical trials through the National Institutes of Health.&nbsp;  Instead, as Dr. Bonner's remark and the handling of Dr. Abrams's protocol indicate, the government has responded by urging others to investigate the medical potential of marijuana and then creating obstacles that make the research impossible to pursue.</FONT> 
<P>
<TABLE WIDTH=100%>
<TR><TD><DIV ALIGN=left><FONT SIZE=+1><BR><BR>
Boston, MA 02115</FONT></DIV></TD><TD><DIV ALIGN=right><FONT SIZE=+1>LESTER GRINSPOON, M.D.
<BR>JAMES B. BAKALAR
<BR>Harvard Medical School&nbsp;</FONT></DIV></TD></TR>
</TABLE>
<P>
<TABLE WIDTH=100%>
<TR><TD><DIV ALIGN=left><FONT SIZE=+1><BR><BR>
Cambridge, MA 02138</FONT><DIV></TD><TD><DIV ALIGN=right><FONT SIZE=+1>RICK DOBLIN
<BR>John F. Kennedy
<BR>School of Government&nbsp;</FONT></DIV></TD></TR>
</TABLE></FONT>
<P> 
<OL>
<A NAME="1"><LI></A>Grinspoon L, Bakalar JB.&nbsp;  Marihuana, the forbidden medicine.&nbsp;  New Haven:  Yale University Press, 1993. 
<A NAME="2"><LI></A><I>Idem</I>.&nbsp;  Marihuana as medicine: a plea for 
reconsideration.&nbsp;  JAMA 1995;273:1875-6. 
<A NAME="3"><LI></A>Young FL.&nbsp;  Opinion and recommended ruling, 
marijuana rescheduling petition.&nbsp;  Department of Justice, Drug 
Enforcement Administration.&nbsp;  Docket 86-22.&nbsp;  Washington, D.C.:  
Drug Enforcement Administration, September 1988. 
<A NAME="4"><LI></A>Marijuana scheduling petition: denial of petition: remand.&nbsp;  Fed Regist 1992;57:10503. 
</OL>
<P><FONT SIZE=+1> 
<BR><DD><I>Editor's note:</I> Drs. Leshner and Abrams were offered the 
opportunity to respond.&nbsp;  Dr. Leshner declined to do so.&nbsp;  Dr. 
Abrams's reply follows. 
 
<P><DD><I>To the Editor:</I> The San Francisco Community Consortium is an 
association of providers of care for patients infected with the human immunodeficiency virus (HIV) in the San Francisco Bay area.&nbsp;  The consortium conducts community-based clinical trials of therapies of potential benefit to our patients.&nbsp;  Inhaled marijuana is being used increasingly by people with HIV infection, especially for its purported benefit as an anti-emetic agent and an appetite stimulant in those with the AIDS wasting syndrome.&nbsp;  Up to 2000 people infected with HIV are reported to be obtaining marijuana at a cannabis buyer's club in our area.&nbsp;  The California State Assembly has recently endorsed legislation to make medicinal marijuana available to patients with life-threatening illnesses. 
<BR><DD>In an effort to determine whether inhaled marijuana is truly of any potential benefit and, more important, to evaluate its safety in people with AIDS, the Community Consortium designed a pilot study.&nbsp;  We thought it would be appropriate to conduct a small study of the overall feasibility of investigating inhaled marijuana use by such patients, before embarking on a full-scale trial of its efficacy.&nbsp;  The pilot-drug-evaluation staff at the FDA provided valuable comments on the design of the protocol.&nbsp;  
Pulmonary-function tests, lymphocyte-sub-group analyses, and measurements of viral burden by the branched-DNA technique were to be performed serially for safety.&nbsp;  Body composition was to be measured by state-of-the-art techniques to assess potential trends in the amelioration of wasting. 
<BR><DD>The FDA and the institutional review board supported the study.&nbsp;  Unfortunately, the DEA and the NIDA opposed it.&nbsp;  Most 
disturbing was the absence of a response from either agency for an unacceptably long period, followed by the NIDA's outright rejection of the proposal without any opportunity for dialogue or compromise.&nbsp;  Such behavior is offensive not only to the investigators but to the patients for whom we seek to find safe and effective treatments.</FONT> 
<P> 
<TABLE WIDTH=100%>
<TR><TD><DIV ALIGN=left><FONT SIZE=+1><BR><BR><BR><BR>
San Francisco, CA 94143</FONT></DIV></TD>
<TD><DIV ALIGN=right><FONT SIZE=+1>DONALD I. ABRAMS, M.D.
<BR>CARROLL C. CHILD, R.N., M.S.
<BR>THOMAS F. MITCHELL, M.P.H.
<BR>University of California 
<BR>San Francisco&nbsp;</FONT></DIV></TD></TR>
</TABLE>
<P><I>New England Journal of Medicine
<BR>Sept. 7, 1995
<BR>Vol. 333&nbsp;  No. 10&nbsp;  pp. 670-671</I>
</BODY>
</HTML>

</DOC>
<DOC>
<DOCNO>WT01-B18-281</DOCNO>
<DOCOLDNO>IA087-000632-B043-48</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/grubor.html 206.61.184.43 19970122072444 text/html 28813
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:24:34 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:05:28 GMT
Content-length: 28597
</DOCHDR>
<HTML>
<HEAD><TITLE>Grubor v. Pennsylvania - October 1995</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000" LINK="#0000FF" VLINK="#FF0000" ALINK="#FF00FF">
<CENTER><B><FONT SIZE=3>No: __________</FONT></CENTER><P><HR>
<CENTER><FONT SIZE=3>IN THE</FONT><BR>
<FONT SIZE=5>SUPREME COURT OF THE UNITED STATES</FONT><BR>
<FONT SIZE=3>OCTOBER TERM, 1995</FONT></CENTER><HR><P>
<FONT SIZE=3><CENTER>JOHN M. GRUBOR,</CENTER>
<CENTER>Petitioner,</CENTER><P>

<CENTER>vs.</CENTER><P>

<CENTER>THE COMMONWEALTH OF PENNSYLVANIA<BR>
DEPARTMENT OF TRANSPORTATION<BR>
BUREAU OF DRIVER LICENSING,</CENTER>
<CENTER>Respondent.</CENTER><P>
<HR>
<CENTER>ON PETITION FOR WRIT OF CERTIORARI TO THE<BR>
SUPREME COURT OF PENNSYLVANIA</CENTER>
<HR>
<FONT SIZE=4><CENTER>PETITION FOR WRIT OF CERTIORARI</CENTER></FONT>
<HR><P>
<CENTER>Filed <I>pro se</I> by:<P>

<A HREF="mailto:drg@pgh.org">John M. Grubor</A>, J.D.<BR>
P.O. Box 114<BR>
E. McKeesport, Pa. 15035<P>


<I>Petitioner</I></CENTER>
<HR>
<CENTER>QUESTIONS PRESENTED FOR REVIEW</CENTER>
<P>
1. Whether a State Court may rule that a Sanction (Driver's License Suspension) passed under a "Crimes Code" is merely a "collateral civil consequence" or an "additional civil penalty," thereby depriving a Defendant of his 5th Amendment Constitutional Rights, by being given the cruel and unusual punishment of being twice placed in jeopardy for the same offense, and being deprived of his liberty and property without Due Process of Law.
<P>
2. Whether a State may deny Due Process of Law to a Defendant who has executed a plea bargain, by later demanding additional Penalties (Driver's License Suspension and over $10,000 in costs) which were not disclosed to the Defendant at the time of the court colloquy on the plea bargain agreement.
<P>
3. Whether a Defendant is denied Due Process of Law by being required to present his entire case within less than five minutes.  (Defendant's entire Defense case is on pages 5 to 10 of the Lower Court Transcript.)
<P>
4. Whether a State may deprive a Defendant of his Liberty and inflict Cruel and Unusual Punishment (Driver's License Suspension) for a Defendant's justifiable use (Medical Necessity) of a controlled substance (Cannabis) which had nothing to do with an automobile or the State Motor Vehicle Code, and whether Due Process demands that the defense of "justification" be available at all proceedings that are derived from the original criminal conviction.
<P>
5. Whether a State may refuse to issue an "Occupational Limited License" thereby denying the fundamental right of Liberty to a Defendant who is in a "suspect class" of "Medical Necessity Users of a Controlled Substance," who's actions are "Justified" under Common Law, the Pennsylvania State Law and section 503 of the Model Penal Code, and whether Due Process demands that the "justification" defense be available at all proceedings that are derived from the original conviction.
<P>
<CENTER>(i)</CENTER><HR>
<PRE>
                      TABLE OF CONTENTS

ITEM                                                        PAGE

TABLE OF AUTHORITIES........................................ iii

OPINIONS BELOW..............................................   2

JURISDICTION................................................   2

CONSTITUTIONAL PROVISIONS AND STATUTES INVOLVED.............   2

STATEMENT OF THE CASE.......................................   3

REASONS FOR GRANTING THE WRIT...............................   5

     STATE vs. STATE CONFLICT...............................   5

     STATE COURTS DECIDE IMPORTANT QUESTION OF
     FEDERAL LAW THAT SHOULD BE SETTLED BY THIS COURT.......   7

     STATE SUPREME COURT DECIDES A QUESTION OF
     FEDERAL LAW IN A WAY THAT CONFLICTS WITH
     APPLICABLE UNITED STATES SUPREME COURT DECISIONS.......   7

CONCLUSION..................................................  11

APPENDIX:                                                EXHIBIT

TRIAL COURT TRANSCRIPT......................................   A

OPINION OF THE TRIAL COURT..................................   B

ORDER OF THE TRIAL COURT....................................   C

OPINION OF THE COMMONWEALTH COURT OF PENNSYLVANIA...........   D

ORDER OF THE COMMONWEALTH COURT OF PENNSYLVANIA.............   E

ORDER OF THE SUPREME COURT OF PENNSYLVANIA..................   F

PRIMARY STATUTE AT ISSUE....................................   G

SECONDARY STATUTE AT ISSUE..................................   H

CALIFORNIA "SMOKE A JOINT, LOSE YOUR LICENSE" LAW...........   J

MARIJUANA POLICY PROJECT PUBLICATION........................   K

<CENTER>(ii)</CENTER><HR>
                       TABLE OF AUTHORITIES

ITEM                                                            PAGE(S)

CASES:

<I>Duffey v. Department of Transportation, Bureau of Driver</I>>
<I>Licensing,</I> 639 A.2d 1174, <I>cert. Denied (pre Kurth Ranch),</I>
513 U.S. ___, 115 S.Ct. 223 (1994)............................      6,7

<I><a href="../NORML/LAWS/hills.html">WANDA JOY HILLS vs. IOWA DEPARTMENT OF
TRANSPORTATION AND MOTOR VEHICLE DIVISION</A></I>
at IOWA SUPREME COURT DOCKET No. 111/94-453
(Filed July 14, 1995 -- slip not yet published.)..............        6

<I>Plowman v. Department of Transportation, Bureau of Driver</I>
<I>Licensing,</I> 535 Pa. 314, 635 A.2d 124 (1993) .................. 7,8,9,11

<I>United States v.Halper,</I> 490 U.S. 435, 109 S.Ct. 1892 (1989)... 7,8,9,11

<I>Montana v. Kurth Ranch,</I> ___ U.S. ___, 114 S.Ct. 1937 (1994)...        7

<I>Wylie v Department of Transportation, Bureau of Driver</I>
<I>Licensing,</I> 638 A.2d 433 (Pa. Cmwlth. 1994)....................        8


JURISDICTION: ................................................        2


CONSTITUTIONAL PROVISIONS:

     UNITED STATES CONSTITUTION -- AMENDMENT V................        2

     UNITED STATES CONSTITUTION -- AMENDMENT VIII.............        3

STATUTES INVOLVED:

     PRIMARY STATE STATUTE AT ISSUE...........................        3

     SECONDARY STATE STATUTE AT ISSUE.........................        3

     UNITED STATES CODE TITLE 28 SECTION 1257.................        2

<CENTER>(iii)</CENTER></PRE><HR>
<CENTER><FONT SIZE=3>IN THE</FONT><BR>
<FONT SIZE=5>SUPREME COURT OF THE UNITED STATES</FONT><BR>
<FONT SIZE=3>OCTOBER TERM, 1995</FONT></CENTER><P>
<CENTER><B><FONT SIZE=3>No: __________</FONT></CENTER><P>
<FONT SIZE=3><CENTER>JOHN M. GRUBOR,</CENTER>
<CENTER>Petitioner,</CENTER><P>

<CENTER>vs.</CENTER><P>

<CENTER>THE COMMONWEALTH OF PENNSYLVANIA<BR>
DEPARTMENT OF TRANSPORTATION<BR>
BUREAU OF DRIVER LICENSING,</CENTER>
<CENTER>Respondent.</CENTER><P>
<HR>
<CENTER>ON PETITION FOR WRIT OF CERTIORARI TO THE<BR>
SUPREME COURT OF PENNSYLVANIA</CENTER>
<HR>
<FONT SIZE=4><CENTER>PETITION FOR WRIT OF CERTIORARI</CENTER></FONT>
<HR><P>

Petitioner, JOHN M. GRUBOR, J.D. respectfully requests that a Writ of Certiorari issue to review the Judgment and Order of the Supreme Court of Pennsylvania denying Petitioner's Allocatur Petition for Allowance of Appeal from the Judgment and Order of the Commonwealth Court of Pennsylvania.<P>

<CENTER>1</CENTER><HR>

<CENTER>OPINIONS BELOW</CENTER><P>

On November 4, 1993, after a five minute hearing, the Trial Court upheld the
suspension of Petitioner's Driver's license for an offense that had nothing to do with the Motor Vehicle Code. The Opinion of the Trial Court is attached to this Petition in the appendix, infra, and labeled as "Exhibit B." The Petitioner filed a timely appeal to the Commonwealth Court of Pennsylvania. The Opinion and Order of the Commonwealth Court are also in the appendix and labeled Exhibits "D" and "E," respectively. The Order of the Supreme Court of Pennsylvania, denying a review of the Commonwealth Court decision, is also attached in the appendix and labeled as "Exhibit F."<P>

<CENTER>JURISDICTION</CENTER><P>

The Petitioner filed a timely Allocatur Petition for Allowance of Appeal to the Supreme Court of Pennsylvania, and on July 18, 1995, the Pennsylvania
Supreme Court denied Petitioner's Petition. The jurisdiction of this Honorable Supreme Court of the United States to review the final order of a State Supreme Court is vested in Title 28 UNITED STATES CODE Section 1257 and United States Supreme Court Rule 13. Thereby, Petitioner has 90 days from the State Supreme Court's Decision date within which to file a Petition for Certiorari.<P>

<CENTER>CONSTITUTIONAL PROVISIONS AND STATUTES INVOLVED</CENTER><P>

There are two Constitutional Provisions involved in the instant case. They are:<P>

"United States Constitution, Amendment V<BR>
No person shall be held to answer for a capital, or otherwise infamous crime, unless on a presentment or indictment of a grand jury, except in cases arising in<P>

<CENTER>2</CENTER><HR>

the land or naval forces, or in the militia, when in actual service in time of war or public danger; nor shall any person be subject for the same offense to be twice put in jeopardy of life or limb; nor shall be compelled in any criminal case to be a witness against himself, nor be deprived of life, liberty, or property, without due process of law; nor shall private property be taken for public use, without just compensation," and,<P>

"United States Constitution, Amendment VIII<BR>
Excessive bail shall not be required, nor excessive fines imposed, nor cruel and unusual punishments inflicted."<P>

There are two statutes involved in the instant case. The Primary Statute is the Pennsylvania State Controlled Substance Act, 35 P.S. section 780-113(m) which mandated a driver's license suspension for any conviction under the State Controlled Substance Act, the verbatim text of which is set forth in the Appendix, and marked as "Exhibit G."<P>

The Secondary Statute involved is of the Pennsylvania State Motor Vehicle Code, 75 Pa.C.S. Section 1553, which excludes the Petitioner from eligibility for the issuance of an "Occupational limited license," the verbatim text of which is set forth in the Appendix, and marked as "Exhibit H."<P>

<CENTER>STATEMENT OF THE CASE</CENTER><P>

This Case involves the bona fide medical use of a controlled substance
(Cannabis) for a "life or death" medical necessity. In January of 1982, Petitioner had an auto accident in which he received a severe impact injury to his head. Thereafter, Petitioner began having bloody nocturnal epileptic seizures. For almost five years, Petitioner was treated with Dilantin and other prescription drugs by three different Neurologists, but none of the Physicians or prescription drugs were able to stop the Petitioner's bloody seizures. Because of the<P>

<CENTER>3</CENTER><HR>

nocturnal seizures, Petitioner was in fear of his death for two reasons. The first was the possibility of ending a seizure on his back and thereby suffocating on the "swallowing of the tongue" effect. But he was also fearing death from "drowning in his own blood." On many a morning, Petitioner woke up with blood all over his pillow and sheets. His tongue was severely bitten into on both sides and the taste of blood would last for days. Sometime it would take weeks for the tongue to heal and the pain resulting from the back spasms during the seizures would last for months. In 1986, Petitioner read a book by a Harvard Physician, Dr. Lester Grinspoon, and the medical literature indicated that Cannabis was the only known substance to actually stop epileptic seizures from occurring.<P>

Because Petitioner had "no legal alternative," he began using Cannabis for his life threatening medical necessity in late 1986, and he has had no seizures ever since. In the spring of 1991, Petitioner was charged with the possession of 1/3 ounce the controlled substance Cannabis, and in March of 1992, Petitioner plead guilty to "possession" of Cannabis. The trial court was aware of the Petitioner's claim of a "medical necessity," and a plea bargain of "one year probation with NO other penalty" was agreed to by the parties. Neither during the plea bargain discussions with the Prosecution nor during the Trial Court Colloquy on the guilty plea was there ever any discussion of any "additional penalty" of a driver's license suspension, and the Petitioner was not aware of any "additional penalty." If Petitioner had been aware of an "additional penalty" at the time of the plea, he would not have entered into the plea bargain agreement with the Prosecutor.<P>

In April 1992, when the Pennsylvania Department of Transportation's Bureau of Driver Licensing tried to suspend Petitioner's Driver's License, Petitioner filed a Statutory Appeal and was then scheduled for a <I>de novo</I> hearing on November 4, 1992. Before beginning the hearing, Petitioner was told by the Court "tipstaff" that he would be allowed only FIVE minutes to present his entire defense case to the trial court, and because of that pre-set limitation, Petitioner was not able to
call any other witnesses to testify but himself. Petitioner's defense began on page five of the hearing transcript. (See "Exhibit A" for the relevant sections of<P>

<CENTER>4</CENTER><HR>

the trial transcript.) Although Petitioner had five separate arguments to present, for the convenience of the Trial Court he told the Judge (page 6 of the transcript) that he would "get them in in five minutes." Only three minutes later, (at page 9 of the Transcript) the Judge said to the Petitioner: "Finish up, please." Petitioner's entire defense is contained in pages 5 to 10 of the trial transcript which is attached in the Appendix to this Petition and marked as "Exhibit A."<P>

Petitioner thereafter filed a timely appeal to the Commonwealth Court of
Pennsylvania, and on October 28, 1994, the Commonwealth Court rendered an
opinion on Petitioner's appeal, hereafter attached in the appendix to this Petition and marked as "Exhibit D." Thereafter, Petitioner filed a timely petition for reconsideration, which was denied. Finally, Petitioner filed an Allocatur Petition for Allowance of Appeal to the Supreme Court of Pennsylvania which was denied on July 18, 1995. This Certiorari Petition now requests a review of that Order.<P>

<CENTER>REASONS FOR GRANTING THE WRIT</CENTER><P>

Under Rule 10 of the U.S. Supreme Court rules, there are stated three main
"characters of compelling reasons" which are considered by this Honorable
Supreme Court of the United States when considering review on a Writ of
Certiorari. Both the second and the third "characters of compelling reasons" are applicable to the instant case, and the third character is twice applicable.<P>

FIRST REASON FOR GRANTING THE WRIT:<BR>
STATE vs. STATE CONFLICT.<P>

The second character of "compelling reason" stated in Rule 10 is when:<BR>
"A state court of last resort has decided a federal question in a way that conflicts with the decision of another state court of last resort or of a United States Court of appeals;" That is exactly what has occurred in the instant case. Because of some 1989 Federal mandates to the States (updated Code found at Title 23 U.S.C. section 159), all 50 of the United States have been mandated to pass<P>

<CENTER>5</CENTER><HR>

some kind of "smoke a joint, lose your license" law to keep their share of
Federal Highway funds. The 50 different states have responded in scores of different ways (See Marijuana Policy Project Article at Exhibit K) and over 31 states have "opted-out" by legislative vote, and have decided to forego Federal Highway funds in amounts of up to $100 million dollars a year. (See 1995 California "Smoke a Joint, Lose your License Law" in Appendix as "Exhibit J) This option by the California Legislature creates a great indication of the "peoples' view" of these license suspension regulations' constitutionality or fairness, and the Courts of the States are just as divided.<P>

At the present time, only 18 States have opted to continue to follow this Federal mandate (See MPP Article, Exhibit K) and in the States that have, the States' Supreme Courts have been just as divided when rendering opinions directly opposite to other State Courts. The crux of the matter at issue in the instant case is whether Petitioner's driver's license suspension, as mandated by the Pennsylvania State Crimes Code, is actually a "criminal penalty" or a "collateral civil consequence" from which he is entitled to no constitutional protections. In the case at bar, the highest State Court of Pennsylvania has held the later, thus denying the Petitioner his constitutional rights in the instant driver's license suspension case. See <I>Duffey v. Department of Transportation, Bureau of Driver Licensing,</I> 639 A.2d 1174 (1994). But other State Courts have held that this type of driver's license suspension was a "criminal penalty" and therefore any proceedings must be subjected to all Constitutional rights protections. See the very recent IOWA Supreme Court Decision in <I><a href="../NORML/LAWS/hills.html">WANDA JOY HILLS vs. IOWA DEPARTMENT OF TRANSPORTATION AND MOTOR VEHICLE DIVISION</A></I> at No. 111/94-453 (Filed July 14, 1995 -- slip opinion not yet published.)<P>

The third "compelling reason" stated in U.S. Supreme Court Rule 10 is when:<BR>
"A state court ... has decided an important question of federal law that has not been, but should be, settled by this Court, OR has decided a federal question in a way that conflicts with applicable decisions of this Court." BOTH are true in the case at bar.<P>

<CENTER>6</CENTER><HR>

SECOND REASON FOR GRANTING THE WRIT:<BR>
STATE COURTS DECIDE IMPORTANT QUESTION OF<BR>
FEDERAL LAW THAT SHOULD BE SETTLED BY THIS COURT.<P>

Initially, the very important decision of federal law, concerning the
"constitutional rights applicability" to "federally mandated driver's license suspensions," has never been considered or decided by this Honorable Supreme Court of the United States. This may well be a 10th Amendment issue in all 50 States that sorely needs to be addressed and decided as quickly as possible. The backlog of criminal cases that this Federal driver's license mandate has created is a major national problem (See MPP article at Exhibit K) and it has all been caused by the Federal Statute at Title 23 U.S.C. Section 159, the constitutionality of which Statute has never been decided by this Honorable Court. However, that does not preclude this Honorable Supreme Court of the United States from taking plenary jurisdiction <I>ab initio.</I><P>

THIRD REASON FOR GRANTING THE WRIT:<BR>
STATE SUPREME COURT DECIDES A QUESTION OF FEDERAL LAW IN A WAY<BR>
THAT CONFLICTS WITH APPLICABLE UNITED STATES SUPREME COURT<BR>
DECISIONS.<P>

The second half of the U.S. Supreme Court's Rule 10 "third compelling reason
criteria" is the most applicable in the instant case, because the Pennsylvania Supreme Court's decisions in <I>Duffey v. Department of Transportation, Bureau of Driver Licensing,</I> 536 Pa. 436, 639 A.2d 1174, <I>cert. denied (pre Kurth Ranch),</I> 513 U.S. ___, 115 S.Ct. 223, 130 L.Ed.2d 149 (1994) and <I>Plowman v. Department of Transportation, Bureau of Driver Licensing,</I> 535 Pa. 314, 635 A.2d 124 (1993) (1994) (which were cited by the Commonwealth Court of Pennsylvania in deciding the instant case -- See opinion in Appendix as Exhibit D) are in DIRECT conflict with the recent United States Supreme Court decisions in <I>United States v. Halper,</I> 490 U.S. 435, 104 L.Ed 2d 487, 109 S.Ct. 1892 (1989) and <I>Montana v. Kurth Ranch,</I> ___ U.S. ___, 114 S.Ct. 1937 (1994).<P>

<CENTER>7</CENTER><HR>

The recent Pennsylvania Commonwealth Court case of <I>Wylie v Department of Transportation, Bureau of Driver's Licensing,</I> 638 A.2d 433 (Pa. Cmwlth. 1994) points out the major problem in the case at bar, and a reading of that Court's opinion and it's following of the <I>Plowman</I> case, id, points out the gross conflict between the Pennsylvania Case Law in <I>Plowman</I> and this Honorable United States Supreme Court's controlling Federal Law decision rendered in <I>U.S. v  Halper,</I> id. In <I>Wylie,</I> id, at pg. 435, when considering the "primary statute at issue" in the instant case, the Pennsylvania Commonwealth Court Held:<P>

<BLOCKQUOTE>"The due process constitutional challenge raised by Wylie is controlled by<BR>
our Supreme Court's recent decision in <I>Plowman,</I> id.... -- the Supreme<BR>
Court held that the DETERRENCE of illegal drug use was a legitimate<BR>
state interest, and Section 13(m) was reasonably related to that end."<BR>
(Emphasis supplied)</BLOCKQUOTE><P>

From this we get the purpose of the "primary statute at issue" in the instant case, which was determined to be "deterrence," and indeed, the Supreme Court of Pennsylvania states in the <I>Plowman,</I> id, Opinion at pg. 127:<P>

<BLOCKQUOTE>"the maximum PENALTY for the criminal violation of possession of<BR>
marijuana is 30 days of imprisonment and/or a $500 fine. It is doubtful<BR>
that such a PENALTY would be imposed for a first-time offense. In fact,<BR>
a first offense may merit nothing more than a small fine. As such, the<BR>
prospect of losing one's driver's license may DETER a potential drug user<BR>
from committing that first drug offense. At least, that potential user may<BR>
consider the loss of his/her license and it's effect on employment..."<BR>
(emphasis supplied)</BLOCKQUOTE><P>

From this <I>Plowman</I> holding, it seems clear that the Pennsylvania Supreme Court considers the primary statute at issue herein, 13(m), to have a legitimate state interest for the purpose of DETERRING the illegal use of drugs in Pennsylvania. But is the Pennsylvania <I>Plowman</I> case "good law" when tested by this Honorable Court's decision in <I>Halper,</I> id? The answer is a resounding NO! According to this Honorable United States Supreme Court, if the sanction is characterized as a "deterrent," it must be considered a double-jeopardy violation of due-process.<P>

<CENTER>8</CENTER><HR>

In <I>Halper v. United States,</I> at 490 US 435, 448 (1989), this Honorable Supreme Court of the United States held that:<P>

<BLOCKQUOTE>"... the determination whether a given civil sanction constitutes<BR>
punishment in the relevant sense requires a particularized assessment of<BR>
the penalty imposed and the purposes that the penalty may fairly be said<BR>
to serve. Simply put, a civil as well as a criminal sanction constitutes<BR>
punishment when the sanction applied in the individual case serves<BR>
the goals of punishment."</BLOCKQUOTE><P>

And finally, in <I>Halper,</I> id, at pgs. 448-449, this Honorable Supreme Court states:<P>

<BLOCKQUOTE>"a defendant who has already been punished in a criminal prosecution<BR>
may not be subjected to an additional civil sanction to the extent that the<BR>
second sanction may not be fairly characterized as remedial, but only as a<BR>
DETERRENT or retribution." (emphasis supplied)</BLOCKQUOTE><P>

The Pennsylvania Court in <I>Plowman</I> held that the purpose of the "primary statute at issue" in the instant case was "deterrence," and this Honorable United States Supreme Court held in <I>Halper</I> that if the purpose or characterization of a sanction was a "deterrent," that the defendant may not be subjected to the sanction. The Pennsylvania <I>Plowman</I> case, by which the decision in the instant case was supported, is in DIRECT conflict with this Honorable Court's ruling in
the <I>Halper,</I> id, and thereby creates some very valid grounds for the granting of the Writ of Certiorari to the Petitioner in the case at bar.<P>

In the lower court, Petitioner argued that his 90-day suspension in this case was a violation of due-process, because it took away his constitutional protections against equal protection denial and the cruel and unusual punishment of double jeopardy. Indeed the Commonwealth Court understood this very well when it stated that Petitioner asserted at the trial, "(1) that he was not advised that his driver's license would be suspended if he pleaded guilty," (a double-jeopardy assertion) and "(3) that the ninety-day suspension is cruel and unusual punishment and a violation of due process," (an assertion of both 5th and llth Amendment rights -- See pg. 3&4, Commonwealth Court Opinion, Exhibit D, Appendix.) Double Jeopardy is indeed a kind of "cruel and unusual punishment," and all of these issues were raised at the trial court in a "three minute rush"<P>

<CENTER>9</CENTER><HR>

defense, and they were preserved for appeal by that proceeding, as well as could be expected given the restrictions imposed by the trial court. The five issues that were preserved for review in both the trial and appellate courts were:<P>

1. Whether a State may rule that a Sanction (Driver's License Suspension)
passed under a "Crimes Code" is merely a "collateral civil consequence" or an "additional civil penalty," thereby depriving a Defendant of his 5th Amendment Constitutional Rights, by being given the cruel and unusual punishment of being twice placed in jeopardy for the same offense, and being deprived of his liberty and property without Due Process of Law.<P>

2. Whether a State may deny Due Process of Law to a Defendant who has
executed a plea bargain, by later demanding additional Penalties (Driver's
License Suspension and over $10,000 in costs) which were not disclosed to the Defendant at the time of the court colloquy on the plea bargain agreement.<P>

3. Whether a Defendant is denied Due Process of Law by being required to
present his entire case within less than five minutes. (Defendant's entire
Defense case is on pages 5 to 10 of the Lower Court Transcript.)<P>

4. Whether a State may deprive a Defendant of his Liberty and inflict Cruel and Unusual Punishment (Driver's License Suspension) for a Defendant's justifiable use (Medical Necessity) of a controlled substance (Cannabis) which had nothing to do with an automobile or the State Motor Vehicle Code, and whether Due Process demands that the defense of "justification" be available at all proceedings that are derived from the original criminal conviction.<P>

5. Whether a State may refuse to issue an "Occupational Limited License"
thereby denying the fundamental right of Liberty to a Defendant who is in a
"suspect class" of "Medical Necessity Users of a Controlled Substance," who's actions are "Justified" under Common Law, the State Pennsylvania Law and section 503 of the Model Penal Code, and whether Due Process demands that<P>

<CENTER>10</CENTER><HR>

the "justification" defense be available at all proceedings that are derived from the original conviction.<P>

All of these issues were presented to the Commonwealth Court of Pennsylvania, and a copy of the above five issues, in proposed Certiorari form, was attached to Petitioner's Allocatur Petition for Allowance of Appeal. The Pennsylvania Supreme Court's finding that Petitioner's Driver's license was a "collateral civil consequence" or a "civil consequence of a criminal violation" is very hard to justify, when one examines the source of the sanction, which was the Pennsylvania "Crimes Code." In addition, the <I>Plowman</I> decision, upon which the
Commonwealth Court relies, is in gross conflict with the <I>Halper</I> decision of this Honorable United States Supreme Court, and therefore it must be overruled.<P>

<CENTER>CONCLUSION</CENTER><P>

This is a very valid case of some State Law being in conflict with other State Law, and that alone is sufficient reason for the granting of a Writ of Certiorari to Petitioner. However, it is clear from a reading of the Pennsylvania case law that the decisions of the Pennsylvania Supreme Court are in direct conflict with this Honorable Court's <I>Halper</I> decision, and therefore a writ of Certiorari to the Pennsylvania Supreme Court is Petitioner's only effective remedy.<P>

WHEREFORE, Petitioner respectfully prays to this Honorable Supreme Court of
the United States to issue a Writ of Certiorari to review the Judgment and Order of the Commonwealth Court of Pennsylvania, and the Judgment and Order of the Supreme Court of Pennsylvania.<P>

Respectfully submitted,<P>

by ____________________<P>

<A HREF="mailto:drg@pgh.org">John M. Grubor</A>, <I>pro se,</I> Petitioner<P>

<CENTER>11</CENTER></B><HR></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-282</DOCNO>
<DOCOLDNO>IA087-000628-B025-268</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/apha.html 206.61.184.43 19970122060856 text/html 12456
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:08:44 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:20 GMT
Content-length: 12240
</DOCHDR>
<HTML>
<HEAD><TITLE>American Public Health Association</TITLE>
<META NAME="AUTHOR" CONTENTS="American Public Health Association">
<META NAME="SUMMARY" CONTENTS="Access to Therapeutic Marijuana">
<META NAME="KEYWORDS" CONTENTS="Marijuana, marijuana, Cannabis, cannabis">
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#FF0000" ALINK="#FF00FF">
<FONT SIZE=+1>American Journal of Public Health
<BR>March 1996, Vol. 86, No. 3, pp. 441-442

<P><B>9513:&nbsp;  Access to Therapeutic Marijuana/Cannabis</B> 
 
<P>The American Public Health Association, 
<DD>Being aware that cannabis/marijuana has been used medicinally 
for centuries and that cannabis products were widely prescribed 
by physicians in the United States until 1937;<SUP><SMALL><a href="#1">1</a>,<a href="#2">2</a></SMALL></SUP> and 
<DD>Being aware that "marijuana" prohibition began with the 
Marijuana Tax Act of 1937 under false claims despite disagreeing 
testimony from the AMA's representative;<SUP><SMALL><a href="#3">3</a>,<a href="#4">4</a></SMALL></SUP> and 
<DD>Being further aware that the Controlled Substances Act of 1970 
completely prohibited all medicinal use of marijuana by placing 
it in the most restrictive category of Schedule I, whereby drugs 
must meet three criteria for placement in this category: 1) have 
no therapeutic value, 2) are not safe for medical use, and 3) 
have a high abuse potential;<SUP><SMALL><a href="#5">5</a></SMALL></SUP> and 
<DD>Being cognizant that the Drug Enforcement Administration's own 
administrative law judge ruled in 1988 that marijuana must be 
removed from Schedule I and made available for physicians to 
prescribe;<SUP><SMALL><a href="#6">6-8</a></SMALL></SUP> and 
<DD>Knowing that 36 states have passed legislation recognizing 
marijuana's therapeutic value;<SUP><SMALL><a href="#9">9</a>,<a href="#10">10</a></SMALL></SUP> and 
<DD>Also knowing that the only available access to legal marijuana 
which was through the Food and Drug Administration's 
Investigational New Drug Program has been closed by the Secretary 
of Health and Human Services since 1992;<SUP><SMALL><a href="#11">11</a></SMALL></SUP> and 
<DD>Understanding that while synthetic Tetrahydrocannibinol (THC) 
is available in pill form, it is only one of approximately 60 
cannabinoids which may have medicinal value individually or in 
some combination; and 
<DD>Understanding that marijuana has an extremely wide acute 
margin of safety for use under medical supervision and cannot 
cause lethal reactions;<SUP><SMALL><a href="#6">6</a>,<a href="#32">32</a>,<a href="#34">34</a></SMALL></SUP> and 
<DD>Understanding that marijuana has been reported to be effective 
in: a) reducing intraocular pressure in glaucoma;<SUP><SMALL><a href="#12">12</a>,<a href="#13">13</a></SMALL></SUP> b) 
reducing nausea and vomiting associated with chemotherapy;<SUP><SMALL><a href="#14">14-16</a></SMALL></SUP> 
c) stimulating the appetite for patients living with AIDS 
(acquired immunodeficiency syndrome) and suffering from the 
wasting syndrome;<SUP><SMALL><a href="#17">17-19</a></SMALL></SUP> d) controlling spasticity associated with spinal cord injury and multiple sclerosis;<SUP><SMALL><a href="#20">20-25</a></SMALL></SUP> e) decreasing the suffering from chronic pain;<SUP><SMALL><a href="#26">26-28</a></SMALL></SUP> and f) controlling seizures associated with seizure disorders;<SUP><SMALL><a href="#29">29-31</a></SMALL></SUP> and 
<DD>Understanding that marijuana seems to work differently than 
many conventional medications for the above problems, making it a 
possible option for persons resistant to the conventional 
medications;<SUP><SMALL><a href="#32">32</a>,<a href="#33">33</a></SMALL></SUP> and 
<DD>Being concerned that desperate patients and their families are 
choosing to break the law to obtain this medicine when conventional medicines or treatments have not been effective for them or are too toxic;<SUP><SMALL><a href="#34">34</a>,<a href="#35">35</a></SMALL></SUP> and 
<DD>Realizing that this places ill persons at risk for criminal 
charges and at risk for obtaining contaminated medicine because 
of the lack of quality control; and 
<DD>Realizing that thousands of patients not helped by conventional medications and treatments, may find relief from their suffering with the use of marijuana if their primary care providers were able to prescribe this medicine; and 
<DD>Concluding that cannabis/marijuana was wrongfully placed in 
Schedule I of the Controlled Substances depriving patients of its 
therapeutic potential; 
<DD>Recognizing that APHA adopted a resolution (7014) on Marijuana 
and the Law which urged federal and state drugs laws to exclude 
marijuana from classification as a narcotic drug;<SUP><SMALL><a href="#36">36</a></SMALL></SUP> and 
<DD>Concluding that greater harm is caused by the legal 
consequences of its prohibition than possible risks of medicinal 
use; therefore 
<DD>1.&nbsp;  Encourages research of the therapeutic properties of 
various cannabinoids and combinations of cannabinoids; and 
<DD>2.&nbsp;  Encourages research on alternative methods of 
administration to decrease the harmfull effects related to 
smoking; and 
<DD>3.&nbsp;  Urges the Administration and Congress to move 
expeditiously to make cannabis available as a legal medicine 
where shown to be safe and effective and to immediately allow 
access to therapeutic cannibis through the Investigational New 
Drug Program. 
 
<P><B>References</B></FONT>
<OL>
<a name="1"><LI></a>Abel EA.&nbsp; <I>Marihuana: The First Twelve Thousand Years.</I>&nbsp; New York: McGraw-Hill Book Company, 1982. 
<a name="2"><LI></a>Mikuriya TH, ed.&nbsp; <I>Marijuana: Medical Papers 1839-1972.</I>&nbsp; Oakland, CA: Medi-Comp Press, 1973. 
<a name="3"><LI></a>Bonnie RJ, Whitebread II, CH.&nbsp; <I>The Marihuana Conviction: A History of Marihuana Prohibition in the United States.</I>&nbsp; Charlottesville, VA: University Press of Virginia, 1974. 
<a name="4"><LI></a>National Commission on Marihuana and Drug Abuse (RP Shafer, Chairman).&nbsp; <I>Marihuana: A Signal of Misunderstanding.</I>&nbsp; New York: The New American Library, Inc., 1972. 
<a name="5"><LI></a>Controlled Substances Act of 1970 (Pub.L. 91-513, October 27, 1970, 21USC801 et seq.). 
<a name="6"><LI></a>In the Matter of Marihuana Rescheduling Petition, Docket     86-22.&nbsp; Opinion, Recommended Ruling, Findings of Fact, Conclusions of Law, and Decision of Administrative Law Judge.&nbsp; September 6, 1988. Washington, DC: Drug Enforcement Agency, 1988. 
<a name="7"><LI></a>Randall RC.&nbsp; <I>Marijuana, Medicine and the Law.</I>&nbsp; Washington, DC: Galen Press, 1988. 
<a name="8"><LI></a>Randall RC.&nbsp; <I>Marijuana, Medicine and the Law.</I>&nbsp; Vol. II.&nbsp; Washington. DC: Galen Press, 1989. 
<a name="9"><LI></a>Alliance for Cannabis Therapeutics: No accepted medical value??&nbsp; <I>ACT News</I>.&nbsp; Spring, 1995;4. 
<a name="10"><LI></a>Grinspoon L, Bakalar, JB.&nbsp; Marihuana as medicine: a plea for reconsideration.&nbsp; <I>JAMA.</I>&nbsp; 1995;273(23):1875-l876. <a name="11"><LI></a>Government extinguishes marijuana access, advocates smell politics.&nbsp; <I>JAMA.</I>&nbsp; May 20, 1992;267(19):2673-2674. 
<a name="12"><LI></a>Colasanti BK.&nbsp; Review: Ocular hypotensive affect of marihuana cannabinoids: correlate of central action or separate phenomenon.&nbsp; <I>J Ocular Pharmacol.</I>&nbsp; 1986;2(3):295-304. 
<a name="13"><LI></a>Hepler RS, Frank IM.&nbsp; Marihuana smoking and intraocular pressure.&nbsp; <I>JAMA.</I>&nbsp; 1971;2l7:1392. 
<a name="14"><LI></a>Sallan SE, Zinberg NE, Frei III E.&nbsp; Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.&nbsp; <I>New Engl J Med.</I>&nbsp; 1975;293(16):795-797. 
<a name="15"><LI></a>Sallan SE, Cronin C, Zelen M, Zinberg NE.&nbsp; Antiemetics in patients receiving chemotherapy for cancer.&nbsp; <I>New Engl J Med.</I> 1980;302:135-138. 
<a name="16"><LI></a>Vinciguerra V, Moore T, Brennan E.&nbsp; Inhalation marijuana as an antiemetic for cancer chemotherapy.&nbsp; <I>NY State J Med.</I>&nbsp; 1988;88:525-527. 
<a name="17"><LI></a>Nelson K, Walsh D, Deeter P. et al.&nbsp; A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia.&nbsp; <I>J Palliative Care.</I>&nbsp; 1994;1O(1):14-18. <a name="18"><LI></a>Regelson W, Butler JR, Schultz J et al.&nbsp; Delta-9-THC as an effective antidepressant and appetite stimulating agent in advanced cancer patients.&nbsp; In <I>Int Conf Pharmacol Cannabis.</I>&nbsp; S Szara, MC Braude, eds.&nbsp; Savannah: Raven, 1975. 
<a name="19"><LI></a>Foltin RW, Fischman MW, Byrne MF.&nbsp; Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.&nbsp; <I>Appetite.</I>&nbsp; 1988;11:1-14. 
<a name="20"><LI></a>Clifford DB.&nbsp; Tetrahydrocannabinol for tremor in multiple sclerosis.&nbsp; <I>Ann Neurol.</I>&nbsp; 1983:13:669-671. 
<a name="21"><LI></a>Malec J, Harvey RF, Cayner JJ.&nbsp; Cannabis effect on spasticity in spinal cord injury.&nbsp; <I>Arch Phys Med Rehab.</I>&nbsp; 1982;35:198. 
<a name="22"><LI></a>Meinck H, Schonle PW, Conrad B.&nbsp; Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.&nbsp; <I>J Neurol.</I> 1989;236:l20-l22. 
<a name="23"><LI></a>Petro D.&nbsp; Marihuana as a therapeutic agent for muscle spasm or spasticity.&nbsp; <I>Psychosomatics.</I>&nbsp; 1980;21:81-85. 
<a name="24"><LI></a>Petro D, Ellenberger C.&nbsp; Treatment of human spasticity with delta-9-tetrahydrocannabinol.&nbsp; <I>J Clin Pharmacol.</I>&nbsp; 1981;21:413S-416S. 
<a name="25"><LI></a>Ungerleider JT, Andyrsiak T, Fairbanks L, et al.&nbsp; Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. 
<a name="26"><LI></a>Johnson MR, Melvin LS, Althius, TH et al.&nbsp; Selective and potent analgesics derived from cannabinoids.&nbsp; <I>J Clin Pharmacol.</I>&nbsp; 1981;21:271S-282S. 
<a name="27"><LI></a>Maurer M, Henn V, Dittrich A, et al.&nbsp; Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.&nbsp; <I>Eur Arch Psychiatry Clin Neurosci.</I> 1990;240:1-4. 
<a name="28"><LI></a>Noyes Jr. R, Brunk SF, Avery DH, et al.&nbsp; The analgesic properties of delta-9-tetrahydrocannabinol and codeine.&nbsp; <I>Clin Pharmacol Ther.</I>&nbsp; 1975;l8(l):84-89. 
<a name="29"><LI></a>Cunha JM, Carlini EA, Pereira AE, et al.&nbsp; Chronic administration of cannabidiol to healthy volunteers and epileptic patients.&nbsp; <I>Pharmacology.</I>&nbsp; 1980;21:175-185. 
<a name="30"><LI></a>Feeney D.&nbsp; Marihuana use among epileptics.&nbsp; <I>JAMA.</I> 1976;235:1105. 
<a name="31"><LI></a>Karler R, Turkanis SA.&nbsp; The cannabinoids as potential antiepileptics.&nbsp; <I>J Clin Pharmacol.</I>&nbsp; 1981;21:437S-448S. 
<a name="32"><LI></a>Institute of Medicine.&nbsp; <I>Marijuana and Health.</I>&nbsp; Washington, DC: National Academy Press, 1982. 
<a name="33"><LI></a>Mechoulam R, ed.&nbsp; <I>Cannabinoids as Therapeutic Agents.</I>&nbsp; Boca Raton, FL: CRC Press, 1986. 
<a name="34"><LI></a>Cannabis clubs open for medicinal business.&nbsp; <I>USA Today.</I>&nbsp; October 1, 1993:B1,B5. 
<a name="35"><LI></a>Berger J.&nbsp; Mother's homemade marijuana: a plan to aid her son leads to arrest and push for change.&nbsp; <I>The New York Times.</I>&nbsp; October 11, 1993. 
<a name="36"><LI></a>American Public Health Association Resolution No. 7014: Marijuana and the Law.&nbsp; APHA Public Policy Statements, 1948-present, cumulative.&nbsp; Washington, DC: APHA, current volume.
</OL>
<I>The American Public Health Association (APHA) is the oldest and largest organization of public health professionals in the world.&nbsp;  The APHA represents more than 50,000 members and has been effectively influencing policies and setting priorities in public health since 1872.&nbsp;  For more information on the APHA medical marijuana resolution, please contact Jeff Jacobs of the American Public Health Association @ (202) 789-5600.</I>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-283</DOCNO>
<DOCOLDNO>IA087-000628-B026-6</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/hr2618.html 206.61.184.43 19970122060925 text/html 19173
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:09:15 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:05:15 GMT
Content-length: 18957
</DOCHDR>
<html><head><title>H.R. 2618 (therapeutic use of marihuana)</title></head><body>
<h2><a href="stroup.html">Legislative Alert</a><br>
<a href="aclu.html">ACLU medical marijuana survey</a><br>
<a href="dpf.html">Drug Policy Foundation: NEWS RELEASE</a><br>
<a href="sponsors.html">Target list of potential co-sponsors</a><br>
<a href="sample.html">Dr. Grinspoon's sample letter</a></h2>
<hr><pre><b>104th CONGRESS
1ST SESSION
H.R. 2618

IN THE HOUSE OF REPRESENTATIVES

MR. FRANK of Massachusetts, MR. JOHNSTON, MRS. PELOSI, 
introduced the following bill; which was referred to the 
Committee on

A BILL

To provide for the therapeutic use of marihuana in situations 
     involving life-threatening or sense-threatening illnesses 
     and to provide adequate supplies of marihuana for such 
     use.

     Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,

SECTION 1.  DEFINITIONS.

     <a href="http://www.law.cornell.edu/uscode/21/802.html">Section 102(16)</a> of the Controlled Substances Act is 
amended by adding at the end thereof the following new 
sentence:  "Such term also does not include 
tetrahydrocannabinols not derived, extracted, or prepared 
from plant Cannabis sativa L.".

SEC. 2.  AUTHORIZING THE MEDICAL PRESCRIPTION OF
          MARIHUANA.

     (a) SCHEDULE I AMENDMENT. -- PARAGRAPH (C) OF 
SCHEDULE I OF <a href="http://www.law.cornell.edu/uscode/21/812.html">SECTION 202(C)</a> OF THE CONTROLLED 
SUBSTANCES ACT IS AMENDED --

          (1) by striking out subparagraph (10);

          (2) by redesignating subparagraphs (11) 
     through (17) as subparagraphs (10) through (16), 
     respectively; and

          (3) by amending subparagraph (16) (as so re-
     designated) to read as follows:

          "(16) Tetrahydrocannabinols not derived, man-
     ufactured, or prepared from the plant Cannabis 
     sativa L.".

     (b) SCHEDULE II AMENDMENT. -- PARAGRAPH (A) OF 
SCHEDULE II OF SECTION 202(C) OF THE CONTROLLED 
SUBSTANCES ACT IS AMENDED BY ADDING AT THE END 
THEREOF THE FOLLOWING NEW SUBPARAGRAPH:

          "(5) Marihuana.".

SEC. 3.  PRODUCTION AND DISTRIBUTION OF MEDICINAL 
          MARIHUANA.

     (a) RULEMAKING. -- SECTION 301 OF THE CON-
TROLLED SUBSTANCES ACT IS AMENDED BY ADDING AT 
THE END THEREOF THE FOLLOWING:  ", EXCEPT THAT 
RULES AND REGULATIONS SPECIFICALLY RELATING TO 
THE REGULATION AND CONROL OF THE PRODUCTION, 
DISTRIBUTION, AND DISPENSING OF MARIHUANA TO SEC-
TIONS 312 AND 313 SHALL BE PROMULGATED BY THE SEC-
RETARY.".

     (b) PRODUCTION AND DISTRIBUTION. -- PART C OF 
THE CONTROLLED SUBSTANCES ACT IS AMENDED BY 
ADDING AT THE END THE FOLLOWING:

     "OFFICE FOR THE SUPPLY OF INTERNATIONALLY 
          CONTROLLED DRUGS

     "SEC. 311.  (a) There is established in the Depart-
ment of Health and Human Services an office to be known 
as the Office for the Supply of Internationally Controlled 
Drugs (hereinafter referred to in this section and sections 
312 and 313 as the 'Office').  The Office shall be respon-
sible for regulating, administering, and supervising the do-
mestic production of marihuana and, in accordance with 
section 313, for the distribution of marihuana for medical, 
scientific, and research purposes.

     "(b) The Office shall be under the direction of a Chief 
Officer who shall be appointed by the Secretary.  The Sec-
retary is authorized to delegate his powers and responsibil-
ities under sections 312 and 313 to the Chief Officer.

     "PRODUCTION OF MEDICINAL MARIHUANA

     "SEC. 312.  (a) The Secretary shall take all necessary
actions to secure and maintain a supply of marihuana ade-
quate for the legitimate medical, research, scientific, and 
export needs of the United States.  The Secretary shall de-
termine the total quantity of marihuana to be produced 
each calendar year to provide for the estimated medical, 
scientific, and research needs of the United States, for the 
establishment of reserve stocks, and for any lawful export 
requirements established by the Attorney General under 
section 1003.  Based on the determination under the pre-
ceding sentence, the Secretary shall recommend to the At-
torney General the aggregate production quotas that must 
be established for marihuana under section 306(a).  The 
recommendation of the Secretary concerning the aggregate 
production quotas for marihuana shall be binding on the 
Attorney General.

     "(b)(1) In order to maintain an adequate supply of 
marihuana, the Secretary shall periodically publish notices 
soliciting bids on a contract or contracts for the domestic 
cultivation and delivery of marihuana.  All bids submitted 
must specify the areas in which, and the land on which, 
cultivation of marihuana will be conducted.  All bids sub-
mitted must be accompanied by an application for reg-
istration under section 302.

     "(2) The Secretary shall forward a copy of the reg-
istration application to the Attorney General.  The Sec-
retary, after consultation with the Attorney General, shall 
recommend to the Attorney General that the application 
for registration be granted or denied, taking into account 
the factors set forth in section 303(a).  The recommenda-
tions of the Secretary concerning the registration of appli-
cants to produce marihuana shall be binding on the Attor-
ney General.

     "(3) The Secretary may accept of reject any bid that 
is submitted by registered bidders, taking into consider-
ation (A) the factors set forth in section 303(a), and (B) 
price.  Marihuana may be produced only by accepted bid-
ders, solely on the land specified in the applicants' bids.  
The Secretary shall provide persons whose bids have been 
accepted with marihuana seeds capable of germination.  
Such seeds shall be obtained by the Secretary from legiti-
mate commercial producers of marihuana or, if this is not 
feasible, the National Institute on Drug Abuse, the Attor-
ney General through the Drug Enforcement Administra-
tion, or the Secretary of Agriculture shall provide the Sec-
retary with an adequate supply of seeds capable of germi-
nation.

     "(c) Upon acceptance of a bid for the production of 
marihuana, the Secretary shall establish an individual 
quota for the production of marihuana for the bidder and 
shall recommend to the Attorney General that this quota 
be assigned to the bidder where required under section 
306.  The recommendations of the Secretary concerning in-
dividual quotas for the production of marihuana, including 
recommendations that such a quota be decreased or in-
creased, shall be binding on the Attorney General.

     "(d) The Secretary may revoke or suspend the ac-
ceptance of any bid for the production of marihuana prior 
to the expiration of the contract executed on the basis of 
the bid upon a finding by the Secretary (1) that the bidder 
has materially breached the terms of the contract relating 
to the maintenance of effective controls against diversion 
of marihuana into other than legitimate medical, scientific, 
and industrial channels; or (2) that any of the reasons 
specified in section 304(a) are applicable.  Upon such rev-
ocation or suspension, the Secretary shall recommend to 
the Attorney General that the bidder's registration for the 
production of marihuana be revoked or suspended pursu-
ant to section 304 and such recommendatios by the Sec-
retary shall be binding on the Attorney General.

     "(e) Within four months of the end of the harvest 
of marihuana grown by registered bidders pursuant to 
contract with the Office, the Office or its delegate or dele-
gates shall take physical possession of the marihuana har-
vested.

     "(f)(1) The Secretary may, at his discretion, periodi-
cally publish notices soliciting bids on a contract of con-
tracts for the physical collection, processing, and shipping 
of marihuana crops produced under contracts entered into 
under subsection (b) or of imported or forfeited stocks de-
scribed in subsections (g) and (h).  All bids submitted must 
be accompanied by an application for registration under 
section 302.

     "(2) The Secretary shall forward a copy of the reg-
istration application to the Attorney General.  The Sec-
retary, after consultation with the Attorney General, shall 
recommend to the Attorney General that the application 
for registration be granted or denied, taking into account 
the factors set forth in section 303(b) and such rec-
ommendatios of the Secretary shall be binding on the At-
ttorney General.

     "(3) The Secretary may accept or reject any bids sub-
mitted by registered bidders, taking into consideration (A) 
the factors set forth in section 303(b); (B) the provisions 
in the bid for the processing of raw marihuana into medi-
cally usable forms, including the provisions for the mainte-
nance of controlled amounts of tetrahydrocannabinols in 
each dosage unit; and (C) price.

     "(g) If a supply of marihuana adequate to meet do-
mestic medical, scientific, and research needs is not ob-
tained through contractual arrangements with domestic 
registered bidders, the Secretary shall declare that a state 
of emergency exists.  The declaration by the Secretary of 
a state of emergency due to inadequate domestic supplies 
of marihuana shall have the same effect as a finding by 
the Attorney General of an emergency due to inadequate 
domestic supplies under section 1002(a)(2)(A).  If no ap-
plicants are registered to import marihuana under sections 
1007 and 1008 within sixty days of the date of the dec-
laration by the Secretary that a state of emergency exists, 
the Secretary shall make arrangements for the direct im-
portation by the Office of a supply of marihuana adequate 
for domestic medical, scientific, and research needs.

     "(h) If, while a state of emergency declared under 
subsection (g) exists, the Secretary finds that a supply of 
marihuana adequate for domestic medical, scientific, and 
research needs cannot be obtained through importation, 
then the Secretary may request that the Attorney General 
forward to the Office forfeited stocks of marihuana that 
are unadulterated with other substances, pursuant to sec-
tion 511(e).

     "DISTRIBUTION OF MEDICINAL MARIHUANA

     "SEC. 313.  (a) Marihuana shall be distributed only 
to hospitals and pharmacies that are --

          "(1) registered under section 303(f) to dispense 
     drugs in schedule II of section 202; and

          "(2) specified by (A) an eligible physician who 
     plans to use marihuana in the treatment of the nau-
     sea of patients who are undergoing cancer chemo-
     therapy or radiology or in the treatment of patients 
     who have glaucoma, AIDS wasting syndrome, or 
     muscle spasms from certain spastic disorders, in-
     cluding multiple sclerosis, paraplegia, and quadriple-
     gia; or (B) a person who has obtained approval by 
     the Secretary of an investigational new drug applica-
     tion under section 505(i) of the Federal Food, Drug, 
     and Cosmetic Act for research involving the use of 
     marihuana.

     "(b) In order to be certified as a physician eligible 
for purposes of subsection (a)(2)(A), the physician must 
file a written application with the Office seeking permis-
sion to use marihuana in his practice.  Such an application 
shall be approved or denied within thirty days of its receipt 
by the Office, or, where possible, within such shorter time 
as is deemed essential by the applicant in cases of medical 
emergency.  If an application is not acted upon within thir-
ty days of its receipt by the Office, it shall be deemed 
approved.  To be approved an application must affirma-
tively state (1) that the applicant is a physician registered 
under section 303(f) to dispense controlled drugs in sched-
ule II of section 202; (2) the applicants's registration num-
ber; (3) that the applicant will use the requested mari-
huana solely for the treatment of glaucoma, AIDS wasting 
syndrome, muscle spasms from certain spastic disorders, 
including multiple sclerosis, paraplegia, and quadriplegia, 
or the nausea associated with cancer chemotherapy or ra-
diology; (4) the name of all pharmacies or hospitals reg-
istered to dispense schedule II drugs that the applicant 
is requesting that supplies of marihuana be sent to; (5) 
that the applicant will inform the Office of any adverse 
reactions by his patients to the use of marihuana; and (6) 
that prior to administratio of marihuana to any patient, 
he will obtain from the patient a signed consent form stat-
ing that informed patient consent has been obtained.  Un-
less the Secretary determines that an application which 
makes the statements required by the preceding sentence 
contains a misstatement of fact, the application shall be 
approved upon payment of a reasonable fee to cover the 
costs of processing the application.  Approval of the phys-
cian's application may be suspended or revoked by the 
Secretary for good cause shown.

     "(c)(1) Upon certification of a physician as eligible 
under subsection (b), the Secretary shall issue serially 
numbered marihuana oder forms to all registered phar-
macies or hospitals listed on the eligible physician's appli-
cation form.  Whenever any such form is issued to a phar-
macy or hospital the Secretary shall, before delivery there-
of, insert therein the name of the pharmacy or hospital, 
and it shall be unlawful for any other person (A) to use 
such form for the purpose of obtaining controlled sub-
stances; or (B) to furnish such form to any person with 
intent thereby to procure the distribution of such sun-
stances.

     "(2) It shall be unlawful for any person to obtain by 
means of order forms issued under this subsection con-
trolled substances for any purpose other than their use, 
distribution, dispensing, or administration in the conduct 
of a lawful business in such substances or in the course 
or his professional practice or research.

     "(3) Written orders made on marihuana order forms 
issued under this subsection shall satisfy the requirements 
of section 308(a).

     "(4) The preservation and availability requirements 
of section 308(c) apply to orders made on forms issued 
under this subsection.

     "(d) Hospitals and pharmacies may obtain supplies 
of marihuana only by forwarding a written order to the 
Secretary on the form issued in blank in accordance with 
subsection (c).  Upon receipt from a hospital or pharmacy 
of a properly completed marihuana order form requesting 
a supply of marihuana the Office or its delegate or dele-
gates shall forward a supply of marihuana to the phar-
macy or hospital within a reasonable time.  If notified by 
an eligible physician that there is a medical urgency for 
immediate shipment, the Office or its delegate or delegates 
shall forward a supply of marihuana within five days of 
such notice, or sooner if feasible.  Also, upon receipt by 
the Secretary of a written request of a person who has 
obtained approval of an investigational new drug applica-
tion under section 505(i) of the Federal Food, Drug, and 
Cosmetic Act for research involving the use of marihuana, 
the Office or its delegate or delegates shall forward a sup-
ply of marihuana to the specified pharmacy or hospital 
licensed to dispense schedule II drugs within a reasonable 
time.

     "(e) The Secretary is directed to set a price for mari-
huana that will recoup, within a reasonable time, all of 
the costs incurred by the Federal Government in produc-
ing, processing, and distributing marihuana.

     "(f) Within six months from the date of the enact-
ment of this section, the Secretary, after consultation with 
the Attorney General, shall promulgate regulations con-
sistent with public health and safety that are in accord 
with the provisions of this title to ensure adequate sup-
ply of medically usable marihuana and to ensure proper 
safeguards regarding the production, storage, processing,
distribution, and dispensing of marihuana so as to prevent 
its diversion into other than legitimate medical, scientific, 
or research channels.".

     (c) Penalty. -- Section 402(a) of the Controlled Sub-
stances Act is amended (1) by striking out "or" at the 
end of paragraph (9), (2) by stiking out the period at 
the end of paragraph (10) and inserting in lieu thereof 
"; or", and (3) by adding at the end the following new 
paragraph:

          "(11) to use an oder form issued under section 
     313(c) in a manner prohibited by such section or to 
     furnish such a form in violation of such section.".

SEC. 4.  COMPLIANCE WITH THE FEDERAL FOOD, DRUG,
          AND COSMETIC ACT.

     The Federal Food, Drug, and Cosmetic Act is amend-
ed by inserting after section 505 the following:

     "THERAPEUTIC USE OF MARIHUANA

     "SEC. 505A.  (a) Nothwithstanding section 505(a), the 
approval of the Secretary shall not be required for the in-
troduction or delivery of marihuana into interstate com-
merce in compliance with the requirements of sections 312 
and 313 of the Controlled Substances Act.

     "(b) Marihuana is defined as a prescription drug for 
purposes of section 503(b).  Only physicians who are eligi-
ble to obtain marihuana under section 313(b) of the Con-
trolled Substances Act may issue written prescriptions au-
thorizing the dispensing or marihuana under section 
503(b).".

SEC. 5.  AUTHORIZATION OF APPROPRIATIONS.

     There is authorized to be appropriated not to exceed 
$5,000,000 for the fiscal year 1996, and $5,000,000 for 
the fiscal year 1997, for the use of the Office for the Sup-
ply of Internationally Controlled Drugs in conducting, 
contracting for, supervising, and administering the pro-
duction, testing, processing, distribution, and dispensing 
of marihuana.

SEC. 6.  INTERIM PROVISIONS.

     The Secretary of Health and Human Services shall 
procure a supply of marihuana adequate for the scientific, 
medical, and research needs of the United States within 
12 months after the date of the enactment of this Act.  
The Secretary of Health and Human Services and the At-
torney General shall ensure that persons now receiving 
marihuana pursuant to research projects approved by the 
Secretary of Health and Human Services continue to re-
ceive uninterrupted supplies until the system for the proc-
essing and distribution of marihuana produced pursuant 
to the Controlled Substances Act is fully operational.

</b></pre>
</body></html>






</DOC>
<DOC>
<DOCNO>WT01-B18-284</DOCNO>
<DOCOLDNO>IA087-000628-B026-162</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/lancet.html 206.61.184.43 19970122061105 text/html 5479
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:10:56 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:05:00 GMT
Content-length: 5264
</DOCHDR>
<HTML>
<HEAD><TITLE>The Lancet</TITLE>
<META NAME="AUTHOR" CONTENTS="American Public Health Association">
<META NAME="SUMMARY" CONTENTS="Access to Therapeutic Marijuana">
<META NAME="KEYWORDS" CONTENTS="Marijuana, marijuana, Cannabis, cannabis">
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#FF0000" ALINK="#FF00FF">
<FONT SIZE=+1><B>THE LANCET</B> 
<BR>Volume 346, Number 8985, November 11, 1995, p. 1241
 
<P>EDITORIAL 
 
<P><B>Deglamorising cannabis</B> 
 
<DD>The smoking of cannabis, even long term, is not harmful to health.&nbsp;  Yet this widely used substance is illegal just about everywhere.&nbsp;  There have been numerous calls over the years for the legalisation, or at least decriminalisation, of soft drugs, among which cannabis remains the most popular with all social groups.&nbsp;  In this highly contentious area, the Dutch attitude has been often mentioned as the voice of sanity.&nbsp;  In the Netherlands, customers of coffee shops can buy up to 30 g of cannabis for about 10 pounds ($15) although the drug is technically illegal.&nbsp;  The shops are not allowed to advertise, or to sell cannabis to individuals aged under 16 years. 
 
<DD>Prominent among those currently calling for legislative reform - and going further by making constructive proposals - are police chiefs and city medical officers, people who know only too well that the existing policies in most countries are ineffective and unworkable.&nbsp;  Meanwhile, politicians have largely remained silent, seemingly afraid of offending powerful segments of the electorate or merely of being perceived as weak in the face of rising crime figures.&nbsp;  When the occasional politician raises her head above the parapet - as the British opposition MP Clare Short did recently in calling for a fresh debate on decriminalisation of cannabis - the response is tediously predictable: widespread condemnation from political colleagues and overwhelming support from those who have to cope with the end result of political inertia. 
 
<DD>In the case of Ms Short, not only was she speedily reprimanded by the party leader, but also party officials claimed that their non-legalisation stance was entirely logical since legalisation of cannabis would "increase the supply, reduce the price, and increase the usage".&nbsp;  According to a Home Office report earlier this year, the number of people taking cannabis 
has doubled in a decade - without any help from "liberal" measures.&nbsp;  Perhaps the politicians' real fear was that freedom to use soft drugs would automatically progress to increased use of substances such as cocaine and heroin.&nbsp;  If so, they must have overlooked the recent Dutch government review which pointed out that decriminalisation of possession of soft drugs has not led to a rise in the use of hard drugs. 
 
<DD>If the Dutch approach is so successful, why are changes afoot in The Hague to tighten up that country's drug policy?&nbsp;  First Amsterdam's mayor proposed closing down half the city's coffee shops that sell cannabis, and in doing so he rejected a report by his health department in favour of legalisation of soft drugs.&nbsp;  Then the Dutch government, which had made an election promise to legalise cannabis, last month issued a discussion 
paper which mirrored the Amsterdam plan.&nbsp;  If, as expected, the Dutch parliament agrees the latest proposals, half the country's 4000 cannabis-selling coffee shops will close and the amount that can be sold to an individual will be cut to 5 g.&nbsp;  Since the government's own review provides no ammunition for such a change in policy, the real reason behind the new measures must lie elsewhere.&nbsp;  One need look no further than the Netherlands' neighbours and co-signatories of the Schengen agreement, which introduced a border-free zone between the Netherlands, France, Germany, Spain, Luxembourg, and Belgium.&nbsp;  When France, in particular, threatened to end the agreement, claiming that the Netherlands was the major supplier of Europe's drugs, some action had to be taken and the coffee shops became the scapegoat. 
 
<DD>Leaving politics aside, where is the harm in decriminalising cannabis?&nbsp;  There is none to the health of the consumers, and the criminal fraternity who depend for their succour on prohibition would hate it.&nbsp;  But decriminalisation of possession does not go far enough in our view.&nbsp;  That has to be accompanied by controls on source, distribution, and advertising, much as happens with tobacco.&nbsp;   A system, in fact, remarkably close to the existing one in Dutch coffee shops. 
 
<DD>Cannabis has become a political football, and one that governments continually duck.&nbsp;  Like footballs, however, it bounces back.&nbsp;  Sooner or later politicians will have to stop running scared and address the evidence: cannabis per se is not a hazard to society but driving it further underground may well be. 
 
<P><DD><I>The Lancet</I>

<P>THE LANCET
<BR>655 Avenue of the Americas
<BR>New York, NY 10010
<BR>Tel: (212) 633 3800
<BR>Fax: (212) 633 3850
<BR>
<P>THE LANCET
<BR>42, Bedford Square
<BR>London, WC1B 3SL
<BR>Tel: +44 (0) 171 436 4981
<BR>Fax: +44 (0) 171 323 6441
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-285</DOCNO>
<DOCOLDNO>IA087-000628-B026-202</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/weld.html 206.61.184.43 19970122061122 text/html 8078
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:11:13 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:05:32 GMT
Content-length: 7863
</DOCHDR>
<html><pre>THE BOSTON GLOBE * SATURDAY, NOVEMBER 25, 1995 * PAGE 
13 
 
Pot, a balm to some, faces a new hurdle 
 
By Dolores Kong 
GLOBE STAFF 
 
   The treatment for the cancer spreading throughout David 
Getchell's body causes nausea and vomiting so severe that the 51-
year-old scientist can barely eat.  Only one drug helps: 
marijuana. 
   "It makes life more bearable, and you can hang on and fight," 
said Getchell, who worked as a pediatric chemist at Massachusetts 
General Hospital before he became too sick.  "That's why I'm 
still alive." 
   But a bill to allow patients like Getchell to use medical 
necessity as a legal defense if they are arrested for possessing 
marijuana, passed early this month by the Legislature, has met 
unexpected resistance from Gov. Weld. 
   Weld has sent the bill back to the Legislature, requesting an 
amendment that would allow the legal defense only for certified 
participants in a Department of Public Health therapeutic 
research program - of which there are none. 
   The program, created by a 1991 law, has never enrolled anyone 
because the federal government has stopped providing a legal 
supply of medical marijuana, although the state has renewed 
efforts to get federal approval for supplying marijuana to 
patients. 
   Weld said in an interview that "unlike others, I do think that 
there's some evidence that marijuana has some value for treating 
some medical conditions," such as glaucoma, AIDS wasting 
syndrome, or the side effects of chemotherapy. 
   "I just think the bill is just too wide open.  The self-
diagnosis approach is too wide open," he said. 
   Getchell, a fair-skinned redhead diagnosed in 1990 with 
melanoma, an aggressive skin cancer that resulted from severe 
sunburn when he was an adolescent, fought hard to get the bill 
passed.  He said he cannot understand Weld's action, pointing out 
that in 1992, the governor commuted the sentence of Joseph 
Hutchins, who was growing and using marijuana so that he could 
eat despite scleroderma, an incurable disease that hardened his 
esophagus and made it extremely hard to swallow. 
   "What I would want to say to Gov. Weld is that this is an 
issue of compassion," Getchell said.  "It's not about winning or 
not winning the drug war.  It's about sick and dying people and a 
way to help them under medical supervision." 
   Rep. Patricia D. Jehlen (D-Somerville), the bill's sponsor and 
Getchell's state representative, said she did not understand 
Weld's action either, since legislators have all along 
incorporated suggestions on the wording from the governor's 
office.  "All I know is that it doesn't make sense, given what he 
did with Hutchins," Jehlen said. 
   Hutchins has appealed his conviction, but the Supreme Judicial 
Court ruled in 1991 that he could not use a medical-necessity 
defense.  The Legislature pased the current bill to recognize 
such a defense in Massachusetts, giving patients like Getchell 
the ability to bring up medical evidence in court, Jehlen said.  
She has filed an amendment that she believes would deal with 
Weld's concerns, but with this year's legislative session over, 
the bill will have to wait until January. 
   Hutchins now lives in Washington state, which recognizes the 
medical-necessity defense, according to Jon Holmes, a volunteer 
serving on the drug policy task force of the Civil Liberties 
Union of Massachusetts. 
   Weld said his thinking has not changed since he commuted 
Hutchins' sentence, but that the bill as passed does not have 
safeguards in place to ensure that only those with legitimate 
medical claims like Hutchins can use the medical-necessity 
defense. 
   "The bill I originally sent back didn't have the word 'doctor' 
anywhere near it," Weld said.  That suggests anyone arrested for 
marijuana possession would assert medical necessity "in virtually 
every case," he said. 
   Opponents of the medical use of marijuana have argued that 
there are legal alternatives to treat pain, nausea and other 
medical symptoms, and that legalizing just one use of the drug 
would open the door to marijuana becoming legal overall.  In the 
early 1990s, the Bush administration stopped taking new 
applications for a US-run medical marijuana program; only eight 
persons getting the drug legally through the program are still 
alive.  The Clinton administration has been unwilling to reopen 
the program. 
   Rep. Barney Frank (D-Mass.), who earlier this month filed a 
bill in Congress to permit doctors once again to prescribe 
marijuana to patients with certain diseases, said that the 
political climate in this country appears to be getting in the 
way of compassionate use of the drug. 
   "We are allowing the political impulses to apprea 'tough on 
drugs' to interfere with alleviating pain and suffering," said 
Frank, who noted that House Speaker Newt Gingrich had been a 
cosponsor to a 1982 bill that would also have allowed doctors to 
prescribe marijuana. 
   Dr. Lester Grinspoon - a Harvard psychiatrist whose book, 
"Marijuana: The Forbidden Medicine," is available in seven 
languages - said he believes Weld's amendment dooms the medical 
use of marijuana in this state.  "It's a cowardly way of vetoing, 
in my view," Grinspoon said, adding that he does not expect the 
state public health program ever to get federal approval for a 
supply. 
   David Mulligan, the state public health commissioner, 
disagreed, saying he is hopeful that within the next year the 
program can get approval to get a supply from the federal 
government or to grow its own marijuana under strict security.  
The state does not want to jeopardize negotiations by appearing 
to condone illegal use of marijuana in the meantime, Mulligan 
said. 
   The stat also does not want to use marijuana seized in drug 
raids for medical purposes, he added, since it might have 
impurities that could be harmful to those with suppressed immune 
systems. 
   Aside from tying the medical necessity defense to participants 
in the state public health program, Weld's amendment expands the 
medical conditions that make patients eligible for the program by 
adding AIDS and spasticity associated with multiple sclerosis, 
Mulligan said. 
   Even if the state program were approved, it might not help 
Rhonda Lemoine, 39, who says she has been using marijuana to 
treat the chronic pain from muscle spasms and degenerative 
arthritis of the spine since a car accident in 1991.  Her 
condition is not one of the eligible medical conditions currently 
listed by the program. 
   "I couldn't work for a long time" with the pain and the loss 
of appetite, said Lemoine, the medical marijuana coordinator for 
the Massachusetts Cannabis Reform Coalition, which supports 
Jehlin's bill.  "I use marijuana as an appetite enhancer, and it 
helps with the muscle spasms.  I've gone from basically being 
bedridden to being functioning." 
   Lemoine, he husband and her son were arrested last year in an 
early morning raid at their central Massachusetts home, after an 
acquaintance who was arrested on crack cocaine charges turned 
them in as part of a plea bargain.  Lemoine was willing to plead 
guilty to a charge of possessing an ounce of marijuana, but she 
had to plead guilty to distribution as well to get charges 
against her husband dropped, Lemoine said.  Her husband paid a 
fine, her son got six months' probation and she got a suspended 
one-year sentence, with probation until February 1996. 
   "I want to stay healthy and do whatever I can," said Lemoine, 
who has been able to open her own business after beginning to use 
marijuana.  "It's the only law I'm breaking, and I'm trying to 
change that one."</pre></html>
</DOC>
<DOC>
<DOCNO>WT01-B18-286</DOCNO>
<DOCOLDNO>IA087-000628-B026-230</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/pate.html 206.61.184.43 19970122061137 text/html 20040
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 06:11:25 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:06:33 GMT
Content-length: 19824
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<DD><TITLE>Potential medical uses of Cannabis</TITLE>
<DD><META NAME="AUTHOR" CONTENT="Pate, David W.">
<DD><META NAME="SUMMARY" CONTENT="Guide to the scientific literature<BR>
on potential medical uses of Cannabis and the cannabinoids">
<DD><META NAME="KEYWORDS" CONTENT="Cannabis, cannabis, Marijuana, marijuana">
<DD><META NAME="GENERATOR" CONTENT="Mozilla/3.0b5aGold (Win95; I) [Netscape]">
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#FF0000" ALINK="#FF00FF">
<CENTER><H3><HR NOSHADE>Guide to the scientific literature<BR>
on potential medical uses of Cannabis and the cannabinoids</H3></CENTER>
<CENTER>David W. Pate</CENTER><P>
<CENTER>International Hemp Assocation<BR>
P.O. Box 75007, 1070AA Amsterdam<BR>
The Netherlands</CENTER>
<HR NOSHADE>
     <STRONG>Pate, D.W. 1995.  Guide to the scientific literature on potential medical uses of Cannabis and the cannabinoids.</STRONG>  <EM>Journal of the International Hemp Association</EM> 2(2): 74-76.
<P>Marijuana and its component cannabinoids have been demonstrated to affect many medical conditions.  However, original sources on this topic are often difficult to access, as they are diffusely distributed across a voluminous scientific literature.  This bibliography gathers most of the primary (and some of the secondary) citations available, categorized according to medical indication.
<HR NOSHADE>

<H4>Introduction</H4>

 <P>     Widespread reports of self-medication with Cannabis have aroused medical and scientific interest in the potential application of cannabinoids for the treatment of a variely of diseases.  Some limited human trials or case studies have revealed the safety and efficacy of this class of compounds for the symptomatic treatment of a broad number of ailments.  The results of tests on other animals or in vitro experiments imply new paths of clinical investigation.  The references below represent a starting point for further inquiry.  Included are papers regardless of their experimental outcome.  Not included are citations related to the presently approved uses of THC (i.e cancer chemotherapy nausea amelioration, AIDS patient appetite stimulation).

<P><STRONG>Anxiety and Psychosis</STRONG>
<UL>
<LI>Guimares, F.S. <EM><EM>et al.</EM></EM>, 1990.  Anxiolytic effect of cannabidiol in the elevated plus-maze.  <EM>Psychopharmacology</EM> 100: 558-559.
<LI>Guimares, F.S. <EM>et al.</EM>, 1994.  Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.  <EM>Gen. Pharmac.</EM> 25: 161-164.
<LI>Zuardi, A.W. <EM>et al.</EM>, 1982.  Action of cannabidiol on the anxiety and other effects produced by delta-9-THC in normal subjects.  <EM>Psychopharmacology</EM> 76: 245-250.
<LI>Zuardi, A.W. <EM>et al.</EM>, 1991.  Effects of cannabidiol in animal models predictive of antipsychotic activity.  <EM>Psychopharmacology</EM> 104: 260-264.
<LI>Zuardi, A.W. <EM>et al.</EM>, 1993.  Effects of ipsapirone and cannabidiol on human experimental anxiety.  <EM>J. Psychophamacol.</EM> 7: 82-88.
</UL>

<P><STRONG>Asthma</STRONG>
<UL>
<LI>Gong, H. <EM>et al.</EM>, 1984.  Acute and subacute bronchial effects of oral cannabinoids.  <EM>Clin. Pharm. Ther.</EM> 35: 26-32.
<LI>Graham, J.D.P., 1986.  The bronchodilator action of cannabinoids.  In Cannabinoids as Therapeutic Agents, R. Mechoulam, Ed., CRC Press, Boca Raton, Florida, pp. 147-158.
<LI>Hartley, J.P., <EM>et al.</EM>, 1978.  Bronchodilator effect of delta-9-THC.  <EM>Br. J. Clin. Pharmacol.</EM> 5: 523.
<LI>Karniol, I.G., <EM>et al.</EM>, 1974.  Cannabidiol interferes with the effects of delta-9-tetrahydrocannabinol in man.  <EM>Eur. J. Pharmac.</EM> 28: 172.
<LI>Tashkin, D., <EM>et al.</EM>, 1973.  Acute pulmonary physiologic effects of smoked marijuana and oral delta-9-tetrahydrocannabinol in healthy young men.  <EM>New Engl. J. Med.</EM> 289: 336-341.
<LI>Tashkin, D., <EM>et al.</EM>, 1976.  Acute effects of smoked marijuana on airway dynamics in spontaneous and experimentally induced bronchial asthma.  <EM>In</EM> The Pharmacology of Marijuana, Braude and Szara, Eds., Raven Press, New York, pp. 785-799.
<LI>Vachon, L. <EM>et al.</EM>, 1976.  Airways respons to aerosolized delta-9-THC preliminary report.  <EM>In</EM> The Therapeutic Potential of Marijuana, Cohen, S. and Stillman, R.C., Eds., Plenum Press, New York, p. 111.
<LI>Vachon, L. <EM>et al.</EM>, 1976.  Airways response to micro-aerosolized delta-9-THC.  <EM>Chest</EM> 70: 444.
<LI>Williams, S.J. <EM>et al.</EM>, 1976.  Bronchodilator effect of delta-9-THC administered by aerosol to asthmatic patients.  <EM>Thorax</EM> 31: 720.
</UL>

<P><STRONG>Epilepsy</STRONG>
<UL>
<LI>Ames, F.R. and Cridland, S., 1986.  Anticonvulsant effect of cannabidiol.  <EM>S. Afr. Med. J.</EM> 69: 14.
<LI>Consroe, P.F. <EM>et al.</EM>, 1975.  Anticonvulsant nature of marihuana smoking.  <EM>J.A.M.A.</EM> 234: 306-307.
<LI>Cunha, J.M. <EM>et al.</EM>, 1980.  Chronic administration of cannabidiol to healthy volunteers and epileptic patients.  <EM>Pharmacology</EM> 21: 175-185.
<LI>Davis, J.P. and Ramsey, H.H., 1949.  Anti-epileptic action of marijuana-active substances.  <EM>Fed. Proc. Am. Soc. Exp. Biol.</EM> 8: 284.
<LI>Feeney, D. 1976.  Marihuana use among epileptics.  <EM>J.A.M.A.</EM> 235: 1105.
<LI>Karler, R. and Turkanis, S.A. 1981.  The cannabinoids as potential antiepileptics.  <EM>J. Clinical Pharmacology</EM> 21: 437S-448S.
<LI>Karler, R. <EM>et al.</EM>, 1973.  The anti-convulsant activity of cannabidiol and cannabinol.  <EM>Life Sci.</EM> 13: 1527-1531.
<LI>Karler, R. <EM>et al.</EM>, 1984.  Interaction between delta-9-tetrahydrocannabinol and kindling by electrical and chemical stimulation in mice.  <EM>Neuropharmacology</EM> 23: 1315-1320.
<LI>Karler, R. <EM>et al.</EM>, 1989.  Pentylenetetrazole kindling in mice.  <EM>Neuropharmacology</EM> 28: 775-780.
<LI>Karler, R. <EM>et al.</EM>, 1974.  Anticonvulsant properties of delta-9-tetrahydrocannabinol and other cannabinoids.  <EM>Life Sci.</EM> 15: 931-947.
<LI>Karler, R. <EM>et al.</EM>, 1986.  Prolonged CNS hyperexcitability in mice after a single exposure to delta-9-tetrahydrocannabinol.  <EM>Neuropharmacology</EM> 25: 441-446.
<LI>Karler, R. and Turkanis, S., 1976.  The anti-epileptic potential of the cannabinoids.  <EM>In</EM> The Therapeutic Potential of Marijuana, Cohen and Stillman, Eds., Plenum Press, New York, pp. 383-396.
<LI>Turkanis, S. <EM>et al.</EM>, 1974.  Anti-convulsant properties of cannabinol.  <EM>Res. Comm. Chem. Pathol. Pharmacol.</EM> 8: 231-246.
</UL>

<P><STRONG>Glaucoma</STRONG>
<UL>
<LI>Colasanti, B.K. 1986.  Review: Ocular hypotensive affect of marihuana cannabinoids: correlate of central action or separate phenomenon.  <EM>J. Ocular Pharmacology</EM> 2(3): 295-304.
<LI>Colasanti, B.K. <EM>et al.</EM>, 1984.  Ocular hypotension, ocular toxicity, and neurotoxicity in response to marijuana extract and cannabidiol.  <EM>Gen. Pharmacol.</EM> 15: 479.
<LI>Colasanti, B.K. <EM>et al.</EM>, 1984.  Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta-9-tetrahydrocannabinol or cannabichromene.  <EM>Exp. Eye Res.</EM> 38: 63.
<LI>Colasanti, B.K. <EM>et al.</EM>, 1984.  Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.  <EM>Exp. Eye Res.</EM> 39: 231-259.
<LI>Crawford, W. & Merritt, J.C., 1979.  Effects of tetrahydrocannabinol on arterial and intraocular hypertension.  <EM>Int. J. Clin. Pharmacol. Biopharmacol.</EM> 17: 191-196.
<LI>Green, K. and McDonald, T.F., 1987.  Ocular toxicology of marijuana: an update.  <EM>J. Toxicol.-Cut. and Ocular Toxicol.</EM> 6: 309-334.
<LI>Hepler, R.S. and Frank, I.M. 1971.  Marihuana smoking and intraocular pressure.  <EM>J.A.M.A.</EM> 217: 1392.
<LI>Hepler, R.S. et at., 1976.  Ocular effects of marijuana smoking.  <EM>In</EM> The Pharmacology of Marijuana, Braude, M.C., and Szara, S., Eds., Raven Press, New York, p. 813.
<LI>Levitt, M. et at., 1981.  Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta-9-tetrahydrocannabinol in cancer chemotherapy: ophthalmologic implications.  <EM>J. Clin. Pharmacol.</EM> 21: 103S.
<LI>Merritt, J.C. et at., 1980.  Effect of marijuana on intraocular and blood pressure in glaucoma.  <EM>Ophthalmology</EM> 87: 222.
<LI>Merritt, J.C. et at., 1981.  Topical delta-9-tetrahydrocannabinol in hypertensive glaucomas.  <EM>J. Pharm. Pharmacol.</EM> 33: 40-41.
<LI>Merritt, J.C. et at., 1981.  Topical delta-9-tetrahydrocannabinol and aqueous dynamics in glaucoma.  <EM>J. Clin. Pharmacol.</EM> 21: 467S-471S.
<LI>Merritt, J.C. et at., 1980.  Oral delta-9-tetrahydrocannabinol in heterogenous glaucomas.  <EM>Ann. Opthalmol.</EM> 12: 8.
<LI>Merritt, J.C. et at., 1982.  Topical delta-9-tetrahydrocannabinol as a potential glaucoma agent.  <EM>Glaucoma</EM> 4: 253-255.
<LI>Shapiro, D., 1974.  The ocular manifestation of the cannabinoids.  <EM>Ophthalmologia</EM> 168: 366-369.
</UL>

<P><STRONG>Inflammation and Swelling</STRONG>
<UL>
<LI>Barret, M.L. <EM>et al.</EM>, 1985.  Isolation from <EM>Cannabis sativa</EM> L. of Cannflavon-a novel inhibitor or prostaglandin production.  <EM>Biochem. Pharmacol.</EM> 34: 2019.
<LI>Burstein, S.H. <EM>et al.</EM>, 1989.  Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid.  <EM>J. Pharmacol. Exp. Therap.</EM> 251: 531-535.
<LI>Evans, A.T. <EM>et al.</EM>, 1987.  Actions of Cannabis constituents on enzymes or arachidonate metabolism: anti-inflammatory potential.  <EM>Biochem. Pharmacol.</EM> 36: 2037-2040.
<LI>Formukong, E.A. <EM>et al.</EM>, 1987.  Cannabinoids, the active constituents of Cannabis sativa L. inhibit both human and rabbit platelet aggregation.  <EM>Br. J. Pharmacol.</EM> 92(S): 601.
<LI>Formukong, E.A. <EM>et al.</EM>, 1989.  The inhibitory effects of cannabinoids, the active constituents of <EM>Cannabis sativa</EM> L. on human and rabbit platelet aggregation.  <EM>J. Pharm. Pharmacol.</EM> 41: 705-709.
<LI>Formukong, E.A. <EM>et al.</EM>, 1988.  Analgesic and anti-inflammatory activity of constituents of <EM>Cannabis sativa</EM> L.  <EM>Inflammation</EM> 12: 361-371.
<LI>Sofia, R.D. <EM>et al.</EM>, 1973.  Antiedemic and analgesic properties of delta-9-tetrahydrocannabinol compared with three other drugs.  <EM>Eur. J. Pharmacol.</EM> 35: 7-16.
<LI>Sofia, R.D. <EM>et al.</EM>, 1974.  Comparative anti-phlogistic activity of delta-9-tetrahydrocannabinol, hydrocortisone and aspirin in various rat paw edema models.  <EM>Life Sci.</EM> 15: 251-260.
</UL>

<P><STRONG>Microbial Infections</STRONG>
<UL>
<LI>Blevins, R.D. and Damie, M.R., 1980.  The effect of delta-9-THC on Herpes simplex virus replication.  <EM>J. Gen. Virol.</EM> 49: 427.
<LI>Dahiya, M.S. and Jain, G.C., 1977.  Antibacterial activity of cannabidiol and tetrahydrocannabinol.  <EM>Indian Drugs Pharm. Ind.</EM> 12: 31-34.
<LI>ElSohly, H.N. <EM>et al.</EM>, 1982.  Synthesis and antimicrobial activity of certain cannabichromene and cannabigerol related compounds.  <EM>J. Pharm. Sci.</EM> 71: 1319-1323.
<LI>Ferenczy, L. et at., 1958.  An antibacterial preparatum from hemp (<EM>Cannabis sativa</EM> L.).  <EM>Naturwissenschaften.</EM> 45: 188.
<LI>Grlic, L., 1962.  A comparative study on some chemical and biological characteristics of various samples of <EM>Cannabis</EM> resin.  <EM>Bull. Narc.</EM> 14: 37-46.
<LI>Kabelik, J. <EM>et al.</EM>, 1960.  <EM>Cannabis</EM> as a medicament.  <EM>Bull. Narc.</EM> 12: 5.
<LI>Krejci, Z., 1958.  Hanf (<EM>Cannabis sativa</EM>)- Antibiotisches heilmittel.  2. Methodik und ergebnisse der bakteriologischen untersuchungen und vorlaufige klinische erfahrungen.  <EM>Pharmazie</EM> 13: 155-164.
<LI>Krejci, Z., 1970.  Changes with maturation in amounts of biologically interesting substances of <EM>Cannabis</EM>.  <EM>In</EM> The Botany and Chemistry of <EM>Cannabis</EM>, Proc. Conf., Joyce, C.R.B., Ed., J. & A. Churchill, London, pp. 49-55.
<LI>Krejci, Z., 1961.  The problem of substances with antibacterial action: <EM>Cannabis</EM> effect.  <EM>Casop. Lek. Cesk.</EM> 43: 1341-1354.
<LI>Martinec, T. and Felklova, M., 1959.  Einfluss veraschiedener dungung suf die antibakterielle aktivitat des hanfes, <EM>Cannabis sativa</EM> L.  <EM>Pharmazie</EM> 14: 276-279.
<LI>Martinec, T. and Felkiova, M., 1959.  Veranderungen der antibakteriellen aktivitat im verlaus der individuellen entwicklung des hanfes (<EM>Cannabis sativa</EM> L.).  <EM>Pharmazie</EM> 14: 279-281.
<LI>Radosevic, A. <EM>et al.</EM>, 1962.  Antibiotic activity of various types of <EM>Cannabis</EM> resin.  <EM>UN Secretariat Doc.</EM> ST/SOA/SER.S/6. 9 Jan. 25.
<LI>Radosevic, A. <EM>et al.</EM>, 1962.  Antibiotic activity of various types of <EM>Cannabis</EM> resin.  <EM>Nature</EM> 195: 1007-1009.
<LI>Van Kingeren, B. and Ten Ham, M., 1976.  Antibacterial activity of delta-9-THC and cannabidiol.  <EM>Ant. van Leeuw. J. Microbiol. Serol.</EM> 42: 9.
</UL>

<P><STRONG>Movement Disorders</STRONG>
<UL>
<LI>Consroe, P. <EM>et al.</EM>, 1986.  Open label evaluation of cannabidiol in dystonic movement disorders.  <EM>Int. J. Neurosci.</EM> 30: 277-282.
<LI>Consroe, P. <EM>et al.</EM>, 1991.  Controlled clinical trial of cannabidiol in Huntington's disease.  <EM>Pharmacol. Biochem. Behav.</EM> 40: 701-708.
<LI>Frankel, J.P. <EM>et al.</EM>, 1990.  Marijuana for Parkinsonian tremor.  <EM>J. Neurol. Neurosurg. Psychiatry</EM> 53: 436.
<LI>Hemming, M. and Yellowle, P.M., 1993.  Effective treatment of Tourette's-Syndrome with marijuana.  <EM>J. Psychopharmacol.</EM> 7: 389-391.
<LI>Moss, D.E. <EM>et al.</EM>, 1989.  Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders.  <EM>Life Sci.</EM> 44: 1521-1525.
<LI>Ruchman, M.C., 1988.  Role of cannabidiol in the medical treatment of Meige's syndrome.  <EM>Ear Nose Throat J.</EM> 67: 919.
<LI>Sandyk, R. <EM>et al.</EM>, 1986.  Cannabidiol in dystonic movement disorders.  <EM>Psychiatry Res.</EM> 18: 291.
<LI>Snider, S.R. and Consroe, P., 1984.  Treatment of Meige syndrome with cannabidiol.  <EM>Neurology</EM> 34(S1): 147.
<LI>Snider, S.R. and Consroe, P., 1985.  Beneficial and adverse effects of cannabidiol in a Parkinson patient with sinemet-induced dystonic dyskinesia.  <EM>Neurology</EM> 35(S1): 201.
</UL>

<P><STRONG>Multiple Sclerosis, Spasticity and other Neuromuscular Disorders</STRONG>
<UL>
<LI>Clifford, David B., 1983.  Tetrahydrocannabinol for tremor in Multiple Sclerosis.  <EM>Ann. Neurol.</EM> 13: 669-671.
<LI>Dunn, M. and Davis, R., 1974.  The perceived effects of marijuana on spinal cord injured males.  <EM>Paraplegia</EM> 12: 175.
<LI>Elkin, R. <EM>et al.</EM>, 1987.  Delta-9-tetrahydrocannabinol: a novel treatment of inflammatory demyelination.  <EM>Fed. Proc.</EM> 46: 1378.
<LI>Greenberg, H.S. <EM>et al.</EM>, 1990.  Marijuana and its effect on postural stability in Multiple Sclerosis patients with controls.  <EM>Neurology</EM> 40(S1): 259.
<LI>Hanigan, W.C. <EM>et al.</EM>, 1986.  The effects of delta-9-tetrahydrocannabinol on human spasticity.  <EM>J. Am. Soc. Clin. Pharmacol.</EM> 39: 198.
<LI>Lyman, W.D. <EM>et al.</EM>, 1989.  Delta-9-tetrahydrocannabinol: A novel treatment for experimental autoimmune encephalitis.  <EM>J. Neuroimmunol.</EM> 23: 73-82.
<LI>Malec, J. <EM>et al.</EM>, 1982.  <EM>Cannabis</EM> effect on spasticity in spinal cord injury.  <EM>Arch. Phys. Med. Rehab.</EM> 63: 116.
<LI>Mauer, M. <EM>et al.</EM>, 1990.  Delta-9-tetrahydrocannabinol shows anti-spastic and analgesic effects in a single case double-blind trial.  <EM>Eur. Arch. Psychiatry Clin. Neurosci.</EM> 240: 1-4.
<LI>Meinck, H.M. <EM>et al.</EM>, 1989.  Effect of cannabinoids on spasticity and ataxia in Multiple Sclerosis.  <EM>J. Neurol.</EM> 236: 120-122.
<LI>Petro, D. 1980.  Marihuana as a therapeutic agent for muscle spasm or spasticity.  <EM>Psychosomatics</EM> 21: 81-85.
<LI>Petro, D. and Ellenberger, C., Jr., 1981.  Treatment of human spasticity with delta-9-tetrahydrocannabinol.  <EM>J. Clin. Pharmacol.</EM> 21: 413S-416S.
<LI>Truong, X.T. and Hanigan, W.C., 1986.  Effect of delta-9-tetrahydrocannabinol on electromyographic measurements in human spasticity.  <EM>J. Am. Soc. Clin. Pharmacol. Therap.</EM> 39: 232.
<LI>Ungerleider, J.T. <EM>et al.</EM>, 1987.  Delta-9-tetrahydrocannabinol in the treatment of spasticity associated with Multiple Sclerosis.  <EM>Adv. Alcohol Subst. Abuse</EM> 7: 39-50.
</UL>

<P><STRONG>Niemann-Pick Disease</STRONG>
<UL>
<LI>Burstein, S. <EM>et al.</EM>, 1984.  Stimulation of sphingomyelin hydrolysis by cannabidiol in fibroblasts from a Niemann-Pick patient.  <EM>Biochem. Biophys. Res. Comm.</EM> 121: 168-173.
</UL>

<P><STRONG>Opiate and Alcohol Addiction</STRONG>
<UL>
<LI>Bhargava, H.N., 1976.  Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent rats.  <EM>Psychopharmacology</EM> 49: 267.
<LI>Carder, B., 1975.  Blockage of morphine abstinence by delta-9-THC.  <EM>Science</EM> 190: 590.
<LI>Hine, B. <EM>et al.</EM>, 1975.  Morphine-dependent rats: blockage of precipitated abstinence by THC.  <EM>Science</EM> 187: 443.
<LI>Mikuriya, T., 1970.  <EM>Cannabis</EM> substitution: an adjunctive tool in the treatment of alcoholism.  <EM>Med. Times</EM> 98: 187-191.
<LI>Rosenberg, C., 1976.  The use of marijuana in the treatment of alcoholism.  <EM>In</EM> The Therapeutic Potential of Marijuana, Cohen and Stillman, Eds., Plenum Press, New York, pp. 173-185.
<LI>Rosenberg, C.M. <EM>et al.</EM>, 1978.  <EM>Cannabis</EM> in the treatment of alcoholism.  <EM>J. Stud. Alcohol</EM> 39: 155.
<LI>Scher, J., 1971.  Marijuana as an agent in rehabilitating alcoholics.  <EM>Am. J. Psychiatry</EM> 127: 971-972.
</UL>


<P><STRONG>Pain</STRONG>
<UL>
<LI>Harris, L., 1976.  Analgesic and antitumor potential of the cannabinoids.  <EM>In</EM> The Therapeutic Potential of Marijuana, Cohen and Stillman, Eds., Plenum Press, New York, pp. 299-305.
<LI>Milstein, S.L. <EM>et al.</EM>, 1975.  Marijuana-produced changes in pain tolerance: experienced and non-experienced subjects.  <EM>Int. Pharmacopsychiatry</EM> 10: 177-182.
<LI>Noyes, S.J., Jr. and Baram, D.A., 1974.  <EM>Cannabis</EM> analgesia.  <EM>Compr. Psychiatry</EM> 15: 5.
<LI>Noyes, S.J., Jr. <EM>et al.</EM>, 1975.  The analgesic properties of delta-9-tetrahydrocannabinol and codeine.  <EM>Clin. Pharmacol. Ther.</EM> 18: 84-89.
<LI>Noyes, S.J., Jr. <EM>et al.</EM>, 1975.  The analgesic effect of delta-9-tetrahydrocannabinol.  <EM>J. Clin. Pharamacol.</EM> 15: 139.
<LI>Volfe, Z. <EM>et al.</EM>, 1985.  Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients.  <EM>Int. J. Clin. Pharm. Res.</EM> 5: 243-246.
<LI>Zeidenberg, P., <EM>et al.</EM>, 1973.  Effect of oral administration of delta-9-tetrahydrocannabinol on memory, speech and perception of thermal stimulation: results with four normal human subjects.  Preliminary report.  <EM>Compr. Psychiatry</EM> 14: 549.
</UL>

<P><STRONG>Ulcers</STRONG>
<UL>
<LI>Bateman, D.N., 1987.  Delta-9-tetrahydrocannabinol and gastric emptying.  <EM>Br. J. Clin. Pharmacol.</EM> 15: 139.
<LI>Douthwaite, A.H., 1947.  Choice of drugs in the treatment of duodenal ulcer.  <EM>Br. Med. J.</EM> 43: 4514.
<LI>Nalin, D.R. <EM>et al.</EM>, 1978.  <EM>Cannabis</EM>, hypochlrohydria and cholera.  <EM>Lancet</EM> 2: 859.
<LI>Sofia, R.D. <EM>et al.</EM>, 1978.  Evaluation of antiulcer activity of delta-9-tetrahydrocannabinol in the Shay rat test.  <EM>Pharmacology</EM> 17: 173.
</UL>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT01-B18-287</DOCNO>
<DOCOLDNO>IA087-000632-B043-104</DOCOLDNO>
<DOCHDR>
http://206.61.184.43:80/olsen/MEDICAL/bmj.html 206.61.184.43 19970122072509 text/html 12402
HTTP/1.0 200 OK
Date: Wednesday, 22-Jan-97 07:25:00 GMT
Server: WebSitePro/1.1f (S/N wpo-0deb)
Allow-ranges: bytes
Content-type: text/html
Last-modified: Sunday, 01-Dec-96 18:04:08 GMT
Content-length: 12186
</DOCHDR>
<HTML>
<HEAD><TITLE>British Medical Journal</TITLE>
<META NAME="AUTHOR" CONTENTS="American Public Health Association">
<META NAME="SUMMARY" CONTENTS="Access to Therapeutic Marijuana">
<META NAME="KEYWORDS" CONTENTS="Marijuana, marijuana, Cannabis, cannabis">
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#FF0000" ALINK="#FF00FF">
<TT><B>BRITISH MEDICAL JOURNAL</B>
<BR>Volume 311, December 23-30, 1995

<P>Editorial:
<P><B>The war on drugs
<P>Prohibition isn't working
<BR>some legalisation will help.</B>

<P><DD>Drugs, says psychiatrist Thomas Szasz, have taken over the lead role from sex in the "the grand morality play of human existence.&nbsp;  "No longer, says Szasz, "are men, women, and children tempted, corrupted, and ruined by the irresistibly sweet pleasures of sex; instead, they are tempted, corrupted, and ruined by the irresistibly sweet pleasures of drugs."<SUP><SMALL><A HREF="#1">1</A></SMALL></SUP>&nbsp;   Because dealing with drugs is viewed as a moral problem, politicians tend to compete in their zeal to banish the evil from the kingdom.&nbsp;  Those who talk of legalisation are dismissed as mavericks, and whipped back into line.  The British government's drug strategy for the next three years states baldly "There will be no legalisation of any currently controlled drugs."<SUP><SMALL><A HREF="#2">2</A></SMALL></SUP>&nbsp;  But some legalisation would help.
<DD>The politicians fighting the jihad against drugs want to obliterate the enemy.&nbsp;  They, of course, make an exception for legal drugs like alcohol, nicotine, and caffeine; indeed, British government last week recommended tee totallers take up drinking alcohol for the good of their health.<SUP><SMALL><A HREF="#3">3</A></SMALL></SUP>&nbsp;  Yet a world devoid of drugs seems as unlikely as a world devoid of poverty and sin.&nbsp;  Thomas Sydenham observed 300 years ago "Among the remedies which it has pleased Almighty God to give to man to relieve his sufferings, none is so universal and so efficacious as opium"<SUP><SMALL><A HREF="#4">4</A></SMALL></SUP>; and Aldous Huxley wrote "That humanity at large will ever be able to dispense Artificial Paradises seems very unlikely.&nbsp;  Most men women lead lives at the worst so painful, at the best monotonous, poor and limited that the urge to escape longing to transcend themselves if only for a few moments, is and has always been one of the principal appetites of the soul."<SUP><SMALL><A HREF="#5">5</A></SMALL></SUP>
<DD>If we accept that a world without drugs is unachievable (and probably intolerable) then the important question, argues drug policy expert Ethan Nadelmann, becomes "What are the best means to regulate the production, distribution and consumption of the great variety of psychoactive substances available today and in the foreseeable future?"<SUP><SMALL><A HREF="#6">6</A></SMALL></SUP>&nbsp;  To reduce the debate to arguments between "prohibitionists" and "legalisers" is to oversimplify, but it's a useful device for beginning to understand the issues.&nbsp;  The case for legalising drugs begins with the failure of current prohibitionist policies.&nbsp;  The United States has been conducting a "war on drugs" for seven decades, during which time there have been steady increases in seizures of illegal drugs, the numbers of people using drugs, and the health and social costs of drug taking.&nbsp;  Economists argue from first principles that the war on drugs must fail.&nbsp;  Any success in reducing the supply will raise the price of illegal drugs.&nbsp;  Addicts must then commit more crime to feed their habit; and a rise in the profit margins of drug smugglers urges them on to greater efforts.
<DD>The history of the drug trade is that supply always meets demand.&nbsp;  Milton Friedman, the Nobel prize winning economist, puts it thus: "Illegality creates obscene profits that finance the murderous tactics of the drug lords; illegality leads to the corruption of law enforcement officials; illegality monopolises the efforts of honest law forces so that they are starved of resources to fight the simpler crimes of robbery, theft and assault."<SUP><SMALL><A HREF="#7">7</A></SMALL></SUP>&nbsp;  The main result of the United States war on drugs is a prison system bursting with petty drug offenders, most of them African-Americans.
<DD>Britain has never been as warlike as the United States in efforts to control drugs.&nbsp;  British policy is, however, essentially prohibitionist, and yet about seven million people in Britain have taken cannabis at some time in their lives.<SUP><SMALL><A HREF="#8">8</A></SMALL></SUP>&nbsp;  About a quarter to a third of young people have tried solvents or illegal drugs by their 20th  birthday<SUP><SMALL><A HREF="#9">9</A></SMALL></SUP>, and in one survey the proportion of young people who had been offered drugs rose from 2% in 1969 to 41% in 1994.<SUP><SMALL><A HREF="#9">9</A></SMALL></SUP>&nbsp;  LSD and ecstasy have now also been absorbed into mainstream youth culture, with about 9% of those aged 16 to l9 having used ecstasy and about 8% LSD.<SUP><SMALL><A HREF="#9">9</A></SMALL></SUP>&nbsp;  These high reported prevalences are likely to be true because seizures of cannabis more than tripled from 23,592 in 1984 to 107,629 in 1994, ecstasy seizures increased from 39 in 1989 to 715 in 1994, and heroin seizures rose from 2,995 in 1984 to 4,480 in 1994.<SUP><SMALL><A HREF="#10">10</A></SMALL></SUP>

<P><B>Time to consider going Dutch?</B>
<DD>Other countries have been more willing to experiment with decriminalisation and legalization.&nbsp;  The Netherlands effectively decriminalised penal possession of drugs in 1976, and cannabis is sold in "coffee shops."&nbsp;  The Dutch are now coming under great pressure to reverse their experiment from neighbouring countries, worried that they are being flooded with drugs from the Netherlands.&nbsp;  Yet the 1976 changes in the Netherlands seem to have been followed by a fall in use of cannabis: from 13 % of those aged 17-18 in 1976 to 6% in 1985.&nbsp;  Monthly prevalence of cannabis use among Dutch high school students is around 5.4% compared with 29% in the United States.<SUP><SMALL><A HREF="#11">11</A></SMALL></SUP>&nbsp;  Forbidden fruit may, indeed, be sweetest.
<DD>One simple argument for criminalising drugs is often used  by governments in the context of tobacco: that the state has no right to interfere with what individuals do in private so long as they don't harm others.&nbsp;  Another argument is that legalisation would cut the huge costs of enforcement, prosecution, and imprisonment.&nbsp;  Thirdly, a legal market could allow quality control of drugs and education on how to avoid them or use them more safely; drugs might more predictably be prevented from reaching the young and vulnerable.&nbsp;  Finally, many of the adverse health effects of drugs stem from criminalisation rather than from the drugs themselves.&nbsp;  Anyway, current policy is clearly not driven by totting up the good and bad effects of drugs: few are more harmful than tobacco.
<DD>Although the arguments for legalisation can be expressed forcefully, almost nobody argues for a free, legal, unregulated market for all drugs, and clearly no single policy will cover all drugs.&nbsp;  Nadelmann says: "It is imperative that any drug policy distinguishes between casual use that results in little or no harm to anyone, drug misuse that causes harm primarily to the consumer, and drug misuse that results in palpable harm to others - and then focuses primarily on the last of these, secondarily on preventing the misuse of drugs, and little at all on casual drug use."<SUP><SMALL><A HREF="#6">6</A></SMALL></SUP>
<DD>The key question is how the world would look if drugs were legal.&nbsp;  The Australian National Task Force on Cannabis has identified five options for cannabis legislation: total prohibition; prohibition with civil penalties; partial prohibition; regulation of the production, distribution, and sale of cannabis; and free availability.<SUP><SMALL><A HREF="#12">12</A></SMALL></SUP>&nbsp;  The task force opted for keeping possession, cultivation, and sale in any quantity illegal but decriminalising "simple personal use or possession ... without compromising activities aimed at deterring cannabis use."&nbsp;  Others - for instance, economist Richard Stevenson have tried to describe a world where large companies produce, distribute, and advertise drugs like heroin and cocaine and invest heavily in research designed to produce drugs that will satisfy customers' wants while making them safer.<SUP><SMALL><A HREF="#13">13</A></SMALL></SUP>&nbsp;  Much more work needs to be done on envisaging a world that includes some legalisation of drugs.&nbsp;  But it's clear that purely prohibitionist policies don't work and make the problems of drug abuse worse.
<DD>Governments worldwide have followed illogical and often counterproductive drug policies, primarily because drug use is seen in moral terms.&nbsp;  Wars on drugs are doomed to failure, but experiments with decriminalising and even legalising drugs - as in the Netherlands - have shown promising results.&nbsp;  Policies that allow some decriminalisation and legalisation are much more likely than prohibition to succeed in achieving everybody's aim of minimising the harm from drug abuse.

<P>RICHARD  SMITH, Editor
<BR>British Medical Journal
<BR>BMJ, London WC1H 9JR
<BR>BMJ volume 311 23-3O DECEMBER 1995</TT>
<FONT SIZE=-1><OL>
<A NAME="1"><LI></A>Szasz T.&nbsp;  The morality of drug controls.  In: Hamowy R, ed.&nbsp;  <I>Dealing with drugs: consequences of government control.</I>  Lexington, Mass: Lexington, 1987
<A NAME="2"><LI></A>Lord President of the Council and Leader of the House of Commons, Secretary of State for the Home Department, Secretary of State for Health, Secretary of State for Health, Secretary of State for Education, and the Paymaster General.&nbsp;  <I>Tackling drugs together: a strategy for England for 1995-98.</I>&nbsp;  London: HMSO, 1995.
<A NAME="3"><LI></A>Interdepartemental Working Group.&nbsp;  <I>Sensible Drinking.</I>&nbsp;  London: department of Health,1995.
<A NAME="4"><LI></A>Sydenham T.&nbsp;  Quoted from: Merry J.&nbsp;  A short history of narcotic addiction and the case for regulated legislation.  In: Stevenson R.&nbsp;  <I>Winning the war on drugs: to legalise or not.</I>&nbsp;  London: Institute for Economic Affairs, 1994.
<A NAME="5"><LI></A>Huxley A.&nbsp;  <I>The doors of perception and heaven and hell.</I>&nbsp;  London: Penguin, 1959
<A NAME="6"><LI></A>Nadelmann E.A.&nbsp;  Progressive legalisers, progressive prohibitionists and the reduction of drug related harm.&nbsp;  In: Heather N, Wodak A, Nadelmann E, and O'Hare P, eds.&nbsp;  <I>Psychoactive drugs and harm reduction: from faith to science.</I>&nbsp;  London: Whurr, 1993.
<A NAME="7"><LI></A>Friedman M.&nbsp;  An open letter to Bill Bennett.&nbsp;  <I>Wall Street Journal</I> 1989; 7 September.&nbsp;  A14
<A NAME="8"><LI></A>Baker O, Marsden J.&nbsp;  Institute for the Study of Drug Dependence.&nbsp;  <I>Drug misuse in Britain 1994.</I>&nbsp;  London ISSD, 1994.
<A NAME="9"><LI></A>Wright JD, Pearl L.&nbsp;  Knowledge and experience of young people regarding drug abuse, 1969-94.&nbsp;  <I>BMJ</I> 1995; 310:20-4
<A NAME="10"><LI></A>Anonymous.&nbsp;  Statistics of drug seizures and offenders dealt with, United Kingdom, 1994.&nbsp;  Statistical Bulletin 1995: Issue 24/95.&nbsp;  (ISSN 0143 6384).
<A NAME="11"><LI></A>Morgan JP, Riley D, Chesher GB.&nbsp;  Cannabis: legal reform, medicinal use and harm reduction.&nbsp;  In: Heather N, Wodak A, Nadelmann E, and O'Hare P, eds.&nbsp;  <I>Psychoactive drugs and harm reduction: from faith to science.</I>&nbsp;  London: Whurr, 1993
<A NAME="12"><LI></A>Ali R, Christie P.&nbsp;  <I>Report of the National Task Force on Cannabis.</I>&nbsp;  Canberra: Australian Government Publishing Service, 1994.
<A NAME="13"><LI></A>Stevenson R.&nbsp;  <I>Winning the war on drugs: to legalise or not.</I>&nbsp;  London: Institute for Economic Affairs, 1994.
</OL></FONT>
</BODY>
</HTML>
</DOC>
